cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
KIRC	cis	1	rs1000113	chr5:150240076	IRGM	chr5:150226085-150280295:+	0.62	8.07	5.25E-15	Crohn's disease	
KIRC	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.34	4.31	1.93E-5	Crohn's disease	
KIRC	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.45	7.21	2.09E-12	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs10002541	chr4:56395011	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.85	0.000131	Personality dimensions	
KIRC	cis	1	rs10002541	chr4:56395011	TMEM165	chr4:56262090-56292342:+	0.22	6.04	2.93E-9	Personality dimensions	
KIRC	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.47	8.92	8.67E-18	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs10005989	chr4:56405206	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.89	0.000114	Personality dimensions	
KIRC	cis	1	rs10005989	chr4:56405206	TMEM165	chr4:56262090-56292342:+	0.23	6.41	3.43E-10	Personality dimensions	
KIRC	cis	1	rs10006789	chr4:1330333	CRIPAK	chr4:1385340-1389782:+	0.25	6.07	2.48E-9	Systolic blood pressure	
KIRC	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.52	-10.75	2.12E-24	Longevity	
KIRC	cis	1	rs10009541	chr4:17682218	LAP3	chr4:17578927-17609590:+	0.21	6.41	3.3E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10009541	chr4:17682218	MED28	chr4:17616273-17629791:+	-0.16	-3.53	0.000451	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10009741	chr4:75711506	BTC	chr4:75671448-75719882:-	0.27	3.53	0.000451	Electroencephalogram traits	
KIRC	cis	1	rs10011647	chr4:75711216	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs10011865	chr4:17645710	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.72E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10011865	chr4:17645710	MED28	chr4:17616273-17629791:+	0.18	3.99	7.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10012335	chr4:17628630	LAP3	chr4:17578927-17609590:+	-0.2	-6.1	2.17E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10012335	chr4:17628630	MED28	chr4:17616273-17629791:+	0.23	5.27	2.04E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10014189	chr4:75710935	BTC	chr4:75671448-75719882:-	-0.27	-3.79	0.000168	Electroencephalogram traits	
KIRC	cis	1	rs1001446	chr19:32900957	ZNF507	chr19:32836514-32878571:+	0.16	3.56	0.000406	Bipolar disorder	
KIRC	cis	1	rs10015752	chr4:108891445	HADH	chr4:108910940-108956330:+	0.26	3.68	0.000255	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs10016506	chr4:56396674	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.9	0.000108	Personality dimensions	
KIRC	cis	1	rs10016506	chr4:56396674	TMEM165	chr4:56262090-56292342:+	0.22	6.02	3.41E-9	Personality dimensions	
KIRC	cis	1	rs10018049	chr4:39117401	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs10019681	chr4:89832532	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.59	0.000357	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10019856	chr4:17615742	LAP3	chr4:17578927-17609590:+	-0.21	-6.55	1.4E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10019856	chr4:17615742	MED28	chr4:17616273-17629791:+	0.23	5.29	1.85E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10023155	chr4:108890626	HADH	chr4:108910940-108956330:+	0.25	3.53	0.000458	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs10023907	chr4:88772535	MEPE	chr4:88754140-88767942:+	-0.22	-4.35	1.61E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.16	4.31	1.93E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.15	-4.01	7.05E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs10026775	chr4:39116775	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.42	7.37	6.95E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs10027437	chr4:103557251	MANBA	chr4:103552644-103682151:-	0.16	3.68	0.000256	Primary biliary cirrhosis	
KIRC	cis	1	rs10027755	chr4:17615954	LAP3	chr4:17578927-17609590:+	-0.22	-6.72	5.0E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10027755	chr4:17615954	MED28	chr4:17616273-17629791:+	0.19	4.3	2.04E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10027813	chr4:39121438	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs10028589	chr4:89841060	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.53	0.00046	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10028679	chr4:89841170	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.53	0.00046	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10030904	chr4:39115223	WDR19	chr4:39184024-39287429:+	0.19	4.96	9.76E-7	Uric acid levels	
KIRC	cis	1	rs10032326	chr4:17630717	LAP3	chr4:17578927-17609590:+	-0.2	-6.08	2.43E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10032326	chr4:17630717	MED28	chr4:17616273-17629791:+	0.24	5.47	7.09E-8	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10034433	chr4:56421176	SRD5A3	chr4:56212409-56237866:+	-0.18	-4.04	6.23E-5	Personality dimensions	
KIRC	cis	1	rs10034433	chr4:56421176	TMEM165	chr4:56262090-56292342:+	0.22	6.23	1.01E-9	Personality dimensions	
KIRC	cis	1	rs10035646	chr5:115534974	COMMD10	chr5:115420727-115628978:+	0.35	4.15	3.87E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10036292	chr5:115595871	COMMD10	chr5:115420727-115628978:+	0.33	3.78	0.000178	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10037055	chr5:176691279	PRELID1	chr5:176730835-176733949:+	-0.13	-3.78	0.000173	Migraine without aura	
KIRC	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.39	-8.82	1.94E-17	Eye color traits	
KIRC	cis	1	rs1003719	chr21:38491095	TTC3	chr21:38445571-38575406:+	0.19	3.88	0.00012	Eye color traits	
KIRC	cis	1	rs10041072	chr5:150259642	IRGM	chr5:150226085-150280295:+	0.48	6.71	5.26E-11	Crohn's disease	
KIRC	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.31	4.32	1.87E-5	Crohn's disease	
KIRC	cis	1	rs10042278	chr5:115532928	COMMD10	chr5:115420727-115628978:+	0.35	4.15	3.87E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10043228	chr5:115597048	COMMD10	chr5:115420727-115628978:+	0.33	3.78	0.000178	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1004467	chr10:104594507	SFXN2	chr10:104474298-104498946:+	-0.28	-3.65	0.000289	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs1004909	chr16:48725580	ABCC11	chr16:48200822-48281479:-	-0.2	-3.54	0.000436	Response to tocilizumab in rheumatoid arthritis	
KIRC	cis	1	rs10050159	chr4:106765915	INTS12	chr4:106603787-106629881:-	-0.55	-6.64	7.92E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs10050333	chr4:106765813	INTS12	chr4:106603787-106629881:-	-0.55	-6.64	7.92E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs10051240	chr5:115569931	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.82	16.48	4.18E-49	Type 2 diabetes	
KIRC	cis	1	rs10051804	chr5:150226424	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs10051924	chr5:150226639	IRGM	chr5:150226085-150280295:+	0.53	7.22	1.9E-12	Crohn's disease	
KIRC	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.37	5.06	6.03E-7	Crohn's disease	
KIRC	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.16	4.12	4.5E-5	Large artery stroke	
KIRC	cis	1	rs10052606	chr5:150272217	IRGM	chr5:150226085-150280295:+	0.49	6.71	5.23E-11	Crohn's disease	
KIRC	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.31	4.1	4.76E-5	Crohn's disease	
KIRC	cis	1	rs10053750	chr5:150270051	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs10055868	chr5:115471612	COMMD10	chr5:115420727-115628978:+	0.33	3.87	0.000124	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10056340	chr5:110190052	CAMK4	chr5:110559648-110820746:+	0.19	4.04	6.25E-5	Asthma and hay fever	
KIRC	cis	1	rs10056340	chr5:110190052	TMEM232	chr5:109624934-110062381:-	0.2	3.86	0.00013	Asthma and hay fever	
KIRC	cis	1	rs10057988	chr5:150272062	IRGM	chr5:150226085-150280295:+	0.49	6.71	5.23E-11	Crohn's disease	
KIRC	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.31	4.1	4.76E-5	Crohn's disease	
KIRC	cis	1	rs10058821	chr5:150226385	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs10058943	chr5:150226586	IRGM	chr5:150226085-150280295:+	0.53	7.22	1.9E-12	Crohn's disease	
KIRC	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.37	5.06	6.03E-7	Crohn's disease	
KIRC	cis	1	rs10061105	chr5:150255185	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs10062350	chr5:115453497	COMMD10	chr5:115420727-115628978:+	0.38	3.97	8.08E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10063647	chr5:127371588	SLC12A2	chr5:127419483-127525379:+	0.13	3.79	0.00017	Height	
KIRC	cis	1	rs10065172	chr5:150227998	IRGM	chr5:150226085-150280295:+	0.54	7.37	6.86E-13	Crohn's disease	
KIRC	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.38	5.08	5.43E-7	Crohn's disease	
KIRC	cis	1	rs10066259	chr5:115451892	COMMD10	chr5:115420727-115628978:+	0.34	3.75	0.000195	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1006722	chr4:17618713	LAP3	chr4:17578927-17609590:+	0.21	6.55	1.41E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1006722	chr4:17618713	MED28	chr4:17616273-17629791:+	-0.18	-4.08	5.32E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10069077	chr5:110170026	TMEM232	chr5:109624934-110062381:-	-0.35	-5.19	3.06E-7	Mortality in heart failure	
KIRC	cis	1	rs1007133	chr10:38225293	LOC399744	chr10:38717074-38741080:+	-0.23	-3.57	0.000389	Obesity (extreme)	
KIRC	cis	1	rs10073364	chr5:115592582	COMMD10	chr5:115420727-115628978:+	0.33	3.78	0.000178	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10073425	chr5:110163206	TMEM232	chr5:109624934-110062381:-	0.23	4.28	2.21E-5	Asthma and hay fever	
KIRC	cis	1	rs10076701	chr5:131596419	PDLIM4	chr5:131593351-131609145:+	-0.22	-4.25	2.5E-5	Blood metabolite levels	
KIRC	cis	1	rs10078157	chr5:174972372	FAF2	chr5:175875356-175937074:+	-0.21	-3.69	0.000249	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs10078968	chr5:150244273	IRGM	chr5:150226085-150280295:+	0.53	7.31	1.08E-12	Crohn's disease	
KIRC	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.11E-7	Crohn's disease	
KIRC	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.31	5.15	3.79E-7	Fat distribution (HIV)	
KIRC	cis	1	rs10079394	chr5:115600919	COMMD10	chr5:115420727-115628978:+	0.34	3.86	0.000127	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10079417	chr5:79143194	LOC441089	chr5:79646424-79647785:-	0.18	3.7	0.000241	Toenail selenium levels	
KIRC	cis	1	rs10080429	chr6:109738106	AKD1	chr6:109814059-110012415:-	-0.25	-5.25	2.23E-7	Height	
KIRC	cis	1	rs10080429	chr6:109738106	SMPD2	chr6:109761931-109765121:+	0.17	4.18	3.47E-5	Height	
KIRC	cis	1	rs1008150	chr12:47810290	PFKM	chr12:48499706-48539887:+	0.23	3.83	0.000146	Metabolite levels (HVA/5-HIAA ratio)	
KIRC	cis	1	rs10083343	chr14:65853133	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs10083346	chr14:65853273	LOC645431	chr14:65877313-65879335:-	-0.43	-5.92	5.97E-9	Ischemic stroke	
KIRC	cis	1	rs10083348	chr14:65853401	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs10083421	chr14:65851158	LOC645431	chr14:65877313-65879335:-	-0.43	-5.89	6.91E-9	Ischemic stroke	
KIRC	cis	1	rs10083485	chr14:65853114	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs10083488	chr14:65853346	LOC645431	chr14:65877313-65879335:-	-0.45	-6.23	9.99E-10	Ischemic stroke	
KIRC	cis	1	rs10083525	chr14:65851556	LOC645431	chr14:65877313-65879335:-	0.42	5.78	1.33E-8	Ischemic stroke	
KIRC	cis	1	rs1008374	chr4:17683219	LAP3	chr4:17578927-17609590:+	-0.22	-6.67	6.59E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1008374	chr4:17683219	MED28	chr4:17616273-17629791:+	0.17	3.7	0.000243	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1008375	chr4:17682834	LAP3	chr4:17578927-17609590:+	-0.21	-6.3	6.62E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1008375	chr4:17682834	MED28	chr4:17616273-17629791:+	0.2	4.41	1.27E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10084773	chr4:108922798	HADH	chr4:108910940-108956330:+	-0.26	-3.54	0.000432	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs10086327	chr8:89406955	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10087268	chr8:89414888	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10088380	chr8:89416018	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10089941	chr8:89420861	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs1009051	chr3:49521549	CCDC36	chr3:49235861-49295537:+	0.26	4.98	8.8E-7	Menarche (age at onset)	
KIRC	cis	1	rs1009051	chr3:49521549	NCKIPSD	chr3:48711280-48723334:-	0.21	4.18	3.45E-5	Menarche (age at onset)	
KIRC	cis	1	rs1009051	chr3:49521549	P4HTM	chr3:49027341-49044579:+	0.18	4.04	6.17E-5	Menarche (age at onset)	
KIRC	cis	1	rs1009051	chr3:49521549	WDR6	chr3:49044637-49053386:+	-0.2	-5.23	2.43E-7	Menarche (age at onset)	
KIRC	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.24	-3.6	0.000345	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs1009242	chr9:131916832	SET	chr9:131445934-131458674:+	-0.16	-3.53	0.000458	Blood metabolite ratios	
KIRC	cis	1	rs10093191	chr8:89411565	MMP16	chr8:89049462-89339717:-	0.29	3.81	0.000159	Electrodermal activity	
KIRC	cis	1	rs10093818	chr8:89421010	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs10094278	chr8:89414854	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10095262	chr8:89432538	MMP16	chr8:89049462-89339717:-	0.31	4.19	3.26E-5	Electrodermal activity	
KIRC	cis	1	rs10095499	chr8:89432760	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.19E-5	Electrodermal activity	
KIRC	cis	1	rs10096195	chr8:89432587	MMP16	chr8:89049462-89339717:-	-0.29	-4.22	2.85E-5	Electrodermal activity	
KIRC	cis	1	rs10097930	chr8:96025735	C8orf38	chr8:95908040-96088396:+	-0.24	-3.83	0.000146	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs10098145	chr8:110135829	TMEM74	chr8:109619080-109799770:-	-0.18	-3.58	0.000375	Body mass (lean)	
KIRC	cis	1	rs10098453	chr8:96029756	C8orf38	chr8:95908040-96088396:+	0.25	3.86	0.000128	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs10098834	chr8:89430837	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs10099075	chr8:89431248	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs10099233	chr8:89403561	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10099461	chr8:89403715	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10099697	chr8:89418325	MMP16	chr8:89049462-89339717:-	0.32	4.23	2.81E-5	Electrodermal activity	
KIRC	cis	1	rs10100089	chr8:96025093	C8orf38	chr8:95908040-96088396:+	-0.27	-4.23	2.74E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs10100842	chr8:96025903	C8orf38	chr8:95908040-96088396:+	-0.24	-3.75	0.000194	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs1010117	chr20:23608421	CST3	chr20:23608536-23618574:-	-0.14	-3.96	8.63E-5	Chronic kidney disease	
KIRC	cis	1	rs10102505	chr8:89416415	MMP16	chr8:89049462-89339717:-	0.32	4.27	2.31E-5	Electrodermal activity	
KIRC	cis	1	rs10103178	chr8:89411050	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10103336	chr8:89403893	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10103474	chr8:89411286	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10103769	chr8:8573036	CLDN23	chr8:8559666-8561616:+	0.22	3.58	0.000371	Obesity-related traits	
KIRC	cis	1	rs10103841	chr8:96025904	C8orf38	chr8:95908040-96088396:+	-0.24	-3.75	0.000194	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs1010447	chr1:11269796	MTOR	chr1:11166589-11322608:-	-0.13	-3.5	0.000516	Body mass index	
KIRC	cis	1	rs10104706	chr8:89406894	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs10109475	chr8:89414848	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10110453	chr8:89432552	MMP16	chr8:89049462-89339717:-	0.3	4.13	4.22E-5	Electrodermal activity	
KIRC	cis	1	rs10110635	chr8:96025069	C8orf38	chr8:95908040-96088396:+	-0.27	-4.22	2.86E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs10111010	chr8:62411161	CLVS1	chr8:62200525-62414202:+	-0.3	-5.27	2.03E-7	Whole-brain volume	
KIRC	cis	1	rs10111179	chr8:89421080	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs10111300	chr8:96025631	C8orf38	chr8:95908040-96088396:+	-0.27	-4.17	3.58E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs10112258	chr8:89414904	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10112810	chr8:89431405	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs10113214	chr8:89432421	MMP16	chr8:89049462-89339717:-	0.31	4.19	3.26E-5	Electrodermal activity	
KIRC	cis	1	rs10113545	chr8:96029707	C8orf38	chr8:95908040-96088396:+	-0.25	-3.86	0.00013	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs1011598	chr3:168913181	GPR160	chr3:169755735-169803181:+	-0.33	-3.84	0.000137	Multiple myeloma (hyperdiploidy)	
KIRC	cis	1	rs1011599	chr3:168912578	GPR160	chr3:169755735-169803181:+	-0.33	-3.86	0.000129	Multiple myeloma (hyperdiploidy)	
KIRC	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.5	-9.74	1.22E-20	Rheumatoid arthritis	
KIRC	cis	1	rs10117059	chr9:123653477	PSMD5	chr9:123578334-123605206:-	-0.35	-6.61	9.73E-11	Rheumatoid arthritis	
KIRC	cis	1	rs1012053	chr13:42653437	EPSTI1	chr13:43462122-43566377:-	0.21	3.95	9.07E-5	Bipolar disorder	
KIRC	cis	1	rs10127539	chr1:110620117	ALX3	chr1:110602998-110613322:-	-0.22	-4.74	2.78E-6	Blood metabolite levels	
KIRC	cis	1	rs10128658	chr11:71733519	C11orf59	chr11:71808339-71814322:-	-0.22	-3.85	0.000133	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1013338	chr22:38974154	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.76	0.000191	Resting heart rate	
KIRC	cis	1	rs1013338	chr22:38974154	LOC646851	chr22:38974125-39052634:-	0.12	3.81	0.000156	Resting heart rate	
KIRC	cis	1	rs10135	chr22:39082174	LOC646851	chr22:38974125-39052634:-	-0.12	-3.75	0.000194	Resting heart rate	
KIRC	cis	1	rs10136440	chr14:104397367	XRCC3	chr14:104163955-104181823:-	0.12	3.55	0.00042	Bipolar disorder	
KIRC	cis	1	rs10136947	chr14:65854611	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs10136948	chr14:75511075	MLH3	chr14:75480467-75518235:-	0.23	5.67	2.44E-8	Height	
KIRC	cis	1	rs10136948	chr14:75511075	NEK9	chr14:75548819-75593778:-	0.14	3.84	0.000139	Height	
KIRC	cis	1	rs10136953	chr14:65854676	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs10137323	chr14:76685733	ESRRB	chr14:76837690-76968178:+	-0.37	-5.05	6.22E-7	Blood pressure	
KIRC	cis	1	rs10138183	chr14:75615227	MLH3	chr14:75480467-75518235:-	0.24	6.22	1.03E-9	Height	
KIRC	cis	1	rs10138183	chr14:75615227	NEK9	chr14:75548819-75593778:-	0.15	4.22	2.87E-5	Height	
KIRC	cis	1	rs10138763	chr14:88457402	GPR65	chr14:88471496-88478414:+	0.12	3.63	0.000314	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs10138765	chr14:65860239	LOC645431	chr14:65877313-65879335:-	-0.45	-6.13	1.79E-9	Ischemic stroke	
KIRC	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.33	-8.54	1.56E-16	Common traits (Other)	
KIRC	cis	1	rs10140851	chr14:75512612	MLH3	chr14:75480467-75518235:-	0.24	5.93	5.66E-9	Height	
KIRC	cis	1	rs10140851	chr14:75512612	NEK9	chr14:75548819-75593778:-	0.14	4.04	6.12E-5	Height	
KIRC	cis	1	rs1014098	chr1:119458215	WARS2	chr1:119573841-119683295:-	-0.26	-4.28	2.25E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10142626	chr14:75555636	MLH3	chr14:75480467-75518235:-	0.23	5.76	1.5E-8	Height	
KIRC	cis	1	rs10142626	chr14:75555636	NEK9	chr14:75548819-75593778:-	0.13	3.74	0.000205	Height	
KIRC	cis	1	rs10142865	chr14:75555624	MLH3	chr14:75480467-75518235:-	0.23	5.76	1.5E-8	Height	
KIRC	cis	1	rs10142865	chr14:75555624	NEK9	chr14:75548819-75593778:-	0.13	3.74	0.000205	Height	
KIRC	cis	1	rs10143132	chr14:75525850	MLH3	chr14:75480467-75518235:-	0.24	5.97	4.54E-9	Height	
KIRC	cis	1	rs10143132	chr14:75525850	NEK9	chr14:75548819-75593778:-	0.14	4	7.29E-5	Height	
KIRC	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.32	-8.72	4.07E-17	Common traits (Other)	
KIRC	cis	1	rs10146374	chr14:65857412	LOC645431	chr14:65877313-65879335:-	-0.44	-5.98	4.31E-9	Ischemic stroke	
KIRC	cis	1	rs10146482	chr14:75574087	MLH3	chr14:75480467-75518235:-	0.23	5.89	7.16E-9	Height	
KIRC	cis	1	rs10146482	chr14:75574087	NEK9	chr14:75548819-75593778:-	0.14	3.94	9.16E-5	Height	
KIRC	cis	1	rs10149651	chr14:104394440	TDRD9	chr14:104394817-104519002:+	-0.25	-3.84	0.000137	Bipolar disorder	
KIRC	cis	1	rs10149651	chr14:104394440	XRCC3	chr14:104163955-104181823:-	0.11	3.52	0.000475	Bipolar disorder	
KIRC	cis	1	rs10149880	chr14:75633008	MLH3	chr14:75480467-75518235:-	-0.23	-5.86	8.27E-9	Height	
KIRC	cis	1	rs10149880	chr14:75633008	NEK9	chr14:75548819-75593778:-	-0.13	-3.82	0.000151	Height	
KIRC	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.32	-8.63	8.39E-17	Common traits (Other)	
KIRC	cis	1	rs10152119	chr15:84570381	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.27E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs10152139	chr15:84570262	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.51	7.99E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs10155014	chr3:49432321	CCDC36	chr3:49235861-49295537:+	0.26	4.92	1.16E-6	Menarche (age at onset)	
KIRC	cis	1	rs10155014	chr3:49432321	GMPPB	chr3:49758932-49761384:-	-0.15	-3.54	0.000434	Menarche (age at onset)	
KIRC	cis	1	rs10155014	chr3:49432321	NCKIPSD	chr3:48711280-48723334:-	0.23	4.56	6.43E-6	Menarche (age at onset)	
KIRC	cis	1	rs10155014	chr3:49432321	P4HTM	chr3:49027341-49044579:+	0.2	4.57	6.21E-6	Menarche (age at onset)	
KIRC	cis	1	rs10155014	chr3:49432321	TREX1	chr3:48501186-48509043:+	-0.16	-4.09	5.03E-5	Menarche (age at onset)	
KIRC	cis	1	rs10155014	chr3:49432321	WDR6	chr3:49044637-49053386:+	-0.21	-5.34	1.43E-7	Menarche (age at onset)	
KIRC	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.92	-22.06	6.86E-76	Homocysteine levels	
KIRC	cis	1	rs10164319	chr19:18569833	SSBP4	chr19:18530221-18545371:+	-0.13	-4.62	4.89E-6	Breast cancer	
KIRC	cis	1	rs10164323	chr19:18569492	SSBP4	chr19:18530221-18545371:+	-0.13	-4.57	6.08E-6	Breast cancer	
KIRC	cis	1	rs10165098	chr2:27796526	NRBP1	chr2:27650657-27665122:+	0.14	3.61	0.000343	Oral cavity cancer	
KIRC	cis	1	rs10165099	chr2:3402591	TTC15	chr2:3383446-3488857:+	0.25	5.51	5.72E-8	Obesity-related traits	
KIRC	cis	1	rs10165485	chr2:54481636	ACYP2	chr2:54342410-54532433:+	-0.22	-3.93	9.53E-5	Telomere length	
KIRC	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs10169714	chr2:73808773	TPRKB	chr2:73956957-73964517:-	-0.21	-5.47	7.14E-8	Metabolite levels	
KIRC	cis	1	rs10172118	chr2:219913512	FAM134A	chr2:220042939-220050190:+	-0.29	-3.68	0.000261	Height	
KIRC	cis	1	rs10172118	chr2:219913512	USP37	chr2:219314974-219433084:-	-0.24	-3.72	0.000223	Height	
KIRC	cis	1	rs10173081	chr2:102957348	IL18R1	chr2:102927962-103015215:+	0.2	3.5	0.000506	Asthma	
KIRC	cis	1	rs10173081	chr2:102957348	IL1RL1	chr2:102927962-102968497:+	0.44	7.54	2.16E-13	Asthma	
KIRC	cis	1	rs10175180	chr2:73673123	TPRKB	chr2:73956957-73964517:-	-0.19	-4.98	8.62E-7	Metabolite levels	
KIRC	cis	1	rs10177466	chr2:219910988	FAM134A	chr2:220042939-220050190:+	-0.27	-3.54	0.000431	Height	
KIRC	cis	1	rs10177466	chr2:219910988	USP37	chr2:219314974-219433084:-	-0.24	-3.99	7.75E-5	Height	
KIRC	cis	1	rs10177970	chr2:37512968	CEBPZ	chr2:37428778-37458740:-	0.18	5.06	5.93E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs10177970	chr2:37512968	QPCT	chr2:37571753-37600464:+	0.19	3.53	0.000452	Chronic lymphocytic leukemia	
KIRC	cis	1	rs10178409	chr2:73855507	TPRKB	chr2:73956957-73964517:-	-0.19	-4.69	3.47E-6	Urinary metabolites	
KIRC	cis	1	rs10178975	chr2:37514564	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.19	3.09E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs10178975	chr2:37514564	QPCT	chr2:37571753-37600464:+	-0.2	-3.69	0.000248	Chronic lymphocytic leukemia	
KIRC	cis	1	rs10178982	chr2:202227640	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.89	1.36E-6	Basal cell carcinoma	
KIRC	cis	1	rs1017908	chr11:77948095	NARS2	chr11:78147017-78285909:-	-0.18	-3.69	0.00025	Testicular germ cell tumor	
KIRC	cis	1	rs10179134	chr2:73637519	TPRKB	chr2:73956957-73964517:-	-0.2	-5.09	4.96E-7	Metabolite levels	
KIRC	cis	1	rs10179271	chr2:136910834	DARS	chr2:136664254-136743222:-	0.14	3.71	0.00023	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs10179458	chr2:102934974	IL1RL1	chr2:102927962-102968497:+	0.39	6.76	3.81E-11	Asthma	
KIRC	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.46	10.3	1.04E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs10184227	chr2:198894305	RFTN2	chr2:198435528-198540584:-	-0.1	-3.53	0.000457	Dermatomyositis	
KIRC	cis	1	rs10184268	chr2:73627044	TPRKB	chr2:73956957-73964517:-	-0.19	-4.9	1.28E-6	Metabolite levels	
KIRC	cis	1	rs10185421	chr2:137537699	THSD7B	chr2:137523115-138435287:+	-0.18	-4.09	4.96E-5	Pancreatic cancer	
KIRC	cis	1	rs10186501	chr2:73697844	TPRKB	chr2:73956957-73964517:-	-0.19	-5	8.02E-7	Metabolite levels	
KIRC	cis	1	rs10187192	chr2:73713500	TPRKB	chr2:73956957-73964517:-	-0.21	-5.48	6.66E-8	Metabolite levels	
KIRC	cis	1	rs10187416	chr2:73713741	TPRKB	chr2:73956957-73964517:-	-0.19	-5.03	7.01E-7	Metabolite levels	
KIRC	cis	1	rs10187501	chr2:165532454	SLC38A11	chr2:165754812-165812035:-	0.25	4.42	1.2E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs10189154	chr2:102937544	IL1RL1	chr2:102927962-102968497:+	0.4	6.94	1.24E-11	Asthma	
KIRC	cis	1	rs10189526	chr2:102937883	IL1RL1	chr2:102927962-102968497:+	0.4	6.94	1.24E-11	Asthma	
KIRC	cis	1	rs10189574	chr2:73698518	TPRKB	chr2:73956957-73964517:-	-0.19	-4.94	1.06E-6	Metabolite levels	
KIRC	cis	1	rs10189996	chr2:240908800	NDUFA10	chr2:240900158-240964798:-	0.2	4.24	2.63E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs10190219	chr2:73658331	TPRKB	chr2:73956957-73964517:-	-0.2	-5.07	5.63E-7	Metabolite levels	
KIRC	cis	1	rs1019217	chr11:22842622	SVIP	chr11:22843600-22851382:-	0.32	7.23	1.82E-12	Dialysis-related mortality	
KIRC	cis	1	rs10193373	chr2:281886	FAM150B	chr2:279563-288308:-	-0.22	-4.3	2.05E-5	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.29	-5.87	8.05E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs10193610	chr2:240940618	NDUFA10	chr2:240900158-240964798:-	0.2	4.36	1.58E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs10193972	chr2:73717656	TPRKB	chr2:73956957-73964517:-	-0.19	-5.02	7.03E-7	Metabolite levels	
KIRC	cis	1	rs10195155	chr2:70354475	ANXA4	chr2:69969127-70053594:+	-0.2	-4.05	5.85E-5	Obesity-related traits	
KIRC	cis	1	rs10195155	chr2:70354475	FAM136A	chr2:70523109-70529220:-	-0.24	-4.72	3.01E-6	Obesity-related traits	
KIRC	cis	1	rs10197172	chr2:219955936	USP37	chr2:219314974-219433084:-	-0.27	-4.05	5.94E-5	Height	
KIRC	cis	1	rs10201445	chr2:219914717	FAM134A	chr2:220042939-220050190:+	-0.29	-3.68	0.000261	Height	
KIRC	cis	1	rs10201445	chr2:219914717	USP37	chr2:219314974-219433084:-	-0.24	-3.72	0.000223	Height	
KIRC	cis	1	rs1020410	chr2:176784138	HOXD8	chr2:176994422-176997076:+	-0.16	-3.51	0.000486	Obesity-related traits	
KIRC	cis	1	rs10205364	chr2:27794233	NRBP1	chr2:27650657-27665122:+	0.14	3.58	0.00038	Oral cavity cancer	
KIRC	cis	1	rs10205487	chr2:70151471	ANXA4	chr2:69969127-70053594:+	0.22	5.24	2.38E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs10206231	chr2:202229225	ALS2CR12	chr2:202153148-202222101:-	-0.27	-5.21	2.71E-7	Basal cell carcinoma	
KIRC	cis	1	rs10206993	chr2:240900919	NDUFA10	chr2:240900158-240964798:-	0.21	4.57	6.27E-6	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs10207220	chr2:73785046	TPRKB	chr2:73956957-73964517:-	-0.21	-5.37	1.22E-7	Metabolite levels	
KIRC	cis	1	rs10208155	chr2:61115039	C2orf74	chr2:61372243-61391964:+	0.39	6.56	1.36E-10	Inflammatory skin disease	
KIRC	cis	1	rs10208728	chr2:219917303	USP37	chr2:219314974-219433084:-	-0.22	-3.58	0.000375	Height	
KIRC	cis	1	rs10209620	chr2:61173941	C2orf74	chr2:61372243-61391964:+	0.39	6.49	2.09E-10	Inflammatory skin disease	
KIRC	cis	1	rs10209870	chr2:161192545	PLA2R1	chr2:160798012-160919121:-	0.2	3.63	0.000312	Type 2 diabetes	
KIRC	cis	1	rs1021464	chr1:76375415	MSH4	chr1:76262630-76378923:+	-0.29	-4.36	1.56E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs10215453	chr7:77488678	PTPN12	chr7:77166773-77269388:+	-0.15	-3.9	0.000109	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs10216533	chr8:143763690	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.35E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs10216533	chr8:143763690	LYNX1	chr8:143845758-143859640:-	-0.21	-4.11	4.71E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs10216533	chr8:143763690	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000162	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.84	9.59	4.22E-20	Coronary heart disease	
KIRC	cis	1	rs10220572	chr14:88464887	GPR65	chr14:88471496-88478414:+	0.13	4.01	7.07E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs1022687	chr20:47648854	CSE1L	chr20:47662838-47713484:+	-0.18	-4.58	5.76E-6	Anger	
KIRC	cis	1	rs10228845	chr7:21583617	CDCA7L	chr7:21940518-21985542:-	-0.17	-3.83	0.000146	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.89	-25.39	4.4E-92	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs10229224	chr7:21583921	CDCA7L	chr7:21940518-21985542:-	-0.16	-3.62	0.000325	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.89	-25.69	1.55E-93	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs10234018	chr7:66146284	LOC493754	chr7:65993446-66057363:-	0.16	3.53	0.000451	Aortic root size	
KIRC	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.58	11.75	2.56E-28	Paget's disease	
KIRC	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.54	-8.81	2.01E-17	Paget's disease	
KIRC	cis	1	rs1023586	chr14:81462283	TSHR	chr14:81421869-81612646:+	-0.33	-6.37	4.3E-10	Graves' disease	
KIRC	cis	1	rs10238520	chr7:3341615	SDK1	chr7:3341080-4308629:+	-0.18	-3.51	0.000491	Motion sickness	
KIRC	cis	1	rs10242018	chr7:110929652	IMMP2L	chr7:110303110-111202538:-	0.17	3.73	0.000211	Schizophrenia	
KIRC	cis	1	rs10247443	chr7:50620586	FIGNL1	chr7:50511834-50518088:-	-0.21	-4.25	2.53E-5	Malaria	
KIRC	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs10247526	chr7:65780696	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs10250513	chr7:50621488	FIGNL1	chr7:50511834-50518088:-	-0.23	-4.67	3.89E-6	Malaria	
KIRC	cis	1	rs10252765	chr7:66228732	LOC493754	chr7:65993446-66057363:-	-0.16	-3.49	0.000519	Aortic root size	
KIRC	cis	1	rs10255299	chr7:111527560	TMEM168	chr7:112405789-112430478:-	-0.28	-3.96	8.69E-5	C-reactive protein and white blood cell count	
KIRC	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.25	5.46	7.46E-8	Longevity;Endometriosis	
KIRC	cis	1	rs1027087	chr12:26470850	BHLHE41	chr12:26272961-26278003:-	0.36	6.89	1.67E-11	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1027087	chr12:26470850	SSPN	chr12:26348269-26405853:+	0.2	4.09	4.99E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10274773	chr7:66133578	LOC493754	chr7:65993446-66057363:-	0.17	3.65	0.00029	Aortic root size	
KIRC	cis	1	rs10279537	chr7:77474961	PTPN12	chr7:77166773-77269388:+	-0.14	-3.74	0.000202	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs1028390	chr6:55935791	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.24	4.67	3.94E-6	Atopic dermatitis	
KIRC	cis	1	rs1028488	chr6:170590475	DLL1	chr6:170591296-170599697:-	0.19	5.01	7.63E-7	Interferon alpha levels in systemic lupus erythematosus	
KIRC	cis	1	rs1029408	chr11:2309855	C11orf21	chr11:2317507-2323143:-	-0.17	-3.58	0.000376	Obesity-related traits	
KIRC	cis	1	rs1030136	chr2:190735660	ASNSD1	chr2:190526125-190535556:+	-0.33	-4.64	4.48E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs1030420	chr8:67360725	ADHFE1	chr8:67344718-67381042:+	-0.2	-4.25	2.55E-5	Blood metabolite levels	
KIRC	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.51	-8.4	4.54E-16	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1032524	chr1:201790826	SHISA4	chr1:201858032-201861426:+	0.16	4.34	1.7E-5	Body mass index	
KIRC	cis	1	rs1034219	chr1:93022678	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs1034527	chr8:120939125	TNFRSF11B	chr8:119935797-119964383:-	0.25	3.8	0.000165	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.22	-4.53	7.24E-6	Melanoma;Esophageal squamous cell carcinoma	
KIRC	cis	1	rs1036036	chr4:39112724	WDR19	chr4:39184024-39287429:+	0.19	5.01	7.57E-7	Uric acid levels	
KIRC	cis	1	rs1036037	chr4:39112892	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs1036038	chr4:39113003	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs1037036	chr17:18764077	FAM18B	chr17:18684582-18710026:+	-0.27	-5.99	3.9E-9	Educational attainment (years of education)	
KIRC	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.5	-8.32	8.15E-16	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1039438	chr5:156476770	HAVCR1	chr5:156456531-156486130:-	-0.44	-9.82	6.34E-21	Hypertriglyceridemia	
KIRC	cis	1	rs1039438	chr5:156476770	HAVCR2	chr5:156512843-156536138:-	-0.4	-7.63	1.22E-13	Hypertriglyceridemia	
KIRC	cis	1	rs1039438	chr5:156476770	TIMD4	chr5:156346293-156390266:-	-0.32	-5.98	4.36E-9	Hypertriglyceridemia	
KIRC	cis	1	rs1039664	chr7:65449716	CCT6P1	chr7:65216092-65228661:+	0.28	5.56	4.44E-8	Diabetic kidney disease	
KIRC	cis	1	rs1039664	chr7:65449716	CRCP	chr7:65579805-65619551:+	-0.3	-4.08	5.32E-5	Diabetic kidney disease	
KIRC	cis	1	rs10400248	chr11:247029	PSMD13	chr11:236808-252984:+	-0.15	-4.91	1.26E-6	Menarche (age at onset)	
KIRC	cis	1	rs10402468	chr19:17384003	ANKLE1	chr19:17392454-17398454:+	0.17	3.62	0.00032	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10402727	chr19:52370379	ZNF577	chr19:52359056-52394145:-	-0.28	-5.05	6.25E-7	Breast cancer	
KIRC	cis	1	rs10402727	chr19:52370379	ZNF649	chr19:52392489-52408247:-	-0.24	-4.9	1.27E-6	Breast cancer	
KIRC	cis	1	rs10402988	chr19:52363104	ZNF577	chr19:52359056-52394145:-	-0.3	-5.57	4.12E-8	Breast cancer	
KIRC	cis	1	rs10402988	chr19:52363104	ZNF649	chr19:52392489-52408247:-	-0.24	-4.95	1.02E-6	Breast cancer	
KIRC	cis	1	rs10403249	chr19:18604942	SSBP4	chr19:18530221-18545371:+	-0.13	-4.63	4.62E-6	Breast cancer	
KIRC	cis	1	rs10403540	chr19:39204846	CAPN12	chr19:39220832-39235114:-	-0.14	-4.44	1.13E-5	Heart rate	
KIRC	cis	1	rs1040393	chr1:166861596	MAEL	chr1:166958519-166991447:+	0.29	3.79	0.000169	Schizophrenia	
KIRC	cis	1	rs10404211	chr19:33093565	ANKRD27	chr19:33087907-33166102:-	0.32	4.41	1.29E-5	Eosinophilic esophagitis	
KIRC	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.45	8.57	1.28E-16	Phospholipid levels (plasma)	
KIRC	cis	1	rs10405348	chr19:12062853	GCDH	chr19:13001974-13010782:+	-0.3	-3.53	0.000461	Multiple sclerosis	
KIRC	cis	1	rs10405348	chr19:12062853	ZNF763	chr19:12035900-12091196:+	-0.46	-5.84	9.37E-9	Multiple sclerosis	
KIRC	cis	1	rs10405382	chr19:32896716	ZNF507	chr19:32836514-32878571:+	0.18	3.67	0.000267	Bipolar disorder	
KIRC	cis	1	rs10405457	chr19:44296582	ZNF155	chr19:44488355-44502477:+	-0.25	-5.13	4.14E-7	Breast cancer	
KIRC	cis	1	rs10405457	chr19:44296582	ZNF404	chr19:44376516-44384288:-	-0.31	-6.18	1.35E-9	Breast cancer	
KIRC	cis	1	rs10405636	chr19:18538742	SSBP4	chr19:18530221-18545371:+	-0.13	-4.61	5.14E-6	Breast cancer	
KIRC	cis	1	rs10406750	chr19:33097144	ANKRD27	chr19:33087907-33166102:-	0.32	4.87	1.53E-6	Eosinophilic esophagitis	
KIRC	cis	1	rs10406750	chr19:33097144	RGS9BP	chr19:33166313-33169206:+	0.29	3.79	0.000167	Eosinophilic esophagitis	
KIRC	cis	1	rs10406778	chr19:39170473	CAPN12	chr19:39220832-39235114:-	-0.13	-3.93	9.67E-5	Heart rate	
KIRC	cis	1	rs10406920	chr19:17389648	ANKLE1	chr19:17392454-17398454:+	0.19	4.18	3.43E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10407204	chr19:33097353	ANKRD27	chr19:33087907-33166102:-	0.32	4.88	1.45E-6	Eosinophilic esophagitis	
KIRC	cis	1	rs10407204	chr19:33097353	RGS9BP	chr19:33166313-33169206:+	0.29	3.82	0.000152	Eosinophilic esophagitis	
KIRC	cis	1	rs1040726	chr20:3264267	ITPA	chr20:3190056-3204504:+	-0.29	-6.93	1.29E-11	IFN-related cytopenia	
KIRC	cis	1	rs1040727	chr20:3264292	ITPA	chr20:3190056-3204504:+	-0.27	-6.54	1.47E-10	IFN-related cytopenia	
KIRC	cis	1	rs10409331	chr19:52370962	ZNF577	chr19:52359056-52394145:-	-0.28	-5.05	6.25E-7	Breast cancer	
KIRC	cis	1	rs10409331	chr19:52370962	ZNF649	chr19:52392489-52408247:-	-0.24	-4.9	1.27E-6	Breast cancer	
KIRC	cis	1	rs10409483	chr19:18590223	SSBP4	chr19:18530221-18545371:+	-0.13	-4.61	5.09E-6	Breast cancer	
KIRC	cis	1	rs10409485	chr19:41920765	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.83	0.000144	Height	
KIRC	cis	1	rs10409505	chr19:18590251	SSBP4	chr19:18530221-18545371:+	-0.13	-4.61	5.09E-6	Breast cancer	
KIRC	cis	1	rs10409835	chr19:32888660	ZNF507	chr19:32836514-32878571:+	0.17	3.58	0.00037	Bipolar disorder	
KIRC	cis	1	rs10410651	chr19:45160896	CEACAM19	chr19:45174724-45187625:+	0.13	3.51	0.00049	Multiple sclerosis	
KIRC	cis	1	rs10410651	chr19:45160896	PVR	chr19:45147098-45169426:+	0.4	7.92	1.54E-14	Multiple sclerosis	
KIRC	cis	1	rs10411009	chr19:18606266	SSBP4	chr19:18530221-18545371:+	-0.13	-4.43	1.15E-5	Breast cancer	
KIRC	cis	1	rs10411161	chr19:52372976	ZNF577	chr19:52359056-52394145:-	-0.27	-4.69	3.59E-6	Breast cancer	
KIRC	cis	1	rs10411161	chr19:52372976	ZNF649	chr19:52392489-52408247:-	-0.24	-4.78	2.25E-6	Breast cancer	
KIRC	cis	1	rs10412080	chr19:52373508	ZNF577	chr19:52359056-52394145:-	-0.29	-5.2	2.85E-7	Breast cancer	
KIRC	cis	1	rs10412080	chr19:52373508	ZNF649	chr19:52392489-52408247:-	-0.25	-5.12	4.4E-7	Breast cancer	
KIRC	cis	1	rs10412219	chr19:33413246	SLC7A9	chr19:33321421-33360683:-	0.17	4.98	8.74E-7	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
KIRC	cis	1	rs10413237	chr19:18548249	SSBP4	chr19:18530221-18545371:+	-0.13	-4.56	6.42E-6	Breast cancer	
KIRC	cis	1	rs10413735	chr19:41921071	ATP5SL	chr19:41937224-41945810:-	0.16	3.76	0.000194	Height	
KIRC	cis	1	rs10414104	chr19:52368132	ZNF577	chr19:52359056-52394145:-	-0.3	-5.46	7.6E-8	Breast cancer	
KIRC	cis	1	rs10414104	chr19:52368132	ZNF649	chr19:52392489-52408247:-	-0.25	-5.09	5.05E-7	Breast cancer	
KIRC	cis	1	rs10414248	chr19:12151626	ZNF763	chr19:12035900-12091196:+	-0.47	-5.83	9.68E-9	Multiple sclerosis	
KIRC	cis	1	rs10415219	chr19:39150235	CAPN12	chr19:39220832-39235114:-	-0.13	-3.87	0.000121	Heart rate	
KIRC	cis	1	rs10415744	chr19:32880580	ZNF507	chr19:32836514-32878571:+	0.19	3.86	0.000127	Bipolar disorder	
KIRC	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.25	5.93	5.55E-9	Bone properties (heel)	
KIRC	cis	1	rs10416265	chr19:33605300	GPATCH1	chr19:33571786-33621318:+	0.24	5.6	3.54E-8	Bone properties (heel)	
KIRC	cis	1	rs10416600	chr19:18386063	JUND	chr19:18390563-18392432:-	-0.17	-3.72	0.000219	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10416600	chr19:18386063	KIAA1683	chr19:18367906-18385319:-	-0.24	-5.89	7.09E-9	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10416600	chr19:18386063	MAST3	chr19:18208603-18262498:+	0.14	3.77	0.000182	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10416654	chr19:17385176	ANKLE1	chr19:17392454-17398454:+	0.19	4.07	5.37E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10417006	chr19:12157253	ZNF763	chr19:12035900-12091196:+	-0.36	-4.99	8.14E-7	Multiple sclerosis	
KIRC	cis	1	rs10417152	chr19:32888900	ZNF507	chr19:32836514-32878571:+	0.17	3.62	0.000322	Bipolar disorder	
KIRC	cis	1	rs10417311	chr19:41902038	ATP5SL	chr19:41937224-41945810:-	0.16	3.83	0.000142	Height	
KIRC	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.25	-6.56	1.33E-10	Gut microbiome composition (summer)	
KIRC	cis	1	rs10417997	chr19:41902361	ATP5SL	chr19:41937224-41945810:-	0.15	3.55	0.000427	Height	
KIRC	cis	1	rs10418154	chr19:17386006	ANKLE1	chr19:17392454-17398454:+	0.19	4.07	5.37E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10418362	chr19:17386107	ANKLE1	chr19:17392454-17398454:+	0.19	4.07	5.37E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10419620	chr19:12148947	ZNF763	chr19:12035900-12091196:+	-0.47	-5.83	9.68E-9	Multiple sclerosis	
KIRC	cis	1	rs10420683	chr19:12133769	ZNF763	chr19:12035900-12091196:+	-0.45	-5.57	4.11E-8	Multiple sclerosis	
KIRC	cis	1	rs10421560	chr19:39186613	CAPN12	chr19:39220832-39235114:-	-0.13	-4	7.36E-5	Heart rate	
KIRC	cis	1	rs10421887	chr19:44294849	ZNF155	chr19:44488355-44502477:+	0.23	4.87	1.47E-6	Breast cancer	
KIRC	cis	1	rs10421887	chr19:44294849	ZNF404	chr19:44376516-44384288:-	0.3	6.17	1.44E-9	Breast cancer	
KIRC	cis	1	rs10422783	chr19:41906436	ATP5SL	chr19:41937224-41945810:-	0.16	3.77	0.000184	Height	
KIRC	cis	1	rs10422956	chr19:41901261	ATP5SL	chr19:41937224-41945810:-	0.16	3.76	0.000191	Height	
KIRC	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.25	5.91	6.39E-9	Bone properties (heel)	
KIRC	cis	1	rs10425939	chr19:17397244	ANKLE1	chr19:17392454-17398454:+	0.18	3.79	0.00017	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs10425982	chr19:18586519	SSBP4	chr19:18530221-18545371:+	-0.14	-4.71	3.24E-6	Breast cancer	
KIRC	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.8	-19.45	3.24E-63	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs1042658	chr17:38173902	MED24	chr17:38175351-38210889:-	-0.15	-3.62	0.000319	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs10427083	chr19:18550276	SSBP4	chr19:18530221-18545371:+	-0.13	-4.63	4.65E-6	Breast cancer	
KIRC	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.31	6.81	2.88E-11	Multiple sclerosis	
KIRC	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.47	-12.48	2.47E-31	Multiple sclerosis	
KIRC	cis	1	rs10431505	chr12:58178589	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.24	9.4E-10	Multiple sclerosis	
KIRC	cis	1	rs10431765	chr15:66044551	DPP8	chr15:65737999-65810035:-	-0.12	-4.79	2.16E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs1043441	chr22:39130964	LOC646851	chr22:38974125-39052634:-	0.13	3.73	0.000212	Resting heart rate	
KIRC	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.1	4.55	6.77E-6	Height	
KIRC	cis	1	rs1043550	chr7:128409225	OPN1SW	chr7:128412545-128415844:-	0.24	4.12	4.4E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs1043674	chr14:75549370	MLH3	chr14:75480467-75518235:-	0.23	5.8	1.17E-8	Height	
KIRC	cis	1	rs1043674	chr14:75549370	NEK9	chr14:75548819-75593778:-	0.13	3.75	0.000198	Height	
KIRC	cis	1	rs1043806	chr1:147229299	ACP6	chr1:147119168-147142634:-	-0.24	-4.17	3.64E-5	Cognitive performance	
KIRC	cis	1	rs10439607	chr20:30258541	COX4I2	chr20:30225691-30232800:+	0.13	3.5	0.000511	Subcortical brain region volumes	
KIRC	cis	1	rs10439608	chr20:30258814	COX4I2	chr20:30225691-30232800:+	0.14	3.76	0.000193	Subcortical brain region volumes	
KIRC	cis	1	rs10440301	chr4:17663199	LAP3	chr4:17578927-17609590:+	-0.21	-6.64	8.12E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10440301	chr4:17663199	MED28	chr4:17616273-17629791:+	0.18	4.12	4.36E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10442	chr19:18545341	SSBP4	chr19:18530221-18545371:+	-0.13	-4.64	4.54E-6	Breast cancer	
KIRC	cis	1	rs10445014	chr16:58160974	C16orf80	chr16:58147497-58163296:-	0.38	3.72	0.000224	Telomere length	
KIRC	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.78	-16.92	3.91E-51	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs10445782	chr2:192101365	STAT4	chr2:191894306-192038902:-	0.17	4.48	9.26E-6	Obesity-related traits	
KIRC	cis	1	rs10445783	chr2:192101498	STAT4	chr2:191894306-192038902:-	0.17	4.45	1.04E-5	Obesity-related traits	
KIRC	cis	1	rs10445821	chr2:219909780	FAM134A	chr2:220042939-220050190:+	-0.29	-3.82	0.000151	Height	
KIRC	cis	1	rs10445821	chr2:219909780	USP37	chr2:219314974-219433084:-	-0.22	-3.57	0.000384	Height	
KIRC	cis	1	rs10445823	chr2:219910164	FAM134A	chr2:220042939-220050190:+	-0.27	-3.72	0.00022	Height	
KIRC	cis	1	rs10445823	chr2:219910164	USP37	chr2:219314974-219433084:-	-0.23	-3.83	0.000146	Height	
KIRC	cis	1	rs10445823	chr2:219910164	ZNF142	chr2:219502644-219524261:-	-0.24	-3.52	0.000477	Height	
KIRC	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.94	-22.63	1.08E-78	Homocysteine levels	
KIRC	cis	1	rs10450894	chr14:81825172	STON2	chr14:81727000-81893748:-	0.38	7.13	3.57E-12	Night sleep phenotypes	
KIRC	cis	1	rs10450939	chr14:81825202	STON2	chr14:81727000-81893748:-	0.38	7.13	3.57E-12	Night sleep phenotypes	
KIRC	cis	1	rs10453046	chr8:33773179	DUSP26	chr8:33448856-33457439:-	-0.18	-3.59	0.000362	Body mass index	
KIRC	cis	1	rs10453874	chr1:100272610	AGL	chr1:100315640-100389579:+	0.24	4.77	2.46E-6	White matter integrity (interaction)	
KIRC	cis	1	rs10453874	chr1:100272610	FRRS1	chr1:100174259-100231349:-	0.19	4.01	7.1E-5	White matter integrity (interaction)	
KIRC	cis	1	rs10454142	chr2:48646399	GTF2A1L	chr2:48844948-48960284:+	-0.34	-5.67	2.43E-8	Sex hormone-binding globulin levels	
KIRC	cis	1	rs10454142	chr2:48646399	STON1-GTF2A1L	chr2:48796159-48906746:+	-0.36	-6.57	1.23E-10	Sex hormone-binding globulin levels	
KIRC	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.47	-10.16	3.6E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs1045531	chr8:143763547	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.32E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045531	chr8:143763547	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045531	chr8:143763547	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000165	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.5	-10.36	6.17E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.48	-10.28	1.23E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.46	-10.12	5.03E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs1045547	chr8:143763757	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.32E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045547	chr8:143763757	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045547	chr8:143763757	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000165	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045574	chr8:143763958	LY6K	chr8:143781529-143785582:+	0.25	4.44	1.11E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045574	chr8:143763958	LYNX1	chr8:143845758-143859640:-	-0.2	-3.94	9.47E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045574	chr8:143763958	PSCA	chr8:143761875-143764142:+	0.21	3.84	0.000139	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045605	chr8:143764101	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.31E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045605	chr8:143764101	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.67E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs1045605	chr8:143764101	PSCA	chr8:143761875-143764142:+	0.21	3.79	0.000166	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs10456078	chr6:35118075	TCP11	chr6:35085849-35109187:-	-0.25	-4.24	2.64E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs10456078	chr6:35118075	UHRF1BP1	chr6:34759794-34853117:+	-0.18	-4.89	1.35E-6	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs10456362	chr6:28221816	ZNF187	chr6:28234788-28245978:+	0.24	4.22	2.95E-5	Depression	
KIRC	cis	1	rs10456362	chr6:28221816	ZNF323	chr6:28292517-28324048:-	-0.28	-3.97	8.4E-5	Depression	
KIRC	cis	1	rs10456362	chr6:28221816	ZSCAN23	chr6:28393287-28411279:-	-0.26	-3.85	0.000134	Depression	
KIRC	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.4	-9.27	5.53E-19	Folate pathway vitamin levels	
KIRC	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.27	9.16	1.3E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs10459230	chr12:48850996	TROAP	chr12:49716971-49725513:+	-0.19	-3.86	0.00013	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs10459917	chr17:2009752	SRR	chr17:2207248-2228553:+	-0.34	-5.36	1.27E-7	Body mass index	
KIRC	cis	1	rs10460009	chr18:2948029	LOC727896	chr18:2943215-2946621:-	-0.24	-3.73	0.000215	Type 2 diabetes	
KIRC	cis	1	rs1046073	chr20:25281333	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.26	8.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.28	-5.25	2.27E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.8	16.38	1.26E-48	Type 2 diabetes	
KIRC	cis	1	rs10463240	chr5:150256853	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs10463307	chr5:150254620	IRGM	chr5:150226085-150280295:+	0.56	7.38	6.42E-13	Crohn's disease	
KIRC	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.35	4.52	7.6E-6	Crohn's disease	
KIRC	cis	1	rs10463310	chr5:150260905	IRGM	chr5:150226085-150280295:+	0.51	6.87	1.89E-11	Crohn's disease	
KIRC	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.31	4.21	3.05E-5	Crohn's disease	
KIRC	cis	1	rs10465756	chr1:93029698	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs10468513	chr17:53062903	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.92	0.000102	Breast cancer	
KIRC	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.33	6.37	4.3E-10	Glycated hemoglobin levels	
KIRC	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.32	6.34	5.14E-10	Glycated hemoglobin levels	
KIRC	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.33	6.38	3.91E-10	Glycated hemoglobin levels	
KIRC	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.31	-9.07	2.64E-18	Longevity	
KIRC	cis	1	rs1047171	chr20:25428786	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1047171	chr20:25428786	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1047206	chr11:64089216	C11orf20	chr11:64067863-64072238:+	-0.35	-5.38	1.17E-7	Mean platelet volume	
KIRC	cis	1	rs1047418	chr14:75605792	MLH3	chr14:75480467-75518235:-	0.24	6.11	2.01E-9	Height	
KIRC	cis	1	rs1047418	chr14:75605792	NEK9	chr14:75548819-75593778:-	0.14	3.9	0.000109	Height	
KIRC	cis	1	rs10478026	chr5:110196467	CAMK4	chr5:110559648-110820746:+	0.18	3.82	0.000152	Asthma and hay fever	
KIRC	cis	1	rs10478026	chr5:110196467	TMEM232	chr5:109624934-110062381:-	0.22	4.32	1.85E-5	Asthma and hay fever	
KIRC	cis	1	rs10478278	chr5:115452758	COMMD10	chr5:115420727-115628978:+	0.32	3.7	0.000239	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10478288	chr5:115505621	COMMD10	chr5:115420727-115628978:+	0.32	3.75	0.000194	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs10479179	chr5:137564115	CDC25C	chr5:137620959-137674044:-	-0.23	-6.36	4.58E-10	Resting heart rate	
KIRC	cis	1	rs10483863	chr14:75322327	MLH3	chr14:75480467-75518235:-	-0.16	-3.91	0.000103	Caffeine consumption	
KIRC	cis	1	rs10483863	chr14:75322327	RPS6KL1	chr14:75372347-75389958:-	-0.16	-3.54	0.000436	Caffeine consumption	
KIRC	cis	1	rs10484629	chr6:133117870	VNN2	chr6:133065010-133084598:-	-0.22	-3.57	0.000392	Type 2 diabetes nephropathy	
KIRC	cis	1	rs10488821	chr11:30502175	C11orf46	chr11:30344649-30359978:+	-0.33	-6.61	9.8E-11	QRS complex (12-leadsum)	
KIRC	cis	1	rs10490958	chr10:17233450	TRDMT1	chr10:17184983-17243681:-	0.33	7.55	2.02E-13	Homocysteine levels	
KIRC	cis	1	rs10491280	chr5:132196383	LEAP2	chr5:132209358-132210581:+	-0.27	-4.71	3.23E-6	Apolipoprotein A-IV levels	
KIRC	cis	1	rs10491280	chr5:132196383	SHROOM1	chr5:132158012-132166590:-	-0.26	-5.47	7.25E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs10492096	chr12:6580582	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.02	6.76E-5	Hip geometry	
KIRC	cis	1	rs10494217	chr1:119469188	WARS2	chr1:119573841-119683295:-	0.31	4.85	1.68E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10494304	chr1:156285764	BGLAP	chr1:156182784-156213112:+	-0.34	-7.56	1.95E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10494304	chr1:156285764	CCT3	chr1:156278752-156308195:-	0.17	4.4	1.35E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10494563	chr1:183376980	LAMC2	chr1:183155174-183214262:+	-0.31	-3.67	0.000272	Obesity-related traits	
KIRC	cis	1	rs10494874	chr1:205754688	PM20D1	chr1:205797154-205819245:-	-0.37	-5.74	1.6E-8	Prostate-specific antigen levels	
KIRC	cis	1	rs1049564	chr14:20940606	PNP	chr14:20937542-20945246:+	-0.31	-5.02	7.26E-7	Interferon alpha levels in systemic lupus erythematosus	
KIRC	cis	1	rs10496174	chr2:70153436	ANXA4	chr2:69969127-70053594:+	-0.21	-5.15	3.81E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs10496191	chr2:73673798	TPRKB	chr2:73956957-73964517:-	-0.19	-4.98	8.62E-7	Metabolite levels	
KIRC	cis	1	rs10496193	chr2:73773503	TPRKB	chr2:73956957-73964517:-	-0.21	-5.4	1.02E-7	Metabolite levels	
KIRC	cis	1	rs10496444	chr2:113553668	DDX11L2	chr2:114356606-114359153:-	-0.25	-4.06	5.64E-5	Endometriosis	
KIRC	cis	1	rs10496444	chr2:113553668	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.3	2.02E-5	Endometriosis	
KIRC	cis	1	rs10496445	chr2:113552158	DDX11L2	chr2:114356606-114359153:-	-0.25	-4.06	5.81E-5	Endometriosis	
KIRC	cis	1	rs10496445	chr2:113552158	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.43	1.16E-5	Endometriosis	
KIRC	cis	1	rs1049887	chr1:10460485	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000348	Hepatocellular carcinoma	
KIRC	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.48	10.28	1.23E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.89	8.48	2.49E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs10501426	chr11:78057122	NARS2	chr11:78147017-78285909:-	-0.21	-4.9	1.29E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10503872	chr8:30437031	RBPMS	chr8:30241944-30429734:+	0.17	3.63	0.000314	Metabolite levels  (X-11787)	
KIRC	cis	1	rs10504839	chr8:89439731	MMP16	chr8:89049462-89339717:-	0.31	4	7.15E-5	Electrodermal activity	
KIRC	cis	1	rs10504841	chr8:89415821	MMP16	chr8:89049462-89339717:-	-0.31	-4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs10505430	chr8:124191933	DERL1	chr8:124025568-124054648:-	-0.33	-3.79	0.000171	Urinary uromodulin levels	
KIRC	cis	1	rs10506839	chr12:81445603	ACSS3	chr12:81471809-81649582:+	0.17	3.82	0.000149	Neuroticism	
KIRC	cis	1	rs10506839	chr12:81445603	LIN7A	chr12:81191171-81331694:-	0.19	4.88	1.42E-6	Neuroticism	
KIRC	cis	1	rs10508921	chr10:52010708	FAM21A	chr10:51827684-51893268:+	-0.41	-5.22	2.6E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs10509125	chr10:61926866	ANK3	chr10:61788160-62493155:-	0.15	3.54	0.000435	Behavioral disturbance or psychiatric symptoms and prion disease	
KIRC	cis	1	rs10509741	chr10:101917366	CWF19L1	chr10:101992055-102027437:-	-0.29	-3.54	0.000437	Schizophrenia	
KIRC	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.16	-5.33	1.52E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10509767	chr10:74045917	SPOCK2	chr10:73818793-73848790:-	0.21	4.08	5.25E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10510761	chr3:52965255	RFT1	chr3:53122503-53164470:-	-0.29	-4.45	1.08E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs10510761	chr3:52965255	SFMBT1	chr3:52938628-53080070:-	0.25	3.58	0.000381	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs10510761	chr3:52965255	TMEM110	chr3:52867139-52931547:-	-0.31	-5.39	1.08E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs10511393	chr3:119290051	CD80	chr3:119243142-119278481:-	-0.14	-3.53	0.000457	Vitiligo	
KIRC	cis	1	rs10516525	chr4:106668025	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs10516526	chr4:106688904	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs10516527	chr4:106734346	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs10518128	chr4:75713368	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs10518693	chr15:40700022	C15orf23	chr15:40674922-40686488:+	-0.17	-4.04	6.26E-5	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs10518693	chr15:40700022	DISP2	chr15:40650434-40663256:+	0.31	6.01	3.52E-9	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs10518839	chr15:56484363	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.07E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10518842	chr15:56495136	TEX9	chr15:56657644-56738071:+	-0.27	-4.84	1.74E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10518843	chr15:56496525	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10519203	chr15:78814046	CHRNA5	chr15:78857906-78886458:+	0.3	5.8	1.17E-8	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10519226	chr15:49738233	DTWD1	chr15:49913226-49937332:+	-0.25	-4.85	1.61E-6	Thyroid volume	
KIRC	cis	1	rs10521114	chr16:20089754	LYRM1	chr16:20911557-20936326:+	-0.15	-3.61	0.000342	Attention deficit hyperactivity disorder (inattention symptoms)	
KIRC	cis	1	rs10521115	chr16:20090645	LYRM1	chr16:20911557-20936326:+	-0.15	-3.55	0.000426	Attention deficit hyperactivity disorder (inattention symptoms)	
KIRC	cis	1	rs1052483	chr2:219934348	USP37	chr2:219314974-219433084:-	0.28	4.46	1.01E-5	Height	
KIRC	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.74	-11.12	7.63E-26	Diastolic blood pressure	
KIRC	cis	1	rs1053639	chr10:74035041	SPOCK2	chr10:73818793-73848790:-	-0.21	-3.96	8.64E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs1054029	chr4:103553053	MANBA	chr4:103552644-103682151:-	0.16	3.63	0.000311	Primary biliary cirrhosis	
KIRC	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.14	-4.75	2.66E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs1055321	chr11:22834402	SVIP	chr11:22843600-22851382:-	0.27	4.17	3.64E-5	Dialysis-related mortality	
KIRC	cis	1	rs1056204	chr2:9647091	ITGB1BP1	chr2:9545823-9563643:-	-0.18	-3.74	0.000202	Alcohol dependence (age at onset)	
KIRC	cis	1	rs1056610	chr22:39080078	BAIAP2L2	chr22:38480897-38506676:-	-0.14	-3.6	0.000347	Resting heart rate	
KIRC	cis	1	rs1056610	chr22:39080078	LOC646851	chr22:38974125-39052634:-	-0.12	-3.8	0.000161	Resting heart rate	
KIRC	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.27	-5.42	9.14E-8	Narcolepsy	
KIRC	cis	1	rs1060330	chr3:52288945	GNL3	chr3:52719936-52728508:+	-0.14	-3.67	0.000266	Electroencephalogram traits	
KIRC	cis	1	rs1061377	chr4:39124750	WDR19	chr4:39184024-39287429:+	0.18	4.73	2.89E-6	Uric acid levels	
KIRC	cis	1	rs1062687	chr22:39134715	LOC646851	chr22:38974125-39052634:-	0.12	3.78	0.000175	Resting heart rate	
KIRC	cis	1	rs1062794	chr20:30381758	COX4I2	chr20:30225691-30232800:+	0.15	4.03	6.32E-5	Subcortical brain region volumes	
KIRC	cis	1	rs1064039	chr20:23618427	CST3	chr20:23608536-23618574:-	-0.13	-3.67	0.000267	Chronic kidney disease	
KIRC	cis	1	rs1064261	chr1:11288758	MTOR	chr1:11166589-11322608:-	-0.17	-4.29	2.11E-5	Body mass index	
KIRC	cis	1	rs1065201	chr22:39069510	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs1067352	chr2:44669724	PREPL	chr2:44545903-44588944:-	-0.14	-3.82	0.00015	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs10732856	chr11:116907113	PCSK7	chr11:117075789-117102811:-	-0.27	-5.26	2.16E-7	Protein quantitative trait loci	
KIRC	cis	1	rs10733886	chr10:74039074	SPOCK2	chr10:73818793-73848790:-	-0.22	-4.13	4.24E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.35	7.72	6.21E-14	Pancreatic cancer	
KIRC	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.83	19.11	1.36E-61	Homocysteine levels	
KIRC	cis	1	rs10736426	chr1:45984353	MUTYH	chr1:45794915-45806142:-	-0.14	-4.07	5.39E-5	Homocysteine levels	
KIRC	cis	1	rs10736724	chr11:62913258	SLC22A24	chr11:62847414-62911693:-	0.32	7.28	1.28E-12	Conotruncal heart defects	
KIRC	cis	1	rs10736781	chr11:71650368	C11orf59	chr11:71808339-71814322:-	-0.2	-3.8	0.000164	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10736786	chr11:71763274	C11orf59	chr11:71808339-71814322:-	-0.21	-3.81	0.000156	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10739388	chr9:115977175	BSPRY	chr9:116111812-116133512:+	0.17	3.54	0.000438	Hematology traits	
KIRC	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.36	-7.24	1.66E-12	Hematology traits	
KIRC	cis	1	rs10740397	chr10:74039762	SPOCK2	chr10:73818793-73848790:-	-0.22	-4.13	4.24E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10740398	chr10:74046191	SPOCK2	chr10:73818793-73848790:-	-0.21	-4.05	5.95E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.32	-7.21	2.08E-12	Pancreatic cancer	
KIRC	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.33	7.25	1.6E-12	Pancreatic cancer	
KIRC	cis	1	rs10742175	chr11:27333897	BDNFOS	chr11:27528399-27719773:+	0.16	3.49	0.000522	Bone mineral density (paediatric, skull)	
KIRC	cis	1	rs1074263	chr5:42750751	CCDC152	chr5:42756920-42802539:+	0.23	5.27	2.0E-7	Height	
KIRC	cis	1	rs10743425	chr12:8705164	CLEC4D	chr12:8666136-8674958:+	0.2	3.87	0.000124	Response to radiotherapy in prostate cancer (overall toxicity)	
KIRC	cis	1	rs10743579	chr12:26461145	BHLHE41	chr12:26272961-26278003:-	0.37	6.9	1.62E-11	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10743579	chr12:26461145	RASSF8	chr12:26111969-26232824:+	0.19	3.72	0.000225	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10743579	chr12:26461145	SSPN	chr12:26348269-26405853:+	0.18	3.8	0.000165	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1074407	chr22:38156183	TRIOBP	chr22:38082344-38172562:+	0.34	7.21	2.07E-12	Optic cup area;Vertical cup-disc ratio	
KIRC	cis	1	rs10744625	chr12:3868168	EFCAB4B	chr12:3716318-3862366:-	0.22	3.7	0.000242	Homeostasis model assessment of insulin resistance (interaction);Fasting insulin (interaction)	
KIRC	cis	1	rs10747468	chr1:95686291	RWDD3	chr1:95583479-95712773:+	0.27	4	7.43E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs10747586	chr12:50983565	LIMA1	chr12:50569565-50677353:-	0.2	3.98	7.91E-5	Fibrinogen	
KIRC	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.31	6.67	6.81E-11	Multiple sclerosis	
KIRC	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.49	-13.07	8.34E-34	Multiple sclerosis	
KIRC	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.47	2.39E-10	Multiple sclerosis	
KIRC	cis	1	rs10748526	chr10:82273079	TSPAN14	chr10:82214038-82282390:+	0.2	3.78	0.000177	Post bronchodilator FEV1	
KIRC	cis	1	rs10749609	chr10:82249752	TSPAN14	chr10:82214038-82282390:+	0.21	3.83	0.000144	Post bronchodilator FEV1	
KIRC	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs10749860	chr1:46328210	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs10750100	chr11:116917244	PCSK7	chr11:117075789-117102811:-	-0.26	-5.19	3.11E-7	Protein quantitative trait loci	
KIRC	cis	1	rs10750101	chr11:116979689	PCSK7	chr11:117075789-117102811:-	-0.27	-5.06	5.75E-7	Protein quantitative trait loci	
KIRC	cis	1	rs10751189	chr11:71670578	C11orf59	chr11:71808339-71814322:-	0.22	4.13	4.19E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10751190	chr11:71680757	C11orf59	chr11:71808339-71814322:-	-0.21	-3.74	0.000207	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10751193	chr11:71785356	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.58E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10752615	chr1:156248609	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10752615	chr1:156248609	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10753232	chr1:180950126	MR1	chr1:181003139-181024633:+	0.13	3.51	0.000482	Progressive supranuclear palsy	
KIRC	cis	1	rs10754283	chr1:90112431	LRRC8C	chr1:90098644-90185093:+	0.12	4.37	1.5E-5	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.52	10.7	3.32E-24	Height	
KIRC	cis	1	rs10755146	chr3:190985158	UTS2D	chr3:190984945-191048325:-	-0.21	-3.81	0.000155	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.36	-7.41	5.41E-13	Hematology traits	
KIRC	cis	1	rs10760021	chr9:100697648	C9orf156	chr9:100666772-100684852:-	-0.29	-6.37	4.18E-10	Quantitative traits	
KIRC	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.53	-10.58	9.48E-24	Rheumatoid arthritis	
KIRC	cis	1	rs10760118	chr9:123641616	PSMD5	chr9:123578334-123605206:-	-0.37	-6.94	1.24E-11	Rheumatoid arthritis	
KIRC	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.48	-9.51	8.09E-20	Rheumatoid arthritis	
KIRC	cis	1	rs10760121	chr9:123647915	PSMD5	chr9:123578334-123605206:-	-0.36	-6.73	4.53E-11	Rheumatoid arthritis	
KIRC	cis	1	rs10760589	chr9:131906293	SET	chr9:131445934-131458674:+	-0.18	-3.92	9.94E-5	Blood metabolite ratios	
KIRC	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.28	-6.75	4.03E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.28	-6.69	6.15E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10761742	chr10:65085048	NRBF2	chr10:64893007-64914785:+	-0.28	-6.87	1.89E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10762504	chr10:74039335	SPOCK2	chr10:73818793-73848790:-	-0.22	-4.14	4.03E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10762505	chr10:74046212	SPOCK2	chr10:73818793-73848790:-	0.21	4.08	5.14E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10765913	chr11:11976195	DKK3	chr11:11984545-12031316:-	0.2	5.22	2.57E-7	Metabolite levels (Dihydroxy docosatrienoic acid)	
KIRC	cis	1	rs10766969	chr11:22849952	GAS2	chr11:22688160-22834546:+	-0.2	-3.69	0.000252	Dialysis-related mortality	
KIRC	cis	1	rs10766969	chr11:22849952	SVIP	chr11:22843600-22851382:-	-0.36	-7.78	4.15E-14	Dialysis-related mortality	
KIRC	cis	1	rs10769025	chr11:44289435	ACCS	chr11:44087475-44105569:+	-0.15	-4.41	1.26E-5	Gout	
KIRC	cis	1	rs10769054	chr11:5566489	TRIM6	chr11:5617347-5634188:+	-0.21	-4.95	9.94E-7	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10770856	chr12:8705406	CLEC4D	chr12:8666136-8674958:+	-0.22	-4.31	1.95E-5	Response to radiotherapy in prostate cancer (overall toxicity)	
KIRC	cis	1	rs10770857	chr12:8705469	CLEC4D	chr12:8666136-8674958:+	0.2	3.85	0.000131	Response to radiotherapy in prostate cancer (overall toxicity)	
KIRC	cis	1	rs1077358	chr4:103553926	MANBA	chr4:103552644-103682151:-	0.16	3.64	0.0003	Primary biliary cirrhosis	
KIRC	cis	1	rs1077514	chr1:23766233	TCEA3	chr1:23707555-23751261:-	-0.17	-3.84	0.000141	Cholesterol, total	
KIRC	cis	1	rs10775302	chr16:67792439	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.9	1.32E-6	Crohn's disease	
KIRC	cis	1	rs1077889	chr20:25267893	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10779751	chr1:11284336	MTOR	chr1:11166589-11322608:-	-0.17	-4.35	1.63E-5	Body mass index	
KIRC	cis	1	rs10782922	chr1:92974595	EVI5	chr1:92974255-93257961:-	-0.2	-4.65	4.31E-6	Cholesterol, total	
KIRC	cis	1	rs10783342	chr12:50628466	LIMA1	chr12:50569565-50677353:-	-0.31	-6.61	1.01E-10	Schizophrenia	
KIRC	cis	1	rs10783573	chr12:53728369	ESPL1	chr12:53662083-53687427:+	0.23	5.83	1.01E-8	Bone mineral density;Bone mineral density (spine)	
KIRC	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.31	6.77	3.72E-11	Multiple sclerosis	
KIRC	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.48	-12.58	1.0E-31	Multiple sclerosis	
KIRC	cis	1	rs10783847	chr12:58196447	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.38	3.96E-10	Multiple sclerosis	
KIRC	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.31	6.77	3.72E-11	Multiple sclerosis	
KIRC	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.48	-12.58	1.0E-31	Multiple sclerosis	
KIRC	cis	1	rs10783848	chr12:58196528	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.38	3.96E-10	Multiple sclerosis	
KIRC	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.14	-5.07	5.67E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.9	1.01E-17	Body mass index	
KIRC	cis	1	rs10789475	chr1:46304177	MUTYH	chr1:45794915-45806142:-	0.12	3.69	0.000246	Body mass index	
KIRC	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.47	-8.91	9.42E-18	Body mass index	
KIRC	cis	1	rs10789481	chr1:46383583	MUTYH	chr1:45794915-45806142:-	0.14	4.21	2.98E-5	Body mass index	
KIRC	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.91E-18	Body mass index	
KIRC	cis	1	rs10789487	chr1:46420221	MUTYH	chr1:45794915-45806142:-	0.15	4.37	1.49E-5	Body mass index	
KIRC	cis	1	rs1078968	chr3:53123486	ITIH3	chr3:52828784-52843025:+	0.14	3.55	0.000416	Height	
KIRC	cis	1	rs1078968	chr3:53123486	ITIH4	chr3:52847007-52866554:-	0.14	3.69	0.000248	Height	
KIRC	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.45	-12.11	8.2E-30	Height	
KIRC	cis	1	rs10790172	chr11:116927740	PCSK7	chr11:117075789-117102811:-	-0.29	-5.56	4.43E-8	Protein quantitative trait loci	
KIRC	cis	1	rs10790518	chr11:122520706	ASAM	chr11:122943035-123066007:-	0.16	3.81	0.000159	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs10790625	chr11:123917393	C11orf61	chr11:124636394-124670299:-	-0.1	-3.67	0.00027	Male fertility	
KIRC	cis	1	rs10792441	chr11:64360629	SLC22A12	chr11:64358282-64369820:+	-0.17	-4.53	7.51E-6	Urate levels in obese individuals	
KIRC	cis	1	rs10793016	chr11:71755063	C11orf59	chr11:71808339-71814322:-	0.22	4.11	4.64E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10793295	chr11:77996521	NARS2	chr11:78147017-78285909:-	0.16	3.67	0.00027	Testicular germ cell tumor	
KIRC	cis	1	rs10793302	chr11:78040961	NARS2	chr11:78147017-78285909:-	-0.21	-4.74	2.76E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10793303	chr11:78060750	NARS2	chr11:78147017-78285909:-	-0.19	-4.24	2.61E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10793304	chr11:78064907	NARS2	chr11:78147017-78285909:-	-0.2	-4.82	1.88E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10793308	chr11:78086005	NARS2	chr11:78147017-78285909:-	-0.18	-4.2	3.14E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10793309	chr11:78093799	NARS2	chr11:78147017-78285909:-	-0.18	-4.25	2.58E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10793311	chr11:78104399	NARS2	chr11:78147017-78285909:-	-0.18	-3.97	8.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs1079389	chr10:1161980	IDI2	chr10:1064847-1071799:-	0.32	3.58	0.000378	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs1079390	chr10:1161653	IDI2	chr10:1064847-1071799:-	0.32	3.58	0.000378	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs10794302	chr11:234102	PSMD13	chr11:236808-252984:+	-0.15	-5	7.8E-7	Menarche (age at onset)	
KIRC	cis	1	rs10794639	chr16:377367	TMEM8A	chr16:420777-431978:-	-0.17	-4.65	4.32E-6	Bone mineral density (spine);Bone mineral density	
KIRC	cis	1	rs1079467	chr11:7969711	EIF3F	chr11:8008445-8017716:+	0.17	3.55	0.000422	Response to anti-TNF therapy in rheumatoid arthritis	
KIRC	cis	1	rs10795452	chr10:17192712	TRDMT1	chr10:17184983-17243681:-	0.33	7.41	5.49E-13	Homocysteine levels	
KIRC	cis	1	rs10795465	chr10:17260525	TRDMT1	chr10:17184983-17243681:-	0.2	4.65	4.31E-6	Cholesterol, total	
KIRC	cis	1	rs1079596	chr11:113296619	TTC12	chr11:113185251-113244016:+	0.33	4.95	1.01E-6	Select biomarker traits	
KIRC	cis	1	rs1079597	chr11:113296286	TTC12	chr11:113185251-113244016:+	0.33	4.94	1.07E-6	Select biomarker traits	
KIRC	cis	1	rs10797880	chr1:183376810	LAMC2	chr1:183155174-183214262:+	-0.32	-3.66	0.000284	Obesity-related traits	
KIRC	cis	1	rs10798304	chr1:171258642	FMO4	chr1:171283486-171311222:+	-0.26	-5.25	2.28E-7	Sudden cardiac arrest	
KIRC	cis	1	rs10798686	chr1:179470357	C1orf125	chr1:179335107-179523868:+	0.31	3.99	7.54E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs1080060	chr2:27768808	NRBP1	chr2:27650657-27665122:+	0.14	3.7	0.000236	Oral cavity cancer	
KIRC	cis	1	rs10803550	chr2:136907790	DARS	chr2:136664254-136743222:-	0.14	3.63	0.000313	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.22	-4.6	5.45E-6	Melanoma;Esophageal squamous cell carcinoma	
KIRC	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.66E-40	Height	
KIRC	cis	1	rs10804632	chr3:134294501	CEP63	chr3:134204575-134293852:+	0.33	6.54	1.56E-10	Height	
KIRC	cis	1	rs10805357	chr4:17652352	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.72E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10805357	chr4:17652352	MED28	chr4:17616273-17629791:+	0.18	3.99	7.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10805358	chr4:17652450	LAP3	chr4:17578927-17609590:+	-0.21	-6.41	3.37E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10805358	chr4:17652450	MED28	chr4:17616273-17629791:+	0.17	3.76	0.000192	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10805359	chr4:17684886	LAP3	chr4:17578927-17609590:+	-0.21	-6.54	1.56E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10805359	chr4:17684886	MED28	chr4:17616273-17629791:+	0.16	3.65	0.000284	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.14	-4.52	7.84E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10807508	chr6:55950812	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs10807510	chr6:56006672	COL21A1	chr6:55921389-56258892:-	-0.48	-7.39	6.2E-13	Psychosis (atypical)	
KIRC	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.63	2.96E-8	Diabetic kidney disease	
KIRC	cis	1	rs10807701	chr7:65724686	CRCP	chr7:65579805-65619551:+	0.31	4.25	2.51E-5	Diabetic kidney disease	
KIRC	cis	1	rs10807701	chr7:65724686	LOC493754	chr7:65993446-66057363:-	-0.23	-3.6	0.000349	Diabetic kidney disease	
KIRC	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.26	5.15	3.76E-7	Diabetic kidney disease	
KIRC	cis	1	rs10807702	chr7:65767843	CRCP	chr7:65579805-65619551:+	-0.37	-5.03	7.0E-7	Diabetic kidney disease	
KIRC	cis	1	rs10813951	chr9:33128021	B4GALT1	chr9:33110639-33167356:-	0.25	4.57	6.17E-6	IgG glycosylation	
KIRC	cis	1	rs10813957	chr9:33153527	B4GALT1	chr9:33110639-33167356:-	-0.24	-4.16	3.68E-5	IgG glycosylation	
KIRC	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.5	-9.87	4.04E-21	Rheumatoid arthritis	
KIRC	cis	1	rs10818480	chr9:123643170	PSMD5	chr9:123578334-123605206:-	-0.35	-6.64	8.33E-11	Rheumatoid arthritis	
KIRC	cis	1	rs10819087	chr9:128695180	PBX3	chr9:128509617-128729653:+	0.21	5.01	7.58E-7	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs10819464	chr9:131876277	SET	chr9:131445934-131458674:+	-0.18	-3.88	0.000117	Blood metabolite ratios	
KIRC	cis	1	rs10819466	chr9:131881492	SET	chr9:131445934-131458674:+	-0.18	-3.89	0.000115	Blood metabolite ratios	
KIRC	cis	1	rs10819469	chr9:131882067	PPP2R4	chr9:131873244-131911223:+	0.19	3.56	0.000399	Blood metabolite ratios	
KIRC	cis	1	rs10819469	chr9:131882067	SET	chr9:131445934-131458674:+	-0.18	-3.9	0.000108	Blood metabolite ratios	
KIRC	cis	1	rs10819471	chr9:131896325	C9orf78	chr9:132589565-132597572:-	-0.17	-3.49	0.000525	Blood metabolite ratios	
KIRC	cis	1	rs10819471	chr9:131896325	SET	chr9:131445934-131458674:+	-0.18	-3.96	8.59E-5	Blood metabolite ratios	
KIRC	cis	1	rs10819861	chr9:98867813	C9orf130	chr9:98568372-98638259:-	-0.19	-3.75	0.000197	Electrocardiographic traits	
KIRC	cis	1	rs10820633	chr9:99214796	CDC14B	chr9:99262397-99382112:-	-0.16	-3.6	0.000353	Height	
KIRC	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.27	-6.58	1.22E-10	Triglycerides	
KIRC	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.28	-6.69	6.15E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10822161	chr10:65118203	NRBF2	chr10:64893007-64914785:+	-0.29	-7.03	6.9E-12	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10822163	chr10:65124098	NRBF2	chr10:64893007-64914785:+	-0.29	-7.03	7.0E-12	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10823156	chr10:69951841	MYPN	chr10:69865876-69971771:+	-0.24	-4.5	8.61E-6	Height	
KIRC	cis	1	rs10823911	chr10:74040034	SPOCK2	chr10:73818793-73848790:-	-0.22	-4.13	4.24E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs10824026	chr10:75421208	NUDT13	chr10:74870210-74891580:+	-0.18	-3.54	0.000443	Atrial fibrillation	
KIRC	cis	1	rs10825492	chr10:52008730	FAM21A	chr10:51827684-51893268:+	-0.39	-4.98	8.6E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs10827829	chr10:38104282	LOC399744	chr10:38717074-38741080:+	0.22	3.69	0.00025	Obesity (extreme)	
KIRC	cis	1	rs10827831	chr10:38110813	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs10827832	chr10:38119941	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.34	7.56	1.87E-13	Pancreatic cancer	
KIRC	cis	1	rs10833824	chr11:22847485	SVIP	chr11:22843600-22851382:-	-0.33	-7.41	5.49E-13	Dialysis-related mortality	
KIRC	cis	1	rs10833825	chr11:22850753	SVIP	chr11:22843600-22851382:-	-0.36	-7.74	5.47E-14	Dialysis-related mortality	
KIRC	cis	1	rs10835661	chr11:30381076	C11orf46	chr11:30344649-30359978:+	0.25	3.9	0.000108	Sex hormone levels;Menopause (age at onset)	
KIRC	cis	1	rs10838276	chr11:5555503	TRIM6	chr11:5617347-5634188:+	0.17	3.91	0.000106	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10838277	chr11:5555551	TRIM6	chr11:5617347-5634188:+	-0.2	-4.83	1.79E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10838290	chr11:5560150	TRIM6	chr11:5617347-5634188:+	-0.19	-4.62	4.85E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10838291	chr11:5560226	TRIM6	chr11:5617347-5634188:+	-0.2	-4.73	2.94E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10838299	chr11:5566830	TRIM6	chr11:5617347-5634188:+	-0.21	-4.94	1.06E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.23	1.93E-22	Subjective well-being	
KIRC	cis	1	rs10838738	chr11:47663049	PSMC3	chr11:47440320-47448024:-	0.12	3.8	0.000163	Subjective well-being	
KIRC	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.03	1.04E-21	Subjective well-being	
KIRC	cis	1	rs10838747	chr11:47716324	PSMC3	chr11:47440320-47448024:-	0.13	4.04	6.07E-5	Subjective well-being	
KIRC	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.47	-9.87	3.96E-21	Subjective well-being	
KIRC	cis	1	rs10838748	chr11:47716381	PSMC3	chr11:47440320-47448024:-	0.13	4.08	5.27E-5	Subjective well-being	
KIRC	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.47	-9.86	4.47E-21	Subjective well-being	
KIRC	cis	1	rs10838757	chr11:47763016	PSMC3	chr11:47440320-47448024:-	0.12	3.54	0.000436	Subjective well-being	
KIRC	cis	1	rs10842703	chr12:26456188	BHLHE41	chr12:26272961-26278003:-	0.39	7.37	6.86E-13	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10842703	chr12:26456188	RASSF8	chr12:26111969-26232824:+	0.21	4.19	3.25E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10842703	chr12:26456188	SSPN	chr12:26348269-26405853:+	0.21	4.26	2.41E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10842708	chr12:26474867	BHLHE41	chr12:26272961-26278003:-	0.36	6.94	1.18E-11	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10842708	chr12:26474867	RASSF8	chr12:26111969-26232824:+	0.18	3.65	0.000285	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10842708	chr12:26474867	SSPN	chr12:26348269-26405853:+	0.17	3.57	0.000397	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs10845106	chr12:10472338	KLRD1	chr12:10457050-10469849:+	-0.21	-3.7	0.000242	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs10846579	chr12:124407403	CCDC92	chr12:124420955-124457163:-	0.19	4.89	1.38E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10846579	chr12:124407403	DNAH10	chr12:124247042-124420265:+	0.2	3.94	9.24E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10846580	chr12:124415453	CCDC92	chr12:124420955-124457163:-	0.16	4.08	5.26E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs10849462	chr12:6575992	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.12	4.36E-5	Hip geometry	
KIRC	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.17	-5.12	4.42E-7	Lung cancer	
KIRC	cis	1	rs10849691	chr12:120154254	CIT	chr12:120123598-120315092:-	0.23	4.93	1.1E-6	Urgency urinary incontinence	
KIRC	cis	1	rs10851599	chr15:56154064	NEDD4	chr15:56119131-56285835:-	0.2	4.77	2.39E-6	Keloid	
KIRC	cis	1	rs10851604	chr15:56510059	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	4.04E-18	Body mass index	
KIRC	cis	1	rs1085243	chr1:46544768	MUTYH	chr1:45794915-45806142:-	0.14	4.01	7.12E-5	Body mass index	
KIRC	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.93	7.97E-18	Body mass index	
KIRC	cis	1	rs1085244	chr1:46563680	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.72E-5	Body mass index	
KIRC	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.65	9.59	4.28E-20	White matter microstructure (global fractional anisotropy)	
KIRC	cis	1	rs10853287	chr18:2941377	LOC727896	chr18:2943215-2946621:-	-0.25	-3.79	0.000172	Type 2 diabetes	
KIRC	cis	1	rs10853751	chr19:41903220	ATP5SL	chr19:41937224-41945810:-	0.16	3.83	0.000142	Height	
KIRC	cis	1	rs10857811	chr1:110617688	ALX3	chr1:110602998-110613322:-	0.23	4.91	1.22E-6	Blood metabolite levels	
KIRC	cis	1	rs10857975	chr1:113321594	FAM19A3	chr1:113263189-113269854:+	-0.2	-3.61	0.000336	Hyperactive-impulsive symptoms	
KIRC	cis	1	rs10862219	chr12:81430043	ACSS3	chr12:81471809-81649582:+	0.16	3.76	0.000189	Neuroticism	
KIRC	cis	1	rs10862219	chr12:81430043	LIN7A	chr12:81191171-81331694:-	0.18	4.69	3.57E-6	Neuroticism	
KIRC	cis	1	rs10862222	chr12:81436607	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs10862222	chr12:81436607	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs10862368	chr12:82244514	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs10862371	chr12:82249298	PPFIA2	chr12:81652880-82153109:-	0.39	6.95	1.13E-11	Resting heart rate	
KIRC	cis	1	rs10862372	chr12:82249804	PPFIA2	chr12:81652880-82153109:-	0.38	6.74	4.26E-11	Resting heart rate	
KIRC	cis	1	rs10862373	chr12:82250657	PPFIA2	chr12:81652880-82153109:-	0.36	6.7	5.6E-11	Resting heart rate	
KIRC	cis	1	rs10862374	chr12:82250809	PPFIA2	chr12:81652880-82153109:-	0.39	6.92	1.35E-11	Resting heart rate	
KIRC	cis	1	rs10863936	chr1:212237798	INTS7	chr1:212114698-212208884:-	-0.17	-3.91	0.000105	Height	
KIRC	cis	1	rs10865363	chr2:67946891	ARHGAP25	chr2:68906746-69053948:+	0.13	3.56	0.000405	Major depressive disorder (broad)	
KIRC	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.72	-10.97	3.13E-25	Diastolic blood pressure	
KIRC	cis	1	rs10865956	chr3:49581559	CCDC36	chr3:49235861-49295537:+	0.26	4.9	1.33E-6	Menarche (age at onset)	
KIRC	cis	1	rs10865956	chr3:49581559	NCKIPSD	chr3:48711280-48723334:-	0.22	4.36	1.55E-5	Menarche (age at onset)	
KIRC	cis	1	rs10865956	chr3:49581559	P4HTM	chr3:49027341-49044579:+	0.18	3.94	9.27E-5	Menarche (age at onset)	
KIRC	cis	1	rs10865956	chr3:49581559	WDR6	chr3:49044637-49053386:+	-0.22	-5.46	7.45E-8	Menarche (age at onset)	
KIRC	cis	1	rs10866659	chr5:156937043	ADAM19	chr5:156822542-157002768:-	-0.12	-4.35	1.62E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs10869777	chr9:79049157	RFK	chr9:79000433-79009444:-	0.2	4.13	4.26E-5	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
KIRC	cis	1	rs10869777	chr9:79049157	RPSAP9	chr9:79013515-79014954:+	-0.2	-4.59	5.72E-6	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
KIRC	cis	1	rs10869778	chr9:79050338	RFK	chr9:79000433-79009444:-	0.22	4.62	4.92E-6	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
KIRC	cis	1	rs10869778	chr9:79050338	RPSAP9	chr9:79013515-79014954:+	-0.2	-4.42	1.22E-5	Acute graft versus host disease in bone marrow transplantation (recipient effect)	
KIRC	cis	1	rs10871290	chr16:74472696	RFWD3	chr16:74655298-74700779:-	0.17	3.95	9.03E-5	Breast cancer	
KIRC	cis	1	rs10872032	chr6:109676776	AKD1	chr6:109814059-110012415:-	-0.21	-4.34	1.69E-5	Height	
KIRC	cis	1	rs10872032	chr6:109676776	SMPD2	chr6:109761931-109765121:+	0.2	4.77	2.37E-6	Height	
KIRC	cis	1	rs10872997	chr14:22722969	PRMT5	chr14:23389733-23398661:-	0.22	3.52	0.000473	Periodontal disease-related phenotypes	
KIRC	cis	1	rs10873275	chr14:75531460	MLH3	chr14:75480467-75518235:-	0.24	5.96	4.72E-9	Height	
KIRC	cis	1	rs10873275	chr14:75531460	NEK9	chr14:75548819-75593778:-	0.13	3.69	0.000247	Height	
KIRC	cis	1	rs10874122	chr1:75235866	C1orf173	chr1:75033796-75139422:-	-0.38	-6.59	1.13E-10	Resistin levels	
KIRC	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.19	-4.44	1.11E-5	Cholesterol, total	
KIRC	cis	1	rs10875179	chr1:99200198	SNX7	chr1:99127236-99226054:+	-0.18	-4.52	7.75E-6	Proinsulin levels	
KIRC	cis	1	rs10875746	chr12:48518264	ASB8	chr12:48541575-48551377:-	0.34	6.71	5.42E-11	Longevity (90 years and older)	
KIRC	cis	1	rs10875746	chr12:48518264	SLC48A1	chr12:48165370-48176535:+	0.21	3.61	0.000332	Longevity (90 years and older)	
KIRC	cis	1	rs10875818	chr12:48865212	ZNF641	chr12:48735912-48745021:-	-0.16	-3.56	0.000406	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.3	6.28	7.33E-10	Multiple sclerosis	
KIRC	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.49	-12.66	4.59E-32	Multiple sclerosis	
KIRC	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.32	-6.84	2.24E-11	Multiple sclerosis	
KIRC	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.33	7.1	4.26E-12	Multiple sclerosis	
KIRC	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.45	-11.61	9.48E-28	Multiple sclerosis	
KIRC	cis	1	rs10877013	chr12:58165085	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.21	1.13E-9	Multiple sclerosis	
KIRC	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.32	6.95	1.13E-11	Multiple sclerosis	
KIRC	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.45	-11.73	3.01E-28	Multiple sclerosis	
KIRC	cis	1	rs10877014	chr12:58167661	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.21	1.08E-9	Multiple sclerosis	
KIRC	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.31	6.65	7.56E-11	Multiple sclerosis	
KIRC	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.48	-12.59	9.12E-32	Multiple sclerosis	
KIRC	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.42	3.14E-10	Multiple sclerosis	
KIRC	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.32	-6.76	3.78E-11	Multiple sclerosis	
KIRC	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.5	13.35	5.03E-35	Multiple sclerosis	
KIRC	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.29	6.45	2.65E-10	Multiple sclerosis	
KIRC	cis	1	rs10882514	chr10:96782898	CYP2C9	chr10:96698415-96749147:+	0.18	3.51	0.000482	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.25	6.74	4.29E-11	Blood metabolite levels	
KIRC	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.13	-4.31	1.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.14E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.13	-4.45	1.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.13	-4.47	9.76E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.13	-4.47	9.76E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.13	-4.47	9.76E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.14	-4.61	5.22E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.14	-4.53	7.42E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.13	-4.61	5.17E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.13	-4.61	5.17E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	6.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.13	-4.57	6.28E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.16	-5.17	3.39E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.14	-4.72	3.05E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.13	-4.26	2.39E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10883513	chr10:102316964	SEC31B	chr10:102246403-102289636:-	-0.14	-4.71	3.27E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs10887150	chr10:124180578	ARMS2	chr10:124214179-124216867:+	-0.19	-3.58	0.000374	Height	
KIRC	cis	1	rs10887226	chr10:81713074	LOC219347	chr10:81805991-81838949:-	0.59	5.04	6.42E-7	Rheumatoid arthritis	
KIRC	cis	1	rs10887226	chr10:81713074	LOC650623	chr10:81442731-81448648:+	-0.34	-3.55	0.000416	Rheumatoid arthritis	
KIRC	cis	1	rs1088984	chr11:2377581	C11orf21	chr11:2317507-2323143:-	-0.17	-4.12	4.35E-5	Bacteremia	
KIRC	cis	1	rs1088985	chr11:2377852	C11orf21	chr11:2317507-2323143:-	-0.17	-4.1	4.85E-5	Bacteremia	
KIRC	cis	1	rs1088986	chr11:2377862	C11orf21	chr11:2317507-2323143:-	-0.17	-4.24	2.65E-5	Bacteremia	
KIRC	cis	1	rs1088987	chr11:2379196	C11orf21	chr11:2317507-2323143:-	-0.16	-4.15	3.92E-5	Bacteremia	
KIRC	cis	1	rs1088988	chr11:2380470	C11orf21	chr11:2317507-2323143:-	-0.18	-4.37	1.51E-5	Bacteremia	
KIRC	cis	1	rs1088990	chr11:2381771	C11orf21	chr11:2317507-2323143:-	-0.17	-4.35	1.62E-5	Bacteremia	
KIRC	cis	1	rs1088993	chr11:2382631	C11orf21	chr11:2317507-2323143:-	-0.18	-4.56	6.54E-6	Bacteremia	
KIRC	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.2	9.7E-19	Body mass index	
KIRC	cis	1	rs10890352	chr1:46283628	MUTYH	chr1:45794915-45806142:-	0.14	4.06	5.74E-5	Body mass index	
KIRC	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.49E-19	Body mass index	
KIRC	cis	1	rs10890354	chr1:46305347	MUTYH	chr1:45794915-45806142:-	0.13	3.86	0.000129	Body mass index	
KIRC	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.81	2.01E-17	Body mass index	
KIRC	cis	1	rs10890361	chr1:46346234	MUTYH	chr1:45794915-45806142:-	0.14	4.29	2.18E-5	Body mass index	
KIRC	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.47	9.09	2.27E-18	Body mass index	
KIRC	cis	1	rs10890363	chr1:46356148	MUTYH	chr1:45794915-45806142:-	-0.13	-3.87	0.000123	Body mass index	
KIRC	cis	1	rs10890383	chr1:46588503	CCDC163P	chr1:45960581-45965646:-	-0.48	-8.91	9.06E-18	Body mass index	
KIRC	cis	1	rs10890383	chr1:46588503	MUTYH	chr1:45794915-45806142:-	0.16	4.68	3.67E-6	Body mass index	
KIRC	cis	1	rs10896043	chr11:65543827	SNX32	chr11:65601410-65621170:+	-0.29	-4.83	1.84E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs10897009	chr11:59923194	MS4A2	chr11:59856137-59866014:+	0.18	4.04	6.31E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs10897518	chr11:64360705	SLC22A12	chr11:64358282-64369820:+	0.16	4.38	1.42E-5	Urate levels in obese individuals	
KIRC	cis	1	rs10898191	chr11:71194601	DHCR7	chr11:71145459-71159477:-	-0.28	-4.63	4.58E-6	Vitamin D levels	
KIRC	cis	1	rs10898193	chr11:71197083	DHCR7	chr11:71145459-71159477:-	0.28	4.6	5.25E-6	Vitamin D levels	
KIRC	cis	1	rs10898211	chr11:71210677	DHCR7	chr11:71145459-71159477:-	-0.3	-4.84	1.74E-6	Vitamin D levels	
KIRC	cis	1	rs10898223	chr11:71219264	DHCR7	chr11:71145459-71159477:-	-0.29	-4.72	3.01E-6	Vitamin D levels	
KIRC	cis	1	rs10898234	chr11:71236684	DHCR7	chr11:71145459-71159477:-	-0.28	-4.57	6.23E-6	Vitamin D levels	
KIRC	cis	1	rs10898814	chr11:71736505	C11orf59	chr11:71808339-71814322:-	-0.22	-3.85	0.000133	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs10899453	chr11:77997482	NARS2	chr11:78147017-78285909:-	-0.17	-3.79	0.000168	Testicular germ cell tumor	
KIRC	cis	1	rs10899454	chr11:77997513	NARS2	chr11:78147017-78285909:-	-0.17	-3.79	0.000168	Testicular germ cell tumor	
KIRC	cis	1	rs10899455	chr11:77999163	NARS2	chr11:78147017-78285909:-	-0.17	-3.88	0.000119	Testicular germ cell tumor	
KIRC	cis	1	rs10899456	chr11:78000155	NARS2	chr11:78147017-78285909:-	-0.17	-3.88	0.00012	Testicular germ cell tumor	
KIRC	cis	1	rs10899474	chr11:78043636	NARS2	chr11:78147017-78285909:-	-0.21	-4.6	5.43E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10899475	chr11:78051610	NARS2	chr11:78147017-78285909:-	-0.21	-4.91	1.22E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10899476	chr11:78051794	NARS2	chr11:78147017-78285909:-	-0.2	-4.34	1.72E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899477	chr11:78052104	NARS2	chr11:78147017-78285909:-	-0.2	-4.34	1.75E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899478	chr11:78052238	NARS2	chr11:78147017-78285909:-	-0.21	-4.88	1.4E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10899479	chr11:78052539	NARS2	chr11:78147017-78285909:-	-0.2	-4.33	1.78E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899481	chr11:78058721	NARS2	chr11:78147017-78285909:-	0.18	4.2	3.17E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899483	chr11:78061057	NARS2	chr11:78147017-78285909:-	-0.2	-4.8	2.12E-6	Testicular germ cell tumor	
KIRC	cis	1	rs10899485	chr11:78072383	NARS2	chr11:78147017-78285909:-	0.18	4.33	1.8E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899486	chr11:78072398	NARS2	chr11:78147017-78285909:-	-0.19	-4.14	4.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899489	chr11:78095373	NARS2	chr11:78147017-78285909:-	-0.18	-4.3	2.08E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899491	chr11:78106305	NARS2	chr11:78147017-78285909:-	-0.18	-4.03	6.39E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899492	chr11:78109810	NARS2	chr11:78147017-78285909:-	-0.17	-3.97	8.21E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10899495	chr11:78123293	NARS2	chr11:78147017-78285909:-	-0.19	-4.23	2.74E-5	Testicular germ cell tumor	
KIRC	cis	1	rs10900224	chr10:46024534	ALOX5	chr10:45869629-45941561:+	-0.16	-3.66	0.000277	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs10901513	chr10:127699936	UROS	chr10:127477148-127511837:-	-0.18	-4.51	8.15E-6	Visceral fat	
KIRC	cis	1	rs10901514	chr10:127700066	UROS	chr10:127477148-127511837:-	-0.18	-4.5	8.54E-6	Visceral fat	
KIRC	cis	1	rs10901520	chr10:127718837	UROS	chr10:127477148-127511837:-	-0.18	-4.71	3.27E-6	Visceral fat	
KIRC	cis	1	rs10902110	chr11:237648	PSMD13	chr11:236808-252984:+	-0.15	-4.98	8.67E-7	Menarche (age at onset)	
KIRC	cis	1	rs10902112	chr11:244106	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs10902113	chr11:245523	PSMD13	chr11:236808-252984:+	-0.15	-5.07	5.71E-7	Menarche (age at onset)	
KIRC	cis	1	rs10902114	chr11:246234	PSMD13	chr11:236808-252984:+	-0.15	-5.01	7.68E-7	Menarche (age at onset)	
KIRC	cis	1	rs10902728	chr1:26598281	ZNF593	chr1:26496388-26497362:+	0.14	3.9	0.000109	Obesity-related traits	
KIRC	cis	1	rs10904908	chr10:17260290	TRDMT1	chr10:17184983-17243681:-	0.2	4.68	3.65E-6	Cholesterol, total	
KIRC	cis	1	rs10904909	chr10:17264521	TRDMT1	chr10:17184983-17243681:-	0.2	4.6	5.25E-6	Cholesterol, total	
KIRC	cis	1	rs10906982	chr15:84568158	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.47	9.61E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs10906983	chr15:84569183	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs10908387	chr1:35677039	C1orf216	chr1:36179477-36184790:-	-0.25	-3.74	0.000202	Endometrial cancer	
KIRC	cis	1	rs10908419	chr1:154567699	IL6R	chr1:154377669-154440188:+	0.16	4.33	1.82E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRC	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.34	7.43	4.85E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908494	chr1:156263097	CCT3	chr1:156278752-156308195:-	-0.18	-4.65	4.28E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.34	7.43	4.57E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908495	chr1:156263940	CCT3	chr1:156278752-156308195:-	-0.17	-4.36	1.61E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.34	7.55	2.03E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908496	chr1:156264000	CCT3	chr1:156278752-156308195:-	-0.18	-4.47	9.54E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.34	7.43	4.77E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908498	chr1:156278175	CCT3	chr1:156278752-156308195:-	-0.17	-4.3	2.03E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.34	7.43	4.77E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908499	chr1:156279176	CCT3	chr1:156278752-156308195:-	-0.17	-4.3	2.03E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908500	chr1:156280671	BGLAP	chr1:156182784-156213112:+	0.31	6.85	2.13E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908500	chr1:156280671	CCT3	chr1:156278752-156308195:-	-0.18	-4.48	9.4E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908502	chr1:156300082	BGLAP	chr1:156182784-156213112:+	0.34	7.5	2.88E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10908502	chr1:156300082	CCT3	chr1:156278752-156308195:-	-0.17	-4.39	1.39E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs10910623	chr1:232938699	KIAA1383	chr1:232940638-232946092:+	-0.4	-3.5	0.000514	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
KIRC	cis	1	rs10910845	chr1:145723120	NUDT17	chr1:145586494-145590461:-	-0.17	-3.76	0.000188	Urate levels;Urate levels in overweight individuals	
KIRC	cis	1	rs10911251	chr1:183081194	LAMC2	chr1:183155174-183214262:+	0.23	4.6	5.46E-6	Colorectal cancer	
KIRC	cis	1	rs10911329	chr1:183379958	LAMC2	chr1:183155174-183214262:+	-0.32	-3.7	0.000243	Obesity-related traits	
KIRC	cis	1	rs10912749	chr1:171277506	FMO4	chr1:171283486-171311222:+	0.27	5.2	2.95E-7	Sudden cardiac arrest	
KIRC	cis	1	rs10926984	chr1:243462153	SDCCAG8	chr1:243419320-243663392:+	-0.29	-3.77	0.000184	Obesity (early onset extreme)	
KIRC	cis	1	rs10926986	chr1:243467611	SDCCAG8	chr1:243419320-243663392:+	0.34	4.5	8.63E-6	Obesity (early onset extreme)	
KIRC	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.17	-3.57	0.000387	Idiopathic membranous nephropathy	
KIRC	cis	1	rs10929965	chr2:160906931	PLA2R1	chr2:160798012-160919121:-	-0.18	-3.71	0.000231	Idiopathic membranous nephropathy	
KIRC	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.19	3.89	0.000115	Idiopathic membranous nephropathy	
KIRC	cis	1	rs10929966	chr2:160908341	PLA2R1	chr2:160798012-160919121:-	0.18	3.79	0.000169	Idiopathic membranous nephropathy	
KIRC	cis	1	rs10929978	chr2:161169956	PLA2R1	chr2:160798012-160919121:-	0.2	3.73	0.000217	Type 2 diabetes	
KIRC	cis	1	rs10932772	chr2:219177148	GPBAR1	chr2:219125738-219128582:+	-0.17	-3.61	0.00034	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.39	7.53	2.39E-13	Urinary metabolites	
KIRC	cis	1	rs10934850	chr3:127886957	KBTBD12	chr3:127634318-127706513:+	0.29	4.02	6.74E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10934850	chr3:127886957	RUVBL1	chr3:127783627-127872757:-	0.35	4.96	9.66E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.58	-14.09	3.14E-38	Height	
KIRC	cis	1	rs10935120	chr3:134233092	CEP63	chr3:134204575-134293852:+	-0.31	-6.11	2.06E-9	Height	
KIRC	cis	1	rs10937226	chr3:185302885	TMEM41A	chr3:185207389-185216845:-	0.17	3.55	0.000415	Systolic blood pressure	
KIRC	cis	1	rs10937463	chr3:190985247	UTS2D	chr3:190984945-191048325:-	0.2	3.63	0.000317	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs10937464	chr3:190985274	UTS2D	chr3:190984945-191048325:-	-0.21	-3.78	0.000178	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs10937465	chr3:190985279	UTS2D	chr3:190984945-191048325:-	-0.21	-3.78	0.000178	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs10939738	chr4:17604295	LAP3	chr4:17578927-17609590:+	-0.19	-5.93	5.61E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939738	chr4:17604295	MED28	chr4:17616273-17629791:+	0.2	4.64	4.41E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939740	chr4:17617490	LAP3	chr4:17578927-17609590:+	-0.19	-5.71	1.97E-8	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939740	chr4:17617490	MED28	chr4:17616273-17629791:+	0.21	4.64	4.41E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939742	chr4:17659936	LAP3	chr4:17578927-17609590:+	-0.21	-6.43	2.94E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939742	chr4:17659936	MED28	chr4:17616273-17629791:+	0.17	3.89	0.000112	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939743	chr4:17662731	LAP3	chr4:17578927-17609590:+	-0.21	-6.53	1.6E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939743	chr4:17662731	MED28	chr4:17616273-17629791:+	0.18	4.08	5.2E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939744	chr4:17664473	LAP3	chr4:17578927-17609590:+	-0.21	-6.47	2.29E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939744	chr4:17664473	MED28	chr4:17616273-17629791:+	0.18	4.12	4.44E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939746	chr4:17684951	LAP3	chr4:17578927-17609590:+	0.21	6.62	9.48E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939746	chr4:17684951	MED28	chr4:17616273-17629791:+	-0.17	-3.76	0.000194	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939747	chr4:17691166	LAP3	chr4:17578927-17609590:+	-0.22	-6.62	9.29E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939747	chr4:17691166	MED28	chr4:17616273-17629791:+	0.2	4.35	1.62E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939748	chr4:17691230	LAP3	chr4:17578927-17609590:+	-0.22	-6.62	9.29E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939748	chr4:17691230	MED28	chr4:17616273-17629791:+	0.2	4.35	1.62E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939749	chr4:17692319	LAP3	chr4:17578927-17609590:+	-0.2	-6.23	9.91E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939749	chr4:17692319	MED28	chr4:17616273-17629791:+	0.2	4.57	6.25E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939750	chr4:17692422	LAP3	chr4:17578927-17609590:+	-0.19	-5.95	5.11E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939750	chr4:17692422	MED28	chr4:17616273-17629791:+	0.21	4.81	1.96E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939756	chr4:17693867	LAP3	chr4:17578927-17609590:+	-0.2	-6.14	1.68E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10939756	chr4:17693867	MED28	chr4:17616273-17629791:+	0.21	4.79	2.18E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.5	-10.51	1.73E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.46	-10.13	4.6E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.46	-9.99	1.47E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs10945682	chr6:161069941	PLG	chr6:161123274-161174345:+	0.31	6.17	1.37E-9	Lipoprotein (a) levels	
KIRC	cis	1	rs10945683	chr6:161069952	PLG	chr6:161123274-161174345:+	0.26	5.28	1.89E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs10946198	chr6:167404432	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs10946199	chr6:167404492	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs10946834	chr6:26533664	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs10946835	chr6:26533757	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs10948974	chr6:55992520	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs10948975	chr6:55992744	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs10950032	chr7:65738591	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs10954872	chr8:29978612	MBOAT4	chr8:29989188-30002200:-	-0.33	-4.76	2.55E-6	Migraine	
KIRC	cis	1	rs10955943	chr8:120944143	DSCC1	chr8:120846182-120868170:-	-0.19	-4.03	6.54E-5	Interstitial lung disease	
KIRC	cis	1	rs10957125	chr8:61194170	CA8	chr8:61101423-61193954:-	0.29	5.56	4.42E-8	Response to amphetamines	
KIRC	cis	1	rs10957375	chr8:67355484	ADHFE1	chr8:67344718-67381042:+	0.23	4.73	2.92E-6	Blood metabolite levels	
KIRC	cis	1	rs10966	chr20:25282944	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.49	2.12E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10966	chr20:25282944	FAM182A	chr20:26035250-26067552:+	-0.28	-5.37	1.22E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs10971721	chr9:33827694	NUDT2	chr9:34329504-34343695:+	0.3	3.73	0.000212	Body mass index	
KIRC	cis	1	rs10984361	chr9:100681490	C9orf156	chr9:100666772-100684852:-	-0.29	-6.52	1.75E-10	Quantitative traits	
KIRC	cis	1	rs10984506	chr9:100716140	C9orf156	chr9:100666772-100684852:-	-0.29	-6.3	6.39E-10	Quantitative traits	
KIRC	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.49	12.92	3.59E-33	Blood metabolite levels	
KIRC	cis	1	rs10988214	chr9:131883752	SET	chr9:131445934-131458674:+	-0.17	-3.82	0.000147	Blood metabolite ratios	
KIRC	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.15	3.8	0.000162	Blood metabolite ratios	
KIRC	cis	1	rs10988223	chr9:131903021	PPP2R4	chr9:131873244-131911223:+	0.22	4.14	4.04E-5	Blood metabolite ratios	
KIRC	cis	1	rs10988223	chr9:131903021	SET	chr9:131445934-131458674:+	-0.17	-3.66	0.000274	Blood metabolite ratios	
KIRC	cis	1	rs10988224	chr9:131903334	SET	chr9:131445934-131458674:+	-0.18	-3.95	8.93E-5	Blood metabolite ratios	
KIRC	cis	1	rs10988232	chr9:131915348	SET	chr9:131445934-131458674:+	-0.16	-3.53	0.000447	Blood metabolite ratios	
KIRC	cis	1	rs10997979	chr10:69937192	MYPN	chr10:69865876-69971771:+	0.24	4.5	8.39E-6	Height	
KIRC	cis	1	rs10997982	chr10:69939548	MYPN	chr10:69865876-69971771:+	-0.24	-4.55	6.65E-6	Height	
KIRC	cis	1	rs10998009	chr10:69953416	MYPN	chr10:69865876-69971771:+	-0.24	-4.48	9.21E-6	Height	
KIRC	cis	1	rs11004802	chr10:52011440	FAM21A	chr10:51827684-51893268:+	-0.32	-4.39	1.36E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs11008099	chr10:30834632	MTPAP	chr10:30598731-30663377:-	0.3	3.56	0.000409	QT interval	
KIRC	cis	1	rs11011339	chr10:37996346	LOC399744	chr10:38717074-38741080:+	0.23	3.94	9.29E-5	Obesity (extreme)	
KIRC	cis	1	rs11011344	chr10:38004846	LOC399744	chr10:38717074-38741080:+	0.23	3.92	0.000101	Obesity (extreme)	
KIRC	cis	1	rs11013962	chr10:24495586	PRINS	chr10:24536054-24544975:+	-0.18	-4	7.23E-5	Common traits (Other)	
KIRC	cis	1	rs11022131	chr11:12072213	DKK3	chr11:11984545-12031316:-	0.17	4.04	6.15E-5	Warfarin maintenance dose	
KIRC	cis	1	rs11026412	chr11:22114093	ANO5	chr11:22214722-22304913:+	0.26	4.9	1.29E-6	Parkinson's disease	
KIRC	cis	1	rs11026416	chr11:22125058	ANO5	chr11:22214722-22304913:+	0.29	5.2	2.91E-7	Parkinson's disease	
KIRC	cis	1	rs11026797	chr11:22822270	SVIP	chr11:22843600-22851382:-	0.25	4.04	6.08E-5	Dialysis-related mortality	
KIRC	cis	1	rs11026798	chr11:22822579	SVIP	chr11:22843600-22851382:-	0.25	4.05	6.05E-5	Dialysis-related mortality	
KIRC	cis	1	rs11026804	chr11:22841582	GAS2	chr11:22688160-22834546:+	0.19	3.61	0.000332	Dialysis-related mortality	
KIRC	cis	1	rs11026804	chr11:22841582	SVIP	chr11:22843600-22851382:-	0.31	6.83	2.46E-11	Dialysis-related mortality	
KIRC	cis	1	rs11031058	chr11:30375889	C11orf46	chr11:30344649-30359978:+	0.29	4.45	1.08E-5	Sex hormone levels;Menopause (age at onset)	
KIRC	cis	1	rs11037984	chr11:5556662	TRIM6	chr11:5617347-5634188:+	-0.19	-4.5	8.28E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11037993	chr11:5557197	TRIM6	chr11:5617347-5634188:+	-0.2	-4.63	4.58E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11038000	chr11:5557704	TRIM6	chr11:5617347-5634188:+	-0.19	-4.5	8.28E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11038004	chr11:5557918	TRIM6	chr11:5617347-5634188:+	-0.19	-4.5	8.28E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.46	-9.73	1.28E-20	Subjective well-being	
KIRC	cis	1	rs11039255	chr11:47495746	PSMC3	chr11:47440320-47448024:-	0.13	3.93	9.55E-5	Subjective well-being	
KIRC	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs11039390	chr11:47796295	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.04	9.36E-22	Subjective well-being	
KIRC	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.13E-21	Subjective well-being	
KIRC	cis	1	rs11040899	chr11:6520015	FXC1	chr11:6502677-6505910:+	0.16	4.18	3.38E-5	DNA methylation (variation)	
KIRC	cis	1	rs11045982	chr12:8665760	CLEC4D	chr12:8666136-8674958:+	0.37	5.69	2.13E-8	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
KIRC	cis	1	rs11045983	chr12:8666118	CLEC4D	chr12:8666136-8674958:+	0.37	5.7	2.05E-8	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
KIRC	cis	1	rs11048457	chr12:26463174	BHLHE41	chr12:26272961-26278003:-	-0.37	-7.12	3.84E-12	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs11048457	chr12:26463174	RASSF8	chr12:26111969-26232824:+	-0.18	-3.62	0.000322	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs11048457	chr12:26463174	SSPN	chr12:26348269-26405853:+	-0.18	-3.72	0.000223	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs11049532	chr12:28476912	CCDC91	chr12:28332210-28703098:+	0.19	3.57	0.000385	Height	
KIRC	cis	1	rs11057393	chr12:124403769	CCDC92	chr12:124420955-124457163:-	0.17	4.31	1.95E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11057394	chr12:124407676	CCDC92	chr12:124420955-124457163:-	0.19	4.89	1.38E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11057394	chr12:124407676	DNAH10	chr12:124247042-124420265:+	0.2	3.94	9.24E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11057396	chr12:124419062	CCDC92	chr12:124420955-124457163:-	0.19	4.87	1.47E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11057397	chr12:124419728	CCDC92	chr12:124420955-124457163:-	0.18	4.75	2.69E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11057399	chr12:124425078	CCDC92	chr12:124420955-124457163:-	0.19	5.03	6.78E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1105881	chr15:42072530	JMJD7-PLA2G4B	chr15:42120283-42140345:+	0.11	3.91	0.000103	Educational attainment	
KIRC	cis	1	rs1105881	chr15:42072530	SPTBN5	chr15:42140345-42186275:-	0.13	3.63	0.000316	Educational attainment	
KIRC	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.51	7.93	1.45E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs11064210	chr12:6576721	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.01	7.05E-5	Hip geometry	
KIRC	cis	1	rs11064218	chr12:6586261	TAPBPL	chr12:6561177-6575601:+	-0.25	-3.94	9.34E-5	Hip geometry	
KIRC	cis	1	rs11064881	chr12:120146925	PRKAB1	chr12:120105757-120119428:+	-0.61	-7.46	3.83E-13	Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.13	-4.51	7.93E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.29	6.08	2.38E-9	HDL cholesterol	
KIRC	cis	1	rs11068224	chr12:117324967	FBXW8	chr12:117348761-117470180:+	-0.37	-4.88	1.41E-6	Subcortical brain region volumes	
KIRC	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.27	7.19	2.37E-12	QT interval	
KIRC	cis	1	rs11070800	chr15:50907347	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.92E-14	QT interval	
KIRC	cis	1	rs11070800	chr15:50907347	TRPM7	chr15:50852491-50978994:-	0.13	3.76	0.000193	QT interval	
KIRC	cis	1	rs11070805	chr15:50964192	SPPL2A	chr15:50999739-51057910:-	0.27	6.99	8.81E-12	QT interval	
KIRC	cis	1	rs11070807	chr15:50974505	SPPL2A	chr15:50999739-51057910:-	0.29	7.26	1.46E-12	QT interval	
KIRC	cis	1	rs11071246	chr15:56377778	TEX9	chr15:56657644-56738071:+	-0.27	-4.63	4.6E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11071253	chr15:56471123	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.02E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11071846	chr15:65792839	DPP8	chr15:65737999-65810035:-	0.12	4.84	1.73E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs11072603	chr15:76881138	SCAPER	chr15:76640529-77197744:-	-0.17	-5.87	7.72E-9	Blood metabolite levels	
KIRC	cis	1	rs11072800	chr15:79045857	ADAMTS7	chr15:79051546-79103773:-	-0.13	-3.68	0.000258	Coronary artery disease or large artery stroke	
KIRC	cis	1	rs11072804	chr15:79078486	CTSH	chr15:79214092-79237420:-	0.18	3.88	0.000117	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11072805	chr15:79078518	CTSH	chr15:79214092-79237420:-	0.18	3.88	0.000117	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1107328	chr9:131917534	CRAT	chr9:131857075-131873070:-	-0.16	-3.74	0.000206	Blood metabolite ratios	
KIRC	cis	1	rs11075734	chr16:69801397	COG4	chr16:70514473-70557457:-	-0.21	-3.88	0.000119	IgE levels	
KIRC	cis	1	rs11076105	chr16:55614197	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.22	2.85E-5	Thyroid hormone levels	
KIRC	cis	1	rs11076106	chr16:55614447	LPCAT2	chr16:55542913-55620581:+	-0.18	-4.44	1.09E-5	Thyroid hormone levels	
KIRC	cis	1	rs1107767	chr16:68020063	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.55	6.77E-6	Crohn's disease	
KIRC	cis	1	rs1107767	chr16:68020063	TPPP3	chr16:67423714-67427421:-	-0.26	-3.53	0.000451	Crohn's disease	
KIRC	cis	1	rs11079034	chr17:40288890	DHX58	chr17:40253422-40264751:-	-0.35	-6.92	1.36E-11	Fibrinogen levels	
KIRC	cis	1	rs11079159	chr17:53373550	HLF	chr17:53342321-53402426:+	0.17	3.54	0.000434	QRS duration	
KIRC	cis	1	rs11079508	chr17:61750066	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs11079508	chr17:61750066	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs11079509	chr17:61762148	FTSJ3	chr17:61896795-61905031:-	0.33	6.25	9.02E-10	Body mass index	
KIRC	cis	1	rs11079509	chr17:61762148	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.3	2.09E-5	Body mass index	
KIRC	cis	1	rs11079511	chr17:61858537	DDX42	chr17:61851567-61896676:+	-0.17	-3.64	0.000301	Body mass index	
KIRC	cis	1	rs11079511	chr17:61858537	FTSJ3	chr17:61896795-61905031:-	0.33	6.46	2.54E-10	Body mass index	
KIRC	cis	1	rs11079511	chr17:61858537	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.43	1.15E-5	Body mass index	
KIRC	cis	1	rs11080114	chr17:28407287	EFCAB5	chr17:28256874-28435469:+	-0.38	-6.67	6.65E-11	Coffee consumption (cups per day)	
KIRC	cis	1	rs11083475	chr19:39188112	CAPN12	chr19:39220832-39235114:-	-0.14	-4.51	7.97E-6	Heart rate	
KIRC	cis	1	rs11085466	chr19:21751811	ZNF429	chr19:21688437-21739068:+	0.19	3.73	0.00021	Colorectal or endometrial cancer	
KIRC	cis	1	rs11086102	chr19:18398628	JUND	chr19:18390563-18392432:-	-0.17	-3.84	0.000139	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11086102	chr19:18398628	KIAA1683	chr19:18367906-18385319:-	-0.23	-5.74	1.67E-8	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11086102	chr19:18398628	MAST3	chr19:18208603-18262498:+	0.14	3.73	0.000213	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11087520	chr20:25436827	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.94	1.21E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.29	-5.6	3.45E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11087521	chr20:25440648	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.7	5.52E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.34	-6.37	4.22E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11088226	chr21:33925531	TCP10L	chr21:33947152-33957845:-	-0.38	-6.64	7.96E-11	Gastritis	
KIRC	cis	1	rs1109227	chr3:48479207	SHISA5	chr3:48509197-48542228:-	-0.12	-3.55	0.000422	Longevity	
KIRC	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.32	-9.23	7.35E-19	Longevity	
KIRC	cis	1	rs11096982	chr4:39134867	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs11097431	chr4:95506842	PDLIM5	chr4:95373038-95589376:+	-0.2	-4.31	1.98E-5	Response to simvastatin treatment (PCSK9 protein level change)	
KIRC	cis	1	rs11097901	chr4:106729933	INTS12	chr4:106603787-106629881:-	-0.55	-5.83	9.84E-9	Post bronchodilator FEV1	
KIRC	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.52	8.09	4.59E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs11100	chr20:25281184	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.29	6.74E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.91E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs11101730	chr10:135197336	PAOX	chr10:135192741-135205197:+	-0.39	-5.41	9.79E-8	Blood metabolite levels	
KIRC	cis	1	rs11101731	chr10:135197376	PAOX	chr10:135192741-135205197:+	-0.39	-5.41	9.79E-8	Blood metabolite levels	
KIRC	cis	1	rs1110209	chr2:161199498	PLA2R1	chr2:160798012-160919121:-	0.19	3.51	0.000485	Type 2 diabetes	
KIRC	cis	1	rs11111789	chr12:104191540	NT5DC3	chr12:104164231-104234975:-	-0.24	-4.19	3.34E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs11111791	chr12:104193271	NT5DC3	chr12:104164231-104234975:-	-0.24	-3.99	7.62E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs11111792	chr12:104194857	NT5DC3	chr12:104164231-104234975:-	-0.24	-4.19	3.23E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs11114703	chr12:81434989	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114703	chr12:81434989	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114704	chr12:81436269	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114704	chr12:81436269	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114710	chr12:81440183	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114710	chr12:81440183	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114711	chr12:81440265	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114711	chr12:81440265	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114720	chr12:81443764	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114720	chr12:81443764	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114722	chr12:81447755	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114722	chr12:81447755	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114723	chr12:81449343	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114723	chr12:81449343	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114724	chr12:81449717	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114724	chr12:81449717	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114735	chr12:81457413	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114735	chr12:81457413	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114736	chr12:81457508	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114736	chr12:81457508	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114737	chr12:81457732	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114737	chr12:81457732	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114739	chr12:81459675	ACSS3	chr12:81471809-81649582:+	0.16	3.73	0.000215	Neuroticism	
KIRC	cis	1	rs11114739	chr12:81459675	LIN7A	chr12:81191171-81331694:-	0.19	4.77	2.44E-6	Neuroticism	
KIRC	cis	1	rs11114740	chr12:81459887	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs11114740	chr12:81459887	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs11114743	chr12:81464705	ACSS3	chr12:81471809-81649582:+	0.16	3.52	0.00047	Neuroticism	
KIRC	cis	1	rs11114743	chr12:81464705	LIN7A	chr12:81191171-81331694:-	0.2	5.01	7.49E-7	Neuroticism	
KIRC	cis	1	rs11115015	chr12:82174543	PPFIA2	chr12:81652880-82153109:-	0.41	7.33	9.05E-13	Resting heart rate	
KIRC	cis	1	rs11115017	chr12:82176914	PPFIA2	chr12:81652880-82153109:-	0.4	7.23	1.87E-12	Resting heart rate	
KIRC	cis	1	rs11115030	chr12:82203021	PPFIA2	chr12:81652880-82153109:-	0.4	7.16	2.82E-12	Resting heart rate	
KIRC	cis	1	rs11115047	chr12:82232773	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs11119884	chr1:212400146	TMEM206	chr1:212537819-212588267:-	0.19	3.8	0.000159	Intelligence (childhood)	
KIRC	cis	1	rs11119885	chr1:212400998	TMEM206	chr1:212537819-212588267:-	0.18	3.58	0.00038	Intelligence (childhood)	
KIRC	cis	1	rs11121022	chr1:7836659	VAMP3	chr1:7831329-7841491:+	0.17	3.63	0.000309	Morning vs. evening chronotype	
KIRC	cis	1	rs11121319	chr1:9145280	CLSTN1	chr1:9789080-9884550:-	0.19	3.65	0.000291	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs11121319	chr1:9145280	GPR157	chr1:9164476-9189356:-	0.21	4.12	4.47E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs11121323	chr1:9156071	CLSTN1	chr1:9789080-9884550:-	0.19	3.52	0.000465	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs11121323	chr1:9156071	GPR157	chr1:9164476-9189356:-	0.21	3.8	0.000161	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.27	-6.59	1.13E-10	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs11121532	chr1:10277898	RBP7	chr1:10057255-10076077:+	0.15	3.55	0.00042	Hepatocellular carcinoma	
KIRC	cis	1	rs1112163	chr8:89425263	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs11121702	chr1:11293147	MTOR	chr1:11166589-11322608:-	-0.16	-4.2	3.2E-5	Body mass index	
KIRC	cis	1	rs11121703	chr1:11293792	MTOR	chr1:11166589-11322608:-	0.16	4.28	2.27E-5	Body mass index	
KIRC	cis	1	rs11121704	chr1:11293959	MTOR	chr1:11166589-11322608:-	0.14	3.78	0.000178	Body mass index	
KIRC	cis	1	rs11121706	chr1:11302065	MTOR	chr1:11166589-11322608:-	-0.16	-4.18	3.39E-5	Body mass index	
KIRC	cis	1	rs11121710	chr1:11313244	MTOR	chr1:11166589-11322608:-	-0.16	-4.19	3.23E-5	Body mass index	
KIRC	cis	1	rs11121711	chr1:11317661	MTOR	chr1:11166589-11322608:-	-0.16	-4.33	1.8E-5	Body mass index	
KIRC	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.69	-14.49	5.4E-40	Renal function-related traits (BUN)	
KIRC	cis	1	rs11124575	chr2:37500435	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.82	1.94E-6	Chronic lymphocytic leukemia	
KIRC	cis	1	rs111248783	chr4:106770998	INTS12	chr4:106603787-106629881:-	-0.73	-7.51	2.77E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11125074	chr2:46655260	CRIPT	chr2:46844325-46852880:+	0.16	3.84	0.000141	HDL cholesterol	
KIRC	cis	1	rs11125529	chr2:54475866	ACYP2	chr2:54342410-54532433:+	0.21	3.82	0.000152	Telomere length	
KIRC	cis	1	rs111259072	chr19:12156569	ZNF763	chr19:12035900-12091196:+	-0.36	-4.99	8.14E-7	Multiple sclerosis	
KIRC	cis	1	rs11126251	chr2:70163434	ANXA4	chr2:69969127-70053594:+	-0.22	-5.29	1.85E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs11127071	chr2:27838058	NRBP1	chr2:27650657-27665122:+	0.14	3.72	0.000225	Oral cavity cancer	
KIRC	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.47	-10.12	5.06E-22	Body mass index	
KIRC	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.32	-9.26	5.85E-19	Longevity	
KIRC	cis	1	rs11130171	chr3:48462461	SHISA5	chr3:48509197-48542228:-	-0.12	-3.55	0.000415	Longevity	
KIRC	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.32	-9.2	9.24E-19	Longevity	
KIRC	cis	1	rs11130189	chr3:49347357	CCDC36	chr3:49235861-49295537:+	0.25	4.83	1.84E-6	Menarche (age at onset)	
KIRC	cis	1	rs11130189	chr3:49347357	NCKIPSD	chr3:48711280-48723334:-	0.22	4.42	1.22E-5	Menarche (age at onset)	
KIRC	cis	1	rs11130189	chr3:49347357	P4HTM	chr3:49027341-49044579:+	0.17	3.84	0.000138	Menarche (age at onset)	
KIRC	cis	1	rs11130189	chr3:49347357	TREX1	chr3:48501186-48509043:+	-0.15	-3.79	0.000169	Menarche (age at onset)	
KIRC	cis	1	rs11130189	chr3:49347357	WDR6	chr3:49044637-49053386:+	-0.22	-5.76	1.44E-8	Menarche (age at onset)	
KIRC	cis	1	rs11130190	chr3:49402137	CCDC36	chr3:49235861-49295537:+	0.25	4.71	3.16E-6	Menarche (age at onset)	
KIRC	cis	1	rs11130190	chr3:49402137	NCKIPSD	chr3:48711280-48723334:-	0.22	4.46	1.0E-5	Menarche (age at onset)	
KIRC	cis	1	rs11130190	chr3:49402137	P4HTM	chr3:49027341-49044579:+	0.21	4.65	4.33E-6	Menarche (age at onset)	
KIRC	cis	1	rs11130190	chr3:49402137	TREX1	chr3:48501186-48509043:+	-0.15	-3.81	0.000157	Menarche (age at onset)	
KIRC	cis	1	rs11130190	chr3:49402137	WDR6	chr3:49044637-49053386:+	-0.2	-5.02	7.18E-7	Menarche (age at onset)	
KIRC	cis	1	rs11130213	chr3:49712297	UBA7	chr3:49842639-49851391:-	0.15	4.06	5.8E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs11130338	chr3:53120924	ITIH3	chr3:52828784-52843025:+	0.15	3.71	0.000234	Height	
KIRC	cis	1	rs11130338	chr3:53120924	ITIH4	chr3:52847007-52866554:-	0.14	3.61	0.000343	Height	
KIRC	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.45	-11.89	7.06E-29	Height	
KIRC	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.72	-11.01	2.06E-25	Triptolide cytotoxicity	
KIRC	cis	1	rs11132254	chr4:185611592	CCDC111	chr4:185570767-185616112:+	0.19	3.81	0.000158	Kawasaki disease	
KIRC	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.61	-12.71	2.84E-32	Kawasaki disease	
KIRC	cis	1	rs111323769	chr4:171049059	AADAT	chr4:170981374-171011372:-	-0.46	-4.41	1.26E-5	Thyroid hormone levels	
KIRC	cis	1	rs11133399	chr4:56413831	SRD5A3	chr4:56212409-56237866:+	-0.21	-4.47	9.86E-6	Personality dimensions	
KIRC	cis	1	rs11133399	chr4:56413831	TMEM165	chr4:56262090-56292342:+	0.23	6.24	9.15E-10	Personality dimensions	
KIRC	cis	1	rs111344533	chr16:4654144	NMRAL1	chr16:4511696-4526307:-	-0.36	-4.18	3.42E-5	Obesity-related traits	
KIRC	cis	1	rs11134779	chr5:156936766	ADAM19	chr5:156822542-157002768:-	-0.11	-4.06	5.58E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs11134789	chr5:156944199	ADAM19	chr5:156822542-157002768:-	0.12	4.3	2.07E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs1114380	chr2:73804708	TPRKB	chr2:73956957-73964517:-	-0.21	-5.47	7.14E-8	Metabolite levels	
KIRC	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.42	-11.53	1.86E-27	Lewy body disease	
KIRC	cis	1	rs11148252	chr13:53009048	NEK3	chr13:52706780-52733996:-	0.16	4.08	5.15E-5	Lewy body disease	
KIRC	cis	1	rs11148252	chr13:53009048	VPS36	chr13:52986739-53024763:-	0.28	6.66	7.17E-11	Lewy body disease	
KIRC	cis	1	rs1115240	chr14:27090388	NOVA1	chr14:26915090-27066960:-	-0.23	-3.99	7.55E-5	Educational attainment (years of education)	
KIRC	cis	1	rs111547017	chr6:43341689	ZNF318	chr6:43278872-43337181:-	0.22	3.75	0.000195	Schizophrenia	
KIRC	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.25	5.08	5.24E-7	Atopic dermatitis	
KIRC	cis	1	rs11157696	chr14:50105746	RPL36AL	chr14:50085407-50087349:-	-0.34	-8.15	2.84E-15	Carotid intima media thickness	
KIRC	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.31	8.02	7.37E-15	Common traits (Other)	
KIRC	cis	1	rs11159117	chr14:75584867	MLH3	chr14:75480467-75518235:-	0.24	6	3.8E-9	Height	
KIRC	cis	1	rs11159117	chr14:75584867	NEK9	chr14:75548819-75593778:-	0.14	3.88	0.000116	Height	
KIRC	cis	1	rs11159183	chr14:76662902	ESRRB	chr14:76837690-76968178:+	0.34	4.88	1.42E-6	Blood pressure	
KIRC	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs11159833	chr14:88476004	GPR65	chr14:88471496-88478414:+	0.13	3.88	0.000117	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs11159856	chr14:88883929	SPATA7	chr14:88852012-88904802:+	-0.2	-4.03	6.4E-5	Coronary artery calcification	
KIRC	cis	1	rs111602331	chr20:44557474	PLTP	chr20:44527397-44540786:-	-0.17	-4.07	5.4E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs11161510	chr1:76210289	ACADM	chr1:76190043-76229353:+	-0.2	-5.54	4.82E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs11161511	chr1:76210477	ACADM	chr1:76190043-76229353:+	-0.18	-4.91	1.22E-6	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs11161515	chr1:76212559	ACADM	chr1:76190043-76229353:+	0.2	5.56	4.3E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs11161521	chr1:76216330	ACADM	chr1:76190043-76229353:+	0.2	5.56	4.3E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs111632381	chr4:171108188	AADAT	chr4:170981374-171011372:-	-0.38	-3.87	0.000123	Thyroid hormone levels	
KIRC	cis	1	rs11163924	chr1:76132070	ACADM	chr1:76190043-76229353:+	-0.19	-5.42	9.27E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs111641740	chr20:33707177	PROCR	chr20:33758727-33765164:+	-0.29	-3.93	9.75E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.19	-4.33	1.8E-5	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs11166080	chr1:99186307	SNX7	chr1:99127236-99226054:+	0.19	4.9	1.3E-6	Proinsulin levels	
KIRC	cis	1	rs11166335	chr1:100257778	AGL	chr1:100315640-100389579:+	0.23	4.49	8.77E-6	White matter integrity (interaction)	
KIRC	cis	1	rs11166335	chr1:100257778	FRRS1	chr1:100174259-100231349:-	0.2	4.01	7.02E-5	White matter integrity (interaction)	
KIRC	cis	1	rs11166341	chr1:100268232	AGL	chr1:100315640-100389579:+	0.23	4.51	8.01E-6	White matter integrity (interaction)	
KIRC	cis	1	rs11166341	chr1:100268232	FRRS1	chr1:100174259-100231349:-	0.2	4.09	4.99E-5	White matter integrity (interaction)	
KIRC	cis	1	rs11166344	chr1:100272171	AGL	chr1:100315640-100389579:+	-0.25	-4.92	1.16E-6	White matter integrity (interaction)	
KIRC	cis	1	rs11166344	chr1:100272171	FRRS1	chr1:100174259-100231349:-	-0.18	-3.8	0.000162	White matter integrity (interaction)	
KIRC	cis	1	rs11166346	chr1:100273470	AGL	chr1:100315640-100389579:+	0.24	4.75	2.63E-6	White matter integrity (interaction)	
KIRC	cis	1	rs11166346	chr1:100273470	FRRS1	chr1:100174259-100231349:-	0.2	4.16	3.71E-5	White matter integrity (interaction)	
KIRC	cis	1	rs11167515	chr5:150239471	IRGM	chr5:150226085-150280295:+	0.6	7.82	3.16E-14	Crohn's disease	
KIRC	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.38	4.82	1.91E-6	Crohn's disease	
KIRC	cis	1	rs11167518	chr5:150258920	IRGM	chr5:150226085-150280295:+	0.52	7.06	5.53E-12	Crohn's disease	
KIRC	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.32	4.3	2.06E-5	Crohn's disease	
KIRC	cis	1	rs11167519	chr5:150265407	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs11167520	chr5:150265639	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs11167521	chr5:150271785	IRGM	chr5:150226085-150280295:+	0.5	6.75	4.0E-11	Crohn's disease	
KIRC	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.32	4.31	1.95E-5	Crohn's disease	
KIRC	cis	1	rs11167526	chr5:150332481	IRGM	chr5:150226085-150280295:+	0.54	6.5	1.97E-10	Crohn's disease	
KIRC	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.43	5.27	2.07E-7	Crohn's disease	
KIRC	cis	1	rs11168576	chr12:48840418	ZNF641	chr12:48735912-48745021:-	0.17	3.63	0.000318	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs111696803	chr9:100696636	C9orf156	chr9:100666772-100684852:-	-0.3	-6.62	9.24E-11	Quantitative traits	
KIRC	cis	1	rs1117010	chr4:48410949	OCIAD1	chr4:48833015-48863831:+	-0.23	-5.25	2.3E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs111706465	chr2:239452382	ILKAP	chr2:239079044-239112324:-	-0.24	-3.99	7.48E-5	Morning vs. evening chronotype	
KIRC	cis	1	rs11171803	chr12:56718422	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs11171803	chr12:56718422	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs11171806	chr12:56733531	RPS26	chr12:56435686-56438005:+	0.42	3.87	0.000125	Psoriasis vulgaris	
KIRC	cis	1	rs11172254	chr12:57968738	TSFM	chr12:58176536-58191367:+	0.22	5.66	2.55E-8	Rheumatoid arthritis	
KIRC	cis	1	rs11172254	chr12:57968738	XRCC6BP1	chr12:58335445-58351051:+	0.15	3.52	0.000472	Rheumatoid arthritis	
KIRC	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.29	6.15	1.63E-9	Multiple sclerosis	
KIRC	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.49	-12.91	4.16E-33	Multiple sclerosis	
KIRC	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.09	2.19E-9	Multiple sclerosis	
KIRC	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.31	6.61	9.95E-11	Multiple sclerosis	
KIRC	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.51	-13.47	1.58E-35	Multiple sclerosis	
KIRC	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.53	1.59E-10	Multiple sclerosis	
KIRC	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.31	6.56	1.31E-10	Multiple sclerosis	
KIRC	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.51	-13.57	6.07E-36	Multiple sclerosis	
KIRC	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.52	1.76E-10	Multiple sclerosis	
KIRC	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.31	6.56	1.31E-10	Multiple sclerosis	
KIRC	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.51	-13.57	6.07E-36	Multiple sclerosis	
KIRC	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.52	1.76E-10	Multiple sclerosis	
KIRC	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.31	6.77	3.72E-11	Multiple sclerosis	
KIRC	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.48	-12.58	1.0E-31	Multiple sclerosis	
KIRC	cis	1	rs11172344	chr12:58193448	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.38	3.96E-10	Multiple sclerosis	
KIRC	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.32	6.83	2.49E-11	Multiple sclerosis	
KIRC	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.51	-13.24	1.6E-34	Multiple sclerosis	
KIRC	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.18	1.36E-9	Multiple sclerosis	
KIRC	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.32	6.82	2.6E-11	Multiple sclerosis	
KIRC	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.51	-13.28	1.08E-34	Multiple sclerosis	
KIRC	cis	1	rs11172351	chr12:58213485	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.1	2.13E-9	Multiple sclerosis	
KIRC	cis	1	rs1117367	chr15:76872330	SCAPER	chr15:76640529-77197744:-	-0.17	-5.75	1.55E-8	Blood metabolite levels	
KIRC	cis	1	rs11174812	chr12:40425087	LRRK2	chr12:40618813-40763084:+	-0.14	-3.61	0.000342	Leprosy	
KIRC	cis	1	rs111873045	chr4:106639712	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.23	6.13	1.8E-9	Blood metabolite levels	
KIRC	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.24	6.55	1.41E-10	Blood metabolite levels	
KIRC	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.24	6.47	2.31E-10	Blood metabolite levels	
KIRC	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.24	6.4	3.56E-10	Blood metabolite levels	
KIRC	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.25	6.75	4.03E-11	Blood metabolite levels	
KIRC	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.25	6.69	5.85E-11	Blood metabolite levels	
KIRC	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.25	6.94	1.25E-11	Blood metabolite levels	
KIRC	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.26	-6.93	1.31E-11	Blood metabolite levels	
KIRC	cis	1	rs111885088	chr12:56657216	RPS26	chr12:56435686-56438005:+	-0.48	-4.22	2.94E-5	Psoriasis vulgaris	
KIRC	cis	1	rs111899361	chr7:1112348	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.62	3.2E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.85	8.19	2.2E-15	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.14	-4.7	3.42E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.14	-4.68	3.77E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.13	-4.51	7.93E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.13	-4.31	1.98E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.13	-4.31	1.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.13	-4.45	1.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.13	-4.45	1.04E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.17	-5.41	9.95E-8	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.14	-4.75	2.7E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.85E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.85E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.13	-4.54	7.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.14	-4.78	2.3E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.13	-4.55	6.85E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.14E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.13	-4.36	1.58E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.13	4.71	3.28E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.28	3.6	0.000347	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.16	-3.51	0.00048	Schizophrenia	
KIRC	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.35	-7.83	3.02E-14	Schizophrenia	
KIRC	cis	1	rs11200595	chr10:124142629	ARMS2	chr10:124214179-124216867:+	-0.18	-3.52	0.000467	Height	
KIRC	cis	1	rs11200964	chr10:81731442	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200964	chr10:81731442	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs11200965	chr10:81731452	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200965	chr10:81731452	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs11200967	chr10:81731562	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200967	chr10:81731562	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs11200971	chr10:81731950	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200971	chr10:81731950	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs11200982	chr10:81732349	LOC219347	chr10:81805991-81838949:-	-0.48	-4.53	7.22E-6	Rheumatoid arthritis	
KIRC	cis	1	rs11200984	chr10:81732366	LOC219347	chr10:81805991-81838949:-	-0.42	-4.26	2.43E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200984	chr10:81732366	LOC650623	chr10:81442731-81448648:+	0.3	3.66	0.000283	Rheumatoid arthritis	
KIRC	cis	1	rs11200985	chr10:81732653	LOC219347	chr10:81805991-81838949:-	-0.45	-4.31	1.93E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11200985	chr10:81732653	LOC650623	chr10:81442731-81448648:+	0.34	3.95	8.84E-5	Rheumatoid arthritis	
KIRC	cis	1	rs11201012	chr10:81739989	LOC219347	chr10:81805991-81838949:-	0.56	4.72	3.06E-6	Rheumatoid arthritis	
KIRC	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	1.06	15.75	1.04E-45	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	1.1	16.28	3.81E-48	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-1.05	-16.03	5.32E-47	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs112017572	chr19:12089903	GCDH	chr19:13001974-13010782:+	-0.34	-3.76	0.000193	Multiple sclerosis	
KIRC	cis	1	rs112017572	chr19:12089903	ZNF763	chr19:12035900-12091196:+	-0.53	-6.4	3.53E-10	Multiple sclerosis	
KIRC	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-1.05	-15.66	2.64E-45	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs11206230	chr1:54325688	TMEM48	chr1:54233390-54304175:-	-0.21	-3.49	0.000517	Nonalcoholic fatty liver disease	
KIRC	cis	1	rs112071449	chr4:171013233	AADAT	chr4:170981374-171011372:-	-0.43	-4.34	1.76E-5	Thyroid hormone levels	
KIRC	cis	1	rs112074246	chr19:12128021	ZNF763	chr19:12035900-12091196:+	-0.47	-5.84	9.6E-9	Multiple sclerosis	
KIRC	cis	1	rs112074927	chr4:75716421	BTC	chr4:75671448-75719882:-	0.28	3.67	0.000267	Electroencephalogram traits	
KIRC	cis	1	rs11210359	chr1:74339167	LRRIQ3	chr1:74491704-74663871:-	0.22	3.96	8.44E-5	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs1121089	chr4:17676476	LAP3	chr4:17578927-17609590:+	-0.21	-6.47	2.32E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1121089	chr4:17676476	MED28	chr4:17616273-17629791:+	0.16	3.57	0.000394	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1121090	chr4:17676437	LAP3	chr4:17578927-17609590:+	-0.2	-6.32	5.7E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1121090	chr4:17676437	MED28	chr4:17616273-17629791:+	0.17	3.69	0.00025	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1121091	chr4:17676386	LAP3	chr4:17578927-17609590:+	-0.2	-6.32	5.7E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1121091	chr4:17676386	MED28	chr4:17616273-17629791:+	0.17	3.69	0.00025	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.92	-21.99	1.41E-75	Homocysteine levels	
KIRC	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.3	4.29E-19	Body mass index	
KIRC	cis	1	rs11211199	chr1:46287869	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.35	2.97E-19	Body mass index	
KIRC	cis	1	rs11211208	chr1:46334256	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.54E-5	Body mass index	
KIRC	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs11211230	chr1:46406767	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.74	3.48E-17	Body mass index	
KIRC	cis	1	rs11211234	chr1:46438787	MUTYH	chr1:45794915-45806142:-	0.14	4.29	2.19E-5	Body mass index	
KIRC	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.75	3.27E-17	Body mass index	
KIRC	cis	1	rs11211241	chr1:46452683	MUTYH	chr1:45794915-45806142:-	0.14	4.28	2.24E-5	Body mass index	
KIRC	cis	1	rs11211394	chr1:47383352	CYP4A22	chr1:47603107-47614526:+	0.47	9.05	3.03E-18	Blood metabolite levels	
KIRC	cis	1	rs112143304	chr17:61822401	FTSJ3	chr17:61896795-61905031:-	0.32	6.1	2.17E-9	Body mass index	
KIRC	cis	1	rs112143304	chr17:61822401	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.26	2.4E-5	Body mass index	
KIRC	cis	1	rs11216316	chr11:117081500	PCSK7	chr11:117075789-117102811:-	0.31	5.9	6.79E-9	Protein quantitative trait loci	
KIRC	cis	1	rs112181719	chr10:81728929	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs1122326	chr17:40274873	DHX58	chr17:40253422-40264751:-	-0.31	-6.02	3.29E-9	Fibrinogen levels	
KIRC	cis	1	rs11226613	chr11:104972518	GRIA4	chr11:105480800-105852819:+	-0.26	-3.67	0.000265	Bronchopulmonary dysplasia	
KIRC	cis	1	rs11227284	chr11:65503224	SNX32	chr11:65601410-65621170:+	0.3	4.99	8.32E-7	Systemic lupus erythematosus	
KIRC	cis	1	rs11227288	chr11:65516588	SNX32	chr11:65601410-65621170:+	0.26	4.49	8.79E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs112279857	chr8:89463938	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.41E-5	Electrodermal activity	
KIRC	cis	1	rs11229555	chr11:58408687	ZFP91	chr11:58346587-58388513:+	-0.12	-3.61	0.000331	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs11230147	chr11:59877394	MS4A2	chr11:59856137-59866014:+	0.17	3.79	0.00017	Alzheimer's disease (late onset)	
KIRC	cis	1	rs11230155	chr11:59904959	MS4A2	chr11:59856137-59866014:+	0.17	3.59	0.000369	Alzheimer's disease (late onset)	
KIRC	cis	1	rs11230160	chr11:59919165	MS4A2	chr11:59856137-59866014:+	-0.19	-4.14	4.11E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs11230161	chr11:59920231	MS4A2	chr11:59856137-59866014:+	-0.19	-4.08	5.16E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs1123072	chr16:67898797	ATP6V0D1	chr16:67471917-67515089:-	-0.32	-4.5	8.5E-6	Crohn's disease	
KIRC	cis	1	rs112315514	chr19:12113334	ZNF763	chr19:12035900-12091196:+	-0.47	-5.84	9.38E-9	Multiple sclerosis	
KIRC	cis	1	rs11231757	chr11:64106317	CCDC88B	chr11:64107695-64125005:+	-0.09	-3.6	0.000354	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
KIRC	cis	1	rs11233933	chr11:71210070	DHCR7	chr11:71145459-71159477:-	-0.29	-4.66	3.99E-6	Vitamin D levels	
KIRC	cis	1	rs11233977	chr11:71221605	DHCR7	chr11:71145459-71159477:-	-0.27	-4.48	9.22E-6	Vitamin D levels	
KIRC	cis	1	rs11234027	chr11:71234107	DHCR7	chr11:71145459-71159477:-	-0.3	-4.79	2.17E-6	Vitamin D levels	
KIRC	cis	1	rs11235558	chr11:72373798	STARD10	chr11:72465775-72504750:-	0.15	3.63	0.000309	Rheumatoid arthritis	
KIRC	cis	1	rs11237438	chr11:77998488	NARS2	chr11:78147017-78285909:-	-0.17	-3.79	0.000168	Testicular germ cell tumor	
KIRC	cis	1	rs11237456	chr11:78040780	NARS2	chr11:78147017-78285909:-	-0.21	-5.01	7.58E-7	Testicular germ cell tumor	
KIRC	cis	1	rs11237460	chr11:78056274	NARS2	chr11:78147017-78285909:-	-0.21	-4.86	1.57E-6	Testicular germ cell tumor	
KIRC	cis	1	rs11237462	chr11:78058812	NARS2	chr11:78147017-78285909:-	-0.19	-4.24	2.61E-5	Testicular germ cell tumor	
KIRC	cis	1	rs11237468	chr11:78072833	NARS2	chr11:78147017-78285909:-	-0.2	-4.65	4.31E-6	Testicular germ cell tumor	
KIRC	cis	1	rs11237469	chr11:78072875	NARS2	chr11:78147017-78285909:-	-0.19	-4.14	4.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs11237471	chr11:78082604	NARS2	chr11:78147017-78285909:-	-0.18	-4.2	3.15E-5	Testicular germ cell tumor	
KIRC	cis	1	rs11237480	chr11:78110385	NARS2	chr11:78147017-78285909:-	-0.17	-3.93	9.6E-5	Testicular germ cell tumor	
KIRC	cis	1	rs11239544	chr10:46007533	ALOX5	chr10:45869629-45941561:+	-0.17	-3.74	0.000205	Cholesterol, total	
KIRC	cis	1	rs11239545	chr10:46012245	ALOX5	chr10:45869629-45941561:+	0.16	3.67	0.000265	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs11239545	chr10:46012245	OR13A1	chr10:45798102-45811056:-	0.2	3.86	0.000128	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs11239930	chr1:146560564	CHD1L	chr1:146714291-146767441:+	-0.21	-4.01	7.07E-5	AIDS progression	
KIRC	cis	1	rs112401426	chr1:76466103	MSH4	chr1:76262630-76378923:+	-0.26	-3.89	0.000115	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs11240594	chr1:205896235	SLC26A9	chr1:205882179-205912588:-	-0.24	-4.42	1.19E-5	Response to antipsychotic treatment	
KIRC	cis	1	rs112428033	chr5:115618260	COMMD10	chr5:115420727-115628978:+	0.38	3.83	0.000145	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs11242	chr3:53125922	ITIH3	chr3:52828784-52843025:+	-0.15	-3.73	0.000211	Height	
KIRC	cis	1	rs11242	chr3:53125922	ITIH4	chr3:52847007-52866554:-	-0.17	-4.35	1.62E-5	Height	
KIRC	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.43	11.6	9.56E-28	Height	
KIRC	cis	1	rs112434347	chr3:127840447	KBTBD12	chr3:127634318-127706513:+	0.27	3.6	0.000352	Post bronchodilator FEV1	
KIRC	cis	1	rs112434347	chr3:127840447	RPN1	chr3:128338813-128399918:-	0.21	3.56	0.000411	Post bronchodilator FEV1	
KIRC	cis	1	rs112434347	chr3:127840447	RUVBL1	chr3:127783627-127872757:-	0.34	4.79	2.19E-6	Post bronchodilator FEV1	
KIRC	cis	1	rs1124769	chr15:51352249	SPPL2A	chr15:50999739-51057910:-	0.25	5.39	1.08E-7	Cognitive performance	
KIRC	cis	1	rs11247915	chr1:26650550	GRRP1	chr1:26485511-26489118:+	-0.11	-3.54	0.00043	Obesity-related traits	
KIRC	cis	1	rs11247973	chr4:1094314	C4orf48	chr4:2043689-2045697:+	-0.15	-3.63	0.000311	Recombination rate (males)	
KIRC	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.44	7.31	1.1E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.44	7.22	1.88E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11250249	chr10:1116999	IDI2	chr10:1064847-1071799:-	0.37	4	7.29E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs11250252	chr10:1124939	IDI2	chr10:1064847-1071799:-	0.33	3.87	0.000124	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs11250264	chr10:1151723	IDI2	chr10:1064847-1071799:-	0.32	3.68	0.000256	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs112526325	chr16:67761917	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.87	1.53E-6	Crohn's disease	
KIRC	cis	1	rs112528936	chr4:106633029	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.26	-3.94	9.28E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs112537273	chr8:38248306	DDHD2	chr8:38089009-38120286:+	0.19	3.49	0.000516	Schizophrenia	
KIRC	cis	1	rs112537273	chr8:38248306	FGFR1	chr8:38268657-38326352:-	0.23	3.57	0.000393	Schizophrenia	
KIRC	cis	1	rs1125394	chr11:113297185	TTC12	chr11:113185251-113244016:+	0.33	4.91	1.25E-6	Select biomarker traits	
KIRC	cis	1	rs112564090	chr4:171024368	AADAT	chr4:170981374-171011372:-	-0.43	-4.15	3.85E-5	Thyroid hormone levels	
KIRC	cis	1	rs11259928	chr15:84568095	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.46	1.02E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259929	chr15:84577202	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259930	chr15:84577350	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259932	chr15:84580057	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.35	1.61E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259933	chr15:84580156	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.39	1.35E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259934	chr15:84580171	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.35	1.61E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259935	chr15:84580427	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.35	1.61E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259936	chr15:84580582	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.5	8.45E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11259937	chr15:84587833	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.59	5.5E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11264119	chr1:35676580	C1orf216	chr1:36179477-36184790:-	-0.26	-3.96	8.63E-5	Endometrial cancer	
KIRC	cis	1	rs11264120	chr1:35676595	C1orf216	chr1:36179477-36184790:-	-0.26	-3.96	8.63E-5	Endometrial cancer	
KIRC	cis	1	rs11264203	chr1:36239234	C1orf216	chr1:36179477-36184790:-	-0.39	-5.94	5.23E-9	Schizophrenia	
KIRC	cis	1	rs11264211	chr1:36270607	C1orf216	chr1:36179477-36184790:-	-0.36	-5.59	3.69E-8	Schizophrenia	
KIRC	cis	1	rs11264213	chr1:36283954	C1orf216	chr1:36179477-36184790:-	-0.35	-5.44	8.53E-8	Schizophrenia	
KIRC	cis	1	rs11264422	chr1:155907823	ADAM15	chr1:155023422-155035252:+	0.16	3.67	0.000269	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs11264462	chr1:156241728	BGLAP	chr1:156182784-156213112:+	0.34	7.26	1.53E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264462	chr1:156241728	CCT3	chr1:156278752-156308195:-	-0.19	-4.61	5.21E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.34	7.52	2.47E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264464	chr1:156250887	CCT3	chr1:156278752-156308195:-	-0.19	-4.8	2.13E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264467	chr1:156273061	BGLAP	chr1:156182784-156213112:+	-0.29	-6.3	6.38E-10	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264467	chr1:156273061	CCT3	chr1:156278752-156308195:-	0.16	4.03	6.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.34	7.5	2.87E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264468	chr1:156274585	CCT3	chr1:156278752-156308195:-	-0.18	-4.37	1.53E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs11264533	chr1:156718448	SLC25A44	chr1:156163730-156182586:+	0.14	3.5	0.000506	HDL cholesterol	
KIRC	cis	1	rs11264533	chr1:156718448	TTC24	chr1:156552022-156556902:+	-0.15	-3.93	9.62E-5	HDL cholesterol	
KIRC	cis	1	rs11264534	chr1:156720550	TTC24	chr1:156552022-156556902:+	-0.14	-3.65	0.000293	HDL cholesterol	
KIRC	cis	1	rs11264535	chr1:156722424	TTC24	chr1:156552022-156556902:+	-0.15	-3.98	7.87E-5	HDL cholesterol	
KIRC	cis	1	rs112654776	chr4:106765058	INTS12	chr4:106603787-106629881:-	-0.7	-7.47	3.69E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs1127311	chr1:154556663	IL6R	chr1:154377669-154440188:+	0.14	3.8	0.000165	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRC	cis	1	rs1127313	chr1:154556425	IL6R	chr1:154377669-154440188:+	-0.13	-3.55	0.000418	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRC	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs112765800	chr19:12125345	ZNF763	chr19:12035900-12091196:+	-0.47	-5.84	9.6E-9	Multiple sclerosis	
KIRC	cis	1	rs112777695	chr20:33693177	PROCR	chr20:33758727-33765164:+	-0.27	-3.67	0.00027	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs112795376	chr4:75716413	BTC	chr4:75671448-75719882:-	0.28	3.67	0.000267	Electroencephalogram traits	
KIRC	cis	1	rs1128320	chr11:244167	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs1128322	chr11:244197	PSMD13	chr11:236808-252984:+	0.16	5.26	2.11E-7	Menarche (age at onset)	
KIRC	cis	1	rs112868021	chr17:6687391	FBXO39	chr17:6679552-6700420:+	-0.37	-3.64	0.000301	Blood metabolite levels	
KIRC	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.14	-4.82	1.88E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs112932244	chr6:101590842	GRIK2	chr6:101846905-102517957:+	0.51	4.54	7.09E-6	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs1129448	chr22:38170026	TRIOBP	chr22:38082344-38172562:+	0.36	7.87	2.13E-14	Optic cup area;Vertical cup-disc ratio	
KIRC	cis	1	rs113031122	chr4:171049923	AADAT	chr4:170981374-171011372:-	-0.46	-4.41	1.26E-5	Thyroid hormone levels	
KIRC	cis	1	rs113033627	chr19:12166369	ZNF763	chr19:12035900-12091196:+	-0.36	-4.95	9.97E-7	Multiple sclerosis	
KIRC	cis	1	rs1130650	chr14:20940626	PNP	chr14:20937542-20945246:+	-0.3	-4.89	1.36E-6	Interferon alpha levels in systemic lupus erythematosus	
KIRC	cis	1	rs113066613	chr7:1094128	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs113075795	chr14:65968955	LOC645431	chr14:65877313-65879335:-	-0.49	-6.45	2.56E-10	Ischemic stroke	
KIRC	cis	1	rs113098833	chr14:103824592	PPP1R13B	chr14:104200088-104313927:-	0.23	3.51	0.00049	Red blood cell traits	
KIRC	cis	1	rs113104740	chr4:171063897	AADAT	chr4:170981374-171011372:-	-0.49	-4.67	3.89E-6	Thyroid hormone levels	
KIRC	cis	1	rs1131095	chr3:49714225	UBA7	chr3:49842639-49851391:-	0.15	4.04	6.26E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs113134232	chr17:61715461	FTSJ3	chr17:61896795-61905031:-	0.33	6.26	8.42E-10	Body mass index	
KIRC	cis	1	rs113134232	chr17:61715461	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.24	2.67E-5	Body mass index	
KIRC	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.79	10.59	8.84E-24	Multiple system atrophy	
KIRC	cis	1	rs113146460	chr7:1105164	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.52	5.57E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs1131498	chr1:169676486	SELL	chr1:169659810-169680837:-	-0.19	-4.64	4.43E-6	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs113179672	chr12:117327241	FBXW8	chr12:117348761-117470180:+	-0.37	-4.93	1.14E-6	Subcortical brain region volumes	
KIRC	cis	1	rs113205216	chr12:117326943	FBXW8	chr12:117348761-117470180:+	-0.32	-4.14	4.03E-5	Subcortical brain region volumes	
KIRC	cis	1	rs1133090	chr16:68021468	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-4.41	1.26E-5	Crohn's disease	
KIRC	cis	1	rs113315674	chr9:100720053	C9orf156	chr9:100666772-100684852:-	-0.29	-6.4	3.54E-10	Quantitative traits	
KIRC	cis	1	rs113330537	chr11:22818731	SVIP	chr11:22843600-22851382:-	0.27	4.08	5.25E-5	Dialysis-related mortality	
KIRC	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.78	-16.96	2.37E-51	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs113352275	chr15:78840567	CHRNA5	chr15:78857906-78886458:+	-0.3	-5.31	1.68E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs113427979	chr19:32855408	ZNF507	chr19:32836514-32878571:+	0.18	3.67	0.000273	Bipolar disorder	
KIRC	cis	1	rs1135172	chr1:11301714	MTOR	chr1:11166589-11322608:-	0.14	3.81	0.000156	Body mass index	
KIRC	cis	1	rs113572538	chr4:171036112	AADAT	chr4:170981374-171011372:-	-0.46	-4.48	9.37E-6	Thyroid hormone levels	
KIRC	cis	1	rs113575110	chr7:1084394	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.75	1.59E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	1.11	19.33	1.21E-62	Heschl's gyrus morphology	
KIRC	cis	1	rs113638727	chr15:40706101	IVD	chr15:40697686-40713512:+	-0.37	-5.61	3.41E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs113738158	chr8:89445712	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs113751790	chr4:171024528	AADAT	chr4:170981374-171011372:-	-0.44	-4.24	2.61E-5	Thyroid hormone levels	
KIRC	cis	1	rs113752978	chr4:171047434	AADAT	chr4:170981374-171011372:-	-0.46	-4.41	1.26E-5	Thyroid hormone levels	
KIRC	cis	1	rs113767110	chr4:106599814	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs113790048	chr19:12123995	ZNF763	chr19:12035900-12091196:+	-0.45	-5.57	4.11E-8	Multiple sclerosis	
KIRC	cis	1	rs113792528	chr8:89439450	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs1137	chr2:74939176	AUP1	chr2:74753776-74756974:-	0.14	3.64	0.000306	Myopia (pathological)	
KIRC	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.61	14.52	3.94E-40	Height	
KIRC	cis	1	rs1138273	chr3:134261437	CEP63	chr3:134204575-134293852:+	0.33	6.49	2.05E-10	Height	
KIRC	cis	1	rs113835537	chr11:66339639	DPP3	chr11:66247880-66277130:+	-0.21	-4.55	6.82E-6	Airway imaging phenotypes	
KIRC	cis	1	rs113848378	chr5:132192372	LEAP2	chr5:132209358-132210581:+	0.37	5.67	2.44E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs113848378	chr5:132192372	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.67E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs113855569	chr10:81728958	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs113858334	chr7:1073476	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.77	1.36E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs113899210	chr4:106664189	INTS12	chr4:106603787-106629881:-	-0.57	-6.21	1.14E-9	Post bronchodilator FEV1	
KIRC	cis	1	rs1139178	chr16:69781468	COG4	chr16:70514473-70557457:-	-0.2	-3.65	0.000292	IgE levels	
KIRC	cis	1	rs11400459	chr7:17385506	AHR	chr7:17338276-17385775:+	0.29	5.85	8.65E-9	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level);Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	
KIRC	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.35	7.79	3.98E-14	Pancreatic cancer	
KIRC	cis	1	rs1141313	chr2:27460968	C2orf28	chr2:27434899-27440044:+	0.16	4.6	5.35E-6	Blood metabolite levels	
KIRC	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.39	-9.01	4.38E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.25	8.39	5.13E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs114142124	chr11:78047537	NARS2	chr11:78147017-78285909:-	-0.19	-4.15	3.94E-5	Testicular germ cell tumor	
KIRC	cis	1	rs114171212	chr4:106616191	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs114176245	chr11:102719534	MMP1	chr11:102660641-102668966:-	0.39	4.06	5.59E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs114200987	chr14:35586916	KIAA0391	chr14:35591776-35786673:+	0.25	4.2	3.21E-5	Atopic dermatitis	
KIRC	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.26	5.13	4.22E-7	Atopic dermatitis	
KIRC	cis	1	rs114244137	chr5:150264753	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs114256679	chr4:106636598	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs114433731	chr8:89439454	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs114490726	chr4:17680898	LAP3	chr4:17578927-17609590:+	-0.21	-6.57	1.24E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs114490726	chr4:17680898	MED28	chr4:17616273-17629791:+	0.16	3.5	0.000498	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs114520702	chr2:203697092	ICA1L	chr2:203637873-203736371:-	0.29	3.72	0.000218	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs114562844	chr3:52991584	RFT1	chr3:53122503-53164470:-	0.36	5.49	6.28E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs114562844	chr3:52991584	SFMBT1	chr3:52938628-53080070:-	-0.26	-3.57	0.000391	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs114562844	chr3:52991584	TMEM110	chr3:52867139-52931547:-	0.37	6.29	7.02E-10	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs1147610	chr10:105941167	C10orf79	chr10:105889647-105992120:-	0.18	4.4	1.31E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.29	-5.08	5.37E-7	Polycystic ovary syndrome	
KIRC	cis	1	rs114810099	chr4:75708771	BTC	chr4:75671448-75719882:-	0.31	4.25	2.52E-5	Electroencephalogram traits	
KIRC	cis	1	rs114832687	chr18:51836446	C18orf54	chr18:51885171-51908403:+	-0.15	-3.6	0.000348	Psoriasis	
KIRC	cis	1	rs114832687	chr18:51836446	POLI	chr18:51795849-51824602:+	0.15	3.56	0.000405	Psoriasis	
KIRC	cis	1	rs11485508	chr1:152253167	FLG	chr1:152274651-152297679:-	-0.21	-3.62	0.000325	Atopic dermatitis	
KIRC	cis	1	rs11485508	chr1:152253167	HRNR	chr1:152184558-152196669:-	0.24	3.98	8.03E-5	Atopic dermatitis	
KIRC	cis	1	rs114897909	chr8:89449958	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs114914341	chr16:4617621	NMRAL1	chr16:4511696-4526307:-	-0.37	-4.39	1.37E-5	Obesity-related traits	
KIRC	cis	1	rs11492508	chr10:38098136	LOC399744	chr10:38717074-38741080:+	0.21	3.55	0.000422	Obesity (extreme)	
KIRC	cis	1	rs11492718	chr10:96787377	CYP2C9	chr10:96698415-96749147:+	0.18	3.52	0.000479	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs114948279	chr20:33733641	PROCR	chr20:33758727-33765164:+	-0.33	-4.23	2.82E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.74	11.13	7.24E-26	Diastolic blood pressure	
KIRC	cis	1	rs11513782	chr12:81464588	ACSS3	chr12:81471809-81649582:+	0.16	3.52	0.00047	Neuroticism	
KIRC	cis	1	rs11513782	chr12:81464588	LIN7A	chr12:81191171-81331694:-	0.2	5.01	7.49E-7	Neuroticism	
KIRC	cis	1	rs115177506	chr4:75708112	BTC	chr4:75671448-75719882:-	0.27	3.56	0.00041	Electroencephalogram traits	
KIRC	cis	1	rs11519750	chr12:81464627	LIN7A	chr12:81191171-81331694:-	0.2	4.96	9.87E-7	Neuroticism	
KIRC	cis	1	rs11519754	chr12:82209181	PPFIA2	chr12:81652880-82153109:-	0.41	7.28	1.33E-12	Resting heart rate	
KIRC	cis	1	rs1152591	chr14:64680848	MTHFD1	chr14:64854759-64926727:+	-0.23	-5.4	1.04E-7	Atrial fibrillation	
KIRC	cis	1	rs11532322	chr12:123731423	ARL6IP4	chr12:123464880-123467461:+	0.15	3.99	7.61E-5	Schizophrenia	
KIRC	cis	1	rs11532322	chr12:123731423	CDK2AP1	chr12:123745542-123756687:-	0.2	5.86	8.17E-9	Schizophrenia	
KIRC	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.28	5.71	1.93E-8	Diabetic kidney disease	
KIRC	cis	1	rs11538349	chr7:65421871	CRCP	chr7:65579805-65619551:+	-0.32	-4.4	1.31E-5	Diabetic kidney disease	
KIRC	cis	1	rs11538549	chr1:27248283	PIGV	chr1:27114455-27124886:+	-0.41	-4.59	5.68E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs115400054	chr2:203676105	ICA1L	chr2:203637873-203736371:-	0.29	3.61	0.000331	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs11542436	chr17:61778689	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.96E-10	Body mass index	
KIRC	cis	1	rs11542436	chr17:61778689	TCAM1P	chr17:61934376-61941738:+	-0.27	-4.83	1.78E-6	Body mass index	
KIRC	cis	1	rs115515961	chr18:51836253	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.28	-5.78	1.3E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs11555809	chr1:27216669	PIGV	chr1:27114455-27124886:+	-0.35	-4.02	6.62E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	1.11	19.29	1.99E-62	Heschl's gyrus morphology	
KIRC	cis	1	rs11557072	chr15:40713374	IVD	chr15:40697686-40713512:+	-0.37	-5.59	3.71E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs115630919	chr5:115505416	COMMD10	chr5:115420727-115628978:+	0.38	3.93	9.53E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1156340	chr17:66889120	ABCA8	chr17:66863433-66951533:-	-0.18	-3.68	0.000259	HDL cholesterol	
KIRC	cis	1	rs115743514	chr22:51011933	CPT1B	chr22:51007291-51017096:-	-0.27	-5.32	1.55E-7	Narcolepsy	
KIRC	cis	1	rs11575229	chr12:56750737	RPS26	chr12:56435686-56438005:+	-0.51	-4.39	1.41E-5	Psoriasis vulgaris	
KIRC	cis	1	rs11575231	chr12:56744445	COQ10A	chr12:56660642-56664748:+	-0.34	-3.5	0.000499	Psoriasis vulgaris	
KIRC	cis	1	rs11575231	chr12:56744445	RPS26	chr12:56435686-56438005:+	-0.52	-4.49	8.88E-6	Psoriasis vulgaris	
KIRC	cis	1	rs11575232	chr12:56744422	COQ10A	chr12:56660642-56664748:+	-0.34	-3.5	0.000499	Psoriasis vulgaris	
KIRC	cis	1	rs11575232	chr12:56744422	RPS26	chr12:56435686-56438005:+	-0.52	-4.49	8.88E-6	Psoriasis vulgaris	
KIRC	cis	1	rs11577151	chr1:183381795	LAMC2	chr1:183155174-183214262:+	0.3	3.53	0.000447	Obesity-related traits	
KIRC	cis	1	rs115772301	chr1:27075684	PIGV	chr1:27114455-27124886:+	-0.39	-4.54	7.11E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs115779493	chr13:96300448	UGGT2	chr13:96453838-96705736:-	-0.29	-3.89	0.000112	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
KIRC	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.46	8.83	1.72E-17	Body mass index	
KIRC	cis	1	rs11579634	chr1:46466391	MUTYH	chr1:45794915-45806142:-	-0.14	-4.15	3.92E-5	Body mass index	
KIRC	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.21	5.42	9.07E-8	Large artery stroke	
KIRC	cis	1	rs115852057	chr6:55983101	COL21A1	chr6:55921389-56258892:-	-0.48	-7.46	3.79E-13	Psychosis (atypical)	
KIRC	cis	1	rs11588062	chr1:46779764	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.75	2.65E-6	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs11588062	chr1:46779764	NSUN4	chr1:46806390-46830690:+	0.26	4.64	4.38E-6	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs11588857	chr1:204587047	MFSD4	chr1:205538112-205572045:+	0.21	3.54	0.000432	Educational attainment (college completion)	
KIRC	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.44	8.1	4.31E-15	Body mass index	
KIRC	cis	1	rs11589562	chr1:46466721	MUTYH	chr1:45794915-45806142:-	-0.13	-3.59	0.00036	Body mass index	
KIRC	cis	1	rs11590365	chr1:152165489	FLG	chr1:152274651-152297679:-	0.23	3.72	0.000226	Atopic dermatitis	
KIRC	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.25	6.77	3.57E-11	Blood metabolite levels	
KIRC	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.63	6.79	3.26E-11	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs11597286	chr10:38106455	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs11600716	chr11:59924422	MS4A2	chr11:59856137-59866014:+	0.17	3.72	0.00022	Alzheimer's disease (late onset)	
KIRC	cis	1	rs11600990	chr11:64082807	C11orf20	chr11:64067863-64072238:+	-0.36	-5.44	8.44E-8	Mean platelet volume	
KIRC	cis	1	rs11601161	chr11:78073280	NARS2	chr11:78147017-78285909:-	-0.19	-4.14	4.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs11601196	chr11:78043431	NARS2	chr11:78147017-78285909:-	-0.21	-4.68	3.73E-6	Testicular germ cell tumor	
KIRC	cis	1	rs11601590	chr11:78073288	NARS2	chr11:78147017-78285909:-	-0.2	-4.65	4.31E-6	Testicular germ cell tumor	
KIRC	cis	1	rs11602903	chr11:64358241	SLC22A12	chr11:64358282-64369820:+	-0.17	-4.68	3.68E-6	Urate levels in obese individuals	
KIRC	cis	1	rs11603112	chr11:78073491	NARS2	chr11:78147017-78285909:-	-0.2	-4.65	4.31E-6	Testicular germ cell tumor	
KIRC	cis	1	rs116034011	chr4:106735622	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11603890	chr11:58402251	ZFP91	chr11:58346587-58388513:+	-0.12	-3.7	0.000244	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs11604149	chr11:6519642	FXC1	chr11:6502677-6505910:+	-0.16	-4.27	2.39E-5	DNA methylation (variation)	
KIRC	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.47	-9.84	5.37E-21	Subjective well-being	
KIRC	cis	1	rs11609231	chr12:50932430	LIMA1	chr12:50569565-50677353:-	-0.23	-4.55	6.6E-6	Fibrinogen	
KIRC	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.1	3.53	0.000447	Breast size	
KIRC	cis	1	rs11613196	chr12:82173251	PPFIA2	chr12:81652880-82153109:-	-0.41	-7.37	7.31E-13	Resting heart rate	
KIRC	cis	1	rs11613331	chr12:351467	CCDC77	chr12:498516-551804:+	-0.19	-3.9	0.00011	Blood metabolite ratios	
KIRC	cis	1	rs116134049	chr5:115529655	COMMD10	chr5:115420727-115628978:+	0.39	4.03	6.54E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.28	-4.56	6.38E-6	Alzheimer's disease (APOE e4 interaction)	
KIRC	cis	1	rs11623413	chr14:75588824	MLH3	chr14:75480467-75518235:-	-0.24	-6	3.82E-9	Height	
KIRC	cis	1	rs11623413	chr14:75588824	NEK9	chr14:75548819-75593778:-	-0.13	-3.77	0.000185	Height	
KIRC	cis	1	rs11624293	chr14:88488821	GPR65	chr14:88471496-88478414:+	0.13	3.7	0.000236	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.33	8.96	6.55E-18	Common traits (Other)	
KIRC	cis	1	rs11629674	chr15:56469583	TEX9	chr15:56657644-56738071:+	-0.28	-4.96	9.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs116300850	chr5:76852234	LOC728723	chr5:76382623-76444175:+	0.2	3.57	0.000392	Alzheimer disease and age of onset	
KIRC	cis	1	rs11630417	chr15:68012609	IQCH	chr15:67547188-67794139:+	0.18	3.63	0.000315	Motion sickness	
KIRC	cis	1	rs11631518	chr15:56441360	TEX9	chr15:56657644-56738071:+	-0.29	-5.26	2.12E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11631910	chr15:56524096	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11632023	chr15:56457442	TEX9	chr15:56657644-56738071:+	-0.28	-4.96	9.44E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11632081	chr15:56524268	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11632087	chr15:56524307	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11632096	chr15:56210499	NEDD4	chr15:56119131-56285835:-	0.2	4.62	4.99E-6	Keloid	
KIRC	cis	1	rs11632157	chr15:59476088	LDHAL6B	chr15:59499042-59500707:+	-0.31	-3.91	0.000105	Metabolite levels	
KIRC	cis	1	rs11632310	chr15:65882326	DPP8	chr15:65737999-65810035:-	-0.12	-4.89	1.35E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs11632394	chr15:56511949	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11632465	chr15:85282045	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.47	9.84E-6	Schizophrenia	
KIRC	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.21	-4.15	3.95E-5	Schizophrenia	
KIRC	cis	1	rs11632619	chr15:56508995	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11633263	chr15:56135559	NEDD4	chr15:56119131-56285835:-	0.21	4.77	2.39E-6	Keloid	
KIRC	cis	1	rs11633301	chr15:84585038	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.51	8.12E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11633313	chr15:56135709	NEDD4	chr15:56119131-56285835:-	0.2	4.72	3.06E-6	Keloid	
KIRC	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.36	-6.84	2.37E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11634404	chr15:56413388	TEX9	chr15:56657644-56738071:+	-0.27	-4.59	5.66E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11634455	chr15:56490549	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11634689	chr15:56516920	TEX9	chr15:56657644-56738071:+	-0.28	-5.07	5.52E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11634746	chr15:50941496	SPPL2A	chr15:50999739-51057910:-	0.28	7.45	4.21E-13	QT interval	
KIRC	cis	1	rs11634746	chr15:50941496	TRPM7	chr15:50852491-50978994:-	0.12	3.56	0.000405	QT interval	
KIRC	cis	1	rs11636040	chr15:56439202	TEX9	chr15:56657644-56738071:+	-0.27	-4.69	3.49E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11636148	chr15:65796880	DPP8	chr15:65737999-65810035:-	0.11	4.55	6.66E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs11636964	chr15:50899616	SPPL2A	chr15:50999739-51057910:-	0.29	7.78	4.24E-14	QT interval	
KIRC	cis	1	rs11636964	chr15:50899616	TRPM7	chr15:50852491-50978994:-	0.13	3.81	0.000158	QT interval	
KIRC	cis	1	rs11637027	chr15:67937755	IQCH	chr15:67547188-67794139:+	0.18	3.71	0.000229	Motion sickness	
KIRC	cis	1	rs11637142	chr15:85295927	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.45	1.08E-5	Schizophrenia	
KIRC	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.21	-4.03	6.4E-5	Schizophrenia	
KIRC	cis	1	rs11637228	chr15:50899972	SPPL2A	chr15:50999739-51057910:-	0.29	7.78	4.24E-14	QT interval	
KIRC	cis	1	rs11637228	chr15:50899972	TRPM7	chr15:50852491-50978994:-	0.13	3.81	0.000158	QT interval	
KIRC	cis	1	rs11637431	chr15:65882251	DPP8	chr15:65737999-65810035:-	-0.12	-4.89	1.35E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs11637515	chr15:56511683	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11637519	chr15:59476316	LDHAL6B	chr15:59499042-59500707:+	-0.32	-3.79	0.000171	Metabolite levels	
KIRC	cis	1	rs11637852	chr15:63397151	LACTB	chr15:63414032-63434254:+	0.19	3.83	0.000144	HDL cholesterol	
KIRC	cis	1	rs11637866	chr15:84587958	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11637998	chr15:56516133	TEX9	chr15:56657644-56738071:+	-0.28	-5.07	5.52E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11638290	chr15:85227636	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.51	8.24E-6	Schizophrenia	
KIRC	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.22	-4.22	2.96E-5	Schizophrenia	
KIRC	cis	1	rs11638297	chr15:84782417	GOLGA6L5	chr15:85047738-85060078:-	-0.15	-4.24	2.62E-5	Schizophrenia	
KIRC	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.24	-4.77	2.39E-6	Schizophrenia	
KIRC	cis	1	rs11638394	chr15:84778928	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.39	1.39E-5	Schizophrenia	
KIRC	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.26	-5.07	5.66E-7	Schizophrenia	
KIRC	cis	1	rs11638709	chr15:56493724	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11638815	chr15:83352282	C15orf40	chr15:83657724-83680393:-	-0.29	-4.95	1.03E-6	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
KIRC	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.15	4.44	1.12E-5	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
KIRC	cis	1	rs116397649	chr5:115506021	COMMD10	chr5:115420727-115628978:+	0.38	3.93	9.53E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs11641365	chr16:88773893	CTU2	chr16:88772891-88781784:+	0.19	4.7	3.36E-6	Autism spectrum disorder-related traits	
KIRC	cis	1	rs11642377	chr16:20109653	LYRM1	chr16:20911557-20936326:+	-0.15	-3.63	0.000317	Attention deficit hyperactivity disorder (inattention symptoms)	
KIRC	cis	1	rs116434420	chr5:115582971	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs11644838	chr16:69812705	COG4	chr16:70514473-70557457:-	-0.2	-3.62	0.00032	IgE levels	
KIRC	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.63	9.74	1.15E-20	Urinary metabolites	
KIRC	cis	1	rs11647507	chr16:20095628	LYRM1	chr16:20911557-20936326:+	-0.15	-3.49	0.000523	Attention deficit hyperactivity disorder (inattention symptoms)	
KIRC	cis	1	rs11647946	chr16:4462836	LOC342346	chr16:4606491-4650317:+	0.21	3.67	0.000267	Schizophrenia	
KIRC	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.41	10.84	1.0E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11650372	chr17:45721795	ITGB3	chr17:45331208-45421658:+	0.18	4.23	2.73E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11650372	chr17:45721795	TBKBP1	chr17:45772630-45789427:+	-0.18	-4.56	6.43E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11651264	chr17:79576394	ARL16	chr17:79648234-79650954:-	0.18	4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs11651264	chr17:79576394	NPLOC4	chr17:79523915-79604138:-	0.12	3.71	0.000234	Eye color traits	
KIRC	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.63	-14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs11652797	chr17:79574124	ARL16	chr17:79648234-79650954:-	-0.17	-4.39	1.36E-5	Eye color traits	
KIRC	cis	1	rs11652797	chr17:79574124	NPLOC4	chr17:79523915-79604138:-	-0.11	-3.61	0.000334	Eye color traits	
KIRC	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.63	14.85	1.26E-41	Eye color traits	
KIRC	cis	1	rs11653	chr7:128409580	OPN1SW	chr7:128412545-128415844:-	0.24	4.06	5.76E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs11654335	chr17:61797579	FTSJ3	chr17:61896795-61905031:-	0.33	6.47	2.35E-10	Body mass index	
KIRC	cis	1	rs11654335	chr17:61797579	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.61	5.17E-6	Body mass index	
KIRC	cis	1	rs11657081	chr17:61792339	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.47E-10	Body mass index	
KIRC	cis	1	rs11657081	chr17:61792339	TCAM1P	chr17:61934376-61941738:+	-0.27	-4.87	1.53E-6	Body mass index	
KIRC	cis	1	rs11657120	chr17:61857218	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.43E-10	Body mass index	
KIRC	cis	1	rs11657120	chr17:61857218	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.86E-6	Body mass index	
KIRC	cis	1	rs11657217	chr17:77709339	ENPP7	chr17:77704882-77716020:+	-0.24	-5.02	7.18E-7	Diastolic blood pressure response to hydrochlorothiazide in hypertension	
KIRC	cis	1	rs11657306	chr17:61704822	DDX42	chr17:61851567-61896676:+	-0.16	-3.51	0.000496	Body mass index	
KIRC	cis	1	rs11657306	chr17:61704822	FTSJ3	chr17:61896795-61905031:-	0.31	6.21	1.12E-9	Body mass index	
KIRC	cis	1	rs11657306	chr17:61704822	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.07	5.47E-5	Body mass index	
KIRC	cis	1	rs11658175	chr17:61923838	FTSJ3	chr17:61896795-61905031:-	0.32	6.42	3.15E-10	Body mass index	
KIRC	cis	1	rs11658175	chr17:61923838	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.48	9.39E-6	Body mass index	
KIRC	cis	1	rs11658329	chr17:61763031	DDX42	chr17:61851567-61896676:+	0.16	3.55	0.000424	Body mass index	
KIRC	cis	1	rs11658329	chr17:61763031	FTSJ3	chr17:61896795-61905031:-	-0.31	-6.26	8.03E-10	Body mass index	
KIRC	cis	1	rs11658329	chr17:61763031	TCAM1P	chr17:61934376-61941738:+	0.26	4.68	3.66E-6	Body mass index	
KIRC	cis	1	rs11658555	chr17:18817486	FAM18B	chr17:18684582-18710026:+	0.23	5.24	2.32E-7	Pancreatic cancer	
KIRC	cis	1	rs11658740	chr17:61751069	FTSJ3	chr17:61896795-61905031:-	0.32	6.36	4.66E-10	Body mass index	
KIRC	cis	1	rs11658740	chr17:61751069	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.38E-6	Body mass index	
KIRC	cis	1	rs11663558	chr18:21133937	NPC1	chr18:21108363-21166581:-	0.19	3.7	0.000237	Body mass index	
KIRC	cis	1	rs116648076	chr2:99882347	LIPT1	chr2:99771418-99779611:+	0.28	4.78	2.31E-6	IgG glycosylation	
KIRC	cis	1	rs11665924	chr19:44286982	ZNF155	chr19:44488355-44502477:+	-0.25	-5.26	2.14E-7	Breast cancer	
KIRC	cis	1	rs11665924	chr19:44286982	ZNF404	chr19:44376516-44384288:-	-0.31	-6.31	6.01E-10	Breast cancer	
KIRC	cis	1	rs11668269	chr19:22513960	ZNF98	chr19:22573899-22605148:-	0.31	6.36	4.44E-10	Telomere length	
KIRC	cis	1	rs11669175	chr19:44289824	KCNN4	chr19:44270687-44285409:-	-0.12	-3.52	0.000467	Breast cancer	
KIRC	cis	1	rs11669175	chr19:44289824	ZNF155	chr19:44488355-44502477:+	-0.24	-5.09	5.02E-7	Breast cancer	
KIRC	cis	1	rs11669175	chr19:44289824	ZNF404	chr19:44376516-44384288:-	-0.31	-6.35	4.92E-10	Breast cancer	
KIRC	cis	1	rs11670668	chr19:41920454	ATP5SL	chr19:41937224-41945810:-	0.16	3.85	0.000135	Height	
KIRC	cis	1	rs11670757	chr19:41913431	ATP5SL	chr19:41937224-41945810:-	0.15	3.49	0.000526	Height	
KIRC	cis	1	rs11673344	chr19:37684966	HKR1	chr19:37803739-37855355:+	0.16	3.93	9.69E-5	Obesity-related traits	
KIRC	cis	1	rs11673344	chr19:37684966	ZNF585B	chr19:37675724-37701451:-	0.14	3.74	0.000203	Obesity-related traits	
KIRC	cis	1	rs11674602	chr2:73723185	TPRKB	chr2:73956957-73964517:-	-0.2	-5.22	2.65E-7	Metabolite levels	
KIRC	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.29	5.93	5.5E-9	Diabetic kidney disease	
KIRC	cis	1	rs1167613	chr7:65487439	CRCP	chr7:65579805-65619551:+	-0.29	-4.05	5.93E-5	Diabetic kidney disease	
KIRC	cis	1	rs1167725	chr12:120968559	POP5	chr12:121016849-121019201:-	-0.17	-4.04	6.09E-5	Type 1 diabetes nephropathy	
KIRC	cis	1	rs1167726	chr12:120967364	POP5	chr12:121016849-121019201:-	0.16	4.04	6.27E-5	Type 1 diabetes nephropathy	
KIRC	cis	1	rs1167727	chr12:120965508	POP5	chr12:121016849-121019201:-	-0.16	-3.96	8.57E-5	Type 1 diabetes nephropathy	
KIRC	cis	1	rs116781589	chr11:71825006	C11orf59	chr11:71808339-71814322:-	0.23	4.01	7.09E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.24	-8.51	1.98E-16	Body mass index	
KIRC	cis	1	rs1167827	chr7:75163169	STAG3L1	chr7:74988447-75026250:+	-0.22	-5.08	5.27E-7	Body mass index	
KIRC	cis	1	rs116795182	chr5:76852236	LOC728723	chr5:76382623-76444175:+	0.2	3.57	0.000392	Alzheimer disease and age of onset	
KIRC	cis	1	rs11681497	chr2:242344333	SEPT2	chr2:242254723-242293439:+	0.38	5.6	3.54E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs11681777	chr2:192121467	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs11684337	chr2:3395287	TTC15	chr2:3383446-3488857:+	-0.24	-5.2	2.96E-7	Obesity-related traits	
KIRC	cis	1	rs116849218	chr12:56683975	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs116867513	chr19:22166026	ZNF257	chr19:22235266-22273901:+	0.37	4.91	1.23E-6	Body mass index (change over time)	
KIRC	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.47	9.92	2.73E-21	Body mass index	
KIRC	cis	1	rs11689392	chr2:73622026	TPRKB	chr2:73956957-73964517:-	-0.19	-4.9	1.28E-6	Metabolite levels	
KIRC	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.47	10.09	6.2E-22	Body mass index	
KIRC	cis	1	rs11691372	chr2:192114678	STAT4	chr2:191894306-192038902:-	0.17	4.48	9.16E-6	Obesity-related traits	
KIRC	cis	1	rs11692425	chr2:3395383	TTC15	chr2:3383446-3488857:+	0.23	4.91	1.25E-6	Obesity-related traits	
KIRC	cis	1	rs11693602	chr2:161224658	PLA2R1	chr2:160798012-160919121:-	-0.22	-3.96	8.54E-5	Type 2 diabetes	
KIRC	cis	1	rs11695244	chr2:242176706	FARP2	chr2:242295711-242434255:+	0.2	4.27	2.33E-5	Chronic lymphocytic leukemia	
KIRC	cis	1	rs11696396	chr20:47753019	CSE1L	chr20:47662838-47713484:+	0.18	4.68	3.74E-6	Anger	
KIRC	cis	1	rs11696501	chr20:44124523	WFDC10B	chr20:44313291-44333658:-	-0.17	-3.77	0.000182	Brain structure	
KIRC	cis	1	rs11696501	chr20:44124523	WFDC3	chr20:44402847-44420547:-	0.32	5.64	2.8E-8	Brain structure	
KIRC	cis	1	rs11696870	chr20:47725607	CSE1L	chr20:47662838-47713484:+	0.18	4.8	2.08E-6	Anger	
KIRC	cis	1	rs11696991	chr20:60959694	HAR1B	chr20:61726845-61733671:-	0.23	3.86	0.000128	Colorectal cancer	
KIRC	cis	1	rs11699551	chr20:55087964	C20orf43	chr20:55043647-55093942:+	0.21	4.9	1.29E-6	Refractive astigmatism	
KIRC	cis	1	rs116995979	chr15:56524043	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11699883	chr20:55087041	C20orf43	chr20:55043647-55093942:+	0.18	4.08	5.15E-5	Refractive astigmatism	
KIRC	cis	1	rs11701049	chr21:35868144	KCNE1	chr21:35818989-35884573:-	0.3	4.43	1.18E-5	Electrocardiographic traits	
KIRC	cis	1	rs11701091	chr21:33920244	TCP10L	chr21:33947152-33957845:-	-0.4	-6.77	3.58E-11	Gastritis	
KIRC	cis	1	rs11701627	chr21:33927794	TCP10L	chr21:33947152-33957845:-	-0.35	-6.11	2.01E-9	Gastritis	
KIRC	cis	1	rs11701860	chr21:35871440	KCNE1	chr21:35818989-35884573:-	0.29	4.34	1.71E-5	Electrocardiographic traits	
KIRC	cis	1	rs117031571	chr15:84572654	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.27	2.3E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11703914	chr22:24767602	C22orf45	chr22:24825178-24826344:-;chr22	0.17	4.15	3.91E-5	Gut microbiome composition (summer)	
KIRC	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.23	-5.92	6.01E-9	Gut microbiome composition (summer)	
KIRC	cis	1	rs11704021	chr22:39074716	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.68	0.000254	Resting heart rate	
KIRC	cis	1	rs11704021	chr22:39074716	LOC646851	chr22:38974125-39052634:-	0.13	4.06	5.59E-5	Resting heart rate	
KIRC	cis	1	rs11705483	chr22:46630544	PKDREJ	chr22:46651561-46659219:-	-0.35	-4.31	1.93E-5	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.61	14.45	7.63E-40	Height	
KIRC	cis	1	rs11706117	chr3:134212526	CEP63	chr3:134204575-134293852:+	0.32	6.14	1.71E-9	Height	
KIRC	cis	1	rs11706304	chr3:128050614	KBTBD12	chr3:127634318-127706513:+	0.28	3.73	0.00021	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706304	chr3:128050614	RUVBL1	chr3:127783627-127872757:-	0.31	4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706420	chr3:58392411	PXK	chr3:58318617-58410878:+	-0.2	-4.45	1.08E-5	Cholesterol, total	
KIRC	cis	1	rs11706455	chr3:127891991	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.31E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706455	chr3:127891991	RPN1	chr3:128338813-128399918:-	0.22	3.7	0.00024	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706455	chr3:127891991	RUVBL1	chr3:127783627-127872757:-	0.33	4.64	4.36E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706826	chr3:128032991	RUVBL1	chr3:127783627-127872757:-	0.31	4.49	8.78E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706852	chr3:128032887	RUVBL1	chr3:127783627-127872757:-	0.31	4.44	1.11E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706908	chr3:128033048	KBTBD12	chr3:127634318-127706513:+	0.25	3.49	0.000521	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11706908	chr3:128033048	RUVBL1	chr3:127783627-127872757:-	0.3	4.4	1.3E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11707462	chr3:127838630	KBTBD12	chr3:127634318-127706513:+	0.27	3.68	0.000256	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11707462	chr3:127838630	RPN1	chr3:128338813-128399918:-	0.22	3.82	0.00015	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11707462	chr3:127838630	RUVBL1	chr3:127783627-127872757:-	0.33	4.73	2.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.61	14.54	3.19E-40	Height	
KIRC	cis	1	rs11708531	chr3:134224902	CEP63	chr3:134204575-134293852:+	0.33	6.44	2.85E-10	Height	
KIRC	cis	1	rs11708590	chr3:58336635	PXK	chr3:58318617-58410878:+	-0.19	-4.03	6.5E-5	Cholesterol, total	
KIRC	cis	1	rs11709066	chr3:127874912	KBTBD12	chr3:127634318-127706513:+	-0.26	-3.51	0.000488	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11709066	chr3:127874912	RPN1	chr3:128338813-128399918:-	-0.22	-3.73	0.000215	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11709066	chr3:127874912	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.28	2.19E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11709377	chr3:127815670	KBTBD12	chr3:127634318-127706513:+	0.26	3.52	0.000468	Post bronchodilator FEV1	
KIRC	cis	1	rs11709377	chr3:127815670	RPN1	chr3:128338813-128399918:-	0.22	3.63	0.000311	Post bronchodilator FEV1	
KIRC	cis	1	rs11709377	chr3:127815670	RUVBL1	chr3:127783627-127872757:-	0.34	4.85	1.63E-6	Post bronchodilator FEV1	
KIRC	cis	1	rs11709525	chr3:49690496	UBA7	chr3:49842639-49851391:-	0.16	4.13	4.33E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs11709611	chr3:128067275	KBTBD12	chr3:127634318-127706513:+	0.28	3.83	0.000144	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11709611	chr3:128067275	RUVBL1	chr3:127783627-127872757:-	0.31	4.39	1.36E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11709976	chr3:58325347	PXK	chr3:58318617-58410878:+	0.18	4.05	5.88E-5	Cholesterol, total	
KIRC	cis	1	rs11710058	chr3:58383048	PXK	chr3:58318617-58410878:+	0.25	4.98	8.89E-7	Cholesterol, total	
KIRC	cis	1	rs11710136	chr3:190985993	UTS2D	chr3:190984945-191048325:-	-0.21	-3.74	0.000205	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs11710434	chr3:49346130	CCDC36	chr3:49235861-49295537:+	0.26	5.12	4.47E-7	Menarche (age at onset)	
KIRC	cis	1	rs11710434	chr3:49346130	NCKIPSD	chr3:48711280-48723334:-	0.23	4.66	4.0E-6	Menarche (age at onset)	
KIRC	cis	1	rs11710434	chr3:49346130	P4HTM	chr3:49027341-49044579:+	0.18	4.09	5.08E-5	Menarche (age at onset)	
KIRC	cis	1	rs11710434	chr3:49346130	TREX1	chr3:48501186-48509043:+	-0.15	-3.73	0.000217	Menarche (age at onset)	
KIRC	cis	1	rs11710434	chr3:49346130	WDR6	chr3:49044637-49053386:+	-0.22	-5.74	1.61E-8	Menarche (age at onset)	
KIRC	cis	1	rs11710497	chr3:11045896	SLC6A1	chr3:11034420-11080934:+	0.27	4.5	8.58E-6	Longitudinal alcohol consumption	
KIRC	cis	1	rs11710627	chr3:128047009	KBTBD12	chr3:127634318-127706513:+	0.27	3.67	0.00027	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11710627	chr3:128047009	RUVBL1	chr3:127783627-127872757:-	0.31	4.31	1.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11710704	chr3:128047236	KBTBD12	chr3:127634318-127706513:+	0.26	3.55	0.000416	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11710704	chr3:128047236	RUVBL1	chr3:127783627-127872757:-	0.29	4.04	6.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11711710	chr3:127872506	KBTBD12	chr3:127634318-127706513:+	0.28	3.78	0.000173	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11711710	chr3:127872506	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11711710	chr3:127872506	RUVBL1	chr3:127783627-127872757:-	0.34	4.79	2.18E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11712111	chr3:156608940	LEKR1	chr3:156544076-156763918:+	0.36	7.77	4.61E-14	Multiple sclerosis (severity)	
KIRC	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.31	-8.82	1.83E-17	Longevity	
KIRC	cis	1	rs11712653	chr3:53070875	RFT1	chr3:53122503-53164470:-	-0.31	-5	8.08E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11712653	chr3:53070875	TMEM110	chr3:52867139-52931547:-	-0.28	-5	7.84E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11712798	chr3:127894294	KBTBD12	chr3:127634318-127706513:+	0.27	3.65	0.000287	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11712798	chr3:127894294	RPN1	chr3:128338813-128399918:-	0.22	3.73	0.000211	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11712798	chr3:127894294	RUVBL1	chr3:127783627-127872757:-	0.32	4.52	7.75E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11712915	chr3:85596665	CADM2	chr3:85008133-86117948:+	0.23	3.74	0.000209	Longevity (90 years and older)	
KIRC	cis	1	rs11713206	chr3:52999243	RFT1	chr3:53122503-53164470:-	0.36	5.24	2.35E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11713206	chr3:52999243	TMEM110	chr3:52867139-52931547:-	0.37	5.98	4.3E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11713214	chr3:58445991	PXK	chr3:58318617-58410878:+	0.21	4.06	5.65E-5	Cholesterol, total	
KIRC	cis	1	rs11713230	chr3:160355942	TRIM59	chr3:160153292-160167626:-	0.24	4.03	6.44E-5	Primary biliary cirrhosis	
KIRC	cis	1	rs11713902	chr3:85604425	CADM2	chr3:85008133-86117948:+	0.25	4.15	3.95E-5	Longevity (90 years and older)	
KIRC	cis	1	rs11714052	chr3:127814457	KBTBD12	chr3:127634318-127706513:+	0.29	3.94	9.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714052	chr3:127814457	RPN1	chr3:128338813-128399918:-	0.22	3.62	0.00033	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714052	chr3:127814457	RUVBL1	chr3:127783627-127872757:-	0.35	4.88	1.4E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.36	6.92	1.39E-11	Cognitive performance	
KIRC	cis	1	rs11714619	chr3:127850076	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714619	chr3:127850076	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714619	chr3:127850076	RUVBL1	chr3:127783627-127872757:-	0.34	4.83	1.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11714876	chr3:53101640	RFT1	chr3:53122503-53164470:-	-0.28	-4.5	8.58E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11714876	chr3:53101640	TMEM110	chr3:52867139-52931547:-	-0.29	-5.37	1.2E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11715394	chr3:127893564	KBTBD12	chr3:127634318-127706513:+	0.3	3.99	7.58E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11715394	chr3:127893564	RUVBL1	chr3:127783627-127872757:-	0.32	4.51	8.05E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11715445	chr3:58343888	PXK	chr3:58318617-58410878:+	0.21	4.18	3.37E-5	Cholesterol, total	
KIRC	cis	1	rs11716941	chr3:127875374	KBTBD12	chr3:127634318-127706513:+	-0.31	-4.21	3.07E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11716941	chr3:127875374	RPN1	chr3:128338813-128399918:-	-0.21	-3.64	0.000303	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11716941	chr3:127875374	RUVBL1	chr3:127783627-127872757:-	-0.35	-5	7.79E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs117173094	chr10:81714191	LOC219347	chr10:81805991-81838949:-	0.59	5.04	6.42E-7	Rheumatoid arthritis	
KIRC	cis	1	rs117173094	chr10:81714191	LOC650623	chr10:81442731-81448648:+	-0.34	-3.55	0.000416	Rheumatoid arthritis	
KIRC	cis	1	rs11717423	chr3:58330177	PXK	chr3:58318617-58410878:+	0.21	4.33	1.79E-5	Cholesterol, total	
KIRC	cis	1	rs11717619	chr3:53003179	RFT1	chr3:53122503-53164470:-	0.34	5.15	3.73E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11717619	chr3:53003179	SFMBT1	chr3:52938628-53080070:-	-0.25	-3.51	0.000486	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11717619	chr3:53003179	TMEM110	chr3:52867139-52931547:-	0.33	5.69	2.2E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs11718165	chr3:49696797	UBA7	chr3:49842639-49851391:-	0.14	3.72	0.00022	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs117185818	chr17:6712357	FBXO39	chr17:6679552-6700420:+	-0.36	-3.49	0.000516	Blood metabolite levels	
KIRC	cis	1	rs11719079	chr3:127824049	KBTBD12	chr3:127634318-127706513:+	0.26	3.58	0.000375	Post bronchodilator FEV1	
KIRC	cis	1	rs11719079	chr3:127824049	RUVBL1	chr3:127783627-127872757:-	0.35	4.95	1.01E-6	Post bronchodilator FEV1	
KIRC	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.38	7.3	1.15E-12	Cognitive performance	
KIRC	cis	1	rs11719546	chr3:127872602	KBTBD12	chr3:127634318-127706513:+	0.27	3.71	0.00023	Post bronchodilator FEV1	
KIRC	cis	1	rs11719546	chr3:127872602	RPN1	chr3:128338813-128399918:-	0.23	3.99	7.59E-5	Post bronchodilator FEV1	
KIRC	cis	1	rs11719546	chr3:127872602	RUVBL1	chr3:127783627-127872757:-	0.34	4.86	1.61E-6	Post bronchodilator FEV1	
KIRC	cis	1	rs11719762	chr3:49409002	CCDC36	chr3:49235861-49295537:+	0.25	4.92	1.16E-6	Menarche (age at onset)	
KIRC	cis	1	rs11719762	chr3:49409002	GMPPB	chr3:49758932-49761384:-	-0.15	-3.56	0.00041	Menarche (age at onset)	
KIRC	cis	1	rs11719762	chr3:49409002	NCKIPSD	chr3:48711280-48723334:-	0.22	4.5	8.28E-6	Menarche (age at onset)	
KIRC	cis	1	rs11719762	chr3:49409002	P4HTM	chr3:49027341-49044579:+	0.19	4.47	9.68E-6	Menarche (age at onset)	
KIRC	cis	1	rs11719762	chr3:49409002	TREX1	chr3:48501186-48509043:+	-0.16	-4.12	4.39E-5	Menarche (age at onset)	
KIRC	cis	1	rs11719762	chr3:49409002	WDR6	chr3:49044637-49053386:+	-0.21	-5.34	1.43E-7	Menarche (age at onset)	
KIRC	cis	1	rs11719957	chr3:58415031	PXK	chr3:58318617-58410878:+	0.26	5.13	4.19E-7	Cholesterol, total	
KIRC	cis	1	rs11720239	chr3:127817955	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11720542	chr3:49357427	CCDC36	chr3:49235861-49295537:+	0.27	5.23	2.47E-7	Menarche (age at onset)	
KIRC	cis	1	rs11720542	chr3:49357427	NCKIPSD	chr3:48711280-48723334:-	0.22	4.55	6.85E-6	Menarche (age at onset)	
KIRC	cis	1	rs11720542	chr3:49357427	P4HTM	chr3:49027341-49044579:+	0.18	4.02	6.69E-5	Menarche (age at onset)	
KIRC	cis	1	rs11720542	chr3:49357427	TREX1	chr3:48501186-48509043:+	-0.15	-3.72	0.000221	Menarche (age at onset)	
KIRC	cis	1	rs11720542	chr3:49357427	WDR6	chr3:49044637-49053386:+	-0.22	-5.61	3.44E-8	Menarche (age at onset)	
KIRC	cis	1	rs11721213	chr3:128067441	RPN1	chr3:128338813-128399918:-	-0.2	-3.5	0.000505	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11721213	chr3:128067441	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.88	1.42E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11721318	chr3:121429485	IQCB1	chr3:121488610-121553926:-	0.35	6.59	1.1E-10	Cognitive performance	
KIRC	cis	1	rs11722037	chr4:17683811	LAP3	chr4:17578927-17609590:+	-0.21	-6.49	2.09E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11722037	chr4:17683811	MED28	chr4:17616273-17629791:+	0.16	3.68	0.000258	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.43	7.35	8.32E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11722225	chr4:106766430	INTS12	chr4:106603787-106629881:-	-0.71	-7.48	3.31E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.43	7.4	5.7E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11723225	chr4:106746065	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11723240	chr4:106736936	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.43	7.35	8.32E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.43	7.31	1.06E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11723639	chr4:106741163	INTS12	chr4:106603787-106629881:-	-0.65	-6.72	4.95E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.5	10.27	1.4E-22	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.45	7.43	4.6E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.45	7.43	4.6E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11724495	chr4:17621310	LAP3	chr4:17578927-17609590:+	-0.2	-6.16	1.49E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11724495	chr4:17621310	MED28	chr4:17616273-17629791:+	0.19	4.38	1.46E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11724839	chr4:106638256	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11724884	chr4:106677384	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs117249133	chr20:33773630	PROCR	chr20:33758727-33765164:+	-0.3	-3.97	8.18E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11726094	chr4:106773387	INTS12	chr4:106603787-106629881:-	-0.72	-7.34	8.89E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11726124	chr4:106766496	INTS12	chr4:106603787-106629881:-	0.64	6.84	2.3E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11726248	chr4:171053519	AADAT	chr4:170981374-171011372:-	-0.49	-4.76	2.52E-6	Thyroid hormone levels	
KIRC	cis	1	rs11726249	chr4:171053563	AADAT	chr4:170981374-171011372:-	-0.49	-4.76	2.52E-6	Thyroid hormone levels	
KIRC	cis	1	rs11726569	chr4:106606608	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11726609	chr4:56400869	SRD5A3	chr4:56212409-56237866:+	0.17	3.75	0.000195	Personality dimensions	
KIRC	cis	1	rs11726609	chr4:56400869	TMEM165	chr4:56262090-56292342:+	-0.21	-5.64	2.81E-8	Personality dimensions	
KIRC	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.44	8.2	2.06E-15	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11727189	chr4:106619140	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11727312	chr4:17669185	LAP3	chr4:17578927-17609590:+	-0.2	-5.99	3.96E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11727312	chr4:17669185	MED28	chr4:17616273-17629791:+	0.16	3.55	0.000426	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11727348	chr4:106679848	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11727500	chr4:106745948	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11727546	chr4:103557664	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.000153	Primary biliary cirrhosis	
KIRC	cis	1	rs11727735	chr4:106631870	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11727745	chr4:106716527	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11727803	chr4:88213158	HSD17B11	chr4:88257691-88312455:-	0.18	3.95	9.11E-5	Platelet count	
KIRC	cis	1	rs11727835	chr4:88213244	HSD17B11	chr4:88257691-88312455:-	0.18	3.95	9.11E-5	Platelet count	
KIRC	cis	1	rs11727875	chr4:39135319	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs11728044	chr4:106604786	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11728716	chr4:106755996	INTS12	chr4:106603787-106629881:-	0.69	7.27	1.42E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs11729169	chr4:171019391	AADAT	chr4:170981374-171011372:-	-0.44	-4.29	2.17E-5	Thyroid hormone levels	
KIRC	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.44	7.35	8.16E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11730202	chr4:210096	ZNF718	chr4:53272-156488:+	0.41	6.76	3.87E-11	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs11730354	chr4:106773435	INTS12	chr4:106603787-106629881:-	-0.69	-7.14	3.31E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs11731386	chr4:106600338	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11731417	chr4:106746012	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11731442	chr4:171006215	AADAT	chr4:170981374-171011372:-	-0.38	-3.75	0.000194	Thyroid hormone levels	
KIRC	cis	1	rs117316403	chr20:33693175	PROCR	chr20:33758727-33765164:+	-0.27	-3.6	0.000347	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11731714	chr4:106675946	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11731938	chr4:106725140	INTS12	chr4:106603787-106629881:-	-0.65	-6.75	4.11E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11732213	chr4:1704244	TMEM129	chr4:1717680-1723084:-	0.17	3.54	0.00044	Urinary bladder cancer;Bladder cancer	
KIRC	cis	1	rs11732298	chr4:106701679	INTS12	chr4:106603787-106629881:-	0.62	6.7	5.47E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11732383	chr4:171051627	AADAT	chr4:170981374-171011372:-	-0.49	-4.76	2.52E-6	Thyroid hormone levels	
KIRC	cis	1	rs11732629	chr4:106754347	INTS12	chr4:106603787-106629881:-	-0.7	-7.28	1.29E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs11732650	chr4:106754231	INTS12	chr4:106603787-106629881:-	-0.69	-7.26	1.48E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs11732763	chr4:171010101	AADAT	chr4:170981374-171011372:-	-0.42	-3.93	9.85E-5	Thyroid hormone levels	
KIRC	cis	1	rs11733093	chr4:106765063	INTS12	chr4:106603787-106629881:-	-0.73	-7.51	2.77E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11733124	chr4:106677541	INTS12	chr4:106603787-106629881:-	-0.63	-6.61	1.01E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs11733150	chr4:106765351	INTS12	chr4:106603787-106629881:-	-0.7	-7.47	3.69E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11733223	chr4:106765525	INTS12	chr4:106603787-106629881:-	0.69	7.44	4.3E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs11733225	chr4:106705363	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.46	10.16	3.57E-22	Renal underexcretion gout;Gout	
KIRC	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.31	7.41	5.28E-13	Renal underexcretion gout;Gout	
KIRC	cis	1	rs11733287	chr4:106705339	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11733654	chr4:106730710	INTS12	chr4:106603787-106629881:-	-0.64	-6.69	5.92E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11733850	chr4:171023301	AADAT	chr4:170981374-171011372:-	-0.44	-4.24	2.61E-5	Thyroid hormone levels	
KIRC	cis	1	rs11733864	chr4:56321530	SRD5A3	chr4:56212409-56237866:+	0.18	4.06	5.72E-5	Personality dimensions	
KIRC	cis	1	rs11733864	chr4:56321530	TMEM165	chr4:56262090-56292342:+	-0.23	-6.38	3.93E-10	Personality dimensions	
KIRC	cis	1	rs11734571	chr4:106703557	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11735092	chr4:88226231	HSD17B11	chr4:88257691-88312455:-	0.19	4.05	5.99E-5	Platelet count	
KIRC	cis	1	rs11735213	chr4:106527508	INTS12	chr4:106603787-106629881:-	-0.66	-6.63	8.8E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11735527	chr4:106679692	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11735851	chr4:106697254	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11736834	chr4:106708764	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11736859	chr4:106708785	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs11736939	chr4:171031170	AADAT	chr4:170981374-171011372:-	-0.41	-4.13	4.18E-5	Thyroid hormone levels	
KIRC	cis	1	rs11737138	chr4:17657986	LAP3	chr4:17578927-17609590:+	-0.2	-6.29	6.96E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11737138	chr4:17657986	MED28	chr4:17616273-17629791:+	0.18	3.97	8.2E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.44	8.2	2.06E-15	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs117372845	chr11:71568849	C11orf59	chr11:71808339-71814322:-	0.22	3.91	0.000106	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs11737950	chr5:156436211	HAVCR1	chr5:156456531-156486130:-	-0.45	-9.97	1.69E-21	Hypertriglyceridemia	
KIRC	cis	1	rs11737950	chr5:156436211	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.56	1.97E-13	Hypertriglyceridemia	
KIRC	cis	1	rs11737950	chr5:156436211	TIMD4	chr5:156346293-156390266:-	-0.36	-6.78	3.45E-11	Hypertriglyceridemia	
KIRC	cis	1	rs11738335	chr5:60950211	FLJ37543	chr5:60933636-61002362:+	0.21	3.52	0.000475	Alzheimer's disease	
KIRC	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.83	16.81	1.22E-50	Type 2 diabetes	
KIRC	cis	1	rs11739619	chr5:150264662	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs11739677	chr5:150294883	IRGM	chr5:150226085-150280295:+	0.55	7.04	6.19E-12	Crohn's disease	
KIRC	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.41	5.28	1.97E-7	Crohn's disease	
KIRC	cis	1	rs11740172	chr5:150300278	IRGM	chr5:150226085-150280295:+	0.54	6.93	1.28E-11	Crohn's disease	
KIRC	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.4	5.17	3.47E-7	Crohn's disease	
KIRC	cis	1	rs11740496	chr5:156435402	HAVCR1	chr5:156456531-156486130:-	0.46	9.98	1.59E-21	Hypertriglyceridemia	
KIRC	cis	1	rs11740496	chr5:156435402	HAVCR2	chr5:156512843-156536138:-	0.43	7.81	3.39E-14	Hypertriglyceridemia	
KIRC	cis	1	rs11740496	chr5:156435402	TIMD4	chr5:156346293-156390266:-	0.37	6.77	3.66E-11	Hypertriglyceridemia	
KIRC	cis	1	rs11740499	chr5:156431741	HAVCR1	chr5:156456531-156486130:-	-0.43	-9.41	1.78E-19	Hypertriglyceridemia	
KIRC	cis	1	rs11740499	chr5:156431741	HAVCR2	chr5:156512843-156536138:-	-0.4	-7.33	9.35E-13	Hypertriglyceridemia	
KIRC	cis	1	rs11740499	chr5:156431741	TIMD4	chr5:156346293-156390266:-	-0.35	-6.48	2.18E-10	Hypertriglyceridemia	
KIRC	cis	1	rs11741861	chr5:150277909	IRGM	chr5:150226085-150280295:+	-0.61	-8.01	8.21E-15	Crohn's disease	
KIRC	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.36	-4.64	4.35E-6	Crohn's disease	
KIRC	cis	1	rs11743488	chr5:150279218	IRGM	chr5:150226085-150280295:+	0.61	7.61	1.35E-13	Crohn's disease	
KIRC	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.41	5.07	5.5E-7	Crohn's disease	
KIRC	cis	1	rs11746108	chr5:150264622	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs11746128	chr5:156421250	HAVCR1	chr5:156456531-156486130:-	-0.43	-9.72	1.45E-20	Hypertriglyceridemia	
KIRC	cis	1	rs11746128	chr5:156421250	HAVCR2	chr5:156512843-156536138:-	-0.38	-7.11	3.96E-12	Hypertriglyceridemia	
KIRC	cis	1	rs11746128	chr5:156421250	TIMD4	chr5:156346293-156390266:-	-0.36	-6.98	9.61E-12	Hypertriglyceridemia	
KIRC	cis	1	rs11746560	chr5:150185925	IRGM	chr5:150226085-150280295:+	0.65	7.82	3.1E-14	Crohn's disease	
KIRC	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.44	5.21	2.8E-7	Crohn's disease	
KIRC	cis	1	rs11746807	chr5:150300419	IRGM	chr5:150226085-150280295:+	0.54	6.93	1.28E-11	Crohn's disease	
KIRC	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.4	5.17	3.47E-7	Crohn's disease	
KIRC	cis	1	rs11747065	chr5:150295486	IRGM	chr5:150226085-150280295:+	0.54	6.93	1.28E-11	Crohn's disease	
KIRC	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.4	5.17	3.47E-7	Crohn's disease	
KIRC	cis	1	rs11747270	chr5:150258867	IRGM	chr5:150226085-150280295:+	-0.49	-6.83	2.44E-11	Crohn's disease	
KIRC	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.3	-4.14	4.05E-5	Crohn's disease	
KIRC	cis	1	rs11748151	chr5:150226292	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs11748158	chr5:150226345	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs11748553	chr5:150184553	IRGM	chr5:150226085-150280295:+	0.65	7.82	3.1E-14	Crohn's disease	
KIRC	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.44	5.21	2.8E-7	Crohn's disease	
KIRC	cis	1	rs11749391	chr5:150229066	IRGM	chr5:150226085-150280295:+	0.52	7.16	2.9E-12	Crohn's disease	
KIRC	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.38	5.15	3.68E-7	Crohn's disease	
KIRC	cis	1	rs11751618	chr6:87236328	CGA	chr6:87795222-87804824:-	-0.16	-3.57	0.000387	Gut microbiome composition (winter)	
KIRC	cis	1	rs11752297	chr6:33735154	LEMD2	chr6:33738991-33756906:-	-0.15	-3.65	0.000286	Crohn's disease	
KIRC	cis	1	rs11753083	chr6:33761111	LEMD2	chr6:33738991-33756906:-	0.23	5.12	4.46E-7	Body mass index	
KIRC	cis	1	rs11754690	chr6:33744157	LEMD2	chr6:33738991-33756906:-	0.23	5.18	3.16E-7	Body mass index	
KIRC	cis	1	rs11754744	chr6:26202605	HIST1H3E	chr6:26224427-26226589:+	0.43	5.4	1.03E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs117550412	chr10:121424962	TIAL1	chr10:121332978-121356541:-	-0.19	-3.92	0.000101	Dilated cardiomyopathy	
KIRC	cis	1	rs11755210	chr6:26202768	HIST1H3E	chr6:26224427-26226589:+	0.43	5.4	1.03E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs11755593	chr6:33740325	LEMD2	chr6:33738991-33756906:-	0.23	5.17	3.35E-7	Body mass index	
KIRC	cis	1	rs11756120	chr6:26529808	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs11758351	chr6:26203910	HIST1H3E	chr6:26224427-26226589:+	0.45	5.68	2.31E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.45	-9.67	2.06E-20	Response to antipsychotic treatment	
KIRC	cis	1	rs11759804	chr6:151875122	C6orf97	chr6:151815175-151942327:+	0.2	3.91	0.000105	Bone mineral density (spine)	
KIRC	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.49	-10.42	3.86E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs11761941	chr7:1097183	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11763020	chr7:1060288	ZFAND2A	chr7:1192544-1199855:-	-0.37	-6.34	5.09E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11763147	chr7:65326821	LOC493754	chr7:65993446-66057363:-	0.17	3.8	0.000163	Corneal structure	
KIRC	cis	1	rs11763147	chr7:65326821	VKORC1L1	chr7:65338257-65423532:+	0.13	3.89	0.000112	Corneal structure	
KIRC	cis	1	rs11763793	chr7:1094342	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs117638181	chr19:22163014	ZNF257	chr19:22235266-22273901:+	0.35	4.79	2.18E-6	Body mass index (change over time)	
KIRC	cis	1	rs11763835	chr7:1094513	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11764748	chr7:1094508	ZFAND2A	chr7:1192544-1199855:-	-0.3	-5.29	1.82E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11766175	chr7:128405013	OPN1SW	chr7:128412545-128415844:-	0.25	4.19	3.29E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs11766526	chr7:1101433	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.53E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11767527	chr7:1097394	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.56E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11768309	chr7:97773812	BAIAP2L1	chr7:97920964-98030427:-	-0.14	-3.56	0.0004	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs117683816	chr12:56638267	RPS26	chr12:56435686-56438005:+	-0.51	-4.33	1.77E-5	Psoriasis vulgaris	
KIRC	cis	1	rs11768761	chr7:1069807	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11770909	chr7:1086716	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.75	1.59E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11771526	chr7:32342618	KBTBD2	chr7:32907778-32931468:-	-0.24	-3.52	0.000469	Body mass index	
KIRC	cis	1	rs1177202	chr2:61074576	PUS10	chr2:61167550-61245365:-	0.16	4.31	1.99E-5	Psoriasis	
KIRC	cis	1	rs1177206	chr2:61075189	PUS10	chr2:61167550-61245365:-	0.17	4.42	1.19E-5	Psoriasis	
KIRC	cis	1	rs1177207	chr2:61075209	PUS10	chr2:61167550-61245365:-	0.16	4.23	2.77E-5	Psoriasis	
KIRC	cis	1	rs1177211	chr2:61078350	PUS10	chr2:61167550-61245365:-	0.15	4.06	5.78E-5	Psoriasis	
KIRC	cis	1	rs11773829	chr7:66141074	LOC493754	chr7:65993446-66057363:-	0.17	3.69	0.000248	Aortic root size	
KIRC	cis	1	rs11774085	chr8:96020877	C8orf38	chr8:95908040-96088396:+	-0.3	-4.28	2.28E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.24	-3.6	0.000345	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs117779516	chr12:56750872	RPS26	chr12:56435686-56438005:+	-0.52	-4.33	1.8E-5	Psoriasis vulgaris	
KIRC	cis	1	rs117802529	chr20:33786677	PROCR	chr20:33758727-33765164:+	-0.33	-4.3	2.03E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.000262	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs11781619	chr8:96017323	C8orf38	chr8:95908040-96088396:+	-0.28	-3.99	7.68E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.78	-9.67	2.08E-20	Epithelial ovarian cancer;Ovarian cancer	
KIRC	cis	1	rs11785269	chr8:110125307	TMEM74	chr8:109619080-109799770:-	-0.18	-3.56	0.000402	Body mass (lean)	
KIRC	cis	1	rs11786380	chr8:96028136	C8orf38	chr8:95908040-96088396:+	-0.24	-3.65	0.000288	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs11786878	chr8:96033292	C8orf38	chr8:95908040-96088396:+	-0.26	-3.93	9.6E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs11789898	chr9:136925663	BRD3	chr9:136895454-136933655:-	0.22	4.71	3.26E-6	Platelet count	
KIRC	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.47	-10.56	1.09E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs11792861	chr9:111809295	C9orf5	chr9:111777416-111882225:-	0.13	3.87	0.000125	Menarche (age at onset)	
KIRC	cis	1	rs11792861	chr9:111809295	C9orf6	chr9:111696673-111703235:+	-0.21	-3.67	0.000264	Menarche (age at onset)	
KIRC	cis	1	rs11801695	chr1:205916175	PM20D1	chr1:205797154-205819245:-	-0.25	-4.25	2.54E-5	Cystic fibrosis-related diabetes	
KIRC	cis	1	rs118059236	chr7:1073202	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.75	1.54E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs11807824	chr1:27270338	PIGV	chr1:27114455-27124886:+	-0.33	-3.96	8.72E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.65	7.15E-17	Body mass index	
KIRC	cis	1	rs11810993	chr1:46478793	MUTYH	chr1:45794915-45806142:-	0.14	4.07	5.42E-5	Body mass index	
KIRC	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	1.07	15.47	1.97E-44	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs118130855	chr12:56677979	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs11813099	chr10:17183451	TRDMT1	chr10:17184983-17243681:-	-0.37	-8.32	8.62E-16	Homocysteine levels	
KIRC	cis	1	rs118135259	chr15:56495784	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11816485	chr10:1147974	IDI2	chr10:1064847-1071799:-	0.32	3.69	0.000249	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.13	-4.26	2.39E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs11818314	chr10:1148157	IDI2	chr10:1064847-1071799:-	0.32	3.7	0.000244	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs11819230	chr10:1128812	IDI2	chr10:1064847-1071799:-	0.33	3.86	0.000129	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs11819869	chr11:46560680	MDK	chr11:46402334-46405374:+	-0.2	-3.52	0.000466	Schizophrenia	
KIRC	cis	1	rs11821094	chr11:73061905	RELT	chr11:73087405-73108518:+	0.16	3.62	0.000324	Pulmonary function (interaction)	
KIRC	cis	1	rs11832315	chr12:50943932	LIMA1	chr12:50569565-50677353:-	-0.22	-4.35	1.68E-5	Fibrinogen	
KIRC	cis	1	rs11833002	chr12:124446616	CCDC92	chr12:124420955-124457163:-	0.2	5.35	1.37E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11833002	chr12:124446616	DNAH10	chr12:124247042-124420265:+	0.19	3.9	0.00011	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11835839	chr12:124431049	CCDC92	chr12:124420955-124457163:-	0.21	5.37	1.22E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11835839	chr12:124431049	DNAH10	chr12:124247042-124420265:+	0.19	3.87	0.000122	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs11844348	chr14:65859480	LOC645431	chr14:65877313-65879335:-	-0.44	-5.98	4.31E-9	Ischemic stroke	
KIRC	cis	1	rs11844747	chr14:65870128	LOC645431	chr14:65877313-65879335:-	0.49	6.58	1.17E-10	Ischemic stroke	
KIRC	cis	1	rs11845639	chr14:75570293	MLH3	chr14:75480467-75518235:-	0.23	5.97	4.4E-9	Height	
KIRC	cis	1	rs11845639	chr14:75570293	NEK9	chr14:75548819-75593778:-	0.14	4.08	5.24E-5	Height	
KIRC	cis	1	rs11845794	chr14:65848118	LOC645431	chr14:65877313-65879335:-	-0.43	-5.8	1.21E-8	Ischemic stroke	
KIRC	cis	1	rs11849252	chr14:66069769	LOC645431	chr14:65877313-65879335:-	-0.45	-6.12	1.92E-9	Ischemic stroke	
KIRC	cis	1	rs11850160	chr14:65848123	LOC645431	chr14:65877313-65879335:-	-0.43	-5.8	1.21E-8	Ischemic stroke	
KIRC	cis	1	rs11850163	chr14:65848145	LOC645431	chr14:65877313-65879335:-	-0.42	-5.68	2.33E-8	Ischemic stroke	
KIRC	cis	1	rs11850847	chr14:65933798	LOC645431	chr14:65877313-65879335:-	-0.54	-6.65	7.52E-11	Ischemic stroke	
KIRC	cis	1	rs11851013	chr14:66016212	LOC645431	chr14:65877313-65879335:-	-0.5	-6.59	1.1E-10	Ischemic stroke	
KIRC	cis	1	rs11851772	chr14:66022047	LOC645431	chr14:65877313-65879335:-	-0.5	-6.45	2.58E-10	Ischemic stroke	
KIRC	cis	1	rs11853052	chr15:84576159	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.6	-10.29	1.12E-22	Tumor biomarkers	
KIRC	cis	1	rs11856184	chr15:43919162	STRC	chr15:43891762-43924561:-	0.22	4.45	1.08E-5	Tumor biomarkers	
KIRC	cis	1	rs11856184	chr15:43919162	TUBGCP4	chr15:43663313-43698238:+	0.18	4	7.37E-5	Tumor biomarkers	
KIRC	cis	1	rs11858210	chr15:79078358	CTSH	chr15:79214092-79237420:-	0.18	3.86	0.00013	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	1.09	18.91	1.22E-60	Heschl's gyrus morphology	
KIRC	cis	1	rs11858714	chr15:40717447	IVD	chr15:40697686-40713512:+	-0.33	-5	8.08E-7	Heschl's gyrus morphology	
KIRC	cis	1	rs11861657	chr16:67824395	ATP6V0D1	chr16:67471917-67515089:-	-0.33	-5.18	3.18E-7	Crohn's disease	
KIRC	cis	1	rs11861657	chr16:67824395	C16orf86	chr16:67700717-67702659:+	-0.29	-3.63	0.00031	Crohn's disease	
KIRC	cis	1	rs11862083	chr16:4649720	NMRAL1	chr16:4511696-4526307:-	-0.33	-4.07	5.36E-5	Obesity-related traits	
KIRC	cis	1	rs11862744	chr16:31057800	MYST1	chr16:31128985-31142713:+	0.15	4	7.38E-5	Response to metformin (IC50)	
KIRC	cis	1	rs11865098	chr16:67857436	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.75	2.63E-6	Crohn's disease	
KIRC	cis	1	rs11867405	chr17:40570741	NAGLU	chr17:40687951-40696464:+	-0.18	-3.75	0.000198	Crohn's disease	
KIRC	cis	1	rs11867934	chr17:16933404	LRRC48	chr17:17876127-17920187:+	0.18	3.83	0.000143	Diabetic retinopathy	
KIRC	cis	1	rs11867934	chr17:16933404	NT5M	chr17:17206680-17250975:+	0.22	3.99	7.47E-5	Diabetic retinopathy	
KIRC	cis	1	rs11869069	chr17:40287101	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs11870797	chr17:61804622	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	3.06E-10	Body mass index	
KIRC	cis	1	rs11870797	chr17:61804622	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.43E-6	Body mass index	
KIRC	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.4	-10.41	4.28E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11870935	chr17:45732605	ITGB3	chr17:45331208-45421658:+	-0.18	-4.32	1.92E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11870935	chr17:45732605	TBKBP1	chr17:45772630-45789427:+	0.16	4.21	3.06E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs11871767	chr17:61698723	FTSJ3	chr17:61896795-61905031:-	0.34	6.71	5.16E-11	Body mass index	
KIRC	cis	1	rs11871767	chr17:61698723	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.35	1.66E-5	Body mass index	
KIRC	cis	1	rs11871801	chr17:40570772	NAGLU	chr17:40687951-40696464:+	-0.17	-3.67	0.00027	Crohn's disease	
KIRC	cis	1	rs11879853	chr19:23029434	ZNF492	chr19:22817126-22850472:+	0.38	5.65	2.68E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs11880333	chr19:49144790	SEC1	chr19:49141296-49185501:+	-0.55	-5.69	2.21E-8	Elevated serum carcinoembryonic antigen levels	
KIRC	cis	1	rs11880539	chr19:41918949	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.67	0.000267	Height	
KIRC	cis	1	rs11880710	chr19:12156895	ZNF763	chr19:12035900-12091196:+	0.3	4.63	4.6E-6	Multiple sclerosis	
KIRC	cis	1	rs11881224	chr19:22220340	ZNF257	chr19:22235266-22273901:+	0.35	4.9	1.32E-6	Body mass index (change over time)	
KIRC	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.66	16.04	4.97E-47	Schizophrenia	
KIRC	cis	1	rs11882234	chr19:22145727	ZNF257	chr19:22235266-22273901:+	0.33	4.51	8.2E-6	Body mass index (change over time)	
KIRC	cis	1	rs11882273	chr19:2173836	DOT1L	chr19:2164148-2232576:+	0.18	6.62	9.46E-11	Height	
KIRC	cis	1	rs11882498	chr19:23060012	ZNF492	chr19:22817126-22850472:+	-0.39	-5.81	1.13E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs11883104	chr19:41923799	ATP5SL	chr19:41937224-41945810:-	0.16	3.71	0.000229	Height	
KIRC	cis	1	rs11887056	chr2:99243861	UNC50	chr2:99225042-99234975:+	-0.23	-3.95	8.86E-5	Bipolar disorder	
KIRC	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.44	8.63	8.41E-17	Urinary metabolites	
KIRC	cis	1	rs11893500	chr2:70154187	ANXA4	chr2:69969127-70053594:+	-0.21	-5.15	3.66E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.65	-8.32	8.18E-16	Plasma clusterin levels	
KIRC	cis	1	rs11893881	chr2:73824373	TPRKB	chr2:73956957-73964517:-	-0.21	-5.51	5.7E-8	Metabolite levels	
KIRC	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.42	7.88	2.07E-14	Urinary metabolites	
KIRC	cis	1	rs11899740	chr2:73631212	TPRKB	chr2:73956957-73964517:-	-0.2	-5.2	2.88E-7	Metabolite levels	
KIRC	cis	1	rs11899902	chr2:73631564	TPRKB	chr2:73956957-73964517:-	-0.18	-4.67	3.91E-6	Metabolite levels	
KIRC	cis	1	rs11901272	chr2:73720444	TPRKB	chr2:73956957-73964517:-	-0.19	-5.03	6.94E-7	Metabolite levels	
KIRC	cis	1	rs11902198	chr2:70144596	ANXA4	chr2:69969127-70053594:+	-0.22	-5.2	2.84E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs11903916	chr2:73815328	TPRKB	chr2:73956957-73964517:-	-0.19	-5.2	2.98E-7	Metabolite levels	
KIRC	cis	1	rs1190596	chr14:102595625	RAGE	chr14:102690838-102771531:-	0.2	4.69	3.57E-6	Behavioural disinhibition (generation interaction)	
KIRC	cis	1	rs11906148	chr20:33784021	PROCR	chr20:33758727-33765164:+	-0.33	-4.3	2.03E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11906318	chr20:33729442	PROCR	chr20:33758727-33765164:+	-0.27	-3.81	0.000154	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11907010	chr20:33737661	PROCR	chr20:33758727-33765164:+	-0.32	-4.08	5.34E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11907011	chr20:33767770	PROCR	chr20:33758727-33765164:+	-0.31	-4.1	4.79E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11908100	chr20:33729479	PROCR	chr20:33758727-33765164:+	-0.27	-3.81	0.000154	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11908232	chr20:33729477	PROCR	chr20:33758727-33765164:+	-0.27	-3.81	0.000154	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11908473	chr20:60957770	HAR1B	chr20:61726845-61733671:-	0.23	3.75	0.000201	Colorectal cancer	
KIRC	cis	1	rs11908683	chr20:33720920	PROCR	chr20:33758727-33765164:+	-0.3	-3.83	0.000145	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs11918654	chr3:5188246	ARL8B	chr3:5163930-5222599:+	-0.15	-3.72	0.000225	Disc degeneration (lumbar)	
KIRC	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.61	-14.56	2.6E-40	Height	
KIRC	cis	1	rs11919350	chr3:134235970	CEP63	chr3:134204575-134293852:+	-0.32	-6.22	1.06E-9	Height	
KIRC	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.69	9.15	1.45E-18	Diastolic blood pressure	
KIRC	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs11927068	chr3:134266321	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs11928090	chr3:49604904	CCDC36	chr3:49235861-49295537:+	0.29	5.55	4.7E-8	Menarche (age at onset)	
KIRC	cis	1	rs11928090	chr3:49604904	NCKIPSD	chr3:48711280-48723334:-	0.22	4.45	1.08E-5	Menarche (age at onset)	
KIRC	cis	1	rs11928090	chr3:49604904	WDR6	chr3:49044637-49053386:+	-0.23	-6.06	2.67E-9	Menarche (age at onset)	
KIRC	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.61	-14.43	1.01E-39	Height	
KIRC	cis	1	rs11928499	chr3:134232350	CEP63	chr3:134204575-134293852:+	-0.33	-6.27	7.65E-10	Height	
KIRC	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.74	11	2.26E-25	Diastolic blood pressure	
KIRC	cis	1	rs11931061	chr4:56338793	SRD5A3	chr4:56212409-56237866:+	0.18	4.02	6.74E-5	Personality dimensions	
KIRC	cis	1	rs11931061	chr4:56338793	TMEM165	chr4:56262090-56292342:+	-0.23	-6.45	2.63E-10	Personality dimensions	
KIRC	cis	1	rs11938970	chr4:119660152	METTL14	chr4:119606574-119632075:+	-0.23	-3.55	0.000423	Cannabis dependence	
KIRC	cis	1	rs11939380	chr4:1086871	C4orf48	chr4:2043689-2045697:+	0.14	3.53	0.000459	Recombination rate (males)	
KIRC	cis	1	rs11947857	chr4:17691047	LAP3	chr4:17578927-17609590:+	0.23	6.7	5.44E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11947857	chr4:17691047	MED28	chr4:17616273-17629791:+	-0.24	-5.04	6.59E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs11950957	chr5:150253914	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs11951515	chr5:43382858	NNT	chr5:43602791-43705667:+	-0.15	-4.37	1.52E-5	Metabolite levels  (X-11787)	
KIRC	cis	1	rs11951694	chr5:150254338	IRGM	chr5:150226085-150280295:+	0.56	7.68	8.37E-14	Crohn's disease	
KIRC	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.36	4.85	1.63E-6	Crohn's disease	
KIRC	cis	1	rs11955172	chr5:150254378	IRGM	chr5:150226085-150280295:+	0.56	7.68	8.37E-14	Crohn's disease	
KIRC	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.36	4.85	1.63E-6	Crohn's disease	
KIRC	cis	1	rs11957134	chr5:150230950	IRGM	chr5:150226085-150280295:+	-0.61	-7.75	5.0E-14	Crohn's disease	
KIRC	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.39	-4.88	1.44E-6	Crohn's disease	
KIRC	cis	1	rs11965538	chr6:28239915	ZNF187	chr6:28234788-28245978:+	-0.28	-4.8	2.09E-6	Depression	
KIRC	cis	1	rs11965538	chr6:28239915	ZNF323	chr6:28292517-28324048:-	0.29	4.01	7.05E-5	Depression	
KIRC	cis	1	rs11965538	chr6:28239915	ZSCAN23	chr6:28393287-28411279:-	0.26	3.76	0.000193	Depression	
KIRC	cis	1	rs11974702	chr7:99163951	CNPY4	chr7:99717265-99723126:+	-0.23	-3.61	0.000336	Blood metabolite levels	
KIRC	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.41	-7.72	6.17E-14	Obesity-related traits	
KIRC	cis	1	rs11975942	chr7:143740580	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.21	2.79E-7	Obesity-related traits	
KIRC	cis	1	rs11975942	chr7:143740580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.16	2.65E-15	Obesity-related traits	
KIRC	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	1.05	21.44	6.87E-73	Educational attainment (years of education)	
KIRC	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.63	1.18E-13	Obesity-related traits	
KIRC	cis	1	rs11976037	chr7:143741024	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.17	3.35E-7	Obesity-related traits	
KIRC	cis	1	rs11976037	chr7:143741024	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.09	4.37E-15	Obesity-related traits	
KIRC	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.41	-7.79	3.9E-14	Obesity-related traits	
KIRC	cis	1	rs11976180	chr7:143741580	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.32	1.54E-7	Obesity-related traits	
KIRC	cis	1	rs11976180	chr7:143741580	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.33	8.02E-16	Obesity-related traits	
KIRC	cis	1	rs1198433	chr1:23756695	TCEA3	chr1:23707555-23751261:-	0.17	3.67	0.000265	Cholesterol, total	
KIRC	cis	1	rs11990438	chr8:124087460	DERL1	chr8:124025568-124054648:-	-0.21	-3.65	0.00029	Diabetic kidney disease	
KIRC	cis	1	rs11992152	chr8:124189455	DERL1	chr8:124025568-124054648:-	0.32	3.57	0.000385	Urinary uromodulin levels	
KIRC	cis	1	rs11995536	chr8:120945268	DSCC1	chr8:120846182-120868170:-	-0.19	-4.15	3.86E-5	Interstitial lung disease	
KIRC	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.79	2.36E-17	Body mass index	
KIRC	cis	1	rs12021587	chr1:46472759	MUTYH	chr1:45794915-45806142:-	0.14	4.14	4.15E-5	Body mass index	
KIRC	cis	1	rs12022194	chr1:156312331	BGLAP	chr1:156182784-156213112:+	0.35	7.54	2.23E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12022194	chr1:156312331	CCT3	chr1:156278752-156308195:-	-0.17	-4.2	3.14E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12022784	chr1:179469016	C1orf125	chr1:179335107-179523868:+	0.33	4.04	6.25E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12023333	chr1:100267478	AGL	chr1:100315640-100389579:+	0.25	4.9	1.31E-6	White matter integrity (interaction)	
KIRC	cis	1	rs12023333	chr1:100267478	FRRS1	chr1:100174259-100231349:-	0.17	3.56	0.000411	White matter integrity (interaction)	
KIRC	cis	1	rs12023357	chr1:179474732	C1orf125	chr1:179335107-179523868:+	0.33	4.02	6.6E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12023438	chr1:156254358	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12023704	chr1:156294149	BGLAP	chr1:156182784-156213112:+	0.35	7.6	1.51E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12023704	chr1:156294149	CCT3	chr1:156278752-156308195:-	-0.17	-4.32	1.88E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12024020	chr1:99186573	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs12024813	chr1:156224529	BGLAP	chr1:156182784-156213112:+	0.32	6.73	4.63E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12024813	chr1:156224529	CCT3	chr1:156278752-156308195:-	-0.18	-4.5	8.35E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12027103	chr1:156244856	BGLAP	chr1:156182784-156213112:+	0.35	7.53	2.32E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12027103	chr1:156244856	CCT3	chr1:156278752-156308195:-	-0.19	-4.71	3.21E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12027741	chr1:156248148	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12027741	chr1:156248148	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12029787	chr1:179473917	C1orf125	chr1:179335107-179523868:+	0.33	4.04	6.25E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.51	7.78	4.14E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.51	7.78	4.14E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs1203156	chr6:88079694	C6orf162	chr6:88032306-88052043:+	-0.18	-3.94	9.43E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs1203156	chr6:88079694	C6orf164	chr6:88032306-88109459:+	-0.18	-4.37	1.53E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs12032364	chr1:11286872	MTOR	chr1:11166589-11322608:-	-0.17	-4.34	1.74E-5	Body mass index	
KIRC	cis	1	rs12033171	chr1:100267597	AGL	chr1:100315640-100389579:+	0.23	4.44	1.1E-5	White matter integrity (interaction)	
KIRC	cis	1	rs12033171	chr1:100267597	FRRS1	chr1:100174259-100231349:-	0.19	3.97	8.24E-5	White matter integrity (interaction)	
KIRC	cis	1	rs12036718	chr1:48549313	SLC5A9	chr1:48688357-48714316:+	0.25	3.84	0.000139	Yu-Zhi constitution type in type 2 diabetes	
KIRC	cis	1	rs12038203	chr1:156248265	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12038203	chr1:156248265	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12038217	chr1:156248297	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12038217	chr1:156248297	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12038481	chr1:156284815	BGLAP	chr1:156182784-156213112:+	0.35	7.65	1.05E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12038481	chr1:156284815	CCT3	chr1:156278752-156308195:-	-0.17	-4.38	1.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12040868	chr1:156284803	BGLAP	chr1:156182784-156213112:+	0.35	7.6	1.51E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12040868	chr1:156284803	CCT3	chr1:156278752-156308195:-	-0.17	-4.32	1.88E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.51	7.81	3.45E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.34	7.43	4.77E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12041164	chr1:156279811	CCT3	chr1:156278752-156308195:-	-0.17	-4.3	2.03E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12045262	chr1:99194741	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs12045339	chr1:156294211	BGLAP	chr1:156182784-156213112:+	0.34	7.62	1.29E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12045339	chr1:156294211	CCT3	chr1:156278752-156308195:-	-0.16	-4.04	6.08E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12047808	chr1:179469314	C1orf125	chr1:179335107-179523868:+	0.31	3.99	7.68E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.79	2.36E-17	Body mass index	
KIRC	cis	1	rs12049588	chr1:46472422	MUTYH	chr1:45794915-45806142:-	0.14	4.14	4.15E-5	Body mass index	
KIRC	cis	1	rs12050159	chr14:27073705	NOVA1	chr14:26915090-27066960:-	-0.27	-4.67	3.86E-6	Educational attainment (years of education)	
KIRC	cis	1	rs12050300	chr14:74386523	ENTPD5	chr14:74424715-74486026:-	-0.25	-3.66	0.000284	Morning vs. evening chronotype	
KIRC	cis	1	rs12050300	chr14:74386523	LIN52	chr14:74551656-74667117:+	0.29	3.9	0.000111	Morning vs. evening chronotype	
KIRC	cis	1	rs12050434	chr14:74341438	LIN52	chr14:74551656-74667117:+	0.29	4.12	4.44E-5	Morning vs. evening chronotype	
KIRC	cis	1	rs12052257	chr2:202241594	ALS2CR12	chr2:202153148-202222101:-	0.23	4.68	3.66E-6	Basal cell carcinoma	
KIRC	cis	1	rs12053519	chr2:99875018	LIPT1	chr2:99771418-99779611:+	0.25	4.45	1.08E-5	IgG glycosylation	
KIRC	cis	1	rs12054923	chr5:150249059	IRGM	chr5:150226085-150280295:+	0.56	7.4	5.83E-13	Crohn's disease	
KIRC	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.35	4.52	7.71E-6	Crohn's disease	
KIRC	cis	1	rs12055786	chr6:153431125	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs1205592	chr1:11305663	MTOR	chr1:11166589-11322608:-	-0.15	-3.91	0.000103	Body mass index	
KIRC	cis	1	rs12057692	chr1:9145013	CLSTN1	chr1:9789080-9884550:-	0.19	3.8	0.000162	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12057692	chr1:9145013	GPR157	chr1:9164476-9189356:-	0.21	4.26	2.46E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12061918	chr1:9153438	CLSTN1	chr1:9789080-9884550:-	0.21	3.98	7.96E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12061918	chr1:9153438	GPR157	chr1:9164476-9189356:-	0.21	3.88	0.000117	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12061999	chr1:9153629	CLSTN1	chr1:9789080-9884550:-	0.21	3.76	0.000187	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12061999	chr1:9153629	GPR157	chr1:9164476-9189356:-	0.22	4	7.32E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12065456	chr1:9156861	CLSTN1	chr1:9789080-9884550:-	0.2	3.57	0.000395	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12065456	chr1:9156861	GPR157	chr1:9164476-9189356:-	0.2	3.72	0.000226	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12078893	chr1:76370862	MSH4	chr1:76262630-76378923:+	-0.29	-4.36	1.56E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs12080794	chr1:9151325	CLSTN1	chr1:9789080-9884550:-	-0.21	-3.64	0.000298	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12082448	chr1:76353225	MSH4	chr1:76262630-76378923:+	-0.3	-4.68	3.66E-6	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs12083902	chr1:36275112	C1orf216	chr1:36179477-36184790:-	-0.34	-5.23	2.48E-7	Schizophrenia	
KIRC	cis	1	rs12084589	chr1:159688441	CRP	chr1:159682080-159684379:-	0.3	3.65	0.000294	C-reactive protein	
KIRC	cis	1	rs12091720	chr1:76186949	ACADM	chr1:76190043-76229353:+	0.19	5.28	1.93E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs12095069	chr1:76463072	MSH4	chr1:76262630-76378923:+	-0.28	-4.13	4.26E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs12101255	chr14:81451052	TSHR	chr14:81421869-81612646:+	-0.35	-6.84	2.25E-11	Graves' disease	
KIRC	cis	1	rs12101261	chr14:81451229	TSHR	chr14:81421869-81612646:+	-0.35	-6.77	3.69E-11	Graves' disease	
KIRC	cis	1	rs12101597	chr15:65935195	DPP8	chr15:65737999-65810035:-	-0.12	-4.9	1.32E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs12105996	chr20:33731010	PROCR	chr20:33758727-33765164:+	-0.27	-3.84	0.00014	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs12106067	chr20:55086063	C20orf43	chr20:55043647-55093942:+	0.17	3.76	0.000189	Refractive astigmatism	
KIRC	cis	1	rs12117903	chr1:156311165	BGLAP	chr1:156182784-156213112:+	0.34	7.48	3.26E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12117903	chr1:156311165	CCT3	chr1:156278752-156308195:-	-0.17	-4.2	3.12E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.34	7.49	3.04E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12117947	chr1:156244058	CCT3	chr1:156278752-156308195:-	-0.19	-4.82	1.9E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12117951	chr1:156305286	BGLAP	chr1:156182784-156213112:+	0.34	7.47	3.51E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12117951	chr1:156305286	CCT3	chr1:156278752-156308195:-	-0.17	-4.33	1.78E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12118238	chr1:156235221	BGLAP	chr1:156182784-156213112:+	0.32	6.89	1.64E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12118238	chr1:156235221	CCT3	chr1:156278752-156308195:-	-0.2	-4.85	1.66E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.51	7.79	3.82E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12121805	chr1:156257876	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12122180	chr1:156244559	BGLAP	chr1:156182784-156213112:+	0.34	7.47	3.7E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12122180	chr1:156244559	CCT3	chr1:156278752-156308195:-	-0.19	-4.77	2.42E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.27	-6.59	1.13E-10	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs12123977	chr1:76209754	ACADM	chr1:76190043-76229353:+	-0.18	-4.97	9.11E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs12126607	chr1:76217097	ACADM	chr1:76190043-76229353:+	0.2	5.59	3.71E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.51	7.86	2.36E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12127402	chr1:76205643	ACADM	chr1:76190043-76229353:+	0.19	5.26	2.18E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.29	-7.07	5.37E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs12130219	chr1:152162106	FLG2	chr1:152321214-152332482:-	0.31	5.37	1.21E-7	Inflammatory skin disease	
KIRC	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.3	5.07	5.63E-7	Inflammatory skin disease	
KIRC	cis	1	rs12130219	chr1:152162106	HRNR	chr1:152184558-152196669:-	-0.35	-5.6	3.48E-8	Inflammatory skin disease	
KIRC	cis	1	rs12130220	chr1:10359944	RBP7	chr1:10057255-10076077:+	0.14	3.53	0.000455	Hepatocellular carcinoma	
KIRC	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.51	7.82	3.03E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12130361	chr1:156260301	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12130361	chr1:156260301	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12131796	chr1:200878727	KIF21B	chr1:200938520-200992828:-	0.12	3.93	9.82E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12132298	chr1:200875095	KIF21B	chr1:200938520-200992828:-	0.13	4.05	5.81E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12132349	chr1:200875242	KIF21B	chr1:200938520-200992828:-	0.13	4.05	5.81E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.35	-7.72	6.24E-14	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12132794	chr1:156281020	CCT3	chr1:156278752-156308195:-	0.17	4.18	3.44E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12132919	chr1:156318141	BGLAP	chr1:156182784-156213112:+	0.36	7.72	6.23E-14	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12132919	chr1:156318141	CCT3	chr1:156278752-156308195:-	-0.15	-3.55	0.000422	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.52	8.09	4.59E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs12133982	chr1:119464002	WARS2	chr1:119573841-119683295:-	0.3	4.76	2.51E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12134163	chr1:119466993	WARS2	chr1:119573841-119683295:-	0.3	4.92	1.18E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12134983	chr1:156290409	BGLAP	chr1:156182784-156213112:+	0.35	7.65	1.05E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12134983	chr1:156290409	CCT3	chr1:156278752-156308195:-	-0.17	-4.38	1.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12135657	chr1:119470813	WARS2	chr1:119573841-119683295:-	0.31	4.92	1.16E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12138343	chr1:119495317	WARS2	chr1:119573841-119683295:-	0.3	4.6	5.27E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12139321	chr1:156230429	BGLAP	chr1:156182784-156213112:+	0.32	6.78	3.34E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12139321	chr1:156230429	CCT3	chr1:156278752-156308195:-	-0.19	-4.63	4.66E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.31	3.87E-19	Body mass index	
KIRC	cis	1	rs12139630	chr1:46350935	MUTYH	chr1:45794915-45806142:-	0.13	3.81	0.000158	Body mass index	
KIRC	cis	1	rs12139690	chr1:119491316	WARS2	chr1:119573841-119683295:-	0.31	4.85	1.68E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12140314	chr1:99185971	SNX7	chr1:99127236-99226054:+	0.21	5.15	3.73E-7	Proinsulin levels	
KIRC	cis	1	rs12141094	chr1:99186110	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs12141236	chr1:156302575	BGLAP	chr1:156182784-156213112:+	0.34	7.5	2.88E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12141236	chr1:156302575	CCT3	chr1:156278752-156308195:-	-0.17	-4.39	1.39E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12141651	chr1:119492703	WARS2	chr1:119573841-119683295:-	0.29	4.54	7.05E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12142808	chr1:156230546	BGLAP	chr1:156182784-156213112:+	0.32	6.77	3.53E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12142808	chr1:156230546	CCT3	chr1:156278752-156308195:-	-0.19	-4.71	3.23E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12143789	chr1:119497154	WARS2	chr1:119573841-119683295:-	-0.25	-3.98	7.76E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.31	3.87E-19	Body mass index	
KIRC	cis	1	rs12144263	chr1:46352446	MUTYH	chr1:45794915-45806142:-	0.13	3.81	0.000158	Body mass index	
KIRC	cis	1	rs12144610	chr1:119501103	WARS2	chr1:119573841-119683295:-	0.31	4.9	1.32E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12145310	chr1:20901064	CDA	chr1:20915444-20945398:+	-0.2	-3.57	0.000394	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs12145351	chr1:20901181	CDA	chr1:20915444-20945398:+	-0.19	-3.52	0.000474	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs12145375	chr1:151785229	PI4KB	chr1:151264413-151300133:-	-0.33	-3.55	0.000414	Depressive symptoms (SSRI exposure interaction)	
KIRC	cis	1	rs12145743	chr1:156700651	TTC24	chr1:156552022-156556902:+	-0.15	-4.18	3.4E-5	HDL cholesterol	
KIRC	cis	1	rs12145833	chr1:243483754	SDCCAG8	chr1:243419320-243663392:+	0.31	4.06	5.59E-5	Obesity (early onset extreme)	
KIRC	cis	1	rs12147952	chr14:76624884	ESRRB	chr14:76837690-76968178:+	-0.32	-4.46	1.02E-5	Blood pressure	
KIRC	cis	1	rs12148769	chr15:24152094	HERC2P2	chr15:23282265-23378259:-	-0.19	-4.45	1.04E-5	Menarche (age at onset)	
KIRC	cis	1	rs12148786	chr15:76800362	SCAPER	chr15:76640529-77197744:-	-0.18	-6.25	8.72E-10	Blood metabolite levels	
KIRC	cis	1	rs12148	chr22:50962208	TYMP	chr22:50964184-50968514:-	0.16	5.39	1.07E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs12152964	chr5:115609965	COMMD10	chr5:115420727-115628978:+	0.39	4.03	6.43E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12153717	chr5:115571914	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12155623	chr8:49812201	EFCAB1	chr8:49623351-49647870:-	0.24	4.44	1.09E-5	Sudden cardiac arrest	
KIRC	cis	1	rs12157904	chr22:37982012	SH3BP1	chr22:38030661-38062939:+	-0.29	-5.28	1.98E-7	Response to anti-depressant treatment in major depressive disorder	
KIRC	cis	1	rs12158264	chr22:38001504	SH3BP1	chr22:38030661-38062939:+	0.22	4.32	1.88E-5	Response to anti-depressant treatment in major depressive disorder	
KIRC	cis	1	rs12161427	chr1:156705822	TTC24	chr1:156552022-156556902:+	-0.15	-4.11	4.62E-5	HDL cholesterol	
KIRC	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.44	7.05	5.79E-12	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1218282	chr13:79455832	EDNRB	chr13:78469616-78549664:-	0.24	4.01	7.01E-5	Response to statin therapy	
KIRC	cis	1	rs12185102	chr15:75352201	PPCDC	chr15:75315927-75343066:+	0.2	4.63	4.76E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs12185102	chr15:75352201	RPP25	chr15:75247443-75249775:-	0.19	3.54	0.000443	Blood trace element (Zn levels)	
KIRC	cis	1	rs12185102	chr15:75352201	SCAMP5	chr15:75287901-75313836:+	0.26	4.69	3.5E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs12185764	chr20:44550020	PLTP	chr20:44527397-44540786:-	-0.16	-3.74	0.000206	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs12189567	chr6:55933942	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12189571	chr6:55933987	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.47	-10.04	9.7E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.47	-10.22	2.12E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12190671	chr6:55959857	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12190695	chr6:55943429	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12190930	chr6:55977027	COL21A1	chr6:55921389-56258892:-	-0.47	-7.44	4.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12191865	chr6:56014006	COL21A1	chr6:55921389-56258892:-	-0.47	-7.18	2.49E-12	Psychosis (atypical)	
KIRC	cis	1	rs12192279	chr6:110055313	AKD1	chr6:109814059-110012415:-	0.3	3.7	0.000236	Hematological parameters	
KIRC	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.48	-10.31	9.5E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12193911	chr6:55966889	COL21A1	chr6:55921389-56258892:-	-0.48	-7.54	2.29E-13	Psychosis (atypical)	
KIRC	cis	1	rs12194192	chr6:55954089	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12194997	chr6:55970434	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12195340	chr6:55967008	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.49	-10.27	1.41E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12196050	chr6:55985113	COL21A1	chr6:55921389-56258892:-	-0.48	-7.46	3.79E-13	Psychosis (atypical)	
KIRC	cis	1	rs12196213	chr6:55932547	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.48	-9.86	4.48E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12196526	chr6:55955754	COL21A1	chr6:55921389-56258892:-	0.44	7	8.27E-12	Psychosis (atypical)	
KIRC	cis	1	rs12196670	chr6:55941044	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12196709	chr6:55941100	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12196860	chr6:55950374	COL21A1	chr6:55921389-56258892:-	-0.46	-7.27	1.4E-12	Psychosis (atypical)	
KIRC	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.41	-10	1.37E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.25	8.69	5.02E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs12196944	chr6:55941564	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12197114	chr6:109735498	AKD1	chr6:109814059-110012415:-	-0.27	-5.42	9.06E-8	Height	
KIRC	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.21	4.86	1.56E-6	Height	
KIRC	cis	1	rs12197951	chr6:55946916	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12198225	chr6:55947475	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.15E-13	Psychosis (atypical)	
KIRC	cis	1	rs12198637	chr6:55981400	COL21A1	chr6:55921389-56258892:-	-0.47	-7.31	1.07E-12	Psychosis (atypical)	
KIRC	cis	1	rs12199015	chr6:132058947	ENPP3	chr6:131949582-132068549:+	-0.52	-5.88	7.29E-9	Response to fenofibrate (adiponectin levels)	
KIRC	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.47	-10.18	2.98E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.47	-10.35	6.88E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.48	-10.47	2.41E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12200525	chr6:55982301	COL21A1	chr6:55921389-56258892:-	-0.47	-7.44	4.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12200667	chr6:55982461	COL21A1	chr6:55921389-56258892:-	-0.48	-7.46	3.79E-13	Psychosis (atypical)	
KIRC	cis	1	rs12201413	chr6:55933348	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.49	-10.42	3.86E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.46	-10.12	5.03E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.46	-10.11	5.51E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.43	-10.43	3.36E-23	Folate pathway vitamin levels	
KIRC	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.25	8.3	9.81E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs12203179	chr6:55994237	COL21A1	chr6:55921389-56258892:-	0.49	8.23	1.64E-15	Psychosis (atypical)	
KIRC	cis	1	rs12203286	chr6:55994438	COL21A1	chr6:55921389-56258892:-	-0.48	-7.38	6.59E-13	Psychosis (atypical)	
KIRC	cis	1	rs12203407	chr6:55994431	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12203464	chr6:55934339	COL21A1	chr6:55921389-56258892:-	-0.48	-7.56	1.95E-13	Psychosis (atypical)	
KIRC	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.47	-9.9	3.19E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12203653	chr6:55964693	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.51E-12	Psychosis (atypical)	
KIRC	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.47	-9.91	2.89E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12203977	chr6:133122760	VNN2	chr6:133065010-133084598:-	-0.22	-3.67	0.000266	Type 2 diabetes nephropathy	
KIRC	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.49	-10.85	8.42E-25	Response to antipsychotic treatment	
KIRC	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.46	-9.85	4.98E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12204789	chr6:55947818	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.15E-13	Psychosis (atypical)	
KIRC	cis	1	rs12205230	chr6:55995496	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.47	-10.2	2.41E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.47	-9.63	2.89E-20	Response to antipsychotic treatment	
KIRC	cis	1	rs12205653	chr6:55960169	COL21A1	chr6:55921389-56258892:-	-0.47	-7.48	3.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12205903	chr6:55960583	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12206779	chr6:132055593	ENPP3	chr6:131949582-132068549:+	0.5	5.49	6.44E-8	Response to fenofibrate (adiponectin levels)	
KIRC	cis	1	rs12206920	chr6:55966027	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12207120	chr6:55936134	COL21A1	chr6:55921389-56258892:-	-0.46	-7.35	8.17E-13	Psychosis (atypical)	
KIRC	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.47	-10.35	6.88E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.46	-10.06	8.24E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12207665	chr6:55991330	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.48	-10.47	2.41E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12208500	chr6:55933259	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12208615	chr6:55933489	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12208823	chr6:55966902	COL21A1	chr6:55921389-56258892:-	-0.48	-7.54	2.29E-13	Psychosis (atypical)	
KIRC	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.47	-10.2	2.41E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12209192	chr6:55967702	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12209420	chr6:55937876	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12209464	chr6:55985189	COL21A1	chr6:55921389-56258892:-	-0.5	-7.62	1.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12209509	chr6:55962183	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12209529	chr6:55932278	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12210228	chr6:55973083	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.46E-13	Psychosis (atypical)	
KIRC	cis	1	rs12210402	chr6:55943418	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12210468	chr6:55934393	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12211223	chr6:55959848	COL21A1	chr6:55921389-56258892:-	-0.47	-7.44	4.41E-13	Psychosis (atypical)	
KIRC	cis	1	rs12211619	chr6:56014005	COL21A1	chr6:55921389-56258892:-	-0.47	-7.18	2.49E-12	Psychosis (atypical)	
KIRC	cis	1	rs12212032	chr6:56005703	COL21A1	chr6:55921389-56258892:-	-0.48	-7.5	2.85E-13	Psychosis (atypical)	
KIRC	cis	1	rs12212135	chr6:55965006	COL21A1	chr6:55921389-56258892:-	-0.48	-7.5	2.87E-13	Psychosis (atypical)	
KIRC	cis	1	rs12212143	chr6:55965055	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12212211	chr6:55995226	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.47	-10.31	1.01E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.48	-10.47	2.41E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12213291	chr6:55957074	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12213571	chr6:55957493	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.46	-10.3	1.08E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12214519	chr6:55966884	COL21A1	chr6:55921389-56258892:-	-0.48	-7.54	2.29E-13	Psychosis (atypical)	
KIRC	cis	1	rs12214594	chr6:56010824	COL21A1	chr6:55921389-56258892:-	-0.47	-7.29	1.21E-12	Psychosis (atypical)	
KIRC	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.48	-10.14	4.25E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.47	-10.27	1.4E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12215913	chr6:55996995	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.49	-10.62	6.83E-24	Response to antipsychotic treatment	
KIRC	cis	1	rs12216314	chr6:55997673	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.48	-10.29	1.13E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs12216994	chr1:179477137	C1orf125	chr1:179335107-179523868:+	0.33	4.02	6.6E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12216996	chr1:179477591	C1orf125	chr1:179335107-179523868:+	-0.31	-3.97	8.09E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs12217477	chr10:81731756	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12217477	chr10:81731756	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12218176	chr10:81731372	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12218176	chr10:81731372	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12218540	chr10:81736361	LOC219347	chr10:81805991-81838949:-	0.53	4.59	5.55E-6	Rheumatoid arthritis	
KIRC	cis	1	rs12218540	chr10:81736361	LOC650623	chr10:81442731-81448648:+	-0.33	-3.56	0.000411	Rheumatoid arthritis	
KIRC	cis	1	rs12218952	chr10:81731392	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12218952	chr10:81731392	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12219080	chr10:81709279	LOC219347	chr10:81805991-81838949:-	0.47	4.45	1.06E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.13	-4.42	1.21E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.13	-4.51	7.93E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.94	-14.68	7.64E-41	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs12228111	chr12:91460513	KERA	chr12:91444273-91452131:-	0.34	3.55	0.000419	Diabetic kidney disease	
KIRC	cis	1	rs12228207	chr12:104196734	NT5DC3	chr12:104164231-104234975:-	-0.24	-4.06	5.62E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs12229563	chr12:91460424	KERA	chr12:91444273-91452131:-	0.34	3.55	0.000419	Diabetic kidney disease	
KIRC	cis	1	rs12232351	chr15:56140995	NEDD4	chr15:56119131-56285835:-	0.2	4.77	2.37E-6	Keloid	
KIRC	cis	1	rs12232914	chr2:70117176	ANXA4	chr2:69969127-70053594:+	-0.22	-5.17	3.39E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs12237653	chr9:2551654	FLJ35024	chr9:2422702-2622373:-	0.38	5.53	5.28E-8	Gambling	
KIRC	cis	1	rs12241958	chr10:81731274	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12241958	chr10:81731274	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12242005	chr10:81731290	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12242005	chr10:81731290	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12243096	chr10:101812302	CWF19L1	chr10:101992055-102027437:-	0.29	5.46	7.37E-8	Bone mineral density	
KIRC	cis	1	rs12243433	chr10:81732777	LOC219347	chr10:81805991-81838949:-	0.46	4.37	1.48E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12243433	chr10:81732777	LOC650623	chr10:81442731-81448648:+	-0.33	-3.84	0.000139	Rheumatoid arthritis	
KIRC	cis	1	rs12245535	chr10:81733004	LOC219347	chr10:81805991-81838949:-	0.46	4.37	1.48E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12245535	chr10:81733004	LOC650623	chr10:81442731-81448648:+	-0.33	-3.84	0.000139	Rheumatoid arthritis	
KIRC	cis	1	rs12247653	chr10:81731061	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12247653	chr10:81731061	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12247705	chr10:81731118	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12247705	chr10:81731118	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs12250141	chr10:1160106	IDI2	chr10:1064847-1071799:-	0.36	3.86	0.000131	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs12260159	chr10:100702737	HPSE2	chr10:100218877-100995619:-	0.43	5.58	4.02E-8	Migraine	
KIRC	cis	1	rs12264259	chr10:81732788	LOC219347	chr10:81805991-81838949:-	0.46	4.37	1.48E-5	Rheumatoid arthritis	
KIRC	cis	1	rs12264259	chr10:81732788	LOC650623	chr10:81442731-81448648:+	-0.33	-3.84	0.000139	Rheumatoid arthritis	
KIRC	cis	1	rs12270434	chr11:78103300	NARS2	chr11:78147017-78285909:-	-0.17	-4.04	6.15E-5	Testicular germ cell tumor	
KIRC	cis	1	rs12271805	chr11:22827465	SVIP	chr11:22843600-22851382:-	0.26	4.35	1.65E-5	Dialysis-related mortality	
KIRC	cis	1	rs12272213	chr11:71816219	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs12275855	chr11:5559202	TRIM6	chr11:5617347-5634188:+	-0.19	-4.57	6.12E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12277648	chr11:78054336	NARS2	chr11:78147017-78285909:-	-0.21	-4.86	1.54E-6	Testicular germ cell tumor	
KIRC	cis	1	rs12281140	chr11:22823334	SVIP	chr11:22843600-22851382:-	0.26	4.15	3.88E-5	Dialysis-related mortality	
KIRC	cis	1	rs12283462	chr11:71835406	C11orf59	chr11:71808339-71814322:-	0.21	3.59	0.00037	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs12286198	chr11:30503194	C11orf46	chr11:30344649-30359978:+	-0.33	-6.61	9.8E-11	QRS complex (12-leadsum)	
KIRC	cis	1	rs12286337	chr11:30503297	C11orf46	chr11:30344649-30359978:+	-0.33	-6.61	9.8E-11	QRS complex (12-leadsum)	
KIRC	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.35	7.73	5.78E-14	Pancreatic cancer	
KIRC	cis	1	rs12287832	chr11:65553492	SNX32	chr11:65601410-65621170:+	0.33	5.45	7.72E-8	Systemic lupus erythematosus	
KIRC	cis	1	rs12291678	chr11:71570977	C11orf51	chr11:71817424-71823822:-	0.2	3.52	0.000475	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs12291678	chr11:71570977	C11orf59	chr11:71808339-71814322:-	0.22	3.9	0.000111	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs12293188	chr11:22819374	SVIP	chr11:22843600-22851382:-	0.24	3.95	8.86E-5	Dialysis-related mortality	
KIRC	cis	1	rs12293885	chr11:71816092	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.43E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs12294104	chr11:30382899	C11orf46	chr11:30344649-30359978:+	0.26	3.92	0.0001	Sex hormone levels;Menopause (age at onset)	
KIRC	cis	1	rs12294369	chr11:5567068	TRIM6	chr11:5617347-5634188:+	0.21	4.96	9.86E-7	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12295403	chr11:18689653	LDHC	chr11:18433853-18472792:+	-0.22	-3.53	0.000455	Ovarian reserve	
KIRC	cis	1	rs12298484	chr12:124418674	CCDC92	chr12:124420955-124457163:-	0.19	4.88	1.46E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12299125	chr12:123862447	CDK2AP1	chr12:123745542-123756687:-	-0.26	-7.22	1.93E-12	Educational attainment;Height;Head circumference (infant)	
KIRC	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.17	-3.71	0.000232	Colorectal cancer	
KIRC	cis	1	rs12301673	chr12:124455818	CCDC92	chr12:124420955-124457163:-	0.2	5.31	1.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12303914	chr12:10471050	KLRD1	chr12:10457050-10469849:+	-0.21	-3.71	0.000232	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs12309274	chr12:975948	RAD52	chr12:1021255-1099219:-	-0.17	-3.63	0.00031	Colorectal cancer	
KIRC	cis	1	rs12310837	chr12:120880572	COQ5	chr12:120941083-120966964:-	0.2	3.58	0.000371	Type 1 diabetes nephropathy	
KIRC	cis	1	rs12310837	chr12:120880572	POP5	chr12:121016849-121019201:-	-0.16	-3.81	0.000154	Type 1 diabetes nephropathy	
KIRC	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.18	-4.03	6.34E-5	Colorectal cancer	
KIRC	cis	1	rs12317176	chr12:124404718	CCDC92	chr12:124420955-124457163:-	0.19	4.92	1.17E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12317176	chr12:124404718	DNAH10	chr12:124247042-124420265:+	0.2	3.96	8.56E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12324912	chr15:75361006	PPCDC	chr15:75315927-75343066:+	0.18	4.1	4.9E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.23	4.07	5.4E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12325866	chr17:61755974	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs12325866	chr17:61755974	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs12326543	chr18:76409371	ATP9B	chr18:76829397-77138280:+	-0.18	-3.5	0.000511	Rheumatoid arthritis	
KIRC	cis	1	rs12326600	chr18:44596497	HDHD2	chr18:44633782-44676871:-	0.35	3.51	0.00049	Sitting height ratio	
KIRC	cis	1	rs12330157	chr3:58364562	PXK	chr3:58318617-58410878:+	0.23	4.75	2.69E-6	Cholesterol, total	
KIRC	cis	1	rs12332489	chr5:115579386	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12332585	chr5:115581395	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12332658	chr5:115545606	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000105	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12338076	chr9:139121740	QSOX2	chr9:139098182-139137687:-	0.26	4.8	2.08E-6	Height	
KIRC	cis	1	rs12342831	chr9:33124872	B4GALT1	chr9:33110639-33167356:-	-0.25	-4.47	9.51E-6	IgG glycosylation	
KIRC	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.13	-4.54	7.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.14	-4.77	2.4E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs12355784	chr10:65121565	NRBF2	chr10:64893007-64914785:+	-0.31	-7.49	3.04E-13	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs12357418	chr10:37993860	LOC399744	chr10:38717074-38741080:+	0.22	3.53	0.000462	Obesity (extreme)	
KIRC	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.13	-4.61	5.17E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.24	6.41	3.32E-10	Blood metabolite levels	
KIRC	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs12361031	chr11:47783076	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.22	2.04E-22	Subjective well-being	
KIRC	cis	1	rs12363232	chr11:47623890	PSMC3	chr11:47440320-47448024:-	0.13	3.98	7.86E-5	Subjective well-being	
KIRC	cis	1	rs12366580	chr12:82222784	PPFIA2	chr12:81652880-82153109:-	0.41	7.18	2.59E-12	Resting heart rate	
KIRC	cis	1	rs12367791	chr12:82237278	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs12372841	chr13:42549812	KIAA0564	chr13:42140962-42535221:-	0.19	3.95	8.87E-5	Calcium levels	
KIRC	cis	1	rs12374256	chr4:106617361	INTS12	chr4:106603787-106629881:-	-0.64	-6.67	6.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs12377604	chr9:100697287	C9orf156	chr9:100666772-100684852:-	-0.29	-6.58	1.17E-10	Quantitative traits	
KIRC	cis	1	rs12401379	chr1:2058580	SLC35E2	chr1:1590990-1677431:-	0.18	4.01	6.9E-5	Height	
KIRC	cis	1	rs12402052	chr1:10318652	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000351	Hepatocellular carcinoma	
KIRC	cis	1	rs12402661	chr1:9146340	CLSTN1	chr1:9789080-9884550:-	0.2	3.84	0.000137	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12402661	chr1:9146340	GPR157	chr1:9164476-9189356:-	0.2	3.98	8.02E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.46	-9	4.56E-18	Body mass index	
KIRC	cis	1	rs12405451	chr1:46384326	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.53E-5	Body mass index	
KIRC	cis	1	rs12405816	chr1:9153170	CLSTN1	chr1:9789080-9884550:-	0.21	3.9	0.000108	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12405816	chr1:9153170	GPR157	chr1:9164476-9189356:-	0.2	3.81	0.000156	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12407992	chr1:10311983	RBP7	chr1:10057255-10076077:+	0.16	3.9	0.000109	Hepatocellular carcinoma	
KIRC	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.27	5.28E-19	Body mass index	
KIRC	cis	1	rs12409773	chr1:46358831	MUTYH	chr1:45794915-45806142:-	0.13	3.76	0.00019	Body mass index	
KIRC	cis	1	rs12410060	chr1:75245848	C1orf173	chr1:75033796-75139422:-	-0.37	-6.47	2.32E-10	Resistin levels	
KIRC	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.27	5.35E-19	Body mass index	
KIRC	cis	1	rs12410071	chr1:46358886	MUTYH	chr1:45794915-45806142:-	0.13	3.76	0.000187	Body mass index	
KIRC	cis	1	rs12410657	chr1:47278471	CYP4A22	chr1:47603107-47614526:+	0.44	7.58	1.73E-13	Blood metabolite levels	
KIRC	cis	1	rs12410724	chr1:76459134	MSH4	chr1:76262630-76378923:+	-0.28	-4.21	3.07E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.2	9.7E-19	Body mass index	
KIRC	cis	1	rs12411269	chr1:46271052	MUTYH	chr1:45794915-45806142:-	0.14	4.06	5.74E-5	Body mass index	
KIRC	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.25	-4.48	9.06E-6	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs12415303	chr10:69964141	MYPN	chr10:69865876-69971771:+	-0.25	-4.75	2.67E-6	Height	
KIRC	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.48	-10.03	1.05E-21	Arsenic metabolism	
KIRC	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.05	8.91E-22	Subjective well-being	
KIRC	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.48	10.17	3.2E-22	Subjective well-being	
KIRC	cis	1	rs12419692	chr11:47624714	PSMC3	chr11:47440320-47448024:-	-0.13	-4.02	6.71E-5	Subjective well-being	
KIRC	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs12421210	chr11:47779586	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs1242229	chr11:117062370	PCSK7	chr11:117075789-117102811:-	-0.28	-5.4	1.01E-7	Protein quantitative trait loci	
KIRC	cis	1	rs12422771	chr12:6580273	TAPBPL	chr12:6561177-6575601:+	-0.26	-4.02	6.76E-5	Hip geometry	
KIRC	cis	1	rs12423912	chr12:104176295	NT5DC3	chr12:104164231-104234975:-	-0.3	-3.96	8.71E-5	Sense of smell	
KIRC	cis	1	rs12425283	chr12:104176292	NT5DC3	chr12:104164231-104234975:-	-0.3	-3.96	8.71E-5	Sense of smell	
KIRC	cis	1	rs12425790	chr12:121452504	P2RX4	chr12:121647664-121671907:+	-0.21	-3.69	0.000248	Type 2 diabetes	
KIRC	cis	1	rs12428035	chr13:96300872	UGGT2	chr13:96453838-96705736:-	0.28	3.83	0.000146	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
KIRC	cis	1	rs12428	chr20:25433821	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.13E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs12428	chr20:25433821	FAM182A	chr20:26035250-26067552:+	0.29	5.52	5.47E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs12429254	chr13:96299663	UGGT2	chr13:96453838-96705736:-	-0.31	-4.18	3.41E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
KIRC	cis	1	rs12429385	chr13:96301936	UGGT2	chr13:96453838-96705736:-	-0.29	-4.05	6.02E-5	Glomerular filtration rate (cystatin C);Response to statins (LDL cholesterol change)	
KIRC	cis	1	rs12431420	chr14:66001076	LOC645431	chr14:65877313-65879335:-	-0.5	-6.65	7.7E-11	Ischemic stroke	
KIRC	cis	1	rs12433416	chr14:65854175	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs12433423	chr14:65854237	LOC645431	chr14:65877313-65879335:-	-0.46	-6.3	6.5E-10	Ischemic stroke	
KIRC	cis	1	rs12433464	chr14:88824015	SPATA7	chr14:88852012-88904802:+	-0.19	-3.98	7.87E-5	Coronary artery calcification	
KIRC	cis	1	rs12433692	chr14:27074370	NOVA1	chr14:26915090-27066960:-	-0.24	-4.2	3.16E-5	Educational attainment (years of education)	
KIRC	cis	1	rs12433827	chr14:66055610	LOC645431	chr14:65877313-65879335:-	-0.5	-6.01	3.51E-9	Ischemic stroke	
KIRC	cis	1	rs12434024	chr14:100175275	CYP46A1	chr14:100150755-100193637:+	0.2	3.85	0.000134	Scalp hair shape	
KIRC	cis	1	rs12434101	chr14:88478827	GPR65	chr14:88471496-88478414:+	0.12	3.66	0.000281	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12434585	chr14:65938368	LOC645431	chr14:65877313-65879335:-	-0.49	-6.54	1.5E-10	Ischemic stroke	
KIRC	cis	1	rs12435391	chr14:75601737	MLH3	chr14:75480467-75518235:-	0.24	6.12	1.87E-9	Height	
KIRC	cis	1	rs12435391	chr14:75601737	NEK9	chr14:75548819-75593778:-	0.15	4.17	3.65E-5	Height	
KIRC	cis	1	rs12435835	chr14:65499909	CHURC1	chr14:65381140-65411309:+	0.25	5.96	4.8E-9	Red blood cell traits	
KIRC	cis	1	rs12435908	chr14:66121468	LOC645431	chr14:65877313-65879335:-	0.46	6.26	8.14E-10	Ischemic stroke	
KIRC	cis	1	rs12436146	chr14:81821282	STON2	chr14:81727000-81893748:-	0.38	7.2	2.29E-12	Night sleep phenotypes	
KIRC	cis	1	rs12437310	chr14:76642757	ESRRB	chr14:76837690-76968178:+	0.36	5.17	3.31E-7	Blood pressure	
KIRC	cis	1	rs12438181	chr15:78812098	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.6	3.44E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs12438305	chr15:50912454	SPPL2A	chr15:50999739-51057910:-	0.29	7.66	9.53E-14	QT interval	
KIRC	cis	1	rs12438305	chr15:50912454	TRPM7	chr15:50852491-50978994:-	0.13	3.73	0.000215	QT interval	
KIRC	cis	1	rs12438659	chr15:78824924	CHRNA5	chr15:78857906-78886458:+	-0.3	-5.67	2.36E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs12439744	chr15:50899211	SPPL2A	chr15:50999739-51057910:-	0.29	7.78	4.24E-14	QT interval	
KIRC	cis	1	rs12439744	chr15:50899211	TRPM7	chr15:50852491-50978994:-	0.13	3.81	0.000158	QT interval	
KIRC	cis	1	rs12441354	chr15:78821016	CHRNA5	chr15:78857906-78886458:+	-0.29	-5.45	7.89E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs12441426	chr15:78812329	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.64	2.82E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs12441433	chr15:76816015	SCAPER	chr15:76640529-77197744:-	-0.19	-6.4	3.62E-10	Blood metabolite levels	
KIRC	cis	1	rs12442510	chr15:66099113	DPP8	chr15:65737999-65810035:-	0.11	4.48	9.28E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs12442787	chr15:50918107	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.63E-14	QT interval	
KIRC	cis	1	rs12442787	chr15:50918107	TRPM7	chr15:50852491-50978994:-	0.13	3.75	0.000199	QT interval	
KIRC	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.57	-9.71	1.53E-20	Tumor biomarkers	
KIRC	cis	1	rs12443102	chr15:43932103	STRC	chr15:43891762-43924561:-	0.21	4.25	2.52E-5	Tumor biomarkers	
KIRC	cis	1	rs12443102	chr15:43932103	TUBGCP4	chr15:43663313-43698238:+	0.19	4.04	6.17E-5	Tumor biomarkers	
KIRC	cis	1	rs12443118	chr15:56406027	TEX9	chr15:56657644-56738071:+	-0.27	-4.59	5.66E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12443137	chr15:76840832	SCAPER	chr15:76640529-77197744:-	-0.16	-5.54	4.9E-8	Blood metabolite levels	
KIRC	cis	1	rs12444156	chr16:71841257	HP	chr16:72088508-72094957:+	-0.26	-3.67	0.000272	Post bronchodilator FEV1	
KIRC	cis	1	rs12445650	chr16:31044897	MYST1	chr16:31128985-31142713:+	0.15	4.03	6.5E-5	Response to metformin (IC50)	
KIRC	cis	1	rs12446201	chr16:69815586	COG4	chr16:70514473-70557457:-	-0.21	-3.82	0.000151	IgE levels	
KIRC	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.41	4.95	1.01E-6	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
KIRC	cis	1	rs12447826	chr16:4464617	C16orf5	chr16:4560679-4588816:-	0.16	3.53	0.000456	Schizophrenia	
KIRC	cis	1	rs12447826	chr16:4464617	LOC342346	chr16:4606491-4650317:+	0.2	3.53	0.000454	Schizophrenia	
KIRC	cis	1	rs12459350	chr19:2176586	DOT1L	chr19:2164148-2232576:+	0.19	6.73	4.5E-11	Height	
KIRC	cis	1	rs12460161	chr19:44293986	ZNF155	chr19:44488355-44502477:+	-0.26	-5.27	2.04E-7	Breast cancer	
KIRC	cis	1	rs12460161	chr19:44293986	ZNF404	chr19:44376516-44384288:-	-0.31	-6.2	1.19E-9	Breast cancer	
KIRC	cis	1	rs12462270	chr19:39201488	CAPN12	chr19:39220832-39235114:-	-0.14	-4.46	1.02E-5	Heart rate	
KIRC	cis	1	rs12465609	chr2:161179485	PLA2R1	chr2:160798012-160919121:-	0.19	3.54	0.000445	Type 2 diabetes	
KIRC	cis	1	rs12470450	chr2:232113888	ARMC9	chr2:232063342-232238606:+	0.21	4.41	1.28E-5	Food antigen IgG levels	
KIRC	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.66	-8.32	8.19E-16	Plasma clusterin levels	
KIRC	cis	1	rs12473760	chr2:136905697	DARS	chr2:136664254-136743222:-	0.14	3.81	0.000158	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs12476804	chr2:161194255	PLA2R1	chr2:160798012-160919121:-	0.19	3.57	0.000396	Type 2 diabetes	
KIRC	cis	1	rs12478744	chr2:23947589	C2orf84	chr2:24397531-24414566:+	-0.25	-4.42	1.18E-5	Obesity-related traits	
KIRC	cis	1	rs12478744	chr2:23947589	LOC375190	chr2:24299728-24397519:+	0.25	6.26	8.5E-10	Obesity-related traits	
KIRC	cis	1	rs12478842	chr2:113550688	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.97	8.35E-5	Endometriosis	
KIRC	cis	1	rs12478842	chr2:113550688	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.38	1.46E-5	Endometriosis	
KIRC	cis	1	rs12479210	chr2:102949161	IL1RL1	chr2:102927962-102968497:+	-0.18	-3.54	0.000441	Serum protein levels (sST2)	
KIRC	cis	1	rs12479491	chr20:30265450	COX4I2	chr20:30225691-30232800:+	0.13	3.63	0.000309	Subcortical brain region volumes	
KIRC	cis	1	rs12481568	chr20:42901255	L3MBTL	chr20:42136350-42179593:+	-0.15	-3.6	0.000354	Cognitive performance	
KIRC	cis	1	rs12482477	chr21:43517233	C21orf128	chr21:43522244-43528644:-	0.51	8.33	7.51E-16	IgG glycosylation	
KIRC	cis	1	rs12484859	chr22:29844884	RFPL1S	chr22:29833006-29838118:-	-0.26	-4.93	1.14E-6	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs12485237	chr22:29837286	RFPL1S	chr22:29833006-29838118:-	-0.24	-4.45	1.08E-5	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs12488768	chr3:53086234	SFMBT1	chr3:52938628-53080070:-	0.43	10.08	6.78E-22	Ulcerative colitis	
KIRC	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.6	14.21	9.17E-39	Height	
KIRC	cis	1	rs12490835	chr3:134223730	CEP63	chr3:134204575-134293852:+	0.32	6.21	1.1E-9	Height	
KIRC	cis	1	rs12495617	chr3:126797796	CHST13	chr3:126243176-126262133:+	0.17	3.62	0.000319	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs12498722	chr4:103554522	MANBA	chr4:103552644-103682151:-	0.17	3.83	0.000147	Primary biliary cirrhosis	
KIRC	cis	1	rs12499266	chr4:39119753	RFC1	chr4:39289076-39367995:-	-0.15	-3.71	0.000234	Uric acid levels	
KIRC	cis	1	rs12499266	chr4:39119753	WDR19	chr4:39184024-39287429:+	-0.19	-4.9	1.28E-6	Uric acid levels	
KIRC	cis	1	rs12499307	chr4:80911371	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs12505475	chr4:159635244	PPID	chr4:159630280-159644552:-	0.19	3.53	0.000451	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
KIRC	cis	1	rs12505749	chr4:57334112	SRP72	chr4:57333762-57369846:+	-0.27	-3.9	0.000109	Airflow obstruction	
KIRC	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.45	7.49	3.05E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs12506899	chr4:74319283	CXCL1	chr4:74735109-74736953:+	0.19	3.9	0.000108	Tumor biomarkers	
KIRC	cis	1	rs12507142	chr4:17656103	LAP3	chr4:17578927-17609590:+	-0.2	-6.31	6.18E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12507142	chr4:17656103	MED28	chr4:17616273-17629791:+	0.22	4.94	1.05E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12511991	chr4:48422768	OCIAD1	chr4:48833015-48863831:+	-0.24	-5.29	1.78E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs12514600	chr5:115470655	COMMD10	chr5:115420727-115628978:+	0.39	4.04	6.23E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12515251	chr5:115626966	COMMD10	chr5:115420727-115628978:+	0.38	3.93	9.6E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12515308	chr5:115450441	COMMD10	chr5:115420727-115628978:+	0.34	3.9	0.000111	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12515466	chr5:115591877	COMMD10	chr5:115420727-115628978:+	0.33	3.78	0.000178	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12515585	chr5:156430150	HAVCR1	chr5:156456531-156486130:-	-0.45	-10.06	8.1E-22	Hypertriglyceridemia	
KIRC	cis	1	rs12515585	chr5:156430150	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.66	9.65E-14	Hypertriglyceridemia	
KIRC	cis	1	rs12515585	chr5:156430150	TIMD4	chr5:156346293-156390266:-	-0.37	-6.86	2.01E-11	Hypertriglyceridemia	
KIRC	cis	1	rs12516100	chr5:115451750	COMMD10	chr5:115420727-115628978:+	0.39	4.05	6.04E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12517508	chr5:115423574	COMMD10	chr5:115420727-115628978:+	0.34	3.89	0.000112	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12519989	chr5:115562642	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000103	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12520076	chr5:115458830	COMMD10	chr5:115420727-115628978:+	0.39	4.04	6.31E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12520568	chr5:115621505	COMMD10	chr5:115420727-115628978:+	0.37	4.12	4.4E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12520632	chr5:115591766	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12521440	chr5:115670364	COMMD10	chr5:115420727-115628978:+	0.4	4.13	4.3E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12521612	chr5:115582605	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12522027	chr5:115616531	COMMD10	chr5:115420727-115628978:+	0.39	4.05	5.96E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12522248	chr5:156479426	HAVCR1	chr5:156456531-156486130:-	-0.4	-8.92	8.46E-18	Hypertriglyceridemia	
KIRC	cis	1	rs12522248	chr5:156479426	HAVCR2	chr5:156512843-156536138:-	-0.39	-7.27	1.4E-12	Hypertriglyceridemia	
KIRC	cis	1	rs12522248	chr5:156479426	TIMD4	chr5:156346293-156390266:-	-0.29	-5.52	5.59E-8	Hypertriglyceridemia	
KIRC	cis	1	rs12522441	chr5:115523805	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12523347	chr5:115572395	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs12524768	chr6:33760478	LEMD2	chr6:33738991-33756906:-	0.23	5.31	1.68E-7	Body mass index	
KIRC	cis	1	rs12524835	chr6:33730843	LEMD2	chr6:33738991-33756906:-	0.24	5.49	6.29E-8	Body mass index	
KIRC	cis	1	rs12526225	chr6:169861325	WDR27	chr6:169857307-170102159:-	0.15	3.62	0.00032	HIV-1 control	
KIRC	cis	1	rs12526465	chr6:161068607	PLG	chr6:161123274-161174345:+	0.29	4.09	5.08E-5	Triglycerides	
KIRC	cis	1	rs12530288	chr6:131298399	LOC285733	chr6:131148324-131156430:+	-0.22	-3.72	0.00022	Lentiform nucleus volume	
KIRC	cis	1	rs12530	chr22:32783904	SLC5A4	chr22:32614465-32651318:-	-0.2	-3.57	0.000397	IgG glycosylation	
KIRC	cis	1	rs12533022	chr7:128382873	OPN1SW	chr7:128412545-128415844:-	0.22	3.75	0.000201	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs12537549	chr7:3361023	SDK1	chr7:3341080-4308629:+	0.2	4.01	7.03E-5	Motion sickness	
KIRC	cis	1	rs12540417	chr7:137077103	PTN	chr7:136912092-137028546:-	-0.21	-3.56	0.000408	Schizophrenia	
KIRC	cis	1	rs12544462	chr8:110113003	TMEM74	chr8:109619080-109799770:-	-0.2	-3.85	0.000131	Body mass (lean)	
KIRC	cis	1	rs12547941	chr8:29980332	MBOAT4	chr8:29989188-30002200:-	0.33	4.73	2.97E-6	Migraine	
KIRC	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs12561806	chr1:46396776	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.34	7.36	7.61E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12563631	chr1:156258953	CCT3	chr1:156278752-156308195:-	-0.19	-4.72	3.0E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.16	1.36E-18	Body mass index	
KIRC	cis	1	rs12564541	chr1:46380237	MUTYH	chr1:45794915-45806142:-	0.13	3.94	9.3E-5	Body mass index	
KIRC	cis	1	rs12567463	chr1:152180128	FLG	chr1:152274651-152297679:-	0.25	4.09	4.96E-5	Atopic dermatitis	
KIRC	cis	1	rs12567463	chr1:152180128	HRNR	chr1:152184558-152196669:-	-0.23	-3.56	0.000404	Atopic dermatitis	
KIRC	cis	1	rs12571820	chr10:38009354	LOC399744	chr10:38717074-38741080:+	0.23	3.54	0.000442	Obesity (extreme)	
KIRC	cis	1	rs12573978	chr11:46578400	MDK	chr11:46402334-46405374:+	-0.23	-3.87	0.000121	Schizophrenia	
KIRC	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.56	-12.78	1.46E-32	Forced vital capacity	
KIRC	cis	1	rs12578934	chr12:91466496	KERA	chr12:91444273-91452131:-	0.34	3.53	0.000451	Diabetic kidney disease	
KIRC	cis	1	rs12579753	chr12:82219376	PPFIA2	chr12:81652880-82153109:-	0.37	6.7	5.63E-11	Resting heart rate	
KIRC	cis	1	rs12580330	chr12:82241280	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs12583	chr3:49571462	CCDC36	chr3:49235861-49295537:+	-0.26	-4.77	2.42E-6	Menarche (age at onset)	
KIRC	cis	1	rs12583	chr3:49571462	NCKIPSD	chr3:48711280-48723334:-	-0.21	-4.13	4.23E-5	Menarche (age at onset)	
KIRC	cis	1	rs12583	chr3:49571462	P4HTM	chr3:49027341-49044579:+	-0.16	-3.57	0.000392	Menarche (age at onset)	
KIRC	cis	1	rs12583	chr3:49571462	WDR6	chr3:49044637-49053386:+	0.22	5.55	4.55E-8	Menarche (age at onset)	
KIRC	cis	1	rs12587386	chr14:88827764	SPATA7	chr14:88852012-88904802:+	-0.19	-4.08	5.25E-5	Coronary artery calcification	
KIRC	cis	1	rs12588240	chr14:75612083	MLH3	chr14:75480467-75518235:-	0.24	6.22	1.03E-9	Height	
KIRC	cis	1	rs12588240	chr14:75612083	NEK9	chr14:75548819-75593778:-	0.15	4.22	2.87E-5	Height	
KIRC	cis	1	rs12589376	chr14:75561152	MLH3	chr14:75480467-75518235:-	0.23	5.92	5.98E-9	Height	
KIRC	cis	1	rs12589376	chr14:75561152	NEK9	chr14:75548819-75593778:-	0.13	3.75	0.000195	Height	
KIRC	cis	1	rs12589467	chr14:88823583	SPATA7	chr14:88852012-88904802:+	-0.19	-4.06	5.74E-5	Coronary artery calcification	
KIRC	cis	1	rs12589480	chr14:88881270	SPATA7	chr14:88852012-88904802:+	-0.2	-4.21	3.07E-5	Coronary artery calcification	
KIRC	cis	1	rs12589815	chr14:75544101	MLH3	chr14:75480467-75518235:-	0.23	5.84	9.48E-9	Height	
KIRC	cis	1	rs12589815	chr14:75544101	NEK9	chr14:75548819-75593778:-	0.13	3.67	0.000268	Height	
KIRC	cis	1	rs12589876	chr14:75544189	MLH3	chr14:75480467-75518235:-	0.24	6.11	1.97E-9	Height	
KIRC	cis	1	rs12589876	chr14:75544189	NEK9	chr14:75548819-75593778:-	0.15	4.14	4.11E-5	Height	
KIRC	cis	1	rs12590452	chr14:75548756	MLH3	chr14:75480467-75518235:-	0.23	5.8	1.17E-8	Height	
KIRC	cis	1	rs12590452	chr14:75548756	NEK9	chr14:75548819-75593778:-	0.13	3.75	0.000198	Height	
KIRC	cis	1	rs12591093	chr15:56510287	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12591150	chr15:56499482	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12591151	chr15:56499483	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12591296	chr15:59486640	LDHAL6B	chr15:59499042-59500707:+	0.34	3.96	8.46E-5	Metabolite levels	
KIRC	cis	1	rs12591751	chr15:50972497	SPPL2A	chr15:50999739-51057910:-	0.27	7.01	7.63E-12	QT interval	
KIRC	cis	1	rs12591980	chr15:56499326	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12592130	chr15:56465885	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.02E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12592899	chr15:56525311	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12593096	chr15:56506298	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12593439	chr15:56531365	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12593713	chr15:56513500	TEX9	chr15:56657644-56738071:+	-0.28	-5.05	6.09E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12593752	chr15:56485967	TEX9	chr15:56657644-56738071:+	-0.28	-4.93	1.13E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12594061	chr15:66046429	DPP8	chr15:65737999-65810035:-	-0.12	-4.74	2.85E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs12594212	chr15:76802014	SCAPER	chr15:76640529-77197744:-	-0.17	-6.01	3.49E-9	Blood metabolite levels	
KIRC	cis	1	rs12594245	chr15:56499380	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12594541	chr15:76834368	SCAPER	chr15:76640529-77197744:-	-0.17	-5.76	1.47E-8	Blood metabolite levels	
KIRC	cis	1	rs12594908	chr15:56493287	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12595072	chr15:56418771	TEX9	chr15:56657644-56738071:+	-0.27	-4.59	5.66E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12595323	chr15:56506243	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12595366	chr15:56459914	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.02E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12595496	chr15:56528806	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12595649	chr15:56494368	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12600635	chr17:17142896	NT5M	chr17:17206680-17250975:+	0.22	3.59	0.000369	IgG glycosylation	
KIRC	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.35	6.2	1.15E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.36	6.28	7.32E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs12602286	chr17:19236954	EPN2	chr17:19140690-19240027:+	-0.18	-4.26	2.42E-5	Schizophrenia	
KIRC	cis	1	rs12602286	chr17:19236954	GRAPL	chr17:19030782-19062148:+	0.24	3.93	9.86E-5	Schizophrenia	
KIRC	cis	1	rs12603327	chr17:40290552	DHX58	chr17:40253422-40264751:-	-0.35	-6.99	8.96E-12	Fibrinogen levels	
KIRC	cis	1	rs12603330	chr17:40290589	DHX58	chr17:40253422-40264751:-	-0.35	-7.01	7.9E-12	Fibrinogen levels	
KIRC	cis	1	rs12608504	chr19:18389135	JUND	chr19:18390563-18392432:-	-0.17	-3.79	0.000168	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12608504	chr19:18389135	KIAA1683	chr19:18367906-18385319:-	-0.23	-5.65	2.7E-8	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12608504	chr19:18389135	MAST3	chr19:18208603-18262498:+	0.14	3.82	0.000149	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12608544	chr19:49136651	SEC1	chr19:49141296-49185501:+	-0.49	-4.72	3.07E-6	Elevated serum carcinoembryonic antigen levels	
KIRC	cis	1	rs12610373	chr19:18398284	JUND	chr19:18390563-18392432:-	-0.18	-3.9	0.000108	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12610373	chr19:18398284	KIAA1683	chr19:18367906-18385319:-	-0.22	-5.4	1.01E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12610373	chr19:18398284	MAST3	chr19:18208603-18262498:+	0.14	3.68	0.000261	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12611088	chr19:44072802	ZNF575	chr19:44029649-44040282:+	-0.22	-4.97	9.01E-7	Plasma amyloid beta peptide concentrations (ABx-42)	
KIRC	cis	1	rs12611334	chr19:40229409	LOC400696	chr19:40170014-40177013:+	-0.22	-4.68	3.78E-6	Schizophrenia	
KIRC	cis	1	rs12612788	chr2:113555296	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.81	0.000153	Endometriosis	
KIRC	cis	1	rs12612788	chr2:113555296	RPL23AP7	chr2:114368816-114384715:-	-0.26	-4.54	7.12E-6	Endometriosis	
KIRC	cis	1	rs12613947	chr2:70161342	ANXA4	chr2:69969127-70053594:+	-0.22	-5.24	2.41E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs12615749	chr2:54475885	ACYP2	chr2:54342410-54532433:+	-0.22	-3.93	9.7E-5	Telomere length	
KIRC	cis	1	rs12615793	chr2:54475914	ACYP2	chr2:54342410-54532433:+	0.21	3.86	0.00013	Telomere length	
KIRC	cis	1	rs12616955	chr2:136902666	DARS	chr2:136664254-136743222:-	0.14	3.63	0.000313	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs12618262	chr2:190708073	ASNSD1	chr2:190526125-190535556:+	0.34	4.77	2.44E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs12618262	chr2:190708073	ORMDL1	chr2:190634994-190649097:-	-0.23	-3.56	0.000406	Subcutaneous adipose tissue	
KIRC	cis	1	rs12618769	chr2:99239931	EIF5B	chr2:99953834-100016726:+	0.18	3.52	0.00047	Bipolar disorder	
KIRC	cis	1	rs12618769	chr2:99239931	UNC50	chr2:99225042-99234975:+	0.26	4.56	6.51E-6	Bipolar disorder	
KIRC	cis	1	rs12619985	chr2:46641627	CRIPT	chr2:46844325-46852880:+	0.17	4.19	3.34E-5	HDL cholesterol	
KIRC	cis	1	rs12620810	chr2:86391481	LOC90784	chr2:86247339-86250991:-	-0.37	-3.9	0.000111	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs12621280	chr2:232132984	ARMC9	chr2:232063342-232238606:+	0.27	5.28	1.94E-7	Food antigen IgG levels	
KIRC	cis	1	rs12621567	chr2:232118813	ARMC9	chr2:232063342-232238606:+	0.22	4.62	4.99E-6	Food antigen IgG levels	
KIRC	cis	1	rs12622222	chr2:180103575	CCDC141	chr2:179697347-179914786:-	-0.31	-3.74	0.000204	Late-onset Alzheimer's disease	
KIRC	cis	1	rs12623494	chr2:99245917	UNC50	chr2:99225042-99234975:+	-0.24	-4.11	4.53E-5	Bipolar disorder	
KIRC	cis	1	rs12623832	chr2:192125644	MYO1B	chr2:192110107-192290115:+	0.11	3.7	0.000236	Obesity-related traits	
KIRC	cis	1	rs12623832	chr2:192125644	STAT4	chr2:191894306-192038902:-	0.16	4.35	1.62E-5	Obesity-related traits	
KIRC	cis	1	rs12627787	chr22:51012381	CPT1B	chr22:51007291-51017096:-	-0.27	-5.32	1.55E-7	Narcolepsy	
KIRC	cis	1	rs12632274	chr3:160343281	TRIM59	chr3:160153292-160167626:-	0.23	3.9	0.000107	Primary biliary cirrhosis	
KIRC	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs12637751	chr3:134266124	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs12638253	chr3:156626091	LEKR1	chr3:156544076-156763918:+	-0.35	-7.43	4.63E-13	Multiple sclerosis (severity)	
KIRC	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs12643926	chr4:56310621	SRD5A3	chr4:56212409-56237866:+	0.19	4.12	4.42E-5	Personality dimensions	
KIRC	cis	1	rs12643926	chr4:56310621	TMEM165	chr4:56262090-56292342:+	-0.23	-6.4	3.65E-10	Personality dimensions	
KIRC	cis	1	rs12644950	chr4:155537321	FGA	chr4:155504280-155511897:-	0.25	3.95	8.98E-5	Fibrinogen	
KIRC	cis	1	rs12644950	chr4:155537321	FGB	chr4:155484132-155492236:+	0.28	4.38	1.43E-5	Fibrinogen	
KIRC	cis	1	rs12646078	chr4:56368204	SRD5A3	chr4:56212409-56237866:+	0.21	4.44	1.13E-5	Personality dimensions	
KIRC	cis	1	rs12646078	chr4:56368204	TMEM165	chr4:56262090-56292342:+	-0.22	-5.9	6.57E-9	Personality dimensions	
KIRC	cis	1	rs12646251	chr4:39134371	KLB	chr4:39408473-39453151:+	0.21	3.8	0.000166	Uric acid levels	
KIRC	cis	1	rs12646251	chr4:39134371	RFC1	chr4:39289076-39367995:-	0.15	3.73	0.000213	Uric acid levels	
KIRC	cis	1	rs12646251	chr4:39134371	WDR19	chr4:39184024-39287429:+	0.18	4.64	4.41E-6	Uric acid levels	
KIRC	cis	1	rs12647929	chr4:1092019	C4orf48	chr4:2043689-2045697:+	-0.15	-3.73	0.000216	Recombination rate (males)	
KIRC	cis	1	rs12648232	chr4:17612537	LAP3	chr4:17578927-17609590:+	0.19	5.8	1.15E-8	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12648232	chr4:17612537	MED28	chr4:17616273-17629791:+	-0.22	-5.11	4.6E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs12648534	chr4:89799206	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.74	0.000204	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs12649527	chr4:48376802	OCIAD1	chr4:48833015-48863831:+	0.23	5.23	2.55E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs12649528	chr4:48376806	OCIAD1	chr4:48833015-48863831:+	0.22	4.86	1.55E-6	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs12652003	chr5:150231945	IRGM	chr5:150226085-150280295:+	0.6	7.75	5.25E-14	Crohn's disease	
KIRC	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.39	4.88	1.42E-6	Crohn's disease	
KIRC	cis	1	rs12656538	chr5:150251380	IRGM	chr5:150226085-150280295:+	0.65	8.04	6.31E-15	Crohn's disease	
KIRC	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.42	5.08	5.21E-7	Crohn's disease	
KIRC	cis	1	rs12656600	chr5:150311872	IRGM	chr5:150226085-150280295:+	0.52	6.57	1.24E-10	Crohn's disease	
KIRC	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.4	5.02	7.3E-7	Crohn's disease	
KIRC	cis	1	rs12659118	chr5:150324622	IRGM	chr5:150226085-150280295:+	0.54	6.79	3.26E-11	Crohn's disease	
KIRC	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.41	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs12659961	chr5:110187004	CAMK4	chr5:110559648-110820746:+	0.18	3.76	0.000193	Asthma and hay fever	
KIRC	cis	1	rs12659961	chr5:110187004	TMEM232	chr5:109624934-110062381:-	0.22	4.23	2.75E-5	Asthma and hay fever	
KIRC	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.5	-10.56	1.15E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.46	-9.85	4.98E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.45	9.77	9.59E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs12664322	chr6:87803671	C6orf162	chr6:88032306-88052043:+	0.19	3.93	9.72E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.49	10.73	2.55E-24	Response to antipsychotic treatment	
KIRC	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.47	-9.64	2.75E-20	Response to antipsychotic treatment	
KIRC	cis	1	rs12672953	chr7:150539695	ABP1	chr7:150526069-150558379:+	0.2	3.52	0.000466	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs12675542	chr8:29986454	MBOAT4	chr8:29989188-30002200:-	-0.4	-5.67	2.43E-8	Migraine	
KIRC	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.26	5.16	3.48E-7	Gout	
KIRC	cis	1	rs1267817	chr7:66110040	CRCP	chr7:65579805-65619551:+	-0.32	-4.41	1.24E-5	Gout	
KIRC	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.27	5.27	2.04E-7	Gout	
KIRC	cis	1	rs1267818	chr7:66107024	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.27	5.22	2.69E-7	Diabetic kidney disease	
KIRC	cis	1	rs1267820	chr7:66050295	CRCP	chr7:65579805-65619551:+	-0.35	-4.69	3.55E-6	Diabetic kidney disease	
KIRC	cis	1	rs12681963	chr8:29982518	MBOAT4	chr8:29989188-30002200:-	-0.34	-4.6	5.34E-6	Migraine	
KIRC	cis	1	rs12691307	chr16:29939877	TBX6	chr16:30097117-30103208:-	0.17	4.01	6.89E-5	Schizophrenia	
KIRC	cis	1	rs12692592	chr2:161163381	PLA2R1	chr2:160798012-160919121:-	0.19	3.49	0.000518	Type 2 diabetes	
KIRC	cis	1	rs12692737	chr2:165554309	SLC38A11	chr2:165754812-165812035:-	0.27	4.85	1.68E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.28	5.6	3.46E-8	Diabetic kidney disease	
KIRC	cis	1	rs12698509	chr7:65418876	CRCP	chr7:65579805-65619551:+	-0.32	-4.46	9.95E-6	Diabetic kidney disease	
KIRC	cis	1	rs12700789	chr7:3358276	SDK1	chr7:3341080-4308629:+	0.2	3.86	0.000127	Motion sickness	
KIRC	cis	1	rs12710454	chr21:40656919	HMGN1	chr21:40714247-40721270:-	-0.29	-5.98	4.24E-9	Cognitive function	
KIRC	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.2	-4.29	2.13E-5	Cognitive function	
KIRC	cis	1	rs12711519	chr1:9149450	CLSTN1	chr1:9789080-9884550:-	0.19	3.7	0.000242	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12711519	chr1:9149450	GPR157	chr1:9164476-9189356:-	0.19	3.84	0.00014	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12711741	chr2:113553165	DDX11L2	chr2:114356606-114359153:-	-0.26	-4.17	3.64E-5	Endometriosis	
KIRC	cis	1	rs12711741	chr2:113553165	RPL23AP7	chr2:114368816-114384715:-	-0.26	-4.51	8.07E-6	Endometriosis	
KIRC	cis	1	rs1271200	chr12:32441270	BICD1	chr12:32260185-32531140:+	0.17	3.98	7.83E-5	Pancreatic cancer	
KIRC	cis	1	rs12712133	chr2:102866273	IL18R1	chr2:102927962-103015215:+	0.16	3.56	0.000404	Primary biliary cirrhosis	
KIRC	cis	1	rs12712530	chr2:37505561	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.18	3.28E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs12712530	chr2:37505561	QPCT	chr2:37571753-37600464:+	-0.2	-3.72	0.000221	Chronic lymphocytic leukemia	
KIRC	cis	1	rs12713280	chr2:55081376	RPL23AP32	chr2:54756359-54756978:+	0.18	3.56	0.00041	Economic and political preferences	
KIRC	cis	1	rs12713281	chr2:55081762	RPL23AP32	chr2:54756359-54756978:+	-0.19	-3.69	0.00025	Economic and political preferences	
KIRC	cis	1	rs12714629	chr3:85598424	CADM2	chr3:85008133-86117948:+	0.23	3.74	0.000209	Longevity (90 years and older)	
KIRC	cis	1	rs12725198	chr1:16080171	FBLIM1	chr1:16083154-16114431:+	-0.23	-7	7.99E-12	Cardiac Troponin-T levels	
KIRC	cis	1	rs12725220	chr1:99184798	SNX7	chr1:99127236-99226054:+	-0.19	-4.55	6.73E-6	Proinsulin levels	
KIRC	cis	1	rs12725694	chr1:16080501	FBLIM1	chr1:16083154-16114431:+	0.24	7.08	5.0E-12	Cardiac Troponin-T levels	
KIRC	cis	1	rs12725833	chr1:16080618	FBLIM1	chr1:16083154-16114431:+	0.24	7.08	4.75E-12	Cardiac Troponin-T levels	
KIRC	cis	1	rs12726081	chr1:27037575	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12726287	chr1:27039228	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12729444	chr1:27037154	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12730386	chr1:27037989	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12731749	chr1:27085562	PIGV	chr1:27114455-27124886:+	-0.39	-4.55	6.58E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12733173	chr1:152173972	FLG2	chr1:152321214-152332482:-	0.31	5.37	1.21E-7	Inflammatory skin disease	
KIRC	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.3	5.07	5.63E-7	Inflammatory skin disease	
KIRC	cis	1	rs12733173	chr1:152173972	HRNR	chr1:152184558-152196669:-	-0.35	-5.6	3.48E-8	Inflammatory skin disease	
KIRC	cis	1	rs12736630	chr1:9153885	CLSTN1	chr1:9789080-9884550:-	0.21	3.6	0.000346	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12737946	chr1:27079894	PIGV	chr1:27114455-27124886:+	-0.39	-4.54	7.11E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12738345	chr1:27019744	PIGV	chr1:27114455-27124886:+	-0.39	-4.32	1.91E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12738912	chr1:9152080	CLSTN1	chr1:9789080-9884550:-	0.21	3.61	0.000337	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12739698	chr1:27230033	PIGV	chr1:27114455-27124886:+	-0.4	-4.55	6.6E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12741472	chr1:27221609	PIGV	chr1:27114455-27124886:+	-0.36	-4.17	3.52E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12742115	chr1:27079931	PIGV	chr1:27114455-27124886:+	-0.39	-4.54	7.11E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12742376	chr1:27285195	PIGV	chr1:27114455-27124886:+	-0.37	-4.19	3.34E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12744212	chr1:180952516	MR1	chr1:181003139-181024633:+	-0.14	-3.88	0.000117	Progressive supranuclear palsy	
KIRC	cis	1	rs12744221	chr1:145645606	NUDT17	chr1:145586494-145590461:-	0.29	6.12	1.91E-9	Epilepsy (remission after treatment)	
KIRC	cis	1	rs12744221	chr1:145645606	PDZK1	chr1:145727726-145764073:+	-0.13	-3.75	0.000194	Epilepsy (remission after treatment)	
KIRC	cis	1	rs12748152	chr1:27138393	PIGV	chr1:27114455-27124886:+	-0.39	-4.57	6.09E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12749053	chr1:95660556	RWDD3	chr1:95583479-95712773:+	0.31	4.36	1.54E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs12751024	chr1:228605819	TRIM11	chr1:228581379-228594517:-	-0.24	-3.49	0.000527	Hip circumference (psychosocial stress interaction)	
KIRC	cis	1	rs12751466	chr1:9147856	CLSTN1	chr1:9789080-9884550:-	0.2	3.59	0.000363	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12752711	chr1:27250258	PIGV	chr1:27114455-27124886:+	-0.36	-4.19	3.26E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12754041	chr1:180957962	MR1	chr1:181003139-181024633:+	-0.14	-3.88	0.000117	Progressive supranuclear palsy	
KIRC	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.32	-5.52	5.36E-8	Polycystic ovary syndrome	
KIRC	cis	1	rs1275469	chr12:75935230	GLIPR1L2	chr12:75784889-75825591:+	-0.3	-5.2	2.92E-7	Polycystic ovary syndrome	
KIRC	cis	1	rs1275501	chr2:27419282	C2orf28	chr2:27434899-27440044:+	-0.15	-4.27	2.37E-5	Blood metabolite levels	
KIRC	cis	1	rs1275522	chr2:27426878	C2orf28	chr2:27434899-27440044:+	-0.15	-4.29	2.17E-5	Blood metabolite levels	
KIRC	cis	1	rs1275528	chr2:27430781	C2orf28	chr2:27434899-27440044:+	-0.15	-4.29	2.13E-5	Blood metabolite levels	
KIRC	cis	1	rs1275530	chr2:27432547	C2orf28	chr2:27434899-27440044:+	-0.15	-4.38	1.47E-5	Blood metabolite levels	
KIRC	cis	1	rs1275537	chr2:27441302	C2orf28	chr2:27434899-27440044:+	0.14	4.02	6.81E-5	Blood metabolite levels	
KIRC	cis	1	rs1275537	chr2:27441302	NRBP1	chr2:27650657-27665122:+	-0.16	-3.99	7.67E-5	Blood metabolite levels	
KIRC	cis	1	rs1275538	chr2:27441397	C2orf28	chr2:27434899-27440044:+	0.14	4.04	6.19E-5	Blood metabolite levels	
KIRC	cis	1	rs1275538	chr2:27441397	NRBP1	chr2:27650657-27665122:+	-0.16	-3.99	7.66E-5	Blood metabolite levels	
KIRC	cis	1	rs12755552	chr1:95685026	RWDD3	chr1:95583479-95712773:+	0.35	4.56	6.38E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs12755780	chr1:9148184	CLSTN1	chr1:9789080-9884550:-	0.21	3.83	0.000146	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12756074	chr1:27047893	PIGV	chr1:27114455-27124886:+	-0.39	-4.3	2.05E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12756959	chr1:9148939	CLSTN1	chr1:9789080-9884550:-	0.21	4.05	6.02E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12756959	chr1:9148939	GPR157	chr1:9164476-9189356:-	0.21	4.09	5.07E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12760175	chr1:46447840	CCDC163P	chr1:45960581-45965646:-	-0.47	-8.79	2.4E-17	Body mass index	
KIRC	cis	1	rs12760175	chr1:46447840	MUTYH	chr1:45794915-45806142:-	0.17	4.91	1.21E-6	Body mass index	
KIRC	cis	1	rs12760466	chr1:99201371	SNX7	chr1:99127236-99226054:+	-0.18	-4.3	2.03E-5	Proinsulin levels	
KIRC	cis	1	rs12760759	chr1:27158344	PIGV	chr1:27114455-27124886:+	0.42	5.25	2.28E-7	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs12760830	chr1:9148946	CLSTN1	chr1:9789080-9884550:-	0.21	4.05	6.02E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12760830	chr1:9148946	GPR157	chr1:9164476-9189356:-	0.21	4.09	5.07E-5	Response to antidepressant treatment (citalopram)	
KIRC	cis	1	rs12761361	chr10:89427203	PAPSS2	chr10:89419476-89507460:+	0.17	3.68	0.000255	Exercise (leisure time)	
KIRC	cis	1	rs12768613	chr10:81916566	PLAC9	chr10:81892258-81904784:+	-0.2	-5.01	7.67E-7	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs12768834	chr10:74043874	SPOCK2	chr10:73818793-73848790:-	-0.21	-4.04	6.18E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs12771477	chr10:17209464	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.28	1.1E-15	Homocysteine levels	
KIRC	cis	1	rs12772239	chr10:37988944	LOC399744	chr10:38717074-38741080:+	0.22	3.5	0.000505	Obesity (extreme)	
KIRC	cis	1	rs12772275	chr10:17204542	TRDMT1	chr10:17184983-17243681:-	-0.35	-8.06	5.57E-15	Homocysteine levels	
KIRC	cis	1	rs12773642	chr10:17196055	TRDMT1	chr10:17184983-17243681:-	-0.37	-8.41	4.28E-16	Homocysteine levels	
KIRC	cis	1	rs12774134	chr10:4963327	AKR1C1	chr10:4934796-5020157:+	-0.38	-4.99	8.24E-7	Height	
KIRC	cis	1	rs12774134	chr10:4963327	AKR1C2	chr10:4964715-5060207:-	0.55	6.67	6.61E-11	Height	
KIRC	cis	1	rs12777800	chr10:1070361	IDI2	chr10:1064847-1071799:-	-0.24	-3.8	0.000162	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs12780285	chr10:69958749	MYPN	chr10:69865876-69971771:+	-0.25	-4.59	5.55E-6	Height	
KIRC	cis	1	rs12780845	chr10:17223244	TRDMT1	chr10:17184983-17243681:-	-0.32	-7.47	3.52E-13	Homocysteine levels	
KIRC	cis	1	rs12781471	chr10:96765362	CYP2C9	chr10:96698415-96749147:+	0.18	3.6	0.000348	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs12782687	chr10:17223368	TRDMT1	chr10:17184983-17243681:-	-0.32	-7.38	6.41E-13	Homocysteine levels	
KIRC	cis	1	rs12783490	chr10:17223716	TRDMT1	chr10:17184983-17243681:-	-0.34	-7.84	2.76E-14	Homocysteine levels	
KIRC	cis	1	rs12786214	chr11:64364203	SLC22A12	chr11:64358282-64369820:+	-0.16	-4.4	1.32E-5	Urate levels in obese individuals	
KIRC	cis	1	rs12786344	chr11:3021392	NAP1L4	chr11:2965661-3013607:-	0.21	4.82	1.88E-6	Calcium levels	
KIRC	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.07	7.39E-22	Subjective well-being	
KIRC	cis	1	rs12787765	chr11:58400686	ZFP91	chr11:58346587-58388513:+	-0.12	-3.7	0.000244	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12789252	chr11:18690389	LDHC	chr11:18433853-18472792:+	-0.23	-3.69	0.000249	Ovarian reserve	
KIRC	cis	1	rs12789474	chr11:3024139	NAP1L4	chr11:2965661-3013607:-	0.2	4.7	3.41E-6	Calcium levels	
KIRC	cis	1	rs12798150	chr11:3019260	NAP1L4	chr11:2965661-3013607:-	0.2	4.71	3.25E-6	Calcium levels	
KIRC	cis	1	rs12799215	chr11:58405674	ZFP91	chr11:58346587-58388513:+	-0.13	-3.86	0.000129	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs12804412	chr11:3020782	NAP1L4	chr11:2965661-3013607:-	0.21	4.82	1.88E-6	Calcium levels	
KIRC	cis	1	rs12806	chr10:101911142	CWF19L1	chr10:101992055-102027437:-	-0.29	-3.62	0.00033	Schizophrenia	
KIRC	cis	1	rs12809125	chr12:124407991	CCDC92	chr12:124420955-124457163:-	0.19	4.89	1.38E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12809125	chr12:124407991	DNAH10	chr12:124247042-124420265:+	0.2	3.94	9.24E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12811063	chr12:81440720	ACSS3	chr12:81471809-81649582:+	-0.17	-3.82	0.000147	Neuroticism	
KIRC	cis	1	rs12811063	chr12:81440720	LIN7A	chr12:81191171-81331694:-	-0.2	-4.99	8.23E-7	Neuroticism	
KIRC	cis	1	rs12811607	chr12:82233619	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs12821073	chr12:82183260	PPFIA2	chr12:81652880-82153109:-	0.38	6.93	1.28E-11	Resting heart rate	
KIRC	cis	1	rs12827398	chr12:81445457	ACSS3	chr12:81471809-81649582:+	0.17	3.9	0.000109	Neuroticism	
KIRC	cis	1	rs12827398	chr12:81445457	LIN7A	chr12:81191171-81331694:-	0.19	4.95	1.01E-6	Neuroticism	
KIRC	cis	1	rs12827923	chr12:82242067	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs12828040	chr12:7326541	PEX5	chr12:7341759-7371167:+	0.55	12.35	8.4E-31	IgG glycosylation	
KIRC	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.55	-11.91	5.55E-29	IgG glycosylation	
KIRC	cis	1	rs12830268	chr12:82233627	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs1284464	chr12:57964617	TSFM	chr12:58176536-58191367:+	-0.23	-5.8	1.18E-8	Rheumatoid arthritis	
KIRC	cis	1	rs1284464	chr12:57964617	XRCC6BP1	chr12:58335445-58351051:+	-0.17	-3.88	0.000117	Rheumatoid arthritis	
KIRC	cis	1	rs12864890	chr13:99126457	STK24	chr13:99102455-99229396:-	-0.28	-5.56	4.43E-8	Longevity	
KIRC	cis	1	rs12879542	chr14:75507525	MLH3	chr14:75480467-75518235:-	0.23	5.82	1.04E-8	Height	
KIRC	cis	1	rs12879542	chr14:75507525	NEK9	chr14:75548819-75593778:-	0.13	3.73	0.000214	Height	
KIRC	cis	1	rs12879642	chr14:76682967	ESRRB	chr14:76837690-76968178:+	0.34	4.78	2.35E-6	Blood pressure	
KIRC	cis	1	rs12889309	chr14:75593902	MLH3	chr14:75480467-75518235:-	0.23	5.96	4.71E-9	Height	
KIRC	cis	1	rs12889309	chr14:75593902	NEK9	chr14:75548819-75593778:-	0.14	3.9	0.000109	Height	
KIRC	cis	1	rs12889472	chr14:75543979	MLH3	chr14:75480467-75518235:-	0.23	5.83	9.94E-9	Height	
KIRC	cis	1	rs12889472	chr14:75543979	NEK9	chr14:75548819-75593778:-	0.13	3.63	0.000308	Height	
KIRC	cis	1	rs12897094	chr14:75579416	MLH3	chr14:75480467-75518235:-	0.23	5.86	8.4E-9	Height	
KIRC	cis	1	rs12897094	chr14:75579416	NEK9	chr14:75548819-75593778:-	0.13	3.68	0.000257	Height	
KIRC	cis	1	rs12898259	chr15:75369780	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.68E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000228	Blood trace element (Zn levels)	
KIRC	cis	1	rs12898430	chr15:76874923	SCAPER	chr15:76640529-77197744:-	-0.17	-5.96	4.63E-9	Blood metabolite levels	
KIRC	cis	1	rs12899981	chr15:85302373	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.45	1.07E-5	Schizophrenia	
KIRC	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.21	-4.06	5.66E-5	Schizophrenia	
KIRC	cis	1	rs12900061	chr15:66009248	DPP8	chr15:65737999-65810035:-	-0.15	-4.61	5.07E-6	Educational attainment (years of education)	
KIRC	cis	1	rs12900863	chr15:73094671	ADPGK	chr15:73043710-73076667:-	0.17	3.92	9.9E-5	Body mass index	
KIRC	cis	1	rs12901243	chr15:75374233	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.87E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000227	Blood trace element (Zn levels)	
KIRC	cis	1	rs12902672	chr15:84716986	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.32	1.89E-5	Schizophrenia	
KIRC	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.26	-4.99	8.27E-7	Schizophrenia	
KIRC	cis	1	rs12903134	chr15:85337699	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.68	3.76E-6	Schizophrenia	
KIRC	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.21	-4.06	5.62E-5	Schizophrenia	
KIRC	cis	1	rs12903201	chr15:75370776	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.87E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000227	Blood trace element (Zn levels)	
KIRC	cis	1	rs12903820	chr15:84723820	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.37	1.49E-5	Schizophrenia	
KIRC	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.26	-5.01	7.69E-7	Schizophrenia	
KIRC	cis	1	rs12905057	chr15:85210765	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.42	1.21E-5	Schizophrenia	
KIRC	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.22	-4.24	2.7E-5	Schizophrenia	
KIRC	cis	1	rs12906196	chr15:65884888	DPP8	chr15:65737999-65810035:-	-0.13	-5	7.97E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs12907038	chr15:58244032	ALDH1A2	chr15:58245628-58571462:-	-0.19	-3.6	0.000344	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
KIRC	cis	1	rs12908161	chr15:85207825	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.44	1.11E-5	Schizophrenia	
KIRC	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.2	-3.87	0.000124	Schizophrenia	
KIRC	cis	1	rs12908549	chr15:85322351	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.57	6.17E-6	Schizophrenia	
KIRC	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.21	-4.1	4.73E-5	Schizophrenia	
KIRC	cis	1	rs12909095	chr15:43558142	STRC	chr15:43891762-43924561:-	0.23	5.79	1.21E-8	Lung cancer	
KIRC	cis	1	rs12909280	chr15:85429356	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-3.83	0.000146	Alzheimer's disease (age of onset)	
KIRC	cis	1	rs12910012	chr15:85298662	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.45	1.07E-5	Schizophrenia	
KIRC	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.21	-4.06	5.66E-5	Schizophrenia	
KIRC	cis	1	rs12910644	chr15:75358388	PPCDC	chr15:75315927-75343066:+	0.19	4.24	2.63E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.27	4.65	4.17E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.54	-12.45	3.38E-31	Type 2 diabetes	
KIRC	cis	1	rs12910992	chr15:90372465	C15orf38	chr15:90443832-90456222:-	0.14	3.5	0.000516	Type 2 diabetes	
KIRC	cis	1	rs12911132	chr15:43560436	STRC	chr15:43891762-43924561:-	0.23	5.7	2.07E-8	Lung cancer	
KIRC	cis	1	rs12911736	chr15:85240008	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.51	8.24E-6	Schizophrenia	
KIRC	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.22	-4.22	2.96E-5	Schizophrenia	
KIRC	cis	1	rs12912388	chr15:85344550	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.58	5.84E-6	Schizophrenia	
KIRC	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.2	-4	7.32E-5	Schizophrenia	
KIRC	cis	1	rs12912924	chr15:69635381	NOX5	chr15:69222864-69349073:+	-0.43	-3.5	0.000502	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs12914773	chr15:68019958	IQCH	chr15:67547188-67794139:+	0.18	3.56	0.000413	Motion sickness	
KIRC	cis	1	rs12914857	chr15:84581166	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.35	1.61E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs12915234	chr15:84758301	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.44	1.09E-5	Schizophrenia	
KIRC	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.26	-4.96	9.55E-7	Schizophrenia	
KIRC	cis	1	rs12916348	chr15:84765527	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.5	8.54E-6	Schizophrenia	
KIRC	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.26	-4.99	8.46E-7	Schizophrenia	
KIRC	cis	1	rs12917429	chr15:85425097	GOLGA6L5	chr15:85047738-85060078:-	0.15	4.02	6.59E-5	Alzheimer's disease (age of onset)	
KIRC	cis	1	rs12924769	chr16:20111813	LYRM1	chr16:20911557-20936326:+	-0.15	-3.6	0.000343	Attention deficit hyperactivity disorder (inattention symptoms)	
KIRC	cis	1	rs12938856	chr17:40570649	NAGLU	chr17:40687951-40696464:+	-0.18	-3.76	0.000192	Crohn's disease	
KIRC	cis	1	rs12940106	chr17:53067683	TOM1L1	chr17:52978052-53039328:+	-0.18	-4.66	3.97E-6	Breast cancer	
KIRC	cis	1	rs12948099	chr17:79600799	ARL16	chr17:79648234-79650954:-	-0.18	-4.5	8.47E-6	Eye color traits	
KIRC	cis	1	rs12948099	chr17:79600799	NPLOC4	chr17:79523915-79604138:-	-0.13	-4	7.15E-5	Eye color traits	
KIRC	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.61	13.78	7.54E-37	Eye color traits	
KIRC	cis	1	rs12948909	chr17:40570602	NAGLU	chr17:40687951-40696464:+	-0.18	-3.84	0.000138	Crohn's disease	
KIRC	cis	1	rs12969657	chr18:67536496	CD226	chr18:67530195-67624232:-	0.19	5.93	5.64E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs12980225	chr19:23026745	ZNF492	chr19:22817126-22850472:+	-0.38	-5.62	3.22E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs12980403	chr19:18398139	JUND	chr19:18390563-18392432:-	-0.18	-3.9	0.000108	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12980403	chr19:18398139	KIAA1683	chr19:18367906-18385319:-	-0.22	-5.4	1.01E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12980403	chr19:18398139	MAST3	chr19:18208603-18262498:+	0.14	3.68	0.000261	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs12982593	chr19:2175891	DOT1L	chr19:2164148-2232576:+	0.18	6.59	1.1E-10	Height	
KIRC	cis	1	rs12983458	chr19:2168612	DOT1L	chr19:2164148-2232576:+	0.18	6.66	7.08E-11	Height	
KIRC	cis	1	rs12983770	chr19:23023614	ZNF492	chr19:22817126-22850472:+	-0.38	-5.62	3.22E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs12986413	chr19:2170954	DOT1L	chr19:2164148-2232576:+	-0.18	-6.43	3.01E-10	Height	
KIRC	cis	1	rs12988385	chr2:231036311	SP110	chr2:231033645-231084827:-	0.3	4.43	1.14E-5	Obesity-related traits	
KIRC	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.29	-5.34	1.43E-7	Response to metformin (IC50)	
KIRC	cis	1	rs12995739	chr2:231037481	SP110	chr2:231033645-231084827:-	0.3	4.43	1.14E-5	Obesity-related traits	
KIRC	cis	1	rs12999430	chr2:70306785	ANXA4	chr2:69969127-70053594:+	-0.18	-3.62	0.000324	Obesity-related traits	
KIRC	cis	1	rs12999430	chr2:70306785	FAM136A	chr2:70523109-70529220:-	-0.23	-4.58	5.83E-6	Obesity-related traits	
KIRC	cis	1	rs13000462	chr2:113534024	DDX11L2	chr2:114356606-114359153:-	0.22	3.58	0.000374	Endometriosis	
KIRC	cis	1	rs13000462	chr2:113534024	RPL23AP7	chr2:114368816-114384715:-	0.26	4.59	5.7E-6	Endometriosis	
KIRC	cis	1	rs13000817	chr2:70273707	ANXA4	chr2:69969127-70053594:+	-0.18	-3.55	0.000429	Obesity-related traits	
KIRC	cis	1	rs13000817	chr2:70273707	FAM136A	chr2:70523109-70529220:-	-0.23	-4.54	6.99E-6	Obesity-related traits	
KIRC	cis	1	rs13001325	chr2:102939036	IL1RL1	chr2:102927962-102968497:+	-0.18	-3.56	0.000406	Serum protein levels (sST2)	
KIRC	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.48	9.11	1.97E-18	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs13008738	chr2:61078921	C2orf74	chr2:61372243-61391964:+	0.39	6.33	5.29E-10	Inflammatory skin disease	
KIRC	cis	1	rs13009294	chr2:113552678	DDX11L2	chr2:114356606-114359153:-	-0.26	-4.17	3.64E-5	Endometriosis	
KIRC	cis	1	rs13009294	chr2:113552678	RPL23AP7	chr2:114368816-114384715:-	-0.26	-4.51	8.07E-6	Endometriosis	
KIRC	cis	1	rs13010639	chr2:231035745	SP110	chr2:231033645-231084827:-	0.28	4.17	3.6E-5	Obesity-related traits	
KIRC	cis	1	rs13010998	chr2:231035729	SP110	chr2:231033645-231084827:-	0.31	4.54	6.95E-6	Obesity-related traits	
KIRC	cis	1	rs13014235	chr2:202215492	ALS2CR12	chr2:202153148-202222101:-	-0.24	-4.66	4.01E-6	Basal cell carcinoma	
KIRC	cis	1	rs13015457	chr2:70125763	ANXA4	chr2:69969127-70053594:+	-0.22	-5.24	2.42E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs13016946	chr2:137535866	THSD7B	chr2:137523115-138435287:+	-0.19	-4.05	5.86E-5	Pancreatic cancer	
KIRC	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.89	1.34E-6	Melanoma;Esophageal squamous cell carcinoma	
KIRC	cis	1	rs13019004	chr2:192110219	MYO1B	chr2:192110107-192290115:+	-0.11	-3.61	0.00034	Obesity-related traits	
KIRC	cis	1	rs13019004	chr2:192110219	STAT4	chr2:191894306-192038902:-	-0.15	-3.86	0.000131	Obesity-related traits	
KIRC	cis	1	rs1302019	chr6:147971574	SASH1	chr6:148663729-148873184:+	0.32	3.63	0.000311	Myopia (pathological)	
KIRC	cis	1	rs13025209	chr2:231038169	SP110	chr2:231033645-231084827:-	0.26	3.99	7.49E-5	Obesity-related traits	
KIRC	cis	1	rs13025520	chr2:231038029	SP110	chr2:231033645-231084827:-	0.29	4.38	1.42E-5	Obesity-related traits	
KIRC	cis	1	rs13026621	chr2:27807624	NRBP1	chr2:27650657-27665122:+	0.14	3.64	0.000296	Oral cavity cancer	
KIRC	cis	1	rs13027814	chr2:113551105	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.97	8.35E-5	Endometriosis	
KIRC	cis	1	rs13027814	chr2:113551105	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.38	1.46E-5	Endometriosis	
KIRC	cis	1	rs13028508	chr2:70118427	ANXA4	chr2:69969127-70053594:+	0.22	5.25	2.3E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs13032333	chr2:9620701	IAH1	chr2:9614670-9636671:+	-0.16	-3.66	0.000281	Alcohol dependence (age at onset)	
KIRC	cis	1	rs13032363	chr2:9620740	IAH1	chr2:9614670-9636671:+	-0.16	-3.54	0.000437	Alcohol dependence (age at onset)	
KIRC	cis	1	rs13033143	chr2:61161095	C2orf74	chr2:61372243-61391964:+	0.38	6.46	2.45E-10	Inflammatory skin disease	
KIRC	cis	1	rs13037594	chr20:55040168	C20orf43	chr20:55043647-55093942:+	0.21	5	7.76E-7	Refractive astigmatism	
KIRC	cis	1	rs13038305	chr20:23610262	CST3	chr20:23608536-23618574:-	-0.15	-4.01	7.09E-5	Chronic kidney disease	
KIRC	cis	1	rs13038621	chr20:47908060	CSE1L	chr20:47662838-47713484:+	-0.17	-3.59	0.000364	Height	
KIRC	cis	1	rs13038834	chr20:25441433	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.55	1.42E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.33	-6.13	1.82E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs13039536	chr20:23612305	CST3	chr20:23608536-23618574:-	-0.14	-3.86	0.000127	Chronic kidney disease	
KIRC	cis	1	rs13041070	chr20:23614261	CST3	chr20:23608536-23618574:-	-0.13	-3.51	0.000494	Chronic kidney disease	
KIRC	cis	1	rs1304164	chr2:198877234	RFTN2	chr2:198435528-198540584:-	0.17	4.7	3.38E-6	Ulcerative colitis	
KIRC	cis	1	rs1304165	chr2:198877300	RFTN2	chr2:198435528-198540584:-	0.16	4.51	8.26E-6	Ulcerative colitis	
KIRC	cis	1	rs13041953	chr20:55081353	C20orf43	chr20:55043647-55093942:+	0.2	4.55	6.75E-6	Refractive astigmatism	
KIRC	cis	1	rs13043313	chr20:60958269	HAR1B	chr20:61726845-61733671:-	0.22	3.67	0.000272	Colorectal cancer	
KIRC	cis	1	rs13043526	chr20:55088798	C20orf43	chr20:55043647-55093942:+	0.2	4.72	3.12E-6	Refractive astigmatism	
KIRC	cis	1	rs13053758	chr22:29855489	RFPL1S	chr22:29833006-29838118:-	-0.26	-5.03	6.93E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13053817	chr22:29847722	RFPL1S	chr22:29833006-29838118:-	0.3	5.85	8.66E-9	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13054354	chr22:29840180	RFPL1S	chr22:29833006-29838118:-	-0.27	-5.14	3.98E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13055259	chr22:29856892	RFPL1S	chr22:29833006-29838118:-	-0.27	-5.04	6.35E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13055556	chr22:29840367	RFPL1S	chr22:29833006-29838118:-	-0.31	-5.81	1.08E-8	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13055707	chr22:29851172	RFPL1S	chr22:29833006-29838118:-	-0.26	-5	7.81E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13056719	chr22:24724099	C22orf45	chr22:24825178-24826344:-;chr22	0.16	3.91	0.000105	Gut microbiome composition (summer)	
KIRC	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.25	-6.39	3.8E-10	Gut microbiome composition (summer)	
KIRC	cis	1	rs13057382	chr22:29850334	RFPL1S	chr22:29833006-29838118:-	-0.26	-4.91	1.21E-6	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13057815	chr22:29853526	RFPL1S	chr22:29833006-29838118:-	-0.26	-5.03	6.93E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.15	-3.75	0.000198	Electrocardiographic conduction measures	
KIRC	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.01	2.49E-42	Height	
KIRC	cis	1	rs13059720	chr3:134242021	CEP63	chr3:134204575-134293852:+	-0.34	-6.59	1.14E-10	Height	
KIRC	cis	1	rs13059975	chr3:127849684	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13059975	chr3:127849684	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13059975	chr3:127849684	RUVBL1	chr3:127783627-127872757:-	0.34	4.83	1.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13060453	chr3:127810738	KBTBD12	chr3:127634318-127706513:+	0.26	3.52	0.000468	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13060453	chr3:127810738	RPN1	chr3:128338813-128399918:-	0.22	3.63	0.000311	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13060453	chr3:127810738	RUVBL1	chr3:127783627-127872757:-	0.34	4.85	1.63E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13060489	chr3:58339287	PXK	chr3:58318617-58410878:+	0.21	4.18	3.37E-5	Cholesterol, total	
KIRC	cis	1	rs13062252	chr3:127828631	KBTBD12	chr3:127634318-127706513:+	0.26	3.54	0.000443	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13062252	chr3:127828631	RPN1	chr3:128338813-128399918:-	0.22	3.75	0.000194	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13062252	chr3:127828631	RUVBL1	chr3:127783627-127872757:-	0.33	4.75	2.68E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1306395	chr2:61076272	PUS10	chr2:61167550-61245365:-	0.17	4.48	9.4E-6	Psoriasis	
KIRC	cis	1	rs13065269	chr3:160352319	TRIM59	chr3:160153292-160167626:-	0.23	3.9	0.000109	Primary biliary cirrhosis	
KIRC	cis	1	rs13065569	chr3:141077615	SLC25A36	chr3:140660662-140698785:+	-0.2	-4.09	5.01E-5	Prion diseases	
KIRC	cis	1	rs13066269	chr3:58449244	PXK	chr3:58318617-58410878:+	0.21	4.05	5.9E-5	Cholesterol, total	
KIRC	cis	1	rs13067306	chr3:94243713	STX19	chr3:93733215-93747454:-	0.33	4.66	4.12E-6	Blood pressure measurement (high sodium intervention)	
KIRC	cis	1	rs13067650	chr3:127889542	KBTBD12	chr3:127634318-127706513:+	0.29	4.05	5.9E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13067650	chr3:127889542	RUVBL1	chr3:127783627-127872757:-	0.34	4.89	1.35E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13068223	chr3:156470955	KCNAB1	chr3:155838337-156256927:+	-0.14	-3.81	0.000156	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs13069054	chr3:127855982	KBTBD12	chr3:127634318-127706513:+	0.28	3.85	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13069054	chr3:127855982	RPN1	chr3:128338813-128399918:-	0.23	3.98	7.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13069054	chr3:127855982	RUVBL1	chr3:127783627-127872757:-	0.33	4.71	3.19E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13069724	chr3:48478039	SHISA5	chr3:48509197-48542228:-	-0.13	-3.81	0.000158	Longevity	
KIRC	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.32	-9.41	1.74E-19	Longevity	
KIRC	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.31	-8.77	2.85E-17	Longevity	
KIRC	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.79	2.38E-41	Height	
KIRC	cis	1	rs13071551	chr3:134310867	CEP63	chr3:134204575-134293852:+	-0.33	-6.44	2.88E-10	Height	
KIRC	cis	1	rs13071688	chr3:58398730	PXK	chr3:58318617-58410878:+	0.25	5.11	4.64E-7	Cholesterol, total	
KIRC	cis	1	rs13071740	chr3:127881568	KBTBD12	chr3:127634318-127706513:+	0.3	4.07	5.43E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13071740	chr3:127881568	RPN1	chr3:128338813-128399918:-	0.24	4	7.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13071740	chr3:127881568	RUVBL1	chr3:127783627-127872757:-	0.34	4.86	1.6E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13072395	chr3:52980573	RFT1	chr3:53122503-53164470:-	0.33	4.82	1.91E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13072395	chr3:52980573	SFMBT1	chr3:52938628-53080070:-	-0.28	-3.81	0.000155	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13072395	chr3:52980573	TMEM110	chr3:52867139-52931547:-	0.35	5.79	1.21E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.16	4.29	2.1E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs13072818	chr3:53074263	RFT1	chr3:53122503-53164470:-	0.39	6.09	2.29E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13072818	chr3:53074263	TMEM110	chr3:52867139-52931547:-	0.35	6.16	1.5E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.16	4.25	2.6E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.16	4.25	2.6E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs13074231	chr3:160355428	TRIM59	chr3:160153292-160167626:-	0.22	3.84	0.000141	Primary biliary cirrhosis	
KIRC	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.32	-9.13	1.73E-18	Longevity	
KIRC	cis	1	rs13076951	chr3:58436703	PXK	chr3:58318617-58410878:+	0.22	4.32	1.92E-5	Cholesterol, total	
KIRC	cis	1	rs13077359	chr3:190983412	UTS2D	chr3:190984945-191048325:-	-0.22	-3.96	8.72E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs13077660	chr3:85616260	CADM2	chr3:85008133-86117948:+	-0.27	-4.63	4.68E-6	Longevity (90 years and older)	
KIRC	cis	1	rs13077790	chr3:127882658	KBTBD12	chr3:127634318-127706513:+	0.3	4.07	5.43E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13077790	chr3:127882658	RPN1	chr3:128338813-128399918:-	0.24	4	7.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13077790	chr3:127882658	RUVBL1	chr3:127783627-127872757:-	0.34	4.86	1.6E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13077913	chr3:127882604	KBTBD12	chr3:127634318-127706513:+	0.3	4.09	5.01E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13077913	chr3:127882604	RPN1	chr3:128338813-128399918:-	0.24	4	7.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13077913	chr3:127882604	RUVBL1	chr3:127783627-127872757:-	0.35	4.9	1.32E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13078787	chr3:58430487	PXK	chr3:58318617-58410878:+	0.23	4.39	1.35E-5	Cholesterol, total	
KIRC	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.16	4.31	1.92E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.05	1.61E-42	Height	
KIRC	cis	1	rs13081177	chr3:134289860	CEP63	chr3:134204575-134293852:+	-0.34	-6.58	1.16E-10	Height	
KIRC	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.93	5.61E-42	Height	
KIRC	cis	1	rs13081688	chr3:134259954	CEP63	chr3:134204575-134293852:+	-0.34	-6.57	1.22E-10	Height	
KIRC	cis	1	rs13082038	chr3:127828456	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13083794	chr3:121464928	IQCB1	chr3:121488610-121553926:-	0.35	6.59	1.1E-10	Cognitive performance	
KIRC	cis	1	rs13085791	chr3:49721798	UBA7	chr3:49842639-49851391:-	0.15	3.99	7.74E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs13087299	chr3:94229344	STX19	chr3:93733215-93747454:-	0.33	4.79	2.16E-6	Blood pressure measurement (high sodium intervention)	
KIRC	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.35	6.65	7.52E-11	Cognitive performance	
KIRC	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.82	1.79E-41	Height	
KIRC	cis	1	rs13087875	chr3:134261123	CEP63	chr3:134204575-134293852:+	-0.33	-6.47	2.28E-10	Height	
KIRC	cis	1	rs13088281	chr3:53147576	RFT1	chr3:53122503-53164470:-	-0.38	-5.81	1.09E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13088281	chr3:53147576	TMEM110	chr3:52867139-52931547:-	-0.32	-5.32	1.56E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs13088309	chr3:49368317	CCDC36	chr3:49235861-49295537:+	0.24	4.7	3.35E-6	Menarche (age at onset)	
KIRC	cis	1	rs13088309	chr3:49368317	NCKIPSD	chr3:48711280-48723334:-	0.23	4.69	3.6E-6	Menarche (age at onset)	
KIRC	cis	1	rs13088309	chr3:49368317	P4HTM	chr3:49027341-49044579:+	0.18	4.12	4.44E-5	Menarche (age at onset)	
KIRC	cis	1	rs13088309	chr3:49368317	TREX1	chr3:48501186-48509043:+	-0.14	-3.58	0.000375	Menarche (age at onset)	
KIRC	cis	1	rs13088309	chr3:49368317	WDR6	chr3:49044637-49053386:+	-0.2	-5.23	2.51E-7	Menarche (age at onset)	
KIRC	cis	1	rs13088455	chr3:53087482	SFMBT1	chr3:52938628-53080070:-	0.43	10.11	5.22E-22	Ulcerative colitis	
KIRC	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.17	4.28	2.22E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs13089966	chr3:134279197	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.79	2.38E-41	Height	
KIRC	cis	1	rs13090969	chr3:134307257	CEP63	chr3:134204575-134293852:+	-0.33	-6.44	2.88E-10	Height	
KIRC	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.32	-9.1	2.07E-18	Longevity	
KIRC	cis	1	rs13092437	chr3:85595726	CADM2	chr3:85008133-86117948:+	0.23	3.74	0.000209	Longevity (90 years and older)	
KIRC	cis	1	rs13095660	chr3:127848156	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13095660	chr3:127848156	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13095660	chr3:127848156	RUVBL1	chr3:127783627-127872757:-	0.34	4.83	1.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13095912	chr3:185302098	TMEM41A	chr3:185207389-185216845:-	0.17	3.57	0.00039	Systolic blood pressure	
KIRC	cis	1	rs13096020	chr3:58367771	PXK	chr3:58318617-58410878:+	0.23	4.71	3.26E-6	Cholesterol, total	
KIRC	cis	1	rs13096474	chr3:49443081	CCDC36	chr3:49235861-49295537:+	-0.25	-4.83	1.79E-6	Menarche (age at onset)	
KIRC	cis	1	rs13096474	chr3:49443081	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.7	3.43E-6	Menarche (age at onset)	
KIRC	cis	1	rs13096474	chr3:49443081	P4HTM	chr3:49027341-49044579:+	-0.2	-4.46	1.02E-5	Menarche (age at onset)	
KIRC	cis	1	rs13096474	chr3:49443081	WDR6	chr3:49044637-49053386:+	0.2	5.24	2.31E-7	Menarche (age at onset)	
KIRC	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.01	2.49E-42	Height	
KIRC	cis	1	rs13096604	chr3:134250099	CEP63	chr3:134204575-134293852:+	-0.34	-6.59	1.14E-10	Height	
KIRC	cis	1	rs13099	chr14:75599155	MLH3	chr14:75480467-75518235:-	-0.25	-6.26	8.35E-10	Height	
KIRC	cis	1	rs13099	chr14:75599155	NEK9	chr14:75548819-75593778:-	-0.15	-4.3	2.07E-5	Height	
KIRC	cis	1	rs13100229	chr3:185343200	TMEM41A	chr3:185207389-185216845:-	0.17	3.65	0.000291	Systolic blood pressure	
KIRC	cis	1	rs13102385	chr4:56345255	SRD5A3	chr4:56212409-56237866:+	0.18	4.02	6.76E-5	Personality dimensions	
KIRC	cis	1	rs13102385	chr4:56345255	TMEM165	chr4:56262090-56292342:+	-0.23	-6.48	2.15E-10	Personality dimensions	
KIRC	cis	1	rs13104971	chr4:53820155	USP46	chr4:53457129-53525502:-	-0.23	-3.86	0.00013	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	
KIRC	cis	1	rs13105385	chr4:48404094	OCIAD1	chr4:48833015-48863831:+	-0.23	-5.22	2.57E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs13106338	chr4:17676871	LAP3	chr4:17578927-17609590:+	0.2	6.24	9.37E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs13106338	chr4:17676871	MED28	chr4:17616273-17629791:+	-0.16	-3.62	0.000319	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs13107797	chr4:108928069	HADH	chr4:108910940-108956330:+	-0.26	-3.59	0.000367	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.49	-8.1	4.24E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs13109200	chr4:39126016	WDR19	chr4:39184024-39287429:+	0.18	4.73	2.89E-6	Uric acid levels	
KIRC	cis	1	rs13110633	chr4:48470296	OCIAD1	chr4:48833015-48863831:+	0.18	3.59	0.000359	Schizophrenia	
KIRC	cis	1	rs13119927	chr4:17691640	LAP3	chr4:17578927-17609590:+	0.22	6.61	9.68E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs13119927	chr4:17691640	MED28	chr4:17616273-17629791:+	-0.18	-4.01	7.1E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.47	10.28	1.25E-22	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.31	7.52	2.5E-13	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13121235	chr4:56311947	SRD5A3	chr4:56212409-56237866:+	0.19	4.13	4.33E-5	Personality dimensions	
KIRC	cis	1	rs13121235	chr4:56311947	TMEM165	chr4:56262090-56292342:+	-0.23	-6.39	3.78E-10	Personality dimensions	
KIRC	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.35	-6.1	2.1E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs13123545	chr4:76535466	CDKL2	chr4:76501705-76555721:-	0.17	3.72	0.000219	Magnesium levels	
KIRC	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.46	10.16	3.57E-22	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.31	7.41	5.28E-13	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs13133311	chr4:88217223	HSD17B11	chr4:88257691-88312455:-	0.19	4.12	4.37E-5	Platelet count	
KIRC	cis	1	rs13136090	chr4:76534792	CDKL2	chr4:76501705-76555721:-	0.17	3.76	0.000187	Magnesium levels	
KIRC	cis	1	rs13136813	chr4:108922915	HADH	chr4:108910940-108956330:+	-0.26	-3.59	0.000364	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.46	9.98	1.68E-21	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.3	7.13	3.6E-12	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13142655	chr4:88195494	HSD17B11	chr4:88257691-88312455:-	0.19	4.15	3.87E-5	Platelet count	
KIRC	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.46	10.15	3.89E-22	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.31	7.4	5.85E-13	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13144374	chr4:39130479	WDR19	chr4:39184024-39287429:+	0.18	4.73	2.89E-6	Uric acid levels	
KIRC	cis	1	rs13146371	chr4:1082887	C4orf48	chr4:2043689-2045697:+	-0.14	-3.53	0.000454	Recombination rate (males)	
KIRC	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.45	9.8	7.51E-21	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13146880	chr4:48031499	NIPAL1	chr4:48018791-48039078:+	0.3	7.19	2.3E-12	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13153099	chr5:156436195	HAVCR1	chr5:156456531-156486130:-	-0.45	-9.97	1.69E-21	Hypertriglyceridemia	
KIRC	cis	1	rs13153099	chr5:156436195	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.56	1.97E-13	Hypertriglyceridemia	
KIRC	cis	1	rs13153099	chr5:156436195	TIMD4	chr5:156346293-156390266:-	-0.36	-6.78	3.45E-11	Hypertriglyceridemia	
KIRC	cis	1	rs1316768	chr1:19323602	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs13168670	chr5:140146899	PCDHA10	chr5:140235634-140391929:+	-0.27	-5.04	6.65E-7	Schizophrenia	
KIRC	cis	1	rs13168670	chr5:140146899	PCDHA7	chr5:140213969-140391929:+	-0.23	-4.41	1.27E-5	Schizophrenia	
KIRC	cis	1	rs13168670	chr5:140146899	WDR55	chr5:140044384-140050551:+	-0.26	-5.74	1.6E-8	Schizophrenia	
KIRC	cis	1	rs13169155	chr5:156426663	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.15	3.76E-22	Hypertriglyceridemia	
KIRC	cis	1	rs13169155	chr5:156426663	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.7	7.45E-14	Hypertriglyceridemia	
KIRC	cis	1	rs13169155	chr5:156426663	TIMD4	chr5:156346293-156390266:-	-0.36	-6.79	3.14E-11	Hypertriglyceridemia	
KIRC	cis	1	rs13169465	chr5:156426916	HAVCR1	chr5:156456531-156486130:-	-0.45	-9.97	1.72E-21	Hypertriglyceridemia	
KIRC	cis	1	rs13169465	chr5:156426916	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.61	1.33E-13	Hypertriglyceridemia	
KIRC	cis	1	rs13169465	chr5:156426916	TIMD4	chr5:156346293-156390266:-	-0.36	-6.78	3.34E-11	Hypertriglyceridemia	
KIRC	cis	1	rs13169621	chr5:156426974	HAVCR1	chr5:156456531-156486130:-	-0.47	-10.23	1.91E-22	Hypertriglyceridemia	
KIRC	cis	1	rs13169621	chr5:156426974	HAVCR2	chr5:156512843-156536138:-	-0.43	-7.97	1.11E-14	Hypertriglyceridemia	
KIRC	cis	1	rs13169621	chr5:156426974	TIMD4	chr5:156346293-156390266:-	-0.37	-6.77	3.64E-11	Hypertriglyceridemia	
KIRC	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.47	-9.74	1.19E-20	Subjective well-being	
KIRC	cis	1	rs1317149	chr11:47486885	PSMC3	chr11:47440320-47448024:-	0.13	3.95	8.84E-5	Subjective well-being	
KIRC	cis	1	rs13175381	chr5:60962766	FLJ37543	chr5:60933636-61002362:+	0.23	3.82	0.000152	Alzheimer's disease	
KIRC	cis	1	rs13177576	chr5:125917249	LMNB1	chr5:126112833-126172709:+	0.17	3.63	0.000317	Osteoporosis	
KIRC	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.16	5.28	1.93E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs13181803	chr5:156429177	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.15	3.71E-22	Hypertriglyceridemia	
KIRC	cis	1	rs13181803	chr5:156429177	HAVCR2	chr5:156512843-156536138:-	-0.42	-7.71	6.58E-14	Hypertriglyceridemia	
KIRC	cis	1	rs13181803	chr5:156429177	TIMD4	chr5:156346293-156390266:-	-0.37	-6.81	2.86E-11	Hypertriglyceridemia	
KIRC	cis	1	rs13182	chr4:39122913	WDR19	chr4:39184024-39287429:+	0.18	4.64	4.46E-6	Uric acid levels	
KIRC	cis	1	rs13190742	chr6:163008758	PACRG	chr6:163148164-163736523:+	0.47	6.2	1.19E-9	Body mass index	
KIRC	cis	1	rs13191362	chr6:163033350	PACRG	chr6:163148164-163736523:+	0.55	7.06	5.54E-12	Body mass index	
KIRC	cis	1	rs13192132	chr6:161022423	PLG	chr6:161123274-161174345:+	0.27	5.21	2.83E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs13192894	chr6:163052444	PACRG	chr6:163148164-163736523:+	0.57	6.98	9.21E-12	Body mass index	
KIRC	cis	1	rs13193193	chr6:88209091	C6orf164	chr6:88032306-88109459:+	0.32	3.73	0.000212	Obesity-related traits	
KIRC	cis	1	rs13193282	chr6:163015442	PACRG	chr6:163148164-163736523:+	0.47	6.26	8.4E-10	Body mass index	
KIRC	cis	1	rs13193470	chr6:88357627	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs13193703	chr6:88239749	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs13193927	chr6:88239784	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.49	-10.42	3.86E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs13195226	chr6:163006421	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.87	-10.15	3.71E-22	Schizophrenia	
KIRC	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.87	-10.15	3.71E-22	Schizophrenia	
KIRC	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.48	-10.28	1.23E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.21E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs13199223	chr6:163001083	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs13200106	chr6:88276287	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs13200329	chr6:163004418	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs13200462	chr6:28218199	ZNF187	chr6:28234788-28245978:+	-0.27	-4.7	3.38E-6	Depression	
KIRC	cis	1	rs13200462	chr6:28218199	ZNF323	chr6:28292517-28324048:-	0.27	3.65	0.000288	Depression	
KIRC	cis	1	rs13200462	chr6:28218199	ZSCAN23	chr6:28393287-28411279:-	0.26	3.65	0.000288	Depression	
KIRC	cis	1	rs13201023	chr6:162981381	PACRG	chr6:163148164-163736523:+	0.42	5.64	2.78E-8	Body mass index	
KIRC	cis	1	rs13201083	chr6:89918597	GABRR1	chr6:89887223-89927496:-	0.42	5.77	1.43E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs13202339	chr6:163081812	PACRG	chr6:163148164-163736523:+	0.58	6.89	1.69E-11	Body mass index	
KIRC	cis	1	rs13203957	chr6:88370764	C6orf164	chr6:88032306-88109459:+	0.3	3.64	0.000301	Obesity-related traits	
KIRC	cis	1	rs13204013	chr6:163002480	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs13204439	chr6:163015358	PACRG	chr6:163148164-163736523:+	-0.43	-5.97	4.53E-9	Body mass index	
KIRC	cis	1	rs13204592	chr6:88240202	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs13205357	chr6:88217661	C6orf164	chr6:88032306-88109459:+	0.32	3.79	0.00017	Obesity-related traits	
KIRC	cis	1	rs13206253	chr6:163166902	PACRG	chr6:163148164-163736523:+	0.45	5.93	5.75E-9	Body mass index	
KIRC	cis	1	rs13206536	chr6:88323444	C6orf164	chr6:88032306-88109459:+	0.3	3.75	0.0002	Obesity-related traits	
KIRC	cis	1	rs13207239	chr6:163008772	PACRG	chr6:163148164-163736523:+	0.47	6.2	1.19E-9	Body mass index	
KIRC	cis	1	rs13207671	chr6:162979056	PACRG	chr6:163148164-163736523:+	0.47	6.33	5.5E-10	Body mass index	
KIRC	cis	1	rs13208201	chr6:88311457	C6orf164	chr6:88032306-88109459:+	0.35	4.13	4.31E-5	Obesity-related traits	
KIRC	cis	1	rs13208550	chr6:88268996	C6orf164	chr6:88032306-88109459:+	0.33	3.88	0.000117	Obesity-related traits	
KIRC	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.64	1.1E-13	Obesity-related traits	
KIRC	cis	1	rs1320893	chr7:143752112	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.54	4.96E-8	Obesity-related traits	
KIRC	cis	1	rs1320893	chr7:143752112	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.36	6.09E-16	Obesity-related traits	
KIRC	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.85	2.51E-14	Obesity-related traits	
KIRC	cis	1	rs1320894	chr7:143751802	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.47	7.15E-8	Obesity-related traits	
KIRC	cis	1	rs1320894	chr7:143751802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs13209100	chr6:163159350	PACRG	chr6:163148164-163736523:+	0.45	6.27	7.86E-10	Body mass index	
KIRC	cis	1	rs13209728	chr6:162997533	PACRG	chr6:163148164-163736523:+	0.42	5.86	8.17E-9	Body mass index	
KIRC	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.78	23.49	7.6E-83	Pulse pressure	
KIRC	cis	1	rs13210412	chr6:163019478	PACRG	chr6:163148164-163736523:+	0.43	5.94	5.47E-9	Body mass index	
KIRC	cis	1	rs13210756	chr6:163009030	PACRG	chr6:163148164-163736523:+	0.43	5.89	7.27E-9	Body mass index	
KIRC	cis	1	rs1321196	chr6:161081842	PLG	chr6:161123274-161174345:+	-0.27	-5.22	2.65E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs13212608	chr6:163032128	PACRG	chr6:163148164-163736523:+	0.48	6.02	3.36E-9	Body mass index	
KIRC	cis	1	rs13213408	chr6:162998049	PACRG	chr6:163148164-163736523:+	0.44	5.77	1.36E-8	Body mass index	
KIRC	cis	1	rs13213582	chr6:151873896	C6orf97	chr6:151815175-151942327:+	0.2	3.89	0.000116	Bone mineral density (spine)	
KIRC	cis	1	rs13213812	chr6:88212312	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs13214516	chr6:163121583	PACRG	chr6:163148164-163736523:+	0.59	7.05	6.1E-12	Body mass index	
KIRC	cis	1	rs13214667	chr6:116637440	TSPYL4	chr6:116571133-116575261:-	0.14	3.5	0.000516	Fast beta electroencephalogram	
KIRC	cis	1	rs1321480	chr6:26532742	BTN2A3	chr6:26422317-26431927:+	0.12	3.58	0.000371	Educational attainment	
KIRC	cis	1	rs1321481	chr6:26538210	BTN2A3	chr6:26422317-26431927:+	0.12	3.68	0.00026	Educational attainment	
KIRC	cis	1	rs13215017	chr6:89918264	GABRR1	chr6:89887223-89927496:-	0.42	5.77	1.43E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs13215491	chr6:163010325	PACRG	chr6:163148164-163736523:+	0.47	6.09	2.27E-9	Body mass index	
KIRC	cis	1	rs13215566	chr6:89918638	GABRR1	chr6:89887223-89927496:-	0.33	4.68	3.7E-6	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs13216482	chr6:88216252	C6orf164	chr6:88032306-88109459:+	0.32	3.73	0.000212	Obesity-related traits	
KIRC	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.46	-10.2	2.5E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs13218900	chr6:163081638	PACRG	chr6:163148164-163736523:+	0.58	6.89	1.69E-11	Body mass index	
KIRC	cis	1	rs13220048	chr6:163004325	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs13220181	chr6:163004401	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.89	-10.12	4.94E-22	Schizophrenia	
KIRC	cis	1	rs13220510	chr6:56779141	BEND6	chr6:56819773-56892138:+	-0.28	-5.7	2.06E-8	Menarche (age at onset)	
KIRC	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.16E-8	Diabetic kidney disease	
KIRC	cis	1	rs13220979	chr7:65363204	CRCP	chr7:65579805-65619551:+	-0.32	-4.45	1.06E-5	Diabetic kidney disease	
KIRC	cis	1	rs1322319	chr10:38145509	LOC399744	chr10:38717074-38741080:+	0.23	3.84	0.000137	Obesity (extreme)	
KIRC	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.82	3.18E-14	Obesity-related traits	
KIRC	cis	1	rs13226728	chr7:143746578	OR2A1	chr7:144015236-144016148:+;chr7	-0.3	-5.6	3.58E-8	Obesity-related traits	
KIRC	cis	1	rs13226728	chr7:143746578	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.64	7.77E-17	Obesity-related traits	
KIRC	cis	1	rs13230698	chr7:3361125	SDK1	chr7:3341080-4308629:+	0.2	4.01	7.03E-5	Motion sickness	
KIRC	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.27	5.39	1.11E-7	Diabetic kidney disease	
KIRC	cis	1	rs13235972	chr7:65883605	CRCP	chr7:65579805-65619551:+	-0.33	-4.54	6.92E-6	Diabetic kidney disease	
KIRC	cis	1	rs13236574	chr7:137078142	PTN	chr7:136912092-137028546:-	-0.22	-3.73	0.000212	Schizophrenia	
KIRC	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.28	5.41	9.71E-8	Diabetic kidney disease	
KIRC	cis	1	rs13237037	chr7:65997882	CRCP	chr7:65579805-65619551:+	-0.34	-4.56	6.55E-6	Diabetic kidney disease	
KIRC	cis	1	rs13239306	chr7:66136017	LOC493754	chr7:65993446-66057363:-	0.18	3.84	0.000139	Aortic root size	
KIRC	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.79	3.98E-14	Obesity-related traits	
KIRC	cis	1	rs13243677	chr7:143746572	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.49	6.43E-8	Obesity-related traits	
KIRC	cis	1	rs13243677	chr7:143746572	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.56	1.39E-16	Obesity-related traits	
KIRC	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.3	5.83	9.75E-9	Diabetic kidney disease	
KIRC	cis	1	rs13247184	chr7:65358928	CRCP	chr7:65579805-65619551:+	-0.32	-4.27	2.35E-5	Diabetic kidney disease	
KIRC	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.85	22.64	1.01E-78	Bone mineral density	
KIRC	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.87	24.08	9.73E-86	Bone mineral density	
KIRC	cis	1	rs13258638	chr8:143683582	ARC	chr8:143692410-143695833:-	0.29	5.79	1.21E-8	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs13258681	chr8:124714722	ANXA13	chr8:124693035-124749647:-	0.2	3.64	0.0003	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs13259747	chr8:143683567	ARC	chr8:143692410-143695833:-	0.28	5.64	2.78E-8	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs13259806	chr8:124190103	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13260318	chr8:124190165	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13260626	chr8:124190317	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13260775	chr8:124190167	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13260798	chr8:124190192	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13261021	chr8:124190239	DERL1	chr8:124025568-124054648:-	0.32	3.57	0.000388	Urinary uromodulin levels	
KIRC	cis	1	rs13261066	chr8:124190276	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13261100	chr8:124190312	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs13264329	chr8:124090512	DERL1	chr8:124025568-124054648:-	0.21	3.55	0.000425	Diabetic kidney disease	
KIRC	cis	1	rs13266699	chr8:8570313	CLDN23	chr8:8559666-8561616:+	-0.22	-3.61	0.000335	Obesity-related traits	
KIRC	cis	1	rs13267501	chr8:8574058	CLDN23	chr8:8559666-8561616:+	0.23	3.63	0.000314	Obesity-related traits	
KIRC	cis	1	rs13268130	chr8:11116321	AMAC1L2	chr8:11188495-11189695:+	0.23	3.61	0.000334	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs13269597	chr8:110134939	TMEM74	chr8:109619080-109799770:-	-0.18	-3.58	0.000375	Body mass (lean)	
KIRC	cis	1	rs13271966	chr8:8575472	CLDN23	chr8:8559666-8561616:+	0.22	3.53	0.00046	Obesity-related traits	
KIRC	cis	1	rs13277078	chr8:126050879	LOC157381	chr8:125951884-125963337:+	-0.28	-3.51	0.000491	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs13282915	chr8:8570891	CLDN23	chr8:8559666-8561616:+	0.22	3.62	0.000328	Obesity-related traits	
KIRC	cis	1	rs13284407	chr9:95888521	NINJ1	chr9:95883772-95896570:-	-0.21	-3.68	0.000259	Obesity (early onset extreme)	
KIRC	cis	1	rs13298119	chr9:95887154	NINJ1	chr9:95883772-95896570:-	-0.21	-3.82	0.00015	Obesity (early onset extreme)	
KIRC	cis	1	rs13299270	chr9:95887108	NINJ1	chr9:95883772-95896570:-	-0.21	-3.82	0.00015	Obesity (early onset extreme)	
KIRC	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs13310597	chr7:65598540	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.27	-6.49	2.11E-10	IFN-related cytopenia	
KIRC	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.3	9.05	3.03E-18	Longevity	
KIRC	cis	1	rs13314673	chr3:101661383	SENP7	chr3:101043120-101232085:-	0.17	3.75	0.000201	Psoriasis vulgaris;Psoriasis	
KIRC	cis	1	rs13315871	chr3:58381287	PXK	chr3:58318617-58410878:+	0.24	4.8	2.11E-6	Cholesterol, total	
KIRC	cis	1	rs13316695	chr3:49684917	UBA7	chr3:49842639-49851391:-	0.16	4.09	5.05E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs13317835	chr3:58383275	PXK	chr3:58318617-58410878:+	0.25	4.98	8.89E-7	Cholesterol, total	
KIRC	cis	1	rs13321783	chr3:119615375	GSK3B	chr3:119540804-119813264:-	-0.14	-3.76	0.00019	HDL cholesterol	
KIRC	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs13322305	chr3:134310791	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs13322887	chr3:49555583	CCDC36	chr3:49235861-49295537:+	-0.26	-5.02	7.25E-7	Menarche (age at onset)	
KIRC	cis	1	rs13322887	chr3:49555583	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.51	8.13E-6	Menarche (age at onset)	
KIRC	cis	1	rs13322887	chr3:49555583	P4HTM	chr3:49027341-49044579:+	-0.18	-4.18	3.45E-5	Menarche (age at onset)	
KIRC	cis	1	rs13322887	chr3:49555583	WDR6	chr3:49044637-49053386:+	0.22	5.55	4.58E-8	Menarche (age at onset)	
KIRC	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.74	9.85	4.68E-21	Diastolic blood pressure	
KIRC	cis	1	rs13326508	chr3:168922096	GPR160	chr3:169755735-169803181:+	-0.31	-3.59	0.000364	Multiple myeloma (hyperdiploidy)	
KIRC	cis	1	rs13328032	chr4:89809873	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.63	0.000318	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs13328298	chr6:126016580	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs13333317	chr16:67872251	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.75	2.63E-6	Crohn's disease	
KIRC	cis	1	rs13339239	chr16:67809401	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.7	3.29E-6	Crohn's disease	
KIRC	cis	1	rs13339262	chr16:50091383	HEATR3	chr16:50099881-50139373:+	-0.29	-4.05	5.83E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1333963	chr6:163192571	PACRG	chr6:163148164-163736523:+	0.58	6.57	1.23E-10	Body mass index	
KIRC	cis	1	rs13340033	chr22:29846339	RFPL1S	chr22:29833006-29838118:-	-0.3	-5.86	8.54E-9	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs13340181	chr3:185325612	TMEM41A	chr3:185207389-185216845:-	0.17	3.5	0.000504	Systolic blood pressure	
KIRC	cis	1	rs13353478	chr3:85621395	CADM2	chr3:85008133-86117948:+	0.25	4.03	6.33E-5	Longevity (90 years and older)	
KIRC	cis	1	rs13356202	chr5:137564588	CDC25C	chr5:137620959-137674044:-	-0.23	-6.34	4.97E-10	Resting heart rate	
KIRC	cis	1	rs13357258	chr5:115444166	COMMD10	chr5:115420727-115628978:+	0.34	3.92	9.94E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs13361189	chr5:150223387	IRGM	chr5:150226085-150280295:+	0.54	7.52	2.58E-13	Crohn's disease	
KIRC	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.35	4.91	1.21E-6	Crohn's disease	
KIRC	cis	1	rs13362043	chr5:115596262	COMMD10	chr5:115420727-115628978:+	0.34	3.95	9.05E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs13375749	chr1:53695882	DIO1	chr1:54359861-54376758:+	-0.2	-3.55	0.000417	Blood metabolite levels	
KIRC	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.47	-10.4	4.52E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.47	-10.2	2.41E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs13380863	chr17:61780793	FTSJ3	chr17:61896795-61905031:-	0.33	6.35	4.72E-10	Body mass index	
KIRC	cis	1	rs13380863	chr17:61780793	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.63	4.76E-6	Body mass index	
KIRC	cis	1	rs13381239	chr18:67526725	CD226	chr18:67530195-67624232:-	-0.2	-6.01	3.61E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs13383871	chr2:73631779	TPRKB	chr2:73956957-73964517:-	-0.19	-4.98	8.59E-7	Metabolite levels	
KIRC	cis	1	rs13384952	chr2:73723959	TPRKB	chr2:73956957-73964517:-	0.2	5.04	6.57E-7	Metabolite levels	
KIRC	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.73	-14.12	2.39E-38	Prostate cancer	
KIRC	cis	1	rs13386793	chr2:219972574	USP37	chr2:219314974-219433084:-	-0.26	-4.1	4.84E-5	Height	
KIRC	cis	1	rs13393738	chr2:219914144	FAM134A	chr2:220042939-220050190:+	-0.29	-3.68	0.000261	Height	
KIRC	cis	1	rs13393738	chr2:219914144	USP37	chr2:219314974-219433084:-	-0.24	-3.72	0.000223	Height	
KIRC	cis	1	rs13394499	chr2:219969085	USP37	chr2:219314974-219433084:-	-0.26	-3.94	9.44E-5	Height	
KIRC	cis	1	rs1339458	chr1:10328338	RBP7	chr1:10057255-10076077:+	0.15	3.56	0.000407	Hepatocellular carcinoma	
KIRC	cis	1	rs13396442	chr2:219971530	USP37	chr2:219314974-219433084:-	-0.25	-3.89	0.000114	Height	
KIRC	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.62	8.4	4.65E-16	Rheumatoid arthritis	
KIRC	cis	1	rs13398523	chr2:219910452	FAM134A	chr2:220042939-220050190:+	-0.27	-3.72	0.00022	Height	
KIRC	cis	1	rs13398523	chr2:219910452	USP37	chr2:219314974-219433084:-	-0.23	-3.83	0.000146	Height	
KIRC	cis	1	rs13398523	chr2:219910452	ZNF142	chr2:219502644-219524261:-	-0.24	-3.52	0.000477	Height	
KIRC	cis	1	rs13398898	chr2:219927747	USP37	chr2:219314974-219433084:-	-0.27	-4.09	5.07E-5	Height	
KIRC	cis	1	rs13398956	chr2:73720258	TPRKB	chr2:73956957-73964517:-	-0.21	-5.35	1.36E-7	Metabolite levels	
KIRC	cis	1	rs13404123	chr2:219916797	USP37	chr2:219314974-219433084:-	0.23	3.83	0.000146	Height	
KIRC	cis	1	rs1340684	chr1:76471146	MSH4	chr1:76262630-76378923:+	-0.27	-4.01	7.08E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs13408294	chr2:202171573	CFLAR	chr2:201980816-202029001:+	-0.22	-3.67	0.000268	Rheumatoid arthritis	
KIRC	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.59	-8.5	2.13E-16	Rheumatoid arthritis	
KIRC	cis	1	rs13408337	chr2:219971526	USP37	chr2:219314974-219433084:-	-0.25	-3.89	0.000114	Height	
KIRC	cis	1	rs13408569	chr2:102955056	IL1RL1	chr2:102927962-102968497:+	0.44	7.54	2.28E-13	Asthma	
KIRC	cis	1	rs13408661	chr2:102955082	IL1RL1	chr2:102927962-102968497:+	0.44	7.53	2.35E-13	Asthma	
KIRC	cis	1	rs13409250	chr2:37463642	CEBPZ	chr2:37428778-37458740:-	-0.2	-5.4	1.03E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs13409250	chr2:37463642	PRKD3	chr2:37477648-37544222:-	-0.13	-3.58	0.000374	Chronic lymphocytic leukemia	
KIRC	cis	1	rs13412036	chr2:219910454	FAM134A	chr2:220042939-220050190:+	-0.27	-3.72	0.00022	Height	
KIRC	cis	1	rs13412036	chr2:219910454	USP37	chr2:219314974-219433084:-	-0.23	-3.83	0.000146	Height	
KIRC	cis	1	rs13412036	chr2:219910454	ZNF142	chr2:219502644-219524261:-	-0.24	-3.52	0.000477	Height	
KIRC	cis	1	rs13415839	chr2:232126534	ARMC9	chr2:232063342-232238606:+	0.23	4.75	2.61E-6	Food antigen IgG levels	
KIRC	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs13419740	chr2:219969097	USP37	chr2:219314974-219433084:-	-0.25	-3.87	0.000122	Height	
KIRC	cis	1	rs13421462	chr2:73719875	TPRKB	chr2:73956957-73964517:-	-0.2	-5.27	2.0E-7	Metabolite levels	
KIRC	cis	1	rs13423003	chr2:219111341	STK36	chr2:219536762-219567439:+	0.24	3.68	0.000259	Smooth-surface caries	
KIRC	cis	1	rs13424612	chr2:240900121	NDUFA10	chr2:240900158-240964798:-	0.24	5.21	2.74E-7	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs13428235	chr2:73633430	TPRKB	chr2:73956957-73964517:-	-0.18	-4.79	2.23E-6	Metabolite levels	
KIRC	cis	1	rs13429940	chr2:70379868	ANXA4	chr2:69969127-70053594:+	-0.18	-3.52	0.000472	Obesity-related traits	
KIRC	cis	1	rs13429940	chr2:70379868	FAM136A	chr2:70523109-70529220:-	-0.2	-3.98	8.02E-5	Obesity-related traits	
KIRC	cis	1	rs13431267	chr2:73782200	TPRKB	chr2:73956957-73964517:-	-0.21	-5.37	1.22E-7	Metabolite levels	
KIRC	cis	1	rs13431828	chr2:102954653	IL1RL1	chr2:102927962-102968497:+	0.44	7.54	2.28E-13	Asthma	
KIRC	cis	1	rs13432605	chr2:73810981	TPRKB	chr2:73956957-73964517:-	-0.21	-5.39	1.07E-7	Metabolite levels	
KIRC	cis	1	rs1345824	chr5:42724062	CCDC152	chr5:42756920-42802539:+	0.22	5.08	5.39E-7	Height	
KIRC	cis	1	rs1346719	chr3:53077372	RFT1	chr3:53122503-53164470:-	0.29	4.76	2.53E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs1346719	chr3:53077372	SFMBT1	chr3:52938628-53080070:-	-0.26	-3.95	8.91E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs1346719	chr3:53077372	TMEM110	chr3:52867139-52931547:-	0.24	4.3	2.01E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs134869	chr22:42652074	C22orf32	chr22:42475699-42480287:+	0.24	6.17	1.45E-9	Cognitive function	
KIRC	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.26	-7.4	5.6E-13	Cognitive function	
KIRC	cis	1	rs134873	chr22:42657566	C22orf32	chr22:42475699-42480287:+	0.24	6.11	2.01E-9	Cognitive function	
KIRC	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.25	-7.38	6.75E-13	Cognitive function	
KIRC	cis	1	rs134882	chr22:42670965	C22orf32	chr22:42475699-42480287:+	0.22	5.66	2.62E-8	Cognitive function	
KIRC	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.25	-7.33	9.55E-13	Cognitive function	
KIRC	cis	1	rs134900	chr22:42683343	C22orf32	chr22:42475699-42480287:+	0.23	6.01	3.56E-9	Cognitive function	
KIRC	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.25	-7.3	1.13E-12	Cognitive function	
KIRC	cis	1	rs134902	chr22:42683997	C22orf32	chr22:42475699-42480287:+	0.23	5.91	6.17E-9	Cognitive function	
KIRC	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.25	-7.25	1.62E-12	Cognitive function	
KIRC	cis	1	rs1349636	chr4:75712260	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs1351452	chr11:116943354	PCSK7	chr11:117075789-117102811:-	0.27	5.29	1.87E-7	Protein quantitative trait loci	
KIRC	cis	1	rs1352433	chr4:48393680	OCIAD1	chr4:48833015-48863831:+	0.24	5.24	2.32E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs1354181	chr16:55607809	LPCAT2	chr16:55542913-55620581:+	-0.16	-4.14	4.04E-5	Thyroid hormone levels	
KIRC	cis	1	rs1354521	chr8:89415173	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs1354522	chr8:89415493	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs1354523	chr8:89415541	MMP16	chr8:89049462-89339717:-	0.3	4.01	7.06E-5	Electrodermal activity	
KIRC	cis	1	rs1354524	chr8:89415605	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs1355412	chr8:29985683	MBOAT4	chr8:29989188-30002200:-	0.31	4.62	4.99E-6	Migraine	
KIRC	cis	1	rs1355438	chr3:141767853	TFDP2	chr3:141671329-141868311:-	-0.22	-4.31	1.95E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.59	14.32	2.95E-39	Height	
KIRC	cis	1	rs1357762	chr3:134264859	CEP63	chr3:134204575-134293852:+	0.33	6.57	1.27E-10	Height	
KIRC	cis	1	rs1359781	chr6:33762104	LEMD2	chr6:33738991-33756906:-	-0.14	-3.62	0.000324	Crohn's disease	
KIRC	cis	1	rs1360172	chr9:131907980	SET	chr9:131445934-131458674:+	-0.17	-3.83	0.000142	Blood metabolite ratios	
KIRC	cis	1	rs1369313	chr15:66084255	DPP8	chr15:65737999-65810035:-	-0.12	-4.74	2.82E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.61	-13.83	4.36E-37	Type 2 diabetes	
KIRC	cis	1	rs137115	chr22:43011403	RRP7B	chr22:42951347-42978017:-	0.16	3.67	0.000265	Parental extreme longevity (95 years and older)	
KIRC	cis	1	rs1374531	chr4:106523932	INTS12	chr4:106603787-106629881:-	-0.58	-6.05	2.87E-9	Post bronchodilator FEV1	
KIRC	cis	1	rs1376608	chr7:137074761	PTN	chr7:136912092-137028546:-	-0.21	-3.67	0.000265	Schizophrenia	
KIRC	cis	1	rs1377032	chr4:75712104	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs138209	chr22:50539413	MOV10L1	chr22:50528435-50600115:+	0.34	8.31	9.08E-16	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs138209	chr22:50539413	PANX2	chr22:50609160-50618723:+	0.18	3.83	0.000144	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs1382339	chr5:115558163	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000103	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1382340	chr5:115558161	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000103	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs138244	chr22:50565367	MOV10L1	chr22:50528435-50600115:+	0.33	8.23	1.61E-15	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs138249	chr22:50569790	MOV10L1	chr22:50528435-50600115:+	0.35	8.53	1.69E-16	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs138250	chr22:50570361	MOV10L1	chr22:50528435-50600115:+	0.34	8.37	5.6E-16	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs138252	chr22:50570873	MOV10L1	chr22:50528435-50600115:+	0.33	8.18	2.34E-15	Gestational age at birth in labor-initiated deliveries (child effect)	
KIRC	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.36	-7.21	2.06E-12	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs138573550	chr3:127840025	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1	
KIRC	cis	1	rs138702	chr22:39132601	LOC646851	chr22:38974125-39052634:-	-0.14	-4.24	2.71E-5	Resting heart rate	
KIRC	cis	1	rs138704	chr22:39133410	LOC646851	chr22:38974125-39052634:-	0.13	3.93	9.78E-5	Resting heart rate	
KIRC	cis	1	rs138705	chr22:39133803	LOC646851	chr22:38974125-39052634:-	0.12	3.58	0.000374	Resting heart rate	
KIRC	cis	1	rs138706	chr22:39137834	LOC646851	chr22:38974125-39052634:-	0.12	3.52	0.00047	Resting heart rate	
KIRC	cis	1	rs138709	chr22:39139216	LOC646851	chr22:38974125-39052634:-	0.12	3.76	0.000193	Resting heart rate	
KIRC	cis	1	rs138713	chr22:39142615	LOC646851	chr22:38974125-39052634:-	0.12	3.57	0.000386	Resting heart rate	
KIRC	cis	1	rs1388527	chr11:6948441	ZNF215	chr11:6947654-7005861:+	-0.28	-4.13	4.17E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs138879185	chr17:6707261	FBXO39	chr17:6679552-6700420:+	-0.44	-9.42	1.71E-19	Mild influenza (H1N1) infection	
KIRC	cis	1	rs1389369	chr1:212400536	TMEM206	chr1:212537819-212588267:-	0.18	3.51	0.000491	Intelligence (childhood)	
KIRC	cis	1	rs1389370	chr1:212400617	TMEM206	chr1:212537819-212588267:-	0.18	3.52	0.000475	Intelligence (childhood)	
KIRC	cis	1	rs1389384	chr1:100274761	AGL	chr1:100315640-100389579:+	0.23	4.55	6.68E-6	White matter integrity (interaction)	
KIRC	cis	1	rs1389384	chr1:100274761	FRRS1	chr1:100174259-100231349:-	0.2	4.21	2.99E-5	White matter integrity (interaction)	
KIRC	cis	1	rs1390006	chr17:56890663	RAD51C	chr17:56769963-56811690:+	-0.2	-3.66	0.000278	Cognitive test performance	
KIRC	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs1392104	chr7:65759107	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs1393244	chr5:132186007	LEAP2	chr5:132209358-132210581:+	0.32	5.29	1.8E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs1393244	chr5:132186007	SHROOM1	chr5:132158012-132166590:-	0.26	5.14	3.9E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs1393258	chr16:55608032	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.38	1.44E-5	Thyroid hormone levels	
KIRC	cis	1	rs13943	chr22:22116202	MAPK1	chr22:22113949-22221970:-	0.19	5.33	1.49E-7	Multiple sclerosis	
KIRC	cis	1	rs1394510	chr8:89438952	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs1394515	chr8:89409993	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.27	-7.07	5.29E-12	QT interval	
KIRC	cis	1	rs1395	chr2:27424636	C2orf28	chr2:27434899-27440044:+	-0.15	-4.32	1.91E-5	Blood metabolite levels	
KIRC	cis	1	rs1398676	chr12:26459420	BHLHE41	chr12:26272961-26278003:-	0.38	7.09	4.69E-12	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1398676	chr12:26459420	RASSF8	chr12:26111969-26232824:+	0.2	3.93	9.69E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1398676	chr12:26459420	SSPN	chr12:26348269-26405853:+	0.2	4.12	4.48E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1399196	chr11:78071876	NARS2	chr11:78147017-78285909:-	-0.19	-4.49	8.93E-6	Testicular germ cell tumor	
KIRC	cis	1	rs1401138	chr1:2063149	SLC35E2	chr1:1590990-1677431:-	0.18	4	7.22E-5	Height	
KIRC	cis	1	rs1401687	chr2:136908062	DARS	chr2:136664254-136743222:-	0.14	3.74	0.000207	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs140244541	chr2:203808532	ICA1L	chr2:203637873-203736371:-	0.28	3.88	0.000119	LDL cholesterol	
KIRC	cis	1	rs1403284	chr2:73726662	TPRKB	chr2:73956957-73964517:-	0.18	4.54	7.06E-6	Metabolite levels	
KIRC	cis	1	rs140330585	chr15:78866445	CHRNA5	chr15:78857906-78886458:+	-0.34	-6.74	4.4E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.28	5.89	7.04E-9	Diabetic kidney disease	
KIRC	cis	1	rs1404147	chr7:65264524	CRCP	chr7:65579805-65619551:+	-0.28	-3.94	9.17E-5	Diabetic kidney disease	
KIRC	cis	1	rs1406947	chr20:33969530	CPNE1	chr20:34213968-34262539:-	0.27	5.29	1.81E-7	Height	
KIRC	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.28	7.46	3.74E-13	Height	
KIRC	cis	1	rs140839642	chr11:102728812	MMP1	chr11:102660641-102668966:-	0.34	3.71	0.000234	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs1411478	chr1:180962282	MR1	chr1:181003139-181024633:+	-0.15	-3.97	8.33E-5	Progressive supranuclear palsy	
KIRC	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.31	8.8	2.14E-17	Fibrinogen levels	
KIRC	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.32	9.03	3.61E-18	Fibrinogen levels	
KIRC	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.36	-7.21	2.06E-12	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.47	-9.9	3.19E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs1417437	chr1:70154441	LRRC7	chr1:70032868-70589169:+	0.21	3.52	0.000473	Orofacial clefts	
KIRC	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.13	4.74	2.81E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs14178	chr16:67969531	ATP6V0D1	chr16:67471917-67515089:-	-0.32	-4.94	1.06E-6	Crohn's disease	
KIRC	cis	1	rs1418639	chr6:125999940	HEY2	chr6:126068780-126082414:+	-0.18	-4.3	2.02E-5	Endometrial cancer	
KIRC	cis	1	rs1418642	chr6:125999768	HEY2	chr6:126068780-126082414:+	-0.17	-4.1	4.9E-5	Endometrial cancer	
KIRC	cis	1	rs1418788	chr1:90947832	ZNF326	chr1:90460678-90494094:+	-0.19	-3.65	0.000284	Coronary artery calcification	
KIRC	cis	1	rs1418948	chr6:126007018	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.68E-5	Endometrial cancer	
KIRC	cis	1	rs1418951	chr6:125996185	HEY2	chr6:126068780-126082414:+	-0.17	-4.19	3.28E-5	Endometrial cancer	
KIRC	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.28	-4.8	2.09E-6	Depression	
KIRC	cis	1	rs1419183	chr6:28242794	ZNF323	chr6:28292517-28324048:-	0.29	4.01	7.05E-5	Depression	
KIRC	cis	1	rs1419183	chr6:28242794	ZSCAN23	chr6:28393287-28411279:-	0.26	3.76	0.000193	Depression	
KIRC	cis	1	rs1420101	chr2:102957716	IL1RL1	chr2:102927962-102968497:+	-0.2	-4.1	4.76E-5	Serum protein levels (sST2)	
KIRC	cis	1	rs1420685	chr16:50719674	SNX20	chr16:50700211-50715264:-	0.08	4.06	5.8E-5	Leprosy	
KIRC	cis	1	rs1422500	chr5:115569312	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1422795	chr5:156936364	ADAM19	chr5:156822542-157002768:-	-0.12	-4.34	1.76E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.77	15.67	2.48E-45	Type 2 diabetes	
KIRC	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.77	15.7	1.79E-45	Type 2 diabetes	
KIRC	cis	1	rs1423653	chr5:42751448	CCDC152	chr5:42756920-42802539:+	0.23	5.27	2.0E-7	Height	
KIRC	cis	1	rs1427593	chr2:137555224	THSD7B	chr2:137523115-138435287:+	0.2	4.31	2.0E-5	Pancreatic cancer	
KIRC	cis	1	rs1428551	chr5:150259832	IRGM	chr5:150226085-150280295:+	0.55	7.43	4.78E-13	Crohn's disease	
KIRC	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.34	4.47	9.49E-6	Crohn's disease	
KIRC	cis	1	rs1428552	chr5:150259831	IRGM	chr5:150226085-150280295:+	0.5	6.85	2.21E-11	Crohn's disease	
KIRC	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.72E-5	Crohn's disease	
KIRC	cis	1	rs1428554	chr5:150257616	IRGM	chr5:150226085-150280295:+	0.56	7.59	1.62E-13	Crohn's disease	
KIRC	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.37	5.02	7.1E-7	Crohn's disease	
KIRC	cis	1	rs1428555	chr5:150257391	IRGM	chr5:150226085-150280295:+	-0.57	-7.57	1.83E-13	Crohn's disease	
KIRC	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.35	-4.63	4.7E-6	Crohn's disease	
KIRC	cis	1	rs143000161	chr2:165710540	SLC38A11	chr2:165754812-165812035:-	0.47	5.82	1.05E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs1440087	chr2:198871476	RFTN2	chr2:198435528-198540584:-	0.17	4.58	5.87E-6	Ulcerative colitis	
KIRC	cis	1	rs1440088	chr2:198871417	RFTN2	chr2:198435528-198540584:-	0.13	3.62	0.00033	Ulcerative colitis	
KIRC	cis	1	rs1440090	chr2:198879297	RFTN2	chr2:198435528-198540584:-	0.17	4.68	3.69E-6	Ulcerative colitis	
KIRC	cis	1	rs1440091	chr2:198879457	RFTN2	chr2:198435528-198540584:-	0.16	4.75	2.66E-6	Ulcerative colitis	
KIRC	cis	1	rs144073979	chr22:18886814	DGCR6	chr22:18893541-18899600:+	-0.55	-8.63	8.03E-17	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs144098432	chr18:51816394	C18orf54	chr18:51885171-51908403:+	-0.15	-3.86	0.000127	Inflammatory skin disease	
KIRC	cis	1	rs144098432	chr18:51816394	POLI	chr18:51795849-51824602:+	0.15	3.8	0.000164	Inflammatory skin disease	
KIRC	cis	1	rs1451374	chr7:50622653	FIGNL1	chr7:50511834-50518088:-	-0.23	-4.74	2.75E-6	Malaria	
KIRC	cis	1	rs1451375	chr7:50622712	FIGNL1	chr7:50511834-50518088:-	0.23	4.67	3.85E-6	Malaria	
KIRC	cis	1	rs1451707	chr6:56801877	BEND6	chr6:56819773-56892138:+	-0.29	-5.68	2.34E-8	Menarche (age at onset)	
KIRC	cis	1	rs1451708	chr6:56802201	BEND6	chr6:56819773-56892138:+	-0.29	-5.71	1.99E-8	Menarche (age at onset)	
KIRC	cis	1	rs1452311	chr4:75715017	BTC	chr4:75671448-75719882:-	0.28	3.64	0.000305	Electroencephalogram traits	
KIRC	cis	1	rs1452408	chr15:90891117	IQGAP1	chr15:90931473-91045475:+	0.13	3.71	0.000227	Rheumatoid arthritis	
KIRC	cis	1	rs1452408	chr15:90891117	TTLL13	chr15:90792764-90815443:+	0.27	4.66	4.09E-6	Rheumatoid arthritis	
KIRC	cis	1	rs1454499	chr2:70062939	SNRNP27	chr2:70121090-70132348:+	0.2	3.69	0.00025	Colorectal or endometrial cancer	
KIRC	cis	1	rs1454749	chr2:192105635	MYO1B	chr2:192110107-192290115:+	-0.1	-3.49	0.000525	Obesity-related traits	
KIRC	cis	1	rs1454749	chr2:192105635	STAT4	chr2:191894306-192038902:-	-0.16	-4.37	1.54E-5	Obesity-related traits	
KIRC	cis	1	rs1458726	chr11:30505879	C11orf46	chr11:30344649-30359978:+	-0.33	-6.61	9.8E-11	QRS complex (12-leadsum)	
KIRC	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.28	7.94	1.29E-14	Longevity	
KIRC	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.77	3.69E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1460561	chr6:56797574	BEND6	chr6:56819773-56892138:+	-0.25	-4.94	1.08E-6	Menarche (age at onset)	
KIRC	cis	1	rs1463679	chr12:26470169	BHLHE41	chr12:26272961-26278003:-	0.36	6.75	4.1E-11	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1463679	chr12:26470169	SSPN	chr12:26348269-26405853:+	0.19	3.85	0.000135	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1464569	chr3:49460350	CCDC36	chr3:49235861-49295537:+	0.25	4.81	1.98E-6	Menarche (age at onset)	
KIRC	cis	1	rs1464569	chr3:49460350	NCKIPSD	chr3:48711280-48723334:-	0.2	3.92	9.9E-5	Menarche (age at onset)	
KIRC	cis	1	rs1464569	chr3:49460350	P4HTM	chr3:49027341-49044579:+	0.19	4.21	3.08E-5	Menarche (age at onset)	
KIRC	cis	1	rs1464569	chr3:49460350	TREX1	chr3:48501186-48509043:+	-0.16	-4.09	5.04E-5	Menarche (age at onset)	
KIRC	cis	1	rs1464569	chr3:49460350	WDR6	chr3:49044637-49053386:+	-0.21	-5.27	2.02E-7	Menarche (age at onset)	
KIRC	cis	1	rs1465880	chr2:240932326	NDUFA10	chr2:240900158-240964798:-	0.19	4.07	5.41E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs1466214	chr4:1073760	C4orf48	chr4:2043689-2045697:+	-0.14	-3.49	0.000521	Recombination rate (males)	
KIRC	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.73	-15.5	1.43E-44	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1466788	chr1:110618730	ALX3	chr1:110602998-110613322:-	-0.22	-4.76	2.51E-6	Blood metabolite levels	
KIRC	cis	1	rs1468333	chr5:137552970	CDC25C	chr5:137620959-137674044:-	-0.21	-6.03	3.17E-9	Resting heart rate	
KIRC	cis	1	rs1469712	chr19:19528821	HAPLN4	chr19:19366453-19384074:-	0.31	6.85	2.14E-11	Schizophrenia	
KIRC	cis	1	rs1469712	chr19:19528821	SF4	chr19:19387323-19431307:-	0.14	3.72	0.000226	Schizophrenia	
KIRC	cis	1	rs1469712	chr19:19528821	TM6SF2	chr19:19375174-19384074:-	0.15	3.57	0.000391	Schizophrenia	
KIRC	cis	1	rs1471399	chr4:88774073	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs1471401	chr4:88774340	MEPE	chr4:88754140-88767942:+	-0.23	-4.42	1.2E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs1471403	chr4:88775243	MEPE	chr4:88754140-88767942:+	0.22	4.32	1.92E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.99	8.92E-12	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1471552	chr15:84570734	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.4	1.34E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1471553	chr15:84571038	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1471633	chr1:145723739	NUDT17	chr1:145586494-145590461:-	0.17	3.73	0.000212	Urate levels;Urate levels in overweight individuals	
KIRC	cis	1	rs1472001	chr11:46484685	MDK	chr11:46402334-46405374:+	-0.22	-3.64	0.000298	Schizophrenia	
KIRC	cis	1	rs1472189	chr11:11983885	DKK3	chr11:11984545-12031316:-	0.19	5.1	4.89E-7	Metabolite levels (Dihydroxy docosatrienoic acid)	
KIRC	cis	1	rs1473248	chr19:41923314	ATP5SL	chr19:41937224-41945810:-	-0.17	-3.96	8.66E-5	Height	
KIRC	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.77	-23.4	1.95E-82	Pulse pressure	
KIRC	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.36	-7.21	2.06E-12	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1475695	chr9:100691168	C9orf156	chr9:100666772-100684852:-	-0.3	-6.61	9.8E-11	Quantitative traits	
KIRC	cis	1	rs1475696	chr9:100691397	C9orf156	chr9:100666772-100684852:-	-0.3	-6.62	9.24E-11	Quantitative traits	
KIRC	cis	1	rs1475911	chr21:43513480	C21orf128	chr21:43522244-43528644:-	0.47	7.83	2.98E-14	IgG glycosylation	
KIRC	cis	1	rs1480823	chr15:84585746	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.43	1.14E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1480827	chr15:84577792	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1480955	chr15:100581989	ADAMTS17	chr15:100511643-100882183:-	-0.31	-5.12	4.36E-7	Gastroesophageal reflux disease	
KIRC	cis	1	rs1480956	chr15:100582974	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.56	6.29E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs1484994	chr20:30305975	COX4I2	chr20:30225691-30232800:+	0.14	3.84	0.000137	Subcortical brain region volumes	
KIRC	cis	1	rs148734725	chr3:49406708	TREX1	chr3:48501186-48509043:+	-0.15	-3.78	0.000177	Educational attainment (college completion)	
KIRC	cis	1	rs148734725	chr3:49406708	UBA7	chr3:49842639-49851391:-	0.14	3.81	0.000159	Educational attainment (college completion)	
KIRC	cis	1	rs1498312	chr1:76177849	ACADM	chr1:76190043-76229353:+	0.19	5.42	9.06E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs1498315	chr1:76159225	ACADM	chr1:76190043-76229353:+	0.19	5.33	1.49E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs1498316	chr1:76159198	ACADM	chr1:76190043-76229353:+	0.19	5.31	1.62E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.6	14.3	3.83E-39	Height	
KIRC	cis	1	rs1498718	chr3:134205920	CEP63	chr3:134204575-134293852:+	0.32	6.13	1.81E-9	Height	
KIRC	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.5	6.07E-8	Diabetic kidney disease	
KIRC	cis	1	rs1499613	chr7:65730860	CRCP	chr7:65579805-65619551:+	0.32	4.44	1.09E-5	Diabetic kidney disease	
KIRC	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.27	5.29	1.85E-7	Diabetic kidney disease	
KIRC	cis	1	rs1499614	chr7:65730798	CRCP	chr7:65579805-65619551:+	-0.33	-4.49	8.94E-6	Diabetic kidney disease	
KIRC	cis	1	rs1502006	chr16:55610366	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.16	3.7E-5	Thyroid hormone levels	
KIRC	cis	1	rs1502007	chr16:55613522	LPCAT2	chr16:55542913-55620581:+	0.21	5.15	3.79E-7	Thyroid hormone levels	
KIRC	cis	1	rs1503875	chr4:18128280	QDPR	chr4:17488020-17513857:-	-0.13	-3.52	0.000471	Illicit drug use	
KIRC	cis	1	rs1509123	chr17:6683878	FBXO39	chr17:6679552-6700420:+	0.37	3.58	0.000371	Blood metabolite levels	
KIRC	cis	1	rs150986675	chr11:102777303	MMP1	chr11:102660641-102668966:-	0.44	4.58	5.77E-6	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.19	3.9	0.000111	Idiopathic membranous nephropathy	
KIRC	cis	1	rs1511218	chr2:160906390	PLA2R1	chr2:160798012-160919121:-	0.18	3.82	0.000148	Idiopathic membranous nephropathy	
KIRC	cis	1	rs151317012	chr4:106806194	INTS12	chr4:106603787-106629881:-	-0.7	-7.24	1.69E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.51	-13.57	5.95E-36	Ankylosing spondylitis	
KIRC	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.48	8.28	1.14E-15	Ankylosing spondylitis	
KIRC	cis	1	rs1519810	chr8:120936177	TNFRSF11B	chr8:119935797-119964383:-	0.24	3.72	0.000224	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.35	-7.79	3.87E-14	Pancreatic cancer	
KIRC	cis	1	rs1522106	chr4:56307214	SRD5A3	chr4:56212409-56237866:+	-0.22	-4.67	3.92E-6	Personality dimensions	
KIRC	cis	1	rs1522106	chr4:56307214	TMEM165	chr4:56262090-56292342:+	0.2	5.36	1.24E-7	Personality dimensions	
KIRC	cis	1	rs1522108	chr4:56380733	SRD5A3	chr4:56212409-56237866:+	0.21	4.44	1.08E-5	Personality dimensions	
KIRC	cis	1	rs1522108	chr4:56380733	TMEM165	chr4:56262090-56292342:+	-0.22	-5.76	1.5E-8	Personality dimensions	
KIRC	cis	1	rs1522110	chr4:56380283	SRD5A3	chr4:56212409-56237866:+	0.18	4.01	6.89E-5	Personality dimensions	
KIRC	cis	1	rs1522110	chr4:56380283	TMEM165	chr4:56262090-56292342:+	-0.22	-6.16	1.46E-9	Personality dimensions	
KIRC	cis	1	rs1522111	chr4:56329563	SRD5A3	chr4:56212409-56237866:+	0.18	3.99	7.74E-5	Personality dimensions	
KIRC	cis	1	rs1522111	chr4:56329563	TMEM165	chr4:56262090-56292342:+	-0.22	-6.09	2.23E-9	Personality dimensions	
KIRC	cis	1	rs1526080	chr15:84589920	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1526081	chr15:84590066	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1528402	chr2:27857517	NRBP1	chr2:27650657-27665122:+	0.14	3.65	0.000288	Oral cavity cancer	
KIRC	cis	1	rs1528404	chr2:27846603	NRBP1	chr2:27650657-27665122:+	-0.14	-3.71	0.000226	Oral cavity cancer	
KIRC	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.38	-7.32	9.67E-13	Obesity-related traits	
KIRC	cis	1	rs1533266	chr7:143766714	OR2A1	chr7:144015236-144016148:+;chr7	-0.27	-5.05	6.05E-7	Obesity-related traits	
KIRC	cis	1	rs1533266	chr7:143766714	OR2A9P	chr7:143991573-143997832:+;chr7	-0.44	-7.98	9.78E-15	Obesity-related traits	
KIRC	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.46	3.77E-13	Obesity-related traits	
KIRC	cis	1	rs1533267	chr7:143766440	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.21	2.82E-7	Obesity-related traits	
KIRC	cis	1	rs1533267	chr7:143766440	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.17	2.57E-15	Obesity-related traits	
KIRC	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.46	3.77E-13	Obesity-related traits	
KIRC	cis	1	rs1533268	chr7:143766358	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.21	2.82E-7	Obesity-related traits	
KIRC	cis	1	rs1533268	chr7:143766358	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.17	2.57E-15	Obesity-related traits	
KIRC	cis	1	rs1533463	chr2:113538782	DDX11L2	chr2:114356606-114359153:-	0.23	3.8	0.000165	Endometriosis	
KIRC	cis	1	rs1533463	chr2:113538782	RPL23AP7	chr2:114368816-114384715:-	0.25	4.34	1.69E-5	Endometriosis	
KIRC	cis	1	rs1533665	chr15:78530940	WDR61	chr15:78575580-78591940:-	0.16	3.51	0.000482	Personality dimensions	
KIRC	cis	1	rs1533825	chr11:214163	PSMD13	chr11:236808-252984:+	0.15	4.73	2.98E-6	Menarche (age at onset)	
KIRC	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.85	1.28E-41	Height	
KIRC	cis	1	rs1534025	chr3:134313304	CEP63	chr3:134204575-134293852:+	-0.33	-6.45	2.7E-10	Height	
KIRC	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.6	14.67	8.2E-41	Height	
KIRC	cis	1	rs1534026	chr3:134284767	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.34E-11	Height	
KIRC	cis	1	rs1534471	chr2:73647508	TPRKB	chr2:73956957-73964517:-	-0.19	-4.92	1.17E-6	Metabolite levels	
KIRC	cis	1	rs1535786	chr13:28170189	POLR1D	chr13:28194895-28241547:+	0.2	4.46	9.98E-6	Large B-cell lymphoma	
KIRC	cis	1	rs1539893	chr18:66544755	TMX3	chr18:66340927-66382353:-	0.19	3.79	0.000166	Liver enzyme levels (alanine transaminase)	
KIRC	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.62	1.25E-13	Obesity-related traits	
KIRC	cis	1	rs1540894	chr7:143767676	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.33	1.48E-7	Obesity-related traits	
KIRC	cis	1	rs1540894	chr7:143767676	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.21	1.88E-15	Obesity-related traits	
KIRC	cis	1	rs1540927	chr20:33931344	CPNE1	chr20:34213968-34262539:-	0.27	5.39	1.11E-7	Height	
KIRC	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.28	7.65	1.03E-13	Height	
KIRC	cis	1	rs1541306	chr11:71708013	C11orf59	chr11:71808339-71814322:-	-0.24	-4.45	1.04E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1546059	chr7:65654709	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.7	2.02E-8	Diabetic kidney disease	
KIRC	cis	1	rs1546059	chr7:65654709	CRCP	chr7:65579805-65619551:+	0.32	4.35	1.67E-5	Diabetic kidney disease	
KIRC	cis	1	rs1546059	chr7:65654709	LOC493754	chr7:65993446-66057363:-	-0.22	-3.5	0.000506	Diabetic kidney disease	
KIRC	cis	1	rs1546753	chr3:119557075	GSK3B	chr3:119540804-119813264:-	-0.14	-3.87	0.000123	HDL cholesterol	
KIRC	cis	1	rs1548226	chr20:43983777	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.55	0.000423	Psoriasis	
KIRC	cis	1	rs1552994	chr1:152171461	FLG2	chr1:152321214-152332482:-	0.31	5.37	1.21E-7	Inflammatory skin disease	
KIRC	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.3	5.07	5.63E-7	Inflammatory skin disease	
KIRC	cis	1	rs1552994	chr1:152171461	HRNR	chr1:152184558-152196669:-	-0.35	-5.6	3.48E-8	Inflammatory skin disease	
KIRC	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.5	6.07E-8	Diabetic kidney disease	
KIRC	cis	1	rs1553174	chr7:65731194	CRCP	chr7:65579805-65619551:+	0.32	4.44	1.09E-5	Diabetic kidney disease	
KIRC	cis	1	rs1553609	chr7:66197139	LOC493754	chr7:65993446-66057363:-	-0.17	-3.76	0.000193	Aortic root size	
KIRC	cis	1	rs1553610	chr7:66197233	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000194	Aortic root size	
KIRC	cis	1	rs1554120	chr3:150935371	P2RY12	chr3:151055238-151102544:-	0.21	3.58	0.000382	Heschl's gyrus morphology	
KIRC	cis	1	rs1555095	chr6:56003683	COL21A1	chr6:55921389-56258892:-	-0.45	-7.19	2.41E-12	Psychosis (atypical)	
KIRC	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.78	-17.06	8.05E-52	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1556562	chr1:93034023	EVI5	chr1:92974255-93257961:-	0.21	4.96	9.74E-7	Cholesterol, total	
KIRC	cis	1	rs1557121	chr1:173353881	SERPINC1	chr1:173872943-173886516:-	-0.28	-4.58	5.84E-6	Rheumatoid arthritis	
KIRC	cis	1	rs1557503	chr22:51013072	CPT1B	chr22:51007291-51017096:-	-0.27	-5.32	1.59E-7	Narcolepsy	
KIRC	cis	1	rs1558377	chr4:17650758	LAP3	chr4:17578927-17609590:+	-0.21	-6.46	2.52E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1558377	chr4:17650758	MED28	chr4:17616273-17629791:+	0.21	4.74	2.81E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1558378	chr4:17650351	LAP3	chr4:17578927-17609590:+	-0.21	-6.46	2.52E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1558378	chr4:17650351	MED28	chr4:17616273-17629791:+	0.21	4.74	2.81E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.79	15.95	1.2E-46	Type 2 diabetes	
KIRC	cis	1	rs1560396	chr4:39113712	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs1560397	chr4:39113885	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs1560706	chr19:10838004	SLC44A2	chr19:10713121-10755234:+	-0.22	-3.68	0.000259	LDL cholesterol	
KIRC	cis	1	rs1561288	chr2:25369002	POMC	chr2:25383722-25391559:-	0.24	4.57	6.11E-6	Body mass index	
KIRC	cis	1	rs1561289	chr2:25369040	POMC	chr2:25383722-25391559:-	-0.26	-4.84	1.76E-6	Body mass index	
KIRC	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.3	-8.67	5.98E-17	Longevity	
KIRC	cis	1	rs15637	chr17:61772050	DDX42	chr17:61851567-61896676:+	-0.17	-3.61	0.000338	Body mass index	
KIRC	cis	1	rs15637	chr17:61772050	FTSJ3	chr17:61896795-61905031:-	0.32	6.37	4.19E-10	Body mass index	
KIRC	cis	1	rs15637	chr17:61772050	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.46	1.03E-5	Body mass index	
KIRC	cis	1	rs156407	chr7:23315639	GPNMB	chr7:23286316-23314728:+	-0.22	-4.66	4.12E-6	Parkinson's disease	
KIRC	cis	1	rs156421	chr7:23312487	GPNMB	chr7:23286316-23314728:+	-0.2	-4.24	2.72E-5	Parkinson's disease	
KIRC	cis	1	rs156425	chr7:23309119	GPNMB	chr7:23286316-23314728:+	0.19	4.24	2.61E-5	Parkinson's disease	
KIRC	cis	1	rs1564472	chr15:84569793	GOLGA6L5	chr15:85047738-85060078:-	-0.12	-3.95	8.84E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1564473	chr15:84569942	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.56	6.33E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1564474	chr15:84570033	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	8.95E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1564475	chr15:84572229	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs1564892	chr12:104445742	TDG	chr12:104359593-104382655:+	0.2	4.47	9.58E-6	Corneal structure	
KIRC	cis	1	rs1567337	chr5:115514834	COMMD10	chr5:115420727-115628978:+	0.19	3.69	0.000246	Metabolite levels  (X-11787)	
KIRC	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.52	-13.57	6.03E-36	Blood metabolite levels	
KIRC	cis	1	rs1567890	chr11:78101700	NARS2	chr11:78147017-78285909:-	-0.19	-4.2	3.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs1568657	chr15:83726179	C15orf40	chr15:83657724-83680393:-	0.32	5.12	4.41E-7	Kawasaki disease	
KIRC	cis	1	rs1569716	chr22:38998519	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.92	0.000103	Resting heart rate	
KIRC	cis	1	rs1569716	chr22:38998519	LOC646851	chr22:38974125-39052634:-	0.14	4.43	1.17E-5	Resting heart rate	
KIRC	cis	1	rs1569933	chr6:161071212	PLG	chr6:161123274-161174345:+	0.26	5.1	4.74E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs1570004	chr20:33958253	CPNE1	chr20:34213968-34262539:-	0.26	5.29	1.8E-7	Height	
KIRC	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.29	7.7	7.14E-14	Height	
KIRC	cis	1	rs1570836	chr1:92972457	EVI5	chr1:92974255-93257961:-	-0.2	-4.65	4.31E-6	Cholesterol, total	
KIRC	cis	1	rs1570837	chr1:93006816	EVI5	chr1:92974255-93257961:-	-0.2	-4.72	3.13E-6	Cholesterol, total	
KIRC	cis	1	rs1570860	chr1:19322651	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs1570861	chr1:19322549	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs1571229	chr9:131913711	SET	chr9:131445934-131458674:+	-0.17	-3.67	0.000268	Blood metabolite ratios	
KIRC	cis	1	rs1573502	chr11:71747428	C11orf59	chr11:71808339-71814322:-	-0.22	-3.94	9.14E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.28	-6.86	2.05E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs157640	chr20:53414539	BCAS1	chr20:52560079-52687304:-	-0.16	-3.52	0.000467	Celiac disease	
KIRC	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.49	-10.35	6.91E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.47	-9.9	3.19E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs1578794	chr6:126015469	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs1580509	chr8:89464569	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.28E-5	Electrodermal activity	
KIRC	cis	1	rs1585932	chr15:100585637	ADAMTS17	chr15:100511643-100882183:-	0.28	4.72	3.13E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs1585933	chr15:100585715	ADAMTS17	chr15:100511643-100882183:-	0.3	4.9	1.33E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs1586936	chr1:76366877	MSH4	chr1:76262630-76378923:+	-0.29	-4.38	1.47E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs1587922	chr3:51918228	GPR62	chr3:51989330-51991519:+	-0.21	-3.81	0.000155	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs1592917	chr5:115569414	COMMD10	chr5:115420727-115628978:+	0.38	3.93	9.53E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1593071	chr5:42786309	CCDC152	chr5:42756920-42802539:+	0.23	5.14	3.85E-7	Height	
KIRC	cis	1	rs1595825	chr2:198875464	RFTN2	chr2:198435528-198540584:-	0.17	4.7	3.38E-6	Ulcerative colitis	
KIRC	cis	1	rs1599280	chr6:56792576	BEND6	chr6:56819773-56892138:+	-0.27	-5.33	1.48E-7	Menarche (age at onset)	
KIRC	cis	1	rs1599281	chr6:56789311	BEND6	chr6:56819773-56892138:+	0.23	4.96	9.88E-7	Menarche (age at onset)	
KIRC	cis	1	rs1599476	chr8:120351800	NOV	chr8:120428552-120436678:+	-0.29	-4.65	4.2E-6	Hypertension	
KIRC	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.31	6.61	9.76E-11	Multiple sclerosis	
KIRC	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.51	-13.52	1.01E-35	Multiple sclerosis	
KIRC	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.5	1.92E-10	Multiple sclerosis	
KIRC	cis	1	rs1600678	chr15:100579450	ADAMTS17	chr15:100511643-100882183:-	-0.24	-4.12	4.37E-5	Gastroesophageal reflux disease	
KIRC	cis	1	rs160208	chr3:12159294	SYN2	chr3:12045862-12233530:+	-0.39	-4.81	2.02E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs160214	chr3:12168910	SYN2	chr3:12045862-12233530:+	-0.37	-4.59	5.49E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs1604921	chr8:89462984	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.28E-5	Electrodermal activity	
KIRC	cis	1	rs1605070	chr3:51917015	GPR62	chr3:51989330-51991519:+	0.2	3.51	0.00049	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.28	5.53	5.03E-8	Diabetic kidney disease	
KIRC	cis	1	rs160633	chr7:65528228	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.25	-5.26	2.09E-7	Diabetic kidney disease	
KIRC	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.27	5.42	9.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs160637	chr7:65584318	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.27	5.42	9.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs160639	chr7:65579987	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.26	5.09	5.12E-7	Diabetic kidney disease	
KIRC	cis	1	rs160642	chr7:65558373	CRCP	chr7:65579805-65619551:+	-0.34	-4.65	4.27E-6	Diabetic kidney disease	
KIRC	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.26	5.08	5.24E-7	Diabetic kidney disease	
KIRC	cis	1	rs160644	chr7:65558186	CRCP	chr7:65579805-65619551:+	-0.34	-4.66	4.03E-6	Diabetic kidney disease	
KIRC	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.26	5.08	5.37E-7	Diabetic kidney disease	
KIRC	cis	1	rs160646	chr7:65556280	CRCP	chr7:65579805-65619551:+	-0.34	-4.64	4.53E-6	Diabetic kidney disease	
KIRC	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.26	4.96	9.64E-7	Diabetic kidney disease	
KIRC	cis	1	rs160648	chr7:65543384	CRCP	chr7:65579805-65619551:+	-0.35	-4.61	5.23E-6	Diabetic kidney disease	
KIRC	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.26	4.98	8.55E-7	Diabetic kidney disease	
KIRC	cis	1	rs160652	chr7:65538431	CRCP	chr7:65579805-65619551:+	-0.35	-4.6	5.37E-6	Diabetic kidney disease	
KIRC	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.27	5.17	3.36E-7	Diabetic kidney disease	
KIRC	cis	1	rs160655	chr7:65533214	CRCP	chr7:65579805-65619551:+	-0.34	-4.59	5.7E-6	Diabetic kidney disease	
KIRC	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.73	11.03	1.8E-25	Diastolic blood pressure	
KIRC	cis	1	rs1609682	chr2:113540205	DDX11L2	chr2:114356606-114359153:-	0.24	3.92	0.0001	Endometriosis	
KIRC	cis	1	rs1609682	chr2:113540205	RPL23AP7	chr2:114368816-114384715:-	0.25	4.45	1.04E-5	Endometriosis	
KIRC	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.5	-10.03	1.02E-21	Rheumatoid arthritis	
KIRC	cis	1	rs1609810	chr9:123642351	PSMD5	chr9:123578334-123605206:-	-0.35	-6.68	6.32E-11	Rheumatoid arthritis	
KIRC	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.71	-10.51	1.79E-23	Diastolic blood pressure	
KIRC	cis	1	rs1612249	chr6:126014916	HEY2	chr6:126068780-126082414:+	0.18	4.3	2.06E-5	Endometrial cancer	
KIRC	cis	1	rs1613369	chr8:16701921	SLC7A2	chr8:17354600-17428073:+	-0.19	-3.51	0.000497	Parkinson's disease	
KIRC	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs1614223	chr12:120964043	POP5	chr12:121016849-121019201:-	-0.16	-3.9	0.00011	Type 1 diabetes nephropathy	
KIRC	cis	1	rs1615504	chr18:67526644	CD226	chr18:67530195-67624232:-	0.21	6.31	6.3E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs1618893	chr7:66096119	CCT6P1	chr7:65216092-65228661:+	0.21	4.18	3.48E-5	Diabetic kidney disease	
KIRC	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.35	-4.88	1.44E-6	Diabetic kidney disease	
KIRC	cis	1	rs1625980	chr4:16152859	FLJ39653	chr4:16228286-16259810:+	-0.21	-3.6	0.000353	Kidney disease (early stage) in type 1 diabetes	
KIRC	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.74	-11.39	6.66E-27	Diastolic blood pressure	
KIRC	cis	1	rs1630556	chr6:126013155	HEY2	chr6:126068780-126082414:+	0.17	4.1	4.89E-5	Endometrial cancer	
KIRC	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.16	-3.57	0.000395	Rheumatoid arthritis	
KIRC	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.35	9.17	1.2E-18	Rheumatoid arthritis	
KIRC	cis	1	rs1633360	chr12:58108052	XRCC6BP1	chr12:58335445-58351051:+	0.18	4.19	3.32E-5	Rheumatoid arthritis	
KIRC	cis	1	rs1634409	chr17:18836177	FAM18B	chr17:18684582-18710026:+	-0.25	-5.58	3.98E-8	Educational attainment (years of education)	
KIRC	cis	1	rs1634411	chr17:18833810	FAM18B	chr17:18684582-18710026:+	-0.25	-5.57	4.16E-8	Educational attainment (years of education)	
KIRC	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs1638731	chr7:66144679	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.27	5.41	9.67E-8	Diabetic kidney disease	
KIRC	cis	1	rs1638734	chr7:66097539	CRCP	chr7:65579805-65619551:+	-0.32	-4.36	1.6E-5	Diabetic kidney disease	
KIRC	cis	1	rs164106	chr17:74290566	FAM100B	chr17:74261286-74267379:+	-0.16	-4.66	4.06E-6	White matter hyperintensities in ischemic stroke	
KIRC	cis	1	rs1655841	chr15:65721043	DPP8	chr15:65737999-65810035:-	-0.12	-4.69	3.55E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs1655843	chr15:65721261	DPP8	chr15:65737999-65810035:-	-0.13	-5.03	6.73E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs1659685	chr2:27420690	C2orf28	chr2:27434899-27440044:+	-0.15	-4.37	1.51E-5	Blood metabolite levels	
KIRC	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.15	-4.33	1.78E-5	Blood metabolite levels	
KIRC	cis	1	rs1665982	chr3:47905079	ZNF589	chr3:48282596-48329113:+	-0.16	-3.75	0.000196	Educational attainment (years of education)	
KIRC	cis	1	rs166663	chr7:23316742	GPNMB	chr7:23286316-23314728:+	-0.19	-4.02	6.76E-5	Parkinson's disease	
KIRC	cis	1	rs166925	chr19:41926098	ATP5SL	chr19:41937224-41945810:-	0.16	3.77	0.000186	Height	
KIRC	cis	1	rs1678033	chr14:102435852	RAGE	chr14:102690838-102771531:-	-0.15	-3.62	0.000327	Menopause (age at onset)	
KIRC	cis	1	rs1678542	chr12:57968715	TSFM	chr12:58176536-58191367:+	0.24	6.02	3.41E-9	Rheumatoid arthritis	
KIRC	cis	1	rs1678542	chr12:57968715	XRCC6BP1	chr12:58335445-58351051:+	0.17	3.82	0.00015	Rheumatoid arthritis	
KIRC	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.28	-4.92	1.19E-6	Polycystic ovary syndrome	
KIRC	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.28	4.78	2.35E-6	Depression	
KIRC	cis	1	rs1679709	chr6:28228342	ZNF323	chr6:28292517-28324048:-	-0.29	-3.99	7.67E-5	Depression	
KIRC	cis	1	rs1679709	chr6:28228342	ZSCAN23	chr6:28393287-28411279:-	-0.26	-3.75	0.000195	Depression	
KIRC	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.27	4.73	2.86E-6	Depression	
KIRC	cis	1	rs1679732	chr6:28221264	ZNF323	chr6:28292517-28324048:-	-0.29	-3.99	7.54E-5	Depression	
KIRC	cis	1	rs1679732	chr6:28221264	ZSCAN23	chr6:28393287-28411279:-	-0.26	-3.79	0.000167	Depression	
KIRC	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.5	-8.29	1.07E-15	Bone mineral density	
KIRC	cis	1	rs16830920	chr2:135465466	TMEM163	chr2:135213331-135525334:-	-0.33	-4.6	5.38E-6	Gut microbiome composition (winter)	
KIRC	cis	1	rs16830945	chr2:135471748	TMEM163	chr2:135213331-135525334:-	0.3	4.25	2.55E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs16832155	chr2:190749841	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.51	7.9E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs16832158	chr2:190758688	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.55	6.79E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.59	8.38	5.44E-16	Rheumatoid arthritis	
KIRC	cis	1	rs16842559	chr1:159676171	CRP	chr1:159682080-159684379:-	0.35	3.74	0.000205	C-reactive protein	
KIRC	cis	1	rs16842568	chr1:159676220	CRP	chr1:159682080-159684379:-	0.34	3.62	0.000326	C-reactive protein	
KIRC	cis	1	rs16844002	chr3:128053487	KBTBD12	chr3:127634318-127706513:+	0.25	3.54	0.000445	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs16844002	chr3:128053487	RUVBL1	chr3:127783627-127872757:-	0.28	4.16	3.73E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.18	-3.79	0.00017	Idiopathic membranous nephropathy	
KIRC	cis	1	rs16844715	chr2:160915106	PLA2R1	chr2:160798012-160919121:-	-0.18	-3.81	0.000158	Idiopathic membranous nephropathy	
KIRC	cis	1	rs16854186	chr1:179473704	C1orf125	chr1:179335107-179523868:+	0.5	5.57	4.18E-8	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs16869456	chr6:33714622	IP6K3	chr6:33689443-33714762:-	-0.44	-5.01	7.68E-7	Phosphorus levels	
KIRC	cis	1	rs16869458	chr6:33714639	IP6K3	chr6:33689443-33714762:-	-0.44	-5.01	7.68E-7	Phosphorus levels	
KIRC	cis	1	rs16869464	chr6:33715127	IP6K3	chr6:33689443-33714762:-	-0.43	-4.95	1.01E-6	Phosphorus levels	
KIRC	cis	1	rs16869466	chr6:33715265	IP6K3	chr6:33689443-33714762:-	-0.43	-4.95	1.01E-6	Phosphorus levels	
KIRC	cis	1	rs16876336	chr5:78323482	ARSB	chr5:78073039-78282357:-	-0.2	-4.19	3.31E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs16876336	chr5:78323482	BHMT	chr5:78407604-78428112:+	-0.26	-5.43	8.94E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.49	-11.02	1.87E-25	Response to antipsychotic treatment	
KIRC	cis	1	rs16882035	chr8:89404717	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs16882273	chr8:89424350	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.47E-5	Electrodermal activity	
KIRC	cis	1	rs16882408	chr8:89432995	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.19E-5	Electrodermal activity	
KIRC	cis	1	rs16882464	chr8:89435664	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs16882621	chr8:89439610	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs16882905	chr8:89453959	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882914	chr8:89454231	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882925	chr8:89455407	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882945	chr8:89456145	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882947	chr8:89456247	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882948	chr8:89456851	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs16882949	chr8:89457287	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000103	Electrodermal activity	
KIRC	cis	1	rs16882951	chr8:89457398	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000103	Electrodermal activity	
KIRC	cis	1	rs16882953	chr8:89457480	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000103	Electrodermal activity	
KIRC	cis	1	rs16882960	chr8:89457884	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs16882980	chr8:89458652	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs16883006	chr8:89460425	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs16883010	chr8:89460453	MMP16	chr8:89049462-89339717:-	-0.3	-3.98	8.07E-5	Electrodermal activity	
KIRC	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.45	5.62	3.09E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs16891397	chr6:26200256	HIST1H3E	chr6:26224427-26226589:+	0.43	5.46	7.69E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs16891401	chr6:26202337	HIST1H3E	chr6:26224427-26226589:+	0.43	5.4	1.03E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs16891405	chr6:26204506	HIST1H3E	chr6:26224427-26226589:+	0.44	5.51	5.67E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs16892496	chr8:110109851	TMEM74	chr8:109619080-109799770:-	0.19	3.69	0.00025	Body mass (lean)	
KIRC	cis	1	rs16893320	chr5:60953099	FLJ37543	chr5:60933636-61002362:+	0.22	3.58	0.000378	Alzheimer's disease	
KIRC	cis	1	rs16893322	chr5:60953327	FLJ37543	chr5:60933636-61002362:+	0.21	3.52	0.000463	Alzheimer's disease	
KIRC	cis	1	rs16894959	chr6:34825662	UHRF1BP1	chr6:34759794-34853117:+	0.31	6.69	5.81E-11	Pubertal anthropometrics	
KIRC	cis	1	rs16895812	chr6:42495278	PRPH2	chr6:42664334-42690358:-	-0.21	-3.55	0.000426	Obesity-related traits	
KIRC	cis	1	rs16898084	chr8:124190377	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs16898086	chr8:124190445	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs16898088	chr8:124190501	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs16899788	chr6:167431326	FGFR1OP	chr6:167412816-167454065:+	0.32	3.69	0.000244	Smooth-surface caries	
KIRC	cis	1	rs1690333	chr15:57909186	GCOM1	chr15:57884114-58009752:+	0.19	3.7	0.00024	HDL cholesterol	
KIRC	cis	1	rs16909919	chr9:98265780	C9orf130	chr9:98568372-98638259:-	-0.2	-3.58	0.00038	Height	
KIRC	cis	1	rs16910180	chr11:22821843	SVIP	chr11:22843600-22851382:-	0.28	4.37	1.54E-5	Dialysis-related mortality	
KIRC	cis	1	rs16917224	chr8:96030110	C8orf38	chr8:95908040-96088396:+	-0.25	-3.83	0.000144	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs16918881	chr8:62416173	CLVS1	chr8:62200525-62414202:+	-0.28	-4.78	2.26E-6	Whole-brain volume	
KIRC	cis	1	rs16920793	chr11:30507095	C11orf46	chr11:30344649-30359978:+	0.29	5.85	8.91E-9	QRS complex (12-leadsum)	
KIRC	cis	1	rs1692141	chr1:147230217	ACP6	chr1:147119168-147142634:-	-0.25	-4.45	1.05E-5	Cognitive performance	
KIRC	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.56	-10.04	9.86E-22	Bilirubin levels	
KIRC	cis	1	rs16930343	chr10:29800468	LOC387647	chr10:29698483-29776785:+	0.22	4.12	4.45E-5	Platelet thrombus formation	
KIRC	cis	1	rs16944254	chr15:90898527	IQGAP1	chr15:90931473-91045475:+	0.12	3.56	0.000404	Rheumatoid arthritis	
KIRC	cis	1	rs16944254	chr15:90898527	TTLL13	chr15:90792764-90815443:+	0.27	4.64	4.35E-6	Rheumatoid arthritis	
KIRC	cis	1	rs16947005	chr17:61702989	FTSJ3	chr17:61896795-61905031:-	-0.32	-6.34	5.22E-10	Body mass index	
KIRC	cis	1	rs16947005	chr17:61702989	TCAM1P	chr17:61934376-61941738:+	0.24	4.34	1.74E-5	Body mass index	
KIRC	cis	1	rs16947014	chr17:61719032	FTSJ3	chr17:61896795-61905031:-	0.32	6.26	8.27E-10	Body mass index	
KIRC	cis	1	rs16947014	chr17:61719032	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.52	7.71E-6	Body mass index	
KIRC	cis	1	rs16947042	chr17:61766457	DDX42	chr17:61851567-61896676:+	-0.17	-3.63	0.000308	Body mass index	
KIRC	cis	1	rs16947042	chr17:61766457	FTSJ3	chr17:61896795-61905031:-	0.32	6.36	4.58E-10	Body mass index	
KIRC	cis	1	rs16947042	chr17:61766457	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.35E-6	Body mass index	
KIRC	cis	1	rs16948048	chr17:47440466	GNGT2	chr17:47283597-47286743:-	-0.15	-4.55	6.64E-6	Diastolic blood pressure	
KIRC	cis	1	rs16948048	chr17:47440466	ZNF652	chr17:47366569-47439835:-	0.19	4.13	4.33E-5	Diastolic blood pressure	
KIRC	cis	1	rs16948098	chr15:44219607	ADAL	chr15:43622872-43646094:+	-0.59	-6.86	2.01E-11	Serum albumin level	
KIRC	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.72	-15.48	1.79E-44	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs16952611	chr18:48382668	MRO	chr18:48321491-48351754:-	-0.28	-4.94	1.05E-6	Entorhinal cortical thickness	
KIRC	cis	1	rs16952848	chr18:44597829	HDHD2	chr18:44633782-44676871:-	0.35	3.51	0.00049	Sitting height ratio	
KIRC	cis	1	rs16955471	chr17:53058807	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs16957524	chr16:67798005	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-5.58	3.98E-8	Crohn's disease	
KIRC	cis	1	rs16957524	chr16:67798005	C16orf86	chr16:67700717-67702659:+	-0.31	-3.93	9.76E-5	Crohn's disease	
KIRC	cis	1	rs16957524	chr16:67798005	GFOD2	chr16:67708437-67753273:-	-0.25	-3.85	0.000134	Crohn's disease	
KIRC	cis	1	rs16957590	chr16:67934725	ATP6V0D1	chr16:67471917-67515089:-	0.34	5.39	1.07E-7	Crohn's disease	
KIRC	cis	1	rs16957590	chr16:67934725	C16orf86	chr16:67700717-67702659:+	0.28	3.52	0.000465	Crohn's disease	
KIRC	cis	1	rs16958432	chr18:44631773	HDHD2	chr18:44633782-44676871:-	0.36	3.69	0.000246	Sitting height ratio	
KIRC	cis	1	rs16958440	chr18:44632884	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs16958701	chr18:44655241	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs16959799	chr16:58229628	C16orf80	chr16:58147497-58163296:-	0.32	3.61	0.000332	Telomere length	
KIRC	cis	1	rs16970287	chr15:79228257	CTSH	chr15:79214092-79237420:-	-0.25	-3.84	0.000139	Bipolar disorder	
KIRC	cis	1	rs16972767	chr19:39153044	CAPN12	chr19:39220832-39235114:-	-0.12	-3.61	0.000337	Heart rate	
KIRC	cis	1	rs16974263	chr19:40913539	PLD3	chr19:40854332-40884389:+	0.22	3.54	0.000434	Otitis media (recurrent);Otitis media (chronic);Otitis media	
KIRC	cis	1	rs16976792	chr15:56477485	TEX9	chr15:56657644-56738071:+	-0.28	-4.9	1.27E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs16976801	chr15:56487811	TEX9	chr15:56657644-56738071:+	-0.28	-4.93	1.13E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs16976821	chr15:56495555	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs16976831	chr15:56522460	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs16976832	chr15:56526217	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1697845	chr5:75922504	F2RL2	chr5:75911308-75919240:-	-0.32	-6.4	3.52E-10	Hearing impairment	
KIRC	cis	1	rs16979973	chr20:55056589	C20orf43	chr20:55043647-55093942:+	0.21	4.84	1.69E-6	Refractive astigmatism	
KIRC	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.49	-8.1	4.24E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.47	-7.74	5.53E-14	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.47	-7.74	5.53E-14	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.49	-8.21	1.84E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.5	-8.34	7.25E-16	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs17007930	chr12:81445762	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs17007930	chr12:81445762	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs170149	chr17:6595930	DVL2	chr17:7128661-7137863:-	0.25	3.57	0.000398	Blood metabolite levels	
KIRC	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.28	5.55	4.67E-8	Diabetic kidney disease	
KIRC	cis	1	rs1701750	chr7:65467145	CRCP	chr7:65579805-65619551:+	-0.28	-3.9	0.000109	Diabetic kidney disease	
KIRC	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.28	5.55	4.67E-8	Diabetic kidney disease	
KIRC	cis	1	rs1701758	chr7:65470201	CRCP	chr7:65579805-65619551:+	-0.28	-3.9	0.000109	Diabetic kidney disease	
KIRC	cis	1	rs17027011	chr2:86406556	LOC90784	chr2:86247339-86250991:-	-0.36	-3.85	0.000131	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.51	7.81	3.45E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.52	8.07	5.1E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs17032414	chr3:10158302	RPUSD3	chr3:9879534-9885702:-	-0.15	-3.55	0.000425	Alzheimer's disease	
KIRC	cis	1	rs17035960	chr4:106531846	INTS12	chr4:106603787-106629881:-	-0.66	-6.52	1.75E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs17036105	chr4:106603272	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036120	chr4:106621508	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036123	chr4:106622190	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036125	chr4:106623674	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036129	chr4:106624529	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036139	chr4:106632657	INTS12	chr4:106603787-106629881:-	-0.64	-6.59	1.13E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs17036177	chr4:106672511	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036189	chr4:106687959	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036225	chr4:106710092	INTS12	chr4:106603787-106629881:-	-0.6	-6.38	4.04E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs17036230	chr4:106715148	INTS12	chr4:106603787-106629881:-	-0.64	-6.73	4.56E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036258	chr4:106737382	INTS12	chr4:106603787-106629881:-	-0.65	-6.72	4.95E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036308	chr4:106749593	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17036310	chr4:106752340	INTS12	chr4:106603787-106629881:-	-0.64	-6.72	4.96E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs17037427	chr1:11873416	MIIP	chr1:12079512-12092106:+	-0.13	-3.5	0.000498	QRS complex (12-leadsum)	
KIRC	cis	1	rs17038253	chr4:108902766	HADH	chr4:108910940-108956330:+	-0.26	-3.54	0.000437	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs17045711	chr2:54476678	ACYP2	chr2:54342410-54532433:+	-0.21	-3.8	0.00016	Telomere length	
KIRC	cis	1	rs17051310	chr4:122106293	CCNA2	chr4:122737600-122745088:-	0.29	4.34	1.7E-5	Breast cancer	
KIRC	cis	1	rs17052727	chr3:53070914	RFT1	chr3:53122503-53164470:-	0.39	6.16	1.5E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs17052727	chr3:53070914	TMEM110	chr3:52867139-52931547:-	0.35	6.18	1.35E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs1705607	chr3:141800293	TFDP2	chr3:141671329-141868311:-	-0.21	-4.25	2.54E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs1705614	chr3:141811257	TFDP2	chr3:141671329-141868311:-	-0.21	-4.14	4.06E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.77	11.61	8.88E-28	Diastolic blood pressure	
KIRC	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.69	10.87	7.32E-25	Diastolic blood pressure	
KIRC	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.69	9.89	3.3E-21	Diastolic blood pressure	
KIRC	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.75	11.21	3.45E-26	Diastolic blood pressure	
KIRC	cis	1	rs17065214	chr5:174971946	FAF2	chr5:175875356-175937074:+	0.23	4.16	3.68E-5	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs17070580	chr6:109738714	AKD1	chr6:109814059-110012415:-	0.26	5.39	1.1E-7	Height	
KIRC	cis	1	rs17070580	chr6:109738714	SMPD2	chr6:109761931-109765121:+	-0.16	-3.76	0.000187	Height	
KIRC	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.04	3.31E-18	Body mass index	
KIRC	cis	1	rs1707304	chr1:46598269	MUTYH	chr1:45794915-45806142:-	0.13	3.88	0.000119	Body mass index	
KIRC	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.94	7.61E-18	Body mass index	
KIRC	cis	1	rs1707321	chr1:46505309	MUTYH	chr1:45794915-45806142:-	0.13	4.02	6.6E-5	Body mass index	
KIRC	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.93	7.97E-18	Body mass index	
KIRC	cis	1	rs1707335	chr1:46571921	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.72E-5	Body mass index	
KIRC	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.67	5.83E-17	Body mass index	
KIRC	cis	1	rs1707336	chr1:46493460	MUTYH	chr1:45794915-45806142:-	0.13	3.94	9.45E-5	Body mass index	
KIRC	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.98E-18	Body mass index	
KIRC	cis	1	rs1707340	chr1:46514942	MUTYH	chr1:45794915-45806142:-	0.13	3.84	0.00014	Body mass index	
KIRC	cis	1	rs17083581	chr6:153429447	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs17085889	chr4:56402115	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.89	0.000114	Personality dimensions	
KIRC	cis	1	rs17085889	chr4:56402115	TMEM165	chr4:56262090-56292342:+	0.23	6.41	3.43E-10	Personality dimensions	
KIRC	cis	1	rs17092297	chr20:33703134	PROCR	chr20:33758727-33765164:+	0.28	4.13	4.3E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs17093141	chr14:74326903	LIN52	chr14:74551656-74667117:+	0.27	4.79	2.24E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs17093141	chr14:74326903	PTGR2	chr14:74318534-74352166:+	0.26	3.81	0.000154	Morning vs. evening chronotype	
KIRC	cis	1	rs17093141	chr14:74326903	ZNF410	chr14:74318674-74398803:+	0.23	3.52	0.000476	Morning vs. evening chronotype	
KIRC	cis	1	rs17093474	chr14:74342413	LIN52	chr14:74551656-74667117:+	0.25	4.56	6.5E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs17093474	chr14:74342413	PTGR2	chr14:74318534-74352166:+	0.23	3.54	0.000432	Morning vs. evening chronotype	
KIRC	cis	1	rs17094021	chr14:74394295	LIN52	chr14:74551656-74667117:+	0.27	4.76	2.59E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs17094021	chr14:74394295	ZNF410	chr14:74318674-74398803:+	0.24	3.62	0.000329	Morning vs. evening chronotype	
KIRC	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.32	8.6	9.87E-17	Common traits (Other)	
KIRC	cis	1	rs17097836	chr1:76462006	MSH4	chr1:76262630-76378923:+	-0.28	-4.15	3.94E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs17097841	chr1:76462641	MSH4	chr1:76262630-76378923:+	-0.28	-4.13	4.16E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs17097863	chr1:76468787	MSH4	chr1:76262630-76378923:+	-0.26	-3.82	0.000148	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs17098927	chr14:100171095	CYP46A1	chr14:100150755-100193637:+	0.21	4.18	3.41E-5	Scalp hair shape	
KIRC	cis	1	rs17109512	chr10:100127551	PYROXD2	chr10:100143323-100174978:-	0.44	4.5	8.47E-6	Aspartate aminotransferase	
KIRC	cis	1	rs17111346	chr14:81452172	TSHR	chr14:81421869-81612646:+	-0.35	-6.76	3.81E-11	Graves' disease	
KIRC	cis	1	rs17111376	chr5:150226899	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.14	-4.83	1.84E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs17115231	chr12:75933675	GLIPR1L2	chr12:75784889-75825591:+	-0.29	-4.95	1.01E-6	Polycystic ovary syndrome	
KIRC	cis	1	rs17117784	chr15:24153136	HERC2P2	chr15:23282265-23378259:-	-0.17	-4.05	5.95E-5	Menarche (age at onset)	
KIRC	cis	1	rs17118403	chr12:56630067	RPS26	chr12:56435686-56438005:+	-0.52	-4.38	1.47E-5	Psoriasis vulgaris	
KIRC	cis	1	rs17118409	chr12:56630764	RPS26	chr12:56435686-56438005:+	-0.52	-4.38	1.47E-5	Psoriasis vulgaris	
KIRC	cis	1	rs17118439	chr12:56667604	RPS26	chr12:56435686-56438005:+	0.49	4.48	9.1E-6	Psoriasis vulgaris	
KIRC	cis	1	rs17120139	chr11:116774201	PCSK7	chr11:117075789-117102811:-	0.28	5.29	1.85E-7	Protein quantitative trait loci	
KIRC	cis	1	rs17121651	chr14:50097172	RPL36AL	chr14:50085407-50087349:-	0.32	7.36	7.5E-13	Carotid intima media thickness	
KIRC	cis	1	rs17122021	chr11:118145686	MPZL2	chr11:118124135-118135009:-	-0.14	-3.61	0.000334	Pain	
KIRC	cis	1	rs17124700	chr14:88905629	SPATA7	chr14:88852012-88904802:+	-0.19	-3.95	8.93E-5	Coronary artery calcification	
KIRC	cis	1	rs171257	chr6:101048197	GRIK2	chr6:101846905-102517957:+	0.59	6.18	1.3E-9	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs17132442	chr5:110192122	CAMK4	chr5:110559648-110820746:+	-0.17	-3.55	0.000428	Asthma and hay fever	
KIRC	cis	1	rs17132442	chr5:110192122	TMEM232	chr5:109624934-110062381:-	-0.2	-3.81	0.000154	Asthma and hay fever	
KIRC	cis	1	rs17133587	chr10:4809075	TUBAL3	chr10:5435062-5446793:-	0.22	3.61	0.00034	Allergic rhinitis	
KIRC	cis	1	rs1713422	chr14:20940834	PNP	chr14:20937542-20945246:+	-0.32	-5.05	6.27E-7	Interferon alpha levels in systemic lupus erythematosus	
KIRC	cis	1	rs17135348	chr7:100881080	MUC12	chr7:100648075-100662216:+	0.36	3.71	0.000231	QT interval	
KIRC	cis	1	rs17138884	chr5:115425628	COMMD10	chr5:115420727-115628978:+	0.35	4.16	3.71E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17138917	chr5:115469316	COMMD10	chr5:115420727-115628978:+	0.31	3.7	0.000242	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139192	chr5:115561710	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000106	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139193	chr5:115562073	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000106	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139224	chr5:115568193	COMMD10	chr5:115420727-115628978:+	0.37	4.23	2.79E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139265	chr5:115578810	COMMD10	chr5:115420727-115628978:+	0.36	3.99	7.57E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139314	chr5:115607127	COMMD10	chr5:115420727-115628978:+	0.39	4.04	6.06E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17139457	chr5:115640603	COMMD10	chr5:115420727-115628978:+	-0.34	-3.85	0.000135	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs17140062	chr10:17202840	TRDMT1	chr10:17184983-17243681:-	-0.38	-8.56	1.42E-16	Homocysteine levels	
KIRC	cis	1	rs17144465	chr7:21504427	SP4	chr7:21467689-21554149:+	0.23	3.54	0.000444	Major depressive disorder;Major depressive disorder (broad)	
KIRC	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.29	5.9	6.61E-9	Diabetic kidney disease	
KIRC	cis	1	rs1715235	chr7:65488394	CRCP	chr7:65579805-65619551:+	-0.29	-4.09	5.12E-5	Diabetic kidney disease	
KIRC	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.34	-4.48	9.39E-6	Blood metabolite levels	
KIRC	cis	1	rs17161966	chr11:71815308	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs17161991	chr11:71839960	C11orf59	chr11:71808339-71814322:-	0.21	3.68	0.000255	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs17162311	chr1:27174966	PIGV	chr1:27114455-27124886:+	0.4	4.93	1.13E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17162339	chr1:27252823	PIGV	chr1:27114455-27124886:+	0.36	4.21	3.0E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17162387	chr1:27293356	PIGV	chr1:27114455-27124886:+	-0.36	-4.35	1.67E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.44	7.44	4.45E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.51	9.49	9.44E-20	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs17166268	chr5:132180990	LEAP2	chr5:132209358-132210581:+	-0.31	-5.18	3.29E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs17166268	chr5:132180990	SHROOM1	chr5:132158012-132166590:-	-0.25	-4.92	1.18E-6	Apolipoprotein A-IV levels	
KIRC	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.71	-10.51	1.79E-23	Diastolic blood pressure	
KIRC	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.72	-10.97	3.13E-25	Diastolic blood pressure	
KIRC	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.75	-11.46	3.46E-27	Diastolic blood pressure	
KIRC	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.74	-11.42	5.26E-27	Diastolic blood pressure	
KIRC	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.73	11.03	1.8E-25	Diastolic blood pressure	
KIRC	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.73	11.07	1.2E-25	Diastolic blood pressure	
KIRC	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.74	-11.19	4.26E-26	Diastolic blood pressure	
KIRC	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.69	10.64	5.63E-24	Diastolic blood pressure	
KIRC	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.74	-11.39	6.66E-27	Diastolic blood pressure	
KIRC	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.74	-11.19	4.26E-26	Diastolic blood pressure	
KIRC	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.75	-11.71	3.77E-28	Diastolic blood pressure	
KIRC	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.75	-11.4	6.25E-27	Diastolic blood pressure	
KIRC	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.71	-10.49	2.08E-23	Diastolic blood pressure	
KIRC	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.71	-10.49	2.03E-23	Diastolic blood pressure	
KIRC	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.74	-11.19	4.26E-26	Diastolic blood pressure	
KIRC	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.75	-11.46	3.46E-27	Diastolic blood pressure	
KIRC	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.75	-11.46	3.46E-27	Diastolic blood pressure	
KIRC	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.74	-11.29	1.76E-26	Diastolic blood pressure	
KIRC	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.75	11.68	4.9E-28	Diastolic blood pressure	
KIRC	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.75	-11.59	1.08E-27	Diastolic blood pressure	
KIRC	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.72	10.97	3.13E-25	Diastolic blood pressure	
KIRC	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.71	10.87	7.36E-25	Diastolic blood pressure	
KIRC	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.67	-10.68	3.83E-24	Diastolic blood pressure	
KIRC	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.75	-11.62	8.03E-28	Diastolic blood pressure	
KIRC	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.74	11.12	7.75E-26	Diastolic blood pressure	
KIRC	cis	1	rs17170843	chr7:37078931	SFRP4	chr7:37945536-37956525:-	0.36	3.53	0.000459	QT interval	
KIRC	cis	1	rs17171767	chr5:137493528	CDC25C	chr5:137620959-137674044:-	0.19	5.51	5.81E-8	Resting heart rate	
KIRC	cis	1	rs17171770	chr5:137514815	CDC25C	chr5:137620959-137674044:-	-0.23	-6.29	6.98E-10	Resting heart rate	
KIRC	cis	1	rs17171772	chr5:137514853	CDC25C	chr5:137620959-137674044:-	-0.21	-6.04	2.93E-9	Resting heart rate	
KIRC	cis	1	rs17185907	chr1:119465793	WARS2	chr1:119573841-119683295:-	0.31	4.88	1.4E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs17185933	chr1:119474772	WARS2	chr1:119573841-119683295:-	0.3	4.79	2.18E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1719890	chr3:119577868	GSK3B	chr3:119540804-119813264:-	-0.15	-3.97	8.29E-5	HDL cholesterol	
KIRC	cis	1	rs1719894	chr3:119590322	GSK3B	chr3:119540804-119813264:-	-0.15	-3.96	8.53E-5	HDL cholesterol	
KIRC	cis	1	rs17206232	chr5:64433400	PPWD1	chr5:64859131-64883368:+	-0.26	-4.29	2.15E-5	Schizophrenia	
KIRC	cis	1	rs17207042	chr18:67537351	CD226	chr18:67530195-67624232:-	0.21	6.37	4.28E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs17218267	chr6:55935111	COL21A1	chr6:55921389-56258892:-	-0.46	-7.34	8.74E-13	Psychosis (atypical)	
KIRC	cis	1	rs17218309	chr6:55935196	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17218770	chr6:55942956	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17219063	chr6:56000228	COL21A1	chr6:55921389-56258892:-	-0.45	-7.04	6.45E-12	Psychosis (atypical)	
KIRC	cis	1	rs17219126	chr6:56001681	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs17219382	chr6:56009638	COL21A1	chr6:55921389-56258892:-	0.46	7.3	1.14E-12	Psychosis (atypical)	
KIRC	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.18	-4.01	6.91E-5	Colorectal cancer	
KIRC	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.27	5.44	8.27E-8	Diabetic kidney disease	
KIRC	cis	1	rs1723267	chr7:65473314	CRCP	chr7:65579805-65619551:+	-0.29	-4.02	6.76E-5	Diabetic kidney disease	
KIRC	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.27	5.43	8.76E-8	Diabetic kidney disease	
KIRC	cis	1	rs1723269	chr7:65472786	CRCP	chr7:65579805-65619551:+	-0.3	-4.11	4.66E-5	Diabetic kidney disease	
KIRC	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.28	5.51	5.77E-8	Diabetic kidney disease	
KIRC	cis	1	rs1723270	chr7:65469830	CRCP	chr7:65579805-65619551:+	-0.29	-4.01	7.1E-5	Diabetic kidney disease	
KIRC	cis	1	rs17246007	chr14:65865671	LOC645431	chr14:65877313-65879335:-	0.43	5.76	1.48E-8	Ischemic stroke	
KIRC	cis	1	rs17246035	chr14:65874130	LOC645431	chr14:65877313-65879335:-	-0.5	-6.43	3.01E-10	Ischemic stroke	
KIRC	cis	1	rs17246042	chr14:65874330	LOC645431	chr14:65877313-65879335:-	-0.51	-6.66	7.32E-11	Ischemic stroke	
KIRC	cis	1	rs17246259	chr14:66075327	LOC645431	chr14:65877313-65879335:-	-0.47	-6.26	8.07E-10	Ischemic stroke	
KIRC	cis	1	rs17280791	chr4:76503379	CDKL2	chr4:76501705-76555721:-	0.17	3.9	0.000111	Magnesium levels	
KIRC	cis	1	rs17293608	chr10:1056252	IDI2	chr10:1064847-1071799:-	-0.25	-3.85	0.000134	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.79	-8.17	2.56E-15	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs1731847	chr7:155655522	INSIG1	chr7:155089486-155101942:+	0.17	3.82	0.000151	Triptolide cytotoxicity	
KIRC	cis	1	rs17318666	chr19:41940342	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.64	0.000297	Height	
KIRC	cis	1	rs1732170	chr3:119583676	GSK3B	chr3:119540804-119813264:-	-0.15	-3.97	8.29E-5	HDL cholesterol	
KIRC	cis	1	rs173334	chr6:88080223	C6orf162	chr6:88032306-88052043:+	-0.18	-3.96	8.56E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs173334	chr6:88080223	C6orf164	chr6:88032306-88109459:+	-0.17	-4.07	5.54E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs17336353	chr4:95516516	PDLIM5	chr4:95373038-95589376:+	-0.21	-4.29	2.16E-5	Response to simvastatin treatment (PCSK9 protein level change)	
KIRC	cis	1	rs17340509	chr1:27274700	PIGV	chr1:27114455-27124886:+	-0.34	-3.8	0.000161	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.2	4.02	6.79E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17341301	chr2:160902420	PLA2R1	chr2:160798012-160919121:-	0.2	4.1	4.9E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17356923	chr1:27282676	PIGV	chr1:27114455-27124886:+	-0.37	-4.19	3.34E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17360053	chr1:22499530	HSPC157	chr1:22351707-22357713:+	-0.24	-3.94	9.18E-5	Obesity-related traits	
KIRC	cis	1	rs17360994	chr1:27278573	PIGV	chr1:27114455-27124886:+	-0.34	-3.8	0.000161	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs17361668	chr11:102720344	MMP1	chr11:102660641-102668966:-	0.35	3.84	0.000139	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs17362650	chr2:9676413	ITGB1BP1	chr2:9545823-9563643:-	-0.17	-3.5	0.000499	Alcohol dependence (age at onset)	
KIRC	cis	1	rs1737944	chr17:18840433	FAM18B	chr17:18684582-18710026:+	-0.23	-5.12	4.29E-7	Educational attainment (years of education)	
KIRC	cis	1	rs1737947	chr17:18831432	FAM18B	chr17:18684582-18710026:+	0.23	5.29	1.84E-7	Pancreatic cancer	
KIRC	cis	1	rs17385641	chr7:77362489	PHTF2	chr7:77428109-77586818:+	0.14	3.67	0.000271	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs17386555	chr2:242371825	ANO7	chr2:242127924-242164791:+	0.26	3.61	0.000333	Prostate cancer	
KIRC	cis	1	rs1739347	chr6:126014157	HEY2	chr6:126068780-126082414:+	0.18	4.27	2.36E-5	Endometrial cancer	
KIRC	cis	1	rs1739348	chr6:126014573	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs1739349	chr6:126014984	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs1739352	chr6:126005310	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.79E-5	Endometrial cancer	
KIRC	cis	1	rs1739354	chr6:126017808	HEY2	chr6:126068780-126082414:+	0.18	4.4	1.31E-5	Endometrial cancer	
KIRC	cis	1	rs1739357	chr6:126019655	HEY2	chr6:126068780-126082414:+	0.16	3.91	0.000103	Endometrial cancer	
KIRC	cis	1	rs1739362	chr6:126020703	HEY2	chr6:126068780-126082414:+	0.18	4.26	2.44E-5	Endometrial cancer	
KIRC	cis	1	rs1739363	chr6:126020980	HEY2	chr6:126068780-126082414:+	0.18	4.36	1.6E-5	Endometrial cancer	
KIRC	cis	1	rs1739367	chr6:126004720	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.8E-5	Endometrial cancer	
KIRC	cis	1	rs1739371	chr6:126011291	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.66E-5	Endometrial cancer	
KIRC	cis	1	rs1739373	chr6:126011509	HEY2	chr6:126068780-126082414:+	0.17	4.11	4.66E-5	Endometrial cancer	
KIRC	cis	1	rs1739374	chr6:126011825	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.83E-5	Endometrial cancer	
KIRC	cis	1	rs1739375	chr6:126012013	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.83E-5	Endometrial cancer	
KIRC	cis	1	rs1739376	chr6:126012084	HEY2	chr6:126068780-126082414:+	0.17	4.1	4.78E-5	Endometrial cancer	
KIRC	cis	1	rs1739377	chr6:126012236	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.79E-5	Endometrial cancer	
KIRC	cis	1	rs1739378	chr6:126012262	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.75E-5	Endometrial cancer	
KIRC	cis	1	rs1739380	chr6:126012858	HEY2	chr6:126068780-126082414:+	0.17	4.1	4.89E-5	Endometrial cancer	
KIRC	cis	1	rs17396382	chr1:10290268	RBP7	chr1:10057255-10076077:+	0.16	3.69	0.000254	Hepatocellular carcinoma	
KIRC	cis	1	rs17396823	chr7:128384605	OPN1SW	chr7:128412545-128415844:-	-0.23	-3.94	9.14E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs17398137	chr3:100625703	PCNP	chr3:101293042-101313279:+	0.19	3.78	0.000174	Optic disc area	
KIRC	cis	1	rs17398137	chr3:100625703	RG9MTD1	chr3:101280712-101285087:+	0.2	3.56	0.000402	Optic disc area	
KIRC	cis	1	rs17398137	chr3:100625703	TBC1D23	chr3:99979686-100044078:+	0.22	3.84	0.000137	Optic disc area	
KIRC	cis	1	rs17400427	chr15:49741071	DTWD1	chr15:49913226-49937332:+	-0.25	-4.85	1.61E-6	Thyroid volume	
KIRC	cis	1	rs17404153	chr3:132163200	NPHP3	chr3:132363641-132441276:-	0.19	4.25	2.59E-5	HDL cholesterol;LDL cholesterol	
KIRC	cis	1	rs1740428	chr6:161081331	PLG	chr6:161123274-161174345:+	-0.27	-5.29	1.84E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs17419851	chr6:24749413	CMAH	chr6:25081297-25166793:-	0.23	3.78	0.000177	Neutrophil count	
KIRC	cis	1	rs17431934	chr9:100695776	C9orf156	chr9:100666772-100684852:-	-0.3	-6.62	9.24E-11	Quantitative traits	
KIRC	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	1.03	28.5	5.54E-107	Carotid intima media thickness	
KIRC	cis	1	rs17435590	chr7:97784061	BAIAP2L1	chr7:97920964-98030427:-	-0.14	-3.55	0.000418	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs17435847	chr7:97792820	BAIAP2L1	chr7:97920964-98030427:-	-0.14	-3.56	0.000402	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs17450788	chr19:22224755	ZNF257	chr19:22235266-22273901:+	0.35	4.85	1.64E-6	Body mass index (change over time)	
KIRC	cis	1	rs17450853	chr6:56788004	BEND6	chr6:56819773-56892138:+	-0.24	-5.14	3.96E-7	Menarche (age at onset)	
KIRC	cis	1	rs17454527	chr2:180134018	CCDC141	chr2:179697347-179914786:-	-0.29	-3.61	0.00034	Late-onset Alzheimer's disease	
KIRC	cis	1	rs17455002	chr6:88345193	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs174551	chr11:61573684	C11orf10	chr11:61556603-61560085:-	0.13	3.68	0.000259	LDL cholesterol	
KIRC	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	0.5	9.06	2.86E-18	LDL cholesterol	
KIRC	cis	1	rs17475665	chr7:128408313	OPN1SW	chr7:128412545-128415844:-	0.25	4.19	3.29E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs1747593	chr6:604158	EXOC2	chr6:485139-693109:-	0.3	3.66	0.000277	Sitting height ratio	
KIRC	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.29	5.67	2.38E-8	Sex hormone-binding globulin levels	
KIRC	cis	1	rs17507481	chr4:17620066	LAP3	chr4:17578927-17609590:+	-0.21	-6.45	2.67E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs17507481	chr4:17620066	MED28	chr4:17616273-17629791:+	0.22	5.03	6.81E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs17508864	chr4:39130645	WDR19	chr4:39184024-39287429:+	0.18	4.67	3.95E-6	Uric acid levels	
KIRC	cis	1	rs17513621	chr2:99246559	UNC50	chr2:99225042-99234975:+	-0.23	-3.92	0.000102	Bipolar disorder	
KIRC	cis	1	rs17516673	chr5:132196711	LEAP2	chr5:132209358-132210581:+	0.37	5.7	1.99E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs17516673	chr5:132196711	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.76E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs17523471	chr3:185304018	TMEM41A	chr3:185207389-185216845:-	0.16	3.5	0.000507	Systolic blood pressure	
KIRC	cis	1	rs17525350	chr1:169669815	SELL	chr1:169659810-169680837:-	-0.2	-4.92	1.18E-6	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs17528859	chr11:59867379	MS4A2	chr11:59856137-59866014:+	0.17	3.78	0.000177	Alzheimer's disease (late onset)	
KIRC	cis	1	rs17529983	chr11:59927039	MS4A2	chr11:59856137-59866014:+	0.18	3.79	0.000167	Alzheimer's disease (late onset)	
KIRC	cis	1	rs17530005	chr7:137079284	PTN	chr7:136912092-137028546:-	-0.21	-3.57	0.00039	Schizophrenia	
KIRC	cis	1	rs17538840	chr2:61077817	C2orf74	chr2:61372243-61391964:+	-0.37	-6.09	2.24E-9	Inflammatory skin disease	
KIRC	cis	1	rs175425	chr14:75626131	MLH3	chr14:75480467-75518235:-	-0.25	-6.27	7.68E-10	Height	
KIRC	cis	1	rs175425	chr14:75626131	NEK9	chr14:75548819-75593778:-	-0.15	-4.36	1.56E-5	Height	
KIRC	cis	1	rs175426	chr14:75624134	MLH3	chr14:75480467-75518235:-	-0.25	-6.44	2.8E-10	Height	
KIRC	cis	1	rs175426	chr14:75624134	NEK9	chr14:75548819-75593778:-	-0.15	-4.41	1.24E-5	Height	
KIRC	cis	1	rs175436	chr14:75608683	MLH3	chr14:75480467-75518235:-	-0.25	-6.33	5.55E-10	Height	
KIRC	cis	1	rs175436	chr14:75608683	NEK9	chr14:75548819-75593778:-	-0.14	-4.05	6.0E-5	Height	
KIRC	cis	1	rs175442	chr14:75603564	MLH3	chr14:75480467-75518235:-	-0.24	-6.19	1.27E-9	Height	
KIRC	cis	1	rs175442	chr14:75603564	NEK9	chr14:75548819-75593778:-	-0.15	-4.22	2.84E-5	Height	
KIRC	cis	1	rs175443	chr14:75601963	MLH3	chr14:75480467-75518235:-	-0.25	-6.33	5.34E-10	Height	
KIRC	cis	1	rs175443	chr14:75601963	NEK9	chr14:75548819-75593778:-	-0.13	-3.79	0.000166	Height	
KIRC	cis	1	rs175449	chr14:75590846	MLH3	chr14:75480467-75518235:-	-0.25	-6.26	8.35E-10	Height	
KIRC	cis	1	rs175449	chr14:75590846	NEK9	chr14:75548819-75593778:-	-0.15	-4.3	2.07E-5	Height	
KIRC	cis	1	rs175492	chr14:75545220	MLH3	chr14:75480467-75518235:-	0.23	5.94	5.46E-9	Height	
KIRC	cis	1	rs175492	chr14:75545220	NEK9	chr14:75548819-75593778:-	0.15	4.21	3.02E-5	Height	
KIRC	cis	1	rs17549954	chr17:61707032	FTSJ3	chr17:61896795-61905031:-	0.34	6.49	2.1E-10	Body mass index	
KIRC	cis	1	rs17549954	chr17:61707032	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.42	1.19E-5	Body mass index	
KIRC	cis	1	rs175512	chr14:75523382	MLH3	chr14:75480467-75518235:-	-0.23	-5.62	3.23E-8	Height	
KIRC	cis	1	rs175512	chr14:75523382	NEK9	chr14:75548819-75593778:-	-0.13	-3.74	0.000205	Height	
KIRC	cis	1	rs17557261	chr6:161088399	PLG	chr6:161123274-161174345:+	0.3	4.09	4.96E-5	Triglycerides	
KIRC	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.48	-7.87	2.16E-14	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.5	8.11	3.84E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.5	-8.4	4.67E-16	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs17594365	chr17:11088545	SHISA6	chr17:11144740-11462196:+	0.3	3.76	0.00019	Obesity-related traits	
KIRC	cis	1	rs17594964	chr5:132188712	LEAP2	chr5:132209358-132210581:+	0.37	5.67	2.44E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs17594964	chr5:132188712	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.67E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.56	-13.03	1.18E-33	Forced vital capacity	
KIRC	cis	1	rs17598927	chr6:26184640	HIST1H3E	chr6:26224427-26226589:+	-0.34	-4.06	5.8E-5	Renal underexcretion gout;Gout	
KIRC	cis	1	rs17600551	chr15:85319258	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.57	6.17E-6	Schizophrenia	
KIRC	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.21	-4.1	4.73E-5	Schizophrenia	
KIRC	cis	1	rs17601029	chr15:85347709	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.43	1.15E-5	Schizophrenia	
KIRC	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.2	-4.02	6.71E-5	Schizophrenia	
KIRC	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.88	8.32	8.61E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs1760621	chr1:183156006	LAMC2	chr1:183155174-183214262:+	0.29	6.2	1.17E-9	Hypertriglyceridemia	
KIRC	cis	1	rs1760624	chr1:183158552	LAMC2	chr1:183155174-183214262:+	0.29	6.2	1.2E-9	Hypertriglyceridemia	
KIRC	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.41	-9.6	3.7E-20	Temperament	
KIRC	cis	1	rs17608677	chr2:219936871	ATG9A	chr2:220082847-220094361:-	0.26	3.8	0.000162	Height	
KIRC	cis	1	rs17608677	chr2:219936871	FAM134A	chr2:220042939-220050190:+	0.28	4.08	5.16E-5	Height	
KIRC	cis	1	rs17608677	chr2:219936871	ZFAND2B	chr2:220071529-220074369:+	0.17	3.72	0.000224	Height	
KIRC	cis	1	rs17609940	chr6:35034800	UHRF1BP1	chr6:34759794-34853117:+	0.17	3.54	0.000431	Coronary heart disease	
KIRC	cis	1	rs17617337	chr10:121426884	TIAL1	chr10:121332978-121356541:-	-0.19	-3.94	9.22E-5	Dilated cardiomyopathy	
KIRC	cis	1	rs17628883	chr4:171009009	AADAT	chr4:170981374-171011372:-	-0.43	-4.08	5.31E-5	Thyroid hormone levels	
KIRC	cis	1	rs17628895	chr4:171021185	AADAT	chr4:170981374-171011372:-	-0.45	-4.51	8.14E-6	Thyroid hormone levels	
KIRC	cis	1	rs17628931	chr4:171030807	AADAT	chr4:170981374-171011372:-	-0.49	-4.98	8.95E-7	Thyroid hormone levels	
KIRC	cis	1	rs17630758	chr22:24136542	C22orf43	chr22:23950640-23974487:-	0.19	3.51	0.000488	IgG glycosylation	
KIRC	cis	1	rs17632	chr20:47713063	CSE1L	chr20:47662838-47713484:+	0.17	4.56	6.48E-6	Anger	
KIRC	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.28	7.27	1.38E-12	QT interval	
KIRC	cis	1	rs17645649	chr15:50900370	SPPL2A	chr15:50999739-51057910:-	0.29	7.7	7.31E-14	QT interval	
KIRC	cis	1	rs17645649	chr15:50900370	TRPM7	chr15:50852491-50978994:-	0.13	3.74	0.000205	QT interval	
KIRC	cis	1	rs17645826	chr15:50950141	SPPL2A	chr15:50999739-51057910:-	0.28	7.09	4.59E-12	QT interval	
KIRC	cis	1	rs1764625	chr1:197299000	CFHR3	chr1:196743930-196762872:+	0.25	5.21	2.8E-7	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs17646946	chr1:152062767	HRNR	chr1:152184558-152196669:-	0.26	3.94	9.21E-5	Common traits (Other)	
KIRC	cis	1	rs1764786	chr1:197300496	CFHR3	chr1:196743930-196762872:+	0.28	5.71	1.93E-8	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs17648499	chr14:54855553	CDKN3	chr14:54863673-54886932:+	-0.14	-3.53	0.000446	Response to antipsychotic treatment in schizophrenia (working memory)	
KIRC	cis	1	rs17655003	chr2:219930481	FAM134A	chr2:220042939-220050190:+	-0.29	-3.56	0.000406	Height	
KIRC	cis	1	rs17655003	chr2:219930481	USP37	chr2:219314974-219433084:-	-0.27	-4.22	2.95E-5	Height	
KIRC	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.8	-8.43	3.81E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	1.11	19.45	3.09E-63	Heschl's gyrus morphology	
KIRC	cis	1	rs17671194	chr15:40667539	IVD	chr15:40697686-40713512:+	-0.37	-5.64	2.85E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.95	-17.07	7.78E-52	Heschl's gyrus morphology	
KIRC	cis	1	rs17671250	chr15:40673124	IVD	chr15:40697686-40713512:+	0.3	4.85	1.61E-6	Heschl's gyrus morphology	
KIRC	cis	1	rs1768208	chr3:39523003	RPSA	chr3:39448204-39454030:+	0.17	4.55	6.87E-6	Corticobasal degeneration;Progressive supranuclear palsy	
KIRC	cis	1	rs17683841	chr6:55944441	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17683846	chr6:55945010	COL21A1	chr6:55921389-56258892:-	-0.49	-7.63	1.18E-13	Psychosis (atypical)	
KIRC	cis	1	rs17685143	chr6:56774788	BEND6	chr6:56819773-56892138:+	-0.29	-5.76	1.46E-8	Menarche (age at onset)	
KIRC	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	4.04E-18	Body mass index	
KIRC	cis	1	rs1768803	chr1:46546208	MUTYH	chr1:45794915-45806142:-	0.14	4.01	7.12E-5	Body mass index	
KIRC	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.47	-8.94	7.44E-18	Body mass index	
KIRC	cis	1	rs1768816	chr1:46528599	MUTYH	chr1:45794915-45806142:-	0.13	3.97	8.23E-5	Body mass index	
KIRC	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.35	6.76	3.83E-11	Cognitive performance	
KIRC	cis	1	rs17692461	chr12:82171755	PPFIA2	chr12:81652880-82153109:-	0.41	7.32	9.66E-13	Resting heart rate	
KIRC	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.61	14.74	3.96E-41	Height	
KIRC	cis	1	rs17694011	chr3:134213981	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.98E-10	Height	
KIRC	cis	1	rs17696958	chr16:77785013	NUDT7	chr16:77756411-77776153:+	0.22	3.53	0.000456	Obesity-related traits	
KIRC	cis	1	rs17698817	chr14:88822976	SPATA7	chr14:88852012-88904802:+	-0.19	-4	7.39E-5	Coronary artery calcification	
KIRC	cis	1	rs17709242	chr19:40181873	LOC400696	chr19:40170014-40177013:+	0.18	3.87	0.000126	Schizophrenia	
KIRC	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.29	-5.78	1.3E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.29	-5.95	5.12E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.28	-5.72	1.86E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs17727568	chr5:150244688	IRGM	chr5:150226085-150280295:+	0.65	7.96	1.18E-14	Crohn's disease	
KIRC	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.41	4.94	1.06E-6	Crohn's disease	
KIRC	cis	1	rs17729632	chr12:8987417	NECAP1	chr12:8234807-8250373:+	0.23	3.52	0.000462	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
KIRC	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.16	4.23	2.75E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs17737030	chr18:48775644	MBD1	chr18:47793256-47808144:-	-0.27	-4.2	3.1E-5	Immune response to anthrax vaccine	
KIRC	cis	1	rs17745344	chr17:53048319	TOM1L1	chr17:52978052-53039328:+	-0.19	-5	7.97E-7	Breast cancer	
KIRC	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.14	-4.72	3.08E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs17748942	chr12:82170478	PPFIA2	chr12:81652880-82153109:-	0.41	7.33	9.05E-13	Resting heart rate	
KIRC	cis	1	rs17749267	chr12:82178308	PPFIA2	chr12:81652880-82153109:-	-0.36	-6.51	1.83E-10	Resting heart rate	
KIRC	cis	1	rs17751067	chr6:55944196	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17751085	chr6:55945212	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17751143	chr6:55947368	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.15E-13	Psychosis (atypical)	
KIRC	cis	1	rs1775151	chr1:205745684	PM20D1	chr1:205797154-205819245:-	-0.31	-4.85	1.62E-6	Parkinson's disease	
KIRC	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.17	4.38	1.47E-5	Parkinson's disease	
KIRC	cis	1	rs17752459	chr6:56798755	BEND6	chr6:56819773-56892138:+	-0.27	-5.34	1.42E-7	Menarche (age at onset)	
KIRC	cis	1	rs17754780	chr6:126664333	CENPW	chr6:126661253-126804465:+	-0.15	-4.66	3.99E-6	Type 1 diabetes	
KIRC	cis	1	rs17756240	chr4:57355192	SRP72	chr4:57333762-57369846:+	-0.26	-3.69	0.000247	Airflow obstruction	
KIRC	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.72	15.14	6.52E-43	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.79	-17.98	3.63E-56	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1777183	chr6:126011995	HEY2	chr6:126068780-126082414:+	0.17	4.02	6.83E-5	Endometrial cancer	
KIRC	cis	1	rs1777194	chr6:126004883	HEY2	chr6:126068780-126082414:+	-0.17	-4.02	6.7E-5	Endometrial cancer	
KIRC	cis	1	rs1777195	chr6:126006861	HEY2	chr6:126068780-126082414:+	0.16	3.81	0.000158	Endometrial cancer	
KIRC	cis	1	rs17772064	chr14:88822871	SPATA7	chr14:88852012-88904802:+	-0.19	-4.27	2.36E-5	Coronary artery calcification	
KIRC	cis	1	rs17772222	chr14:88826482	SPATA7	chr14:88852012-88904802:+	0.17	3.5	0.000516	Coronary artery calcification	
KIRC	cis	1	rs1777222	chr6:126021030	HEY2	chr6:126068780-126082414:+	0.19	4.57	6.24E-6	Endometrial cancer	
KIRC	cis	1	rs1777225	chr6:126018270	HEY2	chr6:126068780-126082414:+	0.17	4.19	3.27E-5	Endometrial cancer	
KIRC	cis	1	rs1777226	chr6:126017691	HEY2	chr6:126068780-126082414:+	0.17	4.19	3.27E-5	Endometrial cancer	
KIRC	cis	1	rs17772288	chr14:88827366	SPATA7	chr14:88852012-88904802:+	-0.19	-4.09	4.99E-5	Coronary artery calcification	
KIRC	cis	1	rs17779494	chr15:43579223	STRC	chr15:43891762-43924561:-	-0.22	-5.63	3.02E-8	Lung cancer	
KIRC	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.26	4.62	4.78E-6	Depression	
KIRC	cis	1	rs1778508	chr6:28229881	ZNF323	chr6:28292517-28324048:-	-0.29	-4.15	3.97E-5	Depression	
KIRC	cis	1	rs1778508	chr6:28229881	ZSCAN23	chr6:28393287-28411279:-	-0.25	-3.75	0.000195	Depression	
KIRC	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.28	4.78	2.35E-6	Depression	
KIRC	cis	1	rs1778511	chr6:28229411	ZNF323	chr6:28292517-28324048:-	-0.29	-3.99	7.67E-5	Depression	
KIRC	cis	1	rs1778511	chr6:28229411	ZSCAN23	chr6:28393287-28411279:-	-0.26	-3.75	0.000195	Depression	
KIRC	cis	1	rs1779410	chr1:205248759	DSTYK	chr1:205111632-205180727:-	0.15	3.85	0.000136	Mean platelet volume	
KIRC	cis	1	rs17800886	chr5:150309539	IRGM	chr5:150226085-150280295:+	0.5	6.42	3.22E-10	Crohn's disease	
KIRC	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.4	5.17	3.45E-7	Crohn's disease	
KIRC	cis	1	rs17800987	chr5:150323428	IRGM	chr5:150226085-150280295:+	0.5	6.51	1.87E-10	Crohn's disease	
KIRC	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.38	4.94	1.05E-6	Crohn's disease	
KIRC	cis	1	rs17809330	chr15:65889250	DPP8	chr15:65737999-65810035:-	0.13	5.04	6.56E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs17818028	chr17:53062755	TOM1L1	chr17:52978052-53039328:+	0.19	4.96	9.82E-7	Breast cancer	
KIRC	cis	1	rs17818151	chr6:55943812	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs17818399	chr2:46826026	ATP6V1E2	chr2:46738988-46769696:-	-0.2	-3.8	0.000165	Height	
KIRC	cis	1	rs17818399	chr2:46826026	CRIPT	chr2:46844325-46852880:+	0.29	6.77	3.64E-11	Height	
KIRC	cis	1	rs17818399	chr2:46826026	PIGF	chr2:46808414-46844251:-	0.35	7.49	3.08E-13	Height	
KIRC	cis	1	rs17818561	chr6:56007398	COL21A1	chr6:55921389-56258892:-	-0.48	-7.4	5.93E-13	Psychosis (atypical)	
KIRC	cis	1	rs17818687	chr6:56010117	COL21A1	chr6:55921389-56258892:-	-0.48	-7.4	5.93E-13	Psychosis (atypical)	
KIRC	cis	1	rs17826057	chr12:66633164	TMBIM4	chr12:66530718-66563807:-	0.39	4.29	2.13E-5	Smooth-surface caries	
KIRC	cis	1	rs17826448	chr14:65852017	LOC645431	chr14:65877313-65879335:-	0.39	5.42	9.48E-8	Ischemic stroke	
KIRC	cis	1	rs17826466	chr14:65852170	LOC645431	chr14:65877313-65879335:-	-0.44	-5.92	6.09E-9	Ischemic stroke	
KIRC	cis	1	rs17826580	chr14:65915262	LOC645431	chr14:65877313-65879335:-	-0.49	-6.59	1.13E-10	Ischemic stroke	
KIRC	cis	1	rs17826724	chr14:66068320	LOC645431	chr14:65877313-65879335:-	-0.47	-6.26	8.23E-10	Ischemic stroke	
KIRC	cis	1	rs17826736	chr14:66082202	LOC645431	chr14:65877313-65879335:-	-0.46	-6.29	6.86E-10	Ischemic stroke	
KIRC	cis	1	rs17826790	chr14:66103427	LOC645431	chr14:65877313-65879335:-	-0.48	-6.39	3.82E-10	Ischemic stroke	
KIRC	cis	1	rs17826796	chr14:66104187	LOC645431	chr14:65877313-65879335:-	-0.48	-6.42	3.18E-10	Ischemic stroke	
KIRC	cis	1	rs17826820	chr14:66113837	LOC645431	chr14:65877313-65879335:-	-0.49	-6.43	3.04E-10	Ischemic stroke	
KIRC	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.19	3.89	0.000115	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17831161	chr2:160909360	PLA2R1	chr2:160798012-160919121:-	0.18	3.79	0.000169	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.19	3.89	0.000115	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17831191	chr2:160911332	PLA2R1	chr2:160798012-160919121:-	0.18	3.79	0.000169	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.2	4.1	4.88E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17831251	chr2:160914156	PLA2R1	chr2:160798012-160919121:-	0.19	4.01	7.04E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.78	-16.96	2.37E-51	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1783521	chr11:64106291	CCDC88B	chr11:64107695-64125005:+	-0.09	-3.6	0.000354	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
KIRC	cis	1	rs17836662	chr22:50672154	SELO	chr22:50639408-50656044:+	-0.13	-4.32	1.85E-5	Obesity-related traits	
KIRC	cis	1	rs17839567	chr16:31057945	MYST1	chr16:31128985-31142713:+	0.15	4.05	5.85E-5	Response to metformin (IC50)	
KIRC	cis	1	rs1783961	chr11:71576095	C11orf51	chr11:71817424-71823822:-	0.21	3.71	0.000231	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1783961	chr11:71576095	C11orf59	chr11:71808339-71814322:-	0.25	4.36	1.55E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs17848459	chr22:51012311	CPT1B	chr22:51007291-51017096:-	-0.27	-5.32	1.55E-7	Narcolepsy	
KIRC	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.29	-3.51	0.00048	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs1788100	chr18:67540723	CD226	chr18:67530195-67624232:-	-0.19	-5.88	7.7E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1788103	chr18:67538824	CD226	chr18:67530195-67624232:-	-0.19	-5.85	8.64E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1788232	chr18:67527609	CD226	chr18:67530195-67624232:-	0.21	6.45	2.66E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs17884887	chr10:81703433	LOC219347	chr10:81805991-81838949:-	0.53	4.55	6.63E-6	Rheumatoid arthritis	
KIRC	cis	1	rs1790947	chr18:67527760	CD226	chr18:67530195-67624232:-	0.21	6.49	2.08E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1790961	chr18:67525286	CD226	chr18:67530195-67624232:-	0.21	6.31	6.3E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1794693	chr6:167405670	RNASET2	chr6:167343008-167412795:-	-0.15	-3.71	0.000226	Crohn's disease	
KIRC	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.34	-5.82	1.05E-8	Polycystic ovary syndrome	
KIRC	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.27	5.35	1.35E-7	Diabetic kidney disease	
KIRC	cis	1	rs1796220	chr7:66062100	CRCP	chr7:65579805-65619551:+	-0.34	-4.57	6.15E-6	Diabetic kidney disease	
KIRC	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.27	5.38	1.14E-7	Diabetic kidney disease	
KIRC	cis	1	rs1796228	chr7:66033084	CRCP	chr7:65579805-65619551:+	-0.33	-4.53	7.49E-6	Diabetic kidney disease	
KIRC	cis	1	rs1799922	chr7:128415195	OPN1SW	chr7:128412545-128415844:-	0.22	3.71	0.000227	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.28	5.54	4.97E-8	Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.13	-4.61	5.17E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs1800795	chr7:22766645	MGC87042	chr7:22459066-22539798:-	-0.23	-4.27	2.37E-5	Cerebrospinal fluid clusterin levels in APOEe4- carriers	
KIRC	cis	1	rs1802236	chr12:56679751	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs1802295	chr10:70931474	ATOH7	chr10:69990386-69991855:-	0.18	3.68	0.000254	Type 2 diabetes	
KIRC	cis	1	rs1802295	chr10:70931474	HKDC1	chr10:70980059-71027314:+	0.2	3.79	0.000169	Type 2 diabetes	
KIRC	cis	1	rs1805074	chr5:78324352	ARSB	chr5:78073039-78282357:-	-0.2	-4.27	2.37E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs1805074	chr5:78324352	BHMT	chr5:78407604-78428112:+	-0.26	-5.5	6.2E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs180515	chr17:58024275	DHX40P1	chr17:58053385-58096336:-	0.23	4.59	5.56E-6	Multiple sclerosis	
KIRC	cis	1	rs1807019	chr18:48378106	MRO	chr18:48321491-48351754:-	-0.31	-5.62	3.1E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs1808382	chr19:39151034	CAPN12	chr19:39220832-39235114:-	-0.13	-4.09	5.02E-5	Heart rate	
KIRC	cis	1	rs1808579	chr18:21104888	NPC1	chr18:21108363-21166581:-	0.19	3.83	0.000145	Body mass index	
KIRC	cis	1	rs1810049	chr15:84576052	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1813217	chr11:59872498	MS4A2	chr11:59856137-59866014:+	0.17	3.79	0.00017	Alzheimer's disease (late onset)	
KIRC	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.6	14.15	1.72E-38	Height	
KIRC	cis	1	rs1814336	chr3:134200823	CEP63	chr3:134204575-134293852:+	0.32	6.02	3.3E-9	Height	
KIRC	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.61	14.58	2.16E-40	Height	
KIRC	cis	1	rs1814337	chr3:134200682	CEP63	chr3:134204575-134293852:+	0.33	6.42	3.1E-10	Height	
KIRC	cis	1	rs1815787	chr11:116921397	PCSK7	chr11:117075789-117102811:-	-0.26	-5.2	2.94E-7	Subjective well-being	
KIRC	cis	1	rs1816256	chr5:150272853	IRGM	chr5:150226085-150280295:+	0.55	7.31	1.04E-12	Crohn's disease	
KIRC	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.32	4.19	3.33E-5	Crohn's disease	
KIRC	cis	1	rs1817684	chr8:89464778	MMP16	chr8:89049462-89339717:-	0.31	4	7.29E-5	Electrodermal activity	
KIRC	cis	1	rs1818950	chr15:84722521	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.38	1.43E-5	Schizophrenia	
KIRC	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.25	-4.81	2.03E-6	Schizophrenia	
KIRC	cis	1	rs1819333	chr6:167373547	RNASET2	chr6:167343008-167412795:-	-0.14	-3.53	0.000461	Crohn's disease	
KIRC	cis	1	rs1820682	chr5:150262142	IRGM	chr5:150226085-150280295:+	0.51	6.87	1.89E-11	Crohn's disease	
KIRC	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.31	4.21	3.05E-5	Crohn's disease	
KIRC	cis	1	rs1823238	chr3:185341970	TMEM41A	chr3:185207389-185216845:-	0.18	3.77	0.000181	Systolic blood pressure	
KIRC	cis	1	rs1823874	chr15:100357435	C15orf51	chr15:100330361-100347132:-	-0.38	-7.73	6.04E-14	IgG glycosylation	
KIRC	cis	1	rs1823913	chr2:192118047	MYO1B	chr2:192110107-192290115:+	-0.11	-3.79	0.000167	Obesity-related traits	
KIRC	cis	1	rs1823913	chr2:192118047	STAT4	chr2:191894306-192038902:-	-0.17	-4.48	9.19E-6	Obesity-related traits	
KIRC	cis	1	rs1830074	chr7:6718674	PMS2CL	chr7:6749757-6793492:+	-0.24	-4.89	1.34E-6	Body mass index	
KIRC	cis	1	rs1832938	chr6:125988964	HEY2	chr6:126068780-126082414:+	-0.16	-3.94	9.12E-5	Endometrial cancer	
KIRC	cis	1	rs1832979	chr6:125997436	HEY2	chr6:126068780-126082414:+	-0.16	-3.94	9.29E-5	Endometrial cancer	
KIRC	cis	1	rs1832980	chr6:125997444	HEY2	chr6:126068780-126082414:+	-0.18	-4.27	2.29E-5	Endometrial cancer	
KIRC	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.78	15.92	1.73E-46	Type 2 diabetes	
KIRC	cis	1	rs1839622	chr12:7334534	PEX5	chr12:7341759-7371167:+	0.57	12.88	5.17E-33	IgG glycosylation	
KIRC	cis	1	rs1839972	chr15:90891354	IQGAP1	chr15:90931473-91045475:+	0.13	3.69	0.000253	Rheumatoid arthritis	
KIRC	cis	1	rs1839972	chr15:90891354	TTLL13	chr15:90792764-90815443:+	0.26	4.56	6.33E-6	Rheumatoid arthritis	
KIRC	cis	1	rs1840377	chr2:192122718	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.16	4.27	2.33E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs1844056	chr8:89460105	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs1847575	chr8:89462925	MMP16	chr8:89049462-89339717:-	0.31	4.03	6.51E-5	Electrodermal activity	
KIRC	cis	1	rs1848093	chr15:84755527	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.44	1.09E-5	Schizophrenia	
KIRC	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.26	-4.96	9.55E-7	Schizophrenia	
KIRC	cis	1	rs1849004	chr19:22142455	ZNF257	chr19:22235266-22273901:+	0.33	4.49	8.93E-6	Body mass index (change over time)	
KIRC	cis	1	rs1852264	chr15:84589940	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1853665	chr6:150298842	ULBP1	chr6:150285143-150294844:+	-0.34	-5.35	1.36E-7	Radiation response	
KIRC	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.5	-8.39	4.91E-16	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs185538822	chr4:106803682	INTS12	chr4:106603787-106629881:-	-0.7	-7.26	1.5E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs1856859	chr6:151860110	C6orf97	chr6:151815175-151942327:+	-0.18	-3.54	0.000441	Bone mineral density (spine)	
KIRC	cis	1	rs1857354	chr1:75902948	SLC44A5	chr1:75667816-76143610:-	-0.36	-3.56	0.000411	Whole-brain volume (Alzheimer's disease interaction)	
KIRC	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.49	-10.47	2.46E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs1858482	chr1:152306921	HRNR	chr1:152184558-152196669:-	0.27	4.55	6.62E-6	Atopic dermatitis	
KIRC	cis	1	rs185968827	chr6:56708510	BEND6	chr6:56819773-56892138:+	-0.25	-4.47	9.51E-6	Alzheimer disease and age of onset	
KIRC	cis	1	rs1860596	chr4:17660082	LAP3	chr4:17578927-17609590:+	-0.2	-6.3	6.51E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1860596	chr4:17660082	MED28	chr4:17616273-17629791:+	0.22	5.07	5.48E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1860597	chr4:17657650	LAP3	chr4:17578927-17609590:+	-0.2	-6.29	6.96E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1860597	chr4:17657650	MED28	chr4:17616273-17629791:+	0.18	3.97	8.2E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1861444	chr2:37464511	CEBPZ	chr2:37428778-37458740:-	0.2	5.73	1.74E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs1861444	chr2:37464511	PRKD3	chr2:37477648-37544222:-	0.13	3.59	0.000361	Chronic lymphocytic leukemia	
KIRC	cis	1	rs1862228	chr5:78314051	ARSB	chr5:78073039-78282357:-	-0.2	-4.23	2.73E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs1862228	chr5:78314051	BHMT	chr5:78407604-78428112:+	-0.24	-5.07	5.7E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.78	15.92	1.73E-46	Type 2 diabetes	
KIRC	cis	1	rs1862630	chr5:42754243	CCDC152	chr5:42756920-42802539:+	0.23	5.3	1.72E-7	Height	
KIRC	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.27	5.42	9.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs186378	chr7:65582058	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.59	14.08	3.57E-38	Height	
KIRC	cis	1	rs1863913	chr3:134200205	CEP63	chr3:134204575-134293852:+	0.31	6.05	2.83E-9	Height	
KIRC	cis	1	rs1863998	chr5:150271753	IRGM	chr5:150226085-150280295:+	0.49	6.67	6.83E-11	Crohn's disease	
KIRC	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.33	4.55	6.86E-6	Crohn's disease	
KIRC	cis	1	rs1864367	chr3:53111704	ITIH3	chr3:52828784-52843025:+	0.15	3.78	0.000177	Height	
KIRC	cis	1	rs1864367	chr3:53111704	ITIH4	chr3:52847007-52866554:-	0.15	3.76	0.000191	Height	
KIRC	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.44	-11.68	4.91E-28	Height	
KIRC	cis	1	rs1865761	chr18:67539392	CD226	chr18:67530195-67624232:-	0.2	6.14	1.7E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs1866295	chr12:104186946	NT5DC3	chr12:104164231-104234975:-	-0.22	-3.84	0.00014	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs1867146	chr15:75354971	PPCDC	chr15:75315927-75343066:+	0.19	4.27	2.32E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.27	4.67	3.83E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs1869365	chr17:40293865	DHX58	chr17:40253422-40264751:-	-0.36	-7.02	7.2E-12	Fibrinogen levels	
KIRC	cis	1	rs1869596	chr1:110624104	ALX3	chr1:110602998-110613322:-	-0.21	-4.54	6.9E-6	Blood metabolite levels	
KIRC	cis	1	rs1870137	chr10:82269848	TSPAN14	chr10:82214038-82282390:+	0.21	3.8	0.000165	Post bronchodilator FEV1	
KIRC	cis	1	rs1870138	chr10:82269611	TSPAN14	chr10:82214038-82282390:+	0.21	3.84	0.000138	Post bronchodilator FEV1	
KIRC	cis	1	rs1872329	chr2:54471823	ACYP2	chr2:54342410-54532433:+	-0.21	-3.86	0.000128	Telomere length	
KIRC	cis	1	rs1872992	chr12:26457190	BHLHE41	chr12:26272961-26278003:-	0.39	7.37	6.86E-13	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1872992	chr12:26457190	RASSF8	chr12:26111969-26232824:+	0.21	4.19	3.25E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1872992	chr12:26457190	SSPN	chr12:26348269-26405853:+	0.21	4.26	2.41E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs1873494	chr7:65649899	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs1873494	chr7:65649899	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs187455071	chr4:106805884	INTS12	chr4:106603787-106629881:-	-0.69	-7.24	1.73E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.61	14.3	3.72E-39	Height	
KIRC	cis	1	rs1874883	chr3:134205071	CEP63	chr3:134204575-134293852:+	0.31	5.97	4.45E-9	Height	
KIRC	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.31	6.56	1.31E-10	Multiple sclerosis	
KIRC	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.51	-13.57	6.07E-36	Multiple sclerosis	
KIRC	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.52	1.76E-10	Multiple sclerosis	
KIRC	cis	1	rs1875903	chr8:89417410	MMP16	chr8:89049462-89339717:-	0.32	4.27	2.31E-5	Electrodermal activity	
KIRC	cis	1	rs1876673	chr5:115450773	COMMD10	chr5:115420727-115628978:+	0.38	3.83	0.000147	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1876674	chr5:115450969	COMMD10	chr5:115420727-115628978:+	0.32	3.72	0.000223	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs1877316	chr17:61766880	FTSJ3	chr17:61896795-61905031:-	0.33	6.54	1.5E-10	Body mass index	
KIRC	cis	1	rs1877316	chr17:61766880	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.55	6.84E-6	Body mass index	
KIRC	cis	1	rs1879344	chr15:56488827	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1879345	chr15:56488934	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1879347	chr15:56489159	TEX9	chr15:56657644-56738071:+	0.28	5.08	5.35E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1879349	chr15:56485061	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.04E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs1880376	chr3:134270347	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.02	2.17E-42	Height	
KIRC	cis	1	rs1880377	chr3:134270468	CEP63	chr3:134204575-134293852:+	-0.34	-6.53	1.64E-10	Height	
KIRC	cis	1	rs1880730	chr15:84584184	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	9.02E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs1881123	chr7:1084706	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.75	1.59E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs1881245	chr2:73649928	TPRKB	chr2:73956957-73964517:-	-0.2	-5.15	3.75E-7	Metabolite levels	
KIRC	cis	1	rs1882099	chr4:1352685	CRIPAK	chr4:1385340-1389782:+	0.26	6.05	2.77E-9	Systolic blood pressure	
KIRC	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.54	4.98E-8	Gout	
KIRC	cis	1	rs1882655	chr7:66147057	CRCP	chr7:65579805-65619551:+	0.31	4.27	2.34E-5	Gout	
KIRC	cis	1	rs1884418	chr20:55070076	C20orf43	chr20:55043647-55093942:+	0.2	4.78	2.35E-6	Refractive astigmatism	
KIRC	cis	1	rs1884946	chr6:26545308	BTN2A3	chr6:26422317-26431927:+	0.12	3.54	0.000437	Educational attainment	
KIRC	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.78	-16.83	1.04E-50	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs1886242	chr6:35117656	TCP11	chr6:35085849-35109187:-	0.24	4.07	5.45E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs1886242	chr6:35117656	UHRF1BP1	chr6:34759794-34853117:+	0.18	4.81	2.0E-6	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs1886682	chr1:92977275	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs1886683	chr1:92976023	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs1888997	chr20:25298988	ENTPD6	chr20:25176339-25207360:+	0.24	6.44	2.76E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.29	5.52	5.34E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1888998	chr20:25291826	ENTPD6	chr20:25176339-25207360:+	0.24	6.55	1.46E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.32	6	3.83E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1888999	chr20:25291848	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.52	1.7E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1888999	chr20:25291848	FAM182A	chr20:26035250-26067552:+	-0.33	-6.12	1.9E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1890967	chr1:76459544	MSH4	chr1:76262630-76378923:+	-0.29	-4.13	4.18E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs1891498	chr1:147226791	ACP6	chr1:147119168-147142634:-	0.25	4.43	1.18E-5	Cognitive performance	
KIRC	cis	1	rs1891969	chr1:114185855	PHTF1	chr1:114239824-114302098:-	0.29	6.25	9.01E-10	Bacteremia	
KIRC	cis	1	rs1892846	chr22:22186479	MAPK1	chr22:22113949-22221970:-	0.2	5.71	1.92E-8	Multiple sclerosis	
KIRC	cis	1	rs1892848	chr22:22186562	MAPK1	chr22:22113949-22221970:-	0.2	5.71	1.92E-8	Multiple sclerosis	
KIRC	cis	1	rs1893447	chr11:77973182	NARS2	chr11:78147017-78285909:-	-0.17	-3.92	0.000102	Testicular germ cell tumor	
KIRC	cis	1	rs1893448	chr11:77969180	NARS2	chr11:78147017-78285909:-	-0.17	-3.84	0.00014	Testicular germ cell tumor	
KIRC	cis	1	rs1895457	chr5:42765332	CCDC152	chr5:42756920-42802539:+	0.23	5.09	5.06E-7	Height	
KIRC	cis	1	rs1896473	chr2:137533702	THSD7B	chr2:137523115-138435287:+	-0.19	-3.99	7.65E-5	Pancreatic cancer	
KIRC	cis	1	rs1896707	chr5:150245129	IRGM	chr5:150226085-150280295:+	0.52	7.29	1.21E-12	Crohn's disease	
KIRC	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.19E-7	Crohn's disease	
KIRC	cis	1	rs1896708	chr5:150245076	IRGM	chr5:150226085-150280295:+	0.56	7.4	5.81E-13	Crohn's disease	
KIRC	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.35	4.57	6.22E-6	Crohn's disease	
KIRC	cis	1	rs1896709	chr5:150245032	IRGM	chr5:150226085-150280295:+	0.53	7.31	1.08E-12	Crohn's disease	
KIRC	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.11E-7	Crohn's disease	
KIRC	cis	1	rs1897136	chr4:39132862	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs1897137	chr4:39133007	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs1900014	chr10:69943947	MYPN	chr10:69865876-69971771:+	-0.23	-4.22	2.91E-5	Height	
KIRC	cis	1	rs1900120	chr14:76626516	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs1900122	chr14:76629517	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs1900125	chr14:76657470	ESRRB	chr14:76837690-76968178:+	-0.32	-4.6	5.25E-6	Blood pressure	
KIRC	cis	1	rs1902660	chr10:82263683	TSPAN14	chr10:82214038-82282390:+	0.21	3.89	0.000114	Post bronchodilator FEV1	
KIRC	cis	1	rs1903330	chr6:56776985	BEND6	chr6:56819773-56892138:+	0.27	5.48	6.88E-8	Menarche (age at onset)	
KIRC	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.83	16.84	9.37E-51	Type 2 diabetes	
KIRC	cis	1	rs1911155	chr15:84787635	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.42	1.23E-5	Schizophrenia	
KIRC	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.25	-4.87	1.49E-6	Schizophrenia	
KIRC	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.21E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.46	-10.13	4.73E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.85	1.29E-41	Height	
KIRC	cis	1	rs1917130	chr3:134313773	CEP63	chr3:134204575-134293852:+	-0.33	-6.35	4.83E-10	Height	
KIRC	cis	1	rs1919125	chr2:27801403	NRBP1	chr2:27650657-27665122:+	0.14	3.58	0.000381	Oral cavity cancer	
KIRC	cis	1	rs1919126	chr2:27801418	NRBP1	chr2:27650657-27665122:+	0.14	3.58	0.000381	Oral cavity cancer	
KIRC	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs1919948	chr7:143762843	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs1919948	chr7:143762843	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.38	-7.42	4.96E-13	Obesity-related traits	
KIRC	cis	1	rs1919949	chr7:143767723	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.21	2.81E-7	Obesity-related traits	
KIRC	cis	1	rs1919949	chr7:143767723	OR2A9P	chr7:143991573-143997832:+;chr7	-0.44	-8.1	4.27E-15	Obesity-related traits	
KIRC	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.49	3.19E-13	Obesity-related traits	
KIRC	cis	1	rs1919950	chr7:143767898	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.26	2.16E-7	Obesity-related traits	
KIRC	cis	1	rs1919950	chr7:143767898	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.2	1.97E-15	Obesity-related traits	
KIRC	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.37	-7.13	3.46E-12	Obesity-related traits	
KIRC	cis	1	rs1919951	chr7:143768891	OR2A1	chr7:144015236-144016148:+;chr7	-0.27	-4.97	9.1E-7	Obesity-related traits	
KIRC	cis	1	rs1919951	chr7:143768891	OR2A9P	chr7:143991573-143997832:+;chr7	-0.42	-7.72	6.33E-14	Obesity-related traits	
KIRC	cis	1	rs1920638	chr3:160345169	TRIM59	chr3:160153292-160167626:-	0.23	3.9	0.000107	Primary biliary cirrhosis	
KIRC	cis	1	rs1921348	chr12:81458380	ACSS3	chr12:81471809-81649582:+	0.17	3.9	0.00011	Neuroticism	
KIRC	cis	1	rs1921348	chr12:81458380	LIN7A	chr12:81191171-81331694:-	0.19	5	7.88E-7	Neuroticism	
KIRC	cis	1	rs1921350	chr12:81458279	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs1921350	chr12:81458279	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs1921352	chr12:81456746	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs1921352	chr12:81456746	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.78	23.75	3.97E-84	Pulse pressure	
KIRC	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.75	21.89	4.35E-75	Pulse pressure	
KIRC	cis	1	rs1925169	chr6:55996576	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs1925173	chr6:55999939	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs1928020	chr13:36695968	SOHLH2	chr13:36742347-36871992:-	0.25	3.6	0.000352	Optic cup area	
KIRC	cis	1	rs1930961	chr22:25875265	ADRBK2	chr22:25960861-26125256:+	-0.23	-4.61	5.04E-6	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	0.68	9.83	5.87E-21	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs1935772	chr6:125994708	HEY2	chr6:126068780-126082414:+	-0.17	-4.09	4.96E-5	Endometrial cancer	
KIRC	cis	1	rs1935773	chr6:125996475	HEY2	chr6:126068780-126082414:+	-0.16	-3.87	0.000122	Endometrial cancer	
KIRC	cis	1	rs1935774	chr6:125996661	HEY2	chr6:126068780-126082414:+	0.15	3.6	0.00035	Endometrial cancer	
KIRC	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.27	-6.64	8.33E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.23	4.33	1.83E-5	Depression	
KIRC	cis	1	rs1936365	chr6:28268452	ZNF323	chr6:28292517-28324048:-	-0.32	-4.77	2.4E-6	Depression	
KIRC	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.3	-4.72	3.08E-6	Depression	
KIRC	cis	1	rs1937332	chr10:90826779	CH25H	chr10:90965696-90967071:-	0.2	3.72	0.000225	Obesity-related traits	
KIRC	cis	1	rs1937334	chr10:90826252	CH25H	chr10:90965696-90967071:-	-0.2	-3.88	0.00012	Obesity-related traits	
KIRC	cis	1	rs1938598	chr11:58413910	ZFP91	chr11:58346587-58388513:+	-0.13	-3.86	0.000129	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs1939245	chr11:71742532	C11orf59	chr11:71808339-71814322:-	-0.22	-3.87	0.000121	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1939247	chr11:71740521	C11orf59	chr11:71808339-71814322:-	-0.22	-3.85	0.000133	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs1939748	chr11:62911079	SLC22A24	chr11:62847414-62911693:-	0.33	7.6	1.46E-13	Conotruncal heart defects	
KIRC	cis	1	rs1939749	chr11:62910849	SLC22A24	chr11:62847414-62911693:-	0.33	7.63	1.18E-13	Conotruncal heart defects	
KIRC	cis	1	rs1947859	chr4:171082172	AADAT	chr4:170981374-171011372:-	-0.37	-3.81	0.000157	Thyroid hormone levels	
KIRC	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.21	-4.84	1.75E-6	Brain structure	
KIRC	cis	1	rs1950400	chr14:27105035	NOVA1	chr14:26915090-27066960:-	-0.26	-4.67	3.9E-6	Educational attainment (years of education)	
KIRC	cis	1	rs1950406	chr14:27079598	NOVA1	chr14:26915090-27066960:-	-0.25	-4.47	9.78E-6	Educational attainment (years of education)	
KIRC	cis	1	rs1950408	chr14:27075414	NOVA1	chr14:26915090-27066960:-	-0.27	-4.66	4.12E-6	Educational attainment (years of education)	
KIRC	cis	1	rs1951931	chr6:150296898	ULBP1	chr6:150285143-150294844:+	-0.36	-5.68	2.27E-8	Radiation response	
KIRC	cis	1	rs1952012	chr14:50098896	RPL36AL	chr14:50085407-50087349:-	0.31	7.05	6.1E-12	Carotid intima media thickness	
KIRC	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.51	-10.03	1.02E-21	Rheumatoid arthritis	
KIRC	cis	1	rs1953126	chr9:123640500	PSMD5	chr9:123578334-123605206:-	-0.36	-6.71	5.27E-11	Rheumatoid arthritis	
KIRC	cis	1	rs1953417	chr14:65878909	LOC645431	chr14:65877313-65879335:-	-0.49	-6.56	1.31E-10	Ischemic stroke	
KIRC	cis	1	rs1953600	chr10:81911725	PLAC9	chr10:81892258-81904784:+	-0.11	-4.19	3.31E-5	Sarcoidosis	
KIRC	cis	1	rs1954361	chr6:126001423	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.8E-5	Endometrial cancer	
KIRC	cis	1	rs1955599	chr14:88825132	SPATA7	chr14:88852012-88904802:+	-0.19	-4.1	4.82E-5	Coronary artery calcification	
KIRC	cis	1	rs1955600	chr14:88825384	SPATA7	chr14:88852012-88904802:+	-0.19	-4.1	4.82E-5	Coronary artery calcification	
KIRC	cis	1	rs1955822	chr14:27083239	NOVA1	chr14:26915090-27066960:-	-0.27	-4.67	3.92E-6	Educational attainment (years of education)	
KIRC	cis	1	rs1957977	chr14:50090603	RPL36AL	chr14:50085407-50087349:-	0.36	8.18	2.29E-15	Carotid intima media thickness	
KIRC	cis	1	rs196128	chr1:2078444	SLC35E2	chr1:1590990-1677431:-	0.16	3.56	0.000408	Height	
KIRC	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.49	-10.54	1.35E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.28	5.52	5.55E-8	Diabetic kidney disease	
KIRC	cis	1	rs1964692	chr7:65454183	CRCP	chr7:65579805-65619551:+	-0.29	-3.94	9.47E-5	Diabetic kidney disease	
KIRC	cis	1	rs1966423	chr2:202216661	ALS2CR12	chr2:202153148-202222101:-	-0.26	-5.17	3.43E-7	Basal cell carcinoma	
KIRC	cis	1	rs1966839	chr7:50627101	FIGNL1	chr7:50511834-50518088:-	-0.25	-5.21	2.71E-7	Malaria	
KIRC	cis	1	rs1967017	chr1:145723645	NUDT17	chr1:145586494-145590461:-	0.17	3.73	0.000212	Urate levels;Urate levels in overweight individuals	
KIRC	cis	1	rs197154	chr19:4983748	ANKRD24	chr19:4183351-4224811:+	0.25	3.82	0.000152	Periodontitis (CDC/AAP)	
KIRC	cis	1	rs1971898	chr15:90890836	TTLL13	chr15:90792764-90815443:+	0.25	4.34	1.72E-5	Rheumatoid arthritis	
KIRC	cis	1	rs1972669	chr2:27767107	NRBP1	chr2:27650657-27665122:+	0.14	3.72	0.000224	Oral cavity cancer	
KIRC	cis	1	rs1974624	chr4:17650281	LAP3	chr4:17578927-17609590:+	-0.2	-6.37	4.35E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1974624	chr4:17650281	MED28	chr4:17616273-17629791:+	0.22	4.98	8.66E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1975174	chr19:22515251	ZNF98	chr19:22573899-22605148:-	0.31	6.45	2.56E-10	Telomere length	
KIRC	cis	1	rs1979214	chr2:70137498	ANXA4	chr2:69969127-70053594:+	-0.21	-5.18	3.3E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.63	2.96E-8	Diabetic kidney disease	
KIRC	cis	1	rs1979823	chr7:65704613	CRCP	chr7:65579805-65619551:+	0.31	4.25	2.51E-5	Diabetic kidney disease	
KIRC	cis	1	rs1979823	chr7:65704613	LOC493754	chr7:65993446-66057363:-	-0.23	-3.6	0.000349	Diabetic kidney disease	
KIRC	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.95	-15.91	1.86E-46	Schizophrenia	
KIRC	cis	1	rs1981898	chr14:76175565	TTLL5	chr14:76127621-76421421:+	0.2	4.96	9.44E-7	Large artery stroke	
KIRC	cis	1	rs1982009	chr4:39124873	WDR19	chr4:39184024-39287429:+	0.18	4.67	3.95E-6	Uric acid levels	
KIRC	cis	1	rs1982861	chr3:49577665	CCDC36	chr3:49235861-49295537:+	0.25	4.78	2.33E-6	Menarche (age at onset)	
KIRC	cis	1	rs1982861	chr3:49577665	NCKIPSD	chr3:48711280-48723334:-	0.22	4.31	1.97E-5	Menarche (age at onset)	
KIRC	cis	1	rs1982861	chr3:49577665	P4HTM	chr3:49027341-49044579:+	0.17	3.89	0.000116	Menarche (age at onset)	
KIRC	cis	1	rs1982861	chr3:49577665	WDR6	chr3:49044637-49053386:+	-0.22	-5.47	7.01E-8	Menarche (age at onset)	
KIRC	cis	1	rs1985359	chr19:40226728	LOC400696	chr19:40170014-40177013:+	0.21	4.43	1.18E-5	Schizophrenia	
KIRC	cis	1	rs1986074	chr15:50857452	SPPL2A	chr15:50999739-51057910:-	0.27	7.19	2.31E-12	QT interval	
KIRC	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.42	7.37	6.95E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs1990674	chr17:53061075	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.08	5.31E-5	Breast cancer	
KIRC	cis	1	rs1991411	chr2:137534796	THSD7B	chr2:137523115-138435287:+	-0.19	-3.99	7.65E-5	Pancreatic cancer	
KIRC	cis	1	rs199347	chr7:23293746	GPNMB	chr7:23286316-23314728:+	-0.19	-4.17	3.64E-5	Parkinson's disease	
KIRC	cis	1	rs199348	chr7:23293098	GPNMB	chr7:23286316-23314728:+	-0.16	-3.51	0.000494	Parkinson's disease	
KIRC	cis	1	rs199351	chr7:23300049	GPNMB	chr7:23286316-23314728:+	-0.19	-4.14	4.0E-5	Parkinson's disease	
KIRC	cis	1	rs199357	chr7:23288309	GPNMB	chr7:23286316-23314728:+	0.17	3.7	0.000238	Parkinson's disease	
KIRC	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.71	9.26	5.91E-19	Diastolic blood pressure	
KIRC	cis	1	rs1995156	chr11:5566112	TRIM6	chr11:5617347-5634188:+	-0.2	-4.88	1.44E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.46	-10.13	4.73E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs1997243	chr7:1083777	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.87	8.13E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs1998035	chr14:66126230	LOC645431	chr14:65877313-65879335:-	-0.49	-6.42	3.14E-10	Ischemic stroke	
KIRC	cis	1	rs1998615	chr6:87808289	C6orf162	chr6:88032306-88052043:+	0.2	4.18	3.5E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs1998616	chr6:87808430	C6orf162	chr6:88032306-88052043:+	0.19	4.1	4.92E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.46	-10.09	6.14E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs2000614	chr11:116915742	PCSK7	chr11:117075789-117102811:-	-0.26	-5.19	3.11E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2000615	chr11:116915819	PCSK7	chr11:117075789-117102811:-	-0.29	-5.53	5.1E-8	Protein quantitative trait loci	
KIRC	cis	1	rs2000616	chr11:116916529	PCSK7	chr11:117075789-117102811:-	-0.26	-5.19	3.11E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2002842	chr18:76409597	ATP9B	chr18:76829397-77138280:+	-0.19	-3.51	0.000483	Rheumatoid arthritis	
KIRC	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.14	-4.68	3.77E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2003301	chr7:66147656	LOC493754	chr7:65993446-66057363:-	0.17	3.8	0.000164	Aortic root size	
KIRC	cis	1	rs2004711	chr5:150225068	IRGM	chr5:150226085-150280295:+	0.53	7.27	1.34E-12	Crohn's disease	
KIRC	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.38	5.21	2.74E-7	Crohn's disease	
KIRC	cis	1	rs2005108	chr11:102770353	MMP1	chr11:102660641-102668966:-	0.42	4.44	1.11E-5	Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.56	-12.73	2.22E-32	Forced vital capacity	
KIRC	cis	1	rs2006893	chr22:22128678	MAPK1	chr22:22113949-22221970:-	0.18	5.21	2.74E-7	Multiple sclerosis	
KIRC	cis	1	rs2007981	chr19:18567555	SSBP4	chr19:18530221-18545371:+	-0.13	-4.53	7.37E-6	Breast cancer	
KIRC	cis	1	rs2008905	chr11:17184623	NUCB2	chr11:17281887-17371521:+	0.16	3.52	0.000468	Schizophrenia	
KIRC	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.24	4.87	1.48E-6	Atopic dermatitis	
KIRC	cis	1	rs2011064	chr15:50957625	SPPL2A	chr15:50999739-51057910:-	0.27	6.89	1.72E-11	QT interval	
KIRC	cis	1	rs2011331	chr1:152286002	FLG	chr1:152274651-152297679:-	0.23	3.99	7.62E-5	Atopic dermatitis	
KIRC	cis	1	rs2011331	chr1:152286002	HRNR	chr1:152184558-152196669:-	-0.23	-3.85	0.000136	Atopic dermatitis	
KIRC	cis	1	rs2012917	chr1:212405771	TMEM206	chr1:212537819-212588267:-	0.2	4.08	5.24E-5	Intelligence (childhood)	
KIRC	cis	1	rs2013288	chr17:61785904	FTSJ3	chr17:61896795-61905031:-	0.33	6.51	1.88E-10	Body mass index	
KIRC	cis	1	rs2013288	chr17:61785904	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.46E-6	Body mass index	
KIRC	cis	1	rs2013815	chr6:167373812	RNASET2	chr6:167343008-167412795:-	0.14	3.69	0.000246	Crohn's disease	
KIRC	cis	1	rs2014252	chr2:27462405	C2orf28	chr2:27434899-27440044:+	0.16	4.55	6.78E-6	Blood metabolite levels	
KIRC	cis	1	rs2014521	chr17:40283413	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.89E-11	Fibrinogen levels	
KIRC	cis	1	rs201466262	chr8:52407936	PXDNL	chr8:52232144-52722005:-	-0.25	-4.6	5.38E-6	Mild influenza (H1N1) infection	
KIRC	cis	1	rs2015336	chr17:18073610	FAM106A	chr17:18427880-18430160:-	-0.27	-4.11	4.71E-5	Obesity-related traits	
KIRC	cis	1	rs2015336	chr17:18073610	LOC220594	chr17:18414577-18445234:-	-0.34	-5.35	1.37E-7	Obesity-related traits	
KIRC	cis	1	rs2015336	chr17:18073610	TOP3A	chr17:18177235-18218321:-	0.19	3.56	0.000413	Obesity-related traits	
KIRC	cis	1	rs2016161	chr20:23621174	CST3	chr20:23608536-23618574:-	0.14	4.07	5.36E-5	Chronic kidney disease	
KIRC	cis	1	rs2016266	chr12:53727955	ESPL1	chr12:53662083-53687427:+	-0.23	-5.89	7.05E-9	Bone mineral density;Bone mineral density (spine)	
KIRC	cis	1	rs2016559	chr1:11269917	MTOR	chr1:11166589-11322608:-	-0.18	-4.6	5.48E-6	Body mass index	
KIRC	cis	1	rs2017962	chr19:22208751	ZNF208	chr19:22115760-22193745:-	0.3	4.98	8.88E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.44	7.9	1.79E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.58	-8.32	8.27E-16	Rheumatoid arthritis	
KIRC	cis	1	rs2019814	chr11:93168885	CCDC67	chr11:93063156-93171634:+	-0.27	-4.13	4.3E-5	Pulmonary function decline	
KIRC	cis	1	rs202053	chr6:13273643	TBC1D7	chr6:13266774-13328770:-	-0.32	-6.05	2.76E-9	HIV-1 viral setpoint	
KIRC	cis	1	rs202070	chr6:13267938	TBC1D7	chr6:13266774-13328770:-	-0.31	-5.66	2.61E-8	HIV-1 viral setpoint	
KIRC	cis	1	rs202072	chr6:13268211	TBC1D7	chr6:13266774-13328770:-	0.31	5.86	8.43E-9	HIV-1 viral setpoint	
KIRC	cis	1	rs202073	chr6:13268605	TBC1D7	chr6:13266774-13328770:-	0.31	5.63	2.97E-8	HIV-1 viral setpoint	
KIRC	cis	1	rs202074	chr6:13269363	TBC1D7	chr6:13266774-13328770:-	-0.31	-5.72	1.87E-8	HIV-1 viral setpoint	
KIRC	cis	1	rs202077	chr6:13271438	TBC1D7	chr6:13266774-13328770:-	-0.32	-6.05	2.8E-9	HIV-1 viral setpoint	
KIRC	cis	1	rs2024627	chr1:11298790	MTOR	chr1:11166589-11322608:-	-0.16	-4.2	3.15E-5	Body mass index	
KIRC	cis	1	rs2024959	chr20:47695391	CSE1L	chr20:47662838-47713484:+	0.18	4.66	4.13E-6	Anger	
KIRC	cis	1	rs2027003	chr20:25350498	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2027004	chr20:25350618	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2027299	chr6:126685827	CENPW	chr6:126661253-126804465:+	-0.15	-4.86	1.61E-6	Type 1 diabetes	
KIRC	cis	1	rs2027760	chr11:73036481	RELT	chr11:73087405-73108518:+	0.19	3.93	9.76E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs2027761	chr11:73036179	RELT	chr11:73087405-73108518:+	0.19	3.96	8.43E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs2027763	chr11:73035799	RELT	chr11:73087405-73108518:+	0.19	4.26	2.45E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.61	-13.77	8.27E-37	Type 2 diabetes	
KIRC	cis	1	rs2030838	chr15:84583810	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	9.02E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2030839	chr15:84583959	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.54E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2030840	chr15:84584134	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	9.02E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2031365	chr6:87805592	C6orf162	chr6:88032306-88052043:+	0.19	3.96	8.56E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs2031366	chr6:87805890	C6orf162	chr6:88032306-88052043:+	0.18	3.92	9.89E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs2031367	chr6:87807180	C6orf162	chr6:88032306-88052043:+	0.2	4.36	1.61E-5	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.19	-4.33	1.8E-5	Cholesterol, total	
KIRC	cis	1	rs2031532	chr13:50080847	CAB39L	chr13:49882787-50018221:-	0.34	7.39	6.2E-13	Cardiac hypertrophy	
KIRC	cis	1	rs2031532	chr13:50080847	RCBTB1	chr13:50106082-50159719:-	0.22	5.67	2.38E-8	Cardiac hypertrophy	
KIRC	cis	1	rs2031532	chr13:50080847	SETDB2	chr13:50018429-50069138:+	0.14	3.66	0.000283	Cardiac hypertrophy	
KIRC	cis	1	rs2033973	chr6:159099187	TMEM181	chr6:158957468-159056466:+	0.21	3.75	0.000201	Lipoprotein (a) levels	
KIRC	cis	1	rs2034343	chr3:185337854	TMEM41A	chr3:185207389-185216845:-	0.17	3.53	0.00046	Systolic blood pressure	
KIRC	cis	1	rs2034344	chr3:185337788	TMEM41A	chr3:185207389-185216845:-	0.18	3.68	0.000258	Systolic blood pressure	
KIRC	cis	1	rs2034899	chr5:78316188	ARSB	chr5:78073039-78282357:-	-0.19	-4.01	7.12E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2034899	chr5:78316188	BHMT	chr5:78407604-78428112:+	-0.25	-5.17	3.3E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2034900	chr5:78315964	ARSB	chr5:78073039-78282357:-	0.2	4.13	4.26E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2034900	chr5:78315964	BHMT	chr5:78407604-78428112:+	0.25	5.1	4.71E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2035343	chr15:100581288	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.58	5.82E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2036402	chr5:156464242	HAVCR1	chr5:156456531-156486130:-	-0.46	-9.94	2.19E-21	Hypertriglyceridemia	
KIRC	cis	1	rs2036402	chr5:156464242	HAVCR2	chr5:156512843-156536138:-	-0.42	-7.62	1.23E-13	Hypertriglyceridemia	
KIRC	cis	1	rs2036402	chr5:156464242	TIMD4	chr5:156346293-156390266:-	-0.37	-6.85	2.22E-11	Hypertriglyceridemia	
KIRC	cis	1	rs2036534	chr15:78826948	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.77	1.4E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2037965	chr3:128025044	COPG	chr3:128968453-128996614:+	-0.24	-3.67	0.000273	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2037965	chr3:128025044	RPN1	chr3:128338813-128399918:-	-0.23	-3.93	9.52E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2037965	chr3:128025044	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.79	2.15E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2039415	chr1:160854445	CD244	chr1:160799951-160832645:-	-0.11	-3.59	0.000366	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2039415	chr1:160854445	NHLH1	chr1:160336861-160342638:+	-0.18	-4.14	4.14E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2041837	chr2:37468564	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.39	1.11E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2041837	chr2:37468564	PRKD3	chr2:37477648-37544222:-	-0.13	-3.56	0.000402	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2041840	chr2:37467264	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.22	2.62E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2041840	chr2:37467264	PRKD3	chr2:37477648-37544222:-	-0.13	-3.53	0.000461	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2041840	chr2:37467264	QPCT	chr2:37571753-37600464:+	-0.19	-3.49	0.000526	Chronic lymphocytic leukemia	
KIRC	cis	1	rs204246	chr6:13723374	CCDC90A	chr6:13791021-13814789:-	0.16	3.54	0.000445	Breast cancer	
KIRC	cis	1	rs2044029	chr15:71679959	SENP8	chr15:72410754-72433303:+	-0.14	-3.52	0.000465	Airflow obstruction	
KIRC	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.28	8.23	1.68E-15	Longevity	
KIRC	cis	1	rs2046120	chr15:84567762	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2050265	chr1:11879699	NPPA	chr1:11905769-11907840:-	-0.2	-3.53	0.00046	QRS complex (12-leadsum)	
KIRC	cis	1	rs2051391	chr21:35876438	KCNE1	chr21:35818989-35884573:-	0.3	4.42	1.22E-5	Electrocardiographic traits	
KIRC	cis	1	rs2055127	chr1:235598973	B3GALNT2	chr1:235610533-235667781:-	-0.3	-7.72	6.24E-14	Adiposity	
KIRC	cis	1	rs2055127	chr1:235598973	TBCE	chr1:235530728-235612280:+	-0.21	-4.75	2.69E-6	Adiposity	
KIRC	cis	1	rs2055682	chr7:66260289	LOC493754	chr7:65993446-66057363:-	-0.17	-3.58	0.00037	Aortic root size	
KIRC	cis	1	rs2055682	chr7:66260289	TPST1	chr7:65670259-65825437:+	0.2	3.6	0.000352	Aortic root size	
KIRC	cis	1	rs2055712	chr15:84581605	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.35	1.61E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2056297	chr2:136899116	DARS	chr2:136664254-136743222:-	0.14	3.67	0.000265	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs205638	chr2:74950067	AUP1	chr2:74753776-74756974:-	-0.13	-3.49	0.000527	Myopia (pathological)	
KIRC	cis	1	rs205638	chr2:74950067	MRPL53	chr2:74699110-74699923:-	-0.14	-3.5	0.000502	Myopia (pathological)	
KIRC	cis	1	rs2056486	chr2:73717567	TPRKB	chr2:73956957-73964517:-	-0.19	-5.02	7.03E-7	Metabolite levels	
KIRC	cis	1	rs2056544	chr15:76826003	SCAPER	chr15:76640529-77197744:-	-0.18	-6.11	2.04E-9	Blood metabolite levels	
KIRC	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.6	14.5	5.03E-40	Height	
KIRC	cis	1	rs2056603	chr3:134312749	CEP63	chr3:134204575-134293852:+	0.33	6.44	2.73E-10	Height	
KIRC	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs2056604	chr3:134312648	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs2056938	chr20:44022672	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000438	Psoriasis	
KIRC	cis	1	rs2057831	chr5:137535133	CDC25C	chr5:137620959-137674044:-	-0.21	-5.94	5.42E-9	Resting heart rate	
KIRC	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.41	-5.88	7.47E-9	Subcutaneous adipose tissue	
KIRC	cis	1	rs2058337	chr4:17678649	LAP3	chr4:17578927-17609590:+	-0.21	-6.46	2.49E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2058338	chr4:17678600	LAP3	chr4:17578927-17609590:+	0.22	6.68	6.18E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2058339	chr4:17678456	LAP3	chr4:17578927-17609590:+	-0.21	-6.47	2.3E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2058339	chr4:17678456	MED28	chr4:17616273-17629791:+	0.16	3.66	0.000274	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	0.28	5.79	1.23E-8	HDL cholesterol	
KIRC	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.35	7.77	4.49E-14	Pancreatic cancer	
KIRC	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.2	4.55	6.62E-6	Brain structure	
KIRC	cis	1	rs2061999	chr15:84582740	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.38	1.43E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2062340	chr2:54480245	ACYP2	chr2:54342410-54532433:+	-0.2	-3.58	0.000372	Telomere length	
KIRC	cis	1	rs2064088	chr22:39053382	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs2066558	chr13:50610595	EBPL	chr13:50234811-50265623:-	-0.18	-3.63	0.000316	Height	
KIRC	cis	1	rs2066725	chr17:41891473	DHX8	chr17:41561334-41604166:+	0.13	3.59	0.000357	Triglycerides	
KIRC	cis	1	rs2066725	chr17:41891473	MPP3	chr17:41878169-41910538:-	0.17	4.08	5.21E-5	Triglycerides	
KIRC	cis	1	rs2066818	chr12:56753822	RPS26	chr12:56435686-56438005:+	-0.51	-4.39	1.41E-5	Psoriasis vulgaris	
KIRC	cis	1	rs2066819	chr12:56750204	RPS26	chr12:56435686-56438005:+	-0.51	-4.39	1.41E-5	Psoriasis vulgaris	
KIRC	cis	1	rs2066854	chr4:155535181	FGA	chr4:155504280-155511897:-	0.24	3.83	0.000142	Fibrinogen	
KIRC	cis	1	rs2066854	chr4:155535181	FGB	chr4:155484132-155492236:+	0.27	4.26	2.43E-5	Fibrinogen	
KIRC	cis	1	rs2066861	chr4:155527436	FGA	chr4:155504280-155511897:-	0.23	3.61	0.000339	Fibrinogen	
KIRC	cis	1	rs2066861	chr4:155527436	FGB	chr4:155484132-155492236:+	0.26	4.05	5.82E-5	Fibrinogen	
KIRC	cis	1	rs2066864	chr4:155525695	FGB	chr4:155484132-155492236:+	0.25	3.8	0.000162	Fibrinogen	
KIRC	cis	1	rs2066865	chr4:155525276	FGB	chr4:155484132-155492236:+	0.25	3.83	0.000142	Fibrinogen	
KIRC	cis	1	rs2069133	chr15:57918069	GCOM1	chr15:57884114-58009752:+	-0.19	-3.71	0.000228	HDL cholesterol	
KIRC	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.31	-6.49	2.1E-10	Multiple sclerosis	
KIRC	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.51	13.2	2.38E-34	Multiple sclerosis	
KIRC	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.3	6.51	1.78E-10	Multiple sclerosis	
KIRC	cis	1	rs2069940	chr20:33759272	PROCR	chr20:33758727-33765164:+	-0.3	-3.93	9.56E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.36	-6.85	2.12E-11	Cognitive performance	
KIRC	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.16	-4.22	2.87E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs2070970	chr11:59861983	MS4A2	chr11:59856137-59866014:+	0.17	3.79	0.000172	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2071373	chr2:113540084	DDX11L2	chr2:114356606-114359153:-	0.23	3.76	0.00019	Endometriosis	
KIRC	cis	1	rs2071373	chr2:113540084	RPL23AP7	chr2:114368816-114384715:-	0.25	4.43	1.17E-5	Endometriosis	
KIRC	cis	1	rs2071376	chr2:113535395	DDX11L2	chr2:114356606-114359153:-	0.23	3.8	0.000164	Endometriosis	
KIRC	cis	1	rs2071376	chr2:113535395	RPL23AP7	chr2:114368816-114384715:-	0.25	4.47	9.62E-6	Endometriosis	
KIRC	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.31	6.49	2.05E-10	Multiple sclerosis	
KIRC	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.5	-13.1	6.48E-34	Multiple sclerosis	
KIRC	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.48	2.2E-10	Multiple sclerosis	
KIRC	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.34	9.18	1.09E-18	Common traits (Other)	
KIRC	cis	1	rs2072794	chr22:39150543	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.53	0.000451	Resting heart rate	
KIRC	cis	1	rs2072794	chr22:39150543	LOC646851	chr22:38974125-39052634:-	0.12	3.68	0.000263	Resting heart rate	
KIRC	cis	1	rs2072795	chr22:39064209	LOC646851	chr22:38974125-39052634:-	-0.14	-4.26	2.48E-5	Resting heart rate	
KIRC	cis	1	rs2072796	chr22:39064230	LOC646851	chr22:38974125-39052634:-	0.13	4.08	5.13E-5	Resting heart rate	
KIRC	cis	1	rs2072798	chr22:39148483	LOC646851	chr22:38974125-39052634:-	0.12	3.66	0.000275	Resting heart rate	
KIRC	cis	1	rs2073294	chr14:66082493	LOC645431	chr14:65877313-65879335:-	-0.46	-6.13	1.75E-9	Ischemic stroke	
KIRC	cis	1	rs2074018	chr11:2309634	C11orf21	chr11:2317507-2323143:-	0.18	3.8	0.000164	Obesity-related traits	
KIRC	cis	1	rs2074771	chr2:242350944	SEPT2	chr2:242254723-242293439:+	0.38	5.59	3.75E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2075060	chr17:36925750	PSMB3	chr17:36909002-36920477:+	-0.1	-4.51	8.22E-6	Height	
KIRC	cis	1	rs2075292	chr11:116732512	PCSK7	chr11:117075789-117102811:-	-0.27	-4.88	1.44E-6	Protein quantitative trait loci	
KIRC	cis	1	rs2075555	chr17:48274291	SGCA	chr17:48243366-48253292:+	0.23	4.08	5.23E-5	Breast cancer	
KIRC	cis	1	rs2075678	chr20:47701339	CSE1L	chr20:47662838-47713484:+	0.15	3.8	0.00016	Anger	
KIRC	cis	1	rs2076028	chr22:39150450	LOC646851	chr22:38974125-39052634:-	0.12	3.57	0.000394	Resting heart rate	
KIRC	cis	1	rs2076474	chr6:56007082	COL21A1	chr6:55921389-56258892:-	-0.48	-7.4	5.93E-13	Psychosis (atypical)	
KIRC	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.92	-22.1	4.33E-76	Homocysteine levels	
KIRC	cis	1	rs2078089	chr19:22209753	ZNF208	chr19:22115760-22193745:-	0.3	4.98	8.88E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.44	7.9	1.79E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.23	-4.33	1.83E-5	Basal cell carcinoma	
KIRC	cis	1	rs2080303	chr2:202165206	PPIL3	chr2:201735680-201753999:-	-0.19	-3.75	0.000199	Basal cell carcinoma	
KIRC	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.23	-4.02	6.66E-5	Obesity-related traits	
KIRC	cis	1	rs2081302	chr2:23945355	LOC375190	chr2:24299728-24397519:+	0.23	5.44	8.2E-8	Obesity-related traits	
KIRC	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.49	-8.1	4.24E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs2083731	chr15:75368538	PPCDC	chr15:75315927-75343066:+	0.16	3.81	0.000156	Blood trace element (Zn levels)	
KIRC	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.21	3.8	0.000163	Blood trace element (Zn levels)	
KIRC	cis	1	rs2084761	chr19:52156057	SIGLEC12	chr19:51994613-52005043:-	-0.33	-3.87	0.000123	Plasma plasminogen levels	
KIRC	cis	1	rs2085629	chr8:110228044	TMEM74	chr8:109619080-109799770:-	-0.18	-3.63	0.000307	Night sleep phenotypes	
KIRC	cis	1	rs2087946	chr1:212405396	TMEM206	chr1:212537819-212588267:-	0.2	3.97	8.11E-5	Intelligence (childhood)	
KIRC	cis	1	rs2089162	chr15:78739763	CHRNA5	chr15:78857906-78886458:+	-0.26	-4.85	1.64E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2089222	chr12:117002658	NCRNA00173	chr12:116971227-116974317:+	0.31	4.21	3.06E-5	Acute lymphoblastic leukemia (childhood)	
KIRC	cis	1	rs2092931	chr6:161077342	PLG	chr6:161123274-161174345:+	-0.26	-5.12	4.27E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs2092990	chr20:3346338	ITPA	chr20:3190056-3204504:+	-0.27	-6.44	2.8E-10	IFN-related cytopenia	
KIRC	cis	1	rs2093395	chr6:41155026	LOC221442	chr6:41068773-41108567:+	-0.18	-5.76	1.47E-8	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2093396	chr6:41155000	LOC221442	chr6:41068773-41108567:+	0.18	5.58	3.98E-8	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2098297	chr14:75619118	MLH3	chr14:75480467-75518235:-	-0.23	-5.88	7.3E-9	Height	
KIRC	cis	1	rs2098297	chr14:75619118	NEK9	chr14:75548819-75593778:-	-0.15	-4.21	2.98E-5	Height	
KIRC	cis	1	rs2102896	chr2:136906640	DARS	chr2:136664254-136743222:-	0.13	3.54	0.000443	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs2103936	chr10:38253333	LOC399744	chr10:38717074-38741080:+	-0.23	-3.62	0.000321	Obesity (extreme)	
KIRC	cis	1	rs2105325	chr1:173349725	SERPINC1	chr1:173872943-173886516:-	0.27	4.51	7.91E-6	Rheumatoid arthritis	
KIRC	cis	1	rs2106107	chr22:29835987	RFPL1S	chr22:29833006-29838118:-	0.25	4.87	1.5E-6	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs2108622	chr19:15990431	CYP4F11	chr19:16023180-16045676:-	-0.36	-5.93	5.58E-9	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs2108622	chr19:15990431	CYP4F2	chr19:15988834-16008884:-	-0.19	-3.62	0.000323	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs2109522	chr4:17658645	LAP3	chr4:17578927-17609590:+	-0.2	-6.29	6.96E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2109522	chr4:17658645	MED28	chr4:17616273-17629791:+	0.18	3.97	8.2E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2110001	chr7:150517022	ABP1	chr7:150526069-150558379:+	0.25	5.46	7.37E-8	Height	
KIRC	cis	1	rs2110001	chr7:150517022	TMEM176A	chr7:150497854-150502208:+	0.22	5.28	1.92E-7	Height	
KIRC	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.81	15.53	1.11E-44	Type 2 diabetes	
KIRC	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.85	17.38	2.47E-53	Type 2 diabetes	
KIRC	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.24	-4.33	1.8E-5	Obesity-related traits	
KIRC	cis	1	rs2113422	chr2:23939007	LOC375190	chr2:24299728-24397519:+	0.23	5.75	1.52E-8	Obesity-related traits	
KIRC	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.24	-4.29	2.18E-5	Obesity-related traits	
KIRC	cis	1	rs2113423	chr2:23942287	LOC375190	chr2:24299728-24397519:+	0.23	5.79	1.25E-8	Obesity-related traits	
KIRC	cis	1	rs2114646	chr2:170624221	FASTKD1	chr2:170386265-170430424:-	0.29	4.64	4.49E-6	Obesity-related traits	
KIRC	cis	1	rs2115069	chr5:150252365	IRGM	chr5:150226085-150280295:+	0.58	7.62	1.3E-13	Crohn's disease	
KIRC	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.36	4.65	4.28E-6	Crohn's disease	
KIRC	cis	1	rs2115671	chr15:50956432	SPPL2A	chr15:50999739-51057910:-	0.25	6.46	2.51E-10	QT interval	
KIRC	cis	1	rs211718	chr1:76106675	ACADM	chr1:76190043-76229353:+	0.18	5.18	3.14E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs211723	chr1:76103030	ACADM	chr1:76190043-76229353:+	-0.19	-5.21	2.82E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs2118404	chr2:25377329	POMC	chr2:25383722-25391559:-	0.24	4.55	6.75E-6	Body mass index	
KIRC	cis	1	rs2119992	chr6:153449670	MTRF1L	chr6:153308401-153323925:-	0.18	3.54	0.000441	Prostate cancer	
KIRC	cis	1	rs2120019	chr15:75334184	PPCDC	chr15:75315927-75343066:+	0.2	4.55	6.88E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs2120019	chr15:75334184	RPP25	chr15:75247443-75249775:-	0.21	3.86	0.00013	Blood trace element (Zn levels)	
KIRC	cis	1	rs2120019	chr15:75334184	SCAMP5	chr15:75287901-75313836:+	0.24	4.35	1.64E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs2120107	chr15:76869789	SCAPER	chr15:76640529-77197744:-	-0.16	-5.43	8.87E-8	Blood metabolite levels	
KIRC	cis	1	rs2121067	chr14:76617651	ESRRB	chr14:76837690-76968178:+	0.35	4.88	1.43E-6	Blood pressure	
KIRC	cis	1	rs2121070	chr14:76650764	ESRRB	chr14:76837690-76968178:+	0.36	5.12	4.27E-7	Blood pressure	
KIRC	cis	1	rs2121071	chr14:76665477	ESRRB	chr14:76837690-76968178:+	0.32	4.65	4.28E-6	Blood pressure	
KIRC	cis	1	rs2121075	chr14:76675540	ESRRB	chr14:76837690-76968178:+	0.33	4.67	3.9E-6	Blood pressure	
KIRC	cis	1	rs2121077	chr14:76676355	ESRRB	chr14:76837690-76968178:+	-0.32	-4.46	9.99E-6	Blood pressure	
KIRC	cis	1	rs2125211	chr4:103559876	MANBA	chr4:103552644-103682151:-	-0.17	-3.9	0.000111	Primary biliary cirrhosis	
KIRC	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.29	-5.81	1.14E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs2127905	chr11:117026374	PCSK7	chr11:117075789-117102811:-	-0.27	-5.24	2.35E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.7	10.15	3.71E-22	Diastolic blood pressure	
KIRC	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.61	-13	1.62E-33	Kawasaki disease	
KIRC	cis	1	rs2133134	chr1:76179587	ACADM	chr1:76190043-76229353:+	0.19	5.31	1.63E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs2134044	chr6:101075354	ASCC3	chr6:100956609-101329224:-	0.13	3.5	0.000503	Menarche (age at onset)	
KIRC	cis	1	rs2134265	chr15:63398196	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.000138	HDL cholesterol	
KIRC	cis	1	rs2135507	chr4:83586671	TMEM150C	chr4:83405604-83483510:-	-0.26	-6.48	2.19E-10	Juvenile osteochondritis dissecans	
KIRC	cis	1	rs2135880	chr15:84589613	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2140195	chr2:73702344	TPRKB	chr2:73956957-73964517:-	-0.2	-5.09	4.96E-7	Metabolite levels	
KIRC	cis	1	rs2140270	chr3:49439440	CCDC36	chr3:49235861-49295537:+	-0.25	-4.71	3.14E-6	Menarche (age at onset)	
KIRC	cis	1	rs2140270	chr3:49439440	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.52	7.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs2140270	chr3:49439440	P4HTM	chr3:49027341-49044579:+	-0.21	-4.75	2.65E-6	Menarche (age at onset)	
KIRC	cis	1	rs2140270	chr3:49439440	TREX1	chr3:48501186-48509043:+	0.15	3.78	0.000179	Menarche (age at onset)	
KIRC	cis	1	rs2140270	chr3:49439440	WDR6	chr3:49044637-49053386:+	0.2	5.02	7.1E-7	Menarche (age at onset)	
KIRC	cis	1	rs2141668	chr3:160336032	TRIM59	chr3:160153292-160167626:-	0.23	3.88	0.000118	Primary biliary cirrhosis	
KIRC	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.28	5.5	5.96E-8	Gout	
KIRC	cis	1	rs2141924	chr7:66186246	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.35E-5	Gout	
KIRC	cis	1	rs2143062	chr6:27353852	ZNF391	chr6:27356524-27369227:+	0.33	6.55	1.44E-10	Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs2143290	chr1:169088679	BLZF1	chr1:169337194-169365778:+	0.22	3.69	0.000249	QT interval	
KIRC	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.43	-5.41	9.84E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.43	5.34	1.39E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs2143950	chr14:35572357	KIAA0391	chr14:35591776-35786673:+	0.24	3.96	8.45E-5	Atopic dermatitis	
KIRC	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.26	5.13	4.25E-7	Atopic dermatitis	
KIRC	cis	1	rs2144726	chr6:161076247	PLG	chr6:161123274-161174345:+	-0.26	-5.12	4.42E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs2144845	chr10:38221519	LOC399744	chr10:38717074-38741080:+	-0.22	-3.52	0.000474	Obesity (extreme)	
KIRC	cis	1	rs2147712	chr14:50091684	RPL36AL	chr14:50085407-50087349:-	0.35	8.09	4.39E-15	Carotid intima media thickness	
KIRC	cis	1	rs2149085	chr6:167371110	RNASET2	chr6:167343008-167412795:-	0.14	3.57	0.000398	Crohn's disease	
KIRC	cis	1	rs2152375	chr14:65915778	LOC645431	chr14:65877313-65879335:-	-0.52	-6.61	9.84E-11	Ischemic stroke	
KIRC	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.25	6.69	5.85E-11	Blood metabolite levels	
KIRC	cis	1	rs2153837	chr9:115463001	HSDL2	chr9:115142351-115234684:+	0.22	3.5	0.000498	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.4	-8.98	5.28E-18	Eye color traits	
KIRC	cis	1	rs2154536	chr21:38492147	TTC3	chr21:38445571-38575406:+	0.18	3.83	0.000147	Eye color traits	
KIRC	cis	1	rs2155583	chr11:116915217	PCSK7	chr11:117075789-117102811:-	-0.28	-5.36	1.26E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2156257	chr6:163100710	PACRG	chr6:163148164-163736523:+	0.58	7.03	6.72E-12	Body mass index	
KIRC	cis	1	rs2158100	chr17:18811479	FAM18B	chr17:18684582-18710026:+	0.23	5.32	1.59E-7	Pancreatic cancer	
KIRC	cis	1	rs2159583	chr4:17658838	LAP3	chr4:17578927-17609590:+	-0.21	-6.43	2.94E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2159583	chr4:17658838	MED28	chr4:17616273-17629791:+	0.17	3.89	0.000112	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2159584	chr4:17620568	LAP3	chr4:17578927-17609590:+	-0.2	-6.11	2.0E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2159584	chr4:17620568	MED28	chr4:17616273-17629791:+	0.23	5.31	1.64E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2160215	chr14:81461472	TSHR	chr14:81421869-81612646:+	-0.32	-6.29	6.87E-10	Graves' disease	
KIRC	cis	1	rs2160392	chr2:37527393	CEBPZ	chr2:37428778-37458740:-	-0.18	-4.98	8.69E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160392	chr2:37527393	QPCT	chr2:37571753-37600464:+	-0.19	-3.56	0.000409	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160393	chr2:37516950	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.19	3.0E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160393	chr2:37516950	QPCT	chr2:37571753-37600464:+	-0.2	-3.71	0.000229	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160395	chr2:37479862	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.16	3.52E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160395	chr2:37479862	PRKD3	chr2:37477648-37544222:-	-0.13	-3.54	0.000445	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2160860	chr8:39823145	IDO2	chr8:39792474-39873910:+	0.18	4	7.3E-5	Blood metabolite levels	
KIRC	cis	1	rs2162269	chr15:73090262	ADPGK	chr15:73043710-73076667:-	0.17	3.84	0.000139	Body mass index	
KIRC	cis	1	rs2162478	chr2:231038640	SP110	chr2:231033645-231084827:-	0.23	3.61	0.000335	Obesity-related traits	
KIRC	cis	1	rs2163167	chr3:53131772	ITIH4	chr3:52847007-52866554:-	0.14	3.71	0.000233	Height	
KIRC	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.45	-11.86	9.11E-29	Height	
KIRC	cis	1	rs2163272	chr4:39114410	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs2163273	chr4:39114455	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs216345	chr9:33799370	NUDT2	chr9:34329504-34343695:+	-0.31	-6.4	3.46E-10	Bipolar disorder	
KIRC	cis	1	rs2163846	chr19:22505844	ZNF98	chr19:22573899-22605148:-	0.3	6.18	1.37E-9	Telomere length	
KIRC	cis	1	rs2165237	chr2:198875003	RFTN2	chr2:198435528-198540584:-	0.17	4.7	3.38E-6	Ulcerative colitis	
KIRC	cis	1	rs2165525	chr11:59906792	MS4A2	chr11:59856137-59866014:+	0.17	3.59	0.000369	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.48	-10.66	4.69E-24	Response to antipsychotic treatment	
KIRC	cis	1	rs2168154	chr3:190987963	UTS2D	chr3:190984945-191048325:-	-0.2	-3.72	0.000224	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.49	10.02	1.18E-21	Body mass index	
KIRC	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.46	-9.94	2.17E-21	Body mass index	
KIRC	cis	1	rs2171481	chr8:89459614	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs2172252	chr3:49678307	UBA7	chr3:49842639-49851391:-	0.16	4.07	5.4E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs217263	chr5:137480666	CDC25C	chr5:137620959-137674044:-	-0.21	-5.89	7.26E-9	Resting heart rate	
KIRC	cis	1	rs217274	chr5:137490974	CDC25C	chr5:137620959-137674044:-	-0.22	-5.95	4.92E-9	Resting heart rate	
KIRC	cis	1	rs2174608	chr15:50871993	SPPL2A	chr15:50999739-51057910:-	0.27	7.23	1.85E-12	QT interval	
KIRC	cis	1	rs2174608	chr15:50871993	TRPM7	chr15:50852491-50978994:-	0.12	3.49	0.000523	QT interval	
KIRC	cis	1	rs2175366	chr19:22128279	ZNF208	chr19:22115760-22193745:-	0.28	4.72	3.0E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.4	7.2	2.14E-12	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.19	3.9	0.000111	Idiopathic membranous nephropathy	
KIRC	cis	1	rs2175416	chr2:160904021	PLA2R1	chr2:160798012-160919121:-	0.18	3.82	0.000148	Idiopathic membranous nephropathy	
KIRC	cis	1	rs2177129	chr4:56365414	SRD5A3	chr4:56212409-56237866:+	0.18	4.01	7.09E-5	Personality dimensions	
KIRC	cis	1	rs2177129	chr4:56365414	TMEM165	chr4:56262090-56292342:+	-0.23	-6.46	2.47E-10	Personality dimensions	
KIRC	cis	1	rs2177268	chr3:49439725	CCDC36	chr3:49235861-49295537:+	-0.25	-4.71	3.14E-6	Menarche (age at onset)	
KIRC	cis	1	rs2177268	chr3:49439725	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.52	7.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs2177268	chr3:49439725	P4HTM	chr3:49027341-49044579:+	-0.21	-4.75	2.65E-6	Menarche (age at onset)	
KIRC	cis	1	rs2177268	chr3:49439725	TREX1	chr3:48501186-48509043:+	0.15	3.78	0.000179	Menarche (age at onset)	
KIRC	cis	1	rs2177268	chr3:49439725	WDR6	chr3:49044637-49053386:+	0.2	5.02	7.1E-7	Menarche (age at onset)	
KIRC	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs2177601	chr3:134245434	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs2177703	chr7:65391717	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs2178451	chr3:160335836	TRIM59	chr3:160153292-160167626:-	0.23	3.88	0.000118	Primary biliary cirrhosis	
KIRC	cis	1	rs2179142	chr22:39037954	LOC646851	chr22:38974125-39052634:-	0.12	3.76	0.000187	Resting heart rate	
KIRC	cis	1	rs2181043	chr10:17217803	TRDMT1	chr10:17184983-17243681:-	-0.32	-7.49	3.13E-13	Homocysteine levels	
KIRC	cis	1	rs2181203	chr10:81716105	LOC219347	chr10:81805991-81838949:-	0.59	5.04	6.42E-7	Rheumatoid arthritis	
KIRC	cis	1	rs2181203	chr10:81716105	LOC650623	chr10:81442731-81448648:+	-0.34	-3.55	0.000416	Rheumatoid arthritis	
KIRC	cis	1	rs2181205	chr10:81704156	LOC219347	chr10:81805991-81838949:-	0.53	4.53	7.3E-6	Rheumatoid arthritis	
KIRC	cis	1	rs2184000	chr20:25395878	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2184000	chr20:25395878	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2184602	chr14:65915672	LOC645431	chr14:65877313-65879335:-	-0.49	-6.59	1.13E-10	Ischemic stroke	
KIRC	cis	1	rs2186637	chr11:71570115	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.7E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs218695	chr17:6593546	DVL2	chr17:7128661-7137863:-	0.27	4.03	6.43E-5	Blood metabolite levels	
KIRC	cis	1	rs218698	chr17:6594700	DVL2	chr17:7128661-7137863:-	0.25	3.62	0.00033	Blood metabolite levels	
KIRC	cis	1	rs2187143	chr18:48371565	MRO	chr18:48321491-48351754:-	0.31	5.38	1.14E-7	Entorhinal cortical thickness	
KIRC	cis	1	rs2193172	chr12:15332342	ATF7IP	chr12:14518611-14651696:+	-0.14	-3.69	0.000253	Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs2195987	chr19:24149545	ZNF681	chr19:23921999-23941693:-	0.21	4.09	5.09E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2196172	chr2:198889893	RFTN2	chr2:198435528-198540584:-	-0.1	-3.52	0.000469	Dermatomyositis	
KIRC	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.46	7.39	6.05E-13	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs2200578	chr2:99876244	LIPT1	chr2:99771418-99779611:+	0.29	4.89	1.36E-6	IgG glycosylation	
KIRC	cis	1	rs2201867	chr11:5558273	TRIM6	chr11:5617347-5634188:+	-0.2	-4.65	4.29E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2201868	chr11:5558211	TRIM6	chr11:5617347-5634188:+	-0.19	-4.5	8.28E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2205802	chr22:39046327	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.44	12.6	8.31E-32	Type 1 diabetes autoantibodies	
KIRC	cis	1	rs2211418	chr6:125995503	HEY2	chr6:126068780-126082414:+	-0.16	-3.96	8.49E-5	Endometrial cancer	
KIRC	cis	1	rs2211419	chr6:125995533	HEY2	chr6:126068780-126082414:+	0.17	4.09	5.08E-5	Endometrial cancer	
KIRC	cis	1	rs2211420	chr6:125995549	HEY2	chr6:126068780-126082414:+	-0.18	-4.43	1.16E-5	Endometrial cancer	
KIRC	cis	1	rs2215450	chr4:17675394	LAP3	chr4:17578927-17609590:+	-0.2	-6.29	6.98E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2215450	chr4:17675394	MED28	chr4:17616273-17629791:+	0.19	4.37	1.51E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2217266	chr5:150272621	IRGM	chr5:150226085-150280295:+	0.49	6.71	5.23E-11	Crohn's disease	
KIRC	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.31	4.1	4.76E-5	Crohn's disease	
KIRC	cis	1	rs2224038	chr14:27079960	NOVA1	chr14:26915090-27066960:-	-0.27	-4.67	3.8E-6	Educational attainment (years of education)	
KIRC	cis	1	rs2224949	chr14:50096560	RPL36AL	chr14:50085407-50087349:-	-0.33	-7.68	8.52E-14	Carotid intima media thickness	
KIRC	cis	1	rs2226070	chr10:96776721	CYP2C9	chr10:96698415-96749147:+	0.18	3.51	0.000488	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.8	-19.5	1.9E-63	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs2227336	chr17:38174855	MED24	chr17:38175351-38210889:-	-0.15	-3.62	0.000329	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs2227564	chr10:75673101	PLAU	chr10:75670862-75677256:+	0.22	4.02	6.65E-5	Inflammatory bowel disease	
KIRC	cis	1	rs2228479	chr16:89985940	FANCA	chr16:89803959-89883065:-	0.69	10.4	4.33E-23	Skin colour saturation	
KIRC	cis	1	rs2228479	chr16:89985940	SPIRE2	chr16:89894907-89937727:+	0.31	3.51	0.000493	Skin colour saturation	
KIRC	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.48	12.32	1.2E-30	Homocysteine levels	
KIRC	cis	1	rs2231626	chr20:44002665	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.56	0.000403	Psoriasis	
KIRC	cis	1	rs2231940	chr19:41944237	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.75	0.000198	Height	
KIRC	cis	1	rs2234962	chr10:121429633	TIAL1	chr10:121332978-121356541:-	-0.19	-3.87	0.000123	Dilated cardiomyopathy	
KIRC	cis	1	rs2235230	chr22:39124467	LOC646851	chr22:38974125-39052634:-	-0.13	-3.67	0.000265	Resting heart rate	
KIRC	cis	1	rs2235714	chr6:52138226	TRAM2	chr6:52362202-52441862:-	-0.14	-3.5	0.000509	Pre-treatment pain in head and neck squamous cell carcinoma	
KIRC	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.26	-6.25	8.71E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236089	chr20:3257194	ITPA	chr20:3190056-3204504:+	-0.28	-6.57	1.23E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236092	chr20:3258188	ITPA	chr20:3190056-3204504:+	-0.27	-6.41	3.41E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236098	chr20:3267133	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.29	-6.98	9.22E-12	IFN-related cytopenia	
KIRC	cis	1	rs2236106	chr20:3278410	C20orf194	chr20:3229948-3388587:-	0.18	3.64	0.000296	IFN-related cytopenia	
KIRC	cis	1	rs2236106	chr20:3278410	ITPA	chr20:3190056-3204504:+	-0.27	-6.35	4.76E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236107	chr20:3285821	ITPA	chr20:3190056-3204504:+	-0.26	-6.24	9.1E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236108	chr20:3286331	C20orf194	chr20:3229948-3388587:-	0.18	3.57	0.000396	IFN-related cytopenia	
KIRC	cis	1	rs2236108	chr20:3286331	ITPA	chr20:3190056-3204504:+	-0.27	-6.33	5.43E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236117	chr20:3302021	C20orf194	chr20:3229948-3388587:-	0.18	3.55	0.000423	IFN-related cytopenia	
KIRC	cis	1	rs2236117	chr20:3302021	ITPA	chr20:3190056-3204504:+	-0.27	-6.4	3.6E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.28	-6.77	3.57E-11	IFN-related cytopenia	
KIRC	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.27	-6.41	3.36E-10	IFN-related cytopenia	
KIRC	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.28	6.72	4.82E-11	IFN-related cytopenia	
KIRC	cis	1	rs2236246	chr14:104379206	XRCC3	chr14:104163955-104181823:-	0.12	3.77	0.000181	Bipolar disorder	
KIRC	cis	1	rs2236247	chr14:104378087	TDRD9	chr14:104394817-104519002:+	0.23	3.58	0.000371	Bipolar disorder	
KIRC	cis	1	rs2236247	chr14:104378087	XRCC3	chr14:104163955-104181823:-	-0.13	-4.29	2.18E-5	Bipolar disorder	
KIRC	cis	1	rs2239181	chr12:48255949	RAPGEF3	chr12:48128455-48164823:-	0.2	3.59	0.000361	Gout	
KIRC	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.32	8.6	1.05E-16	Common traits (Other)	
KIRC	cis	1	rs2239898	chr11:3024462	NAP1L4	chr11:2965661-3013607:-	0.2	4.67	3.89E-6	Calcium levels	
KIRC	cis	1	rs2240009	chr17:40283142	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs2240010	chr17:40278081	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs224058	chr10:64498865	ADO	chr10:64564516-64568238:+	0.16	3.65	0.00029	Vogt-Koyanagi-Harada syndrome	
KIRC	cis	1	rs2241106	chr1:156218910	BGLAP	chr1:156182784-156213112:+	0.31	6.43	3.01E-10	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2241106	chr1:156218910	CCT3	chr1:156278752-156308195:-	-0.18	-4.44	1.12E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2241107	chr1:156182710	PMF1	chr1:156182784-156209831:+	0.14	3.63	0.000312	Testicular germ cell tumor	
KIRC	cis	1	rs224139	chr10:64473716	ADO	chr10:64564516-64568238:+	-0.19	-4.5	8.29E-6	Vogt-Koyanagi-Harada syndrome	
KIRC	cis	1	rs2241706	chr19:41912807	ATP5SL	chr19:41937224-41945810:-	0.16	3.71	0.000226	Height	
KIRC	cis	1	rs2241708	chr19:41912270	ATP5SL	chr19:41937224-41945810:-	0.15	3.6	0.000355	Height	
KIRC	cis	1	rs2241709	chr19:41912250	ATP5SL	chr19:41937224-41945810:-	0.15	3.49	0.000526	Height	
KIRC	cis	1	rs2241710	chr19:41912092	ATP5SL	chr19:41937224-41945810:-	0.16	3.71	0.000226	Height	
KIRC	cis	1	rs2241711	chr19:41911980	ATP5SL	chr19:41937224-41945810:-	0.16	3.78	0.000175	Height	
KIRC	cis	1	rs2242150	chr3:48505964	SHISA5	chr3:48509197-48542228:-	0.13	3.61	0.00034	Longevity	
KIRC	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.3	8.4	4.76E-16	Longevity	
KIRC	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.51	10.53	1.47E-23	Longevity	
KIRC	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.51	10.53	1.47E-23	Longevity	
KIRC	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.51	10.53	1.47E-23	Longevity	
KIRC	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.25	-5.07	5.73E-7	Height	
KIRC	cis	1	rs224329	chr20:34019579	FER1L4	chr20:34146508-34195484:-	-0.11	-3.55	0.000417	Height	
KIRC	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.28	-7.62	1.23E-13	Height	
KIRC	cis	1	rs224333	chr20:34023962	CPNE1	chr20:34213968-34262539:-	-0.26	-5.12	4.37E-7	Height	
KIRC	cis	1	rs224333	chr20:34023962	FER1L4	chr20:34146508-34195484:-	-0.11	-3.55	0.00042	Height	
KIRC	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.28	-7.29	1.21E-12	Height	
KIRC	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.28	5.31	1.64E-7	Diabetic kidney disease	
KIRC	cis	1	rs2243480	chr7:65599196	CRCP	chr7:65579805-65619551:+	-0.34	-4.52	7.62E-6	Diabetic kidney disease	
KIRC	cis	1	rs2244508	chr11:77948515	NARS2	chr11:78147017-78285909:-	-0.16	-3.55	0.000425	Testicular germ cell tumor	
KIRC	cis	1	rs2245133	chr6:131931092	ENPP3	chr6:131949582-132068549:+	0.24	3.74	0.000203	L-arginine levels	
KIRC	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.57	-9.63	2.85E-20	Tumor biomarkers	
KIRC	cis	1	rs2245715	chr15:43818052	STRC	chr15:43891762-43924561:-	0.2	3.95	8.97E-5	Tumor biomarkers	
KIRC	cis	1	rs2245715	chr15:43818052	TUBGCP4	chr15:43663313-43698238:+	0.19	3.98	8.02E-5	Tumor biomarkers	
KIRC	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.3	8.63	8.05E-17	Fibrinogen levels	
KIRC	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.31	8.68	5.65E-17	Fibrinogen levels	
KIRC	cis	1	rs2247139	chr12:122380274	WDR66	chr12:122356480-122441830:+	-0.33	-3.5	0.000514	Urinary metabolites	
KIRC	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.28	-5.57	4.12E-8	Height	
KIRC	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.27	-7.42	4.98E-13	Height	
KIRC	cis	1	rs2248551	chr6:131924689	ENPP3	chr6:131949582-132068549:+	0.24	4.02	6.77E-5	L-arginine levels	
KIRC	cis	1	rs2250752	chr12:51106091	LIMA1	chr12:50569565-50677353:-	-0.25	-4.87	1.52E-6	Fibrinogen	
KIRC	cis	1	rs2250886	chr11:6529642	FXC1	chr11:6502677-6505910:+	-0.15	-3.9	0.000108	DNA methylation (variation)	
KIRC	cis	1	rs2250886	chr11:6529642	RRP8	chr11:6621154-6624811:-	-0.15	-3.5	0.000501	DNA methylation (variation)	
KIRC	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.45	-11.07	1.29E-25	Homocysteine levels	
KIRC	cis	1	rs2251115	chr6:49446509	MUT	chr6:49398994-49431031:-	0.12	3.86	0.000129	Homocysteine levels	
KIRC	cis	1	rs2251603	chr12:51049653	LIMA1	chr12:50569565-50677353:-	0.24	4.82	1.88E-6	Fibrinogen	
KIRC	cis	1	rs2251773	chr12:48851822	ZNF641	chr12:48735912-48745021:-	-0.15	-3.49	0.000522	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.56	-9.44	1.45E-19	Tumor biomarkers	
KIRC	cis	1	rs2251844	chr15:43836478	STRC	chr15:43891762-43924561:-	0.19	3.94	9.31E-5	Tumor biomarkers	
KIRC	cis	1	rs2251844	chr15:43836478	TUBGCP4	chr15:43663313-43698238:+	0.19	4.16	3.75E-5	Tumor biomarkers	
KIRC	cis	1	rs2252259	chr20:47662823	CSE1L	chr20:47662838-47713484:+	-0.18	-4.66	4.07E-6	Anger	
KIRC	cis	1	rs2252502	chr7:158738634	WDR60	chr7:158649269-158738882:+	0.21	5.29	1.87E-7	Height	
KIRC	cis	1	rs2252589	chr12:51041957	LIMA1	chr12:50569565-50677353:-	-0.24	-4.74	2.76E-6	Fibrinogen	
KIRC	cis	1	rs2253209	chr3:53115160	ITIH3	chr3:52828784-52843025:+	0.15	3.81	0.000156	Height	
KIRC	cis	1	rs2253209	chr3:53115160	ITIH4	chr3:52847007-52866554:-	0.14	3.63	0.000312	Height	
KIRC	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.44	-11.6	1.0E-27	Height	
KIRC	cis	1	rs2253213	chr1:11265785	MTOR	chr1:11166589-11322608:-	-0.16	-4	7.18E-5	Body mass index	
KIRC	cis	1	rs2253612	chr2:201568433	CASP8	chr2:202098166-202152434:+	-0.25	-4.24	2.72E-5	Alcohol dependence	
KIRC	cis	1	rs2253612	chr2:201568433	KCTD18	chr2:201353686-201374792:-	-0.25	-4.16	3.67E-5	Alcohol dependence	
KIRC	cis	1	rs2253612	chr2:201568433	ORC2L	chr2:201774895-201828410:-	-0.2	-3.99	7.62E-5	Alcohol dependence	
KIRC	cis	1	rs2253656	chr3:53119099	ITIH3	chr3:52828784-52843025:+	0.15	3.78	0.000173	Height	
KIRC	cis	1	rs2253656	chr3:53119099	ITIH4	chr3:52847007-52866554:-	0.14	3.52	0.000472	Height	
KIRC	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.44	-11.51	2.34E-27	Height	
KIRC	cis	1	rs2253685	chr3:53119703	ITIH3	chr3:52828784-52843025:+	0.15	3.88	0.000121	Height	
KIRC	cis	1	rs2253685	chr3:53119703	ITIH4	chr3:52847007-52866554:-	0.14	3.64	0.000304	Height	
KIRC	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.45	-11.9	5.91E-29	Height	
KIRC	cis	1	rs2253796	chr3:53120098	ITIH3	chr3:52828784-52843025:+	0.15	3.82	0.000148	Height	
KIRC	cis	1	rs2253796	chr3:53120098	ITIH4	chr3:52847007-52866554:-	0.14	3.61	0.000331	Height	
KIRC	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.45	-11.9	5.96E-29	Height	
KIRC	cis	1	rs2253998	chr14:102496352	RAGE	chr14:102690838-102771531:-	0.16	3.93	9.58E-5	Menopause (age at onset)	
KIRC	cis	1	rs2254230	chr9:131905177	CRAT	chr9:131857075-131873070:-	-0.15	-3.54	0.000442	Blood metabolite ratios	
KIRC	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.55	9.23	7.76E-19	Tumor biomarkers	
KIRC	cis	1	rs2255042	chr15:43834318	STRC	chr15:43891762-43924561:-	-0.19	-3.91	0.000106	Tumor biomarkers	
KIRC	cis	1	rs2255042	chr15:43834318	TUBGCP4	chr15:43663313-43698238:+	-0.17	-3.63	0.000308	Tumor biomarkers	
KIRC	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.56	-9.41	1.76E-19	Tumor biomarkers	
KIRC	cis	1	rs2255051	chr15:43846161	STRC	chr15:43891762-43924561:-	0.2	4.1	4.89E-5	Tumor biomarkers	
KIRC	cis	1	rs2255051	chr15:43846161	TUBGCP4	chr15:43663313-43698238:+	0.19	4.08	5.13E-5	Tumor biomarkers	
KIRC	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.57	-9.52	7.3E-20	Tumor biomarkers	
KIRC	cis	1	rs2255440	chr15:43830467	STRC	chr15:43891762-43924561:-	0.2	4.1	4.8E-5	Tumor biomarkers	
KIRC	cis	1	rs2255440	chr15:43830467	TUBGCP4	chr15:43663313-43698238:+	0.19	4.02	6.84E-5	Tumor biomarkers	
KIRC	cis	1	rs2256686	chr20:44017331	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.61	0.000342	Psoriasis	
KIRC	cis	1	rs2256920	chr11:6508124	FXC1	chr11:6502677-6505910:+	-0.16	-4.05	5.95E-5	DNA methylation (variation)	
KIRC	cis	1	rs2257420	chr20:25275890	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.61E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.27	-5.14	3.88E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257432	chr20:25271086	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257496	chr20:25279315	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs2257790	chr7:65600450	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs2257808	chr20:25266450	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.41	3.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.28	-5.2	2.9E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257809	chr20:25266476	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.41	3.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.28	-5.2	2.9E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257982	chr20:25269630	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.78E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.27	-5.19	3.01E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257985	chr20:25269743	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257988	chr20:25270003	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257991	chr20:25270339	ENTPD6	chr20:25176339-25207360:+	0.23	6.31	6.11E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2257991	chr20:25270339	FAM182A	chr20:26035250-26067552:+	0.27	5.01	7.72E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258066	chr20:25271326	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258135	chr20:25272323	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258201	chr20:25272490	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258563	chr20:25273435	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258617	chr20:25274318	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258719	chr20:25275843	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.6	1.04E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.32	-6.05	2.78E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258769	chr20:25276680	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258879	chr20:25279213	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258884	chr20:25279539	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259837	chr20:25280205	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259873	chr20:25280781	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259926	chr20:25281733	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259928	chr20:25281834	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259956	chr20:25282433	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.32	5.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.96E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2262909	chr19:22135270	ZNF208	chr19:22115760-22193745:-	0.26	4.35	1.64E-5	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2262909	chr19:22135270	ZNF257	chr19:22235266-22273901:+	0.4	7.11	4.12E-12	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2263759	chr20:44011502	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.57	0.000391	Psoriasis	
KIRC	cis	1	rs2263764	chr20:44025815	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000442	Psoriasis	
KIRC	cis	1	rs2266967	chr22:22156789	MAPK1	chr22:22113949-22221970:-	0.2	5.81	1.13E-8	Multiple sclerosis	
KIRC	cis	1	rs2267393	chr22:39101619	LOC646851	chr22:38974125-39052634:-	0.11	3.57	0.000396	Resting heart rate	
KIRC	cis	1	rs2267394	chr22:39101633	LOC646851	chr22:38974125-39052634:-	0.11	3.57	0.000396	Resting heart rate	
KIRC	cis	1	rs2268617	chr14:75608728	MLH3	chr14:75480467-75518235:-	0.25	6.4	3.55E-10	Height	
KIRC	cis	1	rs2268617	chr14:75608728	NEK9	chr14:75548819-75593778:-	0.15	4.28	2.28E-5	Height	
KIRC	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.17	4.34	1.71E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.15	4.15	3.83E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.16	4.15	3.84E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs2268957	chr14:66113233	LOC645431	chr14:65877313-65879335:-	0.49	6.5	1.89E-10	Ischemic stroke	
KIRC	cis	1	rs2268958	chr14:66128238	LOC645431	chr14:65877313-65879335:-	-0.55	-6.75	4.13E-11	Ischemic stroke	
KIRC	cis	1	rs2268960	chr14:66145500	LOC645431	chr14:65877313-65879335:-	-0.49	-6.52	1.69E-10	Ischemic stroke	
KIRC	cis	1	rs2269186	chr14:104379912	TDRD9	chr14:104394817-104519002:+	0.25	3.79	0.000171	Bipolar disorder	
KIRC	cis	1	rs2269186	chr14:104379912	XRCC3	chr14:104163955-104181823:-	-0.13	-3.95	9.08E-5	Bipolar disorder	
KIRC	cis	1	rs2269381	chr22:51020069	CPT1B	chr22:51007291-51017096:-	-0.35	-5.91	6.36E-9	Narcolepsy	
KIRC	cis	1	rs2269382	chr22:51018911	CPT1B	chr22:51007291-51017096:-	-0.35	-6.04	3.05E-9	Narcolepsy	
KIRC	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.17	3.54	0.000443	Height	
KIRC	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.34	7.52	2.47E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2270291	chr1:156244992	CCT3	chr1:156278752-156308195:-	-0.19	-4.8	2.13E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2270369	chr16:50714333	SNX20	chr16:50700211-50715264:-	0.07	3.74	0.000202	Leprosy	
KIRC	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.76	-11.74	2.65E-28	Diastolic blood pressure	
KIRC	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.73	-11.22	3.32E-26	Diastolic blood pressure	
KIRC	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.63	-7.89	1.87E-14	Rheumatoid arthritis	
KIRC	cis	1	rs2272563	chr11:236871	PSMD13	chr11:236808-252984:+	-0.15	-5.03	6.91E-7	Menarche (age at onset)	
KIRC	cis	1	rs2272565	chr11:244414	PSMD13	chr11:236808-252984:+	-0.15	-5.07	5.71E-7	Menarche (age at onset)	
KIRC	cis	1	rs2272695	chr4:103555803	MANBA	chr4:103552644-103682151:-	0.17	3.81	0.000155	Primary biliary cirrhosis	
KIRC	cis	1	rs2272696	chr4:103555821	MANBA	chr4:103552644-103682151:-	0.17	3.81	0.000155	Primary biliary cirrhosis	
KIRC	cis	1	rs2272697	chr4:103555992	MANBA	chr4:103552644-103682151:-	0.17	3.81	0.000155	Primary biliary cirrhosis	
KIRC	cis	1	rs2273130	chr6:88219037	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs2273610	chr14:104387642	TDRD9	chr14:104394817-104519002:+	0.24	3.6	0.000353	Bipolar disorder	
KIRC	cis	1	rs2273610	chr14:104387642	XRCC3	chr14:104163955-104181823:-	-0.12	-3.65	0.000294	Bipolar disorder	
KIRC	cis	1	rs2273653	chr20:47770756	CSE1L	chr20:47662838-47713484:+	0.15	3.72	0.000226	Anger	
KIRC	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.14	-4.78	2.32E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2273695	chr10:102259568	SEC31B	chr10:102246403-102289636:-	-0.15	-5.08	5.28E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2273832	chr1:156233143	BGLAP	chr1:156182784-156213112:+	0.32	6.8	2.9E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2273832	chr1:156233143	CCT3	chr1:156278752-156308195:-	-0.2	-4.81	1.99E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2273833	chr1:156233189	BGLAP	chr1:156182784-156213112:+	0.32	6.82	2.62E-11	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2273833	chr1:156233189	CCT3	chr1:156278752-156308195:-	-0.19	-4.77	2.41E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.51	10.44	3.23E-23	Longevity	
KIRC	cis	1	rs2274273	chr14:55614636	KIAA0831	chr14:55833110-55878576:-	0.14	3.74	0.000205	Protein biomarker	
KIRC	cis	1	rs2275424	chr1:10356562	RBP7	chr1:10057255-10076077:+	0.15	3.56	0.000399	Hepatocellular carcinoma	
KIRC	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.66	6.49E-17	Body mass index	
KIRC	cis	1	rs2275426	chr1:46487552	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.84E-5	Body mass index	
KIRC	cis	1	rs2276014	chr11:64081445	C11orf20	chr11:64067863-64072238:+	-0.36	-5.47	7.25E-8	Mean platelet volume	
KIRC	cis	1	rs2276153	chr11:58407740	ZFP91	chr11:58346587-58388513:+	-0.13	-3.8	0.00016	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2276161	chr2:135470735	TMEM163	chr2:135213331-135525334:-	-0.3	-4.31	1.98E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.16	4.16	3.81E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.49	-10.09	6.56E-22	Body mass index	
KIRC	cis	1	rs2277027	chr5:156932376	ADAM19	chr5:156822542-157002768:-	0.12	4.33	1.82E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.68	-12.41	5.09E-31	Cholesterol, total	
KIRC	cis	1	rs2277862	chr20:34152782	ERGIC3	chr20:34129778-34145404:+	-0.24	-5.47	7.22E-8	Cholesterol, total	
KIRC	cis	1	rs2277862	chr20:34152782	UQCC	chr20:33890383-33999833:-	-0.2	-4.27	2.39E-5	Cholesterol, total	
KIRC	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.17	-3.87	0.000122	Colorectal cancer	
KIRC	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.34	7.52	2.47E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2277870	chr1:156246792	CCT3	chr1:156278752-156308195:-	-0.19	-4.8	2.13E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.34	7.52	2.47E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2277871	chr1:156246742	CCT3	chr1:156278752-156308195:-	-0.19	-4.8	2.13E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2278238	chr19:18576484	SSBP4	chr19:18530221-18545371:+	-0.13	-4.62	4.99E-6	Breast cancer	
KIRC	cis	1	rs2279077	chr3:48474249	SHISA5	chr3:48509197-48542228:-	-0.13	-3.66	0.000276	Longevity	
KIRC	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.33	-9.31	3.92E-19	Longevity	
KIRC	cis	1	rs2279144	chr19:39201781	CAPN12	chr19:39220832-39235114:-	-0.14	-4.46	1.02E-5	Heart rate	
KIRC	cis	1	rs2279581	chr15:40300092	RPUSD2	chr15:40861537-40866661:+	-0.25	-3.7	0.000242	Response to haloperidol in psychosis	
KIRC	cis	1	rs2279581	chr15:40300092	SRP14	chr15:40327891-40331389:-	-0.28	-4.67	3.87E-6	Response to haloperidol in psychosis	
KIRC	cis	1	rs2280141	chr10:124193181	ARMS2	chr10:124214179-124216867:+	-0.19	-3.7	0.000236	Height	
KIRC	cis	1	rs2281019	chr22:39064378	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs2281020	chr22:39064406	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs2281021	chr22:39064667	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs2281494	chr20:3235494	ITPA	chr20:3190056-3204504:+	-0.27	-6.5	2.0E-10	IFN-related cytopenia	
KIRC	cis	1	rs2281497	chr20:3258874	ITPA	chr20:3190056-3204504:+	-0.27	-6.46	2.41E-10	IFN-related cytopenia	
KIRC	cis	1	rs2281500	chr20:3262824	ITPA	chr20:3190056-3204504:+	-0.28	-6.79	3.1E-11	IFN-related cytopenia	
KIRC	cis	1	rs2281503	chr20:3263636	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs2282679	chr4:72608383	NPFFR2	chr4:72897521-73018748:+	-0.19	-3.5	0.000504	Vitamin D levels;Vitamin D insufficiency	
KIRC	cis	1	rs2283231	chr11:2916715	SLC22A18	chr11:2920951-2946475:+	0.21	4.18	3.45E-5	Gout	
KIRC	cis	1	rs2283792	chr22:22131125	MAPK1	chr22:22113949-22221970:-	0.21	5.96	4.78E-9	Multiple sclerosis	
KIRC	cis	1	rs2285087	chr4:3088211	GRK4	chr4:2965343-3042474:+	-0.22	-4	7.31E-5	Parental longevity (mother's age at death)	
KIRC	cis	1	rs2285657	chr17:40272594	DHX58	chr17:40253422-40264751:-	-0.35	-6.84	2.35E-11	Fibrinogen levels	
KIRC	cis	1	rs2285810	chr12:112699540	C12orf47	chr12:112277573-112280706:-	0.16	4.13	4.26E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs2285810	chr12:112699540	TMEM116	chr12:112369103-112450989:-	0.17	3.89	0.000116	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs2285946	chr7:21583329	CDCA7L	chr7:21940518-21985542:-	-0.16	-3.59	0.00036	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.89	-25.35	6.81E-92	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285947	chr7:21584088	CDCA7L	chr7:21940518-21985542:-	0.15	3.51	0.000485	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.88	25.29	1.33E-91	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285949	chr7:21584243	CDCA7L	chr7:21940518-21985542:-	-0.16	-3.62	0.000325	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.89	-25.68	1.72E-93	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285950	chr7:21584432	CDCA7L	chr7:21940518-21985542:-	0.16	3.61	0.000333	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.9	26	4.82E-95	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs2286498	chr7:22857504	TRA2A	chr7:23544402-23571656:-	0.12	3.55	0.000416	Fibrinogen	
KIRC	cis	1	rs2286614	chr11:64068310	C11orf20	chr11:64067863-64072238:+	-0.36	-5.43	8.61E-8	Mean platelet volume	
KIRC	cis	1	rs2286684	chr7:66129830	LOC493754	chr7:65993446-66057363:-	0.17	3.65	0.00029	Aortic root size	
KIRC	cis	1	rs2286771	chr4:17643848	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.75E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2286771	chr4:17643848	MED28	chr4:17616273-17629791:+	0.18	3.98	7.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2286809	chr11:22851455	SVIP	chr11:22843600-22851382:-	0.33	7.33	9.24E-13	Dialysis-related mortality	
KIRC	cis	1	rs2287670	chr19:33095057	ANKRD27	chr19:33087907-33166102:-	0.33	5.02	7.07E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs2287670	chr19:33095057	RGS9BP	chr19:33166313-33169206:+	0.28	3.69	0.000246	Eosinophilic esophagitis	
KIRC	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.25	5.91	6.39E-9	Bone properties (heel)	
KIRC	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.25	-5.86	8.24E-9	Bone properties (heel)	
KIRC	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.43	-7.5	2.97E-13	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs2288073	chr2:24413298	LOC375190	chr2:24299728-24397519:+	0.28	6.64	8.19E-11	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs2288344	chr15:56122347	NEDD4	chr15:56119131-56285835:-	0.22	5.27	2.08E-7	Keloid	
KIRC	cis	1	rs2288871	chr19:41917868	ATP5SL	chr19:41937224-41945810:-	0.15	3.58	0.000375	Height	
KIRC	cis	1	rs2289130	chr18:44626630	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs2289131	chr18:44602864	HDHD2	chr18:44633782-44676871:-	0.38	3.92	9.95E-5	Sitting height ratio	
KIRC	cis	1	rs2289132	chr18:44602292	HDHD2	chr18:44633782-44676871:-	0.38	3.92	9.95E-5	Sitting height ratio	
KIRC	cis	1	rs2289258	chr12:104173880	NT5DC3	chr12:104164231-104234975:-	-0.3	-3.87	0.000121	Sense of smell	
KIRC	cis	1	rs2289329	chr15:40705159	C15orf23	chr15:40674922-40686488:+	-0.18	-4.06	5.61E-5	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs2289329	chr15:40705159	DISP2	chr15:40650434-40663256:+	0.33	6.35	4.97E-10	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs2289836	chr14:76640125	ESRRB	chr14:76837690-76968178:+	-0.32	-4.48	9.34E-6	Blood pressure	
KIRC	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.31	-9.1	2.12E-18	Longevity	
KIRC	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.46	-9.51	8.0E-20	Subjective well-being	
KIRC	cis	1	rs2290850	chr11:47807774	PSMC3	chr11:47440320-47448024:-	0.12	3.55	0.000425	Subjective well-being	
KIRC	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.28	-5.69	2.15E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs2291361	chr12:56717805	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs2291361	chr12:56717805	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs2291738	chr12:56815281	TIMELESS	chr12:56810157-56843200:-	-0.17	-4.66	4.07E-6	Axial length	
KIRC	cis	1	rs2292030	chr5:132161294	LEAP2	chr5:132209358-132210581:+	0.32	4.82	1.87E-6	Apolipoprotein A-IV levels	
KIRC	cis	1	rs2292030	chr5:132161294	SHROOM1	chr5:132158012-132166590:-	0.3	5.42	9.45E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs2292174	chr15:50924956	SPPL2A	chr15:50999739-51057910:-	0.29	7.69	8.03E-14	QT interval	
KIRC	cis	1	rs2292174	chr15:50924956	TRPM7	chr15:50852491-50978994:-	0.13	3.68	0.000258	QT interval	
KIRC	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.75	15.3	1.21E-43	Cognitive function	
KIRC	cis	1	rs2292572	chr11:78052864	NARS2	chr11:78147017-78285909:-	-0.2	-4.72	2.99E-6	Testicular germ cell tumor	
KIRC	cis	1	rs2292573	chr11:78053139	NARS2	chr11:78147017-78285909:-	-0.21	-4.88	1.4E-6	Testicular germ cell tumor	
KIRC	cis	1	rs2292626	chr10:124186714	ARMS2	chr10:124214179-124216867:+	-0.18	-3.51	0.000494	Height	
KIRC	cis	1	rs2292986	chr19:21776332	ZNF429	chr19:21688437-21739068:+	-0.19	-3.66	0.000278	Colorectal or endometrial cancer	
KIRC	cis	1	rs2293167	chr11:211644	PSMD13	chr11:236808-252984:+	0.15	4.88	1.45E-6	Menarche (age at onset)	
KIRC	cis	1	rs2294008	chr8:143761931	LY6K	chr8:143781529-143785582:+	0.26	4.48	9.45E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294008	chr8:143761931	LYNX1	chr8:143845758-143859640:-	-0.21	-4.2	3.17E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294008	chr8:143761931	PSCA	chr8:143761875-143764142:+	0.21	3.72	0.000224	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294010	chr8:143762430	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.35E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294010	chr8:143762430	LYNX1	chr8:143845758-143859640:-	-0.21	-4.11	4.71E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294010	chr8:143762430	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000162	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2294296	chr22:39053049	LOC646851	chr22:38974125-39052634:-	0.15	4.48	9.41E-6	Resting heart rate	
KIRC	cis	1	rs2295028	chr20:47582958	CSE1L	chr20:47662838-47713484:+	-0.17	-4.58	5.81E-6	Anger	
KIRC	cis	1	rs2295135	chr14:88894210	SPATA7	chr14:88852012-88904802:+	-0.2	-4.03	6.4E-5	Coronary artery calcification	
KIRC	cis	1	rs2295714	chr20:47739814	CSE1L	chr20:47662838-47713484:+	0.18	4.77	2.43E-6	Anger	
KIRC	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.14E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.16	-5.4	1.01E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.16	-5.4	1.01E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.17	-5.41	9.95E-8	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.13	-4.54	7.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295779	chr10:102296061	SEC31B	chr10:102246403-102289636:-	-0.14	-4.76	2.57E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.14	-4.48	9.46E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2295872	chr10:38146218	LOC399744	chr10:38717074-38741080:+	0.23	3.84	0.000137	Obesity (extreme)	
KIRC	cis	1	rs2295888	chr20:33722863	PROCR	chr20:33758727-33765164:+	-0.26	-3.67	0.000264	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs2296375	chr1:156309372	BGLAP	chr1:156182784-156213112:+	0.34	7.24	1.74E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2296375	chr1:156309372	CCT3	chr1:156278752-156308195:-	-0.16	-3.73	0.000212	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.24	6.4	3.49E-10	Blood metabolite levels	
KIRC	cis	1	rs2296747	chr6:33744882	LEMD2	chr6:33738991-33756906:-	-0.16	-4.01	7.05E-5	Crohn's disease	
KIRC	cis	1	rs2296748	chr6:33745071	LEMD2	chr6:33738991-33756906:-	-0.15	-3.82	0.000149	Crohn's disease	
KIRC	cis	1	rs2297112	chr9:131900180	SET	chr9:131445934-131458674:+	-0.18	-3.94	9.28E-5	Blood metabolite ratios	
KIRC	cis	1	rs2297496	chr20:25295787	ENTPD6	chr20:25176339-25207360:+	0.24	6.42	3.24E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.28	5.3	1.74E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2297497	chr20:25297909	ENTPD6	chr20:25176339-25207360:+	0.24	6.46	2.45E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.28	5.32	1.61E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.15	-4.79	2.25E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.14	-4.81	2.03E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2298456	chr11:71730715	C11orf59	chr11:71808339-71814322:-	0.19	3.5	0.000513	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2298457	chr11:71734211	C11orf59	chr11:71808339-71814322:-	-0.22	-3.85	0.000133	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2298608	chr11:58404467	ZFP91	chr11:58346587-58388513:+	0.12	3.5	0.000499	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2298948	chr2:75926565	MRPL19	chr2:75873909-75897879:+	0.18	4.06	5.63E-5	Hippocampal atrophy	
KIRC	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.24	5.88	7.64E-9	Height	
KIRC	cis	1	rs2300601	chr14:75639571	NEK9	chr14:75548819-75593778:-	0.15	4.2	3.14E-5	Height	
KIRC	cis	1	rs2300867	chr14:66129154	LOC645431	chr14:65877313-65879335:-	-0.49	-6.45	2.6E-10	Ischemic stroke	
KIRC	cis	1	rs2300871	chr14:66147694	LOC645431	chr14:65877313-65879335:-	0.46	6.17	1.43E-9	Ischemic stroke	
KIRC	cis	1	rs2300872	chr14:66147761	LOC645431	chr14:65877313-65879335:-	-0.52	-6.51	1.81E-10	Ischemic stroke	
KIRC	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.36	4.47	9.57E-6	Blood metabolite levels	
KIRC	cis	1	rs2302138	chr14:74363305	LIN52	chr14:74551656-74667117:+	0.26	4.57	6.16E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs2302138	chr14:74363305	PTGR2	chr14:74318534-74352166:+	0.26	3.82	0.000149	Morning vs. evening chronotype	
KIRC	cis	1	rs2302139	chr14:74362935	LIN52	chr14:74551656-74667117:+	0.24	4.41	1.29E-5	Morning vs. evening chronotype	
KIRC	cis	1	rs2302190	chr17:56584508	TRIM37	chr17:57060002-57184266:-	0.18	4.13	4.3E-5	Vitamin D levels	
KIRC	cis	1	rs2303040	chr19:39138608	CAPN12	chr19:39220832-39235114:-	-0.13	-3.91	0.000105	Heart rate	
KIRC	cis	1	rs2303129	chr5:78324482	ARSB	chr5:78073039-78282357:-	-0.2	-4.22	2.86E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2303129	chr5:78324482	BHMT	chr5:78407604-78428112:+	-0.26	-5.46	7.42E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2303339	chr2:86346180	LOC90784	chr2:86247339-86250991:-	0.34	3.51	0.000494	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs2303695	chr19:18562624	SSBP4	chr19:18530221-18545371:+	-0.13	-4.46	1.03E-5	Breast cancer	
KIRC	cis	1	rs2303697	chr19:18546678	SSBP4	chr19:18530221-18545371:+	-0.14	-4.65	4.24E-6	Breast cancer	
KIRC	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.27	-5.01	7.66E-7	Multiple sclerosis	
KIRC	cis	1	rs2303759	chr19:49869051	SLC6A16	chr19:49792894-49828474:-	0.19	3.51	0.000489	Multiple sclerosis	
KIRC	cis	1	rs2304242	chr19:41944616	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.59	0.000361	Height	
KIRC	cis	1	rs2306693	chr12:56680531	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs2306694	chr12:56680636	RPS26	chr12:56435686-56438005:+	0.52	4.6	5.33E-6	Psoriasis vulgaris	
KIRC	cis	1	rs2306786	chr15:59487930	LDHAL6B	chr15:59499042-59500707:+	-0.34	-3.93	9.63E-5	Metabolite levels	
KIRC	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.5	7.42	4.94E-13	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.52	8.18	2.43E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs2307383	chr6:88367560	C6orf164	chr6:88032306-88109459:+	0.3	3.64	0.000301	Obesity-related traits	
KIRC	cis	1	rs2307389	chr6:88318883	C6orf164	chr6:88032306-88109459:+	0.33	4	7.22E-5	Obesity-related traits	
KIRC	cis	1	rs230812	chr5:42797761	CCDC152	chr5:42756920-42802539:+	-0.22	-4.96	9.65E-7	Height	
KIRC	cis	1	rs230813	chr5:42799033	CCDC152	chr5:42756920-42802539:+	-0.22	-4.96	9.65E-7	Height	
KIRC	cis	1	rs230814	chr5:42799271	CCDC152	chr5:42756920-42802539:+	-0.22	-4.96	9.65E-7	Height	
KIRC	cis	1	rs2309757	chr2:100807725	LONRF2	chr2:100889754-100939195:-	0.26	4.72	3.01E-6	Educational attainment (college completion)	
KIRC	cis	1	rs2309757	chr2:100807725	PDCL3	chr2:101179418-101193201:+	-0.19	-4.06	5.77E-5	Educational attainment (college completion)	
KIRC	cis	1	rs2310997	chr3:48678011	WDR6	chr3:49044637-49053386:+	0.28	4.5	8.4E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2311439	chr17:76080086	LGALS3BP	chr17:76967336-76976061:-	0.22	3.49	0.000527	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs2312462	chr3:49601255	CCDC36	chr3:49235861-49295537:+	0.26	5.25	2.3E-7	Menarche (age at onset)	
KIRC	cis	1	rs2312462	chr3:49601255	NCKIPSD	chr3:48711280-48723334:-	0.21	4.42	1.19E-5	Menarche (age at onset)	
KIRC	cis	1	rs2312462	chr3:49601255	P4HTM	chr3:49027341-49044579:+	0.17	4.1	4.92E-5	Menarche (age at onset)	
KIRC	cis	1	rs2312462	chr3:49601255	WDR6	chr3:49044637-49053386:+	-0.24	-6.58	1.21E-10	Menarche (age at onset)	
KIRC	cis	1	rs2315281	chr19:19480099	HAPLN4	chr19:19366453-19384074:-	-0.31	-6.77	3.62E-11	Schizophrenia	
KIRC	cis	1	rs2315281	chr19:19480099	SF4	chr19:19387323-19431307:-	-0.14	-3.72	0.000221	Schizophrenia	
KIRC	cis	1	rs2315504	chr17:39046881	TMEM99	chr17:38975374-38992526:+	-0.21	-4.34	1.72E-5	Height	
KIRC	cis	1	rs2315556	chr4:17670861	LAP3	chr4:17578927-17609590:+	-0.21	-6.41	3.42E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2315556	chr4:17670861	MED28	chr4:17616273-17629791:+	0.17	3.79	0.000169	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2315560	chr4:17677305	LAP3	chr4:17578927-17609590:+	-0.2	-6.35	4.7E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2315560	chr4:17677305	MED28	chr4:17616273-17629791:+	0.16	3.65	0.00029	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2315561	chr4:17679695	LAP3	chr4:17578927-17609590:+	-0.21	-6.46	2.44E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs231873	chr11:2785542	LOC100133545	chr11:2004440-2011150:-	-0.21	-3.85	0.000133	Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs231876	chr11:2784661	LOC100133545	chr11:2004440-2011150:-	-0.2	-3.64	0.000306	Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs2319398	chr3:119612942	GSK3B	chr3:119540804-119813264:-	0.15	4.04	6.22E-5	HDL cholesterol	
KIRC	cis	1	rs2319399	chr3:119636207	GSK3B	chr3:119540804-119813264:-	0.14	3.85	0.000135	HDL cholesterol	
KIRC	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.48	-10.12	4.94E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs2326387	chr6:126680489	CENPW	chr6:126661253-126804465:+	-0.15	-4.86	1.59E-6	Type 1 diabetes	
KIRC	cis	1	rs2326680	chr20:5942955	MCM8	chr20:5931298-5975829:+	-0.3	-7.49	3.18E-13	HIV-1 viral setpoint	
KIRC	cis	1	rs2329340	chr7:50620229	FIGNL1	chr7:50511834-50518088:-	-0.21	-4.32	1.86E-5	Malaria	
KIRC	cis	1	rs2329341	chr7:50620275	FIGNL1	chr7:50511834-50518088:-	-0.21	-4.32	1.86E-5	Malaria	
KIRC	cis	1	rs2329342	chr7:50624971	FIGNL1	chr7:50511834-50518088:-	0.23	4.66	4.12E-6	Malaria	
KIRC	cis	1	rs2331903	chr1:180950869	MR1	chr1:181003139-181024633:+	-0.13	-3.65	0.000285	Progressive supranuclear palsy	
KIRC	cis	1	rs2336723	chr3:53106047	ITIH4	chr3:52847007-52866554:-	0.14	3.61	0.000336	Height	
KIRC	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.44	-11.49	2.8E-27	Height	
KIRC	cis	1	rs2338555	chr1:152309380	HRNR	chr1:152184558-152196669:-	-0.27	-4.54	7.12E-6	Atopic dermatitis	
KIRC	cis	1	rs2338556	chr1:152309427	HRNR	chr1:152184558-152196669:-	-0.27	-4.54	7.12E-6	Atopic dermatitis	
KIRC	cis	1	rs2339345	chr18:49957255	DCC	chr18:49866571-51057782:+	-0.2	-3.58	0.000382	Glucose homeostasis traits	
KIRC	cis	1	rs2340536	chr8:96010435	C8orf38	chr8:95908040-96088396:+	-0.27	-3.79	0.000172	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs2340952	chr8:39823239	IDO2	chr8:39792474-39873910:+	0.18	3.92	0.0001	Blood metabolite levels	
KIRC	cis	1	rs2344180	chr5:150267357	IRGM	chr5:150226085-150280295:+	0.5	6.79	3.12E-11	Crohn's disease	
KIRC	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.34	4.58	5.94E-6	Crohn's disease	
KIRC	cis	1	rs2344181	chr5:150262574	IRGM	chr5:150226085-150280295:+	0.5	6.78	3.3E-11	Crohn's disease	
KIRC	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.33	4.44	1.1E-5	Crohn's disease	
KIRC	cis	1	rs2345001	chr5:150266518	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs2346177	chr2:46642249	CRIPT	chr2:46844325-46852880:+	-0.17	-4.07	5.44E-5	HDL cholesterol	
KIRC	cis	1	rs2346177	chr2:46642249	SRBD1	chr2:45615820-45838433:-	-0.16	-3.83	0.000145	HDL cholesterol	
KIRC	cis	1	rs2349075	chr2:202223566	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.94	1.09E-6	Basal cell carcinoma	
KIRC	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.63	-14.11	2.65E-38	Type 2 diabetes	
KIRC	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.62	-14.02	6.34E-38	Type 2 diabetes	
KIRC	cis	1	rs2353312	chr4:48369395	OCIAD1	chr4:48833015-48863831:+	0.23	5.23	2.55E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.42	7.3	1.11E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.92	-22.64	1.03E-78	Homocysteine levels	
KIRC	cis	1	rs2356559	chr1:45981512	MUTYH	chr1:45794915-45806142:-	0.13	3.84	0.000137	Homocysteine levels	
KIRC	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.86	-20.3	2.48E-67	Homocysteine levels	
KIRC	cis	1	rs2356561	chr1:45980862	MUTYH	chr1:45794915-45806142:-	0.14	4.05	5.88E-5	Homocysteine levels	
KIRC	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.36	-9.49	9.33E-20	Common traits (Other)	
KIRC	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.31	-8.41	4.15E-16	Common traits (Other)	
KIRC	cis	1	rs2359811	chr19:22152876	ZNF257	chr19:22235266-22273901:+	0.35	4.75	2.66E-6	Body mass index (change over time)	
KIRC	cis	1	rs2359820	chr19:22208114	ZNF257	chr19:22235266-22273901:+	0.34	4.72	3.05E-6	Body mass index (change over time)	
KIRC	cis	1	rs2359821	chr19:22208314	ZNF208	chr19:22115760-22193745:-	0.3	4.98	8.88E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.44	7.9	1.79E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2360977	chr14:76654481	ESRRB	chr14:76837690-76968178:+	0.33	4.72	3.01E-6	Blood pressure	
KIRC	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.29	-7.38	6.51E-13	HIV-1 viral setpoint	
KIRC	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.27	-6.91	1.44E-11	HIV-1 viral setpoint	
KIRC	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.3	-8.68	5.43E-17	Longevity	
KIRC	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.28	8.17	2.54E-15	Longevity	
KIRC	cis	1	rs2363286	chr7:1091625	ZFAND2A	chr7:1192544-1199855:-	-0.32	-5.56	4.45E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.67	-8.52	1.92E-16	Plasma clusterin levels	
KIRC	cis	1	rs2363736	chr11:71656967	C11orf59	chr11:71808339-71814322:-	-0.22	-4.04	6.24E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2364143	chr5:78316227	ARSB	chr5:78073039-78282357:-	-0.19	-4.01	7.12E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2364143	chr5:78316227	BHMT	chr5:78407604-78428112:+	-0.25	-5.17	3.3E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs2368395	chr10:29808562	LOC387647	chr10:29698483-29776785:+	0.21	3.99	7.71E-5	Platelet thrombus formation	
KIRC	cis	1	rs2368984	chr14:104372055	TDRD9	chr14:104394817-104519002:+	0.24	3.68	0.000254	Bipolar disorder	
KIRC	cis	1	rs2368984	chr14:104372055	XRCC3	chr14:104163955-104181823:-	-0.13	-3.98	7.85E-5	Bipolar disorder	
KIRC	cis	1	rs236918	chr11:117091609	PCSK7	chr11:117075789-117102811:-	0.31	5.9	6.79E-9	Protein quantitative trait loci	
KIRC	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.62	14.63	1.19E-40	Height	
KIRC	cis	1	rs2370578	chr3:134199612	CEP63	chr3:134204575-134293852:+	0.32	6.09	2.28E-9	Height	
KIRC	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.6	14.51	4.41E-40	Height	
KIRC	cis	1	rs2370641	chr3:134222161	CEP63	chr3:134204575-134293852:+	0.32	6.31	6.24E-10	Height	
KIRC	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.6	14.22	8.8E-39	Height	
KIRC	cis	1	rs2370642	chr3:134222136	CEP63	chr3:134204575-134293852:+	0.32	6.12	1.94E-9	Height	
KIRC	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.68	8.49E-14	Obesity-related traits	
KIRC	cis	1	rs2371244	chr7:143757611	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.51	5.89E-8	Obesity-related traits	
KIRC	cis	1	rs2371244	chr7:143757611	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.71E-16	Obesity-related traits	
KIRC	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.65	1.01E-13	Obesity-related traits	
KIRC	cis	1	rs2371247	chr7:143764179	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.41	9.85E-8	Obesity-related traits	
KIRC	cis	1	rs2371247	chr7:143764179	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.4	4.46E-16	Obesity-related traits	
KIRC	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs2371248	chr7:143764189	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs2371248	chr7:143764189	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs2371454	chr12:56647243	COQ10A	chr12:56660642-56664748:+	0.36	3.65	0.000295	Psoriasis vulgaris	
KIRC	cis	1	rs2371454	chr12:56647243	RPS26	chr12:56435686-56438005:+	0.5	4.32	1.88E-5	Psoriasis vulgaris	
KIRC	cis	1	rs2373115	chr11:78091150	NARS2	chr11:78147017-78285909:-	-0.16	-3.79	0.000166	Testicular germ cell tumor	
KIRC	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.86	1.15E-41	Height	
KIRC	cis	1	rs2373865	chr3:134291556	CEP63	chr3:134204575-134293852:+	-0.33	-6.45	2.69E-10	Height	
KIRC	cis	1	rs237741	chr20:47903680	CSE1L	chr20:47662838-47713484:+	-0.17	-3.59	0.000364	Height	
KIRC	cis	1	rs237743	chr20:47903019	CSE1L	chr20:47662838-47713484:+	0.17	3.55	0.000422	Height	
KIRC	cis	1	rs2381284	chr4:39119596	WDR19	chr4:39184024-39287429:+	0.18	4.84	1.77E-6	Uric acid levels	
KIRC	cis	1	rs2381285	chr4:39114395	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs238164	chr20:47844341	CSE1L	chr20:47662838-47713484:+	-0.17	-3.5	0.000498	Height	
KIRC	cis	1	rs238174	chr20:47879109	CSE1L	chr20:47662838-47713484:+	-0.17	-3.54	0.000439	Height	
KIRC	cis	1	rs238198	chr20:47899060	CSE1L	chr20:47662838-47713484:+	-0.17	-3.61	0.000332	Height	
KIRC	cis	1	rs238200	chr20:47899652	CSE1L	chr20:47662838-47713484:+	-0.17	-3.67	0.000268	Height	
KIRC	cis	1	rs2384654	chr2:27847364	NRBP1	chr2:27650657-27665122:+	0.14	3.71	0.000232	Oral cavity cancer	
KIRC	cis	1	rs2387299	chr10:1163427	IDI2	chr10:1064847-1071799:-	0.32	3.58	0.000378	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs2387880	chr20:25377787	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2387880	chr20:25377787	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2387881	chr20:25378172	ENTPD6	chr20:25176339-25207360:+	0.25	6.91	1.44E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2387881	chr20:25378172	FAM182A	chr20:26035250-26067552:+	0.29	5.47	7.29E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2387884	chr20:25379069	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2387884	chr20:25379069	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2391159	chr1:92971951	EVI5	chr1:92974255-93257961:-	-0.19	-4.53	7.33E-6	Cholesterol, total	
KIRC	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs239192	chr6:101131107	GRIK2	chr6:101846905-102517957:+	0.52	5.4	1.01E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs239200	chr6:101125201	GRIK2	chr6:101846905-102517957:+	0.52	5.4	1.01E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs239205	chr6:101136664	GRIK2	chr6:101846905-102517957:+	0.49	5.2	2.88E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs2392074	chr1:100257091	AGL	chr1:100315640-100389579:+	0.23	4.46	1.02E-5	White matter integrity (interaction)	
KIRC	cis	1	rs2392074	chr1:100257091	FRRS1	chr1:100174259-100231349:-	0.19	3.99	7.7E-5	White matter integrity (interaction)	
KIRC	cis	1	rs239214	chr6:101147110	GRIK2	chr6:101846905-102517957:+	0.57	6	3.88E-9	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs239243	chr6:101092265	GRIK2	chr6:101846905-102517957:+	0.49	5.33	1.49E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs2393593	chr6:26285683	HIST1H3G	chr6:26271147-26271612:-	0.19	3.62	0.000327	Educational attainment	
KIRC	cis	1	rs2393670	chr6:26535541	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs2393969	chr10:65140440	NRBF2	chr10:64893007-64914785:+	-0.27	-6.45	2.63E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2395400	chr6:33770076	LEMD2	chr6:33738991-33756906:-	0.2	4.51	8.07E-6	Body mass index	
KIRC	cis	1	rs2395449	chr6:33728755	LEMD2	chr6:33738991-33756906:-	-0.15	-3.74	0.000206	Crohn's disease	
KIRC	cis	1	rs239916	chr22:22316272	MAPK1	chr22:22113949-22221970:-	0.19	4.61	5.15E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs239916	chr22:22316272	YPEL1	chr22:22051828-22090071:-	0.19	3.52	0.000462	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs239919	chr22:22313128	MAPK1	chr22:22113949-22221970:-	0.19	4.62	4.9E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs2400865	chr12:81435638	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs2400865	chr12:81435638	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs2400866	chr12:81435788	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs2400866	chr12:81435788	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs2400979	chr12:82197353	PPFIA2	chr12:81652880-82153109:-	0.4	7.16	2.82E-12	Resting heart rate	
KIRC	cis	1	rs2401004	chr12:82214822	PPFIA2	chr12:81652880-82153109:-	0.39	6.97	9.83E-12	Resting heart rate	
KIRC	cis	1	rs2401172	chr15:84576957	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401173	chr15:84576970	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-4.28	2.24E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401174	chr15:84576992	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401175	chr15:84578217	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.36	1.57E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401176	chr15:84578364	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.48	9.13E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401179	chr15:84578948	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.46	1.02E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs2401180	chr15:84579186	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.46	1.02E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs240144	chr6:101080270	GRIK2	chr6:101846905-102517957:+	0.59	6.26	8.18E-10	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs240157	chr6:101062677	GRIK2	chr6:101846905-102517957:+	0.59	6.18	1.3E-9	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs2403083	chr8:86108149	LRRCC1	chr8:86019377-86058312:+	0.27	4.96	9.86E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs2404602	chr15:77030792	SCAPER	chr15:76640529-77197744:-	-0.16	-5.36	1.28E-7	Blood metabolite levels	
KIRC	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.16	-5.73	1.75E-8	Blood metabolite levels	
KIRC	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.16	-5.73	1.75E-8	Blood metabolite levels	
KIRC	cis	1	rs240782	chr6:100965257	GRIK2	chr6:101846905-102517957:+	0.55	5.89	7.19E-9	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs240785	chr6:100973377	GRIK2	chr6:101846905-102517957:+	-0.51	-5.65	2.73E-8	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs2412459	chr15:40295959	GCHFR	chr15:41056285-41059911:+	-0.21	-3.65	0.000287	Response to haloperidol in psychosis	
KIRC	cis	1	rs2412459	chr15:40295959	SRP14	chr15:40327891-40331389:-	-0.3	-4.8	2.06E-6	Response to haloperidol in psychosis	
KIRC	cis	1	rs2413544	chr22:39059404	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.99E-5	Resting heart rate	
KIRC	cis	1	rs2413545	chr22:39092524	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.68	0.000261	Resting heart rate	
KIRC	cis	1	rs2413546	chr22:39107001	LOC646851	chr22:38974125-39052634:-	0.13	3.82	0.000153	Resting heart rate	
KIRC	cis	1	rs2413547	chr22:39107338	LOC646851	chr22:38974125-39052634:-	0.13	3.82	0.000153	Resting heart rate	
KIRC	cis	1	rs2413583	chr22:39659773	CBY1	chr22:39052658-39069853:+	0.18	3.7	0.000235	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs2414060	chr15:50873262	SPPL2A	chr15:50999739-51057910:-	0.27	7.23	1.85E-12	QT interval	
KIRC	cis	1	rs2414060	chr15:50873262	TRPM7	chr15:50852491-50978994:-	0.12	3.49	0.000523	QT interval	
KIRC	cis	1	rs2414465	chr15:56505714	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2414467	chr15:56527163	TEX9	chr15:56657644-56738071:+	-0.27	-4.87	1.53E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2414468	chr15:56527277	TEX9	chr15:56657644-56738071:+	-0.28	-5.03	6.95E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2414471	chr15:56534504	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.08E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2414472	chr15:56534724	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.08E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2414884	chr15:66075872	DPP8	chr15:65737999-65810035:-	-0.12	-4.81	1.99E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs2414885	chr15:66034624	DPP8	chr15:65737999-65810035:-	-0.12	-4.81	1.96E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs2415253	chr15:75375699	PPCDC	chr15:75315927-75343066:+	0.17	4.06	5.58E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.21	3.82	0.00015	Blood trace element (Zn levels)	
KIRC	cis	1	rs2415255	chr15:75332412	PPCDC	chr15:75315927-75343066:+	0.2	4.55	6.88E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs2415255	chr15:75332412	RPP25	chr15:75247443-75249775:-	0.21	3.86	0.00013	Blood trace element (Zn levels)	
KIRC	cis	1	rs2415255	chr15:75332412	SCAMP5	chr15:75287901-75313836:+	0.24	4.35	1.64E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs2417577	chr9:100701446	C9orf156	chr9:100666772-100684852:-	-0.3	-6.71	5.13E-11	Quantitative traits	
KIRC	cis	1	rs2418487	chr15:100585610	ADAMTS17	chr15:100511643-100882183:-	0.28	4.72	3.13E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.7	2.02E-8	Diabetic kidney disease	
KIRC	cis	1	rs2420170	chr7:65656053	CRCP	chr7:65579805-65619551:+	0.32	4.35	1.67E-5	Diabetic kidney disease	
KIRC	cis	1	rs2420170	chr7:65656053	LOC493754	chr7:65993446-66057363:-	-0.22	-3.5	0.000506	Diabetic kidney disease	
KIRC	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs2420171	chr7:65637760	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs2421016	chr10:124167512	ARMS2	chr10:124214179-124216867:+	-0.2	-3.67	0.000265	Height	
KIRC	cis	1	rs2421555	chr2:73816955	TPRKB	chr2:73956957-73964517:-	-0.19	-5.07	5.62E-7	Metabolite levels	
KIRC	cis	1	rs242271	chr6:88082029	C6orf162	chr6:88032306-88052043:+	-0.18	-3.77	0.00018	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs242271	chr6:88082029	C6orf164	chr6:88032306-88109459:+	-0.19	-4.63	4.74E-6	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs2424700	chr20:25266513	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.41	3.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424700	chr20:25266513	FAM182A	chr20:26035250-26067552:+	-0.28	-5.2	2.9E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424704	chr20:25273929	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.34	5.18E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.28	-5.32	1.53E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424710	chr20:25283886	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.35	4.79E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.29	-5.47	7.05E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424712	chr20:25416942	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424712	chr20:25416942	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424713	chr20:25418482	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.61	9.83E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.33	-6.25	8.71E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424716	chr20:25423538	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.79	3.15E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2424716	chr20:25423538	FAM182A	chr20:26035250-26067552:+	-0.29	-5.5	6.22E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.27	-5.47	7.3E-8	Height	
KIRC	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.28	-7.66	9.91E-14	Height	
KIRC	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.27	-5.35	1.36E-7	Height	
KIRC	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.29	-7.79	3.92E-14	Height	
KIRC	cis	1	rs2425697	chr20:44025175	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000442	Psoriasis	
KIRC	cis	1	rs2426106	chr20:47639464	CSE1L	chr20:47662838-47713484:+	-0.18	-4.73	2.98E-6	Anger	
KIRC	cis	1	rs2426109	chr20:47662627	CSE1L	chr20:47662838-47713484:+	-0.17	-4.55	6.64E-6	Anger	
KIRC	cis	1	rs2426112	chr20:47690139	CSE1L	chr20:47662838-47713484:+	-0.18	-4.8	2.09E-6	Anger	
KIRC	cis	1	rs2426113	chr20:47690189	CSE1L	chr20:47662838-47713484:+	-0.18	-4.72	3.02E-6	Anger	
KIRC	cis	1	rs2426116	chr20:47693047	CSE1L	chr20:47662838-47713484:+	-0.18	-4.83	1.84E-6	Anger	
KIRC	cis	1	rs2430494	chr2:37463620	CEBPZ	chr2:37428778-37458740:-	-0.19	-5	7.77E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2431349	chr5:75921330	F2RL2	chr5:75911308-75919240:-	-0.35	-6.75	3.97E-11	Hearing impairment	
KIRC	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.82	16.88	6.01E-51	Type 2 diabetes	
KIRC	cis	1	rs2444240	chr11:120040442	OAF	chr11:120081747-120100649:+	0.2	4.23	2.74E-5	Corneal curvature	
KIRC	cis	1	rs2447151	chr8:120384770	NOV	chr8:120428552-120436678:+	-0.29	-4.68	3.67E-6	Hypertension	
KIRC	cis	1	rs2447152	chr8:120384278	NOV	chr8:120428552-120436678:+	-0.3	-4.73	2.97E-6	Hypertension	
KIRC	cis	1	rs2447153	chr8:120383871	NOV	chr8:120428552-120436678:+	-0.29	-4.66	4.1E-6	Hypertension	
KIRC	cis	1	rs2447155	chr8:120380303	NOV	chr8:120428552-120436678:+	-0.29	-4.66	3.99E-6	Hypertension	
KIRC	cis	1	rs2447159	chr8:120375189	NOV	chr8:120428552-120436678:+	-0.32	-5.11	4.65E-7	Hypertension	
KIRC	cis	1	rs2447160	chr8:120374473	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2447163	chr8:120373249	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2447164	chr8:120371887	NOV	chr8:120428552-120436678:+	-0.32	-5.11	4.66E-7	Hypertension	
KIRC	cis	1	rs2447165	chr8:120371318	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2447167	chr8:120366068	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2447168	chr8:120365613	NOV	chr8:120428552-120436678:+	-0.3	-4.84	1.75E-6	Hypertension	
KIRC	cis	1	rs2447169	chr8:120365063	NOV	chr8:120428552-120436678:+	0.32	5.09	5.07E-7	Hypertension	
KIRC	cis	1	rs2447171	chr8:120360953	NOV	chr8:120428552-120436678:+	-0.32	-5.07	5.63E-7	Hypertension	
KIRC	cis	1	rs2447172	chr8:120360863	NOV	chr8:120428552-120436678:+	-0.32	-5.07	5.63E-7	Hypertension	
KIRC	cis	1	rs2447174	chr8:120358571	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2447176	chr8:120356892	NOV	chr8:120428552-120436678:+	-0.28	-4.35	1.67E-5	Hypertension	
KIRC	cis	1	rs2447178	chr8:120356188	NOV	chr8:120428552-120436678:+	-0.27	-4.32	1.91E-5	Hypertension	
KIRC	cis	1	rs2447179	chr8:120355775	NOV	chr8:120428552-120436678:+	-0.29	-4.45	1.08E-5	Hypertension	
KIRC	cis	1	rs2447181	chr8:120354288	NOV	chr8:120428552-120436678:+	-0.29	-4.6	5.34E-6	Hypertension	
KIRC	cis	1	rs2447183	chr8:120352978	NOV	chr8:120428552-120436678:+	-0.29	-4.61	5.11E-6	Hypertension	
KIRC	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.54	9.52	7.06E-20	Tumor biomarkers	
KIRC	cis	1	rs2447196	chr15:43893818	STRC	chr15:43891762-43924561:-	-0.19	-4.11	4.68E-5	Tumor biomarkers	
KIRC	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.57	-9.97	1.73E-21	Tumor biomarkers	
KIRC	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.19	-3.87	0.000126	Tumor biomarkers	
KIRC	cis	1	rs2447208	chr15:43933895	STRC	chr15:43891762-43924561:-	0.2	4.18	3.5E-5	Tumor biomarkers	
KIRC	cis	1	rs2447208	chr15:43933895	TUBGCP4	chr15:43663313-43698238:+	0.18	3.93	9.79E-5	Tumor biomarkers	
KIRC	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.6	-10.37	5.8E-23	Tumor biomarkers	
KIRC	cis	1	rs2447211	chr15:43936351	STRC	chr15:43891762-43924561:-	0.22	4.5	8.48E-6	Tumor biomarkers	
KIRC	cis	1	rs2447211	chr15:43936351	TUBGCP4	chr15:43663313-43698238:+	0.18	3.9	0.000111	Tumor biomarkers	
KIRC	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.49	11.94	4.23E-29	Homocysteine levels	
KIRC	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.41	9.87	4.03E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.27	-9.13	1.7E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs2452552	chr1:228976700	ARF1	chr1:228270361-228286912:+	-0.16	-3.78	0.000177	Basal cell carcinoma	
KIRC	cis	1	rs2455219	chr5:75922581	F2RL2	chr5:75911308-75919240:-	-0.34	-6.6	1.04E-10	Hearing impairment	
KIRC	cis	1	rs2456009	chr15:65840082	DPP8	chr15:65737999-65810035:-	0.12	4.88	1.4E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs2459629	chr5:42790874	CCDC152	chr5:42756920-42802539:+	-0.22	-4.98	8.79E-7	Height	
KIRC	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs2460422	chr7:65601505	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs2460882	chr12:53787953	PRR13	chr12:53835433-53840426:+	-0.2	-4.37	1.48E-5	Percentage gas trapping	
KIRC	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.85	9.06E-9	Diabetic kidney disease	
KIRC	cis	1	rs2462569	chr7:65474846	CRCP	chr7:65579805-65619551:+	0.27	3.86	0.00013	Diabetic kidney disease	
KIRC	cis	1	rs2463160	chr10:117966731	GFRA1	chr10:117816444-118033126:-	0.23	3.55	0.000428	Migraine with aura	
KIRC	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.51	-13.7	1.53E-36	Ankylosing spondylitis	
KIRC	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.48	8.25	1.37E-15	Ankylosing spondylitis	
KIRC	cis	1	rs2465120	chr7:65620974	CCT6P1	chr7:65216092-65228661:+	0.29	5.83	9.79E-9	Diabetic kidney disease	
KIRC	cis	1	rs2465120	chr7:65620974	CRCP	chr7:65579805-65619551:+	-0.32	-4.42	1.22E-5	Diabetic kidney disease	
KIRC	cis	1	rs2468942	chr12:48840491	ZNF641	chr12:48735912-48745021:-	0.16	3.56	0.000405	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs2469996	chr8:120353011	NOV	chr8:120428552-120436678:+	-0.29	-4.7	3.42E-6	Hypertension	
KIRC	cis	1	rs2469997	chr8:120353267	NOV	chr8:120428552-120436678:+	0.29	4.55	6.72E-6	Hypertension	
KIRC	cis	1	rs2469998	chr8:120354022	NOV	chr8:120428552-120436678:+	-0.29	-4.65	4.2E-6	Hypertension	
KIRC	cis	1	rs2469999	chr8:120354695	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.68E-6	Hypertension	
KIRC	cis	1	rs2470003	chr8:120357482	NOV	chr8:120428552-120436678:+	-0.32	-5.11	4.5E-7	Hypertension	
KIRC	cis	1	rs2470006	chr8:120358591	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470008	chr8:120359366	NOV	chr8:120428552-120436678:+	-0.32	-5.11	4.5E-7	Hypertension	
KIRC	cis	1	rs2470009	chr8:120359377	NOV	chr8:120428552-120436678:+	-0.32	-5.11	4.5E-7	Hypertension	
KIRC	cis	1	rs2470012	chr8:120360488	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470014	chr8:120360820	NOV	chr8:120428552-120436678:+	-0.29	-4.58	5.82E-6	Hypertension	
KIRC	cis	1	rs2470016	chr8:120361220	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470017	chr8:120361534	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470021	chr8:120362644	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470024	chr8:120363181	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470025	chr8:120364727	NOV	chr8:120428552-120436678:+	-0.25	-4.02	6.79E-5	Hypertension	
KIRC	cis	1	rs2470026	chr8:120365112	NOV	chr8:120428552-120436678:+	0.32	5.08	5.4E-7	Hypertension	
KIRC	cis	1	rs2470028	chr8:120365878	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2470033	chr8:120375066	NOV	chr8:120428552-120436678:+	-0.29	-4.63	4.69E-6	Hypertension	
KIRC	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.54	8.95	6.91E-18	Tumor biomarkers	
KIRC	cis	1	rs2470134	chr15:43849886	STRC	chr15:43891762-43924561:-	-0.19	-3.92	0.000102	Tumor biomarkers	
KIRC	cis	1	rs2470134	chr15:43849886	TUBGCP4	chr15:43663313-43698238:+	-0.2	-4.29	2.11E-5	Tumor biomarkers	
KIRC	cis	1	rs2471851	chr11:113301069	TTC12	chr11:113185251-113244016:+	0.35	5.2	2.92E-7	Select biomarker traits	
KIRC	cis	1	rs2471854	chr11:113299639	TTC12	chr11:113185251-113244016:+	-0.31	-4.74	2.82E-6	Select biomarker traits	
KIRC	cis	1	rs2471857	chr11:113298339	TTC12	chr11:113185251-113244016:+	-0.31	-4.72	3.05E-6	Select biomarker traits	
KIRC	cis	1	rs2471884	chr11:117010320	PCSK7	chr11:117075789-117102811:-	-0.27	-5.28	1.9E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2472476	chr9:107531956	NIPSNAP3A	chr9:107509969-107535189:+	0.2	4.17	3.59E-5	Obesity-related traits	
KIRC	cis	1	rs2472478	chr9:107531361	NIPSNAP3A	chr9:107509969-107535189:+	0.2	4.17	3.59E-5	Obesity-related traits	
KIRC	cis	1	rs2474777	chr20:25272633	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.34	5.12E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2474777	chr20:25272633	FAM182A	chr20:26035250-26067552:+	-0.27	-5.16	3.62E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2479013	chr6:2356979	GMDS	chr6:1624042-2245846:-	-0.2	-3.99	7.62E-5	Tuberculosis	
KIRC	cis	1	rs2482427	chr9:107532425	NIPSNAP3A	chr9:107509969-107535189:+	0.2	4.2	3.2E-5	Obesity-related traits	
KIRC	cis	1	rs2482911	chr20:25395528	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482919	chr20:25299756	ENTPD6	chr20:25176339-25207360:+	0.24	6.54	1.48E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.32	5.94	5.4E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482927	chr20:25327151	ENTPD6	chr20:25176339-25207360:+	0.25	6.63	8.7E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.33	6.08	2.36E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482928	chr20:25331530	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482930	chr20:25334115	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482931	chr20:25334445	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482937	chr20:25340786	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482940	chr20:25349830	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482941	chr20:25361216	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482943	chr20:25380593	ENTPD6	chr20:25176339-25207360:+	0.24	6.41	3.37E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.34	6.39	3.8E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.93	7.97E-18	Body mass index	
KIRC	cis	1	rs2486447	chr1:46545724	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.72E-5	Body mass index	
KIRC	cis	1	rs2487715	chr9:107532394	NIPSNAP3A	chr9:107509969-107535189:+	0.24	5.02	7.04E-7	Obesity-related traits	
KIRC	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.13	-4.55	6.87E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.88E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.13	-4.55	6.87E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489037	chr10:102319918	SEC31B	chr10:102246403-102289636:-	0.13	4.33	1.81E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.13	-4.36	1.55E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.14	-4.87	1.5E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.14	-4.8	2.08E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.16	-5.19	3.07E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.13	-4.62	4.92E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.14	-4.88	1.43E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.14	-4.65	4.15E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.13	-4.68	3.72E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.14	-4.59	5.7E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489051	chr10:102351785	SEC31B	chr10:102246403-102289636:-	0.14	4.91	1.21E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.14	-5	7.9E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2492859	chr6:34645266	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.43	3.01E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2494112	chr1:201787833	SHISA4	chr1:201858032-201861426:+	-0.16	-4.33	1.78E-5	Body mass index	
KIRC	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.12	-3.84	0.00014	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495734	chr10:102338686	SEC31B	chr10:102246403-102289636:-	-0.15	-4.82	1.87E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495736	chr10:102338410	SEC31B	chr10:102246403-102289636:-	-0.15	-4.72	3.01E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495737	chr10:102338344	SEC31B	chr10:102246403-102289636:-	-0.15	-5.06	5.75E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495739	chr10:102335507	SEC31B	chr10:102246403-102289636:-	-0.15	-5.07	5.49E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.13	-4.38	1.45E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.16	-5.17	3.43E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495743	chr10:102329739	SEC31B	chr10:102246403-102289636:-	-0.14	-4.69	3.57E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.13	-4.57	6.16E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.17E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.14	-4.65	4.31E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.13	-4.36	1.55E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.13	-4.55	6.84E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495753	chr10:102325640	SEC31B	chr10:102246403-102289636:-	-0.14	-4.64	4.37E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.13	-4.55	6.84E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.16	-5.11	4.49E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.16	-5.11	4.49E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495759	chr10:102320363	SEC31B	chr10:102246403-102289636:-	-0.14	-4.46	1.0E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.15	-4.79	2.21E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.21	4.82	1.9E-6	Brain structure	
KIRC	cis	1	rs2500404	chr20:25359758	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500405	chr20:25360826	ENTPD6	chr20:25176339-25207360:+	0.25	6.69	5.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.33	6.31	6.19E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500418	chr20:25382268	ENTPD6	chr20:25176339-25207360:+	0.24	6.57	1.25E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.33	6.27	7.67E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500424	chr20:25391969	ENTPD6	chr20:25176339-25207360:+	0.25	6.66	7.4E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.34	6.43	3.03E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500432	chr20:25290512	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.13	1.76E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.3	-5.54	4.8E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500436	chr20:25406366	ENTPD6	chr20:25176339-25207360:+	0.24	6.51	1.79E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.31	5.83	9.73E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500443	chr20:25331442	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500446	chr20:25339664	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.08E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.31	5.89	7.15E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500448	chr20:25404027	ENTPD6	chr20:25176339-25207360:+	0.24	6.57	1.25E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.33	6.28	7.22E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.42	10.16	3.45E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.25	-8.6	1.01E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.42	10.07	7.37E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.25	-8.6	1.03E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs2502757	chr9:136586954	SARDH	chr9:136528686-136605077:-	-0.34	-6.32	5.83E-10	Asthma	
KIRC	cis	1	rs2505675	chr6:2355675	GMDS	chr6:1624042-2245846:-	0.19	3.91	0.000103	Tuberculosis	
KIRC	cis	1	rs2508858	chr11:71805405	C11orf59	chr11:71808339-71814322:-	0.22	3.93	9.52E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2510036	chr11:77966788	NARS2	chr11:78147017-78285909:-	-0.17	-3.61	0.000336	Testicular germ cell tumor	
KIRC	cis	1	rs2510037	chr11:77966099	NARS2	chr11:78147017-78285909:-	-0.17	-3.72	0.000218	Testicular germ cell tumor	
KIRC	cis	1	rs2510041	chr11:77945284	NARS2	chr11:78147017-78285909:-	-0.17	-3.74	0.000209	Testicular germ cell tumor	
KIRC	cis	1	rs2510043	chr11:77977481	NARS2	chr11:78147017-78285909:-	-0.17	-3.86	0.000128	Testicular germ cell tumor	
KIRC	cis	1	rs2510047	chr11:77988668	NARS2	chr11:78147017-78285909:-	0.19	4.28	2.21E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2510050	chr11:77982564	NARS2	chr11:78147017-78285909:-	-0.17	-3.66	0.00028	Testicular germ cell tumor	
KIRC	cis	1	rs2510051	chr11:77981171	NARS2	chr11:78147017-78285909:-	-0.18	-3.93	9.79E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2510054	chr11:77959659	NARS2	chr11:78147017-78285909:-	0.16	3.5	0.000506	Testicular germ cell tumor	
KIRC	cis	1	rs2510340	chr18:21142438	NPC1	chr18:21108363-21166581:-	0.18	3.62	0.000328	Body mass index	
KIRC	cis	1	rs2511075	chr11:71780257	C11orf59	chr11:71808339-71814322:-	-0.23	-4.06	5.6E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2511076	chr11:71783827	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.58E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2511114	chr11:71792147	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2511116	chr11:71802160	C11orf59	chr11:71808339-71814322:-	-0.22	-3.93	9.52E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs2511155	chr11:77969223	NARS2	chr11:78147017-78285909:-	-0.18	-3.82	0.000152	Testicular germ cell tumor	
KIRC	cis	1	rs2511166	chr11:77964331	NARS2	chr11:78147017-78285909:-	-0.18	-3.97	8.24E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2511168	chr11:77965081	NARS2	chr11:78147017-78285909:-	-0.17	-3.81	0.000158	Testicular germ cell tumor	
KIRC	cis	1	rs2511169	chr11:77965321	NARS2	chr11:78147017-78285909:-	-0.17	-3.7	0.000239	Testicular germ cell tumor	
KIRC	cis	1	rs2511175	chr11:77975081	NARS2	chr11:78147017-78285909:-	-0.19	-3.98	7.95E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2511182	chr11:77982130	NARS2	chr11:78147017-78285909:-	-0.18	-3.67	0.000265	Testicular germ cell tumor	
KIRC	cis	1	rs2511185	chr11:77982496	NARS2	chr11:78147017-78285909:-	-0.18	-3.88	0.000117	Testicular germ cell tumor	
KIRC	cis	1	rs2511186	chr11:77984306	NARS2	chr11:78147017-78285909:-	-0.18	-3.93	9.79E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2511187	chr11:77985849	NARS2	chr11:78147017-78285909:-	-0.18	-3.67	0.000265	Testicular germ cell tumor	
KIRC	cis	1	rs2511190	chr11:77988310	NARS2	chr11:78147017-78285909:-	-0.17	-3.65	0.000291	Testicular germ cell tumor	
KIRC	cis	1	rs2512532	chr11:77968641	NARS2	chr11:78147017-78285909:-	-0.18	-3.99	7.46E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2512535	chr11:77971468	NARS2	chr11:78147017-78285909:-	-0.17	-3.79	0.000169	Testicular germ cell tumor	
KIRC	cis	1	rs2512537	chr11:77971947	NARS2	chr11:78147017-78285909:-	-0.17	-3.5	0.000514	Testicular germ cell tumor	
KIRC	cis	1	rs2512538	chr11:77972461	NARS2	chr11:78147017-78285909:-	-0.17	-3.62	0.000327	Testicular germ cell tumor	
KIRC	cis	1	rs2512541	chr11:77981747	NARS2	chr11:78147017-78285909:-	-0.18	-3.93	9.79E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2512542	chr11:77981780	NARS2	chr11:78147017-78285909:-	-0.17	-3.82	0.000153	Testicular germ cell tumor	
KIRC	cis	1	rs2512544	chr11:77986371	NARS2	chr11:78147017-78285909:-	-0.17	-3.66	0.00028	Testicular germ cell tumor	
KIRC	cis	1	rs2512546	chr11:77957276	NARS2	chr11:78147017-78285909:-	-0.17	-3.71	0.000227	Testicular germ cell tumor	
KIRC	cis	1	rs2512547	chr11:77960888	NARS2	chr11:78147017-78285909:-	-0.17	-3.66	0.000275	Testicular germ cell tumor	
KIRC	cis	1	rs2512550	chr11:77943848	NARS2	chr11:78147017-78285909:-	-0.17	-3.88	0.000118	Testicular germ cell tumor	
KIRC	cis	1	rs2513093	chr11:116806687	PCSK7	chr11:117075789-117102811:-	-0.27	-5.18	3.21E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2513095	chr11:116806269	PCSK7	chr11:117075789-117102811:-	-0.28	-5.36	1.28E-7	Protein quantitative trait loci	
KIRC	cis	1	rs2521263	chr11:2308762	C11orf21	chr11:2317507-2323143:-	-0.18	-3.77	0.000179	Obesity-related traits	
KIRC	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.54	-8.89	1.08E-17	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs2524005	chr6:29899677	TRIM31	chr6:30070674-30080867:-	-0.25	-3.65	0.000287	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs2524005	chr6:29899677	VARS2	chr6:30881982-30894233:+	-0.22	-4	7.39E-5	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.66	10.6	8.27E-24	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs2524300	chr17:39040877	TMEM99	chr17:38975374-38992526:+	0.21	4.35	1.65E-5	Height	
KIRC	cis	1	rs2524306	chr17:39035811	TMEM99	chr17:38975374-38992526:+	0.22	4.5	8.5E-6	Height	
KIRC	cis	1	rs252716	chr5:110425063	TSLP	chr5:110405778-110413722:+	0.23	4.3	2.05E-5	Eosinophilic esophagitis	
KIRC	cis	1	rs2527199	chr7:158737113	WDR60	chr7:158649269-158738882:+	0.21	5.27	2.02E-7	Height	
KIRC	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.84	17.08	6.5E-52	Type 2 diabetes	
KIRC	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.82	16.61	1.09E-49	Type 2 diabetes	
KIRC	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.82	16.5	3.64E-49	Type 2 diabetes	
KIRC	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.81	16.58	1.44E-49	Type 2 diabetes	
KIRC	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.83	16.95	2.85E-51	Type 2 diabetes	
KIRC	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.84	16.66	6.07E-50	Type 2 diabetes	
KIRC	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.84	-17	1.63E-51	Type 2 diabetes	
KIRC	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.82	16.88	6.01E-51	Type 2 diabetes	
KIRC	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.83	16.95	2.85E-51	Type 2 diabetes	
KIRC	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.84	17.35	3.53E-53	Type 2 diabetes	
KIRC	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.84	17.35	3.53E-53	Type 2 diabetes	
KIRC	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.27	5.35	1.35E-7	Diabetic kidney disease	
KIRC	cis	1	rs2533288	chr7:66056711	CRCP	chr7:65579805-65619551:+	-0.34	-4.57	6.15E-6	Diabetic kidney disease	
KIRC	cis	1	rs2540053	chr2:201567968	CASP8	chr2:202098166-202152434:+	0.23	4.09	4.93E-5	Alcohol dependence	
KIRC	cis	1	rs2540053	chr2:201567968	KCTD18	chr2:201353686-201374792:-	0.21	3.67	0.00027	Alcohol dependence	
KIRC	cis	1	rs2540053	chr2:201567968	ORC2L	chr2:201774895-201828410:-	0.22	4.7	3.3E-6	Alcohol dependence	
KIRC	cis	1	rs2540053	chr2:201567968	TRAK2	chr2:202241931-202316319:-	0.23	4.23	2.83E-5	Alcohol dependence	
KIRC	cis	1	rs2540977	chr2:37462228	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.2	2.93E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2540977	chr2:37462228	PRKD3	chr2:37477648-37544222:-	-0.14	-3.58	0.000375	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2541161	chr9:131884802	PPP2R4	chr9:131873244-131911223:+	-0.19	-3.57	0.000386	Blood metabolite ratios	
KIRC	cis	1	rs2541161	chr9:131884802	SET	chr9:131445934-131458674:+	0.17	3.69	0.000252	Blood metabolite ratios	
KIRC	cis	1	rs2541164	chr9:131876908	SET	chr9:131445934-131458674:+	-0.18	-3.7	0.000241	Blood metabolite ratios	
KIRC	cis	1	rs2543376	chr14:76609923	ESRRB	chr14:76837690-76968178:+	0.28	3.94	9.34E-5	Blood pressure	
KIRC	cis	1	rs2543382	chr14:76624887	ESRRB	chr14:76837690-76968178:+	0.36	5.08	5.29E-7	Blood pressure	
KIRC	cis	1	rs2543383	chr14:76626703	ESRRB	chr14:76837690-76968178:+	0.35	4.94	1.07E-6	Blood pressure	
KIRC	cis	1	rs2543384	chr14:76627301	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs2543387	chr14:76629046	ESRRB	chr14:76837690-76968178:+	0.34	4.92	1.17E-6	Blood pressure	
KIRC	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.85	17.46	1.05E-53	Type 2 diabetes	
KIRC	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.85	17.46	1.05E-53	Type 2 diabetes	
KIRC	cis	1	rs2549803	chr5:96174929	ERAP1	chr5:96096515-96149837:-	-0.23	-5.5	5.96E-8	Urate levels (BMI interaction)	
KIRC	cis	1	rs2555154	chr11:6524556	FXC1	chr11:6502677-6505910:+	-0.17	-4.43	1.14E-5	DNA methylation (variation)	
KIRC	cis	1	rs2555155	chr11:6522804	FXC1	chr11:6502677-6505910:+	-0.16	-4.21	3.02E-5	DNA methylation (variation)	
KIRC	cis	1	rs2558105	chr2:137561758	THSD7B	chr2:137523115-138435287:+	0.2	4.23	2.72E-5	Pancreatic cancer	
KIRC	cis	1	rs2558106	chr2:137561843	THSD7B	chr2:137523115-138435287:+	0.2	4.26	2.4E-5	Pancreatic cancer	
KIRC	cis	1	rs2560303	chr5:121428330	LOX	chr5:121400163-121414055:-	0.19	4.44	1.09E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs2564921	chr3:53125585	ITIH4	chr3:52847007-52866554:-	-0.16	-4.03	6.32E-5	Height	
KIRC	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.44	11.68	4.66E-28	Height	
KIRC	cis	1	rs2564926	chr3:53094730	RFT1	chr3:53122503-53164470:-	-0.32	-5.05	6.15E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs2564926	chr3:53094730	SFMBT1	chr3:52938628-53080070:-	0.24	3.51	0.000495	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs2564926	chr3:53094730	TMEM110	chr3:52867139-52931547:-	-0.33	-5.85	9.04E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs2564940	chr3:53107569	ITIH3	chr3:52828784-52843025:+	0.15	3.87	0.000125	Height	
KIRC	cis	1	rs2564940	chr3:53107569	ITIH4	chr3:52847007-52866554:-	0.16	4.01	7.12E-5	Height	
KIRC	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.44	-11.65	6.15E-28	Height	
KIRC	cis	1	rs2564956	chr3:53070462	SFMBT1	chr3:52938628-53080070:-	-0.44	-10.32	8.85E-23	Ulcerative colitis	
KIRC	cis	1	rs2569754	chr19:41936734	ATP5SL	chr19:41937224-41945810:-	0.16	3.64	0.000305	Height	
KIRC	cis	1	rs2572910	chr8:143770135	LY6K	chr8:143781529-143785582:+	0.26	4.59	5.67E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.22	-4.46	1.03E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2572910	chr8:143770135	PSCA	chr8:143761875-143764142:+	0.21	3.79	0.000172	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2573346	chr10:81918041	PLAC9	chr10:81892258-81904784:+	0.11	3.89	0.000112	Sarcoidosis	
KIRC	cis	1	rs2577383	chr10:117966778	GFRA1	chr10:117816444-118033126:-	0.23	3.53	0.000454	Migraine with aura	
KIRC	cis	1	rs2577384	chr10:117968824	GFRA1	chr10:117816444-118033126:-	0.23	3.58	0.000376	Migraine with aura	
KIRC	cis	1	rs2581782	chr3:53122257	ITIH3	chr3:52828784-52843025:+	0.14	3.57	0.000386	Height	
KIRC	cis	1	rs2581782	chr3:53122257	ITIH4	chr3:52847007-52866554:-	0.14	3.71	0.000235	Height	
KIRC	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.45	-12.12	7.83E-30	Height	
KIRC	cis	1	rs2581783	chr3:53122258	ITIH3	chr3:52828784-52843025:+	0.14	3.57	0.000386	Height	
KIRC	cis	1	rs2581783	chr3:53122258	ITIH4	chr3:52847007-52866554:-	0.14	3.71	0.000235	Height	
KIRC	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.45	-12.12	7.83E-30	Height	
KIRC	cis	1	rs2581786	chr3:53126143	ITIH4	chr3:52847007-52866554:-	0.15	3.75	0.000197	Height	
KIRC	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.45	-11.83	1.22E-28	Height	
KIRC	cis	1	rs2581787	chr3:53127677	ITIH4	chr3:52847007-52866554:-	0.14	3.6	0.000352	Height	
KIRC	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.45	-11.94	4.19E-29	Height	
KIRC	cis	1	rs2581794	chr3:53036206	RFT1	chr3:53122503-53164470:-	-0.29	-6.48	2.17E-10	Schizophrenia	
KIRC	cis	1	rs2581794	chr3:53036206	SFMBT1	chr3:52938628-53080070:-	-0.36	-7.58	1.65E-13	Schizophrenia	
KIRC	cis	1	rs2583471	chr11:59861814	MS4A2	chr11:59856137-59866014:+	0.17	3.79	0.000172	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2585179	chr8:143774193	LY6K	chr8:143781529-143785582:+	0.27	4.73	2.91E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.22	-4.39	1.41E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2585179	chr8:143774193	PSCA	chr8:143761875-143764142:+	0.21	3.82	0.000153	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2586759	chr18:48379064	MRO	chr18:48321491-48351754:-	-0.31	-5.62	3.2E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs2591092	chr14:76630133	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs2591094	chr14:76632335	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs2593321	chr3:22122396	VENTXP7	chr3:21447218-21448175:+	-0.16	-3.69	0.000251	HIV-1 viral setpoint	
KIRC	cis	1	rs259346	chr1:95728746	RWDD3	chr1:95583479-95712773:+	0.25	3.54	0.000435	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs259354	chr1:95718205	RWDD3	chr1:95583479-95712773:+	-0.32	-4.35	1.62E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs259359	chr1:95709039	RWDD3	chr1:95583479-95712773:+	-0.31	-4.21	3.01E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs2595500	chr11:6963165	ZNF215	chr11:6947654-7005861:+	0.28	4.1	4.82E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs2595501	chr11:6955340	ZNF215	chr11:6947654-7005861:+	-0.32	-4.61	5.11E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs2605582	chr11:93163799	CCDC67	chr11:93063156-93171634:+	-0.26	-4	7.37E-5	Pulmonary function decline	
KIRC	cis	1	rs2605583	chr11:93164957	CCDC67	chr11:93063156-93171634:+	-0.27	-4.05	5.98E-5	Pulmonary function decline	
KIRC	cis	1	rs2605585	chr11:93171862	CCDC67	chr11:93063156-93171634:+	-0.26	-3.84	0.000138	Pulmonary function decline	
KIRC	cis	1	rs2608216	chr11:93149172	CCDC67	chr11:93063156-93171634:+	-0.25	-3.82	0.00015	Pulmonary function decline	
KIRC	cis	1	rs2608953	chr6:131926334	ENPP3	chr6:131949582-132068549:+	-0.24	-3.69	0.000244	L-arginine levels	
KIRC	cis	1	rs2608985	chr6:131917379	ENPP3	chr6:131949582-132068549:+	0.23	3.6	0.000351	L-arginine levels	
KIRC	cis	1	rs261360	chr20:5037774	C20orf30	chr20:5049130-5093733:-	-0.17	-4.61	5.12E-6	Hair morphology	
KIRC	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.6	-10.2	2.53E-22	Tumor biomarkers	
KIRC	cis	1	rs2614811	chr15:43913487	STRC	chr15:43891762-43924561:-	0.22	4.5	8.39E-6	Tumor biomarkers	
KIRC	cis	1	rs2614811	chr15:43913487	TUBGCP4	chr15:43663313-43698238:+	0.18	3.92	9.99E-5	Tumor biomarkers	
KIRC	cis	1	rs2617170	chr12:10560957	KLRC1	chr12:10594863-10606984:-	0.31	6.25	8.98E-10	Behcet's disease	
KIRC	cis	1	rs2617170	chr12:10560957	KLRC3	chr12:10564918-10588592:-	0.29	6.31	6.12E-10	Behcet's disease	
KIRC	cis	1	rs2617170	chr12:10560957	KLRC4	chr12:10559985-10562356:-	-0.22	-4.59	5.62E-6	Behcet's disease	
KIRC	cis	1	rs2617433	chr5:96176441	ERAP1	chr5:96096515-96149837:-	-0.24	-5.8	1.18E-8	Urate levels (BMI interaction)	
KIRC	cis	1	rs262147	chr7:158745142	WDR60	chr7:158649269-158738882:+	-0.22	-3.76	0.000192	Hippocampal volume	
KIRC	cis	1	rs2622527	chr15:100580828	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.58	5.82E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2622528	chr15:100582371	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.56	6.29E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.72	10.96	3.37E-25	Diastolic blood pressure	
KIRC	cis	1	rs2625984	chr3:129339101	PLXND1	chr3:129274056-129325582:-	0.11	3.52	0.000474	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs262641	chr1:2104981	SLC35E2	chr1:1590990-1677431:-	-0.15	-3.52	0.000475	Height	
KIRC	cis	1	rs262647	chr1:2095699	SLC35E2	chr1:1590990-1677431:-	0.16	3.56	0.000407	Height	
KIRC	cis	1	rs262651	chr1:2091397	SLC35E2	chr1:1590990-1677431:-	0.16	3.53	0.000446	Height	
KIRC	cis	1	rs262654	chr1:2089526	SLC35E2	chr1:1590990-1677431:-	0.17	3.57	0.000384	Height	
KIRC	cis	1	rs262657	chr1:2088577	SLC35E2	chr1:1590990-1677431:-	0.17	3.6	0.000352	Height	
KIRC	cis	1	rs262665	chr1:2083173	SLC35E2	chr1:1590990-1677431:-	0.16	3.55	0.000419	Height	
KIRC	cis	1	rs262667	chr1:2082722	SLC35E2	chr1:1590990-1677431:-	0.16	3.55	0.000416	Height	
KIRC	cis	1	rs262670	chr1:2082458	SLC35E2	chr1:1590990-1677431:-	0.17	3.6	0.000349	Height	
KIRC	cis	1	rs262672	chr1:2080813	SLC35E2	chr1:1590990-1677431:-	0.16	3.56	0.000408	Height	
KIRC	cis	1	rs262676	chr1:2078482	SLC35E2	chr1:1590990-1677431:-	0.16	3.56	0.000408	Height	
KIRC	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.35	5.87	7.95E-9	Cocaine dependence	
KIRC	cis	1	rs2630	chr15:50849399	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.48E-13	QT interval	
KIRC	cis	1	rs2630	chr15:50849399	TRPM7	chr15:50852491-50978994:-	0.12	3.51	0.000488	QT interval	
KIRC	cis	1	rs2637678	chr6:116787378	FAM26F	chr6:116782556-116784933:+	0.2	5.41	9.77E-8	Ulcerative colitis	
KIRC	cis	1	rs2638090	chr11:6955142	ZNF215	chr11:6947654-7005861:+	-0.32	-4.61	5.11E-6	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs2638092	chr11:6961746	ZNF215	chr11:6947654-7005861:+	-0.29	-4.24	2.68E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs2644128	chr1:201793440	SHISA4	chr1:201858032-201861426:+	0.16	4.33	1.77E-5	Body mass index	
KIRC	cis	1	rs2648337	chr3:12162280	SYN2	chr3:12045862-12233530:+	-0.38	-4.66	4.04E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs2648708	chr10:12601439	LOC283070	chr10:12875133-12877544:+	-0.23	-3.62	0.00032	Calcium levels	
KIRC	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.5	-13.37	4.24E-35	Ankylosing spondylitis	
KIRC	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.48	8.26	1.27E-15	Ankylosing spondylitis	
KIRC	cis	1	rs2651807	chr11:2378840	C11orf21	chr11:2317507-2323143:-	-0.17	-4.29	2.16E-5	Bacteremia	
KIRC	cis	1	rs2652816	chr15:63403368	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.000139	HDL cholesterol	
KIRC	cis	1	rs2652832	chr15:63396928	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.00014	HDL cholesterol	
KIRC	cis	1	rs2652833	chr15:63396885	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.00014	HDL cholesterol	
KIRC	cis	1	rs2652834	chr15:63396867	LACTB	chr15:63414032-63434254:+	0.19	3.92	0.000102	HDL cholesterol	
KIRC	cis	1	rs2652835	chr15:63396408	LACTB	chr15:63414032-63434254:+	0.19	3.83	0.000143	HDL cholesterol	
KIRC	cis	1	rs2652838	chr15:63396088	LACTB	chr15:63414032-63434254:+	0.19	3.83	0.000143	HDL cholesterol	
KIRC	cis	1	rs2652840	chr15:63393220	LACTB	chr15:63414032-63434254:+	0.21	4.24	2.68E-5	HDL cholesterol	
KIRC	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.49	-8.13	3.5E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs2656056	chr15:78722519	CHRNA5	chr15:78857906-78886458:+	0.21	3.65	0.000293	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2657345	chr7:158744169	WDR60	chr7:158649269-158738882:+	0.22	5.44	8.49E-8	Height	
KIRC	cis	1	rs2657365	chr7:158722753	WDR60	chr7:158649269-158738882:+	0.21	5.22	2.64E-7	Height	
KIRC	cis	1	rs2658778	chr11:93148948	CCDC67	chr11:93063156-93171634:+	-0.26	-3.92	9.92E-5	Pulmonary function decline	
KIRC	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.26	3.97	8.23E-5	Pulmonary function decline	
KIRC	cis	1	rs2658781	chr11:93166368	CCDC67	chr11:93063156-93171634:+	0.26	4.02	6.78E-5	Pulmonary function decline	
KIRC	cis	1	rs2658782	chr11:93166731	CCDC67	chr11:93063156-93171634:+	-0.27	-4.09	5.0E-5	Pulmonary function decline	
KIRC	cis	1	rs2659889	chr7:66217112	LOC493754	chr7:65993446-66057363:-	-0.17	-3.83	0.000146	Aortic root size	
KIRC	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.28	5.57	4.24E-8	Gout	
KIRC	cis	1	rs2659903	chr7:66180931	CRCP	chr7:65579805-65619551:+	-0.31	-4.23	2.75E-5	Gout	
KIRC	cis	1	rs2659903	chr7:66180931	LOC493754	chr7:65993446-66057363:-	0.22	3.49	0.000523	Gout	
KIRC	cis	1	rs2659906	chr7:66165310	LOC493754	chr7:65993446-66057363:-	-0.17	-3.78	0.000177	Aortic root size	
KIRC	cis	1	rs2659909	chr7:66160279	LOC493754	chr7:65993446-66057363:-	-0.17	-3.66	0.000276	Aortic root size	
KIRC	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs2659911	chr7:66158420	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2659912	chr7:66157999	LOC493754	chr7:65993446-66057363:-	-0.18	-3.89	0.000115	Aortic root size	
KIRC	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs2659913	chr7:66157336	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2659915	chr7:66153101	LOC493754	chr7:65993446-66057363:-	-0.16	-3.57	0.000398	Aortic root size	
KIRC	cis	1	rs2663905	chr15:81359137	C15orf26	chr15:81391749-81441515:+	-0.25	-4.47	9.5E-6	QT interval (interaction)	
KIRC	cis	1	rs2664035	chr4:48220839	OCIAD1	chr4:48833015-48863831:+	0.18	4.31	1.95E-5	Rheumatoid arthritis	
KIRC	cis	1	rs2665826	chr17:61944924	FTSJ3	chr17:61896795-61905031:-	0.33	6.55	1.43E-10	Body mass index	
KIRC	cis	1	rs2665826	chr17:61944924	PSMC5	chr17:61904810-61909386:+	0.14	3.57	0.000387	Body mass index	
KIRC	cis	1	rs2665826	chr17:61944924	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.58	5.85E-6	Body mass index	
KIRC	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.74	11.12	7.75E-26	Diastolic blood pressure	
KIRC	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.72	10.9	5.56E-25	Diastolic blood pressure	
KIRC	cis	1	rs2684898	chr12:51046825	LIMA1	chr12:50569565-50677353:-	-0.26	-5.17	3.43E-7	Fibrinogen	
KIRC	cis	1	rs2684900	chr12:51019556	LIMA1	chr12:50569565-50677353:-	-0.23	-4.46	1.03E-5	Fibrinogen	
KIRC	cis	1	rs2687723	chr3:127865559	KBTBD12	chr3:127634318-127706513:+	0.3	4.06	5.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2687723	chr3:127865559	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2687723	chr3:127865559	RUVBL1	chr3:127783627-127872757:-	0.34	4.87	1.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2687730	chr3:127915457	KBTBD12	chr3:127634318-127706513:+	0.28	3.8	0.000166	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2687730	chr3:127915457	RUVBL1	chr3:127783627-127872757:-	0.33	4.6	5.36E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2687950	chr13:50718468	EBPL	chr13:50234811-50265623:-	-0.19	-3.74	0.000205	Height	
KIRC	cis	1	rs2700479	chr12:51020471	LIMA1	chr12:50569565-50677353:-	-0.23	-4.46	1.03E-5	Fibrinogen	
KIRC	cis	1	rs2700482	chr12:51083265	LIMA1	chr12:50569565-50677353:-	-0.24	-4.76	2.5E-6	Fibrinogen	
KIRC	cis	1	rs2700485	chr12:51103992	LIMA1	chr12:50569565-50677353:-	-0.25	-4.87	1.52E-6	Fibrinogen	
KIRC	cis	1	rs2705123	chr12:48878792	ZNF641	chr12:48735912-48745021:-	-0.16	-3.5	0.000509	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs2705520	chr3:112269287	ABHD10	chr3:111697828-111712208:+	0.27	4.36	1.56E-5	Asthma (childhood onset)	
KIRC	cis	1	rs2705520	chr3:112269287	ATG3	chr3:112251360-112280485:-	0.41	6.27	7.65E-10	Asthma (childhood onset)	
KIRC	cis	1	rs2705520	chr3:112269287	C3orf17	chr3:112721294-112738555:-	0.33	4.73	2.87E-6	Asthma (childhood onset)	
KIRC	cis	1	rs2705520	chr3:112269287	CCDC52	chr3:113161567-113234034:-	0.3	4.32	1.9E-5	Asthma (childhood onset)	
KIRC	cis	1	rs2705520	chr3:112269287	PHLDB2	chr3:111451327-111695362:+	0.3	4.09	5.06E-5	Asthma (childhood onset)	
KIRC	cis	1	rs2705520	chr3:112269287	SLC35A5	chr3:112280895-112303002:+	0.28	4.73	2.91E-6	Asthma (childhood onset)	
KIRC	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs2707828	chr7:66171377	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs2707830	chr7:66167645	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.27	5.35	1.35E-7	Diabetic kidney disease	
KIRC	cis	1	rs2707831	chr7:66062511	CRCP	chr7:65579805-65619551:+	-0.34	-4.57	6.15E-6	Diabetic kidney disease	
KIRC	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.26	5.24	2.32E-7	Gout	
KIRC	cis	1	rs2707832	chr7:66136549	CRCP	chr7:65579805-65619551:+	-0.31	-4.25	2.54E-5	Gout	
KIRC	cis	1	rs2707836	chr7:66160435	LOC493754	chr7:65993446-66057363:-	-0.17	-3.78	0.000177	Aortic root size	
KIRC	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs2707838	chr7:66159201	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.28	5.47	7.2E-8	Gout	
KIRC	cis	1	rs2707840	chr7:66158015	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.27	5.35	1.35E-7	Diabetic kidney disease	
KIRC	cis	1	rs2707844	chr7:66059509	CRCP	chr7:65579805-65619551:+	-0.34	-4.57	6.15E-6	Diabetic kidney disease	
KIRC	cis	1	rs2707845	chr7:66198798	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000194	Aortic root size	
KIRC	cis	1	rs2707850	chr7:66203870	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000197	Aortic root size	
KIRC	cis	1	rs2707854	chr7:66212597	LOC493754	chr7:65993446-66057363:-	-0.17	-3.83	0.000146	Aortic root size	
KIRC	cis	1	rs2707856	chr7:66211010	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000197	Aortic root size	
KIRC	cis	1	rs2714470	chr2:37486527	CEBPZ	chr2:37428778-37458740:-	-0.19	-5.05	6.05E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2714470	chr2:37486527	PRKD3	chr2:37477648-37544222:-	-0.13	-3.55	0.000418	Chronic lymphocytic leukemia	
KIRC	cis	1	rs2714470	chr2:37486527	QPCT	chr2:37571753-37600464:+	-0.2	-3.63	0.000318	Chronic lymphocytic leukemia	
KIRC	cis	1	rs271621	chr19:18631332	SSBP4	chr19:18530221-18545371:+	-0.14	-4.77	2.42E-6	Breast cancer	
KIRC	cis	1	rs271623	chr19:18628947	SSBP4	chr19:18530221-18545371:+	-0.14	-4.8	2.06E-6	Breast cancer	
KIRC	cis	1	rs271624	chr19:18627953	ARMC6	chr19:19144471-19170310:+	-0.14	-3.53	0.000462	Breast cancer	
KIRC	cis	1	rs271624	chr19:18627953	SSBP4	chr19:18530221-18545371:+	-0.15	-5.16	3.53E-7	Breast cancer	
KIRC	cis	1	rs2717562	chr8:143776668	LY6K	chr8:143781529-143785582:+	0.28	4.79	2.24E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.22	-4.32	1.86E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2717562	chr8:143776668	PSCA	chr8:143761875-143764142:+	0.21	3.73	0.000216	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2723620	chr11:6523657	FXC1	chr11:6502677-6505910:+	-0.16	-4.09	4.98E-5	DNA methylation (variation)	
KIRC	cis	1	rs2726808	chr4:183137757	DCTD	chr4:183811245-183838630:-	0.17	3.49	0.000519	Schizophrenia	
KIRC	cis	1	rs2727099	chr15:66063428	DPP8	chr15:65737999-65810035:-	-0.12	-4.9	1.28E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs2727159	chr15:100582745	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.55	6.8E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2727160	chr15:100582463	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.56	6.29E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2727161	chr15:100582357	ADAMTS17	chr15:100511643-100882183:-	-0.27	-4.73	2.9E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs2729780	chr15:63404639	LACTB	chr15:63414032-63434254:+	0.19	3.81	0.000157	HDL cholesterol	
KIRC	cis	1	rs2729781	chr15:63404265	LACTB	chr15:63414032-63434254:+	0.19	3.85	0.000135	HDL cholesterol	
KIRC	cis	1	rs2729782	chr15:63403354	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.000139	HDL cholesterol	
KIRC	cis	1	rs2729783	chr15:63403316	LACTB	chr15:63414032-63434254:+	0.18	3.52	0.000462	HDL cholesterol	
KIRC	cis	1	rs2729784	chr15:63402735	LACTB	chr15:63414032-63434254:+	0.19	3.85	0.000135	HDL cholesterol	
KIRC	cis	1	rs2729785	chr15:63402574	LACTB	chr15:63414032-63434254:+	0.19	3.85	0.000135	HDL cholesterol	
KIRC	cis	1	rs2729788	chr15:63400378	LACTB	chr15:63414032-63434254:+	0.19	3.9	0.000108	HDL cholesterol	
KIRC	cis	1	rs2729830	chr15:63395812	LACTB	chr15:63414032-63434254:+	0.19	3.87	0.000124	HDL cholesterol	
KIRC	cis	1	rs2729833	chr15:63397044	LACTB	chr15:63414032-63434254:+	0.18	3.68	0.000254	HDL cholesterol	
KIRC	cis	1	rs2730241	chr7:158723014	WDR60	chr7:158649269-158738882:+	0.18	4.37	1.51E-5	Height	
KIRC	cis	1	rs2730245	chr7:158724789	WDR60	chr7:158649269-158738882:+	0.21	5.16	3.56E-7	Height	
KIRC	cis	1	rs2731434	chr12:51109875	LIMA1	chr12:50569565-50677353:-	-0.26	-5.1	4.91E-7	Fibrinogen	
KIRC	cis	1	rs2731439	chr12:51060350	LIMA1	chr12:50569565-50677353:-	-0.24	-4.76	2.53E-6	Fibrinogen	
KIRC	cis	1	rs2731440	chr12:51057627	LIMA1	chr12:50569565-50677353:-	-0.24	-4.78	2.27E-6	Fibrinogen	
KIRC	cis	1	rs2731442	chr12:51054655	LIMA1	chr12:50569565-50677353:-	-0.24	-4.75	2.68E-6	Fibrinogen	
KIRC	cis	1	rs2731443	chr12:51094138	LIMA1	chr12:50569565-50677353:-	-0.25	-4.91	1.26E-6	Fibrinogen	
KIRC	cis	1	rs2733954	chr16:85836256	COX4NB	chr16:85812233-85833148:-	-0.19	-4.63	4.64E-6	Leprosy	
KIRC	cis	1	rs2733955	chr16:85836291	COX4NB	chr16:85812233-85833148:-	-0.19	-4.51	8.21E-6	Leprosy	
KIRC	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.42	-8.97	5.7E-18	Information processing speed	
KIRC	cis	1	rs2736371	chr8:11105529	AMAC1L2	chr8:11188495-11189695:+	0.19	4.08	5.21E-5	Retinal vascular caliber	
KIRC	cis	1	rs2738186	chr10:38255989	LOC399744	chr10:38717074-38741080:+	-0.23	-3.62	0.000321	Obesity (extreme)	
KIRC	cis	1	rs2738187	chr10:38260305	LOC399744	chr10:38717074-38741080:+	-0.23	-3.69	0.000244	Obesity (extreme)	
KIRC	cis	1	rs2738219	chr10:38158260	LOC399744	chr10:38717074-38741080:+	-0.23	-3.83	0.000145	Obesity (extreme)	
KIRC	cis	1	rs2738222	chr10:38183674	LOC399744	chr10:38717074-38741080:+	-0.24	-3.75	0.000194	Obesity (extreme)	
KIRC	cis	1	rs2738223	chr10:38185898	LOC399744	chr10:38717074-38741080:+	-0.22	-3.68	0.000254	Obesity (extreme)	
KIRC	cis	1	rs2738225	chr10:38193129	LOC399744	chr10:38717074-38741080:+	-0.24	-3.82	0.000149	Obesity (extreme)	
KIRC	cis	1	rs2738413	chr14:64679960	MTHFD1	chr14:64854759-64926727:+	-0.22	-5.47	7.16E-8	Atrial fibrillation	
KIRC	cis	1	rs2740544	chr13:50617640	EBPL	chr13:50234811-50265623:-	-0.18	-3.58	0.00038	Height	
KIRC	cis	1	rs2741435	chr20:43988198	SYS1-DBNDD2	chr20:43991701-44039245:+	0.24	3.62	0.000324	Psoriasis	
KIRC	cis	1	rs2741611	chr20:44020809	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000438	Psoriasis	
KIRC	cis	1	rs2741612	chr20:44019972	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000438	Psoriasis	
KIRC	cis	1	rs2741639	chr20:44008432	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.5	0.000498	Psoriasis	
KIRC	cis	1	rs2741640	chr20:44008408	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.5	0.000505	Psoriasis	
KIRC	cis	1	rs2743414	chr20:43991566	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000435	Psoriasis	
KIRC	cis	1	rs2743419	chr20:43992645	SYS1-DBNDD2	chr20:43991701-44039245:+	0.24	3.6	0.000347	Psoriasis	
KIRC	cis	1	rs2743423	chr20:43993539	SYS1-DBNDD2	chr20:43991701-44039245:+	0.23	3.54	0.000436	Psoriasis	
KIRC	cis	1	rs2743439	chr20:43999636	SYS1-DBNDD2	chr20:43991701-44039245:+	0.24	3.67	0.000272	Psoriasis	
KIRC	cis	1	rs2744947	chr6:34657809	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.43	3.01E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2744954	chr6:34621470	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.46	2.55E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2744955	chr6:34618958	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.39	3.8E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2744956	chr6:34618937	UHRF1BP1	chr6:34759794-34853117:+	0.31	6.47	2.37E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2744972	chr6:34659054	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.38	3.93E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2747714	chr6:126007620	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.79E-5	Endometrial cancer	
KIRC	cis	1	rs2747717	chr6:126008435	HEY2	chr6:126068780-126082414:+	0.17	4.22	2.95E-5	Endometrial cancer	
KIRC	cis	1	rs2747719	chr6:126009214	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.78E-5	Endometrial cancer	
KIRC	cis	1	rs2747720	chr6:126009458	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.78E-5	Endometrial cancer	
KIRC	cis	1	rs2747722	chr6:126009629	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.78E-5	Endometrial cancer	
KIRC	cis	1	rs2747723	chr6:126010790	HEY2	chr6:126068780-126082414:+	0.17	4.19	3.33E-5	Endometrial cancer	
KIRC	cis	1	rs2747724	chr6:126004935	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.8E-5	Endometrial cancer	
KIRC	cis	1	rs2747725	chr6:126012397	HEY2	chr6:126068780-126082414:+	0.17	4.05	6.05E-5	Endometrial cancer	
KIRC	cis	1	rs2748431	chr17:76105754	LGALS3BP	chr17:76967336-76976061:-	0.24	3.53	0.000458	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs2749564	chr10:38178815	LOC399744	chr10:38717074-38741080:+	-0.23	-3.64	0.000299	Obesity (extreme)	
KIRC	cis	1	rs2749592	chr10:38258842	LOC399744	chr10:38717074-38741080:+	0.17	3.63	0.000308	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs2749592	chr10:38258842	ZNF248	chr10:38090447-38147012:-	-0.26	-5.63	3.01E-8	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.5	-13.42	2.69E-35	Ankylosing spondylitis	
KIRC	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.48	8.45	3.06E-16	Ankylosing spondylitis	
KIRC	cis	1	rs2753878	chr10:38171504	LOC399744	chr10:38717074-38741080:+	-0.22	-3.68	0.000254	Obesity (extreme)	
KIRC	cis	1	rs2757047	chr6:167374489	RNASET2	chr6:167343008-167412795:-	0.14	3.62	0.000319	Crohn's disease	
KIRC	cis	1	rs2762353	chr6:25794431	SLC17A1	chr6:25783127-25832287:-	0.13	3.64	0.000303	Blood metabolite levels	
KIRC	cis	1	rs2769347	chr6:167371737	RNASET2	chr6:167343008-167412795:-	0.14	3.57	0.000398	Crohn's disease	
KIRC	cis	1	rs2769354	chr6:167379771	RNASET2	chr6:167343008-167412795:-	0.15	3.72	0.000218	Crohn's disease	
KIRC	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.5	13.58	5.37E-36	Ankylosing spondylitis	
KIRC	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.47	-8.26	1.31E-15	Ankylosing spondylitis	
KIRC	cis	1	rs2782	chr22:50961854	TYMP	chr22:50964184-50968514:-	0.16	5.26	2.11E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs2786111	chr1:197306099	CFHR3	chr1:196743930-196762872:+	0.28	5.74	1.64E-8	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs2786113	chr1:197304081	CFHR3	chr1:196743930-196762872:+	-0.26	-5.4	1.03E-7	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs2789679	chr10:81907884	PLAC9	chr10:81892258-81904784:+	0.11	3.97	8.36E-5	Sarcoidosis	
KIRC	cis	1	rs279150	chr19:12095630	ZNF763	chr19:12035900-12091196:+	-0.37	-5.19	3.04E-7	Multiple sclerosis	
KIRC	cis	1	rs2797154	chr6:126005197	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.79E-5	Endometrial cancer	
KIRC	cis	1	rs2797158	chr6:126009398	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.78E-5	Endometrial cancer	
KIRC	cis	1	rs2797160	chr6:126010116	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.78E-5	Endometrial cancer	
KIRC	cis	1	rs2797161	chr6:126010789	HEY2	chr6:126068780-126082414:+	0.17	4.19	3.33E-5	Endometrial cancer	
KIRC	cis	1	rs2798330	chr1:112409504	OVGP1	chr1:111956938-111970399:-	0.32	3.56	0.000407	Response to radiotherapy in cancer (late toxicity)	
KIRC	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.28	-4.78	2.35E-6	Depression	
KIRC	cis	1	rs2799077	chr6:28234597	ZNF323	chr6:28292517-28324048:-	0.29	3.99	7.67E-5	Depression	
KIRC	cis	1	rs2799077	chr6:28234597	ZSCAN23	chr6:28393287-28411279:-	0.26	3.75	0.000195	Depression	
KIRC	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.25	-4.45	1.06E-5	Depression	
KIRC	cis	1	rs2799079	chr6:28235176	ZNF323	chr6:28292517-28324048:-	0.26	3.66	0.000275	Depression	
KIRC	cis	1	rs2799079	chr6:28235176	ZSCAN23	chr6:28393287-28411279:-	0.24	3.61	0.000331	Depression	
KIRC	cis	1	rs2799501	chr10:38167038	LOC399744	chr10:38717074-38741080:+	-0.22	-3.67	0.000268	Obesity (extreme)	
KIRC	cis	1	rs2799505	chr10:38223014	LOC399744	chr10:38717074-38741080:+	-0.23	-3.57	0.000389	Obesity (extreme)	
KIRC	cis	1	rs2799507	chr10:38227064	LOC399744	chr10:38717074-38741080:+	-0.23	-3.57	0.000389	Obesity (extreme)	
KIRC	cis	1	rs2805591	chr10:98812283	TM9SF3	chr10:98277868-98346809:-	-0.21	-4.08	5.33E-5	Diastolic blood pressure (alcohol consumption interaction)	
KIRC	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.45	-7.37	7.13E-13	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.47	-7.65	1.01E-13	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs2807278	chr6:131809920	ENPP3	chr6:131949582-132068549:+	0.21	4.19	3.27E-5	Obesity	
KIRC	cis	1	rs2811381	chr3:127997912	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.68	0.000257	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811381	chr3:127997912	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.45	1.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811387	chr3:128015178	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.9	0.000111	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811387	chr3:128015178	RPN1	chr3:128338813-128399918:-	-0.2	-3.55	0.000419	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811387	chr3:128015178	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.4	1.3E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811390	chr3:128021481	COPG	chr3:128968453-128996614:+	-0.24	-3.65	0.000293	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811390	chr3:128021481	RPN1	chr3:128338813-128399918:-	-0.23	-3.94	9.31E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811390	chr3:128021481	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.88	1.44E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811391	chr3:128022368	COPG	chr3:128968453-128996614:+	-0.24	-3.65	0.000293	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811391	chr3:128022368	RPN1	chr3:128338813-128399918:-	-0.23	-3.94	9.31E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811391	chr3:128022368	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.88	1.44E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811392	chr3:128023976	COPG	chr3:128968453-128996614:+	-0.24	-3.64	0.000303	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811392	chr3:128023976	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.75	0.0002	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811392	chr3:128023976	RPN1	chr3:128338813-128399918:-	-0.24	-3.9	0.00011	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811392	chr3:128023976	RUVBL1	chr3:127783627-127872757:-	-0.37	-5.04	6.43E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811393	chr3:128023999	COPG	chr3:128968453-128996614:+	-0.23	-3.55	0.000415	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811393	chr3:128023999	RUVBL1	chr3:127783627-127872757:-	-0.35	-5	8.04E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811396	chr3:127987356	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000437	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811396	chr3:127987356	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.26	2.46E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811397	chr3:128027237	COPG	chr3:128968453-128996614:+	-0.24	-3.67	0.000273	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811397	chr3:128027237	RPN1	chr3:128338813-128399918:-	-0.23	-3.93	9.52E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811397	chr3:128027237	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.79	2.15E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811414	chr3:127991177	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000117	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811414	chr3:127991177	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.33	1.83E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811416	chr3:127991938	RUVBL1	chr3:127783627-127872757:-	-0.26	-3.53	0.00045	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811511	chr3:127912988	KBTBD12	chr3:127634318-127706513:+	0.29	3.95	9.0E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811511	chr3:127912988	RPN1	chr3:128338813-128399918:-	0.21	3.51	0.000488	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811511	chr3:127912988	RUVBL1	chr3:127783627-127872757:-	0.32	4.59	5.5E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811518	chr3:128013645	RPN1	chr3:128338813-128399918:-	-0.23	-3.87	0.000122	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811518	chr3:128013645	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.38	1.44E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811519	chr3:128012876	RPN1	chr3:128338813-128399918:-	-0.23	-3.89	0.000112	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811519	chr3:128012876	RUVBL1	chr3:127783627-127872757:-	-0.32	-4.43	1.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811522	chr3:128011423	RPN1	chr3:128338813-128399918:-	-0.21	-3.58	0.00037	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811522	chr3:128011423	RUVBL1	chr3:127783627-127872757:-	-0.28	-3.95	8.88E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811523	chr3:128011397	RPN1	chr3:128338813-128399918:-	0.22	3.72	0.000223	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811523	chr3:128011397	RUVBL1	chr3:127783627-127872757:-	0.3	4.31	1.94E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811525	chr3:127999430	RPN1	chr3:128338813-128399918:-	-0.22	-3.65	0.000295	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811525	chr3:127999430	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.3	2.08E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811526	chr3:127995718	RPN1	chr3:128338813-128399918:-	-0.22	-3.76	0.000193	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811526	chr3:127995718	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.3	2.09E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811527	chr3:127994604	RPN1	chr3:128338813-128399918:-	-0.22	-3.79	0.000171	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811527	chr3:127994604	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.33	1.78E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811528	chr3:127994436	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.78	0.000174	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811528	chr3:127994436	RPN1	chr3:128338813-128399918:-	-0.22	-3.64	0.000301	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811528	chr3:127994436	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.5	8.44E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811530	chr3:127993166	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.89	0.000116	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811530	chr3:127993166	RPN1	chr3:128338813-128399918:-	-0.23	-3.84	0.000137	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811530	chr3:127993166	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.64	4.37E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811533	chr3:127991729	RUVBL1	chr3:127783627-127872757:-	-0.28	-4	7.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811534	chr3:127991108	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.12	4.43E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811536	chr3:127988919	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000117	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811536	chr3:127988919	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.33	1.83E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811537	chr3:127987924	COPG	chr3:128968453-128996614:+	0.23	3.51	0.000482	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811537	chr3:127987924	KBTBD12	chr3:127634318-127706513:+	0.26	3.54	0.000439	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811537	chr3:127987924	RPN1	chr3:128338813-128399918:-	0.23	3.99	7.74E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811537	chr3:127987924	RUVBL1	chr3:127783627-127872757:-	0.32	4.56	6.48E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811538	chr3:127986631	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000445	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811538	chr3:127986631	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.16	3.78E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811539	chr3:127986473	KBTBD12	chr3:127634318-127706513:+	0.26	3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811539	chr3:127986473	RPN1	chr3:128338813-128399918:-	0.25	4.2	3.18E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811539	chr3:127986473	RUVBL1	chr3:127783627-127872757:-	0.32	4.58	5.79E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811540	chr3:127985569	RPN1	chr3:128338813-128399918:-	-0.21	-3.59	0.000358	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811540	chr3:127985569	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.17	3.65E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811541	chr3:127984794	RPN1	chr3:128338813-128399918:-	-0.21	-3.58	0.000377	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811541	chr3:127984794	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.16	3.72E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811542	chr3:127983800	RPN1	chr3:128338813-128399918:-	-0.21	-3.59	0.000358	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811542	chr3:127983800	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.17	3.65E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811543	chr3:127983796	RPN1	chr3:128338813-128399918:-	-0.21	-3.59	0.000358	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811543	chr3:127983796	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.17	3.65E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811544	chr3:127983495	RPN1	chr3:128338813-128399918:-	-0.21	-3.59	0.000358	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811544	chr3:127983495	RUVBL1	chr3:127783627-127872757:-	-0.29	-4.17	3.65E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811545	chr3:127983148	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811545	chr3:127983148	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811549	chr3:127938708	KBTBD12	chr3:127634318-127706513:+	-0.27	-3.61	0.000331	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811549	chr3:127938708	RPN1	chr3:128338813-128399918:-	-0.21	-3.56	0.000412	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2811549	chr3:127938708	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.78	2.33E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2812216	chr13:50711643	EBPL	chr13:50234811-50265623:-	-0.18	-3.58	0.000371	Height	
KIRC	cis	1	rs2812217	chr13:50711803	EBPL	chr13:50234811-50265623:-	-0.19	-3.74	0.000207	Height	
KIRC	cis	1	rs2812222	chr13:50714998	EBPL	chr13:50234811-50265623:-	-0.19	-3.73	0.00021	Height	
KIRC	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.47	-10.48	2.34E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs2814993	chr6:34618893	UHRF1BP1	chr6:34759794-34853117:+	-0.28	-6	3.76E-9	Pubertal anthropometrics	
KIRC	cis	1	rs2814994	chr6:34620153	UHRF1BP1	chr6:34759794-34853117:+	0.31	6.51	1.8E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2814996	chr6:34621314	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.38	3.94E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2815005	chr6:34638847	UHRF1BP1	chr6:34759794-34853117:+	0.3	6.43	3.01E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.46	-10.11	5.19E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.47	-10.48	2.34E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs2820292	chr1:201784287	SHISA4	chr1:201858032-201861426:+	-0.14	-3.77	0.00018	Body mass index	
KIRC	cis	1	rs2821131	chr1:197302402	CFHR3	chr1:196743930-196762872:+	0.26	5.46	7.45E-8	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs282175	chr1:26895802	MAP3K6	chr1:27681670-27693337:-	0.15	3.64	0.0003	Glucose homeostasis traits	
KIRC	cis	1	rs282522	chr3:56629678	CCDC66	chr3:56591184-56655846:+	0.13	3.8	0.000164	Height	
KIRC	cis	1	rs282523	chr3:56630166	CCDC66	chr3:56591184-56655846:+	-0.12	-3.57	0.000393	Height	
KIRC	cis	1	rs2832183	chr21:30482150	N6AMT1	chr21:30244513-30257693:-	-0.22	-4.02	6.77E-5	Dental caries	
KIRC	cis	1	rs2832183	chr21:30482150	NCRNA00189	chr21:30565801-30660525:+	0.23	4.28	2.23E-5	Dental caries	
KIRC	cis	1	rs2832184	chr21:30483265	N6AMT1	chr21:30244513-30257693:-	-0.22	-4	7.21E-5	Dental caries	
KIRC	cis	1	rs2832184	chr21:30483265	NCRNA00189	chr21:30565801-30660525:+	0.23	4.18	3.42E-5	Dental caries	
KIRC	cis	1	rs2832185	chr21:30483761	N6AMT1	chr21:30244513-30257693:-	-0.22	-3.94	9.13E-5	Dental caries	
KIRC	cis	1	rs2832185	chr21:30483761	NCRNA00189	chr21:30565801-30660525:+	0.22	4.08	5.17E-5	Dental caries	
KIRC	cis	1	rs2832189	chr21:30487414	N6AMT1	chr21:30244513-30257693:-	-0.21	-3.94	9.27E-5	Dental caries	
KIRC	cis	1	rs2832189	chr21:30487414	NCRNA00189	chr21:30565801-30660525:+	0.24	4.32	1.87E-5	Dental caries	
KIRC	cis	1	rs2832190	chr21:30488226	N6AMT1	chr21:30244513-30257693:-	-0.21	-3.95	8.81E-5	Dental caries	
KIRC	cis	1	rs2832190	chr21:30488226	NCRNA00189	chr21:30565801-30660525:+	0.23	4.28	2.21E-5	Dental caries	
KIRC	cis	1	rs2832191	chr21:30489300	N6AMT1	chr21:30244513-30257693:-	-0.21	-3.91	0.000104	Dental caries	
KIRC	cis	1	rs2832191	chr21:30489300	NCRNA00189	chr21:30565801-30660525:+	0.23	4.31	1.93E-5	Dental caries	
KIRC	cis	1	rs2832259	chr21:30584698	CCT8	chr21:30428650-30446010:-	0.32	4.32	1.89E-5	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs2832267	chr21:30591662	CCT8	chr21:30428650-30446010:-	0.31	4.07	5.4E-5	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs2832270	chr21:30594532	CCT8	chr21:30428650-30446010:-	0.32	4.49	8.89E-6	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs2832272	chr21:30597403	CCT8	chr21:30428650-30446010:-	0.32	4.28	2.26E-5	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs2833693	chr21:33552512	SOD1	chr21:33031935-33041241:+	-0.15	-3.62	0.000327	Temperament	
KIRC	cis	1	rs2833696	chr21:33554583	SOD1	chr21:33031935-33041241:+	0.14	3.52	0.000476	Temperament	
KIRC	cis	1	rs2833888	chr21:33927560	TCP10L	chr21:33947152-33957845:-	-0.39	-6.66	7.29E-11	Gastritis	
KIRC	cis	1	rs2833889	chr21:33927768	TCP10L	chr21:33947152-33957845:-	0.37	6.39	3.77E-10	Gastritis	
KIRC	cis	1	rs2833890	chr21:33927886	TCP10L	chr21:33947152-33957845:-	0.36	6.32	5.71E-10	Gastritis	
KIRC	cis	1	rs2834498	chr21:35874149	KCNE1	chr21:35818989-35884573:-	0.31	4.64	4.54E-6	Electrocardiographic traits	
KIRC	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.4	-9.04	3.36E-18	Eye color traits	
KIRC	cis	1	rs2835607	chr21:38491973	TTC3	chr21:38445571-38575406:+	0.19	3.89	0.000112	Eye color traits	
KIRC	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.4	-9.03	3.57E-18	Eye color traits	
KIRC	cis	1	rs2835608	chr21:38493455	TTC3	chr21:38445571-38575406:+	0.19	3.9	0.000109	Eye color traits	
KIRC	cis	1	rs283601	chr5:73244709	ENC1	chr5:73923235-73937249:-	0.15	3.51	0.000483	Obesity-related traits	
KIRC	cis	1	rs283602	chr5:73245047	ENC1	chr5:73923235-73937249:-	0.16	3.66	0.000284	Obesity-related traits	
KIRC	cis	1	rs283604	chr5:73246177	ENC1	chr5:73923235-73937249:-	0.16	3.67	0.000266	Obesity-related traits	
KIRC	cis	1	rs28360546	chr6:163210973	PACRG	chr6:163148164-163736523:+	0.6	6.7	5.47E-11	Body mass index	
KIRC	cis	1	rs283605	chr5:73246387	ENC1	chr5:73923235-73937249:-	0.16	3.67	0.000266	Obesity-related traits	
KIRC	cis	1	rs28360661	chr21:40681972	HMGN1	chr21:40714247-40721270:-	-0.29	-6.05	2.82E-9	Cognitive function	
KIRC	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.2	-4.07	5.42E-5	Cognitive function	
KIRC	cis	1	rs283607	chr5:73246644	ENC1	chr5:73923235-73937249:-	0.15	3.63	0.000308	Obesity-related traits	
KIRC	cis	1	rs283608	chr5:73247333	ENC1	chr5:73923235-73937249:-	0.16	3.67	0.000266	Obesity-related traits	
KIRC	cis	1	rs283610	chr5:73248512	ENC1	chr5:73923235-73937249:-	0.16	3.65	0.000288	Obesity-related traits	
KIRC	cis	1	rs28363725	chr8:96027108	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28365850	chr14:35591316	KIAA0391	chr14:35591776-35786673:+	0.25	4.18	3.48E-5	Atopic dermatitis	
KIRC	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.25	4.92	1.16E-6	Atopic dermatitis	
KIRC	cis	1	rs28367503	chr16:67854534	ATP6V0D1	chr16:67471917-67515089:-	-0.33	-5.29	1.79E-7	Crohn's disease	
KIRC	cis	1	rs28367503	chr16:67854534	C16orf86	chr16:67700717-67702659:+	-0.28	-3.56	0.000401	Crohn's disease	
KIRC	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.28	5.94	5.21E-9	Cognitive function	
KIRC	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.2	4.3	2.09E-5	Cognitive function	
KIRC	cis	1	rs28372828	chr1:156253031	BGLAP	chr1:156182784-156213112:+	0.34	7.5	3.0E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs28372828	chr1:156253031	CCT3	chr1:156278752-156308195:-	-0.19	-4.75	2.72E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs28374715	chr15:41563950	NDUFAF1	chr15:41679553-41694642:-	0.22	4.39	1.35E-5	Ulcerative colitis	
KIRC	cis	1	rs28378156	chr8:96027127	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28379681	chr7:1070539	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.49	-8.68	5.77E-17	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRC	cis	1	rs28381487	chr6:88320798	C6orf164	chr6:88032306-88109459:+	0.3	3.75	0.0002	Obesity-related traits	
KIRC	cis	1	rs28381552	chr6:88377049	C6orf164	chr6:88032306-88109459:+	0.29	3.56	0.000413	Obesity-related traits	
KIRC	cis	1	rs28382321	chr1:19327782	RNF186	chr1:20140523-20141771:-	0.27	3.59	0.000366	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28385570	chr6:88241155	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs2839181	chr21:47685939	C21orf56	chr21:47581063-47604373:-	-0.21	-4.38	1.45E-5	Testicular germ cell tumor	
KIRC	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.37	-8	8.45E-15	Testicular germ cell tumor	
KIRC	cis	1	rs2839181	chr21:47685939	MCM3AP	chr21:47655048-47705236:-	0.21	4.96	9.7E-7	Testicular germ cell tumor	
KIRC	cis	1	rs2839186	chr21:47690068	C21orf56	chr21:47581063-47604373:-	-0.18	-3.75	0.000195	Testicular germ cell tumor	
KIRC	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.4	-8.73	3.78E-17	Testicular germ cell tumor	
KIRC	cis	1	rs2839186	chr21:47690068	MCM3AP	chr21:47655048-47705236:-	0.21	5.01	7.44E-7	Testicular germ cell tumor	
KIRC	cis	1	rs2839337	chr21:47987167	C21orf56	chr21:47581063-47604373:-	0.27	5.24	2.35E-7	Lymphocyte counts	
KIRC	cis	1	rs2839434	chr21:43418905	C21orf121	chr21:43442113-43445060:+	0.34	5.9	6.81E-9	Hand grip strength	
KIRC	cis	1	rs2839465	chr21:43511232	C21orf128	chr21:43522244-43528644:-	0.43	6.91	1.52E-11	IgG glycosylation	
KIRC	cis	1	rs2839466	chr21:43512324	C21orf128	chr21:43522244-43528644:-	-0.44	-7.46	3.91E-13	IgG glycosylation	
KIRC	cis	1	rs2839467	chr21:43513200	C21orf128	chr21:43522244-43528644:-	-0.5	-8.22	1.77E-15	IgG glycosylation	
KIRC	cis	1	rs28396304	chr19:12081484	GCDH	chr19:13001974-13010782:+	-0.34	-3.76	0.000193	Multiple sclerosis	
KIRC	cis	1	rs28396304	chr19:12081484	ZNF763	chr19:12035900-12091196:+	-0.53	-6.4	3.53E-10	Multiple sclerosis	
KIRC	cis	1	rs28398771	chr1:19326771	RNF186	chr1:20140523-20141771:-	0.29	3.9	0.000109	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28398771	chr1:19326771	TMCO4	chr1:20008707-20126758:-	0.25	3.5	0.000503	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28399702	chr14:35625217	KIAA0391	chr14:35591776-35786673:+	0.2	3.57	0.000394	Atopic dermatitis	
KIRC	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.25	5.1	4.89E-7	Atopic dermatitis	
KIRC	cis	1	rs28399710	chr7:1070631	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs28406132	chr8:96030377	C8orf38	chr8:95908040-96088396:+	-0.24	-3.66	0.00028	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs28409322	chr3:134252385	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs28409655	chr4:48391379	OCIAD1	chr4:48833015-48863831:+	0.24	5.31	1.67E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs28414285	chr8:89427336	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs28416221	chr4:75710773	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs28416696	chr2:54484326	ACYP2	chr2:54342410-54532433:+	-0.22	-3.88	0.000117	Telomere length	
KIRC	cis	1	rs28417607	chr4:171028664	AADAT	chr4:170981374-171011372:-	-0.45	-4.76	2.49E-6	Thyroid hormone levels	
KIRC	cis	1	rs28417694	chr3:58373939	PXK	chr3:58318617-58410878:+	0.22	4.63	4.72E-6	Cholesterol, total	
KIRC	cis	1	rs28417827	chr1:19324393	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs2842315	chr14:68959229	PLEKHH1	chr14:68000008-68056255:+	0.16	3.91	0.000107	Breast cancer	
KIRC	cis	1	rs28428724	chr4:75711826	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs28429352	chr1:19324685	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28436199	chr17:18751730	FAM18B	chr17:18684582-18710026:+	-0.27	-6.16	1.49E-9	Educational attainment (years of education)	
KIRC	cis	1	rs28437878	chr15:78807872	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.68	2.25E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs28440026	chr8:96026744	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28444423	chr15:65982141	DPP8	chr15:65737999-65810035:-	-0.12	-4.81	2.03E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs28446827	chr8:89420016	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs28448438	chr4:56416665	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.76	0.000186	Personality dimensions	
KIRC	cis	1	rs28448438	chr4:56416665	TMEM165	chr4:56262090-56292342:+	0.22	5.91	6.49E-9	Personality dimensions	
KIRC	cis	1	rs28453840	chr2:136522941	DARS	chr2:136664254-136743222:-	-0.19	-4.7	3.33E-6	Cholesterol, total	
KIRC	cis	1	rs2845857	chr11:71715215	C11orf59	chr11:71808339-71814322:-	-0.22	-3.78	0.000174	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs28463311	chr17:61919643	FTSJ3	chr17:61896795-61905031:-	0.33	6.44	2.82E-10	Body mass index	
KIRC	cis	1	rs28463311	chr17:61919643	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.51	8.25E-6	Body mass index	
KIRC	cis	1	rs28463765	chr4:56412434	SRD5A3	chr4:56212409-56237866:+	-0.21	-4.35	1.62E-5	Personality dimensions	
KIRC	cis	1	rs28463765	chr4:56412434	TMEM165	chr4:56262090-56292342:+	0.22	5.77	1.38E-8	Personality dimensions	
KIRC	cis	1	rs284648	chr19:41926790	ATP5SL	chr19:41937224-41945810:-	0.17	3.9	0.00011	Height	
KIRC	cis	1	rs284649	chr19:41926838	ATP5SL	chr19:41937224-41945810:-	0.17	3.9	0.00011	Height	
KIRC	cis	1	rs284650	chr19:41927129	ATP5SL	chr19:41937224-41945810:-	0.17	3.9	0.00011	Height	
KIRC	cis	1	rs284651	chr19:41928336	ATP5SL	chr19:41937224-41945810:-	0.16	3.85	0.000134	Height	
KIRC	cis	1	rs284652	chr19:41928652	ATP5SL	chr19:41937224-41945810:-	0.17	3.9	0.00011	Height	
KIRC	cis	1	rs28465556	chr4:39121189	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs284655	chr19:41928765	ATP5SL	chr19:41937224-41945810:-	0.16	3.85	0.000131	Height	
KIRC	cis	1	rs284656	chr19:41929251	ATP5SL	chr19:41937224-41945810:-	0.16	3.83	0.000143	Height	
KIRC	cis	1	rs284657	chr19:41929915	ATP5SL	chr19:41937224-41945810:-	0.16	3.75	0.000194	Height	
KIRC	cis	1	rs284658	chr19:41929988	ATP5SL	chr19:41937224-41945810:-	0.15	3.62	0.00033	Height	
KIRC	cis	1	rs284663	chr19:41932612	ATP5SL	chr19:41937224-41945810:-	0.15	3.51	0.000482	Height	
KIRC	cis	1	rs28468623	chr7:98922812	CYP3A5	chr7:99245818-99332821:-	0.35	4.48	9.26E-6	Blood metabolite levels	
KIRC	cis	1	rs28469723	chr20:33700717	PROCR	chr20:33758727-33765164:+	-0.27	-3.63	0.000317	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs28473493	chr15:100583942	ADAMTS17	chr15:100511643-100882183:-	0.31	5.13	4.16E-7	Gastroesophageal reflux disease	
KIRC	cis	1	rs28473493	chr15:100583942	FLJ42289	chr15:100884662-100890923:-	0.22	3.7	0.000239	Gastroesophageal reflux disease	
KIRC	cis	1	rs2847577	chr18:48364819	MRO	chr18:48321491-48351754:-	-0.32	-5.91	6.15E-9	Entorhinal cortical thickness	
KIRC	cis	1	rs2847655	chr11:59865671	MS4A2	chr11:59856137-59866014:+	0.18	3.95	9.01E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2847666	chr11:59859576	MS4A2	chr11:59856137-59866014:+	0.18	3.92	0.000102	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2847667	chr11:59859609	MS4A2	chr11:59856137-59866014:+	0.18	3.94	9.34E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs2847668	chr11:59862261	MS4A2	chr11:59856137-59866014:+	0.17	3.79	0.000172	Alzheimer's disease (late onset)	
KIRC	cis	1	rs28477467	chr8:96032905	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.000255	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28480159	chr4:17685707	LAP3	chr4:17578927-17609590:+	-0.21	-6.54	1.5E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28480159	chr4:17685707	MED28	chr4:17616273-17629791:+	0.16	3.66	0.000276	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28480631	chr1:19327839	RNF186	chr1:20140523-20141771:-	0.27	3.59	0.000366	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.33	-6.39	3.68E-10	Glycated hemoglobin levels	
KIRC	cis	1	rs28488297	chr4:106767226	INTS12	chr4:106603787-106629881:-	-0.55	-6.64	7.92E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs28489489	chr3:58443755	PXK	chr3:58318617-58410878:+	0.23	4.53	7.44E-6	Cholesterol, total	
KIRC	cis	1	rs28490940	chr16:68010262	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.43	1.16E-5	Crohn's disease	
KIRC	cis	1	rs2849246	chr18:48371896	ME2	chr18:48405435-48474258:+	-0.16	-3.5	0.0005	Entorhinal cortical thickness	
KIRC	cis	1	rs2849246	chr18:48371896	MRO	chr18:48321491-48351754:-	-0.32	-5.76	1.48E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs28494067	chr15:50908272	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.92E-14	QT interval	
KIRC	cis	1	rs28494067	chr15:50908272	TRPM7	chr15:50852491-50978994:-	0.13	3.76	0.000193	QT interval	
KIRC	cis	1	rs28496357	chr8:96030511	C8orf38	chr8:95908040-96088396:+	-0.25	-3.85	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28497813	chr4:17685503	LAP3	chr4:17578927-17609590:+	-0.21	-6.54	1.5E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28497813	chr4:17685503	MED28	chr4:17616273-17629791:+	0.16	3.66	0.000276	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28501187	chr4:17643620	LAP3	chr4:17578927-17609590:+	-0.21	-6.47	2.37E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28501187	chr4:17643620	MED28	chr4:17616273-17629791:+	0.18	3.96	8.56E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28502530	chr14:65850968	LOC645431	chr14:65877313-65879335:-	-0.44	-5.98	4.35E-9	Ischemic stroke	
KIRC	cis	1	rs28504107	chr11:71832519	C11orf59	chr11:71808339-71814322:-	0.21	3.8	0.000165	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs28505299	chr1:19328458	RNF186	chr1:20140523-20141771:-	0.28	3.64	0.0003	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28505711	chr1:19329712	RNF186	chr1:20140523-20141771:-	0.28	3.63	0.000317	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28512382	chr10:1092195	IDI2	chr10:1064847-1071799:-	-0.24	-3.73	0.000212	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs28514423	chr4:56429239	SRD5A3	chr4:56212409-56237866:+	-0.18	-4.02	6.69E-5	Personality dimensions	
KIRC	cis	1	rs28514423	chr4:56429239	TMEM165	chr4:56262090-56292342:+	0.22	6.09	2.22E-9	Personality dimensions	
KIRC	cis	1	rs28517362	chr6:151876387	C6orf97	chr6:151815175-151942327:+	0.21	3.95	8.85E-5	Bone mineral density (spine)	
KIRC	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.13	-4.59	5.62E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs28528096	chr7:1070912	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs28529050	chr4:89820790	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.69	0.000252	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs28529552	chr4:75705581	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs28539246	chr17:29226630	SUZ12P	chr17:29035714-29097067:+	-0.12	-4.44	1.11E-5	Height	
KIRC	cis	1	rs28540190	chr19:49135043	SEC1	chr19:49141296-49185501:+	-0.56	-5.71	1.99E-8	Elevated serum carcinoembryonic antigen levels	
KIRC	cis	1	rs28542077	chr8:124190896	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs2854218	chr17:61942940	FTSJ3	chr17:61896795-61905031:-	0.33	6.47	2.37E-10	Body mass index	
KIRC	cis	1	rs2854218	chr17:61942940	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.56	6.44E-6	Body mass index	
KIRC	cis	1	rs2854219	chr17:61942682	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.92E-10	Body mass index	
KIRC	cis	1	rs2854219	chr17:61942682	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.6	5.28E-6	Body mass index	
KIRC	cis	1	rs2854223	chr17:61939014	DDX42	chr17:61851567-61896676:+	-0.16	-3.5	0.000515	Body mass index	
KIRC	cis	1	rs2854223	chr17:61939014	FTSJ3	chr17:61896795-61905031:-	0.31	6.27	7.59E-10	Body mass index	
KIRC	cis	1	rs2854223	chr17:61939014	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.57	6.22E-6	Body mass index	
KIRC	cis	1	rs28545485	chr4:17645376	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.72E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28545485	chr4:17645376	MED28	chr4:17616273-17629791:+	0.18	3.99	7.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2854977	chr17:40710892	NAGLU	chr17:40687951-40696464:+	0.39	4.23	2.76E-5	Systolic blood pressure change trajectories	
KIRC	cis	1	rs2855017	chr11:59866309	MS4A2	chr11:59856137-59866014:+	0.18	3.83	0.000147	Alzheimer's disease (late onset)	
KIRC	cis	1	rs28552744	chr4:17620165	LAP3	chr4:17578927-17609590:+	-0.21	-6.65	7.49E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28552744	chr4:17620165	MED28	chr4:17616273-17629791:+	0.19	4.28	2.25E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28556680	chr15:66023799	DPP8	chr15:65737999-65810035:-	-0.12	-4.97	9.25E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs28558133	chr6:26531433	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs28558726	chr17:53058676	TOM1L1	chr17:52978052-53039328:+	-0.15	-4.08	5.26E-5	Breast cancer	
KIRC	cis	1	rs28567450	chr6:34747409	UHRF1BP1	chr6:34759794-34853117:+	0.29	6.36	4.52E-10	Pubertal anthropometrics	
KIRC	cis	1	rs2856	chr20:25433536	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.92	1.35E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs2856	chr20:25433536	FAM182A	chr20:26035250-26067552:+	-0.3	-5.77	1.39E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs28572116	chr4:56424344	SRD5A3	chr4:56212409-56237866:+	-0.19	-3.99	7.55E-5	Personality dimensions	
KIRC	cis	1	rs28572116	chr4:56424344	TMEM165	chr4:56262090-56292342:+	0.21	5.85	8.95E-9	Personality dimensions	
KIRC	cis	1	rs28572537	chr19:18552208	SSBP4	chr19:18530221-18545371:+	-0.13	-4.45	1.07E-5	Breast cancer	
KIRC	cis	1	rs28575256	chr1:19320915	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28575371	chr4:75699537	BTC	chr4:75671448-75719882:-	0.3	4.08	5.21E-5	Electroencephalogram traits	
KIRC	cis	1	rs2857891	chr11:6962957	ZNF215	chr11:6947654-7005861:+	-0.28	-4.17	3.55E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs28581869	chr8:89427256	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs28582059	chr4:56408404	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.91	0.000105	Personality dimensions	
KIRC	cis	1	rs28582059	chr4:56408404	TMEM165	chr4:56262090-56292342:+	0.23	6.31	6.24E-10	Personality dimensions	
KIRC	cis	1	rs28600316	chr4:75711790	BTC	chr4:75671448-75719882:-	0.27	3.53	0.000451	Electroencephalogram traits	
KIRC	cis	1	rs28602663	chr1:76235355	ACADM	chr1:76190043-76229353:+	0.16	4.62	4.93E-6	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs28602670	chr15:78768167	CHRNA5	chr15:78857906-78886458:+	-0.22	-3.96	8.51E-5	Post bronchodilator FEV1	
KIRC	cis	1	rs28607301	chr4:39138080	WDR19	chr4:39184024-39287429:+	0.18	4.7	3.4E-6	Uric acid levels	
KIRC	cis	1	rs28608578	chr4:75713550	BTC	chr4:75671448-75719882:-	0.27	3.53	0.000451	Electroencephalogram traits	
KIRC	cis	1	rs2860975	chr10:96766934	CYP2C9	chr10:96698415-96749147:+	-0.18	-3.67	0.000266	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs28616734	chr8:96021443	C8orf38	chr8:95908040-96088396:+	-0.25	-3.8	0.00016	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28623160	chr1:19320838	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28624331	chr8:124190768	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs28624565	chr4:75713287	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs28626045	chr14:75589195	MLH3	chr14:75480467-75518235:-	0.24	6	3.83E-9	Height	
KIRC	cis	1	rs28626045	chr14:75589195	NEK9	chr14:75548819-75593778:-	0.14	3.89	0.000115	Height	
KIRC	cis	1	rs28626594	chr4:171028516	AADAT	chr4:170981374-171011372:-	-0.45	-4.76	2.49E-6	Thyroid hormone levels	
KIRC	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.54	12.13	7.34E-30	Forced vital capacity	
KIRC	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.54	12.08	1.1E-29	Forced vital capacity	
KIRC	cis	1	rs28629854	chr9:98262833	C9orf130	chr9:98568372-98638259:-	0.2	3.55	0.000422	Height	
KIRC	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.52	-11.9	5.96E-29	Forced vital capacity	
KIRC	cis	1	rs28633203	chr1:19328460	RNF186	chr1:20140523-20141771:-	0.3	3.94	9.12E-5	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28637863	chr4:75706357	BTC	chr4:75671448-75719882:-	0.28	3.84	0.000137	Electroencephalogram traits	
KIRC	cis	1	rs28640237	chr15:66070962	DPP8	chr15:65737999-65810035:-	-0.12	-4.97	9.39E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs28647657	chr4:75713724	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs2864	chr5:137523430	CDC25C	chr5:137620959-137674044:-	-0.23	-6.25	8.72E-10	Resting heart rate	
KIRC	cis	1	rs28651004	chr1:19321065	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28651964	chr8:96026781	C8orf38	chr8:95908040-96088396:+	-0.24	-3.65	0.00029	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28655136	chr16:68001447	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-4.59	5.5E-6	Crohn's disease	
KIRC	cis	1	rs28655955	chr19:12064771	GCDH	chr19:13001974-13010782:+	-0.37	-4.11	4.59E-5	Multiple sclerosis	
KIRC	cis	1	rs28655955	chr19:12064771	ZNF763	chr19:12035900-12091196:+	-0.58	-7.01	7.55E-12	Multiple sclerosis	
KIRC	cis	1	rs28660477	chr15:56145267	NEDD4	chr15:56119131-56285835:-	0.2	4.77	2.38E-6	Keloid	
KIRC	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.5	-8.29	1.07E-15	Bone mineral density	
KIRC	cis	1	rs2866406	chr4:103554019	MANBA	chr4:103552644-103682151:-	0.16	3.65	0.000289	Primary biliary cirrhosis	
KIRC	cis	1	rs2866407	chr4:103554108	MANBA	chr4:103552644-103682151:-	0.16	3.65	0.000289	Primary biliary cirrhosis	
KIRC	cis	1	rs2866408	chr4:103554113	MANBA	chr4:103552644-103682151:-	0.16	3.65	0.000289	Primary biliary cirrhosis	
KIRC	cis	1	rs2866409	chr4:103554261	MANBA	chr4:103552644-103682151:-	0.16	3.65	0.000289	Primary biliary cirrhosis	
KIRC	cis	1	rs2866413	chr4:103557077	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs2866414	chr4:103557219	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs28664971	chr17:28437410	EFCAB5	chr17:28256874-28435469:+	0.31	5.6	3.46E-8	Coffee consumption (cups per day)	
KIRC	cis	1	rs28668389	chr3:58323942	PXK	chr3:58318617-58410878:+	0.18	4.05	5.88E-5	Cholesterol, total	
KIRC	cis	1	rs28668419	chr16:68010195	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-4.43	1.16E-5	Crohn's disease	
KIRC	cis	1	rs28670674	chr4:56407103	SRD5A3	chr4:56212409-56237866:+	-0.21	-4.39	1.41E-5	Personality dimensions	
KIRC	cis	1	rs28670674	chr4:56407103	TMEM165	chr4:56262090-56292342:+	0.21	5.61	3.34E-8	Personality dimensions	
KIRC	cis	1	rs2867318	chr19:52363472	ZNF577	chr19:52359056-52394145:-	-0.3	-5.57	4.12E-8	Breast cancer	
KIRC	cis	1	rs2867318	chr19:52363472	ZNF649	chr19:52392489-52408247:-	-0.24	-4.95	1.02E-6	Breast cancer	
KIRC	cis	1	rs28679372	chr16:67882932	ATP6V0D1	chr16:67471917-67515089:-	0.32	4.19	3.36E-5	Crohn's disease	
KIRC	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.25	-7.06	5.6E-12	Educational attainment;Height;Head circumference (infant)	
KIRC	cis	1	rs28686865	chr1:19324411	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs2868985	chr2:56191470	CCDC88A	chr2:55514978-55647057:-	-0.18	-3.77	0.000181	Schizophrenia	
KIRC	cis	1	rs2868985	chr2:56191470	MTIF2	chr2:55463758-55496384:-	-0.21	-3.91	0.000104	Schizophrenia	
KIRC	cis	1	rs28690197	chr1:19324238	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28693609	chr4:17645233	LAP3	chr4:17578927-17609590:+	-0.21	-6.4	3.58E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28693609	chr4:17645233	MED28	chr4:17616273-17629791:+	0.19	4.19	3.28E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2869548	chr15:78922638	CHRNA5	chr15:78857906-78886458:+	-0.36	-7.05	5.87E-12	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs28695767	chr4:75697131	BTC	chr4:75671448-75719882:-	0.28	3.88	0.000121	Electroencephalogram traits	
KIRC	cis	1	rs2869716	chr20:47779340	CSE1L	chr20:47662838-47713484:+	0.15	3.81	0.000158	Anger	
KIRC	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.71	9.26	5.91E-19	Diastolic blood pressure	
KIRC	cis	1	rs28712702	chr8:96026980	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs28715564	chr1:19325084	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28718130	chr15:50909489	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.92E-14	QT interval	
KIRC	cis	1	rs28718130	chr15:50909489	TRPM7	chr15:50852491-50978994:-	0.13	3.76	0.000193	QT interval	
KIRC	cis	1	rs2872958	chr4:17665032	LAP3	chr4:17578927-17609590:+	-0.21	-6.42	3.14E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2872958	chr4:17665032	MED28	chr4:17616273-17629791:+	0.18	4.09	5.02E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2872959	chr4:17677163	LAP3	chr4:17578927-17609590:+	0.2	6.3	6.7E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs2872959	chr4:17677163	MED28	chr4:17616273-17629791:+	-0.16	-3.65	0.000287	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.7	10.21	2.35E-22	Diastolic blood pressure	
KIRC	cis	1	rs2874121	chr17:61731024	FTSJ3	chr17:61896795-61905031:-	0.32	6.26	8.27E-10	Body mass index	
KIRC	cis	1	rs2874121	chr17:61731024	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.52	7.71E-6	Body mass index	
KIRC	cis	1	rs2874131	chr14:68245699	ZFYVE26	chr14:68213237-68283306:-	-0.13	-3.55	0.000427	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.49	-8.67	5.82E-17	Bone mineral density	
KIRC	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.5	-8.68	5.49E-17	Bone mineral density	
KIRC	cis	1	rs28763597	chr4:80910950	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs2876629	chr6:55981048	COL21A1	chr6:55921389-56258892:-	-0.47	-7.44	4.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs28768402	chr8:89412652	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs28770330	chr15:56248743	NEDD4	chr15:56119131-56285835:-	0.22	4.96	9.48E-7	Keloid	
KIRC	cis	1	rs28773028	chr15:56262339	NEDD4	chr15:56119131-56285835:-	0.22	4.95	9.93E-7	Keloid	
KIRC	cis	1	rs28773168	chr4:75709804	BTC	chr4:75671448-75719882:-	0.32	4.32	1.91E-5	Electroencephalogram traits	
KIRC	cis	1	rs28776777	chr12:91450082	KERA	chr12:91444273-91452131:-	0.33	3.49	0.000525	Diabetic kidney disease	
KIRC	cis	1	rs28806527	chr1:19328077	RNF186	chr1:20140523-20141771:-	0.29	3.93	9.84E-5	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs2880791	chr5:150267376	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs28811905	chr3:136252052	IL20RB	chr3:136676707-136729920:+	0.15	3.49	0.000516	Body mass index;Height	
KIRC	cis	1	rs28817917	chr15:50965846	SPPL2A	chr15:50999739-51057910:-	0.27	7.07	5.26E-12	QT interval	
KIRC	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs28828688	chr17:46732153	SNX11	chr17:46184911-46200105:+	-0.37	-3.85	0.000135	Platelet thrombus formation	
KIRC	cis	1	rs28828688	chr17:46732153	ZNF652	chr17:47366569-47439835:-	-0.33	-3.53	0.000453	Platelet thrombus formation	
KIRC	cis	1	rs28830602	chr4:80908833	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs28836882	chr6:55998918	COL21A1	chr6:55921389-56258892:-	-0.48	-7.37	7.1E-13	Psychosis (atypical)	
KIRC	cis	1	rs28840430	chr1:19328242	RNF186	chr1:20140523-20141771:-	0.28	3.64	0.0003	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs28842234	chr4:80908938	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.29	8.46	2.88E-16	Longevity	
KIRC	cis	1	rs2885880	chr11:71655847	C11orf59	chr11:71808339-71814322:-	-0.22	-4.04	6.3E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs28877640	chr8:89412955	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.6	14.07	3.71E-38	Height	
KIRC	cis	1	rs2887797	chr3:134202506	CEP63	chr3:134204575-134293852:+	0.32	6.01	3.55E-9	Height	
KIRC	cis	1	rs2890659	chr4:39127021	WDR19	chr4:39184024-39287429:+	0.18	4.67	3.95E-6	Uric acid levels	
KIRC	cis	1	rs2891586	chr10:38101643	LOC399744	chr10:38717074-38741080:+	0.21	3.55	0.000422	Obesity (extreme)	
KIRC	cis	1	rs2892838	chr7:17324624	AHR	chr7:17338276-17385775:+	0.25	5.07	5.55E-7	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level);Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	
KIRC	cis	1	rs2893685	chr12:117001193	NCRNA00173	chr12:116971227-116974317:+	-0.26	-3.51	0.00049	Acute lymphoblastic leukemia (childhood)	
KIRC	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.16	-5.7	2.03E-8	Blood metabolite levels	
KIRC	cis	1	rs2897770	chr13:50325070	EBPL	chr13:50234811-50265623:-	-0.27	-4.67	3.83E-6	Obesity-related traits	
KIRC	cis	1	rs2899462	chr15:50939254	SPPL2A	chr15:50999739-51057910:-	0.28	7.44	4.33E-13	QT interval	
KIRC	cis	1	rs2899596	chr15:56502586	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2899597	chr15:56502930	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs2901438	chr2:73665656	TPRKB	chr2:73956957-73964517:-	-0.18	-4.59	5.57E-6	Metabolite levels	
KIRC	cis	1	rs2902858	chr11:46524013	MDK	chr11:46402334-46405374:+	-0.22	-3.77	0.000183	Schizophrenia	
KIRC	cis	1	rs2903283	chr4:103557753	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs2905425	chr19:19475717	HAPLN4	chr19:19366453-19384074:-	-0.29	-6.32	5.67E-10	Schizophrenia	
KIRC	cis	1	rs2905425	chr19:19475717	SF4	chr19:19387323-19431307:-	-0.16	-4.08	5.22E-5	Schizophrenia	
KIRC	cis	1	rs2906124	chr5:137528835	CDC25C	chr5:137620959-137674044:-	-0.21	-5.93	5.61E-9	Resting heart rate	
KIRC	cis	1	rs2906127	chr5:137539466	CDC25C	chr5:137620959-137674044:-	-0.23	-6.17	1.45E-9	Resting heart rate	
KIRC	cis	1	rs2906128	chr5:137550054	CDC25C	chr5:137620959-137674044:-	-0.23	-6.31	6.08E-10	Resting heart rate	
KIRC	cis	1	rs2910851	chr5:42787232	CCDC152	chr5:42756920-42802539:+	0.23	5.14	3.85E-7	Height	
KIRC	cis	1	rs2910855	chr5:42782335	CCDC152	chr5:42756920-42802539:+	0.21	4.9	1.3E-6	Height	
KIRC	cis	1	rs2910856	chr5:42781376	CCDC152	chr5:42756920-42802539:+	0.23	5.11	4.7E-7	Height	
KIRC	cis	1	rs2910862	chr5:42766404	CCDC152	chr5:42756920-42802539:+	0.23	5.09	5.06E-7	Height	
KIRC	cis	1	rs2910864	chr5:42763707	CCDC152	chr5:42756920-42802539:+	0.23	5.09	5.06E-7	Height	
KIRC	cis	1	rs2910869	chr5:42741846	CCDC152	chr5:42756920-42802539:+	0.24	5.35	1.36E-7	Height	
KIRC	cis	1	rs2910872	chr5:42730292	CCDC152	chr5:42756920-42802539:+	0.22	5.07	5.73E-7	Height	
KIRC	cis	1	rs2910875	chr5:42719826	CCDC152	chr5:42756920-42802539:+	0.23	5.14	3.85E-7	Height	
KIRC	cis	1	rs2911130	chr5:96183427	ERAP1	chr5:96096515-96149837:-	-0.23	-5.54	5.0E-8	Urate levels (BMI interaction)	
KIRC	cis	1	rs2911131	chr5:96185949	ERAP1	chr5:96096515-96149837:-	0.23	5.61	3.41E-8	Urate levels (BMI interaction)	
KIRC	cis	1	rs2911132	chr5:96186988	ERAP1	chr5:96096515-96149837:-	-0.23	-5.39	1.11E-7	Urate levels (BMI interaction)	
KIRC	cis	1	rs2911140	chr5:96179943	ERAP1	chr5:96096515-96149837:-	-0.24	-5.76	1.44E-8	Urate levels (BMI interaction)	
KIRC	cis	1	rs2916062	chr19:24184261	ZNF681	chr19:23921999-23941693:-	0.2	3.82	0.00015	Testicular germ cell tumor	
KIRC	cis	1	rs2916068	chr19:19516433	HAPLN4	chr19:19366453-19384074:-	0.32	7.09	4.55E-12	Schizophrenia	
KIRC	cis	1	rs2916068	chr19:19516433	TM6SF2	chr19:19375174-19384074:-	0.15	3.58	0.000379	Schizophrenia	
KIRC	cis	1	rs2920280	chr8:143761144	LY6K	chr8:143781529-143785582:+	0.28	4.9	1.32E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920280	chr8:143761144	LYNX1	chr8:143845758-143859640:-	-0.18	-3.59	0.000365	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920280	chr8:143761144	PSCA	chr8:143761875-143764142:+	0.2	3.59	0.000359	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920282	chr8:143757763	LY6K	chr8:143781529-143785582:+	0.25	4.37	1.54E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920282	chr8:143757763	LYNX1	chr8:143845758-143859640:-	-0.21	-4.18	3.51E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920283	chr8:143757037	LY6K	chr8:143781529-143785582:+	0.25	4.35	1.66E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920283	chr8:143757037	LYNX1	chr8:143845758-143859640:-	-0.21	-4.16	3.74E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920286	chr8:143754728	LY6K	chr8:143781529-143785582:+	0.25	4.36	1.56E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920286	chr8:143754728	LYNX1	chr8:143845758-143859640:-	-0.21	-4.13	4.26E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920292	chr8:143765699	LY6K	chr8:143781529-143785582:+	0.25	4.41	1.28E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.21	-4.28	2.27E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920292	chr8:143765699	PSCA	chr8:143761875-143764142:+	0.21	3.76	0.000191	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.3E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.22	-4.36	1.59E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920293	chr8:143765414	PSCA	chr8:143761875-143764142:+	0.21	3.83	0.000142	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920294	chr8:143765326	LY6K	chr8:143781529-143785582:+	0.25	4.3	2.09E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.21	-4.17	3.64E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920294	chr8:143765326	PSCA	chr8:143761875-143764142:+	0.21	3.78	0.000177	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920295	chr8:143764937	LY6K	chr8:143781529-143785582:+	0.25	4.36	1.59E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.22	-4.34	1.73E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920295	chr8:143764937	PSCA	chr8:143761875-143764142:+	0.22	3.93	9.72E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920296	chr8:143763109	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.32E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920296	chr8:143763109	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920296	chr8:143763109	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000165	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920297	chr8:143763083	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.32E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920297	chr8:143763083	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920297	chr8:143763083	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000165	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920298	chr8:143763043	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.32E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920298	chr8:143763043	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920298	chr8:143763043	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000165	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.6	-10.32	8.98E-23	Tumor biomarkers	
KIRC	cis	1	rs2920781	chr15:43924682	STRC	chr15:43891762-43924561:-	0.22	4.44	1.09E-5	Tumor biomarkers	
KIRC	cis	1	rs2920781	chr15:43924682	TUBGCP4	chr15:43663313-43698238:+	0.18	3.95	9.09E-5	Tumor biomarkers	
KIRC	cis	1	rs2926702	chr8:71167994	XKR9	chr8:71581600-71648176:+	0.33	4.21	3.01E-5	Non-small cell lung cancer	
KIRC	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.6	-10.29	1.12E-22	Tumor biomarkers	
KIRC	cis	1	rs2927072	chr15:43922398	STRC	chr15:43891762-43924561:-	0.22	4.45	1.08E-5	Tumor biomarkers	
KIRC	cis	1	rs2927072	chr15:43922398	TUBGCP4	chr15:43663313-43698238:+	0.18	4	7.37E-5	Tumor biomarkers	
KIRC	cis	1	rs2929282	chr15:44245931	ADAL	chr15:43622872-43646094:+	-0.39	-4.95	1.03E-6	Triglycerides	
KIRC	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.42	-6.18	1.35E-9	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.39	-10.01	1.3E-21	Multiple sclerosis or amyotrophic lateral sclerosis	
KIRC	cis	1	rs2935183	chr17:45607572	ITGB3	chr17:45331208-45421658:+	-0.16	-3.74	0.000202	Multiple sclerosis or amyotrophic lateral sclerosis	
KIRC	cis	1	rs2935183	chr17:45607572	TBKBP1	chr17:45772630-45789427:+	0.17	4.25	2.5E-5	Multiple sclerosis or amyotrophic lateral sclerosis	
KIRC	cis	1	rs2938670	chr15:78740688	CHRNA5	chr15:78857906-78886458:+	-0.19	-3.64	0.000296	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2941740	chr6:152009638	ESR1	chr6:152011631-152424406:+	0.2	3.85	0.000134	Bone properties (heel)	
KIRC	cis	1	rs2941741	chr6:152008982	ESR1	chr6:152011631-152424406:+	0.19	3.56	0.000399	Bone properties (heel)	
KIRC	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.35	6.76	3.9E-11	Obesity-related traits	
KIRC	cis	1	rs2951308	chr7:143767149	OR2A1	chr7:144015236-144016148:+;chr7	0.26	4.88	1.41E-6	Obesity-related traits	
KIRC	cis	1	rs2951308	chr7:143767149	OR2A9P	chr7:143991573-143997832:+;chr7	0.42	7.62	1.3E-13	Obesity-related traits	
KIRC	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.65	1.01E-13	Obesity-related traits	
KIRC	cis	1	rs2951353	chr7:143761116	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.41	9.85E-8	Obesity-related traits	
KIRC	cis	1	rs2951353	chr7:143761116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.4	4.46E-16	Obesity-related traits	
KIRC	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs2951354	chr7:143761001	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs2951354	chr7:143761001	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.8	3.63E-14	Obesity-related traits	
KIRC	cis	1	rs2951360	chr7:143757349	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.46	7.37E-8	Obesity-related traits	
KIRC	cis	1	rs2951360	chr7:143757349	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.51	2.06E-16	Obesity-related traits	
KIRC	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.89	1.87E-14	Obesity-related traits	
KIRC	cis	1	rs2951363	chr7:143754724	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.53	5.12E-8	Obesity-related traits	
KIRC	cis	1	rs2951363	chr7:143754724	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.56	1.43E-16	Obesity-related traits	
KIRC	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.85	2.51E-14	Obesity-related traits	
KIRC	cis	1	rs2951364	chr7:143754483	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.47	7.15E-8	Obesity-related traits	
KIRC	cis	1	rs2951364	chr7:143754483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.85	2.51E-14	Obesity-related traits	
KIRC	cis	1	rs2951368	chr7:143752821	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.47	7.15E-8	Obesity-related traits	
KIRC	cis	1	rs2951368	chr7:143752821	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.85	2.51E-14	Obesity-related traits	
KIRC	cis	1	rs2951369	chr7:143752638	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.47	7.15E-8	Obesity-related traits	
KIRC	cis	1	rs2951369	chr7:143752638	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.83	2.88E-14	Obesity-related traits	
KIRC	cis	1	rs2951372	chr7:143749503	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.46	7.6E-8	Obesity-related traits	
KIRC	cis	1	rs2951372	chr7:143749503	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs2955077	chr3:127958869	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955077	chr3:127958869	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955077	chr3:127958869	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955078	chr3:127959186	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955078	chr3:127959186	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955078	chr3:127959186	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955079	chr3:127959824	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955079	chr3:127959824	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955080	chr3:127959865	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955080	chr3:127959865	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955081	chr3:127960299	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955081	chr3:127960299	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955081	chr3:127960299	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955082	chr3:127960334	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955082	chr3:127960334	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955083	chr3:127961178	KBTBD12	chr3:127634318-127706513:+	-0.3	-3.95	8.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955083	chr3:127961178	RPN1	chr3:128338813-128399918:-	-0.22	-3.67	0.000273	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955083	chr3:127961178	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.56	6.41E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955085	chr3:127962757	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955085	chr3:127962757	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955085	chr3:127962757	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955086	chr3:127963191	RPN1	chr3:128338813-128399918:-	-0.22	-3.76	0.000188	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955086	chr3:127963191	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.44	1.1E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955088	chr3:127963710	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955088	chr3:127963710	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955088	chr3:127963710	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955089	chr3:127969330	RPN1	chr3:128338813-128399918:-	-0.22	-3.71	0.000231	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955089	chr3:127969330	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.35	1.66E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955090	chr3:127969371	RPN1	chr3:128338813-128399918:-	-0.22	-3.71	0.000231	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955090	chr3:127969371	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.35	1.66E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955091	chr3:127971361	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.7	0.000241	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955095	chr3:127977665	KBTBD12	chr3:127634318-127706513:+	0.26	3.63	0.000315	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955095	chr3:127977665	RPN1	chr3:128338813-128399918:-	0.24	4.21	2.99E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955095	chr3:127977665	RUVBL1	chr3:127783627-127872757:-	0.33	4.71	3.22E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955096	chr3:127977866	KBTBD12	chr3:127634318-127706513:+	0.29	3.93	9.67E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955096	chr3:127977866	RPN1	chr3:128338813-128399918:-	0.22	3.69	0.000246	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955096	chr3:127977866	RUVBL1	chr3:127783627-127872757:-	0.33	4.61	5.12E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955097	chr3:127978505	KBTBD12	chr3:127634318-127706513:+	-0.27	-3.64	0.000303	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955097	chr3:127978505	RPN1	chr3:128338813-128399918:-	-0.22	-3.8	0.000161	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955097	chr3:127978505	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.23E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955099	chr3:127979654	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955099	chr3:127979654	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955100	chr3:127993325	RPN1	chr3:128338813-128399918:-	-0.23	-3.9	0.000109	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955100	chr3:127993325	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955101	chr3:128009612	RPN1	chr3:128338813-128399918:-	-0.21	-3.53	0.000451	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955101	chr3:128009612	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.19	3.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955126	chr3:127926254	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.89	0.000112	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955126	chr3:127926254	RUVBL1	chr3:127783627-127872757:-	-0.32	-4.49	8.82E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955129	chr3:127929207	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.73	0.000214	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955129	chr3:127929207	RPN1	chr3:128338813-128399918:-	-0.23	-3.89	0.000114	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955129	chr3:127929207	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.8	2.05E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955130	chr3:127937814	KBTBD12	chr3:127634318-127706513:+	-0.27	-3.61	0.000331	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955130	chr3:127937814	RPN1	chr3:128338813-128399918:-	-0.21	-3.56	0.000412	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2955130	chr3:127937814	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.78	2.33E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2956716	chr12:48856183	ZNF641	chr12:48735912-48745021:-	-0.16	-3.62	0.000327	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs2957356	chr8:120373995	NOV	chr8:120428552-120436678:+	-0.29	-4.62	4.84E-6	Hypertension	
KIRC	cis	1	rs2957357	chr8:120378699	NOV	chr8:120428552-120436678:+	-0.32	-5.15	3.81E-7	Hypertension	
KIRC	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.29	5.74	1.66E-8	Diabetic kidney disease	
KIRC	cis	1	rs2961102	chr7:65424658	CRCP	chr7:65579805-65619551:+	-0.31	-4.24	2.63E-5	Diabetic kidney disease	
KIRC	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.85	2.51E-14	Obesity-related traits	
KIRC	cis	1	rs2961115	chr7:143753371	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.47	7.15E-8	Obesity-related traits	
KIRC	cis	1	rs2961115	chr7:143753371	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.69E-16	Obesity-related traits	
KIRC	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.97	1.09E-14	Obesity-related traits	
KIRC	cis	1	rs2961117	chr7:143755253	OR2A1	chr7:144015236-144016148:+;chr7	-0.3	-5.63	3.01E-8	Obesity-related traits	
KIRC	cis	1	rs2961117	chr7:143755253	OR2A9P	chr7:143991573-143997832:+;chr7	-0.47	-8.77	2.83E-17	Obesity-related traits	
KIRC	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.83	2.99E-14	Obesity-related traits	
KIRC	cis	1	rs2961118	chr7:143755443	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.53	5.16E-8	Obesity-related traits	
KIRC	cis	1	rs2961118	chr7:143755443	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.62	8.79E-17	Obesity-related traits	
KIRC	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.79	3.91E-14	Obesity-related traits	
KIRC	cis	1	rs2961119	chr7:143755852	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.42	9.05E-8	Obesity-related traits	
KIRC	cis	1	rs2961119	chr7:143755852	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.73E-16	Obesity-related traits	
KIRC	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.82	3.1E-14	Obesity-related traits	
KIRC	cis	1	rs2961120	chr7:143756585	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.49	6.37E-8	Obesity-related traits	
KIRC	cis	1	rs2961120	chr7:143756585	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.55	1.54E-16	Obesity-related traits	
KIRC	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs2961125	chr7:143761770	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs2961125	chr7:143761770	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs2961126	chr7:143762736	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs2961126	chr7:143762736	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.59	1.56E-13	Obesity-related traits	
KIRC	cis	1	rs2961128	chr7:143763483	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.29	1.85E-7	Obesity-related traits	
KIRC	cis	1	rs2961128	chr7:143763483	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.29	1.05E-15	Obesity-related traits	
KIRC	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.39	-7.49	3.19E-13	Obesity-related traits	
KIRC	cis	1	rs2961132	chr7:143768128	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.26	2.16E-7	Obesity-related traits	
KIRC	cis	1	rs2961132	chr7:143768128	OR2A9P	chr7:143991573-143997832:+;chr7	-0.45	-8.2	1.97E-15	Obesity-related traits	
KIRC	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.37	-7.19	2.33E-12	Obesity-related traits	
KIRC	cis	1	rs2961134	chr7:143771062	OR2A1	chr7:144015236-144016148:+;chr7	-0.26	-4.95	1.04E-6	Obesity-related traits	
KIRC	cis	1	rs2961134	chr7:143771062	OR2A9P	chr7:143991573-143997832:+;chr7	-0.41	-7.63	1.18E-13	Obesity-related traits	
KIRC	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.41	8.11	3.97E-15	Obesity-related traits	
KIRC	cis	1	rs2961144	chr7:143747870	OR2A1	chr7:144015236-144016148:+;chr7	0.28	5.43	8.92E-8	Obesity-related traits	
KIRC	cis	1	rs2961144	chr7:143747870	OR2A9P	chr7:143991573-143997832:+;chr7	0.45	8.42	4.03E-16	Obesity-related traits	
KIRC	cis	1	rs2965188	chr19:19522557	HAPLN4	chr19:19366453-19384074:-	0.31	6.86	2.02E-11	Schizophrenia	
KIRC	cis	1	rs2965188	chr19:19522557	SF4	chr19:19387323-19431307:-	0.14	3.73	0.000213	Schizophrenia	
KIRC	cis	1	rs2965188	chr19:19522557	TM6SF2	chr19:19375174-19384074:-	0.15	3.57	0.000387	Schizophrenia	
KIRC	cis	1	rs2965198	chr19:19473030	HAPLN4	chr19:19366453-19384074:-	-0.32	-7.02	7.28E-12	Schizophrenia	
KIRC	cis	1	rs2965198	chr19:19473030	SF4	chr19:19387323-19431307:-	-0.15	-3.98	7.9E-5	Schizophrenia	
KIRC	cis	1	rs2965198	chr19:19473030	TM6SF2	chr19:19375174-19384074:-	-0.15	-3.65	0.000289	Schizophrenia	
KIRC	cis	1	rs2966379	chr2:161123251	PLA2R1	chr2:160798012-160919121:-	0.21	3.76	0.00019	Type 2 diabetes	
KIRC	cis	1	rs2967781	chr5:137557609	CDC25C	chr5:137620959-137674044:-	-0.23	-6.39	3.85E-10	Resting heart rate	
KIRC	cis	1	rs2967782	chr5:137529682	CDC25C	chr5:137620959-137674044:-	-0.21	-5.86	8.56E-9	Resting heart rate	
KIRC	cis	1	rs2967784	chr5:137539239	CDC25C	chr5:137620959-137674044:-	-0.23	-6.17	1.45E-9	Resting heart rate	
KIRC	cis	1	rs2972767	chr5:42749057	CCDC152	chr5:42756920-42802539:+	0.23	5.27	2.0E-7	Height	
KIRC	cis	1	rs2972770	chr5:42731772	CCDC152	chr5:42756920-42802539:+	0.23	5.15	3.78E-7	Height	
KIRC	cis	1	rs2972994	chr5:42756500	CCDC152	chr5:42756920-42802539:+	0.23	5.3	1.77E-7	Height	
KIRC	cis	1	rs2972998	chr5:42763512	CCDC152	chr5:42756920-42802539:+	0.23	5.09	5.06E-7	Height	
KIRC	cis	1	rs2972999	chr5:42763797	CCDC152	chr5:42756920-42802539:+	0.22	5.05	6.33E-7	Height	
KIRC	cis	1	rs2973006	chr5:42772154	CCDC152	chr5:42756920-42802539:+	0.23	5.16	3.62E-7	Height	
KIRC	cis	1	rs2973011	chr5:42782492	CCDC152	chr5:42756920-42802539:+	-0.22	-4.92	1.18E-6	Height	
KIRC	cis	1	rs2973015	chr5:42717992	CCDC152	chr5:42756920-42802539:+	0.22	4.97	9.11E-7	Height	
KIRC	cis	1	rs2973018	chr5:42723790	CCDC152	chr5:42756920-42802539:+	0.22	5.12	4.42E-7	Height	
KIRC	cis	1	rs2973023	chr5:42732883	CCDC152	chr5:42756920-42802539:+	0.23	5.15	3.78E-7	Height	
KIRC	cis	1	rs2973029	chr5:42746566	CCDC152	chr5:42756920-42802539:+	0.24	5.35	1.36E-7	Height	
KIRC	cis	1	rs2976388	chr8:143760256	LY6K	chr8:143781529-143785582:+	0.27	4.76	2.59E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976388	chr8:143760256	LYNX1	chr8:143845758-143859640:-	-0.19	-3.62	0.000319	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976392	chr8:143762932	LY6K	chr8:143781529-143785582:+	0.25	4.34	1.7E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976392	chr8:143762932	LYNX1	chr8:143845758-143859640:-	-0.2	-4.02	6.8E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976392	chr8:143762932	PSCA	chr8:143761875-143764142:+	0.2	3.67	0.000269	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976394	chr8:143763622	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.31E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976394	chr8:143763622	LYNX1	chr8:143845758-143859640:-	-0.2	-3.99	7.67E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976394	chr8:143763622	PSCA	chr8:143761875-143764142:+	0.21	3.79	0.000166	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976396	chr8:143764001	LY6K	chr8:143781529-143785582:+	-0.26	-4.52	7.69E-6	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976396	chr8:143764001	LYNX1	chr8:143845758-143859640:-	0.19	3.87	0.000121	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976396	chr8:143764001	PSCA	chr8:143761875-143764142:+	-0.19	-3.49	0.000518	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976398	chr8:143764879	LY6K	chr8:143781529-143785582:+	0.25	4.3	2.01E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.21	-4.17	3.63E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2976398	chr8:143764879	PSCA	chr8:143761875-143764142:+	0.21	3.78	0.000174	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2977993	chr9:131608786	C9orf114	chr9:131584346-131592085:-	0.21	4.35	1.68E-5	Schizophrenia	
KIRC	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.56	15.1	9.82E-43	Schizophrenia	
KIRC	cis	1	rs2978982	chr8:143763490	LY6K	chr8:143781529-143785582:+	0.25	4.4	1.35E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2978982	chr8:143763490	LYNX1	chr8:143845758-143859640:-	-0.21	-4.11	4.71E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2978982	chr8:143763490	PSCA	chr8:143761875-143764142:+	0.21	3.8	0.000162	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
KIRC	cis	1	rs2982572	chr6:152010561	ESR1	chr6:152011631-152424406:+	0.2	3.85	0.000134	Bone properties (heel)	
KIRC	cis	1	rs2982573	chr6:152010534	ESR1	chr6:152011631-152424406:+	0.21	4.01	6.92E-5	Bone properties (heel)	
KIRC	cis	1	rs2983236	chr6:161072331	PLG	chr6:161123274-161174345:+	-0.25	-5.04	6.63E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs2984613	chr1:156197380	PMF1	chr1:156182784-156209831:+	-0.15	-3.69	0.000249	Intracerebral hemorrhage;White matter hyperintensity burden	
KIRC	cis	1	rs2985684	chr14:50101682	RPL36AL	chr14:50085407-50087349:-	0.33	7.39	6.29E-13	Carotid intima media thickness	
KIRC	cis	1	rs2985687	chr14:50100386	RPL36AL	chr14:50085407-50087349:-	0.31	7.04	6.46E-12	Carotid intima media thickness	
KIRC	cis	1	rs2985696	chr14:50094913	RPL36AL	chr14:50085407-50087349:-	0.34	7.79	3.93E-14	Carotid intima media thickness	
KIRC	cis	1	rs2985697	chr14:50092902	RPL36AL	chr14:50085407-50087349:-	0.37	8.76	3.0E-17	Carotid intima media thickness	
KIRC	cis	1	rs2993207	chr1:155873314	HCN3	chr1:155247374-155259638:+	0.11	3.5	0.000501	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.91	-21.51	3.29E-73	Homocysteine levels	
KIRC	cis	1	rs2996027	chr12:120164283	CIT	chr12:120123598-120315092:-	0.22	4.59	5.56E-6	Urgency urinary incontinence	
KIRC	cis	1	rs2996029	chr12:120165182	CIT	chr12:120123598-120315092:-	0.24	5.05	6.21E-7	Urgency urinary incontinence	
KIRC	cis	1	rs2999061	chr3:127993623	KBTBD12	chr3:127634318-127706513:+	0.27	3.75	0.000199	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999061	chr3:127993623	RPN1	chr3:128338813-128399918:-	0.22	3.93	9.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999061	chr3:127993623	RUVBL1	chr3:127783627-127872757:-	0.31	4.43	1.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999062	chr3:127993606	RPN1	chr3:128338813-128399918:-	-0.22	-3.79	0.000169	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999062	chr3:127993606	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.4	1.31E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999065	chr3:127981438	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999065	chr3:127981438	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999066	chr3:127980286	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999066	chr3:127980286	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999067	chr3:127978531	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999067	chr3:127978531	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999068	chr3:127977978	RPN1	chr3:128338813-128399918:-	-0.21	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999068	chr3:127977978	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.24	2.69E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999069	chr3:127971609	RPN1	chr3:128338813-128399918:-	-0.23	-3.92	0.0001	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999069	chr3:127971609	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.43	1.17E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999070	chr3:127964651	RPN1	chr3:128338813-128399918:-	-0.22	-3.68	0.000255	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999070	chr3:127964651	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.38	1.46E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999071	chr3:127963615	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999071	chr3:127963615	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999072	chr3:127962876	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.88	0.000118	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999072	chr3:127962876	RPN1	chr3:128338813-128399918:-	-0.21	-3.54	0.000432	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999072	chr3:127962876	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.61	5.06E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999073	chr3:127962329	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999073	chr3:127962329	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999076	chr3:127958692	RPN1	chr3:128338813-128399918:-	-0.22	-3.71	0.000229	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999076	chr3:127958692	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.4	1.3E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999077	chr3:127958414	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.87	0.000125	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999077	chr3:127958414	RPN1	chr3:128338813-128399918:-	-0.21	-3.5	0.000514	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999077	chr3:127958414	RUVBL1	chr3:127783627-127872757:-	-0.33	-4.56	6.5E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999079	chr3:127957232	RPN1	chr3:128338813-128399918:-	-0.22	-3.69	0.000248	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999079	chr3:127957232	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.42	1.22E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999084	chr3:127952488	RPN1	chr3:128338813-128399918:-	-0.22	-3.7	0.000241	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999084	chr3:127952488	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.46	1.02E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999085	chr3:127951559	RPN1	chr3:128338813-128399918:-	-0.22	-3.7	0.000241	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999085	chr3:127951559	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.46	1.02E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999086	chr3:127951248	RPN1	chr3:128338813-128399918:-	-0.22	-3.7	0.000241	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999086	chr3:127951248	RUVBL1	chr3:127783627-127872757:-	-0.31	-4.46	1.02E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999089	chr3:127935159	KBTBD12	chr3:127634318-127706513:+	-0.29	-3.84	0.000138	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999089	chr3:127935159	RPN1	chr3:128338813-128399918:-	-0.22	-3.61	0.00034	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999089	chr3:127935159	RUVBL1	chr3:127783627-127872757:-	-0.34	-4.72	3.04E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999090	chr3:127931340	KBTBD12	chr3:127634318-127706513:+	0.3	4.01	6.87E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs2999090	chr3:127931340	RUVBL1	chr3:127783627-127872757:-	0.26	3.58	0.000372	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs3002702	chr20:25268920	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.42	3.18E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs3002702	chr20:25268920	FAM182A	chr20:26035250-26067552:+	-0.27	-5.17	3.31E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs3003214	chr1:244605036	C1orf101	chr1:244617679-244803660:+	0.16	3.69	0.000247	Dementia and core Alzheimer's disease neuropathologic changes	
KIRC	cis	1	rs3007030	chr14:50086563	RPL36AL	chr14:50085407-50087349:-	0.36	7.83	3.02E-14	Carotid intima media thickness	
KIRC	cis	1	rs3007031	chr14:50102269	RPL36AL	chr14:50085407-50087349:-	0.33	7.39	6.3E-13	Carotid intima media thickness	
KIRC	cis	1	rs3018275	chr18:67525857	CD226	chr18:67530195-67624232:-	0.2	6.21	1.13E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs3018301	chr11:71792071	C11orf59	chr11:71808339-71814322:-	-0.21	-3.96	8.54E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs3018302	chr11:71790942	C11orf59	chr11:71808339-71814322:-	-0.22	-3.95	9.11E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.51	-13.64	3.0E-36	Ankylosing spondylitis	
KIRC	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.48	8.28	1.09E-15	Ankylosing spondylitis	
KIRC	cis	1	rs303081	chr4:124069070	FGF2	chr4:123747863-123819390:+	-0.22	-3.65	0.000287	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs303084	chr4:124066948	FGF2	chr4:123747863-123819390:+	-0.22	-3.71	0.000234	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.5	-13.42	2.65E-35	Ankylosing spondylitis	
KIRC	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.47	8.18	2.34E-15	Ankylosing spondylitis	
KIRC	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.51	-13.59	4.75E-36	Ankylosing spondylitis	
KIRC	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.48	8.25	1.35E-15	Ankylosing spondylitis	
KIRC	cis	1	rs303806	chr12:52166503	FIGNL2	chr12:52211677-52216208:-	0.23	3.78	0.000178	Morning vs. evening chronotype	
KIRC	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.51	-13.59	4.75E-36	Ankylosing spondylitis	
KIRC	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.48	8.25	1.35E-15	Ankylosing spondylitis	
KIRC	cis	1	rs306002	chr4:124041403	FGF2	chr4:123747863-123819390:+	-0.23	-3.88	0.000118	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs307567	chr3:12166424	SYN2	chr3:12045862-12233530:+	-0.37	-4.71	3.28E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs307571	chr3:12126112	SYN2	chr3:12045862-12233530:+	-0.4	-4.95	1.03E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs307594	chr3:12106191	SYN2	chr3:12045862-12233530:+	0.36	4.53	7.48E-6	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs3088162	chr20:23607752	CST3	chr20:23608536-23618574:-	-0.14	-3.97	8.37E-5	Chronic kidney disease	
KIRC	cis	1	rs308971	chr3:12116620	SYN2	chr3:12045862-12233530:+	-0.43	-5.46	7.61E-8	Fasting insulin-related traits (interaction with BMI)	
KIRC	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.36	6.89	1.69E-11	Erythrocyte sedimentation rate	
KIRC	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.57	-11.93	4.73E-29	Erythrocyte sedimentation rate	
KIRC	cis	1	rs3091244	chr1:159684665	CRP	chr1:159682080-159684379:-	0.33	3.92	9.9E-5	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRC	cis	1	rs3091497	chr20:47645427	CSE1L	chr20:47662838-47713484:+	-0.15	-3.79	0.000167	Anger	
KIRC	cis	1	rs3091529	chr20:47647068	CSE1L	chr20:47662838-47713484:+	-0.18	-4.58	5.76E-6	Anger	
KIRC	cis	1	rs3091866	chr20:47648353	CSE1L	chr20:47662838-47713484:+	-0.18	-4.73	2.98E-6	Anger	
KIRC	cis	1	rs3092039	chr20:47678770	CSE1L	chr20:47662838-47713484:+	-0.18	-4.68	3.62E-6	Anger	
KIRC	cis	1	rs3092374	chr20:47663944	CSE1L	chr20:47662838-47713484:+	-0.18	-4.58	5.79E-6	Anger	
KIRC	cis	1	rs3092411	chr20:47690591	CSE1L	chr20:47662838-47713484:+	-0.18	-4.72	3.02E-6	Anger	
KIRC	cis	1	rs3092720	chr20:47640466	CSE1L	chr20:47662838-47713484:+	-0.18	-4.66	4.07E-6	Anger	
KIRC	cis	1	rs3092744	chr20:44025282	SYS1-DBNDD2	chr20:43991701-44039245:+	0.22	3.51	0.000481	Psoriasis	
KIRC	cis	1	rs3093059	chr1:159685136	CRP	chr1:159682080-159684379:-	0.33	3.92	9.9E-5	C-reactive protein	
KIRC	cis	1	rs3093075	chr1:159679913	CRP	chr1:159682080-159684379:-	0.33	3.93	9.72E-5	C-reactive protein	
KIRC	cis	1	rs3097417	chr3:53088601	RFT1	chr3:53122503-53164470:-	-0.27	-4.39	1.39E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs3097417	chr3:53088601	TMEM110	chr3:52867139-52931547:-	-0.28	-5.16	3.55E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.85	17.46	1.05E-53	Type 2 diabetes	
KIRC	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.46	-7.61	1.33E-13	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.59	-10.09	6.58E-22	Tumor biomarkers	
KIRC	cis	1	rs3101443	chr15:43912372	STRC	chr15:43891762-43924561:-	0.22	4.41	1.24E-5	Tumor biomarkers	
KIRC	cis	1	rs3101443	chr15:43912372	TUBGCP4	chr15:43663313-43698238:+	0.18	3.92	9.95E-5	Tumor biomarkers	
KIRC	cis	1	rs3101852	chr15:50848370	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.44	4.48E-13	QT interval	
KIRC	cis	1	rs3101852	chr15:50848370	TRPM7	chr15:50852491-50978994:-	-0.12	-3.53	0.000455	QT interval	
KIRC	cis	1	rs3101853	chr15:50848382	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.46	3.8E-13	QT interval	
KIRC	cis	1	rs3101853	chr15:50848382	TRPM7	chr15:50852491-50978994:-	-0.12	-3.64	0.000301	QT interval	
KIRC	cis	1	rs3101855	chr15:50859874	SPPL2A	chr15:50999739-51057910:-	0.28	7.44	4.48E-13	QT interval	
KIRC	cis	1	rs3101855	chr15:50859874	TRPM7	chr15:50852491-50978994:-	0.12	3.55	0.000414	QT interval	
KIRC	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.5	-8.19	2.19E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs3105590	chr15:50864145	SPPL2A	chr15:50999739-51057910:-	0.28	7.37	7.12E-13	QT interval	
KIRC	cis	1	rs3105590	chr15:50864145	TRPM7	chr15:50852491-50978994:-	0.12	3.51	0.000481	QT interval	
KIRC	cis	1	rs3105591	chr15:50869042	SPPL2A	chr15:50999739-51057910:-	0.27	7.16	2.98E-12	QT interval	
KIRC	cis	1	rs3105593	chr15:50845018	SPPL2A	chr15:50999739-51057910:-	0.25	6.73	4.69E-11	QT interval	
KIRC	cis	1	rs3105593	chr15:50845018	TRPM7	chr15:50852491-50978994:-	0.12	3.67	0.000265	QT interval	
KIRC	cis	1	rs3107669	chr3:119567101	GSK3B	chr3:119540804-119813264:-	-0.14	-3.66	0.000277	HDL cholesterol	
KIRC	cis	1	rs3109878	chr15:50836243	SPPL2A	chr15:50999739-51057910:-	0.25	6.64	8.35E-11	QT interval	
KIRC	cis	1	rs3109878	chr15:50836243	TRPM7	chr15:50852491-50978994:-	0.12	3.65	0.000293	QT interval	
KIRC	cis	1	rs3109879	chr15:50837618	SPPL2A	chr15:50999739-51057910:-	0.28	7.05	6.02E-12	QT interval	
KIRC	cis	1	rs3109880	chr15:50837812	SPPL2A	chr15:50999739-51057910:-	0.27	6.95	1.17E-11	QT interval	
KIRC	cis	1	rs3109881	chr15:50839272	SPPL2A	chr15:50999739-51057910:-	0.27	6.92	1.34E-11	QT interval	
KIRC	cis	1	rs3109888	chr15:50860694	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.36E-13	QT interval	
KIRC	cis	1	rs3109888	chr15:50860694	TRPM7	chr15:50852491-50978994:-	0.12	3.57	0.000392	QT interval	
KIRC	cis	1	rs3109892	chr15:50877011	SPPL2A	chr15:50999739-51057910:-	0.27	7.08	4.86E-12	QT interval	
KIRC	cis	1	rs3109894	chr15:50878574	SPPL2A	chr15:50999739-51057910:-	0.27	6.97	1.03E-11	QT interval	
KIRC	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.27	7.2	2.21E-12	QT interval	
KIRC	cis	1	rs3110337	chr8:120378478	NOV	chr8:120428552-120436678:+	-0.29	-4.66	3.99E-6	Hypertension	
KIRC	cis	1	rs3110496	chr17:27917771	TP53I13	chr17:27895739-27900174:+	0.14	4.03	6.4E-5	Height	
KIRC	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.49	-8.17	2.54E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs3118632	chr9:131901284	PPP2R4	chr9:131873244-131911223:+	-0.2	-3.81	0.000154	Blood metabolite ratios	
KIRC	cis	1	rs3118632	chr9:131901284	SET	chr9:131445934-131458674:+	0.18	3.8	0.000162	Blood metabolite ratios	
KIRC	cis	1	rs3120034	chr1:183167051	LAMC2	chr1:183155174-183214262:+	0.31	6.35	4.74E-10	Hypertriglyceridemia	
KIRC	cis	1	rs3120662	chr1:152302865	FLG	chr1:152274651-152297679:-	0.2	3.51	0.000495	Atopic dermatitis	
KIRC	cis	1	rs3120662	chr1:152302865	HRNR	chr1:152184558-152196669:-	-0.27	-4.4	1.3E-5	Atopic dermatitis	
KIRC	cis	1	rs3124510	chr9:131899690	PPP2R4	chr9:131873244-131911223:+	-0.2	-3.78	0.000175	Blood metabolite ratios	
KIRC	cis	1	rs3124510	chr9:131899690	SET	chr9:131445934-131458674:+	0.17	3.7	0.000241	Blood metabolite ratios	
KIRC	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.18	-4.36	1.59E-5	Blood metabolite ratios	
KIRC	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.14	-3.51	0.000486	Blood metabolite ratios	
KIRC	cis	1	rs3124513	chr9:131904593	PPP2R4	chr9:131873244-131911223:+	-0.21	-3.93	9.68E-5	Blood metabolite ratios	
KIRC	cis	1	rs3124513	chr9:131904593	SET	chr9:131445934-131458674:+	0.17	3.66	0.000277	Blood metabolite ratios	
KIRC	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.14	-3.51	0.000486	Blood metabolite ratios	
KIRC	cis	1	rs3124514	chr9:131904608	PPP2R4	chr9:131873244-131911223:+	-0.21	-3.93	9.68E-5	Blood metabolite ratios	
KIRC	cis	1	rs3124514	chr9:131904608	SET	chr9:131445934-131458674:+	0.17	3.66	0.000277	Blood metabolite ratios	
KIRC	cis	1	rs3126085	chr1:152300817	FLG	chr1:152274651-152297679:-	0.21	3.68	0.000259	Atopic dermatitis	
KIRC	cis	1	rs3126085	chr1:152300817	HRNR	chr1:152184558-152196669:-	-0.27	-4.41	1.29E-5	Atopic dermatitis	
KIRC	cis	1	rs3126092	chr1:152307955	HRNR	chr1:152184558-152196669:-	-0.27	-4.57	6.17E-6	Atopic dermatitis	
KIRC	cis	1	rs3126095	chr1:152309683	HRNR	chr1:152184558-152196669:-	-0.27	-4.57	6.17E-6	Atopic dermatitis	
KIRC	cis	1	rs3131573	chr15:50869601	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.8E-13	QT interval	
KIRC	cis	1	rs3131573	chr15:50869601	TRPM7	chr15:50852491-50978994:-	0.12	3.52	0.000464	QT interval	
KIRC	cis	1	rs3131577	chr15:50863516	SPPL2A	chr15:50999739-51057910:-	0.28	7.44	4.28E-13	QT interval	
KIRC	cis	1	rs3131577	chr15:50863516	TRPM7	chr15:50852491-50978994:-	0.12	3.56	0.000409	QT interval	
KIRC	cis	1	rs3131578	chr15:50861470	SPPL2A	chr15:50999739-51057910:-	-0.28	-7.34	8.4E-13	QT interval	
KIRC	cis	1	rs3131580	chr15:50854926	SPPL2A	chr15:50999739-51057910:-	0.28	7.44	4.48E-13	QT interval	
KIRC	cis	1	rs3131580	chr15:50854926	TRPM7	chr15:50852491-50978994:-	0.12	3.55	0.000414	QT interval	
KIRC	cis	1	rs3131582	chr15:50879670	SPPL2A	chr15:50999739-51057910:-	0.28	7.24	1.68E-12	QT interval	
KIRC	cis	1	rs3131584	chr15:50847401	SPPL2A	chr15:50999739-51057910:-	0.28	7.3	1.13E-12	QT interval	
KIRC	cis	1	rs3131584	chr15:50847401	TRPM7	chr15:50852491-50978994:-	0.12	3.59	0.000359	QT interval	
KIRC	cis	1	rs3131585	chr15:50845796	SPPL2A	chr15:50999739-51057910:-	0.28	7.38	6.52E-13	QT interval	
KIRC	cis	1	rs3131585	chr15:50845796	TRPM7	chr15:50852491-50978994:-	0.12	3.59	0.00037	QT interval	
KIRC	cis	1	rs3131586	chr15:50845236	SPPL2A	chr15:50999739-51057910:-	0.28	7.35	8.26E-13	QT interval	
KIRC	cis	1	rs3131586	chr15:50845236	TRPM7	chr15:50852491-50978994:-	0.13	3.67	0.000267	QT interval	
KIRC	cis	1	rs3131587	chr15:50845101	SPPL2A	chr15:50999739-51057910:-	0.28	7.33	9.42E-13	QT interval	
KIRC	cis	1	rs3131587	chr15:50845101	TRPM7	chr15:50852491-50978994:-	0.12	3.52	0.000467	QT interval	
KIRC	cis	1	rs3131589	chr15:50841053	SPPL2A	chr15:50999739-51057910:-	0.26	6.77	3.61E-11	QT interval	
KIRC	cis	1	rs3131590	chr15:50840955	SPPL2A	chr15:50999739-51057910:-	0.28	7.26	1.45E-12	QT interval	
KIRC	cis	1	rs3131590	chr15:50840955	TRPM7	chr15:50852491-50978994:-	0.12	3.49	0.000527	QT interval	
KIRC	cis	1	rs3131596	chr15:50877575	SPPL2A	chr15:50999739-51057910:-	0.27	7.13	3.44E-12	QT interval	
KIRC	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.29	5.9	6.87E-9	Diabetic kidney disease	
KIRC	cis	1	rs313798	chr7:65493031	CRCP	chr7:65579805-65619551:+	-0.3	-4.18	3.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.29	5.95	5.16E-9	Diabetic kidney disease	
KIRC	cis	1	rs313799	chr7:65494330	CRCP	chr7:65579805-65619551:+	-0.29	-4.04	6.1E-5	Diabetic kidney disease	
KIRC	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.29	5.78	1.35E-8	Diabetic kidney disease	
KIRC	cis	1	rs313802	chr7:65516373	CRCP	chr7:65579805-65619551:+	-0.32	-4.37	1.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.29	5.78	1.35E-8	Diabetic kidney disease	
KIRC	cis	1	rs313803	chr7:65514731	CRCP	chr7:65579805-65619551:+	-0.32	-4.37	1.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.27	5.38	1.14E-7	Diabetic kidney disease	
KIRC	cis	1	rs313807	chr7:65499481	CRCP	chr7:65579805-65619551:+	-0.3	-4.07	5.36E-5	Diabetic kidney disease	
KIRC	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.27	5.35	1.32E-7	Diabetic kidney disease	
KIRC	cis	1	rs313809	chr7:65499983	CRCP	chr7:65579805-65619551:+	-0.31	-4.17	3.53E-5	Diabetic kidney disease	
KIRC	cis	1	rs3138137	chr12:56116981	RDH5	chr12:56114151-56118525:+	-0.19	-4.83	1.81E-6	Refractive error	
KIRC	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.29	5.85	8.93E-9	Diabetic kidney disease	
KIRC	cis	1	rs313813	chr7:65503500	CRCP	chr7:65579805-65619551:+	-0.28	-3.86	0.000129	Diabetic kidney disease	
KIRC	cis	1	rs3138144	chr12:56114769	RDH5	chr12:56114151-56118525:+	-0.2	-5	8.05E-7	Refractive error	
KIRC	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.29	5.72	1.86E-8	Diabetic kidney disease	
KIRC	cis	1	rs313814	chr7:65503293	CRCP	chr7:65579805-65619551:+	-0.32	-4.37	1.48E-5	Diabetic kidney disease	
KIRC	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.28	5.42	9.2E-8	Diabetic kidney disease	
KIRC	cis	1	rs313820	chr7:65574466	CRCP	chr7:65579805-65619551:+	-0.33	-4.48	9.34E-6	Diabetic kidney disease	
KIRC	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.27	5.42	9.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs313824	chr7:65581207	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.26	4.88	1.46E-6	Diabetic kidney disease	
KIRC	cis	1	rs313831	chr7:65551226	CRCP	chr7:65579805-65619551:+	-0.36	-4.78	2.29E-6	Diabetic kidney disease	
KIRC	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.25	4.83	1.84E-6	Diabetic kidney disease	
KIRC	cis	1	rs313832	chr7:65550891	CRCP	chr7:65579805-65619551:+	-0.36	-4.8	2.14E-6	Diabetic kidney disease	
KIRC	cis	1	rs313839	chr19:47221557	FKRP	chr19:47249303-47261832:+	0.42	7.71	6.59E-14	Type 1 diabetes	
KIRC	cis	1	rs313839	chr19:47221557	PRKD2	chr19:47177574-47220384:-	0.27	5.37	1.21E-7	Type 1 diabetes	
KIRC	cis	1	rs315135	chr12:69762987	YEATS4	chr12:69753532-69784575:+	0.65	7.14	3.2E-12	Response to diuretic therapy	
KIRC	cis	1	rs316304	chr7:65616894	CCT6P1	chr7:65216092-65228661:+	0.29	5.82	1.05E-8	Diabetic kidney disease	
KIRC	cis	1	rs316304	chr7:65616894	CRCP	chr7:65579805-65619551:+	-0.32	-4.36	1.58E-5	Diabetic kidney disease	
KIRC	cis	1	rs316304	chr7:65616894	LOC493754	chr7:65993446-66057363:-	0.22	3.5	0.000498	Diabetic kidney disease	
KIRC	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.27	5.24	2.37E-7	Diabetic kidney disease	
KIRC	cis	1	rs316307	chr7:65570171	CRCP	chr7:65579805-65619551:+	-0.34	-4.59	5.66E-6	Diabetic kidney disease	
KIRC	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs316312	chr7:65596491	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs316313	chr7:65593548	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs316317	chr7:65613637	CCT6P1	chr7:65216092-65228661:+	0.28	5.45	8.06E-8	Diabetic kidney disease	
KIRC	cis	1	rs316317	chr7:65613637	CRCP	chr7:65579805-65619551:+	-0.32	-4.31	1.99E-5	Diabetic kidney disease	
KIRC	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.28	5.45	8.06E-8	Diabetic kidney disease	
KIRC	cis	1	rs316318	chr7:65612904	CRCP	chr7:65579805-65619551:+	-0.32	-4.31	1.99E-5	Diabetic kidney disease	
KIRC	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.28	5.45	8.06E-8	Diabetic kidney disease	
KIRC	cis	1	rs316321	chr7:65611613	CRCP	chr7:65579805-65619551:+	-0.32	-4.31	1.99E-5	Diabetic kidney disease	
KIRC	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.28	5.5	5.99E-8	Diabetic kidney disease	
KIRC	cis	1	rs316322	chr7:65611233	CRCP	chr7:65579805-65619551:+	-0.32	-4.3	2.08E-5	Diabetic kidney disease	
KIRC	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.27	5.38	1.14E-7	Diabetic kidney disease	
KIRC	cis	1	rs316325	chr7:65609518	CRCP	chr7:65579805-65619551:+	-0.32	-4.33	1.83E-5	Diabetic kidney disease	
KIRC	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.27	5.38	1.14E-7	Diabetic kidney disease	
KIRC	cis	1	rs316326	chr7:65609453	CRCP	chr7:65579805-65619551:+	-0.32	-4.33	1.83E-5	Diabetic kidney disease	
KIRC	cis	1	rs316327	chr7:65609201	CCT6P1	chr7:65216092-65228661:+	-0.26	-5.11	4.64E-7	Diabetic kidney disease	
KIRC	cis	1	rs316327	chr7:65609201	CRCP	chr7:65579805-65619551:+	0.32	4.41	1.26E-5	Diabetic kidney disease	
KIRC	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.27	5.44	8.55E-8	Diabetic kidney disease	
KIRC	cis	1	rs316329	chr7:65608416	CRCP	chr7:65579805-65619551:+	-0.33	-4.52	7.8E-6	Diabetic kidney disease	
KIRC	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.27	5.21	2.79E-7	Diabetic kidney disease	
KIRC	cis	1	rs316330	chr7:65605372	CRCP	chr7:65579805-65619551:+	-0.34	-4.55	6.88E-6	Diabetic kidney disease	
KIRC	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.74	1.65E-8	Diabetic kidney disease	
KIRC	cis	1	rs316331	chr7:65604622	CRCP	chr7:65579805-65619551:+	0.27	3.82	0.000148	Diabetic kidney disease	
KIRC	cis	1	rs316331	chr7:65604622	LOC493754	chr7:65993446-66057363:-	-0.23	-3.76	0.000188	Diabetic kidney disease	
KIRC	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.28	5.49	6.54E-8	Diabetic kidney disease	
KIRC	cis	1	rs316332	chr7:65604299	CRCP	chr7:65579805-65619551:+	-0.32	-4.39	1.37E-5	Diabetic kidney disease	
KIRC	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs316334	chr7:65602126	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs3170	chr11:105513061	GRIA4	chr11:105480800-105852819:+	-0.23	-3.74	0.000204	Ejection fraction in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.27	-5.41	9.55E-8	Narcolepsy	
KIRC	cis	1	rs3183928	chr9:100684719	C9orf156	chr9:100666772-100684852:-	-0.29	-6.38	3.99E-10	Quantitative traits	
KIRC	cis	1	rs3194585	chr4:103553090	MANBA	chr4:103552644-103682151:-	0.16	3.63	0.000311	Primary biliary cirrhosis	
KIRC	cis	1	rs3197999	chr3:49721532	UBA7	chr3:49842639-49851391:-	0.15	3.85	0.000135	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.57	-9.67	2.13E-20	Dental caries	
KIRC	cis	1	rs3204270	chr17:79682051	TSPAN10	chr17:79609349-79615778:+	-0.35	-4.32	1.87E-5	Dental caries	
KIRC	cis	1	rs320700	chr7:137049477	PTN	chr7:136912092-137028546:-	0.24	4.23	2.8E-5	Educational attainment (years of education)	
KIRC	cis	1	rs3213445	chr22:51015838	CPT1B	chr22:51007291-51017096:-	-0.28	-5.45	7.77E-8	Narcolepsy	
KIRC	cis	1	rs3213446	chr22:51015674	CPT1B	chr22:51007291-51017096:-	-0.27	-5.38	1.13E-7	Narcolepsy	
KIRC	cis	1	rs3213542	chr6:100966006	GRIK2	chr6:101846905-102517957:+	0.55	6.21	1.13E-9	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.83	-19.98	8.38E-66	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs3213762	chr17:38178627	MED24	chr17:38175351-38210889:-	-0.16	-3.72	0.000221	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs3213861	chr19:41919944	ATP5SL	chr19:41937224-41945810:-	0.16	3.85	0.000135	Height	
KIRC	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.31	-9.02	4.01E-18	Longevity	
KIRC	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.46	10.13	4.66E-22	Renal underexcretion gout;Gout	
KIRC	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.31	7.5	2.9E-13	Renal underexcretion gout;Gout	
KIRC	cis	1	rs3310	chr20:3237232	ITPA	chr20:3190056-3204504:+	-0.27	-6.38	3.91E-10	IFN-related cytopenia	
KIRC	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.85	16.92	3.86E-51	Type 2 diabetes	
KIRC	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.84	17.35	3.53E-53	Type 2 diabetes	
KIRC	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.85	17.46	1.05E-53	Type 2 diabetes	
KIRC	cis	1	rs335472	chr5:176984163	DOK3	chr5:176928915-176937427:-	-0.21	-4.57	6.2E-6	Alzheimer disease and age of onset	
KIRC	cis	1	rs337156	chr1:220916683	MOSC2	chr1:220921676-220957594:+	-0.19	-3.92	0.000102	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337157	chr1:220916558	MOSC2	chr1:220921676-220957594:+	-0.18	-3.65	0.000287	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337158	chr1:220915835	MOSC2	chr1:220921676-220957594:+	-0.18	-3.78	0.000179	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337159	chr1:220915423	MOSC2	chr1:220921676-220957594:+	-0.2	-3.99	7.54E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337160	chr1:220914947	MOSC2	chr1:220921676-220957594:+	-0.19	-3.81	0.000156	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337161	chr1:220914920	MOSC2	chr1:220921676-220957594:+	-0.19	-3.81	0.000156	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs337162	chr1:220914866	MOSC2	chr1:220921676-220957594:+	-0.2	-3.99	7.54E-5	Response to antipsychotic therapy (extrapyramidal side effects)	
KIRC	cis	1	rs339301	chr6:117224303	FAM26F	chr6:116782556-116784933:+	-0.14	-3.58	0.00038	Prostate cancer	
KIRC	cis	1	rs339302	chr6:117224641	FAM26F	chr6:116782556-116784933:+	-0.14	-3.58	0.00038	Prostate cancer	
KIRC	cis	1	rs339350	chr6:117221186	FAM26F	chr6:116782556-116784933:+	-0.14	-3.61	0.00034	Prostate cancer	
KIRC	cis	1	rs33988592	chr3:121415610	IQCB1	chr3:121488610-121553926:-	0.35	6.59	1.1E-10	Cognitive performance	
KIRC	cis	1	rs33988845	chr6:100964158	GRIK2	chr6:101846905-102517957:+	0.68	6.85	2.15E-11	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs33993216	chr10:17204139	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.09	4.5E-15	Homocysteine levels	
KIRC	cis	1	rs33998546	chr3:127831038	KBTBD12	chr3:127634318-127706513:+	0.27	3.68	0.000256	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs33998546	chr3:127831038	RPN1	chr3:128338813-128399918:-	0.22	3.82	0.00015	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs33998546	chr3:127831038	RUVBL1	chr3:127783627-127872757:-	0.33	4.73	2.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34006571	chr6:88261908	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000104	Obesity-related traits	
KIRC	cis	1	rs34007246	chr6:88235924	C6orf164	chr6:88032306-88109459:+	0.33	3.94	9.45E-5	Obesity-related traits	
KIRC	cis	1	rs34008333	chr6:88294535	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs34010330	chr19:18559657	SSBP4	chr19:18530221-18545371:+	-0.13	-4.25	2.58E-5	Breast cancer	
KIRC	cis	1	rs34026879	chr1:27068238	PIGV	chr1:27114455-27124886:+	-0.39	-4.56	6.36E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34031374	chr12:82235615	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs34034766	chr2:231036768	SP110	chr2:231033645-231084827:-	0.3	4.43	1.14E-5	Obesity-related traits	
KIRC	cis	1	rs34037437	chr1:95660921	RWDD3	chr1:95583479-95712773:+	0.31	4.36	1.54E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs34052221	chr6:163160803	PACRG	chr6:163148164-163736523:+	0.57	6.66	7.19E-11	Body mass index	
KIRC	cis	1	rs34054042	chr6:88213141	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs34055941	chr9:131895076	CRAT	chr9:131857075-131873070:-	0.15	3.57	0.000386	Blood metabolite ratios	
KIRC	cis	1	rs34055941	chr9:131895076	PPP2R4	chr9:131873244-131911223:+	0.2	3.85	0.000134	Blood metabolite ratios	
KIRC	cis	1	rs34055941	chr9:131895076	SET	chr9:131445934-131458674:+	-0.18	-3.82	0.000153	Blood metabolite ratios	
KIRC	cis	1	rs34066731	chr6:163011047	PACRG	chr6:163148164-163736523:+	0.47	6.09	2.27E-9	Body mass index	
KIRC	cis	1	rs34072732	chr4:106604364	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs34084277	chr19:17387176	ANKLE1	chr19:17392454-17398454:+	0.19	4.07	5.5E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.34	6.6	1.04E-10	Cognitive performance	
KIRC	cis	1	rs34092076	chr8:110119360	TMEM74	chr8:109619080-109799770:-	-0.2	-3.76	0.000189	Body mass (lean)	
KIRC	cis	1	rs34096562	chr8:16701281	FGF20	chr8:16850334-16859674:-	0.21	3.61	0.000337	Parkinson's disease	
KIRC	cis	1	rs34096562	chr8:16701281	SLC7A2	chr8:17354600-17428073:+	-0.19	-3.49	0.000521	Parkinson's disease	
KIRC	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.15	1.4E-18	Body mass index	
KIRC	cis	1	rs34102169	chr1:46424864	MUTYH	chr1:45794915-45806142:-	0.15	4.36	1.61E-5	Body mass index	
KIRC	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.47	-10.34	7.8E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs34117728	chr5:156433497	HAVCR1	chr5:156456531-156486130:-	-0.45	-10.02	1.18E-21	Hypertriglyceridemia	
KIRC	cis	1	rs34117728	chr5:156433497	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.62	1.23E-13	Hypertriglyceridemia	
KIRC	cis	1	rs34117728	chr5:156433497	TIMD4	chr5:156346293-156390266:-	-0.36	-6.8	2.91E-11	Hypertriglyceridemia	
KIRC	cis	1	rs34121720	chr3:53072167	RFT1	chr3:53122503-53164470:-	0.39	6.09	2.29E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34121720	chr3:53072167	TMEM110	chr3:52867139-52931547:-	0.35	6.16	1.5E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34127220	chr16:29842891	LOC440356	chr16:29875004-29879374:+	-0.24	-3.56	0.000403	Multiple sclerosis	
KIRC	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.05	9.0E-22	Subjective well-being	
KIRC	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.28	5.56	4.36E-8	Diabetic kidney disease	
KIRC	cis	1	rs34136756	chr7:65381256	CRCP	chr7:65579805-65619551:+	-0.31	-4.26	2.48E-5	Diabetic kidney disease	
KIRC	cis	1	rs34137501	chr2:9674852	ITGB1BP1	chr2:9545823-9563643:-	-0.17	-3.5	0.000499	Alcohol dependence (age at onset)	
KIRC	cis	1	rs34138336	chr6:163144929	PACRG	chr6:163148164-163736523:+	0.58	6.74	4.33E-11	Body mass index	
KIRC	cis	1	rs34138960	chr15:78831668	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.77	1.4E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34156253	chr5:150226230	IRGM	chr5:150226085-150280295:+	0.52	7	8.08E-12	Crohn's disease	
KIRC	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.38	5.04	6.6E-7	Crohn's disease	
KIRC	cis	1	rs34169305	chr3:141071293	SLC25A36	chr3:140660662-140698785:+	-0.18	-3.81	0.000157	Prion diseases	
KIRC	cis	1	rs34171762	chr19:18559410	SSBP4	chr19:18530221-18545371:+	-0.13	-4.57	6.11E-6	Breast cancer	
KIRC	cis	1	rs34174370	chr3:127849744	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34174370	chr3:127849744	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34174370	chr3:127849744	RUVBL1	chr3:127783627-127872757:-	0.34	4.83	1.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34177053	chr6:163007772	PACRG	chr6:163148164-163736523:+	0.43	5.92	6.05E-9	Body mass index	
KIRC	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.27	5.39	1.11E-7	Diabetic kidney disease	
KIRC	cis	1	rs34192067	chr7:65887657	CRCP	chr7:65579805-65619551:+	-0.33	-4.54	6.92E-6	Diabetic kidney disease	
KIRC	cis	1	rs34192365	chr6:163012382	PACRG	chr6:163148164-163736523:+	0.47	6.25	8.86E-10	Body mass index	
KIRC	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.28	5.64	2.9E-8	Diabetic kidney disease	
KIRC	cis	1	rs34193460	chr7:65393110	CRCP	chr7:65579805-65619551:+	-0.3	-4.16	3.82E-5	Diabetic kidney disease	
KIRC	cis	1	rs34201939	chr1:27093711	PIGV	chr1:27114455-27124886:+	-0.38	-4.46	1.02E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34216334	chr1:27063419	PIGV	chr1:27114455-27124886:+	-0.39	-4.48	9.19E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34226052	chr4:89163523	ABCG2	chr4:89011417-89152474:-	-0.18	-4.17	3.59E-5	Metabolite levels (small molecules and protein measures)	
KIRC	cis	1	rs34228187	chr3:127816433	KBTBD12	chr3:127634318-127706513:+	0.26	3.54	0.000443	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34228187	chr3:127816433	RPN1	chr3:128338813-128399918:-	0.22	3.75	0.000194	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34228187	chr3:127816433	RUVBL1	chr3:127783627-127872757:-	0.33	4.75	2.68E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34228197	chr6:163008232	PACRG	chr6:163148164-163736523:+	0.43	5.89	7.27E-9	Body mass index	
KIRC	cis	1	rs34230359	chr5:156449561	HAVCR1	chr5:156456531-156486130:-	-0.44	-9.62	3.11E-20	Hypertriglyceridemia	
KIRC	cis	1	rs34230359	chr5:156449561	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.6	1.45E-13	Hypertriglyceridemia	
KIRC	cis	1	rs34230359	chr5:156449561	TIMD4	chr5:156346293-156390266:-	-0.35	-6.54	1.54E-10	Hypertriglyceridemia	
KIRC	cis	1	rs34237279	chr15:75361121	PPCDC	chr15:75315927-75343066:+	0.18	4.1	4.9E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.23	4.07	5.4E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs34252323	chr2:135486302	TMEM163	chr2:135213331-135525334:-	-0.31	-4.21	3.04E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs34256197	chr19:18606472	SSBP4	chr19:18530221-18545371:+	-0.13	-4.56	6.4E-6	Breast cancer	
KIRC	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.17	4.34	1.69E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs34275373	chr5:125915744	LMNB1	chr5:126112833-126172709:+	0.18	3.89	0.000116	Osteoporosis	
KIRC	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.48	-10.29	1.13E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs34292685	chr11:64049021	C11orf20	chr11:64067863-64072238:+	-0.35	-5.39	1.09E-7	Mean platelet volume	
KIRC	cis	1	rs34305567	chr22:29853562	RFPL1S	chr22:29833006-29838118:-	-0.26	-4.92	1.18E-6	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs34307072	chr12:104196304	NT5DC3	chr12:104164231-104234975:-	-0.23	-3.99	7.54E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs34313969	chr3:52995166	RFT1	chr3:53122503-53164470:-	0.34	5.23	2.44E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34313969	chr3:52995166	SFMBT1	chr3:52938628-53080070:-	-0.26	-3.71	0.000229	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34313969	chr3:52995166	TMEM110	chr3:52867139-52931547:-	0.34	5.9	6.85E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34320230	chr7:97785500	BAIAP2L1	chr7:97920964-98030427:-	-0.14	-3.55	0.000418	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs34340609	chr3:53077276	RFT1	chr3:53122503-53164470:-	0.33	5.38	1.16E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34340609	chr3:53077276	TMEM110	chr3:52867139-52931547:-	0.28	5.11	4.5E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34344888	chr14:23387585	HAUS4	chr14:23415438-23426335:-	-0.22	-5.47	6.99E-8	Educational attainment (years of education)	
KIRC	cis	1	rs34344906	chr6:162993378	PACRG	chr6:163148164-163736523:+	0.49	6.45	2.59E-10	Body mass index	
KIRC	cis	1	rs34369446	chr6:88212571	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs34373625	chr10:4981201	AKR1C1	chr10:4934796-5020157:+	-0.36	-4.84	1.75E-6	Height	
KIRC	cis	1	rs34373625	chr10:4981201	AKR1C2	chr10:4964715-5060207:-	0.55	6.66	7.39E-11	Height	
KIRC	cis	1	rs34374560	chr20:23609462	CST3	chr20:23608536-23618574:-	-0.14	-3.94	9.46E-5	Chronic kidney disease	
KIRC	cis	1	rs34375435	chr2:75914044	MRPL19	chr2:75873909-75897879:+	0.18	4.13	4.22E-5	Hippocampal atrophy	
KIRC	cis	1	rs34396223	chr1:95697828	RWDD3	chr1:95583479-95712773:+	0.4	5.13	4.19E-7	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs34398656	chr6:162999612	PACRG	chr6:163148164-163736523:+	0.42	5.81	1.13E-8	Body mass index	
KIRC	cis	1	rs34401800	chr15:56469488	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.02E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs34403909	chr3:127810445	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34405766	chr2:135486189	TMEM163	chr2:135213331-135525334:-	-0.31	-4.21	3.04E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.49	-8.55	1.44E-16	Bone mineral density	
KIRC	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.49	-8.65	7.11E-17	Bone mineral density	
KIRC	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.49	-8.65	7.11E-17	Bone mineral density	
KIRC	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.51	10.5	1.87E-23	Body mass index	
KIRC	cis	1	rs34409737	chr5:156457857	HAVCR1	chr5:156456531-156486130:-	-0.46	-9.89	3.5E-21	Hypertriglyceridemia	
KIRC	cis	1	rs34409737	chr5:156457857	HAVCR2	chr5:156512843-156536138:-	-0.43	-7.71	6.78E-14	Hypertriglyceridemia	
KIRC	cis	1	rs34409737	chr5:156457857	TIMD4	chr5:156346293-156390266:-	-0.37	-6.83	2.46E-11	Hypertriglyceridemia	
KIRC	cis	1	rs34409786	chr3:127888175	KBTBD12	chr3:127634318-127706513:+	0.3	4.13	4.27E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34409786	chr3:127888175	RPN1	chr3:128338813-128399918:-	0.22	3.73	0.000212	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34409786	chr3:127888175	RUVBL1	chr3:127783627-127872757:-	0.33	4.82	1.87E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34421316	chr21:43513989	C21orf128	chr21:43522244-43528644:-	0.5	8.15	2.92E-15	IgG glycosylation	
KIRC	cis	1	rs34428306	chr1:152184316	FLG2	chr1:152321214-152332482:-	0.31	5.37	1.21E-7	Inflammatory skin disease	
KIRC	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.3	5.07	5.63E-7	Inflammatory skin disease	
KIRC	cis	1	rs34428306	chr1:152184316	HRNR	chr1:152184558-152196669:-	-0.35	-5.6	3.48E-8	Inflammatory skin disease	
KIRC	cis	1	rs34434809	chr10:17187634	TRDMT1	chr10:17184983-17243681:-	-0.35	-7.9	1.75E-14	Homocysteine levels	
KIRC	cis	1	rs34443622	chr6:163208214	PACRG	chr6:163148164-163736523:+	0.56	6.29	7.01E-10	Body mass index	
KIRC	cis	1	rs34453673	chr5:434722	C5orf55	chr5:441645-443258:-	0.29	5.73	1.75E-8	Cystic fibrosis severity	
KIRC	cis	1	rs34453673	chr5:434722	LOC25845	chr5:470626-473080:-	0.39	6.21	1.08E-9	Cystic fibrosis severity	
KIRC	cis	1	rs34453673	chr5:434722	SLC9A3	chr5:473334-524549:-	0.29	5.3	1.77E-7	Cystic fibrosis severity	
KIRC	cis	1	rs34453673	chr5:434722	TPPP	chr5:659978-693510:-	0.19	3.55	0.000429	Cystic fibrosis severity	
KIRC	cis	1	rs34460334	chr1:27215079	PIGV	chr1:27114455-27124886:+	-0.4	-4.51	8.07E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34473788	chr1:27271519	PIGV	chr1:27114455-27124886:+	-0.33	-3.96	8.72E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs3448	chr3:49396751	CCDC36	chr3:49235861-49295537:+	0.25	4.71	3.16E-6	Menarche (age at onset)	
KIRC	cis	1	rs3448	chr3:49396751	NCKIPSD	chr3:48711280-48723334:-	0.22	4.46	1.0E-5	Menarche (age at onset)	
KIRC	cis	1	rs3448	chr3:49396751	P4HTM	chr3:49027341-49044579:+	0.21	4.65	4.33E-6	Menarche (age at onset)	
KIRC	cis	1	rs3448	chr3:49396751	TREX1	chr3:48501186-48509043:+	-0.15	-3.81	0.000157	Menarche (age at onset)	
KIRC	cis	1	rs3448	chr3:49396751	WDR6	chr3:49044637-49053386:+	-0.2	-5.02	7.18E-7	Menarche (age at onset)	
KIRC	cis	1	rs34496143	chr10:37992658	LOC399744	chr10:38717074-38741080:+	0.22	3.53	0.000462	Obesity (extreme)	
KIRC	cis	1	rs34500464	chr10:17191996	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.19	2.19E-15	Homocysteine levels	
KIRC	cis	1	rs34514856	chr1:27287560	PIGV	chr1:27114455-27124886:+	-0.37	-4.19	3.34E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs34529418	chr7:65403209	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs34556682	chr1:27186149	PIGV	chr1:27114455-27124886:+	-0.41	-4.75	2.61E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34558323	chr10:17184228	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.02	7.75E-15	Homocysteine levels	
KIRC	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.28	5.64	2.84E-8	Diabetic kidney disease	
KIRC	cis	1	rs34560516	chr7:65404092	CRCP	chr7:65579805-65619551:+	-0.3	-4.14	4.1E-5	Diabetic kidney disease	
KIRC	cis	1	rs34562493	chr3:127817022	KBTBD12	chr3:127634318-127706513:+	0.26	3.52	0.000468	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34562493	chr3:127817022	RPN1	chr3:128338813-128399918:-	0.22	3.63	0.000311	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34562493	chr3:127817022	RUVBL1	chr3:127783627-127872757:-	0.34	4.85	1.63E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34570071	chr15:85280212	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.38	1.42E-5	Schizophrenia	
KIRC	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.21	-4.03	6.42E-5	Schizophrenia	
KIRC	cis	1	rs34575783	chr15:63397686	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.000138	HDL cholesterol	
KIRC	cis	1	rs34576193	chr1:27054780	PIGV	chr1:27114455-27124886:+	-0.39	-4.32	1.87E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.28	5.67	2.46E-8	Diabetic kidney disease	
KIRC	cis	1	rs34577383	chr7:65385726	CRCP	chr7:65579805-65619551:+	-0.31	-4.26	2.47E-5	Diabetic kidney disease	
KIRC	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.47	-10.22	2.13E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs34583567	chr15:67983281	IQCH	chr15:67547188-67794139:+	0.18	3.72	0.000225	Motion sickness	
KIRC	cis	1	rs34585496	chr1:27025940	PIGV	chr1:27114455-27124886:+	-0.38	-4.26	2.43E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34586537	chr2:70163316	ANXA4	chr2:69969127-70053594:+	0.22	5.26	2.19E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs34591938	chr6:163087003	PACRG	chr6:163148164-163736523:+	0.57	6.83	2.48E-11	Body mass index	
KIRC	cis	1	rs34592321	chr5:132181675	LEAP2	chr5:132209358-132210581:+	0.35	5.47	7.04E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs34592321	chr5:132181675	SHROOM1	chr5:132158012-132166590:-	0.3	5.57	4.12E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs34594856	chr6:163051845	PACRG	chr6:163148164-163736523:+	0.57	6.98	9.21E-12	Body mass index	
KIRC	cis	1	rs34619021	chr6:163029767	PACRG	chr6:163148164-163736523:+	0.47	6.16	1.53E-9	Body mass index	
KIRC	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.46	-10.13	4.73E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs34626261	chr5:132174880	LEAP2	chr5:132209358-132210581:+	0.34	5.11	4.48E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs34626261	chr5:132174880	SHROOM1	chr5:132158012-132166590:-	0.3	5.5	5.92E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs34629498	chr19:23060720	ZNF492	chr19:22817126-22850472:+	-0.39	-5.81	1.13E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs34637087	chr6:163004064	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.29	5.77	1.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs34637256	chr7:65360131	CRCP	chr7:65579805-65619551:+	-0.33	-4.49	9.0E-6	Diabetic kidney disease	
KIRC	cis	1	rs34645895	chr20:25368373	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs34645895	chr20:25368373	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs34650015	chr6:88294697	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs34653853	chr6:163114362	PACRG	chr6:163148164-163736523:+	0.59	7.05	6.1E-12	Body mass index	
KIRC	cis	1	rs34655790	chr6:163202739	PACRG	chr6:163148164-163736523:+	0.52	6.17	1.38E-9	Body mass index	
KIRC	cis	1	rs34667713	chr1:27292678	PIGV	chr1:27114455-27124886:+	-0.38	-4.33	1.82E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs346785	chr17:74283769	FAM100B	chr17:74261286-74267379:+	0.15	4.52	7.67E-6	White matter hyperintensities in ischemic stroke	
KIRC	cis	1	rs34681611	chr1:27089446	PIGV	chr1:27114455-27124886:+	-0.39	-4.55	6.58E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.78	3.33E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
KIRC	cis	1	rs34693293	chr1:27068971	PIGV	chr1:27114455-27124886:+	-0.39	-4.56	6.36E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34697913	chr6:163000187	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs34700722	chr8:96021876	C8orf38	chr8:95908040-96088396:+	-0.26	-4.06	5.8E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.18E-8	Diabetic kidney disease	
KIRC	cis	1	rs34702770	chr7:65344823	CRCP	chr7:65579805-65619551:+	-0.33	-4.49	8.66E-6	Diabetic kidney disease	
KIRC	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.29	5.77	1.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs34703416	chr7:65300642	CRCP	chr7:65579805-65619551:+	-0.33	-4.49	9.0E-6	Diabetic kidney disease	
KIRC	cis	1	rs34709844	chr3:127818869	KBTBD12	chr3:127634318-127706513:+	0.27	3.6	0.000352	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34709844	chr3:127818869	RPN1	chr3:128338813-128399918:-	0.21	3.56	0.000411	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34709844	chr3:127818869	RUVBL1	chr3:127783627-127872757:-	0.34	4.79	2.19E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34714518	chr6:163080778	PACRG	chr6:163148164-163736523:+	0.58	6.89	1.69E-11	Body mass index	
KIRC	cis	1	rs34725898	chr6:163127302	PACRG	chr6:163148164-163736523:+	0.59	7.07	5.14E-12	Body mass index	
KIRC	cis	1	rs34746918	chr19:18539744	SSBP4	chr19:18530221-18545371:+	-0.13	-4.38	1.46E-5	Breast cancer	
KIRC	cis	1	rs34751999	chr15:84758419	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.44	1.09E-5	Schizophrenia	
KIRC	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.26	-4.96	9.55E-7	Schizophrenia	
KIRC	cis	1	rs34757183	chr3:136143668	IL20RB	chr3:136676707-136729920:+	0.16	3.66	0.000277	Body mass index;Height	
KIRC	cis	1	rs34762726	chr3:49689210	UBA7	chr3:49842639-49851391:-	0.16	4.12	4.35E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs347685	chr3:141807137	TFDP2	chr3:141671329-141868311:-	0.21	4.39	1.4E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs347686	chr3:141807982	TFDP2	chr3:141671329-141868311:-	-0.21	-4.29	2.14E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs34771104	chr4:39129052	WDR19	chr4:39184024-39287429:+	0.18	4.68	3.75E-6	Uric acid levels	
KIRC	cis	1	rs34773528	chr6:163088796	PACRG	chr6:163148164-163736523:+	0.58	7.03	6.72E-12	Body mass index	
KIRC	cis	1	rs34785390	chr4:76534481	CDKL2	chr4:76501705-76555721:-	0.16	3.66	0.000276	Magnesium levels	
KIRC	cis	1	rs34812189	chr6:56806727	BEND6	chr6:56819773-56892138:+	-0.28	-5.4	1.05E-7	Menarche (age at onset)	
KIRC	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.16E-8	Diabetic kidney disease	
KIRC	cis	1	rs34815098	chr7:65292254	CRCP	chr7:65579805-65619551:+	-0.32	-4.45	1.06E-5	Diabetic kidney disease	
KIRC	cis	1	rs34817706	chr3:127861058	KBTBD12	chr3:127634318-127706513:+	0.3	4.06	5.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34817706	chr3:127861058	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34817706	chr3:127861058	RUVBL1	chr3:127783627-127872757:-	0.34	4.87	1.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34822023	chr11:5555244	TRIM6	chr11:5617347-5634188:+	-0.19	-4.6	5.24E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs34847072	chr5:437862	C5orf55	chr5:441645-443258:-	0.3	5.87	8.14E-9	Cystic fibrosis severity	
KIRC	cis	1	rs34847072	chr5:437862	LOC25845	chr5:470626-473080:-	0.39	6.22	1.04E-9	Cystic fibrosis severity	
KIRC	cis	1	rs34847072	chr5:437862	PDCD6	chr5:271736-315089:+	-0.17	-3.5	0.000515	Cystic fibrosis severity	
KIRC	cis	1	rs34847072	chr5:437862	SDHA	chr5:218356-256812:+	-0.19	-3.5	0.000502	Cystic fibrosis severity	
KIRC	cis	1	rs34847072	chr5:437862	SLC9A3	chr5:473334-524549:-	0.29	5.32	1.58E-7	Cystic fibrosis severity	
KIRC	cis	1	rs34847072	chr5:437862	TPPP	chr5:659978-693510:-	0.19	3.61	0.000337	Cystic fibrosis severity	
KIRC	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.52	8.09	4.59E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs34849118	chr2:240919912	NDUFA10	chr2:240900158-240964798:-	0.19	4.12	4.49E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.46	-10.02	1.19E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs34865093	chr5:156424767	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.14	4.25E-22	Hypertriglyceridemia	
KIRC	cis	1	rs34865093	chr5:156424767	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.64	1.14E-13	Hypertriglyceridemia	
KIRC	cis	1	rs34865093	chr5:156424767	TIMD4	chr5:156346293-156390266:-	-0.36	-6.75	4.04E-11	Hypertriglyceridemia	
KIRC	cis	1	rs34878139	chr12:124446253	CCDC92	chr12:124420955-124457163:-	0.2	5.35	1.37E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs34878139	chr12:124446253	DNAH10	chr12:124247042-124420265:+	0.19	3.9	0.00011	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs34885854	chr1:27086249	PIGV	chr1:27114455-27124886:+	-0.39	-4.55	6.58E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34889971	chr1:27188057	PIGV	chr1:27114455-27124886:+	-0.41	-4.75	2.61E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34894912	chr12:82228721	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.64E-12	Resting heart rate	
KIRC	cis	1	rs34897231	chr20:23620268	CST3	chr20:23608536-23618574:-	-0.13	-3.6	0.000347	Chronic kidney disease	
KIRC	cis	1	rs34897866	chr2:231036754	SP110	chr2:231033645-231084827:-	0.3	4.43	1.14E-5	Obesity-related traits	
KIRC	cis	1	rs34899016	chr20:13046318	SPTLC3	chr20:12989627-13147411:+	0.2	3.72	0.000225	Daytime sleep phenotypes	
KIRC	cis	1	rs34900908	chr15:85257599	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.56	6.32E-6	Schizophrenia	
KIRC	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.21	-4.05	5.9E-5	Schizophrenia	
KIRC	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs34910028	chr11:47758449	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs34910254	chr6:55963885	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs34918316	chr6:163005386	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs34927605	chr5:137580418	CDC25C	chr5:137620959-137674044:-	-0.22	-6.14	1.69E-9	Resting heart rate	
KIRC	cis	1	rs34931503	chr6:163003876	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs34933390	chr3:53006265	RFT1	chr3:53122503-53164470:-	0.35	5.28	1.89E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34933390	chr3:53006265	SFMBT1	chr3:52938628-53080070:-	-0.26	-3.69	0.000252	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34933390	chr3:53006265	TMEM110	chr3:52867139-52931547:-	0.33	5.73	1.77E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.28	5.63	2.95E-8	Diabetic kidney disease	
KIRC	cis	1	rs34933526	chr7:65383199	CRCP	chr7:65579805-65619551:+	-0.31	-4.29	2.12E-5	Diabetic kidney disease	
KIRC	cis	1	rs34947476	chr2:135486150	TMEM163	chr2:135213331-135525334:-	-0.31	-4.23	2.8E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs34949904	chr22:24695298	C22orf45	chr22:24825178-24826344:-;chr22	0.15	3.7	0.00024	Gut microbiome composition (summer)	
KIRC	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.25	-6.46	2.49E-10	Gut microbiome composition (summer)	
KIRC	cis	1	rs34953792	chr20:55086281	C20orf43	chr20:55043647-55093942:+	0.2	4.72	3.04E-6	Refractive astigmatism	
KIRC	cis	1	rs34955225	chr3:127825078	KBTBD12	chr3:127634318-127706513:+	0.27	3.6	0.000352	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34955225	chr3:127825078	RPN1	chr3:128338813-128399918:-	0.21	3.56	0.000411	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34955225	chr3:127825078	RUVBL1	chr3:127783627-127872757:-	0.34	4.79	2.19E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs34965813	chr3:185333012	TMEM41A	chr3:185207389-185216845:-	0.17	3.55	0.000422	Systolic blood pressure	
KIRC	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.28	5.48	6.58E-8	Diabetic kidney disease	
KIRC	cis	1	rs34970380	chr7:65431493	CRCP	chr7:65579805-65619551:+	-0.32	-4.32	1.89E-5	Diabetic kidney disease	
KIRC	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.16E-8	Diabetic kidney disease	
KIRC	cis	1	rs34974928	chr7:65364006	CRCP	chr7:65579805-65619551:+	-0.32	-4.45	1.06E-5	Diabetic kidney disease	
KIRC	cis	1	rs34976021	chr1:27298564	PIGV	chr1:27114455-27124886:+	-0.35	-4.2	3.14E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs34983295	chr20:55079380	C20orf43	chr20:55043647-55093942:+	0.2	4.71	3.22E-6	Refractive astigmatism	
KIRC	cis	1	rs35000415	chr7:128585616	IRF5	chr7:128577769-128590086:+	0.25	4.19	3.29E-5	Systemic lupus erythematosus	
KIRC	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.44	7.12	3.86E-12	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs35008770	chr3:160334317	TRIM59	chr3:160153292-160167626:-	0.22	3.79	0.000167	Primary biliary cirrhosis	
KIRC	cis	1	rs35017019	chr6:162982581	PACRG	chr6:163148164-163736523:+	0.47	6.33	5.5E-10	Body mass index	
KIRC	cis	1	rs35021342	chr1:27086227	PIGV	chr1:27114455-27124886:+	-0.38	-4.46	1.02E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35025342	chr6:151876661	C6orf97	chr6:151815175-151942327:+	0.21	3.95	8.85E-5	Bone mineral density (spine)	
KIRC	cis	1	rs35044651	chr6:163004142	PACRG	chr6:163148164-163736523:+	0.45	5.92	5.93E-9	Body mass index	
KIRC	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs35046236	chr7:65408613	CRCP	chr7:65579805-65619551:+	-0.31	-4.35	1.62E-5	Diabetic kidney disease	
KIRC	cis	1	rs35056702	chr6:109736326	AKD1	chr6:109814059-110012415:-	-0.26	-5.34	1.38E-7	Height	
KIRC	cis	1	rs35056702	chr6:109736326	SMPD2	chr6:109761931-109765121:+	0.18	4.24	2.63E-5	Height	
KIRC	cis	1	rs35056836	chr6:88255274	C6orf164	chr6:88032306-88109459:+	0.31	3.69	0.000249	Obesity-related traits	
KIRC	cis	1	rs35058527	chr6:88351078	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.28	5.6	3.49E-8	Diabetic kidney disease	
KIRC	cis	1	rs35058610	chr7:65390925	CRCP	chr7:65579805-65619551:+	-0.32	-4.39	1.37E-5	Diabetic kidney disease	
KIRC	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.6	-13.78	7.31E-37	Forced vital capacity	
KIRC	cis	1	rs35062783	chr10:17202869	TRDMT1	chr10:17184983-17243681:-	-0.38	-8.56	1.42E-16	Homocysteine levels	
KIRC	cis	1	rs35092540	chr6:163090778	PACRG	chr6:163148164-163736523:+	0.59	7.07	5.16E-12	Body mass index	
KIRC	cis	1	rs35103516	chr22:38001748	SH3BP1	chr22:38030661-38062939:+	0.27	4.43	1.15E-5	Response to anti-depressant treatment in major depressive disorder	
KIRC	cis	1	rs35103567	chr6:163183400	PACRG	chr6:163148164-163736523:+	0.55	6.42	3.22E-10	Body mass index	
KIRC	cis	1	rs35105361	chr7:128383768	OPN1SW	chr7:128412545-128415844:-	0.23	3.84	0.000137	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.13	-4.54	7.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs35108146	chr1:27248440	PIGV	chr1:27114455-27124886:+	-0.36	-4.19	3.26E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35115612	chr5:125926839	LMNB1	chr5:126112833-126172709:+	0.16	3.59	0.000359	Osteoporosis	
KIRC	cis	1	rs35116118	chr4:39128913	WDR19	chr4:39184024-39287429:+	0.18	4.73	2.98E-6	Uric acid levels	
KIRC	cis	1	rs35124757	chr6:89918215	GABRR1	chr6:89887223-89927496:-	0.44	5.49	6.55E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs35126854	chr6:163012443	PACRG	chr6:163148164-163736523:+	0.43	5.93	5.79E-9	Body mass index	
KIRC	cis	1	rs35145572	chr3:127847418	KBTBD12	chr3:127634318-127706513:+	0.27	3.7	0.000243	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35145572	chr3:127847418	RPN1	chr3:128338813-128399918:-	0.22	3.82	0.000148	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35145572	chr3:127847418	RUVBL1	chr3:127783627-127872757:-	0.33	4.72	3.01E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35145572	chr3:127847418	SEC61A1	chr3:127771212-127790525:+	0.2	3.51	0.000492	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35159031	chr5:156475430	HAVCR1	chr5:156456531-156486130:-	-0.44	-9.91	2.97E-21	Hypertriglyceridemia	
KIRC	cis	1	rs35159031	chr5:156475430	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.84	2.65E-14	Hypertriglyceridemia	
KIRC	cis	1	rs35159031	chr5:156475430	TIMD4	chr5:156346293-156390266:-	-0.32	-6.04	3.01E-9	Hypertriglyceridemia	
KIRC	cis	1	rs35160687	chr2:86472114	REEP1	chr2:86441122-86564777:-	0.21	4.23	2.76E-5	Night sleep phenotypes	
KIRC	cis	1	rs35179427	chr1:95670888	RWDD3	chr1:95583479-95712773:+	0.41	5.06	5.9E-7	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs35182603	chr20:42898550	L3MBTL	chr20:42136350-42179593:+	-0.15	-3.6	0.000354	Cognitive performance	
KIRC	cis	1	rs35184688	chr17:40272406	DHX58	chr17:40253422-40264751:-	-0.35	-6.89	1.67E-11	Fibrinogen levels	
KIRC	cis	1	rs35194171	chr2:61072183	PUS10	chr2:61167550-61245365:-	-0.16	-4.1	4.72E-5	Psoriasis	
KIRC	cis	1	rs35202312	chr6:56788937	BEND6	chr6:56819773-56892138:+	-0.26	-5.36	1.29E-7	Menarche (age at onset)	
KIRC	cis	1	rs35209719	chr1:212401677	TMEM206	chr1:212537819-212588267:-	0.19	3.8	0.000163	Intelligence (childhood)	
KIRC	cis	1	rs35212593	chr15:78831826	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.86	8.62E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35234062	chr6:88215869	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs352476	chr15:65805389	DPP8	chr15:65737999-65810035:-	0.12	4.73	2.93E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs352479	chr15:65803428	DPP8	chr15:65737999-65810035:-	0.12	4.67	3.85E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs35256560	chr1:27054016	PIGV	chr1:27114455-27124886:+	-0.38	-4.31	2.0E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.3	5.83	9.75E-9	Diabetic kidney disease	
KIRC	cis	1	rs35283677	chr7:65359233	CRCP	chr7:65579805-65619551:+	-0.32	-4.27	2.35E-5	Diabetic kidney disease	
KIRC	cis	1	rs35297609	chr15:84772896	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.5	8.53E-6	Schizophrenia	
KIRC	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.26	-5.03	6.76E-7	Schizophrenia	
KIRC	cis	1	rs35303040	chr6:88266575	C6orf164	chr6:88032306-88109459:+	0.33	3.93	9.87E-5	Obesity-related traits	
KIRC	cis	1	rs35303215	chr22:24801535	C22orf45	chr22:24825178-24826344:-;chr22	0.19	4.28	2.23E-5	Gut microbiome composition (summer)	
KIRC	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.24	-5.82	1.04E-8	Gut microbiome composition (summer)	
KIRC	cis	1	rs35316992	chr15:85248133	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.51	8.24E-6	Schizophrenia	
KIRC	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.22	-4.22	2.96E-5	Schizophrenia	
KIRC	cis	1	rs35324020	chr6:88375913	C6orf164	chr6:88032306-88109459:+	0.3	3.63	0.000318	Obesity-related traits	
KIRC	cis	1	rs35332070	chr19:23034266	ZNF492	chr19:22817126-22850472:+	-0.34	-4.96	9.56E-7	Bronchopulmonary dysplasia	
KIRC	cis	1	rs35341640	chr17:18818228	FAM18B	chr17:18684582-18710026:+	0.23	5.26	2.1E-7	Pancreatic cancer	
KIRC	cis	1	rs35344466	chr3:85633021	CADM2	chr3:85008133-86117948:+	0.26	4.3	2.01E-5	Longevity (90 years and older)	
KIRC	cis	1	rs35363104	chr6:88292301	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs35370743	chr4:106604190	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs35371323	chr15:56379166	TEX9	chr15:56657644-56738071:+	-0.29	-4.96	9.84E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs35383933	chr6:163002869	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.47	-10.57	1.07E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.16E-8	Diabetic kidney disease	
KIRC	cis	1	rs35391607	chr7:65360829	CRCP	chr7:65579805-65619551:+	-0.32	-4.45	1.06E-5	Diabetic kidney disease	
KIRC	cis	1	rs35395156	chr15:67962763	IQCH	chr15:67547188-67794139:+	0.18	3.72	0.000219	Motion sickness	
KIRC	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.29	5.91	6.34E-9	Diabetic kidney disease	
KIRC	cis	1	rs35396113	chr7:65495461	CRCP	chr7:65579805-65619551:+	-0.3	-4.15	3.88E-5	Diabetic kidney disease	
KIRC	cis	1	rs35396113	chr7:65495461	LOC493754	chr7:65993446-66057363:-	0.22	3.52	0.000467	Diabetic kidney disease	
KIRC	cis	1	rs35407375	chr1:27041218	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.48	-10.29	1.13E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs35421223	chr3:127829879	KBTBD12	chr3:127634318-127706513:+	0.29	3.94	9.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35421223	chr3:127829879	RPN1	chr3:128338813-128399918:-	0.22	3.62	0.00033	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35421223	chr3:127829879	RUVBL1	chr3:127783627-127872757:-	0.35	4.88	1.4E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.3	5.83	9.75E-9	Diabetic kidney disease	
KIRC	cis	1	rs35421653	chr7:65363429	CRCP	chr7:65579805-65619551:+	-0.32	-4.27	2.35E-5	Diabetic kidney disease	
KIRC	cis	1	rs35424047	chr6:163029715	PACRG	chr6:163148164-163736523:+	0.47	6.16	1.53E-9	Body mass index	
KIRC	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.27	5.53	5.04E-8	Diabetic kidney disease	
KIRC	cis	1	rs35432774	chr7:65393019	CRCP	chr7:65579805-65619551:+	-0.32	-4.48	9.24E-6	Diabetic kidney disease	
KIRC	cis	1	rs35435780	chr17:79579602	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs35435780	chr17:79579602	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs35437629	chr4:39133332	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs35437840	chr3:127825306	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35438183	chr5:60956220	FLJ37543	chr5:60933636-61002362:+	0.22	3.63	0.000311	Alzheimer's disease	
KIRC	cis	1	rs35449999	chr6:163023465	PACRG	chr6:163148164-163736523:+	0.47	6.24	9.33E-10	Body mass index	
KIRC	cis	1	rs35454259	chr6:27254475	BTN3A2	chr6:26365398-26378546:+	-0.28	-5.34	1.39E-7	Schizophrenia	
KIRC	cis	1	rs35464459	chr10:4964640	AKR1C1	chr10:4934796-5020157:+	-0.39	-4.89	1.35E-6	Height	
KIRC	cis	1	rs35464459	chr10:4964640	AKR1C2	chr10:4964715-5060207:-	0.63	7.36	7.52E-13	Height	
KIRC	cis	1	rs35465301	chr6:88313908	C6orf164	chr6:88032306-88109459:+	0.35	4.13	4.31E-5	Obesity-related traits	
KIRC	cis	1	rs35468197	chr10:4978256	AKR1C1	chr10:4934796-5020157:+	-0.36	-4.84	1.75E-6	Height	
KIRC	cis	1	rs35468197	chr10:4978256	AKR1C2	chr10:4964715-5060207:-	0.55	6.66	7.39E-11	Height	
KIRC	cis	1	rs35468353	chr16:31056433	MYST1	chr16:31128985-31142713:+	0.15	4	7.38E-5	Response to metformin (IC50)	
KIRC	cis	1	rs35476574	chr8:143683784	ARC	chr8:143692410-143695833:-	0.29	5.79	1.21E-8	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs35485559	chr12:81441066	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs35485559	chr12:81441066	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs35488434	chr20:23620401	CST3	chr20:23608536-23618574:-	-0.13	-3.6	0.000347	Chronic kidney disease	
KIRC	cis	1	rs35494431	chr6:88357172	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs35515217	chr3:127813811	KBTBD12	chr3:127634318-127706513:+	0.29	3.94	9.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35515217	chr3:127813811	RPN1	chr3:128338813-128399918:-	0.22	3.62	0.00033	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35515217	chr3:127813811	RUVBL1	chr3:127783627-127872757:-	0.35	4.88	1.4E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35518779	chr5:174972609	FAF2	chr5:175875356-175937074:+	-0.25	-3.94	9.14E-5	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs35522482	chr22:39063015	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs35524990	chr15:85258203	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.49	8.71E-6	Schizophrenia	
KIRC	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.21	-4.06	5.64E-5	Schizophrenia	
KIRC	cis	1	rs35526714	chr12:56634639	RPS26	chr12:56435686-56438005:+	-0.52	-4.24	2.7E-5	Psoriasis vulgaris	
KIRC	cis	1	rs35527216	chr6:56791278	BEND6	chr6:56819773-56892138:+	-0.24	-4.87	1.51E-6	Menarche (age at onset)	
KIRC	cis	1	rs35531186	chr3:127841060	KBTBD12	chr3:127634318-127706513:+	0.27	3.6	0.000352	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35531186	chr3:127841060	RPN1	chr3:128338813-128399918:-	0.21	3.56	0.000411	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35531186	chr3:127841060	RUVBL1	chr3:127783627-127872757:-	0.34	4.79	2.19E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.27	5.46	7.52E-8	Diabetic kidney disease	
KIRC	cis	1	rs35542501	chr7:65431215	CRCP	chr7:65579805-65619551:+	-0.32	-4.49	8.7E-6	Diabetic kidney disease	
KIRC	cis	1	rs35542947	chr3:58323244	PXK	chr3:58318617-58410878:+	0.22	4.39	1.39E-5	Cholesterol, total	
KIRC	cis	1	rs35560426	chr1:27069169	PIGV	chr1:27114455-27124886:+	-0.39	-4.56	6.36E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35564624	chr6:151876494	C6orf97	chr6:151815175-151942327:+	0.2	3.9	0.000107	Bone mineral density (spine)	
KIRC	cis	1	rs35565791	chr22:39063011	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs35571434	chr1:90948313	ZNF326	chr1:90460678-90494094:+	-0.19	-3.64	0.000302	Coronary artery calcification	
KIRC	cis	1	rs35575481	chr6:163007746	PACRG	chr6:163148164-163736523:+	0.47	6.23	9.73E-10	Body mass index	
KIRC	cis	1	rs35576914	chr3:53092270	RFT1	chr3:53122503-53164470:-	0.31	4.64	4.39E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35576914	chr3:53092270	TMEM110	chr3:52867139-52931547:-	0.34	5.77	1.38E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35577967	chr15:75354621	PPCDC	chr15:75315927-75343066:+	0.19	4.33	1.77E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.27	4.67	3.95E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs35583420	chr6:163214327	PACRG	chr6:163148164-163736523:+	0.58	6.53	1.66E-10	Body mass index	
KIRC	cis	1	rs35583548	chr1:27140149	PIGV	chr1:27114455-27124886:+	-0.38	-4.48	9.43E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35593345	chr6:163174981	PACRG	chr6:163148164-163736523:+	0.58	6.64	8.35E-11	Body mass index	
KIRC	cis	1	rs35593940	chr6:88263087	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000104	Obesity-related traits	
KIRC	cis	1	rs35601051	chr11:5555247	TRIM6	chr11:5617347-5634188:+	-0.19	-4.6	5.24E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs35602488	chr3:94246319	STX19	chr3:93733215-93747454:-	0.34	4.76	2.57E-6	Blood pressure measurement (high sodium intervention)	
KIRC	cis	1	rs35607436	chr15:56518208	TEX9	chr15:56657644-56738071:+	-0.28	-5.04	6.35E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs35615194	chr1:27118171	PIGV	chr1:27114455-27124886:+	-0.38	-4.48	9.43E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35617712	chr1:27051223	PIGV	chr1:27114455-27124886:+	-0.38	-4.3	2.02E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35621601	chr3:58323174	PXK	chr3:58318617-58410878:+	0.22	4.39	1.39E-5	Cholesterol, total	
KIRC	cis	1	rs35623865	chr11:46631181	MDK	chr11:46402334-46405374:+	-0.22	-3.8	0.000159	Schizophrenia	
KIRC	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.21	2.34E-22	Subjective well-being	
KIRC	cis	1	rs35624992	chr11:47615798	PSMC3	chr11:47440320-47448024:-	0.13	4.03	6.32E-5	Subjective well-being	
KIRC	cis	1	rs35630683	chr15:85349231	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.41	1.27E-5	Schizophrenia	
KIRC	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.19	-3.57	0.000397	Schizophrenia	
KIRC	cis	1	rs35630951	chr10:17215649	TRDMT1	chr10:17184983-17243681:-	-0.35	-7.97	1.06E-14	Homocysteine levels	
KIRC	cis	1	rs35632377	chr5:156436252	HAVCR1	chr5:156456531-156486130:-	-0.45	-9.97	1.69E-21	Hypertriglyceridemia	
KIRC	cis	1	rs35632377	chr5:156436252	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.56	1.97E-13	Hypertriglyceridemia	
KIRC	cis	1	rs35632377	chr5:156436252	TIMD4	chr5:156346293-156390266:-	-0.36	-6.78	3.45E-11	Hypertriglyceridemia	
KIRC	cis	1	rs35648189	chr15:84740748	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.44	1.09E-5	Schizophrenia	
KIRC	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.26	-4.96	9.55E-7	Schizophrenia	
KIRC	cis	1	rs35658069	chr15:84780146	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.45	1.06E-5	Schizophrenia	
KIRC	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.26	-5.05	6.33E-7	Schizophrenia	
KIRC	cis	1	rs35670307	chr1:228588654	TRIM11	chr1:228581379-228594517:-	-0.24	-3.54	0.000442	Hip circumference (psychosocial stress interaction)	
KIRC	cis	1	rs35696109	chr5:115527756	COMMD10	chr5:115420727-115628978:+	0.39	4.02	6.83E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs35703976	chr2:135486350	TMEM163	chr2:135213331-135525334:-	-0.31	-4.22	2.9E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs35708118	chr7:37080404	SFRP4	chr7:37945536-37956525:-	0.36	3.53	0.000459	QT interval	
KIRC	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs35718987	chr3:134272783	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs35723993	chr6:163008197	PACRG	chr6:163148164-163736523:+	0.47	6.2	1.19E-9	Body mass index	
KIRC	cis	1	rs35724792	chr3:127809616	KBTBD12	chr3:127634318-127706513:+	0.26	3.52	0.000468	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35724792	chr3:127809616	RPN1	chr3:128338813-128399918:-	0.22	3.63	0.000311	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35724792	chr3:127809616	RUVBL1	chr3:127783627-127872757:-	0.34	4.85	1.63E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35726233	chr15:85337800	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.66	4.07E-6	Schizophrenia	
KIRC	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.21	-4.07	5.46E-5	Schizophrenia	
KIRC	cis	1	rs35730213	chr1:200874229	KIF21B	chr1:200938520-200992828:-	0.13	4.1	4.76E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs35734267	chr2:70281190	ANXA4	chr2:69969127-70053594:+	-0.18	-3.62	0.000324	Obesity-related traits	
KIRC	cis	1	rs35734267	chr2:70281190	FAM136A	chr2:70523109-70529220:-	-0.23	-4.58	5.83E-6	Obesity-related traits	
KIRC	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.3	5.82	1.05E-8	Diabetic kidney disease	
KIRC	cis	1	rs35735127	chr7:65300423	CRCP	chr7:65579805-65619551:+	-0.31	-4.19	3.37E-5	Diabetic kidney disease	
KIRC	cis	1	rs35736167	chr15:75332002	PPCDC	chr15:75315927-75343066:+	0.2	4.55	6.88E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs35736167	chr15:75332002	RPP25	chr15:75247443-75249775:-	0.21	3.86	0.00013	Blood trace element (Zn levels)	
KIRC	cis	1	rs35736167	chr15:75332002	SCAMP5	chr15:75287901-75313836:+	0.24	4.35	1.64E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs35737577	chr3:53002557	RFT1	chr3:53122503-53164470:-	0.34	5.25	2.21E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35737577	chr3:53002557	SFMBT1	chr3:52938628-53080070:-	-0.27	-3.85	0.000131	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35737577	chr3:53002557	TMEM110	chr3:52867139-52931547:-	0.34	5.86	8.24E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35741374	chr2:61072567	PUS10	chr2:61167550-61245365:-	-0.16	-4.14	4.03E-5	Psoriasis	
KIRC	cis	1	rs35754151	chr6:163074867	PACRG	chr6:163148164-163736523:+	0.54	6.35	4.9E-10	Body mass index	
KIRC	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.47	-10.57	1.07E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.5	-10.34	7.36E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs35766535	chr1:10284659	RBP7	chr1:10057255-10076077:+	0.15	3.55	0.00042	Hepatocellular carcinoma	
KIRC	cis	1	rs35767091	chr4:56346723	SRD5A3	chr4:56212409-56237866:+	0.18	3.98	7.76E-5	Personality dimensions	
KIRC	cis	1	rs35767091	chr4:56346723	TMEM165	chr4:56262090-56292342:+	-0.22	-6.12	1.87E-9	Personality dimensions	
KIRC	cis	1	rs35767731	chr20:42906937	L3MBTL	chr20:42136350-42179593:+	-0.15	-3.6	0.000354	Cognitive performance	
KIRC	cis	1	rs35792042	chr3:58409668	PXK	chr3:58318617-58410878:+	0.25	4.92	1.17E-6	Cholesterol, total	
KIRC	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.46	-10.09	6.14E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs35808647	chr15:85377441	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-4.67	3.84E-6	Schizophrenia	
KIRC	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.19	-3.61	0.000337	Schizophrenia	
KIRC	cis	1	rs35808787	chr4:106681179	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs35818596	chr6:163001874	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.58E-8	Diabetic kidney disease	
KIRC	cis	1	rs35820085	chr7:65442758	CRCP	chr7:65579805-65619551:+	-0.3	-4.14	4.02E-5	Diabetic kidney disease	
KIRC	cis	1	rs35820211	chr6:163046252	PACRG	chr6:163148164-163736523:+	0.57	6.98	9.21E-12	Body mass index	
KIRC	cis	1	rs35825171	chr1:99186335	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.16E-8	Diabetic kidney disease	
KIRC	cis	1	rs35825738	chr7:65318027	CRCP	chr7:65579805-65619551:+	-0.32	-4.45	1.06E-5	Diabetic kidney disease	
KIRC	cis	1	rs35835884	chr10:127708468	UROS	chr10:127477148-127511837:-	-0.18	-4.74	2.75E-6	Visceral fat	
KIRC	cis	1	rs35837142	chr1:10322358	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000351	Hepatocellular carcinoma	
KIRC	cis	1	rs35849389	chr3:53005235	RFT1	chr3:53122503-53164470:-	0.34	5.17	3.37E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35849389	chr3:53005235	SFMBT1	chr3:52938628-53080070:-	-0.28	-3.88	0.000117	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35849389	chr3:53005235	TMEM110	chr3:52867139-52931547:-	0.34	5.75	1.51E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs35868174	chr5:156425303	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.14	4.25E-22	Hypertriglyceridemia	
KIRC	cis	1	rs35868174	chr5:156425303	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.64	1.14E-13	Hypertriglyceridemia	
KIRC	cis	1	rs35868174	chr5:156425303	TIMD4	chr5:156346293-156390266:-	-0.36	-6.75	4.04E-11	Hypertriglyceridemia	
KIRC	cis	1	rs35868630	chr8:143685933	ARC	chr8:143692410-143695833:-	0.29	5.84	9.47E-9	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs35883214	chr4:76508861	CDKL2	chr4:76501705-76555721:-	0.16	3.56	0.000407	Magnesium levels	
KIRC	cis	1	rs35889327	chr10:29802957	LOC387647	chr10:29698483-29776785:+	0.22	4.09	4.94E-5	Platelet thrombus formation	
KIRC	cis	1	rs35900184	chr8:143693411	ARC	chr8:143692410-143695833:-	0.3	5.98	4.34E-9	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs35902101	chr11:47795169	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs35911566	chr6:162994154	PACRG	chr6:163148164-163736523:+	0.49	6.45	2.59E-10	Body mass index	
KIRC	cis	1	rs35917348	chr6:88362166	C6orf164	chr6:88032306-88109459:+	0.31	3.66	0.000284	Obesity-related traits	
KIRC	cis	1	rs35917448	chr1:27017325	PIGV	chr1:27114455-27124886:+	-0.38	-4.26	2.44E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35925514	chr6:88339180	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs35947214	chr3:127833231	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs35953049	chr6:89916692	GABRR1	chr6:89887223-89927496:-	0.42	5.7	2.1E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs35960805	chr15:85343980	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.64	4.43E-6	Schizophrenia	
KIRC	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.2	-4.01	6.98E-5	Schizophrenia	
KIRC	cis	1	rs35962879	chr1:27283456	PIGV	chr1:27114455-27124886:+	-0.36	-4.32	1.92E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35969145	chr1:27259392	PIGV	chr1:27114455-27124886:+	-0.34	-3.85	0.000132	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs35972482	chr6:88295735	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs35974852	chr6:117229958	FAM26F	chr6:116782556-116784933:+	-0.14	-3.72	0.00022	Prostate cancer	
KIRC	cis	1	rs35988617	chr3:121432902	IQCB1	chr3:121488610-121553926:-	0.35	6.59	1.1E-10	Cognitive performance	
KIRC	cis	1	rs36000835	chr10:4979788	AKR1C1	chr10:4934796-5020157:+	-0.37	-4.62	4.87E-6	Height	
KIRC	cis	1	rs36000835	chr10:4979788	AKR1C2	chr10:4964715-5060207:-	0.66	7.73	6.03E-14	Height	
KIRC	cis	1	rs36004835	chr15:67951542	IQCH	chr15:67547188-67794139:+	0.18	3.69	0.000245	Motion sickness	
KIRC	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.16	4.09	4.96E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs36007635	chr6:163009335	PACRG	chr6:163148164-163736523:+	0.47	6.09	2.27E-9	Body mass index	
KIRC	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.28	5.64	2.84E-8	Diabetic kidney disease	
KIRC	cis	1	rs36033484	chr7:65390558	CRCP	chr7:65579805-65619551:+	-0.3	-4.14	4.1E-5	Diabetic kidney disease	
KIRC	cis	1	rs36033486	chr15:85319692	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.57	6.17E-6	Schizophrenia	
KIRC	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.21	-4.1	4.73E-5	Schizophrenia	
KIRC	cis	1	rs36035949	chr6:109736614	AKD1	chr6:109814059-110012415:-	-0.24	-5	7.81E-7	Height	
KIRC	cis	1	rs36035949	chr6:109736614	SMPD2	chr6:109761931-109765121:+	0.16	3.91	0.000106	Height	
KIRC	cis	1	rs36037390	chr3:58321954	PXK	chr3:58318617-58410878:+	0.21	4.38	1.42E-5	Cholesterol, total	
KIRC	cis	1	rs36041712	chr6:88313705	C6orf164	chr6:88032306-88109459:+	0.35	4.13	4.31E-5	Obesity-related traits	
KIRC	cis	1	rs36042757	chr6:163004744	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs36059338	chr3:127815927	KBTBD12	chr3:127634318-127706513:+	0.26	3.52	0.000468	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs36059338	chr3:127815927	RPN1	chr3:128338813-128399918:-	0.22	3.63	0.000311	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs36059338	chr3:127815927	RUVBL1	chr3:127783627-127872757:-	0.34	4.85	1.63E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs36068983	chr7:65408991	CRCP	chr7:65579805-65619551:+	-0.31	-4.35	1.62E-5	Diabetic kidney disease	
KIRC	cis	1	rs36090629	chr4:39138815	WDR19	chr4:39184024-39287429:+	0.18	4.7	3.4E-6	Uric acid levels	
KIRC	cis	1	rs36096746	chr10:4975353	AKR1C1	chr10:4934796-5020157:+	-0.39	-5.11	4.54E-7	Height	
KIRC	cis	1	rs36096746	chr10:4975353	AKR1C2	chr10:4964715-5060207:-	0.54	6.48	2.24E-10	Height	
KIRC	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.46	-9.89	3.45E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs36097398	chr3:58367330	PXK	chr3:58318617-58410878:+	0.23	4.71	3.18E-6	Cholesterol, total	
KIRC	cis	1	rs36107456	chr6:162997399	PACRG	chr6:163148164-163736523:+	0.42	5.81	1.13E-8	Body mass index	
KIRC	cis	1	rs36113695	chr6:163004733	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs36116701	chr15:63397494	LACTB	chr15:63414032-63434254:+	0.19	3.84	0.000138	HDL cholesterol	
KIRC	cis	1	rs36123022	chr3:12552980	TSEN2	chr3:12525931-12581122:+	0.35	4.99	8.33E-7	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.29	-5.9	6.78E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs364283	chr6:167383750	RNASET2	chr6:167343008-167412795:-	-0.14	-3.64	0.0003	Crohn's disease	
KIRC	cis	1	rs364451	chr6:167384756	RNASET2	chr6:167343008-167412795:-	-0.14	-3.52	0.000476	Crohn's disease	
KIRC	cis	1	rs365189	chr6:167384545	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.47	8.48	2.53E-16	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRC	cis	1	rs3729931	chr3:12626516	MKRN2	chr3:12598594-12625208:+	-0.21	-5.11	4.51E-7	Cardiac hypertrophy	
KIRC	cis	1	rs3730658	chr18:51794699	POLI	chr18:51795849-51824602:+	0.15	3.66	0.000275	Psoriasis	
KIRC	cis	1	rs3730682	chr18:51797332	POLI	chr18:51795849-51824602:+	0.15	3.68	0.000259	Psoriasis	
KIRC	cis	1	rs3730688	chr18:51797948	POLI	chr18:51795849-51824602:+	0.15	3.71	0.000229	Psoriasis	
KIRC	cis	1	rs3730721	chr18:51802928	POLI	chr18:51795849-51824602:+	0.15	3.75	0.000199	Psoriasis	
KIRC	cis	1	rs3730729	chr18:51804702	POLI	chr18:51795849-51824602:+	-0.15	-3.59	0.000359	Psoriasis	
KIRC	cis	1	rs3730758	chr18:51812048	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs3730764	chr18:51812814	POLI	chr18:51795849-51824602:+	0.15	3.76	0.000192	Psoriasis	
KIRC	cis	1	rs3730767	chr18:51813363	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs3730787	chr18:51815443	POLI	chr18:51795849-51824602:+	0.15	3.76	0.000192	Psoriasis	
KIRC	cis	1	rs3730814	chr18:51818901	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs3730818	chr18:51819101	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs3731714	chr2:202060820	PPIL3	chr2:201735680-201753999:-	0.19	3.67	0.000265	Trans fatty acid levels	
KIRC	cis	1	rs3731878	chr2:219920565	USP37	chr2:219314974-219433084:-	-0.26	-3.96	8.62E-5	Height	
KIRC	cis	1	rs3732276	chr2:242343404	SEPT2	chr2:242254723-242293439:+	0.39	5.71	1.95E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs3732408	chr3:121421179	IQCB1	chr3:121488610-121553926:-	0.35	6.59	1.1E-10	Cognitive performance	
KIRC	cis	1	rs3733202	chr4:103556861	MANBA	chr4:103552644-103682151:-	0.19	4.48	9.29E-6	Primary biliary cirrhosis	
KIRC	cis	1	rs3733274	chr4:39122577	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs3733276	chr4:39116911	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs3733277	chr4:39117103	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs3733278	chr4:39117235	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs3733279	chr4:39117245	WDR19	chr4:39184024-39287429:+	0.19	5.02	7.07E-7	Uric acid levels	
KIRC	cis	1	rs3733579	chr4:17694943	LAP3	chr4:17578927-17609590:+	-0.2	-6.05	2.8E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3733579	chr4:17694943	MED28	chr4:17616273-17629791:+	0.21	4.75	2.62E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3734030	chr5:156939880	ADAM19	chr5:156822542-157002768:-	0.12	4.41	1.28E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs3734266	chr6:34823187	UHRF1BP1	chr6:34759794-34853117:+	0.22	4.04	6.23E-5	Systemic lupus erythematosus	
KIRC	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs3734730	chr6:150570940	MTHFD1L	chr6:151186691-151423020:+	0.33	3.62	0.000323	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs3735025	chr7:137074844	PTN	chr7:136912092-137028546:-	-0.21	-3.7	0.000241	Schizophrenia	
KIRC	cis	1	rs3735026	chr7:137074839	PTN	chr7:136912092-137028546:-	-0.21	-3.7	0.000235	Schizophrenia	
KIRC	cis	1	rs3736228	chr11:68201295	SAPS3	chr11:68228186-68382799:+	0.27	3.71	0.000229	Bone mineral density	
KIRC	cis	1	rs3736544	chr4:56309992	SRD5A3	chr4:56212409-56237866:+	0.19	4.07	5.41E-5	Personality dimensions	
KIRC	cis	1	rs3736544	chr4:56309992	TMEM165	chr4:56262090-56292342:+	-0.22	-6.06	2.64E-9	Personality dimensions	
KIRC	cis	1	rs3737628	chr1:1722932	SLC35E2	chr1:1590990-1677431:-	0.17	3.94	9.34E-5	Body mass index	
KIRC	cis	1	rs3738000	chr3:130947435	NEK11	chr3:130745694-131069308:+	-0.22	-4.1	4.77E-5	Carotid intima media thickness	
KIRC	cis	1	rs3738848	chr2:73761881	TPRKB	chr2:73956957-73964517:-	-0.18	-4.75	2.67E-6	Metabolite levels	
KIRC	cis	1	rs3739034	chr2:135483381	TMEM163	chr2:135213331-135525334:-	0.29	4.15	3.85E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs3739036	chr2:135483534	TMEM163	chr2:135213331-135525334:-	0.29	4.13	4.25E-5	Gut microbiome composition (winter)	
KIRC	cis	1	rs3739821	chr9:130702477	DPM2	chr9:130697374-130700763:-	-0.15	-4.13	4.24E-5	Glaucoma (primary angle closure)	
KIRC	cis	1	rs3739821	chr9:130702477	PIP5KL1	chr9:130683809-130693076:-	-0.25	-4.74	2.75E-6	Glaucoma (primary angle closure)	
KIRC	cis	1	rs3739843	chr9:131882961	SET	chr9:131445934-131458674:+	-0.18	-3.87	0.000121	Blood metabolite ratios	
KIRC	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.15	-3.62	0.000319	Blood metabolite ratios	
KIRC	cis	1	rs3739847	chr9:131911574	PPP2R4	chr9:131873244-131911223:+	-0.21	-4.09	5.06E-5	Blood metabolite ratios	
KIRC	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.34	7.56	1.87E-13	Pancreatic cancer	
KIRC	cis	1	rs3742320	chr13:33164418	N4BP2L2	chr13:33006930-33112936:-	0.15	4.31	1.94E-5	Body mass index	
KIRC	cis	1	rs3742377	chr14:100166228	CYP46A1	chr14:100150755-100193637:+	0.19	3.73	0.000215	Scalp hair shape	
KIRC	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.29	-7.72	6.56E-14	IgG glycosylation	
KIRC	cis	1	rs3742704	chr14:88477882	GPR65	chr14:88471496-88478414:+	-0.11	-3.53	0.000455	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs3742773	chr14:75579643	MLH3	chr14:75480467-75518235:-	0.23	5.87	7.85E-9	Height	
KIRC	cis	1	rs3742773	chr14:75579643	NEK9	chr14:75548819-75593778:-	0.14	3.95	9.06E-5	Height	
KIRC	cis	1	rs3742778	chr14:75538217	MLH3	chr14:75480467-75518235:-	-0.23	-5.76	1.43E-8	Height	
KIRC	cis	1	rs3742778	chr14:75538217	NEK9	chr14:75548819-75593778:-	-0.13	-3.67	0.00027	Height	
KIRC	cis	1	rs3742780	chr14:75505008	MLH3	chr14:75480467-75518235:-	0.24	6.04	3.04E-9	Height	
KIRC	cis	1	rs3742780	chr14:75505008	NEK9	chr14:75548819-75593778:-	0.14	3.98	7.93E-5	Height	
KIRC	cis	1	rs3743162	chr15:85430969	GOLGA6L5	chr15:85047738-85060078:-	-0.13	-3.54	0.000433	Alzheimer's disease (age of onset)	
KIRC	cis	1	rs3745672	chr19:12146370	ZNF763	chr19:12035900-12091196:+	-0.44	-5.57	4.24E-8	Multiple sclerosis	
KIRC	cis	1	rs3745734	chr19:49134388	SEC1	chr19:49141296-49185501:+	-0.56	-5.71	1.99E-8	Elevated serum carcinoembryonic antigen levels	
KIRC	cis	1	rs3745859	chr19:39196745	CAPN12	chr19:39220832-39235114:-	-0.14	-4.46	1.02E-5	Heart rate	
KIRC	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.67	15.93	1.61E-46	Schizophrenia	
KIRC	cis	1	rs3746016	chr19:32877259	ZNF507	chr19:32836514-32878571:+	0.18	3.71	0.000229	Bipolar disorder	
KIRC	cis	1	rs3747113	chr22:24717518	C22orf45	chr22:24825178-24826344:-;chr22	-0.15	-3.65	0.000289	Gut microbiome composition (summer)	
KIRC	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.25	6.55	1.43E-10	Gut microbiome composition (summer)	
KIRC	cis	1	rs3747170	chr22:39067331	LOC646851	chr22:38974125-39052634:-	0.14	4.16	3.68E-5	Resting heart rate	
KIRC	cis	1	rs3747172	chr22:39067524	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs3747174	chr22:39069181	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs3747631	chr1:204587569	MFSD4	chr1:205538112-205572045:+	0.21	3.54	0.000432	Educational attainment (college completion)	
KIRC	cis	1	rs3747957	chr1:180953853	MR1	chr1:181003139-181024633:+	-0.14	-3.77	0.000183	Progressive supranuclear palsy	
KIRC	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.52	8.09	4.59E-15	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.16	-5.41	9.95E-8	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.14	-4.96	9.78E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.13	-4.71	3.17E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.14	-5.02	7.05E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750633	chr10:102308214	SEC31B	chr10:102246403-102289636:-	-0.14	-4.74	2.75E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750719	chr10:102248950	SEC31B	chr10:102246403-102289636:-	-0.15	-4.84	1.73E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.14	-4.7	3.41E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3750908	chr11:71822401	C11orf59	chr11:71808339-71814322:-	0.23	4.01	7.09E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs3751196	chr12:104157502	NT5DC3	chr12:104164231-104234975:-	-0.28	-3.69	0.000252	Sense of smell	
KIRC	cis	1	rs3751237	chr12:27963507	LOC100133893	chr12:27915599-27924209:-	0.42	6.24	9.34E-10	Type 2 diabetes	
KIRC	cis	1	rs3751962	chr17:76098719	LGALS3BP	chr17:76967336-76976061:-	0.23	3.56	0.000408	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.29	6.16	1.48E-9	Fractional exhaled nitric oxide (childhood)	
KIRC	cis	1	rs3752950	chr10:17203356	TRDMT1	chr10:17184983-17243681:-	-0.37	-8.38	5.46E-16	Homocysteine levels	
KIRC	cis	1	rs3754439	chr1:110615094	ALX3	chr1:110602998-110613322:-	-0.21	-4.62	4.94E-6	Blood metabolite levels	
KIRC	cis	1	rs3754440	chr1:110613674	ALX3	chr1:110602998-110613322:-	-0.22	-4.64	4.36E-6	Blood metabolite levels	
KIRC	cis	1	rs3756416	chr5:43383502	NNT	chr5:43602791-43705667:+	-0.15	-4.35	1.66E-5	Metabolite levels  (X-11787)	
KIRC	cis	1	rs3756785	chr6:131950401	ENPP3	chr6:131949582-132068549:+	0.24	3.81	0.000157	L-arginine levels	
KIRC	cis	1	rs3757135	chr6:26200707	HIST1H3E	chr6:26224427-26226589:+	0.43	5.38	1.13E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs3757369	chr6:88230960	C6orf164	chr6:88032306-88109459:+	0.29	3.52	0.000478	Obesity-related traits	
KIRC	cis	1	rs3758253	chr9:100700654	C9orf156	chr9:100666772-100684852:-	-0.3	-6.71	5.13E-11	Quantitative traits	
KIRC	cis	1	rs3758254	chr9:100701001	C9orf156	chr9:100666772-100684852:-	-0.3	-6.71	5.13E-11	Quantitative traits	
KIRC	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.25	5.91	6.39E-9	Bone properties (heel)	
KIRC	cis	1	rs3760982	chr19:44286513	ZNF155	chr19:44488355-44502477:+	-0.25	-5.38	1.12E-7	Breast cancer	
KIRC	cis	1	rs3760982	chr19:44286513	ZNF404	chr19:44376516-44384288:-	-0.32	-6.54	1.56E-10	Breast cancer	
KIRC	cis	1	rs3760983	chr19:44286660	ZNF155	chr19:44488355-44502477:+	0.25	5.25	2.23E-7	Breast cancer	
KIRC	cis	1	rs3760983	chr19:44286660	ZNF404	chr19:44376516-44384288:-	0.31	6.43	2.96E-10	Breast cancer	
KIRC	cis	1	rs3761117	chr20:25388070	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs3761117	chr20:25388070	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs3761218	chr20:3776175	CDC25B	chr20:3767578-3786759:+	-0.15	-3.58	0.000372	Bipolar disorder	
KIRC	cis	1	rs3761219	chr20:3776368	CDC25B	chr20:3767578-3786759:+	0.17	3.94	9.32E-5	Bipolar disorder	
KIRC	cis	1	rs3761454	chr22:39066820	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.43	12.45	3.23E-31	Type 1 diabetes autoantibodies	
KIRC	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.16	-5.44	8.49E-8	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3763947	chr11:22835069	SVIP	chr11:22843600-22851382:-	-0.25	-4.17	3.54E-5	Dialysis-related mortality	
KIRC	cis	1	rs3764419	chr17:29164023	SUZ12P	chr17:29035714-29097067:+	-0.11	-4.18	3.39E-5	Height	
KIRC	cis	1	rs3764540	chr19:52380681	ZNF577	chr19:52359056-52394145:-	-0.35	-5.84	9.47E-9	Breast cancer	
KIRC	cis	1	rs3764540	chr19:52380681	ZNF649	chr19:52392489-52408247:-	-0.32	-5.99	3.96E-9	Breast cancer	
KIRC	cis	1	rs3764796	chr8:17157677	FGF20	chr8:16850334-16859674:-	0.29	3.72	0.000225	Calcium levels	
KIRC	cis	1	rs376551	chr6:167384923	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs376574	chr6:167389956	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs3767633	chr1:161826615	FCGR2C	chr1:161551129-161570031:+	-0.2	-3.53	0.00045	IgG glycosylation	
KIRC	cis	1	rs3768707	chr2:215645135	BARD1	chr2:215593275-215674428:-	-0.18	-4.92	1.15E-6	Neuroblastoma	
KIRC	cis	1	rs3769143	chr2:27450724	C2orf28	chr2:27434899-27440044:+	-0.16	-4.73	2.92E-6	Blood metabolite levels	
KIRC	cis	1	rs3769439	chr2:201319021	SPATS2L	chr2:201170604-201346982:+	-0.15	-3.49	0.000522	Urinary albumin-to-creatinine ratio in non-diabetics	
KIRC	cis	1	rs3769693	chr2:99259346	UNC50	chr2:99225042-99234975:+	-0.26	-4.43	1.18E-5	Bipolar disorder	
KIRC	cis	1	rs3769694	chr2:99259239	UNC50	chr2:99225042-99234975:+	-0.27	-4.57	6.22E-6	Bipolar disorder	
KIRC	cis	1	rs3769696	chr2:99258927	UNC50	chr2:99225042-99234975:+	-0.27	-4.69	3.54E-6	Bipolar disorder	
KIRC	cis	1	rs3769697	chr2:99242580	UNC50	chr2:99225042-99234975:+	-0.26	-4.47	9.61E-6	Bipolar disorder	
KIRC	cis	1	rs3770752	chr2:37576136	CEBPZ	chr2:37428778-37458740:-	0.19	4.79	2.22E-6	Schizophrenia	
KIRC	cis	1	rs3771175	chr2:102960210	IL1RL1	chr2:102927962-102968497:+	-0.43	-7.45	4.22E-13	Asthma	
KIRC	cis	1	rs3771180	chr2:102953617	IL18R1	chr2:102927962-103015215:+	0.2	3.51	0.000494	Asthma	
KIRC	cis	1	rs3771180	chr2:102953617	IL1RL1	chr2:102927962-102968497:+	0.44	7.54	2.15E-13	Asthma	
KIRC	cis	1	rs3771531	chr2:70164034	ANXA4	chr2:69969127-70053594:+	-0.21	-5.18	3.21E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.36	6.85	2.21E-11	Cognitive performance	
KIRC	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.36	6.93	1.32E-11	Cognitive performance	
KIRC	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.75	10.09	6.65E-22	Diastolic blood pressure	
KIRC	cis	1	rs3774808	chr3:48481647	SHISA5	chr3:48509197-48542228:-	-0.13	-3.66	0.000276	Longevity	
KIRC	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.33	-9.31	3.92E-19	Longevity	
KIRC	cis	1	rs3777113	chr5:137493897	CDC25C	chr5:137620959-137674044:-	-0.2	-5.74	1.65E-8	Resting heart rate	
KIRC	cis	1	rs3778483	chr6:46627100	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.67	3.93E-6	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs3778483	chr6:46627100	TDRD6	chr6:46655866-46670149:+	0.15	3.5	0.000515	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs3778909	chr7:66255646	LOC493754	chr7:65993446-66057363:-	-0.18	-3.98	7.91E-5	Aortic root size	
KIRC	cis	1	rs3780480	chr9:33163486	B4GALT1	chr9:33110639-33167356:-	-0.24	-4.21	2.97E-5	IgG glycosylation	
KIRC	cis	1	rs3780486	chr9:33139453	B4GALT1	chr9:33110639-33167356:-	-0.25	-4.59	5.69E-6	IgG glycosylation	
KIRC	cis	1	rs3780849	chr10:29804245	LOC387647	chr10:29698483-29776785:+	0.22	4.03	6.33E-5	Platelet thrombus formation	
KIRC	cis	1	rs3781001	chr10:127706028	UROS	chr10:127477148-127511837:-	-0.18	-4.51	8.08E-6	Visceral fat	
KIRC	cis	1	rs3781913	chr11:72373496	STARD10	chr11:72465775-72504750:-	0.15	3.69	0.000247	Rheumatoid arthritis	
KIRC	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.31	6.68	6.55E-11	Multiple sclerosis	
KIRC	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.48	-12.73	2.32E-32	Multiple sclerosis	
KIRC	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.43	3.0E-10	Multiple sclerosis	
KIRC	cis	1	rs3782894	chr12:110026024	MYO1H	chr12:109826524-109886176:+	0.29	6.04	3.09E-9	HDL cholesterol	
KIRC	cis	1	rs3783512	chr2:113547809	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.92	0.0001	Endometriosis	
KIRC	cis	1	rs3783512	chr2:113547809	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.45	1.04E-5	Endometriosis	
KIRC	cis	1	rs3783513	chr2:113547470	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.92	0.0001	Endometriosis	
KIRC	cis	1	rs3783513	chr2:113547470	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.45	1.04E-5	Endometriosis	
KIRC	cis	1	rs3783521	chr2:113543577	DDX11L2	chr2:114356606-114359153:-	-0.23	-3.76	0.00019	Endometriosis	
KIRC	cis	1	rs3783521	chr2:113543577	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.43	1.17E-5	Endometriosis	
KIRC	cis	1	rs3783525	chr2:113541819	DDX11L2	chr2:114356606-114359153:-	-0.23	-3.83	0.000142	Endometriosis	
KIRC	cis	1	rs3783525	chr2:113541819	RPL23AP7	chr2:114368816-114384715:-	-0.24	-4.28	2.24E-5	Endometriosis	
KIRC	cis	1	rs3783526	chr2:113541807	DDX11L2	chr2:114356606-114359153:-	0.23	3.76	0.00019	Endometriosis	
KIRC	cis	1	rs3783526	chr2:113541807	RPL23AP7	chr2:114368816-114384715:-	0.25	4.43	1.17E-5	Endometriosis	
KIRC	cis	1	rs3783533	chr2:113538779	DDX11L2	chr2:114356606-114359153:-	0.24	3.93	9.54E-5	Endometriosis	
KIRC	cis	1	rs3783533	chr2:113538779	RPL23AP7	chr2:114368816-114384715:-	0.25	4.43	1.18E-5	Endometriosis	
KIRC	cis	1	rs3783546	chr2:113534830	DDX11L2	chr2:114356606-114359153:-	0.23	3.8	0.000164	Endometriosis	
KIRC	cis	1	rs3783546	chr2:113534830	RPL23AP7	chr2:114368816-114384715:-	0.25	4.47	9.62E-6	Endometriosis	
KIRC	cis	1	rs3783550	chr2:113532885	DDX11L2	chr2:114356606-114359153:-	-0.23	-3.8	0.000166	Endometriosis	
KIRC	cis	1	rs3783550	chr2:113532885	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.49	8.99E-6	Endometriosis	
KIRC	cis	1	rs3784130	chr14:68962224	PLEKHH1	chr14:68000008-68056255:+	-0.14	-3.57	0.000397	Breast cancer	
KIRC	cis	1	rs3785162	chr16:55603226	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.24	2.67E-5	Thyroid hormone levels	
KIRC	cis	1	rs3786835	chr19:39155880	CAPN12	chr19:39220832-39235114:-	-0.14	-4.17	3.6E-5	Heart rate	
KIRC	cis	1	rs3786839	chr19:39182565	CAPN12	chr19:39220832-39235114:-	-0.13	-4	7.3E-5	Heart rate	
KIRC	cis	1	rs3786845	chr19:39195083	CAPN12	chr19:39220832-39235114:-	-0.15	-4.61	5.02E-6	Heart rate	
KIRC	cis	1	rs3786848	chr19:39207329	CAPN12	chr19:39220832-39235114:-	-0.14	-4.42	1.21E-5	Heart rate	
KIRC	cis	1	rs3786851	chr19:39215333	CAPN12	chr19:39220832-39235114:-	-0.14	-4.43	1.16E-5	Heart rate	
KIRC	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.25	5.91	6.44E-9	Bone properties (heel)	
KIRC	cis	1	rs3787395	chr20:55078573	C20orf43	chr20:55043647-55093942:+	-0.2	-4.64	4.46E-6	Refractive astigmatism	
KIRC	cis	1	rs3787499	chr20:23616807	CST3	chr20:23608536-23618574:-	-0.13	-3.54	0.000429	Chronic kidney disease	
KIRC	cis	1	rs3788332	chr22:22171567	MAPK1	chr22:22113949-22221970:-	0.2	5.81	1.14E-8	Multiple sclerosis	
KIRC	cis	1	rs3788544	chr22:39064966	LOC646851	chr22:38974125-39052634:-	0.14	4.21	2.98E-5	Resting heart rate	
KIRC	cis	1	rs3788545	chr22:39065172	LOC646851	chr22:38974125-39052634:-	0.12	3.76	0.00019	Resting heart rate	
KIRC	cis	1	rs3789045	chr1:204586812	MFSD4	chr1:205538112-205572045:+	0.21	3.54	0.000432	Educational attainment (college completion)	
KIRC	cis	1	rs3789364	chr1:180951043	MR1	chr1:181003139-181024633:+	-0.13	-3.64	0.000298	Progressive supranuclear palsy	
KIRC	cis	1	rs3789967	chr12:124447339	CCDC92	chr12:124420955-124457163:-	0.2	5.19	3.02E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs3789967	chr12:124447339	DNAH10	chr12:124247042-124420265:+	0.19	3.86	0.000127	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs3790515	chr1:151786372	PI4KB	chr1:151264413-151300133:-	0.3	3.81	0.000156	Depressive symptoms (SSRI exposure interaction)	
KIRC	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.29	-5.97	4.57E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.29	-5.97	4.57E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.28	-5.76	1.43E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.27	-5.58	3.84E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.16	4.31	1.92E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs3792528	chr3:38493303	XYLB	chr3:38388251-38456467:+	0.16	4.3	2.06E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs3793079	chr6:33767788	LEMD2	chr6:33738991-33756906:-	-0.14	-3.53	0.000461	Crohn's disease	
KIRC	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.14	5	7.97E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.13	-4.53	7.41E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.12	-4.28	2.2E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs3793938	chr11:71823133	C11orf59	chr11:71808339-71814322:-	0.23	4.03	6.36E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs3794742	chr17:76165548	SYNGR2	chr17:76164671-76169009:+	-0.13	-3.78	0.000175	Adenocarcinoma;Lung cancer	
KIRC	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.54	-8.39	4.99E-16	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs3796509	chr4:39110186	WDR19	chr4:39184024-39287429:+	0.18	4.62	4.8E-6	Uric acid levels	
KIRC	cis	1	rs3796511	chr4:39122206	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs3796619	chr4:1095281	C4orf48	chr4:2043689-2045697:+	-0.14	-3.55	0.000422	Recombination rate (males)	
KIRC	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.63	-13.37	4.13E-35	Kawasaki disease	
KIRC	cis	1	rs3796990	chr4:108936970	HADH	chr4:108910940-108956330:+	0.25	3.6	0.000353	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs3796991	chr4:108937461	HADH	chr4:108910940-108956330:+	-0.26	-3.57	0.000391	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs3796992	chr4:108945631	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs3797537	chr5:78322650	ARSB	chr5:78073039-78282357:-	-0.2	-4.19	3.31E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs3797537	chr5:78322650	BHMT	chr5:78407604-78428112:+	-0.26	-5.43	8.94E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs3797538	chr5:78322671	ARSB	chr5:78073039-78282357:-	-0.2	-4.19	3.31E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs3797538	chr5:78322671	BHMT	chr5:78407604-78428112:+	-0.26	-5.43	8.94E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs3800457	chr6:34663598	UHRF1BP1	chr6:34759794-34853117:+	-0.32	-6.85	2.17E-11	Pubertal anthropometrics	
KIRC	cis	1	rs3800812	chr7:66223461	LOC493754	chr7:65993446-66057363:-	-0.17	-3.83	0.000146	Aortic root size	
KIRC	cis	1	rs3802999	chr12:124414098	CCDC92	chr12:124420955-124457163:-	0.19	4.87	1.51E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs3803403	chr15:85383145	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.87	1.49E-6	Schizophrenia	
KIRC	cis	1	rs3803403	chr15:85383145	LOC388152	chr15:84867600-84898920:-	-0.19	-3.57	0.000397	Schizophrenia	
KIRC	cis	1	rs3803405	chr15:85383640	GOLGA6L5	chr15:85047738-85060078:-	-0.18	-4.83	1.85E-6	Schizophrenia	
KIRC	cis	1	rs3803405	chr15:85383640	LOC388152	chr15:84867600-84898920:-	-0.19	-3.6	0.000353	Schizophrenia	
KIRC	cis	1	rs3803459	chr15:56387859	TEX9	chr15:56657644-56738071:+	-0.28	-4.81	2.01E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs3803538	chr15:90891771	IQGAP1	chr15:90931473-91045475:+	0.14	3.94	9.49E-5	Rheumatoid arthritis	
KIRC	cis	1	rs3803538	chr15:90891771	TTLL13	chr15:90792764-90815443:+	0.26	4.48	9.13E-6	Rheumatoid arthritis	
KIRC	cis	1	rs3803539	chr15:90891982	IQGAP1	chr15:90931473-91045475:+	0.16	4.18	3.41E-5	Rheumatoid arthritis	
KIRC	cis	1	rs3803539	chr15:90891982	TTLL13	chr15:90792764-90815443:+	0.25	4.08	5.26E-5	Rheumatoid arthritis	
KIRC	cis	1	rs3805152	chr4:56359658	SRD5A3	chr4:56212409-56237866:+	0.21	4.44	1.13E-5	Personality dimensions	
KIRC	cis	1	rs3805152	chr4:56359658	TMEM165	chr4:56262090-56292342:+	-0.22	-5.9	6.57E-9	Personality dimensions	
KIRC	cis	1	rs3805154	chr4:56363927	SRD5A3	chr4:56212409-56237866:+	0.18	3.91	0.000106	Personality dimensions	
KIRC	cis	1	rs3805154	chr4:56363927	TMEM165	chr4:56262090-56292342:+	-0.23	-6.26	8.03E-10	Personality dimensions	
KIRC	cis	1	rs3805157	chr4:56364103	SRD5A3	chr4:56212409-56237866:+	0.18	4.01	7.09E-5	Personality dimensions	
KIRC	cis	1	rs3805157	chr4:56364103	TMEM165	chr4:56262090-56292342:+	-0.23	-6.46	2.47E-10	Personality dimensions	
KIRC	cis	1	rs3806108	chr6:33767579	LEMD2	chr6:33738991-33756906:-	-0.14	-3.53	0.000456	Crohn's disease	
KIRC	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.34	7.52	2.47E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806407	chr1:156251742	CCT3	chr1:156278752-156308195:-	-0.19	-4.8	2.13E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806408	chr1:156252137	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806409	chr1:156252291	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs3806417	chr1:156711623	TTC24	chr1:156552022-156556902:+	-0.15	-4.09	5.08E-5	HDL cholesterol	
KIRC	cis	1	rs3806692	chr3:53080987	RFT1	chr3:53122503-53164470:-	0.32	5.09	5.15E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs3806692	chr3:53080987	TMEM110	chr3:52867139-52931547:-	0.3	5.21	2.74E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.41	-10.07	7.68E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.24	8.29	1.05E-15	Folate pathway vitamin levels	
KIRC	cis	1	rs3808894	chr9:100686129	C9orf156	chr9:100666772-100684852:-	-0.29	-6.53	1.65E-10	Quantitative traits	
KIRC	cis	1	rs3809060	chr11:32458807	LOC283267	chr11:33097696-33100999:+	-0.18	-3.68	0.000255	Inguinal hernia	
KIRC	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.4	-10.18	3.06E-22	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs3809868	chr17:45750596	ITGB3	chr17:45331208-45421658:+	-0.17	-4.02	6.69E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs3809868	chr17:45750596	TBKBP1	chr17:45772630-45789427:+	0.16	4.01	6.94E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs3810174	chr19:41904165	ATP5SL	chr19:41937224-41945810:-	0.18	4.22	2.94E-5	Height	
KIRC	cis	1	rs3810175	chr19:41904396	ATP5SL	chr19:41937224-41945810:-	-0.16	-3.69	0.000245	Height	
KIRC	cis	1	rs3810429	chr19:18543270	SSBP4	chr19:18530221-18545371:+	-0.13	-4.56	6.58E-6	Breast cancer	
KIRC	cis	1	rs3810610	chr22:22115498	MAPK1	chr22:22113949-22221970:-	0.19	5.33	1.49E-7	Multiple sclerosis	
KIRC	cis	1	rs3812762	chr11:8751640	ST5	chr11:8714900-8932498:-	-0.17	-4.25	2.59E-5	Hypospadias	
KIRC	cis	1	rs3813227	chr2:73651967	TPRKB	chr2:73956957-73964517:-	0.2	5.31	1.67E-7	Metabolite levels	
KIRC	cis	1	rs3813347	chr6:133119778	VNN2	chr6:133065010-133084598:-	-0.25	-4.02	6.83E-5	Type 2 diabetes nephropathy	
KIRC	cis	1	rs3813948	chr1:207269858	C4BPA	chr1:207277511-207318308:+	0.28	3.63	0.000315	C4b binding protein levels	
KIRC	cis	1	rs3814184	chr10:69966251	ATOH7	chr10:69990386-69991855:-	-0.27	-4.27	2.31E-5	Optic nerve measurement (disc area)	
KIRC	cis	1	rs3814721	chr11:71709272	C11orf59	chr11:71808339-71814322:-	-0.22	-3.99	7.46E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs3814855	chr14:88933360	SPATA7	chr14:88852012-88904802:+	-0.21	-4.32	1.88E-5	Coronary artery calcification	
KIRC	cis	1	rs3814964	chr11:2999507	NAP1L4	chr11:2965661-3013607:-	0.21	4.85	1.68E-6	Calcium levels	
KIRC	cis	1	rs3815413	chr4:17654648	LAP3	chr4:17578927-17609590:+	-0.21	-6.42	3.16E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3815413	chr4:17654648	MED28	chr4:17616273-17629791:+	0.21	4.71	3.21E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3815414	chr4:17606659	LAP3	chr4:17578927-17609590:+	0.22	6.83	2.45E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3815414	chr4:17606659	MED28	chr4:17616273-17629791:+	-0.19	-4.31	1.96E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3815700	chr19:33093252	ANKRD27	chr19:33087907-33166102:-	0.32	4.97	9.2E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs3815700	chr19:33093252	RGS9BP	chr19:33166313-33169206:+	0.28	3.75	0.000196	Eosinophilic esophagitis	
KIRC	cis	1	rs3816037	chr19:41918009	ATP5SL	chr19:41937224-41945810:-	0.15	3.58	0.000375	Height	
KIRC	cis	1	rs3816063	chr8:142161064	DENND3	chr8:142138720-142205906:+	0.19	4.46	1.02E-5	Obesity-related traits	
KIRC	cis	1	rs381664	chr1:2088104	SLC35E2	chr1:1590990-1677431:-	0.16	3.53	0.000446	Height	
KIRC	cis	1	rs3816804	chr12:56680745	RPS26	chr12:56435686-56438005:+	0.42	4.13	4.31E-5	Height	
KIRC	cis	1	rs3816912	chr1:212399849	TMEM206	chr1:212537819-212588267:-	-0.2	-3.94	9.15E-5	Intelligence (childhood)	
KIRC	cis	1	rs3817181	chr17:61776538	FTSJ3	chr17:61896795-61905031:-	0.34	6.54	1.51E-10	Body mass index	
KIRC	cis	1	rs3817181	chr17:61776538	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.48	9.4E-6	Body mass index	
KIRC	cis	1	rs3818262	chr20:47741556	CSE1L	chr20:47662838-47713484:+	0.18	4.83	1.8E-6	Anger	
KIRC	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.42	-10.44	3.21E-23	Folate pathway vitamin levels	
KIRC	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.25	8.44	3.49E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs3823469	chr6:88214498	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs3824496	chr9:100684645	C9orf156	chr9:100666772-100684852:-	-0.29	-6.53	1.65E-10	Quantitative traits	
KIRC	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.3	-3.79	0.000169	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs3824755	chr10:104595849	SFXN2	chr10:104474298-104498946:+	-0.27	-3.6	0.000345	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs3825018	chr11:64358809	SLC22A12	chr11:64358282-64369820:+	-0.17	-4.71	3.25E-6	Urate levels in obese individuals	
KIRC	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.31	6.62	9.08E-11	Multiple sclerosis	
KIRC	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.51	-13.47	1.62E-35	Multiple sclerosis	
KIRC	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.3	-6.51	1.77E-10	Multiple sclerosis	
KIRC	cis	1	rs3825932	chr15:79235446	CTSH	chr15:79214092-79237420:-	0.37	8.4	4.59E-16	Type 1 diabetes	
KIRC	cis	1	rs3826061	chr16:88927221	TRAPPC2L	chr16:88922628-88927591:+	-0.18	-5.27	2.08E-7	Parkinson disease and lewy body pathology	
KIRC	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.78	18.73	9.8E-60	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs3827066	chr20:44586023	PLTP	chr20:44527397-44540786:-	0.26	6.02	3.36E-9	Abdominal aortic aneurysm	
KIRC	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.5	-8.1	4.23E-15	Abdominal aortic aneurysm	
KIRC	cis	1	rs3827107	chr20:55070539	C20orf43	chr20:55043647-55093942:+	0.2	4.78	2.35E-6	Refractive astigmatism	
KIRC	cis	1	rs3827142	chr20:23617007	CST3	chr20:23608536-23618574:-	-0.13	-3.54	0.000429	Chronic kidney disease	
KIRC	cis	1	rs3827143	chr20:23619617	CST3	chr20:23608536-23618574:-	-0.13	-3.6	0.000347	Chronic kidney disease	
KIRC	cis	1	rs3827357	chr22:39079413	LOC646851	chr22:38974125-39052634:-	0.13	3.97	8.22E-5	Resting heart rate	
KIRC	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.27	-5.43	8.58E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs3828496	chr4:48388292	OCIAD1	chr4:48833015-48863831:+	0.23	5.26	2.12E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs3829251	chr11:71194559	DHCR7	chr11:71145459-71159477:-	-0.29	-4.68	3.63E-6	Vitamin D levels	
KIRC	cis	1	rs383402	chr7:65586653	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.87	7.96E-9	Diabetic kidney disease	
KIRC	cis	1	rs383402	chr7:65586653	CRCP	chr7:65579805-65619551:+	0.24	3.52	0.000466	Diabetic kidney disease	
KIRC	cis	1	rs383402	chr7:65586653	LOC493754	chr7:65993446-66057363:-	-0.22	-3.66	0.00028	Diabetic kidney disease	
KIRC	cis	1	rs3843061	chr5:110160392	TMEM232	chr5:109624934-110062381:-	0.25	4.71	3.15E-6	Asthma and hay fever	
KIRC	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.6	14.09	3.25E-38	Height	
KIRC	cis	1	rs3846055	chr3:134203973	CEP63	chr3:134204575-134293852:+	0.3	5.78	1.31E-8	Height	
KIRC	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.59	14.17	1.44E-38	Height	
KIRC	cis	1	rs3846056	chr3:134227292	CEP63	chr3:134204575-134293852:+	0.33	6.51	1.82E-10	Height	
KIRC	cis	1	rs3846357	chr4:17635887	LAP3	chr4:17578927-17609590:+	-0.2	-6.24	9.17E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3846357	chr4:17635887	MED28	chr4:17616273-17629791:+	0.19	4.3	2.01E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.78	23.74	4.32E-84	Pulse pressure	
KIRC	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.31	-5.24	2.39E-7	Polycystic ovary syndrome	
KIRC	cis	1	rs3848129	chr15:50892064	SPPL2A	chr15:50999739-51057910:-	0.28	7.32	9.77E-13	QT interval	
KIRC	cis	1	rs3848130	chr15:50892111	SPPL2A	chr15:50999739-51057910:-	0.28	7.38	6.51E-13	QT interval	
KIRC	cis	1	rs3848562	chr19:52379835	ZNF577	chr19:52359056-52394145:-	0.29	5.43	8.86E-8	Breast cancer	
KIRC	cis	1	rs3848562	chr19:52379835	ZNF649	chr19:52392489-52408247:-	0.26	5.33	1.5E-7	Breast cancer	
KIRC	cis	1	rs3848588	chr19:12142285	ZNF763	chr19:12035900-12091196:+	-0.47	-5.84	9.6E-9	Multiple sclerosis	
KIRC	cis	1	rs3848767	chr20:13049532	SPTLC3	chr20:12989627-13147411:+	0.2	3.8	0.00016	Daytime sleep phenotypes	
KIRC	cis	1	rs385039	chr1:2077409	SLC35E2	chr1:1590990-1677431:-	-0.18	-3.89	0.000112	Height	
KIRC	cis	1	rs3850986	chr15:73091283	ADPGK	chr15:73043710-73076667:-	0.17	3.85	0.000133	Body mass index	
KIRC	cis	1	rs385113	chr6:167403971	RNASET2	chr6:167343008-167412795:-	-0.14	-3.58	0.00038	Crohn's disease	
KIRC	cis	1	rs3853750	chr5:110154309	TMEM232	chr5:109624934-110062381:-	0.28	5.39	1.09E-7	Asthma and hay fever	
KIRC	cis	1	rs3857422	chr5:150268609	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs3857610	chr6:56012458	COL21A1	chr6:55921389-56258892:-	-0.47	-7.19	2.33E-12	Psychosis (atypical)	
KIRC	cis	1	rs3857688	chr7:66127806	LOC493754	chr7:65993446-66057363:-	0.17	3.65	0.00029	Aortic root size	
KIRC	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.31	-5.27	1.98E-7	Polycystic ovary syndrome	
KIRC	cis	1	rs385863	chr6:167386615	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs3862791	chr11:72501002	C11orf51	chr11:71817424-71823822:-	-0.17	-3.55	0.00042	Type 2 diabetes	
KIRC	cis	1	rs386548	chr6:167385533	RNASET2	chr6:167343008-167412795:-	0.16	4.08	5.24E-5	Crohn's disease	
KIRC	cis	1	rs3866330	chr3:49582994	CCDC36	chr3:49235861-49295537:+	0.26	4.99	8.23E-7	Menarche (age at onset)	
KIRC	cis	1	rs3866330	chr3:49582994	NCKIPSD	chr3:48711280-48723334:-	0.22	4.39	1.37E-5	Menarche (age at onset)	
KIRC	cis	1	rs3866330	chr3:49582994	P4HTM	chr3:49027341-49044579:+	0.17	3.84	0.000139	Menarche (age at onset)	
KIRC	cis	1	rs3866330	chr3:49582994	WDR6	chr3:49044637-49053386:+	-0.21	-5.38	1.15E-7	Menarche (age at onset)	
KIRC	cis	1	rs3870339	chr3:49536863	CCDC36	chr3:49235861-49295537:+	0.26	4.98	8.8E-7	Menarche (age at onset)	
KIRC	cis	1	rs3870339	chr3:49536863	NCKIPSD	chr3:48711280-48723334:-	0.21	4.18	3.45E-5	Menarche (age at onset)	
KIRC	cis	1	rs3870339	chr3:49536863	P4HTM	chr3:49027341-49044579:+	0.18	4.04	6.17E-5	Menarche (age at onset)	
KIRC	cis	1	rs3870339	chr3:49536863	WDR6	chr3:49044637-49053386:+	-0.2	-5.23	2.43E-7	Menarche (age at onset)	
KIRC	cis	1	rs3870341	chr3:49584745	CCDC36	chr3:49235861-49295537:+	0.26	4.99	8.38E-7	Menarche (age at onset)	
KIRC	cis	1	rs3870341	chr3:49584745	NCKIPSD	chr3:48711280-48723334:-	0.22	4.4	1.32E-5	Menarche (age at onset)	
KIRC	cis	1	rs3870341	chr3:49584745	P4HTM	chr3:49027341-49044579:+	0.17	3.9	0.000109	Menarche (age at onset)	
KIRC	cis	1	rs3870341	chr3:49584745	WDR6	chr3:49044637-49053386:+	-0.21	-5.29	1.84E-7	Menarche (age at onset)	
KIRC	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.28	5.43	8.59E-8	Diabetic kidney disease	
KIRC	cis	1	rs387676	chr7:65598220	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.3	5.83	9.75E-9	Diabetic kidney disease	
KIRC	cis	1	rs3885839	chr7:65290403	CRCP	chr7:65579805-65619551:+	-0.32	-4.27	2.35E-5	Diabetic kidney disease	
KIRC	cis	1	rs3886589	chr11:71669487	C11orf59	chr11:71808339-71814322:-	-0.23	-4.08	5.33E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.44	7.61	1.34E-13	Red blood cell traits	
KIRC	cis	1	rs3892630	chr19:33181484	SLC7A9	chr19:33321421-33360683:-	-0.27	-6.17	1.4E-9	Red blood cell traits	
KIRC	cis	1	rs389946	chr6:167407268	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs389956	chr6:167407254	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs3900064	chr5:150264414	IRGM	chr5:150226085-150280295:+	-0.52	-7.31	1.06E-12	Crohn's disease	
KIRC	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.3	-4.11	4.58E-5	Crohn's disease	
KIRC	cis	1	rs3905330	chr3:49550774	CCDC36	chr3:49235861-49295537:+	0.27	5.22	2.67E-7	Menarche (age at onset)	
KIRC	cis	1	rs3905330	chr3:49550774	NCKIPSD	chr3:48711280-48723334:-	0.23	4.58	5.77E-6	Menarche (age at onset)	
KIRC	cis	1	rs3905330	chr3:49550774	P4HTM	chr3:49027341-49044579:+	0.18	4.23	2.8E-5	Menarche (age at onset)	
KIRC	cis	1	rs3905330	chr3:49550774	WDR6	chr3:49044637-49053386:+	-0.22	-5.66	2.5E-8	Menarche (age at onset)	
KIRC	cis	1	rs3906527	chr5:150266392	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs3906528	chr5:150266718	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.52	-8.73	3.72E-17	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs3931020	chr1:75235317	C1orf173	chr1:75033796-75139422:-	-0.35	-6.15	1.55E-9	Resistin levels	
KIRC	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.6	14.3	3.83E-39	Height	
KIRC	cis	1	rs3932818	chr3:134206069	CEP63	chr3:134204575-134293852:+	0.32	6.13	1.81E-9	Height	
KIRC	cis	1	rs3933453	chr4:17636319	LAP3	chr4:17578927-17609590:+	-0.2	-6.29	6.92E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3933453	chr4:17636319	MED28	chr4:17616273-17629791:+	0.23	5.29	1.81E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.7	-10.28	1.31E-22	Diastolic blood pressure	
KIRC	cis	1	rs3934135	chr15:84583799	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	9.02E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs3935543	chr17:79579874	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs3935543	chr17:79579874	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs393558	chr6:167397750	RNASET2	chr6:167343008-167412795:-	-0.14	-3.53	0.000447	Crohn's disease	
KIRC	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.43	-8.24	1.52E-15	Urinary metabolites	
KIRC	cis	1	rs393727	chr6:167398632	RNASET2	chr6:167343008-167412795:-	-0.14	-3.52	0.000478	Crohn's disease	
KIRC	cis	1	rs394522	chr6:167398071	RNASET2	chr6:167343008-167412795:-	-0.14	-3.53	0.000446	Crohn's disease	
KIRC	cis	1	rs3950155	chr6:55936254	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.63	-14.11	2.65E-38	Type 2 diabetes	
KIRC	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.32	-6.84	2.35E-11	Schizophrenia	
KIRC	cis	1	rs397119	chr20:25440187	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.94	1.21E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.29	-5.6	3.45E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs397713	chr6:167386714	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs398036	chr20:25439850	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.93	1.27E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.29	-5.65	2.68E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs3981131	chr7:65951677	LOC729156	chr7:66274980-66309813:-	0.17	3.65	0.000289	Aortic root size	
KIRC	cis	1	rs3981351	chr10:115515120	C10orf81	chr10:115511213-115543187:+	-0.21	-3.99	7.74E-5	Obesity-related traits	
KIRC	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.38	7.54	2.2E-13	Obesity-related traits	
KIRC	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.48	-11.72	3.23E-28	Inflammatory skin disease	
KIRC	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.51	8.44	3.34E-16	Inflammatory skin disease	
KIRC	cis	1	rs3999544	chr6:26285867	HIST1H3G	chr6:26271147-26271612:-	0.19	3.62	0.000327	Educational attainment	
KIRC	cis	1	rs400063	chr6:167386592	RNASET2	chr6:167343008-167412795:-	-0.14	-3.67	0.00027	Crohn's disease	
KIRC	cis	1	rs400176	chr6:167406238	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs400837	chr6:167411008	RNASET2	chr6:167343008-167412795:-	-0.16	-3.97	8.37E-5	Crohn's disease	
KIRC	cis	1	rs401166	chr20:25446308	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4013	chr4:103552813	MANBA	chr4:103552644-103682151:-	0.16	3.59	0.000365	Primary biliary cirrhosis	
KIRC	cis	1	rs401897	chr20:55029758	C20orf43	chr20:55043647-55093942:+	0.23	5.35	1.35E-7	Refractive astigmatism	
KIRC	cis	1	rs401897	chr20:55029758	CSTF1	chr20:54967427-54979582:+	0.19	3.85	0.000132	Refractive astigmatism	
KIRC	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs402418	chr7:65509469	CRCP	chr7:65579805-65619551:+	-0.32	-4.33	1.78E-5	Diabetic kidney disease	
KIRC	cis	1	rs402749	chr6:167386104	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.25	6.65	7.86E-11	Blood metabolite levels	
KIRC	cis	1	rs404394	chr20:25447896	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs405553	chr6:167395058	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs406095	chr6:167409087	RNASET2	chr6:167343008-167412795:-	-0.16	-3.97	8.37E-5	Crohn's disease	
KIRC	cis	1	rs4061660	chr17:2004377	SRR	chr17:2207248-2228553:+	0.36	5.29	1.81E-7	Body mass index	
KIRC	cis	1	rs406900	chr6:88085447	C6orf162	chr6:88032306-88052043:+	-0.19	-4.07	5.38E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs406900	chr6:88085447	C6orf164	chr6:88032306-88109459:+	-0.17	-4.09	5.07E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.47	8.94	7.48E-18	Body mass index	
KIRC	cis	1	rs4073846	chr1:46462881	MUTYH	chr1:45794915-45806142:-	-0.14	-4.04	6.15E-5	Body mass index	
KIRC	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4074915	chr17:79579230	ARL16	chr17:79648234-79650954:-	0.18	4.57	6.28E-6	Eye color traits	
KIRC	cis	1	rs4074915	chr17:79579230	NPLOC4	chr17:79523915-79604138:-	0.12	3.68	0.000258	Eye color traits	
KIRC	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.63	-14.84	1.41E-41	Eye color traits	
KIRC	cis	1	rs4074916	chr17:79579248	ARL16	chr17:79648234-79650954:-	0.18	4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs4074916	chr17:79579248	NPLOC4	chr17:79523915-79604138:-	0.12	3.71	0.000234	Eye color traits	
KIRC	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.63	-14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs407515	chr6:167407544	RNASET2	chr6:167343008-167412795:-	-0.16	-3.92	0.000102	Crohn's disease	
KIRC	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.83	1.8E-17	Body mass index	
KIRC	cis	1	rs4076006	chr1:46438076	MUTYH	chr1:45794915-45806142:-	0.15	4.35	1.68E-5	Body mass index	
KIRC	cis	1	rs4076318	chr4:75701081	BTC	chr4:75671448-75719882:-	0.32	4.41	1.29E-5	Electroencephalogram traits	
KIRC	cis	1	rs4077463	chr2:161166234	PLA2R1	chr2:160798012-160919121:-	0.2	3.82	0.000152	Type 2 diabetes	
KIRC	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.28	4.81	1.95E-6	Cystic fibrosis-related diabetes	
KIRC	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.27	4.66	4.07E-6	Cystic fibrosis-related diabetes	
KIRC	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.3	-4.65	4.21E-6	Urate levels in lean individuals	
KIRC	cis	1	rs4078387	chr16:69814047	COG4	chr16:70514473-70557457:-	-0.2	-3.62	0.00032	IgE levels	
KIRC	cis	1	rs408040	chr6:167398903	RNASET2	chr6:167343008-167412795:-	-0.14	-3.53	0.000447	Crohn's disease	
KIRC	cis	1	rs408080	chr6:167392522	RNASET2	chr6:167343008-167412795:-	-0.14	-3.51	0.000493	Crohn's disease	
KIRC	cis	1	rs4083914	chr6:153427706	MTRF1L	chr6:153308401-153323925:-	-0.19	-3.85	0.000136	Prostate cancer	
KIRC	cis	1	rs409035	chr20:5943649	MCM8	chr20:5931298-5975829:+	-0.3	-7.49	3.18E-13	HIV-1 viral setpoint	
KIRC	cis	1	rs409356	chr6:167405226	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs4099209	chr5:110162262	TMEM232	chr5:109624934-110062381:-	0.22	4.25	2.53E-5	Asthma and hay fever	
KIRC	cis	1	rs410128	chr7:65603173	CCT6P1	chr7:65216092-65228661:+	0.27	5.13	4.07E-7	Diabetic kidney disease	
KIRC	cis	1	rs410128	chr7:65603173	CRCP	chr7:65579805-65619551:+	-0.32	-4.23	2.79E-5	Diabetic kidney disease	
KIRC	cis	1	rs412050	chr22:22307519	MAPK1	chr22:22113949-22221970:-	0.18	4.43	1.18E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs4121395	chr11:71669242	C11orf59	chr11:71808339-71814322:-	-0.23	-4.08	5.33E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs412177	chr6:101117899	GRIK2	chr6:101846905-102517957:+	0.52	5.42	9.33E-8	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs41258374	chr6:160182265	PNLDC1	chr6:160221301-160241735:+	0.45	3.59	0.000362	Iron status biomarkers	
KIRC	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.43	5.46	7.69E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.93	-9.86	4.28E-21	Schizophrenia	
KIRC	cis	1	rs41266959	chr2:242275579	ANO7	chr2:242127924-242164791:+	0.29	3.95	8.77E-5	Prostate cancer	
KIRC	cis	1	rs41269844	chr6:161085026	PLG	chr6:161123274-161174345:+	0.3	4.05	5.94E-5	Triglycerides	
KIRC	cis	1	rs41269878	chr6:161070455	PLG	chr6:161123274-161174345:+	0.28	3.94	9.15E-5	Triglycerides	
KIRC	cis	1	rs41271844	chr6:55988932	COL21A1	chr6:55921389-56258892:-	-0.47	-7.4	5.64E-13	Psychosis (atypical)	
KIRC	cis	1	rs41274152	chr7:128399231	OPN1SW	chr7:128412545-128415844:-	0.24	4.15	3.9E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs41280035	chr22:38054038	LGALS1	chr22:38071613-38075807:+	-0.12	-3.66	0.000277	Fat distribution (HIV)	
KIRC	cis	1	rs4128206	chr11:78015952	NARS2	chr11:78147017-78285909:-	-0.17	-3.75	0.000197	Testicular germ cell tumor	
KIRC	cis	1	rs41294396	chr11:64078581	C11orf20	chr11:64067863-64072238:+	-0.36	-5.48	6.66E-8	Mean platelet volume	
KIRC	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.44	7.32	1.01E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs41299637	chr1:200877850	KIF21B	chr1:200938520-200992828:-	0.13	4	7.17E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs41303629	chr1:27057621	PIGV	chr1:27114455-27124886:+	-0.39	-4.32	1.87E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs4130590	chr9:130107964	RPL12	chr9:130209955-130213684:-	-0.14	-3.98	8.04E-5	Bipolar disorder	
KIRC	cis	1	rs41307935	chr1:27181067	PIGV	chr1:27114455-27124886:+	-0.41	-4.88	1.46E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs413232	chr6:167400972	RNASET2	chr6:167343008-167412795:-	-0.14	-3.58	0.00038	Crohn's disease	
KIRC	cis	1	rs41337846	chr17:17139232	NT5M	chr17:17206680-17250975:+	0.21	3.53	0.000449	IgG glycosylation	
KIRC	cis	1	rs4134379	chr11:77992588	NARS2	chr11:78147017-78285909:-	-0.16	-3.74	0.000204	Testicular germ cell tumor	
KIRC	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs4134386	chr1:46395089	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs41363748	chr12:56696056	COQ10A	chr12:56660642-56664748:+	0.32	3.61	0.000339	Psoriasis vulgaris	
KIRC	cis	1	rs41363748	chr12:56696056	RPS26	chr12:56435686-56438005:+	0.42	3.88	0.000118	Psoriasis vulgaris	
KIRC	cis	1	rs41392645	chr12:56696742	RPS26	chr12:56435686-56438005:+	-0.55	-4.88	1.45E-6	Psoriasis vulgaris	
KIRC	cis	1	rs414013	chr6:88085866	C6orf162	chr6:88032306-88052043:+	-0.19	-4.07	5.38E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs414013	chr6:88085866	C6orf164	chr6:88032306-88109459:+	-0.17	-4.09	5.07E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.78	23.44	1.21E-82	Pulse pressure	
KIRC	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.78	23.91	6.21E-85	Pulse pressure	
KIRC	cis	1	rs41423244	chr12:56693520	RPS26	chr12:56435686-56438005:+	0.52	4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs4142481	chr15:56392275	TEX9	chr15:56657644-56738071:+	-0.27	-4.58	5.78E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4144081	chr2:70155482	ANXA4	chr2:69969127-70053594:+	-0.21	-5.17	3.38E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs4144937	chr6:46628516	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.69	3.52E-6	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs4144937	chr6:46628516	TDRD6	chr6:46655866-46670149:+	0.15	3.52	0.000477	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs4145008	chr7:65647511	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs4145008	chr7:65647511	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.16	4.25	2.55E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.17	4.3	2.08E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs4147929	chr19:1063443	ABCA7	chr19:1040102-1065568:+	-0.15	-3.91	0.000106	Alzheimer's disease (late onset)	
KIRC	cis	1	rs4148005	chr17:66882466	ABCA8	chr17:66863433-66951533:-	-0.18	-3.59	0.00036	HDL cholesterol	
KIRC	cis	1	rs4148008	chr17:66875294	ABCA8	chr17:66863433-66951533:-	-0.19	-3.89	0.000113	HDL cholesterol	
KIRC	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.27	5.38	1.13E-7	Diabetic kidney disease	
KIRC	cis	1	rs4149468	chr7:65825690	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.01E-5	Diabetic kidney disease	
KIRC	cis	1	rs4149547	chr2:240933308	NDUFA10	chr2:240900158-240964798:-	0.22	4.72	3.09E-6	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs4149551	chr2:240921463	NDUFA10	chr2:240900158-240964798:-	0.2	4.29	2.15E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs4149556	chr2:240915307	NDUFA10	chr2:240900158-240964798:-	0.2	4.35	1.64E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.33	7.35	7.86E-13	Pancreatic cancer	
KIRC	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.33	7.2	2.18E-12	Pancreatic cancer	
KIRC	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.35	7.69	8.1E-14	Pancreatic cancer	
KIRC	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.33	7.33	9.01E-13	Pancreatic cancer	
KIRC	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.33	7.28	1.32E-12	Pancreatic cancer	
KIRC	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.35	-7.57	1.8E-13	Pancreatic cancer	
KIRC	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.35	7.86	2.33E-14	Pancreatic cancer	
KIRC	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.34	7.54	2.19E-13	Pancreatic cancer	
KIRC	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.34	-7.55	2.1E-13	Pancreatic cancer	
KIRC	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.35	7.74	5.64E-14	Pancreatic cancer	
KIRC	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.34	7.56	1.96E-13	Pancreatic cancer	
KIRC	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.33	7.44	4.29E-13	Pancreatic cancer	
KIRC	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.33	7.44	4.29E-13	Pancreatic cancer	
KIRC	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.33	-7.3	1.13E-12	Pancreatic cancer	
KIRC	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.35	7.72	6.21E-14	Pancreatic cancer	
KIRC	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.33	7.44	4.3E-13	Pancreatic cancer	
KIRC	cis	1	rs415842	chr6:167406681	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs416131	chr6:167406544	RNASET2	chr6:167343008-167412795:-	0.16	4.1	4.88E-5	Crohn's disease	
KIRC	cis	1	rs416451	chr5:75922072	F2RL2	chr5:75911308-75919240:-	-0.34	-6.57	1.29E-10	Hearing impairment	
KIRC	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs419603	chr7:65597341	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.26	-6.52	1.76E-10	Bipolar disorder	
KIRC	cis	1	rs420259	chr16:23634026	PALB2	chr16:23614483-23652678:-	0.17	3.95	9.0E-5	Bipolar disorder	
KIRC	cis	1	rs421214	chr6:167396629	RNASET2	chr6:167343008-167412795:-	-0.15	-3.7	0.000243	Crohn's disease	
KIRC	cis	1	rs421992	chr1:2077260	SLC35E2	chr1:1590990-1677431:-	0.17	3.81	0.000158	Height	
KIRC	cis	1	rs422094	chr6:167397033	RNASET2	chr6:167343008-167412795:-	-0.14	-3.59	0.000361	Crohn's disease	
KIRC	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.28	5.48	6.91E-8	Diabetic kidney disease	
KIRC	cis	1	rs422164	chr7:65586605	CRCP	chr7:65579805-65619551:+	-0.31	-4.31	1.97E-5	Diabetic kidney disease	
KIRC	cis	1	rs422424	chr20:25445446	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs422562	chr6:167406318	RNASET2	chr6:167343008-167412795:-	-0.16	-3.99	7.71E-5	Crohn's disease	
KIRC	cis	1	rs422694	chr6:167406074	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs422780	chr6:167406209	RNASET2	chr6:167343008-167412795:-	-0.14	-3.63	0.000317	Crohn's disease	
KIRC	cis	1	rs422844	chr20:25445591	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.44E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.29	-5.64	2.9E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs423258	chr5:137475787	CDC25C	chr5:137620959-137674044:-	-0.22	-5.98	4.32E-9	Resting heart rate	
KIRC	cis	1	rs4235388	chr4:17682030	LAP3	chr4:17578927-17609590:+	-0.21	-6.57	1.24E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4235388	chr4:17682030	MED28	chr4:17616273-17629791:+	0.16	3.5	0.000498	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.54	12.3	1.47E-30	Forced vital capacity	
KIRC	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4240588	chr6:101158950	GRIK2	chr6:101846905-102517957:+	-0.54	-5.76	1.43E-8	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs4241407	chr3:49600319	CCDC36	chr3:49235861-49295537:+	0.28	5.62	3.09E-8	Menarche (age at onset)	
KIRC	cis	1	rs4241407	chr3:49600319	NCKIPSD	chr3:48711280-48723334:-	0.22	4.47	9.84E-6	Menarche (age at onset)	
KIRC	cis	1	rs4241407	chr3:49600319	P4HTM	chr3:49027341-49044579:+	0.18	4.19	3.36E-5	Menarche (age at onset)	
KIRC	cis	1	rs4241407	chr3:49600319	WDR6	chr3:49044637-49053386:+	-0.22	-5.75	1.57E-8	Menarche (age at onset)	
KIRC	cis	1	rs4242434	chr8:22501830	C8orf58	chr8:22457122-22461660:+	0.21	4.82	1.91E-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	
KIRC	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.14	-4.98	8.97E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4245180	chr11:118144512	MPZL2	chr11:118124135-118135009:-	-0.15	-3.66	0.000282	Pain	
KIRC	cis	1	rs4245459	chr11:78065959	NARS2	chr11:78147017-78285909:-	-0.2	-4.45	1.05E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4245923	chr4:108939337	HADH	chr4:108910940-108956330:+	-0.26	-3.61	0.000341	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4245924	chr4:108946378	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000239	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4246215	chr11:61564299	C11orf10	chr11:61556603-61560085:-	0.13	3.65	0.000289	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
KIRC	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	0.46	8.48	2.58E-16	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
KIRC	cis	1	rs425105	chr19:47208481	FKRP	chr19:47249303-47261832:+	0.37	7.13	3.43E-12	Type 1 diabetes	
KIRC	cis	1	rs425105	chr19:47208481	PRKD2	chr19:47177574-47220384:-	0.25	5.19	3.12E-7	Type 1 diabetes	
KIRC	cis	1	rs425277	chr1:2069172	SLC35E2	chr1:1590990-1677431:-	0.16	3.51	0.000494	Height	
KIRC	cis	1	rs4253766	chr22:46623905	PKDREJ	chr22:46651561-46659219:-	-0.39	-5.2	2.93E-7	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs4253772	chr22:46627603	PKDREJ	chr22:46651561-46659219:-	-0.33	-4.12	4.5E-5	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.33	-5.12	4.45E-7	Urate levels in lean individuals	
KIRC	cis	1	rs4260737	chr6:163137746	PACRG	chr6:163148164-163736523:+	0.58	6.74	4.33E-11	Body mass index	
KIRC	cis	1	rs4261185	chr10:29803931	LOC387647	chr10:29698483-29776785:+	0.22	4.03	6.33E-5	Platelet thrombus formation	
KIRC	cis	1	rs4261510	chr15:90890606	IQGAP1	chr15:90931473-91045475:+	0.16	4.23	2.73E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4261510	chr15:90890606	TTLL13	chr15:90792764-90815443:+	0.26	4.05	6.02E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4261913	chr3:119546197	GSK3B	chr3:119540804-119813264:-	-0.14	-3.85	0.000134	HDL cholesterol	
KIRC	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.36	-6.44	2.74E-10	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs42648	chr7:89977760	GTPBP10	chr7:89969690-90016650:+	0.17	4.31	1.96E-5	Homocysteine levels	
KIRC	cis	1	rs42648	chr7:89977760	STEAP1	chr7:89783689-89794140:+	0.19	3.77	0.000179	Homocysteine levels	
KIRC	cis	1	rs42648	chr7:89977760	STEAP2	chr7:89796904-89866991:+	0.2	3.81	0.000155	Homocysteine levels	
KIRC	cis	1	rs42649	chr7:89977789	GTPBP10	chr7:89969690-90016650:+	0.17	4.28	2.21E-5	Homocysteine levels	
KIRC	cis	1	rs42649	chr7:89977789	STEAP1	chr7:89783689-89794140:+	0.19	3.66	0.000277	Homocysteine levels	
KIRC	cis	1	rs42649	chr7:89977789	STEAP2	chr7:89796904-89866991:+	0.2	3.69	0.000246	Homocysteine levels	
KIRC	cis	1	rs42656	chr7:89981636	GTPBP10	chr7:89969690-90016650:+	0.17	4.13	4.17E-5	Homocysteine levels	
KIRC	cis	1	rs42658	chr7:89981915	GTPBP10	chr7:89969690-90016650:+	0.17	4.16	3.8E-5	Homocysteine levels	
KIRC	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.43	10.31	9.76E-23	Folate pathway vitamin levels	
KIRC	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.25	-8.31	8.72E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs4268415	chr10:4983590	AKR1C1	chr10:4934796-5020157:+	-0.39	-4.95	9.93E-7	Height	
KIRC	cis	1	rs4268415	chr10:4983590	AKR1C2	chr10:4964715-5060207:-	0.45	5.17	3.39E-7	Height	
KIRC	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.29	5.8	1.19E-8	Diabetic kidney disease	
KIRC	cis	1	rs427044	chr7:65508545	CRCP	chr7:65579805-65619551:+	-0.31	-4.25	2.52E-5	Diabetic kidney disease	
KIRC	cis	1	rs4274254	chr12:81458128	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs4274254	chr12:81458128	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs427811	chr1:2075560	SLC35E2	chr1:1590990-1677431:-	0.18	3.84	0.000137	Height	
KIRC	cis	1	rs4278892	chr2:161158738	PLA2R1	chr2:160798012-160919121:-	0.2	3.56	0.000403	Type 2 diabetes	
KIRC	cis	1	rs4279493	chr7:66226620	LOC493754	chr7:65993446-66057363:-	-0.17	-3.83	0.000146	Aortic root size	
KIRC	cis	1	rs4280164	chr14:24771285	ADCY4	chr14:24787571-24804277:-	0.12	4.02	6.6E-5	Parent of origin effect on language impairment (paternal)	
KIRC	cis	1	rs4280918	chr5:110162078	TMEM232	chr5:109624934-110062381:-	0.22	4.25	2.53E-5	Asthma and hay fever	
KIRC	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.52	-10.66	4.52E-24	Longevity	
KIRC	cis	1	rs4283605	chr3:49678651	UBA7	chr3:49842639-49851391:-	0.15	4.04	6.3E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs4283834	chr5:115521463	COMMD10	chr5:115420727-115628978:+	0.33	3.84	0.000137	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs428445	chr20:55036547	C20orf43	chr20:55043647-55093942:+	-0.22	-5.18	3.22E-7	Refractive astigmatism	
KIRC	cis	1	rs4285028	chr3:121660664	IQCB1	chr3:121488610-121553926:-	-0.27	-4.96	9.72E-7	Multiple sclerosis	
KIRC	cis	1	rs4286716	chr5:115519697	COMMD10	chr5:115420727-115628978:+	-0.36	-3.9	0.00011	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs429083	chr6:167383972	RNASET2	chr6:167343008-167412795:-	-0.14	-3.64	0.0003	Crohn's disease	
KIRC	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.43	7.97	1.1E-14	Urinary metabolites	
KIRC	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.54	10.8	1.36E-24	Paget's disease	
KIRC	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.46	-7.37	7.02E-13	Paget's disease	
KIRC	cis	1	rs4295483	chr6:55965456	COL21A1	chr6:55921389-56258892:-	-0.47	-7.48	3.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs4295484	chr6:55965646	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs429657	chr15:65813764	DPP8	chr15:65737999-65810035:-	0.12	4.74	2.85E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs4298408	chr7:3358731	SDK1	chr7:3341080-4308629:+	0.2	3.86	0.000127	Motion sickness	
KIRC	cis	1	rs430097	chr6:167405073	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs430293	chr6:167404958	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs430477	chr6:167389851	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs4304957	chr14:76647572	ESRRB	chr14:76837690-76968178:+	0.37	5.26	2.14E-7	Blood pressure	
KIRC	cis	1	rs4306571	chr17:40814207	NAGLU	chr17:40687951-40696464:+	0.33	3.66	0.000279	Systolic blood pressure change trajectories	
KIRC	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.6	14.62	1.34E-40	Height	
KIRC	cis	1	rs4309773	chr3:134277301	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.44E-11	Height	
KIRC	cis	1	rs4310508	chr10:65138573	NRBF2	chr10:64893007-64914785:+	-0.29	-7.08	5.01E-12	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.28	5.46	7.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs431076	chr7:65600320	CRCP	chr7:65579805-65619551:+	-0.33	-4.43	1.16E-5	Diabetic kidney disease	
KIRC	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.43	8.2	2.0E-15	Urinary metabolites	
KIRC	cis	1	rs4311997	chr10:124179299	ARMS2	chr10:124214179-124216867:+	-0.19	-3.58	0.000383	Height	
KIRC	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.29	5.78	1.35E-8	Diabetic kidney disease	
KIRC	cis	1	rs431318	chr7:65511597	CRCP	chr7:65579805-65619551:+	-0.32	-4.37	1.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs431328	chr19:22222236	ZNF208	chr19:22115760-22193745:-	0.28	4.8	2.15E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.42	7.69	8.06E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.85	17.28	8.02E-53	Type 2 diabetes	
KIRC	cis	1	rs4320797	chr1:99194426	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs4322591	chr14:75600697	MLH3	chr14:75480467-75518235:-	0.23	5.95	5.07E-9	Height	
KIRC	cis	1	rs4322591	chr14:75600697	NEK9	chr14:75548819-75593778:-	0.14	3.89	0.000115	Height	
KIRC	cis	1	rs4323442	chr8:96022986	C8orf38	chr8:95908040-96088396:+	-0.26	-4.06	5.8E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.5	-9.95	2.1E-21	Rheumatoid arthritis	
KIRC	cis	1	rs4323544	chr9:123647377	PSMD5	chr9:123578334-123605206:-	-0.35	-6.66	7.27E-11	Rheumatoid arthritis	
KIRC	cis	1	rs4325265	chr10:81733655	LOC219347	chr10:81805991-81838949:-	0.47	4.44	1.13E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4325265	chr10:81733655	LOC650623	chr10:81442731-81448648:+	-0.34	-3.9	0.000109	Rheumatoid arthritis	
KIRC	cis	1	rs4326865	chr12:81458579	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs4326865	chr12:81458579	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.25	8.96E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4331881	chr5:156944475	ADAM19	chr5:156822542-157002768:-	0.11	4.16	3.69E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs4332428	chr10:4965434	AKR1C1	chr10:4934796-5020157:+	-0.39	-5.07	5.52E-7	Height	
KIRC	cis	1	rs4332428	chr10:4965434	AKR1C2	chr10:4964715-5060207:-	0.54	6.54	1.56E-10	Height	
KIRC	cis	1	rs4333130	chr4:80949829	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.56	0.000409	Ankylosing spondylitis	
KIRC	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs4334685	chr3:134304335	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs4335481	chr10:81733840	LOC219347	chr10:81805991-81838949:-	0.47	4.44	1.13E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4335481	chr10:81733840	LOC650623	chr10:81442731-81448648:+	-0.34	-3.9	0.000109	Rheumatoid arthritis	
KIRC	cis	1	rs4335904	chr2:161171842	PLA2R1	chr2:160798012-160919121:-	0.2	3.76	0.000189	Type 2 diabetes	
KIRC	cis	1	rs433598	chr16:20680206	ACSM1	chr16:20634559-20709066:-	0.34	7.39	6.11E-13	Schizophrenia	
KIRC	cis	1	rs4336432	chr6:55946490	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs4338555	chr11:71755696	C11orf59	chr11:71808339-71814322:-	-0.23	-4.11	4.69E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4338740	chr15:49735297	DTWD1	chr15:49913226-49937332:+	-0.24	-4.89	1.34E-6	Thyroid volume	
KIRC	cis	1	rs4341440	chr10:4965293	AKR1C1	chr10:4934796-5020157:+	-0.39	-5.07	5.52E-7	Height	
KIRC	cis	1	rs4341440	chr10:4965293	AKR1C2	chr10:4964715-5060207:-	0.54	6.54	1.56E-10	Height	
KIRC	cis	1	rs4342423	chr6:33732679	LEMD2	chr6:33738991-33756906:-	-0.15	-3.68	0.00026	Crohn's disease	
KIRC	cis	1	rs4343996	chr7:3362642	SDK1	chr7:3341080-4308629:+	0.2	3.79	0.000167	Motion sickness	
KIRC	cis	1	rs4344684	chr15:63397318	LACTB	chr15:63414032-63434254:+	0.17	3.5	0.000501	HDL cholesterol	
KIRC	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.43	8.17	2.58E-15	Urinary metabolites	
KIRC	cis	1	rs4350617	chr17:28423088	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4351999	chr15:65992380	DPP8	chr15:65737999-65810035:-	-0.12	-4.73	2.9E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.35	7.74	5.64E-14	Pancreatic cancer	
KIRC	cis	1	rs4355335	chr4:80953476	ANTXR2	chr4:80822773-80994477:-	-0.14	-3.5	0.000507	Ankylosing spondylitis	
KIRC	cis	1	rs4356975	chr4:69972463	UGT2A3	chr4:69794177-69817509:-	0.28	7.05	5.97E-12	Obesity-related traits	
KIRC	cis	1	rs4356975	chr4:69972463	UGT2B11	chr4:70066053-70080449:-	0.68	14.39	1.42E-39	Obesity-related traits	
KIRC	cis	1	rs4356975	chr4:69972463	UGT2B7	chr4:69962193-69978704:+	0.25	5.22	2.68E-7	Obesity-related traits	
KIRC	cis	1	rs436039	chr19:22214873	ZNF208	chr19:22115760-22193745:-	0.3	4.96	9.61E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.44	7.9	1.83E-14	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs436045	chr1:2071556	SLC35E2	chr1:1590990-1677431:-	-0.17	-3.76	0.000192	Height	
KIRC	cis	1	rs4362735	chr3:58429893	PXK	chr3:58318617-58410878:+	0.22	4.31	1.99E-5	Cholesterol, total	
KIRC	cis	1	rs4363822	chr15:67992583	IQCH	chr15:67547188-67794139:+	0.18	3.7	0.000235	Motion sickness	
KIRC	cis	1	rs4366490	chr11:62912854	SLC22A24	chr11:62847414-62911693:-	0.33	7.66	9.74E-14	Conotruncal heart defects	
KIRC	cis	1	rs4366668	chr15:65903398	DPP8	chr15:65737999-65810035:-	-0.12	-4.93	1.11E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs436707	chr6:167388843	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs4367085	chr3:58389235	PXK	chr3:58318617-58410878:+	0.25	4.98	8.89E-7	Cholesterol, total	
KIRC	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.6	14.63	1.25E-40	Height	
KIRC	cis	1	rs4367113	chr3:134287975	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.44E-11	Height	
KIRC	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.85	1.3E-41	Height	
KIRC	cis	1	rs4368544	chr3:134300014	CEP63	chr3:134204575-134293852:+	-0.33	-6.41	3.27E-10	Height	
KIRC	cis	1	rs4369337	chr10:81733742	LOC219347	chr10:81805991-81838949:-	0.47	4.44	1.13E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4369337	chr10:81733742	LOC650623	chr10:81442731-81448648:+	-0.34	-3.9	0.000109	Rheumatoid arthritis	
KIRC	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.47	-9.92	2.73E-21	Body mass index	
KIRC	cis	1	rs437298	chr1:76113770	ACADM	chr1:76190043-76229353:+	-0.19	-5.48	6.81E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4373160	chr4:106648641	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs4374747	chr5:156426239	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.16	3.47E-22	Hypertriglyceridemia	
KIRC	cis	1	rs4374747	chr5:156426239	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.73	6.09E-14	Hypertriglyceridemia	
KIRC	cis	1	rs4374747	chr5:156426239	TIMD4	chr5:156346293-156390266:-	-0.36	-6.82	2.57E-11	Hypertriglyceridemia	
KIRC	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.4	10.46	2.58E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4375701	chr17:45712218	ITGB3	chr17:45331208-45421658:+	0.18	4.18	3.45E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4375701	chr17:45712218	TBKBP1	chr17:45772630-45789427:+	-0.17	-4.48	9.43E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.3	4.29E-19	Body mass index	
KIRC	cis	1	rs4376778	chr1:46288846	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.29	5.76	1.44E-8	Diabetic kidney disease	
KIRC	cis	1	rs437889	chr7:65509234	CRCP	chr7:65579805-65619551:+	-0.32	-4.31	1.97E-5	Diabetic kidney disease	
KIRC	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.28	-6.75	3.97E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4379774	chr10:81735389	LOC219347	chr10:81805991-81838949:-	0.58	5.07	5.62E-7	Rheumatoid arthritis	
KIRC	cis	1	rs4379774	chr10:81735389	LOC650623	chr10:81442731-81448648:+	-0.37	-3.97	8.2E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4385200	chr5:130487658	LYRM7	chr5:130506641-130541119:+	-0.31	-3.84	0.000141	Diisocyanate-induced asthma	
KIRC	cis	1	rs4388288	chr6:55948205	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.15E-13	Psychosis (atypical)	
KIRC	cis	1	rs4389526	chr4:80946475	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.56	0.000409	Ankylosing spondylitis	
KIRC	cis	1	rs439237	chr6:167391392	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.49	-8.62	8.55E-17	Bone mineral density	
KIRC	cis	1	rs4393318	chr11:62912785	SLC22A24	chr11:62847414-62911693:-	-0.32	-7.55	2.05E-13	Conotruncal heart defects	
KIRC	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.44	7.24	1.66E-12	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs4394894	chr12:81464831	ACSS3	chr12:81471809-81649582:+	0.16	3.52	0.00047	Neuroticism	
KIRC	cis	1	rs4394894	chr12:81464831	LIN7A	chr12:81191171-81331694:-	0.2	5.01	7.49E-7	Neuroticism	
KIRC	cis	1	rs4394895	chr12:81464942	ACSS3	chr12:81471809-81649582:+	0.16	3.52	0.00047	Neuroticism	
KIRC	cis	1	rs4394895	chr12:81464942	LIN7A	chr12:81191171-81331694:-	0.2	5.01	7.49E-7	Neuroticism	
KIRC	cis	1	rs439553	chr6:167391212	RNASET2	chr6:167343008-167412795:-	-0.14	-3.68	0.000261	Crohn's disease	
KIRC	cis	1	rs4397735	chr10:4965543	AKR1C1	chr10:4934796-5020157:+	-0.39	-4.91	1.25E-6	Height	
KIRC	cis	1	rs4397735	chr10:4965543	AKR1C2	chr10:4964715-5060207:-	0.63	7.36	7.63E-13	Height	
KIRC	cis	1	rs4398671	chr5:115557842	COMMD10	chr5:115420727-115628978:+	0.34	3.91	0.000106	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.28	-6.73	4.75E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4399664	chr19:21778026	ZNF429	chr19:21688437-21739068:+	0.18	3.53	0.000451	Colorectal or endometrial cancer	
KIRC	cis	1	rs4400684	chr10:65012687	NRBF2	chr10:64893007-64914785:+	-0.27	-6.49	2.05E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4405410	chr12:124435788	CCDC92	chr12:124420955-124457163:-	0.19	5.01	7.58E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4405963	chr4:80909351	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.42	8.52	1.85E-16	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRC	cis	1	rs4407429	chr3:119288897	CD80	chr3:119243142-119278481:-	-0.15	-3.57	0.000395	Vitiligo	
KIRC	cis	1	rs4408325	chr11:124821575	CCDC15	chr11:124824017-124911383:+	0.26	5.08	5.35E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4409766	chr10:104616663	SFXN2	chr10:104474298-104498946:+	-0.27	-3.77	0.000183	Hypertension;Systolic blood pressure;Diastolic blood pressure	
KIRC	cis	1	rs4410242	chr2:161192070	PLA2R1	chr2:160798012-160919121:-	0.2	3.66	0.000281	Type 2 diabetes	
KIRC	cis	1	rs441109	chr1:76120430	ACADM	chr1:76190043-76229353:+	-0.19	-5.38	1.14E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.61	14.56	2.57E-40	Height	
KIRC	cis	1	rs4417907	chr3:134291363	CEP63	chr3:134204575-134293852:+	0.33	6.46	2.43E-10	Height	
KIRC	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.45	8.05	6.24E-15	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRC	cis	1	rs4420500	chr15:78962964	CHRNA5	chr15:78857906-78886458:+	-0.24	-4.86	1.56E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.73	4.36E-41	Height	
KIRC	cis	1	rs4423809	chr3:134300107	CEP63	chr3:134204575-134293852:+	-0.33	-6.36	4.41E-10	Height	
KIRC	cis	1	rs4431687	chr9:130111697	SLC2A8	chr9:130159465-130170161:+	-0.17	-3.84	0.000141	Metabolite levels (HVA)	
KIRC	cis	1	rs4442739	chr14:76647645	ESRRB	chr14:76837690-76968178:+	0.36	5.15	3.73E-7	Blood pressure	
KIRC	cis	1	rs4448343	chr9:98266370	C9orf130	chr9:98568372-98638259:-	0.2	3.55	0.000422	Height	
KIRC	cis	1	rs444988	chr6:167389674	RNASET2	chr6:167343008-167412795:-	-0.14	-3.51	0.000493	Crohn's disease	
KIRC	cis	1	rs4452095	chr2:161200221	PLA2R1	chr2:160798012-160919121:-	0.19	3.52	0.000472	Type 2 diabetes	
KIRC	cis	1	rs4452748	chr7:50625056	FIGNL1	chr7:50511834-50518088:-	0.25	5.11	4.62E-7	Malaria	
KIRC	cis	1	rs446392	chr4:124047753	FGF2	chr4:123747863-123819390:+	-0.23	-3.91	0.000106	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4464069	chr16:69816284	COG4	chr16:70514473-70557457:-	-0.23	-4.13	4.23E-5	IgE levels	
KIRC	cis	1	rs4464248	chr2:9691320	ITGB1BP1	chr2:9545823-9563643:-	0.17	3.57	0.000387	Alcohol dependence (age at onset)	
KIRC	cis	1	rs4464939	chr8:110115017	TMEM74	chr8:109619080-109799770:-	-0.19	-3.69	0.000251	Body mass (lean)	
KIRC	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.38	4.02E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.33	5.72	1.8E-8	Coffee consumption (cups per day)	
KIRC	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.47	-7.71	6.79E-14	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs4466773	chr10:81733564	LOC219347	chr10:81805991-81838949:-	0.47	4.44	1.13E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4466773	chr10:81733564	LOC650623	chr10:81442731-81448648:+	-0.34	-3.9	0.000109	Rheumatoid arthritis	
KIRC	cis	1	rs4466774	chr10:81733786	LOC219347	chr10:81805991-81838949:-	0.47	4.44	1.13E-5	Rheumatoid arthritis	
KIRC	cis	1	rs4466774	chr10:81733786	LOC650623	chr10:81442731-81448648:+	-0.34	-3.9	0.000109	Rheumatoid arthritis	
KIRC	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.41	-9.97	1.81E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.26	9.01	4.25E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs447722	chr20:25443510	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4480432	chr10:69938665	MYPN	chr10:69865876-69971771:+	-0.24	-4.6	5.35E-6	Height	
KIRC	cis	1	rs448060	chr6:167382622	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs448396	chr20:25440269	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4489133	chr6:163137793	PACRG	chr6:163148164-163736523:+	0.58	6.74	4.33E-11	Body mass index	
KIRC	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.31	-8.97	5.84E-18	Longevity	
KIRC	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.41	-7.34	8.6E-13	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
KIRC	cis	1	rs4490669	chr6:56789465	BEND6	chr6:56819773-56892138:+	-0.24	-5.14	4.03E-7	Menarche (age at onset)	
KIRC	cis	1	rs4491945	chr3:119598725	GSK3B	chr3:119540804-119813264:-	-0.15	-3.96	8.53E-5	HDL cholesterol	
KIRC	cis	1	rs4497676	chr16:69814950	COG4	chr16:70514473-70557457:-	-0.21	-3.82	0.000151	IgE levels	
KIRC	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.29	-5.86	8.16E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.62	14.63	1.19E-40	Height	
KIRC	cis	1	rs4498009	chr3:134198008	CEP63	chr3:134204575-134293852:+	0.32	6.09	2.28E-9	Height	
KIRC	cis	1	rs4500383	chr1:212391596	TMEM206	chr1:212537819-212588267:-	0.2	4	7.19E-5	Intelligence (childhood)	
KIRC	cis	1	rs4501833	chr1:156716598	TTC24	chr1:156552022-156556902:+	-0.15	-4.01	7.02E-5	HDL cholesterol	
KIRC	cis	1	rs4503373	chr1:99191469	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs4507958	chr1:47383041	CYP4A22	chr1:47603107-47614526:+	0.44	8.53	1.73E-16	Blood metabolite levels	
KIRC	cis	1	rs4509261	chr7:128382285	OPN1SW	chr7:128412545-128415844:-	0.22	3.76	0.000191	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs4509958	chr15:50894175	SPPL2A	chr15:50999739-51057910:-	0.28	7.35	8.3E-13	QT interval	
KIRC	cis	1	rs4512670	chr1:99194052	SNX7	chr1:99127236-99226054:+	0.19	4.9	1.3E-6	Proinsulin levels	
KIRC	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.29	5.9	6.61E-9	Diabetic kidney disease	
KIRC	cis	1	rs451396	chr7:65484074	CRCP	chr7:65579805-65619551:+	-0.29	-4.09	5.12E-5	Diabetic kidney disease	
KIRC	cis	1	rs4514789	chr19:52365654	ZNF577	chr19:52359056-52394145:-	-0.28	-5.14	3.92E-7	Breast cancer	
KIRC	cis	1	rs4514789	chr19:52365654	ZNF649	chr19:52392489-52408247:-	-0.24	-4.86	1.56E-6	Breast cancer	
KIRC	cis	1	rs4515105	chr3:190987891	UTS2D	chr3:190984945-191048325:-	-0.21	-3.8	0.000165	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs4520437	chr1:99195445	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs4525561	chr18:51835955	POLI	chr18:51795849-51824602:+	0.15	3.74	0.000209	Psoriasis	
KIRC	cis	1	rs4531856	chr19:18388383	JUND	chr19:18390563-18392432:-	-0.18	-3.96	8.48E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4531856	chr19:18388383	KIAA1683	chr19:18367906-18385319:-	-0.24	-5.87	7.71E-9	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4531856	chr19:18388383	MAST3	chr19:18208603-18262498:+	0.14	3.8	0.000163	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4531962	chr2:190526683	ASNSD1	chr2:190526125-190535556:+	-0.28	-4	7.38E-5	Subcutaneous adipose tissue	
KIRC	cis	1	rs453329	chr20:25440593	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.8	3.08E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.3	-5.7	2.09E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.37	6.27	7.97E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4533340	chr17:28277951	SSH2	chr17:27952965-28257018:-	0.15	3.53	0.000455	Coffee consumption (cups per day)	
KIRC	cis	1	rs4534636	chr12:8666801	CLEC4D	chr12:8666136-8674958:+	0.39	5.98	4.19E-9	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
KIRC	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.98	3.2E-42	Height	
KIRC	cis	1	rs4535272	chr3:134299916	CEP63	chr3:134204575-134293852:+	-0.33	-6.51	1.84E-10	Height	
KIRC	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.3	-7.49	3.18E-13	HIV-1 viral setpoint	
KIRC	cis	1	rs4544908	chr6:55946166	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.78	2.5E-17	Body mass index	
KIRC	cis	1	rs4545281	chr1:46360054	MUTYH	chr1:45794915-45806142:-	0.14	4.18	3.45E-5	Body mass index	
KIRC	cis	1	rs45472399	chr10:17209967	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.27	1.23E-15	Homocysteine levels	
KIRC	cis	1	rs4547797	chr4:103557192	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.29	5.71	1.9E-8	Diabetic kidney disease	
KIRC	cis	1	rs4548056	chr7:65298873	CRCP	chr7:65579805-65619551:+	-0.33	-4.46	1.0E-5	Diabetic kidney disease	
KIRC	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.47	-9.92	2.73E-21	Body mass index	
KIRC	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.43	7.4	5.85E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs4552585	chr5:137533159	CDC25C	chr5:137620959-137674044:-	-0.23	-6.22	1.05E-9	Resting heart rate	
KIRC	cis	1	rs4553560	chr14:75334199	MLH3	chr14:75480467-75518235:-	-0.15	-3.49	0.00052	Caffeine consumption	
KIRC	cis	1	rs4553560	chr14:75334199	RPS6KL1	chr14:75372347-75389958:-	-0.17	-3.5	0.000501	Caffeine consumption	
KIRC	cis	1	rs45559033	chr14:74341124	LIN52	chr14:74551656-74667117:+	0.26	4.69	3.61E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs45559033	chr14:74341124	PTGR2	chr14:74318534-74352166:+	0.24	3.62	0.000324	Morning vs. evening chronotype	
KIRC	cis	1	rs4559448	chr1:76203456	ACADM	chr1:76190043-76229353:+	0.18	5.18	3.19E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4560537	chr5:150262586	IRGM	chr5:150226085-150280295:+	0.51	6.87	1.89E-11	Crohn's disease	
KIRC	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.31	4.21	3.05E-5	Crohn's disease	
KIRC	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.36	7.39	6.18E-13	Hematology traits	
KIRC	cis	1	rs45615636	chr10:17210591	TRDMT1	chr10:17184983-17243681:-	-0.35	-7.98	9.98E-15	Homocysteine levels	
KIRC	cis	1	rs4564643	chr17:76077894	LGALS3BP	chr17:76967336-76976061:-	0.23	3.69	0.000248	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.86	1.15E-41	Height	
KIRC	cis	1	rs4572812	chr3:134291177	CEP63	chr3:134204575-134293852:+	-0.33	-6.45	2.69E-10	Height	
KIRC	cis	1	rs457352	chr21:31244478	USP16	chr21:30396938-30426805:+	-0.21	-3.5	0.00051	Periodontitis (DPAL)	
KIRC	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4579121	chr4:103558169	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs4579242	chr5:156939498	ADAM19	chr5:156822542-157002768:-	0.11	4.21	3.08E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs4579248	chr5:150268151	IRGM	chr5:150226085-150280295:+	0.63	7.71	6.67E-14	Crohn's disease	
KIRC	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.41	4.97	9.17E-7	Crohn's disease	
KIRC	cis	1	rs4580150	chr16:69814953	COG4	chr16:70514473-70557457:-	-0.2	-3.62	0.00032	IgE levels	
KIRC	cis	1	rs4580704	chr4:56326707	SRD5A3	chr4:56212409-56237866:+	-0.19	-4.02	6.59E-5	Personality dimensions	
KIRC	cis	1	rs4580704	chr4:56326707	TMEM165	chr4:56262090-56292342:+	0.2	5.57	4.11E-8	Personality dimensions	
KIRC	cis	1	rs4581755	chr17:28427898	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.44	7.26	1.49E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.29	5.78	1.35E-8	Diabetic kidney disease	
KIRC	cis	1	rs458291	chr7:65520479	CRCP	chr7:65579805-65619551:+	-0.32	-4.37	1.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs4585221	chr3:58415567	PXK	chr3:58318617-58410878:+	0.26	5.13	4.19E-7	Cholesterol, total	
KIRC	cis	1	rs4586937	chr4:103556462	MANBA	chr4:103552644-103682151:-	-0.17	-3.83	0.000144	Primary biliary cirrhosis	
KIRC	cis	1	rs4594164	chr14:35509571	KIAA0391	chr14:35591776-35786673:+	0.22	3.5	0.00051	Atopic dermatitis	
KIRC	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.24	4.54	7.0E-6	Atopic dermatitis	
KIRC	cis	1	rs459498	chr21:42795027	MX1	chr21:42792520-42831140:+	-0.26	-4.5	8.29E-6	IgG glycosylation	
KIRC	cis	1	rs4595427	chr10:65012944	NRBF2	chr10:64893007-64914785:+	-0.27	-6.49	2.05E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4595905	chr19:18547305	SSBP4	chr19:18530221-18545371:+	-0.14	-4.65	4.24E-6	Breast cancer	
KIRC	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.14	-5.12	4.39E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4604928	chr11:117044203	PCSK7	chr11:117075789-117102811:-	-0.27	-5.27	2.0E-7	Protein quantitative trait loci	
KIRC	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.28	6.21	1.13E-9	Height	
KIRC	cis	1	rs4605213	chr17:49244747	NME2	chr17:49242891-49249104:+	-0.13	-4.05	5.85E-5	Height	
KIRC	cis	1	rs4606360	chr1:173699007	RABGAP1L	chr1:174128634-174959724:+	0.16	3.83	0.000145	Subjective well-being	
KIRC	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.24	4.54	7.04E-6	Subjective well-being	
KIRC	cis	1	rs4609941	chr18:44645491	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs4611044	chr1:99186639	SNX7	chr1:99127236-99226054:+	0.19	4.9	1.3E-6	Proinsulin levels	
KIRC	cis	1	rs4611046	chr1:19322486	RNF186	chr1:20140523-20141771:-	0.28	3.61	0.000332	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs4624820	chr5:141681788	NDFIP1	chr5:141488324-141534006:+	-0.15	-4.04	6.28E-5	Testicular germ cell cancer;Testicular germ cell tumor	
KIRC	cis	1	rs4627050	chr11:18822037	PTPN5	chr11:18749478-18813389:-	-0.22	-4.09	5.13E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
KIRC	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.26	5.08	5.24E-7	Diabetic kidney disease	
KIRC	cis	1	rs462853	chr7:65558167	CRCP	chr7:65579805-65619551:+	-0.34	-4.66	4.03E-6	Diabetic kidney disease	
KIRC	cis	1	rs4628584	chr10:4972697	AKR1C1	chr10:4934796-5020157:+	-0.39	-5.12	4.34E-7	Height	
KIRC	cis	1	rs4628584	chr10:4972697	AKR1C2	chr10:4964715-5060207:-	0.54	6.52	1.73E-10	Height	
KIRC	cis	1	rs4629692	chr6:101623550	GRIK2	chr6:101846905-102517957:+	0.5	5.07	5.63E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs4631576	chr9:100705210	C9orf156	chr9:100666772-100684852:-	-0.31	-6.62	9.16E-11	Quantitative traits	
KIRC	cis	1	rs4632293	chr2:161176379	PLA2R1	chr2:160798012-160919121:-	0.19	3.54	0.000445	Type 2 diabetes	
KIRC	cis	1	rs463535	chr11:2781670	LOC100133545	chr11:2004440-2011150:-	-0.21	-3.7	0.000237	Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs4637335	chr4:80947386	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.56	0.000409	Ankylosing spondylitis	
KIRC	cis	1	rs4638651	chr18:51829870	POLI	chr18:51795849-51824602:+	0.15	3.54	0.000441	Psoriasis	
KIRC	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.47	-9.9	3.04E-21	Body mass index	
KIRC	cis	1	rs4642241	chr4:17617111	LAP3	chr4:17578927-17609590:+	-0.2	-6.23	9.82E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4642241	chr4:17617111	MED28	chr4:17616273-17629791:+	0.2	4.4	1.31E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4643132	chr12:81458555	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs4643132	chr12:81458555	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs4643294	chr15:85250253	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.51	8.24E-6	Schizophrenia	
KIRC	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.22	-4.22	2.96E-5	Schizophrenia	
KIRC	cis	1	rs4643578	chr2:190526684	ASNSD1	chr2:190526125-190535556:+	-0.28	-4	7.38E-5	Subcutaneous adipose tissue	
KIRC	cis	1	rs4646486	chr1:47278997	CYP4A22	chr1:47603107-47614526:+	0.43	7.44	4.26E-13	Blood metabolite levels	
KIRC	cis	1	rs4646492	chr1:47281183	CYP4A22	chr1:47603107-47614526:+	0.43	7.33	9.42E-13	Blood metabolite levels	
KIRC	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.3	6.49	2.02E-10	Multiple sclerosis	
KIRC	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.46	-11.84	1.08E-28	Multiple sclerosis	
KIRC	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-5.9	6.58E-9	Multiple sclerosis	
KIRC	cis	1	rs4646961	chr1:76217169	ACADM	chr1:76190043-76229353:+	0.2	5.59	3.71E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs464783	chr21:42796480	MX1	chr21:42792520-42831140:+	0.25	4.45	1.07E-5	IgG glycosylation	
KIRC	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.29	5.56	4.41E-8	Diabetic kidney disease	
KIRC	cis	1	rs464895	chr7:65527106	CRCP	chr7:65579805-65619551:+	-0.34	-4.55	6.73E-6	Diabetic kidney disease	
KIRC	cis	1	rs4652545	chr1:180947608	MR1	chr1:181003139-181024633:+	-0.13	-3.63	0.000312	Progressive supranuclear palsy	
KIRC	cis	1	rs4652547	chr1:180954089	MR1	chr1:181003139-181024633:+	-0.14	-3.89	0.000116	Progressive supranuclear palsy	
KIRC	cis	1	rs4652548	chr1:180954130	MR1	chr1:181003139-181024633:+	-0.14	-3.89	0.000116	Progressive supranuclear palsy	
KIRC	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.26	5.08	5.24E-7	Diabetic kidney disease	
KIRC	cis	1	rs465359	chr7:65558164	CRCP	chr7:65579805-65619551:+	-0.34	-4.66	4.03E-6	Diabetic kidney disease	
KIRC	cis	1	rs4654863	chr1:20902244	CDA	chr1:20915444-20945398:+	-0.19	-3.5	0.000513	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs4656958	chr1:160856964	CD244	chr1:160799951-160832645:-	-0.11	-3.59	0.000366	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs4656958	chr1:160856964	NHLH1	chr1:160336861-160342638:+	-0.16	-3.56	0.000405	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs4657039	chr1:161462728	FCGR2B	chr1:161632940-161647951:+	-0.14	-3.66	0.000281	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
KIRC	cis	1	rs4657039	chr1:161462728	FCGR2C	chr1:161551129-161570031:+	-0.15	-4.27	2.35E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
KIRC	cis	1	rs4658552	chr1:243412936	SDCCAG8	chr1:243419320-243663392:+	0.21	3.84	0.000138	Educational attainment	
KIRC	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.94	23.22	1.43E-81	Homocysteine levels	
KIRC	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs4660317	chr1:46326226	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs4660319	chr1:46341623	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.23	7.84E-19	Body mass index	
KIRC	cis	1	rs4660321	chr1:46366760	MUTYH	chr1:45794915-45806142:-	0.13	3.87	0.000124	Body mass index	
KIRC	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.83	-19.16	7.91E-62	Homocysteine levels	
KIRC	cis	1	rs4660870	chr1:45995231	MUTYH	chr1:45794915-45806142:-	0.13	3.88	0.000118	Homocysteine levels	
KIRC	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs4660898	chr1:46402171	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.01	4.45E-18	Body mass index	
KIRC	cis	1	rs4660910	chr1:46548402	MUTYH	chr1:45794915-45806142:-	0.14	4.03	6.56E-5	Body mass index	
KIRC	cis	1	rs4660980	chr1:47399497	CYP4A22	chr1:47603107-47614526:+	0.48	9.17	1.18E-18	Blood metabolite levels	
KIRC	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.2	4.02	6.81E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs4664308	chr2:160917497	PLA2R1	chr2:160798012-160919121:-	0.19	3.94	9.31E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.2	4.02	6.81E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs4665147	chr2:160917062	PLA2R1	chr2:160798012-160919121:-	0.19	3.94	9.31E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.24	-4.3	2.05E-5	Obesity-related traits	
KIRC	cis	1	rs4665238	chr2:23942446	LOC375190	chr2:24299728-24397519:+	0.24	5.82	1.08E-8	Obesity-related traits	
KIRC	cis	1	rs4665381	chr2:27757150	NRBP1	chr2:27650657-27665122:+	0.14	3.59	0.000356	Oral cavity cancer	
KIRC	cis	1	rs4665768	chr2:25372229	POMC	chr2:25383722-25391559:-	0.25	4.78	2.29E-6	Body mass index	
KIRC	cis	1	rs4665958	chr2:27443196	C2orf28	chr2:27434899-27440044:+	0.16	4.61	5.05E-6	Blood metabolite levels	
KIRC	cis	1	rs4666007	chr2:27856495	NRBP1	chr2:27650657-27665122:+	0.14	3.65	0.000288	Oral cavity cancer	
KIRC	cis	1	rs4666009	chr2:27857992	NRBP1	chr2:27650657-27665122:+	0.15	3.91	0.000105	Oral cavity cancer	
KIRC	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.46	-9.91	2.81E-21	Body mass index	
KIRC	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.47	-10.01	1.2E-21	Body mass index	
KIRC	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.29	5.77	1.37E-8	Diabetic kidney disease	
KIRC	cis	1	rs466983	chr7:65520496	CRCP	chr7:65579805-65619551:+	-0.32	-4.39	1.39E-5	Diabetic kidney disease	
KIRC	cis	1	rs4671400	chr2:61472632	AHSA2	chr2:61404553-61414058:+	-0.14	-3.82	0.000147	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs4671400	chr2:61472632	C2orf74	chr2:61372243-61391964:+	0.55	6.47	2.27E-10	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs4674086	chr2:201323885	SPATS2L	chr2:201170604-201346982:+	0.15	3.58	0.000373	Urinary albumin-to-creatinine ratio in non-diabetics	
KIRC	cis	1	rs4674	chr19:41930396	ATP5SL	chr19:41937224-41945810:-	0.17	3.9	0.00011	Height	
KIRC	cis	1	rs4675860	chr2:241840417	C2orf54	chr2:241825466-241835573:-	0.4	7.32	9.92E-13	Urinary metabolites	
KIRC	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.42	7.92	1.52E-14	Urinary metabolites	
KIRC	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.42	7.89	1.92E-14	Urinary metabolites	
KIRC	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.43	-8.06	5.42E-15	Urinary metabolites	
KIRC	cis	1	rs4676552	chr3:40048084	ZNF619	chr3:40518633-40530114:+	-0.16	-3.5	0.000508	Information processing speed	
KIRC	cis	1	rs4679903	chr3:160328568	TRIM59	chr3:160153292-160167626:-	-0.23	-4.12	4.52E-5	Primary biliary cirrhosis	
KIRC	cis	1	rs4679904	chr3:160340896	TRIM59	chr3:160153292-160167626:-	0.23	3.87	0.000125	Primary biliary cirrhosis	
KIRC	cis	1	rs4679906	chr3:160351187	TRIM59	chr3:160153292-160167626:-	0.23	3.96	8.65E-5	Primary biliary cirrhosis	
KIRC	cis	1	rs4679907	chr3:160351401	TRIM59	chr3:160153292-160167626:-	-0.21	-3.65	0.000292	Primary biliary cirrhosis	
KIRC	cis	1	rs4681734	chr3:56715009	CCDC66	chr3:56591184-56655846:+	0.14	3.98	7.9E-5	Height	
KIRC	cis	1	rs4682000	chr3:56720591	CCDC66	chr3:56591184-56655846:+	0.14	4.09	4.96E-5	Height	
KIRC	cis	1	rs4683950	chr3:101653958	SENP7	chr3:101043120-101232085:-	0.16	3.52	0.000468	Psoriasis vulgaris;Psoriasis	
KIRC	cis	1	rs4686666	chr3:185342847	TMEM41A	chr3:185207389-185216845:-	0.17	3.6	0.000349	Systolic blood pressure	
KIRC	cis	1	rs4686792	chr3:184552325	C3orf70	chr3:184795840-184870802:-	-0.18	-4.03	6.47E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs4687205	chr3:190983967	UTS2D	chr3:190984945-191048325:-	-0.22	-4.03	6.38E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs4687697	chr3:53090490	SFMBT1	chr3:52938628-53080070:-	0.43	9.94	2.18E-21	Ulcerative colitis	
KIRC	cis	1	rs4687697	chr3:53090490	TMEM110	chr3:52867139-52931547:-	-0.14	-3.56	0.0004	Ulcerative colitis	
KIRC	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.45	12.11	8.42E-30	Height	
KIRC	cis	1	rs4690071	chr4:3086753	GRK4	chr4:2965343-3042474:+	-0.23	-4.09	4.92E-5	Parental longevity (mother's age at death)	
KIRC	cis	1	rs4690909	chr4:159629151	PPID	chr4:159630280-159644552:-	0.19	3.55	0.00042	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
KIRC	cis	1	rs4692790	chr4:171012708	AADAT	chr4:170981374-171011372:-	-0.43	-4.34	1.76E-5	Thyroid hormone levels	
KIRC	cis	1	rs4692791	chr4:171012741	AADAT	chr4:170981374-171011372:-	-0.43	-4.34	1.76E-5	Thyroid hormone levels	
KIRC	cis	1	rs4692792	chr4:171016540	AADAT	chr4:170981374-171011372:-	-0.45	-4.25	2.55E-5	Thyroid hormone levels	
KIRC	cis	1	rs4692793	chr4:171018383	AADAT	chr4:170981374-171011372:-	-0.45	-4.3	2.05E-5	Thyroid hormone levels	
KIRC	cis	1	rs4692801	chr4:171051123	AADAT	chr4:170981374-171011372:-	-0.46	-4.49	8.81E-6	Thyroid hormone levels	
KIRC	cis	1	rs4693089	chr4:84373622	MRPS18C	chr4:84377118-84389352:+	-0.23	-4.96	9.84E-7	Menopause (age at onset)	
KIRC	cis	1	rs4693975	chr4:89821884	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.69	0.000252	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs4693976	chr4:89839840	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.53	0.00046	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.51	-13.8	5.72E-37	Ankylosing spondylitis	
KIRC	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.48	8.28	1.16E-15	Ankylosing spondylitis	
KIRC	cis	1	rs4698198	chr4:17656536	LAP3	chr4:17578927-17609590:+	-0.2	-6.28	7.31E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698198	chr4:17656536	MED28	chr4:17616273-17629791:+	0.18	3.97	8.25E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698199	chr4:17656738	LAP3	chr4:17578927-17609590:+	-0.2	-6.28	7.31E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698199	chr4:17656738	MED28	chr4:17616273-17629791:+	0.18	3.97	8.25E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698200	chr4:17657051	LAP3	chr4:17578927-17609590:+	-0.2	-6.24	9.33E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698200	chr4:17657051	MED28	chr4:17616273-17629791:+	0.18	4.03	6.39E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698634	chr4:17630192	LAP3	chr4:17578927-17609590:+	0.21	6.48	2.22E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698634	chr4:17630192	MED28	chr4:17616273-17629791:+	-0.19	-4.29	2.11E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698635	chr4:17630242	LAP3	chr4:17578927-17609590:+	-0.19	-6.03	3.17E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698635	chr4:17630242	MED28	chr4:17616273-17629791:+	0.24	5.45	7.74E-8	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698641	chr4:17642630	LAP3	chr4:17578927-17609590:+	-0.2	-6.37	4.38E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698641	chr4:17642630	MED28	chr4:17616273-17629791:+	0.22	4.97	9.24E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698648	chr4:17692715	LAP3	chr4:17578927-17609590:+	-0.2	-6.23	9.8E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698648	chr4:17692715	MED28	chr4:17616273-17629791:+	0.21	4.63	4.69E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698649	chr4:17692782	LAP3	chr4:17578927-17609590:+	-0.2	-6.23	9.8E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698649	chr4:17692782	MED28	chr4:17616273-17629791:+	0.21	4.63	4.69E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698651	chr4:17694223	LAP3	chr4:17578927-17609590:+	-0.2	-6.08	2.35E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4698651	chr4:17694223	MED28	chr4:17616273-17629791:+	0.21	4.81	2.01E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4700424	chr5:60963675	FLJ37543	chr5:60933636-61002362:+	0.24	3.88	0.000117	Alzheimer's disease	
KIRC	cis	1	rs4700668	chr5:64435732	PPWD1	chr5:64859131-64883368:+	-0.26	-4.17	3.63E-5	Schizophrenia	
KIRC	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.17	-5.6	3.57E-8	Mean corpuscular hemoglobin	
KIRC	cis	1	rs470292	chr11:102685395	MMP1	chr11:102660641-102668966:-	-0.45	-4.45	1.06E-5	Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs4704729	chr5:156424516	HAVCR1	chr5:156456531-156486130:-	-0.46	-10.14	4.25E-22	Hypertriglyceridemia	
KIRC	cis	1	rs4704729	chr5:156424516	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.64	1.14E-13	Hypertriglyceridemia	
KIRC	cis	1	rs4704729	chr5:156424516	TIMD4	chr5:156346293-156390266:-	-0.36	-6.75	4.04E-11	Hypertriglyceridemia	
KIRC	cis	1	rs4705972	chr5:132179237	LEAP2	chr5:132209358-132210581:+	0.35	5.42	9.23E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs4705972	chr5:132179237	SHROOM1	chr5:132158012-132166590:-	0.32	5.83	9.66E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs470606	chr11:120028202	OAF	chr11:120081747-120100649:+	0.19	4.1	4.75E-5	Corneal curvature	
KIRC	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.47	-10.4	4.33E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.21E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs470928	chr11:102685380	MMP1	chr11:102660641-102668966:-	-0.45	-4.45	1.06E-5	Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs4710147	chr6:167374239	RNASET2	chr6:167343008-167412795:-	0.14	3.62	0.000319	Crohn's disease	
KIRC	cis	1	rs4711346	chr6:33730996	LEMD2	chr6:33738991-33756906:-	0.22	5.05	6.34E-7	Body mass index	
KIRC	cis	1	rs4711351	chr6:33754592	LEMD2	chr6:33738991-33756906:-	-0.14	-3.55	0.000417	Crohn's disease	
KIRC	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.76	22.61	1.39E-78	Pulse pressure	
KIRC	cis	1	rs4713008	chr6:26538268	BTN2A3	chr6:26422317-26431927:+	0.12	3.68	0.00026	Educational attainment	
KIRC	cis	1	rs4713682	chr6:33757047	LEMD2	chr6:33738991-33756906:-	-0.14	-3.63	0.000307	Crohn's disease	
KIRC	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.17	-4.08	5.23E-5	Blood metabolite ratios	
KIRC	cis	1	rs4713	chr9:131910805	PPP2R4	chr9:131873244-131911223:+	-0.23	-4.51	7.93E-6	Blood metabolite ratios	
KIRC	cis	1	rs4714152	chr6:38343341	BTBD9	chr6:38136228-38607924:-	-0.16	-3.68	0.000258	Restless legs syndrome	
KIRC	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.41	-9.97	1.76E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.24	8.3	9.96E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.39	-9.23	7.74E-19	Folate pathway vitamin levels	
KIRC	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.24	8.07	5.34E-15	Folate pathway vitamin levels	
KIRC	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.2	4.8	2.11E-6	Brain structure	
KIRC	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.78	23.34	4.04E-82	Pulse pressure	
KIRC	cis	1	rs4717292	chr7:65895598	LOC729156	chr7:66274980-66309813:-	0.17	3.53	0.000461	Aortic root size	
KIRC	cis	1	rs4717310	chr7:66161007	LOC493754	chr7:65993446-66057363:-	-0.17	-3.78	0.000177	Aortic root size	
KIRC	cis	1	rs4717319	chr7:66242593	LOC493754	chr7:65993446-66057363:-	-0.18	-3.88	0.000118	Aortic root size	
KIRC	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.26	-5.3	1.73E-7	Diabetic kidney disease	
KIRC	cis	1	rs4718269	chr7:65200778	CRCP	chr7:65579805-65619551:+	0.26	3.64	0.000301	Diabetic kidney disease	
KIRC	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.28	5.65	2.71E-8	Diabetic kidney disease	
KIRC	cis	1	rs4718270	chr7:65202407	CRCP	chr7:65579805-65619551:+	-0.31	-4.18	3.45E-5	Diabetic kidney disease	
KIRC	cis	1	rs4718309	chr7:65627764	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.79E-9	Diabetic kidney disease	
KIRC	cis	1	rs4718309	chr7:65627764	CRCP	chr7:65579805-65619551:+	0.32	4.42	1.22E-5	Diabetic kidney disease	
KIRC	cis	1	rs4718315	chr7:65648541	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs4718315	chr7:65648541	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs4718316	chr7:65648731	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs4718316	chr7:65648731	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.73	1.73E-8	Diabetic kidney disease	
KIRC	cis	1	rs4718317	chr7:65648901	CRCP	chr7:65579805-65619551:+	0.34	4.65	4.28E-6	Diabetic kidney disease	
KIRC	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs4718333	chr7:65772758	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.27	-5.31	1.61E-7	Diabetic kidney disease	
KIRC	cis	1	rs4718334	chr7:65789454	CRCP	chr7:65579805-65619551:+	0.35	4.8	2.12E-6	Diabetic kidney disease	
KIRC	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.68	8.49E-14	Obesity-related traits	
KIRC	cis	1	rs4726669	chr7:143758191	OR2A1	chr7:144015236-144016148:+;chr7	-0.29	-5.51	5.89E-8	Obesity-related traits	
KIRC	cis	1	rs4726669	chr7:143758191	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.53	1.71E-16	Obesity-related traits	
KIRC	cis	1	rs4727443	chr7:99593346	CNPY4	chr7:99717265-99723126:+	-0.14	-3.56	0.000403	Interstitial lung disease	
KIRC	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.18	-3.88	0.000118	Interstitial lung disease	
KIRC	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.21	5.81	1.13E-8	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs4728408	chr7:137072096	PTN	chr7:136912092-137028546:-	0.21	3.75	0.000195	Schizophrenia	
KIRC	cis	1	rs473005	chr4:56288125	SRD5A3	chr4:56212409-56237866:+	0.18	3.86	0.000127	Personality dimensions	
KIRC	cis	1	rs473005	chr4:56288125	TMEM165	chr4:56262090-56292342:+	-0.21	-5.95	4.91E-9	Personality dimensions	
KIRC	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.38	11.05	1.46E-25	Response to temozolomide	
KIRC	cis	1	rs473188	chr11:116812029	PCSK7	chr11:117075789-117102811:-	-0.24	-4.89	1.33E-6	Protein quantitative trait loci	
KIRC	cis	1	rs4733384	chr8:29985381	MBOAT4	chr8:29989188-30002200:-	0.37	5.32	1.61E-7	Migraine	
KIRC	cis	1	rs4734190	chr8:110127171	TMEM74	chr8:109619080-109799770:-	-0.18	-3.56	0.000404	Body mass (lean)	
KIRC	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.38	11.15	5.96E-26	Response to temozolomide	
KIRC	cis	1	rs4745948	chr10:69937987	MYPN	chr10:69865876-69971771:+	-0.24	-4.6	5.35E-6	Height	
KIRC	cis	1	rs4746112	chr10:74042995	SPOCK2	chr10:73818793-73848790:-	-0.21	-4.04	6.18E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs4746740	chr10:69960999	MYPN	chr10:69865876-69971771:+	-0.25	-4.78	2.31E-6	Height	
KIRC	cis	1	rs4747241	chr10:74036429	ASCC1	chr10:73856278-73976892:-	0.17	3.56	0.000399	Heschl's gyrus morphology	
KIRC	cis	1	rs4747242	chr10:74037193	ASCC1	chr10:73856278-73976892:-	0.17	3.49	0.000526	Heschl's gyrus morphology	
KIRC	cis	1	rs4747242	chr10:74037193	SPOCK2	chr10:73818793-73848790:-	-0.21	-4.09	5.06E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.41	-11.81	1.37E-28	Response to temozolomide	
KIRC	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.46	-9.54	6.26E-20	Subjective well-being	
KIRC	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.13	4.42E-22	Subjective well-being	
KIRC	cis	1	rs4752856	chr11:47648042	PSMC3	chr11:47440320-47448024:-	0.13	3.98	7.84E-5	Subjective well-being	
KIRC	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.24	1.71E-22	Subjective well-being	
KIRC	cis	1	rs4752857	chr11:47655752	PSMC3	chr11:47440320-47448024:-	0.13	3.83	0.000144	Subjective well-being	
KIRC	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.05	9.24E-22	Subjective well-being	
KIRC	cis	1	rs4754134	chr11:105512824	GRIA4	chr11:105480800-105852819:+	-0.21	-3.5	0.000515	Ejection fraction in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.54	-12.27	1.92E-30	Forced vital capacity	
KIRC	cis	1	rs4758623	chr11:3014953	NAP1L4	chr11:2965661-3013607:-	0.21	4.74	2.85E-6	Calcium levels	
KIRC	cis	1	rs4759042	chr12:57377347	TIMELESS	chr12:56810157-56843200:-	0.15	3.82	0.00015	Migraine	
KIRC	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.73	-14.5	4.96E-40	Cognitive function	
KIRC	cis	1	rs4759318	chr12:54420098	FLJ12825	chr12:54452038-54516018:+	0.29	5.32	1.56E-7	Bone mineral density	
KIRC	cis	1	rs4759787	chr12:131290180	STX2	chr12:131274149-131323811:-	-0.32	-4.48	9.08E-6	Plasma plasminogen activator levels	
KIRC	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.43	-12.12	7.89E-30	Type 1 diabetes	
KIRC	cis	1	rs4765219	chr12:124440110	CCDC92	chr12:124420955-124457163:-	0.19	5.16	3.65E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4765305	chr12:124430612	CCDC92	chr12:124420955-124457163:-	0.19	4.87	1.52E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4765305	chr12:124430612	DNAH10	chr12:124247042-124420265:+	0.2	3.94	9.12E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4766947	chr12:120161401	CIT	chr12:120123598-120315092:-	0.22	4.63	4.67E-6	Urgency urinary incontinence	
KIRC	cis	1	rs4767839	chr12:120160122	CIT	chr12:120123598-120315092:-	0.22	4.74	2.78E-6	Urgency urinary incontinence	
KIRC	cis	1	rs4767841	chr12:120162199	CIT	chr12:120123598-120315092:-	0.22	4.79	2.18E-6	Urgency urinary incontinence	
KIRC	cis	1	rs4775893	chr15:50898695	SPPL2A	chr15:50999739-51057910:-	0.29	7.72	6.41E-14	QT interval	
KIRC	cis	1	rs4775893	chr15:50898695	TRPM7	chr15:50852491-50978994:-	0.13	3.76	0.000189	QT interval	
KIRC	cis	1	rs4775897	chr15:50944066	SPPL2A	chr15:50999739-51057910:-	0.28	7.55	2.0E-13	QT interval	
KIRC	cis	1	rs4775897	chr15:50944066	TRPM7	chr15:50852491-50978994:-	0.12	3.64	0.000296	QT interval	
KIRC	cis	1	rs477687	chr5:134467700	TIFAB	chr5:134784560-134788089:-	0.17	3.81	0.000155	AIDS progression	
KIRC	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.39	11.58	1.22E-27	Response to temozolomide	
KIRC	cis	1	rs477895	chr11:64048912	C11orf20	chr11:64067863-64072238:+	0.28	4.6	5.29E-6	Mean platelet volume	
KIRC	cis	1	rs4783896	chr16:55606360	LPCAT2	chr16:55542913-55620581:+	-0.16	-4.04	6.11E-5	Thyroid hormone levels	
KIRC	cis	1	rs4784549	chr16:55612918	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.33	1.8E-5	Thyroid hormone levels	
KIRC	cis	1	rs4785202	chr16:50095995	HEATR3	chr16:50099881-50139373:+	-0.27	-3.89	0.000114	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs4785203	chr16:50096065	HEATR3	chr16:50099881-50139373:+	-0.27	-3.89	0.000114	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs4785223	chr16:50716048	SNX20	chr16:50700211-50715264:-	0.08	3.81	0.000158	Leprosy	
KIRC	cis	1	rs4787491	chr16:30015337	TBX6	chr16:30097117-30103208:-	0.2	4.78	2.29E-6	Body mass index	
KIRC	cis	1	rs4788187	chr16:29845685	LOC440356	chr16:29875004-29879374:+	0.24	3.72	0.000224	Multiple sclerosis	
KIRC	cis	1	rs4788188	chr16:29860863	LOC440356	chr16:29875004-29879374:+	-0.26	-3.84	0.000138	Multiple sclerosis	
KIRC	cis	1	rs4788196	chr16:29967434	DOC2A	chr16:30016837-30024843:-	-0.13	-3.71	0.000231	Pubertal anthropometrics	
KIRC	cis	1	rs4788196	chr16:29967434	TBX6	chr16:30097117-30103208:-	0.16	3.67	0.000266	Pubertal anthropometrics	
KIRC	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.18	4.67	3.82E-6	Glucocorticoid-induced osteonecrosis	
KIRC	cis	1	rs4789693	chr17:80421870	NARF	chr17:80416060-80446141:+	-0.19	-4.84	1.72E-6	Glucocorticoid-induced osteonecrosis	
KIRC	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.4	-10.35	7.11E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794016	chr17:45725931	ITGB3	chr17:45331208-45421658:+	-0.18	-4.25	2.57E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794016	chr17:45725931	TBKBP1	chr17:45772630-45789427:+	0.15	4.02	6.59E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.39	10.21	2.21E-22	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794048	chr17:45763073	ITGB3	chr17:45331208-45421658:+	0.16	3.75	0.000198	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794048	chr17:45763073	TBKBP1	chr17:45772630-45789427:+	-0.16	-4.15	3.86E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.31	-6.32	5.92E-10	Alzheimer's disease (cognitive decline)	
KIRC	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.38	11.04	1.64E-25	Response to temozolomide	
KIRC	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.79	-19.16	8.06E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.82	-20.21	6.56E-67	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.79	-19.06	2.41E-61	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795412	chr17:38150604	MED24	chr17:38175351-38210889:-	-0.15	-3.64	0.000305	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.79	-19.24	3.16E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795415	chr17:38157995	MED24	chr17:38175351-38210889:-	-0.15	-3.55	0.000425	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.79	-19.24	3.16E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795416	chr17:38158133	MED24	chr17:38175351-38210889:-	-0.15	-3.55	0.000425	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.79	-19.16	8.06E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs479879	chr10:105945985	C10orf79	chr10:105889647-105992120:-	0.2	4.92	1.18E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs479994	chr1:183161729	LAMC2	chr1:183155174-183214262:+	0.27	5.86	8.2E-9	Hypertriglyceridemia	
KIRC	cis	1	rs480132	chr1:183161779	LAMC2	chr1:183155174-183214262:+	0.27	5.84	9.23E-9	Hypertriglyceridemia	
KIRC	cis	1	rs4802200	chr19:44289518	ZNF155	chr19:44488355-44502477:+	-0.26	-5.27	2.01E-7	Breast cancer	
KIRC	cis	1	rs4802200	chr19:44289518	ZNF404	chr19:44376516-44384288:-	-0.31	-6.2	1.16E-9	Breast cancer	
KIRC	cis	1	rs4803463	chr19:41911040	ATP5SL	chr19:41937224-41945810:-	0.18	4.17	3.64E-5	Height	
KIRC	cis	1	rs4803468	chr19:41922352	ATP5SL	chr19:41937224-41945810:-	0.16	3.76	0.000194	Height	
KIRC	cis	1	rs4803469	chr19:41922775	ATP5SL	chr19:41937224-41945810:-	0.16	3.76	0.000194	Height	
KIRC	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.65	15.85	3.54E-46	Schizophrenia	
KIRC	cis	1	rs4803658	chr19:44290013	KCNN4	chr19:44270687-44285409:-	-0.12	-3.52	0.000467	Breast cancer	
KIRC	cis	1	rs4803658	chr19:44290013	ZNF155	chr19:44488355-44502477:+	-0.24	-5.09	5.02E-7	Breast cancer	
KIRC	cis	1	rs4803658	chr19:44290013	ZNF404	chr19:44376516-44384288:-	-0.31	-6.35	4.92E-10	Breast cancer	
KIRC	cis	1	rs4803750	chr19:45247627	MARK4	chr19:45754842-45808541:+	-0.29	-3.52	0.00047	Lipid metabolism phenotypes	
KIRC	cis	1	rs4805754	chr19:32837166	ZNF507	chr19:32836514-32878571:+	0.17	3.56	0.000413	Bipolar disorder	
KIRC	cis	1	rs4805755	chr19:32854470	ANKRD27	chr19:33087907-33166102:-	-0.23	-3.68	0.000259	Bipolar disorder	
KIRC	cis	1	rs4805755	chr19:32854470	ZNF507	chr19:32836514-32878571:+	-0.18	-3.87	0.000123	Bipolar disorder	
KIRC	cis	1	rs4805758	chr19:32866424	ZNF507	chr19:32836514-32878571:+	0.18	3.63	0.000313	Bipolar disorder	
KIRC	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.38	10.75	2.22E-24	Response to temozolomide	
KIRC	cis	1	rs4807208	chr19:2170205	DOT1L	chr19:2164148-2232576:+	0.18	6.7	5.59E-11	Height	
KIRC	cis	1	rs4808133	chr19:18608518	SSBP4	chr19:18530221-18545371:+	-0.13	-4.63	4.64E-6	Breast cancer	
KIRC	cis	1	rs4808134	chr19:18608579	SSBP4	chr19:18530221-18545371:+	-0.13	-4.63	4.64E-6	Breast cancer	
KIRC	cis	1	rs4808136	chr19:18618867	SSBP4	chr19:18530221-18545371:+	0.13	4.6	5.4E-6	Breast cancer	
KIRC	cis	1	rs4808200	chr19:19554803	HAPLN4	chr19:19366453-19384074:-	0.27	5.68	2.23E-8	Schizophrenia	
KIRC	cis	1	rs4808200	chr19:19554803	SF4	chr19:19387323-19431307:-	0.16	4.12	4.51E-5	Schizophrenia	
KIRC	cis	1	rs4808801	chr19:18571141	SSBP4	chr19:18530221-18545371:+	-0.13	-4.61	5.09E-6	Breast cancer	
KIRC	cis	1	rs4808804	chr19:18585325	SSBP4	chr19:18530221-18545371:+	-0.14	-4.87	1.51E-6	Breast cancer	
KIRC	cis	1	rs4810909	chr20:47621372	CSE1L	chr20:47662838-47713484:+	-0.15	-3.66	0.000275	Anger	
KIRC	cis	1	rs4810988	chr20:48465969	CEBPB	chr20:48807376-48809212:+	0.13	3.49	0.000525	Gut microbiota (beta diversity)	
KIRC	cis	1	rs4811694	chr20:55029388	C20orf43	chr20:55043647-55093942:+	0.23	5.38	1.15E-7	Refractive astigmatism	
KIRC	cis	1	rs4811694	chr20:55029388	CSTF1	chr20:54967427-54979582:+	0.19	3.61	0.000337	Refractive astigmatism	
KIRC	cis	1	rs4812048	chr20:57587771	TH1L	chr20:57556311-57570186:+	-0.5	-7.62	1.26E-13	Mean platelet volume	
KIRC	cis	1	rs4813562	chr20:25352588	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4813562	chr20:25352588	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4813563	chr20:25365340	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4813563	chr20:25365340	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4813566	chr20:25386465	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4813566	chr20:25386465	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815404	chr20:25301845	ENTPD6	chr20:25176339-25207360:+	0.24	6.51	1.82E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815405	chr20:25317492	ENTPD6	chr20:25176339-25207360:+	0.24	6.4	3.56E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815406	chr20:25341316	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815406	chr20:25341316	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815407	chr20:25341478	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815407	chr20:25341478	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815408	chr20:25346678	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815408	chr20:25346678	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815409	chr20:25346697	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815409	chr20:25346697	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815411	chr20:25350223	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815411	chr20:25350223	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815412	chr20:25350325	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815412	chr20:25350325	FAM182A	chr20:26035250-26067552:+	-0.3	-5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815417	chr20:25379526	ENTPD6	chr20:25176339-25207360:+	0.25	6.98	9.29E-12	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815417	chr20:25379526	FAM182A	chr20:26035250-26067552:+	0.29	5.56	4.41E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815418	chr20:25382211	ENTPD6	chr20:25176339-25207360:+	0.25	6.81	2.76E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815418	chr20:25382211	FAM182A	chr20:26035250-26067552:+	0.3	5.68	2.3E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815420	chr20:25383979	ENTPD6	chr20:25176339-25207360:+	0.25	6.84	2.36E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815420	chr20:25383979	FAM182A	chr20:26035250-26067552:+	0.29	5.6	3.59E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815421	chr20:25386509	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815421	chr20:25386509	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815424	chr20:25390284	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815424	chr20:25390284	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815426	chr20:25405186	ENTPD6	chr20:25176339-25207360:+	0.25	6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815426	chr20:25405186	FAM182A	chr20:26035250-26067552:+	0.3	5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs4815603	chr20:3772527	CDC25B	chr20:3767578-3786759:+	0.16	3.59	0.000367	Bipolar disorder	
KIRC	cis	1	rs4819388	chr21:45647421	ICOSLG	chr21:45646724-45660834:-	-0.29	-5.07	5.55E-7	Celiac disease	
KIRC	cis	1	rs482013	chr11:71803962	C11orf59	chr11:71808339-71814322:-	-0.22	-3.93	9.52E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4820294	chr22:38071043	LGALS1	chr22:38071613-38075807:+	-0.12	-3.8	0.000163	Fat distribution (HIV)	
KIRC	cis	1	rs4820345	chr22:39091151	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.81	0.000156	Resting heart rate	
KIRC	cis	1	rs4820345	chr22:39091151	LOC646851	chr22:38974125-39052634:-	0.12	3.57	0.000386	Resting heart rate	
KIRC	cis	1	rs4821544	chr22:37258503	NCF4	chr22:37257030-37274058:+	0.16	5.94	5.32E-9	Atopic dermatitis	
KIRC	cis	1	rs4821798	chr22:39021165	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.77	0.000181	Resting heart rate	
KIRC	cis	1	rs4821798	chr22:39021165	LOC646851	chr22:38974125-39052634:-	0.13	4.09	5.09E-5	Resting heart rate	
KIRC	cis	1	rs4821808	chr22:39065739	LOC646851	chr22:38974125-39052634:-	0.13	4.05	5.92E-5	Resting heart rate	
KIRC	cis	1	rs4821809	chr22:39065743	LOC646851	chr22:38974125-39052634:-	0.13	4.05	5.92E-5	Resting heart rate	
KIRC	cis	1	rs4821810	chr22:39072098	LOC646851	chr22:38974125-39052634:-	0.12	3.74	0.000203	Resting heart rate	
KIRC	cis	1	rs4821811	chr22:39075145	LOC646851	chr22:38974125-39052634:-	0.14	4.16	3.7E-5	Resting heart rate	
KIRC	cis	1	rs4821812	chr22:39075235	LOC646851	chr22:38974125-39052634:-	0.13	3.97	8.22E-5	Resting heart rate	
KIRC	cis	1	rs4824112	chr22:50284345	CRELD2	chr22:50312283-50321186:+	0.19	3.6	0.000347	Schizophrenia	
KIRC	cis	1	rs4835669	chr5:137473391	CDC25C	chr5:137620959-137674044:-	-0.2	-5.74	1.61E-8	Resting heart rate	
KIRC	cis	1	rs4835671	chr5:137511801	CDC25C	chr5:137620959-137674044:-	-0.22	-6.15	1.59E-9	Resting heart rate	
KIRC	cis	1	rs483783	chr1:183162152	LAMC2	chr1:183155174-183214262:+	0.26	5.44	8.4E-8	Hypertriglyceridemia	
KIRC	cis	1	rs4838890	chr1:110616679	ALX3	chr1:110602998-110613322:-	-0.24	-5.21	2.75E-7	Blood metabolite levels	
KIRC	cis	1	rs4839103	chr1:110620701	ALX3	chr1:110602998-110613322:-	-0.22	-4.71	3.19E-6	Blood metabolite levels	
KIRC	cis	1	rs4840351	chr8:8573148	CLDN23	chr8:8559666-8561616:+	0.23	3.65	0.000291	Obesity-related traits	
KIRC	cis	1	rs4840352	chr8:8573508	CLDN23	chr8:8559666-8561616:+	0.23	3.65	0.000286	Obesity-related traits	
KIRC	cis	1	rs4842838	chr15:84582124	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.59	5.5E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs4842923	chr15:84581904	GOLGA6L5	chr15:85047738-85060078:-	-0.11	-3.58	0.000379	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs4842924	chr15:84587607	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.43	1.14E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs4845756	chr1:152254919	FLG	chr1:152274651-152297679:-	-0.21	-3.62	0.000325	Atopic dermatitis	
KIRC	cis	1	rs4845756	chr1:152254919	HRNR	chr1:152184558-152196669:-	0.24	3.98	8.03E-5	Atopic dermatitis	
KIRC	cis	1	rs4845854	chr1:11261929	MTOR	chr1:11166589-11322608:-	-0.14	-3.59	0.000369	Body mass index	
KIRC	cis	1	rs4845859	chr1:11304873	MTOR	chr1:11166589-11322608:-	-0.16	-4.16	3.73E-5	Body mass index	
KIRC	cis	1	rs4845934	chr1:10468946	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000345	Hepatocellular carcinoma	
KIRC	cis	1	rs4845982	chr1:11271576	MTOR	chr1:11166589-11322608:-	-0.18	-4.58	5.86E-6	Body mass index	
KIRC	cis	1	rs4845986	chr1:11288633	MTOR	chr1:11166589-11322608:-	-0.17	-4.39	1.37E-5	Body mass index	
KIRC	cis	1	rs4846208	chr1:10313839	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000351	Hepatocellular carcinoma	
KIRC	cis	1	rs4846210	chr1:10322153	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000351	Hepatocellular carcinoma	
KIRC	cis	1	rs4847181	chr1:93028792	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs4848301	chr2:113551694	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.97	8.35E-5	Endometriosis	
KIRC	cis	1	rs4848301	chr2:113551694	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.38	1.46E-5	Endometriosis	
KIRC	cis	1	rs4848302	chr2:113551716	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.97	8.35E-5	Endometriosis	
KIRC	cis	1	rs4848302	chr2:113551716	RPL23AP7	chr2:114368816-114384715:-	-0.25	-4.38	1.46E-5	Endometriosis	
KIRC	cis	1	rs4852375	chr2:70125988	ANXA4	chr2:69969127-70053594:+	-0.23	-5.42	9.11E-8	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs4853036	chr2:70059824	SNRNP27	chr2:70121090-70132348:+	0.2	3.64	0.000303	Colorectal or endometrial cancer	
KIRC	cis	1	rs4853461	chr2:192119298	STAT4	chr2:191894306-192038902:-	0.16	4.12	4.44E-5	Obesity-related traits	
KIRC	cis	1	rs4853462	chr2:192123804	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs4853559	chr2:192100691	STAT4	chr2:191894306-192038902:-	0.16	4.15	3.83E-5	Obesity-related traits	
KIRC	cis	1	rs4853561	chr2:192107706	STAT4	chr2:191894306-192038902:-	0.17	4.5	8.28E-6	Obesity-related traits	
KIRC	cis	1	rs4853562	chr2:192118422	STAT4	chr2:191894306-192038902:-	0.16	4.12	4.44E-5	Obesity-related traits	
KIRC	cis	1	rs4853563	chr2:192119534	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs4853564	chr2:192123665	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs4853565	chr2:192123746	STAT4	chr2:191894306-192038902:-	0.16	4.36	1.6E-5	Obesity-related traits	
KIRC	cis	1	rs4853568	chr2:192126190	STAT4	chr2:191894306-192038902:-	0.16	3.97	8.35E-5	Obesity-related traits	
KIRC	cis	1	rs4853634	chr2:190779231	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.55	6.74E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs4854058	chr2:240923677	NDUFA10	chr2:240900158-240964798:-	0.21	4.53	7.44E-6	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs485554	chr3:172137343	FNDC3B	chr3:171757418-172118490:+	-0.15	-3.56	0.000403	Height	
KIRC	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.39	11.58	1.22E-27	Response to temozolomide	
KIRC	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.29	7.98	1.02E-14	Longevity	
KIRC	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.29	8.08	4.99E-15	Longevity	
KIRC	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.53	11.04	1.68E-25	Longevity	
KIRC	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.52	-10.68	3.84E-24	Longevity	
KIRC	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.52	-10.75	2.12E-24	Longevity	
KIRC	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.62	13.33	6.48E-35	Kawasaki disease	
KIRC	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.56	-9.39	2.1E-19	Tumor biomarkers	
KIRC	cis	1	rs486301	chr15:43836949	STRC	chr15:43891762-43924561:-	0.2	3.97	8.23E-5	Tumor biomarkers	
KIRC	cis	1	rs486301	chr15:43836949	TUBGCP4	chr15:43663313-43698238:+	0.2	4.2	3.12E-5	Tumor biomarkers	
KIRC	cis	1	rs4864998	chr4:56332606	SRD5A3	chr4:56212409-56237866:+	0.21	4.46	1.01E-5	Personality dimensions	
KIRC	cis	1	rs4864998	chr4:56332606	TMEM165	chr4:56262090-56292342:+	-0.22	-5.89	7.18E-9	Personality dimensions	
KIRC	cis	1	rs4865008	chr4:56410855	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.84	0.000138	Personality dimensions	
KIRC	cis	1	rs4865008	chr4:56410855	TMEM165	chr4:56262090-56292342:+	0.22	5.97	4.44E-9	Personality dimensions	
KIRC	cis	1	rs4865010	chr4:56414962	SRD5A3	chr4:56212409-56237866:+	-0.19	-4.11	4.61E-5	Personality dimensions	
KIRC	cis	1	rs4865010	chr4:56414962	TMEM165	chr4:56262090-56292342:+	0.2	5.44	8.48E-8	Personality dimensions	
KIRC	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.18	4.35	1.65E-5	Pediatric autoimmune diseases	
KIRC	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.09	-31.63	1.36E-121	Pediatric autoimmune diseases	
KIRC	cis	1	rs4870040	chr6:151872090	C6orf97	chr6:151815175-151942327:+	0.2	3.89	0.000113	Bone mineral density (spine)	
KIRC	cis	1	rs4870041	chr6:151872324	C6orf97	chr6:151815175-151942327:+	0.2	3.89	0.000113	Bone mineral density (spine)	
KIRC	cis	1	rs4870844	chr8:124092243	DERL1	chr8:124025568-124054648:-	0.21	3.51	0.000487	Diabetic kidney disease	
KIRC	cis	1	rs4871344	chr8:124092075	DERL1	chr8:124025568-124054648:-	0.21	3.51	0.000487	Diabetic kidney disease	
KIRC	cis	1	rs4871	chr6:26545632	BTN2A3	chr6:26422317-26431927:+	0.12	3.56	0.000403	Educational attainment	
KIRC	cis	1	rs4879901	chr9:35518997	FAM166B	chr9:35561945-35563896:-	0.19	3.66	0.000282	Schizophrenia	
KIRC	cis	1	rs4879902	chr9:35519359	FAM166B	chr9:35561945-35563896:-	-0.19	-3.7	0.00024	Schizophrenia	
KIRC	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.42	-11.54	1.66E-27	Lewy body disease	
KIRC	cis	1	rs4886018	chr13:52990717	NEK3	chr13:52706780-52733996:-	0.16	4.09	5.05E-5	Lewy body disease	
KIRC	cis	1	rs4886018	chr13:52990717	VPS36	chr13:52986739-53024763:-	0.28	6.66	7.25E-11	Lewy body disease	
KIRC	cis	1	rs4886615	chr15:75131661	ULK3	chr15:75128459-75135552:-	-0.11	-3.56	0.0004	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRC	cis	1	rs4886818	chr15:76880939	SCAPER	chr15:76640529-77197744:-	-0.17	-5.71	1.99E-8	Blood metabolite levels	
KIRC	cis	1	rs4887067	chr15:78886947	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.78	3.34E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs4887783	chr16:74700743	MLKL	chr16:74705753-74734789:-	0.23	5.23	2.43E-7	Testicular germ cell tumor	
KIRC	cis	1	rs4887783	chr16:74700743	RFWD3	chr16:74655298-74700779:-	-0.17	-4.06	5.74E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4888262	chr16:74670458	MLKL	chr16:74705753-74734789:-	0.17	3.9	0.000111	Testicular germ cell tumor	
KIRC	cis	1	rs4888262	chr16:74670458	RFWD3	chr16:74655298-74700779:-	-0.19	-4.58	6.01E-6	Testicular germ cell tumor	
KIRC	cis	1	rs4888264	chr16:74681632	MLKL	chr16:74705753-74734789:-	0.2	4.41	1.29E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4888264	chr16:74681632	RFWD3	chr16:74655298-74700779:-	-0.17	-4.07	5.52E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4888265	chr16:74683737	MLKL	chr16:74705753-74734789:-	0.19	4.36	1.59E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4888265	chr16:74683737	RFWD3	chr16:74655298-74700779:-	-0.17	-4.02	6.64E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4889609	chr16:31026427	MYST1	chr16:31128985-31142713:+	0.16	4.13	4.23E-5	Response to metformin (IC50)	
KIRC	cis	1	rs4895798	chr6:126000162	HEY2	chr6:126068780-126082414:+	-0.18	-4.3	2.02E-5	Endometrial cancer	
KIRC	cis	1	rs4895807	chr6:126686513	CENPW	chr6:126661253-126804465:+	-0.14	-4.45	1.07E-5	Type 1 diabetes	
KIRC	cis	1	rs4897152	chr6:126002400	HEY2	chr6:126068780-126082414:+	-0.17	-4.02	6.7E-5	Endometrial cancer	
KIRC	cis	1	rs4897153	chr6:126003403	HEY2	chr6:126068780-126082414:+	-0.17	-4.02	6.7E-5	Endometrial cancer	
KIRC	cis	1	rs4899544	chr14:75546556	MLH3	chr14:75480467-75518235:-	0.24	5.95	4.96E-9	Height	
KIRC	cis	1	rs4899544	chr14:75546556	NEK9	chr14:75548819-75593778:-	0.13	3.76	0.000188	Height	
KIRC	cis	1	rs4899546	chr14:75594946	MLH3	chr14:75480467-75518235:-	0.23	5.96	4.82E-9	Height	
KIRC	cis	1	rs4899546	chr14:75594946	NEK9	chr14:75548819-75593778:-	0.14	3.97	8.36E-5	Height	
KIRC	cis	1	rs4899586	chr14:76660856	ESRRB	chr14:76837690-76968178:+	0.33	4.73	2.92E-6	Blood pressure	
KIRC	cis	1	rs490234	chr9:128303734	PBX3	chr9:128509617-128729653:+	0.16	4.11	4.71E-5	Mean arterial pressure	
KIRC	cis	1	rs4902364	chr14:65602006	CHURC1	chr14:65381140-65411309:+	0.16	3.65	0.000285	Obesity-related traits	
KIRC	cis	1	rs4902365	chr14:65602064	CHURC1	chr14:65381140-65411309:+	0.15	3.52	0.000463	Obesity-related traits	
KIRC	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.33	-8.54	1.56E-16	Common traits (Other)	
KIRC	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.33	-8.54	1.56E-16	Common traits (Other)	
KIRC	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.33	-8.54	1.56E-16	Common traits (Other)	
KIRC	cis	1	rs4903275	chr14:75512509	MLH3	chr14:75480467-75518235:-	0.23	5.75	1.59E-8	Height	
KIRC	cis	1	rs4903275	chr14:75512509	NEK9	chr14:75548819-75593778:-	0.13	3.77	0.00018	Height	
KIRC	cis	1	rs4903279	chr14:75546583	MLH3	chr14:75480467-75518235:-	0.24	5.95	4.96E-9	Height	
KIRC	cis	1	rs4903279	chr14:75546583	NEK9	chr14:75548819-75593778:-	0.13	3.76	0.000188	Height	
KIRC	cis	1	rs4903281	chr14:75554361	MLH3	chr14:75480467-75518235:-	0.24	5.93	5.56E-9	Height	
KIRC	cis	1	rs4903281	chr14:75554361	NEK9	chr14:75548819-75593778:-	0.14	4.02	6.7E-5	Height	
KIRC	cis	1	rs4903284	chr14:75592483	MLH3	chr14:75480467-75518235:-	0.24	6.12	1.86E-9	Height	
KIRC	cis	1	rs4903284	chr14:75592483	NEK9	chr14:75548819-75593778:-	0.14	3.91	0.000104	Height	
KIRC	cis	1	rs4903289	chr14:75623988	MLH3	chr14:75480467-75518235:-	-0.24	-6.08	2.44E-9	Height	
KIRC	cis	1	rs4903289	chr14:75623988	NEK9	chr14:75548819-75593778:-	-0.13	-3.75	0.000199	Height	
KIRC	cis	1	rs4903386	chr14:76669658	ESRRB	chr14:76837690-76968178:+	0.32	4.6	5.38E-6	Blood pressure	
KIRC	cis	1	rs4903961	chr14:81462649	TSHR	chr14:81421869-81612646:+	-0.33	-6.46	2.45E-10	Graves' disease	
KIRC	cis	1	rs4906172	chr14:102454933	RAGE	chr14:102690838-102771531:-	-0.15	-3.78	0.000174	Menopause (age at onset)	
KIRC	cis	1	rs4906174	chr14:102495144	RAGE	chr14:102690838-102771531:-	-0.16	-3.98	7.93E-5	Menopause (age at onset)	
KIRC	cis	1	rs4908321	chr1:99194938	SNX7	chr1:99127236-99226054:+	-0.19	-4.63	4.69E-6	Proinsulin levels	
KIRC	cis	1	rs4911178	chr20:33952620	CPNE1	chr20:34213968-34262539:-	0.25	5.02	7.13E-7	Height	
KIRC	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.27	7.38	6.55E-13	Height	
KIRC	cis	1	rs4911180	chr20:33972948	CPNE1	chr20:34213968-34262539:-	0.27	5.41	9.93E-8	Height	
KIRC	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.28	7.46	3.81E-13	Height	
KIRC	cis	1	rs4911491	chr20:33947285	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.3E-8	Height	
KIRC	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.28	7.66	9.91E-14	Height	
KIRC	cis	1	rs4911492	chr20:33951799	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.3E-8	Height	
KIRC	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.28	7.66	9.91E-14	Height	
KIRC	cis	1	rs4911494	chr20:33971914	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.17E-8	Height	
KIRC	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.28	7.63	1.19E-13	Height	
KIRC	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.25	-5.11	4.56E-7	Height	
KIRC	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.27	-7.38	6.73E-13	Height	
KIRC	cis	1	rs4916342	chr1:173347837	SERPINC1	chr1:173872943-173886516:-	0.22	3.98	7.93E-5	Systemic lupus erythematosus	
KIRC	cis	1	rs4917385	chr10:105003721	C10orf32	chr10:104613967-104624718:+	-0.21	-4.18	3.42E-5	Systemic lupus erythematosus	
KIRC	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.14	-4.68	3.77E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4918798	chr10:96750543	CYP2C9	chr10:96698415-96749147:+	0.23	3.67	0.000267	Warfarin maintenance dose	
KIRC	cis	1	rs4919429	chr10:101938630	BLOC1S2	chr10:102033713-102046439:-	-0.29	-4.11	4.62E-5	Schizophrenia	
KIRC	cis	1	rs4919429	chr10:101938630	CWF19L1	chr10:101992055-102027437:-	-0.38	-4.4	1.33E-5	Schizophrenia	
KIRC	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.13	-4.31	1.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.13	-4.31	1.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.13	-4.81	1.96E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.16	-5.16	3.62E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.14	-4.7	3.3E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.17	-5.34	1.45E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.14	-4.71	3.22E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.14	-4.72	3.08E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.48	9.9	3.11E-21	Arsenic metabolism	
KIRC	cis	1	rs4920660	chr2:190744666	ASNSD1	chr2:190526125-190535556:+	-0.31	-4.47	9.55E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs4924935	chr17:18753870	FAM18B	chr17:18684582-18710026:+	-0.27	-6.06	2.63E-9	Pancreatic cancer	
KIRC	cis	1	rs4924986	chr17:19242467	EPN2	chr17:19140690-19240027:+	-0.17	-3.64	0.000303	Schizophrenia	
KIRC	cis	1	rs4925166	chr17:18210810	EVPLL	chr17:18281079-18292958:+	-0.2	-3.88	0.000117	Multiple sclerosis	
KIRC	cis	1	rs4925166	chr17:18210810	FAM106A	chr17:18427880-18430160:-	-0.37	-6.87	1.94E-11	Multiple sclerosis	
KIRC	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.45	-8.59	1.09E-16	Multiple sclerosis	
KIRC	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.29	-6.96	1.06E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs4929983	chr11:2024579	LOC100133545	chr11:2004440-2011150:-	-0.16	-3.75	0.000199	DNA methylation (variation);DNA methylation (parent-of-origin)	
KIRC	cis	1	rs4930103	chr11:2024544	LOC100133545	chr11:2004440-2011150:-	-0.17	-3.88	0.000117	DNA methylation (variation);DNA methylation (parent-of-origin)	
KIRC	cis	1	rs493065	chr11:71796929	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4930723	chr12:124423600	CCDC92	chr12:124420955-124457163:-	0.2	5.17	3.39E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4930725	chr12:124428162	CCDC92	chr12:124420955-124457163:-	0.2	5.04	6.48E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4930726	chr12:124428331	CCDC92	chr12:124420955-124457163:-	0.2	5.1	4.82E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4930726	chr12:124428331	DNAH10	chr12:124247042-124420265:+	0.2	3.94	9.23E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.59	-13.27	1.17E-34	Type 2 diabetes	
KIRC	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.62	-13.97	1.11E-37	Type 2 diabetes	
KIRC	cis	1	rs4935575	chr10:52006165	FAM21A	chr10:51827684-51893268:+	-0.32	-4.39	1.4E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs4936099	chr11:130280725	ADAMTS8	chr11:130274820-130298539:-	0.23	4.19	3.27E-5	Vertical cup-disc ratio	
KIRC	cis	1	rs4936890	chr11:123914742	C11orf61	chr11:124636394-124670299:-	-0.1	-3.66	0.000276	Male fertility	
KIRC	cis	1	rs4936891	chr11:123920645	C11orf61	chr11:124636394-124670299:-	0.1	3.71	0.000235	Male fertility	
KIRC	cis	1	rs4938493	chr11:118144804	MPZL2	chr11:118124135-118135009:-	-0.14	-3.52	0.000463	Pain	
KIRC	cis	1	rs4939311	chr11:59877967	MS4A2	chr11:59856137-59866014:+	0.17	3.78	0.000172	Alzheimer's disease (late onset)	
KIRC	cis	1	rs4939314	chr11:59900575	MS4A2	chr11:59856137-59866014:+	0.16	3.54	0.000437	Alzheimer's disease (late onset)	
KIRC	cis	1	rs494003	chr11:65542298	SNX32	chr11:65601410-65621170:+	0.27	4.65	4.15E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs4943821	chr11:71813747	C11orf59	chr11:71808339-71814322:-	0.24	4.59	5.51E-6	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4944198	chr11:78032605	NARS2	chr11:78147017-78285909:-	-0.2	-4.59	5.63E-6	Testicular germ cell tumor	
KIRC	cis	1	rs4944232	chr11:71642258	C11orf51	chr11:71817424-71823822:-	0.2	3.49	0.000517	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4944232	chr11:71642258	C11orf59	chr11:71808339-71814322:-	0.21	3.79	0.00017	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4944242	chr11:71667141	C11orf59	chr11:71808339-71814322:-	-0.23	-3.91	0.000103	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4944258	chr11:71743393	C11orf59	chr11:71808339-71814322:-	-0.22	-3.93	9.63E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4945261	chr11:77990260	NARS2	chr11:78147017-78285909:-	0.17	3.59	0.000359	Testicular germ cell tumor	
KIRC	cis	1	rs4945267	chr11:78037933	NARS2	chr11:78147017-78285909:-	-0.19	-4.22	2.93E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4945268	chr11:78037936	NARS2	chr11:78147017-78285909:-	-0.19	-4.22	2.93E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4945270	chr11:78068216	NARS2	chr11:78147017-78285909:-	-0.2	-4.5	8.49E-6	Testicular germ cell tumor	
KIRC	cis	1	rs4945274	chr11:78109260	NARS2	chr11:78147017-78285909:-	-0.17	-3.98	7.85E-5	Testicular germ cell tumor	
KIRC	cis	1	rs4945426	chr11:71748146	C11orf59	chr11:71808339-71814322:-	0.22	3.85	0.000134	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4945435	chr11:71759219	C11orf59	chr11:71808339-71814322:-	-0.21	-3.84	0.000139	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4947534	chr7:56079094	GBAS	chr7:56032296-56067871:+	-0.19	-4.21	3.08E-5	Blood metabolite levels;Amino acid levels	
KIRC	cis	1	rs4948102	chr7:56097265	GBAS	chr7:56032296-56067871:+	-0.18	-3.93	9.86E-5	Plasma homocysteine levels (post-methionine load test)	
KIRC	cis	1	rs494965	chr11:120053650	OAF	chr11:120081747-120100649:+	0.18	3.83	0.000144	Corneal curvature	
KIRC	cis	1	rs4949674	chr1:76213715	ACADM	chr1:76190043-76229353:+	0.2	5.59	3.71E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4949872	chr1:76131392	ACADM	chr1:76190043-76229353:+	0.19	5.43	8.98E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4949874	chr1:76161889	ACADM	chr1:76190043-76229353:+	0.19	5.33	1.49E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4949875	chr1:76173080	ACADM	chr1:76190043-76229353:+	0.19	5.41	9.93E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4949876	chr1:76173377	ACADM	chr1:76190043-76229353:+	0.19	5.42	9.06E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4949879	chr1:76237143	ACADM	chr1:76190043-76229353:+	0.16	4.63	4.7E-6	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs4950344	chr1:147227066	ACP6	chr1:147119168-147142634:-	-0.25	-4.36	1.59E-5	Cognitive performance	
KIRC	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.38	6.55	1.42E-10	Menarche (age at onset)	
KIRC	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.16	-4.62	4.97E-6	Menarche (age at onset)	
KIRC	cis	1	rs4953925	chr2:135471290	TMEM163	chr2:135213331-135525334:-	-0.33	-4.75	2.72E-6	Gut microbiome composition (winter)	
KIRC	cis	1	rs4954392	chr2:136901607	DARS	chr2:136664254-136743222:-	0.14	3.63	0.000312	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs4954564	chr2:136895508	DARS	chr2:136664254-136743222:-	0.15	3.91	0.000105	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs4954567	chr2:136901587	DARS	chr2:136664254-136743222:-	0.14	3.74	0.000206	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs4954568	chr2:136910690	DARS	chr2:136664254-136743222:-	0.14	3.71	0.00023	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs4954569	chr2:136913375	DARS	chr2:136664254-136743222:-	0.14	3.73	0.000215	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.61	14.61	1.59E-40	Height	
KIRC	cis	1	rs4955485	chr3:134295843	CEP63	chr3:134204575-134293852:+	0.33	6.53	1.58E-10	Height	
KIRC	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.6	14.67	8.2E-41	Height	
KIRC	cis	1	rs4955555	chr3:134286427	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.34E-11	Height	
KIRC	cis	1	rs495567	chr11:71795488	C11orf59	chr11:71808339-71814322:-	-0.24	-4.6	5.34E-6	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs4956032	chr4:108944579	HADH	chr4:108910940-108956330:+	-0.25	-3.71	0.000228	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4956033	chr4:108944821	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4956034	chr4:108944846	HADH	chr4:108910940-108956330:+	0.26	3.65	0.000288	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4956145	chr4:108931039	HADH	chr4:108910940-108956330:+	-0.26	-3.58	0.000377	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4956146	chr4:108934901	HADH	chr4:108910940-108956330:+	-0.26	-3.57	0.000385	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4956147	chr4:108935871	HADH	chr4:108910940-108956330:+	-0.26	-3.57	0.000385	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs4958422	chr5:150186734	IRGM	chr5:150226085-150280295:+	0.65	7.84	2.65E-14	Crohn's disease	
KIRC	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.44	5.23	2.55E-7	Crohn's disease	
KIRC	cis	1	rs4958424	chr5:150225036	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs4958426	chr5:150278346	IRGM	chr5:150226085-150280295:+	0.64	7.92	1.58E-14	Crohn's disease	
KIRC	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.42	5.07	5.59E-7	Crohn's disease	
KIRC	cis	1	rs4958842	chr5:150224877	IRGM	chr5:150226085-150280295:+	0.61	7.73	5.84E-14	Crohn's disease	
KIRC	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.39	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs4958843	chr5:150224924	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs4958848	chr5:150271122	IRGM	chr5:150226085-150280295:+	0.5	6.75	4.0E-11	Crohn's disease	
KIRC	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.32	4.31	1.95E-5	Crohn's disease	
KIRC	cis	1	rs4958852	chr5:150330631	IRGM	chr5:150226085-150280295:+	0.53	6.18	1.35E-9	Crohn's disease	
KIRC	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.45	5.37	1.23E-7	Crohn's disease	
KIRC	cis	1	rs4964728	chr12:104649733	NT5DC3	chr12:104164231-104234975:-	0.28	4.57	6.16E-6	Toenail selenium levels	
KIRC	cis	1	rs4964794	chr12:104194418	NT5DC3	chr12:104164231-104234975:-	-0.24	-4.17	3.6E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs4964805	chr12:104192824	NT5DC3	chr12:104164231-104234975:-	-0.23	-4.02	6.6E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs4964806	chr12:104192760	NT5DC3	chr12:104164231-104234975:-	-0.23	-4.1	4.8E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs4965271	chr15:100584725	ADAMTS17	chr15:100511643-100882183:-	-0.27	-4.66	4.02E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs4965273	chr15:100584818	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.47	9.54E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs4965274	chr15:100584971	ADAMTS17	chr15:100511643-100882183:-	-0.27	-4.54	6.93E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs4965557	chr15:100583717	ADAMTS17	chr15:100511643-100882183:-	0.27	4.47	9.48E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.56	-9.24	6.91E-19	Tumor biomarkers	
KIRC	cis	1	rs496584	chr15:43831923	STRC	chr15:43891762-43924561:-	0.19	3.73	0.00021	Tumor biomarkers	
KIRC	cis	1	rs496584	chr15:43831923	TUBGCP4	chr15:43663313-43698238:+	0.21	4.42	1.19E-5	Tumor biomarkers	
KIRC	cis	1	rs4968361	chr17:57502828	DHX40P1	chr17:58053385-58096336:-	0.31	4.5	8.59E-6	Schizophrenia	
KIRC	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.18	-4.27	2.29E-5	Cholesterol, total	
KIRC	cis	1	rs4970698	chr1:92972933	EVI5	chr1:92974255-93257961:-	-0.2	-4.59	5.56E-6	Cholesterol, total	
KIRC	cis	1	rs4970705	chr1:92971828	EVI5	chr1:92974255-93257961:-	0.2	4.83	1.8E-6	Cholesterol, total	
KIRC	cis	1	rs4970708	chr1:92986514	EVI5	chr1:92974255-93257961:-	-0.2	-4.71	3.19E-6	Cholesterol, total	
KIRC	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs4970712	chr1:92993547	EVI5	chr1:92974255-93257961:-	0.2	4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs4970941	chr1:151068546	LYSMD1	chr1:151132225-151138424:-	-0.25	-4.72	3.03E-6	Body mass index	
KIRC	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.29	-6.99	8.92E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.29	-6.99	8.92E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.74	-11.39	6.66E-27	Diastolic blood pressure	
KIRC	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.6	14.22	8.07E-39	Height	
KIRC	cis	1	rs4974483	chr3:134219001	CEP63	chr3:134204575-134293852:+	0.31	6.08	2.34E-9	Height	
KIRC	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.62	14.59	1.94E-40	Height	
KIRC	cis	1	rs4974484	chr3:134219019	CEP63	chr3:134204575-134293852:+	0.32	6.17	1.39E-9	Height	
KIRC	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.6	14.22	8.8E-39	Height	
KIRC	cis	1	rs4974493	chr3:134219993	CEP63	chr3:134204575-134293852:+	0.32	6.12	1.94E-9	Height	
KIRC	cis	1	rs4974559	chr4:1380848	CRIPAK	chr4:1385340-1389782:+	-0.22	-5.5	6.2E-8	Systolic blood pressure	
KIRC	cis	1	rs4974601	chr4:1095410	C4orf48	chr4:2043689-2045697:+	-0.14	-3.58	0.000372	Recombination rate (males)	
KIRC	cis	1	rs4974638	chr4:1099201	C4orf48	chr4:2043689-2045697:+	-0.15	-3.76	0.00019	Recombination rate (males)	
KIRC	cis	1	rs4974931	chr4:39110516	WDR19	chr4:39184024-39287429:+	0.18	4.81	1.99E-6	Uric acid levels	
KIRC	cis	1	rs4974997	chr4:39110771	WDR19	chr4:39184024-39287429:+	0.18	4.77	2.44E-6	Uric acid levels	
KIRC	cis	1	rs4974998	chr4:39110749	WDR19	chr4:39184024-39287429:+	0.18	4.69	3.55E-6	Uric acid levels	
KIRC	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.49	-8.1	4.24E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.49	-8.1	4.24E-15	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs4985518	chr16:69787158	COG4	chr16:70514473-70557457:-	-0.2	-3.64	0.000298	IgE levels	
KIRC	cis	1	rs4985523	chr16:69797192	COG4	chr16:70514473-70557457:-	-0.21	-3.81	0.000156	IgE levels	
KIRC	cis	1	rs4987094	chr11:113215923	TTC12	chr11:113185251-113244016:+	0.34	4.01	7.05E-5	Schizophrenia	
KIRC	cis	1	rs4987280	chr1:169679553	SELL	chr1:169659810-169680837:-	-0.2	-4.78	2.32E-6	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs499425	chr11:64105929	CCDC88B	chr11:64107695-64125005:+	0.09	3.61	0.00034	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
KIRC	cis	1	rs5008830	chr3:122030462	DTX3L	chr3:122283185-122294047:+	0.21	3.62	0.000319	Serum parathyroid hormone levels	
KIRC	cis	1	rs5008830	chr3:122030462	WDR5B	chr3:122130700-122134882:-	0.28	4.39	1.39E-5	Serum parathyroid hormone levels	
KIRC	cis	1	rs5011018	chr10:4967006	AKR1C1	chr10:4934796-5020157:+	-0.39	-5.1	4.82E-7	Height	
KIRC	cis	1	rs5011018	chr10:4967006	AKR1C2	chr10:4964715-5060207:-	0.59	7.08	4.95E-12	Height	
KIRC	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.4	-5.8	1.16E-8	Homocysteine levels	
KIRC	cis	1	rs5019665	chr8:120376554	NOV	chr8:120428552-120436678:+	0.3	4.51	7.92E-6	Hypertension	
KIRC	cis	1	rs5026472	chr4:103554773	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs5026473	chr4:103554793	MANBA	chr4:103552644-103682151:-	0.17	3.94	9.32E-5	Primary biliary cirrhosis	
KIRC	cis	1	rs5026476	chr4:103554910	MANBA	chr4:103552644-103682151:-	0.17	3.82	0.00015	Primary biliary cirrhosis	
KIRC	cis	1	rs5027662	chr6:88260442	C6orf164	chr6:88032306-88109459:+	0.31	3.69	0.000249	Obesity-related traits	
KIRC	cis	1	rs5030707	chr20:23618656	CST3	chr20:23608536-23618574:-	-0.13	-3.67	0.000267	Chronic kidney disease	
KIRC	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.39	11.42	5.06E-27	Response to temozolomide	
KIRC	cis	1	rs505802	chr11:64357072	SLC22A12	chr11:64358282-64369820:+	0.17	4.68	3.7E-6	Urate levels in obese individuals	
KIRC	cis	1	rs505987	chr11:102685910	MMP1	chr11:102660641-102668966:-	-0.45	-4.45	1.06E-5	Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.38	11.13	7.09E-26	Response to temozolomide	
KIRC	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.38	-11.09	1.06E-25	Response to temozolomide	
KIRC	cis	1	rs509035	chr3:172163449	FNDC3B	chr3:171757418-172118490:+	0.17	4.05	5.94E-5	Height	
KIRC	cis	1	rs510642	chr1:183162776	LAMC2	chr1:183155174-183214262:+	0.27	5.67	2.35E-8	Hypertriglyceridemia	
KIRC	cis	1	rs510988	chr11:116813804	PCSK7	chr11:117075789-117102811:-	-0.28	-5.29	1.79E-7	Protein quantitative trait loci	
KIRC	cis	1	rs511676	chr11:116824884	PCSK7	chr11:117075789-117102811:-	-0.28	-5.3	1.77E-7	Protein quantitative trait loci	
KIRC	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.38	10.99	2.64E-25	Response to temozolomide	
KIRC	cis	1	rs514591	chr1:196640320	CFHR3	chr1:196743930-196762872:+	0.18	3.6	0.000352	Circulating myeloperoxidase levels (serum)	
KIRC	cis	1	rs515358	chr11:71562302	C11orf59	chr11:71808339-71814322:-	0.21	3.74	0.000205	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs515910	chr10:105966404	C10orf79	chr10:105889647-105992120:-	0.16	3.98	7.85E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.4	11.73	3.01E-28	Response to temozolomide	
KIRC	cis	1	rs517837	chr11:71802359	C11orf59	chr11:71808339-71814322:-	-0.22	-3.95	8.85E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs520146	chr11:102690131	MMP1	chr11:102660641-102668966:-	-0.44	-4.55	6.8E-6	Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs522372	chr1:183157449	LAMC2	chr1:183155174-183214262:+	-0.29	-6.11	2.0E-9	Hypertriglyceridemia	
KIRC	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.39	-11.28	1.83E-26	Response to temozolomide	
KIRC	cis	1	rs524023	chr11:64358265	SLC22A12	chr11:64358282-64369820:+	0.17	4.68	3.7E-6	Urate levels in obese individuals	
KIRC	cis	1	rs525592	chr11:68195104	MRPL21	chr11:68658747-68671303:-	0.15	3.87	0.000124	Bone mineral density	
KIRC	cis	1	rs525592	chr11:68195104	SAPS3	chr11:68228186-68382799:+	-0.21	-4.09	5.05E-5	Bone mineral density	
KIRC	cis	1	rs527154	chr10:105943683	C10orf79	chr10:105889647-105992120:-	0.19	4.53	7.4E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs529522	chr11:71580562	C11orf59	chr11:71808339-71814322:-	0.23	4.28	2.27E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.38	11.4	6.38E-27	Response to temozolomide	
KIRC	cis	1	rs531326	chr11:71570656	C11orf51	chr11:71817424-71823822:-	0.2	3.53	0.000461	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs531326	chr11:71570656	C11orf59	chr11:71808339-71814322:-	0.22	3.87	0.000122	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.39	-11.56	1.5E-27	Response to temozolomide	
KIRC	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.32	6.37	4.18E-10	Metabolic syndrome	
KIRC	cis	1	rs534417	chr1:23784965	TCEA3	chr1:23707555-23751261:-	0.19	4.02	6.74E-5	Cholesterol, total	
KIRC	cis	1	rs537246	chr11:64360630	SLC22A12	chr11:64358282-64369820:+	0.16	4.5	8.38E-6	Urate levels in obese individuals	
KIRC	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.38	11.15	6.14E-26	Response to temozolomide	
KIRC	cis	1	rs541022	chr11:71783056	C11orf59	chr11:71808339-71814322:-	-0.23	-4.17	3.6E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs541126	chr12:120972396	POP5	chr12:121016849-121019201:-	0.16	3.83	0.000147	Type 1 diabetes nephropathy	
KIRC	cis	1	rs542752	chr11:71810644	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs543725	chr11:57483039	MED19	chr11:57471182-57479673:-	-0.21	-4.37	1.51E-5	Schizophrenia	
KIRC	cis	1	rs543725	chr11:57483039	TIMM10	chr11:57295936-57298232:-	-0.22	-5.61	3.3E-8	Schizophrenia	
KIRC	cis	1	rs544352	chr1:183157546	LAMC2	chr1:183155174-183214262:+	0.28	6.06	2.73E-9	Hypertriglyceridemia	
KIRC	cis	1	rs546183	chr1:183157753	LAMC2	chr1:183155174-183214262:+	0.28	6.06	2.73E-9	Hypertriglyceridemia	
KIRC	cis	1	rs547905	chr1:183157924	LAMC2	chr1:183155174-183214262:+	0.29	6.3	6.47E-10	Hypertriglyceridemia	
KIRC	cis	1	rs548127	chr11:71575294	C11orf51	chr11:71817424-71823822:-	-0.19	-3.5	0.000513	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs548127	chr11:71575294	C11orf59	chr11:71808339-71814322:-	-0.21	-3.88	0.000119	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs548181	chr11:125461709	DDX25	chr11:125774272-125793003:+	-0.29	-3.52	0.000473	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Schizophrenia	
KIRC	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.39	11.33	1.15E-26	Response to temozolomide	
KIRC	cis	1	rs548961	chr11:71793887	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs549844	chr1:183158143	LAMC2	chr1:183155174-183214262:+	-0.27	-5.83	1.01E-8	Hypertriglyceridemia	
KIRC	cis	1	rs550098	chr1:197297408	CFHR3	chr1:196743930-196762872:+	0.26	5.32	1.58E-7	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs550213	chr17:30317518	RHOT1	chr17:30469473-30552745:+	-0.2	-3.52	0.000469	Height	
KIRC	cis	1	rs550230	chr11:71602222	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.6E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs551397	chr1:196642072	CFHR3	chr1:196743930-196762872:+	0.18	3.58	0.000376	Circulating myeloperoxidase levels (serum)	
KIRC	cis	1	rs551569	chr1:183158293	LAMC2	chr1:183155174-183214262:+	0.29	6.2	1.2E-9	Hypertriglyceridemia	
KIRC	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.39	11.57	1.37E-27	Response to temozolomide	
KIRC	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.39	11.57	1.29E-27	Response to temozolomide	
KIRC	cis	1	rs555	chr4:17625658	LAP3	chr4:17578927-17609590:+	-0.21	-6.64	8.18E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs555	chr4:17625658	MED28	chr4:17616273-17629791:+	0.19	4.24	2.66E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs556292	chr10:105961957	C10orf79	chr10:105889647-105992120:-	0.17	4.2	3.16E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs55642283	chr8:120384772	NOV	chr8:120428552-120436678:+	-0.3	-4.72	3.11E-6	Hypertension	
KIRC	cis	1	rs55645900	chr21:43515728	C21orf128	chr21:43522244-43528644:-	0.49	8.1	4.11E-15	IgG glycosylation	
KIRC	cis	1	rs55657382	chr11:46634963	MDK	chr11:46402334-46405374:+	-0.21	-3.58	0.00038	Schizophrenia	
KIRC	cis	1	rs55674647	chr17:61794195	FTSJ3	chr17:61896795-61905031:-	0.33	6.25	8.74E-10	Body mass index	
KIRC	cis	1	rs55674647	chr17:61794195	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.3	2.02E-5	Body mass index	
KIRC	cis	1	rs55675294	chr3:128043050	RUVBL1	chr3:127783627-127872757:-	0.29	4.18	3.37E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55684215	chr3:127812792	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55722539	chr14:88878035	SPATA7	chr14:88852012-88904802:+	-0.2	-4.03	6.44E-5	Coronary artery calcification	
KIRC	cis	1	rs55737216	chr9:100695901	C9orf156	chr9:100666772-100684852:-	-0.29	-6.47	2.38E-10	Quantitative traits	
KIRC	cis	1	rs55744319	chr19:15981821	CYP4F11	chr19:16023180-16045676:-	-0.37	-6.04	3.04E-9	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs55744319	chr19:15981821	CYP4F2	chr19:15988834-16008884:-	-0.2	-3.65	0.000292	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs55752096	chr18:48368918	MRO	chr18:48321491-48351754:-	0.32	5.48	6.91E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.27	-5.66	2.5E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs55761949	chr11:77993860	NARS2	chr11:78147017-78285909:-	-0.18	-3.91	0.000106	Testicular germ cell tumor	
KIRC	cis	1	rs55762587	chr5:64436355	PPWD1	chr5:64859131-64883368:+	-0.27	-4.34	1.73E-5	Schizophrenia	
KIRC	cis	1	rs55762931	chr3:127847675	RPN1	chr3:128338813-128399918:-	0.23	4.02	6.76E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55762931	chr3:127847675	RUVBL1	chr3:127783627-127872757:-	0.32	4.7	3.31E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55766457	chr6:88220667	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs55775340	chr6:33751784	LEMD2	chr6:33738991-33756906:-	0.23	5.34	1.38E-7	Body mass index	
KIRC	cis	1	rs55781567	chr15:78857986	CHRNA3	chr15:78885397-78913322:-	-0.23	-3.86	0.000127	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55781567	chr15:78857986	CHRNA5	chr15:78857906-78886458:+	-0.36	-7	8.25E-12	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55786720	chr6:56783647	BEND6	chr6:56819773-56892138:+	-0.26	-5.41	9.81E-8	Menarche (age at onset)	
KIRC	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.16	4.94	1.06E-6	Lung cancer	
KIRC	cis	1	rs55821258	chr8:96292041	C8orf37	chr8:96258235-96281437:-	0.4	4.58	5.88E-6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
KIRC	cis	1	rs55822577	chr6:163069710	PACRG	chr6:163148164-163736523:+	0.58	6.6	1.04E-10	Body mass index	
KIRC	cis	1	rs55825352	chr11:78034424	NARS2	chr11:78147017-78285909:-	-0.2	-4.24	2.64E-5	Testicular germ cell tumor	
KIRC	cis	1	rs55826501	chr1:2059143	SLC35E2	chr1:1590990-1677431:-	0.18	3.86	0.000128	Height	
KIRC	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.48	10.05	8.96E-22	Body mass index	
KIRC	cis	1	rs55838263	chr1:200874728	KIF21B	chr1:200938520-200992828:-	0.13	4.08	5.14E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs55838400	chr3:122032293	WDR5B	chr3:122130700-122134882:-	0.29	4.44	1.12E-5	Serum parathyroid hormone levels	
KIRC	cis	1	rs55842567	chr5:437586	C5orf55	chr5:441645-443258:-	0.3	5.87	8.14E-9	Cystic fibrosis severity	
KIRC	cis	1	rs55842567	chr5:437586	LOC25845	chr5:470626-473080:-	0.39	6.22	1.04E-9	Cystic fibrosis severity	
KIRC	cis	1	rs55842567	chr5:437586	PDCD6	chr5:271736-315089:+	-0.17	-3.5	0.000515	Cystic fibrosis severity	
KIRC	cis	1	rs55842567	chr5:437586	SDHA	chr5:218356-256812:+	-0.19	-3.5	0.000502	Cystic fibrosis severity	
KIRC	cis	1	rs55842567	chr5:437586	SLC9A3	chr5:473334-524549:-	0.29	5.32	1.58E-7	Cystic fibrosis severity	
KIRC	cis	1	rs55842567	chr5:437586	TPPP	chr5:659978-693510:-	0.19	3.61	0.000337	Cystic fibrosis severity	
KIRC	cis	1	rs55847558	chr11:59903793	MS4A2	chr11:59856137-59866014:+	0.17	3.59	0.000369	Alzheimer's disease (late onset)	
KIRC	cis	1	rs55847707	chr6:163003414	PACRG	chr6:163148164-163736523:+	0.46	6.1	2.09E-9	Body mass index	
KIRC	cis	1	rs55848977	chr8:89444200	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs55853058	chr5:64436298	PPWD1	chr5:64859131-64883368:+	-0.26	-4.17	3.53E-5	Schizophrenia	
KIRC	cis	1	rs55868506	chr17:61851686	FTSJ3	chr17:61896795-61905031:-	0.32	6.31	6.02E-10	Body mass index	
KIRC	cis	1	rs55868506	chr17:61851686	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.66	4.1E-6	Body mass index	
KIRC	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.37	-10.74	2.33E-24	Response to temozolomide	
KIRC	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.42	-8.67	5.82E-17	Inflammatory skin disease	
KIRC	cis	1	rs55879323	chr1:152168740	HRNR	chr1:152184558-152196669:-	0.44	8.68	5.77E-17	Inflammatory skin disease	
KIRC	cis	1	rs55880748	chr6:88338586	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs55895244	chr7:65387678	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs55905547	chr20:57589995	TH1L	chr20:57556311-57570186:+	-0.52	-7.75	5.12E-14	Mean platelet volume	
KIRC	cis	1	rs55912359	chr1:114167099	PHTF1	chr1:114239824-114302098:-	0.29	6.17	1.41E-9	Bacteremia	
KIRC	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.6	14.67	8.2E-41	Height	
KIRC	cis	1	rs55913793	chr3:134285968	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.34E-11	Height	
KIRC	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.81	8.47	2.69E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs55925538	chr3:128042877	KBTBD12	chr3:127634318-127706513:+	0.27	3.67	0.00027	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55925538	chr3:128042877	RUVBL1	chr3:127783627-127872757:-	0.31	4.31	1.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55931012	chr9:136949669	BRD3	chr9:136895454-136933655:-	-0.22	-4.5	8.46E-6	Platelet count	
KIRC	cis	1	rs55934348	chr2:99246885	UNC50	chr2:99225042-99234975:+	-0.24	-3.92	0.000102	Bipolar disorder	
KIRC	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.29	-5.84	9.27E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs55938093	chr3:56620172	CCDC66	chr3:56591184-56655846:+	-0.12	-3.61	0.000343	Height	
KIRC	cis	1	rs55939327	chr4:17642937	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.75E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs55939327	chr4:17642937	MED28	chr4:17616273-17629791:+	0.18	3.98	7.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs55941863	chr7:157372989	DNAJB6	chr7:157129710-157210132:+	0.25	3.6	0.000353	Myopia (pathological)	
KIRC	cis	1	rs55942364	chr15:56512961	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs55942649	chr1:179482604	C1orf125	chr1:179335107-179523868:+	0.33	4.1	4.89E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.29	-5.96	4.73E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs559476	chr1:183160704	LAMC2	chr1:183155174-183214262:+	0.28	5.99	3.91E-9	Hypertriglyceridemia	
KIRC	cis	1	rs55957636	chr15:56526620	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs55960393	chr6:88221391	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs55962025	chr4:3112109	GRK4	chr4:2965343-3042474:+	-0.2	-3.56	0.000409	Parental longevity (mother's age at death)	
KIRC	cis	1	rs55971458	chr17:28427016	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs55972015	chr11:71642576	C11orf59	chr11:71808339-71814322:-	-0.22	-3.8	0.00016	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs55973978	chr2:219913814	USP37	chr2:219314974-219433084:-	-0.25	-3.74	0.000206	Height	
KIRC	cis	1	rs55976357	chr5:132194565	LEAP2	chr5:132209358-132210581:+	0.37	5.76	1.5E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs55976357	chr5:132194565	SHROOM1	chr5:132158012-132166590:-	0.32	5.92	6.07E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs55989768	chr3:128043004	RUVBL1	chr3:127783627-127872757:-	0.29	4.18	3.37E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs55990776	chr12:124447466	CCDC92	chr12:124420955-124457163:-	0.2	5.36	1.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs559946	chr11:64358605	SLC22A12	chr11:64358282-64369820:+	0.17	4.68	3.7E-6	Urate levels in obese individuals	
KIRC	cis	1	rs55998153	chr1:179453824	C1orf125	chr1:179335107-179523868:+	0.46	5.35	1.35E-7	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs56004802	chr10:1159187	IDI2	chr10:1064847-1071799:-	0.32	3.59	0.000358	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs56005196	chr15:56519009	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs56006038	chr2:219913837	FAM134A	chr2:220042939-220050190:+	-0.27	-3.56	0.000401	Height	
KIRC	cis	1	rs56006038	chr2:219913837	USP37	chr2:219314974-219433084:-	-0.24	-3.96	8.61E-5	Height	
KIRC	cis	1	rs56015036	chr10:17226767	TRDMT1	chr10:17184983-17243681:-	-0.34	-7.82	3.21E-14	Homocysteine levels	
KIRC	cis	1	rs56015123	chr15:50977228	SPPL2A	chr15:50999739-51057910:-	0.29	7.35	8.18E-13	QT interval	
KIRC	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.29	5.7	2.09E-8	Diabetic kidney disease	
KIRC	cis	1	rs56016656	chr7:65383481	CRCP	chr7:65579805-65619551:+	-0.3	-4.08	5.34E-5	Diabetic kidney disease	
KIRC	cis	1	rs56028644	chr19:17388790	ANKLE1	chr19:17392454-17398454:+	0.19	4.04	6.23E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs56030203	chr6:56783857	BEND6	chr6:56819773-56892138:+	-0.26	-5.41	9.81E-8	Menarche (age at onset)	
KIRC	cis	1	rs56033548	chr2:219936494	FAM134A	chr2:220042939-220050190:+	-0.3	-3.67	0.000273	Height	
KIRC	cis	1	rs56033548	chr2:219936494	USP37	chr2:219314974-219433084:-	-0.27	-4.16	3.72E-5	Height	
KIRC	cis	1	rs56040780	chr16:28861881	EIF3C	chr16:28722782-28747052:+;chr16	0.22	4.03	6.33E-5	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.36	6.95	1.17E-11	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs56040780	chr16:28861881	SULT1A2	chr16:28603266-28608391:-	0.3	6.44	2.77E-10	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs56040780	chr16:28861881	TUFM	chr16:28853732-28857729:-	0.24	6.68	6.44E-11	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs56042615	chr5:437667	C5orf55	chr5:441645-443258:-	0.3	5.87	8.14E-9	Cystic fibrosis severity	
KIRC	cis	1	rs56042615	chr5:437667	LOC25845	chr5:470626-473080:-	0.39	6.22	1.04E-9	Cystic fibrosis severity	
KIRC	cis	1	rs56042615	chr5:437667	PDCD6	chr5:271736-315089:+	-0.17	-3.5	0.000515	Cystic fibrosis severity	
KIRC	cis	1	rs56042615	chr5:437667	SDHA	chr5:218356-256812:+	-0.19	-3.5	0.000502	Cystic fibrosis severity	
KIRC	cis	1	rs56042615	chr5:437667	SLC9A3	chr5:473334-524549:-	0.29	5.32	1.58E-7	Cystic fibrosis severity	
KIRC	cis	1	rs56042615	chr5:437667	TPPP	chr5:659978-693510:-	0.19	3.61	0.000337	Cystic fibrosis severity	
KIRC	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.79	-17.25	1.09E-52	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs56057198	chr17:61733332	FTSJ3	chr17:61896795-61905031:-	0.33	6.27	7.62E-10	Body mass index	
KIRC	cis	1	rs56057198	chr17:61733332	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.33	1.8E-5	Body mass index	
KIRC	cis	1	rs56060232	chr14:104386165	TDRD9	chr14:104394817-104519002:+	0.25	3.75	0.000194	Bipolar disorder	
KIRC	cis	1	rs56060232	chr14:104386165	XRCC3	chr14:104163955-104181823:-	-0.12	-3.68	0.000257	Bipolar disorder	
KIRC	cis	1	rs56069965	chr15:50966973	SPPL2A	chr15:50999739-51057910:-	0.27	7.07	5.26E-12	QT interval	
KIRC	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.36	-7.17	2.77E-12	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs56080544	chr15:50950970	SPPL2A	chr15:50999739-51057910:-	0.28	7.17	2.72E-12	QT interval	
KIRC	cis	1	rs56083605	chr15:56512949	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs56097052	chr5:132194430	LEAP2	chr5:132209358-132210581:+	0.31	5.1	4.73E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs56097052	chr5:132194430	SHROOM1	chr5:132158012-132166590:-	0.27	5.34	1.39E-7	Apolipoprotein A-IV levels	
KIRC	cis	1	rs56098064	chr14:50105849	RPL36AL	chr14:50085407-50087349:-	0.32	7.45	4.02E-13	Carotid intima media thickness	
KIRC	cis	1	rs56101873	chr1:119474790	WARS2	chr1:119573841-119683295:-	0.31	4.87	1.51E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs56104203	chr2:86336256	LOC90784	chr2:86247339-86250991:-	-0.35	-3.62	0.000321	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs56104584	chr5:437542	C5orf55	chr5:441645-443258:-	0.3	5.87	8.14E-9	Cystic fibrosis severity	
KIRC	cis	1	rs56104584	chr5:437542	LOC25845	chr5:470626-473080:-	0.39	6.22	1.04E-9	Cystic fibrosis severity	
KIRC	cis	1	rs56104584	chr5:437542	PDCD6	chr5:271736-315089:+	-0.17	-3.5	0.000515	Cystic fibrosis severity	
KIRC	cis	1	rs56104584	chr5:437542	SDHA	chr5:218356-256812:+	-0.19	-3.5	0.000502	Cystic fibrosis severity	
KIRC	cis	1	rs56104584	chr5:437542	SLC9A3	chr5:473334-524549:-	0.29	5.32	1.58E-7	Cystic fibrosis severity	
KIRC	cis	1	rs56104584	chr5:437542	TPPP	chr5:659978-693510:-	0.19	3.61	0.000337	Cystic fibrosis severity	
KIRC	cis	1	rs56113315	chr19:39184166	CAPN12	chr19:39220832-39235114:-	-0.13	-3.99	7.69E-5	Heart rate	
KIRC	cis	1	rs56118429	chr15:50923849	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.63E-14	QT interval	
KIRC	cis	1	rs56118429	chr15:50923849	TRPM7	chr15:50852491-50978994:-	0.13	3.75	0.000199	QT interval	
KIRC	cis	1	rs56119980	chr4:39141010	KLB	chr4:39408473-39453151:+	0.2	3.51	0.000486	Uric acid levels	
KIRC	cis	1	rs56119980	chr4:39141010	WDR19	chr4:39184024-39287429:+	0.18	4.72	3.1E-6	Uric acid levels	
KIRC	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.72	9.41	1.78E-19	Diastolic blood pressure	
KIRC	cis	1	rs56127630	chr3:49438036	CCDC36	chr3:49235861-49295537:+	-0.25	-4.63	4.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs56127630	chr3:49438036	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.49	8.8E-6	Menarche (age at onset)	
KIRC	cis	1	rs56127630	chr3:49438036	P4HTM	chr3:49027341-49044579:+	-0.21	-4.73	2.86E-6	Menarche (age at onset)	
KIRC	cis	1	rs56127630	chr3:49438036	TREX1	chr3:48501186-48509043:+	0.15	3.72	0.000224	Menarche (age at onset)	
KIRC	cis	1	rs56127630	chr3:49438036	WDR6	chr3:49044637-49053386:+	0.2	4.96	9.58E-7	Menarche (age at onset)	
KIRC	cis	1	rs56131635	chr20:47774343	CSE1L	chr20:47662838-47713484:+	0.18	4.73	2.91E-6	Anger	
KIRC	cis	1	rs56138298	chr22:22316540	MAPK1	chr22:22113949-22221970:-	0.19	4.46	9.97E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs56138298	chr22:22316540	YPEL1	chr22:22051828-22090071:-	0.2	3.75	0.000201	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs56139710	chr1:27269788	PIGV	chr1:27114455-27124886:+	-0.33	-3.96	8.72E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs56145559	chr2:73623439	TPRKB	chr2:73956957-73964517:-	-0.2	-5.07	5.52E-7	Schizophrenia	
KIRC	cis	1	rs56154726	chr2:73721767	TPRKB	chr2:73956957-73964517:-	-0.21	-5.32	1.57E-7	Metabolite levels	
KIRC	cis	1	rs56156930	chr15:56485411	TEX9	chr15:56657644-56738071:+	-0.28	-4.92	1.17E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs56157864	chr5:132267859	LEAP2	chr5:132209358-132210581:+	0.35	5.63	3.05E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs56157864	chr5:132267859	SHROOM1	chr5:132158012-132166590:-	0.31	6.08	2.35E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.72	9.41	1.78E-19	Diastolic blood pressure	
KIRC	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.29	-5.85	8.98E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs56184857	chr1:119468861	WARS2	chr1:119573841-119683295:-	0.31	4.85	1.68E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs56190030	chr1:11887382	NPPA	chr1:11905769-11907840:-	-0.2	-3.63	0.000309	QRS complex (12-leadsum)	
KIRC	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.71	8.71	4.42E-17	Diastolic blood pressure	
KIRC	cis	1	rs56215018	chr15:56526648	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs562179	chr11:116805204	PCSK7	chr11:117075789-117102811:-	-0.27	-5.19	2.99E-7	Protein quantitative trait loci	
KIRC	cis	1	rs56222556	chr2:242364119	ANO7	chr2:242127924-242164791:+	0.25	3.52	0.00047	Prostate cancer	
KIRC	cis	1	rs56227395	chr2:54487496	ACYP2	chr2:54342410-54532433:+	-0.19	-3.73	0.000213	Telomere length	
KIRC	cis	1	rs562469	chr11:71569843	C11orf59	chr11:71808339-71814322:-	0.22	3.84	0.000139	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs56280226	chr17:28429575	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs56287882	chr3:128030343	KBTBD12	chr3:127634318-127706513:+	0.28	3.81	0.000158	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs56287882	chr3:128030343	RUVBL1	chr3:127783627-127872757:-	0.34	4.67	3.82E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.28	5.64	2.84E-8	Diabetic kidney disease	
KIRC	cis	1	rs56291018	chr7:65390339	CRCP	chr7:65579805-65619551:+	-0.3	-4.14	4.1E-5	Diabetic kidney disease	
KIRC	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.2	3.95	8.8E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs56297666	chr2:160902023	PLA2R1	chr2:160798012-160919121:-	0.2	4	7.16E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs563026	chr1:183161037	LAMC2	chr1:183155174-183214262:+	-0.28	-6.12	1.89E-9	Hypertriglyceridemia	
KIRC	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.26	5.33	1.46E-7	Height	
KIRC	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.28	7.62	1.23E-13	Height	
KIRC	cis	1	rs56308330	chr4:17643050	LAP3	chr4:17578927-17609590:+	-0.2	-6.27	7.69E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs56308330	chr4:17643050	MED28	chr4:17616273-17629791:+	0.18	4.04	6.13E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.35	6.75	4.07E-11	Cognitive performance	
KIRC	cis	1	rs56315277	chr6:160163213	PNLDC1	chr6:160221301-160241735:+	0.44	3.49	0.00052	Iron status biomarkers	
KIRC	cis	1	rs56317427	chr10:81861934	MBL1P	chr10:81664654-81710783:+	0.28	4	7.17E-5	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.29	-5.75	1.52E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.24	6.65	7.72E-11	Blood metabolite levels	
KIRC	cis	1	rs56324438	chr8:89440456	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.000102	Electrodermal activity	
KIRC	cis	1	rs56328893	chr3:128041830	KBTBD12	chr3:127634318-127706513:+	0.28	3.73	0.00021	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs56328893	chr3:128041830	RUVBL1	chr3:127783627-127872757:-	0.31	4.3	2.04E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs56345933	chr2:219913735	FAM134A	chr2:220042939-220050190:+	-0.27	-3.56	0.000401	Height	
KIRC	cis	1	rs56345933	chr2:219913735	USP37	chr2:219314974-219433084:-	-0.24	-3.96	8.61E-5	Height	
KIRC	cis	1	rs56348638	chr17:53064550	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.92	0.000102	Breast cancer	
KIRC	cis	1	rs56364559	chr7:77480561	PTPN12	chr7:77166773-77269388:+	-0.14	-3.74	0.000208	Glomerular filtration rate (creatinine);Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs56383601	chr17:61929968	FTSJ3	chr17:61896795-61905031:-	0.33	6.45	2.7E-10	Body mass index	
KIRC	cis	1	rs56383601	chr17:61929968	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.52	7.79E-6	Body mass index	
KIRC	cis	1	rs56388436	chr2:219958903	USP37	chr2:219314974-219433084:-	-0.27	-4.05	5.94E-5	Height	
KIRC	cis	1	rs56390833	chr15:78877381	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.84	2.25E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs563920	chr12:121017439	COQ5	chr12:120941083-120966964:-	0.21	3.82	0.000153	Type 1 diabetes nephropathy	
KIRC	cis	1	rs563920	chr12:121017439	POP5	chr12:121016849-121019201:-	-0.15	-3.6	0.000355	Type 1 diabetes nephropathy	
KIRC	cis	1	rs56392198	chr1:179451124	C1orf125	chr1:179335107-179523868:+	0.46	5.3	1.75E-7	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs56394211	chr10:17186447	TRDMT1	chr10:17184983-17243681:-	-0.34	-7.78	4.14E-14	Homocysteine levels	
KIRC	cis	1	rs56397023	chr5:125915779	LMNB1	chr5:126112833-126172709:+	0.18	3.94	9.33E-5	Osteoporosis	
KIRC	cis	1	rs56398703	chr15:56519486	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs564170	chr11:71569979	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.7E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.39	11.57	1.29E-27	Response to temozolomide	
KIRC	cis	1	rs56658648	chr8:120939638	TNFRSF11B	chr8:119935797-119964383:-	0.25	3.8	0.000165	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs566625	chr1:183161441	LAMC2	chr1:183155174-183214262:+	0.32	6.76	3.95E-11	Hypertriglyceridemia	
KIRC	cis	1	rs56672945	chr2:73622663	TPRKB	chr2:73956957-73964517:-	-0.18	-4.65	4.17E-6	Metabolite levels	
KIRC	cis	1	rs56765024	chr2:198876286	RFTN2	chr2:198435528-198540584:-	0.16	4.51	8.26E-6	Ulcerative colitis	
KIRC	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.39	11.57	1.29E-27	Response to temozolomide	
KIRC	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.72	10.32	9.0E-23	Diastolic blood pressure	
KIRC	cis	1	rs56850662	chr3:128061922	RUVBL1	chr3:127783627-127872757:-	0.3	4.32	1.91E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.47	-13.64	3.03E-36	Crohn's disease	
KIRC	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.45	7.72	6.4E-14	Crohn's disease	
KIRC	cis	1	rs56864281	chr15:85357649	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.56	6.56E-6	Schizophrenia	
KIRC	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.19	-3.59	0.000359	Schizophrenia	
KIRC	cis	1	rs56871534	chr4:76510197	CDKL2	chr4:76501705-76555721:-	0.16	3.56	0.000407	Magnesium levels	
KIRC	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.28	-6.61	9.55E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.79	-19.24	3.16E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs56922390	chr17:38157021	MED24	chr17:38175351-38210889:-	-0.15	-3.55	0.000425	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.38	11.06	1.29E-25	Response to temozolomide	
KIRC	cis	1	rs56932185	chr1:27056643	PIGV	chr1:27114455-27124886:+	-0.38	-4.31	2.0E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs56974987	chr4:17627856	LAP3	chr4:17578927-17609590:+	-0.21	-6.64	8.08E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs56974987	chr4:17627856	MED28	chr4:17616273-17629791:+	0.19	4.25	2.6E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	0.19	4.51	7.96E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs56985706	chr7:65394562	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs56987357	chr14:88824363	SPATA7	chr14:88852012-88904802:+	-0.19	-3.99	7.46E-5	Coronary artery calcification	
KIRC	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	0.19	4.51	7.96E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs57001853	chr5:150272452	IRGM	chr5:150226085-150280295:+	0.49	6.71	5.23E-11	Crohn's disease	
KIRC	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.31	4.1	4.76E-5	Crohn's disease	
KIRC	cis	1	rs57002197	chr15:50873760	SPPL2A	chr15:50999739-51057910:-	0.28	7.36	7.8E-13	QT interval	
KIRC	cis	1	rs57002197	chr15:50873760	TRPM7	chr15:50852491-50978994:-	0.12	3.52	0.000464	QT interval	
KIRC	cis	1	rs57012661	chr14:66172750	LOC645431	chr14:65877313-65879335:-	-0.53	-6.87	1.95E-11	Ischemic stroke	
KIRC	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.13	-4.51	7.93E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.28	5.64	2.9E-8	Diabetic kidney disease	
KIRC	cis	1	rs57057549	chr7:65405738	CRCP	chr7:65579805-65619551:+	-0.3	-4.16	3.82E-5	Diabetic kidney disease	
KIRC	cis	1	rs57060498	chr2:54479230	ACYP2	chr2:54342410-54532433:+	-0.21	-3.8	0.000163	Telomere length	
KIRC	cis	1	rs57064725	chr15:78833036	CHRNA5	chr15:78857906-78886458:+	-0.3	-5.69	2.15E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs57075379	chr14:35577801	KIAA0391	chr14:35591776-35786673:+	0.25	4.21	3.09E-5	Atopic dermatitis	
KIRC	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.27	5.45	7.8E-8	Atopic dermatitis	
KIRC	cis	1	rs57092235	chr8:89451205	MMP16	chr8:89049462-89339717:-	0.3	3.89	0.000113	Electrodermal activity	
KIRC	cis	1	rs57137641	chr12:56741228	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000352	Psoriasis vulgaris	
KIRC	cis	1	rs57137641	chr12:56741228	RPS26	chr12:56435686-56438005:+	-0.52	-4.5	8.59E-6	Psoriasis vulgaris	
KIRC	cis	1	rs57201867	chr14:66093872	LOC645431	chr14:65877313-65879335:-	-0.52	-6.5	1.97E-10	Ischemic stroke	
KIRC	cis	1	rs572169	chr3:172165727	FNDC3B	chr3:171757418-172118490:+	-0.15	-3.61	0.000343	Height	
KIRC	cis	1	rs57217461	chr1:27027916	PIGV	chr1:27114455-27124886:+	-0.39	-4.34	1.72E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs57279772	chr12:56698960	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs57279772	chr12:56698960	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs57283474	chr8:89410289	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs57294261	chr10:81729342	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs57307201	chr17:40572793	NAGLU	chr17:40687951-40696464:+	-0.18	-3.59	0.000361	Crohn's disease	
KIRC	cis	1	rs573211	chr11:120044762	OAF	chr11:120081747-120100649:+	0.19	4.18	3.46E-5	Corneal curvature	
KIRC	cis	1	rs57360215	chr10:81728290	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs57406211	chr5:150170966	IRGM	chr5:150226085-150280295:+	0.66	8.09	4.57E-15	Crohn's disease	
KIRC	cis	1	rs57406211	chr5:150170966	LOC134466	chr5:150310000-150326146:-	0.41	4.96	9.8E-7	Crohn's disease	
KIRC	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.36	6.22	1.07E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs57411618	chr17:28273052	SSH2	chr17:27952965-28257018:-	0.16	3.61	0.000336	Coffee consumption (cups per day)	
KIRC	cis	1	rs57415683	chr13:36684221	SOHLH2	chr13:36742347-36871992:-	0.3	4.31	2.0E-5	Optic cup area	
KIRC	cis	1	rs5743112	chr2:190708982	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.61	5.01E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs5743117	chr2:190714245	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.61	5.01E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs5743202	chr2:190742666	ASNSD1	chr2:190526125-190535556:+	-0.3	-3.9	0.000111	Subcutaneous adipose tissue	
KIRC	cis	1	rs5743208	chr2:190743048	ASNSD1	chr2:190526125-190535556:+	0.33	4.8	2.07E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs57434520	chr5:115648765	COMMD10	chr5:115420727-115628978:+	0.26	3.53	0.000446	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs5745343	chr1:76273805	MSH4	chr1:76262630-76378923:+	0.24	3.84	0.000136	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs5745354	chr1:76275178	MSH4	chr1:76262630-76378923:+	0.22	3.53	0.000461	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs5745542	chr1:76365073	MSH4	chr1:76262630-76378923:+	-0.29	-4.38	1.47E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs57461652	chr11:118146197	MPZL2	chr11:118124135-118135009:-	-0.15	-3.66	0.000284	Pain	
KIRC	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.77	11.64	6.7E-28	Diastolic blood pressure	
KIRC	cis	1	rs5748871	chr22:17603477	IL17RA	chr22:17565849-17591387:+	-0.13	-3.5	0.000501	Discordance in emotional problems in monozygotic twins	
KIRC	cis	1	rs5749806	chr22:22106618	MAPK1	chr22:22113949-22221970:-	0.19	5.35	1.33E-7	Multiple sclerosis	
KIRC	cis	1	rs5749986	chr22:22157661	MAPK1	chr22:22113949-22221970:-	-0.2	-5.81	1.13E-8	Multiple sclerosis	
KIRC	cis	1	rs5750621	chr22:38956166	BAIAP2L2	chr22:38480897-38506676:-	0.16	3.96	8.64E-5	Resting heart rate	
KIRC	cis	1	rs5750621	chr22:38956166	LOC646851	chr22:38974125-39052634:-	0.14	3.99	7.49E-5	Resting heart rate	
KIRC	cis	1	rs5750622	chr22:38956464	LOC646851	chr22:38974125-39052634:-	0.13	3.84	0.000137	Resting heart rate	
KIRC	cis	1	rs5750626	chr22:38977890	BAIAP2L2	chr22:38480897-38506676:-	0.16	3.93	9.72E-5	Resting heart rate	
KIRC	cis	1	rs5750626	chr22:38977890	LOC646851	chr22:38974125-39052634:-	0.13	3.93	9.53E-5	Resting heart rate	
KIRC	cis	1	rs5750627	chr22:38982321	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.94	9.16E-5	Resting heart rate	
KIRC	cis	1	rs5750627	chr22:38982321	LOC646851	chr22:38974125-39052634:-	0.13	4.18	3.51E-5	Resting heart rate	
KIRC	cis	1	rs5750630	chr22:38985818	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.61	0.000334	Resting heart rate	
KIRC	cis	1	rs5750630	chr22:38985818	LOC646851	chr22:38974125-39052634:-	0.13	3.87	0.000122	Resting heart rate	
KIRC	cis	1	rs5750633	chr22:38993467	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.77	0.000182	Resting heart rate	
KIRC	cis	1	rs5750633	chr22:38993467	LOC646851	chr22:38974125-39052634:-	0.13	4.19	3.29E-5	Resting heart rate	
KIRC	cis	1	rs57506367	chr11:118141993	MPZL2	chr11:118124135-118135009:-	-0.15	-3.66	0.000278	Pain	
KIRC	cis	1	rs5750649	chr22:39036769	BAIAP2L2	chr22:38480897-38506676:-	0.13	3.52	0.000473	Resting heart rate	
KIRC	cis	1	rs5750649	chr22:39036769	LOC646851	chr22:38974125-39052634:-	0.13	4	7.27E-5	Resting heart rate	
KIRC	cis	1	rs5750652	chr22:39048316	BAIAP2L2	chr22:38480897-38506676:-	0.13	3.52	0.000473	Resting heart rate	
KIRC	cis	1	rs5750652	chr22:39048316	LOC646851	chr22:38974125-39052634:-	0.13	4	7.27E-5	Resting heart rate	
KIRC	cis	1	rs5750659	chr22:39068789	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs5750662	chr22:39072472	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs5750664	chr22:39072769	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs5750668	chr22:39079964	LOC646851	chr22:38974125-39052634:-	0.13	3.87	0.000123	Resting heart rate	
KIRC	cis	1	rs5750669	chr22:39080638	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.74	0.000207	Resting heart rate	
KIRC	cis	1	rs5750669	chr22:39080638	LOC646851	chr22:38974125-39052634:-	0.13	3.76	0.000193	Resting heart rate	
KIRC	cis	1	rs5750671	chr22:39094619	LOC646851	chr22:38974125-39052634:-	0.11	3.55	0.000422	Resting heart rate	
KIRC	cis	1	rs5750672	chr22:39104168	BAIAP2L2	chr22:38480897-38506676:-	-0.15	-3.91	0.000105	Resting heart rate	
KIRC	cis	1	rs5750672	chr22:39104168	LOC646851	chr22:38974125-39052634:-	-0.13	-4.11	4.65E-5	Resting heart rate	
KIRC	cis	1	rs5750673	chr22:39110124	LOC646851	chr22:38974125-39052634:-	0.13	3.78	0.000177	Resting heart rate	
KIRC	cis	1	rs5750677	chr22:39147715	LOC646851	chr22:38974125-39052634:-	0.12	3.62	0.000327	Resting heart rate	
KIRC	cis	1	rs5751255	chr22:42648408	C22orf32	chr22:42475699-42480287:+	0.24	6.02	3.44E-9	Cognitive function	
KIRC	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.25	-7.13	3.62E-12	Cognitive function	
KIRC	cis	1	rs57514701	chr10:1146169	IDI2	chr10:1064847-1071799:-	0.32	3.65	0.000294	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs5752326	chr22:26843990	HPS4	chr22:26847447-26879820:-	0.26	3.56	0.000402	Ischemic stroke	
KIRC	cis	1	rs5752327	chr22:26844070	HPS4	chr22:26847447-26879820:-	0.26	3.65	0.000286	Ischemic stroke	
KIRC	cis	1	rs57535407	chr11:46570286	MDK	chr11:46402334-46405374:+	-0.21	-3.56	0.000409	Schizophrenia	
KIRC	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.28	-5.67	2.42E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs575474	chr1:183158599	LAMC2	chr1:183155174-183214262:+	0.29	6.2	1.2E-9	Hypertriglyceridemia	
KIRC	cis	1	rs5756813	chr22:38175477	TRIOBP	chr22:38082344-38172562:+	-0.36	-7.99	9.38E-15	Optic cup area;Vertical cup-disc ratio	
KIRC	cis	1	rs5757141	chr22:38957483	BAIAP2L2	chr22:38480897-38506676:-	0.17	4.1	4.8E-5	Resting heart rate	
KIRC	cis	1	rs5757141	chr22:38957483	LOC646851	chr22:38974125-39052634:-	0.14	3.88	0.000117	Resting heart rate	
KIRC	cis	1	rs5757162	chr22:38993370	BAIAP2L2	chr22:38480897-38506676:-	0.16	3.9	0.00011	Resting heart rate	
KIRC	cis	1	rs5757162	chr22:38993370	LOC646851	chr22:38974125-39052634:-	0.15	4.32	1.91E-5	Resting heart rate	
KIRC	cis	1	rs5757166	chr22:38995385	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.77	0.000182	Resting heart rate	
KIRC	cis	1	rs5757166	chr22:38995385	LOC646851	chr22:38974125-39052634:-	0.13	4.19	3.29E-5	Resting heart rate	
KIRC	cis	1	rs5757181	chr22:39013522	BAIAP2L2	chr22:38480897-38506676:-	0.16	4.01	7.11E-5	Resting heart rate	
KIRC	cis	1	rs5757181	chr22:39013522	LOC646851	chr22:38974125-39052634:-	0.14	4.19	3.36E-5	Resting heart rate	
KIRC	cis	1	rs5757187	chr22:39021522	BAIAP2L2	chr22:38480897-38506676:-	-0.14	-3.61	0.000333	Resting heart rate	
KIRC	cis	1	rs5757187	chr22:39021522	LOC646851	chr22:38974125-39052634:-	-0.14	-4.29	2.19E-5	Resting heart rate	
KIRC	cis	1	rs5757193	chr22:39034867	BAIAP2L2	chr22:38480897-38506676:-	-0.15	-3.67	0.000269	Resting heart rate	
KIRC	cis	1	rs5757193	chr22:39034867	LOC646851	chr22:38974125-39052634:-	-0.14	-4.16	3.73E-5	Resting heart rate	
KIRC	cis	1	rs5757196	chr22:39039855	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757200	chr22:39043491	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757203	chr22:39044152	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757204	chr22:39046700	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757208	chr22:39049230	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757211	chr22:39051705	LOC646851	chr22:38974125-39052634:-	0.14	4.28	2.25E-5	Resting heart rate	
KIRC	cis	1	rs5757213	chr22:39053888	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs5757226	chr22:39070550	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs5757231	chr22:39071658	LOC646851	chr22:38974125-39052634:-	-0.14	-4.25	2.6E-5	Resting heart rate	
KIRC	cis	1	rs5757232	chr22:39071677	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs5757234	chr22:39072686	LOC646851	chr22:38974125-39052634:-	0.12	3.74	0.000203	Resting heart rate	
KIRC	cis	1	rs5757253	chr22:39104320	LOC646851	chr22:38974125-39052634:-	0.11	3.55	0.000415	Resting heart rate	
KIRC	cis	1	rs57576577	chr16:31036367	MYST1	chr16:31128985-31142713:+	0.15	3.96	8.49E-5	Response to metformin (IC50)	
KIRC	cis	1	rs5757673	chr22:39837920	APOBEC3A	chr22:39353527-39388783:+	-0.27	-4.4	1.31E-5	Post bronchodilator FEV1	
KIRC	cis	1	rs5758659	chr22:42622003	C22orf32	chr22:42475699-42480287:+	0.24	6.11	2.06E-9	Cognitive function	
KIRC	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.26	-7.44	4.47E-13	Cognitive function	
KIRC	cis	1	rs5758660	chr22:42623718	C22orf32	chr22:42475699-42480287:+	0.24	6.11	1.94E-9	Cognitive function	
KIRC	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.26	-7.42	4.92E-13	Cognitive function	
KIRC	cis	1	rs5758677	chr22:42643039	C22orf32	chr22:42475699-42480287:+	0.24	6.05	2.78E-9	Cognitive function	
KIRC	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.26	-7.39	6.29E-13	Cognitive function	
KIRC	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.67	7.12	3.71E-12	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.72	7.45	4.18E-13	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.7	7.41	5.22E-13	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs5761529	chr22:26843708	HPS4	chr22:26847447-26879820:-	0.26	3.56	0.000402	Ischemic stroke	
KIRC	cis	1	rs5761530	chr22:26843916	HPS4	chr22:26847447-26879820:-	0.25	3.65	0.000285	Ischemic stroke	
KIRC	cis	1	rs576779	chr4:56274307	SRD5A3	chr4:56212409-56237866:+	0.19	4.24	2.65E-5	Personality dimensions	
KIRC	cis	1	rs576779	chr4:56274307	TMEM165	chr4:56262090-56292342:+	-0.22	-6.27	7.99E-10	Personality dimensions	
KIRC	cis	1	rs57678958	chr16:77785315	NUDT7	chr16:77756411-77776153:+	0.23	3.58	0.000373	Obesity-related traits	
KIRC	cis	1	rs57690120	chr20:33731437	PROCR	chr20:33758727-33765164:+	-0.27	-3.84	0.00014	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs576982	chr15:78870803	CHRNA5	chr15:78857906-78886458:+	-0.2	-3.7	0.000242	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs57699322	chr3:128065313	RUVBL1	chr3:127783627-127872757:-	0.3	4.37	1.53E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs5770917	chr22:51017353	CPT1B	chr22:51007291-51017096:-	-0.32	-5.89	6.98E-9	Narcolepsy	
KIRC	cis	1	rs5770922	chr22:51023408	CPT1B	chr22:51007291-51017096:-	-0.35	-5.72	1.81E-8	Narcolepsy	
KIRC	cis	1	rs5770924	chr22:51024542	CPT1B	chr22:51007291-51017096:-	-0.37	-6.16	1.54E-9	Narcolepsy	
KIRC	cis	1	rs5771109	chr22:50678571	CRELD2	chr22:50312283-50321186:+	0.15	3.63	0.000317	Obesity-related traits	
KIRC	cis	1	rs5771109	chr22:50678571	SELO	chr22:50639408-50656044:+	0.13	4.14	4.15E-5	Obesity-related traits	
KIRC	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.38	11.12	7.74E-26	Response to temozolomide	
KIRC	cis	1	rs57735707	chr3:128065815	KBTBD12	chr3:127634318-127706513:+	0.28	3.79	0.000168	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs57735707	chr3:128065815	RUVBL1	chr3:127783627-127872757:-	0.32	4.51	7.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs57738705	chr11:77994489	NARS2	chr11:78147017-78285909:-	-0.18	-3.9	0.000111	Testicular germ cell tumor	
KIRC	cis	1	rs57771217	chr8:89411860	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs578056	chr11:65514874	SNX32	chr11:65601410-65621170:+	0.26	4.49	9.03E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs57807215	chr8:89455068	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs57832572	chr12:8668281	CLEC4D	chr12:8666136-8674958:+	0.35	5.41	9.84E-8	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	
KIRC	cis	1	rs57844481	chr14:76684493	ESRRB	chr14:76837690-76968178:+	-0.37	-5.1	4.88E-7	Blood pressure	
KIRC	cis	1	rs57862275	chr11:22822055	SVIP	chr11:22843600-22851382:-	0.25	4.04	6.08E-5	Dialysis-related mortality	
KIRC	cis	1	rs57870697	chr12:56752874	RPS26	chr12:56435686-56438005:+	-0.51	-4.39	1.41E-5	Psoriasis vulgaris	
KIRC	cis	1	rs57912102	chr19:22136043	ZNF257	chr19:22235266-22273901:+	0.32	4.43	1.15E-5	Body mass index (change over time)	
KIRC	cis	1	rs57925408	chr8:96062930	C8orf38	chr8:95908040-96088396:+	-0.26	-3.99	7.51E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs57928699	chr18:44645593	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs57935196	chr16:77785314	NUDT7	chr16:77756411-77776153:+	0.23	3.58	0.000373	Obesity-related traits	
KIRC	cis	1	rs579890	chr11:116798963	PCSK7	chr11:117075789-117102811:-	-0.27	-5.1	4.71E-7	Protein quantitative trait loci	
KIRC	cis	1	rs57994353	chr9:139356987	SDCCAG3	chr9:139296375-139305054:-	-0.16	-3.6	0.000355	cutaneous squamous cell carcinoma	
KIRC	cis	1	rs580016	chr12:120933977	POP5	chr12:121016849-121019201:-	0.15	3.55	0.00042	Type 1 diabetes nephropathy	
KIRC	cis	1	rs580067	chr1:197298373	CFHR3	chr1:196743930-196762872:+	0.26	5.23	2.5E-7	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs58036957	chr15:56373056	TEX9	chr15:56657644-56738071:+	-0.26	-4.46	1.02E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs58059872	chr8:89451134	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs58062456	chr7:65394852	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs58069930	chr16:50067031	HEATR3	chr16:50099881-50139373:+	-0.28	-3.5	0.000509	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.4	11.61	9.19E-28	Response to temozolomide	
KIRC	cis	1	rs58088385	chr20:33748229	PROCR	chr20:33758727-33765164:+	-0.32	-4.16	3.79E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs58115860	chr14:66057626	LOC645431	chr14:65877313-65879335:-	-0.49	-6.33	5.33E-10	Ischemic stroke	
KIRC	cis	1	rs58162302	chr11:118146199	MPZL2	chr11:118124135-118135009:-	-0.15	-3.66	0.000284	Pain	
KIRC	cis	1	rs58164144	chr8:89437770	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs581686	chr10:105983356	C10orf79	chr10:105889647-105992120:-	0.18	4.47	9.73E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs58189451	chr6:149921388	NUP43	chr6:150045453-150067688:-	-0.38	-7.21	2.06E-12	Lung cancer	
KIRC	cis	1	rs58189451	chr6:149921388	RAET1E	chr6:150204512-150217195:-	0.22	4.37	1.52E-5	Lung cancer	
KIRC	cis	1	rs58204112	chr14:74359417	LIN52	chr14:74551656-74667117:+	0.25	4.42	1.23E-5	Morning vs. evening chronotype	
KIRC	cis	1	rs58204112	chr14:74359417	PTGR2	chr14:74318534-74352166:+	0.26	3.91	0.000106	Morning vs. evening chronotype	
KIRC	cis	1	rs58235466	chr11:78030886	NARS2	chr11:78147017-78285909:-	-0.16	-3.54	0.000437	Testicular germ cell tumor	
KIRC	cis	1	rs58242818	chr4:75699164	BTC	chr4:75671448-75719882:-	0.32	4.41	1.29E-5	Electroencephalogram traits	
KIRC	cis	1	rs58281712	chr4:89810956	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.63	0.000318	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs58289747	chr8:89414691	MMP16	chr8:89049462-89339717:-	0.33	4.21	3.05E-5	Electrodermal activity	
KIRC	cis	1	rs58336952	chr19:12057916	ZNF763	chr19:12035900-12091196:+	-0.46	-5.82	1.02E-8	Multiple sclerosis	
KIRC	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.45	9.45	1.25E-19	Schizophrenia (negative symptoms)	
KIRC	cis	1	rs58399951	chr8:89437490	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs58416181	chr15:85264461	GOLGA6L5	chr15:85047738-85060078:-	-0.17	-4.65	4.21E-6	Schizophrenia	
KIRC	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.22	-4.23	2.73E-5	Schizophrenia	
KIRC	cis	1	rs58421016	chr1:27070529	PIGV	chr1:27114455-27124886:+	-0.39	-4.56	6.36E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs584309	chr10:105956776	C10orf79	chr10:105889647-105992120:-	0.19	4.68	3.76E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs58436485	chr15:90900633	IQGAP1	chr15:90931473-91045475:+	0.16	4.1	4.81E-5	Rheumatoid arthritis	
KIRC	cis	1	rs58436485	chr15:90900633	TTLL13	chr15:90792764-90815443:+	0.25	3.91	0.000105	Rheumatoid arthritis	
KIRC	cis	1	rs58453379	chr8:89438243	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.29	-5.91	6.37E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs58507982	chr11:118146510	MPZL2	chr11:118124135-118135009:-	-0.15	-3.66	0.000284	Pain	
KIRC	cis	1	rs585228	chr11:71773289	C11orf59	chr11:71808339-71814322:-	-0.2	-3.65	0.000295	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs58549151	chr1:10314657	RBP7	chr1:10057255-10076077:+	0.15	3.6	0.000351	Hepatocellular carcinoma	
KIRC	cis	1	rs58565853	chr11:78036707	NARS2	chr11:78147017-78285909:-	-0.2	-4.58	5.94E-6	Testicular germ cell tumor	
KIRC	cis	1	rs58591218	chr19:32890782	ZNF507	chr19:32836514-32878571:+	0.18	3.67	0.00027	Bipolar disorder	
KIRC	cis	1	rs58602070	chr14:65849242	LOC645431	chr14:65877313-65879335:-	-0.42	-5.69	2.18E-8	Ischemic stroke	
KIRC	cis	1	rs58603761	chr2:73726605	TPRKB	chr2:73956957-73964517:-	-0.19	-5.01	7.56E-7	Metabolite levels	
KIRC	cis	1	rs58660500	chr3:53086573	RFT1	chr3:53122503-53164470:-	0.31	4.66	4.09E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs58660500	chr3:53086573	TMEM110	chr3:52867139-52931547:-	0.34	5.79	1.25E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.28	5.38	1.12E-7	Diabetic kidney disease	
KIRC	cis	1	rs58669269	chr7:65951953	CRCP	chr7:65579805-65619551:+	-0.33	-4.36	1.58E-5	Diabetic kidney disease	
KIRC	cis	1	rs58704470	chr10:81729390	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs58717741	chr5:150284936	IRGM	chr5:150226085-150280295:+	0.54	7.18	2.53E-12	Crohn's disease	
KIRC	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.39	5.22	2.61E-7	Crohn's disease	
KIRC	cis	1	rs58729171	chr16:77786018	NUDT7	chr16:77756411-77776153:+	0.23	3.59	0.000367	Obesity-related traits	
KIRC	cis	1	rs58741168	chr8:124191852	DERL1	chr8:124025568-124054648:-	0.33	3.66	0.000276	Urinary uromodulin levels	
KIRC	cis	1	rs58749629	chr20:44571317	PLTP	chr20:44527397-44540786:-	0.25	5.74	1.64E-8	Abdominal aortic aneurysm	
KIRC	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.47	-7.62	1.25E-13	Abdominal aortic aneurysm	
KIRC	cis	1	rs58754325	chr8:89441440	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000106	Electrodermal activity	
KIRC	cis	1	rs58852079	chr12:56706922	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs58852079	chr12:56706922	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs588918	chr11:116856642	PCSK7	chr11:117075789-117102811:-	-0.28	-5.55	4.51E-8	Protein quantitative trait loci	
KIRC	cis	1	rs58934221	chr15:56516381	TEX9	chr15:56657644-56738071:+	-0.29	-5.09	5.13E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs58952297	chr20:44560820	PLTP	chr20:44527397-44540786:-	-0.17	-3.98	8.0E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs58986862	chr3:128061689	RUVBL1	chr3:127783627-127872757:-	0.3	4.32	1.91E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs58991229	chr11:71839878	C11orf59	chr11:71808339-71814322:-	0.21	3.71	0.00023	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs58994609	chr8:89438194	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs59025920	chr15:56409172	TEX9	chr15:56657644-56738071:+	-0.27	-4.6	5.39E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs59030724	chr8:89414702	MMP16	chr8:89049462-89339717:-	0.31	4.13	4.23E-5	Electrodermal activity	
KIRC	cis	1	rs59043278	chr8:89444592	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs59043558	chr5:150334662	IRGM	chr5:150226085-150280295:+	0.43	5.6	3.52E-8	Crohn's disease	
KIRC	cis	1	rs59043558	chr5:150334662	LOC134466	chr5:150310000-150326146:-	0.36	4.69	3.56E-6	Crohn's disease	
KIRC	cis	1	rs59049611	chr11:118139403	MPZL2	chr11:118124135-118135009:-	-0.15	-3.7	0.000238	Pain	
KIRC	cis	1	rs590958	chr15:65735707	DPP8	chr15:65737999-65810035:-	-0.12	-4.85	1.63E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs591058	chr11:102711338	MMP1	chr11:102660641-102668966:-	0.41	7.13	3.59E-12	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
KIRC	cis	1	rs59107062	chr8:89405172	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs59117465	chr14:66052472	LOC645431	chr14:65877313-65879335:-	-0.52	-6.44	2.8E-10	Ischemic stroke	
KIRC	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.34	7.36	7.69E-13	Pancreatic cancer	
KIRC	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	0.19	4.53	7.53E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs59181394	chr16:77785955	NUDT7	chr16:77756411-77776153:+	0.23	3.59	0.000367	Obesity-related traits	
KIRC	cis	1	rs591992	chr12:121019323	COQ5	chr12:120941083-120966964:-	0.21	3.86	0.000128	Type 1 diabetes nephropathy	
KIRC	cis	1	rs591992	chr12:121019323	POP5	chr12:121016849-121019201:-	-0.15	-3.64	0.000296	Type 1 diabetes nephropathy	
KIRC	cis	1	rs59204447	chr14:66106727	LOC645431	chr14:65877313-65879335:-	-0.48	-6.39	3.82E-10	Ischemic stroke	
KIRC	cis	1	rs59217052	chr3:158452456	RARRES1	chr3:158414899-158450275:-	0.21	5.02	7.06E-7	Tetralogy of Fallot	
KIRC	cis	1	rs59226697	chr22:25870037	ADRBK2	chr22:25960861-26125256:+	-0.23	-4.06	5.65E-5	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs59226697	chr22:25870037	CRYBB2	chr22:25615612-25627836:+	0.58	7.2	2.14E-12	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs59227481	chr12:110007993	MYO1H	chr12:109826524-109886176:+	0.2	4.1	4.82E-5	Age-related nuclear cataracts	
KIRC	cis	1	rs59233487	chr10:81729450	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.5	-8.29	1.07E-15	Bone mineral density	
KIRC	cis	1	rs59274738	chr17:28437635	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs59290812	chr8:89441796	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000104	Electrodermal activity	
KIRC	cis	1	rs59295315	chr12:56708576	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs59295315	chr12:56708576	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs59313096	chr3:158452242	RARRES1	chr3:158414899-158450275:-	0.21	5.02	7.06E-7	Tetralogy of Fallot	
KIRC	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	0.19	4.51	8.14E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs59321715	chr5:150313480	IRGM	chr5:150226085-150280295:+	0.61	7.04	6.36E-12	Crohn's disease	
KIRC	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.44	5.08	5.22E-7	Crohn's disease	
KIRC	cis	1	rs59329875	chr20:44547672	PLTP	chr20:44527397-44540786:-	-0.18	-4.22	2.96E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs59343240	chr16:67850529	ATP6V0D1	chr16:67471917-67515089:-	-0.33	-5.29	1.79E-7	Crohn's disease	
KIRC	cis	1	rs59343240	chr16:67850529	C16orf86	chr16:67700717-67702659:+	-0.28	-3.56	0.000401	Crohn's disease	
KIRC	cis	1	rs59343384	chr11:71828038	C11orf59	chr11:71808339-71814322:-	0.23	4.28	2.19E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs59361639	chr6:88215145	C6orf164	chr6:88032306-88109459:+	0.32	3.73	0.000212	Obesity-related traits	
KIRC	cis	1	rs59363432	chr14:74397545	LIN52	chr14:74551656-74667117:+	0.27	4.76	2.53E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs59375902	chr12:81441561	ACSS3	chr12:81471809-81649582:+	0.17	3.91	0.000107	Neuroticism	
KIRC	cis	1	rs59375902	chr12:81441561	LIN7A	chr12:81191171-81331694:-	0.19	4.93	1.12E-6	Neuroticism	
KIRC	cis	1	rs59376497	chr16:67681170	ATP6V0D1	chr16:67471917-67515089:-	-0.36	-5.57	4.18E-8	Crohn's disease	
KIRC	cis	1	rs59376497	chr16:67681170	C16orf86	chr16:67700717-67702659:+	-0.31	-3.84	0.000141	Crohn's disease	
KIRC	cis	1	rs59377495	chr10:1157019	IDI2	chr10:1064847-1071799:-	0.31	3.6	0.000351	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs594074	chr6:6552994	LY86	chr6:6588934-6655216:+	0.14	3.72	0.000222	Diabetic kidney disease	
KIRC	cis	1	rs594206	chr1:147020456	ACP6	chr1:147119168-147142634:-	-0.22	-3.89	0.000114	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	
KIRC	cis	1	rs59425875	chr8:89411899	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs59428107	chr1:47364062	CYP4A22	chr1:47603107-47614526:+	0.48	9.09	2.38E-18	Blood metabolite levels	
KIRC	cis	1	rs59428599	chr10:4970849	AKR1C1	chr10:4934796-5020157:+	-0.38	-4.95	1.03E-6	Height	
KIRC	cis	1	rs59428599	chr10:4970849	AKR1C2	chr10:4964715-5060207:-	0.55	6.57	1.24E-10	Height	
KIRC	cis	1	rs59430846	chr8:89411781	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs59441945	chr2:198879645	RFTN2	chr2:198435528-198540584:-	0.17	4.97	9.17E-7	Ulcerative colitis	
KIRC	cis	1	rs59468948	chr1:156288058	BGLAP	chr1:156182784-156213112:+	0.35	7.65	1.05E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs59468948	chr1:156288058	CCT3	chr1:156278752-156308195:-	-0.17	-4.38	1.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs59495340	chr8:89452311	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs59531858	chr5:150247063	IRGM	chr5:150226085-150280295:+	0.65	8.04	6.31E-15	Crohn's disease	
KIRC	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.42	5.08	5.21E-7	Crohn's disease	
KIRC	cis	1	rs59561356	chr14:66020022	LOC645431	chr14:65877313-65879335:-	-0.5	-6.59	1.15E-10	Ischemic stroke	
KIRC	cis	1	rs59580800	chr8:89437373	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs59626664	chr12:56636975	RPS26	chr12:56435686-56438005:+	-0.51	-4.33	1.77E-5	Psoriasis vulgaris	
KIRC	cis	1	rs59644475	chr10:81729160	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs59645827	chr8:89436001	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs596629	chr11:71562576	C11orf59	chr11:71808339-71814322:-	0.22	3.82	0.000148	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs59676254	chr14:65942840	LOC645431	chr14:65877313-65879335:-	-0.51	-6.85	2.13E-11	Ischemic stroke	
KIRC	cis	1	rs59682592	chr5:132196800	LEAP2	chr5:132209358-132210581:+	0.37	5.7	1.99E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs59682592	chr5:132196800	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.76E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs59682951	chr17:18800766	FAM18B	chr17:18684582-18710026:+	-0.25	-5.65	2.65E-8	Educational attainment (years of education)	
KIRC	cis	1	rs59685862	chr14:66080130	LOC645431	chr14:65877313-65879335:-	-0.48	-6.37	4.36E-10	Ischemic stroke	
KIRC	cis	1	rs59715748	chr5:150189287	IRGM	chr5:150226085-150280295:+	0.65	7.82	3.1E-14	Crohn's disease	
KIRC	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.44	5.21	2.8E-7	Crohn's disease	
KIRC	cis	1	rs59715866	chr1:27079176	PIGV	chr1:27114455-27124886:+	-0.39	-4.54	7.11E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs59725465	chr8:89410497	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs59745808	chr8:89452576	MMP16	chr8:89049462-89339717:-	0.31	3.85	0.000131	Electrodermal activity	
KIRC	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.28	5.69	2.15E-8	Diabetic kidney disease	
KIRC	cis	1	rs59794892	chr7:65415873	CRCP	chr7:65579805-65619551:+	-0.33	-4.52	7.87E-6	Diabetic kidney disease	
KIRC	cis	1	rs59804446	chr4:56429541	SRD5A3	chr4:56212409-56237866:+	-0.21	-4.46	1.03E-5	Personality dimensions	
KIRC	cis	1	rs59804446	chr4:56429541	TMEM165	chr4:56262090-56292342:+	0.21	5.54	4.99E-8	Personality dimensions	
KIRC	cis	1	rs59811639	chr12:56695954	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs59822422	chr14:65889566	LOC645431	chr14:65877313-65879335:-	-0.49	-6.51	1.84E-10	Ischemic stroke	
KIRC	cis	1	rs59918529	chr3:158452705	RARRES1	chr3:158414899-158450275:-	0.21	4.98	8.91E-7	Tetralogy of Fallot	
KIRC	cis	1	rs59921977	chr14:66018659	LOC645431	chr14:65877313-65879335:-	-0.5	-6.59	1.08E-10	Ischemic stroke	
KIRC	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.79	-19.3	1.66E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs59925331	chr17:38169273	MED24	chr17:38175351-38210889:-	-0.15	-3.6	0.000345	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.28	-5.78	1.29E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs5994932	chr22:34823001	LARGE	chr22:33669063-34318584:-	-0.13	-3.53	0.00046	Major depressive disorder	
KIRC	cis	1	rs5995478	chr22:38000468	SH3BP1	chr22:38030661-38062939:+	0.27	4.43	1.15E-5	Response to anti-depressant treatment in major depressive disorder	
KIRC	cis	1	rs5995610	chr22:39064681	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.87E-5	Resting heart rate	
KIRC	cis	1	rs5995808	chr22:40469292	XPNPEP3	chr22:41253094-41363888:+	0.19	3.63	0.000315	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs5997408	chr22:29207915	XBP1	chr22:29190549-29196560:-	-0.19	-3.59	0.000365	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
KIRC	cis	1	rs59980321	chr5:150241813	IRGM	chr5:150226085-150280295:+	0.57	7.55	2.07E-13	Crohn's disease	
KIRC	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.0E-5	Crohn's disease	
KIRC	cis	1	rs5999515	chr22:22145101	MAPK1	chr22:22113949-22221970:-	-0.19	-5.57	4.14E-8	Multiple sclerosis	
KIRC	cis	1	rs5999521	chr22:22146399	MAPK1	chr22:22113949-22221970:-	0.2	5.73	1.7E-8	Multiple sclerosis	
KIRC	cis	1	rs5999750	chr22:22188009	MAPK1	chr22:22113949-22221970:-	0.2	5.71	1.96E-8	Multiple sclerosis	
KIRC	cis	1	rs60000965	chr10:81729165	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6001173	chr22:39015302	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.55	0.000424	Resting heart rate	
KIRC	cis	1	rs6001173	chr22:39015302	LOC646851	chr22:38974125-39052634:-	0.13	4.1	4.74E-5	Resting heart rate	
KIRC	cis	1	rs6001175	chr22:39018334	BAIAP2L2	chr22:38480897-38506676:-	0.15	3.82	0.000153	Resting heart rate	
KIRC	cis	1	rs6001175	chr22:39018334	LOC646851	chr22:38974125-39052634:-	0.13	4.12	4.48E-5	Resting heart rate	
KIRC	cis	1	rs6001182	chr22:39047443	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs6001184	chr22:39052116	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs6001185	chr22:39052155	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs6001188	chr22:39062194	LOC646851	chr22:38974125-39052634:-	0.13	3.85	0.000133	Resting heart rate	
KIRC	cis	1	rs6001191	chr22:39074452	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs6001204	chr22:39100239	LOC646851	chr22:38974125-39052634:-	0.11	3.55	0.000415	Resting heart rate	
KIRC	cis	1	rs6001214	chr22:39149155	LOC646851	chr22:38974125-39052634:-	0.13	3.81	0.000157	Resting heart rate	
KIRC	cis	1	rs6001728	chr22:40434757	APOBEC3H	chr22:39493290-39500070:+	-0.14	-3.56	0.00041	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs6001728	chr22:40434757	XPNPEP3	chr22:41253094-41363888:+	0.19	3.63	0.000311	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs6001734	chr22:40443219	XPNPEP3	chr22:41253094-41363888:+	0.19	3.68	0.000255	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs6001740	chr22:40460111	XPNPEP3	chr22:41253094-41363888:+	0.2	3.83	0.000142	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs6001773	chr22:40505863	XPNPEP3	chr22:41253094-41363888:+	0.2	3.71	0.000227	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs6001774	chr22:40513589	XPNPEP3	chr22:41253094-41363888:+	0.19	3.65	0.000288	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs60018212	chr18:42953909	C18orf25	chr18:43753988-43846954:+	-0.33	-3.55	0.000428	Cerebrospinal fluid clusterin levels	
KIRC	cis	1	rs600193	chr15:65729409	DPP8	chr15:65737999-65810035:-	0.11	4.58	5.92E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs60025964	chr2:99880577	LIPT1	chr2:99771418-99779611:+	0.29	5.02	7.27E-7	IgG glycosylation	
KIRC	cis	1	rs60037734	chr1:35679187	C1orf216	chr1:36179477-36184790:-	-0.27	-3.88	0.000117	Endometrial cancer	
KIRC	cis	1	rs6004669	chr22:25875803	ADRBK2	chr22:25960861-26125256:+	-0.2	-4.19	3.29E-5	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	0.64	9.46	1.17E-19	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs6004673	chr22:25885353	ADRBK2	chr22:25960861-26125256:+	-0.22	-4.72	3.09E-6	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.53	8.07	5.37E-15	Bipolar disorder with mood-incongruent psychosis	
KIRC	cis	1	rs6005807	chr22:28934313	LOC284900	chr22:28315364-28404267:+	0.17	3.53	0.000459	Cerebrospinal fluid p-Tau181p:AB1-42 ratio;Cerebrospinal P-tau181p levels;Cerebrospinal T-tau levels	
KIRC	cis	1	rs600626	chr11:75455309	UVRAG	chr11:75526212-75855281:+	0.2	3.61	0.000337	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	
KIRC	cis	1	rs60078907	chr11:73085834	RELT	chr11:73087405-73108518:+	0.22	4.54	6.9E-6	Pulmonary function (interaction)	
KIRC	cis	1	rs601019	chr10:105976452	C10orf79	chr10:105889647-105992120:-	-0.17	-4.07	5.5E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs6011368	chr20:62886504	MYT1	chr20:62783144-62873604:+	-0.24	-4.43	1.14E-5	Clozapine-induced cytotoxicity	
KIRC	cis	1	rs6011368	chr20:62886504	PCMTD2	chr20:62887048-62907578:+	-0.17	-4.31	2.0E-5	Clozapine-induced cytotoxicity	
KIRC	cis	1	rs6012564	chr20:47541600	CSE1L	chr20:47662838-47713484:+	0.18	4.7	3.42E-6	Anger	
KIRC	cis	1	rs60126902	chr4:75710822	BTC	chr4:75671448-75719882:-	0.27	3.53	0.000451	Electroencephalogram traits	
KIRC	cis	1	rs60134818	chr5:150261043	IRGM	chr5:150226085-150280295:+	0.47	6.5	1.96E-10	Crohn's disease	
KIRC	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.31	4.32	1.9E-5	Crohn's disease	
KIRC	cis	1	rs60144605	chr1:76359699	MSH4	chr1:76262630-76378923:+	-0.29	-4.45	1.06E-5	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.29	-6.02	3.45E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs60178264	chr4:17685308	LAP3	chr4:17578927-17609590:+	-0.21	-6.54	1.5E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs60178264	chr4:17685308	MED28	chr4:17616273-17629791:+	0.16	3.66	0.000276	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs60184524	chr19:44294215	ZNF155	chr19:44488355-44502477:+	-0.24	-5.06	5.89E-7	Breast cancer	
KIRC	cis	1	rs60184524	chr19:44294215	ZNF404	chr19:44376516-44384288:-	-0.31	-6.44	2.82E-10	Breast cancer	
KIRC	cis	1	rs60192116	chr5:174971825	FAF2	chr5:175875356-175937074:+	-0.23	-3.74	0.000205	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs6020100	chr20:48494650	CEBPB	chr20:48807376-48809212:+	0.13	3.56	0.000399	Gut microbiota (beta diversity)	
KIRC	cis	1	rs6020101	chr20:48495761	CEBPB	chr20:48807376-48809212:+	0.13	3.57	0.000395	Gut microbiota (beta diversity)	
KIRC	cis	1	rs60210425	chr15:56494711	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs602128	chr11:102713465	MMP1	chr11:102660641-102668966:-	0.4	6.85	2.12E-11	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
KIRC	cis	1	rs60228288	chr18:44640412	HDHD2	chr18:44633782-44676871:-	0.37	3.86	0.000129	Sitting height ratio	
KIRC	cis	1	rs60245117	chr8:89438405	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs6029552	chr20:39760448	EMILIN3	chr20:39988606-39995498:-	0.18	3.52	0.000469	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs60310240	chr14:88822709	SPATA7	chr14:88852012-88904802:+	-0.19	-4.11	4.59E-5	Coronary artery calcification	
KIRC	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.28	5.54	4.98E-8	Gout	
KIRC	cis	1	rs60326618	chr7:66166358	CRCP	chr7:65579805-65619551:+	-0.31	-4.27	2.34E-5	Gout	
KIRC	cis	1	rs60340200	chr1:27287716	PIGV	chr1:27114455-27124886:+	-0.37	-4.19	3.34E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs60350282	chr8:89460917	MMP16	chr8:89049462-89339717:-	0.32	4.11	4.65E-5	Electrodermal activity	
KIRC	cis	1	rs60362869	chr8:124189971	DERL1	chr8:124025568-124054648:-	0.33	3.6	0.000356	Urinary uromodulin levels	
KIRC	cis	1	rs6036476	chr20:23610308	CST3	chr20:23608536-23618574:-	-0.14	-3.83	0.000142	Chronic kidney disease	
KIRC	cis	1	rs6036478	chr20:23611359	CST3	chr20:23608536-23618574:-	-0.14	-3.78	0.000178	Chronic kidney disease	
KIRC	cis	1	rs6037086	chr20:25306338	ENTPD6	chr20:25176339-25207360:+	0.24	6.53	1.58E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.32	5.93	5.75E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037095	chr20:25335687	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037095	chr20:25335687	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037099	chr20:25356876	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037099	chr20:25356876	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037105	chr20:25374199	ENTPD6	chr20:25176339-25207360:+	0.25	6.9	1.62E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037105	chr20:25374199	FAM182A	chr20:26035250-26067552:+	0.3	5.78	1.35E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037121	chr20:25428311	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037121	chr20:25428311	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6037526	chr20:3251248	ITPA	chr20:3190056-3204504:+	-0.28	-6.72	5.06E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037532	chr20:3267911	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037533	chr20:3268817	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037535	chr20:3270621	ITPA	chr20:3190056-3204504:+	-0.29	-7.06	5.64E-12	IFN-related cytopenia	
KIRC	cis	1	rs6037538	chr20:3282978	C20orf194	chr20:3229948-3388587:-	0.18	3.68	0.00026	IFN-related cytopenia	
KIRC	cis	1	rs6037538	chr20:3282978	ITPA	chr20:3190056-3204504:+	-0.26	-6.22	1.06E-9	IFN-related cytopenia	
KIRC	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.27	-6.36	4.44E-10	IFN-related cytopenia	
KIRC	cis	1	rs6037551	chr20:3306690	ITPA	chr20:3190056-3204504:+	-0.28	-6.66	7.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037553	chr20:3313884	ITPA	chr20:3190056-3204504:+	-0.28	-6.66	7.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037554	chr20:3315613	ITPA	chr20:3190056-3204504:+	-0.28	-6.64	8.16E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037556	chr20:3317890	ITPA	chr20:3190056-3204504:+	-0.28	-6.66	7.35E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.28	-6.63	8.92E-11	IFN-related cytopenia	
KIRC	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.27	-6.54	1.55E-10	IFN-related cytopenia	
KIRC	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.27	-6.54	1.55E-10	IFN-related cytopenia	
KIRC	cis	1	rs6037579	chr20:3347980	ITPA	chr20:3190056-3204504:+	-0.27	-6.37	4.38E-10	IFN-related cytopenia	
KIRC	cis	1	rs6037583	chr20:3360632	ITPA	chr20:3190056-3204504:+	-0.27	-6.44	2.8E-10	IFN-related cytopenia	
KIRC	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.28	-6.53	1.63E-10	IFN-related cytopenia	
KIRC	cis	1	rs60399786	chr3:128062070	RUVBL1	chr3:127783627-127872757:-	0.3	4.32	1.91E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs60401377	chr1:27052247	PIGV	chr1:27114455-27124886:+	-0.38	-4.31	2.0E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs6041826	chr20:13038723	SPTLC3	chr20:12989627-13147411:+	0.21	4.11	4.69E-5	Daytime sleep phenotypes	
KIRC	cis	1	rs60422392	chr18:44621473	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs6042314	chr20:13696129	C20orf7	chr20:13765682-13797872:+	-0.18	-4.28	2.28E-5	Intelligence (childhood)	
KIRC	cis	1	rs60425110	chr15:75333000	PPCDC	chr15:75315927-75343066:+	0.2	4.55	6.88E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs60425110	chr15:75333000	RPP25	chr15:75247443-75249775:-	0.21	3.86	0.00013	Blood trace element (Zn levels)	
KIRC	cis	1	rs60425110	chr15:75333000	SCAMP5	chr15:75287901-75313836:+	0.24	4.35	1.64E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs60447213	chr6:33715159	IP6K3	chr6:33689443-33714762:-	-0.43	-4.95	1.01E-6	Phosphorus levels	
KIRC	cis	1	rs60469280	chr8:89452250	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs6047596	chr20:2225481	ProSAPiP1	chr20:3143273-3154192:-	-0.18	-3.54	0.000431	Diastolic blood pressure	
KIRC	cis	1	rs60482539	chr15:56180297	NEDD4	chr15:56119131-56285835:-	0.21	4.93	1.13E-6	Keloid	
KIRC	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.28	-5.67	2.36E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs6048956	chr20:23609301	CST3	chr20:23608536-23618574:-	-0.14	-3.94	9.44E-5	Chronic kidney disease	
KIRC	cis	1	rs6050542	chr20:25318879	ENTPD6	chr20:25176339-25207360:+	0.24	6.4	3.56E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050544	chr20:25320228	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.05E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.28	5.38	1.12E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050547	chr20:25326012	ENTPD6	chr20:25176339-25207360:+	0.25	6.68	6.4E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050547	chr20:25326012	FAM182A	chr20:26035250-26067552:+	0.29	5.42	9.11E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050555	chr20:25328543	ENTPD6	chr20:25176339-25207360:+	0.25	6.81	2.8E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050555	chr20:25328543	FAM182A	chr20:26035250-26067552:+	0.29	5.36	1.29E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050559	chr20:25329915	ENTPD6	chr20:25176339-25207360:+	-0.26	-7.1	4.27E-12	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050559	chr20:25329915	FAM182A	chr20:26035250-26067552:+	-0.29	-5.47	7.02E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050561	chr20:25334855	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050561	chr20:25334855	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050562	chr20:25336186	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050562	chr20:25336186	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050564	chr20:25344231	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050564	chr20:25344231	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050565	chr20:25347563	ENTPD6	chr20:25176339-25207360:+	0.26	7	8.03E-12	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050565	chr20:25347563	FAM182A	chr20:26035250-26067552:+	0.29	5.47	7.09E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050566	chr20:25351071	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.87E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050566	chr20:25351071	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.72E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050573	chr20:25366065	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.43	2.95E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050573	chr20:25366065	FAM182A	chr20:26035250-26067552:+	-0.28	-5.37	1.19E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050590	chr20:25384994	ENTPD6	chr20:25176339-25207360:+	0.25	6.94	1.23E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050590	chr20:25384994	FAM182A	chr20:26035250-26067552:+	0.3	5.66	2.6E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050598	chr20:25397257	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050598	chr20:25397257	FAM182A	chr20:26035250-26067552:+	-0.3	-5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050599	chr20:25400240	ENTPD6	chr20:25176339-25207360:+	0.25	6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050599	chr20:25400240	FAM182A	chr20:26035250-26067552:+	0.3	5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050602	chr20:25401203	ENTPD6	chr20:25176339-25207360:+	0.25	6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050602	chr20:25401203	FAM182A	chr20:26035250-26067552:+	0.3	5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050609	chr20:25411751	ENTPD6	chr20:25176339-25207360:+	0.25	6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050609	chr20:25411751	FAM182A	chr20:26035250-26067552:+	0.3	5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050617	chr20:25421648	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050617	chr20:25421648	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050626	chr20:25428261	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050626	chr20:25428261	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050629	chr20:25430680	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050629	chr20:25430680	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050630	chr20:25430745	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050630	chr20:25430745	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050631	chr20:25431749	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.66	7.17E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050631	chr20:25431749	FAM182A	chr20:26035250-26067552:+	-0.27	-5.2	2.94E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050632	chr20:25432601	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6050632	chr20:25432601	FAM182A	chr20:26035250-26067552:+	-0.3	-5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.5	11.28	1.88E-26	Colorectal or endometrial cancer	
KIRC	cis	1	rs6051080	chr20:25975674	LOC100134868	chr20:25990435-26002424:+	-0.26	-4.2	3.13E-5	Colorectal or endometrial cancer	
KIRC	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.31	-8.89	1.13E-17	Longevity	
KIRC	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.28	-6.47	2.3E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051702	chr20:3251924	ITPA	chr20:3190056-3204504:+	-0.28	-6.72	5.06E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051703	chr20:3252347	ITPA	chr20:3190056-3204504:+	-0.27	-6.52	1.68E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051705	chr20:3253143	ITPA	chr20:3190056-3204504:+	-0.27	-6.52	1.68E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051708	chr20:3262493	ITPA	chr20:3190056-3204504:+	-0.28	-6.76	3.93E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051709	chr20:3263685	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051712	chr20:3265029	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051713	chr20:3265779	ITPA	chr20:3190056-3204504:+	0.28	6.88	1.75E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051715	chr20:3266548	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051716	chr20:3267736	ITPA	chr20:3190056-3204504:+	-0.27	-6.54	1.47E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051718	chr20:3270370	ITPA	chr20:3190056-3204504:+	-0.29	-7.06	5.64E-12	IFN-related cytopenia	
KIRC	cis	1	rs6051722	chr20:3274435	ITPA	chr20:3190056-3204504:+	-0.29	-6.93	1.29E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.27	-6.43	2.95E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051724	chr20:3279338	C20orf194	chr20:3229948-3388587:-	0.18	3.62	0.00032	IFN-related cytopenia	
KIRC	cis	1	rs6051724	chr20:3279338	ITPA	chr20:3190056-3204504:+	-0.27	-6.34	5.12E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.28	-6.49	2.07E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.27	-6.36	4.44E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051737	chr20:3296992	C20orf194	chr20:3229948-3388587:-	0.18	3.54	0.000445	IFN-related cytopenia	
KIRC	cis	1	rs6051737	chr20:3296992	ITPA	chr20:3190056-3204504:+	-0.27	-6.48	2.16E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051745	chr20:3307243	ITPA	chr20:3190056-3204504:+	-0.28	-6.54	1.54E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051747	chr20:3307945	ITPA	chr20:3190056-3204504:+	-0.28	-6.57	1.26E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051751	chr20:3310049	ITPA	chr20:3190056-3204504:+	-0.28	-6.54	1.54E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.28	-6.58	1.21E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051762	chr20:3321590	ITPA	chr20:3190056-3204504:+	-0.26	-6.22	1.02E-9	IFN-related cytopenia	
KIRC	cis	1	rs6051763	chr20:3321616	ITPA	chr20:3190056-3204504:+	-0.28	-6.63	8.92E-11	IFN-related cytopenia	
KIRC	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.25	6.12	1.92E-9	IFN-related cytopenia	
KIRC	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.28	-6.57	1.28E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051790	chr20:3342994	ITPA	chr20:3190056-3204504:+	-0.28	-6.57	1.28E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051792	chr20:3343519	ITPA	chr20:3190056-3204504:+	-0.28	-6.57	1.28E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051806	chr20:3350319	ITPA	chr20:3190056-3204504:+	-0.27	-6.45	2.6E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051807	chr20:3350485	ITPA	chr20:3190056-3204504:+	-0.26	-6.19	1.26E-9	IFN-related cytopenia	
KIRC	cis	1	rs6051808	chr20:3350697	ITPA	chr20:3190056-3204504:+	-0.27	-6.35	4.7E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051809	chr20:3352551	ITPA	chr20:3190056-3204504:+	-0.27	-6.44	2.8E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051810	chr20:3355384	ITPA	chr20:3190056-3204504:+	-0.27	-6.44	2.8E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.27	-6.49	2.11E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051831	chr20:3373712	C20orf194	chr20:3229948-3388587:-	-0.18	-3.7	0.000243	IFN-related cytopenia	
KIRC	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.26	6.37	4.36E-10	IFN-related cytopenia	
KIRC	cis	1	rs6051838	chr20:3389012	C20orf194	chr20:3229948-3388587:-	0.19	3.8	0.000165	IFN-related cytopenia	
KIRC	cis	1	rs6051838	chr20:3389012	ITPA	chr20:3190056-3204504:+	-0.26	-6.28	7.13E-10	IFN-related cytopenia	
KIRC	cis	1	rs6053815	chr20:5970438	MCM8	chr20:5931298-5975829:+	-0.27	-6.86	2.09E-11	HIV-1 viral setpoint	
KIRC	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.27	-6.91	1.44E-11	HIV-1 viral setpoint	
KIRC	cis	1	rs60554055	chr14:66068285	LOC645431	chr14:65877313-65879335:-	-0.47	-6.18	1.36E-9	Ischemic stroke	
KIRC	cis	1	rs60563713	chr5:78313516	ARSB	chr5:78073039-78282357:-	-0.2	-4.21	3.0E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs60563713	chr5:78313516	BHMT	chr5:78407604-78428112:+	-0.25	-5.32	1.59E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs60571765	chr4:76549046	CDKL2	chr4:76501705-76555721:-	0.16	3.58	0.00038	Magnesium levels	
KIRC	cis	1	rs6058352	chr20:30269179	COX4I2	chr20:30225691-30232800:+	0.14	3.76	0.000193	Subcortical brain region volumes	
KIRC	cis	1	rs6058465	chr20:30397691	COX4I2	chr20:30225691-30232800:+	0.15	4.01	7.03E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6058468	chr20:30406448	COX4I2	chr20:30225691-30232800:+	0.14	3.73	0.000214	Subcortical brain region volumes	
KIRC	cis	1	rs6060222	chr20:33682570	PROCR	chr20:33758727-33765164:+	-0.27	-3.93	9.77E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs6060230	chr20:33689308	PROCR	chr20:33758727-33765164:+	0.27	3.97	8.22E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs6060236	chr20:33692618	PROCR	chr20:33758727-33765164:+	-0.28	-3.69	0.00025	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs6060245	chr20:33699625	PROCR	chr20:33758727-33765164:+	-0.27	-3.63	0.000317	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs6060246	chr20:33701107	PROCR	chr20:33758727-33765164:+	-0.26	-3.52	0.000467	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.27	5.33	1.46E-7	Height	
KIRC	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.3	8.16	2.78E-15	Height	
KIRC	cis	1	rs6060402	chr20:34005240	CPNE1	chr20:34213968-34262539:-	0.26	5.17	3.41E-7	Height	
KIRC	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.3	8	8.88E-15	Height	
KIRC	cis	1	rs6060599	chr20:30257754	COX4I2	chr20:30225691-30232800:+	0.14	3.78	0.000173	Subcortical brain region volumes	
KIRC	cis	1	rs6060621	chr20:30261562	COX4I2	chr20:30225691-30232800:+	0.14	3.72	0.00022	Subcortical brain region volumes	
KIRC	cis	1	rs6060716	chr20:30274847	COX4I2	chr20:30225691-30232800:+	0.14	3.72	0.000219	Subcortical brain region volumes	
KIRC	cis	1	rs6060857	chr20:30300222	COX4I2	chr20:30225691-30232800:+	0.14	3.9	0.000111	Subcortical brain region volumes	
KIRC	cis	1	rs6060915	chr20:30330306	COX4I2	chr20:30225691-30232800:+	0.15	4.02	6.75E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060919	chr20:30331922	COX4I2	chr20:30225691-30232800:+	0.15	4.12	4.47E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060922	chr20:30333909	COX4I2	chr20:30225691-30232800:+	0.15	4.12	4.47E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060932	chr20:30350545	COX4I2	chr20:30225691-30232800:+	0.15	4.12	4.41E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060933	chr20:30351903	COX4I2	chr20:30225691-30232800:+	0.15	4.07	5.45E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060944	chr20:30372114	COX4I2	chr20:30225691-30232800:+	0.15	4.11	4.68E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060950	chr20:30378031	COX4I2	chr20:30225691-30232800:+	0.15	4.06	5.68E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6060962	chr20:30397847	COX4I2	chr20:30225691-30232800:+	0.15	4.01	7.03E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6061231	chr20:60956917	HAR1B	chr20:61726845-61733671:-	0.22	3.74	0.000209	Colorectal cancer	
KIRC	cis	1	rs6063349	chr20:47681882	CSE1L	chr20:47662838-47713484:+	-0.17	-4.14	4.16E-5	Non-response to citalopram or escitalopram and depression	
KIRC	cis	1	rs6063352	chr20:47718594	CSE1L	chr20:47662838-47713484:+	0.18	4.69	3.45E-6	Anger	
KIRC	cis	1	rs6063353	chr20:47719810	CSE1L	chr20:47662838-47713484:+	0.18	4.69	3.45E-6	Anger	
KIRC	cis	1	rs6063354	chr20:47719949	CSE1L	chr20:47662838-47713484:+	0.18	4.69	3.45E-6	Anger	
KIRC	cis	1	rs6063360	chr20:47748375	CSE1L	chr20:47662838-47713484:+	0.18	4.68	3.69E-6	Anger	
KIRC	cis	1	rs6063361	chr20:47757963	CSE1L	chr20:47662838-47713484:+	0.18	4.68	3.74E-6	Anger	
KIRC	cis	1	rs6064401	chr20:55057904	C20orf43	chr20:55043647-55093942:+	0.21	4.95	1.03E-6	Refractive astigmatism	
KIRC	cis	1	rs6064404	chr20:55070798	C20orf43	chr20:55043647-55093942:+	0.19	4.57	6.08E-6	Refractive astigmatism	
KIRC	cis	1	rs6064405	chr20:55070946	C20orf43	chr20:55043647-55093942:+	0.2	4.77	2.43E-6	Refractive astigmatism	
KIRC	cis	1	rs60652743	chr19:47205707	FKRP	chr19:47249303-47261832:+	0.37	7.13	3.43E-12	Type 1 diabetes	
KIRC	cis	1	rs60652743	chr19:47205707	PRKD2	chr19:47177574-47220384:-	0.25	5.19	3.12E-7	Type 1 diabetes	
KIRC	cis	1	rs6065311	chr20:39724338	EMILIN3	chr20:39988606-39995498:-	0.18	3.65	0.00029	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs60654041	chr20:55077917	C20orf43	chr20:55043647-55093942:+	0.2	4.7	3.33E-6	Refractive astigmatism	
KIRC	cis	1	rs6065906	chr20:44554015	PLTP	chr20:44527397-44540786:-	-0.15	-3.62	0.00033	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs6066968	chr20:47727341	CSE1L	chr20:47662838-47713484:+	0.18	4.72	3.07E-6	Anger	
KIRC	cis	1	rs6066975	chr20:47750377	CSE1L	chr20:47662838-47713484:+	-0.14	-3.68	0.000262	Anger	
KIRC	cis	1	rs6066977	chr20:47755075	CSE1L	chr20:47662838-47713484:+	0.18	4.67	3.79E-6	Anger	
KIRC	cis	1	rs6066978	chr20:47755742	CSE1L	chr20:47662838-47713484:+	0.18	4.68	3.74E-6	Anger	
KIRC	cis	1	rs6066982	chr20:47763558	CSE1L	chr20:47662838-47713484:+	0.18	4.72	3.08E-6	Anger	
KIRC	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs60683927	chr7:65394768	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.24	4.67	3.94E-6	Atopic dermatitis	
KIRC	cis	1	rs60697554	chr19:12057759	ZNF763	chr19:12035900-12091196:+	-0.46	-5.82	1.02E-8	Multiple sclerosis	
KIRC	cis	1	rs6069758	chr20:55046735	C20orf43	chr20:55043647-55093942:+	0.22	5	8.04E-7	Refractive astigmatism	
KIRC	cis	1	rs6069763	chr20:55071639	C20orf43	chr20:55043647-55093942:+	-0.19	-4.47	9.48E-6	Refractive astigmatism	
KIRC	cis	1	rs6069766	chr20:55079036	C20orf43	chr20:55043647-55093942:+	0.2	4.68	3.76E-6	Refractive astigmatism	
KIRC	cis	1	rs6069767	chr20:55083478	C20orf43	chr20:55043647-55093942:+	0.21	4.91	1.22E-6	Refractive astigmatism	
KIRC	cis	1	rs60705719	chr1:47382639	CYP4A22	chr1:47603107-47614526:+	0.48	8.96	6.23E-18	Blood metabolite levels	
KIRC	cis	1	rs6070692	chr20:57586374	TH1L	chr20:57556311-57570186:+	-0.52	-7.89	1.84E-14	Mean platelet volume	
KIRC	cis	1	rs6070696	chr20:57597645	TH1L	chr20:57556311-57570186:+	-0.47	-7.55	2.0E-13	Mean platelet volume	
KIRC	cis	1	rs6070697	chr20:57599402	TH1L	chr20:57556311-57570186:+	-0.51	-7.83	2.93E-14	Mean platelet volume	
KIRC	cis	1	rs60719662	chr6:163006643	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs60721872	chr10:81728044	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6072263	chr20:39705546	EMILIN3	chr20:39988606-39995498:-	0.18	3.57	0.000397	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs60722866	chr11:46650438	MDK	chr11:46402334-46405374:+	-0.22	-3.81	0.000159	Schizophrenia	
KIRC	cis	1	rs6073957	chr20:44549476	PLTP	chr20:44527397-44540786:-	-0.17	-3.82	0.000153	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs6073966	chr20:44570192	PLTP	chr20:44527397-44540786:-	-0.17	-3.73	0.000215	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs60743860	chr1:10442926	RBP7	chr1:10057255-10076077:+	0.14	3.52	0.000472	Hepatocellular carcinoma	
KIRC	cis	1	rs607446	chr11:71789252	C11orf59	chr11:71808339-71814322:-	-0.22	-3.98	7.94E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6076336	chr20:25319212	ENTPD6	chr20:25176339-25207360:+	0.24	6.4	3.56E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6076339	chr20:25348712	ENTPD6	chr20:25176339-25207360:+	0.25	7	8.5E-12	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6076339	chr20:25348712	FAM182A	chr20:26035250-26067552:+	0.32	6.09	2.27E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6076345	chr20:25381895	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6076345	chr20:25381895	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs60779425	chr8:89437611	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs607987	chr11:30223574	C11orf46	chr11:30344649-30359978:+	-0.24	-5.33	1.46E-7	Body mass index	
KIRC	cis	1	rs60823703	chr10:81729345	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6083804	chr20:25317060	ENTPD6	chr20:25176339-25207360:+	0.24	6.4	3.56E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083805	chr20:25317356	ENTPD6	chr20:25176339-25207360:+	0.24	6.51	1.82E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.28	5.24	2.38E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083809	chr20:25329309	ENTPD6	chr20:25176339-25207360:+	0.25	6.8	2.94E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083809	chr20:25329309	FAM182A	chr20:26035250-26067552:+	0.29	5.53	5.24E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083813	chr20:25337671	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083813	chr20:25337671	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083825	chr20:25366424	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083825	chr20:25366424	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083828	chr20:25369918	ENTPD6	chr20:25176339-25207360:+	0.25	6.87	1.9E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083828	chr20:25369918	FAM182A	chr20:26035250-26067552:+	0.3	5.84	9.64E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083844	chr20:25386832	ENTPD6	chr20:25176339-25207360:+	0.25	6.91	1.52E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083844	chr20:25386832	FAM182A	chr20:26035250-26067552:+	0.3	5.75	1.53E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083856	chr20:25407585	ENTPD6	chr20:25176339-25207360:+	0.24	6.51	1.79E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.31	5.83	9.73E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083862	chr20:25411086	ENTPD6	chr20:25176339-25207360:+	0.24	6.63	8.85E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6083862	chr20:25411086	FAM182A	chr20:26035250-26067552:+	0.29	5.49	6.3E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.28	-5.56	4.41E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs60844734	chr2:73623205	TPRKB	chr2:73956957-73964517:-	-0.18	-4.65	4.17E-6	Metabolite levels	
KIRC	cis	1	rs60854219	chr18:44646664	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs60866116	chr20:33726150	PROCR	chr20:33758727-33765164:+	-0.27	-3.77	0.000186	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs60868805	chr6:101642852	GRIK2	chr6:101846905-102517957:+	0.51	5.16	3.49E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs6087698	chr20:33948919	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.3E-8	Height	
KIRC	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.28	7.66	9.91E-14	Height	
KIRC	cis	1	rs6087702	chr20:33995945	CPNE1	chr20:34213968-34262539:-	0.27	5.4	1.02E-7	Height	
KIRC	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.29	7.87	2.14E-14	Height	
KIRC	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.27	5.42	9.46E-8	Height	
KIRC	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.29	7.78	4.08E-14	Height	
KIRC	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.27	5.4	1.03E-7	Height	
KIRC	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.28	7.71	7.04E-14	Height	
KIRC	cis	1	rs6087705	chr20:34001250	CPNE1	chr20:34213968-34262539:-	0.27	5.48	6.72E-8	Height	
KIRC	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.29	7.9	1.73E-14	Height	
KIRC	cis	1	rs6087771	chr20:30306724	COX4I2	chr20:30225691-30232800:+	0.13	3.63	0.000309	Subcortical brain region volumes	
KIRC	cis	1	rs6087779	chr20:30370566	COX4I2	chr20:30225691-30232800:+	0.15	4.13	4.31E-5	Subcortical brain region volumes	
KIRC	cis	1	rs6087782	chr20:30391580	COX4I2	chr20:30225691-30232800:+	0.14	3.81	0.000154	Subcortical brain region volumes	
KIRC	cis	1	rs6088799	chr20:33934301	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.21E-8	Height	
KIRC	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.28	7.65	1.03E-13	Height	
KIRC	cis	1	rs6088812	chr20:33974163	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.17E-8	Height	
KIRC	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.28	7.63	1.19E-13	Height	
KIRC	cis	1	rs6088813	chr20:33975181	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.17E-8	Height	
KIRC	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.28	7.63	1.19E-13	Height	
KIRC	cis	1	rs6088815	chr20:33976474	CPNE1	chr20:34213968-34262539:-	0.27	5.35	1.31E-7	Height	
KIRC	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.29	7.76	4.65E-14	Height	
KIRC	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.28	5.58	3.88E-8	Height	
KIRC	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.28	7.75	5.28E-14	Height	
KIRC	cis	1	rs6088820	chr20:33987298	CPNE1	chr20:34213968-34262539:-	0.27	5.41	9.93E-8	Height	
KIRC	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.29	7.89	1.88E-14	Height	
KIRC	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.27	5.42	9.23E-8	Height	
KIRC	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.29	7.8	3.69E-14	Height	
KIRC	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.27	5.42	9.46E-8	Height	
KIRC	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.29	7.78	4.08E-14	Height	
KIRC	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.28	5.58	3.99E-8	Height	
KIRC	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.28	7.73	5.91E-14	Height	
KIRC	cis	1	rs60894020	chr8:89450964	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000103	Electrodermal activity	
KIRC	cis	1	rs60895850	chr8:89412554	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs609181	chr11:71569672	C11orf59	chr11:71808339-71814322:-	0.22	3.98	7.83E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs60927973	chr14:65897331	LOC645431	chr14:65877313-65879335:-	-0.53	-6.63	8.46E-11	Ischemic stroke	
KIRC	cis	1	rs60929805	chr1:95646386	RWDD3	chr1:95583479-95712773:+	0.34	4.6	5.43E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs60932020	chr4:75712138	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs60936033	chr14:65856983	LOC645431	chr14:65877313-65879335:-	-0.44	-6	3.8E-9	Ischemic stroke	
KIRC	cis	1	rs60942639	chr14:66107636	LOC645431	chr14:65877313-65879335:-	-0.52	-6.5	1.97E-10	Ischemic stroke	
KIRC	cis	1	rs60953371	chr8:89444177	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs6095357	chr20:47523865	CSE1L	chr20:47662838-47713484:+	-0.15	-3.62	0.000325	Schizophrenia	
KIRC	cis	1	rs60957376	chr15:85280792	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.53	7.49E-6	Schizophrenia	
KIRC	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.22	-4.16	3.76E-5	Schizophrenia	
KIRC	cis	1	rs60967688	chr17:28437052	EFCAB5	chr17:28256874-28435469:+	0.33	5.92	5.85E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.41	-10	1.37E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.25	8.69	5.02E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs6099171	chr20:55071253	C20orf43	chr20:55043647-55093942:+	0.2	4.74	2.75E-6	Refractive astigmatism	
KIRC	cis	1	rs6099184	chr20:55097478	C20orf43	chr20:55043647-55093942:+	0.2	4.74	2.79E-6	Refractive astigmatism	
KIRC	cis	1	rs60993915	chr6:101580149	GRIK2	chr6:101846905-102517957:+	0.5	4.85	1.68E-6	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs610041	chr11:71797968	C11orf59	chr11:71808339-71814322:-	-0.22	-3.93	9.52E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.58	-12.92	3.72E-33	Forced vital capacity	
KIRC	cis	1	rs61038704	chr14:66172300	LOC645431	chr14:65877313-65879335:-	-0.51	-6.38	3.98E-10	Ischemic stroke	
KIRC	cis	1	rs61044849	chr3:128065466	KBTBD12	chr3:127634318-127706513:+	0.28	3.79	0.000168	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs61044849	chr3:128065466	RUVBL1	chr3:127783627-127872757:-	0.32	4.51	7.97E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6105029	chr20:13039997	SPTLC3	chr20:12989627-13147411:+	0.22	4.26	2.4E-5	Daytime sleep phenotypes	
KIRC	cis	1	rs6107033	chr20:25363591	ENTPD6	chr20:25176339-25207360:+	0.25	7	8.5E-12	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107033	chr20:25363591	FAM182A	chr20:26035250-26067552:+	0.32	6.09	2.27E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107045	chr20:25441936	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.6	1.02E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.31	-5.95	5.02E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107046	chr20:25442049	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.6	1.02E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.31	-5.95	5.02E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107047	chr20:25442097	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.6	1.02E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.31	-5.95	5.02E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs61088422	chr8:89438875	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs6109675	chr20:13039962	SPTLC3	chr20:12989627-13147411:+	0.2	3.86	0.000131	Daytime sleep phenotypes	
KIRC	cis	1	rs6109676	chr20:13040212	SPTLC3	chr20:12989627-13147411:+	0.2	3.72	0.000224	Daytime sleep phenotypes	
KIRC	cis	1	rs6109680	chr20:13046591	SPTLC3	chr20:12989627-13147411:+	0.2	3.72	0.000225	Daytime sleep phenotypes	
KIRC	cis	1	rs6109681	chr20:13047504	SPTLC3	chr20:12989627-13147411:+	0.19	3.59	0.000356	Daytime sleep phenotypes	
KIRC	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.46	-9	4.56E-18	Body mass index	
KIRC	cis	1	rs61102033	chr1:46382441	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.53E-5	Body mass index	
KIRC	cis	1	rs61109805	chr8:89435101	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs6114206	chr20:23611789	CST3	chr20:23608536-23618574:-	-0.14	-3.86	0.000129	Chronic kidney disease	
KIRC	cis	1	rs6114208	chr20:23621734	CST3	chr20:23608536-23618574:-	-0.13	-3.56	0.000404	Chronic kidney disease	
KIRC	cis	1	rs6115140	chr20:25285507	ENTPD6	chr20:25176339-25207360:+	-0.23	-6.35	4.79E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.29	-5.47	7.05E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115146	chr20:25304507	ENTPD6	chr20:25176339-25207360:+	0.24	6.5	1.93E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115146	chr20:25304507	FAM182A	chr20:26035250-26067552:+	0.28	5.23	2.48E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115153	chr20:25325567	ENTPD6	chr20:25176339-25207360:+	0.25	6.76	3.92E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115153	chr20:25325567	FAM182A	chr20:26035250-26067552:+	0.29	5.55	4.6E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115159	chr20:25350944	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115159	chr20:25350944	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115168	chr20:25372891	ENTPD6	chr20:25176339-25207360:+	0.25	6.95	1.16E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115168	chr20:25372891	FAM182A	chr20:26035250-26067552:+	0.3	5.72	1.81E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115182	chr20:25410259	ENTPD6	chr20:25176339-25207360:+	0.25	6.86	1.99E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115182	chr20:25410259	FAM182A	chr20:26035250-26067552:+	0.3	5.67	2.42E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115191	chr20:25440478	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.6	1.02E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.31	-5.95	5.02E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs61172708	chr3:52996052	RFT1	chr3:53122503-53164470:-	0.34	5.23	2.44E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs61172708	chr3:52996052	SFMBT1	chr3:52938628-53080070:-	-0.26	-3.71	0.000229	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs61172708	chr3:52996052	TMEM110	chr3:52867139-52931547:-	0.34	5.9	6.85E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs61177731	chr8:89435708	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs6119650	chr20:30258480	COX4I2	chr20:30225691-30232800:+	0.14	3.88	0.000117	Subcortical brain region volumes	
KIRC	cis	1	rs6119652	chr20:30259445	COX4I2	chr20:30225691-30232800:+	0.13	3.65	0.000291	Subcortical brain region volumes	
KIRC	cis	1	rs61200368	chr6:55943942	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs61204066	chr15:78815298	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.69	2.19E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.67	-12.03	1.79E-29	Triglycerides	
KIRC	cis	1	rs6120974	chr20:34126827	ERGIC3	chr20:34129778-34145404:+	-0.24	-5.34	1.42E-7	Triglycerides	
KIRC	cis	1	rs6120974	chr20:34126827	UQCC	chr20:33890383-33999833:-	-0.21	-4.38	1.43E-5	Triglycerides	
KIRC	cis	1	rs6121038	chr20:30254773	COX4I2	chr20:30225691-30232800:+	0.14	3.9	0.000111	Subcortical brain region volumes	
KIRC	cis	1	rs6121172	chr20:30296095	COX4I2	chr20:30225691-30232800:+	0.14	3.9	0.000111	Subcortical brain region volumes	
KIRC	cis	1	rs6121243	chr20:30415094	COX4I2	chr20:30225691-30232800:+	0.14	3.74	0.000202	Subcortical brain region volumes	
KIRC	cis	1	rs6122763	chr20:47797653	CSE1L	chr20:47662838-47713484:+	-0.18	-4.79	2.19E-6	Anger	
KIRC	cis	1	rs61234864	chr8:89445857	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs6124323	chr20:39794489	EMILIN3	chr20:39988606-39995498:-	0.18	3.53	0.000452	Cholesterol, total;LDL cholesterol	
KIRC	cis	1	rs6125539	chr20:47703810	CSE1L	chr20:47662838-47713484:+	0.17	4.24	2.64E-5	Anger	
KIRC	cis	1	rs6125540	chr20:47704039	CSE1L	chr20:47662838-47713484:+	0.17	4.54	6.95E-6	Anger	
KIRC	cis	1	rs6125576	chr20:47776919	CSE1L	chr20:47662838-47713484:+	0.15	3.79	0.000169	Anger	
KIRC	cis	1	rs61270078	chr15:56478983	TEX9	chr15:56657644-56738071:+	-0.28	-4.9	1.27E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs61270113	chr5:150226263	IRGM	chr5:150226085-150280295:+	0.52	7	8.08E-12	Crohn's disease	
KIRC	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.38	5.04	6.6E-7	Crohn's disease	
KIRC	cis	1	rs61299898	chr6:126007651	HEY2	chr6:126068780-126082414:+	0.17	4.23	2.81E-5	Endometrial cancer	
KIRC	cis	1	rs613089	chr1:147081187	ACP6	chr1:147119168-147142634:-	-0.45	-9.45	1.26E-19	Schizophrenia (negative symptoms)	
KIRC	cis	1	rs61315421	chr14:66076603	LOC645431	chr14:65877313-65879335:-	-0.5	-6.27	7.92E-10	Ischemic stroke	
KIRC	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.38	3.92	9.95E-5	Sitting height ratio	
KIRC	cis	1	rs61320020	chr8:89414644	MMP16	chr8:89049462-89339717:-	0.31	4.13	4.23E-5	Electrodermal activity	
KIRC	cis	1	rs6132835	chr20:25434667	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.78	3.33E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.29	-5.61	3.37E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6133036	chr20:3349682	ITPA	chr20:3190056-3204504:+	-0.27	-6.44	2.8E-10	IFN-related cytopenia	
KIRC	cis	1	rs61360320	chr17:61800392	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	3.06E-10	Body mass index	
KIRC	cis	1	rs61360320	chr17:61800392	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.43E-6	Body mass index	
KIRC	cis	1	rs61373424	chr15:56393235	TEX9	chr15:56657644-56738071:+	-0.27	-4.58	5.78E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs61378129	chr13:36684353	SOHLH2	chr13:36742347-36871992:-	0.3	4.31	2.0E-5	Optic cup area	
KIRC	cis	1	rs6138572	chr20:25435934	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.7	5.52E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.34	-6.37	4.22E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6138575	chr20:25438952	ENTPD6	chr20:25176339-25207360:+	-0.25	-6.7	5.52E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.34	-6.37	4.22E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6139064	chr20:3277050	ITPA	chr20:3190056-3204504:+	-0.29	-6.96	1.04E-11	IFN-related cytopenia	
KIRC	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.27	-6.43	2.95E-10	IFN-related cytopenia	
KIRC	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.27	-6.54	1.55E-10	IFN-related cytopenia	
KIRC	cis	1	rs6139103	chr20:3361140	ITPA	chr20:3190056-3204504:+	-0.27	-6.42	3.2E-10	IFN-related cytopenia	
KIRC	cis	1	rs6139117	chr20:3387785	C20orf194	chr20:3229948-3388587:-	0.21	4	7.21E-5	IFN-related cytopenia	
KIRC	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.26	-5.85	8.78E-9	IFN-related cytopenia	
KIRC	cis	1	rs61394483	chr6:33751945	LEMD2	chr6:33738991-33756906:-	0.23	5.12	4.36E-7	Body mass index	
KIRC	cis	1	rs6141546	chr20:33949282	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.3E-8	Height	
KIRC	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.28	7.66	9.91E-14	Height	
KIRC	cis	1	rs6141548	chr20:33971085	CPNE1	chr20:34213968-34262539:-	0.27	5.4	1.02E-7	Height	
KIRC	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.28	7.66	9.91E-14	Height	
KIRC	cis	1	rs6141549	chr20:33974051	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.17E-8	Height	
KIRC	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.28	7.63	1.19E-13	Height	
KIRC	cis	1	rs614226	chr12:120974510	POP5	chr12:121016849-121019201:-	0.16	3.84	0.00014	Type 1 diabetes nephropathy	
KIRC	cis	1	rs6142358	chr20:33960308	CPNE1	chr20:34213968-34262539:-	-0.27	-5.32	1.55E-7	Height	
KIRC	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.27	-7.33	9.35E-13	Height	
KIRC	cis	1	rs6142359	chr20:33960450	CPNE1	chr20:34213968-34262539:-	0.27	5.37	1.19E-7	Height	
KIRC	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.28	7.65	1.05E-13	Height	
KIRC	cis	1	rs6142360	chr20:33960486	CPNE1	chr20:34213968-34262539:-	0.26	5.17	3.34E-7	Height	
KIRC	cis	1	rs6142360	chr20:33960486	FER1L4	chr20:34146508-34195484:-	0.11	3.64	0.000296	Height	
KIRC	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.28	7.41	5.4E-13	Height	
KIRC	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.26	5.34	1.41E-7	Height	
KIRC	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.28	7.65	1.04E-13	Height	
KIRC	cis	1	rs6142370	chr20:33973378	CPNE1	chr20:34213968-34262539:-	0.27	5.47	7.17E-8	Height	
KIRC	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.28	7.63	1.19E-13	Height	
KIRC	cis	1	rs6142373	chr20:33983314	CPNE1	chr20:34213968-34262539:-	0.27	5.41	9.93E-8	Height	
KIRC	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.29	7.89	1.88E-14	Height	
KIRC	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.27	5.42	9.23E-8	Height	
KIRC	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.29	7.8	3.69E-14	Height	
KIRC	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.28	5.58	3.88E-8	Height	
KIRC	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.28	7.75	5.28E-14	Height	
KIRC	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.27	5.4	1.03E-7	Height	
KIRC	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.28	7.71	7.04E-14	Height	
KIRC	cis	1	rs61457762	chr1:27284157	PIGV	chr1:27114455-27124886:+	-0.36	-4.32	1.92E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs61498756	chr8:89455192	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.99	-14.7	6.17E-41	Blood metabolite levels	
KIRC	cis	1	rs61517255	chr10:17208918	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.25	1.37E-15	Homocysteine levels	
KIRC	cis	1	rs615199	chr6:117113653	FAM162B	chr6:117073360-117086886:-	0.24	6.58	1.16E-10	C-reactive protein levels	
KIRC	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.58	11.84	1.11E-28	Metabolite levels (small molecules and protein measures)	
KIRC	cis	1	rs615284	chr13:28192930	POLR1D	chr13:28194895-28241547:+	-0.21	-4.52	7.55E-6	Large B-cell lymphoma	
KIRC	cis	1	rs61530785	chr5:150261364	IRGM	chr5:150226085-150280295:+	0.58	7.38	6.68E-13	Crohn's disease	
KIRC	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.36	4.55	6.64E-6	Crohn's disease	
KIRC	cis	1	rs61533446	chr8:89455017	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs61558956	chr3:158452655	RARRES1	chr3:158414899-158450275:-	0.21	4.94	1.08E-6	Tetralogy of Fallot	
KIRC	cis	1	rs61596977	chr8:95997165	C8orf38	chr8:95908040-96088396:+	-0.26	-3.69	0.000244	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs61601271	chr10:81727941	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs61605589	chr2:198876532	RFTN2	chr2:198435528-198540584:-	0.17	4.58	6.0E-6	Ulcerative colitis	
KIRC	cis	1	rs616147	chr3:39534481	RPSA	chr3:39448204-39454030:+	0.2	5.13	4.23E-7	Corticobasal degeneration;Progressive supranuclear palsy	
KIRC	cis	1	rs616157	chr12:120925795	POP5	chr12:121016849-121019201:-	0.15	3.61	0.000341	Type 1 diabetes nephropathy	
KIRC	cis	1	rs61634114	chr19:17387254	ANKLE1	chr19:17392454-17398454:+	0.17	3.61	0.000342	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs61662306	chr6:33746697	LEMD2	chr6:33738991-33756906:-	0.23	5.14	3.93E-7	Body mass index	
KIRC	cis	1	rs61667532	chr8:89454997	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs61671299	chr8:89453431	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs61683331	chr8:89455046	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs61705659	chr11:73012101	RELT	chr11:73087405-73108518:+	0.2	4.24	2.69E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs61783200	chr1:46297403	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs61783220	chr1:46335312	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs61786362	chr1:99189342	SNX7	chr1:99127236-99226054:+	0.21	5.18	3.22E-7	Proinsulin levels	
KIRC	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.45	7.73	6.03E-14	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.44	7.41	5.45E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.44	7.32	9.93E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.45	7.43	4.6E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.45	7.43	4.63E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.44	7.3	1.1E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.44	7.62	1.23E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.44	7.62	1.23E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs61806199	chr1:119450102	WARS2	chr1:119573841-119683295:-	0.28	4.37	1.52E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs61806202	chr1:119465457	WARS2	chr1:119573841-119683295:-	0.31	4.88	1.4E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs61806205	chr1:119482315	WARS2	chr1:119573841-119683295:-	0.29	4.69	3.45E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs61806231	chr1:119496482	WARS2	chr1:119573841-119683295:-	0.3	4.7	3.44E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs6180	chr5:42719239	CCDC152	chr5:42756920-42802539:+	0.22	5.04	6.57E-7	Height	
KIRC	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.51	7.81	3.45E-14	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs61819219	chr1:151084375	LYSMD1	chr1:151132225-151138424:-	-0.25	-4.78	2.32E-6	Body mass index	
KIRC	cis	1	rs61826828	chr1:174015261	RABGAP1L	chr1:174128634-174959724:+	0.25	5.1	4.9E-7	Schizophrenia	
KIRC	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.41	6.64	8.35E-11	Schizophrenia	
KIRC	cis	1	rs61833916	chr1:243469946	SDCCAG8	chr1:243419320-243663392:+	-0.29	-3.88	0.000119	Obesity (early onset extreme)	
KIRC	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.29	-6.99	8.92E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.28	-6.66	7.32E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs61852637	chr1:247219636	ZNF695	chr1:247108854-247242069:-	-0.21	-3.76	0.000193	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs61854764	chr10:69965475	ATOH7	chr10:69990386-69991855:-	-0.26	-4.11	4.53E-5	Optic nerve measurement (disc area)	
KIRC	cis	1	rs61856137	chr10:5087978	AKR1C2	chr10:4964715-5060207:-	0.26	3.98	7.87E-5	Longevity	
KIRC	cis	1	rs61858625	chr10:38002042	LOC399744	chr10:38717074-38741080:+	0.23	3.54	0.000432	Obesity (extreme)	
KIRC	cis	1	rs61869036	chr10:121422836	TIAL1	chr10:121332978-121356541:-	-0.18	-3.73	0.000212	Dilated cardiomyopathy	
KIRC	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.25	6.71	5.23E-11	Blood metabolite levels	
KIRC	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.25	6.77	3.57E-11	Blood metabolite levels	
KIRC	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.26	7.07	5.31E-12	Blood metabolite levels	
KIRC	cis	1	rs61879300	chr11:22117880	ANO5	chr11:22214722-22304913:+	0.27	5.04	6.5E-7	Parkinson's disease	
KIRC	cis	1	rs61882678	chr11:46368241	MDK	chr11:46402334-46405374:+	-0.21	-3.52	0.000467	Schizophrenia	
KIRC	cis	1	rs61882746	chr11:46567475	MDK	chr11:46402334-46405374:+	-0.2	-3.5	0.000501	Schizophrenia	
KIRC	cis	1	rs61882750	chr11:46584227	MDK	chr11:46402334-46405374:+	-0.21	-3.64	0.000295	Schizophrenia	
KIRC	cis	1	rs61882758	chr11:46611805	MDK	chr11:46402334-46405374:+	-0.22	-3.86	0.000127	Schizophrenia	
KIRC	cis	1	rs61884264	chr11:46639582	MDK	chr11:46402334-46405374:+	-0.22	-3.81	0.000159	Schizophrenia	
KIRC	cis	1	rs61901691	chr11:59902799	MS4A2	chr11:59856137-59866014:+	0.18	3.81	0.000157	Alzheimer's disease (late onset)	
KIRC	cis	1	rs61934658	chr12:81445968	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs61934658	chr12:81445968	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs61977049	chr14:88827000	SPATA7	chr14:88852012-88904802:+	-0.19	-4.06	5.67E-5	Coronary artery calcification	
KIRC	cis	1	rs61977058	chr14:88881915	SPATA7	chr14:88852012-88904802:+	-0.2	-4.05	5.91E-5	Coronary artery calcification	
KIRC	cis	1	rs61985454	chr14:54850538	CDKN3	chr14:54863673-54886932:+	-0.15	-3.82	0.000152	Response to antipsychotic treatment in schizophrenia (working memory)	
KIRC	cis	1	rs62017189	chr15:50922032	SPPL2A	chr15:50999739-51057910:-	0.29	7.76	4.63E-14	QT interval	
KIRC	cis	1	rs62017189	chr15:50922032	TRPM7	chr15:50852491-50978994:-	0.13	3.75	0.000199	QT interval	
KIRC	cis	1	rs62017206	chr15:50955626	SPPL2A	chr15:50999739-51057910:-	0.27	6.91	1.45E-11	QT interval	
KIRC	cis	1	rs62017210	chr15:50960620	SPPL2A	chr15:50999739-51057910:-	0.27	6.96	1.09E-11	QT interval	
KIRC	cis	1	rs62019272	chr15:90858974	TTLL13	chr15:90792764-90815443:+	0.27	3.91	0.000107	Rheumatoid arthritis	
KIRC	cis	1	rs62019464	chr15:85294469	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.45	1.07E-5	Schizophrenia	
KIRC	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.21	-4.06	5.66E-5	Schizophrenia	
KIRC	cis	1	rs62019469	chr15:85321220	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.57	6.17E-6	Schizophrenia	
KIRC	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.21	-4.1	4.73E-5	Schizophrenia	
KIRC	cis	1	rs62021219	chr15:85256159	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.56	6.32E-6	Schizophrenia	
KIRC	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.21	-4.05	5.9E-5	Schizophrenia	
KIRC	cis	1	rs62026530	chr15:84775840	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.5	8.53E-6	Schizophrenia	
KIRC	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.26	-5.03	6.76E-7	Schizophrenia	
KIRC	cis	1	rs62055047	chr16:71401027	CALB2	chr16:71392626-71424339:+	0.32	3.62	0.000319	Schizophrenia	
KIRC	cis	1	rs62067978	chr17:2013058	SRR	chr17:2207248-2228553:+	0.36	5.43	8.99E-8	Body mass index	
KIRC	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.35	6.1	2.15E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs62070312	chr17:28438877	EFCAB5	chr17:28256874-28435469:+	0.36	6.45	2.58E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs62073605	chr17:18066791	FAM106A	chr17:18427880-18430160:-	-0.26	-3.74	0.000207	Obesity-related traits	
KIRC	cis	1	rs62073605	chr17:18066791	LOC220594	chr17:18414577-18445234:-	-0.33	-4.9	1.33E-6	Obesity-related traits	
KIRC	cis	1	rs62073605	chr17:18066791	TOP3A	chr17:18177235-18218321:-	0.23	4.06	5.74E-5	Obesity-related traits	
KIRC	cis	1	rs62073606	chr17:18069142	FAM106A	chr17:18427880-18430160:-	-0.26	-3.74	0.000207	Obesity-related traits	
KIRC	cis	1	rs62073606	chr17:18069142	LOC220594	chr17:18414577-18445234:-	-0.33	-4.9	1.33E-6	Obesity-related traits	
KIRC	cis	1	rs62073606	chr17:18069142	TOP3A	chr17:18177235-18218321:-	0.23	4.06	5.74E-5	Obesity-related traits	
KIRC	cis	1	rs62096463	chr18:44628928	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs62096464	chr18:44629207	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs62096466	chr18:44636171	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs62096468	chr18:44637566	HDHD2	chr18:44633782-44676871:-	0.38	3.76	0.000192	Sitting height ratio	
KIRC	cis	1	rs62096469	chr18:44638298	HDHD2	chr18:44633782-44676871:-	0.37	3.86	0.000129	Sitting height ratio	
KIRC	cis	1	rs62096470	chr18:44641466	HDHD2	chr18:44633782-44676871:-	0.37	3.86	0.000129	Sitting height ratio	
KIRC	cis	1	rs62096471	chr18:44643814	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs62096474	chr18:44647504	HDHD2	chr18:44633782-44676871:-	0.39	4.06	5.66E-5	Sitting height ratio	
KIRC	cis	1	rs62096476	chr18:44658621	HDHD2	chr18:44633782-44676871:-	0.4	4.18	3.38E-5	Sitting height ratio	
KIRC	cis	1	rs62096478	chr18:44662409	HDHD2	chr18:44633782-44676871:-	0.4	4.18	3.38E-5	Sitting height ratio	
KIRC	cis	1	rs62103177	chr18:77624479	HSBP1L1	chr18:77724582-77730820:+	0.32	4.31	2.01E-5	Opioid sensitivity	
KIRC	cis	1	rs62103177	chr18:77624479	TXNL4A	chr18:77732869-77793915:-	0.25	4.14	4.01E-5	Opioid sensitivity	
KIRC	cis	1	rs62107762	chr19:15982538	CYP4F11	chr19:16023180-16045676:-	-0.37	-6.06	2.63E-9	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs62107762	chr19:15982538	CYP4F2	chr19:15988834-16008884:-	-0.19	-3.63	0.000312	Acenocoumarol maintenance dosage;Vitamin E levels;Circulating phylloquinone levels;Metabolite levels;Response to Vitamin E supplementation;Warfarin maintenance dose	
KIRC	cis	1	rs62112907	chr19:22209569	ZNF257	chr19:22235266-22273901:+	0.34	4.75	2.72E-6	Body mass index (change over time)	
KIRC	cis	1	rs62112917	chr19:22226580	ZNF257	chr19:22235266-22273901:+	0.39	5.17	3.41E-7	Body mass index (change over time)	
KIRC	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.27	-5.37	1.18E-7	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.28	-5.63	2.99E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.28	-5.71	1.96E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.29	-5.96	4.73E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.29	-5.88	7.57E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs62120832	chr19:23064264	ZNF492	chr19:22817126-22850472:+	-0.39	-5.62	3.21E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs62121818	chr19:39167760	CAPN12	chr19:39220832-39235114:-	-0.13	-3.86	0.000129	Heart rate	
KIRC	cis	1	rs62132092	chr2:17770893	SMC6	chr2:17845080-17981462:-	-0.32	-3.71	0.000231	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132093	chr2:17771207	SMC6	chr2:17845080-17981462:-	-0.32	-3.71	0.000231	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132129	chr2:17778782	SMC6	chr2:17845080-17981462:-	-0.29	-3.68	0.000258	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132133	chr2:17780483	SMC6	chr2:17845080-17981462:-	-0.3	-3.65	0.000287	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132135	chr2:17783190	SMC6	chr2:17845080-17981462:-	-0.3	-3.65	0.000287	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132137	chr2:17784194	SMC6	chr2:17845080-17981462:-	-0.3	-3.65	0.000287	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132138	chr2:17784781	SMC6	chr2:17845080-17981462:-	-0.3	-3.65	0.000287	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132139	chr2:17785987	SMC6	chr2:17845080-17981462:-	-0.31	-3.72	0.00022	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132140	chr2:17786559	SMC6	chr2:17845080-17981462:-	-0.31	-3.73	0.000213	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132141	chr2:17786758	SMC6	chr2:17845080-17981462:-	-0.31	-3.73	0.000213	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132142	chr2:17788469	SMC6	chr2:17845080-17981462:-	-0.31	-3.73	0.000213	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132143	chr2:17788743	SMC6	chr2:17845080-17981462:-	-0.31	-3.73	0.000213	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132144	chr2:17788790	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000179	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132145	chr2:17789253	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000179	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132146	chr2:17790133	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000179	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132147	chr2:17790876	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000177	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132148	chr2:17791048	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000177	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132150	chr2:17792359	SMC6	chr2:17845080-17981462:-	-0.29	-3.57	0.000395	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132151	chr2:17792698	SMC6	chr2:17845080-17981462:-	-0.3	-3.67	0.000272	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62132152	chr2:17794404	SMC6	chr2:17845080-17981462:-	-0.31	-3.82	0.000148	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133576	chr2:17795297	SMC6	chr2:17845080-17981462:-	-0.31	-3.82	0.000148	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133577	chr2:17798777	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.00012	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133578	chr2:17799575	SMC6	chr2:17845080-17981462:-	-0.31	-3.85	0.000135	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133579	chr2:17800196	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.00012	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133583	chr2:17805779	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133584	chr2:17805944	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133586	chr2:17806579	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133587	chr2:17806654	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133588	chr2:17807469	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62133589	chr2:17807626	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.000116	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs62136864	chr2:46829124	ATP6V1E2	chr2:46738988-46769696:-	-0.21	-3.95	9.05E-5	Height	
KIRC	cis	1	rs62136864	chr2:46829124	CRIPT	chr2:46844325-46852880:+	0.3	6.92	1.4E-11	Height	
KIRC	cis	1	rs62136864	chr2:46829124	PIGF	chr2:46808414-46844251:-	0.35	7.47	3.54E-13	Height	
KIRC	cis	1	rs62139200	chr2:54475507	ACYP2	chr2:54342410-54532433:+	-0.21	-3.84	0.000139	Telomere length	
KIRC	cis	1	rs62139251	chr2:54478605	ACYP2	chr2:54342410-54532433:+	-0.2	-3.57	0.000396	Telomere length	
KIRC	cis	1	rs62139254	chr2:54480336	ACYP2	chr2:54342410-54532433:+	-0.2	-3.58	0.000372	Telomere length	
KIRC	cis	1	rs62151174	chr2:70363968	ANXA4	chr2:69969127-70053594:+	-0.19	-3.86	0.00013	Obesity-related traits	
KIRC	cis	1	rs62151174	chr2:70363968	FAM136A	chr2:70523109-70529220:-	-0.23	-4.51	8.09E-6	Obesity-related traits	
KIRC	cis	1	rs62151652	chr2:73700131	TPRKB	chr2:73956957-73964517:-	-0.2	-5.01	7.55E-7	Metabolite levels	
KIRC	cis	1	rs62153845	chr2:99887162	LIPT1	chr2:99771418-99779611:+	0.29	4.95	1.0E-6	IgG glycosylation	
KIRC	cis	1	rs62175448	chr2:179990206	CCDC141	chr2:179697347-179914786:-	-0.34	-4.25	2.58E-5	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62175449	chr2:179990211	CCDC141	chr2:179697347-179914786:-	-0.31	-3.76	0.000187	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62175450	chr2:180003056	CCDC141	chr2:179697347-179914786:-	-0.3	-3.52	0.00047	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.19	3.89	0.000115	Idiopathic membranous nephropathy	
KIRC	cis	1	rs62175515	chr2:160909524	PLA2R1	chr2:160798012-160919121:-	0.18	3.79	0.000169	Idiopathic membranous nephropathy	
KIRC	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.19	3.89	0.000115	Idiopathic membranous nephropathy	
KIRC	cis	1	rs62175517	chr2:160911575	PLA2R1	chr2:160798012-160919121:-	0.18	3.79	0.000169	Idiopathic membranous nephropathy	
KIRC	cis	1	rs62177281	chr2:180025012	CCDC141	chr2:179697347-179914786:-	-0.3	-3.52	0.000466	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177283	chr2:180036117	CCDC141	chr2:179697347-179914786:-	-0.32	-3.91	0.000107	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177287	chr2:180052023	CCDC141	chr2:179697347-179914786:-	-0.33	-3.91	0.000103	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177289	chr2:180053737	CCDC141	chr2:179697347-179914786:-	-0.33	-3.91	0.000103	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177291	chr2:180084629	CCDC141	chr2:179697347-179914786:-	-0.33	-3.92	9.92E-5	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177326	chr2:180090704	CCDC141	chr2:179697347-179914786:-	-0.32	-3.9	0.000108	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177327	chr2:180093608	CCDC141	chr2:179697347-179914786:-	-0.32	-3.9	0.000108	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177332	chr2:180110755	CCDC141	chr2:179697347-179914786:-	-0.31	-3.74	0.000204	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177335	chr2:180120188	CCDC141	chr2:179697347-179914786:-	-0.31	-3.74	0.000204	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177336	chr2:180123129	CCDC141	chr2:179697347-179914786:-	-0.31	-3.76	0.000193	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177337	chr2:180125071	CCDC141	chr2:179697347-179914786:-	-0.31	-3.75	0.000195	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62177338	chr2:180126141	CCDC141	chr2:179697347-179914786:-	-0.32	-3.81	0.000158	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62179066	chr2:180131509	CCDC141	chr2:179697347-179914786:-	-0.32	-3.83	0.000144	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62179067	chr2:180135183	CCDC141	chr2:179697347-179914786:-	-0.31	-3.76	0.000193	Late-onset Alzheimer's disease	
KIRC	cis	1	rs62184315	chr2:190771945	ASNSD1	chr2:190526125-190535556:+	-0.21	-4.21	3.06E-5	Alcohol dependence (age at onset)	
KIRC	cis	1	rs62184315	chr2:190771945	ORMDL1	chr2:190634994-190649097:-	0.18	4.06	5.68E-5	Alcohol dependence (age at onset)	
KIRC	cis	1	rs62190367	chr2:242376276	ANO7	chr2:242127924-242164791:+	0.26	3.67	0.000264	Prostate cancer	
KIRC	cis	1	rs62193256	chr2:242362168	ANO7	chr2:242127924-242164791:+	0.25	3.52	0.00047	Prostate cancer	
KIRC	cis	1	rs62210663	chr20:55067481	C20orf43	chr20:55043647-55093942:+	0.2	4.65	4.21E-6	Refractive astigmatism	
KIRC	cis	1	rs62211529	chr20:33959315	CPNE1	chr20:34213968-34262539:-	0.26	5.25	2.3E-7	Height	
KIRC	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.28	7.67	9.22E-14	Height	
KIRC	cis	1	rs62229266	chr21:37460271	CBR1	chr21:37442285-37445464:+	-0.18	-4.2	3.11E-5	Mitral valve prolapse	
KIRC	cis	1	rs62229266	chr21:37460271	SETD4	chr21:37406840-37451687:-	-0.22	-6.53	1.58E-10	Mitral valve prolapse	
KIRC	cis	1	rs62236665	chr22:38059847	LGALS1	chr22:38071613-38075807:+	-0.13	-3.93	9.85E-5	Fat distribution (HIV)	
KIRC	cis	1	rs62236667	chr22:38061520	LGALS1	chr22:38071613-38075807:+	-0.13	-4.13	4.18E-5	Fat distribution (HIV)	
KIRC	cis	1	rs62236668	chr22:38063870	LGALS1	chr22:38071613-38075807:+	-0.13	-4.13	4.18E-5	Fat distribution (HIV)	
KIRC	cis	1	rs62259933	chr3:49469703	CCDC36	chr3:49235861-49295537:+	-0.25	-4.76	2.54E-6	Menarche (age at onset)	
KIRC	cis	1	rs62259933	chr3:49469703	NCKIPSD	chr3:48711280-48723334:-	-0.2	-4	7.43E-5	Menarche (age at onset)	
KIRC	cis	1	rs62259933	chr3:49469703	P4HTM	chr3:49027341-49044579:+	-0.2	-4.39	1.41E-5	Menarche (age at onset)	
KIRC	cis	1	rs62259933	chr3:49469703	TREX1	chr3:48501186-48509043:+	0.15	3.8	0.00016	Menarche (age at onset)	
KIRC	cis	1	rs62259933	chr3:49469703	WDR6	chr3:49044637-49053386:+	0.21	5.14	3.96E-7	Menarche (age at onset)	
KIRC	cis	1	rs62259944	chr3:49430883	CCDC36	chr3:49235861-49295537:+	-0.27	-4.94	1.08E-6	Menarche (age at onset)	
KIRC	cis	1	rs62259944	chr3:49430883	GMPPB	chr3:49758932-49761384:-	0.19	4.17	3.55E-5	Menarche (age at onset)	
KIRC	cis	1	rs62259944	chr3:49430883	NCKIPSD	chr3:48711280-48723334:-	-0.24	-4.46	1.0E-5	Menarche (age at onset)	
KIRC	cis	1	rs62259944	chr3:49430883	P4HTM	chr3:49027341-49044579:+	-0.24	-5.15	3.76E-7	Menarche (age at onset)	
KIRC	cis	1	rs62259944	chr3:49430883	WDR6	chr3:49044637-49053386:+	0.2	4.72	3.0E-6	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	CCDC36	chr3:49235861-49295537:+	-0.28	-5.18	3.22E-7	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	GMPPB	chr3:49758932-49761384:-	0.17	3.89	0.000112	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.43	1.17E-5	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	P4HTM	chr3:49027341-49044579:+	-0.22	-4.93	1.11E-6	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	TREX1	chr3:48501186-48509043:+	0.15	3.59	0.000363	Menarche (age at onset)	
KIRC	cis	1	rs62259947	chr3:49439924	WDR6	chr3:49044637-49053386:+	0.2	5.11	4.65E-7	Menarche (age at onset)	
KIRC	cis	1	rs62261249	chr3:49594060	CCDC36	chr3:49235861-49295537:+	-0.28	-5.12	4.34E-7	Menarche (age at onset)	
KIRC	cis	1	rs62261249	chr3:49594060	GMPPB	chr3:49758932-49761384:-	0.18	3.85	0.000135	Menarche (age at onset)	
KIRC	cis	1	rs62261249	chr3:49594060	NCKIPSD	chr3:48711280-48723334:-	-0.22	-4.21	3.08E-5	Menarche (age at onset)	
KIRC	cis	1	rs62261249	chr3:49594060	P4HTM	chr3:49027341-49044579:+	-0.2	-4.38	1.43E-5	Menarche (age at onset)	
KIRC	cis	1	rs62261249	chr3:49594060	WDR6	chr3:49044637-49053386:+	0.21	5.15	3.68E-7	Menarche (age at onset)	
KIRC	cis	1	rs62265556	chr3:94243253	STX19	chr3:93733215-93747454:-	0.4	5.4	1.02E-7	Blood pressure measurement (high sodium intervention)	
KIRC	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.36	6.82	2.68E-11	Cognitive performance	
KIRC	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.61	14.74	3.96E-41	Height	
KIRC	cis	1	rs62269547	chr3:134214042	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.98E-10	Height	
KIRC	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.66	9.51E-41	Height	
KIRC	cis	1	rs62271513	chr3:134298412	CEP63	chr3:134204575-134293852:+	-0.33	-6.35	4.71E-10	Height	
KIRC	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.73	4.36E-41	Height	
KIRC	cis	1	rs62271514	chr3:134298554	CEP63	chr3:134204575-134293852:+	-0.33	-6.36	4.41E-10	Height	
KIRC	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs62271515	chr3:134300507	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs62283056	chr4:6276630	CRMP1	chr4:5749811-5894785:-	0.22	3.86	0.000126	Cisplatin-induced ototoxicity	
KIRC	cis	1	rs62295634	chr4:17685346	LAP3	chr4:17578927-17609590:+	-0.21	-6.53	1.63E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs62295634	chr4:17685346	MED28	chr4:17616273-17629791:+	0.16	3.66	0.000281	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs62308746	chr4:89805969	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.63	0.000318	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs62309962	chr4:89152990	ABCG2	chr4:89011417-89152474:-	-0.19	-4.39	1.39E-5	Metabolite levels (small molecules and protein measures)	
KIRC	cis	1	rs62310332	chr4:39114559	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs62310476	chr4:89832328	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.6	0.000352	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs62381795	chr5:137577870	CDC25C	chr5:137620959-137674044:-	-0.21	-6.01	3.6E-9	Resting heart rate	
KIRC	cis	1	rs62384189	chr5:115510391	COMMD10	chr5:115420727-115628978:+	0.32	3.62	0.000329	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384212	chr5:115521667	COMMD10	chr5:115420727-115628978:+	0.33	3.84	0.000137	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384213	chr5:115526795	COMMD10	chr5:115420727-115628978:+	0.39	3.99	7.51E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384215	chr5:115528198	COMMD10	chr5:115420727-115628978:+	0.41	4.23	2.73E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384231	chr5:115530304	COMMD10	chr5:115420727-115628978:+	0.34	4.02	6.63E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384233	chr5:115533597	COMMD10	chr5:115420727-115628978:+	0.35	4.15	3.87E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384235	chr5:115534234	COMMD10	chr5:115420727-115628978:+	0.42	4.38	1.47E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384236	chr5:115534637	COMMD10	chr5:115420727-115628978:+	0.42	4.38	1.47E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384237	chr5:115540222	COMMD10	chr5:115420727-115628978:+	0.36	4.17	3.63E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384238	chr5:115542531	COMMD10	chr5:115420727-115628978:+	0.4	4.15	3.91E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384253	chr5:115563415	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384468	chr5:115623850	COMMD10	chr5:115420727-115628978:+	0.39	3.95	8.92E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384469	chr5:115624964	COMMD10	chr5:115420727-115628978:+	0.31	3.58	0.000371	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384476	chr5:115649509	COMMD10	chr5:115420727-115628978:+	0.4	4.11	4.64E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384678	chr5:115422688	COMMD10	chr5:115420727-115628978:+	0.34	3.88	0.000119	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384697	chr5:115438284	COMMD10	chr5:115420727-115628978:+	0.34	3.83	0.000142	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384700	chr5:115443805	COMMD10	chr5:115420727-115628978:+	0.34	3.92	9.94E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62384714	chr5:115452597	COMMD10	chr5:115420727-115628978:+	0.37	3.84	0.000139	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62385177	chr5:115480480	COMMD10	chr5:115420727-115628978:+	0.33	3.84	0.000139	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62385980	chr5:115592908	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62385993	chr5:115602254	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs62391531	chr5:125914726	LMNB1	chr5:126112833-126172709:+	0.18	3.99	7.56E-5	Osteoporosis	
KIRC	cis	1	rs62402013	chr6:26915000	BTN3A2	chr6:26365398-26378546:+	0.19	4.13	4.19E-5	Schizophrenia	
KIRC	cis	1	rs62404566	chr6:35118432	TCP11	chr6:35085849-35109187:-	-0.24	-4.24	2.62E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs62404566	chr6:35118432	UHRF1BP1	chr6:34759794-34853117:+	-0.14	-3.76	0.000192	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs62404862	chr6:55943199	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404863	chr6:55943202	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404865	chr6:55944559	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404866	chr6:55956146	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404867	chr6:55957970	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404868	chr6:55958119	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404869	chr6:55958205	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404893	chr6:55961216	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404894	chr6:55961287	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404895	chr6:55961427	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62404896	chr6:55962092	COL21A1	chr6:55921389-56258892:-	-0.48	-7.57	1.79E-13	Psychosis (atypical)	
KIRC	cis	1	rs62406152	chr6:55932036	COL21A1	chr6:55921389-56258892:-	-0.49	-7.77	4.48E-14	Psychosis (atypical)	
KIRC	cis	1	rs62406153	chr6:55935232	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62406155	chr6:55937492	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62406156	chr6:55941887	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62406157	chr6:55941999	COL21A1	chr6:55921389-56258892:-	-0.47	-7.43	4.6E-13	Psychosis (atypical)	
KIRC	cis	1	rs62411452	chr6:55964425	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62411455	chr6:55968366	COL21A1	chr6:55921389-56258892:-	-0.47	-7.48	3.42E-13	Psychosis (atypical)	
KIRC	cis	1	rs62411456	chr6:55968420	COL21A1	chr6:55921389-56258892:-	-0.47	-7.48	3.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs62411457	chr6:55968487	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs62412799	chr6:55977839	COL21A1	chr6:55921389-56258892:-	-0.47	-7.44	4.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs62412803	chr6:55986547	COL21A1	chr6:55921389-56258892:-	-0.47	-7.29	1.19E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412804	chr6:55986975	COL21A1	chr6:55921389-56258892:-	-0.46	-6.92	1.36E-11	Psychosis (atypical)	
KIRC	cis	1	rs62412805	chr6:55986986	COL21A1	chr6:55921389-56258892:-	-0.45	-6.89	1.67E-11	Psychosis (atypical)	
KIRC	cis	1	rs62412806	chr6:55987105	COL21A1	chr6:55921389-56258892:-	-0.48	-7.48	3.42E-13	Psychosis (atypical)	
KIRC	cis	1	rs62412807	chr6:55987693	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412808	chr6:55987806	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412809	chr6:55987863	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412810	chr6:55988047	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412811	chr6:55988062	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412813	chr6:55988257	COL21A1	chr6:55921389-56258892:-	-0.47	-7.29	1.19E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412814	chr6:55988296	COL21A1	chr6:55921389-56258892:-	-0.47	-7.31	1.09E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412818	chr6:55989784	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs62412819	chr6:55992889	COL21A1	chr6:55921389-56258892:-	-0.47	-7.32	1.01E-12	Psychosis (atypical)	
KIRC	cis	1	rs62412820	chr6:55992934	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs62412822	chr6:55993174	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.13E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413465	chr6:55998202	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413470	chr6:55999537	COL21A1	chr6:55921389-56258892:-	-0.41	-6.59	1.13E-10	Psychosis (atypical)	
KIRC	cis	1	rs62413472	chr6:56000117	COL21A1	chr6:55921389-56258892:-	-0.47	-7.37	7.28E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413473	chr6:56000463	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413474	chr6:56001074	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413475	chr6:56001075	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413476	chr6:56001918	COL21A1	chr6:55921389-56258892:-	-0.46	-7.09	4.59E-12	Psychosis (atypical)	
KIRC	cis	1	rs62413477	chr6:56002434	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413478	chr6:56002867	COL21A1	chr6:55921389-56258892:-	-0.47	-7.33	9.05E-13	Psychosis (atypical)	
KIRC	cis	1	rs62413479	chr6:56004203	COL21A1	chr6:55921389-56258892:-	-0.48	-7.4	5.69E-13	Psychosis (atypical)	
KIRC	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	0.19	4.5	8.5E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs62417666	chr6:88243029	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs62417674	chr6:88249745	C6orf164	chr6:88032306-88109459:+	0.31	3.69	0.000249	Obesity-related traits	
KIRC	cis	1	rs62417676	chr6:88253391	C6orf164	chr6:88032306-88109459:+	0.31	3.69	0.000249	Obesity-related traits	
KIRC	cis	1	rs62417692	chr6:88278941	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs62417693	chr6:88280294	C6orf164	chr6:88032306-88109459:+	0.33	3.91	0.000107	Obesity-related traits	
KIRC	cis	1	rs62417715	chr6:88336688	C6orf164	chr6:88032306-88109459:+	0.32	3.82	0.000153	Obesity-related traits	
KIRC	cis	1	rs62419377	chr6:88211851	C6orf164	chr6:88032306-88109459:+	0.32	3.73	0.000212	Obesity-related traits	
KIRC	cis	1	rs62419378	chr6:88213596	C6orf164	chr6:88032306-88109459:+	0.3	3.54	0.000437	Obesity-related traits	
KIRC	cis	1	rs62466793	chr7:66191517	LOC493754	chr7:65993446-66057363:-	-0.17	-3.7	0.000239	Aortic root size	
KIRC	cis	1	rs62466794	chr7:66191579	LOC493754	chr7:65993446-66057363:-	-0.17	-3.7	0.000239	Aortic root size	
KIRC	cis	1	rs62479588	chr7:128405521	OPN1SW	chr7:128412545-128415844:-	0.25	4.19	3.29E-5	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth)	
KIRC	cis	1	rs624976	chr19:12110238	ZNF763	chr19:12035900-12091196:+	0.36	5.2	2.87E-7	Multiple sclerosis	
KIRC	cis	1	rs625343	chr5:134468714	TIFAB	chr5:134784560-134788089:-	0.18	3.62	0.000321	AIDS progression	
KIRC	cis	1	rs62578379	chr9:123669709	DAB2IP	chr9:124329399-124547807:+	-0.32	-3.57	0.000386	Pre-treatment pain in head and neck squamous cell carcinoma	
KIRC	cis	1	rs62578393	chr9:123691750	DAB2IP	chr9:124329399-124547807:+	-0.32	-3.58	0.000382	Pre-treatment pain in head and neck squamous cell carcinoma	
KIRC	cis	1	rs625917	chr1:183157991	LAMC2	chr1:183155174-183214262:+	0.29	6.2	1.2E-9	Hypertriglyceridemia	
KIRC	cis	1	rs62625008	chr1:95702582	RWDD3	chr1:95583479-95712773:+	0.4	5.13	4.19E-7	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs627804	chr15:65734040	DPP8	chr15:65737999-65810035:-	-0.12	-4.8	2.11E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs629286	chr17:40679159	NAGLU	chr17:40687951-40696464:+	0.42	4.38	1.42E-5	Systolic blood pressure change trajectories	
KIRC	cis	1	rs630539	chr17:40693344	NAGLU	chr17:40687951-40696464:+	-0.39	-4.26	2.41E-5	Systolic blood pressure change trajectories	
KIRC	cis	1	rs633400	chr10:38329421	LOC399744	chr10:38717074-38741080:+	0.22	3.52	0.00047	Obesity (extreme)	
KIRC	cis	1	rs635442	chr11:71570982	C11orf51	chr11:71817424-71823822:-	0.2	3.52	0.000475	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs635442	chr11:71570982	C11orf59	chr11:71808339-71814322:-	0.22	3.9	0.000111	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs638076	chr11:68202580	MRPL21	chr11:68658747-68671303:-	0.13	3.55	0.000414	Bone mineral density (spine)	
KIRC	cis	1	rs638076	chr11:68202580	SAPS3	chr11:68228186-68382799:+	-0.19	-3.87	0.000121	Bone mineral density (spine)	
KIRC	cis	1	rs638781	chr1:183157358	LAMC2	chr1:183155174-183214262:+	0.29	6.09	2.19E-9	Hypertriglyceridemia	
KIRC	cis	1	rs63934	chr11:2789062	LOC100133545	chr11:2004440-2011150:-	0.21	3.76	0.000191	Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.47	-13.61	3.77E-36	Crohn's disease	
KIRC	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.45	7.74	5.5E-14	Crohn's disease	
KIRC	cis	1	rs6413523	chr10:81706135	LOC219347	chr10:81805991-81838949:-	-0.35	-3.68	0.000258	Rheumatoid arthritis	
KIRC	cis	1	rs6415085	chr6:161023460	PLG	chr6:161123274-161174345:+	0.29	5.75	1.57E-8	Lipoprotein (a) levels	
KIRC	cis	1	rs6422512	chr1:93024844	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs6424270	chr1:233176456	C1orf57	chr1:233086370-233114219:+	-0.2	-3.68	0.000259	Bone mineral density (Ward's triangle area)	
KIRC	cis	1	rs6425657	chr1:180956905	MR1	chr1:181003139-181024633:+	-0.14	-3.89	0.000116	Progressive supranuclear palsy	
KIRC	cis	1	rs6425658	chr1:180956985	MR1	chr1:181003139-181024633:+	-0.14	-3.8	0.000162	Progressive supranuclear palsy	
KIRC	cis	1	rs642573	chr11:71780854	C11orf59	chr11:71808339-71814322:-	-0.23	-4.08	5.18E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6427553	chr1:160855813	CD244	chr1:160799951-160832645:-	-0.14	-4.47	9.79E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs642839	chr8:16702669	SLC7A2	chr8:17354600-17428073:+	-0.2	-3.55	0.000417	Parkinson's disease	
KIRC	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.52	10.69	3.76E-24	Height	
KIRC	cis	1	rs6429082	chr1:235600129	B3GALNT2	chr1:235610533-235667781:-	0.28	7.25	1.63E-12	Adiposity	
KIRC	cis	1	rs6429082	chr1:235600129	TBCE	chr1:235530728-235612280:+	0.2	4.59	5.57E-6	Adiposity	
KIRC	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.93	-22.44	9.28E-78	Homocysteine levels	
KIRC	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.81	-19.15	9.38E-62	Homocysteine levels	
KIRC	cis	1	rs6429569	chr1:46001330	MUTYH	chr1:45794915-45806142:-	0.13	4.01	7.06E-5	Homocysteine levels	
KIRC	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.49	9.25	6.58E-19	Body mass index	
KIRC	cis	1	rs6429582	chr1:46321843	MUTYH	chr1:45794915-45806142:-	-0.16	-4.66	4.01E-6	Body mass index	
KIRC	cis	1	rs643025	chr1:197298860	CFHR3	chr1:196743930-196762872:+	-0.26	-5.24	2.37E-7	Lupus nephritis in systemic lupus erythematosus	
KIRC	cis	1	rs6430585	chr2:136506927	DARS	chr2:136664254-136743222:-	-0.23	-5.3	1.76E-7	Corneal structure	
KIRC	cis	1	rs6434950	chr2:198869979	RFTN2	chr2:198435528-198540584:-	0.17	4.69	3.57E-6	Ulcerative colitis	
KIRC	cis	1	rs6435079	chr2:202200331	ALS2CR12	chr2:202153148-202222101:-	-0.26	-4.91	1.23E-6	Basal cell carcinoma	
KIRC	cis	1	rs6435081	chr2:202220623	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.88	1.39E-6	Basal cell carcinoma	
KIRC	cis	1	rs6436106	chr2:219926913	USP37	chr2:219314974-219433084:-	-0.26	-4.03	6.32E-5	Height	
KIRC	cis	1	rs6438552	chr3:119631814	GSK3B	chr3:119540804-119813264:-	0.15	3.95	8.98E-5	HDL cholesterol	
KIRC	cis	1	rs6438553	chr3:119640029	GSK3B	chr3:119540804-119813264:-	0.14	3.95	8.84E-5	HDL cholesterol	
KIRC	cis	1	rs6439116	chr3:127849067	KBTBD12	chr3:127634318-127706513:+	0.29	3.97	8.21E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6439116	chr3:127849067	RPN1	chr3:128338813-128399918:-	0.23	3.91	0.000103	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6439116	chr3:127849067	RUVBL1	chr3:127783627-127872757:-	0.34	4.83	1.8E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6439124	chr3:128007466	RPN1	chr3:128338813-128399918:-	-0.21	-3.53	0.000451	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6439124	chr3:128007466	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.19	3.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs6439484	chr3:134249899	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs6439487	chr3:134260860	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.51	-8.88	1.2E-17	Bone mineral density	
KIRC	cis	1	rs644148	chr19:44970935	ZNF285	chr19:44889809-44905777:-	0.2	3.52	0.000478	Personality dimensions	
KIRC	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.3	8.51	1.97E-16	Longevity	
KIRC	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.31	-8.73	3.68E-17	Longevity	
KIRC	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.29	-8.18	2.32E-15	Longevity	
KIRC	cis	1	rs6442120	chr3:48464503	SHISA5	chr3:48509197-48542228:-	-0.13	-3.65	0.000289	Longevity	
KIRC	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.33	-9.31	3.91E-19	Longevity	
KIRC	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.32	-9.04	3.29E-18	Longevity	
KIRC	cis	1	rs6444530	chr3:190982425	UTS2D	chr3:190984945-191048325:-	-0.21	-3.78	0.000172	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs6444531	chr3:190988002	UTS2D	chr3:190984945-191048325:-	-0.21	-3.72	0.000219	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs6445358	chr3:52308845	GNL3	chr3:52719936-52728508:+	-0.14	-3.58	0.000372	Electroencephalogram traits	
KIRC	cis	1	rs6445358	chr3:52308845	NEK4	chr3:52744803-52804951:-	-0.14	-3.52	0.000476	Electroencephalogram traits	
KIRC	cis	1	rs6445557	chr3:53083969	RFT1	chr3:53122503-53164470:-	-0.29	-4.79	2.25E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs6445557	chr3:53083969	SFMBT1	chr3:52938628-53080070:-	0.23	3.52	0.000465	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs6445557	chr3:53083969	TMEM110	chr3:52867139-52931547:-	-0.25	-4.63	4.61E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs6446262	chr3:49401153	CCDC36	chr3:49235861-49295537:+	0.28	5.18	3.22E-7	Menarche (age at onset)	
KIRC	cis	1	rs6446262	chr3:49401153	GMPPB	chr3:49758932-49761384:-	-0.17	-3.89	0.000112	Menarche (age at onset)	
KIRC	cis	1	rs6446262	chr3:49401153	NCKIPSD	chr3:48711280-48723334:-	0.23	4.43	1.17E-5	Menarche (age at onset)	
KIRC	cis	1	rs6446262	chr3:49401153	P4HTM	chr3:49027341-49044579:+	0.22	4.93	1.11E-6	Menarche (age at onset)	
KIRC	cis	1	rs6446262	chr3:49401153	TREX1	chr3:48501186-48509043:+	-0.15	-3.59	0.000363	Menarche (age at onset)	
KIRC	cis	1	rs6446262	chr3:49401153	WDR6	chr3:49044637-49053386:+	-0.2	-5.11	4.65E-7	Menarche (age at onset)	
KIRC	cis	1	rs6446268	chr3:49445695	CCDC36	chr3:49235861-49295537:+	-0.26	-4.82	1.91E-6	Menarche (age at onset)	
KIRC	cis	1	rs6446268	chr3:49445695	NCKIPSD	chr3:48711280-48723334:-	-0.22	-4.33	1.82E-5	Menarche (age at onset)	
KIRC	cis	1	rs6446268	chr3:49445695	P4HTM	chr3:49027341-49044579:+	-0.21	-4.73	2.9E-6	Menarche (age at onset)	
KIRC	cis	1	rs6446268	chr3:49445695	WDR6	chr3:49044637-49053386:+	0.18	4.59	5.58E-6	Menarche (age at onset)	
KIRC	cis	1	rs6446275	chr3:49466871	CCDC36	chr3:49235861-49295537:+	-0.25	-4.76	2.54E-6	Menarche (age at onset)	
KIRC	cis	1	rs6446275	chr3:49466871	NCKIPSD	chr3:48711280-48723334:-	-0.2	-4	7.43E-5	Menarche (age at onset)	
KIRC	cis	1	rs6446275	chr3:49466871	P4HTM	chr3:49027341-49044579:+	-0.2	-4.39	1.41E-5	Menarche (age at onset)	
KIRC	cis	1	rs6446275	chr3:49466871	TREX1	chr3:48501186-48509043:+	0.15	3.8	0.00016	Menarche (age at onset)	
KIRC	cis	1	rs6446275	chr3:49466871	WDR6	chr3:49044637-49053386:+	0.21	5.14	3.96E-7	Menarche (age at onset)	
KIRC	cis	1	rs6447634	chr4:48413511	OCIAD1	chr4:48833015-48863831:+	-0.24	-5.29	1.78E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs6449319	chr4:17640283	LAP3	chr4:17578927-17609590:+	-0.2	-6.31	6.13E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6449319	chr4:17640283	MED28	chr4:17616273-17629791:+	0.22	4.91	1.25E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6449323	chr4:17683916	LAP3	chr4:17578927-17609590:+	-0.2	-6.34	5.05E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6449323	chr4:17683916	MED28	chr4:17616273-17629791:+	0.17	3.78	0.000174	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.82	16.7	4.22E-50	Type 2 diabetes	
KIRC	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.78	15.87	3.0E-46	Type 2 diabetes	
KIRC	cis	1	rs6453279	chr5:76417074	LOC728723	chr5:76382623-76444175:+	-0.18	-3.71	0.000232	Autism	
KIRC	cis	1	rs6453424	chr5:78315367	ARSB	chr5:78073039-78282357:-	0.2	4.13	4.27E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6453424	chr5:78315367	BHMT	chr5:78407604-78428112:+	0.27	5.45	7.99E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.46	10.28	1.22E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs6455691	chr6:161023209	PLG	chr6:161123274-161174345:+	0.26	5.16	3.63E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6455692	chr6:161023402	PLG	chr6:161123274-161174345:+	0.26	5.16	3.63E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6455693	chr6:161026455	PLG	chr6:161123274-161174345:+	0.26	5.14	3.87E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6457805	chr6:35120443	TCP11	chr6:35085849-35109187:-	-0.25	-4.24	2.72E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs6457805	chr6:35120443	UHRF1BP1	chr6:34759794-34853117:+	-0.18	-4.9	1.28E-6	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs6458307	chr6:42731115	PEX6	chr6:42931613-42946981:-	-0.24	-4.12	4.37E-5	Bipolar disorder	
KIRC	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.46	-11.28	1.89E-26	Homocysteine levels	
KIRC	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.46	-11.41	5.72E-27	Homocysteine levels	
KIRC	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.41	-10.07	7.33E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.25	8.73	3.76E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.41	-9.97	1.81E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.26	9.01	4.25E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.66	2.6E-8	Diabetic kidney disease	
KIRC	cis	1	rs6460260	chr7:65215455	CRCP	chr7:65579805-65619551:+	0.31	4.24	2.63E-5	Diabetic kidney disease	
KIRC	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.66	2.6E-8	Diabetic kidney disease	
KIRC	cis	1	rs6460261	chr7:65215580	CRCP	chr7:65579805-65619551:+	0.31	4.24	2.63E-5	Diabetic kidney disease	
KIRC	cis	1	rs6460274	chr7:65628484	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.79E-9	Diabetic kidney disease	
KIRC	cis	1	rs6460274	chr7:65628484	CRCP	chr7:65579805-65619551:+	0.32	4.42	1.22E-5	Diabetic kidney disease	
KIRC	cis	1	rs6460296	chr7:65895139	LOC729156	chr7:66274980-66309813:-	0.17	3.53	0.000461	Aortic root size	
KIRC	cis	1	rs6461993	chr7:3356463	SDK1	chr7:3341080-4308629:+	0.19	3.82	0.00015	Motion sickness	
KIRC	cis	1	rs6461994	chr7:3356483	SDK1	chr7:3341080-4308629:+	0.2	3.91	0.000105	Motion sickness	
KIRC	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.39	7.68	8.32E-14	Obesity-related traits	
KIRC	cis	1	rs6464573	chr7:143748098	OR2A1	chr7:144015236-144016148:+;chr7	0.28	5.35	1.36E-7	Obesity-related traits	
KIRC	cis	1	rs6464573	chr7:143748098	OR2A9P	chr7:143991573-143997832:+;chr7	0.45	8.36	6.0E-16	Obesity-related traits	
KIRC	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.42	-8.11	3.85E-15	Obesity-related traits	
KIRC	cis	1	rs6464574	chr7:143748257	OR2A1	chr7:144015236-144016148:+;chr7	-0.28	-5.25	2.21E-7	Obesity-related traits	
KIRC	cis	1	rs6464574	chr7:143748257	OR2A9P	chr7:143991573-143997832:+;chr7	-0.46	-8.35	6.91E-16	Obesity-related traits	
KIRC	cis	1	rs6468131	chr8:29981020	MBOAT4	chr8:29989188-30002200:-	-0.36	-5.08	5.31E-7	Migraine	
KIRC	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.42	7.8	3.67E-14	Erythrocyte sedimentation rate	
KIRC	cis	1	rs646867	chr1:25709258	RHD	chr1:25598981-25656935:+	-0.56	-11.27	2.01E-26	Erythrocyte sedimentation rate	
KIRC	cis	1	rs6469877	chr8:120936521	TNFRSF11B	chr8:119935797-119964383:-	0.26	3.91	0.000105	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs6477998	chr9:115997249	CDC26	chr9:116029290-116037869:-	0.37	7.74	5.6E-14	Hematology traits	
KIRC	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.5	-9.95	2.1E-21	Rheumatoid arthritis	
KIRC	cis	1	rs6478484	chr9:123652380	PSMD5	chr9:123578334-123605206:-	-0.35	-6.66	7.27E-11	Rheumatoid arthritis	
KIRC	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.5	-9.82	5.96E-21	Rheumatoid arthritis	
KIRC	cis	1	rs6478486	chr9:123655329	PSMD5	chr9:123578334-123605206:-	-0.37	-6.82	2.6E-11	Rheumatoid arthritis	
KIRC	cis	1	rs6478867	chr9:131903923	CRAT	chr9:131857075-131873070:-	-0.15	-3.56	0.000403	Blood metabolite ratios	
KIRC	cis	1	rs6478867	chr9:131903923	PPP2R4	chr9:131873244-131911223:+	-0.19	-3.69	0.000248	Blood metabolite ratios	
KIRC	cis	1	rs6478867	chr9:131903923	SET	chr9:131445934-131458674:+	0.17	3.73	0.000216	Blood metabolite ratios	
KIRC	cis	1	rs6480314	chr10:69967447	ATOH7	chr10:69990386-69991855:-	0.27	4.41	1.25E-5	Optic nerve measurement (disc area)	
KIRC	cis	1	rs6483880	chr11:22852740	SVIP	chr11:22843600-22851382:-	0.34	7.54	2.2E-13	Dialysis-related mortality	
KIRC	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.59	-13.3	8.67E-35	Forced vital capacity	
KIRC	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.59	13.77	7.91E-37	Forced vital capacity	
KIRC	cis	1	rs6492925	chr15:40304170	SRP14	chr15:40327891-40331389:-	-0.29	-4.74	2.81E-6	Response to haloperidol in psychosis	
KIRC	cis	1	rs6493858	chr15:56736478	TEX9	chr15:56657644-56738071:+	0.16	4	7.23E-5	Relative hand skill in reading disability	
KIRC	cis	1	rs6494521	chr15:65739928	DPP8	chr15:65737999-65810035:-	-0.13	-5.01	7.38E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs6494528	chr15:65865632	DPP8	chr15:65737999-65810035:-	-0.12	-4.68	3.7E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs6494529	chr15:65902922	DPP8	chr15:65737999-65810035:-	-0.12	-4.93	1.11E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs6494532	chr15:65975798	DPP8	chr15:65737999-65810035:-	-0.12	-4.78	2.32E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs6494537	chr15:66051345	DPP8	chr15:65737999-65810035:-	-0.12	-4.87	1.5E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs6495206	chr15:76870963	SCAPER	chr15:76640529-77197744:-	-0.17	-5.75	1.55E-8	Blood metabolite levels	
KIRC	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.62	-13.95	1.3E-37	Type 2 diabetes	
KIRC	cis	1	rs6496665	chr15:90891615	IQGAP1	chr15:90931473-91045475:+	0.13	3.69	0.000253	Rheumatoid arthritis	
KIRC	cis	1	rs6496665	chr15:90891615	TTLL13	chr15:90792764-90815443:+	0.26	4.56	6.33E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6496666	chr15:90891662	IQGAP1	chr15:90931473-91045475:+	0.13	3.63	0.000309	Rheumatoid arthritis	
KIRC	cis	1	rs6496666	chr15:90891662	TTLL13	chr15:90792764-90815443:+	0.26	4.56	6.49E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6496667	chr15:90893668	IQGAP1	chr15:90931473-91045475:+	0.13	3.69	0.00025	Rheumatoid arthritis	
KIRC	cis	1	rs6496667	chr15:90893668	TTLL13	chr15:90792764-90815443:+	0.26	4.5	8.47E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6496668	chr15:90893704	IQGAP1	chr15:90931473-91045475:+	0.16	4.13	4.32E-5	Rheumatoid arthritis	
KIRC	cis	1	rs6496668	chr15:90893704	TTLL13	chr15:90792764-90815443:+	0.25	3.93	9.54E-5	Rheumatoid arthritis	
KIRC	cis	1	rs6496669	chr15:90895265	TTLL13	chr15:90792764-90815443:+	-0.26	-4.52	7.87E-6	Rheumatoid arthritis	
KIRC	cis	1	rs6499253	chr16:69802672	COG4	chr16:70514473-70557457:-	-0.2	-3.63	0.000317	IgE levels	
KIRC	cis	1	rs6499255	chr16:69830328	COG4	chr16:70514473-70557457:-	-0.21	-3.98	8.01E-5	IgE levels	
KIRC	cis	1	rs6499508	chr16:71396290	CALB2	chr16:71392626-71424339:+	0.28	3.49	0.000521	Schizophrenia	
KIRC	cis	1	rs6499766	chr16:55604128	LPCAT2	chr16:55542913-55620581:+	0.16	4.05	5.91E-5	Thyroid hormone levels	
KIRC	cis	1	rs6500602	chr16:4497451	C16orf71	chr16:4784289-4799395:+	-0.21	-4.13	4.26E-5	Schizophrenia	
KIRC	cis	1	rs6502050	chr17:80058236	DCXR	chr17:79993758-79995573:-	0.14	4.03	6.32E-5	Life satisfaction	
KIRC	cis	1	rs6502674	chr17:18776897	FAM18B	chr17:18684582-18710026:+	-0.25	-5.69	2.21E-8	Pancreatic cancer	
KIRC	cis	1	rs6502677	chr17:18803658	FAM18B	chr17:18684582-18710026:+	-0.26	-5.94	5.18E-9	Educational attainment (years of education)	
KIRC	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.79	-19.11	1.39E-61	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs6503716	chr17:40796211	NAGLU	chr17:40687951-40696464:+	0.36	3.88	0.00012	Systolic blood pressure change trajectories	
KIRC	cis	1	rs6504167	chr17:61693194	FTSJ3	chr17:61896795-61905031:-	0.33	6.46	2.4E-10	Body mass index	
KIRC	cis	1	rs6504167	chr17:61693194	PSMC5	chr17:61904810-61909386:+	0.14	3.63	0.000313	Body mass index	
KIRC	cis	1	rs6504167	chr17:61693194	TCAM1P	chr17:61934376-61941738:+	-0.22	-3.78	0.000176	Body mass index	
KIRC	cis	1	rs6504168	chr17:61697469	FTSJ3	chr17:61896795-61905031:-	0.33	6.49	2.13E-10	Body mass index	
KIRC	cis	1	rs6504168	chr17:61697469	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.32	1.89E-5	Body mass index	
KIRC	cis	1	rs6504169	chr17:61709145	FTSJ3	chr17:61896795-61905031:-	0.31	6.13	1.78E-9	Body mass index	
KIRC	cis	1	rs6504169	chr17:61709145	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.61	5.01E-6	Body mass index	
KIRC	cis	1	rs6504170	chr17:61709168	FTSJ3	chr17:61896795-61905031:-	0.33	6.52	1.69E-10	Body mass index	
KIRC	cis	1	rs6504170	chr17:61709168	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.08	5.14E-5	Body mass index	
KIRC	cis	1	rs6504171	chr17:61710010	DDX42	chr17:61851567-61896676:+	-0.17	-3.69	0.000253	Body mass index	
KIRC	cis	1	rs6504171	chr17:61710010	FTSJ3	chr17:61896795-61905031:-	0.32	6.34	5.1E-10	Body mass index	
KIRC	cis	1	rs6504171	chr17:61710010	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.43	1.18E-5	Body mass index	
KIRC	cis	1	rs6504173	chr17:61735056	DDX42	chr17:61851567-61896676:+	-0.17	-3.68	0.000258	Body mass index	
KIRC	cis	1	rs6504173	chr17:61735056	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.44E-10	Body mass index	
KIRC	cis	1	rs6504173	chr17:61735056	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.56E-6	Body mass index	
KIRC	cis	1	rs6504182	chr17:61823672	FTSJ3	chr17:61896795-61905031:-	0.31	6.24	9.32E-10	Body mass index	
KIRC	cis	1	rs6504182	chr17:61823672	TCAM1P	chr17:61934376-61941738:+	-0.27	-4.87	1.5E-6	Body mass index	
KIRC	cis	1	rs6504661	chr17:48580126	MYCBPAP	chr17:48585745-48608861:+	0.31	5.77	1.42E-8	Visceral fat	
KIRC	cis	1	rs6504948	chr17:53049987	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs6504949	chr17:53050133	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs6504950	chr17:53056471	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs6504951	chr17:53056975	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.46	2.53E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.38	-6.67	6.91E-11	Coffee consumption (cups per day)	
KIRC	cis	1	rs6508902	chr19:40182595	LOC400696	chr19:40170014-40177013:+	0.2	4.25	2.6E-5	Schizophrenia	
KIRC	cis	1	rs6508977	chr19:41909346	ATP5SL	chr19:41937224-41945810:-	0.18	4.17	3.64E-5	Height	
KIRC	cis	1	rs6509581	chr19:52363882	ZNF577	chr19:52359056-52394145:-	-0.3	-5.57	4.12E-8	Breast cancer	
KIRC	cis	1	rs6509581	chr19:52363882	ZNF649	chr19:52392489-52408247:-	-0.24	-4.95	1.02E-6	Breast cancer	
KIRC	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.25	5.92	6.06E-9	Bone properties (heel)	
KIRC	cis	1	rs6511313	chr19:22215905	ZNF257	chr19:22235266-22273901:+	0.34	4.87	1.52E-6	Body mass index (change over time)	
KIRC	cis	1	rs6514359	chr20:13039522	SPTLC3	chr20:12989627-13147411:+	0.2	3.83	0.000146	Daytime sleep phenotypes	
KIRC	cis	1	rs6514360	chr20:13039663	SPTLC3	chr20:12989627-13147411:+	0.21	3.98	7.88E-5	Daytime sleep phenotypes	
KIRC	cis	1	rs6514361	chr20:13039810	SPTLC3	chr20:12989627-13147411:+	0.21	3.98	7.88E-5	Daytime sleep phenotypes	
KIRC	cis	1	rs6515375	chr20:23610841	CST3	chr20:23608536-23618574:-	-0.14	-3.88	0.000119	Chronic kidney disease	
KIRC	cis	1	rs6515651	chr20:25414539	ENTPD6	chr20:25176339-25207360:+	0.24	6.79	3.15E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6515651	chr20:25414539	FAM182A	chr20:26035250-26067552:+	0.29	5.5	6.22E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs6515773	chr20:3174105	ITPA	chr20:3190056-3204504:+	0.14	4.11	4.69E-5	Night sleep phenotypes	
KIRC	cis	1	rs6516891	chr21:30483070	N6AMT1	chr21:30244513-30257693:-	-0.22	-4	7.21E-5	Dental caries	
KIRC	cis	1	rs6516891	chr21:30483070	NCRNA00189	chr21:30565801-30660525:+	0.23	4.18	3.42E-5	Dental caries	
KIRC	cis	1	rs6517531	chr21:40637647	HMGN1	chr21:40714247-40721270:-	-0.31	-3.52	0.000474	Temperament (bipolar disorder)	
KIRC	cis	1	rs6518986	chr22:22185347	MAPK1	chr22:22113949-22221970:-	0.2	5.7	2.1E-8	Multiple sclerosis	
KIRC	cis	1	rs6519119	chr22:38989007	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.51	0.000486	Resting heart rate	
KIRC	cis	1	rs6519119	chr22:38989007	LOC646851	chr22:38974125-39052634:-	0.14	4.1	4.92E-5	Resting heart rate	
KIRC	cis	1	rs6519120	chr22:38991393	LOC646851	chr22:38974125-39052634:-	-0.16	-4.9	1.31E-6	Resting heart rate	
KIRC	cis	1	rs6519124	chr22:39045099	BAIAP2L2	chr22:38480897-38506676:-	0.13	3.52	0.000473	Resting heart rate	
KIRC	cis	1	rs6519124	chr22:39045099	LOC646851	chr22:38974125-39052634:-	0.13	4	7.27E-5	Resting heart rate	
KIRC	cis	1	rs652753	chr1:183156569	LAMC2	chr1:183155174-183214262:+	0.29	6.09	2.19E-9	Hypertriglyceridemia	
KIRC	cis	1	rs6532022	chr4:88773734	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs6532023	chr4:88773849	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.53	-10.78	1.67E-24	Longevity	
KIRC	cis	1	rs6532432	chr4:75696811	BTC	chr4:75671448-75719882:-	0.28	3.75	0.000194	Electroencephalogram traits	
KIRC	cis	1	rs6533332	chr4:108919838	HADH	chr4:108910940-108956330:+	-0.26	-3.54	0.000432	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6533337	chr4:108933581	HADH	chr4:108910940-108956330:+	-0.26	-3.57	0.000385	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6533340	chr4:108943532	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6533341	chr4:108943681	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6533342	chr4:108943818	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6539545	chr12:81433197	ACSS3	chr12:81471809-81649582:+	0.17	3.79	0.000171	Neuroticism	
KIRC	cis	1	rs6539545	chr12:81433197	LIN7A	chr12:81191171-81331694:-	0.18	4.66	3.96E-6	Neuroticism	
KIRC	cis	1	rs6540731	chr1:212392163	TMEM206	chr1:212537819-212588267:-	-0.2	-3.98	8.06E-5	Intelligence (childhood)	
KIRC	cis	1	rs6540733	chr1:212392953	TMEM206	chr1:212537819-212588267:-	0.18	3.49	0.000524	Intelligence (childhood)	
KIRC	cis	1	rs6540735	chr1:212400760	TMEM206	chr1:212537819-212588267:-	0.18	3.52	0.000475	Intelligence (childhood)	
KIRC	cis	1	rs6542095	chr2:113529183	DDX11L2	chr2:114356606-114359153:-	-0.24	-3.92	0.000101	Endometriosis	
KIRC	cis	1	rs6542095	chr2:113529183	RPL23AP7	chr2:114368816-114384715:-	-0.27	-4.78	2.3E-6	Endometriosis	
KIRC	cis	1	rs6544065	chr2:37497417	CEBPZ	chr2:37428778-37458740:-	-0.17	-4.57	6.22E-6	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6544065	chr2:37497417	PRKD3	chr2:37477648-37544222:-	-0.13	-3.5	0.000505	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6544065	chr2:37497417	QPCT	chr2:37571753-37600464:+	-0.2	-3.71	0.000233	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.14	-6.51	1.86E-10	Tuberculosis	
KIRC	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.56	11.4	6.26E-27	Tuberculosis	
KIRC	cis	1	rs6545946	chr2:62713533	TMEM17	chr2:62727356-62762780:-	-0.26	-4.81	2.0E-6	Crohn's disease	
KIRC	cis	1	rs6546553	chr2:70111711	ANXA4	chr2:69969127-70053594:+	-0.2	-4.64	4.41E-6	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6546556	chr2:70139001	ANXA4	chr2:69969127-70053594:+	-0.22	-5.22	2.69E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6546558	chr2:70145717	ANXA4	chr2:69969127-70053594:+	-0.22	-5.38	1.16E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6546559	chr2:70145833	ANXA4	chr2:69969127-70053594:+	-0.21	-5.14	3.88E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6546835	chr2:73664715	TPRKB	chr2:73956957-73964517:-	-0.18	-4.79	2.16E-6	Metabolite levels	
KIRC	cis	1	rs6546836	chr2:73677833	TPRKB	chr2:73956957-73964517:-	-0.2	-5.25	2.24E-7	Metabolite levels	
KIRC	cis	1	rs6546837	chr2:73677898	TPRKB	chr2:73956957-73964517:-	-0.19	-5.01	7.63E-7	Metabolite levels	
KIRC	cis	1	rs6546838	chr2:73679280	TPRKB	chr2:73956957-73964517:-	-0.19	-4.98	8.62E-7	Metabolite levels	
KIRC	cis	1	rs6546839	chr2:73680508	TPRKB	chr2:73956957-73964517:-	-0.19	-5.01	7.63E-7	Metabolite levels	
KIRC	cis	1	rs6547734	chr2:27830990	NRBP1	chr2:27650657-27665122:+	0.14	3.61	0.000332	Oral cavity cancer	
KIRC	cis	1	rs6547740	chr2:27854369	NRBP1	chr2:27650657-27665122:+	0.13	3.56	0.000412	Oral cavity cancer	
KIRC	cis	1	rs6547741	chr2:27855924	NRBP1	chr2:27650657-27665122:+	0.14	3.65	0.000288	Oral cavity cancer	
KIRC	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.48	-10.27	1.4E-22	Body mass index	
KIRC	cis	1	rs6554286	chr4:56400304	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.81	0.000156	Personality dimensions	
KIRC	cis	1	rs6554286	chr4:56400304	TMEM165	chr4:56262090-56292342:+	0.22	5.87	7.85E-9	Personality dimensions	
KIRC	cis	1	rs6557265	chr6:153433402	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs6557266	chr6:153433534	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs656640	chr11:71781710	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.58E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6569435	chr6:125998186	HEY2	chr6:126068780-126082414:+	-0.17	-4.07	5.52E-5	Endometrial cancer	
KIRC	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.47	-13.61	3.77E-36	Crohn's disease	
KIRC	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.45	7.74	5.5E-14	Crohn's disease	
KIRC	cis	1	rs6570043	chr6:136134098	C6orf217	chr6:135818939-136037192:+	-0.25	-5.01	7.62E-7	Phosphorus levels	
KIRC	cis	1	rs6571221	chr6:105621189	BVES	chr6:105544700-105585049:-	0.19	3.6	0.000345	Multiple sclerosis	
KIRC	cis	1	rs6574278	chr14:76663838	ESRRB	chr14:76837690-76968178:+	0.32	4.61	5.13E-6	Blood pressure	
KIRC	cis	1	rs6578296	chr11:2779970	LOC100133545	chr11:2004440-2011150:-	0.2	3.71	0.000231	Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs6579234	chr20:33983485	CPNE1	chr20:34213968-34262539:-	0.27	5.41	9.93E-8	Height	
KIRC	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.29	7.89	1.88E-14	Height	
KIRC	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.67	-11.95	3.73E-29	Cholesterol, total	
KIRC	cis	1	rs6579245	chr20:34125271	ERGIC3	chr20:34129778-34145404:+	-0.23	-5.14	3.92E-7	Cholesterol, total	
KIRC	cis	1	rs6579245	chr20:34125271	UQCC	chr20:33890383-33999833:-	-0.21	-4.33	1.79E-5	Cholesterol, total	
KIRC	cis	1	rs6579803	chr5:150255559	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs6579804	chr5:150255931	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs6579806	chr5:150271084	IRGM	chr5:150226085-150280295:+	0.5	6.75	4.0E-11	Crohn's disease	
KIRC	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.32	4.31	1.95E-5	Crohn's disease	
KIRC	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.31	6.68	6.46E-11	Multiple sclerosis	
KIRC	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.45	-11.81	1.47E-28	Multiple sclerosis	
KIRC	cis	1	rs6581155	chr12:58178162	XRCC6BP1	chr12:58335445-58351051:+	-0.28	-6.24	9.47E-10	Multiple sclerosis	
KIRC	cis	1	rs6584347	chr10:101906963	CWF19L1	chr10:101992055-102027437:-	-0.29	-3.52	0.000469	Schizophrenia	
KIRC	cis	1	rs6584347	chr10:101906963	PKD2L1	chr10:102047903-102090243:-	0.29	3.9	0.00011	Schizophrenia	
KIRC	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.12	-4.3	2.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.14	-4.94	1.08E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs6585827	chr10:124165615	ARMS2	chr10:124214179-124216867:+	-0.19	-3.71	0.00023	Height	
KIRC	cis	1	rs6586028	chr10:82253984	TSPAN14	chr10:82214038-82282390:+	0.21	3.69	0.000249	Post bronchodilator FEV1	
KIRC	cis	1	rs658661	chr11:71559269	C11orf59	chr11:71808339-71814322:-	0.22	3.86	0.000126	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6589575	chr11:116733310	PCSK7	chr11:117075789-117102811:-	-0.27	-4.95	9.91E-7	Protein quantitative trait loci	
KIRC	cis	1	rs6589576	chr11:116735788	PCSK7	chr11:117075789-117102811:-	0.23	4.55	6.67E-6	Protein quantitative trait loci	
KIRC	cis	1	rs6589589	chr11:116932428	PCSK7	chr11:117075789-117102811:-	-0.29	-5.58	4.02E-8	Protein quantitative trait loci	
KIRC	cis	1	rs6592448	chr11:71670044	C11orf59	chr11:71808339-71814322:-	0.21	3.71	0.000231	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6592450	chr11:71671166	C11orf59	chr11:71808339-71814322:-	-0.2	-3.87	0.000123	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6592453	chr11:71683231	C11orf59	chr11:71808339-71814322:-	-0.2	-3.58	0.000373	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6592455	chr11:71689541	C11orf59	chr11:71808339-71814322:-	0.22	3.71	0.000233	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs659307	chr1:183163078	LAMC2	chr1:183155174-183214262:+	0.27	5.67	2.47E-8	Hypertriglyceridemia	
KIRC	cis	1	rs6593585	chr1:76140273	ACADM	chr1:76190043-76229353:+	0.19	5.3	1.71E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs6594480	chr5:110173859	TMEM232	chr5:109624934-110062381:-	0.24	4.7	3.37E-6	Asthma and hay fever	
KIRC	cis	1	rs6598060	chr11:243987	PSMD13	chr11:236808-252984:+	-0.16	-5.3	1.73E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598061	chr11:243853	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598062	chr11:243712	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598063	chr11:243672	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598065	chr11:243211	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598066	chr11:243185	PSMD13	chr11:236808-252984:+	-0.15	-5.01	7.6E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598069	chr11:240664	PSMD13	chr11:236808-252984:+	-0.15	-4.97	9.22E-7	Menarche (age at onset)	
KIRC	cis	1	rs6598074	chr11:219398	PSMD13	chr11:236808-252984:+	-0.15	-4.69	3.55E-6	Menarche (age at onset)	
KIRC	cis	1	rs6598955	chr1:26619649	ZNF593	chr1:26496388-26497362:+	0.14	3.72	0.000224	Obesity-related traits	
KIRC	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.7	-10.96	3.42E-25	Diastolic blood pressure	
KIRC	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.73	-11.33	1.17E-26	Diastolic blood pressure	
KIRC	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.44	7.39	6.22E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs6603003	chr15:84565602	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.29E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs6603004	chr15:84568504	GOLGA6L5	chr15:85047738-85060078:-	0.14	4.48	9.22E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs6603975	chr1:92951239	EVI5	chr1:92974255-93257961:-	-0.19	-4.49	8.68E-6	Cholesterol, total	
KIRC	cis	1	rs6603979	chr1:92979354	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs6603984	chr1:93011572	EVI5	chr1:92974255-93257961:-	-0.2	-4.71	3.27E-6	Cholesterol, total	
KIRC	cis	1	rs6603985	chr1:93017159	EVI5	chr1:92974255-93257961:-	-0.21	-4.86	1.56E-6	Cholesterol, total	
KIRC	cis	1	rs6603987	chr1:93019313	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs6603990	chr1:93030735	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs6604026	chr1:93303603	EVI5	chr1:92974255-93257961:-	0.14	3.8	0.000163	Multiple sclerosis	
KIRC	cis	1	rs660602	chr1:183162774	LAMC2	chr1:183155174-183214262:+	0.27	5.67	2.35E-8	Hypertriglyceridemia	
KIRC	cis	1	rs661242	chr11:71579229	C11orf59	chr11:71808339-71814322:-	0.23	4.25	2.55E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs662099	chr15:65726693	DPP8	chr15:65737999-65810035:-	-0.13	-5.02	7.04E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs664172	chr15:78862762	CHRNA5	chr15:78857906-78886458:+	-0.2	-3.7	0.000242	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs66462353	chr15:56186767	NEDD4	chr15:56119131-56285835:-	0.21	4.72	3.08E-6	Keloid	
KIRC	cis	1	rs66481372	chr5:132179592	LEAP2	chr5:132209358-132210581:+	0.36	5.49	6.49E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs66481372	chr5:132179592	SHROOM1	chr5:132158012-132166590:-	0.32	5.85	9.02E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs6648	chr20:47895242	CSE1L	chr20:47662838-47713484:+	-0.17	-3.59	0.000364	Height	
KIRC	cis	1	rs6650153	chr10:5019320	AKR1C1	chr10:4934796-5020157:+	-0.29	-3.7	0.000242	Height	
KIRC	cis	1	rs6650153	chr10:5019320	AKR1C2	chr10:4964715-5060207:-	0.6	7.13	3.42E-12	Height	
KIRC	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.25	-3.8	0.000164	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs6651272	chr8:96047933	C8orf38	chr8:95908040-96088396:+	0.25	3.86	0.000126	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs66529337	chr6:163005662	PACRG	chr6:163148164-163736523:+	0.42	5.7	2.05E-8	Body mass index	
KIRC	cis	1	rs66534347	chr2:240899346	NDUFA10	chr2:240900158-240964798:-	0.21	4.43	1.17E-5	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs66534429	chr6:163003322	PACRG	chr6:163148164-163736523:+	0.42	5.81	1.13E-8	Body mass index	
KIRC	cis	1	rs6656432	chr1:93029453	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs6656450	chr1:151089602	LYSMD1	chr1:151132225-151138424:-	-0.25	-4.8	2.1E-6	Body mass index	
KIRC	cis	1	rs6656815	chr1:27292462	PIGV	chr1:27114455-27124886:+	-0.4	-4.68	3.63E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.2	9.3E-19	Body mass index	
KIRC	cis	1	rs6656992	chr1:46333068	MUTYH	chr1:45794915-45806142:-	0.12	3.66	0.000275	Body mass index	
KIRC	cis	1	rs6657809	chr1:93293063	EVI5	chr1:92974255-93257961:-	0.16	4.28	2.19E-5	Multiple sclerosis	
KIRC	cis	1	rs6657900	chr1:212400866	TMEM206	chr1:212537819-212588267:-	0.18	3.52	0.000475	Intelligence (childhood)	
KIRC	cis	1	rs6659176	chr1:27239920	PIGV	chr1:27114455-27124886:+	-0.35	-3.98	7.99E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs66594243	chr6:163169024	PACRG	chr6:163148164-163736523:+	0.56	6.5	1.89E-10	Body mass index	
KIRC	cis	1	rs66597435	chr12:50945269	LIMA1	chr12:50569565-50677353:-	-0.22	-4.35	1.68E-5	Fibrinogen	
KIRC	cis	1	rs6660565	chr1:171261193	FMO4	chr1:171283486-171311222:+	-0.25	-4.91	1.24E-6	Sudden cardiac arrest	
KIRC	cis	1	rs6661134	chr1:93010908	EVI5	chr1:92974255-93257961:-	-0.2	-4.74	2.77E-6	Cholesterol, total	
KIRC	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.12	1.84E-18	Body mass index	
KIRC	cis	1	rs6661910	chr1:46290632	MUTYH	chr1:45794915-45806142:-	0.13	3.91	0.000107	Body mass index	
KIRC	cis	1	rs66624122	chr10:4981039	AKR1C1	chr10:4934796-5020157:+	-0.36	-4.84	1.75E-6	Height	
KIRC	cis	1	rs66624122	chr10:4981039	AKR1C2	chr10:4964715-5060207:-	0.55	6.66	7.39E-11	Height	
KIRC	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.93	7.97E-18	Body mass index	
KIRC	cis	1	rs6662641	chr1:46571509	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.72E-5	Body mass index	
KIRC	cis	1	rs6663730	chr1:47347425	CYP4A22	chr1:47603107-47614526:+	0.47	8.87	1.33E-17	Blood metabolite levels	
KIRC	cis	1	rs6663731	chr1:47347427	CYP4A22	chr1:47603107-47614526:+	0.47	8.87	1.33E-17	Blood metabolite levels	
KIRC	cis	1	rs66644594	chr12:50932983	LIMA1	chr12:50569565-50677353:-	-0.21	-4.17	3.6E-5	Fibrinogen	
KIRC	cis	1	rs66646148	chr12:82248520	PPFIA2	chr12:81652880-82153109:-	0.39	7	8.17E-12	Resting heart rate	
KIRC	cis	1	rs6665009	chr1:47321982	CYP4A22	chr1:47603107-47614526:+	0.47	8.39	4.8E-16	Blood metabolite levels	
KIRC	cis	1	rs66651343	chr15:43558004	STRC	chr15:43891762-43924561:-	0.23	5.7	2.07E-8	Lung cancer	
KIRC	cis	1	rs6665134	chr1:180949628	MR1	chr1:181003139-181024633:+	-0.13	-3.55	0.00042	Progressive supranuclear palsy	
KIRC	cis	1	rs6666106	chr1:19325916	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs66670902	chr15:56375132	TEX9	chr15:56657644-56738071:+	-0.26	-4.44	1.1E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.93	-22.2	1.36E-76	Homocysteine levels	
KIRC	cis	1	rs6667191	chr1:45982844	MUTYH	chr1:45794915-45806142:-	0.13	3.51	0.000484	Homocysteine levels	
KIRC	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.31	3.87E-19	Body mass index	
KIRC	cis	1	rs6668284	chr1:46354510	MUTYH	chr1:45794915-45806142:-	0.13	3.81	0.000158	Body mass index	
KIRC	cis	1	rs6669008	chr1:114166561	PHTF1	chr1:114239824-114302098:-	0.29	6.25	8.97E-10	Bacteremia	
KIRC	cis	1	rs6669421	chr1:19326234	RNF186	chr1:20140523-20141771:-	0.29	3.9	0.000109	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6669421	chr1:19326234	TMCO4	chr1:20008707-20126758:-	0.25	3.5	0.000503	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs6669522	chr1:46397941	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs6670821	chr1:11308762	MTOR	chr1:11166589-11322608:-	-0.16	-4.16	3.73E-5	Body mass index	
KIRC	cis	1	rs6671200	chr1:95697529	RWDD3	chr1:95583479-95712773:+	-0.3	-4.18	3.51E-5	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs6672180	chr1:76123973	ACADM	chr1:76190043-76229353:+	0.19	5.24	2.43E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.17	1.26E-18	Body mass index	
KIRC	cis	1	rs6672898	chr1:46290588	MUTYH	chr1:45794915-45806142:-	0.13	3.92	0.000101	Body mass index	
KIRC	cis	1	rs6673333	chr1:207459147	CR1	chr1:207669473-207815109:+	-0.16	-3.52	0.000479	Posterior cortical atrophy and Alzheimer's disease	
KIRC	cis	1	rs6674970	chr1:151116279	LYSMD1	chr1:151132225-151138424:-	-0.25	-4.93	1.15E-6	Body mass index	
KIRC	cis	1	rs66753001	chr19:17394839	ANKLE1	chr19:17392454-17398454:+	0.2	4.22	2.85E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.01	4.45E-18	Body mass index	
KIRC	cis	1	rs6675726	chr1:46560643	MUTYH	chr1:45794915-45806142:-	0.14	4.03	6.56E-5	Body mass index	
KIRC	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.23	7.84E-19	Body mass index	
KIRC	cis	1	rs6675946	chr1:46371774	MUTYH	chr1:45794915-45806142:-	0.13	3.87	0.000124	Body mass index	
KIRC	cis	1	rs6676190	chr1:151079317	LYSMD1	chr1:151132225-151138424:-	-0.25	-4.78	2.3E-6	Body mass index	
KIRC	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.91	9.13E-18	Body mass index	
KIRC	cis	1	rs6677007	chr1:46400590	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.8E-5	Body mass index	
KIRC	cis	1	rs66775662	chr6:151876216	C6orf97	chr6:151815175-151942327:+	0.21	3.97	8.36E-5	Bone mineral density (spine)	
KIRC	cis	1	rs66789102	chr6:163104432	PACRG	chr6:163148164-163736523:+	0.58	7.05	5.8E-12	Body mass index	
KIRC	cis	1	rs6678964	chr1:95694268	RWDD3	chr1:95583479-95712773:+	0.26	3.62	0.00033	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs6679002	chr1:63199936	ANGPTL3	chr1:63063187-63071180:+	0.21	4.29	2.11E-5	Blood metabolite levels	
KIRC	cis	1	rs6679073	chr1:205756484	PM20D1	chr1:205797154-205819245:-	-0.37	-5.71	1.91E-8	Prostate-specific antigen levels	
KIRC	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs6679145	chr1:156256000	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs66797613	chr10:1090469	IDI2	chr10:1064847-1071799:-	-0.24	-3.63	0.000308	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs6679878	chr1:11306882	MTOR	chr1:11166589-11322608:-	-0.16	-4.24	2.67E-5	Body mass index	
KIRC	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.5	7.65	1.05E-13	Diastolic blood pressure;Blood pressure	
KIRC	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs6680380	chr1:46300189	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs668092	chr1:35687203	C1orf216	chr1:36179477-36184790:-	-0.24	-3.86	0.000128	Endometrial cancer	
KIRC	cis	1	rs66835002	chr2:9655260	ITGB1BP1	chr2:9545823-9563643:-	-0.18	-3.69	0.000253	Alcohol dependence (age at onset)	
KIRC	cis	1	rs6683515	chr1:186879043	OCLM	chr1:186369704-186370586:+	-0.16	-3.61	0.000338	Epilepsy (generalized)	
KIRC	cis	1	rs6684514	chr1:156255456	BGLAP	chr1:156182784-156213112:+	0.34	7.46	3.86E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs6684514	chr1:156255456	CCT3	chr1:156278752-156308195:-	-0.19	-4.68	3.63E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs66885174	chr10:4975650	AKR1C1	chr10:4934796-5020157:+	-0.39	-4.93	1.13E-6	Height	
KIRC	cis	1	rs66885174	chr10:4975650	AKR1C2	chr10:4964715-5060207:-	0.64	7.49	3.22E-13	Height	
KIRC	cis	1	rs6689305	chr1:100268991	AGL	chr1:100315640-100389579:+	-0.22	-4.35	1.66E-5	White matter integrity (interaction)	
KIRC	cis	1	rs6689305	chr1:100268991	FRRS1	chr1:100174259-100231349:-	-0.17	-3.66	0.000276	White matter integrity (interaction)	
KIRC	cis	1	rs66893089	chr5:116497765	SEMA6A	chr5:115779252-115910551:-	0.37	3.58	0.000382	Periodontitis (DPAL)	
KIRC	cis	1	rs6689820	chr1:19320544	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6690097	chr1:19323050	RNF186	chr1:20140523-20141771:-	0.28	3.62	0.000321	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6690430	chr1:19323381	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6690764	chr1:92976590	EVI5	chr1:92974255-93257961:-	-0.2	-4.77	2.46E-6	Cholesterol, total	
KIRC	cis	1	rs6692187	chr1:93035020	EVI5	chr1:92974255-93257961:-	-0.19	-4.39	1.37E-5	Cholesterol, total	
KIRC	cis	1	rs6693388	chr1:151930645	THEM4	chr1:151846060-151882113:-	-0.32	-5.8	1.15E-8	Blood metabolite ratios	
KIRC	cis	1	rs6694309	chr1:19319619	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.22	8.25E-19	Body mass index	
KIRC	cis	1	rs6695809	chr1:46285461	MUTYH	chr1:45794915-45806142:-	0.13	4.02	6.83E-5	Body mass index	
KIRC	cis	1	rs66965793	chr1:156285814	BGLAP	chr1:156182784-156213112:+	0.35	7.65	1.05E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs66965793	chr1:156285814	CCT3	chr1:156278752-156308195:-	-0.17	-4.38	1.45E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs6696779	chr1:232920825	KIAA1383	chr1:232940638-232946092:+	-0.47	-4.35	1.63E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
KIRC	cis	1	rs66968227	chr11:64070930	C11orf20	chr11:64067863-64072238:+	-0.36	-5.43	8.61E-8	Mean platelet volume	
KIRC	cis	1	rs66968950	chr4:80909460	ANTXR2	chr4:80822773-80994477:-	-0.15	-3.67	0.000269	Ankylosing spondylitis	
KIRC	cis	1	rs6697292	chr1:19320209	RNF186	chr1:20140523-20141771:-	0.27	3.54	0.000438	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs66987356	chr3:127841098	KBTBD12	chr3:127634318-127706513:+	0.29	3.94	9.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs66987356	chr3:127841098	RPN1	chr3:128338813-128399918:-	0.22	3.62	0.00033	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs66987356	chr3:127841098	RUVBL1	chr3:127783627-127872757:-	0.35	4.88	1.4E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs66990486	chr9:100680919	C9orf156	chr9:100666772-100684852:-	-0.29	-6.52	1.75E-10	Quantitative traits	
KIRC	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.5	-10.37	5.94E-23	Height	
KIRC	cis	1	rs6699706	chr1:19326813	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6699979	chr1:154674494	MTX1	chr1:155178490-155183622:+	0.15	3.82	0.000151	Alzheimer's disease in APOE e4- carriers	
KIRC	cis	1	rs6700076	chr1:19325771	RNF186	chr1:20140523-20141771:-	0.27	3.51	0.00048	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6700354	chr1:19327382	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.2	9.7E-19	Body mass index	
KIRC	cis	1	rs6700597	chr1:46284246	MUTYH	chr1:45794915-45806142:-	0.14	4.06	5.74E-5	Body mass index	
KIRC	cis	1	rs6700619	chr1:19326313	RNF186	chr1:20140523-20141771:-	0.27	3.6	0.000356	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs6701614	chr1:46309420	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs6701963	chr1:19329006	RNF186	chr1:20140523-20141771:-	0.28	3.69	0.000251	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs6702126	chr1:99199954	SNX7	chr1:99127236-99226054:+	0.18	4.46	1.02E-5	Proinsulin levels	
KIRC	cis	1	rs6702530	chr1:19329545	RNF186	chr1:20140523-20141771:-	0.28	3.63	0.000317	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs67025553	chr6:163011552	PACRG	chr6:163148164-163736523:+	0.47	6.09	2.27E-9	Body mass index	
KIRC	cis	1	rs6703129	chr1:19324092	RNF186	chr1:20140523-20141771:-	0.27	3.55	0.000416	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.34	7.55	2.03E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs67034206	chr1:156270260	CCT3	chr1:156278752-156308195:-	-0.18	-4.47	9.54E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs67042566	chr6:163006541	PACRG	chr6:163148164-163736523:+	0.46	6	3.68E-9	Body mass index	
KIRC	cis	1	rs67046187	chr6:163068532	PACRG	chr6:163148164-163736523:+	0.57	6.71	5.41E-11	Body mass index	
KIRC	cis	1	rs6704770	chr2:232109816	ARMC9	chr2:232063342-232238606:+	0.23	4.75	2.71E-6	Food antigen IgG levels	
KIRC	cis	1	rs6704784	chr2:192109558	STAT4	chr2:191894306-192038902:-	0.17	4.5	8.28E-6	Obesity-related traits	
KIRC	cis	1	rs670523	chr1:155878732	ADAM15	chr1:155023422-155035252:+	0.16	3.59	0.000363	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs670523	chr1:155878732	HCN3	chr1:155247374-155259638:+	0.11	3.58	0.00038	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs6705489	chr2:73648811	TPRKB	chr2:73956957-73964517:-	-0.2	-5.18	3.22E-7	Metabolite levels	
KIRC	cis	1	rs6706610	chr2:27778091	NRBP1	chr2:27650657-27665122:+	0.14	3.7	0.000235	Oral cavity cancer	
KIRC	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.42	8.52	1.85E-16	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRC	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.19	3.9	0.000111	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6707458	chr2:160914540	PLA2R1	chr2:160798012-160919121:-	0.19	3.94	9.26E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6707722	chr2:73654363	TPRKB	chr2:73956957-73964517:-	-0.18	-4.84	1.72E-6	Metabolite levels	
KIRC	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.48	-10.37	5.63E-23	Body mass index	
KIRC	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.42	7.38	6.41E-13	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs6708328	chr2:24412413	LOC375190	chr2:24299728-24397519:+	-0.29	-6.94	1.19E-11	Venous thromboembolism (SNP x SNP interaction)	
KIRC	cis	1	rs6708331	chr2:70368923	ANXA4	chr2:69969127-70053594:+	-0.2	-4.13	4.25E-5	Obesity-related traits	
KIRC	cis	1	rs6708331	chr2:70368923	FAM136A	chr2:70523109-70529220:-	-0.22	-4.57	6.07E-6	Obesity-related traits	
KIRC	cis	1	rs67094146	chr6:163145412	PACRG	chr6:163148164-163736523:+	0.48	6.41	3.44E-10	Body mass index	
KIRC	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.28	-5.56	4.48E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs6710438	chr2:73820108	TPRKB	chr2:73956957-73964517:-	0.19	4.85	1.66E-6	Metabolite levels	
KIRC	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.46	-9.94	2.17E-21	Body mass index	
KIRC	cis	1	rs6711033	chr2:73746643	TPRKB	chr2:73956957-73964517:-	-0.21	-5.38	1.15E-7	Metabolite levels	
KIRC	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.63	-7.95	1.28E-14	Rheumatoid arthritis	
KIRC	cis	1	rs6711312	chr2:232122348	ARMC9	chr2:232063342-232238606:+	0.23	4.65	4.3E-6	Food antigen IgG levels	
KIRC	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.59	-8.33	8.02E-16	Rheumatoid arthritis	
KIRC	cis	1	rs6712203	chr2:165557318	SLC38A11	chr2:165754812-165812035:-	0.24	4.25	2.54E-5	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs6714736	chr2:202214148	ALS2CR12	chr2:202153148-202222101:-	0.25	4.88	1.45E-6	Basal cell carcinoma	
KIRC	cis	1	rs6715284	chr2:202154397	CFLAR	chr2:201980816-202029001:+	-0.23	-3.93	9.67E-5	Rheumatoid arthritis	
KIRC	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.59	-8.5	2.13E-16	Rheumatoid arthritis	
KIRC	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.63	-8.11	3.99E-15	Rheumatoid arthritis	
KIRC	cis	1	rs6715785	chr2:136910273	DARS	chr2:136664254-136743222:-	0.14	3.6	0.000348	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs6715819	chr2:73772309	TPRKB	chr2:73956957-73964517:-	-0.21	-5.52	5.32E-8	Metabolite levels	
KIRC	cis	1	rs671681	chr11:71782812	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.58E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs6716937	chr2:70127229	ANXA4	chr2:69969127-70053594:+	-0.22	-5.2	2.84E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6717980	chr2:27452784	C2orf28	chr2:27434899-27440044:+	0.16	4.63	4.71E-6	Blood metabolite levels	
KIRC	cis	1	rs6718070	chr2:161170153	PLA2R1	chr2:160798012-160919121:-	0.2	3.68	0.000256	Type 2 diabetes	
KIRC	cis	1	rs6718083	chr2:25362194	POMC	chr2:25383722-25391559:-	0.23	4.38	1.44E-5	Body mass index	
KIRC	cis	1	rs6718128	chr2:27833752	NRBP1	chr2:27650657-27665122:+	-0.14	-3.54	0.00043	Oral cavity cancer	
KIRC	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.19	3.94	9.29E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6719686	chr2:160908292	PLA2R1	chr2:160798012-160919121:-	0.19	3.89	0.000116	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6719931	chr2:219914939	FAM134A	chr2:220042939-220050190:+	-0.29	-3.59	0.000361	Height	
KIRC	cis	1	rs6719931	chr2:219914939	USP37	chr2:219314974-219433084:-	-0.24	-3.78	0.000178	Height	
KIRC	cis	1	rs67205460	chr10:1090366	IDI2	chr10:1064847-1071799:-	-0.24	-3.63	0.000308	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs672059	chr1:183162539	LAMC2	chr1:183155174-183214262:+	0.27	5.62	3.25E-8	Hypertriglyceridemia	
KIRC	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.63	-7.99	9.23E-15	Plasma clusterin levels	
KIRC	cis	1	rs672119	chr1:183162506	LAMC2	chr1:183155174-183214262:+	0.27	5.62	3.25E-8	Hypertriglyceridemia	
KIRC	cis	1	rs6721891	chr2:70146121	ANXA4	chr2:69969127-70053594:+	-0.22	-5.18	3.28E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.59	-7.49	3.05E-13	Plasma clusterin levels	
KIRC	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.67	8.9E-14	Obesity-related traits	
KIRC	cis	1	rs67239267	chr7:143745116	OR2A1	chr7:144015236-144016148:+;chr7	-0.3	-5.53	5.02E-8	Obesity-related traits	
KIRC	cis	1	rs67239267	chr7:143745116	OR2A9P	chr7:143991573-143997832:+;chr7	-0.47	-8.59	1.11E-16	Obesity-related traits	
KIRC	cis	1	rs6724146	chr2:161210655	PLA2R1	chr2:160798012-160919121:-	0.19	3.49	0.000526	Type 2 diabetes	
KIRC	cis	1	rs6724253	chr2:232121998	ARMC9	chr2:232063342-232238606:+	0.22	4.6	5.4E-6	Food antigen IgG levels	
KIRC	cis	1	rs6724465	chr2:219943846	USP37	chr2:219314974-219433084:-	-0.26	-4	7.39E-5	Height	
KIRC	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.42	7.86	2.36E-14	Urinary metabolites	
KIRC	cis	1	rs6724782	chr2:73679990	TPRKB	chr2:73956957-73964517:-	-0.19	-5.01	7.63E-7	Metabolite levels	
KIRC	cis	1	rs6725425	chr2:70150674	ANXA4	chr2:69969127-70053594:+	-0.22	-5.22	2.69E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs67257959	chr19:17158145	HAUS8	chr19:17160573-17186343:-	-0.17	-4.12	4.42E-5	Selective IgA deficiency	
KIRC	cis	1	rs6727751	chr2:161220275	PLA2R1	chr2:160798012-160919121:-	0.2	3.6	0.000354	Type 2 diabetes	
KIRC	cis	1	rs6727897	chr2:69987384	ANXA4	chr2:69969127-70053594:+	-0.28	-6.92	1.38E-11	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs6729760	chr2:70161032	ANXA4	chr2:69969127-70053594:+	-0.22	-5.33	1.52E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6730503	chr2:37528478	CEBPZ	chr2:37428778-37458740:-	0.18	4.95	1.0E-6	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6730503	chr2:37528478	QPCT	chr2:37571753-37600464:+	0.2	3.55	0.000422	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6731095	chr2:192589442	OBFC2A	chr2:192542798-192553247:+	-0.17	-3.51	0.000493	Colorectal cancer	
KIRC	cis	1	rs6732236	chr2:136501509	DARS	chr2:136664254-136743222:-	0.23	5.25	2.28E-7	Corneal structure	
KIRC	cis	1	rs6736360	chr2:190748749	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.57	6.26E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs6736408	chr2:70137774	ANXA4	chr2:69969127-70053594:+	-0.22	-5.2	2.84E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6736866	chr2:73661986	TPRKB	chr2:73956957-73964517:-	-0.21	-5.42	9.48E-8	Metabolite levels	
KIRC	cis	1	rs6737085	chr2:202221441	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.88	1.39E-6	Basal cell carcinoma	
KIRC	cis	1	rs6737921	chr2:27839107	NRBP1	chr2:27650657-27665122:+	0.14	3.72	0.000223	Oral cavity cancer	
KIRC	cis	1	rs67385638	chr11:5290370	HBG2	chr11:5269502-5667011:-	0.23	3.6	0.000352	Hemoglobin levels	
KIRC	cis	1	rs6738627	chr2:165544450	SLC38A11	chr2:165754812-165812035:-	0.26	4.77	2.46E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs6739780	chr2:70138111	ANXA4	chr2:69969127-70053594:+	-0.22	-5.24	2.42E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6740223	chr2:73653332	TPRKB	chr2:73956957-73964517:-	-0.18	-4.84	1.72E-6	Metabolite levels	
KIRC	cis	1	rs6740641	chr2:54482989	ACYP2	chr2:54342410-54532433:+	-0.23	-4.09	5.0E-5	Telomere length	
KIRC	cis	1	rs67411574	chr17:18797337	FAM18B	chr17:18684582-18710026:+	-0.25	-5.9	6.72E-9	Educational attainment (years of education)	
KIRC	cis	1	rs67412075	chr19:17385502	ANKLE1	chr19:17392454-17398454:+	0.19	4.07	5.37E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs6741325	chr2:219907699	USP37	chr2:219314974-219433084:-	0.22	3.81	0.000155	Height	
KIRC	cis	1	rs6741449	chr2:70156589	ANXA4	chr2:69969127-70053594:+	-0.21	-5.16	3.65E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.14	-6.57	1.28E-10	Tuberculosis	
KIRC	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.55	11.34	1.04E-26	Tuberculosis	
KIRC	cis	1	rs674343	chr1:183162052	LAMC2	chr1:183155174-183214262:+	0.27	5.67	2.36E-8	Hypertriglyceridemia	
KIRC	cis	1	rs67445790	chr6:151876730	C6orf97	chr6:151815175-151942327:+	0.21	3.95	8.85E-5	Bone mineral density (spine)	
KIRC	cis	1	rs6745368	chr2:73809974	TPRKB	chr2:73956957-73964517:-	-0.21	-5.37	1.21E-7	Metabolite levels	
KIRC	cis	1	rs67466576	chr10:4977394	AKR1C1	chr10:4934796-5020157:+	-0.37	-4.89	1.34E-6	Height	
KIRC	cis	1	rs67466576	chr10:4977394	AKR1C2	chr10:4964715-5060207:-	0.52	6.33	5.52E-10	Height	
KIRC	cis	1	rs674735	chr11:71560580	C11orf59	chr11:71808339-71814322:-	0.21	3.81	0.000155	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs67487119	chr6:163102657	PACRG	chr6:163148164-163736523:+	0.59	7.07	5.16E-12	Body mass index	
KIRC	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.4	7.53	2.36E-13	Urinary metabolites	
KIRC	cis	1	rs6749052	chr2:27772879	NRBP1	chr2:27650657-27665122:+	0.14	3.7	0.000236	Oral cavity cancer	
KIRC	cis	1	rs6749232	chr2:192115052	STAT4	chr2:191894306-192038902:-	0.17	4.51	8.01E-6	Obesity-related traits	
KIRC	cis	1	rs67504728	chr5:132194045	LEAP2	chr5:132209358-132210581:+	0.37	5.64	2.79E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs67504728	chr5:132194045	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.82E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs6750488	chr2:70146125	ANXA4	chr2:69969127-70053594:+	-0.22	-5.18	3.28E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs67505007	chr15:56196253	NEDD4	chr15:56119131-56285835:-	0.21	4.81	1.98E-6	Keloid	
KIRC	cis	1	rs67505314	chr10:17240134	TRDMT1	chr10:17184983-17243681:-	-0.35	-8.04	6.35E-15	Homocysteine levels	
KIRC	cis	1	rs6750943	chr2:27777904	NRBP1	chr2:27650657-27665122:+	0.14	3.72	0.000223	Oral cavity cancer	
KIRC	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.42	7.71	6.84E-14	Urinary metabolites	
KIRC	cis	1	rs675185	chr11:71775572	C11orf59	chr11:71808339-71814322:-	-0.2	-3.65	0.000295	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs67519234	chr5:132199359	LEAP2	chr5:132209358-132210581:+	0.37	5.7	1.99E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs67519234	chr5:132199359	SHROOM1	chr5:132158012-132166590:-	0.32	5.9	6.76E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs6752757	chr2:219943801	USP37	chr2:219314974-219433084:-	-0.26	-4.01	7.13E-5	Height	
KIRC	cis	1	rs6752978	chr2:165552942	SLC38A11	chr2:165754812-165812035:-	0.27	4.77	2.38E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs6753142	chr2:165544071	SLC38A11	chr2:165754812-165812035:-	0.26	4.71	3.17E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs6753344	chr2:73653138	TPRKB	chr2:73956957-73964517:-	0.2	5.24	2.37E-7	Metabolite levels	
KIRC	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.27	5.3	1.73E-7	Diabetic kidney disease	
KIRC	cis	1	rs67536397	chr7:65947917	CRCP	chr7:65579805-65619551:+	-0.33	-4.4	1.32E-5	Diabetic kidney disease	
KIRC	cis	1	rs675413	chr15:45936745	SPATA5L1	chr15:45694519-45713614:+	0.22	3.58	0.000376	Obesity-related traits	
KIRC	cis	1	rs67544533	chr15:75361539	PPCDC	chr15:75315927-75343066:+	0.18	4.1	4.9E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.23	4.07	5.4E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs6754896	chr2:70138170	ANXA4	chr2:69969127-70053594:+	-0.22	-5.2	2.84E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs6755217	chr2:73641285	TPRKB	chr2:73956957-73964517:-	-0.19	-4.98	8.75E-7	Metabolite levels	
KIRC	cis	1	rs6755241	chr2:73641364	TPRKB	chr2:73956957-73964517:-	-0.19	-4.78	2.28E-6	Metabolite levels	
KIRC	cis	1	rs6756238	chr2:27841305	NRBP1	chr2:27650657-27665122:+	0.14	3.72	0.000224	Oral cavity cancer	
KIRC	cis	1	rs67567111	chr20:23619075	CST3	chr20:23608536-23618574:-	-0.13	-3.7	0.000242	Chronic kidney disease	
KIRC	cis	1	rs6756987	chr2:73687077	TPRKB	chr2:73956957-73964517:-	-0.2	-5.1	4.78E-7	Metabolite levels	
KIRC	cis	1	rs675733	chr17:40703144	NAGLU	chr17:40687951-40696464:+	0.32	3.68	0.000254	Systolic blood pressure change trajectories	
KIRC	cis	1	rs67575175	chr3:127880226	KBTBD12	chr3:127634318-127706513:+	0.3	4.07	5.43E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs67575175	chr3:127880226	RPN1	chr3:128338813-128399918:-	0.24	4	7.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs67575175	chr3:127880226	RUVBL1	chr3:127783627-127872757:-	0.34	4.86	1.6E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.21	-3.88	0.000119	Triptolide cytotoxicity	
KIRC	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.68	-11.22	3.19E-26	Triptolide cytotoxicity	
KIRC	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.2	3.96	8.62E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6759836	chr2:160912802	PLA2R1	chr2:160798012-160919121:-	0.19	3.94	9.12E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.18	3.59	0.00036	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6759924	chr2:160912747	PLA2R1	chr2:160798012-160919121:-	0.18	3.7	0.00024	Idiopathic membranous nephropathy	
KIRC	cis	1	rs6761514	chr2:202227549	ALS2CR12	chr2:202153148-202222101:-	-0.25	-4.97	8.99E-7	Basal cell carcinoma	
KIRC	cis	1	rs6762208	chr3:185331165	TMEM41A	chr3:185207389-185216845:-	-0.17	-3.61	0.00034	Systolic blood pressure	
KIRC	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs6763088	chr3:134254989	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.01	2.49E-42	Height	
KIRC	cis	1	rs6763093	chr3:134254995	CEP63	chr3:134204575-134293852:+	-0.34	-6.59	1.14E-10	Height	
KIRC	cis	1	rs6763815	chr3:132725875	TMEM108	chr3:132757171-133116618:+	-0.18	-3.51	0.000481	IgE grass sensitization	
KIRC	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.75	11.21	3.45E-26	Diastolic blood pressure	
KIRC	cis	1	rs67646369	chr6:163003233	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs67652061	chr5:132280347	LEAP2	chr5:132209358-132210581:+	0.35	5.63	3.05E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs67652061	chr5:132280347	SHROOM1	chr5:132158012-132166590:-	0.31	6.08	2.35E-9	Apolipoprotein A-IV levels	
KIRC	cis	1	rs6765233	chr3:128002850	KBTBD12	chr3:127634318-127706513:+	-0.28	-3.71	0.000227	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6765233	chr3:128002850	RUVBL1	chr3:127783627-127872757:-	-0.32	-4.4	1.32E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.61	14.89	8.19E-42	Height	
KIRC	cis	1	rs6765505	chr3:134208132	CEP63	chr3:134204575-134293852:+	0.33	6.39	3.7E-10	Height	
KIRC	cis	1	rs6766510	chr3:12551807	TSEN2	chr3:12525931-12581122:+	0.35	4.99	8.33E-7	Prostate cancer (gene x gene interaction)	
KIRC	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.59	14.02	6.5E-38	Height	
KIRC	cis	1	rs6766818	chr3:134226159	CEP63	chr3:134204575-134293852:+	0.32	6.22	1.03E-9	Height	
KIRC	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.57	13.27	1.12E-34	Height	
KIRC	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.27	5.04	6.52E-7	Height	
KIRC	cis	1	rs67674204	chr3:127824778	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.72	10.29	1.15E-22	Diastolic blood pressure	
KIRC	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.72	10.05	8.63E-22	Diastolic blood pressure	
KIRC	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.72	10.03	1.08E-21	Diastolic blood pressure	
KIRC	cis	1	rs67696450	chr10:1090684	IDI2	chr10:1064847-1071799:-	-0.24	-3.63	0.000308	Response to angiotensin II receptor blocker therapy	
KIRC	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.6	14.63	1.25E-40	Height	
KIRC	cis	1	rs6769885	chr3:134286913	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.44E-11	Height	
KIRC	cis	1	rs6770152	chr3:53100214	SFMBT1	chr3:52938628-53080070:-	-0.41	-10.14	4.27E-22	Ulcerative colitis	
KIRC	cis	1	rs67701624	chr12:50928938	LIMA1	chr12:50569565-50677353:-	-0.21	-4.13	4.21E-5	Fibrinogen	
KIRC	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.3	-8.78	2.55E-17	Longevity	
KIRC	cis	1	rs6770670	chr3:49686682	UBA7	chr3:49842639-49851391:-	0.16	4.12	4.35E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.16	4.31	1.94E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs6772407	chr3:128044372	RUVBL1	chr3:127783627-127872757:-	0.29	4.18	3.37E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs677279	chr11:71770469	C11orf59	chr11:71808339-71814322:-	-0.2	-3.65	0.000295	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.29	5.73	1.73E-8	Diabetic kidney disease	
KIRC	cis	1	rs67728539	chr7:65378124	CRCP	chr7:65579805-65619551:+	-0.32	-4.38	1.47E-5	Diabetic kidney disease	
KIRC	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.62	14.63	1.2E-40	Height	
KIRC	cis	1	rs6772896	chr3:134203347	CEP63	chr3:134204575-134293852:+	0.32	6.11	2.06E-9	Height	
KIRC	cis	1	rs6773343	chr3:141825598	TFDP2	chr3:141671329-141868311:-	-0.21	-4.28	2.27E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs6773375	chr3:190980432	UTS2D	chr3:190984945-191048325:-	-0.22	-4.13	4.23E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs6773528	chr3:190980379	UTS2D	chr3:190984945-191048325:-	0.23	4.38	1.47E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs67747005	chr6:163150845	PACRG	chr6:163148164-163736523:+	0.47	6.45	2.68E-10	Body mass index	
KIRC	cis	1	rs67766926	chr2:61163581	AHSA2	chr2:61404553-61414058:+	-0.1	-3.98	8.04E-5	Inflammatory skin disease	
KIRC	cis	1	rs67766926	chr2:61163581	C2orf74	chr2:61372243-61391964:+	0.39	6.23	9.93E-10	Inflammatory skin disease	
KIRC	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.32	-9.11	1.91E-18	Longevity	
KIRC	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.45	-9.44	1.43E-19	Schizophrenia (negative symptoms)	
KIRC	cis	1	rs6780538	chr3:190982512	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.61E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.61	-14.61	1.59E-40	Height	
KIRC	cis	1	rs6782563	chr3:134295959	CEP63	chr3:134204575-134293852:+	-0.33	-6.53	1.58E-10	Height	
KIRC	cis	1	rs6782799	chr3:119610793	GSK3B	chr3:119540804-119813264:-	0.15	3.96	8.53E-5	HDL cholesterol	
KIRC	cis	1	rs678292	chr10:105957561	C10orf79	chr10:105889647-105992120:-	0.19	4.54	6.97E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.74	11.17	5.04E-26	Diastolic blood pressure	
KIRC	cis	1	rs6783003	chr3:49524778	CCDC36	chr3:49235861-49295537:+	-0.29	-5.42	9.32E-8	Menarche (age at onset)	
KIRC	cis	1	rs6783003	chr3:49524778	GMPPB	chr3:49758932-49761384:-	0.17	3.79	0.000172	Menarche (age at onset)	
KIRC	cis	1	rs6783003	chr3:49524778	NCKIPSD	chr3:48711280-48723334:-	-0.2	-3.9	0.000109	Menarche (age at onset)	
KIRC	cis	1	rs6783003	chr3:49524778	P4HTM	chr3:49027341-49044579:+	-0.2	-4.41	1.27E-5	Menarche (age at onset)	
KIRC	cis	1	rs6783003	chr3:49524778	WDR6	chr3:49044637-49053386:+	0.21	5.3	1.71E-7	Menarche (age at onset)	
KIRC	cis	1	rs6783253	chr3:127851561	KBTBD12	chr3:127634318-127706513:+	0.3	4.04	6.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6783253	chr3:127851561	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.00014	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6783253	chr3:127851561	RUVBL1	chr3:127783627-127872757:-	0.34	4.77	2.46E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs67840803	chr6:163049048	PACRG	chr6:163148164-163736523:+	0.57	6.98	9.21E-12	Body mass index	
KIRC	cis	1	rs6784159	chr3:127843378	KBTBD12	chr3:127634318-127706513:+	0.27	3.68	0.000256	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6784159	chr3:127843378	RPN1	chr3:128338813-128399918:-	0.22	3.82	0.00015	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6784159	chr3:127843378	RUVBL1	chr3:127783627-127872757:-	0.33	4.73	2.96E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.32	-8.77	2.72E-17	Longevity	
KIRC	cis	1	rs6784421	chr3:156655494	LEKR1	chr3:156544076-156763918:+	0.35	7.56	1.88E-13	Multiple sclerosis (severity)	
KIRC	cis	1	rs6784842	chr3:185342723	TMEM41A	chr3:185207389-185216845:-	0.18	3.72	0.00022	Systolic blood pressure	
KIRC	cis	1	rs6784948	chr3:185342787	TMEM41A	chr3:185207389-185216845:-	0.17	3.6	0.000354	Systolic blood pressure	
KIRC	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.6	-14.79	2.42E-41	Height	
KIRC	cis	1	rs6785027	chr3:134211649	CEP63	chr3:134204575-134293852:+	-0.3	-6.02	3.38E-9	Height	
KIRC	cis	1	rs6785045	chr3:49435243	CCDC36	chr3:49235861-49295537:+	-0.25	-4.71	3.14E-6	Menarche (age at onset)	
KIRC	cis	1	rs6785045	chr3:49435243	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.52	7.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs6785045	chr3:49435243	P4HTM	chr3:49027341-49044579:+	-0.21	-4.75	2.65E-6	Menarche (age at onset)	
KIRC	cis	1	rs6785045	chr3:49435243	TREX1	chr3:48501186-48509043:+	0.15	3.78	0.000179	Menarche (age at onset)	
KIRC	cis	1	rs6785045	chr3:49435243	WDR6	chr3:49044637-49053386:+	0.2	5.02	7.1E-7	Menarche (age at onset)	
KIRC	cis	1	rs6785535	chr3:127834695	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.6	14.6	1.78E-40	Height	
KIRC	cis	1	rs6787371	chr3:134254991	CEP63	chr3:134204575-134293852:+	0.34	6.72	4.97E-11	Height	
KIRC	cis	1	rs6787614	chr3:127817478	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.49	-8.42	4.05E-16	Bone mineral density	
KIRC	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.71	9.43	1.53E-19	Diastolic blood pressure	
KIRC	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.62	14.65	1.02E-40	Height	
KIRC	cis	1	rs6790466	chr3:134197740	CEP63	chr3:134204575-134293852:+	0.32	6.09	2.19E-9	Height	
KIRC	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.75	11.28	1.79E-26	Diastolic blood pressure	
KIRC	cis	1	rs6791514	chr3:141766305	TFDP2	chr3:141671329-141868311:-	-0.23	-4.53	7.4E-6	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs6792572	chr3:119636096	GSK3B	chr3:119540804-119813264:-	0.15	3.95	8.98E-5	HDL cholesterol	
KIRC	cis	1	rs6792584	chr3:67531388	FAM19A1	chr3:68040734-68594769:+	-0.25	-3.95	8.91E-5	Corneal astigmatism	
KIRC	cis	1	rs67927699	chr2:61187415	AHSA2	chr2:61404553-61414058:+	-0.1	-4.25	2.5E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.5	9.37	2.4E-19	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.61	-14.58	2.04E-40	Height	
KIRC	cis	1	rs6793487	chr3:134299426	CEP63	chr3:134204575-134293852:+	-0.33	-6.5	1.91E-10	Height	
KIRC	cis	1	rs67940364	chr3:127833353	RUVBL1	chr3:127783627-127872757:-	0.34	4.8	2.07E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs67941642	chr20:60958108	HAR1B	chr20:61726845-61733671:-	0.22	3.7	0.00024	Colorectal cancer	
KIRC	cis	1	rs6794591	chr3:128031219	RUVBL1	chr3:127783627-127872757:-	0.31	4.45	1.07E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6794875	chr3:48455626	SHISA5	chr3:48509197-48542228:-	-0.14	-3.89	0.000116	Longevity	
KIRC	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.32	-9.09	2.33E-18	Longevity	
KIRC	cis	1	rs67949818	chr3:136212978	IL20RB	chr3:136676707-136729920:+	0.15	3.53	0.000456	Body mass index;Height	
KIRC	cis	1	rs6795653	chr3:119610565	GSK3B	chr3:119540804-119813264:-	0.15	3.96	8.53E-5	HDL cholesterol	
KIRC	cis	1	rs6795976	chr3:190982545	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.61E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs679620	chr11:102713620	MMP1	chr11:102660641-102668966:-	0.41	6.9	1.6E-11	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
KIRC	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs6797834	chr3:127856400	KBTBD12	chr3:127634318-127706513:+	0.3	4.04	6.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6797834	chr3:127856400	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.00014	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6797834	chr3:127856400	RUVBL1	chr3:127783627-127872757:-	0.34	4.77	2.46E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6798749	chr3:128056897	KBTBD12	chr3:127634318-127706513:+	-0.24	-3.6	0.000347	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6798749	chr3:128056897	RUVBL1	chr3:127783627-127872757:-	-0.27	-4.15	3.95E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6800225	chr3:127862178	KBTBD12	chr3:127634318-127706513:+	0.3	4.06	5.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6800225	chr3:127862178	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6800225	chr3:127862178	RUVBL1	chr3:127783627-127872757:-	0.34	4.87	1.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs68005215	chr10:4977435	AKR1C1	chr10:4934796-5020157:+	-0.36	-4.79	2.15E-6	Height	
KIRC	cis	1	rs68005215	chr10:4977435	AKR1C2	chr10:4964715-5060207:-	0.54	6.55	1.42E-10	Height	
KIRC	cis	1	rs6800622	chr3:119580678	GSK3B	chr3:119540804-119813264:-	-0.15	-3.97	8.17E-5	HDL cholesterol	
KIRC	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.58	13.78	7.45E-37	Height	
KIRC	cis	1	rs6800862	chr3:134228628	CEP63	chr3:134204575-134293852:+	0.32	6.31	5.99E-10	Height	
KIRC	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.34	7.44	4.39E-13	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs6800	chr1:156262653	CCT3	chr1:156278752-156308195:-	-0.19	-4.73	2.89E-6	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs6801142	chr3:184698444	C3orf70	chr3:184795840-184870802:-	-0.16	-3.53	0.000452	Heschl's gyrus morphology	
KIRC	cis	1	rs68014803	chr2:192106603	MYO1B	chr2:192110107-192290115:+	-0.11	-3.67	0.000267	Obesity-related traits	
KIRC	cis	1	rs68014803	chr2:192106603	STAT4	chr2:191894306-192038902:-	-0.15	-3.93	9.65E-5	Obesity-related traits	
KIRC	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.59	14.31	3.51E-39	Height	
KIRC	cis	1	rs6801596	chr3:134252114	CEP63	chr3:134204575-134293852:+	0.34	6.59	1.1E-10	Height	
KIRC	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.6	14.41	1.19E-39	Height	
KIRC	cis	1	rs6802654	chr3:134217072	CEP63	chr3:134204575-134293852:+	0.32	6.28	7.52E-10	Height	
KIRC	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.71	10.3	1.09E-22	Diastolic blood pressure	
KIRC	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.71	10.3	1.09E-22	Diastolic blood pressure	
KIRC	cis	1	rs6804449	chr3:184667576	C3orf70	chr3:184795840-184870802:-	-0.17	-3.65	0.000286	Heschl's gyrus morphology	
KIRC	cis	1	rs68045643	chr6:163029709	PACRG	chr6:163148164-163736523:+	0.43	5.94	5.22E-9	Body mass index	
KIRC	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.59	14.17	1.44E-38	Height	
KIRC	cis	1	rs6804770	chr3:134230234	CEP63	chr3:134204575-134293852:+	0.33	6.51	1.82E-10	Height	
KIRC	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.3	-8.58	1.16E-16	Longevity	
KIRC	cis	1	rs6805251	chr3:119560606	GSK3B	chr3:119540804-119813264:-	0.15	3.93	9.81E-5	HDL cholesterol	
KIRC	cis	1	rs6805582	chr3:128029008	RUVBL1	chr3:127783627-127872757:-	0.31	4.45	1.07E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6805609	chr3:49471522	CCDC36	chr3:49235861-49295537:+	-0.34	-5.74	1.6E-8	Menarche (age at onset)	
KIRC	cis	1	rs6805609	chr3:49471522	NCKIPSD	chr3:48711280-48723334:-	-0.21	-3.7	0.000236	Menarche (age at onset)	
KIRC	cis	1	rs6805609	chr3:49471522	P4HTM	chr3:49027341-49044579:+	-0.21	-4.23	2.81E-5	Menarche (age at onset)	
KIRC	cis	1	rs6805609	chr3:49471522	WDR6	chr3:49044637-49053386:+	0.27	5.99	3.9E-9	Menarche (age at onset)	
KIRC	cis	1	rs6805621	chr3:128029204	RUVBL1	chr3:127783627-127872757:-	0.31	4.43	1.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.72	10.05	8.63E-22	Diastolic blood pressure	
KIRC	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.59	-14.54	3.14E-40	Height	
KIRC	cis	1	rs6806417	chr3:134211446	CEP63	chr3:134204575-134293852:+	-0.31	-6.1	2.12E-9	Height	
KIRC	cis	1	rs68069953	chr15:68596573	ITGA11	chr15:68594050-68724492:-	0.13	3.51	0.000488	Major depressive disorder	
KIRC	cis	1	rs68088462	chr15:63397617	LACTB	chr15:63414032-63434254:+	0.18	3.61	0.000343	HDL cholesterol	
KIRC	cis	1	rs6809805	chr3:85553096	CADM2	chr3:85008133-86117948:+	0.21	3.54	0.00044	Longevity (90 years and older)	
KIRC	cis	1	rs6810006	chr3:127856058	RPN1	chr3:128338813-128399918:-	0.23	3.99	7.74E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6810006	chr3:127856058	RUVBL1	chr3:127783627-127872757:-	0.32	4.64	4.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.3	-8.81	2.02E-17	Longevity	
KIRC	cis	1	rs6810610	chr4:108930611	HADH	chr4:108910940-108956330:+	-0.26	-3.58	0.000381	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6810869	chr4:103558514	MANBA	chr4:103552644-103682151:-	0.16	3.78	0.000173	Primary biliary cirrhosis	
KIRC	cis	1	rs6811520	chr4:56315178	SRD5A3	chr4:56212409-56237866:+	0.21	4.59	5.58E-6	Personality dimensions	
KIRC	cis	1	rs6811520	chr4:56315178	TMEM165	chr4:56262090-56292342:+	-0.21	-5.81	1.09E-8	Personality dimensions	
KIRC	cis	1	rs6811887	chr4:17640858	LAP3	chr4:17578927-17609590:+	-0.21	-6.47	2.37E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6811887	chr4:17640858	MED28	chr4:17616273-17629791:+	0.18	3.96	8.56E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6812042	chr4:56396079	SRD5A3	chr4:56212409-56237866:+	0.18	3.93	9.55E-5	Personality dimensions	
KIRC	cis	1	rs6812042	chr4:56396079	TMEM165	chr4:56262090-56292342:+	-0.21	-5.74	1.66E-8	Personality dimensions	
KIRC	cis	1	rs6812540	chr4:39116423	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs68141011	chr6:28217797	ZNF187	chr6:28234788-28245978:+	-0.27	-4.7	3.38E-6	Depression	
KIRC	cis	1	rs68141011	chr6:28217797	ZNF323	chr6:28292517-28324048:-	0.27	3.65	0.000288	Depression	
KIRC	cis	1	rs68141011	chr6:28217797	ZSCAN23	chr6:28393287-28411279:-	0.26	3.65	0.000288	Depression	
KIRC	cis	1	rs68144677	chr6:163149024	PACRG	chr6:163148164-163736523:+	0.58	6.74	4.33E-11	Body mass index	
KIRC	cis	1	rs6816352	chr4:48367968	OCIAD1	chr4:48833015-48863831:+	0.23	5.23	2.55E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs6816687	chr4:95521397	PDLIM5	chr4:95373038-95589376:+	-0.21	-4.35	1.68E-5	Response to simvastatin treatment (PCSK9 protein level change)	
KIRC	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.47	-10.12	5.1E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs6818639	chr4:17633049	LAP3	chr4:17578927-17609590:+	-0.2	-6.24	9.17E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6818639	chr4:17633049	MED28	chr4:17616273-17629791:+	0.19	4.3	2.01E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs68187092	chr15:56380718	TEX9	chr15:56657644-56738071:+	-0.27	-4.62	4.92E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs68189316	chr7:65409169	CRCP	chr7:65579805-65619551:+	-0.31	-4.35	1.62E-5	Diabetic kidney disease	
KIRC	cis	1	rs6819660	chr4:56374577	SRD5A3	chr4:56212409-56237866:+	0.18	4.07	5.47E-5	Personality dimensions	
KIRC	cis	1	rs6819660	chr4:56374577	TMEM165	chr4:56262090-56292342:+	-0.23	-6.4	3.62E-10	Personality dimensions	
KIRC	cis	1	rs6821119	chr4:103555233	MANBA	chr4:103552644-103682151:-	0.16	3.71	0.000233	Primary biliary cirrhosis	
KIRC	cis	1	rs6822866	chr4:171027704	AADAT	chr4:170981374-171011372:-	0.44	4.77	2.45E-6	Thyroid hormone levels	
KIRC	cis	1	rs682331	chr1:184761365	EDEM3	chr1:184659627-184724041:-	-0.12	-3.53	0.000449	Obesity-related traits	
KIRC	cis	1	rs6824057	chr4:56367278	SRD5A3	chr4:56212409-56237866:+	0.21	4.44	1.13E-5	Personality dimensions	
KIRC	cis	1	rs6824057	chr4:56367278	TMEM165	chr4:56262090-56292342:+	-0.22	-5.9	6.57E-9	Personality dimensions	
KIRC	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.52	-10.68	3.88E-24	Longevity	
KIRC	cis	1	rs6828499	chr4:171017475	AADAT	chr4:170981374-171011372:-	-0.46	-4.4	1.33E-5	Thyroid hormone levels	
KIRC	cis	1	rs6829234	chr4:39116206	WDR19	chr4:39184024-39287429:+	0.19	4.94	1.06E-6	Uric acid levels	
KIRC	cis	1	rs6829450	chr4:39116341	WDR19	chr4:39184024-39287429:+	0.19	4.91	1.25E-6	Uric acid levels	
KIRC	cis	1	rs6830485	chr4:108963382	HADH	chr4:108910940-108956330:+	0.26	3.65	0.000288	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.47	-10.31	9.95E-23	Renal underexcretion gout;Gout	
KIRC	cis	1	rs6832503	chr4:48028442	NIPAL1	chr4:48018791-48039078:+	-0.32	-7.75	5.3E-14	Renal underexcretion gout;Gout	
KIRC	cis	1	rs6832769	chr4:56298194	SRD5A3	chr4:56212409-56237866:+	0.17	3.68	0.00026	Personality dimensions	
KIRC	cis	1	rs6832769	chr4:56298194	TMEM165	chr4:56262090-56292342:+	-0.23	-6.52	1.71E-10	Personality dimensions	
KIRC	cis	1	rs6834676	chr4:56298414	SRD5A3	chr4:56212409-56237866:+	0.18	3.97	8.31E-5	Personality dimensions	
KIRC	cis	1	rs6834676	chr4:56298414	TMEM165	chr4:56262090-56292342:+	-0.21	-5.86	8.31E-9	Personality dimensions	
KIRC	cis	1	rs6834806	chr4:75715826	BTC	chr4:75671448-75719882:-	0.32	4.29	2.16E-5	Electroencephalogram traits	
KIRC	cis	1	rs6837335	chr4:48363983	OCIAD1	chr4:48833015-48863831:+	0.23	5.25	2.2E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs6837710	chr4:56374455	SRD5A3	chr4:56212409-56237866:+	0.21	4.54	6.89E-6	Personality dimensions	
KIRC	cis	1	rs6837710	chr4:56374455	TMEM165	chr4:56262090-56292342:+	-0.21	-5.78	1.34E-8	Personality dimensions	
KIRC	cis	1	rs6839064	chr4:103555676	MANBA	chr4:103552644-103682151:-	0.17	3.81	0.000155	Primary biliary cirrhosis	
KIRC	cis	1	rs6846238	chr4:17629939	LAP3	chr4:17578927-17609590:+	-0.19	-6.03	3.17E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6846238	chr4:17629939	MED28	chr4:17616273-17629791:+	0.24	5.45	7.74E-8	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6847968	chr4:75715519	BTC	chr4:75671448-75719882:-	0.32	4.29	2.16E-5	Electroencephalogram traits	
KIRC	cis	1	rs6848360	chr4:17634442	LAP3	chr4:17578927-17609590:+	-0.21	-6.39	3.72E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6848360	chr4:17634442	MED28	chr4:17616273-17629791:+	0.22	5.07	5.64E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6848395	chr4:48394593	OCIAD1	chr4:48833015-48863831:+	0.23	5.24	2.33E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs6848411	chr4:75715789	BTC	chr4:75671448-75719882:-	0.32	4.29	2.16E-5	Electroencephalogram traits	
KIRC	cis	1	rs6849704	chr4:17652031	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.72E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6849704	chr4:17652031	MED28	chr4:17616273-17629791:+	0.18	3.99	7.59E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6851442	chr4:108959282	HADH	chr4:108910940-108956330:+	0.26	3.56	0.000403	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs6851838	chr4:56420747	SRD5A3	chr4:56212409-56237866:+	-0.18	-4.04	6.23E-5	Personality dimensions	
KIRC	cis	1	rs6851838	chr4:56420747	TMEM165	chr4:56262090-56292342:+	0.22	6.23	1.01E-9	Personality dimensions	
KIRC	cis	1	rs6852678	chr4:76542749	CDKL2	chr4:76501705-76555721:-	-0.16	-3.63	0.000314	Magnesium levels	
KIRC	cis	1	rs6853192	chr4:56409254	SRD5A3	chr4:56212409-56237866:+	-0.17	-3.81	0.000155	Personality dimensions	
KIRC	cis	1	rs6853192	chr4:56409254	TMEM165	chr4:56262090-56292342:+	0.22	6.1	2.09E-9	Personality dimensions	
KIRC	cis	1	rs6854733	chr4:17640526	LAP3	chr4:17578927-17609590:+	-0.21	-6.32	5.75E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6854733	chr4:17640526	MED28	chr4:17616273-17629791:+	0.18	3.98	7.87E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6859704	chr5:78943648	CMYA5	chr5:78985659-79096048:+	-0.31	-4.45	1.08E-5	IgG glycosylation	
KIRC	cis	1	rs6860540	chr5:156938327	NIPAL4	chr5:156887027-156901729:+	-0.28	-6.37	4.39E-10	Inflammatory skin disease	
KIRC	cis	1	rs6862569	chr5:156466548	HAVCR1	chr5:156456531-156486130:-	-0.43	-9.82	6.33E-21	Hypertriglyceridemia	
KIRC	cis	1	rs6862569	chr5:156466548	HAVCR2	chr5:156512843-156536138:-	-0.39	-7.35	8.24E-13	Hypertriglyceridemia	
KIRC	cis	1	rs6862569	chr5:156466548	TIMD4	chr5:156346293-156390266:-	-0.33	-6.26	8.18E-10	Hypertriglyceridemia	
KIRC	cis	1	rs6862814	chr5:150245259	IRGM	chr5:150226085-150280295:+	0.53	7.31	1.08E-12	Crohn's disease	
KIRC	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.11E-7	Crohn's disease	
KIRC	cis	1	rs686441	chr10:105950233	C10orf79	chr10:105889647-105992120:-	0.17	4.14	4.08E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs6865893	chr5:78324767	ARSB	chr5:78073039-78282357:-	-0.2	-4.34	1.76E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6865893	chr5:78324767	BHMT	chr5:78407604-78428112:+	-0.26	-5.41	9.54E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6867242	chr5:137561186	CDC25C	chr5:137620959-137674044:-	-0.22	-6.11	2.02E-9	Resting heart rate	
KIRC	cis	1	rs6869502	chr5:110166083	TMEM232	chr5:109624934-110062381:-	0.25	4.82	1.94E-6	Asthma and hay fever	
KIRC	cis	1	rs6874560	chr5:150182713	IRGM	chr5:150226085-150280295:+	0.65	7.79	3.94E-14	Crohn's disease	
KIRC	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.44	5.19	3.01E-7	Crohn's disease	
KIRC	cis	1	rs6875011	chr5:150182710	IRGM	chr5:150226085-150280295:+	0.65	7.96	1.18E-14	Crohn's disease	
KIRC	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.45	5.49	6.51E-8	Crohn's disease	
KIRC	cis	1	rs687557	chr10:105989509	C10orf79	chr10:105889647-105992120:-	0.19	4.53	7.44E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.47	13.64	3.03E-36	Crohn's disease	
KIRC	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.45	-7.72	6.4E-14	Crohn's disease	
KIRC	cis	1	rs6876972	chr5:115642519	COMMD10	chr5:115420727-115628978:+	0.36	3.86	0.000127	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs6877621	chr5:78314379	ARSB	chr5:78073039-78282357:-	-0.2	-4.21	3.0E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6877621	chr5:78314379	BHMT	chr5:78407604-78428112:+	-0.25	-5.32	1.59E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs6880213	chr5:115447414	COMMD10	chr5:115420727-115628978:+	0.34	3.92	9.94E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs6883938	chr5:60962986	FLJ37543	chr5:60933636-61002362:+	0.23	3.82	0.000152	Alzheimer's disease	
KIRC	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.83	16.81	1.22E-50	Type 2 diabetes	
KIRC	cis	1	rs6885792	chr5:110165413	TMEM232	chr5:109624934-110062381:-	0.23	4.45	1.08E-5	Asthma and hay fever	
KIRC	cis	1	rs6886255	chr5:176718361	PRELID1	chr5:176730835-176733949:+	0.15	4.3	2.08E-5	Migraine without aura	
KIRC	cis	1	rs6887276	chr5:127378294	SLC12A2	chr5:127419483-127525379:+	0.13	3.99	7.48E-5	Height	
KIRC	cis	1	rs6893857	chr5:78184403	CMYA5	chr5:78985659-79096048:+	-0.2	-3.54	0.000432	Chronic lymphocytic leukemia	
KIRC	cis	1	rs6900902	chr6:105235757	HACE1	chr6:105175968-105307794:-	-0.17	-4.41	1.28E-5	Thyroid stimulating hormone	
KIRC	cis	1	rs6901250	chr6:117114025	FAM162B	chr6:117073360-117086886:-	-0.23	-6.36	4.66E-10	C-reactive protein levels	
KIRC	cis	1	rs6901575	chr6:28250984	ZNF187	chr6:28234788-28245978:+	-0.28	-4.8	2.1E-6	Depression	
KIRC	cis	1	rs6901575	chr6:28250984	ZNF323	chr6:28292517-28324048:-	0.29	3.94	9.24E-5	Depression	
KIRC	cis	1	rs6901575	chr6:28250984	ZSCAN23	chr6:28393287-28411279:-	0.26	3.73	0.000209	Depression	
KIRC	cis	1	rs6902102	chr6:161025288	PLG	chr6:161123274-161174345:+	0.26	5.14	3.87E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.46	-11.27	2.1E-26	Homocysteine levels	
KIRC	cis	1	rs6904069	chr6:125995134	HEY2	chr6:126068780-126082414:+	-0.17	-4.11	4.57E-5	Endometrial cancer	
KIRC	cis	1	rs6904133	chr6:151881805	C6orf97	chr6:151815175-151942327:+	0.19	3.6	0.000344	Bone mineral density (spine)	
KIRC	cis	1	rs6904991	chr6:33732262	LEMD2	chr6:33738991-33756906:-	-0.15	-3.68	0.00026	Crohn's disease	
KIRC	cis	1	rs6904992	chr6:126016003	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs6905391	chr6:28262686	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.51	0.000494	Depression	
KIRC	cis	1	rs6905391	chr6:28262686	ZNF187	chr6:28234788-28245978:+	-0.24	-4.5	8.44E-6	Depression	
KIRC	cis	1	rs6905391	chr6:28262686	ZNF323	chr6:28292517-28324048:-	0.32	4.64	4.44E-6	Depression	
KIRC	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.29	4.41	1.29E-5	Depression	
KIRC	cis	1	rs6905422	chr6:161068064	PLG	chr6:161123274-161174345:+	0.26	5.31	1.62E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6906446	chr6:161067949	PLG	chr6:161123274-161174345:+	0.29	5.59	3.76E-8	Lipoprotein (a) levels	
KIRC	cis	1	rs6907629	chr6:167569519	GPR31	chr6:167570361-167571319:-	-0.22	-4.99	8.42E-7	Asthma (childhood onset)	
KIRC	cis	1	rs6907823	chr6:153433542	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs6907898	chr6:126666416	CENPW	chr6:126661253-126804465:+	-0.15	-4.71	3.18E-6	Type 1 diabetes	
KIRC	cis	1	rs6908917	chr6:131355864	LOC285733	chr6:131148324-131156430:+	0.18	3.68	0.000258	IgG glycosylation	
KIRC	cis	1	rs6909229	chr6:158572379	SERAC1	chr6:158530536-158589312:-	0.26	4.75	2.6E-6	Lipoprotein (a) levels	
KIRC	cis	1	rs6910233	chr6:33534726	HLA-DPB2	chr6:33080293-33096890:+	0.14	3.9	0.000108	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs6910933	chr6:126017155	HEY2	chr6:126068780-126082414:+	0.17	4.1	4.79E-5	Endometrial cancer	
KIRC	cis	1	rs6913833	chr6:161017451	PLG	chr6:161123274-161174345:+	0.25	5	7.76E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.47	-10.48	2.34E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs6915173	chr6:101632629	GRIK2	chr6:101846905-102517957:+	0.51	5.16	3.49E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.49	-12.21	3.22E-30	Homocysteine levels	
KIRC	cis	1	rs6915336	chr6:101632702	GRIK2	chr6:101846905-102517957:+	0.51	5.16	3.49E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.46	-11.3	1.55E-26	Homocysteine levels	
KIRC	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.46	-11.37	8.05E-27	Homocysteine levels	
KIRC	cis	1	rs6919397	chr6:126659043	CENPW	chr6:126661253-126804465:+	-0.14	-4.32	1.85E-5	Type 1 diabetes	
KIRC	cis	1	rs6919497	chr6:161031638	PLG	chr6:161123274-161174345:+	0.26	5.1	4.88E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6920075	chr6:33731797	LEMD2	chr6:33738991-33756906:-	-0.15	-3.78	0.000176	Crohn's disease	
KIRC	cis	1	rs6921487	chr6:33749293	LEMD2	chr6:33738991-33756906:-	0.22	5.27	2.01E-7	Body mass index	
KIRC	cis	1	rs6922824	chr6:26553815	BTN2A3	chr6:26422317-26431927:+	-0.12	-3.57	0.000395	Educational attainment	
KIRC	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.41	-9.88	3.75E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.25	8.39	4.99E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.46	9.98	1.62E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs6923917	chr6:161031718	PLG	chr6:161123274-161174345:+	0.26	5.17	3.36E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6924002	chr6:117114223	FAM162B	chr6:117073360-117086886:-	0.25	6.63	8.58E-11	C-reactive protein levels	
KIRC	cis	1	rs6924373	chr6:87804222	C6orf162	chr6:88032306-88052043:+	0.18	3.9	0.000108	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	
KIRC	cis	1	rs6925273	chr6:33732448	LEMD2	chr6:33738991-33756906:-	-0.15	-3.83	0.000145	Crohn's disease	
KIRC	cis	1	rs6927161	chr6:126015954	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.28	5.48	6.91E-8	Diabetic kidney disease	
KIRC	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.63	-10.63	6.26E-24	Diabetic kidney disease	
KIRC	cis	1	rs6928	chr22:22115004	MAPK1	chr22:22113949-22221970:-	0.19	5.62	3.1E-8	Multiple sclerosis	
KIRC	cis	1	rs6929299	chr6:161032089	PLG	chr6:161123274-161174345:+	0.24	4.79	2.18E-6	Lipoprotein (a) levels	
KIRC	cis	1	rs6930076	chr6:88088654	C6orf162	chr6:88032306-88052043:+	-0.19	-4.09	5.04E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs6930076	chr6:88088654	C6orf164	chr6:88032306-88109459:+	-0.16	-4.05	5.85E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs6930201	chr6:33738749	LEMD2	chr6:33738991-33756906:-	0.22	5.22	2.64E-7	Body mass index	
KIRC	cis	1	rs693030	chr8:16702511	SLC7A2	chr8:17354600-17428073:+	-0.19	-3.54	0.000431	Parkinson's disease	
KIRC	cis	1	rs6930342	chr6:161025442	PLG	chr6:161123274-161174345:+	0.27	5.29	1.86E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6931160	chr6:153430451	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs6932014	chr6:161026515	PLG	chr6:161123274-161174345:+	0.26	5.17	3.31E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6933174	chr6:33751003	LEMD2	chr6:33738991-33756906:-	0.23	5.12	4.43E-7	Body mass index	
KIRC	cis	1	rs6933176	chr6:26540178	BTN2A3	chr6:26422317-26431927:+	0.12	3.68	0.00026	Educational attainment	
KIRC	cis	1	rs6933302	chr6:126016951	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.41	9.27	5.67E-19	Response to antipsychotic treatment	
KIRC	cis	1	rs6933471	chr6:126017029	HEY2	chr6:126068780-126082414:+	0.18	4.31	1.97E-5	Endometrial cancer	
KIRC	cis	1	rs6933568	chr6:33751261	LEMD2	chr6:33738991-33756906:-	0.22	5.08	5.3E-7	Body mass index	
KIRC	cis	1	rs6933576	chr6:161068176	PLG	chr6:161123274-161174345:+	0.26	5.28	1.94E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6933607	chr6:33743997	LEMD2	chr6:33738991-33756906:-	0.23	5.18	3.16E-7	Body mass index	
KIRC	cis	1	rs6934435	chr6:126017481	HEY2	chr6:126068780-126082414:+	0.18	4.4	1.31E-5	Endometrial cancer	
KIRC	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.46	-9.93	2.51E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs6936177	chr6:34783717	UHRF1BP1	chr6:34759794-34853117:+	0.29	6.43	2.94E-10	Pubertal anthropometrics	
KIRC	cis	1	rs6937879	chr6:161030880	PLG	chr6:161123274-161174345:+	0.27	5.3	1.73E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs6938239	chr6:34683635	UHRF1BP1	chr6:34759794-34853117:+	-0.32	-6.72	5.01E-11	Pubertal anthropometrics	
KIRC	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.47	-13.64	3.03E-36	Crohn's disease	
KIRC	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.45	7.72	6.4E-14	Crohn's disease	
KIRC	cis	1	rs6940353	chr6:33752550	LEMD2	chr6:33738991-33756906:-	0.23	5.13	4.25E-7	Body mass index	
KIRC	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.46	-10.13	4.73E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs6940729	chr6:47552920	GPR111	chr6:47624222-47663805:+	0.31	5.79	1.21E-8	Plasma homocysteine levels	
KIRC	cis	1	rs6940729	chr6:47552920	GPR115	chr6:47653600-47689757:+	0.23	4.51	8.08E-6	Plasma homocysteine levels	
KIRC	cis	1	rs6942022	chr6:33710284	IP6K3	chr6:33689443-33714762:-	-0.44	-5.01	7.6E-7	Phosphorus levels	
KIRC	cis	1	rs6942231	chr6:105191814	HACE1	chr6:105175968-105307794:-	-0.16	-4.22	2.94E-5	Thyroid stimulating hormone	
KIRC	cis	1	rs694609	chr13:28194806	POLR1D	chr13:28194895-28241547:+	-0.2	-4.37	1.49E-5	Large B-cell lymphoma	
KIRC	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.36	4.5	8.52E-6	Blood metabolite levels	
KIRC	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs6949812	chr7:65387101	CRCP	chr7:65579805-65619551:+	-0.31	-4.35	1.62E-5	Diabetic kidney disease	
KIRC	cis	1	rs6949897	chr7:50621920	FIGNL1	chr7:50511834-50518088:-	-0.23	-4.58	5.84E-6	Malaria	
KIRC	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.46	-13.34	5.89E-35	Crohn's disease	
KIRC	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.45	7.69	7.74E-14	Crohn's disease	
KIRC	cis	1	rs6951245	chr7:1058193	ZFAND2A	chr7:1192544-1199855:-	-0.36	-6.26	8.07E-10	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs6952407	chr7:66045512	LOC493754	chr7:65993446-66057363:-	0.18	4.06	5.72E-5	Cotinine glucuronidation	
KIRC	cis	1	rs6958289	chr7:65657111	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.7	2.02E-8	Diabetic kidney disease	
KIRC	cis	1	rs6958289	chr7:65657111	CRCP	chr7:65579805-65619551:+	0.32	4.35	1.67E-5	Diabetic kidney disease	
KIRC	cis	1	rs6958289	chr7:65657111	LOC493754	chr7:65993446-66057363:-	-0.22	-3.5	0.000506	Diabetic kidney disease	
KIRC	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs6958420	chr7:65751171	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs6958520	chr7:66151453	LOC493754	chr7:65993446-66057363:-	-0.17	-3.8	0.000163	Aortic root size	
KIRC	cis	1	rs6959002	chr7:65650496	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs6959002	chr7:65650496	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs6959702	chr7:3356286	SDK1	chr7:3341080-4308629:+	0.21	3.98	7.76E-5	Motion sickness	
KIRC	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.63	2.96E-8	Diabetic kidney disease	
KIRC	cis	1	rs6964245	chr7:65718717	CRCP	chr7:65579805-65619551:+	0.31	4.25	2.51E-5	Diabetic kidney disease	
KIRC	cis	1	rs6964245	chr7:65718717	LOC493754	chr7:65993446-66057363:-	-0.23	-3.6	0.000349	Diabetic kidney disease	
KIRC	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.56	4.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs6964530	chr7:65718851	CRCP	chr7:65579805-65619551:+	0.31	4.22	2.93E-5	Diabetic kidney disease	
KIRC	cis	1	rs6964530	chr7:65718851	LOC493754	chr7:65993446-66057363:-	-0.23	-3.59	0.000369	Diabetic kidney disease	
KIRC	cis	1	rs6965685	chr7:158726462	WDR60	chr7:158649269-158738882:+	-0.21	-5.37	1.22E-7	Height	
KIRC	cis	1	rs6966322	chr7:65646754	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs6966322	chr7:65646754	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs6966619	chr7:3359491	SDK1	chr7:3341080-4308629:+	-0.2	-3.89	0.000113	Motion sickness	
KIRC	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs6970243	chr7:65388490	CRCP	chr7:65579805-65619551:+	-0.31	-4.35	1.62E-5	Diabetic kidney disease	
KIRC	cis	1	rs6970597	chr7:21583519	CDCA7L	chr7:21940518-21985542:-	-0.15	-3.55	0.000422	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.89	-25.15	6.24E-91	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs6970985	chr7:21583597	CDCA7L	chr7:21940518-21985542:-	-0.16	-3.82	0.00015	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.89	-25.51	1.12E-92	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
KIRC	cis	1	rs6974373	chr7:99590893	CNPY4	chr7:99717265-99723126:+	-0.13	-3.49	0.000523	Interstitial lung disease	
KIRC	cis	1	rs6974373	chr7:99590893	SPDYE3	chr7:99912064-99918757:+	0.19	3.63	0.000308	Interstitial lung disease	
KIRC	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.17	-3.66	0.000283	Interstitial lung disease	
KIRC	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs6974723	chr7:65637939	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs6975195	chr7:66124774	LOC493754	chr7:65993446-66057363:-	0.17	3.77	0.000182	Aortic root size	
KIRC	cis	1	rs6976053	chr7:100512119	PMS2L1	chr7:99918263-99933930:-	-0.2	-3.94	9.44E-5	Plasminogen activator inhibitor type 1 levels (PAI-1)	
KIRC	cis	1	rs6976053	chr7:100512119	UFSP1	chr7:100486346-100487339:-	-0.25	-5.18	3.14E-7	Plasminogen activator inhibitor type 1 levels (PAI-1)	
KIRC	cis	1	rs6980323	chr7:3356207	SDK1	chr7:3341080-4308629:+	0.2	4	7.26E-5	Motion sickness	
KIRC	cis	1	rs6980734	chr8:89446680	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs6984009	chr8:96289091	C8orf37	chr8:96258235-96281437:-	0.4	4.58	5.88E-6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
KIRC	cis	1	rs6985880	chr8:96027599	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs6987711	chr8:89425711	MMP16	chr8:89049462-89339717:-	0.32	4.3	2.06E-5	Electrodermal activity	
KIRC	cis	1	rs6988021	chr8:89450084	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs698833	chr2:44735438	PREPL	chr2:44545903-44588944:-	-0.15	-3.98	7.9E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs6989862	chr8:96027568	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs6993270	chr8:120941716	TNFRSF11B	chr8:119935797-119964383:-	-0.24	-3.64	0.000307	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs6999	chr20:55093901	C20orf43	chr20:55043647-55093942:+	0.21	4.93	1.13E-6	Refractive astigmatism	
KIRC	cis	1	rs7000891	chr8:89446259	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7001241	chr8:89446459	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7001875	chr8:89446812	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7002940	chr8:96027392	C8orf38	chr8:95908040-96088396:+	-0.24	-3.62	0.000328	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs7004438	chr8:8574379	CLDN23	chr8:8559666-8561616:+	0.22	3.52	0.000475	Obesity-related traits	
KIRC	cis	1	rs7004757	chr8:89446178	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7005380	chr8:120953873	DSCC1	chr8:120846182-120868170:-	-0.21	-4.51	8.22E-6	Interstitial lung disease	
KIRC	cis	1	rs7006506	chr8:89426102	MMP16	chr8:89049462-89339717:-	0.3	4.02	6.69E-5	Electrodermal activity	
KIRC	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.87	24.09	8.77E-86	Bone mineral density	
KIRC	cis	1	rs7008219	chr8:89451970	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7008542	chr8:96027863	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs7008908	chr8:120936890	TNFRSF11B	chr8:119935797-119964383:-	0.25	3.72	0.000224	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs7014273	chr8:67358694	ADHFE1	chr8:67344718-67381042:+	0.22	4.51	8.02E-6	Blood metabolite levels	
KIRC	cis	1	rs7017842	chr8:143685116	ARC	chr8:143692410-143695833:-	0.29	5.79	1.24E-8	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.88	24.65	1.63E-88	Bone mineral density	
KIRC	cis	1	rs7018226	chr8:89446335	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7018417	chr8:124093718	DERL1	chr8:124025568-124054648:-	0.25	4.31	1.99E-5	Diabetic kidney disease	
KIRC	cis	1	rs7018	chr20:25278261	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.48	2.22E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.27	-5.19	3.02E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7019	chr20:25278278	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.47	2.4E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.29	-5.51	5.8E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7020708	chr9:131885131	SET	chr9:131445934-131458674:+	-0.18	-3.85	0.000134	Blood metabolite ratios	
KIRC	cis	1	rs7020	chr20:25278600	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.48	2.21E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7020	chr20:25278600	FAM182A	chr20:26035250-26067552:+	-0.27	-5.18	3.21E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7021449	chr9:131899312	PPP2R4	chr9:131873244-131911223:+	0.2	3.84	0.00014	Blood metabolite ratios	
KIRC	cis	1	rs7021449	chr9:131899312	SET	chr9:131445934-131458674:+	-0.19	-4	7.32E-5	Blood metabolite ratios	
KIRC	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.36	-7.37	7.26E-13	Hematology traits	
KIRC	cis	1	rs7023900	chr9:131891152	CRAT	chr9:131857075-131873070:-	0.14	3.55	0.000418	Blood metabolite ratios	
KIRC	cis	1	rs7023900	chr9:131891152	PPP2R4	chr9:131873244-131911223:+	0.2	3.78	0.000177	Blood metabolite ratios	
KIRC	cis	1	rs7023900	chr9:131891152	SET	chr9:131445934-131458674:+	-0.18	-3.83	0.000143	Blood metabolite ratios	
KIRC	cis	1	rs7026073	chr9:38040672	DCAF10	chr9:37800551-37867663:+	-0.16	-4.05	6.04E-5	Brain structure	
KIRC	cis	1	rs702872	chr2:61081310	PUS10	chr2:61167550-61245365:-	0.17	4.47	9.68E-6	Psoriasis	
KIRC	cis	1	rs702873	chr2:61081542	PUS10	chr2:61167550-61245365:-	-0.14	-3.81	0.000158	Psoriasis	
KIRC	cis	1	rs7029536	chr9:130110411	RPL12	chr9:130209955-130213684:-	0.15	3.74	0.000206	Metabolite levels (HVA)	
KIRC	cis	1	rs7030887	chr9:100688511	C9orf156	chr9:100666772-100684852:-	-0.29	-6.55	1.46E-10	Quantitative traits	
KIRC	cis	1	rs7030907	chr9:100688577	C9orf156	chr9:100666772-100684852:-	-0.29	-6.55	1.46E-10	Quantitative traits	
KIRC	cis	1	rs7036114	chr9:131893406	CRAT	chr9:131857075-131873070:-	0.15	3.57	0.000386	Blood metabolite ratios	
KIRC	cis	1	rs7036114	chr9:131893406	PPP2R4	chr9:131873244-131911223:+	0.2	3.85	0.000134	Blood metabolite ratios	
KIRC	cis	1	rs7036114	chr9:131893406	SET	chr9:131445934-131458674:+	-0.18	-3.82	0.000153	Blood metabolite ratios	
KIRC	cis	1	rs7036236	chr9:131899299	SET	chr9:131445934-131458674:+	-0.19	-4.06	5.75E-5	Blood metabolite ratios	
KIRC	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.5	-9.86	4.57E-21	Rheumatoid arthritis	
KIRC	cis	1	rs7037140	chr9:123656327	PSMD5	chr9:123578334-123605206:-	-0.37	-6.83	2.48E-11	Rheumatoid arthritis	
KIRC	cis	1	rs7037163	chr9:131894340	CRAT	chr9:131857075-131873070:-	0.15	3.58	0.000383	Blood metabolite ratios	
KIRC	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.31	-6.85	2.12E-11	Multiple sclerosis	
KIRC	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.45	12.06	1.33E-29	Multiple sclerosis	
KIRC	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.29	6.48	2.13E-10	Multiple sclerosis	
KIRC	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.36	-7.37	7.26E-13	Hematology traits	
KIRC	cis	1	rs7042681	chr9:38040828	DCAF10	chr9:37800551-37867663:+	-0.16	-4.04	6.17E-5	Brain structure	
KIRC	cis	1	rs7045138	chr9:100591463	C9orf156	chr9:100666772-100684852:-	0.17	4.05	5.84E-5	Thyroid hormone levels	
KIRC	cis	1	rs7045881	chr9:26935996	IFT74	chr9:26947037-27062923:+	0.29	4.12	4.51E-5	Schizophrenia	
KIRC	cis	1	rs7046290	chr9:90202577	CTSL3	chr9:90387830-90401799:+	-0.27	-3.72	0.000222	Night sleep phenotypes	
KIRC	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.76	14.39	1.51E-39	Cognitive function	
KIRC	cis	1	rs7067773	chr10:52005271	FAM21A	chr10:51827684-51893268:+	0.32	4.38	1.46E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs7070074	chr10:96786886	CYP2C9	chr10:96698415-96749147:+	0.18	3.52	0.000479	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7070296	chr10:65070438	NRBF2	chr10:64893007-64914785:+	-0.28	-6.87	1.93E-11	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7070678	chr10:29812602	LOC387647	chr10:29698483-29776785:+	0.2	3.79	0.000166	Platelet thrombus formation	
KIRC	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.15	-5.22	2.58E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.16	-5.38	1.15E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.8	21.65	6.51E-74	Metabolite levels	
KIRC	cis	1	rs7072634	chr10:17240918	TRDMT1	chr10:17184983-17243681:-	-0.35	-8.02	7.28E-15	Homocysteine levels	
KIRC	cis	1	rs7073497	chr10:100153688	PYROXD2	chr10:100143323-100174978:-	0.42	4.92	1.19E-6	Aspartate aminotransferase	
KIRC	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.14	-5	7.98E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.27	-6.52	1.71E-10	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7077415	chr10:52005293	FAM21A	chr10:51827684-51893268:+	-0.3	-4.05	6.04E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs7078003	chr10:99359412	C10orf62	chr10:99349484-99350690:+	-0.27	-4.01	7.05E-5	Metabolite levels (small molecules and protein measures)	
KIRC	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.15E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.97E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7079481	chr10:69959242	MYPN	chr10:69865876-69971771:+	-0.25	-4.59	5.55E-6	Height	
KIRC	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.14	-4.93	1.11E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7079974	chr10:69959397	MYPN	chr10:69865876-69971771:+	-0.25	-4.78	2.3E-6	Height	
KIRC	cis	1	rs7079976	chr10:124172108	ARMS2	chr10:124214179-124216867:+	-0.19	-3.58	0.00038	Height	
KIRC	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.15	-5.22	2.58E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7081155	chr10:17263140	TRDMT1	chr10:17184983-17243681:-	0.2	4.6	5.48E-6	Cholesterol, total	
KIRC	cis	1	rs7081213	chr10:69954290	MYPN	chr10:69865876-69971771:+	-0.24	-4.52	7.57E-6	Height	
KIRC	cis	1	rs708152	chr11:2384348	C11orf21	chr11:2317507-2323143:-	-0.19	-4.52	7.56E-6	Bacteremia	
KIRC	cis	1	rs708224	chr12:32436409	BICD1	chr12:32260185-32531140:+	0.16	3.89	0.000112	Pancreatic cancer	
KIRC	cis	1	rs7082376	chr10:17232223	TRDMT1	chr10:17184983-17243681:-	-0.34	-7.75	5.03E-14	Homocysteine levels	
KIRC	cis	1	rs7084476	chr10:17211383	TRDMT1	chr10:17184983-17243681:-	-0.35	-7.99	9.13E-15	Homocysteine levels	
KIRC	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.13	-4.52	7.69E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7084921	chr10:101813802	CWF19L1	chr10:101992055-102027437:-	0.29	5.51	5.82E-8	Bone mineral density	
KIRC	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.13	-4.58	5.86E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.13	-4.7	3.43E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.13	-4.48	9.24E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.15	-5.19	2.99E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7094660	chr10:69956912	MYPN	chr10:69865876-69971771:+	-0.25	-4.7	3.39E-6	Height	
KIRC	cis	1	rs7094885	chr10:69953817	MYPN	chr10:69865876-69971771:+	-0.24	-4.55	6.8E-6	Height	
KIRC	cis	1	rs7095607	chr10:69957350	MYPN	chr10:69865876-69971771:+	-0.25	-4.7	3.39E-6	Height	
KIRC	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.8	-19.5	1.9E-63	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs709592	chr17:38175553	MED24	chr17:38175351-38210889:-	-0.15	-3.62	0.000329	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs7095944	chr10:126302936	METTL10	chr10:126447406-126480439:-	-0.35	-7.37	7.03E-13	Asthma	
KIRC	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.24	-4.73	2.88E-6	Diabetic kidney disease	
KIRC	cis	1	rs709607	chr7:65449541	CRCP	chr7:65579805-65619551:+	0.3	4.19	3.26E-5	Diabetic kidney disease	
KIRC	cis	1	rs7096254	chr10:69939906	MYPN	chr10:69865876-69971771:+	-0.25	-4.64	4.45E-6	Height	
KIRC	cis	1	rs7096686	chr10:69940238	MYPN	chr10:69865876-69971771:+	-0.25	-4.64	4.45E-6	Height	
KIRC	cis	1	rs7096692	chr10:17180828	TRDMT1	chr10:17184983-17243681:-	-0.36	-7.9	1.83E-14	Homocysteine levels	
KIRC	cis	1	rs7097656	chr10:82250831	TSPAN14	chr10:82214038-82282390:+	0.21	3.88	0.00012	Post bronchodilator FEV1	
KIRC	cis	1	rs7097701	chr10:124171857	ARMS2	chr10:124214179-124216867:+	-0.19	-3.58	0.00038	Height	
KIRC	cis	1	rs7097	chr13:28197436	POLR1D	chr13:28194895-28241547:+	0.18	3.84	0.000137	Large B-cell lymphoma	
KIRC	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.14	-4.86	1.55E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.13	-4.44	1.12E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7099	chr20:43997646	SYS1-DBNDD2	chr20:43991701-44039245:+	-0.24	-3.75	0.000198	Psoriasis	
KIRC	cis	1	rs7100163	chr10:17181177	TRDMT1	chr10:17184983-17243681:-	-0.35	-7.88	2.07E-14	Homocysteine levels	
KIRC	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.13	-4.43	1.15E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7101701	chr11:71762155	C11orf59	chr11:71808339-71814322:-	-0.21	-3.81	0.000156	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7102787	chr11:73012614	RELT	chr11:73087405-73108518:+	0.2	4.07	5.48E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs7103210	chr11:71648966	C11orf59	chr11:71808339-71814322:-	-0.22	-3.9	0.000109	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7104222	chr11:78007169	NARS2	chr11:78147017-78285909:-	-0.18	-3.97	8.36E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7104764	chr11:229977	PSMD13	chr11:236808-252984:+	-0.16	-5.14	3.85E-7	Menarche (age at onset)	
KIRC	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.47	-9.92	2.56E-21	Subjective well-being	
KIRC	cis	1	rs7105681	chr11:73059341	RELT	chr11:73087405-73108518:+	0.19	3.9	0.00011	Pulmonary function (interaction)	
KIRC	cis	1	rs7105705	chr11:73012319	RELT	chr11:73087405-73108518:+	0.2	4.07	5.48E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs7106748	chr11:71645803	C11orf59	chr11:71808339-71814322:-	-0.23	-3.98	7.98E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7107211	chr11:120262922	TMEM136	chr11:120196016-120204388:+	0.16	3.66	0.000277	Intraocular pressure	
KIRC	cis	1	rs7107356	chr11:47676170	C1QTNF4	chr11:47611216-47615961:-	0.34	7.27	1.39E-12	Neuroticism	
KIRC	cis	1	rs7107905	chr11:73061232	RELT	chr11:73087405-73108518:+	0.16	3.62	0.000324	Pulmonary function (interaction)	
KIRC	cis	1	rs710865	chr1:19568972	KIAA0090	chr1:19544585-19578046:-	-0.17	-4.09	5.03E-5	Brain structure	
KIRC	cis	1	rs710866	chr1:19568722	KIAA0090	chr1:19544585-19578046:-	-0.17	-4.01	7.07E-5	Brain structure	
KIRC	cis	1	rs7109698	chr11:46673344	MDK	chr11:46402334-46405374:+	0.21	3.78	0.000174	Schizophrenia	
KIRC	cis	1	rs7111546	chr11:22829757	SVIP	chr11:22843600-22851382:-	0.24	4.14	4.02E-5	Dialysis-related mortality	
KIRC	cis	1	rs7111986	chr11:78102266	NARS2	chr11:78147017-78285909:-	-0.19	-4.22	2.84E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.61	-13.76	8.79E-37	Type 2 diabetes	
KIRC	cis	1	rs7112229	chr11:46513249	MDK	chr11:46402334-46405374:+	-0.22	-3.65	0.000286	Schizophrenia	
KIRC	cis	1	rs7112234	chr11:78102470	NARS2	chr11:78147017-78285909:-	-0.18	-4.11	4.68E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7112397	chr11:22854616	SVIP	chr11:22843600-22851382:-	0.32	7	8.13E-12	Dialysis-related mortality	
KIRC	cis	1	rs7112513	chr11:117037361	PCSK7	chr11:117075789-117102811:-	-0.28	-5.48	6.75E-8	Protein quantitative trait loci	
KIRC	cis	1	rs7113042	chr11:78035832	NARS2	chr11:78147017-78285909:-	0.18	4.25	2.53E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7113549	chr11:71829967	C11orf59	chr11:71808339-71814322:-	0.23	4.24	2.68E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7114252	chr11:71237606	DHCR7	chr11:71145459-71159477:-	-0.3	-4.78	2.28E-6	Vitamin D levels	
KIRC	cis	1	rs7114963	chr11:116875983	PCSK7	chr11:117075789-117102811:-	-0.28	-5.48	6.63E-8	Protein quantitative trait loci	
KIRC	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.58	-12.92	3.72E-33	Forced vital capacity	
KIRC	cis	1	rs7116495	chr11:71762085	C11orf59	chr11:71808339-71814322:-	-0.21	-3.81	0.000156	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7116698	chr11:77995191	NARS2	chr11:78147017-78285909:-	-0.17	-3.66	0.000276	Testicular germ cell tumor	
KIRC	cis	1	rs7117238	chr11:78040259	NARS2	chr11:78147017-78285909:-	-0.2	-4.63	4.68E-6	Testicular germ cell tumor	
KIRC	cis	1	rs7119122	chr11:123917281	C11orf61	chr11:124636394-124670299:-	0.1	3.88	0.000118	Male fertility	
KIRC	cis	1	rs7119933	chr11:78049750	NARS2	chr11:78147017-78285909:-	-0.2	-4.61	5.02E-6	Testicular germ cell tumor	
KIRC	cis	1	rs7120029	chr11:71198957	DHCR7	chr11:71145459-71159477:-	-0.27	-4.59	5.71E-6	Vitamin D levels	
KIRC	cis	1	rs712022	chr11:22843155	SVIP	chr11:22843600-22851382:-	-0.29	-6.42	3.2E-10	Dialysis-related mortality	
KIRC	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.12	4.82E-22	Subjective well-being	
KIRC	cis	1	rs7120668	chr11:5567854	TRIM6	chr11:5617347-5634188:+	-0.21	-4.95	1.02E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7121260	chr11:71700566	C11orf59	chr11:71808339-71814322:-	-0.22	-4.06	5.8E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7121347	chr11:116867209	PCSK7	chr11:117075789-117102811:-	-0.28	-5.53	5.17E-8	Protein quantitative trait loci	
KIRC	cis	1	rs7122944	chr11:117034619	PCSK7	chr11:117075789-117102811:-	-0.28	-5.44	8.29E-8	Protein quantitative trait loci	
KIRC	cis	1	rs7123517	chr11:117027755	PCSK7	chr11:117075789-117102811:-	-0.27	-5.25	2.29E-7	Protein quantitative trait loci	
KIRC	cis	1	rs7124000	chr11:71754338	C11orf59	chr11:71808339-71814322:-	-0.23	-4.24	2.7E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7124741	chr11:116752219	PCSK7	chr11:117075789-117102811:-	-0.28	-5.09	5.11E-7	Protein quantitative trait loci	
KIRC	cis	1	rs7124974	chr11:59906972	MS4A2	chr11:59856137-59866014:+	0.18	3.81	0.000157	Alzheimer's disease (late onset)	
KIRC	cis	1	rs7125746	chr11:5556005	TRIM6	chr11:5617347-5634188:+	-0.19	-4.5	8.28E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7126396	chr11:22130513	ANO5	chr11:22214722-22304913:+	0.23	4.42	1.19E-5	Parkinson's disease	
KIRC	cis	1	rs7127187	chr11:77995188	NARS2	chr11:78147017-78285909:-	-0.17	-3.73	0.000212	Testicular germ cell tumor	
KIRC	cis	1	rs7127529	chr11:46582072	MDK	chr11:46402334-46405374:+	-0.21	-3.66	0.000278	Schizophrenia	
KIRC	cis	1	rs7127865	chr11:71747781	C11orf59	chr11:71808339-71814322:-	-0.22	-3.94	9.14E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7128029	chr11:244141	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs7128044	chr11:244115	PSMD13	chr11:236808-252984:+	-0.15	-5.16	3.49E-7	Menarche (age at onset)	
KIRC	cis	1	rs7128666	chr11:78102363	NARS2	chr11:78147017-78285909:-	-0.18	-4.01	7.1E-5	Testicular germ cell tumor	
KIRC	cis	1	rs71301804	chr3:53073314	RFT1	chr3:53122503-53164470:-	0.39	6.09	2.29E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs71301804	chr3:53073314	TMEM110	chr3:52867139-52931547:-	0.35	6.16	1.5E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs71301808	chr3:53085577	RFT1	chr3:53122503-53164470:-	0.31	4.66	4.09E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs71301808	chr3:53085577	TMEM110	chr3:52867139-52931547:-	0.34	5.79	1.25E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs71301809	chr3:53090312	RFT1	chr3:53122503-53164470:-	0.31	4.64	4.39E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs71301809	chr3:53090312	TMEM110	chr3:52867139-52931547:-	0.34	5.77	1.38E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs7130829	chr11:71237702	DHCR7	chr11:71145459-71159477:-	-0.29	-4.71	3.21E-6	Vitamin D levels	
KIRC	cis	1	rs71311855	chr3:58320507	PXK	chr3:58318617-58410878:+	0.22	4.39	1.39E-5	Cholesterol, total	
KIRC	cis	1	rs71311857	chr3:58323377	PXK	chr3:58318617-58410878:+	0.22	4.39	1.39E-5	Cholesterol, total	
KIRC	cis	1	rs71311858	chr3:58323793	PXK	chr3:58318617-58410878:+	0.22	4.39	1.39E-5	Cholesterol, total	
KIRC	cis	1	rs71311864	chr3:58372324	PXK	chr3:58318617-58410878:+	0.22	4.63	4.72E-6	Cholesterol, total	
KIRC	cis	1	rs71311865	chr3:58372423	PXK	chr3:58318617-58410878:+	0.22	4.63	4.72E-6	Cholesterol, total	
KIRC	cis	1	rs71311868	chr3:58392874	PXK	chr3:58318617-58410878:+	0.24	4.91	1.24E-6	Cholesterol, total	
KIRC	cis	1	rs71311869	chr3:58398922	PXK	chr3:58318617-58410878:+	0.25	5.11	4.64E-7	Cholesterol, total	
KIRC	cis	1	rs71311870	chr3:58399283	PXK	chr3:58318617-58410878:+	0.26	5.13	4.19E-7	Cholesterol, total	
KIRC	cis	1	rs71311871	chr3:58420613	PXK	chr3:58318617-58410878:+	0.25	4.84	1.73E-6	Cholesterol, total	
KIRC	cis	1	rs71311873	chr3:58447106	PXK	chr3:58318617-58410878:+	0.21	4.05	5.9E-5	Cholesterol, total	
KIRC	cis	1	rs7131305	chr11:5567735	TRIM6	chr11:5617347-5634188:+	-0.2	-4.9	1.3E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs71317058	chr22:38001828	SH3BP1	chr22:38030661-38062939:+	0.27	4.43	1.15E-5	Response to anti-depressant treatment in major depressive disorder	
KIRC	cis	1	rs7131882	chr12:124426736	CCDC92	chr12:124420955-124457163:-	0.2	5.09	5.08E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.15	3.69	0.000246	Blood metabolite ratios	
KIRC	cis	1	rs713219	chr9:131900920	PPP2R4	chr9:131873244-131911223:+	0.21	3.95	9.08E-5	Blood metabolite ratios	
KIRC	cis	1	rs713219	chr9:131900920	SET	chr9:131445934-131458674:+	-0.18	-3.85	0.000131	Blood metabolite ratios	
KIRC	cis	1	rs7132434	chr12:26472562	BHLHE41	chr12:26272961-26278003:-	-0.37	-7.12	3.84E-12	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs7132434	chr12:26472562	RASSF8	chr12:26111969-26232824:+	-0.18	-3.62	0.000322	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs7132434	chr12:26472562	SSPN	chr12:26348269-26405853:+	-0.18	-3.72	0.000223	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs71324766	chr22:29839659	RFPL1S	chr22:29833006-29838118:-	-0.27	-5.03	6.98E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs7132655	chr12:124438973	CCDC92	chr12:124420955-124457163:-	0.2	5.26	2.16E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs71329486	chr22:29831208	RFPL1S	chr22:29833006-29838118:-	-0.3	-5.75	1.53E-8	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs71329487	chr22:29833469	RFPL1S	chr22:29833006-29838118:-	-0.27	-4.98	8.9E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs7133079	chr12:81439523	ACSS3	chr12:81471809-81649582:+	0.17	3.86	0.000127	Neuroticism	
KIRC	cis	1	rs7133079	chr12:81439523	LIN7A	chr12:81191171-81331694:-	0.19	4.9	1.29E-6	Neuroticism	
KIRC	cis	1	rs7133285	chr12:56699429	RPS26	chr12:56435686-56438005:+	0.36	3.62	0.000327	Height	
KIRC	cis	1	rs71334202	chr20:23618652	CST3	chr20:23608536-23618574:-	-0.14	-4.02	6.58E-5	Chronic kidney disease	
KIRC	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	0.29	6.15	1.59E-9	HDL cholesterol	
KIRC	cis	1	rs713835	chr22:38064650	LGALS1	chr22:38071613-38075807:+	-0.13	-4.07	5.46E-5	Fat distribution (HIV)	
KIRC	cis	1	rs7140261	chr14:65973956	LOC645431	chr14:65877313-65879335:-	-0.54	-6.6	1.03E-10	Ischemic stroke	
KIRC	cis	1	rs7141087	chr14:101036052	BEGAIN	chr14:101003486-101036131:-	-0.23	-4.29	2.11E-5	Menarche (age at onset)	
KIRC	cis	1	rs7142235	chr14:75559963	MLH3	chr14:75480467-75518235:-	0.23	5.7	2.06E-8	Height	
KIRC	cis	1	rs7142235	chr14:75559963	NEK9	chr14:75548819-75593778:-	0.13	3.76	0.000191	Height	
KIRC	cis	1	rs71423932	chr2:47202613	MCFD2	chr2:47129017-47168878:-	-0.24	-3.54	0.000444	Response to statin therapy	
KIRC	cis	1	rs7142457	chr14:50097862	RPL36AL	chr14:50085407-50087349:-	0.32	7.14	3.22E-12	Carotid intima media thickness	
KIRC	cis	1	rs7142882	chr14:68959378	PLEKHH1	chr14:68000008-68056255:+	-0.15	-3.7	0.000242	Breast cancer	
KIRC	cis	1	rs7143682	chr14:104413455	TDRD9	chr14:104394817-104519002:+	0.24	3.53	0.000456	Bipolar disorder	
KIRC	cis	1	rs7144423	chr14:35572547	KIAA0391	chr14:35591776-35786673:+	0.22	3.66	0.000282	Atopic dermatitis	
KIRC	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.24	4.7	3.43E-6	Atopic dermatitis	
KIRC	cis	1	rs7145159	chr14:75583268	MLH3	chr14:75480467-75518235:-	0.25	6.28	7.48E-10	Height	
KIRC	cis	1	rs7145159	chr14:75583268	NEK9	chr14:75548819-75593778:-	0.14	4.15	3.84E-5	Height	
KIRC	cis	1	rs7145574	chr14:65884402	LOC645431	chr14:65877313-65879335:-	-0.49	-6.54	1.54E-10	Ischemic stroke	
KIRC	cis	1	rs7145588	chr14:88826796	SPATA7	chr14:88852012-88904802:+	-0.19	-4.06	5.67E-5	Coronary artery calcification	
KIRC	cis	1	rs7147118	chr14:75610170	MLH3	chr14:75480467-75518235:-	0.24	6.2	1.2E-9	Height	
KIRC	cis	1	rs7147118	chr14:75610170	NEK9	chr14:75548819-75593778:-	0.14	4.17	3.65E-5	Height	
KIRC	cis	1	rs7148538	chr14:74392342	LIN52	chr14:74551656-74667117:+	0.27	4.72	3.1E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs7148538	chr14:74392342	PTGR2	chr14:74318534-74352166:+	0.24	3.53	0.00046	Morning vs. evening chronotype	
KIRC	cis	1	rs71514277	chr1:27034428	PIGV	chr1:27114455-27124886:+	-0.38	-4.26	2.44E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.33	8.92	8.51E-18	Common traits (Other)	
KIRC	cis	1	rs7153469	chr14:81820979	STON2	chr14:81727000-81893748:-	0.38	7.08	4.87E-12	Night sleep phenotypes	
KIRC	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.33	8.96	6.57E-18	Common traits (Other)	
KIRC	cis	1	rs7153679	chr14:66012954	LOC645431	chr14:65877313-65879335:-	-0.5	-6.6	1.05E-10	Ischemic stroke	
KIRC	cis	1	rs7154306	chr14:35540499	KIAA0391	chr14:35591776-35786673:+	0.22	3.56	0.000405	Atopic dermatitis	
KIRC	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.24	4.54	7.1E-6	Atopic dermatitis	
KIRC	cis	1	rs71550519	chr6:56780272	BEND6	chr6:56819773-56892138:+	-0.28	-5.7	2.06E-8	Menarche (age at onset)	
KIRC	cis	1	rs7155275	chr14:65502271	CHURC1	chr14:65381140-65411309:+	0.25	5.75	1.59E-8	Red blood cell traits	
KIRC	cis	1	rs7155454	chr14:65502239	CHURC1	chr14:65381140-65411309:+	0.25	5.75	1.59E-8	Red blood cell traits	
KIRC	cis	1	rs7155454	chr14:65502239	RAB15	chr14:65412532-65438875:-	0.17	3.88	0.000119	Red blood cell traits	
KIRC	cis	1	rs7156105	chr14:75541954	MLH3	chr14:75480467-75518235:-	0.23	5.76	1.45E-8	Height	
KIRC	cis	1	rs7156105	chr14:75541954	NEK9	chr14:75548819-75593778:-	0.13	3.71	0.000233	Height	
KIRC	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.24	4.5	8.41E-6	Atopic dermatitis	
KIRC	cis	1	rs7156328	chr14:75532941	MLH3	chr14:75480467-75518235:-	0.24	6.01	3.49E-9	Height	
KIRC	cis	1	rs7156328	chr14:75532941	NEK9	chr14:75548819-75593778:-	0.14	3.99	7.49E-5	Height	
KIRC	cis	1	rs71564866	chr6:56771207	BEND6	chr6:56819773-56892138:+	-0.29	-5.84	9.58E-9	Menarche (age at onset)	
KIRC	cis	1	rs71564868	chr6:56798441	BEND6	chr6:56819773-56892138:+	-0.28	-5.52	5.35E-8	Menarche (age at onset)	
KIRC	cis	1	rs71567659	chr6:163001736	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.33	-9.07	2.64E-18	Common traits (Other)	
KIRC	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.22	5.8	1.19E-8	Anthropometric traits	
KIRC	cis	1	rs7162129	chr15:84566444	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.44E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs7162175	chr15:90897473	IQGAP1	chr15:90931473-91045475:+	0.15	4.01	7.0E-5	Rheumatoid arthritis	
KIRC	cis	1	rs7162175	chr15:90897473	TTLL13	chr15:90792764-90815443:+	0.25	3.92	0.0001	Rheumatoid arthritis	
KIRC	cis	1	rs7162243	chr15:90892631	TTLL13	chr15:90792764-90815443:+	0.26	4.54	7.13E-6	Rheumatoid arthritis	
KIRC	cis	1	rs7162435	chr15:56121334	NEDD4	chr15:56119131-56285835:-	-0.23	-5.37	1.19E-7	Keloid	
KIRC	cis	1	rs7162900	chr15:75368017	PPCDC	chr15:75315927-75343066:+	0.16	3.78	0.000178	Blood trace element (Zn levels)	
KIRC	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.2	3.59	0.000363	Blood trace element (Zn levels)	
KIRC	cis	1	rs7163482	chr15:65739683	DPP8	chr15:65737999-65810035:-	-0.13	-5.01	7.38E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs71636769	chr1:27020591	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs71636770	chr1:27021115	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs71636773	chr1:27051319	PIGV	chr1:27114455-27124886:+	-0.38	-4.31	2.0E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs71636777	chr1:27088268	PIGV	chr1:27114455-27124886:+	-0.39	-4.55	6.58E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs71636783	chr1:27139861	PIGV	chr1:27114455-27124886:+	-0.39	-4.57	6.09E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs71636795	chr1:27241025	PIGV	chr1:27114455-27124886:+	-0.23	-3.51	0.000485	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs7163730	chr15:78814681	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.81	1.09E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	1.08	18.95	8.68E-61	Heschl's gyrus morphology	
KIRC	cis	1	rs7164132	chr15:40675155	IVD	chr15:40697686-40713512:+	-0.36	-5.59	3.76E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7164594	chr15:78803057	CHRNA5	chr15:78857906-78886458:+	-0.31	-5.9	6.67E-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7164727	chr15:73093991	ADPGK	chr15:73043710-73076667:-	0.17	3.94	9.36E-5	Body mass index	
KIRC	cis	1	rs7165102	chr15:65888359	DPP8	chr15:65737999-65810035:-	-0.13	-5.04	6.6E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs71654417	chr1:95661200	RWDD3	chr1:95583479-95712773:+	0.36	4.75	2.61E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs71654418	chr1:95662658	RWDD3	chr1:95583479-95712773:+	0.36	4.75	2.61E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs71654419	chr1:95664497	RWDD3	chr1:95583479-95712773:+	0.37	4.78	2.27E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs7166453	chr15:66013143	DPP8	chr15:65737999-65810035:-	-0.12	-4.87	1.5E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	1.08	18.87	1.93E-60	Heschl's gyrus morphology	
KIRC	cis	1	rs7166991	chr15:40671957	IVD	chr15:40697686-40713512:+	-0.37	-5.74	1.63E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7167138	chr15:50958998	SPPL2A	chr15:50999739-51057910:-	0.27	7.04	6.56E-12	QT interval	
KIRC	cis	1	rs7167285	chr15:75368769	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.87E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000227	Blood trace element (Zn levels)	
KIRC	cis	1	rs7168680	chr15:75369212	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.68E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000228	Blood trace element (Zn levels)	
KIRC	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	1.08	18.95	8.68E-61	Heschl's gyrus morphology	
KIRC	cis	1	rs7169404	chr15:40675443	IVD	chr15:40697686-40713512:+	-0.36	-5.59	3.76E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7170930	chr15:66580853	DIS3L	chr15:66585633-66626235:+	0.58	7.16	2.8E-12	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs7170930	chr15:66580853	MAP2K1	chr15:66679211-66783881:+	-0.53	-6.65	7.64E-11	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs7170930	chr15:66580853	TIPIN	chr15:66629008-66649054:-	-0.55	-6.78	3.32E-11	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs7172118	chr15:78862453	CHRNA5	chr15:78857906-78886458:+	-0.34	-6.73	4.71E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7172335	chr15:65977204	DPP8	chr15:65737999-65810035:-	-0.12	-4.84	1.7E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs7173833	chr15:75369618	PPCDC	chr15:75315927-75343066:+	0.17	4.01	7.05E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.19	3.55	0.000424	Blood trace element (Zn levels)	
KIRC	cis	1	rs7174348	chr15:78792439	CHRNA5	chr15:78857906-78886458:+	-0.23	-4.04	6.24E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7174	chr12:121017171	COQ5	chr12:120941083-120966964:-	0.21	3.86	0.000128	Type 1 diabetes nephropathy	
KIRC	cis	1	rs7174	chr12:121017171	POP5	chr12:121016849-121019201:-	-0.15	-3.64	0.000296	Type 1 diabetes nephropathy	
KIRC	cis	1	rs7175720	chr15:75348962	PPCDC	chr15:75315927-75343066:+	-0.21	-4.74	2.8E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs7175720	chr15:75348962	RPP25	chr15:75247443-75249775:-	-0.2	-3.69	0.000252	Blood trace element (Zn levels)	
KIRC	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.29	-5.2	2.98E-7	Blood trace element (Zn levels)	
KIRC	cis	1	rs7176225	chr15:56126857	NEDD4	chr15:56119131-56285835:-	0.22	5.27	2.02E-7	Keloid	
KIRC	cis	1	rs7177486	chr15:90897109	IQGAP1	chr15:90931473-91045475:+	0.15	3.99	7.63E-5	Rheumatoid arthritis	
KIRC	cis	1	rs7177486	chr15:90897109	TTLL13	chr15:90792764-90815443:+	0.25	3.97	8.23E-5	Rheumatoid arthritis	
KIRC	cis	1	rs7178496	chr15:90896959	IQGAP1	chr15:90931473-91045475:+	0.12	3.53	0.000448	Rheumatoid arthritis	
KIRC	cis	1	rs7178496	chr15:90896959	TTLL13	chr15:90792764-90815443:+	0.26	4.51	8.21E-6	Rheumatoid arthritis	
KIRC	cis	1	rs7178584	chr15:65795200	DPP8	chr15:65737999-65810035:-	0.12	4.66	3.99E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs7178663	chr15:90897058	IQGAP1	chr15:90931473-91045475:+	0.15	4.02	6.72E-5	Rheumatoid arthritis	
KIRC	cis	1	rs7178663	chr15:90897058	TTLL13	chr15:90792764-90815443:+	0.24	3.92	0.000101	Rheumatoid arthritis	
KIRC	cis	1	rs7178962	chr15:84573248	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs7180053	chr15:91114735	ZNF774	chr15:90895477-90904714:+	-0.2	-3.63	0.000311	Information processing speed	
KIRC	cis	1	rs7181141	chr15:63398552	LACTB	chr15:63414032-63434254:+	0.18	3.79	0.000168	HDL cholesterol	
KIRC	cis	1	rs7181245	chr15:78814389	CHRNA5	chr15:78857906-78886458:+	-0.3	-5.74	1.64E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7181333	chr15:66039826	DPP8	chr15:65737999-65810035:-	0.12	4.96	9.5E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs7181447	chr15:78814567	CHRNA5	chr15:78857906-78886458:+	-0.3	-5.74	1.64E-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs718206	chr1:11294474	MTOR	chr1:11166589-11322608:-	-0.16	-4.16	3.74E-5	Body mass index	
KIRC	cis	1	rs7182544	chr15:90897480	IQGAP1	chr15:90931473-91045475:+	0.12	3.52	0.000469	Rheumatoid arthritis	
KIRC	cis	1	rs7182544	chr15:90897480	TTLL13	chr15:90792764-90815443:+	0.26	4.51	8.09E-6	Rheumatoid arthritis	
KIRC	cis	1	rs7182618	chr15:63398622	LACTB	chr15:63414032-63434254:+	0.18	3.79	0.000168	HDL cholesterol	
KIRC	cis	1	rs718314	chr12:26453283	BHLHE41	chr12:26272961-26278003:-	0.39	7.37	6.86E-13	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs718314	chr12:26453283	RASSF8	chr12:26111969-26232824:+	0.21	4.19	3.25E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs718314	chr12:26453283	SSPN	chr12:26348269-26405853:+	0.21	4.26	2.41E-5	Waist-hip ratio;Renal cell carcinoma	
KIRC	cis	1	rs7183263	chr15:84573041	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs718444	chr13:33147052	N4BP2L2	chr13:33006930-33112936:-	0.14	4.02	6.78E-5	Body mass index	
KIRC	cis	1	rs7186227	chr16:55609568	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.16	3.7E-5	Thyroid hormone levels	
KIRC	cis	1	rs7186553	chr16:55604471	LPCAT2	chr16:55542913-55620581:+	-0.18	-4.43	1.15E-5	Thyroid hormone levels	
KIRC	cis	1	rs7186721	chr16:55609474	LPCAT2	chr16:55542913-55620581:+	-0.16	-4.14	4.04E-5	Thyroid hormone levels	
KIRC	cis	1	rs7186908	chr16:72220373	HP	chr16:72088508-72094957:+	-0.29	-5.8	1.19E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7186983	chr16:50098852	HEATR3	chr16:50099881-50139373:+	-0.27	-3.86	0.00013	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs7187350	chr16:50099036	HEATR3	chr16:50099881-50139373:+	-0.27	-3.86	0.00013	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs718847	chr11:116734146	PCSK7	chr11:117075789-117102811:-	-0.27	-4.92	1.2E-6	Protein quantitative trait loci	
KIRC	cis	1	rs7191665	chr16:74688948	MLKL	chr16:74705753-74734789:-	0.2	4.41	1.29E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7191665	chr16:74688948	RFWD3	chr16:74655298-74700779:-	-0.17	-4.07	5.52E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7193487	chr16:50093406	HEATR3	chr16:50099881-50139373:+	-0.29	-4.05	5.83E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs7195763	chr16:4649300	NMRAL1	chr16:4511696-4526307:-	-0.29	-3.84	0.000139	Obesity-related traits	
KIRC	cis	1	rs719756	chr5:42725629	CCDC152	chr5:42756920-42802539:+	0.23	5.15	3.78E-7	Height	
KIRC	cis	1	rs7201320	chr16:74694058	MLKL	chr16:74705753-74734789:-	0.2	4.47	9.7E-6	Testicular germ cell tumor	
KIRC	cis	1	rs7201320	chr16:74694058	RFWD3	chr16:74655298-74700779:-	-0.17	-4.11	4.67E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7202124	chr16:50714029	SNX20	chr16:50700211-50715264:-	-0.07	-3.64	0.000299	Leprosy	
KIRC	cis	1	rs7203315	chr16:10188060	GRIN2A	chr16:9847267-10276611:-	0.25	3.9	0.00011	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs720475	chr7:144074929	OR2A7	chr7:143955790-143974852:-	-0.26	-4.25	2.59E-5	Breast cancer	
KIRC	cis	1	rs7204827	chr16:4467533	C16orf5	chr16:4560679-4588816:-	0.17	3.78	0.000174	Schizophrenia	
KIRC	cis	1	rs7204827	chr16:4467533	C16orf71	chr16:4784289-4799395:+	-0.21	-4.2	3.14E-5	Schizophrenia	
KIRC	cis	1	rs7204827	chr16:4467533	LOC342346	chr16:4606491-4650317:+	0.23	3.97	8.09E-5	Schizophrenia	
KIRC	cis	1	rs7204827	chr16:4467533	NMRAL1	chr16:4511696-4526307:-	-0.14	-3.77	0.000186	Schizophrenia	
KIRC	cis	1	rs7204827	chr16:4467533	VASN	chr16:4421849-4433529:+	-0.2	-3.75	0.000201	Schizophrenia	
KIRC	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.48	2.24E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs7207276	chr17:18065737	FAM106A	chr17:18427880-18430160:-	-0.25	-3.81	0.000156	Obesity-related traits	
KIRC	cis	1	rs7207276	chr17:18065737	LOC220594	chr17:18414577-18445234:-	-0.33	-5.15	3.71E-7	Obesity-related traits	
KIRC	cis	1	rs7207276	chr17:18065737	TOP3A	chr17:18177235-18218321:-	0.2	3.79	0.000171	Obesity-related traits	
KIRC	cis	1	rs7207286	chr17:56514458	TRIM37	chr17:57060002-57184266:-	-0.17	-3.78	0.000173	Vitamin D levels	
KIRC	cis	1	rs7209180	chr17:79581519	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs7209180	chr17:79581519	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs7209435	chr17:61712964	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.000287	Body mass index	
KIRC	cis	1	rs7209435	chr17:61712964	FTSJ3	chr17:61896795-61905031:-	0.32	6.42	3.16E-10	Body mass index	
KIRC	cis	1	rs7209435	chr17:61712964	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.41	1.29E-5	Body mass index	
KIRC	cis	1	rs7209758	chr17:61913621	FTSJ3	chr17:61896795-61905031:-	0.32	6.45	2.57E-10	Body mass index	
KIRC	cis	1	rs7209758	chr17:61913621	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.47	9.76E-6	Body mass index	
KIRC	cis	1	rs7210086	chr17:70641698	SLC39A11	chr17:70642086-71088853:-	-0.17	-3.75	0.000196	Ulcerative colitis	
KIRC	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.4	-10.43	3.52E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs7210738	chr17:45757598	ITGB3	chr17:45331208-45421658:+	-0.19	-4.37	1.51E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs7210738	chr17:45757598	TBKBP1	chr17:45772630-45789427:+	0.16	4.2	3.14E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs7211213	chr17:61769456	DDX42	chr17:61851567-61896676:+	-0.16	-3.52	0.000473	Body mass index	
KIRC	cis	1	rs7211213	chr17:61769456	FTSJ3	chr17:61896795-61905031:-	0.32	6.47	2.35E-10	Body mass index	
KIRC	cis	1	rs7211213	chr17:61769456	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.56	6.48E-6	Body mass index	
KIRC	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.46	2.53E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs7213129	chr17:79581573	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs7213129	chr17:79581573	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.79	-19.3	1.66E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs7214085	chr17:38169095	MED24	chr17:38175351-38210889:-	-0.15	-3.6	0.000345	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs7214312	chr17:61870863	FTSJ3	chr17:61896795-61905031:-	0.32	6.3	6.45E-10	Body mass index	
KIRC	cis	1	rs7214312	chr17:61870863	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.85E-6	Body mass index	
KIRC	cis	1	rs7214921	chr17:40294025	DHX58	chr17:40253422-40264751:-	-0.35	-6.97	1.02E-11	Fibrinogen levels	
KIRC	cis	1	rs7215147	chr17:30266711	RHOT1	chr17:30469473-30552745:+	-0.25	-4.64	4.41E-6	Height	
KIRC	cis	1	rs7216798	chr17:61740963	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.00029	Body mass index	
KIRC	cis	1	rs7216798	chr17:61740963	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.88E-10	Body mass index	
KIRC	cis	1	rs7216798	chr17:61740963	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.53	7.41E-6	Body mass index	
KIRC	cis	1	rs7217982	chr17:61832150	FTSJ3	chr17:61896795-61905031:-	0.32	6.32	5.66E-10	Body mass index	
KIRC	cis	1	rs7217982	chr17:61832150	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.51E-6	Body mass index	
KIRC	cis	1	rs7218686	chr17:40813865	NAGLU	chr17:40687951-40696464:+	0.33	3.66	0.000279	Systolic blood pressure change trajectories	
KIRC	cis	1	rs7219014	chr17:37624790	LOC90110	chr17:37408897-37411148:-	0.15	3.5	0.000513	Urinary metabolites	
KIRC	cis	1	rs7219014	chr17:37624790	PGAP3	chr17:37827376-37844310:-	-0.22	-4.48	9.08E-6	Urinary metabolites	
KIRC	cis	1	rs7219220	chr17:40294280	DHX58	chr17:40253422-40264751:-	-0.35	-6.97	1.02E-11	Fibrinogen levels	
KIRC	cis	1	rs7219307	chr17:11078947	SHISA6	chr17:11144740-11462196:+	0.28	3.56	0.000414	Obesity-related traits	
KIRC	cis	1	rs7219874	chr17:53065807	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.82	0.000148	Breast cancer	
KIRC	cis	1	rs7220821	chr17:61704147	DDX42	chr17:61851567-61896676:+	-0.17	-3.55	0.000415	Body mass index	
KIRC	cis	1	rs7220821	chr17:61704147	FTSJ3	chr17:61896795-61905031:-	0.32	6.37	4.25E-10	Body mass index	
KIRC	cis	1	rs7220821	chr17:61704147	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.26	2.46E-5	Body mass index	
KIRC	cis	1	rs7220892	chr17:61908316	FTSJ3	chr17:61896795-61905031:-	0.32	6.28	7.19E-10	Body mass index	
KIRC	cis	1	rs7220892	chr17:61908316	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.63	4.7E-6	Body mass index	
KIRC	cis	1	rs7221109	chr17:38770286	SMARCE1	chr17:38783976-38804103:-	-0.19	-4.3	2.07E-5	Type 1 diabetes	
KIRC	cis	1	rs7221223	chr17:53059007	TOM1L1	chr17:52978052-53039328:+	-0.18	-4.89	1.39E-6	Breast cancer	
KIRC	cis	1	rs7221743	chr17:28407876	EFCAB5	chr17:28256874-28435469:+	-0.38	-6.67	6.65E-11	Coffee consumption (cups per day)	
KIRC	cis	1	rs7222060	chr17:61868279	FTSJ3	chr17:61896795-61905031:-	0.32	6.3	6.45E-10	Body mass index	
KIRC	cis	1	rs7222060	chr17:61868279	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.85E-6	Body mass index	
KIRC	cis	1	rs7222197	chr17:53047499	TOM1L1	chr17:52978052-53039328:+	0.14	4.09	5.13E-5	Breast cancer	
KIRC	cis	1	rs7222241	chr17:79574714	ARL16	chr17:79648234-79650954:-	-0.18	-4.56	6.43E-6	Eye color traits	
KIRC	cis	1	rs7222241	chr17:79574714	NPLOC4	chr17:79523915-79604138:-	-0.11	-3.63	0.000312	Eye color traits	
KIRC	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.63	14.95	4.36E-42	Eye color traits	
KIRC	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.36	6.22	1.07E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs7222308	chr17:28277041	SSH2	chr17:27952965-28257018:-	0.16	3.61	0.000336	Coffee consumption (cups per day)	
KIRC	cis	1	rs7223231	chr17:18811846	FAM18B	chr17:18684582-18710026:+	-0.25	-5.87	8.04E-9	Educational attainment (years of education)	
KIRC	cis	1	rs7223257	chr17:61787684	FTSJ3	chr17:61896795-61905031:-	0.24	4.72	3.09E-6	Height	
KIRC	cis	1	rs7223257	chr17:61787684	STRADA	chr17:61780196-61819215:-	-0.13	-3.87	0.000125	Height	
KIRC	cis	1	rs7223412	chr17:61808172	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	3.06E-10	Body mass index	
KIRC	cis	1	rs7223412	chr17:61808172	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.43E-6	Body mass index	
KIRC	cis	1	rs7223613	chr17:79574803	ARL16	chr17:79648234-79650954:-	0.18	4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs7223613	chr17:79574803	NPLOC4	chr17:79523915-79604138:-	0.12	3.71	0.000234	Eye color traits	
KIRC	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.63	-14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs7223672	chr17:61720565	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.41E-10	Body mass index	
KIRC	cis	1	rs7223672	chr17:61720565	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.54	7.19E-6	Body mass index	
KIRC	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.46	2.53E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs7223966	chr17:61893398	FTSJ3	chr17:61896795-61905031:-	0.32	6.23	9.81E-10	Body mass index	
KIRC	cis	1	rs7223966	chr17:61893398	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.61	5.06E-6	Body mass index	
KIRC	cis	1	rs7224610	chr17:53364788	HLF	chr17:53342321-53402426:+	0.23	5.38	1.12E-7	Urate levels	
KIRC	cis	1	rs7224737	chr17:40289364	DHX58	chr17:40253422-40264751:-	0.36	7.24	1.65E-12	Fibrinogen levels	
KIRC	cis	1	rs7225608	chr17:40298326	DHX58	chr17:40253422-40264751:-	-0.36	-7	8.25E-12	Fibrinogen levels	
KIRC	cis	1	rs722677	chr5:42748289	CCDC152	chr5:42756920-42802539:+	0.21	4.65	4.23E-6	Height	
KIRC	cis	1	rs722997	chr22:26849666	HPS4	chr22:26847447-26879820:-	0.26	3.56	0.000407	Ischemic stroke	
KIRC	cis	1	rs7238284	chr18:48373876	MRO	chr18:48321491-48351754:-	0.31	5.56	4.49E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs7244202	chr18:67527701	CD226	chr18:67530195-67624232:-	-0.2	-6.01	3.62E-9	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs7246967	chr19:23056346	ZNF492	chr19:22817126-22850472:+	-0.39	-5.75	1.59E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs7247420	chr19:33096786	ANKRD27	chr19:33087907-33166102:-	0.32	4.81	2.02E-6	Eosinophilic esophagitis	
KIRC	cis	1	rs7247420	chr19:33096786	RGS9BP	chr19:33166313-33169206:+	0.29	3.82	0.00015	Eosinophilic esophagitis	
KIRC	cis	1	rs7248273	chr19:33096816	ANKRD27	chr19:33087907-33166102:-	0.35	4.99	8.28E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs7248680	chr19:12165770	ZNF763	chr19:12035900-12091196:+	0.33	4.8	2.09E-6	Multiple sclerosis	
KIRC	cis	1	rs7248845	chr19:33096718	ANKRD27	chr19:33087907-33166102:-	0.33	5	7.83E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs7248845	chr19:33096718	RGS9BP	chr19:33166313-33169206:+	0.29	3.71	0.000232	Eosinophilic esophagitis	
KIRC	cis	1	rs7251653	chr19:18608283	SSBP4	chr19:18530221-18545371:+	-0.14	-4.71	3.14E-6	Breast cancer	
KIRC	cis	1	rs7251903	chr19:39184811	CAPN12	chr19:39220832-39235114:-	-0.13	-3.94	9.43E-5	Heart rate	
KIRC	cis	1	rs7252589	chr19:39170908	CAPN12	chr19:39220832-39235114:-	-0.13	-3.93	9.67E-5	Heart rate	
KIRC	cis	1	rs7252707	chr19:18612257	SSBP4	chr19:18530221-18545371:+	-0.14	-4.68	3.72E-6	Breast cancer	
KIRC	cis	1	rs7252848	chr19:18612351	SSBP4	chr19:18530221-18545371:+	-0.13	-4.51	7.96E-6	Breast cancer	
KIRC	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.29	8.47	2.75E-16	Longevity	
KIRC	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.29	8.62	9.04E-17	Longevity	
KIRC	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.24	5.76	1.43E-8	Bone properties (heel)	
KIRC	cis	1	rs7255066	chr19:45146103	PVR	chr19:45147098-45169426:+	0.38	7.51	2.71E-13	Multiple sclerosis	
KIRC	cis	1	rs7255420	chr19:12157839	ZNF763	chr19:12035900-12091196:+	-0.36	-4.99	8.14E-7	Multiple sclerosis	
KIRC	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.65	16.05	4.45E-47	Schizophrenia	
KIRC	cis	1	rs7256759	chr19:12065010	GCDH	chr19:13001974-13010782:+	-0.3	-3.53	0.000461	Multiple sclerosis	
KIRC	cis	1	rs7256759	chr19:12065010	ZNF763	chr19:12035900-12091196:+	-0.46	-5.84	9.37E-9	Multiple sclerosis	
KIRC	cis	1	rs7257127	chr19:23056699	ZNF492	chr19:22817126-22850472:+	-0.37	-5.45	8.07E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs7258465	chr19:18533642	SSBP4	chr19:18530221-18545371:+	-0.13	-4.5	8.55E-6	Breast cancer	
KIRC	cis	1	rs725908	chr20:33968067	CPNE1	chr20:34213968-34262539:-	0.26	5.22	2.58E-7	Height	
KIRC	cis	1	rs725908	chr20:33968067	FER1L4	chr20:34146508-34195484:-	0.11	3.71	0.000232	Height	
KIRC	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.28	7.48	3.34E-13	Height	
KIRC	cis	1	rs7259376	chr19:22507705	ZNF98	chr19:22573899-22605148:-	-0.31	-6.25	8.74E-10	Telomere length	
KIRC	cis	1	rs7260482	chr19:45143942	PVR	chr19:45147098-45169426:+	0.37	7.32	1.02E-12	Multiple sclerosis	
KIRC	cis	1	rs7260624	chr19:33096562	ANKRD27	chr19:33087907-33166102:-	0.33	5	7.83E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs7260624	chr19:33096562	RGS9BP	chr19:33166313-33169206:+	0.29	3.71	0.000232	Eosinophilic esophagitis	
KIRC	cis	1	rs7261312	chr20:33684909	PROCR	chr20:33758727-33765164:+	-0.27	-3.94	9.46E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs72626249	chr19:52364875	ZNF577	chr19:52359056-52394145:-	-0.3	-5.29	1.85E-7	Breast cancer	
KIRC	cis	1	rs72626249	chr19:52364875	ZNF649	chr19:52392489-52408247:-	-0.24	-4.73	2.87E-6	Breast cancer	
KIRC	cis	1	rs72627113	chr14:74340141	LIN52	chr14:74551656-74667117:+	0.29	4.05	5.91E-5	Morning vs. evening chronotype	
KIRC	cis	1	rs72627113	chr14:74340141	ZNF410	chr14:74318674-74398803:+	0.29	3.51	0.00049	Morning vs. evening chronotype	
KIRC	cis	1	rs72627117	chr14:74355233	LIN52	chr14:74551656-74667117:+	0.26	4.59	5.57E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627117	chr14:74355233	PTGR2	chr14:74318534-74352166:+	0.26	3.82	0.000152	Morning vs. evening chronotype	
KIRC	cis	1	rs72627117	chr14:74355233	ZNF410	chr14:74318674-74398803:+	0.23	3.57	0.000391	Morning vs. evening chronotype	
KIRC	cis	1	rs72627119	chr14:74356274	LIN52	chr14:74551656-74667117:+	0.26	4.57	6.05E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627119	chr14:74356274	PTGR2	chr14:74318534-74352166:+	0.25	3.82	0.00015	Morning vs. evening chronotype	
KIRC	cis	1	rs72627119	chr14:74356274	ZNF410	chr14:74318674-74398803:+	0.24	3.73	0.000216	Morning vs. evening chronotype	
KIRC	cis	1	rs72627120	chr14:74363480	LIN52	chr14:74551656-74667117:+	0.26	4.57	6.16E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627120	chr14:74363480	PTGR2	chr14:74318534-74352166:+	0.26	3.82	0.000149	Morning vs. evening chronotype	
KIRC	cis	1	rs72627122	chr14:74368236	LIN52	chr14:74551656-74667117:+	0.27	4.67	3.92E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627122	chr14:74368236	PTGR2	chr14:74318534-74352166:+	0.26	3.84	0.00014	Morning vs. evening chronotype	
KIRC	cis	1	rs72627123	chr14:74368331	LIN52	chr14:74551656-74667117:+	0.27	4.67	3.92E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627123	chr14:74368331	PTGR2	chr14:74318534-74352166:+	0.26	3.84	0.00014	Morning vs. evening chronotype	
KIRC	cis	1	rs72627124	chr14:74369128	LIN52	chr14:74551656-74667117:+	0.27	4.67	3.92E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627124	chr14:74369128	PTGR2	chr14:74318534-74352166:+	0.26	3.84	0.00014	Morning vs. evening chronotype	
KIRC	cis	1	rs72627125	chr14:74369623	LIN52	chr14:74551656-74667117:+	0.27	4.67	3.92E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627125	chr14:74369623	PTGR2	chr14:74318534-74352166:+	0.26	3.84	0.00014	Morning vs. evening chronotype	
KIRC	cis	1	rs72627126	chr14:74370024	LIN52	chr14:74551656-74667117:+	0.26	4.5	8.52E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627126	chr14:74370024	PTGR2	chr14:74318534-74352166:+	0.26	3.78	0.000174	Morning vs. evening chronotype	
KIRC	cis	1	rs72627127	chr14:74370098	LIN52	chr14:74551656-74667117:+	0.27	4.67	3.92E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627127	chr14:74370098	PTGR2	chr14:74318534-74352166:+	0.26	3.84	0.00014	Morning vs. evening chronotype	
KIRC	cis	1	rs72627129	chr14:74374805	LIN52	chr14:74551656-74667117:+	0.27	4.66	4.14E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627129	chr14:74374805	PTGR2	chr14:74318534-74352166:+	0.26	3.82	0.00015	Morning vs. evening chronotype	
KIRC	cis	1	rs72627130	chr14:74374897	LIN52	chr14:74551656-74667117:+	0.27	4.66	4.14E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs72627130	chr14:74374897	PTGR2	chr14:74318534-74352166:+	0.26	3.82	0.00015	Morning vs. evening chronotype	
KIRC	cis	1	rs72627138	chr14:74401900	LIN52	chr14:74551656-74667117:+	0.27	4.74	2.77E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs7263203	chr20:33773375	PROCR	chr20:33758727-33765164:+	-0.31	-4.1	4.79E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs72639533	chr10:37997810	LOC399744	chr10:38717074-38741080:+	0.22	3.53	0.000462	Obesity (extreme)	
KIRC	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	1.04	15.67	2.55E-45	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs72645460	chr11:116771375	PCSK7	chr11:117075789-117102811:-	0.28	5.25	2.22E-7	Protein quantitative trait loci	
KIRC	cis	1	rs7265317	chr20:33768523	PROCR	chr20:33758727-33765164:+	-0.31	-4.1	4.79E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7265697	chr20:55070664	C20orf43	chr20:55043647-55093942:+	0.2	4.76	2.51E-6	Refractive astigmatism	
KIRC	cis	1	rs72669974	chr4:106519627	INTS12	chr4:106603787-106629881:-	-0.68	-6.58	1.2E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs72669978	chr4:106520852	INTS12	chr4:106603787-106629881:-	-0.68	-6.64	7.93E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72669980	chr4:106523563	INTS12	chr4:106603787-106629881:-	-0.68	-6.66	7.23E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72669982	chr4:106524954	INTS12	chr4:106603787-106629881:-	-0.65	-6.59	1.14E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs72669993	chr4:106583144	INTS12	chr4:106603787-106629881:-	-0.7	-7.29	1.21E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72669995	chr4:106585256	INTS12	chr4:106603787-106629881:-	-0.7	-7.29	1.19E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72669997	chr4:106589782	INTS12	chr4:106603787-106629881:-	-0.69	-6.97	1.0E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671392	chr8:104182171	AZIN1	chr8:103838537-103876397:-	-0.21	-3.56	0.000409	Pelvic organ prolapse	
KIRC	cis	1	rs72671393	chr8:104182488	AZIN1	chr8:103838537-103876397:-	-0.21	-3.56	0.000409	Pelvic organ prolapse	
KIRC	cis	1	rs72671805	chr4:106603014	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671808	chr4:106605720	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671809	chr4:106611537	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671811	chr4:106615603	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671815	chr4:106618219	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671820	chr4:106620983	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671824	chr4:106623223	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671826	chr4:106624502	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671828	chr4:106624800	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671835	chr4:106631356	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.21E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671836	chr4:106633045	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671837	chr4:106635902	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671840	chr4:106638697	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671849	chr4:106643818	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671852	chr4:106646349	INTS12	chr4:106603787-106629881:-	-0.62	-6.4	3.65E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs72671853	chr4:106646886	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671854	chr4:106647023	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671856	chr4:106647366	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671858	chr4:106647679	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671866	chr4:106657658	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671869	chr4:106658658	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671870	chr4:106659345	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671871	chr4:106660324	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671873	chr4:106661194	INTS12	chr4:106603787-106629881:-	-0.66	-6.74	4.49E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671874	chr4:106661970	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671878	chr4:106662692	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671880	chr4:106664424	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671885	chr4:106668546	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671886	chr4:106670589	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671889	chr4:106676301	INTS12	chr4:106603787-106629881:-	-0.66	-6.79	3.09E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671892	chr4:106680363	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671895	chr4:106685633	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72671896	chr4:106685825	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673803	chr4:106696756	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673811	chr4:106707297	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673812	chr4:106710454	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673813	chr4:106710653	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673817	chr4:106713490	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673823	chr4:106719973	INTS12	chr4:106603787-106629881:-	-0.65	-6.75	4.11E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673824	chr4:106724464	INTS12	chr4:106603787-106629881:-	-0.63	-6.65	7.75E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673828	chr4:106730342	INTS12	chr4:106603787-106629881:-	-0.63	-6.52	1.74E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs72673831	chr4:106733380	INTS12	chr4:106603787-106629881:-	-0.64	-6.74	4.31E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673832	chr4:106738760	INTS12	chr4:106603787-106629881:-	-0.65	-6.72	4.95E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673834	chr4:106739374	INTS12	chr4:106603787-106629881:-	-0.65	-6.72	4.95E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs72673853	chr4:106756877	INTS12	chr4:106603787-106629881:-	-0.68	-7.32	1.01E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72673858	chr4:106758056	INTS12	chr4:106603787-106629881:-	-0.71	-7.48	3.28E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs72673860	chr4:106762900	INTS12	chr4:106603787-106629881:-	-0.73	-7.52	2.53E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs72673866	chr4:106771155	INTS12	chr4:106603787-106629881:-	-0.69	-7.14	3.32E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72673870	chr4:106779865	INTS12	chr4:106603787-106629881:-	-0.69	-7.12	3.78E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72673872	chr4:106779925	INTS12	chr4:106603787-106629881:-	-0.69	-7.12	3.78E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs72673873	chr4:106780301	INTS12	chr4:106603787-106629881:-	-0.66	-6.79	3.21E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7267979	chr20:25298087	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.68	6.21E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.27	-5.17	3.4E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7268053	chr20:25328286	ENTPD6	chr20:25176339-25207360:+	0.25	6.8	2.94E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7268053	chr20:25328286	FAM182A	chr20:26035250-26067552:+	0.29	5.53	5.24E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs726838	chr3:141072666	SLC25A36	chr3:140660662-140698785:+	-0.18	-3.86	0.000129	Prion diseases	
KIRC	cis	1	rs72686191	chr1:76218319	ACADM	chr1:76190043-76229353:+	0.19	5.21	2.7E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs726967	chr4:56421713	SRD5A3	chr4:56212409-56237866:+	-0.21	-4.48	9.38E-6	Personality dimensions	
KIRC	cis	1	rs726967	chr4:56421713	TMEM165	chr4:56262090-56292342:+	0.21	5.69	2.16E-8	Personality dimensions	
KIRC	cis	1	rs72696952	chr1:152172694	FLG	chr1:152274651-152297679:-	0.24	3.73	0.000214	Atopic dermatitis	
KIRC	cis	1	rs72696963	chr1:152181189	FLG	chr1:152274651-152297679:-	0.24	3.73	0.000217	Atopic dermatitis	
KIRC	cis	1	rs72696969	chr1:152196339	FLG	chr1:152274651-152297679:-	0.23	3.57	0.000387	Atopic dermatitis	
KIRC	cis	1	rs72698906	chr1:152307184	HRNR	chr1:152184558-152196669:-	-0.25	-3.87	0.000121	Atopic dermatitis	
KIRC	cis	1	rs727005	chr1:36281336	C1orf216	chr1:36179477-36184790:-	-0.35	-5.46	7.34E-8	Schizophrenia	
KIRC	cis	1	rs7270326	chr20:33693582	PROCR	chr20:33758727-33765164:+	-0.25	-3.65	0.000291	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7270354	chr20:44607661	PLTP	chr20:44527397-44540786:-	0.2	4.88	1.44E-6	Abdominal aortic aneurysm	
KIRC	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.47	-7.98	1.02E-14	Abdominal aortic aneurysm	
KIRC	cis	1	rs727088	chr18:67530439	CD226	chr18:67530195-67624232:-	0.21	6.27	7.68E-10	Type 1 diabetes;Type 1 diabetes autoantibodies	
KIRC	cis	1	rs72718804	chr14:55630610	KIAA0831	chr14:55833110-55878576:-	-0.14	-3.57	0.000385	Protein biomarker	
KIRC	cis	1	rs7272164	chr20:47766197	CSE1L	chr20:47662838-47713484:+	0.18	4.72	3.08E-6	Anger	
KIRC	cis	1	rs72734373	chr15:56262183	NEDD4	chr15:56119131-56285835:-	0.22	4.95	9.93E-7	Keloid	
KIRC	cis	1	rs72736464	chr15:56372722	TEX9	chr15:56657644-56738071:+	-0.26	-4.43	1.16E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72736479	chr15:56398952	TEX9	chr15:56657644-56738071:+	-0.27	-4.56	6.49E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72736495	chr15:56410911	TEX9	chr15:56657644-56738071:+	-0.27	-4.59	5.66E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72736498	chr15:56420710	TEX9	chr15:56657644-56738071:+	-0.26	-4.43	1.13E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738604	chr15:56425189	TEX9	chr15:56657644-56738071:+	-0.28	-4.86	1.56E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738605	chr15:56425335	TEX9	chr15:56657644-56738071:+	-0.28	-4.86	1.56E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738607	chr15:56425615	TEX9	chr15:56657644-56738071:+	-0.28	-4.86	1.56E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738608	chr15:56425746	TEX9	chr15:56657644-56738071:+	-0.28	-4.86	1.56E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738615	chr15:56449456	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.4E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738616	chr15:56451242	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.4E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738618	chr15:56451415	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.4E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738631	chr15:56466615	TEX9	chr15:56657644-56738071:+	-0.28	-4.95	1.02E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738636	chr15:56473321	TEX9	chr15:56657644-56738071:+	-0.28	-4.93	1.12E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738638	chr15:56474085	TEX9	chr15:56657644-56738071:+	-0.28	-4.93	1.12E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738646	chr15:56490848	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738648	chr15:56491847	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738654	chr15:56496290	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738656	chr15:56496952	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738662	chr15:56500064	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738664	chr15:56500907	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738666	chr15:56501019	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738667	chr15:56501027	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738668	chr15:56501415	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738674	chr15:56507438	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738675	chr15:56507582	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738676	chr15:56507635	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738679	chr15:56509260	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738680	chr15:56509389	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738682	chr15:56510796	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738683	chr15:56510989	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738684	chr15:56511122	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738694	chr15:56518254	TEX9	chr15:56657644-56738071:+	-0.28	-5.06	5.95E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738696	chr15:56520352	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72738701	chr15:56531056	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72740503	chr15:56532219	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72740506	chr15:56533177	TEX9	chr15:56657644-56738071:+	-0.28	-4.96	9.53E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72740509	chr15:56533519	TEX9	chr15:56657644-56738071:+	-0.28	-4.94	1.07E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs72752168	chr1:232922800	KIAA1383	chr1:232940638-232946092:+	-0.47	-4.35	1.63E-5	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	
KIRC	cis	1	rs727563	chr22:41867377	XPNPEP3	chr22:41253094-41363888:+	-0.19	-3.54	0.000445	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs72758876	chr5:64434562	PPWD1	chr5:64859131-64883368:+	-0.26	-4.23	2.79E-5	Schizophrenia	
KIRC	cis	1	rs72758879	chr5:64437191	PPWD1	chr5:64859131-64883368:+	-0.26	-4.17	3.53E-5	Schizophrenia	
KIRC	cis	1	rs72758880	chr5:64440519	PPWD1	chr5:64859131-64883368:+	-0.26	-4.2	3.18E-5	Schizophrenia	
KIRC	cis	1	rs72758884	chr5:64452214	PPWD1	chr5:64859131-64883368:+	-0.24	-3.8	0.000161	Schizophrenia	
KIRC	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.27	-6.32	5.82E-10	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs7277610	chr21:35883030	KCNE1	chr21:35818989-35884573:-	0.31	4.44	1.12E-5	Electrocardiographic traits	
KIRC	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.47	10.12	4.9E-22	Body mass index	
KIRC	cis	1	rs727859	chr15:100584162	ADAMTS17	chr15:100511643-100882183:-	0.26	4.57	6.18E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs727957	chr21:35880072	KCNE1	chr21:35818989-35884573:-	0.34	4.82	1.94E-6	Electrocardiographic traits	
KIRC	cis	1	rs72796149	chr16:50114885	HEATR3	chr16:50099881-50139373:+	-0.3	-3.71	0.00023	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs72796151	chr16:50117077	HEATR3	chr16:50099881-50139373:+	-0.29	-3.55	0.000419	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs72799458	chr5:132188063	LEAP2	chr5:132209358-132210581:+	0.36	5.62	3.22E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs72799458	chr5:132188063	SHROOM1	chr5:132158012-132166590:-	0.31	5.79	1.22E-8	Apolipoprotein A-IV levels	
KIRC	cis	1	rs728055	chr7:137072531	PTN	chr7:136912092-137028546:-	-0.21	-3.72	0.00022	Schizophrenia	
KIRC	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.78	-16.96	2.37E-51	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs72823064	chr17:40569974	NAGLU	chr17:40687951-40696464:+	-0.18	-3.87	0.000124	Crohn's disease	
KIRC	cis	1	rs72823619	chr2:102924615	IL1RL1	chr2:102927962-102968497:+	0.39	6.55	1.44E-10	Asthma	
KIRC	cis	1	rs72823621	chr2:102925435	IL1RL1	chr2:102927962-102968497:+	0.39	6.55	1.47E-10	Asthma	
KIRC	cis	1	rs72823632	chr2:102931534	IL1RL1	chr2:102927962-102968497:+	0.38	6.54	1.54E-10	Asthma	
KIRC	cis	1	rs72823635	chr2:102931612	IL1RL1	chr2:102927962-102968497:+	0.38	6.53	1.57E-10	Asthma	
KIRC	cis	1	rs72823646	chr2:102954213	IL1RL1	chr2:102927962-102968497:+	0.44	7.54	2.28E-13	Asthma	
KIRC	cis	1	rs72825704	chr2:99239164	UNC50	chr2:99225042-99234975:+	-0.26	-4.45	1.04E-5	Bipolar disorder	
KIRC	cis	1	rs72825710	chr2:99239497	UNC50	chr2:99225042-99234975:+	-0.26	-4.47	9.61E-6	Bipolar disorder	
KIRC	cis	1	rs72825718	chr2:99247152	UNC50	chr2:99225042-99234975:+	-0.24	-4.06	5.6E-5	Bipolar disorder	
KIRC	cis	1	rs72825719	chr2:99247465	UNC50	chr2:99225042-99234975:+	-0.24	-4.01	7.04E-5	Bipolar disorder	
KIRC	cis	1	rs72825720	chr2:99247508	UNC50	chr2:99225042-99234975:+	-0.24	-4	7.3E-5	Bipolar disorder	
KIRC	cis	1	rs72825725	chr2:99251259	UNC50	chr2:99225042-99234975:+	-0.26	-4.3	2.03E-5	Bipolar disorder	
KIRC	cis	1	rs72825727	chr2:99252750	UNC50	chr2:99225042-99234975:+	-0.26	-4.47	9.87E-6	Bipolar disorder	
KIRC	cis	1	rs72825732	chr2:99259778	UNC50	chr2:99225042-99234975:+	-0.26	-4.41	1.25E-5	Bipolar disorder	
KIRC	cis	1	rs72837860	chr2:112007572	BCL2L11	chr2:111878491-111926022:+	0.25	3.52	0.000476	Atopic dermatitis	
KIRC	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.91	-9.93	2.41E-21	Schizophrenia	
KIRC	cis	1	rs72845397	chr11:6950903	ZNF215	chr11:6947654-7005861:+	-0.28	-4.13	4.17E-5	Response to cytadine analogues (cytosine arabinoside)	
KIRC	cis	1	rs72848797	chr17:61934664	FTSJ3	chr17:61896795-61905031:-	0.33	6.45	2.7E-10	Body mass index	
KIRC	cis	1	rs72848797	chr17:61934664	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.52	7.79E-6	Body mass index	
KIRC	cis	1	rs72855860	chr4:75714054	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs728615	chr10:81848089	MBL1P	chr10:81664654-81710783:+	0.27	3.8	0.000162	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs728616	chr10:81847914	MBL1P	chr10:81664654-81710783:+	0.26	3.71	0.000235	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs72867588	chr4:75706640	BTC	chr4:75671448-75719882:-	0.29	3.98	8.02E-5	Electroencephalogram traits	
KIRC	cis	1	rs72867590	chr4:75706651	BTC	chr4:75671448-75719882:-	0.29	3.98	8.02E-5	Electroencephalogram traits	
KIRC	cis	1	rs72867592	chr4:75706767	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs72867594	chr4:75706808	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs72872744	chr2:48704719	LHCGR	chr2:48913921-48982880:-	0.24	3.52	0.000463	Schizophrenia	
KIRC	cis	1	rs72890511	chr4:108888543	HADH	chr4:108910940-108956330:+	0.26	3.54	0.000434	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs7289577	chr22:39042214	LOC646851	chr22:38974125-39052634:-	0.15	4.45	1.05E-5	Resting heart rate	
KIRC	cis	1	rs7289855	chr22:39042221	LOC646851	chr22:38974125-39052634:-	0.16	4.96	9.54E-7	Resting heart rate	
KIRC	cis	1	rs7290298	chr22:40453964	XPNPEP3	chr22:41253094-41363888:+	0.2	3.83	0.000142	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs7290684	chr22:29857664	RFPL1S	chr22:29833006-29838118:-	-0.3	-5.74	1.67E-8	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs7290710	chr22:50677454	CRELD2	chr22:50312283-50321186:+	0.15	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs7290710	chr22:50677454	SELO	chr22:50639408-50656044:+	0.13	4.23	2.76E-5	Obesity-related traits	
KIRC	cis	1	rs7290855	chr22:29852474	RFPL1S	chr22:29833006-29838118:-	-0.26	-5	7.81E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs7291691	chr22:40454069	XPNPEP3	chr22:41253094-41363888:+	0.2	3.83	0.000142	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs7291867	chr22:38062112	LGALS1	chr22:38071613-38075807:+	-0.12	-3.82	0.000149	Fat distribution (HIV)	
KIRC	cis	1	rs72922733	chr11:65520746	SNX32	chr11:65601410-65621170:+	0.3	4.95	1.0E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs72928605	chr2:203832120	ICA1L	chr2:203637873-203736371:-	0.29	3.64	0.000299	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72929710	chr18:48372427	MRO	chr18:48321491-48351754:-	0.32	5.66	2.49E-8	Entorhinal cortical thickness	
KIRC	cis	1	rs72929734	chr18:48381990	MRO	chr18:48321491-48351754:-	0.3	5.28	1.98E-7	Entorhinal cortical thickness	
KIRC	cis	1	rs72931639	chr11:78036703	NARS2	chr11:78147017-78285909:-	-0.2	-4.29	2.1E-5	Testicular germ cell tumor	
KIRC	cis	1	rs72931642	chr11:78037862	NARS2	chr11:78147017-78285909:-	-0.19	-4.22	2.93E-5	Testicular germ cell tumor	
KIRC	cis	1	rs72931690	chr11:78073192	NARS2	chr11:78147017-78285909:-	-0.19	-4.14	4.11E-5	Testicular germ cell tumor	
KIRC	cis	1	rs72932588	chr2:203883193	ICA1L	chr2:203637873-203736371:-	0.28	3.69	0.000253	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932590	chr2:203884308	ICA1L	chr2:203637873-203736371:-	0.28	3.62	0.000326	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932737	chr2:203654540	ICA1L	chr2:203637873-203736371:-	0.27	3.49	0.000517	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932752	chr2:203667526	ICA1L	chr2:203637873-203736371:-	0.28	3.56	0.00041	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932753	chr2:203670122	ICA1L	chr2:203637873-203736371:-	0.28	3.59	0.000367	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932763	chr2:203678658	ICA1L	chr2:203637873-203736371:-	0.28	3.63	0.000315	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932765	chr2:203679183	ICA1L	chr2:203637873-203736371:-	0.28	3.57	0.000385	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932767	chr2:203679306	ICA1L	chr2:203637873-203736371:-	0.28	3.63	0.000315	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932770	chr2:203680954	ICA1L	chr2:203637873-203736371:-	0.28	3.63	0.000315	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932772	chr2:203682304	ICA1L	chr2:203637873-203736371:-	0.28	3.58	0.000378	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932774	chr2:203685728	ICA1L	chr2:203637873-203736371:-	0.29	3.77	0.000185	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932776	chr2:203688300	ICA1L	chr2:203637873-203736371:-	0.29	3.76	0.00019	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932777	chr2:203689914	ICA1L	chr2:203637873-203736371:-	0.28	3.71	0.000227	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932780	chr2:203695826	ICA1L	chr2:203637873-203736371:-	0.28	3.68	0.000255	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932781	chr2:203697278	ICA1L	chr2:203637873-203736371:-	0.29	3.72	0.000218	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932784	chr2:203698470	ICA1L	chr2:203637873-203736371:-	0.29	3.72	0.000218	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932786	chr2:203698737	ICA1L	chr2:203637873-203736371:-	0.29	3.72	0.000218	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932789	chr2:203699379	ICA1L	chr2:203637873-203736371:-	0.28	3.61	0.00034	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932791	chr2:203700870	ICA1L	chr2:203637873-203736371:-	0.27	3.53	0.000451	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72932793	chr2:203701004	ICA1L	chr2:203637873-203736371:-	0.27	3.53	0.000451	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72934514	chr2:203933339	ICA1L	chr2:203637873-203736371:-	0.28	3.52	0.00047	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72934704	chr2:203706433	ICA1L	chr2:203637873-203736371:-	0.27	3.5	0.00051	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.59	-8.16	2.64E-15	Rheumatoid arthritis	
KIRC	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.63	-7.96	1.19E-14	Rheumatoid arthritis	
KIRC	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.63	-7.95	1.28E-14	Rheumatoid arthritis	
KIRC	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.66	-8.33	7.87E-16	Rheumatoid arthritis	
KIRC	cis	1	rs729354	chr11:77962453	NARS2	chr11:78147017-78285909:-	-0.17	-3.72	0.000224	Testicular germ cell tumor	
KIRC	cis	1	rs72936838	chr2:203772984	ICA1L	chr2:203637873-203736371:-	0.27	3.54	0.00043	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72936842	chr2:203773686	ICA1L	chr2:203637873-203736371:-	0.27	3.54	0.00043	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.66	-8.33	7.87E-16	Rheumatoid arthritis	
KIRC	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.67	-8.34	7.1E-16	Rheumatoid arthritis	
KIRC	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.67	-8.34	7.27E-16	Rheumatoid arthritis	
KIRC	cis	1	rs72941252	chr6:101121457	GRIK2	chr6:101846905-102517957:+	0.65	6.42	3.2E-10	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs72949504	chr6:100969648	GRIK2	chr6:101846905-102517957:+	0.68	6.91	1.43E-11	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs72951502	chr1:19327765	RNF186	chr1:20140523-20141771:-	0.27	3.59	0.000366	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs72951729	chr2:219960543	USP37	chr2:219314974-219433084:-	-0.26	-3.94	9.36E-5	Height	
KIRC	cis	1	rs72951738	chr2:219966801	USP37	chr2:219314974-219433084:-	-0.26	-3.94	9.44E-5	Height	
KIRC	cis	1	rs72954221	chr2:99899445	LIPT1	chr2:99771418-99779611:+	0.26	4.57	6.18E-6	IgG glycosylation	
KIRC	cis	1	rs72961173	chr2:99886868	LIPT1	chr2:99771418-99779611:+	0.26	4.57	6.18E-6	IgG glycosylation	
KIRC	cis	1	rs72967917	chr2:219911022	USP37	chr2:219314974-219433084:-	-0.25	-3.75	0.000195	Height	
KIRC	cis	1	rs72967918	chr2:219911844	FAM134A	chr2:220042939-220050190:+	-0.29	-3.68	0.000261	Height	
KIRC	cis	1	rs72967918	chr2:219911844	USP37	chr2:219314974-219433084:-	-0.24	-3.72	0.000223	Height	
KIRC	cis	1	rs72967942	chr2:219917522	USP37	chr2:219314974-219433084:-	-0.24	-3.92	0.000102	Height	
KIRC	cis	1	rs72967946	chr2:219917979	USP37	chr2:219314974-219433084:-	-0.27	-4.01	7.0E-5	Height	
KIRC	cis	1	rs72967954	chr2:219922569	USP37	chr2:219314974-219433084:-	-0.24	-3.72	0.000222	Height	
KIRC	cis	1	rs72981675	chr11:102721251	MMP1	chr11:102660641-102668966:-	0.38	4.01	7.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs72981680	chr11:102721859	MMP1	chr11:102660641-102668966:-	0.37	3.92	0.0001	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs72981683	chr11:102722614	MMP1	chr11:102660641-102668966:-	0.4	4.07	5.5E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs72981698	chr11:102726540	MMP1	chr11:102660641-102668966:-	0.4	4.14	3.99E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs72983508	chr11:102727409	MMP1	chr11:102660641-102668966:-	0.4	4.14	3.99E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs72983513	chr11:102728985	MMP1	chr11:102660641-102668966:-	0.4	4.14	3.99E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73008453	chr6:163013384	PACRG	chr6:163148164-163736523:+	0.47	6.26	8.4E-10	Body mass index	
KIRC	cis	1	rs7300900	chr12:82166821	PPFIA2	chr12:81652880-82153109:-	0.43	7.57	1.85E-13	Resting heart rate	
KIRC	cis	1	rs73015649	chr3:158450298	RARRES1	chr3:158414899-158450275:-	0.21	4.92	1.17E-6	Tetralogy of Fallot	
KIRC	cis	1	rs73015651	chr3:158450922	RARRES1	chr3:158414899-158450275:-	0.22	5.09	5.0E-7	Tetralogy of Fallot	
KIRC	cis	1	rs73015652	chr3:158451383	RARRES1	chr3:158414899-158450275:-	0.2	4.83	1.84E-6	Tetralogy of Fallot	
KIRC	cis	1	rs73015654	chr3:158451654	RARRES1	chr3:158414899-158450275:-	0.21	4.92	1.17E-6	Tetralogy of Fallot	
KIRC	cis	1	rs73015655	chr3:158451882	RARRES1	chr3:158414899-158450275:-	0.21	4.83	1.8E-6	Tetralogy of Fallot	
KIRC	cis	1	rs73016459	chr6:163066323	PACRG	chr6:163148164-163736523:+	0.57	6.69	6.06E-11	Body mass index	
KIRC	cis	1	rs73034207	chr19:32875769	ZNF507	chr19:32836514-32878571:+	0.18	3.68	0.000263	Bipolar disorder	
KIRC	cis	1	rs73034216	chr19:32883416	ZNF507	chr19:32836514-32878571:+	0.17	3.51	0.000495	Bipolar disorder	
KIRC	cis	1	rs73035012	chr6:162997279	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs73035021	chr6:163000716	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs73035023	chr6:163000927	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs73035025	chr6:163000988	PACRG	chr6:163148164-163736523:+	0.46	6.11	1.95E-9	Body mass index	
KIRC	cis	1	rs73036735	chr1:179426268	C1orf125	chr1:179335107-179523868:+	0.47	5.39	1.11E-7	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs73036771	chr1:179463925	C1orf125	chr1:179335107-179523868:+	0.48	5.45	7.95E-8	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs73038541	chr1:179479775	C1orf125	chr1:179335107-179523868:+	0.33	4.1	4.89E-5	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs7303	chr14:75520065	MLH3	chr14:75480467-75518235:-	0.24	5.97	4.54E-9	Height	
KIRC	cis	1	rs7303	chr14:75520065	NEK9	chr14:75548819-75593778:-	0.14	4	7.29E-5	Height	
KIRC	cis	1	rs730543	chr20:47635715	CSE1L	chr20:47662838-47713484:+	-0.18	-4.78	2.35E-6	Anger	
KIRC	cis	1	rs7305655	chr12:51005289	LIMA1	chr12:50569565-50677353:-	0.22	4.42	1.19E-5	Fibrinogen	
KIRC	cis	1	rs73058820	chr2:198864358	RFTN2	chr2:198435528-198540584:-	0.17	4.5	8.39E-6	Ulcerative colitis	
KIRC	cis	1	rs73058821	chr2:198864597	RFTN2	chr2:198435528-198540584:-	0.17	4.5	8.39E-6	Ulcerative colitis	
KIRC	cis	1	rs73058829	chr2:198871145	RFTN2	chr2:198435528-198540584:-	0.17	4.69	3.48E-6	Ulcerative colitis	
KIRC	cis	1	rs73058832	chr2:198873214	RFTN2	chr2:198435528-198540584:-	0.17	4.52	7.55E-6	Ulcerative colitis	
KIRC	cis	1	rs73058834	chr2:198873779	RFTN2	chr2:198435528-198540584:-	0.17	4.58	5.87E-6	Ulcerative colitis	
KIRC	cis	1	rs7306395	chr12:82175867	PPFIA2	chr12:81652880-82153109:-	0.41	7.25	1.56E-12	Resting heart rate	
KIRC	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.74	10.21	2.39E-22	Diastolic blood pressure	
KIRC	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.74	11.33	1.17E-26	Diastolic blood pressure	
KIRC	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.74	11.33	1.17E-26	Diastolic blood pressure	
KIRC	cis	1	rs73070048	chr2:207641394	MDH1B	chr2:207598943-207630050:-	0.39	4.71	3.26E-6	Episodic memory	
KIRC	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.7	10.55	1.24E-23	Diastolic blood pressure	
KIRC	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs7307815	chr12:50922710	LIMA1	chr12:50569565-50677353:-	-0.21	-4.08	5.25E-5	Fibrinogen	
KIRC	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.71	9.23	7.53E-19	Diastolic blood pressure	
KIRC	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.72	10.32	9.0E-23	Diastolic blood pressure	
KIRC	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.7	9.29	4.83E-19	Diastolic blood pressure	
KIRC	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.7	9.29	4.83E-19	Diastolic blood pressure	
KIRC	cis	1	rs73081854	chr3:56628226	CCDC66	chr3:56591184-56655846:+	-0.12	-3.61	0.000331	Height	
KIRC	cis	1	rs73088137	chr3:49448423	CCDC36	chr3:49235861-49295537:+	-0.28	-5.17	3.34E-7	Menarche (age at onset)	
KIRC	cis	1	rs73088137	chr3:49448423	GMPPB	chr3:49758932-49761384:-	0.17	3.86	0.000126	Menarche (age at onset)	
KIRC	cis	1	rs73088137	chr3:49448423	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.41	1.25E-5	Menarche (age at onset)	
KIRC	cis	1	rs73088137	chr3:49448423	P4HTM	chr3:49027341-49044579:+	-0.22	-4.95	1.02E-6	Menarche (age at onset)	
KIRC	cis	1	rs73088137	chr3:49448423	TREX1	chr3:48501186-48509043:+	0.15	3.58	0.000376	Menarche (age at onset)	
KIRC	cis	1	rs73088137	chr3:49448423	WDR6	chr3:49044637-49053386:+	0.2	5.1	4.9E-7	Menarche (age at onset)	
KIRC	cis	1	rs73098690	chr1:216480662	KCTD3	chr1:215740735-215795147:+	0.31	3.49	0.000522	IgG glycosylation	
KIRC	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.19	-4.06	5.66E-5	Colorectal cancer	
KIRC	cis	1	rs731123	chr5:78317728	ARSB	chr5:78073039-78282357:-	-0.2	-4.15	3.89E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs731123	chr5:78317728	BHMT	chr5:78407604-78428112:+	-0.25	-5.21	2.79E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs731124	chr5:78317413	ARSB	chr5:78073039-78282357:-	-0.2	-4.13	4.21E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs731124	chr5:78317413	BHMT	chr5:78407604-78428112:+	-0.26	-5.39	1.06E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs731124	chr5:78317413	DMGDH	chr5:78293430-78365449:-	-0.13	-3.53	0.000462	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs731152	chr17:40279680	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs73116394	chr2:242367915	SEPT2	chr2:242254723-242293439:+	0.4	5.8	1.16E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs73116396	chr2:242368693	SEPT2	chr2:242254723-242293439:+	0.39	5.69	2.13E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs7312329	chr12:3970007	PARP11	chr12:3918027-3982608:-	-0.16	-3.79	0.000171	Cognitive performance	
KIRC	cis	1	rs7312404	chr12:124446728	CCDC92	chr12:124420955-124457163:-	0.2	5.25	2.25E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs73128528	chr20:44582187	PLTP	chr20:44527397-44540786:-	0.26	5.6	3.53E-8	Abdominal aortic aneurysm	
KIRC	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.5	-7.49	3.22E-13	Abdominal aortic aneurysm	
KIRC	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.3	5.79	1.27E-8	Diabetic kidney disease	
KIRC	cis	1	rs73142121	chr7:65311206	CRCP	chr7:65579805-65619551:+	-0.31	-4.22	2.88E-5	Diabetic kidney disease	
KIRC	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.3	5.85	8.68E-9	Diabetic kidney disease	
KIRC	cis	1	rs73142122	chr7:65311298	CRCP	chr7:65579805-65619551:+	-0.3	-4	7.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.29	5.75	1.51E-8	Diabetic kidney disease	
KIRC	cis	1	rs73142162	chr7:65374296	CRCP	chr7:65579805-65619551:+	-0.31	-4.21	3.03E-5	Diabetic kidney disease	
KIRC	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.29	5.75	1.51E-8	Diabetic kidney disease	
KIRC	cis	1	rs73142166	chr7:65375832	CRCP	chr7:65579805-65619551:+	-0.31	-4.21	3.03E-5	Diabetic kidney disease	
KIRC	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.28	5.55	4.69E-8	Diabetic kidney disease	
KIRC	cis	1	rs73150014	chr7:65450919	CRCP	chr7:65579805-65619551:+	-0.29	-3.99	7.65E-5	Diabetic kidney disease	
KIRC	cis	1	rs7315236	chr12:52251933	ANKRD33	chr12:52281793-52285504:+	-0.23	-4.33	1.83E-5	Urate levels	
KIRC	cis	1	rs7315236	chr12:52251933	FIGNL2	chr12:52211677-52216208:-	-0.2	-4.21	3.0E-5	Urate levels	
KIRC	cis	1	rs73154401	chr13:25085667	PARP4	chr13:24995075-25086948:-	-0.22	-3.52	0.00047	Sudden cardiac arrest	
KIRC	cis	1	rs731600	chr11:77963133	NARS2	chr11:78147017-78285909:-	-0.17	-3.8	0.000165	Testicular germ cell tumor	
KIRC	cis	1	rs73165515	chr7:150527724	TMEM176A	chr7:150497854-150502208:+	0.24	3.51	0.000488	HDL cholesterol	
KIRC	cis	1	rs73165541	chr7:150538980	ABP1	chr7:150526069-150558379:+	0.2	3.52	0.000466	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs73186030	chr3:122013465	WDR5B	chr3:122130700-122134882:-	0.28	4.06	5.73E-5	Serum parathyroid hormone levels	
KIRC	cis	1	rs73186044	chr3:122028476	WDR5B	chr3:122130700-122134882:-	0.28	4.25	2.5E-5	Serum parathyroid hormone levels	
KIRC	cis	1	rs73192052	chr12:104190854	NT5DC3	chr12:104164231-104234975:-	-0.24	-3.99	7.62E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs73192053	chr12:104190855	NT5DC3	chr12:104164231-104234975:-	-0.24	-4.19	3.34E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs73192978	chr3:127868275	KBTBD12	chr3:127634318-127706513:+	0.3	4.06	5.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73192978	chr3:127868275	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73192978	chr3:127868275	RUVBL1	chr3:127783627-127872757:-	0.34	4.87	1.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73192979	chr3:127868321	KBTBD12	chr3:127634318-127706513:+	0.3	4.06	5.6E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73192979	chr3:127868321	RPN1	chr3:128338813-128399918:-	0.23	3.84	0.000136	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73192979	chr3:127868321	RUVBL1	chr3:127783627-127872757:-	0.34	4.87	1.47E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73193868	chr21:30600224	CCT8	chr21:30428650-30446010:-	0.39	4.73	2.86E-6	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs73193868	chr21:30600224	RWDD2B	chr21:30378082-30391685:-	0.33	3.66	0.000283	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs7319447	chr13:42551508	KIAA0564	chr13:42140962-42535221:-	-0.19	-3.82	0.000152	Calcium levels	
KIRC	cis	1	rs73197383	chr3:128030474	KBTBD12	chr3:127634318-127706513:+	0.28	3.73	0.000216	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73197383	chr3:128030474	RUVBL1	chr3:127783627-127872757:-	0.33	4.57	6.03E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73197388	chr3:128043920	KBTBD12	chr3:127634318-127706513:+	0.27	3.67	0.00027	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73197388	chr3:128043920	RUVBL1	chr3:127783627-127872757:-	0.31	4.31	1.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73201462	chr3:128059293	KBTBD12	chr3:127634318-127706513:+	0.28	3.73	0.00021	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73201462	chr3:128059293	RUVBL1	chr3:127783627-127872757:-	0.31	4.37	1.48E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7320606	chr13:21052521	IL17D	chr13:21277482-21297236:+	0.2	3.55	0.000419	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRC	cis	1	rs73208601	chr8:17159489	FGF20	chr8:16850334-16859674:-	0.32	3.95	8.92E-5	Calcium levels	
KIRC	cis	1	rs7321269	chr13:100126271	UBAC2	chr13:99852679-100038751:+	-0.24	-3.58	0.000378	Obesity-related traits	
KIRC	cis	1	rs7321381	chr13:100126156	UBAC2	chr13:99852679-100038751:+	-0.24	-3.59	0.000368	Obesity-related traits	
KIRC	cis	1	rs7323058	chr13:42548503	KIAA0564	chr13:42140962-42535221:-	0.19	3.88	0.000119	Calcium levels	
KIRC	cis	1	rs7324557	chr13:24296862	PCOTH	chr13:24463028-24466241:+	0.25	4.79	2.17E-6	Visceral adipose tissue adjusted for BMI	
KIRC	cis	1	rs732528	chr18:48378234	MRO	chr18:48321491-48351754:-	0.31	5.32	1.6E-7	Entorhinal cortical thickness	
KIRC	cis	1	rs73268512	chr14:66088905	LOC645431	chr14:65877313-65879335:-	-0.48	-6.45	2.7E-10	Ischemic stroke	
KIRC	cis	1	rs73268521	chr14:66093243	LOC645431	chr14:65877313-65879335:-	-0.48	-6.39	3.82E-10	Ischemic stroke	
KIRC	cis	1	rs7327068	chr13:100126965	UBAC2	chr13:99852679-100038751:+	-0.24	-3.59	0.000368	Obesity-related traits	
KIRC	cis	1	rs73275307	chr8:89458895	MMP16	chr8:89049462-89339717:-	0.3	3.96	8.53E-5	Electrodermal activity	
KIRC	cis	1	rs73275324	chr8:89461761	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.41E-5	Electrodermal activity	
KIRC	cis	1	rs73275325	chr8:89461776	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.41E-5	Electrodermal activity	
KIRC	cis	1	rs73275337	chr8:89463754	MMP16	chr8:89049462-89339717:-	0.31	4.02	6.68E-5	Electrodermal activity	
KIRC	cis	1	rs73275354	chr8:89465442	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.48E-5	Electrodermal activity	
KIRC	cis	1	rs73275371	chr8:89467552	MMP16	chr8:89049462-89339717:-	0.3	3.86	0.000127	Electrodermal activity	
KIRC	cis	1	rs73276406	chr8:96021760	C8orf38	chr8:95908040-96088396:+	-0.26	-4.02	6.74E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs73276417	chr8:96026312	C8orf38	chr8:95908040-96088396:+	-0.24	-3.68	0.00026	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.23	-3.63	0.000315	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs73279219	chr8:89403161	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs73279224	chr8:89404266	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs73279229	chr8:89404575	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs73279231	chr8:89404664	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs73282209	chr5:150174959	IRGM	chr5:150226085-150280295:+	0.66	7.99	9.33E-15	Crohn's disease	
KIRC	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.44	5.33	1.52E-7	Crohn's disease	
KIRC	cis	1	rs73282213	chr14:65852139	LOC645431	chr14:65877313-65879335:-	-0.45	-6.04	3.04E-9	Ischemic stroke	
KIRC	cis	1	rs73282223	chr14:65854555	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs73282230	chr14:65856015	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs73282232	chr14:65856077	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs73282234	chr5:150195924	IRGM	chr5:150226085-150280295:+	0.64	7.85	2.56E-14	Crohn's disease	
KIRC	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.44	5.3	1.71E-7	Crohn's disease	
KIRC	cis	1	rs73282255	chr5:150223647	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs73282260	chr14:65858964	LOC645431	chr14:65877313-65879335:-	-0.46	-5.99	4.0E-9	Ischemic stroke	
KIRC	cis	1	rs7328352	chr13:42548979	KIAA0564	chr13:42140962-42535221:-	0.19	3.9	0.00011	Calcium levels	
KIRC	cis	1	rs73284121	chr14:65936936	LOC645431	chr14:65877313-65879335:-	-0.49	-6.54	1.5E-10	Ischemic stroke	
KIRC	cis	1	rs73284126	chr5:150261307	IRGM	chr5:150226085-150280295:+	0.51	6.87	1.89E-11	Crohn's disease	
KIRC	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.31	4.21	3.05E-5	Crohn's disease	
KIRC	cis	1	rs73284133	chr14:65946612	LOC645431	chr14:65877313-65879335:-	-0.51	-6.71	5.22E-11	Ischemic stroke	
KIRC	cis	1	rs73284141	chr5:150266086	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs732856	chr22:38060691	LGALS1	chr22:38071613-38075807:+	0.12	3.86	0.000126	Fat distribution (HIV)	
KIRC	cis	1	rs73286118	chr14:66034821	LOC645431	chr14:65877313-65879335:-	-0.54	-6.58	1.18E-10	Ischemic stroke	
KIRC	cis	1	rs73286169	chr14:66078448	LOC645431	chr14:65877313-65879335:-	-0.48	-6.37	4.36E-10	Ischemic stroke	
KIRC	cis	1	rs73286173	chr14:66079540	LOC645431	chr14:65877313-65879335:-	-0.48	-6.45	2.7E-10	Ischemic stroke	
KIRC	cis	1	rs73287339	chr8:89418809	MMP16	chr8:89049462-89339717:-	0.31	4.24	2.66E-5	Electrodermal activity	
KIRC	cis	1	rs73287345	chr8:89421184	MMP16	chr8:89049462-89339717:-	0.32	4.27	2.32E-5	Electrodermal activity	
KIRC	cis	1	rs73287349	chr8:89421980	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73287352	chr8:89422227	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.49E-5	Electrodermal activity	
KIRC	cis	1	rs73287358	chr8:89423653	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73287359	chr8:89423785	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73289232	chr8:89428731	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73289254	chr8:89436902	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs73289257	chr8:89437106	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs73289264	chr8:89437684	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs73289267	chr8:89438027	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs73291151	chr8:89442174	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73291154	chr8:89442943	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73291157	chr8:89443271	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73291159	chr8:89443807	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73291160	chr8:89443985	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73291164	chr8:89445005	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291166	chr8:89445225	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291175	chr8:89446930	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291177	chr8:89447266	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291179	chr8:89447372	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291181	chr8:89448076	MMP16	chr8:89049462-89339717:-	0.28	3.65	0.000285	Electrodermal activity	
KIRC	cis	1	rs73291191	chr8:89450629	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73291192	chr8:89450832	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73292857	chr8:89452516	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73292867	chr8:89454305	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73307913	chr20:44548301	PLTP	chr20:44527397-44540786:-	-0.18	-4.21	2.98E-5	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs73318135	chr20:23618571	CST3	chr20:23608536-23618574:-	-0.13	-3.56	0.000413	Chronic kidney disease	
KIRC	cis	1	rs7332115	chr13:33147548	N4BP2L2	chr13:33006930-33112936:-	0.14	4.02	6.75E-5	Body mass index	
KIRC	cis	1	rs7332763	chr13:33147888	N4BP2L2	chr13:33006930-33112936:-	0.14	4.04	6.26E-5	Body mass index	
KIRC	cis	1	rs733318	chr2:190724141	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.61	5.11E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs73337598	chr17:61732576	FTSJ3	chr17:61896795-61905031:-	0.33	6.54	1.51E-10	Body mass index	
KIRC	cis	1	rs73337598	chr17:61732576	TCAM1P	chr17:61934376-61941738:+	-0.23	-4.17	3.56E-5	Body mass index	
KIRC	cis	1	rs73342417	chr21:30586627	CCT8	chr21:30428650-30446010:-	0.33	4.68	3.76E-6	Response to mTOR inhibitor (everolimus)	
KIRC	cis	1	rs73343333	chr5:125913560	LMNB1	chr5:126112833-126172709:+	0.18	3.87	0.000123	Osteoporosis	
KIRC	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.79	10.59	8.84E-24	Multiple system atrophy	
KIRC	cis	1	rs7338335	chr13:100125296	UBAC2	chr13:99852679-100038751:+	-0.24	-3.59	0.000368	Obesity-related traits	
KIRC	cis	1	rs7338549	chr13:99142745	STK24	chr13:99102455-99229396:-	-0.28	-5.68	2.28E-8	Longevity	
KIRC	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.36	4.41	1.27E-5	Blood metabolite levels	
KIRC	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.36	4.49	8.97E-6	Blood metabolite levels	
KIRC	cis	1	rs73405097	chr22:29855836	RFPL1S	chr22:29833006-29838118:-	-0.3	-5.72	1.81E-8	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs73412140	chr6:33757014	LEMD2	chr6:33738991-33756906:-	0.23	5.13	4.14E-7	Body mass index	
KIRC	cis	1	rs7342654	chr15:31537999	MTMR15	chr15:31196055-31235307:+	0.17	3.54	0.000441	Eosinophilic esophagitis	
KIRC	cis	1	rs7343481	chr20:25300113	ENTPD6	chr20:25176339-25207360:+	0.24	6.41	3.39E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7343481	chr20:25300113	FAM182A	chr20:26035250-26067552:+	0.28	5.25	2.29E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs73449983	chr11:46612332	MDK	chr11:46402334-46405374:+	-0.22	-3.7	0.000235	Schizophrenia	
KIRC	cis	1	rs734801	chr20:23612791	CST3	chr20:23608536-23618574:-	-0.14	-3.9	0.000111	Chronic kidney disease	
KIRC	cis	1	rs73484234	chr11:22822211	SVIP	chr11:22843600-22851382:-	0.28	4.33	1.79E-5	Dialysis-related mortality	
KIRC	cis	1	rs73509052	chr19:12071802	GCDH	chr19:13001974-13010782:+	-0.36	-4.04	6.3E-5	Multiple sclerosis	
KIRC	cis	1	rs73509052	chr19:12071802	ZNF763	chr19:12035900-12091196:+	-0.56	-6.88	1.8E-11	Multiple sclerosis	
KIRC	cis	1	rs73509996	chr19:17393449	ANKLE1	chr19:17392454-17398454:+	0.2	4.25	2.58E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs73510924	chr19:12090150	GCDH	chr19:13001974-13010782:+	-0.34	-3.76	0.000193	Multiple sclerosis	
KIRC	cis	1	rs73510924	chr19:12090150	ZNF763	chr19:12035900-12091196:+	-0.53	-6.4	3.53E-10	Multiple sclerosis	
KIRC	cis	1	rs73510930	chr19:12091762	ZNF763	chr19:12035900-12091196:+	-0.56	-6.72	5.06E-11	Multiple sclerosis	
KIRC	cis	1	rs73539529	chr11:71815596	C11orf59	chr11:71808339-71814322:-	0.22	3.98	7.82E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs73539532	chr11:71815684	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs735403	chr4:103553543	MANBA	chr4:103552644-103682151:-	-0.17	-3.8	0.000159	Primary biliary cirrhosis	
KIRC	cis	1	rs735404	chr4:103553665	MANBA	chr4:103552644-103682151:-	0.16	3.57	0.000391	Primary biliary cirrhosis	
KIRC	cis	1	rs735405	chr4:103553916	MANBA	chr4:103552644-103682151:-	0.16	3.64	0.0003	Primary biliary cirrhosis	
KIRC	cis	1	rs73543609	chr11:71816619	C11orf59	chr11:71808339-71814322:-	0.22	3.96	8.65E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs73543633	chr11:71828844	C11orf59	chr11:71808339-71814322:-	0.21	3.59	0.00037	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs73552479	chr19:21778816	ZNF429	chr19:21688437-21739068:+	0.21	3.98	7.75E-5	Colorectal or endometrial cancer	
KIRC	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.26	5.33	1.46E-7	Height	
KIRC	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.28	7.62	1.23E-13	Height	
KIRC	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.61	14.61	1.5E-40	Height	
KIRC	cis	1	rs7356093	chr3:134238753	CEP63	chr3:134204575-134293852:+	0.33	6.46	2.53E-10	Height	
KIRC	cis	1	rs735765	chr6:28170297	ZNF187	chr6:28234788-28245978:+	-0.23	-3.64	0.000297	Depression	
KIRC	cis	1	rs73579458	chr16:69804764	COG4	chr16:70514473-70557457:-	-0.21	-3.72	0.00022	IgE levels	
KIRC	cis	1	rs7359276	chr15:78892661	CHRNA5	chr15:78857906-78886458:+	0.23	4.36	1.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7359981	chr19:12091659	ZNF763	chr19:12035900-12091196:+	-0.54	-6.43	2.98E-10	Multiple sclerosis	
KIRC	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	0.29	6.15	1.59E-9	HDL cholesterol	
KIRC	cis	1	rs7364173	chr22:50681029	CRELD2	chr22:50312283-50321186:+	-0.15	-3.57	0.000388	Obesity-related traits	
KIRC	cis	1	rs7364173	chr22:50681029	SELO	chr22:50639408-50656044:+	-0.14	-4.38	1.42E-5	Obesity-related traits	
KIRC	cis	1	rs7364173	chr22:50681029	TRABD	chr22:50624354-50638027:+	-0.1	-3.52	0.000475	Obesity-related traits	
KIRC	cis	1	rs7364180	chr22:42218856	CHADL	chr22:41625515-41636935:-	-0.19	-3.9	0.00011	Alzheimer's disease biomarkers	
KIRC	cis	1	rs736825	chr12:54417576	FLJ12825	chr12:54452038-54516018:+	0.29	5.42	9.43E-8	Bone mineral density	
KIRC	cis	1	rs736825	chr12:54417576	HOXC8	chr12:54402890-54406543:+	-0.19	-3.54	0.000437	Bone mineral density	
KIRC	cis	1	rs73692253	chr8:89413736	MMP16	chr8:89049462-89339717:-	0.29	3.81	0.000159	Electrodermal activity	
KIRC	cis	1	rs73692561	chr8:89422086	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73692563	chr8:89422311	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73692564	chr8:89422312	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73692565	chr8:89422384	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs73692571	chr8:89436877	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs73694050	chr8:89443368	MMP16	chr8:89049462-89339717:-	0.3	3.92	0.0001	Electrodermal activity	
KIRC	cis	1	rs73694056	chr8:89447140	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73694066	chr8:89453493	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73694076	chr8:89454910	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs73694079	chr8:89456953	MMP16	chr8:89049462-89339717:-	0.3	3.91	0.000103	Electrodermal activity	
KIRC	cis	1	rs73705828	chr8:120938749	TNFRSF11B	chr8:119935797-119964383:-	0.25	3.85	0.000135	Depressive and manic episodes in bipolar disorder;Depressive episodes in bipolar disorder	
KIRC	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.6	14.4	1.3E-39	Height	
KIRC	cis	1	rs7371896	chr3:134249769	CEP63	chr3:134204575-134293852:+	0.34	6.66	7.15E-11	Height	
KIRC	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.76	-11.72	3.28E-28	Diastolic blood pressure	
KIRC	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.16	4.25	2.6E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.16	4.32	1.92E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs7373998	chr3:128008223	RPN1	chr3:128338813-128399918:-	-0.21	-3.53	0.000451	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7373998	chr3:128008223	RUVBL1	chr3:127783627-127872757:-	-0.3	-4.19	3.33E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs7374158	chr3:134270156	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs7374227	chr3:128001515	RPN1	chr3:128338813-128399918:-	0.21	3.53	0.000456	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7374227	chr3:128001515	RUVBL1	chr3:127783627-127872757:-	0.29	4.02	6.82E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.77E-40	Height	
KIRC	cis	1	rs7374325	chr3:134275601	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.92E-10	Height	
KIRC	cis	1	rs73743328	chr6:33713550	IP6K3	chr6:33689443-33714762:-	-0.44	-5.01	7.6E-7	Phosphorus levels	
KIRC	cis	1	rs73743336	chr6:33715391	IP6K3	chr6:33689443-33714762:-	-0.43	-4.83	1.78E-6	Phosphorus levels	
KIRC	cis	1	rs7374952	chr3:128001367	RUVBL1	chr3:127783627-127872757:-	0.29	4.14	4.15E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7375325	chr4:108918369	HADH	chr4:108910940-108956330:+	-0.26	-3.54	0.000432	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs737693	chr11:102726142	MMP1	chr11:102660641-102668966:-	0.4	4.14	3.99E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs73903017	chr20:33724758	PROCR	chr20:33758727-33765164:+	-0.27	-3.78	0.000175	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs73903019	chr20:33727779	PROCR	chr20:33758727-33765164:+	-0.27	-3.77	0.000186	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs739139	chr22:38067011	LGALS1	chr22:38071613-38075807:+	-0.13	-4.04	6.14E-5	Fat distribution (HIV)	
KIRC	cis	1	rs739496	chr12:111887659	C12orf47	chr12:112277573-112280706:-	0.16	3.87	0.000124	Platelet count	
KIRC	cis	1	rs7395328	chr11:242624	PSMD13	chr11:236808-252984:+	-0.15	-4.97	9.42E-7	Menarche (age at onset)	
KIRC	cis	1	rs7395632	chr11:958789	AP2A2	chr11:925841-1012239:+	0.18	3.51	0.000486	Alzheimer's disease (late onset)	
KIRC	cis	1	rs73958618	chr2:136500475	DARS	chr2:136664254-136743222:-	0.23	5.16	3.58E-7	Corneal structure	
KIRC	cis	1	rs739637	chr17:40280944	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs73979024	chr2:190536755	ASNSD1	chr2:190526125-190535556:+	-0.34	-4.58	5.81E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs73979024	chr2:190536755	ORMDL1	chr2:190634994-190649097:-	0.28	4.22	2.84E-5	Subcutaneous adipose tissue	
KIRC	cis	1	rs73985728	chr2:207668245	MDH1B	chr2:207598943-207630050:-	0.37	3.81	0.000155	Episodic memory	
KIRC	cis	1	rs74019802	chr16:58162210	C16orf80	chr16:58147497-58163296:-	-0.37	-3.53	0.000446	Telomere length	
KIRC	cis	1	rs7406003	chr17:79597597	ARL16	chr17:79648234-79650954:-	-0.18	-4.46	9.93E-6	Eye color traits	
KIRC	cis	1	rs7406003	chr17:79597597	NPLOC4	chr17:79523915-79604138:-	-0.13	-3.92	9.93E-5	Eye color traits	
KIRC	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.62	14	8.12E-38	Eye color traits	
KIRC	cis	1	rs74071851	chr14:88882202	SPATA7	chr14:88852012-88904802:+	-0.2	-4.05	5.93E-5	Coronary artery calcification	
KIRC	cis	1	rs7411035	chr1:160856076	CD244	chr1:160799951-160832645:-	-0.14	-4.47	9.79E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs74117831	chr10:1145707	IDI2	chr10:1064847-1071799:-	0.32	3.7	0.000244	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs74117848	chr10:1160974	IDI2	chr10:1064847-1071799:-	0.32	3.58	0.000378	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs74117849	chr10:1165425	IDI2	chr10:1064847-1071799:-	0.32	3.6	0.000355	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs74117850	chr10:1165777	IDI2	chr10:1064847-1071799:-	0.32	3.59	0.000367	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs74120451	chr10:1126866	IDI2	chr10:1064847-1071799:-	0.33	3.87	0.000124	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs7412746	chr1:150860471	ARNT	chr1:150782186-150849186:-	-0.18	-3.87	0.000124	Melanoma	
KIRC	cis	1	rs7419837	chr2:70146625	ANXA4	chr2:69969127-70053594:+	-0.22	-5.22	2.69E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.15	-4.91	1.22E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs742515	chr6:38347691	BTBD9	chr6:38136228-38607924:-	-0.15	-3.59	0.000364	Restless legs syndrome	
KIRC	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.67	-8.52	1.92E-16	Plasma clusterin levels	
KIRC	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.9	7.89E-42	Height	
KIRC	cis	1	rs7426847	chr3:134267519	CEP63	chr3:134204575-134293852:+	-0.33	-6.48	2.13E-10	Height	
KIRC	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.35	6.6	1.04E-10	Cognitive performance	
KIRC	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.77E-40	Height	
KIRC	cis	1	rs7427492	chr3:134261654	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.92E-10	Height	
KIRC	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs7428326	chr3:134251184	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.61	-14.56	2.6E-40	Height	
KIRC	cis	1	rs7429866	chr3:134236306	CEP63	chr3:134204575-134293852:+	-0.32	-6.22	1.06E-9	Height	
KIRC	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.77E-40	Height	
KIRC	cis	1	rs7432268	chr3:134242051	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.92E-10	Height	
KIRC	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.59	14.31	3.4E-39	Height	
KIRC	cis	1	rs7433663	chr3:134235790	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.89E-10	Height	
KIRC	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.16	4.09	5.12E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs7433991	chr3:134312292	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs74347384	chr7:1072440	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.52	-10.75	2.12E-24	Longevity	
KIRC	cis	1	rs74363821	chr6:26189524	HIST1H3E	chr6:26224427-26226589:+	0.44	5.4	1.04E-7	Renal underexcretion gout;Gout	
KIRC	cis	1	rs7436403	chr4:17692685	LAP3	chr4:17578927-17609590:+	0.21	6.2	1.2E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7436403	chr4:17692685	MED28	chr4:17616273-17629791:+	-0.2	-4.49	8.71E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs74366004	chr7:1088630	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.78	1.3E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs74369356	chr7:1071711	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7438704	chr4:48363245	OCIAD1	chr4:48833015-48863831:+	-0.23	-5.1	4.72E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs74398423	chr4:106720966	INTS12	chr4:106603787-106629881:-	-0.63	-6.55	1.46E-10	Post bronchodilator FEV1	
KIRC	cis	1	rs74403477	chr1:179424380	C1orf125	chr1:179335107-179523868:+	0.48	5.48	6.8E-8	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs744051	chr12:56667298	COQ10A	chr12:56660642-56664748:+	0.35	3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs744051	chr12:56667298	RPS26	chr12:56435686-56438005:+	0.52	4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs74427244	chr15:56519917	TEX9	chr15:56657644-56738071:+	-0.28	-4.97	9.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs74427784	chr6:101582019	GRIK2	chr6:101846905-102517957:+	0.52	4.92	1.17E-6	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs7443669	chr5:115527611	COMMD10	chr5:115420727-115628978:+	0.34	4.02	6.63E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7444	chr22:21976934	CCDC116	chr22:21987086-21991615:+	-0.23	-4.95	1.02E-6	Systemic lupus erythematosus	
KIRC	cis	1	rs74471041	chr3:49542543	CCDC36	chr3:49235861-49295537:+	-0.26	-4.98	8.61E-7	Menarche (age at onset)	
KIRC	cis	1	rs74471041	chr3:49542543	NCKIPSD	chr3:48711280-48723334:-	-0.21	-4.17	3.57E-5	Menarche (age at onset)	
KIRC	cis	1	rs74471041	chr3:49542543	P4HTM	chr3:49027341-49044579:+	-0.19	-4.17	3.59E-5	Menarche (age at onset)	
KIRC	cis	1	rs74471041	chr3:49542543	WDR6	chr3:49044637-49053386:+	0.21	5.21	2.75E-7	Menarche (age at onset)	
KIRC	cis	1	rs74496027	chr12:56726340	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs74496027	chr12:56726340	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs74497593	chr4:106616214	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7450492	chr6:55935891	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs74506535	chr15:59489843	LDHAL6B	chr15:59499042-59500707:+	0.33	3.62	0.00032	Metabolite levels	
KIRC	cis	1	rs7452753	chr6:101053726	ASCC3	chr6:100956609-101329224:-	0.13	3.51	0.000488	Menarche (age at onset)	
KIRC	cis	1	rs7454056	chr6:56003136	COL21A1	chr6:55921389-56258892:-	-0.47	-7.36	7.81E-13	Psychosis (atypical)	
KIRC	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.93	-10.74	2.27E-24	Epithelial ovarian cancer;Ovarian cancer	
KIRC	cis	1	rs74552817	chr2:179990932	CCDC141	chr2:179697347-179914786:-	-0.31	-3.76	0.000187	Late-onset Alzheimer's disease	
KIRC	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.29	5.77	1.4E-8	Diabetic kidney disease	
KIRC	cis	1	rs7456042	chr7:65299778	CRCP	chr7:65579805-65619551:+	-0.33	-4.49	9.0E-6	Diabetic kidney disease	
KIRC	cis	1	rs74568699	chr4:106665995	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs74611500	chr14:66009789	LOC645431	chr14:65877313-65879335:-	-0.5	-6.53	1.64E-10	Ischemic stroke	
KIRC	cis	1	rs7462228	chr8:89410365	MMP16	chr8:89049462-89339717:-	0.31	4.08	5.35E-5	Electrodermal activity	
KIRC	cis	1	rs74626382	chr20:33746668	PROCR	chr20:33758727-33765164:+	-0.32	-4.02	6.69E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7463933	chr8:89464868	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.28E-5	Electrodermal activity	
KIRC	cis	1	rs746489	chr9:131910093	SET	chr9:131445934-131458674:+	-0.17	-3.8	0.000165	Blood metabolite ratios	
KIRC	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.13	-4.6	5.24E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs74652290	chr7:1090109	ZFAND2A	chr7:1192544-1199855:-	-0.35	-6.01	3.56E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7465272	chr8:143691838	ARC	chr8:143692410-143695833:-	0.29	5.72	1.86E-8	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs74673257	chr12:56638077	RPS26	chr12:56435686-56438005:+	-0.51	-4.33	1.77E-5	Psoriasis vulgaris	
KIRC	cis	1	rs74675536	chr2:203673073	ICA1L	chr2:203637873-203736371:-	0.28	3.59	0.000367	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs74703215	chr4:171014283	AADAT	chr4:170981374-171011372:-	-0.46	-4.4	1.33E-5	Thyroid hormone levels	
KIRC	cis	1	rs74703743	chr2:190792622	ASNSD1	chr2:190526125-190535556:+	-0.29	-4.15	3.9E-5	Subcutaneous adipose tissue	
KIRC	cis	1	rs74743307	chr8:89422498	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs7474896	chr10:37982097	LOC399744	chr10:38717074-38741080:+	0.24	3.74	0.000203	Obesity (extreme)	
KIRC	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.39	-11.32	1.26E-26	Response to temozolomide	
KIRC	cis	1	rs74758321	chr8:82667320	CHMP4C	chr8:82644688-82671746:+	-0.94	-10.87	7.6E-25	Epithelial ovarian cancer;Ovarian cancer	
KIRC	cis	1	rs747692	chr6:33737436	LEMD2	chr6:33738991-33756906:-	0.22	5.04	6.43E-7	Body mass index	
KIRC	cis	1	rs747695	chr6:33736672	LEMD2	chr6:33738991-33756906:-	-0.15	-3.76	0.000193	Crohn's disease	
KIRC	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.16	-5.35	1.34E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs74777923	chr6:101652816	GRIK2	chr6:101846905-102517957:+	0.51	5.17	3.36E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs7477	chr17:16246016	ADORA2B	chr17:15848231-15879210:+	-0.18	-3.8	0.000163	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs7477	chr17:16246016	PIGL	chr17:16120509-16229572:+	-0.18	-5.47	7.08E-8	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs7477	chr17:16246016	ZSWIM7	chr17:15879877-15903006:-	-0.29	-7.11	3.89E-12	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs74785791	chr7:1088494	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.78	1.3E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7481584	chr11:3029089	NAP1L4	chr11:2965661-3013607:-	0.19	4.45	1.04E-5	Calcium levels	
KIRC	cis	1	rs7481993	chr11:237875	PSMD13	chr11:236808-252984:+	-0.15	-4.98	8.67E-7	Menarche (age at onset)	
KIRC	cis	1	rs74825034	chr1:27095132	PIGV	chr1:27114455-27124886:+	-0.39	-4.55	6.58E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs7482591	chr11:245861	PSMD13	chr11:236808-252984:+	-0.15	-5.07	5.71E-7	Menarche (age at onset)	
KIRC	cis	1	rs74834816	chr3:58321828	PXK	chr3:58318617-58410878:+	0.21	4.18	3.5E-5	Cholesterol, total	
KIRC	cis	1	rs7483951	chr11:231758	PSMD13	chr11:236808-252984:+	-0.16	-5.2	2.92E-7	Menarche (age at onset)	
KIRC	cis	1	rs748404	chr15:43559231	STRC	chr15:43891762-43924561:-	0.22	5.61	3.42E-8	Lung cancer	
KIRC	cis	1	rs74865159	chr6:161073464	PLG	chr6:161123274-161174345:+	0.28	3.89	0.000113	Triglycerides	
KIRC	cis	1	rs74877653	chr1:2065949	SLC35E2	chr1:1590990-1677431:-	0.17	3.59	0.000357	Height	
KIRC	cis	1	rs74887741	chr7:1110658	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.59	3.7E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.24	6.43	2.94E-10	Blood metabolite levels	
KIRC	cis	1	rs74917833	chr4:106643161	INTS12	chr4:106603787-106629881:-	-0.64	-6.63	8.55E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs74935794	chr2:198871195	RFTN2	chr2:198435528-198540584:-	0.17	4.69	3.48E-6	Ulcerative colitis	
KIRC	cis	1	rs74955473	chr5:150174558	IRGM	chr5:150226085-150280295:+	0.65	7.81	3.28E-14	Crohn's disease	
KIRC	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.43	5.04	6.55E-7	Crohn's disease	
KIRC	cis	1	rs7495968	chr15:58244103	ALDH1A2	chr15:58245628-58571462:-	0.19	3.55	0.000424	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	
KIRC	cis	1	rs74960631	chr2:180049503	CCDC141	chr2:179697347-179914786:-	-0.33	-3.91	0.000103	Late-onset Alzheimer's disease	
KIRC	cis	1	rs7496335	chr15:65758868	DPP8	chr15:65737999-65810035:-	-0.13	-5.13	4.08E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs7496814	chr15:84584959	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.49	9.02E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs74981851	chr12:104176212	NT5DC3	chr12:104164231-104234975:-	-0.3	-3.96	8.71E-5	Sense of smell	
KIRC	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.45	7.53	2.34E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs74984740	chr2:17796007	SMC6	chr2:17845080-17981462:-	-0.31	-3.82	0.000148	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs750027	chr2:61075987	PUS10	chr2:61167550-61245365:-	0.15	4.07	5.44E-5	Psoriasis	
KIRC	cis	1	rs75016635	chr7:1094121	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7502013	chr17:46748071	SNX11	chr17:46184911-46200105:+	0.34	3.57	0.000393	Platelet thrombus formation	
KIRC	cis	1	rs75022895	chr7:116192330	CAV2	chr7:115928127-116148594:+	-0.37	-3.84	0.000137	QT interval	
KIRC	cis	1	rs75024979	chr10:81729853	LOC219347	chr10:81805991-81838949:-	0.56	4.94	1.04E-6	Rheumatoid arthritis	
KIRC	cis	1	rs75024979	chr10:81729853	LOC650623	chr10:81442731-81448648:+	-0.34	-3.68	0.000262	Rheumatoid arthritis	
KIRC	cis	1	rs7503679	chr17:79583843	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs7503679	chr17:79583843	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs750474	chr3:53085280	RFT1	chr3:53122503-53164470:-	0.28	4.53	7.45E-6	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs750474	chr3:53085280	SFMBT1	chr3:52938628-53080070:-	-0.27	-4.06	5.68E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs750474	chr3:53085280	TMEM110	chr3:52867139-52931547:-	0.29	5.35	1.31E-7	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.13	-4.51	7.93E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs75071288	chr5:150224379	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs75073383	chr17:6697075	FBXO39	chr17:6679552-6700420:+	-0.35	-3.53	0.000459	Blood metabolite levels	
KIRC	cis	1	rs75079001	chr19:21757375	ZNF429	chr19:21688437-21739068:+	0.19	3.61	0.000333	Colorectal or endometrial cancer	
KIRC	cis	1	rs75080838	chr5:115557467	COMMD10	chr5:115420727-115628978:+	0.37	3.81	0.000158	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs75092650	chr4:106523436	INTS12	chr4:106603787-106629881:-	-0.68	-6.66	7.23E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs751075	chr3:51377300	GRM2	chr3:51741081-51752623:+	-0.21	-3.5	0.000498	Melanoma	
KIRC	cis	1	rs751096	chr6:33742838	LEMD2	chr6:33738991-33756906:-	-0.23	-5.05	6.31E-7	Body mass index	
KIRC	cis	1	rs7511006	chr22:50676259	CRELD2	chr22:50312283-50321186:+	0.15	3.53	0.000455	Obesity-related traits	
KIRC	cis	1	rs7511006	chr22:50676259	SELO	chr22:50639408-50656044:+	0.14	4.25	2.55E-5	Obesity-related traits	
KIRC	cis	1	rs75117781	chr16:4654204	NMRAL1	chr16:4511696-4526307:-	-0.3	-3.68	0.000258	Obesity-related traits	
KIRC	cis	1	rs7511868	chr1:161463331	FCGR2C	chr1:161551129-161570031:+	-0.14	-4.18	3.41E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
KIRC	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.29	-6.99	8.92E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.28	-6.6	1.06E-10	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs7512552	chr1:150265704	C1orf54	chr1:150244773-150253325:+	0.13	4.19	3.27E-5	Atopic dermatitis	
KIRC	cis	1	rs7512769	chr1:196042662	KCNT2	chr1:196194913-196577499:-	0.21	3.49	0.00052	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs75128809	chr21:43418210	C21orf121	chr21:43442113-43445060:+	0.35	6.03	3.25E-9	Hand grip strength	
KIRC	cis	1	rs75129896	chr10:81758075	LOC219347	chr10:81805991-81838949:-	0.62	5.07	5.57E-7	Rheumatoid arthritis	
KIRC	cis	1	rs7513559	chr1:76173744	ACADM	chr1:76190043-76229353:+	0.19	5.41	9.93E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs75141346	chr2:203685119	ICA1L	chr2:203637873-203736371:-	0.28	3.63	0.000314	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.92	8.58E-18	Body mass index	
KIRC	cis	1	rs7515491	chr1:46355079	MUTYH	chr1:45794915-45806142:-	0.12	3.56	0.000399	Body mass index	
KIRC	cis	1	rs7515577	chr1:93009438	EVI5	chr1:92974255-93257961:-	-0.19	-4.44	1.08E-5	Cholesterol, total	
KIRC	cis	1	rs75156726	chr4:106677999	INTS12	chr4:106603787-106629881:-	-0.63	-6.63	8.54E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7516226	chr1:76234257	ACADM	chr1:76190043-76229353:+	0.18	4.83	1.77E-6	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs75166090	chr2:203692760	ICA1L	chr2:203637873-203736371:-	0.28	3.68	0.000255	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs75167249	chr19:22128655	ZNF257	chr19:22235266-22273901:+	0.32	4.36	1.58E-5	Body mass index (change over time)	
KIRC	cis	1	rs7516739	chr1:180948506	MR1	chr1:181003139-181024633:+	-0.13	-3.63	0.000312	Progressive supranuclear palsy	
KIRC	cis	1	rs751728	chr6:33764033	LEMD2	chr6:33738991-33756906:-	-0.15	-3.76	0.000191	Crohn's disease	
KIRC	cis	1	rs7518038	chr1:76154430	ACADM	chr1:76190043-76229353:+	0.19	5.2	2.93E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.67	-8.53	1.74E-16	Plasma clusterin levels	
KIRC	cis	1	rs75183624	chr3:184777207	C3orf70	chr3:184795840-184870802:-	-0.17	-3.58	0.000383	Heschl's gyrus morphology	
KIRC	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.29	-6.99	8.92E-12	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs7520747	chr1:35678139	C1orf216	chr1:36179477-36184790:-	-0.25	-3.74	0.000202	Endometrial cancer	
KIRC	cis	1	rs7520935	chr1:10354271	RBP7	chr1:10057255-10076077:+	0.15	3.57	0.000389	Hepatocellular carcinoma	
KIRC	cis	1	rs75211977	chr19:21760201	ZNF429	chr19:21688437-21739068:+	0.19	3.63	0.000314	Colorectal or endometrial cancer	
KIRC	cis	1	rs7522462	chr1:200881595	KIF21B	chr1:200938520-200992828:-	-0.12	-3.92	0.000102	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.91E-18	Body mass index	
KIRC	cis	1	rs7522601	chr1:46419021	MUTYH	chr1:45794915-45806142:-	0.15	4.37	1.49E-5	Body mass index	
KIRC	cis	1	rs75226604	chr2:192574533	OBFC2A	chr2:192542798-192553247:+	0.17	3.5	0.000511	Colorectal cancer	
KIRC	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.81	18.52	9.55E-59	Homocysteine levels	
KIRC	cis	1	rs7522705	chr1:45992300	MUTYH	chr1:45794915-45806142:-	-0.15	-4.29	2.17E-5	Homocysteine levels	
KIRC	cis	1	rs7522948	chr1:156275308	BGLAP	chr1:156182784-156213112:+	0.33	7.06	5.42E-12	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
KIRC	cis	1	rs7523455	chr1:19332076	RNF186	chr1:20140523-20141771:-	-0.26	-3.68	0.000257	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs75241339	chr17:80527441	FN3KRP	chr17:80674582-80685889:+	-0.37	-3.53	0.000449	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs7524202	chr1:11297762	MTOR	chr1:11166589-11322608:-	-0.16	-4.2	3.15E-5	Body mass index	
KIRC	cis	1	rs7524467	chr1:76194054	ACADM	chr1:76190043-76229353:+	0.18	5.09	5.14E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.2	9.7E-19	Body mass index	
KIRC	cis	1	rs7524495	chr1:46266932	MUTYH	chr1:45794915-45806142:-	0.14	4.06	5.74E-5	Body mass index	
KIRC	cis	1	rs75247012	chr8:89465349	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.48E-5	Electrodermal activity	
KIRC	cis	1	rs7525957	chr1:11318236	MTOR	chr1:11166589-11322608:-	-0.16	-4.33	1.8E-5	Body mass index	
KIRC	cis	1	rs752621	chr17:61901880	FTSJ3	chr17:61896795-61905031:-	0.33	6.37	4.33E-10	Body mass index	
KIRC	cis	1	rs752621	chr17:61901880	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.59	5.57E-6	Body mass index	
KIRC	cis	1	rs75265219	chr12:56640341	RPS26	chr12:56435686-56438005:+	-0.51	-4.33	1.77E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7526649	chr1:11278163	MTOR	chr1:11166589-11322608:-	-0.16	-4.33	1.78E-5	Body mass index	
KIRC	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	1.08	19.06	2.41E-61	Heschl's gyrus morphology	
KIRC	cis	1	rs75278386	chr15:40678312	IVD	chr15:40697686-40713512:+	-0.36	-5.67	2.37E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7528526	chr1:180948574	MR1	chr1:181003139-181024633:+	-0.13	-3.63	0.000312	Progressive supranuclear palsy	
KIRC	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.43	12.25	2.32E-30	Type 1 diabetes autoantibodies	
KIRC	cis	1	rs75287019	chr20:33721261	PROCR	chr20:33758727-33765164:+	-0.3	-4.02	6.59E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs75287019	chr20:33721261	SPAG4	chr20:34203809-34208965:+	0.24	3.93	9.69E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs75294883	chr5:150196503	IRGM	chr5:150226085-150280295:+	0.63	7.44	4.27E-13	Crohn's disease	
KIRC	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.44	5.11	4.54E-7	Crohn's disease	
KIRC	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.67	-8.58	1.15E-16	Plasma clusterin levels	
KIRC	cis	1	rs7531202	chr1:110616474	ALX3	chr1:110602998-110613322:-	-0.23	-4.97	9.12E-7	Blood metabolite levels	
KIRC	cis	1	rs75321546	chr12:124447465	CCDC92	chr12:124420955-124457163:-	0.2	5.36	1.29E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs75324925	chr2:203698300	ICA1L	chr2:203637873-203736371:-	0.29	3.72	0.000218	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs7533623	chr1:110616475	ALX3	chr1:110602998-110613322:-	-0.21	-4.46	1.03E-5	Blood metabolite levels	
KIRC	cis	1	rs75336711	chr4:171020067	AADAT	chr4:170981374-171011372:-	-0.46	-4.44	1.13E-5	Thyroid hormone levels	
KIRC	cis	1	rs7533888	chr1:76160449	ACADM	chr1:76190043-76229353:+	0.19	5.33	1.49E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.92	-22.1	4.33E-76	Homocysteine levels	
KIRC	cis	1	rs7534624	chr1:22494627	HSPC157	chr1:22351707-22357713:+	0.21	3.72	0.000223	Obesity-related traits	
KIRC	cis	1	rs7534754	chr1:76185308	ACADM	chr1:76190043-76229353:+	0.19	5.28	1.96E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs7535475	chr1:161463587	FCGR2B	chr1:161632940-161647951:+	0.14	3.63	0.000314	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
KIRC	cis	1	rs7535475	chr1:161463587	FCGR2C	chr1:161551129-161570031:+	0.14	4.26	2.39E-5	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	
KIRC	cis	1	rs75358288	chr6:55987364	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.83	-19.46	3.01E-63	Homocysteine levels	
KIRC	cis	1	rs7536557	chr1:45992114	MUTYH	chr1:45794915-45806142:-	0.14	4	7.18E-5	Homocysteine levels	
KIRC	cis	1	rs7536557	chr1:45992114	TESK2	chr1:45809555-45956840:-	-0.14	-3.49	0.000526	Homocysteine levels	
KIRC	cis	1	rs7538856	chr1:205894017	SLC26A9	chr1:205882179-205912588:-	-0.27	-5.04	6.56E-7	Response to antipsychotic treatment	
KIRC	cis	1	rs75389281	chr15:24159672	HERC2P2	chr15:23282265-23378259:-	-0.16	-3.75	0.000201	Menarche (age at onset)	
KIRC	cis	1	rs7539506	chr1:19319097	RNF186	chr1:20140523-20141771:-	0.27	3.5	0.000504	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs7539932	chr1:46292354	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs75399471	chr1:76339092	MSH4	chr1:76262630-76378923:+	-0.37	-4.79	2.25E-6	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.33	3.52E-19	Body mass index	
KIRC	cis	1	rs7540325	chr1:46338217	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000134	Body mass index	
KIRC	cis	1	rs75408336	chr1:179459485	C1orf125	chr1:179335107-179523868:+	0.47	5.4	1.02E-7	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs75412200	chr2:180046477	CCDC141	chr2:179697347-179914786:-	-0.33	-3.92	0.000102	Late-onset Alzheimer's disease	
KIRC	cis	1	rs7543044	chr1:35674311	C1orf216	chr1:36179477-36184790:-	-0.24	-3.79	0.000168	Endometrial cancer	
KIRC	cis	1	rs7543956	chr1:19319121	RNF186	chr1:20140523-20141771:-	0.27	3.5	0.000504	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	
KIRC	cis	1	rs75444304	chr15:90894246	IQGAP1	chr15:90931473-91045475:+	0.12	3.53	0.000462	Rheumatoid arthritis	
KIRC	cis	1	rs75444304	chr15:90894246	TTLL13	chr15:90792764-90815443:+	0.25	4.49	8.87E-6	Rheumatoid arthritis	
KIRC	cis	1	rs7544741	chr1:99196743	SNX7	chr1:99127236-99226054:+	0.19	4.78	2.25E-6	Proinsulin levels	
KIRC	cis	1	rs7546304	chr1:151114484	LYSMD1	chr1:151132225-151138424:-	-0.24	-4.64	4.53E-6	Body mass index	
KIRC	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.28	-6.61	9.55E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs75488469	chr7:1102122	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.75	1.54E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7548962	chr1:76139266	ACADM	chr1:76190043-76229353:+	0.19	5.31	1.64E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs7549109	chr1:11278813	MTOR	chr1:11166589-11322608:-	0.14	3.71	0.000229	Body mass index	
KIRC	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.29	-6.96	1.06E-11	Response to taxane treatment (docetaxel)	
KIRC	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.48	-9.37	2.52E-19	Body mass index	
KIRC	cis	1	rs7550746	chr1:46351719	MUTYH	chr1:45794915-45806142:-	0.13	3.78	0.000174	Body mass index	
KIRC	cis	1	rs755109	chr9:100696203	C9orf156	chr9:100666772-100684852:-	0.32	7.43	4.74E-13	Quantitative traits	
KIRC	cis	1	rs7551124	chr1:23785760	TCEA3	chr1:23707555-23751261:-	0.18	3.78	0.000174	Cholesterol, total	
KIRC	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.5	10.33	8.44E-23	Height	
KIRC	cis	1	rs7552404	chr1:76135946	ACADM	chr1:76190043-76229353:+	0.19	5.31	1.61E-7	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs7553330	chr1:180956015	MR1	chr1:181003139-181024633:+	-0.14	-3.95	9.04E-5	Progressive supranuclear palsy	
KIRC	cis	1	rs7554511	chr1:200877562	KIF21B	chr1:200938520-200992828:-	-0.13	-4.05	5.93E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs755495	chr6:33734128	LEMD2	chr6:33738991-33756906:-	-0.23	-5.36	1.29E-7	Body mass index	
KIRC	cis	1	rs755587	chr20:47720957	CSE1L	chr20:47662838-47713484:+	0.18	4.72	3.07E-6	Anger	
KIRC	cis	1	rs755589	chr20:47721385	CSE1L	chr20:47662838-47713484:+	0.16	4.13	4.19E-5	Anger	
KIRC	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.47	8.98	5.54E-18	Body mass index	
KIRC	cis	1	rs7556436	chr1:46363880	MUTYH	chr1:45794915-45806142:-	-0.14	-4.01	7.07E-5	Body mass index	
KIRC	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.68	5.66E-17	Body mass index	
KIRC	cis	1	rs7556615	chr1:46461369	MUTYH	chr1:45794915-45806142:-	0.14	3.99	7.63E-5	Body mass index	
KIRC	cis	1	rs7558944	chr2:73810909	TPRKB	chr2:73956957-73964517:-	-0.21	-5.39	1.07E-7	Metabolite levels	
KIRC	cis	1	rs75598973	chr12:56746558	COQ10A	chr12:56660642-56664748:+	-0.34	-3.5	0.000499	Psoriasis vulgaris	
KIRC	cis	1	rs75598973	chr12:56746558	RPS26	chr12:56435686-56438005:+	-0.52	-4.49	8.88E-6	Psoriasis vulgaris	
KIRC	cis	1	rs75599828	chr22:22333062	MAPK1	chr22:22113949-22221970:-	0.19	4.1	4.77E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs75599828	chr22:22333062	YPEL1	chr22:22051828-22090071:-	0.21	3.68	0.000254	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs7560327	chr2:190772522	ASNSD1	chr2:190526125-190535556:+	-0.3	-3.8	0.000165	Subcutaneous adipose tissue	
KIRC	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.22	-4.47	9.58E-6	Melanoma;Esophageal squamous cell carcinoma	
KIRC	cis	1	rs7560357	chr2:99247820	UNC50	chr2:99225042-99234975:+	0.26	4.62	4.8E-6	Bipolar disorder	
KIRC	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.49	10.23	1.91E-22	Body mass index	
KIRC	cis	1	rs75648520	chr20:33724221	PROCR	chr20:33758727-33765164:+	-0.3	-3.82	0.000151	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7564878	chr2:56197276	MTIF2	chr2:55463758-55496384:-	-0.19	-3.7	0.000239	Schizophrenia	
KIRC	cis	1	rs7564890	chr2:73641853	TPRKB	chr2:73956957-73964517:-	-0.2	-5.25	2.26E-7	Metabolite levels	
KIRC	cis	1	rs7566277	chr2:99916242	LIPT1	chr2:99771418-99779611:+	0.27	4.67	3.85E-6	IgG glycosylation	
KIRC	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.29	-5.93	5.72E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs756693	chr11:3027889	NAP1L4	chr11:2965661-3013607:-	0.2	4.53	7.42E-6	Calcium levels	
KIRC	cis	1	rs7567389	chr2:127982645	CYP27C1	chr2:127941412-127963343:-	-0.22	-3.98	7.96E-5	Self-rated health	
KIRC	cis	1	rs7569194	chr2:137539014	THSD7B	chr2:137523115-138435287:+	-0.17	-3.58	0.000378	Pancreatic cancer	
KIRC	cis	1	rs756920	chr11:2310870	C11orf21	chr11:2317507-2323143:-	0.17	3.84	0.00014	Obesity-related traits	
KIRC	cis	1	rs7572722	chr2:73724675	TPRKB	chr2:73956957-73964517:-	-0.2	-5.25	2.26E-7	Metabolite levels	
KIRC	cis	1	rs7573442	chr2:70154037	ANXA4	chr2:69969127-70053594:+	-0.21	-5.15	3.66E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs7574570	chr2:192098516	STAT4	chr2:191894306-192038902:-	0.17	4.42	1.21E-5	Obesity-related traits	
KIRC	cis	1	rs75754909	chr12:56726349	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs75754909	chr12:56726349	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7576245	chr2:73829678	TPRKB	chr2:73956957-73964517:-	-0.19	-4.95	1.02E-6	Metabolite levels	
KIRC	cis	1	rs75774363	chr5:150223722	IRGM	chr5:150226085-150280295:+	0.55	7.21	2.02E-12	Crohn's disease	
KIRC	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.34	4.42	1.23E-5	Crohn's disease	
KIRC	cis	1	rs7577696	chr2:32278782	NLRC4	chr2:32449518-32490801:-	-0.12	-4.13	4.29E-5	Inflammatory biomarkers	
KIRC	cis	1	rs7578027	chr2:70401108	ANXA4	chr2:69969127-70053594:+	-0.18	-3.56	0.0004	Obesity-related traits	
KIRC	cis	1	rs7578027	chr2:70401108	FAM136A	chr2:70523109-70529220:-	-0.23	-4.39	1.4E-5	Obesity-related traits	
KIRC	cis	1	rs7578199	chr2:242192848	FARP2	chr2:242295711-242434255:+	-0.19	-4.05	5.93E-5	Chronic lymphocytic leukemia	
KIRC	cis	1	rs7578456	chr2:202235348	ALS2CR12	chr2:202153148-202222101:-	-0.28	-5.39	1.06E-7	Basal cell carcinoma	
KIRC	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.48	-10.39	4.9E-23	Body mass index	
KIRC	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.36	5.35	1.34E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs7579905	chr2:198868109	RFTN2	chr2:198435528-198540584:-	0.16	4.62	4.98E-6	Ulcerative colitis	
KIRC	cis	1	rs75800624	chr18:44633605	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.43	8.7	4.73E-17	Breast cancer (estrogen-receptor negative);Breast cancer	
KIRC	cis	1	rs75804032	chr15:56501130	TEX9	chr15:56657644-56738071:+	-0.29	-5.17	3.38E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs7580658	chr2:128159261	CYP27C1	chr2:127941412-127963343:-	-0.28	-5.27	2.02E-7	Protein C levels	
KIRC	cis	1	rs7580825	chr2:73635148	TPRKB	chr2:73956957-73964517:-	-0.19	-4.8	2.15E-6	Metabolite levels	
KIRC	cis	1	rs7581224	chr2:84709215	DNAH6	chr2:84743579-85046711:+	0.25	5	7.98E-7	Coronary artery calcification	
KIRC	cis	1	rs75817507	chr4:106767623	INTS12	chr4:106603787-106629881:-	-0.71	-7.48	3.31E-13	Post bronchodilator FEV1	
KIRC	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.34	9.16	1.28E-18	Common traits (Other)	
KIRC	cis	1	rs7582606	chr2:73813945	TPRKB	chr2:73956957-73964517:-	-0.2	-5.31	1.66E-7	Metabolite levels	
KIRC	cis	1	rs7582715	chr2:198874310	RFTN2	chr2:198435528-198540584:-	0.17	4.69	3.48E-6	Ulcerative colitis	
KIRC	cis	1	rs75828026	chr3:58346736	PXK	chr3:58318617-58410878:+	0.23	4.6	5.38E-6	Cholesterol, total	
KIRC	cis	1	rs7583255	chr2:73797996	TPRKB	chr2:73956957-73964517:-	-0.21	-5.35	1.37E-7	Metabolite levels	
KIRC	cis	1	rs7584330	chr2:238387228	MLPH	chr2:238395053-238463960:+	0.22	3.77	0.00018	Prostate cancer	
KIRC	cis	1	rs7584535	chr2:232106857	ARMC9	chr2:232063342-232238606:+	0.25	5	8.13E-7	Food antigen IgG levels	
KIRC	cis	1	rs7584575	chr2:73666402	TPRKB	chr2:73956957-73964517:-	-0.19	-4.91	1.25E-6	Metabolite levels	
KIRC	cis	1	rs7585004	chr2:73666645	TPRKB	chr2:73956957-73964517:-	-0.18	-4.72	3.03E-6	Metabolite levels	
KIRC	cis	1	rs7586463	chr2:73798476	TPRKB	chr2:73956957-73964517:-	-0.21	-5.35	1.37E-7	Metabolite levels	
KIRC	cis	1	rs7586856	chr2:219968576	USP37	chr2:219314974-219433084:-	-0.23	-3.59	0.000357	Height	
KIRC	cis	1	rs75888794	chr20:33702998	PROCR	chr20:33758727-33765164:+	-0.27	-3.71	0.000229	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.24	4.68	3.63E-6	Atopic dermatitis	
KIRC	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.68	-8.63	8.06E-17	Plasma clusterin levels	
KIRC	cis	1	rs7590071	chr2:240900947	NDUFA10	chr2:240900158-240964798:-	0.21	4.57	6.27E-6	Odorant perception (isobutyraldehyde)	
KIRC	cis	1	rs75904349	chr4:106526694	INTS12	chr4:106603787-106629881:-	-0.68	-6.71	5.13E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	1.06	15.39	4.5E-44	Chronic obstructive pulmonary disease-related biomarkers	
KIRC	cis	1	rs7591472	chr2:201889751	CFLAR	chr2:201980816-202029001:+	-0.22	-4.12	4.48E-5	Triptolide cytotoxicity	
KIRC	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.73	-12.26	2.11E-30	Triptolide cytotoxicity	
KIRC	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.44	5.49	6.39E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs75924839	chr8:89465223	MMP16	chr8:89049462-89339717:-	0.32	4.12	4.48E-5	Electrodermal activity	
KIRC	cis	1	rs7592560	chr2:68647001	PPP3R1	chr2:68405989-68479651:-	-0.12	-3.57	0.000387	Multiple sclerosis	
KIRC	cis	1	rs75927128	chr14:65895320	LOC645431	chr14:65877313-65879335:-	-0.52	-6.61	9.87E-11	Ischemic stroke	
KIRC	cis	1	rs7593448	chr2:27449293	C2orf28	chr2:27434899-27440044:+	0.16	4.74	2.76E-6	Blood metabolite levels	
KIRC	cis	1	rs7593730	chr2:161171454	PLA2R1	chr2:160798012-160919121:-	-0.2	-3.72	0.000221	Type 2 diabetes	
KIRC	cis	1	rs75942062	chr6:101607944	GRIK2	chr6:101846905-102517957:+	0.53	4.77	2.41E-6	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs7594511	chr2:73681639	TPRKB	chr2:73956957-73964517:-	-0.2	-5.04	6.4E-7	Metabolite levels	
KIRC	cis	1	rs7594645	chr2:207646674	MDH1B	chr2:207598943-207630050:-	0.38	3.78	0.000174	Episodic memory	
KIRC	cis	1	rs7595037	chr2:68647095	PPP3R1	chr2:68405989-68479651:-	-0.12	-3.57	0.000387	Multiple sclerosis	
KIRC	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.28	-5.81	1.09E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs7595949	chr2:219927218	USP37	chr2:219314974-219433084:-	-0.26	-4.03	6.32E-5	Height	
KIRC	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.46	8.8	2.29E-17	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7597155	chr2:69985435	ANXA4	chr2:69969127-70053594:+	-0.28	-6.99	8.78E-12	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7597199	chr2:70341575	ANXA4	chr2:69969127-70053594:+	-0.18	-3.6	0.00035	Obesity-related traits	
KIRC	cis	1	rs7597199	chr2:70341575	FAM136A	chr2:70523109-70529220:-	-0.26	-5.07	5.64E-7	Obesity-related traits	
KIRC	cis	1	rs7598283	chr2:70128717	ANXA4	chr2:69969127-70053594:+	-0.21	-5.18	3.3E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs7598396	chr2:73652628	TPRKB	chr2:73956957-73964517:-	-0.2	-5.18	3.25E-7	Metabolite levels	
KIRC	cis	1	rs7598419	chr2:73798223	TPRKB	chr2:73956957-73964517:-	-0.21	-5.53	5.09E-8	Metabolite levels	
KIRC	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.46	-9.88	3.74E-21	Body mass index	
KIRC	cis	1	rs7598980	chr2:219968422	USP37	chr2:219314974-219433084:-	-0.24	-3.71	0.000233	Height	
KIRC	cis	1	rs76008952	chr11:22829436	SVIP	chr11:22843600-22851382:-	0.27	4.24	2.63E-5	Dialysis-related mortality	
KIRC	cis	1	rs7600987	chr2:219915871	FAM134A	chr2:220042939-220050190:+	-0.29	-3.67	0.000271	Height	
KIRC	cis	1	rs7600989	chr2:219119134	STK36	chr2:219536762-219567439:+	0.23	3.52	0.000472	Smooth-surface caries	
KIRC	cis	1	rs7601738	chr2:242375813	SEPT2	chr2:242254723-242293439:+	-0.37	-5.37	1.19E-7	Chronic lymphocytic leukemia	
KIRC	cis	1	rs76029311	chr4:171001269	AADAT	chr4:170981374-171011372:-	-0.5	-4.61	5.15E-6	Thyroid hormone levels	
KIRC	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.42	7.89	1.94E-14	Urinary metabolites	
KIRC	cis	1	rs7604682	chr2:73788026	TPRKB	chr2:73956957-73964517:-	-0.2	-5.35	1.32E-7	Metabolite levels	
KIRC	cis	1	rs7604798	chr2:27824940	NRBP1	chr2:27650657-27665122:+	0.14	3.61	0.000332	Oral cavity cancer	
KIRC	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.27	5.67	2.41E-8	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs76064624	chr1:95661033	RWDD3	chr1:95583479-95712773:+	0.36	4.75	2.61E-6	Stearic acid (18:0) plasma levels	
KIRC	cis	1	rs76068439	chr10:1121018	IDI2	chr10:1064847-1071799:-	0.37	3.72	0.000221	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs7607014	chr2:73730174	TPRKB	chr2:73956957-73964517:-	0.19	5.01	7.41E-7	Metabolite levels	
KIRC	cis	1	rs7608623	chr2:23948953	C2orf84	chr2:24397531-24414566:+	-0.24	-4.21	3.07E-5	Obesity-related traits	
KIRC	cis	1	rs7608623	chr2:23948953	LOC375190	chr2:24299728-24397519:+	0.26	6.39	3.79E-10	Obesity-related traits	
KIRC	cis	1	rs7608697	chr2:61204641	AHSA2	chr2:61404553-61414058:+	-0.09	-3.96	8.41E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7608697	chr2:61204641	C2orf74	chr2:61372243-61391964:+	0.44	8.33	7.74E-16	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7608910	chr2:61204856	AHSA2	chr2:61404553-61414058:+	0.09	3.95	8.77E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.46	-8.92	8.39E-18	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs7609045	chr2:165555207	SLC38A11	chr2:165754812-165812035:-	0.27	4.86	1.55E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.5	-8.81	2.02E-17	Bone mineral density	
KIRC	cis	1	rs761025	chr20:25426968	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.79	3.15E-11	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs761025	chr20:25426968	FAM182A	chr20:26035250-26067552:+	-0.29	-5.5	6.22E-8	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs76112204	chr5:115618889	COMMD10	chr5:115420727-115628978:+	0.39	4.05	5.96E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs76112431	chr6:55988182	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.61	14.77	2.84E-41	Height	
KIRC	cis	1	rs7611611	chr3:134307877	CEP63	chr3:134204575-134293852:+	0.33	6.42	3.24E-10	Height	
KIRC	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs7611828	chr3:134250325	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs76129108	chr7:1089159	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.83	1.01E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7613491	chr3:49508976	CCDC36	chr3:49235861-49295537:+	-0.29	-5.47	7.16E-8	Menarche (age at onset)	
KIRC	cis	1	rs7613491	chr3:49508976	GMPPB	chr3:49758932-49761384:-	0.17	3.75	0.000196	Menarche (age at onset)	
KIRC	cis	1	rs7613491	chr3:49508976	NCKIPSD	chr3:48711280-48723334:-	-0.2	-3.93	9.71E-5	Menarche (age at onset)	
KIRC	cis	1	rs7613491	chr3:49508976	P4HTM	chr3:49027341-49044579:+	-0.2	-4.39	1.36E-5	Menarche (age at onset)	
KIRC	cis	1	rs7613491	chr3:49508976	WDR6	chr3:49044637-49053386:+	0.22	5.41	1.0E-7	Menarche (age at onset)	
KIRC	cis	1	rs7614727	chr3:52295895	GNL3	chr3:52719936-52728508:+	-0.15	-3.89	0.000115	Electroencephalogram traits	
KIRC	cis	1	rs76151170	chr12:56659320	RPS26	chr12:56435686-56438005:+	-0.48	-4.22	2.94E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.37	-5.71	1.9E-8	Blood pressure (smoking interaction)	
KIRC	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.44	6.61	9.92E-11	Blood pressure (smoking interaction)	
KIRC	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.75	11.23	3.03E-26	Diastolic blood pressure	
KIRC	cis	1	rs7617331	chr3:56624159	CCDC66	chr3:56591184-56655846:+	-0.12	-3.61	0.000331	Height	
KIRC	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.5	-8.42	3.83E-16	Bone mineral density	
KIRC	cis	1	rs76192904	chr1:76359995	MSH4	chr1:76262630-76378923:+	-0.33	-5.03	6.92E-7	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.57	13.26	1.31E-34	Height	
KIRC	cis	1	rs7619451	chr3:134233238	CEP63	chr3:134204575-134293852:+	0.27	5.21	2.82E-7	Height	
KIRC	cis	1	rs76194	chr19:18630580	SSBP4	chr19:18530221-18545371:+	-0.14	-4.77	2.42E-6	Breast cancer	
KIRC	cis	1	rs76195156	chr17:80488094	FN3KRP	chr17:80674582-80685889:+	-0.36	-3.51	0.000497	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs7619789	chr3:49476263	CCDC36	chr3:49235861-49295537:+	0.25	4.8	2.12E-6	Menarche (age at onset)	
KIRC	cis	1	rs7619789	chr3:49476263	NCKIPSD	chr3:48711280-48723334:-	0.2	4.06	5.73E-5	Menarche (age at onset)	
KIRC	cis	1	rs7619789	chr3:49476263	P4HTM	chr3:49027341-49044579:+	0.18	4.03	6.54E-5	Menarche (age at onset)	
KIRC	cis	1	rs7619789	chr3:49476263	TREX1	chr3:48501186-48509043:+	-0.16	-4.07	5.44E-5	Menarche (age at onset)	
KIRC	cis	1	rs7619789	chr3:49476263	WDR6	chr3:49044637-49053386:+	-0.21	-5.28	1.96E-7	Menarche (age at onset)	
KIRC	cis	1	rs76198862	chr6:55988150	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.5	-8.54	1.57E-16	Bone mineral density	
KIRC	cis	1	rs76206767	chr17:80496705	FN3KRP	chr17:80674582-80685889:+	-0.36	-3.51	0.000497	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs76214082	chr7:1102097	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.53E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.74	11.13	7.24E-26	Diastolic blood pressure	
KIRC	cis	1	rs7622420	chr3:53111069	RFT1	chr3:53122503-53164470:-	0.32	5.5	6.03E-8	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs7622420	chr3:53111069	SFMBT1	chr3:52938628-53080070:-	-0.22	-3.5	0.000499	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs7622420	chr3:53111069	TMEM110	chr3:52867139-52931547:-	0.23	4.34	1.7E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs76231455	chr14:52884056	TXNDC16	chr14:52897309-53019301:-	-0.18	-3.58	0.000382	Smooth-surface caries	
KIRC	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.17	4.3	2.06E-5	Electrocardiographic conduction measures	
KIRC	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.74	11.13	7.24E-26	Diastolic blood pressure	
KIRC	cis	1	rs7624377	chr3:190988079	UTS2D	chr3:190984945-191048325:-	-0.21	-3.72	0.000219	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs7625448	chr3:53120766	RFT1	chr3:53122503-53164470:-	0.36	6.01	3.61E-9	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs7625448	chr3:53120766	TMEM110	chr3:52867139-52931547:-	0.24	4.28	2.24E-5	Immune reponse to smallpox (secreted IL-2)	
KIRC	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.27	-5.41	9.92E-8	Narcolepsy	
KIRC	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.27	-5.41	9.92E-8	Narcolepsy	
KIRC	cis	1	rs7628948	chr3:85594169	CADM2	chr3:85008133-86117948:+	0.25	4.07	5.56E-5	Longevity (90 years and older)	
KIRC	cis	1	rs7629072	chr3:52305633	GNL3	chr3:52719936-52728508:+	-0.15	-3.73	0.000216	Electroencephalogram traits	
KIRC	cis	1	rs76292674	chr5:115625260	COMMD10	chr5:115420727-115628978:+	0.33	3.76	0.000193	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs76297018	chr2:86227007	POLR1A	chr2:86253453-86333278:-	-0.37	-4.84	1.73E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.18	3.62	0.00033	Height	
KIRC	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.31	-8.81	2.09E-17	Longevity	
KIRC	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.62	-14.86	1.15E-41	Height	
KIRC	cis	1	rs7630874	chr3:134293291	CEP63	chr3:134204575-134293852:+	-0.33	-6.45	2.69E-10	Height	
KIRC	cis	1	rs7631026	chr3:190979823	UTS2D	chr3:190984945-191048325:-	-0.22	-4.13	4.23E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.74	10.34	7.28E-23	Diastolic blood pressure	
KIRC	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.3	-8.6	1.06E-16	Longevity	
KIRC	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.28	-8.22	1.78E-15	Longevity	
KIRC	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.31	-8.97	5.84E-18	Longevity	
KIRC	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.28	-8.25	1.41E-15	Longevity	
KIRC	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.61	14.72	4.89E-41	Height	
KIRC	cis	1	rs7637227	chr3:134244155	CEP63	chr3:134204575-134293852:+	0.36	7.12	3.65E-12	Height	
KIRC	cis	1	rs7637230	chr3:101663555	SENP7	chr3:101043120-101232085:-	0.17	3.85	0.000134	Psoriasis vulgaris;Psoriasis	
KIRC	cis	1	rs7637404	chr3:190981868	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.53E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs7637449	chr3:56628031	CCDC66	chr3:56591184-56655846:+	-0.12	-3.64	0.000298	Height	
KIRC	cis	1	rs76388414	chr7:1100694	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.53E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs76393969	chr4:171032231	AADAT	chr4:170981374-171011372:-	-0.43	-4.06	5.66E-5	Thyroid hormone levels	
KIRC	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.49	-8.54	1.6E-16	Bone mineral density	
KIRC	cis	1	rs76403598	chr19:12166182	ZNF763	chr19:12035900-12091196:+	-0.36	-4.93	1.1E-6	Multiple sclerosis	
KIRC	cis	1	rs76414143	chr5:115625396	COMMD10	chr5:115420727-115628978:+	0.33	3.76	0.000193	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs76419734	chr4:106624285	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs76430365	chr12:56699993	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs76430365	chr12:56699993	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs76433514	chr5:150306532	IRGM	chr5:150226085-150280295:+	0.55	7.03	6.91E-12	Crohn's disease	
KIRC	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.41	5.25	2.3E-7	Crohn's disease	
KIRC	cis	1	rs76435840	chr11:58285981	CNTF	chr11:58390146-58393203:+	0.24	3.52	0.000478	Lymphoma	
KIRC	cis	1	rs7644148	chr3:49545241	CCDC36	chr3:49235861-49295537:+	-0.26	-4.98	8.61E-7	Menarche (age at onset)	
KIRC	cis	1	rs7644148	chr3:49545241	NCKIPSD	chr3:48711280-48723334:-	-0.21	-4.17	3.57E-5	Menarche (age at onset)	
KIRC	cis	1	rs7644148	chr3:49545241	P4HTM	chr3:49027341-49044579:+	-0.19	-4.17	3.59E-5	Menarche (age at onset)	
KIRC	cis	1	rs7644148	chr3:49545241	WDR6	chr3:49044637-49053386:+	0.21	5.21	2.75E-7	Menarche (age at onset)	
KIRC	cis	1	rs7644510	chr3:190980797	UTS2D	chr3:190984945-191048325:-	-0.2	-3.78	0.000174	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs76449411	chr2:17799354	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.00012	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.61	14.53	3.55E-40	Height	
KIRC	cis	1	rs7645295	chr3:134307734	CEP63	chr3:134204575-134293852:+	0.32	6.24	9.56E-10	Height	
KIRC	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.73	10.28	1.28E-22	Diastolic blood pressure	
KIRC	cis	1	rs76463534	chr17:6695666	FBXO39	chr17:6679552-6700420:+	-0.38	-3.85	0.000131	Blood metabolite levels	
KIRC	cis	1	rs76464924	chr10:81728811	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs76466034	chr12:56719450	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs76466034	chr12:56719450	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7646881	chr3:158453279	RARRES1	chr3:158414899-158450275:-	0.21	5.07	5.51E-7	Tetralogy of Fallot	
KIRC	cis	1	rs7646987	chr3:158453442	RARRES1	chr3:158414899-158450275:-	-0.21	-4.94	1.09E-6	Tetralogy of Fallot	
KIRC	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.77	11.62	8.35E-28	Diastolic blood pressure	
KIRC	cis	1	rs76473275	chr1:243460555	SDCCAG8	chr1:243419320-243663392:+	-0.28	-3.73	0.000217	Obesity (early onset extreme)	
KIRC	cis	1	rs76475039	chr1:179476763	C1orf125	chr1:179335107-179523868:+	0.5	5.56	4.45E-8	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs7647973	chr3:49510931	CCDC36	chr3:49235861-49295537:+	-0.29	-5.47	7.16E-8	Menarche (age at onset)	
KIRC	cis	1	rs7647973	chr3:49510931	GMPPB	chr3:49758932-49761384:-	0.17	3.75	0.000196	Menarche (age at onset)	
KIRC	cis	1	rs7647973	chr3:49510931	NCKIPSD	chr3:48711280-48723334:-	-0.2	-3.93	9.71E-5	Menarche (age at onset)	
KIRC	cis	1	rs7647973	chr3:49510931	P4HTM	chr3:49027341-49044579:+	-0.2	-4.39	1.36E-5	Menarche (age at onset)	
KIRC	cis	1	rs7647973	chr3:49510931	WDR6	chr3:49044637-49053386:+	0.22	5.41	1.0E-7	Menarche (age at onset)	
KIRC	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.75	11.67	5.01E-28	Diastolic blood pressure	
KIRC	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs7648990	chr3:134244390	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs7648995	chr3:49438803	CCDC36	chr3:49235861-49295537:+	-0.25	-4.71	3.14E-6	Menarche (age at onset)	
KIRC	cis	1	rs7648995	chr3:49438803	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.52	7.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs7648995	chr3:49438803	P4HTM	chr3:49027341-49044579:+	-0.21	-4.75	2.65E-6	Menarche (age at onset)	
KIRC	cis	1	rs7648995	chr3:49438803	TREX1	chr3:48501186-48509043:+	0.15	3.78	0.000179	Menarche (age at onset)	
KIRC	cis	1	rs7648995	chr3:49438803	WDR6	chr3:49044637-49053386:+	0.2	5.02	7.1E-7	Menarche (age at onset)	
KIRC	cis	1	rs76494403	chr10:81729731	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.77	11.59	1.13E-27	Diastolic blood pressure	
KIRC	cis	1	rs76506978	chr18:51790340	POLI	chr18:51795849-51824602:+	0.15	3.59	0.000362	Psoriasis	
KIRC	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.31	-9.03	3.64E-18	Longevity	
KIRC	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.29	8.31	9.05E-16	Longevity	
KIRC	cis	1	rs7654093	chr4:155545072	FGA	chr4:155504280-155511897:-	0.23	3.71	0.000235	Fibrinogen	
KIRC	cis	1	rs7654093	chr4:155545072	FGB	chr4:155484132-155492236:+	0.26	4.01	7.08E-5	Fibrinogen	
KIRC	cis	1	rs7654271	chr4:75708071	BTC	chr4:75671448-75719882:-	0.28	3.66	0.000281	Electroencephalogram traits	
KIRC	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.57	-9.87	3.9E-21	Tumor biomarkers	
KIRC	cis	1	rs76542740	chr15:43891512	STRC	chr15:43891762-43924561:-	0.21	4.33	1.8E-5	Tumor biomarkers	
KIRC	cis	1	rs76542740	chr15:43891512	TUBGCP4	chr15:43663313-43698238:+	0.19	4.08	5.19E-5	Tumor biomarkers	
KIRC	cis	1	rs7654345	chr4:17691796	LAP3	chr4:17578927-17609590:+	-0.2	-6.23	9.91E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7654345	chr4:17691796	MED28	chr4:17616273-17629791:+	0.2	4.57	6.25E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs76546854	chr10:81728658	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs76548544	chr5:150223515	IRGM	chr5:150226085-150280295:+	0.53	7.3	1.16E-12	Crohn's disease	
KIRC	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.87E-7	Crohn's disease	
KIRC	cis	1	rs7655122	chr4:39122016	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs76552490	chr11:212015	PSMD13	chr11:236808-252984:+	0.15	4.73	2.86E-6	Menarche (age at onset)	
KIRC	cis	1	rs765527	chr19:22129555	ZNF208	chr19:22115760-22193745:-	-0.29	-4.85	1.65E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.42	-7.53	2.43E-13	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs76553384	chr14:74383679	LIN52	chr14:74551656-74667117:+	0.26	4.54	7.15E-6	Morning vs. evening chronotype	
KIRC	cis	1	rs76553384	chr14:74383679	PTGR2	chr14:74318534-74352166:+	0.26	3.8	0.000165	Morning vs. evening chronotype	
KIRC	cis	1	rs7655399	chr4:75705096	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.43	6.91	1.5E-11	Chronic obstructive pulmonary disease (moderate to severe)	
KIRC	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.36	-6.46	2.44E-10	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs7657926	chr4:39134063	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs7658200	chr4:75712363	BTC	chr4:75671448-75719882:-	0.32	4.45	1.06E-5	Electroencephalogram traits	
KIRC	cis	1	rs7659024	chr4:155520930	FGB	chr4:155484132-155492236:+	0.24	3.75	0.000198	Fibrinogen	
KIRC	cis	1	rs76594057	chr18:44637272	HDHD2	chr18:44633782-44676871:-	0.37	3.87	0.000122	Sitting height ratio	
KIRC	cis	1	rs7659718	chr4:17638020	LAP3	chr4:17578927-17609590:+	-0.2	-6.31	6.09E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7659718	chr4:17638020	MED28	chr4:17616273-17629791:+	0.22	4.92	1.16E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.35	-6.2	1.17E-9	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs7661631	chr4:17679751	LAP3	chr4:17578927-17609590:+	0.21	6.35	4.95E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7661631	chr4:17679751	MED28	chr4:17616273-17629791:+	-0.16	-3.5	0.000502	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7664078	chr4:39118203	WDR19	chr4:39184024-39287429:+	0.19	5.01	7.72E-7	Uric acid levels	
KIRC	cis	1	rs76655667	chr8:89422327	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.43	7.33	9.17E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs76670717	chr4:171008689	AADAT	chr4:170981374-171011372:-	-0.43	-4.08	5.31E-5	Thyroid hormone levels	
KIRC	cis	1	rs7667849	chr4:56388199	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.91	0.000104	Personality dimensions	
KIRC	cis	1	rs7667849	chr4:56388199	TMEM165	chr4:56262090-56292342:+	0.22	6.16	1.48E-9	Personality dimensions	
KIRC	cis	1	rs7668147	chr4:56339384	SRD5A3	chr4:56212409-56237866:+	0.18	4.02	6.74E-5	Personality dimensions	
KIRC	cis	1	rs7668147	chr4:56339384	TMEM165	chr4:56262090-56292342:+	-0.23	-6.45	2.63E-10	Personality dimensions	
KIRC	cis	1	rs76683169	chr10:102358397	SEC31B	chr10:102246403-102289636:-	-0.14	-4.21	2.97E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs76688555	chr2:190747415	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.57	6.26E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs76693798	chr3:184711113	C3orf70	chr3:184795840-184870802:-	-0.19	-4.09	4.99E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs76694233	chr4:106681036	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7669892	chr4:309253	ZNF595	chr4:53227-196092:+	-0.19	-3.67	0.000268	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7669892	chr4:309253	ZNF718	chr4:53272-156488:+	-0.36	-7.55	2.01E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7670225	chr4:56368018	SRD5A3	chr4:56212409-56237866:+	0.18	3.96	8.48E-5	Personality dimensions	
KIRC	cis	1	rs7670225	chr4:56368018	TMEM165	chr4:56262090-56292342:+	-0.22	-6.1	2.06E-9	Personality dimensions	
KIRC	cis	1	rs7671752	chr4:17661398	LAP3	chr4:17578927-17609590:+	-0.22	-6.77	3.58E-11	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7671752	chr4:17661398	MED28	chr4:17616273-17629791:+	0.18	4.05	5.92E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.44	5.45	7.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs7672884	chr4:75707822	BTC	chr4:75671448-75719882:-	0.3	4.11	4.57E-5	Electroencephalogram traits	
KIRC	cis	1	rs7673299	chr4:39110758	WDR19	chr4:39184024-39287429:+	0.18	4.69	3.55E-6	Uric acid levels	
KIRC	cis	1	rs7673500	chr4:17621383	LAP3	chr4:17578927-17609590:+	-0.2	-6.24	9.53E-10	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7673500	chr4:17621383	MED28	chr4:17616273-17629791:+	0.23	5.35	1.32E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7673908	chr4:56394819	SRD5A3	chr4:56212409-56237866:+	-0.18	-4.01	7.03E-5	Personality dimensions	
KIRC	cis	1	rs7673908	chr4:56394819	TMEM165	chr4:56262090-56292342:+	0.23	6.28	7.46E-10	Personality dimensions	
KIRC	cis	1	rs76740259	chr15:56520860	TEX9	chr15:56657644-56738071:+	-0.28	-4.98	8.63E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs76745316	chr12:56627652	RPS26	chr12:56435686-56438005:+	-0.52	-4.38	1.47E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.44	7.68	8.18E-14	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs76751500	chr16:77785771	NUDT7	chr16:77756411-77776153:+	0.23	3.68	0.000261	Obesity-related traits	
KIRC	cis	1	rs7675782	chr4:39121668	WDR19	chr4:39184024-39287429:+	0.19	4.9	1.31E-6	Uric acid levels	
KIRC	cis	1	rs7676008	chr4:39121774	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs7676975	chr4:106763811	INTS12	chr4:106603787-106629881:-	-0.54	-6.68	6.27E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7677526	chr4:56349908	SRD5A3	chr4:56212409-56237866:+	0.18	4.04	6.17E-5	Personality dimensions	
KIRC	cis	1	rs7677526	chr4:56349908	TMEM165	chr4:56262090-56292342:+	-0.23	-6.51	1.84E-10	Personality dimensions	
KIRC	cis	1	rs7679608	chr4:76514201	CDKL2	chr4:76501705-76555721:-	0.16	3.57	0.000387	Magnesium levels	
KIRC	cis	1	rs76796947	chr5:115501040	COMMD10	chr5:115420727-115628978:+	0.31	3.68	0.000256	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7679	chr20:44576502	PLTP	chr20:44527397-44540786:-	0.15	3.55	0.000423	HDL cholesterol;Triglycerides;Gut microbiota (functional units)	
KIRC	cis	1	rs76804143	chr7:1082021	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.87	8.13E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7681116	chr4:39134635	WDR19	chr4:39184024-39287429:+	0.18	4.63	4.65E-6	Uric acid levels	
KIRC	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.81	8.47	2.69E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs7681423	chr4:155542248	FGA	chr4:155504280-155511897:-	0.25	4.04	6.22E-5	Fibrinogen	
KIRC	cis	1	rs7681423	chr4:155542248	FGB	chr4:155484132-155492236:+	0.29	4.43	1.16E-5	Fibrinogen	
KIRC	cis	1	rs7683315	chr4:88773095	MEPE	chr4:88754140-88767942:+	0.23	4.54	7.15E-6	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs76833820	chr7:1070278	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7685082	chr4:39118092	WDR19	chr4:39184024-39287429:+	0.19	5.01	7.72E-7	Uric acid levels	
KIRC	cis	1	rs76854106	chr11:73027110	RELT	chr11:73087405-73108518:+	0.21	4.13	4.19E-5	Pulmonary function (interaction)	
KIRC	cis	1	rs7685468	chr4:39118269	WDR19	chr4:39184024-39287429:+	0.19	4.97	9.11E-7	Uric acid levels	
KIRC	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.44	7.3	1.1E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7686578	chr4:75712726	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs76872831	chr5:150171559	IRGM	chr5:150226085-150280295:+	0.66	8.09	4.57E-15	Crohn's disease	
KIRC	cis	1	rs76872831	chr5:150171559	LOC134466	chr5:150310000-150326146:-	0.41	4.96	9.8E-7	Crohn's disease	
KIRC	cis	1	rs76873509	chr8:38021982	DDHD2	chr8:38089009-38120286:+	0.19	3.49	0.00052	Schizophrenia	
KIRC	cis	1	rs7687539	chr4:89806784	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.65	0.000293	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.34	-6.33	5.29E-10	Plasma amyloid beta peptide concentrations (ABx-40)	
KIRC	cis	1	rs7688014	chr4:103975060	MANBA	chr4:103552644-103682151:-	0.2	4.69	3.57E-6	Schizophrenia	
KIRC	cis	1	rs7688682	chr4:17693794	LAP3	chr4:17578927-17609590:+	0.19	5.92	5.93E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7688682	chr4:17693794	MED28	chr4:17616273-17629791:+	-0.21	-4.76	2.48E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs76901676	chr1:179452520	C1orf125	chr1:179335107-179523868:+	0.46	5.3	1.75E-7	Multiple sclerosis (age of onset)	
KIRC	cis	1	rs76904798	chr12:40614434	LRRK2	chr12:40618813-40763084:+	0.26	4.74	2.79E-6	Parkinson's disease	
KIRC	cis	1	rs7690734	chr4:76537889	CDKL2	chr4:76501705-76555721:-	0.18	4.07	5.47E-5	Magnesium levels	
KIRC	cis	1	rs7691313	chr4:108941174	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs7691506	chr4:108941283	HADH	chr4:108910940-108956330:+	-0.26	-3.7	0.000243	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs7692290	chr4:75712720	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs7692503	chr4:75712852	BTC	chr4:75671448-75719882:-	0.3	4.13	4.21E-5	Electroencephalogram traits	
KIRC	cis	1	rs7692669	chr4:75712905	BTC	chr4:75671448-75719882:-	0.3	4.13	4.19E-5	Electroencephalogram traits	
KIRC	cis	1	rs7694020	chr4:17682597	LAP3	chr4:17578927-17609590:+	-0.23	-7.02	7.23E-12	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7694379	chr4:88186509	HSD17B11	chr4:88257691-88312455:-	0.18	4.02	6.81E-5	Platelet count	
KIRC	cis	1	rs7694760	chr4:39128101	WDR19	chr4:39184024-39287429:+	0.18	4.67	3.95E-6	Uric acid levels	
KIRC	cis	1	rs76949596	chr1:75862560	SLC44A5	chr1:75667816-76143610:-	-0.36	-3.59	0.000357	Whole-brain volume (Alzheimer's disease interaction)	
KIRC	cis	1	rs7695732	chr4:89832791	FAM13AOS	chr4:89630940-89651254:+	-0.12	-3.54	0.00044	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs76959488	chr11:30376314	C11orf46	chr11:30344649-30359978:+	0.29	4.48	9.42E-6	Sex hormone levels;Menopause (age at onset)	
KIRC	cis	1	rs76964550	chr10:81729733	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs76974730	chr17:80533261	FN3KRP	chr17:80674582-80685889:+	-0.37	-3.53	0.000449	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs7697889	chr4:17617961	LAP3	chr4:17578927-17609590:+	-0.2	-6.16	1.49E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs7697889	chr4:17617961	MED28	chr4:17616273-17629791:+	0.23	5.32	1.57E-7	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	1.09	18.89	1.61E-60	Heschl's gyrus morphology	
KIRC	cis	1	rs76994419	chr15:40714150	IVD	chr15:40697686-40713512:+	-0.35	-5.38	1.17E-7	Heschl's gyrus morphology	
KIRC	cis	1	rs77020228	chr12:124418472	CCDC92	chr12:124420955-124457163:-	0.19	4.87	1.47E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs77022811	chr2:190793046	ASNSD1	chr2:190526125-190535556:+	-0.3	-4.21	3.01E-5	Subcutaneous adipose tissue	
KIRC	cis	1	rs77032009	chr12:56679971	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.2	-4.84	1.71E-6	Birdshot chorioretinopathy	
KIRC	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.11	34.02	1.96E-132	Birdshot chorioretinopathy	
KIRC	cis	1	rs7705542	chr5:150228318	IRGM	chr5:150226085-150280295:+	0.54	7.37	6.86E-13	Crohn's disease	
KIRC	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.38	5.08	5.43E-7	Crohn's disease	
KIRC	cis	1	rs7705653	chr5:110142816	TMEM232	chr5:109624934-110062381:-	0.28	5.25	2.29E-7	Asthma and hay fever	
KIRC	cis	1	rs7705658	chr5:78315305	ARSB	chr5:78073039-78282357:-	-0.2	-4.15	3.88E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7705658	chr5:78315305	BHMT	chr5:78407604-78428112:+	-0.26	-5.31	1.69E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs77066891	chr3:184553376	C3orf70	chr3:184795840-184870802:-	-0.18	-3.94	9.24E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.44	7.66	9.8E-14	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs77083167	chr7:1071823	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.83	9.96E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7709388	chr5:150246539	IRGM	chr5:150226085-150280295:+	0.53	7.31	1.08E-12	Crohn's disease	
KIRC	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.11E-7	Crohn's disease	
KIRC	cis	1	rs7709464	chr5:150269441	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs7709472	chr5:78315151	ARSB	chr5:78073039-78282357:-	-0.2	-4.27	2.37E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7709472	chr5:78315151	BHMT	chr5:78407604-78428112:+	-0.25	-5.31	1.69E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7709650	chr5:150246685	IRGM	chr5:150226085-150280295:+	0.57	7.55	2.07E-13	Crohn's disease	
KIRC	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.0E-5	Crohn's disease	
KIRC	cis	1	rs7709757	chr5:78315329	ARSB	chr5:78073039-78282357:-	-0.2	-4.15	3.88E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7709757	chr5:78315329	BHMT	chr5:78407604-78428112:+	-0.26	-5.31	1.69E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7710963	chr5:110164629	TMEM232	chr5:109624934-110062381:-	0.23	4.45	1.08E-5	Asthma and hay fever	
KIRC	cis	1	rs77120931	chr12:56646213	RPS26	chr12:56435686-56438005:+	-0.49	-4.2	3.14E-5	Psoriasis vulgaris	
KIRC	cis	1	rs77127734	chr11:73018413	RELT	chr11:73087405-73108518:+	0.18	3.74	0.000206	Pulmonary function (interaction)	
KIRC	cis	1	rs77127860	chr2:192565400	OBFC2A	chr2:192542798-192553247:+	0.18	3.54	0.000442	Colorectal cancer	
KIRC	cis	1	rs77131854	chr12:56664231	COQ10A	chr12:56660642-56664748:+	-0.36	-3.64	0.000295	Psoriasis vulgaris	
KIRC	cis	1	rs77131854	chr12:56664231	RPS26	chr12:56435686-56438005:+	-0.51	-4.35	1.68E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7714415	chr5:150270292	IRGM	chr5:150226085-150280295:+	0.47	6.51	1.84E-10	Crohn's disease	
KIRC	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.32	4.45	1.05E-5	Crohn's disease	
KIRC	cis	1	rs7714584	chr5:150270420	IRGM	chr5:150226085-150280295:+	0.5	6.88	1.8E-11	Crohn's disease	
KIRC	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.32	4.34	1.69E-5	Crohn's disease	
KIRC	cis	1	rs77148055	chr5:115509920	COMMD10	chr5:115420727-115628978:+	0.38	3.93	9.69E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7715981	chr5:150258107	IRGM	chr5:150226085-150280295:+	0.52	7.09	4.49E-12	Crohn's disease	
KIRC	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.32	4.28	2.23E-5	Crohn's disease	
KIRC	cis	1	rs7716903	chr5:150258574	IRGM	chr5:150226085-150280295:+	0.52	7.06	5.53E-12	Crohn's disease	
KIRC	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.32	4.3	2.06E-5	Crohn's disease	
KIRC	cis	1	rs77186616	chr6:161079003	PLG	chr6:161123274-161174345:+	0.28	3.89	0.000113	Triglycerides	
KIRC	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.88	8.45	3.13E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs7719994	chr5:156430076	HAVCR1	chr5:156456531-156486130:-	-0.45	-10.06	8.1E-22	Hypertriglyceridemia	
KIRC	cis	1	rs7719994	chr5:156430076	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.66	9.65E-14	Hypertriglyceridemia	
KIRC	cis	1	rs7719994	chr5:156430076	TIMD4	chr5:156346293-156390266:-	-0.37	-6.86	2.01E-11	Hypertriglyceridemia	
KIRC	cis	1	rs77214986	chr16:4603722	NMRAL1	chr16:4511696-4526307:-	-0.29	-3.61	0.00034	Obesity-related traits	
KIRC	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.44	7.25	1.6E-12	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7724036	chr5:150284808	IRGM	chr5:150226085-150280295:+	-0.42	-6.19	1.27E-9	Crohn's disease	
KIRC	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.33	-4.85	1.62E-6	Crohn's disease	
KIRC	cis	1	rs7724558	chr5:150328866	IRGM	chr5:150226085-150280295:+	0.52	6.2	1.16E-9	Crohn's disease	
KIRC	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.42	4.99	8.39E-7	Crohn's disease	
KIRC	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.25	-3.8	0.000164	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs7726556	chr5:156478780	HAVCR1	chr5:156456531-156486130:-	-0.4	-8.89	1.13E-17	Hypertriglyceridemia	
KIRC	cis	1	rs7726556	chr5:156478780	HAVCR2	chr5:156512843-156536138:-	-0.38	-7.22	1.91E-12	Hypertriglyceridemia	
KIRC	cis	1	rs7726556	chr5:156478780	TIMD4	chr5:156346293-156390266:-	-0.29	-5.41	9.97E-8	Hypertriglyceridemia	
KIRC	cis	1	rs77266205	chr4:171123106	AADAT	chr4:170981374-171011372:-	-0.4	-3.99	7.44E-5	Thyroid hormone levels	
KIRC	cis	1	rs7727038	chr5:131590257	PDLIM4	chr5:131593351-131609145:+	-0.22	-4.26	2.39E-5	Blood metabolite levels	
KIRC	cis	1	rs7727544	chr5:131590534	PDLIM4	chr5:131593351-131609145:+	-0.22	-4.26	2.39E-5	Blood metabolite levels	
KIRC	cis	1	rs7728181	chr5:60947302	FLJ37543	chr5:60933636-61002362:+	0.22	3.6	0.000349	Alzheimer's disease	
KIRC	cis	1	rs7728612	chr5:110164674	TMEM232	chr5:109624934-110062381:-	0.23	4.45	1.08E-5	Asthma and hay fever	
KIRC	cis	1	rs7729274	chr5:156935908	ADAM19	chr5:156822542-157002768:-	0.12	4.36	1.59E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs7729926	chr5:137514641	CDC25C	chr5:137620959-137674044:-	-0.21	-6.04	2.93E-9	Resting heart rate	
KIRC	cis	1	rs77305932	chr7:1100861	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.53E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7731142	chr5:78325519	ARSB	chr5:78073039-78282357:-	-0.2	-4.29	2.18E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7731142	chr5:78325519	BHMT	chr5:78407604-78428112:+	-0.26	-5.55	4.69E-8	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7731142	chr5:78325519	DMGDH	chr5:78293430-78365449:-	-0.14	-3.8	0.000164	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs77314892	chr4:171013752	AADAT	chr4:170981374-171011372:-	-0.46	-4.4	1.33E-5	Thyroid hormone levels	
KIRC	cis	1	rs7732643	chr5:150261436	IRGM	chr5:150226085-150280295:+	0.5	6.78	3.3E-11	Crohn's disease	
KIRC	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.33	4.44	1.1E-5	Crohn's disease	
KIRC	cis	1	rs7732945	chr5:150261601	IRGM	chr5:150226085-150280295:+	0.51	6.87	1.89E-11	Crohn's disease	
KIRC	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.31	4.21	3.05E-5	Crohn's disease	
KIRC	cis	1	rs77346188	chr7:1114023	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.6	3.62E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7734635	chr5:110158844	TMEM232	chr5:109624934-110062381:-	0.24	4.74	2.78E-6	Asthma and hay fever	
KIRC	cis	1	rs7734778	chr5:150256556	IRGM	chr5:150226085-150280295:+	0.55	7.59	1.52E-13	Crohn's disease	
KIRC	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.38	5.12	4.28E-7	Crohn's disease	
KIRC	cis	1	rs7734928	chr5:150256613	IRGM	chr5:150226085-150280295:+	0.56	7.7	7.45E-14	Crohn's disease	
KIRC	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.36	4.89	1.34E-6	Crohn's disease	
KIRC	cis	1	rs7735031	chr5:78325380	ARSB	chr5:78073039-78282357:-	-0.2	-4.35	1.68E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7735031	chr5:78325380	BHMT	chr5:78407604-78428112:+	-0.25	-5.28	1.9E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs7735519	chr5:110153341	TMEM232	chr5:109624934-110062381:-	0.29	5.4	1.03E-7	Asthma and hay fever	
KIRC	cis	1	rs7735635	chr5:137508336	CDC25C	chr5:137620959-137674044:-	0.22	6.11	1.96E-9	Resting heart rate	
KIRC	cis	1	rs7736554	chr5:150258308	IRGM	chr5:150226085-150280295:+	0.52	7.06	5.53E-12	Crohn's disease	
KIRC	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.32	4.3	2.06E-5	Crohn's disease	
KIRC	cis	1	rs7736873	chr5:150258482	IRGM	chr5:150226085-150280295:+	0.51	6.99	8.74E-12	Crohn's disease	
KIRC	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.33	4.47	9.84E-6	Crohn's disease	
KIRC	cis	1	rs77374467	chr6:24475278	MRS2	chr6:24403153-24425809:+	0.24	3.69	0.00025	Hematological and biochemical traits	
KIRC	cis	1	rs7740107	chr6:130374461	L3MBTL3	chr6:130339734-130462584:+	-0.2	-3.92	0.000102	Height	
KIRC	cis	1	rs7740487	chr6:28216486	ZNF187	chr6:28234788-28245978:+	-0.27	-4.69	3.47E-6	Depression	
KIRC	cis	1	rs7740487	chr6:28216486	ZNF323	chr6:28292517-28324048:-	0.27	3.68	0.000257	Depression	
KIRC	cis	1	rs7740487	chr6:28216486	ZSCAN23	chr6:28393287-28411279:-	0.26	3.67	0.000267	Depression	
KIRC	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.2	4.54	7.12E-6	Brain structure	
KIRC	cis	1	rs7742626	chr6:136132496	C6orf217	chr6:135818939-136037192:+	0.25	4.9	1.31E-6	Phosphorus levels	
KIRC	cis	1	rs7743683	chr6:153432985	MTRF1L	chr6:153308401-153323925:-	0.18	3.56	0.000403	Prostate cancer	
KIRC	cis	1	rs77447765	chr12:56690662	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7747003	chr6:153428982	MTRF1L	chr6:153308401-153323925:-	0.19	3.69	0.000246	Prostate cancer	
KIRC	cis	1	rs77477310	chr14:35615793	KIAA0391	chr14:35591776-35786673:+	0.22	3.7	0.00024	Atopic dermatitis	
KIRC	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.24	4.74	2.78E-6	Atopic dermatitis	
KIRC	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.47	-10.53	1.45E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs77489187	chr4:171002401	AADAT	chr4:170981374-171011372:-	-0.49	-4.46	9.98E-6	Thyroid hormone levels	
KIRC	cis	1	rs7749032	chr6:88316186	C6orf164	chr6:88032306-88109459:+	0.3	3.75	0.0002	Obesity-related traits	
KIRC	cis	1	rs7749685	chr6:38357890	BTBD9	chr6:38136228-38607924:-	-0.16	-3.73	0.000215	Restless legs syndrome	
KIRC	cis	1	rs7750775	chr6:88246451	C6orf164	chr6:88032306-88109459:+	0.27	3.5	0.000509	Obesity-related traits	
KIRC	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.41	-9.64	2.67E-20	Folate pathway vitamin levels	
KIRC	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.25	8.47	2.81E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs7752408	chr6:161021873	PLG	chr6:161123274-161174345:+	0.26	5.17	3.45E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	1.04	18.55	6.81E-59	Heschl's gyrus morphology	
KIRC	cis	1	rs77531164	chr15:40673466	IVD	chr15:40697686-40713512:+	-0.35	-5.46	7.44E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7755323	chr6:33761159	LEMD2	chr6:33738991-33756906:-	0.23	5.31	1.68E-7	Body mass index	
KIRC	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs77562891	chr18:51791235	POLI	chr18:51795849-51824602:+	0.15	3.59	0.000362	Psoriasis	
KIRC	cis	1	rs77564939	chr5:115564294	COMMD10	chr5:115420727-115628978:+	0.33	3.86	0.000126	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs77565539	chr10:81732604	LOC219347	chr10:81805991-81838949:-	0.48	4.5	8.33E-6	Rheumatoid arthritis	
KIRC	cis	1	rs77565539	chr10:81732604	LOC650623	chr10:81442731-81448648:+	-0.31	-3.61	0.000334	Rheumatoid arthritis	
KIRC	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.2	-4.52	7.6E-6	Brain structure	
KIRC	cis	1	rs77584282	chr9:123672383	DAB2IP	chr9:124329399-124547807:+	-0.32	-3.57	0.000386	Pre-treatment pain in head and neck squamous cell carcinoma	
KIRC	cis	1	rs7759001	chr6:27341409	ZNF391	chr6:27356524-27369227:+	0.33	6.45	2.58E-10	Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.48	-12.06	1.38E-29	Homocysteine levels	
KIRC	cis	1	rs7759633	chr6:161070990	PLG	chr6:161123274-161174345:+	0.28	3.84	0.000138	Triglycerides	
KIRC	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.47	-10.35	6.88E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs7760585	chr6:161070870	PLG	chr6:161123274-161174345:+	0.25	5.01	7.65E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs77613724	chr10:81730629	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs77613724	chr10:81730629	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs7761377	chr6:161032481	PLG	chr6:161123274-161174345:+	0.29	5.88	7.47E-9	Lipoprotein (a) levels	
KIRC	cis	1	rs77642814	chr6:101118450	GRIK2	chr6:101846905-102517957:+	0.65	6.47	2.32E-10	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs7764502	chr6:38366137	BTBD9	chr6:38136228-38607924:-	-0.17	-3.72	0.00022	Restless legs syndrome	
KIRC	cis	1	rs7764785	chr6:163009967	PACRG	chr6:163148164-163736523:+	0.47	6.09	2.27E-9	Body mass index	
KIRC	cis	1	rs7766214	chr6:38363168	BTBD9	chr6:38136228-38607924:-	-0.17	-3.92	9.9E-5	Restless legs syndrome	
KIRC	cis	1	rs77665099	chr4:171024601	AADAT	chr4:170981374-171011372:-	-0.41	-4.21	3.01E-5	Thyroid hormone levels	
KIRC	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.21E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs77678056	chr6:126019738	HEY2	chr6:126068780-126082414:+	0.18	4.3	2.09E-5	Endometrial cancer	
KIRC	cis	1	rs7769686	chr6:163199467	PACRG	chr6:163148164-163736523:+	0.52	6.2	1.2E-9	Body mass index	
KIRC	cis	1	rs7769720	chr6:161023620	PLG	chr6:161123274-161174345:+	0.26	5.18	3.23E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs77698001	chr5:150250367	IRGM	chr5:150226085-150280295:+	0.56	7.4	5.83E-13	Crohn's disease	
KIRC	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.35	4.52	7.71E-6	Crohn's disease	
KIRC	cis	1	rs77702926	chr7:1088838	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.83	1.01E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7771129	chr6:161018464	PLG	chr6:161123274-161174345:+	0.25	4.99	8.48E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.46	-9.96	1.86E-21	Response to antipsychotic treatment	
KIRC	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.46	-11.27	2.1E-26	Homocysteine levels	
KIRC	cis	1	rs77760339	chr7:1083927	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.87	8.13E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs77763497	chr20:3250007	ITPA	chr20:3190056-3204504:+	-0.28	-6.48	2.26E-10	IFN-related cytopenia	
KIRC	cis	1	rs77768890	chr12:56725121	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs77768890	chr12:56725121	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.4	-7.67	8.9E-14	Obesity-related traits	
KIRC	cis	1	rs7777389	chr7:143744802	OR2A1	chr7:144015236-144016148:+;chr7	-0.3	-5.53	5.02E-8	Obesity-related traits	
KIRC	cis	1	rs7777389	chr7:143744802	OR2A9P	chr7:143991573-143997832:+;chr7	-0.47	-8.59	1.11E-16	Obesity-related traits	
KIRC	cis	1	rs7777754	chr7:50666033	FIGNL1	chr7:50511834-50518088:-	0.16	3.55	0.000422	Response to zileuton treatment in asthma (FEV1 change interaction)	
KIRC	cis	1	rs7778258	chr7:50666378	FIGNL1	chr7:50511834-50518088:-	-0.21	-4.47	9.59E-6	Response to zileuton treatment in asthma (FEV1 change interaction)	
KIRC	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.63	2.96E-8	Diabetic kidney disease	
KIRC	cis	1	rs7778911	chr7:65694506	CRCP	chr7:65579805-65619551:+	0.31	4.25	2.51E-5	Diabetic kidney disease	
KIRC	cis	1	rs7778911	chr7:65694506	LOC493754	chr7:65993446-66057363:-	-0.23	-3.6	0.000349	Diabetic kidney disease	
KIRC	cis	1	rs7781266	chr7:133505101	SLC35B4	chr7:133974091-134001827:-	0.25	4.26	2.43E-5	Educational attainment (college completion)	
KIRC	cis	1	rs7781698	chr7:65896312	LOC729156	chr7:66274980-66309813:-	0.17	3.59	0.000368	Aortic root size	
KIRC	cis	1	rs7782320	chr7:66177098	LOC493754	chr7:65993446-66057363:-	-0.16	-3.54	0.000432	Aortic root size	
KIRC	cis	1	rs77832597	chr17:76083611	LGALS3BP	chr17:76967336-76976061:-	0.22	3.49	0.000527	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs7783924	chr7:66209057	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000197	Aortic root size	
KIRC	cis	1	rs77849630	chr5:115556900	COMMD10	chr5:115420727-115628978:+	0.39	4.04	6.06E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7785213	chr7:66138978	LOC493754	chr7:65993446-66057363:-	0.17	3.7	0.000239	Aortic root size	
KIRC	cis	1	rs77853814	chr12:56687572	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs77855653	chr4:171024744	AADAT	chr4:170981374-171011372:-	-0.41	-4.21	3.01E-5	Thyroid hormone levels	
KIRC	cis	1	rs77856716	chr5:115565660	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.27	5.39	1.11E-7	Diabetic kidney disease	
KIRC	cis	1	rs778679	chr7:65840911	CRCP	chr7:65579805-65619551:+	-0.33	-4.54	6.92E-6	Diabetic kidney disease	
KIRC	cis	1	rs77868187	chr7:1093968	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.27	5.39	1.11E-7	Diabetic kidney disease	
KIRC	cis	1	rs778691	chr7:65873092	CRCP	chr7:65579805-65619551:+	-0.33	-4.54	6.92E-6	Diabetic kidney disease	
KIRC	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.27	5.39	1.11E-7	Diabetic kidney disease	
KIRC	cis	1	rs778704	chr7:65863467	CRCP	chr7:65579805-65619551:+	-0.33	-4.54	6.92E-6	Diabetic kidney disease	
KIRC	cis	1	rs7787230	chr7:65629099	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.79E-9	Diabetic kidney disease	
KIRC	cis	1	rs7787230	chr7:65629099	CRCP	chr7:65579805-65619551:+	0.32	4.42	1.22E-5	Diabetic kidney disease	
KIRC	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.27	5.43	8.96E-8	Diabetic kidney disease	
KIRC	cis	1	rs778729	chr7:65824419	CRCP	chr7:65579805-65619551:+	-0.33	-4.51	8.0E-6	Diabetic kidney disease	
KIRC	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.14	-6.6	1.05E-10	Tuberculosis	
KIRC	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.57	11.65	6.38E-28	Tuberculosis	
KIRC	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.14	-6.44	2.83E-10	Tuberculosis	
KIRC	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.55	11.39	6.59E-27	Tuberculosis	
KIRC	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.14	-6.53	1.65E-10	Tuberculosis	
KIRC	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.57	11.61	9.46E-28	Tuberculosis	
KIRC	cis	1	rs7788576	chr7:66148302	LOC493754	chr7:65993446-66057363:-	0.17	3.8	0.000163	Aortic root size	
KIRC	cis	1	rs7789184	chr7:66210195	LOC493754	chr7:65993446-66057363:-	-0.17	-3.75	0.000197	Aortic root size	
KIRC	cis	1	rs77902909	chr6:24478715	MRS2	chr6:24403153-24425809:+	0.28	4.11	4.7E-5	Hematological and biochemical traits	
KIRC	cis	1	rs77904669	chr2:180105420	CCDC141	chr2:179697347-179914786:-	-0.31	-3.74	0.000204	Late-onset Alzheimer's disease	
KIRC	cis	1	rs77906836	chr2:190768109	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.48	9.08E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.28	-5.53	5.26E-8	Diabetic kidney disease	
KIRC	cis	1	rs7792391	chr7:65773429	CRCP	chr7:65579805-65619551:+	0.32	4.4	1.3E-5	Diabetic kidney disease	
KIRC	cis	1	rs7794279	chr7:3341806	SDK1	chr7:3341080-4308629:+	-0.18	-3.51	0.000491	Motion sickness	
KIRC	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.28	5.58	3.89E-8	Diabetic kidney disease	
KIRC	cis	1	rs7794661	chr7:65389730	CRCP	chr7:65579805-65619551:+	-0.32	-4.41	1.24E-5	Diabetic kidney disease	
KIRC	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.28	5.61	3.32E-8	Diabetic kidney disease	
KIRC	cis	1	rs7795242	chr7:65390094	CRCP	chr7:65579805-65619551:+	-0.31	-4.32	1.9E-5	Diabetic kidney disease	
KIRC	cis	1	rs77957229	chr6:26185226	HIST1H3E	chr6:26224427-26226589:+	0.34	3.99	7.58E-5	Renal underexcretion gout;Gout	
KIRC	cis	1	rs77961951	chr6:26186075	HIST1H3E	chr6:26224427-26226589:+	0.34	3.99	7.58E-5	Renal underexcretion gout;Gout	
KIRC	cis	1	rs77965541	chr14:52876841	TXNDC16	chr14:52897309-53019301:-	-0.16	-3.52	0.000467	Smooth-surface caries	
KIRC	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs78014296	chr17:80532744	FN3KRP	chr17:80674582-80685889:+	-0.37	-3.53	0.000449	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs78027130	chr4:171019411	AADAT	chr4:170981374-171011372:-	-0.42	-4.32	1.89E-5	Thyroid hormone levels	
KIRC	cis	1	rs78032828	chr2:86309032	LOC90784	chr2:86247339-86250991:-	-0.36	-3.82	0.000152	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
KIRC	cis	1	rs78036474	chr16:77785721	NUDT7	chr16:77756411-77776153:+	0.23	3.59	0.000367	Obesity-related traits	
KIRC	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.7	2.02E-8	Diabetic kidney disease	
KIRC	cis	1	rs7804223	chr7:65664559	CRCP	chr7:65579805-65619551:+	0.32	4.35	1.67E-5	Diabetic kidney disease	
KIRC	cis	1	rs7804223	chr7:65664559	LOC493754	chr7:65993446-66057363:-	-0.22	-3.5	0.000506	Diabetic kidney disease	
KIRC	cis	1	rs78075030	chr6:55987294	COL21A1	chr6:55921389-56258892:-	-0.47	-7.26	1.52E-12	Psychosis (atypical)	
KIRC	cis	1	rs7809615	chr7:99184778	CNPY4	chr7:99717265-99723126:+	-0.24	-3.74	0.000206	Blood metabolite ratios	
KIRC	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.27	5.43	8.97E-8	Diabetic kidney disease	
KIRC	cis	1	rs781142	chr7:65438778	CRCP	chr7:65579805-65619551:+	-0.33	-4.53	7.37E-6	Diabetic kidney disease	
KIRC	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.29	5.93	5.5E-9	Diabetic kidney disease	
KIRC	cis	1	rs781149	chr7:65481284	CRCP	chr7:65579805-65619551:+	-0.29	-4.05	5.93E-5	Diabetic kidney disease	
KIRC	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.29	5.9	6.87E-9	Diabetic kidney disease	
KIRC	cis	1	rs781150	chr7:65480973	CRCP	chr7:65579805-65619551:+	-0.3	-4.18	3.5E-5	Diabetic kidney disease	
KIRC	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.29	5.9	6.61E-9	Diabetic kidney disease	
KIRC	cis	1	rs781156	chr7:65479141	CRCP	chr7:65579805-65619551:+	-0.29	-4.09	5.12E-5	Diabetic kidney disease	
KIRC	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.29	5.87	8.05E-9	Diabetic kidney disease	
KIRC	cis	1	rs781157	chr7:65478311	CRCP	chr7:65579805-65619551:+	-0.29	-4.05	6.04E-5	Diabetic kidney disease	
KIRC	cis	1	rs78121408	chr12:56684798	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs78133532	chr18:51794210	POLI	chr18:51795849-51824602:+	0.15	3.66	0.000275	Psoriasis	
KIRC	cis	1	rs78143408	chr7:1096846	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs78149779	chr12:56694817	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	1.04	18.55	6.81E-59	Heschl's gyrus morphology	
KIRC	cis	1	rs78153629	chr15:40673465	IVD	chr15:40697686-40713512:+	-0.35	-5.46	7.44E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs78158942	chr7:1090440	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.76	1.51E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs78172786	chr17:61847114	FTSJ3	chr17:61896795-61905031:-	0.32	6.31	6.2E-10	Body mass index	
KIRC	cis	1	rs78172786	chr17:61847114	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.56	6.42E-6	Body mass index	
KIRC	cis	1	rs78185558	chr7:1090183	ZFAND2A	chr7:1192544-1199855:-	-0.35	-6.04	2.93E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs78185801	chr7:1096367	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs78186489	chr22:29845703	RFPL1S	chr22:29833006-29838118:-	-0.27	-5.06	6.03E-7	Carotid atherosclerosis in HIV infection	
KIRC	cis	1	rs7818688	chr8:96024082	C8orf38	chr8:95908040-96088396:+	-0.25	-3.8	0.00016	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs7819898	chr8:89452923	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs7820191	chr8:89453170	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs78223982	chr1:76465203	MSH4	chr1:76262630-76378923:+	-0.26	-3.81	0.000158	Attention function in attention deficit hyperactive disorder	
KIRC	cis	1	rs7824557	chr8:11104111	AMAC1L2	chr8:11188495-11189695:+	0.2	4.26	2.45E-5	Retinal vascular caliber	
KIRC	cis	1	rs78246812	chr3:184761338	C3orf70	chr3:184795840-184870802:-	-0.17	-3.84	0.000139	Heschl's gyrus morphology	
KIRC	cis	1	rs7825171	chr8:89424098	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs782590	chr2:55843413	PNPT1	chr2:55861198-55921011:-	-0.15	-3.6	0.000354	Metabolic syndrome	
KIRC	cis	1	rs782594	chr2:55844445	PNPT1	chr2:55861198-55921011:-	-0.15	-3.6	0.000353	Metabolic syndrome	
KIRC	cis	1	rs78267272	chr2:17790782	SMC6	chr2:17845080-17981462:-	-0.31	-3.78	0.000177	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs78268237	chr8:89422511	MMP16	chr8:89049462-89339717:-	0.31	4.26	2.46E-5	Electrodermal activity	
KIRC	cis	1	rs7828207	chr8:110130010	TMEM74	chr8:109619080-109799770:-	-0.19	-3.68	0.000257	Body mass (lean)	
KIRC	cis	1	rs7828596	chr8:89449818	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs78300366	chr11:71205514	DHCR7	chr11:71145459-71159477:-	-0.29	-4.73	2.87E-6	Vitamin D levels	
KIRC	cis	1	rs78308415	chr7:1072634	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.79	1.23E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7832552	chr8:110115676	TMEM74	chr8:109619080-109799770:-	-0.2	-3.81	0.000157	Body mass (lean)	
KIRC	cis	1	rs7832570	chr8:96023795	C8orf38	chr8:95908040-96088396:+	-0.25	-3.85	0.000135	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs783396	chr6:106987370	RTN4IP1	chr6:107018905-107078366:-	-0.32	-3.51	0.000497	Stroke	
KIRC	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.44	7.54	2.19E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs78345298	chr2:192565012	OBFC2A	chr2:192542798-192553247:+	0.18	3.53	0.000457	Colorectal cancer	
KIRC	cis	1	rs7834588	chr8:63883593	GGH	chr8:63927643-63951610:-	0.21	3.99	7.5E-5	Response to Vitamin E supplementation	
KIRC	cis	1	rs78347018	chr6:161025797	PLG	chr6:161123274-161174345:+	0.28	3.91	0.000103	Triglycerides	
KIRC	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.1	3.56	0.000399	Schizophrenia	
KIRC	cis	1	rs7835613	chr8:143682428	ARC	chr8:143692410-143695833:-	0.28	5.87	8.01E-9	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs78362565	chr5:115564293	COMMD10	chr5:115420727-115628978:+	0.35	3.95	8.87E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs78398345	chr19:12154448	ZNF763	chr19:12035900-12091196:+	-0.36	-4.99	8.14E-7	Multiple sclerosis	
KIRC	cis	1	rs7840103	chr8:89462721	MMP16	chr8:89049462-89339717:-	0.31	4.04	6.28E-5	Electrodermal activity	
KIRC	cis	1	rs78420872	chr6:24464429	MRS2	chr6:24403153-24425809:+	0.26	3.92	0.000103	Hematological and biochemical traits	
KIRC	cis	1	rs7842192	chr8:124092625	DERL1	chr8:124025568-124054648:-	0.21	3.51	0.000487	Diabetic kidney disease	
KIRC	cis	1	rs784288	chr3:168971231	GPR160	chr3:169755735-169803181:+	-0.17	-3.75	0.000197	Osteoporosis	
KIRC	cis	1	rs78449408	chr10:81730699	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs78449408	chr10:81730699	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs7845586	chr8:89449435	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.00011	Electrodermal activity	
KIRC	cis	1	rs78461346	chr17:80524184	FN3KRP	chr17:80674582-80685889:+	-0.37	-3.53	0.000449	3-hydroxypropylmercapturic acid levels in smokers	
KIRC	cis	1	rs78465528	chr5:115474406	COMMD10	chr5:115420727-115628978:+	0.35	3.61	0.000334	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7849160	chr9:131874552	SET	chr9:131445934-131458674:+	-0.18	-3.89	0.000115	Blood metabolite ratios	
KIRC	cis	1	rs7849270	chr9:131874641	SET	chr9:131445934-131458674:+	-0.18	-3.93	9.75E-5	Blood metabolite ratios	
KIRC	cis	1	rs78495928	chr12:56635080	RPS26	chr12:56435686-56438005:+	-0.52	-4.38	1.47E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7850311	chr9:38060968	DCAF10	chr9:37800551-37867663:+	-0.16	-4.22	2.95E-5	Brain structure	
KIRC	cis	1	rs78523927	chr7:1089458	ZFAND2A	chr7:1192544-1199855:-	-0.35	-5.83	1.01E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7853377	chr9:86552205	GKAP1	chr9:86354337-86444431:-	-0.21	-4.52	7.8E-6	Height	
KIRC	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.03	3.81E-18	Body mass index	
KIRC	cis	1	rs785464	chr1:46523089	MUTYH	chr1:45794915-45806142:-	0.13	3.85	0.000135	Body mass index	
KIRC	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.89	1.13E-17	Body mass index	
KIRC	cis	1	rs785471	chr1:46518677	MUTYH	chr1:45794915-45806142:-	0.13	3.84	0.00014	Body mass index	
KIRC	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.59	1.1E-16	Body mass index	
KIRC	cis	1	rs785479	chr1:46492144	MUTYH	chr1:45794915-45806142:-	0.13	3.94	9.18E-5	Body mass index	
KIRC	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	4.08E-18	Body mass index	
KIRC	cis	1	rs785481	chr1:46554518	MUTYH	chr1:45794915-45806142:-	0.14	4	7.33E-5	Body mass index	
KIRC	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785485	chr1:46574424	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785488	chr1:46576095	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.01	4.3E-18	Body mass index	
KIRC	cis	1	rs785489	chr1:46576390	MUTYH	chr1:45794915-45806142:-	0.14	4.02	6.63E-5	Body mass index	
KIRC	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785491	chr1:46583418	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.93	7.97E-18	Body mass index	
KIRC	cis	1	rs785492	chr1:46583607	MUTYH	chr1:45794915-45806142:-	0.13	3.96	8.72E-5	Body mass index	
KIRC	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785494	chr1:46586626	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.46	-8.83	1.75E-17	Body mass index	
KIRC	cis	1	rs785495	chr1:46587887	MUTYH	chr1:45794915-45806142:-	0.13	3.89	0.000112	Body mass index	
KIRC	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785503	chr1:46595868	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.02	3.9E-18	Body mass index	
KIRC	cis	1	rs785520	chr1:46568836	MUTYH	chr1:45794915-45806142:-	0.14	4	7.2E-5	Body mass index	
KIRC	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.2	-4.99	8.52E-7	Blood metabolite ratios	
KIRC	cis	1	rs7855278	chr9:131921365	PPP2R4	chr9:131873244-131911223:+	-0.24	-4.56	6.3E-6	Blood metabolite ratios	
KIRC	cis	1	rs78572933	chr6:101611649	GRIK2	chr6:101846905-102517957:+	0.49	4.71	3.25E-6	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs78581866	chr1:27247566	PIGV	chr1:27114455-27124886:+	-0.41	-4.59	5.68E-6	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs78594996	chr17:40570109	NAGLU	chr17:40687951-40696464:+	-0.18	-3.87	0.000124	Crohn's disease	
KIRC	cis	1	rs78602343	chr6:126019768	HEY2	chr6:126068780-126082414:+	0.17	4.09	5.07E-5	Endometrial cancer	
KIRC	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	1.08	19.1	1.53E-61	Heschl's gyrus morphology	
KIRC	cis	1	rs78604110	chr15:40681854	IVD	chr15:40697686-40713512:+	-0.36	-5.63	3.08E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs7861658	chr9:100679954	C9orf156	chr9:100666772-100684852:-	-0.29	-6.44	2.88E-10	Quantitative traits	
KIRC	cis	1	rs78628466	chr7:1068453	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.88	7.68E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs786425	chr12:124085502	ATP6V0A2	chr12:124196865-124246299:+	-0.28	-6.84	2.34E-11	Pubertal anthropometrics	
KIRC	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.2	6.61	1.01E-10	Pubertal anthropometrics	
KIRC	cis	1	rs7864754	chr9:139126120	QSOX2	chr9:139098182-139137687:-	0.25	4.67	3.86E-6	Height	
KIRC	cis	1	rs78679088	chr21:33910827	TCP10L	chr21:33947152-33957845:-	-0.42	-7.08	4.87E-12	Gastritis	
KIRC	cis	1	rs7868408	chr9:131917864	SET	chr9:131445934-131458674:+	-0.16	-3.53	0.000458	Blood metabolite ratios	
KIRC	cis	1	rs7869804	chr9:131913144	SET	chr9:131445934-131458674:+	-0.17	-3.74	0.000202	Blood metabolite ratios	
KIRC	cis	1	rs78704524	chr8:89436384	MMP16	chr8:89049462-89339717:-	0.3	3.9	0.000109	Electrodermal activity	
KIRC	cis	1	rs7870753	chr9:99201585	CDC14B	chr9:99262397-99382112:-	-0.16	-3.62	0.000326	Height	
KIRC	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.95	-10.98	2.73E-25	Epithelial ovarian cancer;Ovarian cancer	
KIRC	cis	1	rs7873102	chr9:38041142	DCAF10	chr9:37800551-37867663:+	-0.16	-4.09	4.98E-5	Brain structure	
KIRC	cis	1	rs78731097	chr17:76083879	LGALS3BP	chr17:76967336-76976061:-	0.22	3.49	0.000527	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-0.95	-10.88	7.0E-25	Epithelial ovarian cancer;Ovarian cancer	
KIRC	cis	1	rs7877	chr1:171254890	FMO4	chr1:171283486-171311222:+	0.27	5.25	2.29E-7	Sudden cardiac arrest	
KIRC	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.28	5.67	2.46E-8	Diabetic kidney disease	
KIRC	cis	1	rs78803505	chr7:65382572	CRCP	chr7:65579805-65619551:+	-0.31	-4.26	2.47E-5	Diabetic kidney disease	
KIRC	cis	1	rs78813423	chr15:79231005	CTSH	chr15:79214092-79237420:-	-0.31	-4.62	4.89E-6	Bipolar disorder	
KIRC	cis	1	rs78822335	chr6:161068192	PLG	chr6:161123274-161174345:+	0.29	3.99	7.47E-5	Triglycerides	
KIRC	cis	1	rs78836001	chr10:4981992	AKR1C1	chr10:4934796-5020157:+	-0.37	-4.65	4.19E-6	Height	
KIRC	cis	1	rs78836001	chr10:4981992	AKR1C2	chr10:4964715-5060207:-	0.64	7.48	3.39E-13	Height	
KIRC	cis	1	rs78841515	chr16:77785455	NUDT7	chr16:77756411-77776153:+	0.23	3.58	0.000373	Obesity-related traits	
KIRC	cis	1	rs78861357	chr7:1095418	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs78896566	chr7:1080182	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.87	8.13E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs789208	chr10:105935096	C10orf79	chr10:105889647-105992120:-	0.18	4.39	1.37E-5	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs7893456	chr10:5007862	AKR1C1	chr10:4934796-5020157:+	-0.3	-4.03	6.45E-5	Height	
KIRC	cis	1	rs7893456	chr10:5007862	AKR1C2	chr10:4964715-5060207:-	0.59	7.22	1.98E-12	Height	
KIRC	cis	1	rs7894268	chr10:17199830	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.21	1.9E-15	Homocysteine levels	
KIRC	cis	1	rs78953187	chr1:93000574	EVI5	chr1:92974255-93257961:-	-0.2	-4.72	3.13E-6	Cholesterol, total	
KIRC	cis	1	rs78967641	chr20:33783053	PROCR	chr20:33758727-33765164:+	-0.32	-4.17	3.56E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7896832	chr10:82257570	TSPAN14	chr10:82214038-82282390:+	0.21	3.9	0.000108	Post bronchodilator FEV1	
KIRC	cis	1	rs78974622	chr22:38059925	LGALS1	chr22:38071613-38075807:+	-0.13	-3.93	9.85E-5	Fat distribution (HIV)	
KIRC	cis	1	rs7898235	chr10:74038181	ASCC1	chr10:73856278-73976892:-	0.17	3.49	0.000526	Heschl's gyrus morphology	
KIRC	cis	1	rs7898235	chr10:74038181	SPOCK2	chr10:73818793-73848790:-	-0.21	-4.09	5.06E-5	Heschl's gyrus morphology	
KIRC	cis	1	rs78996483	chr6:55934556	COL21A1	chr6:55921389-56258892:-	-0.48	-7.51	2.7E-13	Psychosis (atypical)	
KIRC	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	0.19	4.55	6.7E-6	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs7899746	chr10:96787859	CYP2C9	chr10:96698415-96749147:+	0.18	3.6	0.000346	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7900536	chr10:82253701	TSPAN14	chr10:82214038-82282390:+	0.21	3.84	0.000136	Post bronchodilator FEV1	
KIRC	cis	1	rs7900891	chr10:69953042	MYPN	chr10:69865876-69971771:+	-0.24	-4.48	9.21E-6	Height	
KIRC	cis	1	rs7903259	chr10:17259642	TRDMT1	chr10:17184983-17243681:-	-0.17	-4.09	4.99E-5	Cholesterol, total	
KIRC	cis	1	rs7903402	chr10:17259772	TRDMT1	chr10:17184983-17243681:-	0.19	4.51	8.15E-6	Cholesterol, total	
KIRC	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	1.08	18.95	8.68E-61	Heschl's gyrus morphology	
KIRC	cis	1	rs79044944	chr15:40676285	IVD	chr15:40697686-40713512:+	-0.36	-5.59	3.76E-8	Heschl's gyrus morphology	
KIRC	cis	1	rs79048371	chr20:33731484	PROCR	chr20:33758727-33765164:+	-0.32	-4.08	5.23E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.14	-5.04	6.57E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs7908994	chr10:5008383	AKR1C1	chr10:4934796-5020157:+	-0.34	-4.48	9.44E-6	Height	
KIRC	cis	1	rs7908994	chr10:5008383	AKR1C2	chr10:4964715-5060207:-	0.59	7.24	1.73E-12	Height	
KIRC	cis	1	rs79096665	chr15:56507616	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs79101914	chr12:56729739	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs79101914	chr12:56729739	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7910521	chr10:29803661	LOC387647	chr10:29698483-29776785:+	0.22	4.14	4.06E-5	Platelet thrombus formation	
KIRC	cis	1	rs7910598	chr10:29803549	LOC387647	chr10:29698483-29776785:+	0.22	4.09	4.94E-5	Platelet thrombus formation	
KIRC	cis	1	rs7910643	chr10:82251769	TSPAN14	chr10:82214038-82282390:+	0.21	3.79	0.000171	Post bronchodilator FEV1	
KIRC	cis	1	rs7910927	chr10:65138910	NRBF2	chr10:64893007-64914785:+	-0.29	-7.08	5.01E-12	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs7911712	chr10:45319654	CXCL12	chr10:44865607-44880542:-	0.31	3.96	8.56E-5	Emphysema-related traits	
KIRC	cis	1	rs7912093	chr10:17203934	TRDMT1	chr10:17184983-17243681:-	-0.36	-8.07	5.24E-15	Homocysteine levels	
KIRC	cis	1	rs79124463	chr5:64437182	PPWD1	chr5:64859131-64883368:+	-0.25	-4.15	3.93E-5	Schizophrenia	
KIRC	cis	1	rs7912580	chr10:63915972	RTKN2	chr10:63942794-64028466:-	0.3	3.96	8.75E-5	Response to haloperidol in psychosis	
KIRC	cis	1	rs7912631	chr10:101915265	CWF19L1	chr10:101992055-102027437:-	-0.32	-3.87	0.000122	Schizophrenia	
KIRC	cis	1	rs7913582	chr10:69952581	MYPN	chr10:69865876-69971771:+	-0.25	-4.66	4.0E-6	Height	
KIRC	cis	1	rs7913801	chr10:29803731	LOC387647	chr10:29698483-29776785:+	0.22	4.05	5.88E-5	Platelet thrombus formation	
KIRC	cis	1	rs79165785	chr17:46730779	SNX11	chr17:46184911-46200105:+	-0.38	-3.87	0.000122	Platelet thrombus formation	
KIRC	cis	1	rs79165785	chr17:46730779	ZNF652	chr17:47366569-47439835:-	-0.34	-3.6	0.000348	Platelet thrombus formation	
KIRC	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.24	6.52	1.67E-10	Blood metabolite levels	
KIRC	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.46	10.26	1.46E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs7918678	chr10:90829879	CH25H	chr10:90965696-90967071:-	0.21	3.89	0.000112	Obesity-related traits	
KIRC	cis	1	rs79199019	chr14:35581125	KIAA0391	chr14:35591776-35786673:+	0.25	4.29	2.16E-5	Atopic dermatitis	
KIRC	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.27	5.51	5.72E-8	Atopic dermatitis	
KIRC	cis	1	rs7920002	chr10:17259766	TRDMT1	chr10:17184983-17243681:-	0.19	4.51	8.15E-6	Cholesterol, total	
KIRC	cis	1	rs7920112	chr10:17259863	TRDMT1	chr10:17184983-17243681:-	0.19	4.51	8.15E-6	Cholesterol, total	
KIRC	cis	1	rs7920659	chr10:96767924	CYP2C9	chr10:96698415-96749147:+	0.18	3.62	0.00032	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7920888	chr10:90818377	CH25H	chr10:90965696-90967071:-	0.19	3.72	0.000218	Obesity-related traits	
KIRC	cis	1	rs7921162	chr10:17229004	TRDMT1	chr10:17184983-17243681:-	-0.34	-7.84	2.78E-14	Homocysteine levels	
KIRC	cis	1	rs7921185	chr10:4976430	AKR1C1	chr10:4934796-5020157:+	-0.36	-4.79	2.15E-6	Height	
KIRC	cis	1	rs7921185	chr10:4976430	AKR1C2	chr10:4964715-5060207:-	0.54	6.55	1.42E-10	Height	
KIRC	cis	1	rs7922621	chr10:82251544	TSPAN14	chr10:82214038-82282390:+	0.21	3.83	0.000145	Post bronchodilator FEV1	
KIRC	cis	1	rs7923609	chr10:65133822	NRBF2	chr10:64893007-64914785:+	-0.29	-7.05	6.04E-12	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs7927771	chr11:47781306	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs79292725	chr10:81730770	LOC219347	chr10:81805991-81838949:-	0.47	4.46	1.01E-5	Rheumatoid arthritis	
KIRC	cis	1	rs79292725	chr10:81730770	LOC650623	chr10:81442731-81448648:+	-0.31	-3.55	0.000417	Rheumatoid arthritis	
KIRC	cis	1	rs7930103	chr11:46484254	MDK	chr11:46402334-46405374:+	-0.22	-3.64	0.000298	Schizophrenia	
KIRC	cis	1	rs7930454	chr11:73085034	RELT	chr11:73087405-73108518:+	0.22	4.54	6.9E-6	Pulmonary function (interaction)	
KIRC	cis	1	rs7930721	chr11:71737481	C11orf59	chr11:71808339-71814322:-	-0.22	-3.85	0.000133	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs79318564	chr15:84786150	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.42	1.23E-5	Schizophrenia	
KIRC	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.25	-4.87	1.49E-6	Schizophrenia	
KIRC	cis	1	rs7931941	chr11:71667604	C11orf59	chr11:71808339-71814322:-	-0.21	-3.92	0.000101	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs79327308	chr7:1108141	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.5	5.99E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs79341738	chr20:33702104	PROCR	chr20:33758727-33765164:+	-0.27	-3.71	0.000233	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.44	7.44	4.4E-13	Immune response to smallpox vaccine (IL-6)	
KIRC	cis	1	rs7937582	chr11:71744613	C11orf59	chr11:71808339-71814322:-	-0.22	-3.96	8.67E-5	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7938380	chr11:64034866	C11orf20	chr11:64067863-64072238:+	-0.35	-5.46	7.34E-8	Mean platelet volume	
KIRC	cis	1	rs7939107	chr11:64034773	C11orf20	chr11:64067863-64072238:+	-0.35	-5.46	7.34E-8	Mean platelet volume	
KIRC	cis	1	rs7939352	chr11:78003151	NARS2	chr11:78147017-78285909:-	-0.17	-3.82	0.000147	Testicular germ cell tumor	
KIRC	cis	1	rs79396265	chr8:96071272	C8orf38	chr8:95908040-96088396:+	-0.28	-4.19	3.27E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs7939646	chr11:78111613	NARS2	chr11:78147017-78285909:-	0.18	4.15	3.95E-5	Testicular germ cell tumor	
KIRC	cis	1	rs7940310	chr11:117024481	PCSK7	chr11:117075789-117102811:-	-0.27	-5.29	1.79E-7	Protein quantitative trait loci	
KIRC	cis	1	rs79404901	chr5:115449332	COMMD10	chr5:115420727-115628978:+	0.39	4.05	6.04E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7940866	chr11:130817579	SNX19	chr11:130745767-130786382:-	0.21	6.56	1.38E-10	Schizophrenia	
KIRC	cis	1	rs7941030	chr11:122522375	ASAM	chr11:122943035-123066007:-	0.16	3.64	0.000297	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs79412014	chr4:106755444	INTS12	chr4:106603787-106629881:-	-0.7	-7.27	1.43E-12	Post bronchodilator FEV1	
KIRC	cis	1	rs7941617	chr11:78021146	NARS2	chr11:78147017-78285909:-	-0.16	-3.57	0.000395	Testicular germ cell tumor	
KIRC	cis	1	rs79419293	chr2:190625076	ASNSD1	chr2:190526125-190535556:+	-0.42	-5.63	2.98E-8	Subcutaneous adipose tissue	
KIRC	cis	1	rs79422648	chr7:1080241	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.87	8.13E-9	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs79436302	chr14:35578797	KIAA0391	chr14:35591776-35786673:+	0.25	4.21	3.09E-5	Atopic dermatitis	
KIRC	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.27	5.45	7.8E-8	Atopic dermatitis	
KIRC	cis	1	rs79436528	chr12:56686997	RPS26	chr12:56435686-56438005:+	-0.52	-4.51	7.9E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7944109	chr11:5564919	TRIM6	chr11:5617347-5634188:+	-0.2	-4.87	1.47E-6	QRS duration in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs79442859	chr5:150171210	IRGM	chr5:150226085-150280295:+	0.66	8.09	4.57E-15	Crohn's disease	
KIRC	cis	1	rs79442859	chr5:150171210	LOC134466	chr5:150310000-150326146:-	0.41	4.96	9.8E-7	Crohn's disease	
KIRC	cis	1	rs79443843	chr7:1075245	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.65	2.74E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs79444544	chr2:190758532	ASNSD1	chr2:190526125-190535556:+	-0.32	-4.58	5.85E-6	Subcutaneous adipose tissue	
KIRC	cis	1	rs7945652	chr11:5220743	OR51E1	chr11:4665156-4676714:+	-0.18	-3.53	0.000453	HbA2 levels	
KIRC	cis	1	rs7947143	chr11:64090422	C11orf20	chr11:64067863-64072238:+	-0.35	-5.4	1.05E-7	Mean platelet volume	
KIRC	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.36	8.11	4.03E-15	Pancreatic cancer	
KIRC	cis	1	rs79477087	chr11:22116168	ANO5	chr11:22214722-22304913:+	0.27	5.07	5.59E-7	Parkinson's disease	
KIRC	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs7947730	chr11:47786184	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs7948821	chr11:71652485	C11orf59	chr11:71808339-71814322:-	-0.22	-3.88	0.000117	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs79488685	chr4:171031611	AADAT	chr4:170981374-171011372:-	-0.43	-4.06	5.66E-5	Thyroid hormone levels	
KIRC	cis	1	rs7948969	chr11:62907048	SLC22A24	chr11:62847414-62911693:-	0.33	7.59	1.62E-13	Conotruncal heart defects	
KIRC	cis	1	rs7949480	chr11:71697588	C11orf59	chr11:71808339-71814322:-	-0.22	-3.84	0.000137	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs7949790	chr11:30374608	C11orf46	chr11:30344649-30359978:+	0.29	4.45	1.08E-5	Sex hormone levels;Menopause (age at onset)	
KIRC	cis	1	rs7950364	chr11:116898886	PCSK7	chr11:117075789-117102811:-	-0.28	-5.45	8.03E-8	Protein quantitative trait loci	
KIRC	cis	1	rs79508374	chr2:198864568	RFTN2	chr2:198435528-198540584:-	0.16	4.54	6.95E-6	Ulcerative colitis	
KIRC	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	0.28	5.85	9.11E-9	HDL cholesterol	
KIRC	cis	1	rs7953150	chr12:112941571	C12orf47	chr12:112277573-112280706:-	0.16	4.01	6.86E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7953150	chr12:112941571	OAS1	chr12:113344739-113369988:+	0.2	3.81	0.000157	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	0.29	6.16	1.49E-9	HDL cholesterol	
KIRC	cis	1	rs7954638	chr12:96314795	AMDHD1	chr12:96337071-96362369:+	0.17	4.22	2.93E-5	Metabolite levels (small molecules and protein measures)	
KIRC	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.76	11.1	9.85E-26	Diastolic blood pressure	
KIRC	cis	1	rs79568175	chr1:27038216	PIGV	chr1:27114455-27124886:+	-0.39	-4.35	1.65E-5	HDL cholesterol;Triglycerides;LDL cholesterol	
KIRC	cis	1	rs7956826	chr12:82173365	PPFIA2	chr12:81652880-82153109:-	0.39	7.07	5.31E-12	Resting heart rate	
KIRC	cis	1	rs79571438	chr4:106616198	INTS12	chr4:106603787-106629881:-	-0.65	-6.73	4.52E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs7957197	chr12:121460686	P2RX4	chr12:121647664-121671907:+	-0.22	-4.03	6.48E-5	Type 2 diabetes	
KIRC	cis	1	rs79579293	chr14:88822068	SPATA7	chr14:88852012-88904802:+	-0.2	-4.18	3.38E-5	Coronary artery calcification	
KIRC	cis	1	rs7958691	chr12:124440743	CCDC92	chr12:124420955-124457163:-	0.2	5.35	1.34E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs7958691	chr12:124440743	DNAH10	chr12:124247042-124420265:+	0.19	3.9	0.000109	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.89	8.85	1.5E-17	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs7960443	chr12:104645363	NT5DC3	chr12:104164231-104234975:-	0.28	4.57	6.07E-6	Toenail selenium levels	
KIRC	cis	1	rs7961449	chr12:124437215	CCDC92	chr12:124420955-124457163:-	-0.17	-4.27	2.35E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs7961569	chr12:120157345	CIT	chr12:120123598-120315092:-	-0.22	-4.71	3.25E-6	Urgency urinary incontinence	
KIRC	cis	1	rs79617366	chr7:1111958	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.62	3.2E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7961894	chr12:122365583	WDR66	chr12:122356480-122441830:+	0.41	3.92	0.000103	Platelet count;Mean platelet volume	
KIRC	cis	1	rs79633844	chr2:203683990	ICA1L	chr2:203637873-203736371:-	0.28	3.61	0.000334	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.87	8.28	1.11E-15	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs79634040	chr11:71230169	DHCR7	chr11:71145459-71159477:-	-0.28	-4.53	7.52E-6	Vitamin D levels	
KIRC	cis	1	rs7963577	chr12:82174115	PPFIA2	chr12:81652880-82153109:-	0.41	7.33	9.05E-13	Resting heart rate	
KIRC	cis	1	rs7964021	chr12:109997645	MYO1H	chr12:109826524-109886176:+	0.28	5.79	1.24E-8	HDL cholesterol	
KIRC	cis	1	rs7966755	chr12:82221604	PPFIA2	chr12:81652880-82153109:-	0.4	7.15	3.15E-12	Resting heart rate	
KIRC	cis	1	rs79683221	chr7:1096139	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs7968440	chr12:51134741	LIMA1	chr12:50569565-50677353:-	-0.25	-5	8.02E-7	Fibrinogen	
KIRC	cis	1	rs7968810	chr12:54158993	NCKAP1L	chr12:54891495-54936898:+	0.06	3.66	0.000282	Tanning	
KIRC	cis	1	rs7969761	chr12:355842	CCDC77	chr12:498516-551804:+	0.18	3.71	0.000232	Blood metabolite ratios	
KIRC	cis	1	rs79702597	chr14:35558856	KIAA0391	chr14:35591776-35786673:+	0.23	3.93	9.88E-5	Atopic dermatitis	
KIRC	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.26	5.14	3.94E-7	Atopic dermatitis	
KIRC	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.29	-5.88	7.7E-9	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs79718165	chr12:56644251	RPS26	chr12:56435686-56438005:+	-0.51	-4.33	1.77E-5	Psoriasis vulgaris	
KIRC	cis	1	rs7973683	chr12:124449223	CCDC92	chr12:124420955-124457163:-	0.2	5.15	3.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs7973683	chr12:124449223	DNAH10	chr12:124247042-124420265:+	0.19	3.84	0.000137	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs7973719	chr12:7334813	PEX5	chr12:7341759-7371167:+	0.57	12.92	3.67E-33	IgG glycosylation	
KIRC	cis	1	rs79738251	chr2:17786558	SMC6	chr2:17845080-17981462:-	-0.31	-3.73	0.000213	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs79750959	chr12:56702012	COQ10A	chr12:56660642-56664748:+	-0.35	-3.6	0.000348	Psoriasis vulgaris	
KIRC	cis	1	rs79750959	chr12:56702012	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.57E-6	Psoriasis vulgaris	
KIRC	cis	1	rs7975161	chr12:104645405	NT5DC3	chr12:104164231-104234975:-	-0.27	-4.23	2.77E-5	Toenail selenium levels	
KIRC	cis	1	rs79751662	chr4:171014655	AADAT	chr4:170981374-171011372:-	-0.43	-4.36	1.55E-5	Thyroid hormone levels	
KIRC	cis	1	rs7975863	chr12:82227288	PPFIA2	chr12:81652880-82153109:-	0.41	7.22	1.93E-12	Resting heart rate	
KIRC	cis	1	rs7976059	chr12:52251272	ANKRD33	chr12:52281793-52285504:+	-0.23	-4.21	2.99E-5	Urate levels	
KIRC	cis	1	rs7976059	chr12:52251272	FIGNL2	chr12:52211677-52216208:-	-0.2	-4.21	3.08E-5	Urate levels	
KIRC	cis	1	rs79765398	chr7:1073764	ZFAND2A	chr7:1192544-1199855:-	-0.34	-5.77	1.36E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs79770253	chr2:17784158	SMC6	chr2:17845080-17981462:-	-0.3	-3.66	0.000284	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs7977534	chr12:112717920	C12orf47	chr12:112277573-112280706:-	0.16	4.23	2.79E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7977534	chr12:112717920	TMEM116	chr12:112369103-112450989:-	0.18	4.03	6.49E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7977690	chr12:51130414	LIMA1	chr12:50569565-50677353:-	-0.25	-5.01	7.43E-7	Fibrinogen	
KIRC	cis	1	rs79780973	chr5:150174810	IRGM	chr5:150226085-150280295:+	0.66	7.91	1.66E-14	Crohn's disease	
KIRC	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.43	5.04	6.37E-7	Crohn's disease	
KIRC	cis	1	rs7978454	chr12:124316876	ATP6V0A2	chr12:124196865-124246299:+	0.14	3.51	0.000483	IgG glycosylation	
KIRC	cis	1	rs7979473	chr12:121420260	C12orf27	chr12:121407641-121410095:-	-0.12	-3.64	0.000306	C-reactive protein	
KIRC	cis	1	rs7979545	chr12:112790648	C12orf47	chr12:112277573-112280706:-	0.17	4.3	2.06E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7979545	chr12:112790648	TMEM116	chr12:112369103-112450989:-	0.18	4.09	5.02E-5	Oral cavity and pharyngeal cancer	
KIRC	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.26	-7.17	2.64E-12	Educational attainment;Height;Head circumference (infant)	
KIRC	cis	1	rs79824801	chr12:56728137	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs79824801	chr12:56728137	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.13	-4.45	1.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs79846980	chr19:22141343	ZNF257	chr19:22235266-22273901:+	0.34	4.56	6.43E-6	Body mass index (change over time)	
KIRC	cis	1	rs79854439	chr10:81730092	LOC219347	chr10:81805991-81838949:-	0.48	4.55	6.85E-6	Rheumatoid arthritis	
KIRC	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.44	5.6	3.52E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs798744	chr4:1714684	TMEM129	chr4:1717680-1723084:-	-0.16	-3.62	0.000321	Urinary bladder cancer;Bladder cancer	
KIRC	cis	1	rs79888893	chr14:35510676	KIAA0391	chr14:35591776-35786673:+	0.22	3.5	0.00051	Atopic dermatitis	
KIRC	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.24	4.54	7.0E-6	Atopic dermatitis	
KIRC	cis	1	rs79889615	chr5:115591292	COMMD10	chr5:115420727-115628978:+	0.38	3.98	7.82E-5	Asthma or chronic obstructive pulmonary disease	
KIRC	cis	1	rs7989332	chr13:21050575	IL17D	chr13:21277482-21297236:+	0.2	3.61	0.000332	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
KIRC	cis	1	rs7992980	chr13:33181142	N4BP2L2	chr13:33006930-33112936:-	0.15	4.28	2.2E-5	Body mass index	
KIRC	cis	1	rs7994160	chr13:99132749	STK24	chr13:99102455-99229396:-	-0.29	-5.82	1.02E-8	Longevity	
KIRC	cis	1	rs79947284	chr10:81714579	LOC219347	chr10:81805991-81838949:-	0.59	5.04	6.42E-7	Rheumatoid arthritis	
KIRC	cis	1	rs79947284	chr10:81714579	LOC650623	chr10:81442731-81448648:+	-0.34	-3.55	0.000416	Rheumatoid arthritis	
KIRC	cis	1	rs7996093	chr13:99133092	STK24	chr13:99102455-99229396:-	-0.27	-5.53	5.06E-8	Longevity	
KIRC	cis	1	rs7996624	chr13:100127541	UBAC2	chr13:99852679-100038751:+	-0.24	-3.59	0.000368	Obesity-related traits	
KIRC	cis	1	rs7996629	chr13:99128037	STK24	chr13:99102455-99229396:-	-0.27	-5.46	7.34E-8	Longevity	
KIRC	cis	1	rs79986235	chr2:219944135	USP37	chr2:219314974-219433084:-	-0.27	-4.06	5.8E-5	Height	
KIRC	cis	1	rs79987695	chr3:184535604	C3orf70	chr3:184795840-184870802:-	-0.18	-3.77	0.000185	Heschl's gyrus morphology	
KIRC	cis	1	rs7999125	chr13:33145995	N4BP2L2	chr13:33006930-33112936:-	0.15	4.21	3.02E-5	Body mass index	
KIRC	cis	1	rs8000149	chr13:50090025	CAB39L	chr13:49882787-50018221:-	-0.31	-6.9	1.58E-11	Cardiac hypertrophy	
KIRC	cis	1	rs8000149	chr13:50090025	RCBTB1	chr13:50106082-50159719:-	-0.21	-5.39	1.09E-7	Cardiac hypertrophy	
KIRC	cis	1	rs8000149	chr13:50090025	SETDB2	chr13:50018429-50069138:+	-0.16	-4.12	4.41E-5	Cardiac hypertrophy	
KIRC	cis	1	rs800142	chr11:2385071	C11orf21	chr11:2317507-2323143:-	-0.19	-4.51	7.97E-6	Bacteremia	
KIRC	cis	1	rs800153	chr11:2373515	C11orf21	chr11:2317507-2323143:-	-0.16	-3.98	7.89E-5	Bacteremia	
KIRC	cis	1	rs800156	chr11:2376436	C11orf21	chr11:2317507-2323143:-	-0.16	-3.96	8.69E-5	Bacteremia	
KIRC	cis	1	rs800157	chr11:2376602	C11orf21	chr11:2317507-2323143:-	-0.16	-3.84	0.00014	Bacteremia	
KIRC	cis	1	rs800158	chr11:2378447	C11orf21	chr11:2317507-2323143:-	0.16	4.05	5.82E-5	Bacteremia	
KIRC	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.18	4.54	6.98E-6	Bacteremia	
KIRC	cis	1	rs8002861	chr13:44474517	CCDC122	chr13:44410491-44453826:-	-0.24	-4.42	1.18E-5	Leprosy	
KIRC	cis	1	rs8003061	chr14:81451956	TSHR	chr14:81421869-81612646:+	-0.35	-6.77	3.51E-11	Graves' disease	
KIRC	cis	1	rs80031817	chr7:1096793	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.66	2.55E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs8003506	chr14:75586288	MLH3	chr14:75480467-75518235:-	-0.23	-5.83	1.02E-8	Height	
KIRC	cis	1	rs8003506	chr14:75586288	NEK9	chr14:75548819-75593778:-	-0.14	-3.89	0.000116	Height	
KIRC	cis	1	rs8005161	chr14:88472595	GPR65	chr14:88471496-88478414:+	0.13	4.02	6.84E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs8005309	chr14:66056508	LOC645431	chr14:65877313-65879335:-	-0.49	-6.33	5.33E-10	Ischemic stroke	
KIRC	cis	1	rs8005686	chr14:76633967	ESRRB	chr14:76837690-76968178:+	0.36	5.13	4.15E-7	Blood pressure	
KIRC	cis	1	rs8006048	chr14:76683508	ESRRB	chr14:76837690-76968178:+	0.34	4.79	2.23E-6	Blood pressure	
KIRC	cis	1	rs8006176	chr14:101033288	BEGAIN	chr14:101003486-101036131:-	-0.24	-4.41	1.27E-5	Menarche (age at onset)	
KIRC	cis	1	rs8006352	chr14:88467141	GPR65	chr14:88471496-88478414:+	0.13	3.97	8.24E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs8006419	chr14:65500735	CHURC1	chr14:65381140-65411309:+	-0.24	-5.62	3.21E-8	Red blood cell traits	
KIRC	cis	1	rs8006419	chr14:65500735	RAB15	chr14:65412532-65438875:-	-0.17	-3.76	0.000189	Red blood cell traits	
KIRC	cis	1	rs80068722	chr14:65856111	LOC645431	chr14:65877313-65879335:-	-0.43	-5.92	6.09E-9	Ischemic stroke	
KIRC	cis	1	rs80075680	chr5:150223737	IRGM	chr5:150226085-150280295:+	0.53	7.28	1.3E-12	Crohn's disease	
KIRC	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.38	5.14	3.94E-7	Crohn's disease	
KIRC	cis	1	rs8008024	chr14:81818492	STON2	chr14:81727000-81893748:-	0.38	7.12	3.73E-12	Night sleep phenotypes	
KIRC	cis	1	rs80085676	chr2:242347907	SEPT2	chr2:242254723-242293439:+	0.38	5.6	3.54E-8	Chronic lymphocytic leukemia	
KIRC	cis	1	rs80087860	chr2:203673072	ICA1L	chr2:203637873-203736371:-	0.28	3.59	0.000367	Coronary artery disease or large artery stroke;Coronary artery disease or ischemic stroke	
KIRC	cis	1	rs8009171	chr14:81820060	STON2	chr14:81727000-81893748:-	0.38	7.2	2.29E-12	Night sleep phenotypes	
KIRC	cis	1	rs80094748	chr7:1103958	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.57	4.26E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs80095925	chr6:26184942	HIST1H3E	chr6:26224427-26226589:+	0.34	3.95	9.12E-5	Renal underexcretion gout;Gout	
KIRC	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.29	-8.04	6.51E-15	IgG glycosylation	
KIRC	cis	1	rs80123796	chr3:184739700	C3orf70	chr3:184795840-184870802:-	-0.16	-3.57	0.00039	Heschl's gyrus morphology	
KIRC	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.24	4.67	3.94E-6	Atopic dermatitis	
KIRC	cis	1	rs8014170	chr14:50071694	RPL36AL	chr14:50085407-50087349:-	0.36	8.14	3.1E-15	Carotid intima media thickness	
KIRC	cis	1	rs8014194	chr14:95720678	CLMN	chr14:95648276-95786245:-	0.17	3.96	8.7E-5	Response to statin therapy	
KIRC	cis	1	rs8014204	chr14:75322794	RPS6KL1	chr14:75372347-75389958:-	0.17	3.55	0.00042	Caffeine consumption	
KIRC	cis	1	rs8017202	chr14:65854958	LOC645431	chr14:65877313-65879335:-	-0.43	-5.93	5.7E-9	Ischemic stroke	
KIRC	cis	1	rs8017642	chr14:75590822	MLH3	chr14:75480467-75518235:-	0.24	6.14	1.72E-9	Height	
KIRC	cis	1	rs8017642	chr14:75590822	NEK9	chr14:75548819-75593778:-	0.15	4.18	3.44E-5	Height	
KIRC	cis	1	rs8018909	chr14:65960405	LOC645431	chr14:65877313-65879335:-	-0.51	-6.74	4.39E-11	Ischemic stroke	
KIRC	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.24	-4.88	1.4E-6	Blood metabolite ratios	
KIRC	cis	1	rs8019491	chr14:66168110	LOC645431	chr14:65877313-65879335:-	-0.52	-6.79	3.09E-11	Ischemic stroke	
KIRC	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.87	8.31	9.12E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs80212261	chr7:1114012	ZFAND2A	chr7:1192544-1199855:-	-0.33	-5.58	4.02E-8	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs80216128	chr11:22822870	SVIP	chr11:22843600-22851382:-	0.26	3.92	9.98E-5	Dialysis-related mortality	
KIRC	cis	1	rs8023482	chr15:40307095	SRP14	chr15:40327891-40331389:-	-0.3	-4.8	2.12E-6	Response to haloperidol in psychosis	
KIRC	cis	1	rs8023644	chr15:50937123	SPPL2A	chr15:50999739-51057910:-	0.28	7.52	2.48E-13	QT interval	
KIRC	cis	1	rs8023644	chr15:50937123	TRPM7	chr15:50852491-50978994:-	0.12	3.54	0.000437	QT interval	
KIRC	cis	1	rs8023716	chr15:65744861	DPP8	chr15:65737999-65810035:-	-0.13	-5.23	2.53E-7	Mean corpuscular hemoglobin	
KIRC	cis	1	rs8023776	chr15:90897952	IQGAP1	chr15:90931473-91045475:+	-0.12	-3.53	0.000447	Rheumatoid arthritis	
KIRC	cis	1	rs8023776	chr15:90897952	TTLL13	chr15:90792764-90815443:+	-0.27	-4.67	3.86E-6	Rheumatoid arthritis	
KIRC	cis	1	rs8024418	chr15:84586308	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.58	5.85E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs80245547	chr4:106628955	INTS12	chr4:106603787-106629881:-	-0.64	-6.64	8.21E-11	Post bronchodilator FEV1	
KIRC	cis	1	rs8024628	chr15:84586463	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.59	5.53E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs8024944	chr15:56125135	NEDD4	chr15:56119131-56285835:-	0.23	5.31	1.69E-7	Keloid	
KIRC	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.44	5.41	9.73E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs8026172	chr15:56125182	NEDD4	chr15:56119131-56285835:-	0.23	5.31	1.69E-7	Keloid	
KIRC	cis	1	rs8026533	chr15:90893228	IQGAP1	chr15:90931473-91045475:+	0.12	3.63	0.000315	Rheumatoid arthritis	
KIRC	cis	1	rs8026533	chr15:90893228	TTLL13	chr15:90792764-90815443:+	0.26	4.61	5.15E-6	Rheumatoid arthritis	
KIRC	cis	1	rs8027260	chr15:65955172	DPP8	chr15:65737999-65810035:-	0.12	4.59	5.63E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs80277764	chr20:33739456	PROCR	chr20:33758727-33765164:+	-0.31	-3.94	9.24E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs8028182	chr15:75718669	SNUPN	chr15:75890426-75918719:-	0.22	4.36	1.58E-5	Sudden cardiac arrest	
KIRC	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.81	8.3	9.38E-16	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs8029016	chr15:84586464	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.59	5.53E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs8029247	chr15:56273446	NEDD4	chr15:56119131-56285835:-	-0.19	-4.34	1.71E-5	Keloid	
KIRC	cis	1	rs8030379	chr15:84590910	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.6	5.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs8030605	chr15:56504598	TEX9	chr15:56657644-56738071:+	-0.29	-5.11	4.68E-7	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs8031179	chr15:65952034	DPP8	chr15:65737999-65810035:-	-0.12	-4.81	2.04E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.45	5.46	7.37E-8	Renal underexcretion gout;Gout	
KIRC	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.89	8.68	5.74E-17	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
KIRC	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.61	-13.94	1.49E-37	Type 2 diabetes	
KIRC	cis	1	rs80317430	chr12:56727705	COQ10A	chr12:56660642-56664748:+	-0.35	-3.61	0.000334	Psoriasis vulgaris	
KIRC	cis	1	rs80317430	chr12:56727705	RPS26	chr12:56435686-56438005:+	-0.52	-4.52	7.69E-6	Psoriasis vulgaris	
KIRC	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.33	-6.44	2.83E-10	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs8032104	chr15:63400584	LACTB	chr15:63414032-63434254:+	0.19	3.92	9.89E-5	HDL cholesterol	
KIRC	cis	1	rs8032158	chr15:56194877	NEDD4	chr15:56119131-56285835:-	0.21	4.81	1.98E-6	Keloid	
KIRC	cis	1	rs8032675	chr15:67959464	IQCH	chr15:67547188-67794139:+	0.18	3.71	0.000229	Motion sickness	
KIRC	cis	1	rs8033837	chr15:75353975	PPCDC	chr15:75315927-75343066:+	0.2	4.63	4.76E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs8033837	chr15:75353975	RPP25	chr15:75247443-75249775:-	0.19	3.54	0.000443	Blood trace element (Zn levels)	
KIRC	cis	1	rs8033837	chr15:75353975	SCAMP5	chr15:75287901-75313836:+	0.26	4.69	3.5E-6	Blood trace element (Zn levels)	
KIRC	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	1.1	20.17	1.01E-66	Heschl's gyrus morphology	
KIRC	cis	1	rs8033938	chr15:40703114	IVD	chr15:40697686-40713512:+	-0.38	-6.03	3.15E-9	Heschl's gyrus morphology	
KIRC	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.33	-6.49	2.04E-10	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs8034542	chr15:79228371	CTSH	chr15:79214092-79237420:-	-0.24	-3.69	0.000253	Bipolar disorder	
KIRC	cis	1	rs8035639	chr15:65944548	DPP8	chr15:65737999-65810035:-	-0.12	-4.74	2.75E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs8035675	chr15:67965581	IQCH	chr15:67547188-67794139:+	0.18	3.72	0.000219	Motion sickness	
KIRC	cis	1	rs8036197	chr15:75370232	PPCDC	chr15:75315927-75343066:+	0.17	3.93	9.87E-5	Blood trace element (Zn levels)	
KIRC	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.2	3.71	0.000227	Blood trace element (Zn levels)	
KIRC	cis	1	rs8036588	chr15:50956834	SPPL2A	chr15:50999739-51057910:-	0.27	6.91	1.45E-11	QT interval	
KIRC	cis	1	rs8038646	chr15:56263346	NEDD4	chr15:56119131-56285835:-	0.22	5.01	7.65E-7	Keloid	
KIRC	cis	1	rs8041056	chr15:84564817	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.52	7.87E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs8041227	chr15:31538542	MTMR15	chr15:31196055-31235307:+	0.17	3.54	0.000437	Eosinophilic esophagitis	
KIRC	cis	1	rs8041258	chr15:69636622	NOX5	chr15:69222864-69349073:+	0.43	3.81	0.000157	Bipolar disorder and schizophrenia	
KIRC	cis	1	rs8041847	chr15:78529575	DNAJA4	chr15:78556487-78574536:+	-0.19	-3.59	0.000364	Personality dimensions	
KIRC	cis	1	rs8041847	chr15:78529575	WDR61	chr15:78575580-78591940:-	-0.18	-3.88	0.00012	Personality dimensions	
KIRC	cis	1	rs8042366	chr15:66012443	DPP8	chr15:65737999-65810035:-	-0.12	-4.71	3.19E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs8042807	chr15:66012444	DPP8	chr15:65737999-65810035:-	-0.12	-4.85	1.69E-6	Mean corpuscular hemoglobin	
KIRC	cis	1	rs804280	chr8:11612698	NEIL2	chr8:11627172-11644854:+	0.29	5.28	1.9E-7	Myopia (pathological)	
KIRC	cis	1	rs804281	chr8:11611865	NEIL2	chr8:11627172-11644854:+	0.35	6.11	1.99E-9	Myopia (pathological)	
KIRC	cis	1	rs8042825	chr15:90897885	IQGAP1	chr15:90931473-91045475:+	-0.13	-3.85	0.000135	Rheumatoid arthritis	
KIRC	cis	1	rs8042825	chr15:90897885	TTLL13	chr15:90792764-90815443:+	-0.24	-4.18	3.44E-5	Rheumatoid arthritis	
KIRC	cis	1	rs8042849	chr15:78817929	CHRNA5	chr15:78857906-78886458:+	0.33	6.55	1.43E-10	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs804292	chr8:11643915	NEIL2	chr8:11627172-11644854:+	0.24	3.98	8.04E-5	Alcohol dependence;Nicotine use	
KIRC	cis	1	rs8042970	chr15:84586368	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.58	5.85E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs8044653	chr16:55615757	LPCAT2	chr16:55542913-55620581:+	-0.18	-4.44	1.09E-5	Thyroid hormone levels	
KIRC	cis	1	rs8045682	chr16:69786092	COG4	chr16:70514473-70557457:-	-0.2	-3.68	0.000254	IgE levels	
KIRC	cis	1	rs8047014	chr16:69135049	TMED6	chr16:69377160-69385689:-	-0.17	-3.83	0.000146	Attention deficit hyperactivity disorder	
KIRC	cis	1	rs8049173	chr16:11436882	C16orf75	chr16:11343506-11445617:+	0.26	4.49	8.77E-6	Vein graft stenosis in coronary artery bypass grafting	
KIRC	cis	1	rs8049439	chr16:28837515	EIF3C	chr16:28722782-28747052:+;chr16	0.2	3.9	0.000109	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs8049439	chr16:28837515	EIF3CL	chr16:28699879-28747052:+;chr16	0.36	7.25	1.56E-12	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs8049439	chr16:28837515	SULT1A2	chr16:28603266-28608391:-	0.3	6.73	4.6E-11	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs8049439	chr16:28837515	TUFM	chr16:28853732-28857729:-	0.24	6.88	1.81E-11	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
KIRC	cis	1	rs8049622	chr16:67800927	ATP6V0D1	chr16:67471917-67515089:-	-0.35	-5.43	8.58E-8	Crohn's disease	
KIRC	cis	1	rs8049622	chr16:67800927	C16orf86	chr16:67700717-67702659:+	-0.31	-3.81	0.000159	Crohn's disease	
KIRC	cis	1	rs8051653	chr16:67848515	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-5.33	1.45E-7	Crohn's disease	
KIRC	cis	1	rs8051653	chr16:67848515	C16orf86	chr16:67700717-67702659:+	-0.28	-3.54	0.000431	Crohn's disease	
KIRC	cis	1	rs8052287	chr16:67865073	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-4.63	4.76E-6	Crohn's disease	
KIRC	cis	1	rs8055427	chr16:11436883	C16orf75	chr16:11343506-11445617:+	0.26	4.49	8.77E-6	Vein graft stenosis in coronary artery bypass grafting	
KIRC	cis	1	rs8056208	chr16:50097104	HEATR3	chr16:50099881-50139373:+	-0.27	-3.75	0.000199	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs8056893	chr16:68304392	NFATC3	chr16:68118654-68260837:+	0.21	4.01	6.99E-5	Blood metabolite levels;Blood metabolite ratios;Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs8056893	chr16:68304392	TPPP3	chr16:67423714-67427421:-	-0.14	-3.93	9.71E-5	Blood metabolite levels;Blood metabolite ratios;Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs8058835	chr16:67814865	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-5.34	1.44E-7	Crohn's disease	
KIRC	cis	1	rs8060686	chr16:67911517	ATP6V0D1	chr16:67471917-67515089:-	-0.18	-4.41	1.28E-5	HDL cholesterol;Metabolic syndrome	
KIRC	cis	1	rs8060686	chr16:67911517	PRMT7	chr16:68344945-68391162:+	0.18	3.84	0.000141	HDL cholesterol;Metabolic syndrome	
KIRC	cis	1	rs8061384	chr16:67911874	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-5.33	1.45E-7	Crohn's disease	
KIRC	cis	1	rs8061384	chr16:67911874	C16orf86	chr16:67700717-67702659:+	-0.28	-3.54	0.000431	Crohn's disease	
KIRC	cis	1	rs8061699	chr16:4632723	NMRAL1	chr16:4511696-4526307:-	-0.38	-4.88	1.41E-6	Obesity-related traits	
KIRC	cis	1	rs8062783	chr16:74691264	MLKL	chr16:74705753-74734789:-	-0.2	-4.44	1.09E-5	Testicular germ cell tumor	
KIRC	cis	1	rs8062783	chr16:74691264	RFWD3	chr16:74655298-74700779:-	0.16	3.88	0.000118	Testicular germ cell tumor	
KIRC	cis	1	rs8064089	chr16:50094482	HEATR3	chr16:50099881-50139373:+	-0.29	-4.05	5.83E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs8064107	chr16:50094323	HEATR3	chr16:50099881-50139373:+	-0.29	-4.05	5.83E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs8064261	chr17:61705212	FTSJ3	chr17:61896795-61905031:-	0.33	6.45	2.71E-10	Body mass index	
KIRC	cis	1	rs8064261	chr17:61705212	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.41E-6	Body mass index	
KIRC	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.38	4.1E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs8065059	chr17:28417376	LRRC37B2	chr17:28903483-28992715:+	-0.16	-3.52	0.000477	Coffee consumption (cups per day)	
KIRC	cis	1	rs8065261	chr17:28418041	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.35	4.74E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs8065388	chr17:56562132	TRIM37	chr17:57060002-57184266:-	0.17	3.9	0.000109	Vitamin D levels	
KIRC	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.4	10.48	2.35E-23	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8065437	chr17:45721653	ITGB3	chr17:45331208-45421658:+	0.18	4.2	3.2E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8065437	chr17:45721653	TBKBP1	chr17:45772630-45789427:+	-0.17	-4.46	9.94E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.41	10.83	1.07E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8065669	chr17:45724996	ITGB3	chr17:45331208-45421658:+	0.18	4.23	2.72E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8065669	chr17:45724996	TBKBP1	chr17:45772630-45789427:+	-0.17	-4.55	6.71E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8066156	chr17:30361629	RHOT1	chr17:30469473-30552745:+	-0.23	-4.49	8.85E-6	Height	
KIRC	cis	1	rs8066385	chr17:18761133	FAM18B	chr17:18684582-18710026:+	-0.26	-6.13	1.78E-9	Educational attainment (years of education)	
KIRC	cis	1	rs8066558	chr17:30272879	RHOT1	chr17:30469473-30552745:+	-0.22	-3.7	0.00024	Height	
KIRC	cis	1	rs8066719	chr17:61825764	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	2.93E-10	Body mass index	
KIRC	cis	1	rs8066719	chr17:61825764	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.49	9.04E-6	Body mass index	
KIRC	cis	1	rs8067064	chr17:61825984	FTSJ3	chr17:61896795-61905031:-	0.32	6.32	5.82E-10	Body mass index	
KIRC	cis	1	rs8067064	chr17:61825984	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.59	5.68E-6	Body mass index	
KIRC	cis	1	rs8067431	chr17:61817048	FTSJ3	chr17:61896795-61905031:-	0.33	6.41	3.44E-10	Body mass index	
KIRC	cis	1	rs8067431	chr17:61817048	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.45	1.05E-5	Body mass index	
KIRC	cis	1	rs8068603	chr17:61755211	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.00029	Body mass index	
KIRC	cis	1	rs8068603	chr17:61755211	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.88E-10	Body mass index	
KIRC	cis	1	rs8068603	chr17:61755211	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.53	7.41E-6	Body mass index	
KIRC	cis	1	rs8069687	chr17:61883023	FTSJ3	chr17:61896795-61905031:-	-0.32	-6.37	4.27E-10	Body mass index	
KIRC	cis	1	rs8069687	chr17:61883023	TCAM1P	chr17:61934376-61941738:+	0.26	4.69	3.5E-6	Body mass index	
KIRC	cis	1	rs8070446	chr17:40285879	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.79	-19.22	4.17E-62	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs8070454	chr17:38160754	MED24	chr17:38175351-38210889:-	-0.15	-3.51	0.000493	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs8070650	chr17:61744040	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs8070650	chr17:61744040	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs8071056	chr17:40822308	NAGLU	chr17:40687951-40696464:+	0.35	3.83	0.000147	Systolic blood pressure change trajectories	
KIRC	cis	1	rs8071789	chr17:38006333	GSDMA	chr17:38119226-38134019:+	0.3	5.96	4.77E-9	Selective IgA deficiency	
KIRC	cis	1	rs8071789	chr17:38006333	PGAP3	chr17:37827376-37844310:-	-0.16	-3.59	0.000361	Selective IgA deficiency	
KIRC	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.41	-10.69	3.71E-24	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8072100	chr17:45674687	ITGB3	chr17:45331208-45421658:+	-0.17	-4	7.21E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8072100	chr17:45674687	TBKBP1	chr17:45772630-45789427:+	0.18	4.6	5.25E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
KIRC	cis	1	rs8073373	chr17:61703320	DDX42	chr17:61851567-61896676:+	-0.16	-3.52	0.000469	Body mass index	
KIRC	cis	1	rs8073373	chr17:61703320	FTSJ3	chr17:61896795-61905031:-	0.32	6.45	2.62E-10	Body mass index	
KIRC	cis	1	rs8073373	chr17:61703320	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.24	2.67E-5	Body mass index	
KIRC	cis	1	rs8074708	chr17:40286354	DHX58	chr17:40253422-40264751:-	0.37	7.35	8.37E-13	Fibrinogen levels	
KIRC	cis	1	rs8074771	chr17:61735865	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs8074771	chr17:61735865	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs8075061	chr17:61804723	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	3.06E-10	Body mass index	
KIRC	cis	1	rs8075061	chr17:61804723	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.43E-6	Body mass index	
KIRC	cis	1	rs8075257	chr17:61728750	FTSJ3	chr17:61896795-61905031:-	0.32	6.26	8.17E-10	Body mass index	
KIRC	cis	1	rs8075257	chr17:61728750	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.26	2.46E-5	Body mass index	
KIRC	cis	1	rs8075273	chr17:61728881	TCAM1P	chr17:61934376-61941738:+	-0.33	-5.13	4.22E-7	Body mass index	
KIRC	cis	1	rs8075422	chr17:61804686	FTSJ3	chr17:61896795-61905031:-	0.32	6.28	7.51E-10	Body mass index	
KIRC	cis	1	rs8075422	chr17:61804686	TCAM1P	chr17:61934376-61941738:+	-0.27	-4.89	1.34E-6	Body mass index	
KIRC	cis	1	rs8075521	chr17:61804954	FTSJ3	chr17:61896795-61905031:-	0.33	6.43	3.06E-10	Body mass index	
KIRC	cis	1	rs8075521	chr17:61804954	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.43E-6	Body mass index	
KIRC	cis	1	rs807624	chr2:15782471	DDX1	chr2:15731770-15771224:+	0.14	3.69	0.000248	Wilms tumor	
KIRC	cis	1	rs8076336	chr17:18212614	TOP3A	chr17:18177235-18218321:-	0.26	6.08	2.32E-9	Parental longevity (combined parental age at death)	
KIRC	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.39	-9.98	1.67E-21	Metabolite levels	
KIRC	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.34	-9.18	1.15E-18	Metabolite levels	
KIRC	cis	1	rs8076717	chr17:61850301	FTSJ3	chr17:61896795-61905031:-	-0.33	-6.52	1.74E-10	Body mass index	
KIRC	cis	1	rs8076717	chr17:61850301	TCAM1P	chr17:61934376-61941738:+	0.26	4.63	4.6E-6	Body mass index	
KIRC	cis	1	rs8077265	chr17:61732727	DDX42	chr17:61851567-61896676:+	-0.17	-3.68	0.000258	Body mass index	
KIRC	cis	1	rs8077265	chr17:61732727	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.44E-10	Body mass index	
KIRC	cis	1	rs8077265	chr17:61732727	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.56E-6	Body mass index	
KIRC	cis	1	rs8077577	chr17:18064730	FAM106A	chr17:18427880-18430160:-	-0.25	-3.78	0.000177	Obesity-related traits	
KIRC	cis	1	rs8077577	chr17:18064730	LOC220594	chr17:18414577-18445234:-	-0.32	-5.03	6.91E-7	Obesity-related traits	
KIRC	cis	1	rs8077577	chr17:18064730	TOP3A	chr17:18177235-18218321:-	0.22	4.1	4.77E-5	Obesity-related traits	
KIRC	cis	1	rs8078462	chr17:61857937	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.43E-10	Body mass index	
KIRC	cis	1	rs8078462	chr17:61857937	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.86E-6	Body mass index	
KIRC	cis	1	rs8078550	chr17:53053379	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.98	7.94E-5	Breast cancer	
KIRC	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.79	-19.11	1.37E-61	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
KIRC	cis	1	rs8078862	chr17:61854068	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.43E-10	Body mass index	
KIRC	cis	1	rs8078862	chr17:61854068	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.86E-6	Body mass index	
KIRC	cis	1	rs8080211	chr17:61729882	FTSJ3	chr17:61896795-61905031:-	0.33	6.3	6.45E-10	Body mass index	
KIRC	cis	1	rs8080211	chr17:61729882	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.26	2.41E-5	Body mass index	
KIRC	cis	1	rs8080491	chr17:53049869	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs8081537	chr17:77708264	ENPP7	chr17:77704882-77716020:+	-0.25	-5.18	3.21E-7	Diastolic blood pressure response to hydrochlorothiazide in hypertension	
KIRC	cis	1	rs8081541	chr17:61812483	FTSJ3	chr17:61896795-61905031:-	0.33	6.54	1.48E-10	Body mass index	
KIRC	cis	1	rs8081541	chr17:61812483	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.52	7.77E-6	Body mass index	
KIRC	cis	1	rs8081612	chr17:61724695	DDX42	chr17:61851567-61896676:+	0.16	3.55	0.000427	Body mass index	
KIRC	cis	1	rs8081612	chr17:61724695	FTSJ3	chr17:61896795-61905031:-	-0.32	-6.38	4.11E-10	Body mass index	
KIRC	cis	1	rs8081612	chr17:61724695	TCAM1P	chr17:61934376-61941738:+	0.23	4.23	2.77E-5	Body mass index	
KIRC	cis	1	rs8082471	chr17:53067993	TOM1L1	chr17:52978052-53039328:+	-0.13	-3.72	0.000218	Breast cancer	
KIRC	cis	1	rs8082647	chr17:2010597	SRR	chr17:2207248-2228553:+	-0.38	-5.92	6.02E-9	Body mass index	
KIRC	cis	1	rs8093534	chr18:48368020	MRO	chr18:48321491-48351754:-	0.34	5.97	4.55E-9	Entorhinal cortical thickness	
KIRC	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.07	2.61E-18	Body mass index	
KIRC	cis	1	rs809775	chr1:46538040	MUTYH	chr1:45794915-45806142:-	0.14	4	7.43E-5	Body mass index	
KIRC	cis	1	rs809912	chr1:2078385	SLC35E2	chr1:1590990-1677431:-	0.16	3.56	0.000408	Height	
KIRC	cis	1	rs8100042	chr19:22127841	ZNF257	chr19:22235266-22273901:+	0.32	4.36	1.58E-5	Body mass index (change over time)	
KIRC	cis	1	rs8100168	chr19:33093084	ANKRD27	chr19:33087907-33166102:-	0.32	4.33	1.78E-5	Eosinophilic esophagitis	
KIRC	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.26	6.06	2.67E-9	Bone properties (heel)	
KIRC	cis	1	rs8101356	chr19:33093402	ANKRD27	chr19:33087907-33166102:-	0.32	4.97	9.2E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8101356	chr19:33093402	RGS9BP	chr19:33166313-33169206:+	0.28	3.75	0.000196	Eosinophilic esophagitis	
KIRC	cis	1	rs8101881	chr19:33364628	RHPN2	chr19:33469499-33555824:-	0.16	3.66	0.000276	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
KIRC	cis	1	rs8101881	chr19:33364628	SLC7A9	chr19:33321421-33360683:-	0.17	4.99	8.45E-7	Blood metabolite levels;Urinary metabolites (H-NMR features);Urinary metabolites	
KIRC	cis	1	rs8103622	chr19:18572834	SSBP4	chr19:18530221-18545371:+	-0.13	-4.56	6.5E-6	Breast cancer	
KIRC	cis	1	rs8104328	chr19:33094371	ANKRD27	chr19:33087907-33166102:-	0.32	4.97	9.4E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8104328	chr19:33094371	RGS9BP	chr19:33166313-33169206:+	0.28	3.73	0.000215	Eosinophilic esophagitis	
KIRC	cis	1	rs8104559	chr19:22205167	ZNF257	chr19:22235266-22273901:+	0.33	4.51	8.08E-6	Body mass index (change over time)	
KIRC	cis	1	rs8104726	chr19:33094675	ANKRD27	chr19:33087907-33166102:-	0.33	5.02	7.07E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8104726	chr19:33094675	RGS9BP	chr19:33166313-33169206:+	0.28	3.69	0.000246	Eosinophilic esophagitis	
KIRC	cis	1	rs8104729	chr19:33093979	ANKRD27	chr19:33087907-33166102:-	0.32	4.97	9.2E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8104729	chr19:33093979	RGS9BP	chr19:33166313-33169206:+	0.28	3.75	0.000196	Eosinophilic esophagitis	
KIRC	cis	1	rs8105833	chr19:41896145	ATP5SL	chr19:41937224-41945810:-	0.16	3.66	0.000275	Height	
KIRC	cis	1	rs8105895	chr19:22215457	ZNF257	chr19:22235266-22273901:+	0.34	4.7	3.37E-6	Body mass index (change over time)	
KIRC	cis	1	rs8105994	chr19:18593553	SSBP4	chr19:18530221-18545371:+	-0.11	-3.79	0.000167	Breast cancer	
KIRC	cis	1	rs8106929	chr19:52368467	ZNF577	chr19:52359056-52394145:-	-0.3	-5.64	2.8E-8	Breast cancer	
KIRC	cis	1	rs8106929	chr19:52368467	ZNF649	chr19:52392489-52408247:-	-0.26	-5.35	1.33E-7	Breast cancer	
KIRC	cis	1	rs8107367	chr19:18564705	SSBP4	chr19:18530221-18545371:+	-0.13	-4.33	1.81E-5	Breast cancer	
KIRC	cis	1	rs8107416	chr19:39237950	CAPN12	chr19:39220832-39235114:-	-0.15	-4.58	5.98E-6	Heart rate	
KIRC	cis	1	rs8108477	chr19:52364902	ZNF577	chr19:52359056-52394145:-	-0.32	-5.97	4.56E-9	Breast cancer	
KIRC	cis	1	rs8108477	chr19:52364902	ZNF649	chr19:52392489-52408247:-	-0.27	-5.5	5.9E-8	Breast cancer	
KIRC	cis	1	rs8108583	chr19:52364977	ZNF577	chr19:52359056-52394145:-	-0.3	-5.57	4.12E-8	Breast cancer	
KIRC	cis	1	rs8108583	chr19:52364977	ZNF649	chr19:52392489-52408247:-	-0.24	-4.95	1.02E-6	Breast cancer	
KIRC	cis	1	rs8108840	chr19:33094452	ANKRD27	chr19:33087907-33166102:-	0.28	4.38	1.43E-5	Eosinophilic esophagitis	
KIRC	cis	1	rs8108840	chr19:33094452	RGS9BP	chr19:33166313-33169206:+	0.29	3.94	9.39E-5	Eosinophilic esophagitis	
KIRC	cis	1	rs8109345	chr19:52364933	ZNF577	chr19:52359056-52394145:-	-0.31	-5.62	3.22E-8	Breast cancer	
KIRC	cis	1	rs8109345	chr19:52364933	ZNF649	chr19:52392489-52408247:-	-0.24	-4.97	8.99E-7	Breast cancer	
KIRC	cis	1	rs8109573	chr19:18617151	SSBP4	chr19:18530221-18545371:+	-0.14	-4.66	4.1E-6	Breast cancer	
KIRC	cis	1	rs8109768	chr19:33095463	ANKRD27	chr19:33087907-33166102:-	0.33	5.05	6.26E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8109768	chr19:33095463	RGS9BP	chr19:33166313-33169206:+	0.28	3.71	0.000226	Eosinophilic esophagitis	
KIRC	cis	1	rs8109885	chr19:33095557	ANKRD27	chr19:33087907-33166102:-	0.32	4.92	1.17E-6	Eosinophilic esophagitis	
KIRC	cis	1	rs8109885	chr19:33095557	RGS9BP	chr19:33166313-33169206:+	0.28	3.68	0.000254	Eosinophilic esophagitis	
KIRC	cis	1	rs8109990	chr19:33095636	ANKRD27	chr19:33087907-33166102:-	0.32	4.92	1.15E-6	Eosinophilic esophagitis	
KIRC	cis	1	rs8109990	chr19:33095636	RGS9BP	chr19:33166313-33169206:+	0.28	3.68	0.000254	Eosinophilic esophagitis	
KIRC	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.26	6.06	2.67E-9	Bone properties (heel)	
KIRC	cis	1	rs8111316	chr19:52369069	ZNF577	chr19:52359056-52394145:-	-0.29	-5.48	6.6E-8	Breast cancer	
KIRC	cis	1	rs8111316	chr19:52369069	ZNF649	chr19:52392489-52408247:-	-0.24	-5.05	6.25E-7	Breast cancer	
KIRC	cis	1	rs8111708	chr19:18558876	SSBP4	chr19:18530221-18545371:+	-0.12	-4.13	4.27E-5	Breast cancer	
KIRC	cis	1	rs8111746	chr19:39212859	CAPN12	chr19:39220832-39235114:-	-0.14	-4.43	1.13E-5	Heart rate	
KIRC	cis	1	rs8111946	chr19:45152394	PVR	chr19:45147098-45169426:+	0.38	7.32	1.0E-12	Multiple sclerosis	
KIRC	cis	1	rs8112837	chr19:10837030	SLC44A2	chr19:10713121-10755234:+	-0.22	-3.59	0.00036	LDL cholesterol	
KIRC	cis	1	rs8113165	chr19:33096316	ANKRD27	chr19:33087907-33166102:-	0.33	5.03	6.98E-7	Eosinophilic esophagitis	
KIRC	cis	1	rs8113165	chr19:33096316	RGS9BP	chr19:33166313-33169206:+	0.27	3.54	0.000434	Eosinophilic esophagitis	
KIRC	cis	1	rs8113308	chr19:52445386	ZNF350	chr19:52467595-52490079:-	0.25	3.49	0.000521	Survival in endocrine treated breast cancer (estrogen-receptor positive)	
KIRC	cis	1	rs8113312	chr19:23061182	ZNF492	chr19:22817126-22850472:+	-0.38	-5.5	5.9E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs8117100	chr20:33692261	PROCR	chr20:33758727-33765164:+	-0.27	-3.65	0.000294	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs8119827	chr20:33726873	PROCR	chr20:33758727-33765164:+	-0.31	-4.14	4.14E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs8119827	chr20:33726873	SPAG4	chr20:34203809-34208965:+	0.23	3.88	0.000121	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs8123062	chr20:55069310	C20orf43	chr20:55043647-55093942:+	0.21	4.8	2.07E-6	Refractive astigmatism	
KIRC	cis	1	rs8123289	chr20:3253831	ITPA	chr20:3190056-3204504:+	-0.27	-6.28	7.16E-10	IFN-related cytopenia	
KIRC	cis	1	rs8124430	chr20:42897670	L3MBTL	chr20:42136350-42179593:+	-0.15	-3.6	0.000354	Cognitive performance	
KIRC	cis	1	rs8125425	chr20:55067135	C20orf43	chr20:55043647-55093942:+	-0.19	-4.35	1.62E-5	Refractive astigmatism	
KIRC	cis	1	rs8125868	chr20:25324410	ENTPD6	chr20:25176339-25207360:+	0.24	6.6	1.05E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.28	5.38	1.12E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs8131214	chr21:30483386	N6AMT1	chr21:30244513-30257693:-	-0.22	-4	7.27E-5	Dental caries	
KIRC	cis	1	rs8131214	chr21:30483386	NCRNA00189	chr21:30565801-30660525:+	0.23	4.18	3.4E-5	Dental caries	
KIRC	cis	1	rs8133949	chr21:43421114	C21orf121	chr21:43442113-43445060:+	0.35	5.94	5.31E-9	Hand grip strength	
KIRC	cis	1	rs8136657	chr22:40516522	XPNPEP3	chr22:41253094-41363888:+	0.19	3.67	0.000268	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.27	-5.41	9.92E-8	Narcolepsy	
KIRC	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.65	7.39	6.17E-13	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs8138996	chr22:39047435	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs8140617	chr22:38970439	BAIAP2L2	chr22:38480897-38506676:-	-0.16	-3.82	0.000148	Resting heart rate	
KIRC	cis	1	rs8140617	chr22:38970439	LOC646851	chr22:38974125-39052634:-	-0.15	-4.32	1.91E-5	Resting heart rate	
KIRC	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.52	-6.06	2.7E-9	Amyotrophic lateral sclerosis	
KIRC	cis	1	rs8142098	chr22:39058757	LOC646851	chr22:38974125-39052634:-	0.14	4.15	3.99E-5	Resting heart rate	
KIRC	cis	1	rs815306	chr1:76168624	ACADM	chr1:76190043-76229353:+	0.14	4.09	5.01E-5	Daytime sleep phenotypes	
KIRC	cis	1	rs8170	chr19:17389704	ANKLE1	chr19:17392454-17398454:+	0.19	4.18	3.4E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
KIRC	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.31	6.74	4.26E-11	Multiple sclerosis	
KIRC	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.49	-12.98	1.95E-33	Multiple sclerosis	
KIRC	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-6.46	2.45E-10	Multiple sclerosis	
KIRC	cis	1	rs8181679	chr12:50611020	LIMA1	chr12:50569565-50677353:-	0.32	6.72	5.08E-11	Schizophrenia	
KIRC	cis	1	rs8192482	chr15:78886198	CHRNA5	chr15:78857906-78886458:+	-0.35	-6.78	3.34E-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs823128	chr1:205713378	PM20D1	chr1:205797154-205819245:-	-0.4	-3.58	0.000379	Parkinson's disease	
KIRC	cis	1	rs823144	chr1:205744546	PM20D1	chr1:205797154-205819245:-	-0.32	-5.03	6.91E-7	Parkinson's disease	
KIRC	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.18	4.5	8.3E-6	Parkinson's disease	
KIRC	cis	1	rs823156	chr1:205764640	PM20D1	chr1:205797154-205819245:-	-0.46	-6.27	7.83E-10	Parkinson's disease	
KIRC	cis	1	rs823156	chr1:205764640	RAB7L1	chr1:205737115-205744610:-	0.16	3.59	0.000362	Parkinson's disease	
KIRC	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.84	16.83	1.04E-50	Type 2 diabetes	
KIRC	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.82	16.77	1.9E-50	Type 2 diabetes	
KIRC	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.76	15.22	2.76E-43	Type 2 diabetes	
KIRC	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.85	17.38	2.47E-53	Type 2 diabetes	
KIRC	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.85	17.38	2.47E-53	Type 2 diabetes	
KIRC	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.85	17.38	2.47E-53	Type 2 diabetes	
KIRC	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.83	16.89	5.5E-51	Type 2 diabetes	
KIRC	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.85	16.92	3.86E-51	Type 2 diabetes	
KIRC	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.84	16.83	1.01E-50	Type 2 diabetes	
KIRC	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.78	-15.67	2.34E-45	Type 2 diabetes	
KIRC	cis	1	rs833087	chr13:28177227	POLR1D	chr13:28194895-28241547:+	-0.21	-4.52	7.86E-6	Large B-cell lymphoma	
KIRC	cis	1	rs8373	chr11:58378424	ZFP91	chr11:58346587-58388513:+	-0.12	-3.5	0.000503	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
KIRC	cis	1	rs842361	chr2:135340840	TMEM163	chr2:135213331-135525334:-	-0.27	-4.39	1.37E-5	Neuroticism	
KIRC	cis	1	rs842625	chr2:61080482	PUS10	chr2:61167550-61245365:-	0.16	4.12	4.34E-5	Psoriasis	
KIRC	cis	1	rs842626	chr2:61081184	PUS10	chr2:61167550-61245365:-	0.16	4.12	4.34E-5	Psoriasis	
KIRC	cis	1	rs842627	chr2:61082660	PUS10	chr2:61167550-61245365:-	-0.16	-4.23	2.81E-5	Psoriasis	
KIRC	cis	1	rs842631	chr2:61085723	PUS10	chr2:61167550-61245365:-	-0.16	-4.39	1.37E-5	Psoriasis	
KIRC	cis	1	rs842636	chr2:61091950	PUS10	chr2:61167550-61245365:-	0.18	4.69	3.6E-6	Psoriasis	
KIRC	cis	1	rs842638	chr2:61092678	PUS10	chr2:61167550-61245365:-	0.17	4.59	5.58E-6	Psoriasis	
KIRC	cis	1	rs846111	chr1:6279370	GPR153	chr1:6307414-6321035:-	-0.22	-3.83	0.000145	QT interval	
KIRC	cis	1	rs847845	chr6:34923864	UHRF1BP1	chr6:34759794-34853117:+	-0.17	-3.74	0.000208	Non-small cell lung cancer	
KIRC	cis	1	rs847861	chr6:34938809	UHRF1BP1	chr6:34759794-34853117:+	0.19	4.06	5.61E-5	Non-small cell lung cancer	
KIRC	cis	1	rs853676	chr6:28299687	ZKSCAN3	chr6:28317691-28334523:+	-0.18	-3.56	0.000408	Depression	
KIRC	cis	1	rs853676	chr6:28299687	ZNF187	chr6:28234788-28245978:+	-0.24	-4.35	1.62E-5	Depression	
KIRC	cis	1	rs853676	chr6:28299687	ZNF323	chr6:28292517-28324048:-	0.33	4.92	1.15E-6	Depression	
KIRC	cis	1	rs853676	chr6:28299687	ZSCAN23	chr6:28393287-28411279:-	0.29	4.48	9.41E-6	Depression	
KIRC	cis	1	rs853678	chr6:28297313	ZNF187	chr6:28234788-28245978:+	-0.22	-4.07	5.57E-5	Depression	
KIRC	cis	1	rs853678	chr6:28297313	ZNF323	chr6:28292517-28324048:-	0.31	4.53	7.34E-6	Depression	
KIRC	cis	1	rs853678	chr6:28297313	ZSCAN23	chr6:28393287-28411279:-	0.3	4.67	3.87E-6	Depression	
KIRC	cis	1	rs853679	chr6:28296863	ZNF187	chr6:28234788-28245978:+	-0.22	-4.07	5.57E-5	Depression	
KIRC	cis	1	rs853679	chr6:28296863	ZNF323	chr6:28292517-28324048:-	0.31	4.53	7.34E-6	Depression	
KIRC	cis	1	rs853679	chr6:28296863	ZSCAN23	chr6:28393287-28411279:-	0.3	4.67	3.87E-6	Depression	
KIRC	cis	1	rs853685	chr6:28288785	ZNF187	chr6:28234788-28245978:+	-0.23	-4.16	3.79E-5	Depression	
KIRC	cis	1	rs853685	chr6:28288785	ZNF323	chr6:28292517-28324048:-	0.3	4.41	1.27E-5	Depression	
KIRC	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.3	4.64	4.39E-6	Depression	
KIRC	cis	1	rs853694	chr6:28279100	ZNF187	chr6:28234788-28245978:+	-0.24	-4.38	1.46E-5	Depression	
KIRC	cis	1	rs853694	chr6:28279100	ZNF323	chr6:28292517-28324048:-	0.31	4.59	5.51E-6	Depression	
KIRC	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.28	4.4	1.33E-5	Depression	
KIRC	cis	1	rs854384	chr14:25271520	KHNYN	chr14:24898492-24910545:+	-0.16	-3.57	0.000386	Hippocampal volume	
KIRC	cis	1	rs855865	chr1:159028378	IFI16	chr1:158969758-159024943:+	-0.14	-3.5	0.000514	Obesity-related traits	
KIRC	cis	1	rs858239	chr7:23286315	GPNMB	chr7:23286316-23314728:+	-0.21	-4.47	9.84E-6	Parkinson's disease	
KIRC	cis	1	rs858240	chr7:23284237	GPNMB	chr7:23286316-23314728:+	-0.2	-4.4	1.31E-5	Parkinson's disease	
KIRC	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.46	-11.37	8.05E-27	Homocysteine levels	
KIRC	cis	1	rs859767	chr2:135341200	TMEM163	chr2:135213331-135525334:-	-0.25	-4.04	6.18E-5	Neuroticism	
KIRC	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.81	-16.88	6.11E-51	Type 2 diabetes	
KIRC	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.83	16.7	3.92E-50	Type 2 diabetes	
KIRC	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.76	14.57	2.41E-40	Type 2 diabetes	
KIRC	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.83	16.7	3.92E-50	Type 2 diabetes	
KIRC	cis	1	rs867186	chr20:33764554	PROCR	chr20:33758727-33765164:+	0.31	4.18	3.47E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs868530	chr5:156430916	HAVCR1	chr5:156456531-156486130:-	-0.45	-10.06	8.14E-22	Hypertriglyceridemia	
KIRC	cis	1	rs868530	chr5:156430916	HAVCR2	chr5:156512843-156536138:-	-0.41	-7.68	8.34E-14	Hypertriglyceridemia	
KIRC	cis	1	rs868530	chr5:156430916	TIMD4	chr5:156346293-156390266:-	-0.37	-6.84	2.29E-11	Hypertriglyceridemia	
KIRC	cis	1	rs868945	chr2:219924439	USP37	chr2:219314974-219433084:-	-0.24	-3.71	0.000227	Height	
KIRC	cis	1	rs870355	chr17:76166196	SYNGR2	chr17:76164671-76169009:+	0.13	3.93	9.7E-5	Adenocarcinoma;Lung cancer	
KIRC	cis	1	rs871130	chr12:56648777	RPS26	chr12:56435686-56438005:+	0.44	3.86	0.000128	Psoriasis vulgaris	
KIRC	cis	1	rs871546	chr21:43413553	C21orf121	chr21:43442113-43445060:+	0.32	5.46	7.67E-8	Hand grip strength	
KIRC	cis	1	rs873063	chr8:8572447	CLDN23	chr8:8559666-8561616:+	0.22	3.58	0.000371	Obesity-related traits	
KIRC	cis	1	rs873064	chr8:8572380	CLDN23	chr8:8559666-8561616:+	0.22	3.57	0.000394	Obesity-related traits	
KIRC	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.6	13.04	1.15E-33	Kawasaki disease	
KIRC	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.24	6.63	8.83E-11	Blood metabolite levels	
KIRC	cis	1	rs876402	chr14:75601862	MLH3	chr14:75480467-75518235:-	-0.23	-5.8	1.17E-8	Height	
KIRC	cis	1	rs876402	chr14:75601862	NEK9	chr14:75548819-75593778:-	-0.14	-3.97	8.16E-5	Height	
KIRC	cis	1	rs876403	chr14:75602834	MLH3	chr14:75480467-75518235:-	0.23	5.95	4.9E-9	Height	
KIRC	cis	1	rs876403	chr14:75602834	NEK9	chr14:75548819-75593778:-	0.14	3.9	0.000107	Height	
KIRC	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.77	-15.8	6.16E-46	Cognitive function	
KIRC	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.29	6.16	1.49E-9	HDL cholesterol	
KIRC	cis	1	rs878082	chr19:41897674	ATP5SL	chr19:41937224-41945810:-	0.15	3.6	0.000349	Height	
KIRC	cis	1	rs878083	chr19:41897688	ATP5SL	chr19:41937224-41945810:-	0.17	4.16	3.78E-5	Height	
KIRC	cis	1	rs879568	chr18:34311659	C18orf10	chr18:34366472-34409158:-	-0.2	-3.74	0.000207	QRS duration	
KIRC	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.5	-9.95	2.1E-21	Rheumatoid arthritis	
KIRC	cis	1	rs881375	chr9:123652898	PSMD5	chr9:123578334-123605206:-	-0.35	-6.66	7.27E-11	Rheumatoid arthritis	
KIRC	cis	1	rs881827	chr21:48019868	C21orf56	chr21:47581063-47604373:-	-0.21	-4.1	4.77E-5	Lymphocyte counts	
KIRC	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.86	-20.35	1.45E-67	Homocysteine levels	
KIRC	cis	1	rs882803	chr1:45976147	MUTYH	chr1:45794915-45806142:-	0.14	4.1	4.78E-5	Homocysteine levels	
KIRC	cis	1	rs883180	chr16:55612277	LPCAT2	chr16:55542913-55620581:+	-0.17	-4.39	1.41E-5	Thyroid hormone levels	
KIRC	cis	1	rs883394	chr19:39205613	CAPN12	chr19:39220832-39235114:-	-0.13	-3.96	8.71E-5	Heart rate	
KIRC	cis	1	rs883433	chr19:39206288	CAPN12	chr19:39220832-39235114:-	0.14	4.38	1.46E-5	Heart rate	
KIRC	cis	1	rs884247	chr14:65895706	LOC645431	chr14:65877313-65879335:-	-0.49	-6.58	1.19E-10	Ischemic stroke	
KIRC	cis	1	rs884613	chr20:25288505	ENTPD6	chr20:25176339-25207360:+	0.24	6.45	2.63E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.31	5.88	7.29E-9	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.25E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs884977	chr7:1066410	ZFAND2A	chr7:1192544-1199855:-	-0.28	-5.02	7.35E-7	C-reactive protein levels or total cholesterol levels (pleiotropy)	
KIRC	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	-0.29	-6.07	2.6E-9	HDL cholesterol	
KIRC	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.33	6.03	3.13E-9	Breast cancer (early onset);Breast cancer	
KIRC	cis	1	rs889398	chr16:69556715	EXOSC6	chr16:70284134-70285833:-	0.25	4.66	4.05E-6	Body mass index	
KIRC	cis	1	rs889398	chr16:69556715	PDXDC2	chr16:70010210-70099851:-	0.1	3.67	0.000272	Body mass index	
KIRC	cis	1	rs889399	chr16:69556583	EXOSC6	chr16:70284134-70285833:-	0.26	4.79	2.21E-6	Body mass index	
KIRC	cis	1	rs889399	chr16:69556583	PDXDC2	chr16:70010210-70099851:-	0.1	3.6	0.000345	Body mass index	
KIRC	cis	1	rs889704	chr16:71392062	CALB2	chr16:71392626-71424339:+	0.36	3.91	0.000105	Schizophrenia	
KIRC	cis	1	rs8897	chr3:49460407	CCDC36	chr3:49235861-49295537:+	0.24	4.57	6.27E-6	Menarche (age at onset)	
KIRC	cis	1	rs8897	chr3:49460407	GMPPB	chr3:49758932-49761384:-	-0.16	-3.66	0.000283	Menarche (age at onset)	
KIRC	cis	1	rs8897	chr3:49460407	NCKIPSD	chr3:48711280-48723334:-	0.18	3.58	0.000373	Menarche (age at onset)	
KIRC	cis	1	rs8897	chr3:49460407	P4HTM	chr3:49027341-49044579:+	0.2	4.43	1.16E-5	Menarche (age at onset)	
KIRC	cis	1	rs8897	chr3:49460407	TREX1	chr3:48501186-48509043:+	-0.16	-4.04	6.07E-5	Menarche (age at onset)	
KIRC	cis	1	rs8897	chr3:49460407	WDR6	chr3:49044637-49053386:+	-0.21	-5.2	2.94E-7	Menarche (age at onset)	
KIRC	cis	1	rs890749	chr5:121436596	LOX	chr5:121400163-121414055:-	-0.22	-4.86	1.55E-6	Thiazide-induced adverse metabolic effects in hypertensive patients	
KIRC	cis	1	rs891368	chr3:53123273	ITIH3	chr3:52828784-52843025:+	0.14	3.55	0.000416	Height	
KIRC	cis	1	rs891368	chr3:53123273	ITIH4	chr3:52847007-52866554:-	0.14	3.69	0.000248	Height	
KIRC	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.45	-12.11	8.2E-30	Height	
KIRC	cis	1	rs891386	chr18:21103971	NPC1	chr18:21108363-21166581:-	0.18	3.67	0.00027	Body mass index	
KIRC	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.89	11.15	5.99E-26	Multiple system atrophy	
KIRC	cis	1	rs892974	chr3:49398514	CCDC36	chr3:49235861-49295537:+	0.28	5.11	4.52E-7	Menarche (age at onset)	
KIRC	cis	1	rs892974	chr3:49398514	GMPPB	chr3:49758932-49761384:-	-0.18	-4.02	6.58E-5	Menarche (age at onset)	
KIRC	cis	1	rs892974	chr3:49398514	NCKIPSD	chr3:48711280-48723334:-	0.23	4.46	1.03E-5	Menarche (age at onset)	
KIRC	cis	1	rs892974	chr3:49398514	P4HTM	chr3:49027341-49044579:+	0.22	4.87	1.52E-6	Menarche (age at onset)	
KIRC	cis	1	rs892974	chr3:49398514	WDR6	chr3:49044637-49053386:+	-0.21	-5.14	3.96E-7	Menarche (age at onset)	
KIRC	cis	1	rs894737	chr12:54418143	FLJ12825	chr12:54452038-54516018:+	0.29	5.42	9.18E-8	Bone mineral density	
KIRC	cis	1	rs894738	chr12:54417525	FLJ12825	chr12:54452038-54516018:+	0.28	5.25	2.3E-7	Bone mineral density	
KIRC	cis	1	rs897119	chr2:70160658	ANXA4	chr2:69969127-70053594:+	-0.21	-5.19	3.1E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs897120	chr2:70160982	ANXA4	chr2:69969127-70053594:+	0.22	5.37	1.22E-7	Carotid plaque burden (smoking interaction)	
KIRC	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.28	7.9	1.72E-14	Longevity	
KIRC	cis	1	rs900012	chr11:116966435	PCSK7	chr11:117075789-117102811:-	-0.27	-5.12	4.45E-7	Protein quantitative trait loci	
KIRC	cis	1	rs901104	chr11:77930499	NARS2	chr11:78147017-78285909:-	-0.17	-3.55	0.000416	Testicular germ cell tumor	
KIRC	cis	1	rs903027	chr8:62409428	CLVS1	chr8:62200525-62414202:+	0.28	4.72	3.06E-6	Whole-brain volume	
KIRC	cis	1	rs903121	chr1:212405455	TMEM206	chr1:212537819-212588267:-	0.2	3.97	8.11E-5	Intelligence (childhood)	
KIRC	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.28	5.48	6.72E-8	Diabetic kidney disease	
KIRC	cis	1	rs906134	chr7:65444288	CRCP	chr7:65579805-65619551:+	-0.32	-4.34	1.75E-5	Diabetic kidney disease	
KIRC	cis	1	rs909341	chr20:62328742	SLC2A4RG	chr20:62371211-62375401:+	-0.15	-3.54	0.000435	Atopic dermatitis	
KIRC	cis	1	rs909349	chr4:103556316	MANBA	chr4:103552644-103682151:-	-0.17	-3.98	7.85E-5	Primary biliary cirrhosis	
KIRC	cis	1	rs910316	chr14:75626042	MLH3	chr14:75480467-75518235:-	0.24	6.05	2.78E-9	Height	
KIRC	cis	1	rs910316	chr14:75626042	NEK9	chr14:75548819-75593778:-	0.14	4.02	6.72E-5	Height	
KIRC	cis	1	rs910997	chr20:25267301	ENTPD6	chr20:25176339-25207360:+	-0.24	-6.41	3.3E-10	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.28	-5.2	2.9E-7	Liver enzyme levels (alkaline phosphatase)	
KIRC	cis	1	rs911119	chr20:23612737	CST3	chr20:23608536-23618574:-	0.14	3.85	0.000134	Chronic kidney disease	
KIRC	cis	1	rs911411	chr20:47718431	CSE1L	chr20:47662838-47713484:+	0.18	4.69	3.45E-6	Anger	
KIRC	cis	1	rs911913	chr14:100182801	CYP46A1	chr14:100150755-100193637:+	0.21	3.84	0.000139	Scalp hair shape	
KIRC	cis	1	rs912337	chr13:99141272	STK24	chr13:99102455-99229396:-	0.28	5.61	3.36E-8	Longevity	
KIRC	cis	1	rs916583	chr22:23469267	GNAZ	chr22:23412669-23467221:+	-0.17	-3.49	0.000525	Bone mineral density	
KIRC	cis	1	rs916584	chr22:23469433	GNAZ	chr22:23412669-23467221:+	-0.17	-3.52	0.000463	Bone mineral density	
KIRC	cis	1	rs916926	chr17:39030283	TMEM99	chr17:38975374-38992526:+	0.22	4.53	7.36E-6	Height	
KIRC	cis	1	rs917665	chr4:17668504	LAP3	chr4:17578927-17609590:+	0.19	6.04	3.05E-9	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs917665	chr4:17668504	MED28	chr4:17616273-17629791:+	-0.22	-4.91	1.23E-6	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.44	12.39	5.95E-31	Type 1 diabetes	
KIRC	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.24	-4.24	2.68E-5	Obesity-related traits	
KIRC	cis	1	rs918814	chr2:23948466	LOC375190	chr2:24299728-24397519:+	0.23	5.65	2.67E-8	Obesity-related traits	
KIRC	cis	1	rs920573	chr11:59924959	MS4A2	chr11:59856137-59866014:+	0.19	4.17	3.52E-5	Alzheimer's disease (late onset)	
KIRC	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.26	-5.32	1.57E-7	Spherical equivalent (joint main effects and education interaction)	
KIRC	cis	1	rs921450	chr7:50623260	FIGNL1	chr7:50511834-50518088:-	0.23	4.67	3.85E-6	Malaria	
KIRC	cis	1	rs921451	chr7:50623285	FIGNL1	chr7:50511834-50518088:-	-0.23	-4.67	3.85E-6	Malaria	
KIRC	cis	1	rs921943	chr5:78316476	ARSB	chr5:78073039-78282357:-	-0.19	-4.01	7.12E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs921943	chr5:78316476	BHMT	chr5:78407604-78428112:+	-0.25	-5.17	3.3E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.28	8.19	2.14E-15	Longevity	
KIRC	cis	1	rs922664	chr15:84569555	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.5	8.43E-6	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs922672	chr15:100582114	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.56	6.29E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs922673	chr15:100582151	ADAMTS17	chr15:100511643-100882183:-	-0.26	-4.56	6.29E-6	Gastroesophageal reflux disease	
KIRC	cis	1	rs923372	chr4:48410454	OCIAD1	chr4:48833015-48863831:+	-0.23	-5.25	2.3E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.19	-3.93	9.59E-5	Idiopathic membranous nephropathy	
KIRC	cis	1	rs925410	chr2:160912652	PLA2R1	chr2:160798012-160919121:-	-0.18	-3.81	0.000154	Idiopathic membranous nephropathy	
KIRC	cis	1	rs926299	chr22:39095698	LOC646851	chr22:38974125-39052634:-	0.11	3.55	0.000422	Resting heart rate	
KIRC	cis	1	rs926853	chr6:126021435	HEY2	chr6:126068780-126082414:+	0.18	4.46	9.93E-6	Endometrial cancer	
KIRC	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.82	16.48	4.18E-49	Type 2 diabetes	
KIRC	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.21	4.11	4.54E-5	Melanoma;Esophageal squamous cell carcinoma	
KIRC	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.45	6.52	1.69E-10	Blood pressure (smoking interaction)	
KIRC	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.59	14.07	3.84E-38	Height	
KIRC	cis	1	rs9289471	chr3:134230811	CEP63	chr3:134204575-134293852:+	0.31	6.1	2.08E-9	Height	
KIRC	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.59	14.31	3.4E-39	Height	
KIRC	cis	1	rs9289475	chr3:134236459	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.89E-10	Height	
KIRC	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.59	13.98	9.6E-38	Height	
KIRC	cis	1	rs9289476	chr3:134237103	CEP63	chr3:134204575-134293852:+	0.32	6.34	5.11E-10	Height	
KIRC	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.6	14.32	3.13E-39	Height	
KIRC	cis	1	rs9289478	chr3:134268619	CEP63	chr3:134204575-134293852:+	0.33	6.38	4.05E-10	Height	
KIRC	cis	1	rs929039	chr22:38071511	LGALS1	chr22:38071613-38075807:+	-0.13	-3.89	0.000113	Fat distribution (HIV)	
KIRC	cis	1	rs9291659	chr4:17662360	LAP3	chr4:17578927-17609590:+	-0.22	-6.98	9.45E-12	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs9291659	chr4:17662360	MED28	chr4:17616273-17629791:+	0.18	4.11	4.54E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs9294377	chr6:88084839	C6orf162	chr6:88032306-88052043:+	-0.19	-4.05	5.95E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs9294377	chr6:88084839	C6orf164	chr6:88032306-88109459:+	-0.17	-4.21	3.04E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs9295130	chr6:161068891	PLG	chr6:161123274-161174345:+	0.26	5.32	1.59E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.37	-8.86	1.39E-17	Plasma homocysteine levels (post-methionine load test)	
KIRC	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.81	18.72	1.11E-59	Plasma homocysteine levels (post-methionine load test)	
KIRC	cis	1	rs9296504	chr6:46629505	CYP39A1	chr6:46517445-46620523:-	0.19	3.64	0.0003	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9296504	chr6:46629505	SLC25A27	chr6:46620679-46645925:+	0.15	4.86	1.58E-6	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9296505	chr6:46629841	CYP39A1	chr6:46517445-46620523:-	0.19	3.81	0.000155	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9296505	chr6:46629841	SLC25A27	chr6:46620679-46645925:+	0.15	4.88	1.4E-6	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.39	-9.23	7.74E-19	Folate pathway vitamin levels	
KIRC	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.24	8.07	5.34E-15	Folate pathway vitamin levels	
KIRC	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.42	-10.29	1.14E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.25	8.32	8.6E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.78	23.49	7.6E-83	Pulse pressure	
KIRC	cis	1	rs9297464	chr8:89415996	MMP16	chr8:89049462-89339717:-	0.31	4.14	4.04E-5	Electrodermal activity	
KIRC	cis	1	rs9297465	chr8:89416826	MMP16	chr8:89049462-89339717:-	0.32	4.29	2.17E-5	Electrodermal activity	
KIRC	cis	1	rs9297469	chr8:89431787	MMP16	chr8:89049462-89339717:-	0.32	4.44	1.1E-5	Electrodermal activity	
KIRC	cis	1	rs9297470	chr8:89432036	MMP16	chr8:89049462-89339717:-	0.32	4.43	1.18E-5	Electrodermal activity	
KIRC	cis	1	rs9297950	chr8:96025659	C8orf38	chr8:95908040-96088396:+	-0.27	-4.15	3.93E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
KIRC	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.26	-4.75	2.66E-6	Menarche (age at onset)	
KIRC	cis	1	rs929843	chr16:70045748	CLEC18C	chr16:69984626-70220796:+	-0.28	-5.09	5.16E-7	Menarche (age at onset)	
KIRC	cis	1	rs929843	chr16:70045748	EXOSC6	chr16:70284134-70285833:-	-0.47	-7.63	1.2E-13	Menarche (age at onset)	
KIRC	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.17	-5.6	3.63E-8	Menarche (age at onset)	
KIRC	cis	1	rs9302752	chr16:50719103	SNX20	chr16:50700211-50715264:-	0.08	3.84	0.000142	Leprosy	
KIRC	cis	1	rs9303537	chr17:41814008	DUSP3	chr17:41843490-41856368:-	-0.14	-3.72	0.000223	Bone mineral density (hip)	
KIRC	cis	1	rs9304578	chr19:39250337	CAPN12	chr19:39220832-39235114:-	0.14	4.38	1.48E-5	Heart rate	
KIRC	cis	1	rs9304742	chr19:53451291	ZNF321	chr19:53430388-53466114:-	0.19	4.34	1.74E-5	Psoriasis	
KIRC	cis	1	rs9306329	chr22:39072454	LOC646851	chr22:38974125-39052634:-	0.13	4.11	4.59E-5	Resting heart rate	
KIRC	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.52	-10.75	2.12E-24	Longevity	
KIRC	cis	1	rs9309331	chr2:61141615	C2orf74	chr2:61372243-61391964:+	0.36	6.07	2.49E-9	Inflammatory skin disease	
KIRC	cis	1	rs9309473	chr2:73743982	TPRKB	chr2:73956957-73964517:-	-0.21	-5.49	6.43E-8	Metabolite levels	
KIRC	cis	1	rs931058	chr5:150333698	IRGM	chr5:150226085-150280295:+	0.51	6.47	2.3E-10	Crohn's disease	
KIRC	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.37	4.62	4.96E-6	Crohn's disease	
KIRC	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.76	11.43	4.66E-27	Diastolic blood pressure	
KIRC	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.3	-8.6	1.06E-16	Longevity	
KIRC	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.17	-4.26	2.48E-5	Systemic lupus erythematosus	
KIRC	cis	1	rs9312662	chr4:56386371	SRD5A3	chr4:56212409-56237866:+	-0.16	-3.51	0.000496	Personality dimensions	
KIRC	cis	1	rs9312662	chr4:56386371	TMEM165	chr4:56262090-56292342:+	0.22	6	3.88E-9	Personality dimensions	
KIRC	cis	1	rs9313617	chr5:156933458	ADAM19	chr5:156822542-157002768:-	0.12	4.33	1.82E-5	Pulmonary function;Pulmonary function (interaction)	
KIRC	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.33	6.54	1.52E-10	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.42	8.87	1.33E-17	Myopia (pathological)	
KIRC	cis	1	rs9320287	chr6:109744690	AKD1	chr6:109814059-110012415:-	-0.24	-4.98	8.91E-7	Height	
KIRC	cis	1	rs9320287	chr6:109744690	SMPD2	chr6:109761931-109765121:+	0.19	4.43	1.15E-5	Height	
KIRC	cis	1	rs9321050	chr6:126001568	HEY2	chr6:126068780-126082414:+	-0.17	-4.02	6.69E-5	Endometrial cancer	
KIRC	cis	1	rs9322193	chr6:149919143	NUP43	chr6:150045453-150067688:-	-0.33	-6.15	1.61E-9	Lung cancer	
KIRC	cis	1	rs9322193	chr6:149919143	RAET1E	chr6:150204512-150217195:-	0.2	3.93	9.67E-5	Lung cancer	
KIRC	cis	1	rs9322817	chr6:105232233	HACE1	chr6:105175968-105307794:-	-0.16	-4.36	1.6E-5	Thyroid stimulating hormone	
KIRC	cis	1	rs9324403	chr1:99192849	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs9324404	chr1:99192986	SNX7	chr1:99127236-99226054:+	0.2	5.11	4.68E-7	Proinsulin levels	
KIRC	cis	1	rs9324660	chr5:150257054	IRGM	chr5:150226085-150280295:+	0.54	7.51	2.75E-13	Crohn's disease	
KIRC	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.37	5.09	5.02E-7	Crohn's disease	
KIRC	cis	1	rs932644	chr6:167404187	RNASET2	chr6:167343008-167412795:-	-0.15	-3.72	0.000224	Crohn's disease	
KIRC	cis	1	rs932833	chr9:131884041	SET	chr9:131445934-131458674:+	-0.17	-3.82	0.000147	Blood metabolite ratios	
KIRC	cis	1	rs932835	chr9:131887071	CRAT	chr9:131857075-131873070:-	0.14	3.55	0.000418	Blood metabolite ratios	
KIRC	cis	1	rs932835	chr9:131887071	PPP2R4	chr9:131873244-131911223:+	0.2	3.76	0.000187	Blood metabolite ratios	
KIRC	cis	1	rs932835	chr9:131887071	SET	chr9:131445934-131458674:+	-0.18	-3.82	0.00015	Blood metabolite ratios	
KIRC	cis	1	rs9330316	chr2:110284236	SEPT10	chr2:110300374-110371783:-	-0.12	-3.58	0.000375	Schizophrenia	
KIRC	cis	1	rs9332093	chr10:96696555	TCTN3	chr10:97423154-97453900:-	0.27	3.54	0.000436	Blood metabolite levels	
KIRC	cis	1	rs9332245	chr10:96749181	TCTN3	chr10:97423154-97453900:-	0.27	3.52	0.000475	Blood metabolite levels	
KIRC	cis	1	rs9332998	chr1:47404186	CYP4A22	chr1:47603107-47614526:+	-0.5	-9.67	2.14E-20	Blood metabolite levels	
KIRC	cis	1	rs9333029	chr1:47396162	CYP4A22	chr1:47603107-47614526:+	0.47	8.91	9.13E-18	Blood metabolite levels	
KIRC	cis	1	rs933683	chr5:78324003	ARSB	chr5:78073039-78282357:-	-0.18	-3.78	0.000179	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs933683	chr5:78324003	BHMT	chr5:78407604-78428112:+	-0.23	-4.65	4.15E-6	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs933684	chr5:78324075	ARSB	chr5:78073039-78282357:-	-0.21	-4.39	1.4E-5	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs933684	chr5:78324075	BHMT	chr5:78407604-78428112:+	-0.26	-5.39	1.08E-7	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs933684	chr5:78324075	DMGDH	chr5:78293430-78365449:-	-0.13	-3.51	0.000496	Blood trace element (Se levels);Blood and toenail selenium levels	
KIRC	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.6	14.13	2.12E-38	Height	
KIRC	cis	1	rs934093	chr3:134195885	CEP63	chr3:134204575-134293852:+	0.32	6.18	1.34E-9	Height	
KIRC	cis	1	rs934624	chr15:50968906	SPPL2A	chr15:50999739-51057910:-	0.27	6.98	9.22E-12	QT interval	
KIRC	cis	1	rs934625	chr15:50968756	SPPL2A	chr15:50999739-51057910:-	0.27	6.99	8.81E-12	QT interval	
KIRC	cis	1	rs9348968	chr6:35117251	TCP11	chr6:35085849-35109187:-	-0.24	-4.05	5.96E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs9348968	chr6:35117251	UHRF1BP1	chr6:34759794-34853117:+	-0.18	-4.89	1.33E-6	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.78	23.75	3.97E-84	Pulse pressure	
KIRC	cis	1	rs935334	chr14:76613678	ESRRB	chr14:76837690-76968178:+	0.3	4.44	1.12E-5	Blood pressure	
KIRC	cis	1	rs9355813	chr6:161031172	PLG	chr6:161123274-161174345:+	0.27	5.3	1.73E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs9355814	chr6:161031253	PLG	chr6:161123274-161174345:+	0.26	5.12	4.42E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs9357037	chr6:27327349	ZNF391	chr6:27356524-27369227:+	0.35	7.2	2.15E-12	Glomerular filtration rate (creatinine)	
KIRC	cis	1	rs9357271	chr6:38365873	BTBD9	chr6:38136228-38607924:-	-0.17	-3.86	0.00013	Restless legs syndrome	
KIRC	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.2	4.51	7.97E-6	Brain structure	
KIRC	cis	1	rs9362426	chr6:88089874	C6orf162	chr6:88032306-88052043:+	-0.17	-3.63	0.000312	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs9362426	chr6:88089874	C6orf164	chr6:88032306-88109459:+	-0.15	-3.68	0.000255	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs9365179	chr6:161024848	PLG	chr6:161123274-161174345:+	0.26	5.14	3.87E-7	Lipoprotein (a) levels	
KIRC	cis	1	rs936525	chr19:23056189	ZNF492	chr19:22817126-22850472:+	-0.35	-5.26	2.13E-7	Bronchopulmonary dysplasia	
KIRC	cis	1	rs936526	chr19:23055987	ZNF492	chr19:22817126-22850472:+	-0.39	-5.75	1.59E-8	Bronchopulmonary dysplasia	
KIRC	cis	1	rs9368849	chr6:35118236	TCP11	chr6:35085849-35109187:-	-0.25	-4.24	2.64E-5	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs9368849	chr6:35118236	UHRF1BP1	chr6:34759794-34853117:+	-0.18	-4.89	1.35E-6	Airway responsiveness in chronic obstructive pulmonary disease	
KIRC	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.46	-11.3	1.55E-26	Homocysteine levels	
KIRC	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.28	5.55	4.53E-8	Diabetic kidney disease	
KIRC	cis	1	rs937108	chr7:65428452	CRCP	chr7:65579805-65619551:+	-0.33	-4.51	8.03E-6	Diabetic kidney disease	
KIRC	cis	1	rs9371537	chr6:151872500	C6orf97	chr6:151815175-151942327:+	-0.21	-3.94	9.34E-5	Bone mineral density (spine)	
KIRC	cis	1	rs9371538	chr6:151872963	C6orf97	chr6:151815175-151942327:+	-0.18	-3.52	0.000479	Bone mineral density (spine)	
KIRC	cis	1	rs9373580	chr6:101163031	GRIK2	chr6:101846905-102517957:+	-0.54	-5.76	1.43E-8	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs9377228	chr6:149921998	NUP43	chr6:150045453-150067688:-	-0.35	-6.74	4.41E-11	Lung cancer	
KIRC	cis	1	rs9377229	chr6:149928791	NUP43	chr6:150045453-150067688:-	-0.34	-6.22	1.04E-9	Lung cancer	
KIRC	cis	1	rs9377229	chr6:149928791	RAET1E	chr6:150204512-150217195:-	0.23	4.36	1.6E-5	Lung cancer	
KIRC	cis	1	rs9380378	chr6:33765479	LEMD2	chr6:33738991-33756906:-	-0.14	-3.65	0.000289	Crohn's disease	
KIRC	cis	1	rs9380696	chr6:37600774	MDGA1	chr6:37600284-37665766:-	-0.32	-4.12	4.42E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9380743	chr6:38358802	BTBD9	chr6:38136228-38607924:-	-0.15	-3.64	0.000305	Restless legs syndrome	
KIRC	cis	1	rs9381040	chr6:41154650	LOC221442	chr6:41068773-41108567:+	0.18	5.61	3.26E-8	Alzheimer's disease (late onset)	
KIRC	cis	1	rs9381469	chr6:46630068	CYP39A1	chr6:46517445-46620523:-	-0.19	-3.88	0.000118	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9381469	chr6:46630068	SLC25A27	chr6:46620679-46645925:+	-0.15	-4.88	1.41E-6	QRS complex (Sokolow-Lyon)	
KIRC	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.4	8.99	4.92E-18	Homocysteine levels	
KIRC	cis	1	rs9381784	chr6:49398115	MUT	chr6:49398994-49431031:-	-0.13	-3.9	0.00011	Homocysteine levels	
KIRC	cis	1	rs9383649	chr6:153428102	MTRF1L	chr6:153308401-153323925:-	0.19	3.76	0.000186	Prostate cancer	
KIRC	cis	1	rs9383993	chr6:150299299	ULBP1	chr6:150285143-150294844:+	0.3	4.66	4.12E-6	Radiation response	
KIRC	cis	1	rs9388451	chr6:126090377	HEY2	chr6:126068780-126082414:+	-0.15	-3.67	0.000266	Brugada syndrome	
KIRC	cis	1	rs9388486	chr6:126661154	CENPW	chr6:126661253-126804465:+	0.17	5.58	4.01E-8	Type 1 diabetes	
KIRC	cis	1	rs9388489	chr6:126698719	CENPW	chr6:126661253-126804465:+	0.15	4.67	3.95E-6	Type 1 diabetes	
KIRC	cis	1	rs9388490	chr6:126704795	CENPW	chr6:126661253-126804465:+	-0.14	-4.42	1.19E-5	Type 1 diabetes	
KIRC	cis	1	rs938875	chr15:67952922	IQCH	chr15:67547188-67794139:+	0.19	3.9	0.00011	Motion sickness	
KIRC	cis	1	rs938878	chr15:67993366	IQCH	chr15:67547188-67794139:+	0.18	3.7	0.000235	Motion sickness	
KIRC	cis	1	rs9390502	chr6:101057478	ASCC3	chr6:100956609-101329224:-	0.13	3.5	0.000499	Menarche (age at onset)	
KIRC	cis	1	rs9393692	chr6:26276650	HIST1H3G	chr6:26271147-26271612:-	0.19	3.7	0.000238	Educational attainment	
KIRC	cis	1	rs9393731	chr6:26529374	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs9393732	chr6:26530898	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs9394166	chr6:33751122	LEMD2	chr6:33738991-33756906:-	-0.14	-3.64	0.000303	Crohn's disease	
KIRC	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.29	6.66	7.26E-11	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
KIRC	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.48	-8.97	5.72E-18	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
KIRC	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.49	-12.23	2.64E-30	Homocysteine levels	
KIRC	cis	1	rs9397424	chr6:151872791	C6orf97	chr6:151815175-151942327:+	0.2	3.91	0.000104	Bone mineral density (spine)	
KIRC	cis	1	rs9397425	chr6:151873024	C6orf97	chr6:151815175-151942327:+	0.2	3.88	0.000117	Bone mineral density (spine)	
KIRC	cis	1	rs9397427	chr6:151875034	C6orf97	chr6:151815175-151942327:+	0.2	3.91	0.000105	Bone mineral density (spine)	
KIRC	cis	1	rs9397428	chr6:151875080	C6orf97	chr6:151815175-151942327:+	0.2	3.91	0.000106	Bone mineral density (spine)	
KIRC	cis	1	rs9397429	chr6:151877569	C6orf97	chr6:151815175-151942327:+	0.21	3.95	8.91E-5	Bone mineral density (spine)	
KIRC	cis	1	rs9397431	chr6:151883930	C6orf97	chr6:151815175-151942327:+	0.19	3.6	0.000344	Bone mineral density (spine)	
KIRC	cis	1	rs9399693	chr6:149933854	NUP43	chr6:150045453-150067688:-	-0.36	-6.6	1.04E-10	Lung cancer	
KIRC	cis	1	rs9399693	chr6:149933854	RAET1E	chr6:150204512-150217195:-	0.18	3.51	0.000495	Lung cancer	
KIRC	cis	1	rs940045	chr3:49449638	CCDC36	chr3:49235861-49295537:+	0.26	4.92	1.17E-6	Menarche (age at onset)	
KIRC	cis	1	rs940045	chr3:49449638	GMPPB	chr3:49758932-49761384:-	-0.15	-3.53	0.000462	Menarche (age at onset)	
KIRC	cis	1	rs940045	chr3:49449638	NCKIPSD	chr3:48711280-48723334:-	0.22	4.54	7.2E-6	Menarche (age at onset)	
KIRC	cis	1	rs940045	chr3:49449638	P4HTM	chr3:49027341-49044579:+	0.2	4.56	6.49E-6	Menarche (age at onset)	
KIRC	cis	1	rs940045	chr3:49449638	TREX1	chr3:48501186-48509043:+	-0.16	-4.09	4.92E-5	Menarche (age at onset)	
KIRC	cis	1	rs940045	chr3:49449638	WDR6	chr3:49044637-49053386:+	-0.21	-5.33	1.46E-7	Menarche (age at onset)	
KIRC	cis	1	rs9401843	chr6:126004124	HEY2	chr6:126068780-126082414:+	-0.17	-4.02	6.7E-5	Endometrial cancer	
KIRC	cis	1	rs940934	chr15:84575528	GOLGA6L5	chr15:85047738-85060078:-	-0.14	-4.41	1.26E-5	Waist circumference adjusted for body mass index;Waist circumference	
KIRC	cis	1	rs941653	chr14:35592538	KIAA0391	chr14:35591776-35786673:+	0.22	3.74	0.000203	Atopic dermatitis	
KIRC	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.25	4.99	8.19E-7	Atopic dermatitis	
KIRC	cis	1	rs9417261	chr10:38111769	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs9417263	chr10:38114690	LOC399744	chr10:38717074-38741080:+	0.22	3.69	0.00025	Obesity (extreme)	
KIRC	cis	1	rs9417264	chr10:38117570	LOC399744	chr10:38717074-38741080:+	0.22	3.69	0.00025	Obesity (extreme)	
KIRC	cis	1	rs9417268	chr10:38133194	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs941764	chr14:91841069	CATSPERB	chr14:92047118-92198413:-	0.19	3.55	0.000416	Breast cancer	
KIRC	cis	1	rs9418288	chr10:38107136	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs9418289	chr10:38109805	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs9418294	chr10:38115586	LOC399744	chr10:38717074-38741080:+	0.21	3.56	0.000399	Obesity (extreme)	
KIRC	cis	1	rs9418298	chr10:38137236	LOC399744	chr10:38717074-38741080:+	0.22	3.69	0.00025	Obesity (extreme)	
KIRC	cis	1	rs9418299	chr10:38140227	HSD17B7P2	chr10:38645308-38667432:+	0.19	3.5	0.000515	Obesity (extreme)	
KIRC	cis	1	rs9418299	chr10:38140227	LOC399744	chr10:38717074-38741080:+	0.23	3.83	0.000146	Obesity (extreme)	
KIRC	cis	1	rs9419788	chr10:96013705	NOC3L	chr10:96092989-96122683:-	-0.16	-3.5	0.000515	Personality traits in bipolar disorder	
KIRC	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.14	-5.02	7.3E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.14	-4.93	1.12E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.14	-4.89	1.36E-6	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.14	-4.99	8.38E-7	Palmitoleic acid (16:1n-7) plasma levels	
KIRC	cis	1	rs9420	chr11:57510294	MED19	chr11:57471182-57479673:-	0.21	4.29	2.11E-5	Schizophrenia	
KIRC	cis	1	rs9420	chr11:57510294	TIMM10	chr11:57295936-57298232:-	0.21	5.35	1.34E-7	Schizophrenia	
KIRC	cis	1	rs942270	chr1:76177332	ACADM	chr1:76190043-76229353:+	0.2	5.52	5.56E-8	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.29	5.31	1.67E-7	Life satisfaction	
KIRC	cis	1	rs9427094	chr1:154557685	IL6R	chr1:154377669-154440188:+	0.14	3.79	0.00017	C-reactive protein levels or triglyceride levels (pleiotropy)	
KIRC	cis	1	rs9427242	chr1:156725001	SLC25A44	chr1:156163730-156182586:+	-0.14	-3.65	0.000291	HDL cholesterol	
KIRC	cis	1	rs942812	chr10:100153664	PYROXD2	chr10:100143323-100174978:-	0.42	4.92	1.19E-6	Aspartate aminotransferase	
KIRC	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.47	-9.15	1.48E-18	Body mass index	
KIRC	cis	1	rs9429183	chr1:46524582	MUTYH	chr1:45794915-45806142:-	0.13	3.9	0.000107	Body mass index	
KIRC	cis	1	rs9433985	chr1:99187000	SNX7	chr1:99127236-99226054:+	0.19	4.9	1.3E-6	Proinsulin levels	
KIRC	cis	1	rs9434431	chr1:99186960	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs9434437	chr1:99194909	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs943461	chr6:33769409	LEMD2	chr6:33738991-33756906:-	0.21	4.69	3.46E-6	Body mass index	
KIRC	cis	1	rs943462	chr6:33769578	LEMD2	chr6:33738991-33756906:-	0.21	4.69	3.46E-6	Body mass index	
KIRC	cis	1	rs943466	chr6:33731787	LEMD2	chr6:33738991-33756906:-	-0.2	-4.88	1.4E-6	Body mass index	
KIRC	cis	1	rs943477	chr6:33750931	LEMD2	chr6:33738991-33756906:-	-0.14	-3.58	0.000377	Crohn's disease	
KIRC	cis	1	rs9450662	chr6:88088593	C6orf162	chr6:88032306-88052043:+	-0.19	-4.06	5.76E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs9450662	chr6:88088593	C6orf164	chr6:88032306-88109459:+	-0.17	-4.21	3.08E-5	Depressive episodes in bipolar disorder	
KIRC	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.44	12.84	7.81E-33	Type 1 diabetes autoantibodies	
KIRC	cis	1	rs9457247	chr6:167392174	RNASET2	chr6:167343008-167412795:-	-0.15	-3.74	0.000205	Crohn's disease	
KIRC	cis	1	rs945961	chr20:33769926	PROCR	chr20:33758727-33765164:+	-0.31	-4.1	4.79E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
KIRC	cis	1	rs9462007	chr6:34715341	UHRF1BP1	chr6:34759794-34853117:+	0.28	6.09	2.25E-9	Pubertal anthropometrics	
KIRC	cis	1	rs9462016	chr6:34739790	UHRF1BP1	chr6:34759794-34853117:+	0.29	6.41	3.45E-10	Pubertal anthropometrics	
KIRC	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.41	-10.01	1.22E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.26	8.76	3.03E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.41	-10.01	1.22E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.26	8.76	3.03E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.4	9.62	3.18E-20	Folate pathway vitamin levels	
KIRC	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.25	-8.42	3.83E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.41	-10	1.37E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.25	8.69	5.02E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.46	-11.3	1.55E-26	Homocysteine levels	
KIRC	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.41	-9.97	1.78E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.25	8.69	4.96E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.41	-10.04	9.64E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.25	8.64	7.63E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.45	-8.72	4.18E-17	Body mass index	
KIRC	cis	1	rs946529	chr1:46485548	MUTYH	chr1:45794915-45806142:-	0.14	4.06	5.59E-5	Body mass index	
KIRC	cis	1	rs9467778	chr6:26534743	BTN2A3	chr6:26422317-26431927:+	0.12	3.57	0.000385	Educational attainment	
KIRC	cis	1	rs9467779	chr6:26536687	BTN2A3	chr6:26422317-26431927:+	-0.12	-3.67	0.00027	Educational attainment	
KIRC	cis	1	rs9467782	chr6:26542773	BTN2A3	chr6:26422317-26431927:+	0.12	3.64	0.000299	Educational attainment	
KIRC	cis	1	rs9467791	chr6:26562486	BTN2A3	chr6:26422317-26431927:+	-0.12	-3.49	0.000525	Educational attainment	
KIRC	cis	1	rs9468186	chr6:27626631	ZSCAN12	chr6:28346770-28367544:-	0.19	3.74	0.000202	Neuroticism	
KIRC	cis	1	rs9468186	chr6:27626631	ZSCAN23	chr6:28393287-28411279:-	0.25	4.15	3.9E-5	Neuroticism	
KIRC	cis	1	rs9469580	chr6:33715837	IP6K3	chr6:33689443-33714762:-	0.39	4.43	1.16E-5	Phosphorus levels	
KIRC	cis	1	rs9469581	chr6:33715904	IP6K3	chr6:33689443-33714762:-	-0.44	-4.93	1.15E-6	Phosphorus levels	
KIRC	cis	1	rs9469582	chr6:33715939	IP6K3	chr6:33689443-33714762:-	-0.44	-4.93	1.15E-6	Phosphorus levels	
KIRC	cis	1	rs9469860	chr6:34724815	UHRF1BP1	chr6:34759794-34853117:+	0.29	6.43	2.97E-10	Pubertal anthropometrics	
KIRC	cis	1	rs9469890	chr6:34763982	UHRF1BP1	chr6:34759794-34853117:+	0.29	6.36	4.52E-10	Pubertal anthropometrics	
KIRC	cis	1	rs9470765	chr6:38052922	FTSJD2	chr6:37400907-37449282:+	0.28	3.74	0.000209	Type 2 diabetes	
KIRC	cis	1	rs9470779	chr6:38073822	FTSJD2	chr6:37400907-37449282:+	0.27	3.65	0.000285	Type 2 diabetes	
KIRC	cis	1	rs947211	chr1:205752665	PM20D1	chr1:205797154-205819245:-	-0.38	-5.87	7.73E-9	Parkinson's disease	
KIRC	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.18	4.62	4.9E-6	Parkinson's disease	
KIRC	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.39	-9.14	1.5E-18	Folate pathway vitamin levels	
KIRC	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.26	8.56	1.41E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.42	-10	1.37E-21	Homocysteine levels	
KIRC	cis	1	rs9473550	chr6:49385182	MUT	chr6:49398994-49431031:-	0.12	3.78	0.000177	Homocysteine levels	
KIRC	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.41	-10.05	9.12E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.25	8.71	4.58E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.41	-9.98	1.68E-21	Folate pathway vitamin levels	
KIRC	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.25	8.7	4.62E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.41	-10.09	6.38E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.26	8.7	4.92E-17	Folate pathway vitamin levels	
KIRC	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.42	-10.29	1.14E-22	Folate pathway vitamin levels	
KIRC	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.25	8.32	8.6E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.43	-10.43	3.36E-23	Folate pathway vitamin levels	
KIRC	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.25	8.3	9.81E-16	Folate pathway vitamin levels	
KIRC	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.4	-9.47	1.09E-19	Folate pathway vitamin levels	
KIRC	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.25	8.25	1.37E-15	Folate pathway vitamin levels	
KIRC	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.2	4.54	7.12E-6	Brain structure	
KIRC	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.22	-4.71	3.15E-6	Menarche (age at onset)	
KIRC	cis	1	rs947583	chr6:136133659	C6orf217	chr6:135818939-136037192:+	-0.26	-4.99	8.27E-7	Phosphorus levels	
KIRC	cis	1	rs947932	chr11:71656705	C11orf59	chr11:71808339-71814322:-	-0.23	-3.91	0.000103	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs9480933	chr6:109671391	AKD1	chr6:109814059-110012415:-	-0.24	-4.88	1.4E-6	Height	
KIRC	cis	1	rs9480933	chr6:109671391	SMPD2	chr6:109761931-109765121:+	0.17	4.09	4.99E-5	Height	
KIRC	cis	1	rs9480953	chr6:109739144	AKD1	chr6:109814059-110012415:-	-0.26	-5.3	1.69E-7	Height	
KIRC	cis	1	rs9480953	chr6:109739144	SMPD2	chr6:109761931-109765121:+	0.17	4.06	5.64E-5	Height	
KIRC	cis	1	rs9480955	chr6:109744533	AKD1	chr6:109814059-110012415:-	-0.24	-4.9	1.32E-6	Height	
KIRC	cis	1	rs9480955	chr6:109744533	SMPD2	chr6:109761931-109765121:+	0.19	4.46	1.03E-5	Height	
KIRC	cis	1	rs9483335	chr6:132059074	ENPP3	chr6:131949582-132068549:+	-0.43	-5.16	3.65E-7	Response to fenofibrate (adiponectin levels)	
KIRC	cis	1	rs9486047	chr6:105621724	BVES	chr6:105544700-105585049:-	0.19	3.6	0.000345	Multiple sclerosis	
KIRC	cis	1	rs948662	chr11:77979829	NARS2	chr11:78147017-78285909:-	-0.18	-3.85	0.000135	Testicular germ cell tumor	
KIRC	cis	1	rs9487094	chr6:109742015	AKD1	chr6:109814059-110012415:-	-0.25	-5.19	2.98E-7	Height	
KIRC	cis	1	rs9487094	chr6:109742015	SMPD2	chr6:109761931-109765121:+	0.17	4.17	3.58E-5	Height	
KIRC	cis	1	rs9491471	chr6:125991715	HEY2	chr6:126068780-126082414:+	-0.17	-4.12	4.49E-5	Endometrial cancer	
KIRC	cis	1	rs9491624	chr6:126679106	CENPW	chr6:126661253-126804465:+	-0.15	-4.68	3.68E-6	Type 1 diabetes	
KIRC	cis	1	rs949325	chr11:71729656	C11orf59	chr11:71808339-71814322:-	-0.22	-3.79	0.000172	Severe influenza A (H1N1) infection	
KIRC	cis	1	rs9493438	chr6:133098349	VNN2	chr6:133065010-133084598:-	-0.26	-4.13	4.17E-5	Type 2 diabetes nephropathy	
KIRC	cis	1	rs9493443	chr6:133121349	VNN2	chr6:133065010-133084598:-	-0.22	-3.67	0.000266	Type 2 diabetes nephropathy	
KIRC	cis	1	rs9493445	chr6:133125409	VNN2	chr6:133065010-133084598:-	-0.22	-3.67	0.000266	Type 2 diabetes nephropathy	
KIRC	cis	1	rs9493446	chr6:133125643	VNN2	chr6:133065010-133084598:-	-0.22	-3.67	0.000266	Type 2 diabetes nephropathy	
KIRC	cis	1	rs9498532	chr6:101645204	GRIK2	chr6:101846905-102517957:+	0.51	5.16	3.49E-7	Economic and political preferences (immigration/crime)	
KIRC	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.24	-5.63	2.99E-8	Eosinophilic esophagitis (pediatric)	
KIRC	cis	1	rs950027	chr15:45801035	SPATA5L1	chr15:45694519-45713614:+	-0.31	-6.02	3.45E-9	Response to fenofibrate (adiponectin levels)	
KIRC	cis	1	rs950169	chr15:84706461	GOLGA6L5	chr15:85047738-85060078:-	-0.16	-4.3	2.01E-5	Schizophrenia	
KIRC	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.26	-4.94	1.07E-6	Schizophrenia	
KIRC	cis	1	rs950176	chr2:136898078	DARS	chr2:136664254-136743222:-	0.15	3.94	9.36E-5	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs9512760	chr13:28173662	POLR1D	chr13:28194895-28241547:+	0.21	4.56	6.44E-6	Large B-cell lymphoma	
KIRC	cis	1	rs9513430	chr13:99127252	STK24	chr13:99102455-99229396:-	-0.27	-5.44	8.3E-8	Longevity	
KIRC	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.38	-6.57	1.23E-10	Menarche (age at onset)	
KIRC	cis	1	rs951366	chr1:205685352	RAB7L1	chr1:205737115-205744610:-	0.16	4.61	5.11E-6	Menarche (age at onset)	
KIRC	cis	1	rs951623	chr1:212399062	TMEM206	chr1:212537819-212588267:-	0.2	3.91	0.000105	Intelligence (childhood)	
KIRC	cis	1	rs9517320	chr13:99126303	STK24	chr13:99102455-99229396:-	0.3	5.99	3.9E-9	Longevity	
KIRC	cis	1	rs9517322	chr13:99126338	STK24	chr13:99102455-99229396:-	-0.27	-5.47	7.1E-8	Longevity	
KIRC	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.48	-10.04	1.01E-21	Arsenic metabolism	
KIRC	cis	1	rs9531455	chr13:36685304	SOHLH2	chr13:36742347-36871992:-	0.3	4.31	2.0E-5	Optic cup area	
KIRC	cis	1	rs9532969	chr13:42591839	KIAA0564	chr13:42140962-42535221:-	-0.14	-3.58	0.000371	Metabolite levels  (X-11787)	
KIRC	cis	1	rs953387	chr2:136907170	DARS	chr2:136664254-136743222:-	0.14	3.63	0.000313	Arthritis (juvenile idiopathic)	
KIRC	cis	1	rs9535307	chr13:50291842	EBPL	chr13:50234811-50265623:-	-0.26	-4.86	1.61E-6	Obesity-related traits	
KIRC	cis	1	rs9535307	chr13:50291842	TRIM13	chr13:50571143-50592603:+	0.23	3.53	0.000456	Obesity-related traits	
KIRC	cis	1	rs9546421	chr13:36690750	SOHLH2	chr13:36742347-36871992:-	0.31	4.36	1.57E-5	Optic cup area	
KIRC	cis	1	rs9546430	chr13:36692673	SOHLH2	chr13:36742347-36871992:-	0.31	4.31	1.94E-5	Optic cup area	
KIRC	cis	1	rs9546434	chr13:36694391	SOHLH2	chr13:36742347-36871992:-	0.31	4.35	1.68E-5	Optic cup area	
KIRC	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.49	10.52	1.54E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.47	-10.2	2.41E-22	Response to antipsychotic treatment	
KIRC	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.5	-10.51	1.73E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs9567307	chr13:44471877	C13orf31	chr13:44453420-44468067:+	-0.19	-3.95	8.87E-5	Leprosy	
KIRC	cis	1	rs9576321	chr13:38205546	TRPC4	chr13:38210775-38443939:-	-0.11	-3.58	0.000372	Life satisfaction	
KIRC	cis	1	rs9576322	chr13:38205561	TRPC4	chr13:38210775-38443939:-	0.11	3.63	0.000311	Life satisfaction	
KIRC	cis	1	rs958025	chr15:78759348	CHRNA5	chr15:78857906-78886458:+	-0.22	-3.96	8.51E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs9582302	chr13:100125985	UBAC2	chr13:99852679-100038751:+	-0.24	-3.59	0.000368	Obesity-related traits	
KIRC	cis	1	rs9584856	chr13:99126551	STK24	chr13:99102455-99229396:-	-0.27	-5.51	5.79E-8	Longevity	
KIRC	cis	1	rs9584857	chr13:99128572	STK24	chr13:99102455-99229396:-	-0.27	-5.42	9.33E-8	Longevity	
KIRC	cis	1	rs958550	chr7:65635679	CCT6P1	chr7:65216092-65228661:+	-0.25	-5.07	5.62E-7	Diabetic kidney disease	
KIRC	cis	1	rs958550	chr7:65635679	CRCP	chr7:65579805-65619551:+	0.28	3.92	0.000101	Diabetic kidney disease	
KIRC	cis	1	rs958755	chr3:56716922	CCDC66	chr3:56591184-56655846:+	0.14	3.98	7.76E-5	Height	
KIRC	cis	1	rs9591134	chr13:33148216	N4BP2L2	chr13:33006930-33112936:-	0.14	4.04	6.26E-5	Body mass index	
KIRC	cis	1	rs9591143	chr13:33159438	N4BP2L2	chr13:33006930-33112936:-	0.14	4.16	3.67E-5	Body mass index	
KIRC	cis	1	rs9591145	chr13:33161459	N4BP2L2	chr13:33006930-33112936:-	0.15	4.31	1.94E-5	Body mass index	
KIRC	cis	1	rs9591165	chr13:33185153	N4BP2L2	chr13:33006930-33112936:-	0.16	4.7	3.37E-6	Body mass index	
KIRC	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.29	6.08	2.38E-9	HDL cholesterol	
KIRC	cis	1	rs9595905	chr13:33183403	N4BP2L2	chr13:33006930-33112936:-	0.16	4.75	2.67E-6	Body mass index	
KIRC	cis	1	rs9595908	chr13:33184288	N4BP2L2	chr13:33006930-33112936:-	0.15	4.38	1.46E-5	Body mass index	
KIRC	cis	1	rs9596219	chr13:50563447	EBPL	chr13:50234811-50265623:-	-0.19	-3.69	0.000245	Height	
KIRC	cis	1	rs9606944	chr22:32780126	SLC5A4	chr22:32614465-32651318:-	-0.19	-3.53	0.000455	IgG glycosylation	
KIRC	cis	1	rs9606945	chr22:32780396	SLC5A4	chr22:32614465-32651318:-	-0.19	-3.53	0.000455	IgG glycosylation	
KIRC	cis	1	rs9607287	chr22:22163425	MAPK1	chr22:22113949-22221970:-	0.19	5.7	2.09E-8	Multiple sclerosis	
KIRC	cis	1	rs9607566	chr22:39075434	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.62	0.00033	Resting heart rate	
KIRC	cis	1	rs9607566	chr22:39075434	LOC646851	chr22:38974125-39052634:-	0.13	4.05	6.0E-5	Resting heart rate	
KIRC	cis	1	rs9609523	chr22:32781931	SLC5A4	chr22:32614465-32651318:-	-0.2	-3.58	0.000372	IgG glycosylation	
KIRC	cis	1	rs9609527	chr22:32795751	SLC5A4	chr22:32614465-32651318:-	0.19	3.53	0.000462	IgG glycosylation	
KIRC	cis	1	rs9610986	chr22:39025277	BAIAP2L2	chr22:38480897-38506676:-	0.14	3.63	0.000318	Resting heart rate	
KIRC	cis	1	rs9610986	chr22:39025277	LOC646851	chr22:38974125-39052634:-	0.15	4.47	9.66E-6	Resting heart rate	
KIRC	cis	1	rs9610993	chr22:39042818	LOC646851	chr22:38974125-39052634:-	0.14	4.41	1.26E-5	Resting heart rate	
KIRC	cis	1	rs962221	chr1:92970770	EVI5	chr1:92974255-93257961:-	-0.2	-4.65	4.31E-6	Cholesterol, total	
KIRC	cis	1	rs962222	chr1:92970953	EVI5	chr1:92974255-93257961:-	-0.2	-4.65	4.31E-6	Cholesterol, total	
KIRC	cis	1	rs9622833	chr22:39000397	LOC646851	chr22:38974125-39052634:-	0.14	4.25	2.51E-5	Resting heart rate	
KIRC	cis	1	rs9623117	chr22:40452119	XPNPEP3	chr22:41253094-41363888:+	0.2	3.83	0.000142	Prostate cancer (gene x gene interaction);Prostate cancer	
KIRC	cis	1	rs9624326	chr22:24135043	C22orf43	chr22:23950640-23974487:-	-0.19	-3.49	0.000526	IgG glycosylation	
KIRC	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.23	-6.22	1.07E-9	Gut microbiome composition (summer)	
KIRC	cis	1	rs9633740	chr10:82265271	TSPAN14	chr10:82214038-82282390:+	0.21	3.89	0.000113	Post bronchodilator FEV1	
KIRC	cis	1	rs9635251	chr14:65928468	LOC645431	chr14:65877313-65879335:-	-0.5	-6.75	4.04E-11	Ischemic stroke	
KIRC	cis	1	rs9635324	chr15:40703211	C15orf23	chr15:40674922-40686488:+	-0.17	-3.92	0.0001	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs9635324	chr15:40703211	DISP2	chr15:40650434-40663256:+	0.33	6.33	5.46E-10	Blood metabolite levels;Blood metabolite ratios	
KIRC	cis	1	rs963731	chr2:39216873	SOS1	chr2:39208692-39351486:-	-0.24	-4.36	1.59E-5	Corticobasal degeneration	
KIRC	cis	1	rs9645890	chr13:99126637	STK24	chr13:99102455-99229396:-	-0.27	-5.43	8.84E-8	Longevity	
KIRC	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.47	-10.41	4.21E-23	Response to antipsychotic treatment	
KIRC	cis	1	rs9651447	chr10:81736754	LOC219347	chr10:81805991-81838949:-	0.53	4.56	6.46E-6	Rheumatoid arthritis	
KIRC	cis	1	rs9651447	chr10:81736754	LOC650623	chr10:81442731-81448648:+	-0.34	-3.63	0.000316	Rheumatoid arthritis	
KIRC	cis	1	rs9651768	chr11:77996020	NARS2	chr11:78147017-78285909:-	-0.17	-3.85	0.000135	Testicular germ cell tumor	
KIRC	cis	1	rs9651769	chr11:77996166	NARS2	chr11:78147017-78285909:-	-0.18	-3.9	0.000111	Testicular germ cell tumor	
KIRC	cis	1	rs9653282	chr2:165554658	SLC38A11	chr2:165754812-165812035:-	0.27	4.87	1.52E-6	circulating leptin levels;circulating leptin levels adjusted for BMI;Body fat percentage	
KIRC	cis	1	rs9653557	chr2:73795962	TPRKB	chr2:73956957-73964517:-	-0.21	-5.35	1.37E-7	Metabolite levels	
KIRC	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.27	-6.42	3.07E-10	IFN-related cytopenia	
KIRC	cis	1	rs9660180	chr1:1723031	SLC35E2	chr1:1590990-1677431:-	0.17	4.02	6.63E-5	Body mass index	
KIRC	cis	1	rs9660942	chr1:99192989	SNX7	chr1:99127236-99226054:+	0.2	5.11	4.68E-7	Proinsulin levels	
KIRC	cis	1	rs9660992	chr1:205249450	DSTYK	chr1:205111632-205180727:-	0.15	3.85	0.000136	Mean platelet volume	
KIRC	cis	1	rs9661504	chr1:205915667	PM20D1	chr1:205797154-205819245:-	0.24	4.06	5.74E-5	Cystic fibrosis-related diabetes	
KIRC	cis	1	rs9662155	chr1:99193327	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.64E-7	Proinsulin levels	
KIRC	cis	1	rs9662166	chr1:76235906	ACADM	chr1:76190043-76229353:+	0.17	4.69	3.45E-6	Blood metabolite levels;Acylcarnitine levels	
KIRC	cis	1	rs9662170	chr1:99193479	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs9662221	chr1:205915745	PM20D1	chr1:205797154-205819245:-	0.26	4.28	2.25E-5	Cystic fibrosis-related diabetes	
KIRC	cis	1	rs9665626	chr10:104300638	TMEM180	chr10:104221170-104238858:+	-0.28	-3.97	8.34E-5	Schizophrenia	
KIRC	cis	1	rs9665846	chr11:62907832	SLC22A24	chr11:62847414-62911693:-	0.32	7.56	1.96E-13	Conotruncal heart defects	
KIRC	cis	1	rs9674872	chr17:79581931	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs9674872	chr17:79581931	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs9677476	chr2:232126290	ARMC9	chr2:232063342-232238606:+	-0.22	-4.49	8.96E-6	Food antigen IgG levels	
KIRC	cis	1	rs9684708	chr4:56430381	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.94	9.25E-5	Personality dimensions	
KIRC	cis	1	rs9684708	chr4:56430381	TMEM165	chr4:56262090-56292342:+	0.21	5.8	1.19E-8	Personality dimensions	
KIRC	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.95	16	6.97E-47	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
KIRC	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.39	7.61	1.41E-13	Erythrocyte sedimentation rate	
KIRC	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.57	-12.28	1.78E-30	Erythrocyte sedimentation rate	
KIRC	cis	1	rs9697030	chr9:131920181	CRAT	chr9:131857075-131873070:-	0.16	4.02	6.72E-5	Blood metabolite ratios	
KIRC	cis	1	rs9697030	chr9:131920181	PPP2R4	chr9:131873244-131911223:+	0.24	4.5	8.45E-6	Blood metabolite ratios	
KIRC	cis	1	rs970548	chr10:46013277	ALOX5	chr10:45869629-45941561:+	-0.16	-3.78	0.000173	HDL cholesterol;Cholesterol, total	
KIRC	cis	1	rs9727115	chr1:99177253	SNX7	chr1:99127236-99226054:+	-0.19	-4.5	8.43E-6	Proinsulin levels	
KIRC	cis	1	rs9730021	chr1:99189924	SNX7	chr1:99127236-99226054:+	0.21	5.16	3.56E-7	Proinsulin levels	
KIRC	cis	1	rs973009	chr19:39174332	CAPN12	chr19:39220832-39235114:-	-0.16	-3.67	0.000264	Migraine with aura	
KIRC	cis	1	rs9734313	chr11:64358311	SLC22A12	chr11:64358282-64369820:+	-0.17	-4.71	3.25E-6	Urate levels in obese individuals	
KIRC	cis	1	rs974014	chr4:48409363	OCIAD1	chr4:48833015-48863831:+	0.23	5.19	3.1E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs974015	chr4:48409347	OCIAD1	chr4:48833015-48863831:+	-0.22	-4.87	1.48E-6	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs974016	chr4:48409315	OCIAD1	chr4:48833015-48863831:+	-0.23	-5.25	2.3E-7	Crohn's disease;Inflammatory bowel disease	
KIRC	cis	1	rs974495	chr3:49400482	CCDC36	chr3:49235861-49295537:+	0.25	4.92	1.16E-6	Menarche (age at onset)	
KIRC	cis	1	rs974495	chr3:49400482	GMPPB	chr3:49758932-49761384:-	-0.15	-3.56	0.00041	Menarche (age at onset)	
KIRC	cis	1	rs974495	chr3:49400482	NCKIPSD	chr3:48711280-48723334:-	0.22	4.5	8.28E-6	Menarche (age at onset)	
KIRC	cis	1	rs974495	chr3:49400482	P4HTM	chr3:49027341-49044579:+	0.19	4.47	9.68E-6	Menarche (age at onset)	
KIRC	cis	1	rs974495	chr3:49400482	TREX1	chr3:48501186-48509043:+	-0.16	-4.12	4.39E-5	Menarche (age at onset)	
KIRC	cis	1	rs974495	chr3:49400482	WDR6	chr3:49044637-49053386:+	-0.21	-5.34	1.43E-7	Menarche (age at onset)	
KIRC	cis	1	rs9747164	chr17:61864787	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.6E-10	Body mass index	
KIRC	cis	1	rs9747164	chr17:61864787	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.53	7.39E-6	Body mass index	
KIRC	cis	1	rs9747349	chr17:79584297	ARL16	chr17:79648234-79650954:-	-0.18	-4.61	5.21E-6	Eye color traits	
KIRC	cis	1	rs9747349	chr17:79584297	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.71	0.000234	Eye color traits	
KIRC	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.63	14.82	1.78E-41	Eye color traits	
KIRC	cis	1	rs9748176	chr17:79584043	ARL16	chr17:79648234-79650954:-	-0.18	-4.66	4.02E-6	Eye color traits	
KIRC	cis	1	rs9748176	chr17:79584043	NPLOC4	chr17:79523915-79604138:-	-0.12	-3.73	0.000214	Eye color traits	
KIRC	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.63	14.79	2.48E-41	Eye color traits	
KIRC	cis	1	rs975459	chr6:151876909	C6orf97	chr6:151815175-151942327:+	0.21	3.95	8.85E-5	Bone mineral density (spine)	
KIRC	cis	1	rs975752	chr10:101906333	PKD2L1	chr10:102047903-102090243:-	0.28	3.7	0.000242	Schizophrenia	
KIRC	cis	1	rs9767077	chr6:150109615	NUP43	chr6:150045453-150067688:-	-0.35	-6.6	1.03E-10	Lung cancer	
KIRC	cis	1	rs9767077	chr6:150109615	RAET1E	chr6:150204512-150217195:-	0.21	3.96	8.45E-5	Lung cancer	
KIRC	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.29	-5.83	9.92E-9	Diabetic kidney disease	
KIRC	cis	1	rs9769882	chr7:65642925	CRCP	chr7:65579805-65619551:+	0.32	4.43	1.14E-5	Diabetic kidney disease	
KIRC	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.54	12.15	5.71E-30	Forced vital capacity	
KIRC	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.34	7.59	1.53E-13	Pancreatic cancer	
KIRC	cis	1	rs9783386	chr11:18386625	GTF2H1	chr11:18343816-18388590:+	0.36	7.95	1.22E-14	Pancreatic cancer	
KIRC	cis	1	rs9783992	chr2:231035589	SP110	chr2:231033645-231084827:-	0.28	4.25	2.54E-5	Obesity-related traits	
KIRC	cis	1	rs9784019	chr2:231035575	SP110	chr2:231033645-231084827:-	0.28	4.25	2.54E-5	Obesity-related traits	
KIRC	cis	1	rs9788682	chr15:78802586	CHRNA5	chr15:78857906-78886458:+	0.26	4.68	3.77E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs9788721	chr15:78802869	CHRNA3	chr15:78885397-78913322:-	0.21	3.61	0.000332	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.31	6.02	3.41E-9	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
KIRC	cis	1	rs9789748	chr2:17801397	SMC6	chr2:17845080-17981462:-	-0.31	-3.88	0.00012	Psychosis and Alzheimer's disease	
KIRC	cis	1	rs9795476	chr11:235894	PSMD13	chr11:236808-252984:+	-0.15	-5.05	6.27E-7	Menarche (age at onset)	
KIRC	cis	1	rs979971	chr19:39144244	CAPN12	chr19:39220832-39235114:-	-0.13	-3.99	7.52E-5	Heart rate	
KIRC	cis	1	rs979972	chr19:39144167	CAPN12	chr19:39220832-39235114:-	-0.14	-4.36	1.58E-5	Heart rate	
KIRC	cis	1	rs9803732	chr1:100274350	AGL	chr1:100315640-100389579:+	0.24	4.75	2.63E-6	White matter integrity (interaction)	
KIRC	cis	1	rs9803732	chr1:100274350	FRRS1	chr1:100174259-100231349:-	0.2	4.16	3.71E-5	White matter integrity (interaction)	
KIRC	cis	1	rs9803772	chr1:100275761	AGL	chr1:100315640-100389579:+	0.23	4.51	8.16E-6	White matter integrity (interaction)	
KIRC	cis	1	rs9803772	chr1:100275761	FRRS1	chr1:100174259-100231349:-	0.2	4.05	5.89E-5	White matter integrity (interaction)	
KIRC	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.16	3.72	0.000224	Colorectal cancer	
KIRC	cis	1	rs9805979	chr14:75566209	MLH3	chr14:75480467-75518235:-	0.23	5.92	5.98E-9	Height	
KIRC	cis	1	rs9805979	chr14:75566209	NEK9	chr14:75548819-75593778:-	0.13	3.75	0.000195	Height	
KIRC	cis	1	rs9807989	chr2:102971200	IL1RL1	chr2:102927962-102968497:+	0.23	4.87	1.47E-6	Asthma	
KIRC	cis	1	rs9809263	chr3:190989466	UTS2D	chr3:190984945-191048325:-	-0.2	-3.64	0.0003	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.6	14.67	8.2E-41	Height	
KIRC	cis	1	rs9809619	chr3:134280948	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.34E-11	Height	
KIRC	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs9810724	chr3:85615144	CADM2	chr3:85008133-86117948:+	0.26	4.23	2.8E-5	Longevity (90 years and older)	
KIRC	cis	1	rs9812579	chr3:136151250	IL20RB	chr3:136676707-136729920:+	0.18	4.06	5.68E-5	Body mass index;Height	
KIRC	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.32	9.23	7.29E-19	Longevity	
KIRC	cis	1	rs9812791	chr3:49682311	UBA7	chr3:49842639-49851391:-	0.16	4.09	5.05E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.59	14.17	1.44E-38	Height	
KIRC	cis	1	rs9813774	chr3:134227100	CEP63	chr3:134204575-134293852:+	0.33	6.51	1.82E-10	Height	
KIRC	cis	1	rs9813864	chr3:119590974	GSK3B	chr3:119540804-119813264:-	-0.15	-3.96	8.72E-5	HDL cholesterol	
KIRC	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.62	-15.15	5.86E-43	Height	
KIRC	cis	1	rs9814567	chr3:134218557	CEP63	chr3:134204575-134293852:+	-0.31	-6.13	1.73E-9	Height	
KIRC	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.3	-8.38	5.23E-16	Longevity	
KIRC	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.7	9.29	4.81E-19	Diastolic blood pressure	
KIRC	cis	1	rs9817062	chr3:190978642	UTS2D	chr3:190984945-191048325:-	-0.21	-3.88	0.00012	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.32	-9.09	2.36E-18	Longevity	
KIRC	cis	1	rs9818109	chr3:67528739	FAM19A1	chr3:68040734-68594769:+	0.24	3.54	0.000436	Corneal astigmatism	
KIRC	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.69	9.87	4.04E-21	Diastolic blood pressure	
KIRC	cis	1	rs9819072	chr3:58353647	PXK	chr3:58318617-58410878:+	0.23	4.64	4.49E-6	Cholesterol, total	
KIRC	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.6	14.67	8.2E-41	Height	
KIRC	cis	1	rs9819532	chr3:134288644	CEP63	chr3:134204575-134293852:+	0.34	6.74	4.34E-11	Height	
KIRC	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs9821494	chr3:190979316	UTS2D	chr3:190984945-191048325:-	-0.23	-4.18	3.4E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9821570	chr3:58335919	PXK	chr3:58318617-58410878:+	0.22	4.49	8.73E-6	Cholesterol, total	
KIRC	cis	1	rs9822268	chr3:49719729	UBA7	chr3:49842639-49851391:-	0.15	3.99	7.74E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs982256	chr7:110904226	IMMP2L	chr7:110303110-111202538:-	0.16	3.51	0.000492	Schizophrenia	
KIRC	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.71	9.24	6.96E-19	Diastolic blood pressure	
KIRC	cis	1	rs9823373	chr3:136167027	IL20RB	chr3:136676707-136729920:+	0.16	3.67	0.000273	Body mass index;Height	
KIRC	cis	1	rs9823546	chr3:49705512	UBA7	chr3:49842639-49851391:-	0.15	4.07	5.37E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.71	9.26	5.91E-19	Diastolic blood pressure	
KIRC	cis	1	rs9824965	chr3:58433505	PXK	chr3:58318617-58410878:+	0.22	4.32	1.88E-5	Cholesterol, total	
KIRC	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.7	-10.81	1.28E-24	Diastolic blood pressure	
KIRC	cis	1	rs9825916	chr3:85610382	CADM2	chr3:85008133-86117948:+	0.25	4.22	2.84E-5	Longevity (90 years and older)	
KIRC	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.3	-8.66	6.38E-17	Longevity	
KIRC	cis	1	rs9826458	chr3:85640815	CADM2	chr3:85008133-86117948:+	0.26	4.25	2.54E-5	Longevity (90 years and older)	
KIRC	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.6	14.3	3.66E-39	Height	
KIRC	cis	1	rs9826496	chr3:134224437	CEP63	chr3:134204575-134293852:+	0.32	6.23	9.63E-10	Height	
KIRC	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.77E-40	Height	
KIRC	cis	1	rs9827987	chr3:134272621	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.92E-10	Height	
KIRC	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs9828815	chr3:134265749	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.61	14.39	1.48E-39	Height	
KIRC	cis	1	rs9829092	chr3:134229866	CEP63	chr3:134204575-134293852:+	0.33	6.28	7.22E-10	Height	
KIRC	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.74	11.15	6.23E-26	Diastolic blood pressure	
KIRC	cis	1	rs9832488	chr3:190981512	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.53E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9832495	chr3:190981523	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.53E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.6	14.38	1.67E-39	Height	
KIRC	cis	1	rs9832785	chr3:134213070	CEP63	chr3:134204575-134293852:+	0.32	6.12	1.94E-9	Height	
KIRC	cis	1	rs9832873	chr3:190981552	UTS2D	chr3:190984945-191048325:-	-0.22	-3.99	7.53E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9833926	chr3:56650178	CCDC66	chr3:56591184-56655846:+	0.13	3.76	0.000187	Height	
KIRC	cis	1	rs983392	chr11:59923508	MS4A2	chr11:59856137-59866014:+	0.18	3.82	0.000153	Alzheimer's disease (late onset)	
KIRC	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.61	14.32	2.89E-39	Height	
KIRC	cis	1	rs9834755	chr3:134206845	CEP63	chr3:134204575-134293852:+	0.31	6.01	3.57E-9	Height	
KIRC	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs9835204	chr3:134261342	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs9835332	chr3:56667682	CCDC66	chr3:56591184-56655846:+	0.12	3.53	0.000447	Height	
KIRC	cis	1	rs9835434	chr3:190986962	UTS2D	chr3:190984945-191048325:-	-0.21	-3.71	0.000226	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs983543	chr6:126005767	HEY2	chr6:126068780-126082414:+	-0.17	-4.23	2.79E-5	Endometrial cancer	
KIRC	cis	1	rs9835883	chr3:190987251	UTS2D	chr3:190984945-191048325:-	-0.21	-3.71	0.000226	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9836291	chr3:49697459	UBA7	chr3:49842639-49851391:-	0.15	3.92	0.0001	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs9836548	chr3:67510605	FAM19A1	chr3:68040734-68594769:+	0.28	4.1	4.91E-5	Corneal astigmatism	
KIRC	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.37	-7.95	1.21E-14	Multiple sclerosis (severity)	
KIRC	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.31	-8.94	7.57E-18	Longevity	
KIRC	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.75	-11.46	3.46E-27	Diastolic blood pressure	
KIRC	cis	1	rs9839065	chr3:56716089	CCDC66	chr3:56591184-56655846:+	0.14	3.98	7.76E-5	Height	
KIRC	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.75	-11.46	3.46E-27	Diastolic blood pressure	
KIRC	cis	1	rs984040	chr6:126021277	HEY2	chr6:126068780-126082414:+	0.19	4.55	6.88E-6	Endometrial cancer	
KIRC	cis	1	rs9840500	chr3:136621338	IL20RB	chr3:136676707-136729920:+	0.16	3.78	0.000178	Body mass index	
KIRC	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.74	11	2.26E-25	Diastolic blood pressure	
KIRC	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.57	13.5	1.18E-35	Height	
KIRC	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.32	6.29	6.75E-10	Height	
KIRC	cis	1	rs9841529	chr3:136137283	IL20RB	chr3:136676707-136729920:+	0.16	3.75	0.000195	Body mass index;Height	
KIRC	cis	1	rs9842132	chr3:49427933	CCDC36	chr3:49235861-49295537:+	-0.25	-4.71	3.14E-6	Menarche (age at onset)	
KIRC	cis	1	rs9842132	chr3:49427933	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.52	7.69E-6	Menarche (age at onset)	
KIRC	cis	1	rs9842132	chr3:49427933	P4HTM	chr3:49027341-49044579:+	-0.21	-4.75	2.65E-6	Menarche (age at onset)	
KIRC	cis	1	rs9842132	chr3:49427933	TREX1	chr3:48501186-48509043:+	0.15	3.78	0.000179	Menarche (age at onset)	
KIRC	cis	1	rs9842132	chr3:49427933	WDR6	chr3:49044637-49053386:+	0.2	5.02	7.1E-7	Menarche (age at onset)	
KIRC	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.35	-7.41	5.28E-13	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
KIRC	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.69	-10.57	1.07E-23	Diastolic blood pressure	
KIRC	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.76	-11.59	1.11E-27	Diastolic blood pressure	
KIRC	cis	1	rs9844128	chr3:58391127	PXK	chr3:58318617-58410878:+	0.25	5.13	4.17E-7	Cholesterol, total	
KIRC	cis	1	rs9844512	chr3:85544070	CADM2	chr3:85008133-86117948:+	0.22	3.58	0.000382	Longevity (90 years and older)	
KIRC	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.7	9.11	1.96E-18	Diastolic blood pressure	
KIRC	cis	1	rs9847242	chr3:190989523	UTS2D	chr3:190984945-191048325:-	-0.21	-3.75	0.000199	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.73	9.94	2.2E-21	Diastolic blood pressure	
KIRC	cis	1	rs9848323	chr3:101656208	SENP7	chr3:101043120-101232085:-	-0.16	-3.65	0.00029	Psoriasis vulgaris;Psoriasis	
KIRC	cis	1	rs9849399	chr3:85537665	CADM2	chr3:85008133-86117948:+	0.22	3.58	0.000382	Longevity (90 years and older)	
KIRC	cis	1	rs9849482	chr3:58422087	PXK	chr3:58318617-58410878:+	0.25	5.04	6.52E-7	Cholesterol, total	
KIRC	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.31	-8.89	1.13E-17	Longevity	
KIRC	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.61	14.6	1.77E-40	Height	
KIRC	cis	1	rs9850015	chr3:134269541	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.92E-10	Height	
KIRC	cis	1	rs9850717	chr3:58351875	PXK	chr3:58318617-58410878:+	0.23	4.72	3.06E-6	Cholesterol, total	
KIRC	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.61	14.63	1.2E-40	Height	
KIRC	cis	1	rs9851441	chr3:134315091	CEP63	chr3:134204575-134293852:+	0.33	6.32	5.81E-10	Height	
KIRC	cis	1	rs9852327	chr3:190981404	UTS2D	chr3:190984945-191048325:-	-0.22	-4	7.27E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9854249	chr3:190978633	UTS2D	chr3:190984945-191048325:-	-0.21	-3.88	0.00012	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.61	14.76	3.36E-41	Height	
KIRC	cis	1	rs9854299	chr3:134206728	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.94E-10	Height	
KIRC	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.76	11.43	4.66E-27	Diastolic blood pressure	
KIRC	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.69	9.87	4.04E-21	Diastolic blood pressure	
KIRC	cis	1	rs9856076	chr3:190987344	UTS2D	chr3:190984945-191048325:-	-0.21	-3.71	0.000226	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.69	9.87	4.04E-21	Diastolic blood pressure	
KIRC	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.8	12.41	4.94E-31	Diastolic blood pressure	
KIRC	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.61	14.75	3.69E-41	Height	
KIRC	cis	1	rs9856693	chr3:134306913	CEP63	chr3:134204575-134293852:+	0.33	6.38	3.92E-10	Height	
KIRC	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.72	10.62	6.45E-24	Diastolic blood pressure	
KIRC	cis	1	rs9857275	chr3:141078188	SLC25A36	chr3:140660662-140698785:+	-0.17	-3.71	0.000232	Prion diseases	
KIRC	cis	1	rs9857697	chr3:190991384	UTS2D	chr3:190984945-191048325:-	-0.21	-3.76	0.00019	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9857917	chr3:141824845	TFDP2	chr3:141671329-141868311:-	-0.21	-4.26	2.44E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs9858213	chr3:49731861	UBA7	chr3:49842639-49851391:-	0.15	4	7.29E-5	Educational attainment	
KIRC	cis	1	rs9858542	chr3:49701983	UBA7	chr3:49842639-49851391:-	-0.16	-4.17	3.64E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs9860055	chr3:49506900	CCDC36	chr3:49235861-49295537:+	-0.26	-4.98	8.61E-7	Menarche (age at onset)	
KIRC	cis	1	rs9860055	chr3:49506900	NCKIPSD	chr3:48711280-48723334:-	-0.21	-4.17	3.57E-5	Menarche (age at onset)	
KIRC	cis	1	rs9860055	chr3:49506900	P4HTM	chr3:49027341-49044579:+	-0.19	-4.17	3.59E-5	Menarche (age at onset)	
KIRC	cis	1	rs9860055	chr3:49506900	TREX1	chr3:48501186-48509043:+	0.15	3.6	0.000349	Menarche (age at onset)	
KIRC	cis	1	rs9860055	chr3:49506900	WDR6	chr3:49044637-49053386:+	0.21	5.21	2.75E-7	Menarche (age at onset)	
KIRC	cis	1	rs9860970	chr3:58353781	PXK	chr3:58318617-58410878:+	0.23	4.64	4.49E-6	Cholesterol, total	
KIRC	cis	1	rs9862534	chr3:49598064	CCDC36	chr3:49235861-49295537:+	0.24	4.64	4.45E-6	Menarche (age at onset)	
KIRC	cis	1	rs9862534	chr3:49598064	GMPPB	chr3:49758932-49761384:-	-0.15	-3.5	0.000515	Menarche (age at onset)	
KIRC	cis	1	rs9862534	chr3:49598064	NCKIPSD	chr3:48711280-48723334:-	0.19	3.89	0.000114	Menarche (age at onset)	
KIRC	cis	1	rs9862534	chr3:49598064	P4HTM	chr3:49027341-49044579:+	0.16	3.68	0.000254	Menarche (age at onset)	
KIRC	cis	1	rs9862534	chr3:49598064	WDR6	chr3:49044637-49053386:+	-0.22	-5.63	3.08E-8	Menarche (age at onset)	
KIRC	cis	1	rs9862969	chr3:58341917	PXK	chr3:58318617-58410878:+	0.22	4.55	6.65E-6	Cholesterol, total	
KIRC	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs9863786	chr3:134247203	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs986417	chr14:60858761	DHRS7	chr14:60611502-60636561:-	-0.32	-4.07	5.47E-5	Gut microbiota (bacterial taxa)	
KIRC	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.72	9.27	5.61E-19	Diastolic blood pressure	
KIRC	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.6	14.5	5.03E-40	Height	
KIRC	cis	1	rs9864346	chr3:134312352	CEP63	chr3:134204575-134293852:+	0.33	6.44	2.73E-10	Height	
KIRC	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.31	-8.85	1.49E-17	Longevity	
KIRC	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.61	14.58	2.04E-40	Height	
KIRC	cis	1	rs9864439	chr3:134298671	CEP63	chr3:134204575-134293852:+	0.33	6.5	1.91E-10	Height	
KIRC	cis	1	rs9864824	chr3:58394835	PXK	chr3:58318617-58410878:+	-0.22	-4.66	4.12E-6	Cholesterol, total	
KIRC	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.75	11.39	7.07E-27	Diastolic blood pressure	
KIRC	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs9865905	chr3:156649594	LEKR1	chr3:156544076-156763918:+	0.35	7.56	1.88E-13	Multiple sclerosis (severity)	
KIRC	cis	1	rs9866086	chr3:168911333	GPR160	chr3:169755735-169803181:+	-0.31	-3.54	0.000437	Multiple myeloma (hyperdiploidy)	
KIRC	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.74	11.11	8.27E-26	Diastolic blood pressure	
KIRC	cis	1	rs9867325	chr3:136618909	IL20RB	chr3:136676707-136729920:+	0.16	3.78	0.000178	Body mass index	
KIRC	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.73	-10.57	1.01E-23	Diastolic blood pressure	
KIRC	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.74	11.13	7.24E-26	Diastolic blood pressure	
KIRC	cis	1	rs9869576	chr3:58401262	PXK	chr3:58318617-58410878:+	0.26	5.13	4.19E-7	Cholesterol, total	
KIRC	cis	1	rs9869826	chr3:50998816	HYAL3	chr3:50330262-50336899:-	0.37	4.72	3.04E-6	Bacteremia	
KIRC	cis	1	rs9869940	chr3:58401523	PXK	chr3:58318617-58410878:+	0.26	5.13	4.19E-7	Cholesterol, total	
KIRC	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.6	14.65	1.07E-40	Height	
KIRC	cis	1	rs9869981	chr3:134248801	CEP63	chr3:134204575-134293852:+	0.34	6.77	3.64E-11	Height	
KIRC	cis	1	rs9871024	chr3:49554241	CCDC36	chr3:49235861-49295537:+	-0.26	-5.02	7.25E-7	Menarche (age at onset)	
KIRC	cis	1	rs9871024	chr3:49554241	NCKIPSD	chr3:48711280-48723334:-	-0.23	-4.51	8.13E-6	Menarche (age at onset)	
KIRC	cis	1	rs9871024	chr3:49554241	P4HTM	chr3:49027341-49044579:+	-0.18	-4.18	3.45E-5	Menarche (age at onset)	
KIRC	cis	1	rs9871024	chr3:49554241	WDR6	chr3:49044637-49053386:+	0.22	5.55	4.58E-8	Menarche (age at onset)	
KIRC	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.62	14.81	2.02E-41	Height	
KIRC	cis	1	rs9871305	chr3:134213538	CEP63	chr3:134204575-134293852:+	0.32	6.14	1.7E-9	Height	
KIRC	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.72	9.41	1.78E-19	Diastolic blood pressure	
KIRC	cis	1	rs9873400	chr3:85590097	CADM2	chr3:85008133-86117948:+	0.22	3.71	0.000234	Longevity (90 years and older)	
KIRC	cis	1	rs9873477	chr3:119645976	GSK3B	chr3:119540804-119813264:-	0.14	3.77	0.000181	HDL cholesterol	
KIRC	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.7	9.29	4.83E-19	Diastolic blood pressure	
KIRC	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.72	9.34	3.14E-19	Diastolic blood pressure	
KIRC	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.71	10.45	2.98E-23	Diastolic blood pressure	
KIRC	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.58	-13.78	7.06E-37	Height	
KIRC	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.31	-6.19	1.28E-9	Height	
KIRC	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.32	-9.52	7.18E-20	Longevity	
KIRC	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.74	-11.61	9.13E-28	Diastolic blood pressure	
KIRC	cis	1	rs9877400	chr3:190991439	UTS2D	chr3:190984945-191048325:-	0.2	3.65	0.000291	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9877817	chr3:141812759	TFDP2	chr3:141671329-141868311:-	-0.21	-4.16	3.74E-5	Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine)	
KIRC	cis	1	rs9878078	chr3:136237573	IL20RB	chr3:136676707-136729920:+	0.15	3.6	0.000345	Body mass index;Height	
KIRC	cis	1	rs9878373	chr3:56666957	CCDC66	chr3:56591184-56655846:+	0.12	3.53	0.000447	Height	
KIRC	cis	1	rs9878473	chr3:119650788	GSK3B	chr3:119540804-119813264:-	0.15	4	7.36E-5	HDL cholesterol	
KIRC	cis	1	rs9879311	chr3:10415343	GHRLOS	chr3:10322637-10335132:+	0.12	3.63	0.000318	Schizophrenia	
KIRC	cis	1	rs9879725	chr3:51009435	HYAL3	chr3:50330262-50336899:-	-0.4	-4.72	3.05E-6	Bacteremia	
KIRC	cis	1	rs9880211	chr3:136107549	IL20RB	chr3:136676707-136729920:+	0.15	3.51	0.000495	Body mass index;Height	
KIRC	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.32	-9.13	1.73E-18	Longevity	
KIRC	cis	1	rs9882740	chr3:49702484	UBA7	chr3:49842639-49851391:-	0.15	4.01	7.08E-5	Crohn's disease;Ulcerative colitis	
KIRC	cis	1	rs9883189	chr3:136289466	IL20RB	chr3:136676707-136729920:+	0.16	3.7	0.000243	Body mass index;Height	
KIRC	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.59	14.31	3.26E-39	Height	
KIRC	cis	1	rs9883753	chr3:134247231	CEP63	chr3:134204575-134293852:+	0.34	6.6	1.03E-10	Height	
KIRC	cis	1	rs9883759	chr3:48463618	SHISA5	chr3:48509197-48542228:-	-0.13	-3.65	0.000289	Longevity	
KIRC	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.33	-9.31	3.91E-19	Longevity	
KIRC	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.32	-9.09	2.36E-18	Longevity	
KIRC	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.61	14.81	1.95E-41	Height	
KIRC	cis	1	rs9884031	chr3:134256500	CEP63	chr3:134204575-134293852:+	0.34	6.67	6.92E-11	Height	
KIRC	cis	1	rs9885413	chr5:110176128	TMEM232	chr5:109624934-110062381:-	0.33	4.8	2.1E-6	Mortality in heart failure	
KIRC	cis	1	rs988712	chr11:27563382	BDNFOS	chr11:27528399-27719773:+	0.24	4.23	2.73E-5	Obesity	
KIRC	cis	1	rs9889618	chr17:40293467	DHX58	chr17:40253422-40264751:-	-0.35	-6.97	1.02E-11	Fibrinogen levels	
KIRC	cis	1	rs9889640	chr17:40293497	DHX58	chr17:40253422-40264751:-	-0.35	-6.97	1.02E-11	Fibrinogen levels	
KIRC	cis	1	rs9890032	chr17:29165934	SUZ12P	chr17:29035714-29097067:+	0.11	3.92	0.000102	Height	
KIRC	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.47	2.36E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.42	3.2E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9890971	chr17:53059776	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.91	0.000106	Breast cancer	
KIRC	cis	1	rs9891018	chr17:61827856	FTSJ3	chr17:61896795-61905031:-	0.32	6.33	5.3E-10	Body mass index	
KIRC	cis	1	rs9891018	chr17:61827856	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.64	4.4E-6	Body mass index	
KIRC	cis	1	rs9891865	chr17:53060033	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.48	2.22E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9892173	chr17:53060214	TOM1L1	chr17:52978052-53039328:+	-0.15	-4.12	4.34E-5	Breast cancer	
KIRC	cis	1	rs9892848	chr17:53059775	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.91	0.000106	Breast cancer	
KIRC	cis	1	rs9892976	chr17:53060329	TOM1L1	chr17:52978052-53039328:+	-0.15	-4.16	3.76E-5	Breast cancer	
KIRC	cis	1	rs9893306	chr17:53054749	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs9893348	chr17:61676534	FTSJ3	chr17:61896795-61905031:-	0.34	6.48	2.16E-10	Body mass index	
KIRC	cis	1	rs9893348	chr17:61676534	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.15	3.89E-5	Body mass index	
KIRC	cis	1	rs9894429	chr17:79596811	ARL16	chr17:79648234-79650954:-	-0.18	-4.46	9.93E-6	Eye color traits	
KIRC	cis	1	rs9894429	chr17:79596811	NPLOC4	chr17:79523915-79604138:-	-0.13	-3.92	9.93E-5	Eye color traits	
KIRC	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.62	14	8.12E-38	Eye color traits	
KIRC	cis	1	rs9894529	chr17:53055246	TOM1L1	chr17:52978052-53039328:+	-0.15	-4.1	4.74E-5	Breast cancer	
KIRC	cis	1	rs9895661	chr17:59456589	C17orf64	chr17:58499865-58508786:+	0.24	3.81	0.000155	Renal function-related traits (sCR);Chronic kidney disease;Glomerular filtration rate;Glomerular filtration rate in non diabetics (creatinine);Renal function-related traits (eGRFcrea)	
KIRC	cis	1	rs9895808	chr17:53048442	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.99	7.61E-5	Breast cancer	
KIRC	cis	1	rs9895920	chr17:61852719	FTSJ3	chr17:61896795-61905031:-	0.31	6.19	1.24E-9	Body mass index	
KIRC	cis	1	rs9895920	chr17:61852719	TCAM1P	chr17:61934376-61941738:+	-0.27	-4.88	1.45E-6	Body mass index	
KIRC	cis	1	rs9896044	chr17:53048542	TOM1L1	chr17:52978052-53039328:+	-0.15	-4.07	5.57E-5	Breast cancer	
KIRC	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.52	1.76E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.47	2.35E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9897447	chr17:53048469	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.99	7.61E-5	Breast cancer	
KIRC	cis	1	rs9899491	chr17:61934384	FTSJ3	chr17:61896795-61905031:-	0.32	6.42	3.22E-10	Body mass index	
KIRC	cis	1	rs9899491	chr17:61934384	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.57	6.1E-6	Body mass index	
KIRC	cis	1	rs9899788	chr17:61756384	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.00029	Body mass index	
KIRC	cis	1	rs9899788	chr17:61756384	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.88E-10	Body mass index	
KIRC	cis	1	rs9899788	chr17:61756384	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.53	7.41E-6	Body mass index	
KIRC	cis	1	rs9900979	chr17:46726565	SNX11	chr17:46184911-46200105:+	-0.37	-3.83	0.000146	Platelet thrombus formation	
KIRC	cis	1	rs9900979	chr17:46726565	ZNF652	chr17:47366569-47439835:-	-0.34	-3.63	0.000314	Platelet thrombus formation	
KIRC	cis	1	rs9901112	chr17:61730617	FTSJ3	chr17:61896795-61905031:-	0.32	6.25	8.58E-10	Body mass index	
KIRC	cis	1	rs9901112	chr17:61730617	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.88E-6	Body mass index	
KIRC	cis	1	rs9901225	chr17:40755811	HSD17B1	chr17:40703984-40707224:+	-0.22	-5.16	3.52E-7	Colorectal or endometrial cancer	
KIRC	cis	1	rs9901225	chr17:40755811	NT5C3L	chr17:39981424-39992491:-	0.18	4	7.16E-5	Colorectal or endometrial cancer	
KIRC	cis	1	rs9901225	chr17:40755811	TUBG2	chr17:40811266-40819023:+	-0.2	-5.05	6.29E-7	Colorectal or endometrial cancer	
KIRC	cis	1	rs9901507	chr17:61765524	DDX42	chr17:61851567-61896676:+	-0.17	-3.63	0.000308	Body mass index	
KIRC	cis	1	rs9901507	chr17:61765524	FTSJ3	chr17:61896795-61905031:-	0.32	6.36	4.58E-10	Body mass index	
KIRC	cis	1	rs9901507	chr17:61765524	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.5	8.35E-6	Body mass index	
KIRC	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.36	-6.26	8.3E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9902453	chr17:28349095	SSH2	chr17:27952965-28257018:-	-0.16	-3.66	0.000281	Coffee consumption (cups per day)	
KIRC	cis	1	rs9902687	chr17:53048924	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs9902718	chr17:53061622	TOM1L1	chr17:52978052-53039328:+	-0.16	-4.44	1.09E-5	Breast cancer	
KIRC	cis	1	rs9903146	chr17:53057747	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs9903204	chr17:40288062	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.96E-11	Fibrinogen levels	
KIRC	cis	1	rs9903220	chr17:53057865	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs9903444	chr17:53057893	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs9903825	chr17:53057914	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.05	6.05E-5	Breast cancer	
KIRC	cis	1	rs9903897	chr17:61716705	DDX42	chr17:61851567-61896676:+	-0.17	-3.69	0.000253	Body mass index	
KIRC	cis	1	rs9903897	chr17:61716705	FTSJ3	chr17:61896795-61905031:-	0.32	6.34	5.1E-10	Body mass index	
KIRC	cis	1	rs9903897	chr17:61716705	TCAM1P	chr17:61934376-61941738:+	-0.24	-4.43	1.18E-5	Body mass index	
KIRC	cis	1	rs9903903	chr17:61762044	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.00029	Body mass index	
KIRC	cis	1	rs9903903	chr17:61762044	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.88E-10	Body mass index	
KIRC	cis	1	rs9903903	chr17:61762044	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.53	7.41E-6	Body mass index	
KIRC	cis	1	rs9905565	chr17:18758641	FAM18B	chr17:18684582-18710026:+	-0.27	-6.11	1.96E-9	Pancreatic cancer	
KIRC	cis	1	rs9905704	chr17:56632543	SKA2	chr17:57187308-57232800:-	0.19	3.94	9.21E-5	Testicular germ cell tumor	
KIRC	cis	1	rs9905704	chr17:56632543	TRIM37	chr17:57060002-57184266:-	-0.21	-5.09	5.13E-7	Testicular germ cell tumor	
KIRC	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.35	-6.08	2.32E-9	Coffee consumption (cups per day)	
KIRC	cis	1	rs9906340	chr17:28398977	GOSR1	chr17:28804426-28853831:+	0.14	3.57	0.000386	Coffee consumption (cups per day)	
KIRC	cis	1	rs9908044	chr17:61747032	DDX42	chr17:61851567-61896676:+	-0.17	-3.65	0.00029	Body mass index	
KIRC	cis	1	rs9908044	chr17:61747032	FTSJ3	chr17:61896795-61905031:-	0.32	6.35	4.88E-10	Body mass index	
KIRC	cis	1	rs9908044	chr17:61747032	TCAM1P	chr17:61934376-61941738:+	-0.25	-4.53	7.41E-6	Body mass index	
KIRC	cis	1	rs9908102	chr17:12896553	ELAC2	chr17:12895703-12921359:-	0.3	7.07	5.23E-12	Schizophrenia	
KIRC	cis	1	rs9908933	chr17:41817511	DUSP3	chr17:41843490-41856368:-	-0.14	-3.79	0.000172	Bone mineral density (hip)	
KIRC	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.33	-6.37	4.33E-10	Glycated hemoglobin levels	
KIRC	cis	1	rs9909992	chr17:61731931	FTSJ3	chr17:61896795-61905031:-	0.32	6.24	9.21E-10	Body mass index	
KIRC	cis	1	rs9909992	chr17:61731931	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.58	5.86E-6	Body mass index	
KIRC	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.48	-10.02	1.14E-21	Subjective well-being	
KIRC	cis	1	rs9909	chr11:47799775	PSMC3	chr11:47440320-47448024:-	0.12	3.51	0.000497	Subjective well-being	
KIRC	cis	1	rs9911854	chr17:80408348	NARF	chr17:80416060-80446141:+	-0.19	-3.69	0.00025	Protein quantitative trait loci	
KIRC	cis	1	rs9912088	chr17:40288278	DHX58	chr17:40253422-40264751:-	-0.35	-6.87	1.87E-11	Fibrinogen levels	
KIRC	cis	1	rs9912201	chr17:61763208	FTSJ3	chr17:61896795-61905031:-	0.33	6.46	2.46E-10	Body mass index	
KIRC	cis	1	rs9912201	chr17:61763208	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.51	7.93E-6	Body mass index	
KIRC	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.37	-6.47	2.36E-10	Coffee consumption (cups per day)	
KIRC	cis	1	rs9912904	chr17:61763534	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs9912904	chr17:61763534	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs9914266	chr17:2133250	SRR	chr17:2207248-2228553:+	0.43	7.67	9.31E-14	Myocardial infarction	
KIRC	cis	1	rs9914544	chr17:18787828	FAM18B	chr17:18684582-18710026:+	-0.26	-5.98	4.25E-9	Educational attainment (years of education)	
KIRC	cis	1	rs9914577	chr17:2005130	SRR	chr17:2207248-2228553:+	0.37	5.52	5.33E-8	Body mass index	
KIRC	cis	1	rs9914578	chr17:2005136	SRR	chr17:2207248-2228553:+	0.37	5.53	5.24E-8	Body mass index	
KIRC	cis	1	rs9914732	chr17:53054367	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs9915112	chr17:2007826	SRR	chr17:2207248-2228553:+	0.37	5.71	1.92E-8	Body mass index	
KIRC	cis	1	rs9915183	chr17:53047137	TOM1L1	chr17:52978052-53039328:+	-0.14	-3.99	7.61E-5	Breast cancer	
KIRC	cis	1	rs9915255	chr17:40284191	DHX58	chr17:40253422-40264751:-	-0.34	-6.7	5.48E-11	Fibrinogen levels	
KIRC	cis	1	rs9915832	chr17:53054697	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs9916245	chr17:18766825	FAM18B	chr17:18684582-18710026:+	-0.26	-6.03	3.19E-9	Educational attainment (years of education)	
KIRC	cis	1	rs9916642	chr17:53054497	TOM1L1	chr17:52978052-53039328:+	-0.14	-4.03	6.49E-5	Breast cancer	
KIRC	cis	1	rs9917716	chr3:190979147	UTS2D	chr3:190984945-191048325:-	-0.22	-4	7.18E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9917717	chr3:190979176	UTS2D	chr3:190984945-191048325:-	-0.22	-4.01	6.92E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9917773	chr3:190979184	UTS2D	chr3:190984945-191048325:-	-0.22	-4.01	6.92E-5	Age-related hearing impairment (interaction)	
KIRC	cis	1	rs9919599	chr11:116745484	PCSK7	chr11:117075789-117102811:-	-0.28	-5.23	2.49E-7	Protein quantitative trait loci	
KIRC	cis	1	rs9920	chr7:116200092	CAV2	chr7:115928127-116148594:+	0.35	4.53	7.38E-6	QT interval	
KIRC	cis	1	rs9921222	chr16:375782	TMEM8A	chr16:420777-431978:-	0.16	4.51	7.97E-6	Bone mineral density (spine);Bone mineral density	
KIRC	cis	1	rs9921338	chr16:11416839	C16orf75	chr16:11343506-11445617:+	-0.25	-4.32	1.84E-5	Vein graft stenosis in coronary artery bypass grafting	
KIRC	cis	1	rs9923145	chr16:74686166	MLKL	chr16:74705753-74734789:-	0.2	4.41	1.27E-5	Testicular germ cell tumor	
KIRC	cis	1	rs9923145	chr16:74686166	RFWD3	chr16:74655298-74700779:-	-0.17	-4.06	5.59E-5	Testicular germ cell tumor	
KIRC	cis	1	rs992416	chr17:61745905	FTSJ3	chr17:61896795-61905031:-	0.33	6.5	1.98E-10	Body mass index	
KIRC	cis	1	rs992416	chr17:61745905	TCAM1P	chr17:61934376-61941738:+	-0.26	-4.62	4.92E-6	Body mass index	
KIRC	cis	1	rs9924629	chr16:50095506	HEATR3	chr16:50099881-50139373:+	-0.28	-4.01	6.91E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs9925215	chr16:50096130	HEATR3	chr16:50099881-50139373:+	0.25	3.61	0.000343	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs9925659	chr16:55609592	LPCAT2	chr16:55542913-55620581:+	0.19	4.74	2.77E-6	Thyroid hormone levels	
KIRC	cis	1	rs9928374	chr16:67811930	ATP6V0D1	chr16:67471917-67515089:-	0.37	5	7.81E-7	Crohn's disease	
KIRC	cis	1	rs9929496	chr16:74668473	MLKL	chr16:74705753-74734789:-	0.19	4.23	2.84E-5	Testicular germ cell tumor	
KIRC	cis	1	rs9929496	chr16:74668473	RFWD3	chr16:74655298-74700779:-	-0.17	-4.14	4.13E-5	Testicular germ cell tumor	
KIRC	cis	1	rs9931225	chr16:74699293	MLKL	chr16:74705753-74734789:-	0.22	4.89	1.39E-6	Testicular germ cell tumor	
KIRC	cis	1	rs9931225	chr16:74699293	RFWD3	chr16:74655298-74700779:-	-0.17	-4.17	3.59E-5	Testicular germ cell tumor	
KIRC	cis	1	rs9932240	chr16:50094227	HEATR3	chr16:50099881-50139373:+	-0.29	-4.11	4.54E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs993394	chr6:117117143	FAM162B	chr6:117073360-117086886:-	0.25	6.73	4.66E-11	C-reactive protein levels	
KIRC	cis	1	rs9934609	chr16:83638578	HSDL1	chr16:84155744-84178800:-	0.17	3.49	0.000522	Height	
KIRC	cis	1	rs9934700	chr16:83638734	HSDL1	chr16:84155744-84178800:-	0.17	3.55	0.000418	Height	
KIRC	cis	1	rs9936966	chr16:50090366	HEATR3	chr16:50099881-50139373:+	0.28	4.07	5.55E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs9938630	chr16:29837108	LOC440356	chr16:29875004-29879374:+	-0.23	-3.52	0.000466	Multiple sclerosis	
KIRC	cis	1	rs9938862	chr16:67723801	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-5.3	1.73E-7	Crohn's disease	
KIRC	cis	1	rs9938862	chr16:67723801	C16orf86	chr16:67700717-67702659:+	-0.3	-3.77	0.000181	Crohn's disease	
KIRC	cis	1	rs9939085	chr16:67733237	ATP6V0D1	chr16:67471917-67515089:-	-0.34	-5.42	9.14E-8	Crohn's disease	
KIRC	cis	1	rs9939085	chr16:67733237	C16orf86	chr16:67700717-67702659:+	-0.31	-3.88	0.000119	Crohn's disease	
KIRC	cis	1	rs9939349	chr16:50716398	SNX20	chr16:50700211-50715264:-	0.07	3.55	0.000429	Leprosy	
KIRC	cis	1	rs9939710	chr16:50093951	HEATR3	chr16:50099881-50139373:+	-0.29	-4.05	5.83E-5	Esophageal cancer (squamous cell)	
KIRC	cis	1	rs9940227	chr16:55614794	LPCAT2	chr16:55542913-55620581:+	-0.18	-4.33	1.77E-5	Thyroid hormone levels	
KIRC	cis	1	rs9947295	chr18:11759432	GNAL	chr18:11689136-11883144:+	-0.39	-5.66	2.62E-8	QT interval (interaction)	
KIRC	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.63	-15.31	1.04E-43	Height	
KIRC	cis	1	rs9968172	chr3:134231251	CEP63	chr3:134204575-134293852:+	-0.33	-6.47	2.4E-10	Height	
KIRC	cis	1	rs9969804	chr9:95429120	BICD2	chr9:95473645-95527083:-	0.16	3.67	0.000273	Height	
KIRC	cis	1	rs9971695	chr12:124413491	CCDC92	chr12:124420955-124457163:-	0.19	4.8	2.06E-6	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs9971695	chr12:124413491	DNAH10	chr12:124247042-124420265:+	0.2	4.01	7.1E-5	Waist-to-hip ratio adjusted for body mass index	
KIRC	cis	1	rs997295	chr15:68016343	IQCH	chr15:67547188-67794139:+	0.18	3.56	0.000413	Motion sickness	
KIRC	cis	1	rs998404	chr10:29808486	LOC387647	chr10:29698483-29776785:+	-0.21	-3.98	7.83E-5	Platelet thrombus formation	
KIRC	cis	1	rs9984793	chr21:30486471	N6AMT1	chr21:30244513-30257693:-	-0.21	-3.95	8.81E-5	Dental caries	
KIRC	cis	1	rs9984793	chr21:30486471	NCRNA00189	chr21:30565801-30660525:+	0.23	4.28	2.21E-5	Dental caries	
KIRC	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.57	-13.48	1.48E-35	Height	
KIRC	cis	1	rs9985356	chr3:134232920	CEP63	chr3:134204575-134293852:+	-0.32	-6.26	8.18E-10	Height	
KIRC	cis	1	rs9986596	chr6:28219661	ZNF187	chr6:28234788-28245978:+	-0.27	-4.7	3.38E-6	Depression	
KIRC	cis	1	rs9986596	chr6:28219661	ZNF323	chr6:28292517-28324048:-	0.27	3.65	0.000288	Depression	
KIRC	cis	1	rs9986596	chr6:28219661	ZSCAN23	chr6:28393287-28411279:-	0.26	3.65	0.000288	Depression	
KIRC	cis	1	rs9988450	chr1:62924448	ANGPTL3	chr1:63063187-63071180:+	-0.19	-3.9	0.000108	Triglycerides	
KIRC	cis	1	rs9988866	chr11:18392983	GTF2H1	chr11:18343816-18388590:+	0.33	7.33	8.97E-13	Pancreatic cancer	
KIRC	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.59	14.33	2.66E-39	Height	
KIRC	cis	1	rs9989967	chr3:134238964	CEP63	chr3:134204575-134293852:+	0.33	6.56	1.36E-10	Height	
KIRC	cis	1	rs9990333	chr3:195827205	SDHAP1	chr3:195686792-195717150:-	-0.13	-3.87	0.000122	Iron status biomarkers (transferrin saturation);Iron status biomarkers (transferrin levels)	
KIRC	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.6	-14.38	1.67E-39	Height	
KIRC	cis	1	rs9990351	chr3:134239191	CEP63	chr3:134204575-134293852:+	-0.31	-5.95	5.15E-9	Height	
KIRC	cis	1	rs9990702	chr4:88772316	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs9990742	chr4:39121414	WDR19	chr4:39184024-39287429:+	0.18	4.7	3.36E-6	Uric acid levels	
KIRC	cis	1	rs9990755	chr4:39121439	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs9991307	chr4:17662408	LAP3	chr4:17578927-17609590:+	-0.22	-6.98	9.45E-12	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs9991307	chr4:17662408	MED28	chr4:17616273-17629791:+	0.18	4.11	4.54E-5	Parasitemia in Tripanosoma cruzi seropositivity	
KIRC	cis	1	rs9994128	chr4:108888163	HADH	chr4:108910940-108956330:+	0.26	3.54	0.000434	Amyotrophic lateral sclerosis (sporadic)	
KIRC	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.51	-10.61	7.08E-24	Longevity	
KIRC	cis	1	rs9996285	chr4:39132176	WDR19	chr4:39184024-39287429:+	0.19	4.85	1.67E-6	Uric acid levels	
KIRC	cis	1	rs9996834	chr4:103557529	MANBA	chr4:103552644-103682151:-	0.16	3.74	0.000207	Primary biliary cirrhosis	
KIRC	cis	1	rs9997089	chr4:39120883	WDR19	chr4:39184024-39287429:+	0.18	4.83	1.83E-6	Uric acid levels	
KIRC	cis	1	rs9997288	chr4:56347227	SRD5A3	chr4:56212409-56237866:+	0.21	4.67	3.84E-6	Personality dimensions	
KIRC	cis	1	rs9997288	chr4:56347227	TMEM165	chr4:56262090-56292342:+	-0.21	-5.75	1.54E-8	Personality dimensions	
KIRC	cis	1	rs9997663	chr4:75705378	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs9998146	chr4:56397977	SRD5A3	chr4:56212409-56237866:+	-0.18	-3.81	0.000158	Personality dimensions	
KIRC	cis	1	rs9998146	chr4:56397977	TMEM165	chr4:56262090-56292342:+	0.22	6.08	2.38E-9	Personality dimensions	
KIRC	cis	1	rs9998442	chr4:75706141	BTC	chr4:75671448-75719882:-	0.3	4.11	4.65E-5	Electroencephalogram traits	
KIRC	cis	1	rs9998481	chr4:39118835	WDR19	chr4:39184024-39287429:+	0.18	4.81	2.04E-6	Uric acid levels	
KIRC	cis	1	rs9998867	chr4:39119162	WDR19	chr4:39184024-39287429:+	0.18	4.81	2.04E-6	Uric acid levels	
KIRC	cis	1	rs9998898	chr4:88772189	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs9998975	chr4:88772233	MEPE	chr4:88754140-88767942:+	-0.22	-4.3	2.03E-5	Bone mineral density;Bone mineral density (paediatric, total body less head)	
KIRC	cis	1	rs9999327	chr4:39111731	WDR19	chr4:39184024-39287429:+	0.18	4.76	2.5E-6	Uric acid levels	
KIRC	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.5	-12.52	1.81E-31	Migraine without aura	
KIRC	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.57	12.39	5.99E-31	Educational attainment	
KIRC	trans	1	rs1039438	chr5:156476770	LOC100101266	chr19:24344995-24346249:-	-0.35	-6.1	2.14E-9	Hypertriglyceridemia	
KIRC	trans	1	rs10456362	chr6:28221816	BTN3A2	chr6:26365398-26378546:+	0.37	6.44	2.75E-10	Depression	
KIRC	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.56	12	2.34E-29	Educational attainment	
KIRC	trans	1	rs10501335	chr11:55306577	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.87E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs10736655	chr11:55972758	FOLH1B	chr11:89392465-89431885:+	0.41	6.72	5.02E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10742862	chr11:48649316	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.02	7.71E-15	HDL cholesterol	
KIRC	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.19	2.19E-15	HDL cholesterol	
KIRC	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.14	3.21E-15	HDL cholesterol	
KIRC	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.57	12.36	8.37E-31	Educational attainment	
KIRC	trans	1	rs10791857	chr11:55940884	FOLH1B	chr11:89392465-89431885:+	0.4	6.57	1.22E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10792426	chr11:55725055	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.28	7.55E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10794671	chr1:121168242	NBPF14	chr1:148003643-148346791:-	0.39	10.04	9.58E-22	Hip geometry	
KIRC	trans	1	rs10803550	chr2:136907790	TMEM163	chr2:135213331-135525334:-	-0.33	-5.87	8.08E-9	Arthritis (juvenile idiopathic)	
KIRC	trans	1	rs10838801	chr11:48098280	FOLH1B	chr11:89392465-89431885:+	-0.43	-7.27	1.34E-12	Height	
KIRC	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.09	4.58E-15	HDL cholesterol	
KIRC	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.09	4.53E-15	HDL cholesterol	
KIRC	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.12	3.56E-15	HDL cholesterol	
KIRC	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.47	-8.38	5.43E-16	HDL cholesterol	
KIRC	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs10838971	chr11:48606624	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs10839171	chr11:48923034	FOLH1B	chr11:89392465-89431885:+	0.45	8.05	6.14E-15	HDL cholesterol	
KIRC	trans	1	rs10896042	chr11:55898588	FOLH1B	chr11:89392465-89431885:+	0.42	6.95	1.17E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10896103	chr11:55944048	FOLH1B	chr11:89392465-89431885:+	0.4	6.55	1.47E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10897441	chr11:55689411	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.49	2.0E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10897517	chr11:55779734	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.43	3.05E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs10903159	chr1:121181997	NBPF14	chr1:148003643-148346791:-	0.4	10.59	8.41E-24	Hip geometry	
KIRC	trans	1	rs10903159	chr1:121181997	NBPF9	chr1:144146807-145368682:+	0.2	5.98	4.34E-9	Hip geometry	
KIRC	trans	1	rs10903161	chr1:121178741	NBPF14	chr1:148003643-148346791:-	0.39	10.19	2.75E-22	Hip geometry	
KIRC	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.24	1.49E-15	HDL cholesterol	
KIRC	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.37E-15	HDL cholesterol	
KIRC	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.19	2.16E-15	HDL cholesterol	
KIRC	trans	1	rs11039800	chr11:48542579	FOLH1B	chr11:89392465-89431885:+	0.46	8.1	4.24E-15	HDL cholesterol	
KIRC	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.29	1.05E-15	HDL cholesterol	
KIRC	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.16	2.65E-15	HDL cholesterol	
KIRC	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.15	2.96E-15	HDL cholesterol	
KIRC	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.16	2.74E-15	HDL cholesterol	
KIRC	trans	1	rs11039857	chr11:48610853	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs11039862	chr11:48618306	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.01	8.27E-15	HDL cholesterol	
KIRC	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.14	3.21E-15	HDL cholesterol	
KIRC	trans	1	rs11039871	chr11:48626620	FOLH1B	chr11:89392465-89431885:+	0.46	8.17	2.45E-15	HDL cholesterol	
KIRC	trans	1	rs11039890	chr11:48653468	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.06	5.74E-15	HDL cholesterol	
KIRC	trans	1	rs11039904	chr11:48682597	FOLH1B	chr11:89392465-89431885:+	0.54	6.18	1.34E-9	Axial length	
KIRC	trans	1	rs11039978	chr11:48760237	FOLH1B	chr11:89392465-89431885:+	0.54	6.18	1.34E-9	Axial length	
KIRC	trans	1	rs11139535	chr9:84919492	SCGB2A2	chr11:62037630-62040627:+	0.25	5.87	8.11E-9	Airway imaging phenotypes	
KIRC	trans	1	rs11227471	chr11:55959149	FOLH1B	chr11:89392465-89431885:+	0.41	6.55	1.42E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs11231529	chr11:55681336	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.51	1.79E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs11231558	chr11:55688963	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.49	2.0E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs11231676	chr11:55722276	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.34	5.15E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs11246602	chr11:51512090	FOLH1B	chr11:89392465-89431885:+	0.61	6.01	3.5E-9	HDL cholesterol	
KIRC	trans	1	rs11249350	chr1:121178446	NBPF14	chr1:148003643-148346791:-	0.4	10.42	3.91E-23	Hip geometry	
KIRC	trans	1	rs11249351	chr1:121171942	NBPF14	chr1:148003643-148346791:-	0.39	10.03	1.08E-21	Hip geometry	
KIRC	trans	1	rs112655520	chr11:54899616	FOLH1B	chr11:89392465-89431885:+	0.75	5.93	5.79E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs113732116	chr11:55242946	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs114502840	chr11:54899615	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs114635668	chr11:54812845	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs115224187	chr11:48757499	FOLH1B	chr11:89392465-89431885:+	0.46	7.96	1.16E-14	HDL cholesterol	
KIRC	trans	1	rs11530232	chr11:48622376	FOLH1B	chr11:89392465-89431885:+	0.62	6	3.89E-9	Axial length	
KIRC	trans	1	rs115429994	chr11:48761183	FOLH1B	chr11:89392465-89431885:+	0.54	6.18	1.34E-9	Axial length	
KIRC	trans	1	rs115582955	chr11:54823391	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.15E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11629212	chr14:70141589	GAGE2B	chrX:49216634-49242997:+	-0.16	-5.95	4.96E-9	Asthma	
KIRC	trans	1	rs116475522	chr11:55022636	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.86E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs1167827	chr7:75163169	TRIM74	chr7:75021265-75040277:+	-0.25	-6.19	1.25E-9	Body mass index	
KIRC	trans	1	rs117292063	chr11:54987085	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11737950	chr5:156436211	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.27	7.59E-10	Hypertriglyceridemia	
KIRC	trans	1	rs11740496	chr5:156435402	LOC100101266	chr19:24344995-24346249:-	0.36	6.17	1.4E-9	Hypertriglyceridemia	
KIRC	trans	1	rs11746128	chr5:156421250	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.62	9.11E-11	Hypertriglyceridemia	
KIRC	trans	1	rs11746825	chr5:49912509	LOC647121	chr1:121260910-121313686:+	-0.2	-5.94	5.22E-9	Myopia (pathological)	
KIRC	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs11820245	chr11:55240895	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.04E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11820246	chr11:55240901	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.04E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11821647	chr11:54978609	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.7E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11822057	chr11:55242495	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11822296	chr11:56005276	FOLH1B	chr11:89392465-89431885:+	0.42	6.84	2.38E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs11823346	chr11:55214688	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11823401	chr11:55274744	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11824344	chr11:54955198	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.03E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11825077	chr11:54838034	FOLH1B	chr11:89392465-89431885:+	0.75	5.95	4.95E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11826744	chr11:54895914	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11827117	chr11:55315605	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11827274	chr11:54866387	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11828784	chr11:54866721	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs11965538	chr6:28239915	BTN3A2	chr6:26365398-26378546:+	-0.41	-6.93	1.3E-11	Depression	
KIRC	trans	1	rs12038371	chr1:207821046	CD80	chr3:119243142-119278481:-	0.22	6.16	1.54E-9	LDL cholesterol	
KIRC	trans	1	rs12047116	chr1:121185770	NBPF14	chr1:148003643-148346791:-	0.4	10.39	4.97E-23	Hip geometry	
KIRC	trans	1	rs12047116	chr1:121185770	NBPF9	chr1:144146807-145368682:+	0.2	5.88	7.34E-9	Hip geometry	
KIRC	trans	1	rs12145080	chr1:121185531	NBPF14	chr1:148003643-148346791:-	-0.39	-10.15	3.9E-22	Hip geometry	
KIRC	trans	1	rs12145080	chr1:121185531	NBPF9	chr1:144146807-145368682:+	-0.2	-5.88	7.65E-9	Hip geometry	
KIRC	trans	1	rs12225599	chr11:48755868	FOLH1B	chr11:89392465-89431885:+	0.54	6.18	1.34E-9	Axial length	
KIRC	trans	1	rs12280020	chr11:48618844	FOLH1B	chr11:89392465-89431885:+	0.52	6.13	1.73E-9	Axial length	
KIRC	trans	1	rs12281162	chr11:48650491	FOLH1B	chr11:89392465-89431885:+	0.53	6.18	1.31E-9	Axial length	
KIRC	trans	1	rs12285009	chr11:55699230	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.51	1.85E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs12289998	chr11:55847898	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.46	2.42E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs12293522	chr11:49558425	FOLH1B	chr11:89392465-89431885:+	-0.43	-7.92	1.53E-14	Height	
KIRC	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.11	3.85E-15	HDL cholesterol	
KIRC	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs12420372	chr11:48497603	FOLH1B	chr11:89392465-89431885:+	0.45	8.01	8.27E-15	HDL cholesterol	
KIRC	trans	1	rs12420542	chr11:55823294	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.65	7.62E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.14	3.21E-15	HDL cholesterol	
KIRC	trans	1	rs12421879	chr11:48689978	FOLH1B	chr11:89392465-89431885:+	-0.44	-7.88	2.09E-14	HDL cholesterol	
KIRC	trans	1	rs12485307	chr3:178151010	USP10	chr16:84733555-84813525:+	0.57	5.93	5.68E-9	Plasma clusterin levels	
KIRC	trans	1	rs12515585	chr5:156430150	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.38	4.08E-10	Hypertriglyceridemia	
KIRC	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.58	12.43	4.04E-31	Educational attainment	
KIRC	trans	1	rs12533634	chr7:46361063	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs12536255	chr7:46360963	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs12616955	chr2:136902666	TMEM163	chr2:135213331-135525334:-	-0.33	-5.87	8.08E-9	Arthritis (juvenile idiopathic)	
KIRC	trans	1	rs12806328	chr11:48647971	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.03	7.07E-15	HDL cholesterol	
KIRC	trans	1	rs13067245	chr3:178130938	USP10	chr16:84733555-84813525:+	0.57	6.03	3.17E-9	Plasma clusterin levels	
KIRC	trans	1	rs13153099	chr5:156436195	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.27	7.59E-10	Hypertriglyceridemia	
KIRC	trans	1	rs13169155	chr5:156426663	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.4	3.47E-10	Hypertriglyceridemia	
KIRC	trans	1	rs13169465	chr5:156426916	LOC100101266	chr19:24344995-24346249:-	-0.36	-6.13	1.81E-9	Hypertriglyceridemia	
KIRC	trans	1	rs13169621	chr5:156426974	LOC100101266	chr19:24344995-24346249:-	-0.38	-6.43	2.92E-10	Hypertriglyceridemia	
KIRC	trans	1	rs13181803	chr5:156429177	LOC100101266	chr19:24344995-24346249:-	-0.38	-6.46	2.47E-10	Hypertriglyceridemia	
KIRC	trans	1	rs13200462	chr6:28218199	BTN3A2	chr6:26365398-26378546:+	-0.39	-6.53	1.59E-10	Depression	
KIRC	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.48	-10.07	7.39E-22	Educational attainment	
KIRC	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.56	12.06	1.43E-29	Educational attainment	
KIRC	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.56	12.22	3.09E-30	Educational attainment	
KIRC	trans	1	rs1351696	chr11:48382471	FOLH1B	chr11:89392465-89431885:+	-0.52	-5.99	4.07E-9	D-dimer levels	
KIRC	trans	1	rs1419183	chr6:28242794	BTN3A2	chr6:26365398-26378546:+	-0.41	-6.93	1.3E-11	Depression	
KIRC	trans	1	rs1459111	chr11:55256732	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs1481927	chr11:55978956	FOLH1B	chr11:89392465-89431885:+	0.41	6.72	4.86E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs1481928	chr11:56021934	FOLH1B	chr11:89392465-89431885:+	0.42	6.74	4.26E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.57	12.4	5.26E-31	Educational attainment	
KIRC	trans	1	rs1591882	chr1:121183313	NBPF14	chr1:148003643-148346791:-	0.4	10.33	8.57E-23	Hip geometry	
KIRC	trans	1	rs1605364	chr11:48684843	FOLH1B	chr11:89392465-89431885:+	-0.45	-7.9	1.72E-14	HDL cholesterol	
KIRC	trans	1	rs1679709	chr6:28228342	BTN3A2	chr6:26365398-26378546:+	0.4	6.8	2.9E-11	Depression	
KIRC	trans	1	rs1679732	chr6:28221264	BTN3A2	chr6:26365398-26378546:+	0.37	6.24	9.4E-10	Depression	
KIRC	trans	1	rs16899788	chr6:167431326	FBXL4	chr6:99321601-99395849:-	0.45	5.88	7.38E-9	Smooth-surface caries	
KIRC	trans	1	rs17018511	chr1:212277604	AGR3	chr7:16899031-16921613:-	0.59	8.12	3.65E-15	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	ALDH3B2	chr11:67429634-67448685:-	0.7	6.86	2.07E-11	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	ARHGAP36	chrX:130192216-130223856:+	0.58	7.48	3.41E-13	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	FOXA1	chr14:38059193-38064489:-	0.55	6.1	2.06E-9	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	FXYD3	chr19:35606732-35615227:+	0.54	6.28	7.42E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	GATA3	chr10:8096667-8117162:+	0.49	6	3.77E-9	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	KRT13	chr17:39657233-39661865:-	0.57	6.58	1.18E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	KRT4	chr12:53200334-53208335:-	0.57	7.1	4.26E-12	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	KRT5	chr12:52908361-52914243:-	0.61	6.53	1.59E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	KRT6A	chr12:52880959-52887181:-	0.6	6.95	1.15E-11	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	KRT6B	chr12:52840437-52845910:-	0.54	6.59	1.12E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	MAGEA3	chrX:151934653-151938240:-	0.47	6.26	8.48E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	PGLYRP2	chr19:15579459-15590315:-	0.62	7.05	6.08E-12	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	SCGB2A2	chr11:62037630-62040627:+	0.56	7.46	3.87E-13	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	SPRR3	chr1:152974223-152976332:+	0.59	7.47	3.5E-13	Temperament (bipolar disorder)	
KIRC	trans	1	rs17018511	chr1:212277604	TFF1	chr21:43782391-43786644:-	0.5	6.32	5.93E-10	Temperament (bipolar disorder)	
KIRC	trans	1	rs17172677	chr7:46356173	PAGE1	chrX:49452056-49460596:-	-0.22	-5.86	8.17E-9	Hypospadias	
KIRC	trans	1	rs17457391	chr2:216280006	GAGE12D	chrX:49227286-49332820:+;chrX	0.24	6.19	1.23E-9	Coronary heart disease	
KIRC	trans	1	rs17457391	chr2:216280006	GAGE2D	chrX:49197563-49223943:+;chrX	0.27	6.25	8.87E-10	Coronary heart disease	
KIRC	trans	1	rs17458018	chr2:216285375	GAGE12D	chrX:49227286-49332820:+;chrX	0.23	6.05	2.86E-9	Coronary heart disease	
KIRC	trans	1	rs17458018	chr2:216285375	GAGE2D	chrX:49197563-49223943:+;chrX	0.26	6.03	3.16E-9	Coronary heart disease	
KIRC	trans	1	rs17494102	chr11:55258196	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17494249	chr11:55258881	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17578479	chr11:55203672	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17578535	chr11:55204022	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17580938	chr11:55311980	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.87E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17581051	chr11:55314303	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17581337	chr11:55319882	FOLH1B	chr11:89392465-89431885:+	0.74	5.9	6.61E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs17641547	chr3:178129688	USP10	chr16:84733555-84813525:+	0.57	6.03	3.17E-9	Plasma clusterin levels	
KIRC	trans	1	rs17647474	chr3:178146631	USP10	chr16:84733555-84813525:+	0.56	5.96	4.84E-9	Plasma clusterin levels	
KIRC	trans	1	rs1778508	chr6:28229881	BTN3A2	chr6:26365398-26378546:+	0.39	6.76	3.91E-11	Depression	
KIRC	trans	1	rs1778511	chr6:28229411	BTN3A2	chr6:26365398-26378546:+	0.4	6.8	2.9E-11	Depression	
KIRC	trans	1	rs1809986	chr11:48987539	FOLH1B	chr11:89392465-89431885:+	-0.43	-7.52	2.59E-13	HDL cholesterol	
KIRC	trans	1	rs1814175	chr11:49559172	FOLH1B	chr11:89392465-89431885:+	-0.47	-8.59	1.13E-16	Height	
KIRC	trans	1	rs1832558	chr1:121177380	NBPF14	chr1:148003643-148346791:-	0.38	10	1.36E-21	Hip geometry	
KIRC	trans	1	rs1841165	chr11:55256084	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs1842701	chr11:55868142	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.68	6.56E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs1856572	chr1:121169579	NBPF14	chr1:148003643-148346791:-	0.39	10.05	9.01E-22	Hip geometry	
KIRC	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.56	12.28	1.68E-30	Educational attainment	
KIRC	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.57	12.36	8.37E-31	Educational attainment	
KIRC	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.57	12.36	8.37E-31	Educational attainment	
KIRC	trans	1	rs1886328	chr6:17635023	SLCO1A2	chr12:21417535-21548371:-	-0.41	-6	3.77E-9	Obesity-related traits	
KIRC	trans	1	rs1986111	chr1:121204788	NBPF14	chr1:148003643-148346791:-	0.4	10.27	1.43E-22	Hip geometry	
KIRC	trans	1	rs2035406	chr11:55834787	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.62	9.41E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2036402	chr5:156464242	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.29	6.89E-10	Hypertriglyceridemia	
KIRC	trans	1	rs2042591	chr11:55222990	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2056297	chr2:136899116	TMEM163	chr2:135213331-135525334:-	-0.33	-5.91	6.31E-9	Arthritis (juvenile idiopathic)	
KIRC	trans	1	rs2084385	chr3:196553867	LOC646214	chr15:21932514-21940739:-	-0.66	-10.03	1.08E-21	Total ventricular volume (Alzheimer's disease interaction)	
KIRC	trans	1	rs2128139	chr11:56049042	FOLH1B	chr11:89392465-89431885:+	0.43	7	8.38E-12	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2155029	chr11:55211811	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2185281	chr1:121179991	NBPF14	chr1:148003643-148346791:-	0.39	10.22	2.07E-22	Hip geometry	
KIRC	trans	1	rs2186595	chr11:55212033	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2194835	chr11:55237265	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs2216993	chr11:55236954	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2220004	chr11:55895745	FOLH1B	chr11:89392465-89431885:+	0.4	6.62	9.24E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2221559	chr11:48707973	FOLH1B	chr11:89392465-89431885:+	0.47	8.3	9.38E-16	HDL cholesterol	
KIRC	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.56	12.13	6.81E-30	Educational attainment	
KIRC	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.54	11.58	1.15E-27	Educational attainment	
KIRC	trans	1	rs2292239	chr12:56482180	RPS26P11	chrX:71264259-71264809:+	0.4	6.98	9.23E-12	Cognitive function	
KIRC	trans	1	rs2305983	chr11:47858755	FOLH1B	chr11:89392465-89431885:+	0.5	7.59	1.57E-13	Intraocular pressure	
KIRC	trans	1	rs2319969	chr1:121207335	NBPF14	chr1:148003643-148346791:-	0.38	9.92	2.67E-21	Hip geometry	
KIRC	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs2449149	chr11:55876260	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.71	5.16E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2460211	chr11:55894833	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.62	9.2E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2512777	chr11:55874680	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.67	6.72E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2512783	chr11:55895121	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.71	5.29E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2512789	chr11:55902211	FOLH1B	chr11:89392465-89431885:+	0.41	6.6	1.03E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs2705520	chr3:112269287	ATP6V1A	chr3:113465908-113530901:+	0.33	6.35	4.77E-10	Asthma (childhood onset)	
KIRC	trans	1	rs2705520	chr3:112269287	TFG	chr3:100428160-100467810:+	0.4	6.05	2.8E-9	Asthma (childhood onset)	
KIRC	trans	1	rs2799077	chr6:28234597	BTN3A2	chr6:26365398-26378546:+	-0.4	-6.8	2.9E-11	Depression	
KIRC	trans	1	rs2799079	chr6:28235176	BTN3A2	chr6:26365398-26378546:+	-0.38	-6.67	6.87E-11	Depression	
KIRC	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs28752322	chr11:54798443	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs2878332	chr11:54900383	FOLH1B	chr11:89392465-89431885:+	0.75	5.93	5.55E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28801085	chr11:54820624	FOLH1B	chr11:89392465-89431885:+	0.79	6.14	1.66E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28805394	chr11:54813776	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28809233	chr11:54824518	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28826070	chr11:54801549	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.15E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28839871	chr11:54800231	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28848478	chr11:54799302	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28871886	chr11:54822390	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs28897249	chr11:54814284	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.15E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs34099327	chr11:55305250	FOLH1B	chr11:89392465-89431885:+	0.74	5.89	7.16E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs34117728	chr5:156433497	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.27	7.87E-10	Hypertriglyceridemia	
KIRC	trans	1	rs34230359	chr5:156449561	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.28	7.28E-10	Hypertriglyceridemia	
KIRC	trans	1	rs34394199	chr3:178147392	USP10	chr16:84733555-84813525:+	0.56	5.96	4.84E-9	Plasma clusterin levels	
KIRC	trans	1	rs34409737	chr5:156457857	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.2	1.17E-9	Hypertriglyceridemia	
KIRC	trans	1	rs34563044	chr3:178130356	USP10	chr16:84733555-84813525:+	0.57	6.03	3.17E-9	Plasma clusterin levels	
KIRC	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs34865093	chr5:156424767	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.42	3.2E-10	Hypertriglyceridemia	
KIRC	trans	1	rs35159031	chr5:156475430	LOC100101266	chr19:24344995-24346249:-	-0.35	-6.16	1.49E-9	Hypertriglyceridemia	
KIRC	trans	1	rs35420803	chr3:178132062	USP10	chr16:84733555-84813525:+	0.57	5.97	4.38E-9	Plasma clusterin levels	
KIRC	trans	1	rs35632377	chr5:156436252	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.27	7.59E-10	Hypertriglyceridemia	
KIRC	trans	1	rs35868174	chr5:156425303	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.42	3.2E-10	Hypertriglyceridemia	
KIRC	trans	1	rs35968796	chr11:55305322	FOLH1B	chr11:89392465-89431885:+	0.74	5.89	7.1E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs35978031	chr3:178149122	USP10	chr16:84733555-84813525:+	0.56	5.96	4.84E-9	Plasma clusterin levels	
KIRC	trans	1	rs36002519	chr3:178133215	USP10	chr16:84733555-84813525:+	0.57	6.03	3.17E-9	Plasma clusterin levels	
KIRC	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs3949112	chr11:55212093	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs41266839	chr6:26409890	ZFP57	chr6:29640171-29648887:-	0.76	5.93	5.73E-9	Schizophrenia	
KIRC	trans	1	rs4341558	chr11:54869378	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs4367384	chr6:17667635	SLCO1A2	chr12:21417535-21548371:-	-0.44	-6.38	3.99E-10	Obesity-related traits	
KIRC	trans	1	rs4374747	chr5:156426239	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.4	3.52E-10	Hypertriglyceridemia	
KIRC	trans	1	rs4488212	chr11:55212096	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs4517536	chr11:54900569	FOLH1B	chr11:89392465-89431885:+	0.75	5.93	5.55E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs4537777	chr11:55241556	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.04E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs4578407	chr11:55937954	FOLH1B	chr11:89392465-89431885:+	0.4	6.57	1.26E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs4704729	chr5:156424516	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.42	3.2E-10	Hypertriglyceridemia	
KIRC	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.56	11.91	5.69E-29	Educational attainment	
KIRC	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.56	12.22	3.09E-30	Educational attainment	
KIRC	trans	1	rs4759229	chr12:56474480	RPS26P11	chrX:71264259-71264809:+	-0.39	-6.67	6.93E-11	Cognitive function	
KIRC	trans	1	rs4844380	chr1:121193620	NBPF14	chr1:148003643-148346791:-	0.39	10.02	1.11E-21	Hip geometry	
KIRC	trans	1	rs4844381	chr1:121184898	NBPF14	chr1:148003643-148346791:-	0.4	10.47	2.46E-23	Hip geometry	
KIRC	trans	1	rs4844381	chr1:121184898	NBPF9	chr1:144146807-145368682:+	0.2	5.9	6.57E-9	Hip geometry	
KIRC	trans	1	rs4844607	chr1:121184059	NBPF14	chr1:148003643-148346791:-	-0.4	-10.36	6.54E-23	Hip geometry	
KIRC	trans	1	rs4844616	chr1:121171208	NBPF14	chr1:148003643-148346791:-	0.39	10.25	1.57E-22	Hip geometry	
KIRC	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.56	12.26	2.01E-30	Educational attainment	
KIRC	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.09	4.59E-15	HDL cholesterol	
KIRC	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.11	3.8E-15	HDL cholesterol	
KIRC	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.37E-15	HDL cholesterol	
KIRC	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.43	7.59	1.55E-13	HDL cholesterol	
KIRC	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.19	2.19E-15	HDL cholesterol	
KIRC	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.11	3.8E-15	HDL cholesterol	
KIRC	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.37E-15	HDL cholesterol	
KIRC	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.37E-15	HDL cholesterol	
KIRC	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs4882132	chr11:48593125	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.02	7.58E-15	HDL cholesterol	
KIRC	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.14	3.21E-15	HDL cholesterol	
KIRC	trans	1	rs4925166	chr17:18210810	LOC162632	chr17:16614993-16707819:+	0.44	8.81	2.09E-17	Multiple sclerosis	
KIRC	trans	1	rs4929903	chr11:48913332	FOLH1B	chr11:89392465-89431885:+	-0.43	-7.7	7.34E-14	HDL cholesterol	
KIRC	trans	1	rs4939012	chr11:55795598	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.52	1.66E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs4939018	chr11:55816245	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.52	1.74E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs4939026	chr11:55942611	FOLH1B	chr11:89392465-89431885:+	0.4	6.57	1.26E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs4939541	chr11:55724385	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.22	1.05E-9	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs4954392	chr2:136901607	TMEM163	chr2:135213331-135525334:-	-0.33	-5.87	8.04E-9	Arthritis (juvenile idiopathic)	
KIRC	trans	1	rs5025344	chr11:55225024	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55647117	chr11:55340896	FOLH1B	chr11:89392465-89431885:+	0.73	5.93	5.68E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55657388	chr11:55203117	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55693437	chr11:54839081	FOLH1B	chr11:89392465-89431885:+	0.75	5.95	4.95E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55736192	chr11:55241123	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.04E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55744313	chr11:54872326	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs55895944	chr11:55241716	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.04E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs55899800	chr11:54810250	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56063920	chr11:55326249	FOLH1B	chr11:89392465-89431885:+	0.73	5.93	5.68E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56063922	chr11:55272853	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56080803	chr11:54821372	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56147666	chr11:55210551	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56189573	chr11:54810461	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56291726	chr11:55210585	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56299119	chr11:55328348	FOLH1B	chr11:89392465-89431885:+	0.73	5.93	5.68E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs56333107	chr11:55314754	FOLH1B	chr11:89392465-89431885:+	0.75	5.92	5.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs58893672	chr11:55308305	FOLH1B	chr11:89392465-89431885:+	0.75	5.93	5.65E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs60637555	chr3:178143977	USP10	chr16:84733555-84813525:+	0.56	5.96	4.84E-9	Plasma clusterin levels	
KIRC	trans	1	rs61894225	chr11:55344928	FOLH1B	chr11:89392465-89431885:+	0.73	5.94	5.38E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61894245	chr11:55351631	FOLH1B	chr11:89392465-89431885:+	0.73	5.94	5.38E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61894830	chr11:54978120	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.03E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61894831	chr11:54978139	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.03E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61895825	chr11:54808326	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61895829	chr11:54810489	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.15E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61895838	chr11:54819428	FOLH1B	chr11:89392465-89431885:+	0.76	5.95	5.02E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61895863	chr11:54901372	FOLH1B	chr11:89392465-89431885:+	0.75	5.93	5.55E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898062	chr11:54830140	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898066	chr11:54833565	FOLH1B	chr11:89392465-89431885:+	0.76	5.94	5.46E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898073	chr11:54840287	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898074	chr11:54842180	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898076	chr11:54847536	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898110	chr11:54858537	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898112	chr11:54859595	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898135	chr11:54873017	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898136	chr11:54873052	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898148	chr11:54880614	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61898150	chr11:54881308	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916282	chr11:55268646	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916283	chr11:55271200	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916284	chr11:55271500	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916285	chr11:55271681	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916289	chr11:55274279	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916395	chr11:55212505	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916403	chr11:55221229	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916407	chr11:55222470	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916410	chr11:55224869	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61916458	chr11:55234406	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61917926	chr11:55305160	FOLH1B	chr11:89392465-89431885:+	0.74	5.89	7.16E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61917963	chr11:55235759	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918002	chr11:55246517	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918003	chr11:55247690	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918004	chr11:55248982	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918005	chr11:55249242	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918007	chr11:55249435	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918253	chr11:55201447	FOLH1B	chr11:89392465-89431885:+	0.74	5.88	7.7E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61918258	chr11:55205398	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919576	chr11:55324892	FOLH1B	chr11:89392465-89431885:+	0.73	5.93	5.68E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919623	chr11:55334105	FOLH1B	chr11:89392465-89431885:+	0.74	5.91	6.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919672	chr11:55249834	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919673	chr11:55250375	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919674	chr11:55250427	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919677	chr11:55254510	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919682	chr11:55258253	FOLH1B	chr11:89392465-89431885:+	0.72	5.89	6.97E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs61919684	chr11:55259945	FOLH1B	chr11:89392465-89431885:+	0.71	5.89	7.2E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs62202764	chr2:216270146	GAGE12D	chrX:49227286-49332820:+;chrX	0.22	5.92	5.84E-9	Coronary heart disease	
KIRC	trans	1	rs62202764	chr2:216270146	GAGE2D	chrX:49197563-49223943:+;chrX	0.25	5.93	5.55E-9	Coronary heart disease	
KIRC	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.57	12.41	5.18E-31	Educational attainment	
KIRC	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.57	12.41	5.18E-31	Educational attainment	
KIRC	trans	1	rs6459561	chr6:17657651	SLCO1A2	chr12:21417535-21548371:-	-0.44	-6.37	4.29E-10	Obesity-related traits	
KIRC	trans	1	rs6485774	chr11:47773226	FOLH1B	chr11:89392465-89431885:+	0.5	7.69	7.72E-14	Intraocular pressure	
KIRC	trans	1	rs6485784	chr11:47832260	FOLH1B	chr11:89392465-89431885:+	0.49	7.57	1.85E-13	Intraocular pressure	
KIRC	trans	1	rs6485788	chr11:47873883	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.65	1.0E-13	Intraocular pressure	
KIRC	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.44	-7.84	2.64E-14	HDL cholesterol	
KIRC	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs6485882	chr11:48592435	FOLH1B	chr11:89392465-89431885:+	0.45	8.2	1.97E-15	HDL cholesterol	
KIRC	trans	1	rs6485888	chr11:48605339	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs6485903	chr11:48639004	FOLH1B	chr11:89392465-89431885:+	-0.44	-7.83	2.97E-14	HDL cholesterol	
KIRC	trans	1	rs6485907	chr11:48651695	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.06	5.58E-15	HDL cholesterol	
KIRC	trans	1	rs6485911	chr11:48654784	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.02	7.44E-15	HDL cholesterol	
KIRC	trans	1	rs6591721	chr11:55679983	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.47	2.31E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs6591833	chr11:55793961	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.44	2.82E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs6600669	chr1:121213639	NBPF14	chr1:148003643-148346791:-	0.4	10.05	9.07E-22	Hip geometry	
KIRC	trans	1	rs6600671	chr1:121200490	NBPF14	chr1:148003643-148346791:-	-0.37	-9.61	3.5E-20	Hip geometry	
KIRC	trans	1	rs66595819	chr11:55747554	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.48	2.15E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs68141011	chr6:28217797	BTN3A2	chr6:26365398-26378546:+	-0.39	-6.53	1.59E-10	Depression	
KIRC	trans	1	rs6862569	chr5:156466548	LOC100101266	chr19:24344995-24346249:-	-0.35	-6.25	8.64E-10	Hypertriglyceridemia	
KIRC	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.53	13.18	2.8E-34	Migraine without aura	
KIRC	trans	1	rs6901575	chr6:28250984	BTN3A2	chr6:26365398-26378546:+	-0.42	-7.11	3.94E-12	Depression	
KIRC	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.55	11.71	3.66E-28	Educational attainment	
KIRC	trans	1	rs6905391	chr6:28262686	BTN3A2	chr6:26365398-26378546:+	-0.34	-6.14	1.65E-9	Depression	
KIRC	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.55	11.9	5.89E-29	Educational attainment	
KIRC	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.55	-11.86	9.15E-29	Educational attainment	
KIRC	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.11E-30	Educational attainment	
KIRC	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.56	11.94	4.35E-29	Educational attainment	
KIRC	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.11E-30	Educational attainment	
KIRC	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.54	11.6	1.03E-27	Educational attainment	
KIRC	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.56	12.13	6.81E-30	Educational attainment	
KIRC	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.11E-30	Educational attainment	
KIRC	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.56	12.22	3.09E-30	Educational attainment	
KIRC	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.07E-30	Educational attainment	
KIRC	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.02E-30	Educational attainment	
KIRC	trans	1	rs6949328	chr7:46361428	PAGE1	chrX:49452056-49460596:-	0.22	5.89	7.27E-9	Hypospadias	
KIRC	trans	1	rs6949826	chr7:46361603	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs705696	chr12:56480648	RPS26P11	chrX:71264259-71264809:+	0.41	6.72	4.89E-11	Cognitive function	
KIRC	trans	1	rs7101582	chr11:47714610	FOLH1B	chr11:89392465-89431885:+	0.48	7.3	1.17E-12	Intraocular pressure	
KIRC	trans	1	rs7103342	chr11:55268805	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7106100	chr11:55219382	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7106787	chr11:55823576	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.76	3.81E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.11	3.8E-15	HDL cholesterol	
KIRC	trans	1	rs7109287	chr11:55219432	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7111663	chr11:55218922	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7111681	chr11:55218978	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7116208	chr11:55212816	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7119347	chr11:55270585	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7120068	chr11:55753271	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.39	3.84E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.11	3.85E-15	HDL cholesterol	
KIRC	trans	1	rs7121555	chr11:55268934	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7121974	chr11:55821038	FOLH1B	chr11:89392465-89431885:+	-0.41	-6.66	7.43E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.15	2.96E-15	HDL cholesterol	
KIRC	trans	1	rs7124992	chr11:55960545	FOLH1B	chr11:89392465-89431885:+	0.41	6.71	5.21E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7125559	chr11:48984207	FOLH1B	chr11:89392465-89431885:+	0.53	5.96	4.8E-9	Axial length	
KIRC	trans	1	rs7125913	chr11:48984318	FOLH1B	chr11:89392465-89431885:+	0.53	5.96	4.8E-9	Axial length	
KIRC	trans	1	rs7128214	chr11:56025759	FOLH1B	chr11:89392465-89431885:+	0.42	6.78	3.3E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs7130869	chr11:55688691	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.48	2.24E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7131020	chr11:48642132	FOLH1B	chr11:89392465-89431885:+	0.52	6.15	1.59E-9	Axial length	
KIRC	trans	1	rs72843784	chr6:26498758	ZFP57	chr6:29640171-29648887:-	0.74	5.95	5.06E-9	Schizophrenia	
KIRC	trans	1	rs735765	chr6:28170297	BTN3A2	chr6:26365398-26378546:+	-0.48	-7.72	6.17E-14	Depression	
KIRC	trans	1	rs7395662	chr11:48518893	FOLH1B	chr11:89392465-89431885:+	0.46	8.29	1.05E-15	HDL cholesterol	
KIRC	trans	1	rs747782	chr11:47940925	FOLH1B	chr11:89392465-89431885:+	0.52	7.57	1.82E-13	Intraocular pressure	
KIRC	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.18	2.38E-15	HDL cholesterol	
KIRC	trans	1	rs7479134	chr11:48625409	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.14	3.21E-15	HDL cholesterol	
KIRC	trans	1	rs7479498	chr11:48660499	FOLH1B	chr11:89392465-89431885:+	-0.47	-8.45	3.25E-16	HDL cholesterol	
KIRC	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.15	2.96E-15	HDL cholesterol	
KIRC	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.16	2.74E-15	HDL cholesterol	
KIRC	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.45	-7.95	1.22E-14	HDL cholesterol	
KIRC	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.45	-7.96	1.15E-14	HDL cholesterol	
KIRC	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs7532615	chr1:121172840	NBPF14	chr1:148003643-148346791:-	-0.38	-9.98	1.62E-21	Hip geometry	
KIRC	trans	1	rs75524009	chr7:46353778	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs76046642	chr11:55225417	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs76329678	chr5:49830286	LOC647121	chr1:121260910-121313686:+	-0.4	-12.94	2.98E-33	Schizophrenia	
KIRC	trans	1	rs76515019	chr11:54842025	FOLH1B	chr11:89392465-89431885:+	0.76	5.96	4.82E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.56	12.13	6.81E-30	Educational attainment	
KIRC	trans	1	rs7719994	chr5:156430076	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.38	4.08E-10	Hypertriglyceridemia	
KIRC	trans	1	rs7740055	chr6:17664410	SLCO1A2	chr12:21417535-21548371:-	-0.41	-6.02	3.3E-9	Obesity-related traits	
KIRC	trans	1	rs7740487	chr6:28216486	BTN3A2	chr6:26365398-26378546:+	-0.39	-6.58	1.17E-10	Depression	
KIRC	trans	1	rs7764502	chr6:38366137	ESRP1	chr8:95653364-95719692:+	0.31	5.91	6.37E-9	Restless legs syndrome	
KIRC	trans	1	rs7789251	chr7:46357110	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs78414330	chr11:55252243	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7924699	chr11:47893120	FOLH1B	chr11:89392465-89431885:+	0.44	6.83	2.48E-11	Intraocular pressure	
KIRC	trans	1	rs7924882	chr11:55222061	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7925738	chr11:55828756	FOLH1B	chr11:89392465-89431885:+	-0.39	-6.44	2.8E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7925955	chr11:48647533	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.02	7.68E-15	HDL cholesterol	
KIRC	trans	1	rs7927738	chr11:55251545	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs79277988	chr11:55224325	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs7929606	chr11:55275236	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs7935265	chr11:55977308	FOLH1B	chr11:89392465-89431885:+	0.41	6.68	6.41E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7935599	chr11:55251546	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7936124	chr11:55701661	FOLH1B	chr11:89392465-89431885:+	-0.38	-6.45	2.67E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7938880	chr11:48642154	FOLH1B	chr11:89392465-89431885:+	-0.44	-7.89	1.98E-14	HDL cholesterol	
KIRC	trans	1	rs7939774	chr11:56019461	FOLH1B	chr11:89392465-89431885:+	0.42	6.79	3.11E-11	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs7940435	chr11:55274969	FOLH1B	chr11:89392465-89431885:+	0.72	5.87	8.03E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7940928	chr11:55217478	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7941860	chr11:55270188	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7942031	chr11:47868474	FOLH1B	chr11:89392465-89431885:+	0.5	7.71	6.89E-14	Intraocular pressure	
KIRC	trans	1	rs7943676	chr11:55251205	FOLH1B	chr11:89392465-89431885:+	0.72	5.88	7.49E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7944356	chr11:48610154	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.08	4.75E-15	HDL cholesterol	
KIRC	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs7946976	chr11:55206920	FOLH1B	chr11:89392465-89431885:+	0.73	5.86	8.44E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7948486	chr11:48912140	FOLH1B	chr11:89392465-89431885:+	0.44	7.75	5.32E-14	HDL cholesterol	
KIRC	trans	1	rs7948802	chr11:55217012	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.45	-8.09	4.58E-15	HDL cholesterol	
KIRC	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.46	-8.15	2.93E-15	HDL cholesterol	
KIRC	trans	1	rs7950755	chr11:55269990	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs7950964	chr11:55846641	FOLH1B	chr11:89392465-89431885:+	-0.4	-6.55	1.39E-10	Odorant perception (&beta;-damascenone)	
KIRC	trans	1	rs79633274	chr11:55224396	FOLH1B	chr11:89392465-89431885:+	0.71	5.87	7.75E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs80054684	chr7:46353527	PAGE1	chrX:49452056-49460596:-	0.22	5.87	7.77E-9	Hypospadias	
KIRC	trans	1	rs8070473	chr17:33843512	RRS1	chr8:67341263-67342966:+	-0.34	-6.06	2.71E-9	Depression (quantitative trait)	
KIRC	trans	1	rs8188963	chr11:48685693	FOLH1B	chr11:89392465-89431885:+	0.54	6.18	1.34E-9	Axial length	
KIRC	trans	1	rs8189391	chr11:48859789	FOLH1B	chr11:89392465-89431885:+	0.45	7.93	1.47E-14	HDL cholesterol	
KIRC	trans	1	rs853676	chr6:28299687	BTN3A2	chr6:26365398-26378546:+	-0.36	-6.51	1.84E-10	Depression	
KIRC	trans	1	rs853678	chr6:28297313	BTN3A2	chr6:26365398-26378546:+	-0.34	-6.14	1.64E-9	Depression	
KIRC	trans	1	rs853679	chr6:28296863	BTN3A2	chr6:26365398-26378546:+	-0.34	-6.14	1.64E-9	Depression	
KIRC	trans	1	rs853685	chr6:28288785	BTN3A2	chr6:26365398-26378546:+	-0.34	-5.95	4.95E-9	Depression	
KIRC	trans	1	rs853694	chr6:28279100	BTN3A2	chr6:26365398-26378546:+	-0.34	-6.01	3.5E-9	Depression	
KIRC	trans	1	rs868530	chr5:156430916	LOC100101266	chr19:24344995-24346249:-	-0.37	-6.32	5.78E-10	Hypertriglyceridemia	
KIRC	trans	1	rs877636	chr12:56480583	RPS26P11	chrX:71264259-71264809:+	-0.44	-7.69	7.73E-14	Cognitive function	
KIRC	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.54	-11.53	1.98E-27	Educational attainment	
KIRC	trans	1	rs9350052	chr6:17664172	SLCO1A2	chr12:21417535-21548371:-	-0.41	-5.97	4.41E-9	Obesity-related traits	
KIRC	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.54	11.59	1.06E-27	Educational attainment	
KIRC	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.55	11.84	1.1E-28	Educational attainment	
KIRC	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.56	12.13	6.81E-30	Educational attainment	
KIRC	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.54	11.59	1.05E-27	Educational attainment	
KIRC	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.54	11.62	8.52E-28	Educational attainment	
KIRC	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.56	12.1	9.82E-30	Educational attainment	
KIRC	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.56	-12	2.38E-29	Educational attainment	
KIRC	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.56	12.32	1.2E-30	Educational attainment	
KIRC	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.55	11.8	1.57E-28	Educational attainment	
KIRC	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.56	12.13	6.81E-30	Educational attainment	
KIRC	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.56	-11.93	4.59E-29	Educational attainment	
KIRC	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.57	12.36	8.37E-31	Educational attainment	
KIRC	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.57	12.36	8.37E-31	Educational attainment	
KIRC	trans	1	rs953387	chr2:136907170	TMEM163	chr2:135213331-135525334:-	-0.33	-5.87	8.08E-9	Arthritis (juvenile idiopathic)	
KIRC	trans	1	rs9538439	chr13:60066560	TFF1	chr21:43782391-43786644:-	0.31	6.15	1.61E-9	Delta-6 desaturase activity	
KIRC	trans	1	rs9645642	chr11:48705455	FOLH1B	chr11:89392465-89431885:+	-0.45	-7.93	1.4E-14	HDL cholesterol	
KIRC	trans	1	rs9666022	chr11:54871984	FOLH1B	chr11:89392465-89431885:+	0.75	5.94	5.32E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs9666121	chr11:55272448	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs9666612	chr11:54876280	FOLH1B	chr11:89392465-89431885:+	0.75	5.91	6.27E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs9667732	chr11:55272520	FOLH1B	chr11:89392465-89431885:+	0.72	5.86	8.34E-9	Systemic lupus erythematosus	
KIRC	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.57	12.33	1.05E-30	Educational attainment	
KIRC	trans	1	rs9986596	chr6:28219661	BTN3A2	chr6:26365398-26378546:+	-0.39	-6.53	1.59E-10	Depression	
